,lab_id,norm_type,plate_num,plate_row,assay_version_id,plate_col,optical_density,conc,inhibitor,map_version_id
0,10004,Blank 490,1,A,OHSU_HNSCC_derm002,1,-0.009,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
1,10004,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.532,10,Lucitanib ,OHSU_HNSCC_derm002
2,10004,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.51,10,Resveratrol,OHSU_HNSCC_derm002
3,10004,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.357,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
4,10004,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.432,10,Bicalutamide,OHSU_HNSCC_derm002
5,10004,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.518,10,Methotrexate ,OHSU_HNSCC_derm002
6,10004,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.255,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
7,10004,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.145,10,Gefitinib,OHSU_HNSCC_derm002
8,10004,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.286,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
9,10004,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.292,10,Tamatinib/R406,OHSU_HNSCC_derm002
10,10004,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.07,10,Bosutinib,OHSU_HNSCC_derm002
11,10004,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.06,10,PI-103,OHSU_HNSCC_derm002
12,10004,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.41,10,Glycyrrhizin,OHSU_HNSCC_derm002
13,10004,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.448,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
14,10004,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.394,10,GSK-690693,OHSU_HNSCC_derm002
15,10004,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.244,10,Ibrutinib,OHSU_HNSCC_derm002
16,10004,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.044,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
17,10004,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.661,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
18,10004,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.671,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
19,10004,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.239,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
20,10004,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.684,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
21,10004,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.556,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
22,10004,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
23,10004,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.237,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
24,10004,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.579,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
25,10004,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.53,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
26,10004,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.422,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
27,10004,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.063,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
28,10004,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.708,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
29,10004,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.658,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
30,10004,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.577,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
31,10004,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.256,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
32,10004,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.115,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
33,10004,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.718,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
34,10004,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.73,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
35,10004,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.199,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
36,10004,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.733,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
37,10004,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.598,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
38,10004,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.336,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
39,10004,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.243,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
40,10004,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.727,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
41,10004,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.632,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
42,10004,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.724,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
43,10004,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.133,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
44,10004,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.731,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
45,10004,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.725,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
46,10004,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.758,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
47,10004,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.21,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
48,10004,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.165,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
49,10004,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.671,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
50,10004,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.719,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
51,10004,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.191,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
52,10004,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.711,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
53,10004,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.585,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
54,10004,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.501,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
55,10004,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.23,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
56,10004,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
57,10004,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.651,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
58,10004,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.798,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
59,10004,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.228,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
60,10004,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.724,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
61,10004,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.723,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
62,10004,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.779,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
63,10004,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.252,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
64,10004,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.286,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
65,10004,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.659,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
66,10004,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.723,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
67,10004,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.205,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
68,10004,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.704,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
69,10004,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.639,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
70,10004,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.58,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
71,10004,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.308,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
72,10004,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.725,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
73,10004,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.645,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
74,10004,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.76,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
75,10004,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.516,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
76,10004,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.712,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
77,10004,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.691,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
78,10004,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.832,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
79,10004,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.445,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
80,10004,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.465,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
81,10004,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.698,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
82,10004,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.726,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
83,10004,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.287,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
84,10004,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.752,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
85,10004,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.711,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
86,10004,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.68,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
87,10004,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.516,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
88,10004,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
89,10004,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.639,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
90,10004,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.739,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
91,10004,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.612,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
92,10004,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.758,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
93,10004,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.757,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
94,10004,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.799,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
95,10004,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.444,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
96,10004,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.54,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
97,10004,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.663,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
98,10004,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.669,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
99,10004,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.351,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
100,10004,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.781,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
101,10004,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.689,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
102,10004,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.712,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
103,10004,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.609,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
104,10004,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.702,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
105,10004,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.64,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
106,10004,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.744,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
107,10004,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.667,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
108,10004,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.685,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
109,10004,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.68,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
110,10004,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.797,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
111,10004,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.606,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
112,10004,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.487,0,NONE,OHSU_HNSCC_derm002
113,10004,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.674,0,NONE,OHSU_HNSCC_derm002
114,10004,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.71,0,NONE,OHSU_HNSCC_derm002
115,10004,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.727,0,NONE,OHSU_HNSCC_derm002
116,10004,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.712,0,NONE,OHSU_HNSCC_derm002
117,10004,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
118,10004,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.715,0,NONE,OHSU_HNSCC_derm002
119,10004,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.006,10,F-S-V,OHSU_HNSCC_derm002
120,10004,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.693,0,NONE,OHSU_HNSCC_derm002
121,10004,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.682,0,NONE,OHSU_HNSCC_derm002
122,10004,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
123,10004,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.688,0,NONE,OHSU_HNSCC_derm002
124,10004,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.647,0,NONE,OHSU_HNSCC_derm002
125,10004,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.717,0,NONE,OHSU_HNSCC_derm002
126,10004,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.821,0,NONE,OHSU_HNSCC_derm002
127,10004,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.66,0,NONE,OHSU_HNSCC_derm002
128,10004,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.004,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
129,10004,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.416,10,Sorafenib,OHSU_HNSCC_derm002
130,10004,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.741,10,Rosmarinic acid,OHSU_HNSCC_derm002
131,10004,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.496,10,Rapamycin,OHSU_HNSCC_derm002
132,10004,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.69,10,Vismodegib,OHSU_HNSCC_derm002
133,10004,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.161,10,PP242,OHSU_HNSCC_derm002
134,10004,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.62,10,Alectinib,OHSU_HNSCC_derm002
135,10004,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.303,10,Brigatinib,OHSU_HNSCC_derm002
136,10004,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.267,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
137,10004,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.587,10,MK-2206,OHSU_HNSCC_derm002
138,10004,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.245,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
139,10004,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.003,10,Flavopiridol ,OHSU_HNSCC_derm002
140,10004,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.682,10,Indirubin,OHSU_HNSCC_derm002
141,10004,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.616,10,PF-533228,OHSU_HNSCC_derm002
142,10004,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.853,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
143,10004,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.03,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
144,10004,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.011,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
145,10004,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.657,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
146,10004,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.743,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
147,10004,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.497,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
148,10004,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.717,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
149,10004,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.194,3.3333333333333335,PP242,OHSU_HNSCC_derm002
150,10004,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.462,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
151,10004,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.405,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
152,10004,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.256,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
153,10004,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.597,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
154,10004,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.247,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
155,10004,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.005,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
156,10004,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.681,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
157,10004,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.659,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
158,10004,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.797,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
159,10004,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.335,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
160,10004,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.014,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
161,10004,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.71,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
162,10004,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.732,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
163,10004,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.528,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
164,10004,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.698,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
165,10004,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.318,1.1111111111111112,PP242,OHSU_HNSCC_derm002
166,10004,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.55,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
167,10004,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.581,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
168,10004,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.231,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
169,10004,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.619,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
170,10004,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.244,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
171,10004,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.001,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
172,10004,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.761,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
173,10004,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.745,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
174,10004,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.77,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
175,10004,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.265,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
176,10004,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.026,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
177,10004,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.726,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
178,10004,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.707,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
179,10004,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.529,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
180,10004,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.731,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
181,10004,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.433,0.3703703703703704,PP242,OHSU_HNSCC_derm002
182,10004,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.671,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
183,10004,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.58,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
184,10004,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.231,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
185,10004,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.652,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
186,10004,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.257,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
187,10004,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.002,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
188,10004,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.736,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
189,10004,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.726,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
190,10004,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.759,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
191,10004,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.566,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
192,10004,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.074,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
193,10004,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.665,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
194,10004,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.738,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
195,10004,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.558,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
196,10004,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.739,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
197,10004,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.607,0.1234567901234568,PP242,OHSU_HNSCC_derm002
198,10004,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.703,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
199,10004,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.611,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
200,10004,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.24,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
201,10004,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.68,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
202,10004,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.33,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
203,10004,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.312,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
204,10004,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.723,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
205,10004,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.713,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
206,10004,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.816,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
207,10004,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.686,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
208,10004,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.337,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
209,10004,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.706,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
210,10004,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
211,10004,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.53,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
212,10004,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.702,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
213,10004,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.685,0.0411522633744856,PP242,OHSU_HNSCC_derm002
214,10004,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.696,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
215,10004,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.625,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
216,10004,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.233,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
217,10004,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.683,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
218,10004,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.466,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
219,10004,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.552,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
220,10004,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.685,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
221,10004,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
222,10004,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.738,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
223,10004,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.715,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
224,10004,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.536,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
225,10004,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.684,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
226,10004,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.745,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
227,10004,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.593,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
228,10004,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.687,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
229,10004,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,PP242,OHSU_HNSCC_derm002
230,10004,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.671,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
231,10004,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.675,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
232,10004,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.305,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
233,10004,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.638,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
234,10004,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.605,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
235,10004,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.653,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
236,10004,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.674,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
237,10004,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.729,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
238,10004,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.81,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
239,10004,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.704,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
240,10004,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.537,0,NONE,OHSU_HNSCC_derm002
241,10004,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.723,0,NONE,OHSU_HNSCC_derm002
242,10004,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.729,0,NONE,OHSU_HNSCC_derm002
243,10004,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.697,0,NONE,OHSU_HNSCC_derm002
244,10004,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.743,0,NONE,OHSU_HNSCC_derm002
245,10004,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.671,0,NONE,OHSU_HNSCC_derm002
246,10004,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.717,0,NONE,OHSU_HNSCC_derm002
247,10004,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.006,10,F-S-V,OHSU_HNSCC_derm002
248,10004,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.658,0,NONE,OHSU_HNSCC_derm002
249,10004,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.683,0,NONE,OHSU_HNSCC_derm002
250,10004,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.704,0,NONE,OHSU_HNSCC_derm002
251,10004,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.688,0,NONE,OHSU_HNSCC_derm002
252,10004,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.695,0,NONE,OHSU_HNSCC_derm002
253,10004,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.691,0,NONE,OHSU_HNSCC_derm002
254,10004,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.762,0,NONE,OHSU_HNSCC_derm002
255,10004,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.756,0,NONE,OHSU_HNSCC_derm002
256,10004,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.478,10,Emodin,OHSU_HNSCC_derm002
257,10004,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.591,10,Baicalin,OHSU_HNSCC_derm002
258,10004,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.146,10,NVP-TAE-684,OHSU_HNSCC_derm002
259,10004,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.016,10,Panobinostat,OHSU_HNSCC_derm002
260,10004,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.094,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
261,10004,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.647,10,Fulvestrant,OHSU_HNSCC_derm002
262,10004,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.199,10,SCH-772984,OHSU_HNSCC_derm002
263,10004,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.148,10,Trametinib,OHSU_HNSCC_derm002
264,10004,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.173,10,BEZ235,OHSU_HNSCC_derm002
265,10004,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.612,10,MLN120B,OHSU_HNSCC_derm002
266,10004,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.218,10,Ixabepilone,OHSU_HNSCC_derm002
267,10004,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.003,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
268,10004,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.231,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
269,10004,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.326,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
270,10004,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.388,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
271,10004,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.526,10,Letrozole,OHSU_HNSCC_derm002
272,10004,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.539,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
273,10004,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.679,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
274,10004,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.546,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
275,10004,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.023,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
276,10004,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.128,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
277,10004,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.648,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
278,10004,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.204,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
279,10004,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.219,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
280,10004,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.172,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
281,10004,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.601,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
282,10004,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.217,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
283,10004,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.219,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
284,10004,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.297,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
285,10004,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.406,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
286,10004,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.419,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
287,10004,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.598,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
288,10004,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.519,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
289,10004,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.699,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
290,10004,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.641,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
291,10004,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.071,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
292,10004,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.142,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
293,10004,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.672,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
294,10004,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.304,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
295,10004,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.189,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
296,10004,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.201,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
297,10004,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.657,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
298,10004,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.214,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
299,10004,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.236,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
300,10004,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.354,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
301,10004,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.448,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
302,10004,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.451,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
303,10004,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.62,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
304,10004,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.451,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
305,10004,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.636,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
306,10004,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.614,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
307,10004,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.138,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
308,10004,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.235,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
309,10004,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.714,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
310,10004,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.461,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
311,10004,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.221,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
312,10004,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.236,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
313,10004,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.642,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
314,10004,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.221,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
315,10004,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.222,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
316,10004,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.37,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
317,10004,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.441,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
318,10004,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.436,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
319,10004,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.625,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
320,10004,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.495,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
321,10004,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.628,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
322,10004,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.637,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
323,10004,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.169,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
324,10004,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.372,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
325,10004,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.706,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
326,10004,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.563,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
327,10004,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.219,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
328,10004,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.353,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
329,10004,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.699,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
330,10004,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.279,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
331,10004,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.275,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
332,10004,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.425,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
333,10004,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.466,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
334,10004,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.433,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
335,10004,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.633,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
336,10004,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.485,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
337,10004,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.66,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
338,10004,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.7,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
339,10004,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.263,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
340,10004,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.599,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
341,10004,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.667,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
342,10004,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.645,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
343,10004,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.293,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
344,10004,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.637,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
345,10004,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.689,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
346,10004,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.354,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
347,10004,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.325,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
348,10004,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.517,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
349,10004,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.633,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
350,10004,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.401,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
351,10004,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.5,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
352,10004,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.483,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
353,10004,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.652,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
354,10004,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.683,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
355,10004,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.499,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
356,10004,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.671,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
357,10004,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.722,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
358,10004,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.681,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
359,10004,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.353,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
360,10004,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.692,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
361,10004,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.7,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
362,10004,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.433,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
363,10004,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
364,10004,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.584,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
365,10004,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.729,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
366,10004,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.434,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
367,10004,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.456,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
368,10004,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.589,0,NONE,OHSU_HNSCC_derm002
369,10004,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.502,0,NONE,OHSU_HNSCC_derm002
370,10004,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
371,10004,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.514,0,NONE,OHSU_HNSCC_derm002
372,10004,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
373,10004,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.43,0,NONE,OHSU_HNSCC_derm002
374,10004,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.444,0,NONE,OHSU_HNSCC_derm002
375,10004,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.514,0,NONE,OHSU_HNSCC_derm002
376,10004,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.476,0,NONE,OHSU_HNSCC_derm002
377,10004,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.513,0,NONE,OHSU_HNSCC_derm002
378,10004,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.437,0,NONE,OHSU_HNSCC_derm002
379,10004,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.399,0,NONE,OHSU_HNSCC_derm002
380,10004,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.404,0,NONE,OHSU_HNSCC_derm002
381,10004,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
382,10004,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.42,0,NONE,OHSU_HNSCC_derm002
383,10004,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.504,0,NONE,OHSU_HNSCC_derm002
384,10004,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.633,10,Coumarin,OHSU_HNSCC_derm002
385,10004,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.099,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
386,10004,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.123,10,Foretinib (XL-880),OHSU_HNSCC_derm002
387,10004,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.74,10,Elesclomol,OHSU_HNSCC_derm002
388,10004,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.429,10,Vemurafenib,OHSU_HNSCC_derm002
389,10004,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.15,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
390,10004,Blank 490,2,G,OHSU_HNSCC_derm002,1,-0.003,10,Ponatinib,OHSU_HNSCC_derm002
391,10004,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.245,10,Gefitinib,OHSU_HNSCC_derm002
392,10004,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.303,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
393,10004,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.613,1,Sunitinib (1mM),OHSU_HNSCC_derm002
394,10004,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.628,10,Curcumin,OHSU_HNSCC_derm002
395,10004,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.048,10,PF-562271,OHSU_HNSCC_derm002
396,10004,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.535,10,STO609,OHSU_HNSCC_derm002
397,10004,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.433,10,Lenvatinib,OHSU_HNSCC_derm002
398,10004,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.146,10,Entrectinib,OHSU_HNSCC_derm002
399,10004,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.677,10,Ethyl Gallate ,OHSU_HNSCC_derm002
400,10004,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.62,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
401,10004,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.297,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
402,10004,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.366,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
403,10004,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.639,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
404,10004,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.588,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
405,10004,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.154,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
406,10004,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.115,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
407,10004,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.241,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
408,10004,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.59,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
409,10004,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.646,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
410,10004,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.71,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
411,10004,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.585,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
412,10004,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.582,3.3333333333333335,STO609,OHSU_HNSCC_derm002
413,10004,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.688,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
414,10004,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.645,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
415,10004,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.605,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
416,10004,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.603,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
417,10004,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.263,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
418,10004,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.649,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
419,10004,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.585,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
420,10004,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.632,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
421,10004,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.139,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
422,10004,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.74,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
423,10004,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.261,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
424,10004,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.662,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
425,10004,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.683,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
426,10004,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.696,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
427,10004,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.65,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
428,10004,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.873,1.1111111111111112,STO609,OHSU_HNSCC_derm002
429,10004,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.788,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
430,10004,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.767,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
431,10004,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.735,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
432,10004,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.606,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
433,10004,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.221,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
434,10004,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.64,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
435,10004,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.484,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
436,10004,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
437,10004,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.261,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
438,10004,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.737,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
439,10004,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.261,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
440,10004,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
441,10004,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.696,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
442,10004,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.681,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
443,10004,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.739,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
444,10004,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.772,0.3703703703703704,STO609,OHSU_HNSCC_derm002
445,10004,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.631,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
446,10004,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.598,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
447,10004,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.763,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
448,10004,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.587,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
449,10004,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.235,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
450,10004,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.627,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
451,10004,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.499,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
452,10004,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.753,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
453,10004,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.401,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
454,10004,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.768,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
455,10004,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.458,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
456,10004,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.684,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
457,10004,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.691,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
458,10004,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.704,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
459,10004,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.718,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
460,10004,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.692,0.1234567901234568,STO609,OHSU_HNSCC_derm002
461,10004,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.676,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
462,10004,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.642,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
463,10004,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.739,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
464,10004,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.583,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
465,10004,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.269,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
466,10004,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.599,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
467,10004,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.399,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
468,10004,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.783,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
469,10004,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.637,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
470,10004,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.763,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
471,10004,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.599,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
472,10004,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.686,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
473,10004,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.689,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
474,10004,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
475,10004,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.681,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
476,10004,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.795,0.0411522633744856,STO609,OHSU_HNSCC_derm002
477,10004,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.721,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
478,10004,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.678,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
479,10004,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.773,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
480,10004,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.565,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
481,10004,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.399,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
482,10004,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.715,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
483,10004,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.609,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
484,10004,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.79,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
485,10004,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.744,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
486,10004,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.803,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
487,10004,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.653,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
488,10004,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.31,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
489,10004,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.26,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
490,10004,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.745,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
491,10004,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.692,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
492,10004,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.778,0.013717421124828532,STO609,OHSU_HNSCC_derm002
493,10004,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.705,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
494,10004,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.802,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
495,10004,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.824,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
496,10004,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.541,0,NONE,OHSU_HNSCC_derm002
497,10004,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.689,0,NONE,OHSU_HNSCC_derm002
498,10004,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.799,0,NONE,OHSU_HNSCC_derm002
499,10004,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.691,0,NONE,OHSU_HNSCC_derm002
500,10004,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.79,0,NONE,OHSU_HNSCC_derm002
501,10004,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.785,0,NONE,OHSU_HNSCC_derm002
502,10004,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.28,0,NONE,OHSU_HNSCC_derm002
503,10004,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
504,10004,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.6,0,NONE,OHSU_HNSCC_derm002
505,10004,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.705,0,NONE,OHSU_HNSCC_derm002
506,10004,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
507,10004,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
508,10004,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.767,0,NONE,OHSU_HNSCC_derm002
509,10004,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.683,0,NONE,OHSU_HNSCC_derm002
510,10004,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.744,0,NONE,OHSU_HNSCC_derm002
511,10004,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.755,0,NONE,OHSU_HNSCC_derm002
512,10004,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.092,10,GDC-0941,OHSU_HNSCC_derm002
513,10004,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.674,10,Dovitinib,OHSU_HNSCC_derm002
514,10004,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.401,10,BI-2536,OHSU_HNSCC_derm002
515,10004,Blank 490,2,D,OHSU_HNSCC_derm002,9,-0.001,10,TP-0903 ,OHSU_HNSCC_derm002
516,10004,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.083,10,Belinostat,OHSU_HNSCC_derm002
517,10004,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.068,10,INK-128,OHSU_HNSCC_derm002
518,10004,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.106,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
519,10004,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.272,10,Brigatinib,OHSU_HNSCC_derm002
520,10004,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.037,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
521,10004,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.054,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
522,10004,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.464,10,Pazopanib,OHSU_HNSCC_derm002
523,10004,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.745,10,AZD4547,OHSU_HNSCC_derm002
524,10004,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.732,10,Pomalidomide ,OHSU_HNSCC_derm002
525,10004,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.57,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
526,10004,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.673,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
527,10004,Blank 490,2,P,OHSU_HNSCC_derm002,9,-0.008,10,Staurosporin,OHSU_HNSCC_derm002
528,10004,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.088,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
529,10004,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.641,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
530,10004,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.619,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
531,10004,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.009,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
532,10004,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.125,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
533,10004,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.098,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
534,10004,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.12,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
535,10004,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.422,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
536,10004,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.29,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
537,10004,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.28,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
538,10004,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.596,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
539,10004,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.647,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
540,10004,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.762,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
541,10004,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.679,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
542,10004,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.834,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
543,10004,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.004,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
544,10004,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.189,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
545,10004,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.68,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
546,10004,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.622,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
547,10004,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.009,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
548,10004,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.261,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
549,10004,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.137,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
550,10004,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.134,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
551,10004,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.525,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
552,10004,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.218,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
553,10004,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.369,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
554,10004,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.736,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
555,10004,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.719,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
556,10004,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.73,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
557,10004,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.655,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
558,10004,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.799,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
559,10004,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.01,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
560,10004,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.342,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
561,10004,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.812,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
562,10004,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.492,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
563,10004,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.397,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
564,10004,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.43,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
565,10004,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.176,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
566,10004,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.161,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
567,10004,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.612,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
568,10004,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.28,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
569,10004,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.488,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
570,10004,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.671,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
571,10004,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.726,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
572,10004,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.826,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
573,10004,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.721,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
574,10004,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.669,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
575,10004,Blank 490,2,P,OHSU_HNSCC_derm002,12,-0.004,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
576,10004,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.44,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
577,10004,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.749,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
578,10004,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.324,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
579,10004,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.484,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
580,10004,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.618,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
581,10004,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.279,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
582,10004,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.193,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
583,10004,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.589,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
584,10004,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.256,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
585,10004,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.599,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
586,10004,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.79,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
587,10004,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.644,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
588,10004,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.81,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
589,10004,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
590,10004,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.8,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
591,10004,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.085,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
592,10004,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.481,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
593,10004,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.801,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
594,10004,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.318,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
595,10004,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.655,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
596,10004,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.767,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
597,10004,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.302,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
598,10004,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.289,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
599,10004,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.689,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
600,10004,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.28,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
601,10004,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.689,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
602,10004,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.687,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
603,10004,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.706,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
604,10004,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.836,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
605,10004,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.693,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
606,10004,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.876,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
607,10004,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.443,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
608,10004,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.455,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
609,10004,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.809,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
610,10004,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.641,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
611,10004,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.715,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
612,10004,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.834,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
613,10004,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.548,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
614,10004,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.271,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
615,10004,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.721,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
616,10004,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.332,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
617,10004,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.681,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
618,10004,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.921,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
619,10004,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.693,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
620,10004,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.785,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
621,10004,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.764,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
622,10004,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.61,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
623,10004,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.329,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
624,10004,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.544,0,NONE,OHSU_HNSCC_derm002
625,10004,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.745,0,NONE,OHSU_HNSCC_derm002
626,10004,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.807,0,NONE,OHSU_HNSCC_derm002
627,10004,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.777,0,NONE,OHSU_HNSCC_derm002
628,10004,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.767,0,NONE,OHSU_HNSCC_derm002
629,10004,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.804,0,NONE,OHSU_HNSCC_derm002
630,10004,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.783,0,NONE,OHSU_HNSCC_derm002
631,10004,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
632,10004,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.757,0,NONE,OHSU_HNSCC_derm002
633,10004,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.76,0,NONE,OHSU_HNSCC_derm002
634,10004,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.758,0,NONE,OHSU_HNSCC_derm002
635,10004,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.698,0,NONE,OHSU_HNSCC_derm002
636,10004,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.728,0,NONE,OHSU_HNSCC_derm002
637,10004,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.696,0,NONE,OHSU_HNSCC_derm002
638,10004,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.78,0,NONE,OHSU_HNSCC_derm002
639,10004,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.686,0,NONE,OHSU_HNSCC_derm002
640,10004,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.403,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
641,10004,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.698,10,Hesperidin,OHSU_HNSCC_derm002
642,10004,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.782,10,Esculetin,OHSU_HNSCC_derm002
643,10004,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.167,10,Selinexor ,OHSU_HNSCC_derm002
644,10004,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.504,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
645,10004,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.709,10,BMX-IN-1,OHSU_HNSCC_derm002
646,10004,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.079,1,Dasatinib (1mM),OHSU_HNSCC_derm002
647,10004,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.179,10,Trametinib,OHSU_HNSCC_derm002
648,10004,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.186,10,BEZ235,OHSU_HNSCC_derm002
649,10004,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.015,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
650,10004,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.689,10,Nilotinib,OHSU_HNSCC_derm002
651,10004,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.583,10,Enzalutamide,OHSU_HNSCC_derm002
652,10004,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.779,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
653,10004,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.272,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
654,10004,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.006,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
655,10004,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.371,10,Axitinib,OHSU_HNSCC_derm002
656,10004,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.379,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
657,10004,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.779,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
658,10004,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.635,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
659,10004,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.152,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
660,10004,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.719,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
661,10004,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.611,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
662,10004,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.246,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
663,10004,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.218,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
664,10004,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.197,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
665,10004,Blank 490,2,J,OHSU_HNSCC_derm002,18,-0.003,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
666,10004,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.692,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
667,10004,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.802,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
668,10004,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.735,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
669,10004,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.412,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
670,10004,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.004,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
671,10004,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.45,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
672,10004,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.466,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
673,10004,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.83,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
674,10004,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.54,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
675,10004,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.201,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
676,10004,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.588,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
677,10004,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.479,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
678,10004,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.334,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
679,10004,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.219,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
680,10004,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.181,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
681,10004,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.01,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
682,10004,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.687,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
683,10004,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.77,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
684,10004,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.801,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
685,10004,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.522,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
686,10004,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.004,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
687,10004,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.803,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
688,10004,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.395,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
689,10004,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.776,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
690,10004,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.726,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
691,10004,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.44,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
692,10004,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.677,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
693,10004,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.61,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
694,10004,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.751,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
695,10004,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.215,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
696,10004,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.24,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
697,10004,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.022,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
698,10004,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.653,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
699,10004,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.738,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
700,10004,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.659,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
701,10004,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.435,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
702,10004,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.446,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
703,10004,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.69,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
704,10004,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.504,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
705,10004,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.58,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
706,10004,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.732,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
707,10004,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.615,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
708,10004,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.831,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
709,10004,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.799,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
710,10004,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.688,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
711,10004,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.187,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
712,10004,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.323,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
713,10004,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.06,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
714,10004,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.757,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
715,10004,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.751,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
716,10004,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.691,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
717,10004,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.582,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
718,10004,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.745,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
719,10004,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.625,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
720,10004,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.515,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
721,10004,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.701,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
722,10004,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.801,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
723,10004,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.678,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
724,10004,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.647,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
725,10004,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.856,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
726,10004,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.772,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
727,10004,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.307,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
728,10004,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.62,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
729,10004,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.46,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
730,10004,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.651,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
731,10004,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.73,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
732,10004,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.814,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
733,10004,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.814,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
734,10004,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.861,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
735,10004,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.655,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
736,10004,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.511,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
737,10004,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.612,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
738,10004,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.682,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
739,10004,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.783,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
740,10004,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.748,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
741,10004,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.651,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
742,10004,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.872,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
743,10004,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.389,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
744,10004,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
745,10004,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.71,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
746,10004,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.681,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
747,10004,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.827,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
748,10004,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.765,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
749,10004,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.757,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
750,10004,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.778,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
751,10004,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.653,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
752,10004,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.619,0,NONE,OHSU_HNSCC_derm002
753,10004,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.56,0,NONE,OHSU_HNSCC_derm002
754,10004,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
755,10004,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.581,0,NONE,OHSU_HNSCC_derm002
756,10004,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.516,0,NONE,OHSU_HNSCC_derm002
757,10004,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.6,0,NONE,OHSU_HNSCC_derm002
758,10004,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.627,0,NONE,OHSU_HNSCC_derm002
759,10004,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.711,0,NONE,OHSU_HNSCC_derm002
760,10004,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.624,0,NONE,OHSU_HNSCC_derm002
761,10004,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.649,0,NONE,OHSU_HNSCC_derm002
762,10004,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
763,10004,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.667,0,NONE,OHSU_HNSCC_derm002
764,10004,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.633,0,NONE,OHSU_HNSCC_derm002
765,10004,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.675,0,NONE,OHSU_HNSCC_derm002
766,10004,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.686,0,NONE,OHSU_HNSCC_derm002
767,10004,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.68,0,NONE,OHSU_HNSCC_derm002
768,10004,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.624,10,Thalidomide ,OHSU_HNSCC_derm002
769,10004,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.193,10,Vandetanib,OHSU_HNSCC_derm002
770,10004,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.619,10,Oleic acid,OHSU_HNSCC_derm002
771,10004,Blank 490,3,D,OHSU_HNSCC_derm002,1,-0.011,10,A-674563,OHSU_HNSCC_derm002
772,10004,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.173,10,Lapatinib,OHSU_HNSCC_derm002
773,10004,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.725,10,Apocynin (vanillin),OHSU_HNSCC_derm002
774,10004,Blank 490,3,G,OHSU_HNSCC_derm002,1,-0.006,10,AT-7519,OHSU_HNSCC_derm002
775,10004,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.219,10,Gefitinib,OHSU_HNSCC_derm002
776,10004,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.273,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
777,10004,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.136,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
778,10004,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.062,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
779,10004,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.537,10,JQ1,OHSU_HNSCC_derm002
780,10004,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.912,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
781,10004,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.691,10,Cerdulatinib,OHSU_HNSCC_derm002
782,10004,Blank 490,3,O,OHSU_HNSCC_derm002,1,-0.004,10,Romidepsin,OHSU_HNSCC_derm002
783,10004,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.012,10,Gilteritinib,OHSU_HNSCC_derm002
784,10004,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.674,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
785,10004,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.376,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
786,10004,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.67,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
787,10004,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.316,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
788,10004,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.221,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
789,10004,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.718,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
790,10004,Blank 490,3,G,OHSU_HNSCC_derm002,2,-0.006,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
791,10004,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.234,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
792,10004,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.611,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
793,10004,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.193,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
794,10004,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.183,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
795,10004,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.599,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
796,10004,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.951,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
797,10004,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.861,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
798,10004,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.001,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
799,10004,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.665,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
800,10004,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.611,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
801,10004,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.444,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
802,10004,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.785,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
803,10004,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.445,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
804,10004,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.286,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
805,10004,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.745,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
806,10004,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.008,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
807,10004,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.236,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
808,10004,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.688,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
809,10004,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.262,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
810,10004,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.223,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
811,10004,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.697,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
812,10004,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.803,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
813,10004,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.834,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
814,10004,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.002,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
815,10004,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.634,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
816,10004,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.575,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
817,10004,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.628,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
818,10004,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.641,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
819,10004,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.504,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
820,10004,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.301,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
821,10004,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.642,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
822,10004,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.432,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
823,10004,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.236,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
824,10004,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.674,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
825,10004,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.328,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
826,10004,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.21,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
827,10004,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.705,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
828,10004,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.813,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
829,10004,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.707,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
830,10004,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.0,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
831,10004,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.732,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
832,10004,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.581,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
833,10004,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.637,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
834,10004,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.697,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
835,10004,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.525,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
836,10004,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.508,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
837,10004,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.633,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
838,10004,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.654,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
839,10004,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.299,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
840,10004,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.765,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
841,10004,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.519,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
842,10004,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.256,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
843,10004,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.738,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
844,10004,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.788,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
845,10004,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.762,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
846,10004,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.01,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
847,10004,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.845,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
848,10004,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.615,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
849,10004,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.688,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
850,10004,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.746,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
851,10004,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.577,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
852,10004,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.652,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
853,10004,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.638,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
854,10004,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.744,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
855,10004,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.568,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
856,10004,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.727,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
857,10004,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.548,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
858,10004,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.471,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
859,10004,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.769,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
860,10004,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.788,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
861,10004,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.754,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
862,10004,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.017,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
863,10004,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.727,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
864,10004,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.677,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
865,10004,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.691,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
866,10004,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.645,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
867,10004,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.574,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
868,10004,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.633,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
869,10004,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.616,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
870,10004,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.706,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
871,10004,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.644,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
872,10004,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.762,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
873,10004,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.681,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
874,10004,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.608,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
875,10004,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.729,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
876,10004,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.759,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
877,10004,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.692,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
878,10004,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.004,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
879,10004,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.781,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
880,10004,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.669,0,NONE,OHSU_HNSCC_derm002
881,10004,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.696,0,NONE,OHSU_HNSCC_derm002
882,10004,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.682,0,NONE,OHSU_HNSCC_derm002
883,10004,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.601,0,NONE,OHSU_HNSCC_derm002
884,10004,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.666,0,NONE,OHSU_HNSCC_derm002
885,10004,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.679,0,NONE,OHSU_HNSCC_derm002
886,10004,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.7,0,NONE,OHSU_HNSCC_derm002
887,10004,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
888,10004,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.274,0,NONE,OHSU_HNSCC_derm002
889,10004,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.663,0,NONE,OHSU_HNSCC_derm002
890,10004,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.806,0,NONE,OHSU_HNSCC_derm002
891,10004,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.757,0,NONE,OHSU_HNSCC_derm002
892,10004,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.782,0,NONE,OHSU_HNSCC_derm002
893,10004,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.738,0,NONE,OHSU_HNSCC_derm002
894,10004,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.791,0,NONE,OHSU_HNSCC_derm002
895,10004,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.808,0,NONE,OHSU_HNSCC_derm002
896,10004,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.598,10,Anastrazole,OHSU_HNSCC_derm002
897,10004,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.378,10,JNJ-28312141 ,OHSU_HNSCC_derm002
898,10004,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.57,10,Genistein,OHSU_HNSCC_derm002
899,10004,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.614,10,Abscisic acid,OHSU_HNSCC_derm002
900,10004,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.389,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
901,10004,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.708,10,Ruxolitinib,OHSU_HNSCC_derm002
902,10004,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.571,10,TAK-659,OHSU_HNSCC_derm002
903,10004,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.234,10,Brigatinib,OHSU_HNSCC_derm002
904,10004,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.276,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
905,10004,Blank 490,3,J,OHSU_HNSCC_derm002,9,-0.002,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
906,10004,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.13,10,Vorinostat,OHSU_HNSCC_derm002
907,10004,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.724,10,Lenalidomide,OHSU_HNSCC_derm002
908,10004,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.734,10,NVP-ADW742,OHSU_HNSCC_derm002
909,10004,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.671,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
910,10004,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.901,10,Echinatin,OHSU_HNSCC_derm002
911,10004,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.029,10,YM-155,OHSU_HNSCC_derm002
912,10004,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.559,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
913,10004,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.642,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
914,10004,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.646,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
915,10004,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.599,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
916,10004,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.415,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
917,10004,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.711,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
918,10004,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.542,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
919,10004,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.335,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
920,10004,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.259,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
921,10004,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.357,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
922,10004,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.199,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
923,10004,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.72,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
924,10004,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.684,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
925,10004,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.686,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
926,10004,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.717,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
927,10004,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.014,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
928,10004,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.612,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
929,10004,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.691,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
930,10004,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.64,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
931,10004,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.641,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
932,10004,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.416,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
933,10004,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.652,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
934,10004,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.654,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
935,10004,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.478,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
936,10004,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.239,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
937,10004,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.533,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
938,10004,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.334,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
939,10004,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.708,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
940,10004,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.693,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
941,10004,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.751,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
942,10004,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.803,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
943,10004,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.013,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
944,10004,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.623,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
945,10004,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.73,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
946,10004,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.691,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
947,10004,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.598,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
948,10004,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.379,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
949,10004,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.694,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
950,10004,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.643,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
951,10004,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.59,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
952,10004,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.235,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
953,10004,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.49,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
954,10004,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.466,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
955,10004,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.778,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
956,10004,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.757,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
957,10004,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.677,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
958,10004,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.761,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
959,10004,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.017,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
960,10004,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.622,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
961,10004,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.734,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
962,10004,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.761,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
963,10004,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.611,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
964,10004,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.375,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
965,10004,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.661,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
966,10004,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.684,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
967,10004,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.602,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
968,10004,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.228,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
969,10004,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.576,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
970,10004,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.682,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
971,10004,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.711,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
972,10004,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.723,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
973,10004,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.737,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
974,10004,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.684,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
975,10004,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.004,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
976,10004,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.583,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
977,10004,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.69,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
978,10004,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.691,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
979,10004,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.575,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
980,10004,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.453,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
981,10004,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.671,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
982,10004,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.725,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
983,10004,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.647,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
984,10004,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.264,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
985,10004,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.66,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
986,10004,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.707,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
987,10004,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.642,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
988,10004,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.745,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
989,10004,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.794,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
990,10004,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.78,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
991,10004,Blank 490,3,P,OHSU_HNSCC_derm002,14,-0.013,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
992,10004,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.556,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
993,10004,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.739,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
994,10004,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.669,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
995,10004,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.566,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
996,10004,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.578,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
997,10004,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.706,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
998,10004,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.711,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
999,10004,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.628,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
1000,10004,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.285,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1001,10004,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.696,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
1002,10004,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.706,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
1003,10004,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.757,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
1004,10004,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.755,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
1005,10004,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.793,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
1006,10004,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.766,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
1007,10004,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.017,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
1008,10004,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.592,0,NONE,OHSU_HNSCC_derm002
1009,10004,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.752,0,NONE,OHSU_HNSCC_derm002
1010,10004,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.704,0,NONE,OHSU_HNSCC_derm002
1011,10004,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
1012,10004,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.7,0,NONE,OHSU_HNSCC_derm002
1013,10004,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.677,0,NONE,OHSU_HNSCC_derm002
1014,10004,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.271,0,NONE,OHSU_HNSCC_derm002
1015,10004,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
1016,10004,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.692,0,NONE,OHSU_HNSCC_derm002
1017,10004,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.677,0,NONE,OHSU_HNSCC_derm002
1018,10004,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.773,0,NONE,OHSU_HNSCC_derm002
1019,10004,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.723,0,NONE,OHSU_HNSCC_derm002
1020,10004,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.758,0,NONE,OHSU_HNSCC_derm002
1021,10004,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.836,0,NONE,OHSU_HNSCC_derm002
1022,10004,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.75,0,NONE,OHSU_HNSCC_derm002
1023,10004,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.775,0,NONE,OHSU_HNSCC_derm002
1024,10004,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.601,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1025,10004,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.718,10,Stevioside,OHSU_HNSCC_derm002
1026,10004,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.629,10,Pemetrexed,OHSU_HNSCC_derm002
1027,10004,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.079,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1028,10004,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.398,10,GSK-1838705A,OHSU_HNSCC_derm002
1029,10004,Blank 490,3,F,OHSU_HNSCC_derm002,17,0.01,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1030,10004,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.653,10,Imatinib,OHSU_HNSCC_derm002
1031,10004,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.168,10,Trametinib,OHSU_HNSCC_derm002
1032,10004,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.153,10,BEZ235,OHSU_HNSCC_derm002
1033,10004,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.363,10,Saracatinib,OHSU_HNSCC_derm002
1034,10004,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.689,10,I-BET 762,OHSU_HNSCC_derm002
1035,10004,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.234,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
1036,10004,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.695,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
1037,10004,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.445,10,Crizotinib,OHSU_HNSCC_derm002
1038,10004,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.499,10,MGCD-265,OHSU_HNSCC_derm002
1039,10004,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.153,10,Erlotinib,OHSU_HNSCC_derm002
1040,10004,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.63,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1041,10004,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.7,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
1042,10004,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.577,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
1043,10004,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.107,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1044,10004,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.533,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
1045,10004,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.129,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1046,10004,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.702,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
1047,10004,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.178,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
1048,10004,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.149,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
1049,10004,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.6,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
1050,10004,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.733,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
1051,10004,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.232,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
1052,10004,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.757,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
1053,10004,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.67,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
1054,10004,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.509,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
1055,10004,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.197,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
1056,10004,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.63,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1057,10004,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.698,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
1058,10004,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.587,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
1059,10004,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.141,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1060,10004,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.555,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
1061,10004,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.17,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1062,10004,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.711,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
1063,10004,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.208,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
1064,10004,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.176,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
1065,10004,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.795,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
1066,10004,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.67,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
1067,10004,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.249,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
1068,10004,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.731,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
1069,10004,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.64,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
1070,10004,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.661,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
1071,10004,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.277,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
1072,10004,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.586,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1073,10004,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.662,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
1074,10004,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.622,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
1075,10004,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.271,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1076,10004,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.587,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
1077,10004,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.222,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1078,10004,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.706,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
1079,10004,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.236,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
1080,10004,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.257,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
1081,10004,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.756,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
1082,10004,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.716,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
1083,10004,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.258,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
1084,10004,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.732,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
1085,10004,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.778,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
1086,10004,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.731,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
1087,10004,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.331,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
1088,10004,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.565,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1089,10004,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.697,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
1090,10004,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.664,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
1091,10004,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.362,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1092,10004,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.585,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
1093,10004,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.317,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1094,10004,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.644,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
1095,10004,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.238,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
1096,10004,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.317,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
1097,10004,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.759,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
1098,10004,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.726,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
1099,10004,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.29,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
1100,10004,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.722,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
1101,10004,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.754,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
1102,10004,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.743,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
1103,10004,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.531,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
1104,10004,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.621,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1105,10004,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.686,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
1106,10004,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.666,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
1107,10004,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.525,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1108,10004,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.669,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
1109,10004,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.511,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1110,10004,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.695,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
1111,10004,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.246,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
1112,10004,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.602,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
1113,10004,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.721,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
1114,10004,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.715,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
1115,10004,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.495,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
1116,10004,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.736,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
1117,10004,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.766,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
1118,10004,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.745,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
1119,10004,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.656,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
1120,10004,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.587,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
1121,10004,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.644,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
1122,10004,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.692,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
1123,10004,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.631,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
1124,10004,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.731,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
1125,10004,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.668,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
1126,10004,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.756,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
1127,10004,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.378,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
1128,10004,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.731,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
1129,10004,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.723,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
1130,10004,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.761,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
1131,10004,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.744,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
1132,10004,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.515,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
1133,10004,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
1134,10004,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.786,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
1135,10004,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.69,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
1136,10004,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.625,0,NONE,OHSU_HNSCC_derm002
1137,10004,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.616,0,NONE,OHSU_HNSCC_derm002
1138,10004,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.621,0,NONE,OHSU_HNSCC_derm002
1139,10004,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
1140,10004,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.71,0,NONE,OHSU_HNSCC_derm002
1141,10004,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.637,0,NONE,OHSU_HNSCC_derm002
1142,10004,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.665,0,NONE,OHSU_HNSCC_derm002
1143,10004,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.819,0,NONE,OHSU_HNSCC_derm002
1144,10004,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.807,0,NONE,OHSU_HNSCC_derm002
1145,10004,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.769,0,NONE,OHSU_HNSCC_derm002
1146,10004,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.833,0,NONE,OHSU_HNSCC_derm002
1147,10004,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.8,0,NONE,OHSU_HNSCC_derm002
1148,10004,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.654,0,NONE,OHSU_HNSCC_derm002
1149,10004,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.72,0,NONE,OHSU_HNSCC_derm002
1150,10004,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.743,0,NONE,OHSU_HNSCC_derm002
1151,10004,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.658,0,NONE,OHSU_HNSCC_derm002
1152,10004,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.02,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1153,10004,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.131,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1154,10004,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.011,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1155,10004,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.016,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1156,10004,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.008,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1157,10004,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.002,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1158,10004,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.002,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1159,10004,Blank 490,4,H,OHSU_HNSCC_derm002,1,-0.006,10,Gefitinib,OHSU_HNSCC_derm002
1160,10004,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.012,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
1161,10004,Blank 490,4,J,OHSU_HNSCC_derm002,1,-0.001,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1162,10004,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.054,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1163,10004,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.113,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1164,10004,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.128,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1165,10004,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.117,10,VOLASERTIB x,OHSU_HNSCC_derm002
1166,10004,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.395,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1167,10004,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.007,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1168,10004,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.059,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1169,10004,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.178,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1170,10004,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.594,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1171,10004,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.436,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1172,10004,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.032,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1173,10004,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.081,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1174,10004,Blank 490,4,G,OHSU_HNSCC_derm002,2,-0.004,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1175,10004,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.281,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
1176,10004,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.616,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
1177,10004,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.03,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1178,10004,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.182,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1179,10004,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.125,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1180,10004,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.199,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1181,10004,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.593,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
1182,10004,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.537,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1183,10004,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.02,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1184,10004,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.186,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1185,10004,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.322,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1186,10004,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.801,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1187,10004,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.405,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1188,10004,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.148,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1189,10004,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.071,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1190,10004,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.038,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1191,10004,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.28,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
1192,10004,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.855,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
1193,10004,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.087,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1194,10004,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.236,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1195,10004,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.186,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1196,10004,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.291,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1197,10004,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.521,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
1198,10004,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.701,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1199,10004,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.052,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1200,10004,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.287,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1201,10004,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.518,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1202,10004,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.892,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1203,10004,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.449,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1204,10004,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.341,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1205,10004,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.136,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1206,10004,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.154,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1207,10004,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.341,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
1208,10004,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.79,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
1209,10004,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.172,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1210,10004,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.441,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1211,10004,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.381,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1212,10004,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.435,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1213,10004,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.423,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
1214,10004,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.638,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1215,10004,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.05,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1216,10004,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.614,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1217,10004,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.655,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1218,10004,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.929,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1219,10004,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.501,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1220,10004,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.385,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1221,10004,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.258,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1222,10004,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.171,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1223,10004,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.427,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
1224,10004,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.884,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
1225,10004,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.27,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1226,10004,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.345,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1227,10004,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.46,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1228,10004,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.642,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1229,10004,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.339,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
1230,10004,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.878,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1231,10004,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.174,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1232,10004,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.738,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1233,10004,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.744,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1234,10004,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.83,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1235,10004,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.646,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1236,10004,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.627,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1237,10004,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.45,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1238,10004,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.168,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1239,10004,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.601,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
1240,10004,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.832,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
1241,10004,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.429,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1242,10004,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.623,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1243,10004,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.666,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1244,10004,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.721,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1245,10004,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.376,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
1246,10004,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.799,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1247,10004,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.296,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1248,10004,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.793,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
1249,10004,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.789,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
1250,10004,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.934,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
1251,10004,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.751,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
1252,10004,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.745,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
1253,10004,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.604,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
1254,10004,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.207,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
1255,10004,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.719,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
1256,10004,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.866,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
1257,10004,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.55,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
1258,10004,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.819,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
1259,10004,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.674,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
1260,10004,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.811,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
1261,10004,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.72,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
1262,10004,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.86,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1263,10004,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.358,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
1264,10004,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.755,0,NONE,OHSU_HNSCC_derm002
1265,10004,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.883,0,NONE,OHSU_HNSCC_derm002
1266,10004,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.903,0,NONE,OHSU_HNSCC_derm002
1267,10004,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.82,0,NONE,OHSU_HNSCC_derm002
1268,10004,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.825,0,NONE,OHSU_HNSCC_derm002
1269,10004,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.806,0,NONE,OHSU_HNSCC_derm002
1270,10004,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.831,0,NONE,OHSU_HNSCC_derm002
1271,10004,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
1272,10004,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.864,0,NONE,OHSU_HNSCC_derm002
1273,10004,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.78,0,NONE,OHSU_HNSCC_derm002
1274,10004,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.918,0,NONE,OHSU_HNSCC_derm002
1275,10004,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.805,0,NONE,OHSU_HNSCC_derm002
1276,10004,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.893,0,NONE,OHSU_HNSCC_derm002
1277,10004,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.777,0,NONE,OHSU_HNSCC_derm002
1278,10004,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.747,0,NONE,OHSU_HNSCC_derm002
1279,10004,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.778,0,NONE,OHSU_HNSCC_derm002
1280,10004,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.182,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1281,10004,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.313,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1282,10004,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.104,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
1283,10004,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.493,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1284,10004,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.158,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1285,10004,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.023,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
1286,10004,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.299,10,AZD2014 x ,OHSU_HNSCC_derm002
1287,10004,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.325,10,Brigatinib,OHSU_HNSCC_derm002
1288,10004,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.321,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1289,10004,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.017,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1290,10004,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.201,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1291,10004,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.016,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
1292,10004,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.249,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1293,10004,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.272,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1294,10004,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.184,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1295,10004,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.149,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1296,10004,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.364,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1297,10004,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.295,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1298,10004,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.123,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
1299,10004,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.559,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1300,10004,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.219,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1301,10004,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.037,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
1302,10004,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.327,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
1303,10004,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.478,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
1304,10004,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.33,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1305,10004,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.133,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1306,10004,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.261,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1307,10004,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.045,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
1308,10004,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.384,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1309,10004,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.272,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1310,10004,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.24,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1311,10004,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.186,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1312,10004,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.38,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1313,10004,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.322,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1314,10004,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.187,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
1315,10004,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.697,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1316,10004,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.263,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1317,10004,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.059,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
1318,10004,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.401,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
1319,10004,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.609,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
1320,10004,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.314,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1321,10004,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.181,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1322,10004,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.276,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1323,10004,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.511,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
1324,10004,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.341,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1325,10004,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.383,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1326,10004,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.341,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1327,10004,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.298,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1328,10004,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.443,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1329,10004,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.35,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1330,10004,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.279,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
1331,10004,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.743,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1332,10004,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.318,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1333,10004,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.139,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
1334,10004,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.54,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
1335,10004,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.636,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
1336,10004,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.321,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1337,10004,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.259,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1338,10004,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.324,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1339,10004,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.6,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
1340,10004,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.302,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1341,10004,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.491,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1342,10004,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.339,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1343,10004,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.465,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1344,10004,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.485,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1345,10004,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.406,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1346,10004,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.569,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
1347,10004,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.71,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1348,10004,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.427,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1349,10004,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.277,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
1350,10004,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.731,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
1351,10004,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
1352,10004,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.277,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1353,10004,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.467,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1354,10004,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.436,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1355,10004,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.779,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
1356,10004,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.305,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1357,10004,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.655,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1358,10004,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.553,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1359,10004,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.605,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1360,10004,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.656,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1361,10004,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.705,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1362,10004,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.845,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
1363,10004,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.822,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1364,10004,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.628,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1365,10004,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.431,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
1366,10004,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.806,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
1367,10004,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
1368,10004,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.316,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1369,10004,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.633,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1370,10004,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.645,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1371,10004,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.772,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
1372,10004,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.337,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1373,10004,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.729,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1374,10004,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.737,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1375,10004,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.723,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1376,10004,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.647,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
1377,10004,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.765,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
1378,10004,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.88,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
1379,10004,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.772,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1380,10004,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.744,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
1381,10004,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.685,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
1382,10004,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.754,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
1383,10004,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.771,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
1384,10004,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.387,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1385,10004,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.777,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
1386,10004,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.691,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
1387,10004,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.82,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
1388,10004,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.39,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1389,10004,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.895,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
1390,10004,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.738,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
1391,10004,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.696,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
1392,10004,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.754,0,NONE,OHSU_HNSCC_derm002
1393,10004,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.848,0,NONE,OHSU_HNSCC_derm002
1394,10004,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.865,0,NONE,OHSU_HNSCC_derm002
1395,10004,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.716,0,NONE,OHSU_HNSCC_derm002
1396,10004,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.805,0,NONE,OHSU_HNSCC_derm002
1397,10004,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.736,0,NONE,OHSU_HNSCC_derm002
1398,10004,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.788,0,NONE,OHSU_HNSCC_derm002
1399,10004,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
1400,10004,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.83,0,NONE,OHSU_HNSCC_derm002
1401,10004,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.811,0,NONE,OHSU_HNSCC_derm002
1402,10004,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.837,0,NONE,OHSU_HNSCC_derm002
1403,10004,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.782,0,NONE,OHSU_HNSCC_derm002
1404,10004,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.865,0,NONE,OHSU_HNSCC_derm002
1405,10004,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.824,0,NONE,OHSU_HNSCC_derm002
1406,10004,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.804,0,NONE,OHSU_HNSCC_derm002
1407,10004,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.766,0,NONE,OHSU_HNSCC_derm002
1408,10004,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.277,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1409,10004,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.056,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1410,10004,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.108,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1411,10004,Blank 490,4,D,OHSU_HNSCC_derm002,17,0.013,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1412,10004,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.023,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1413,10004,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.102,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1414,10004,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.19,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1415,10004,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.194,10,Trametinib,OHSU_HNSCC_derm002
1416,10004,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.162,10,BEZ235,OHSU_HNSCC_derm002
1417,10004,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.007,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1418,10004,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.374,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1419,10004,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.003,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1420,10004,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.377,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1421,10004,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.951,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1422,10004,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.316,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1423,10004,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.137,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1424,10004,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.436,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1425,10004,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.217,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1426,10004,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.066,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1427,10004,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.016,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1428,10004,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.381,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1429,10004,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.203,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1430,10004,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.411,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1431,10004,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.228,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
1432,10004,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.169,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
1433,10004,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.083,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1434,10004,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.538,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1435,10004,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.055,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1436,10004,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.369,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1437,10004,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.84,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1438,10004,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.349,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1439,10004,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.212,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1440,10004,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.705,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1441,10004,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.247,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1442,10004,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.294,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1443,10004,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.018,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1444,10004,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.194,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1445,10004,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.27,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1446,10004,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.449,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1447,10004,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.24,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
1448,10004,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.17,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
1449,10004,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.159,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1450,10004,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.653,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1451,10004,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.079,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1452,10004,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.386,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1453,10004,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.795,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1454,10004,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.308,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1455,10004,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.223,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1456,10004,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.769,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1457,10004,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.333,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1458,10004,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.307,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1459,10004,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.026,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1460,10004,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.697,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1461,10004,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.349,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1462,10004,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.595,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1463,10004,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.237,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
1464,10004,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.248,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
1465,10004,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.204,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1466,10004,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.699,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1467,10004,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.249,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1468,10004,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.382,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1469,10004,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.818,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1470,10004,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.437,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1471,10004,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.279,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1472,10004,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.809,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1473,10004,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.501,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1474,10004,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.379,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1475,10004,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.049,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1476,10004,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.388,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1477,10004,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.509,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1478,10004,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.679,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1479,10004,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.294,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
1480,10004,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.353,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
1481,10004,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.299,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1482,10004,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.735,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1483,10004,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.654,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1484,10004,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.482,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1485,10004,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.86,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1486,10004,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.588,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1487,10004,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.389,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1488,10004,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.806,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1489,10004,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.668,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1490,10004,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.596,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1491,10004,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.064,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1492,10004,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.858,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1493,10004,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.712,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1494,10004,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.791,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1495,10004,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.335,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
1496,10004,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.593,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
1497,10004,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.55,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1498,10004,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.822,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1499,10004,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.879,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1500,10004,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.724,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1501,10004,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.807,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1502,10004,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.55,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1503,10004,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.601,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1504,10004,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.824,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
1505,10004,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.705,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
1506,10004,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.633,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1507,10004,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.071,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
1508,10004,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.67,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
1509,10004,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.718,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
1510,10004,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.85,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
1511,10004,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.384,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
1512,10004,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.779,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
1513,10004,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.755,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
1514,10004,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.794,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1515,10004,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.885,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1516,10004,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.746,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
1517,10004,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.731,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1518,10004,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.765,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
1519,10004,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.64,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1520,10004,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.761,0,NONE,OHSU_HNSCC_derm002
1521,10004,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.733,0,NONE,OHSU_HNSCC_derm002
1522,10004,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.762,0,NONE,OHSU_HNSCC_derm002
1523,10004,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.72,0,NONE,OHSU_HNSCC_derm002
1524,10004,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.742,0,NONE,OHSU_HNSCC_derm002
1525,10004,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.78,0,NONE,OHSU_HNSCC_derm002
1526,10004,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.86,0,NONE,OHSU_HNSCC_derm002
1527,10004,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.795,0,NONE,OHSU_HNSCC_derm002
1528,10004,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.839,0,NONE,OHSU_HNSCC_derm002
1529,10004,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.778,0,NONE,OHSU_HNSCC_derm002
1530,10004,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.76,0,NONE,OHSU_HNSCC_derm002
1531,10004,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.86,0,NONE,OHSU_HNSCC_derm002
1532,10004,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.796,0,NONE,OHSU_HNSCC_derm002
1533,10004,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.765,0,NONE,OHSU_HNSCC_derm002
1534,10004,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.746,0,NONE,OHSU_HNSCC_derm002
1535,10004,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.635,0,NONE,OHSU_HNSCC_derm002
1536,10004,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.16,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1537,10004,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.214,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1538,10004,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.014,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1539,10004,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.201,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1540,10004,Blank 490,5,E,OHSU_HNSCC_derm002,1,-0.012,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1541,10004,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.054,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1542,10004,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.192,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1543,10004,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.225,10,Gefitinib,OHSU_HNSCC_derm002
1544,10004,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.209,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
1545,10004,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.002,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1546,10004,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.489,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1547,10004,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.216,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1548,10004,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.003,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1549,10004,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.216,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1550,10004,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.021,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1551,10004,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.0,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1552,10004,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.187,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1553,10004,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.257,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1554,10004,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.021,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1555,10004,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.298,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1556,10004,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.113,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1557,10004,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.102,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1558,10004,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.321,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1559,10004,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.265,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
1560,10004,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.483,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
1561,10004,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.02,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1562,10004,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.558,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1563,10004,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.271,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1564,10004,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.021,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1565,10004,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.24,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1566,10004,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.065,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1567,10004,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.007,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1568,10004,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.185,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1569,10004,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.272,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1570,10004,Blank 490,5,C,OHSU_HNSCC_derm002,3,-0.01,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1571,10004,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.497,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1572,10004,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.166,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1573,10004,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.322,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1574,10004,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.508,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1575,10004,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.254,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
1576,10004,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.671,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
1577,10004,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.057,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1578,10004,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.555,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1579,10004,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.291,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1580,10004,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.055,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1581,10004,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.226,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1582,10004,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.119,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1583,10004,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.085,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1584,10004,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.198,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1585,10004,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.319,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1586,10004,Blank 490,5,C,OHSU_HNSCC_derm002,4,-0.007,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1587,10004,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.712,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1588,10004,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.234,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1589,10004,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.688,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1590,10004,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.7,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1591,10004,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.31,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
1592,10004,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
1593,10004,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.151,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1594,10004,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.581,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1595,10004,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.411,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1596,10004,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.198,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1597,10004,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.316,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1598,10004,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.126,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1599,10004,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.159,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1600,10004,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.201,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1601,10004,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.422,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1602,10004,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.0,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1603,10004,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.733,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1604,10004,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.438,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1605,10004,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.73,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1606,10004,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.679,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1607,10004,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.395,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
1608,10004,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.671,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
1609,10004,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.292,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1610,10004,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.615,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1611,10004,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.474,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1612,10004,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.327,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1613,10004,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.485,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1614,10004,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.238,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1615,10004,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.231,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1616,10004,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.268,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1617,10004,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.609,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1618,10004,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.007,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1619,10004,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.72,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1620,10004,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.582,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1621,10004,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.742,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1622,10004,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.713,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1623,10004,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.624,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
1624,10004,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.717,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
1625,10004,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.442,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1626,10004,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.696,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1627,10004,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.583,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1628,10004,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.372,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1629,10004,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.639,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1630,10004,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.327,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1631,10004,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.472,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1632,10004,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.252,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1633,10004,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.712,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
1634,10004,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.053,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
1635,10004,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.621,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
1636,10004,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.683,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
1637,10004,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.752,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
1638,10004,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.701,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
1639,10004,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.663,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
1640,10004,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.714,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
1641,10004,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.674,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
1642,10004,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.729,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
1643,10004,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.716,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1644,10004,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.749,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1645,10004,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.58,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
1646,10004,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.737,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
1647,10004,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.547,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
1648,10004,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.692,0,NONE,OHSU_HNSCC_derm002
1649,10004,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.817,0,NONE,OHSU_HNSCC_derm002
1650,10004,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.755,0,NONE,OHSU_HNSCC_derm002
1651,10004,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.771,0,NONE,OHSU_HNSCC_derm002
1652,10004,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.696,0,NONE,OHSU_HNSCC_derm002
1653,10004,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
1654,10004,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
1655,10004,Blank 490,5,H,OHSU_HNSCC_derm002,8,0.003,10,F-S-V,OHSU_HNSCC_derm002
1656,10004,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.751,0,NONE,OHSU_HNSCC_derm002
1657,10004,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.76,0,NONE,OHSU_HNSCC_derm002
1658,10004,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.695,0,NONE,OHSU_HNSCC_derm002
1659,10004,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.674,0,NONE,OHSU_HNSCC_derm002
1660,10004,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.786,0,NONE,OHSU_HNSCC_derm002
1661,10004,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.753,0,NONE,OHSU_HNSCC_derm002
1662,10004,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.722,0,NONE,OHSU_HNSCC_derm002
1663,10004,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.625,0,NONE,OHSU_HNSCC_derm002
1664,10004,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.01,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1665,10004,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.614,10,APTO-253 x,OHSU_HNSCC_derm002
1666,10004,Blank 490,5,C,OHSU_HNSCC_derm002,9,-0.013,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1667,10004,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.691,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1668,10004,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.165,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1669,10004,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.01,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1670,10004,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.018,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1671,10004,Blank 490,5,H,OHSU_HNSCC_derm002,9,-0.018,10,Brigatinib,OHSU_HNSCC_derm002
1672,10004,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.292,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1673,10004,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.02,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1674,10004,Blank 490,5,K,OHSU_HNSCC_derm002,9,-0.004,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1675,10004,Blank 490,5,L,OHSU_HNSCC_derm002,9,-0.013,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1676,10004,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.218,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1677,10004,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.218,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1678,10004,Blank 490,5,O,OHSU_HNSCC_derm002,9,-0.022,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1679,10004,Blank 490,5,P,OHSU_HNSCC_derm002,9,-0.009,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1680,10004,Blank 490,5,A,OHSU_HNSCC_derm002,10,-0.005,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1681,10004,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.519,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
1682,10004,Blank 490,5,C,OHSU_HNSCC_derm002,10,-0.004,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1683,10004,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.625,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1684,10004,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.192,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1685,10004,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.033,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1686,10004,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.25,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1687,10004,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.349,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
1688,10004,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.282,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1689,10004,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.05,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1690,10004,Blank 490,5,K,OHSU_HNSCC_derm002,10,-0.016,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1691,10004,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.007,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1692,10004,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.258,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1693,10004,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.244,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1694,10004,Blank 490,5,O,OHSU_HNSCC_derm002,10,-0.009,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1695,10004,Blank 490,5,P,OHSU_HNSCC_derm002,10,-0.007,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1696,10004,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.006,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1697,10004,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.745,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
1698,10004,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.013,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1699,10004,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.695,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1700,10004,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.231,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1701,10004,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.056,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1702,10004,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.248,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1703,10004,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.532,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
1704,10004,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.271,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1705,10004,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.063,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1706,10004,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.113,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1707,10004,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.002,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1708,10004,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.275,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1709,10004,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.277,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1710,10004,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.083,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1711,10004,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.016,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1712,10004,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.015,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1713,10004,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.817,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
1714,10004,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.041,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1715,10004,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.735,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1716,10004,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.304,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1717,10004,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.069,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1718,10004,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.251,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1719,10004,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.673,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
1720,10004,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.259,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1721,10004,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.108,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1722,10004,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.451,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1723,10004,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.044,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1724,10004,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.344,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1725,10004,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.376,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1726,10004,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.505,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1727,10004,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.547,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1728,10004,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.014,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1729,10004,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.79,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
1730,10004,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.138,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1731,10004,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.625,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1732,10004,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.449,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1733,10004,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.132,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1734,10004,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.26,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1735,10004,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.649,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
1736,10004,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.264,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1737,10004,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.165,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1738,10004,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.613,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1739,10004,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.102,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1740,10004,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.519,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1741,10004,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.445,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1742,10004,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.627,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1743,10004,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.581,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1744,10004,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.02,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1745,10004,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.8,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
1746,10004,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.269,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1747,10004,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.766,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1748,10004,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.596,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1749,10004,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.352,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1750,10004,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.289,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1751,10004,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.764,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
1752,10004,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.318,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1753,10004,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.401,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1754,10004,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.702,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1755,10004,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.215,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1756,10004,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.746,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1757,10004,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.665,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1758,10004,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.582,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1759,10004,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.518,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1760,10004,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.061,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
1761,10004,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.722,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
1762,10004,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.52,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
1763,10004,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.742,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
1764,10004,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.701,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
1765,10004,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.542,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1766,10004,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.367,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1767,10004,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.756,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
1768,10004,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.324,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
1769,10004,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.699,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
1770,10004,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.659,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1771,10004,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.401,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
1772,10004,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.781,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
1773,10004,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.68,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1774,10004,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.685,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1775,10004,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.675,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1776,10004,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.723,0,NONE,OHSU_HNSCC_derm002
1777,10004,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.812,0,NONE,OHSU_HNSCC_derm002
1778,10004,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.775,0,NONE,OHSU_HNSCC_derm002
1779,10004,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.774,0,NONE,OHSU_HNSCC_derm002
1780,10004,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.728,0,NONE,OHSU_HNSCC_derm002
1781,10004,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.743,0,NONE,OHSU_HNSCC_derm002
1782,10004,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.758,0,NONE,OHSU_HNSCC_derm002
1783,10004,Blank 490,5,H,OHSU_HNSCC_derm002,16,-0.003,10,F-S-V,OHSU_HNSCC_derm002
1784,10004,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.767,0,NONE,OHSU_HNSCC_derm002
1785,10004,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
1786,10004,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.844,0,NONE,OHSU_HNSCC_derm002
1787,10004,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.714,0,NONE,OHSU_HNSCC_derm002
1788,10004,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.665,0,NONE,OHSU_HNSCC_derm002
1789,10004,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.668,0,NONE,OHSU_HNSCC_derm002
1790,10004,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.699,0,NONE,OHSU_HNSCC_derm002
1791,10004,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.395,0,NONE,OHSU_HNSCC_derm002
1792,10004,Blank 490,5,A,OHSU_HNSCC_derm002,17,-0.003,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1793,10004,Blank 490,5,B,OHSU_HNSCC_derm002,17,-0.001,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1794,10004,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.021,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1795,10004,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.168,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1796,10004,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.363,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1797,10004,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.167,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1798,10004,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.224,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1799,10004,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.192,10,Trametinib,OHSU_HNSCC_derm002
1800,10004,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.089,10,BEZ235,OHSU_HNSCC_derm002
1801,10004,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.087,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1802,10004,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.268,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1803,10004,Blank 490,5,L,OHSU_HNSCC_derm002,17,-0.001,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1804,10004,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.29,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1805,10004,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.151,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1806,10004,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.601,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1807,10004,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.085,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1808,10004,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.0,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1809,10004,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.139,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1810,10004,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.042,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1811,10004,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.342,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1812,10004,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.417,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1813,10004,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.235,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1814,10004,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.243,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1815,10004,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.224,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
1816,10004,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.118,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
1817,10004,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.196,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1818,10004,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.258,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1819,10004,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.009,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1820,10004,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.399,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1821,10004,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.267,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1822,10004,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.656,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1823,10004,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.235,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1824,10004,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.513,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1825,10004,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.854,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1826,10004,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.044,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1827,10004,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.389,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1828,10004,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.524,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1829,10004,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.241,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1830,10004,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.258,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1831,10004,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.243,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
1832,10004,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.158,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
1833,10004,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.242,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1834,10004,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.19,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1835,10004,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.051,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1836,10004,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.431,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1837,10004,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.304,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1838,10004,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.783,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1839,10004,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.231,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1840,10004,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.755,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1841,10004,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.799,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1842,10004,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.095,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1843,10004,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.453,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1844,10004,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.684,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1845,10004,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.27,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1846,10004,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.348,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1847,10004,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.214,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
1848,10004,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.158,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
1849,10004,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.365,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1850,10004,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.285,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1851,10004,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.078,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1852,10004,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.527,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1853,10004,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.323,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1854,10004,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.705,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1855,10004,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.241,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1856,10004,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.718,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1857,10004,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.794,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1858,10004,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.208,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1859,10004,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.655,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1860,10004,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.749,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1861,10004,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.404,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1862,10004,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.55,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1863,10004,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.223,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
1864,10004,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.349,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
1865,10004,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.696,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1866,10004,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.433,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1867,10004,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.211,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1868,10004,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.671,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1869,10004,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.476,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1870,10004,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.738,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1871,10004,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.227,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1872,10004,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.729,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1873,10004,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.733,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1874,10004,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.303,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1875,10004,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.725,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1876,10004,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.842,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1877,10004,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.575,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1878,10004,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.615,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1879,10004,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.346,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
1880,10004,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.601,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
1881,10004,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.702,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1882,10004,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.614,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1883,10004,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.389,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1884,10004,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.623,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1885,10004,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.613,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1886,10004,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.71,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1887,10004,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.296,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1888,10004,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.715,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1889,10004,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.773,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
1890,10004,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.475,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1891,10004,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.707,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
1892,10004,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.754,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
1893,10004,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.674,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1894,10004,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.748,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
1895,10004,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.33,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
1896,10004,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.698,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
1897,10004,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.772,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
1898,10004,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.678,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
1899,10004,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.516,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
1900,10004,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.67,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
1901,10004,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.718,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1902,10004,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.608,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
1903,10004,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.324,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
1904,10004,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.75,0,NONE,OHSU_HNSCC_derm002
1905,10004,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.782,0,NONE,OHSU_HNSCC_derm002
1906,10004,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.649,0,NONE,OHSU_HNSCC_derm002
1907,10004,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.692,0,NONE,OHSU_HNSCC_derm002
1908,10004,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.572,0,NONE,OHSU_HNSCC_derm002
1909,10004,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.716,0,NONE,OHSU_HNSCC_derm002
1910,10004,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.642,0,NONE,OHSU_HNSCC_derm002
1911,10004,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.69,0,NONE,OHSU_HNSCC_derm002
1912,10004,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.695,0,NONE,OHSU_HNSCC_derm002
1913,10004,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.65,0,NONE,OHSU_HNSCC_derm002
1914,10004,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.701,0,NONE,OHSU_HNSCC_derm002
1915,10004,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.566,0,NONE,OHSU_HNSCC_derm002
1916,10004,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.748,0,NONE,OHSU_HNSCC_derm002
1917,10004,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.224,0,NONE,OHSU_HNSCC_derm002
1918,10004,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.746,0,NONE,OHSU_HNSCC_derm002
1919,10004,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.604,0,NONE,OHSU_HNSCC_derm002
1920,10004,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.103,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1921,10004,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.017,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
1922,10004,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.013,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
1923,10004,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.046,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1924,10004,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.01,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
1925,10004,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.015,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1926,10004,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.703,10,IMR 1,OHSU_HNSCC_derm002
1927,10004,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.273,10,Gefitinib,OHSU_HNSCC_derm002
1928,10004,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.347,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
1929,10004,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.582,0,DMSO,OHSU_HNSCC_derm002
1930,10004,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.779,0,DMSO ,OHSU_HNSCC_derm002
1931,10004,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.519,0,DMSO,OHSU_HNSCC_derm002
1932,10004,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.75,0,DMSO ,OHSU_HNSCC_derm002
1933,10004,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.324,0,DMSO,OHSU_HNSCC_derm002
1934,10004,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.465,0,DMSO ,OHSU_HNSCC_derm002
1935,10004,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.307,0,DMSO,OHSU_HNSCC_derm002
1936,10004,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.143,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1937,10004,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.043,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
1938,10004,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.03,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
1939,10004,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.273,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1940,10004,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.099,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
1941,10004,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.014,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1942,10004,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.671,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
1943,10004,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.297,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
1944,10004,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.551,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
1945,10004,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.619,0,DMSO,OHSU_HNSCC_derm002
1946,10004,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.669,0,DMSO ,OHSU_HNSCC_derm002
1947,10004,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.507,0,DMSO,OHSU_HNSCC_derm002
1948,10004,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.729,0,DMSO ,OHSU_HNSCC_derm002
1949,10004,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.423,0,DMSO,OHSU_HNSCC_derm002
1950,10004,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.565,0,DMSO ,OHSU_HNSCC_derm002
1951,10004,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.38,0,DMSO,OHSU_HNSCC_derm002
1952,10004,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.222,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1953,10004,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.136,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
1954,10004,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.084,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
1955,10004,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.243,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1956,10004,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.394,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
1957,10004,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.026,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1958,10004,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.746,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
1959,10004,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.281,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
1960,10004,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.689,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
1961,10004,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.538,0,DMSO,OHSU_HNSCC_derm002
1962,10004,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.647,0,DMSO ,OHSU_HNSCC_derm002
1963,10004,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.624,0,DMSO,OHSU_HNSCC_derm002
1964,10004,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.753,0,DMSO ,OHSU_HNSCC_derm002
1965,10004,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.417,0,DMSO,OHSU_HNSCC_derm002
1966,10004,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.633,0,DMSO ,OHSU_HNSCC_derm002
1967,10004,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.349,0,DMSO,OHSU_HNSCC_derm002
1968,10004,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.381,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1969,10004,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.618,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
1970,10004,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.178,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
1971,10004,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.261,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1972,10004,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.6,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
1973,10004,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.219,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1974,10004,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.65,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
1975,10004,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.282,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
1976,10004,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.709,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
1977,10004,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.605,0,DMSO,OHSU_HNSCC_derm002
1978,10004,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.648,0,DMSO ,OHSU_HNSCC_derm002
1979,10004,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.58,0,DMSO,OHSU_HNSCC_derm002
1980,10004,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.649,0,DMSO ,OHSU_HNSCC_derm002
1981,10004,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.459,0,DMSO,OHSU_HNSCC_derm002
1982,10004,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.544,0,DMSO ,OHSU_HNSCC_derm002
1983,10004,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.42,0,DMSO,OHSU_HNSCC_derm002
1984,10004,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.519,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
1985,10004,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.738,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
1986,10004,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.324,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
1987,10004,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.32,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
1988,10004,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.664,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
1989,10004,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.604,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
1990,10004,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.691,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
1991,10004,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.464,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
1992,10004,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.733,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
1993,10004,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.555,0,DMSO,OHSU_HNSCC_derm002
1994,10004,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.748,0,DMSO ,OHSU_HNSCC_derm002
1995,10004,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.692,0,DMSO,OHSU_HNSCC_derm002
1996,10004,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.832,0,DMSO ,OHSU_HNSCC_derm002
1997,10004,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.476,0,DMSO,OHSU_HNSCC_derm002
1998,10004,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.685,0,DMSO ,OHSU_HNSCC_derm002
1999,10004,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.426,0,DMSO,OHSU_HNSCC_derm002
2000,10004,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.635,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2001,10004,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.78,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
2002,10004,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.509,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
2003,10004,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.397,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
2004,10004,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.671,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
2005,10004,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.716,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
2006,10004,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.744,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
2007,10004,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.523,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
2008,10004,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.734,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
2009,10004,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.527,0,DMSO,OHSU_HNSCC_derm002
2010,10004,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.71,0,DMSO ,OHSU_HNSCC_derm002
2011,10004,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.565,0,DMSO,OHSU_HNSCC_derm002
2012,10004,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.774,0,DMSO ,OHSU_HNSCC_derm002
2013,10004,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.324,0,DMSO,OHSU_HNSCC_derm002
2014,10004,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.568,0,DMSO ,OHSU_HNSCC_derm002
2015,10004,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.397,0,DMSO,OHSU_HNSCC_derm002
2016,10004,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.692,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2017,10004,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.862,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
2018,10004,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.748,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
2019,10004,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.554,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
2020,10004,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.73,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
2021,10004,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.74,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
2022,10004,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.73,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
2023,10004,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.669,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
2024,10004,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.764,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
2025,10004,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.593,0,DMSO,OHSU_HNSCC_derm002
2026,10004,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.739,0,DMSO ,OHSU_HNSCC_derm002
2027,10004,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.569,0,DMSO,OHSU_HNSCC_derm002
2028,10004,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.743,0,DMSO ,OHSU_HNSCC_derm002
2029,10004,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.44,0,DMSO,OHSU_HNSCC_derm002
2030,10004,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.664,0,DMSO ,OHSU_HNSCC_derm002
2031,10004,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.399,0,DMSO,OHSU_HNSCC_derm002
2032,10004,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.755,0,NONE,OHSU_HNSCC_derm002
2033,10004,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.785,0,NONE,OHSU_HNSCC_derm002
2034,10004,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.816,0,NONE,OHSU_HNSCC_derm002
2035,10004,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.626,0,NONE,OHSU_HNSCC_derm002
2036,10004,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.753,0,NONE,OHSU_HNSCC_derm002
2037,10004,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.73,0,NONE,OHSU_HNSCC_derm002
2038,10004,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.767,0,NONE,OHSU_HNSCC_derm002
2039,10004,Blank 490,6,H,OHSU_HNSCC_derm002,8,0.004,10,F-S-V,OHSU_HNSCC_derm002
2040,10004,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.771,0,NONE,OHSU_HNSCC_derm002
2041,10004,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
2042,10004,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.76,0,NONE,OHSU_HNSCC_derm002
2043,10004,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.651,0,NONE,OHSU_HNSCC_derm002
2044,10004,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.76,0,NONE,OHSU_HNSCC_derm002
2045,10004,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.445,0,NONE,OHSU_HNSCC_derm002
2046,10004,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.643,0,NONE,OHSU_HNSCC_derm002
2047,10004,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.33,0,NONE,OHSU_HNSCC_derm002
2048,10004,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.535,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2049,10004,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.009,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2050,10004,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.222,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2051,10004,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.163,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2052,10004,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.356,5,Vandetanib (5mM),OHSU_HNSCC_derm002
2053,10004,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.776,0,DMSO,OHSU_HNSCC_derm002
2054,10004,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.657,0,DMSO ,OHSU_HNSCC_derm002
2055,10004,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.295,10,Brigatinib,OHSU_HNSCC_derm002
2056,10004,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.3,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2057,10004,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.584,0,DMSO,OHSU_HNSCC_derm002
2058,10004,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.657,0,DMSO ,OHSU_HNSCC_derm002
2059,10004,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.476,0,DMSO,OHSU_HNSCC_derm002
2060,10004,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.703,0,DMSO ,OHSU_HNSCC_derm002
2061,10004,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.464,0,DMSO,OHSU_HNSCC_derm002
2062,10004,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.58,0,DMSO ,OHSU_HNSCC_derm002
2063,10004,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.393,0,DMSO,OHSU_HNSCC_derm002
2064,10004,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.736,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2065,10004,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.02,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2066,10004,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.34,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2067,10004,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.204,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2068,10004,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.435,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
2069,10004,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.747,0,DMSO,OHSU_HNSCC_derm002
2070,10004,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.749,0,DMSO ,OHSU_HNSCC_derm002
2071,10004,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.401,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
2072,10004,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.291,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2073,10004,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.624,0,DMSO,OHSU_HNSCC_derm002
2074,10004,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.778,0,DMSO ,OHSU_HNSCC_derm002
2075,10004,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.553,0,DMSO,OHSU_HNSCC_derm002
2076,10004,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.649,0,DMSO ,OHSU_HNSCC_derm002
2077,10004,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.45,0,DMSO,OHSU_HNSCC_derm002
2078,10004,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.643,0,DMSO ,OHSU_HNSCC_derm002
2079,10004,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.427,0,DMSO,OHSU_HNSCC_derm002
2080,10004,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.703,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2081,10004,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.057,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2082,10004,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.409,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2083,10004,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.22,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2084,10004,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.564,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
2085,10004,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.672,0,DMSO,OHSU_HNSCC_derm002
2086,10004,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.684,0,DMSO ,OHSU_HNSCC_derm002
2087,10004,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.614,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
2088,10004,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.296,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2089,10004,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.636,0,DMSO,OHSU_HNSCC_derm002
2090,10004,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.716,0,DMSO ,OHSU_HNSCC_derm002
2091,10004,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.619,0,DMSO,OHSU_HNSCC_derm002
2092,10004,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.773,0,DMSO ,OHSU_HNSCC_derm002
2093,10004,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.374,0,DMSO,OHSU_HNSCC_derm002
2094,10004,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.589,0,DMSO ,OHSU_HNSCC_derm002
2095,10004,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.406,0,DMSO,OHSU_HNSCC_derm002
2096,10004,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.78,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2097,10004,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.126,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2098,10004,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.47,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2099,10004,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.263,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2100,10004,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.603,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
2101,10004,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.736,0,DMSO,OHSU_HNSCC_derm002
2102,10004,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.727,0,DMSO ,OHSU_HNSCC_derm002
2103,10004,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.623,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
2104,10004,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.286,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2105,10004,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.648,0,DMSO,OHSU_HNSCC_derm002
2106,10004,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.705,0,DMSO ,OHSU_HNSCC_derm002
2107,10004,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.662,0,DMSO,OHSU_HNSCC_derm002
2108,10004,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.781,0,DMSO ,OHSU_HNSCC_derm002
2109,10004,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.501,0,DMSO,OHSU_HNSCC_derm002
2110,10004,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.576,0,DMSO ,OHSU_HNSCC_derm002
2111,10004,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.563,0,DMSO,OHSU_HNSCC_derm002
2112,10004,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.794,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2113,10004,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.308,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2114,10004,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.625,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2115,10004,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.391,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2116,10004,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.672,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
2117,10004,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.602,0,DMSO,OHSU_HNSCC_derm002
2118,10004,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.675,0,DMSO ,OHSU_HNSCC_derm002
2119,10004,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.714,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
2120,10004,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.257,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2121,10004,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.671,0,DMSO,OHSU_HNSCC_derm002
2122,10004,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.797,0,DMSO ,OHSU_HNSCC_derm002
2123,10004,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.545,0,DMSO,OHSU_HNSCC_derm002
2124,10004,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.741,0,DMSO ,OHSU_HNSCC_derm002
2125,10004,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.482,0,DMSO,OHSU_HNSCC_derm002
2126,10004,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.517,0,DMSO ,OHSU_HNSCC_derm002
2127,10004,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.577,0,DMSO,OHSU_HNSCC_derm002
2128,10004,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.778,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2129,10004,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.583,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2130,10004,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.775,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2131,10004,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.557,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2132,10004,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.694,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
2133,10004,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.675,0,DMSO,OHSU_HNSCC_derm002
2134,10004,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.74,0,DMSO ,OHSU_HNSCC_derm002
2135,10004,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.627,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
2136,10004,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.3,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2137,10004,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.637,0,DMSO,OHSU_HNSCC_derm002
2138,10004,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.713,0,DMSO ,OHSU_HNSCC_derm002
2139,10004,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.643,0,DMSO,OHSU_HNSCC_derm002
2140,10004,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.633,0,DMSO ,OHSU_HNSCC_derm002
2141,10004,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.538,0,DMSO,OHSU_HNSCC_derm002
2142,10004,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.613,0,DMSO ,OHSU_HNSCC_derm002
2143,10004,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.529,0,DMSO,OHSU_HNSCC_derm002
2144,10004,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.77,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2145,10004,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.748,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
2146,10004,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.736,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
2147,10004,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.647,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
2148,10004,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.679,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
2149,10004,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.667,0,DMSO,OHSU_HNSCC_derm002
2150,10004,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.615,0,DMSO ,OHSU_HNSCC_derm002
2151,10004,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.68,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
2152,10004,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.352,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2153,10004,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.702,0,DMSO,OHSU_HNSCC_derm002
2154,10004,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.696,0,DMSO ,OHSU_HNSCC_derm002
2155,10004,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.66,0,DMSO,OHSU_HNSCC_derm002
2156,10004,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.802,0,DMSO ,OHSU_HNSCC_derm002
2157,10004,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.554,0,DMSO,OHSU_HNSCC_derm002
2158,10004,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.455,0,DMSO ,OHSU_HNSCC_derm002
2159,10004,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.61,0,DMSO,OHSU_HNSCC_derm002
2160,10004,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.718,0,NONE,OHSU_HNSCC_derm002
2161,10004,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.79,0,NONE,OHSU_HNSCC_derm002
2162,10004,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.753,0,NONE,OHSU_HNSCC_derm002
2163,10004,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.649,0,NONE,OHSU_HNSCC_derm002
2164,10004,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.725,0,NONE,OHSU_HNSCC_derm002
2165,10004,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
2166,10004,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.721,0,NONE,OHSU_HNSCC_derm002
2167,10004,Blank 490,6,H,OHSU_HNSCC_derm002,16,-0.004,10,F-S-V,OHSU_HNSCC_derm002
2168,10004,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.741,0,NONE,OHSU_HNSCC_derm002
2169,10004,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.702,0,NONE,OHSU_HNSCC_derm002
2170,10004,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.738,0,NONE,OHSU_HNSCC_derm002
2171,10004,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.711,0,NONE,OHSU_HNSCC_derm002
2172,10004,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.725,0,NONE,OHSU_HNSCC_derm002
2173,10004,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.66,0,NONE,OHSU_HNSCC_derm002
2174,10004,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.585,0,NONE,OHSU_HNSCC_derm002
2175,10004,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.63,0,NONE,OHSU_HNSCC_derm002
2176,10004,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.111,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2177,10004,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.078,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2178,10004,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.75,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2179,10004,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.031,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2180,10004,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.709,10,LY3039478 ,OHSU_HNSCC_derm002
2181,10004,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.255,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2182,10004,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.304,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2183,10004,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.287,10,Trametinib,OHSU_HNSCC_derm002
2184,10004,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.106,10,BEZ235,OHSU_HNSCC_derm002
2185,10004,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.668,0,DMSO,OHSU_HNSCC_derm002
2186,10004,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.695,0,DMSO ,OHSU_HNSCC_derm002
2187,10004,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.616,0,DMSO,OHSU_HNSCC_derm002
2188,10004,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.749,0,DMSO ,OHSU_HNSCC_derm002
2189,10004,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.52,0,DMSO,OHSU_HNSCC_derm002
2190,10004,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.602,0,DMSO ,OHSU_HNSCC_derm002
2191,10004,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.547,0,DMSO,OHSU_HNSCC_derm002
2192,10004,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.169,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2193,10004,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.312,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2194,10004,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.787,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2195,10004,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.043,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2196,10004,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.725,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
2197,10004,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.25,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2198,10004,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.261,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2199,10004,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.205,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
2200,10004,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.104,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
2201,10004,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.665,0,DMSO,OHSU_HNSCC_derm002
2202,10004,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.682,0,DMSO ,OHSU_HNSCC_derm002
2203,10004,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.632,0,DMSO,OHSU_HNSCC_derm002
2204,10004,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.726,0,DMSO ,OHSU_HNSCC_derm002
2205,10004,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.697,0,DMSO,OHSU_HNSCC_derm002
2206,10004,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.512,0,DMSO ,OHSU_HNSCC_derm002
2207,10004,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.636,0,DMSO,OHSU_HNSCC_derm002
2208,10004,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.227,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2209,10004,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.394,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2210,10004,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.733,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2211,10004,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.055,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2212,10004,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.716,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
2213,10004,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.255,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2214,10004,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.185,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2215,10004,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.23,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
2216,10004,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.112,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
2217,10004,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.549,0,DMSO,OHSU_HNSCC_derm002
2218,10004,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.758,0,DMSO ,OHSU_HNSCC_derm002
2219,10004,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.664,0,DMSO,OHSU_HNSCC_derm002
2220,10004,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.588,0,DMSO ,OHSU_HNSCC_derm002
2221,10004,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.685,0,DMSO,OHSU_HNSCC_derm002
2222,10004,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.562,0,DMSO ,OHSU_HNSCC_derm002
2223,10004,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.509,0,DMSO,OHSU_HNSCC_derm002
2224,10004,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.337,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2225,10004,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.524,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2226,10004,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.739,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2227,10004,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.118,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2228,10004,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.681,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
2229,10004,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.262,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2230,10004,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.294,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2231,10004,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.21,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
2232,10004,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.132,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
2233,10004,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.658,0,DMSO,OHSU_HNSCC_derm002
2234,10004,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.716,0,DMSO ,OHSU_HNSCC_derm002
2235,10004,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.731,0,DMSO,OHSU_HNSCC_derm002
2236,10004,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.798,0,DMSO ,OHSU_HNSCC_derm002
2237,10004,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.774,0,DMSO,OHSU_HNSCC_derm002
2238,10004,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.584,0,DMSO ,OHSU_HNSCC_derm002
2239,10004,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.561,0,DMSO,OHSU_HNSCC_derm002
2240,10004,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.528,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2241,10004,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.674,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2242,10004,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.759,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2243,10004,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.313,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2244,10004,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.652,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
2245,10004,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.377,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2246,10004,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.374,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2247,10004,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.223,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
2248,10004,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.149,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
2249,10004,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.655,0,DMSO,OHSU_HNSCC_derm002
2250,10004,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.686,0,DMSO ,OHSU_HNSCC_derm002
2251,10004,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.705,0,DMSO,OHSU_HNSCC_derm002
2252,10004,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.842,0,DMSO ,OHSU_HNSCC_derm002
2253,10004,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.661,0,DMSO,OHSU_HNSCC_derm002
2254,10004,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.539,0,DMSO ,OHSU_HNSCC_derm002
2255,10004,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.462,0,DMSO,OHSU_HNSCC_derm002
2256,10004,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.657,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2257,10004,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.775,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2258,10004,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.761,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2259,10004,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.556,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2260,10004,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.79,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
2261,10004,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.593,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2262,10004,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.398,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2263,10004,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.268,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
2264,10004,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.355,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
2265,10004,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.784,0,DMSO,OHSU_HNSCC_derm002
2266,10004,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.708,0,DMSO ,OHSU_HNSCC_derm002
2267,10004,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.672,0,DMSO,OHSU_HNSCC_derm002
2268,10004,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.727,0,DMSO ,OHSU_HNSCC_derm002
2269,10004,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.748,0,DMSO,OHSU_HNSCC_derm002
2270,10004,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.682,0,DMSO ,OHSU_HNSCC_derm002
2271,10004,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.555,0,DMSO,OHSU_HNSCC_derm002
2272,10004,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.742,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
2273,10004,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.715,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
2274,10004,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.698,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
2275,10004,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.665,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
2276,10004,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.702,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
2277,10004,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.687,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
2278,10004,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.696,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
2279,10004,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.347,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
2280,10004,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.566,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
2281,10004,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.711,0,DMSO,OHSU_HNSCC_derm002
2282,10004,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.64,0,DMSO ,OHSU_HNSCC_derm002
2283,10004,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.7,0,DMSO,OHSU_HNSCC_derm002
2284,10004,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.677,0,DMSO ,OHSU_HNSCC_derm002
2285,10004,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.704,0,DMSO,OHSU_HNSCC_derm002
2286,10004,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.58,0,DMSO ,OHSU_HNSCC_derm002
2287,10004,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.583,0,DMSO,OHSU_HNSCC_derm002
2288,10004,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.721,0,NONE,OHSU_HNSCC_derm002
2289,10004,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.784,0,NONE,OHSU_HNSCC_derm002
2290,10004,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.685,0,NONE,OHSU_HNSCC_derm002
2291,10004,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.653,0,NONE,OHSU_HNSCC_derm002
2292,10004,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.787,0,NONE,OHSU_HNSCC_derm002
2293,10004,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.683,0,NONE,OHSU_HNSCC_derm002
2294,10004,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.537,0,NONE,OHSU_HNSCC_derm002
2295,10004,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.721,0,NONE,OHSU_HNSCC_derm002
2296,10004,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.709,0,NONE,OHSU_HNSCC_derm002
2297,10004,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.662,0,NONE,OHSU_HNSCC_derm002
2298,10004,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.753,0,NONE,OHSU_HNSCC_derm002
2299,10004,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.622,0,NONE,OHSU_HNSCC_derm002
2300,10004,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.567,0,NONE,OHSU_HNSCC_derm002
2301,10004,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.642,0,NONE,OHSU_HNSCC_derm002
2302,10004,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.639,0,NONE,OHSU_HNSCC_derm002
2303,10004,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.532,0,NONE,OHSU_HNSCC_derm002
2304,10139,Blank 490,1,A,OHSU_HNSCC_derm002,1,-0.037,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
2305,10139,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.841,10,Lucitanib ,OHSU_HNSCC_derm002
2306,10139,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.25,10,Resveratrol,OHSU_HNSCC_derm002
2307,10139,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.368,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2308,10139,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.449,10,Bicalutamide,OHSU_HNSCC_derm002
2309,10139,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.805,10,Methotrexate ,OHSU_HNSCC_derm002
2310,10139,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.175,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2311,10139,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.439,10,Gefitinib,OHSU_HNSCC_derm002
2312,10139,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.344,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
2313,10139,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.458,10,Tamatinib/R406,OHSU_HNSCC_derm002
2314,10139,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.316,10,Bosutinib,OHSU_HNSCC_derm002
2315,10139,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.099,10,PI-103,OHSU_HNSCC_derm002
2316,10139,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.417,10,Glycyrrhizin,OHSU_HNSCC_derm002
2317,10139,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.578,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
2318,10139,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.163,10,GSK-690693,OHSU_HNSCC_derm002
2319,10139,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.538,10,Ibrutinib,OHSU_HNSCC_derm002
2320,10139,Blank 490,1,A,OHSU_HNSCC_derm002,2,-0.014,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
2321,10139,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.909,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
2322,10139,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.475,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
2323,10139,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.531,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2324,10139,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.53,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
2325,10139,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.995,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
2326,10139,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.317,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2327,10139,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.771,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
2328,10139,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.649,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
2329,10139,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.662,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
2330,10139,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.388,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
2331,10139,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.141,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
2332,10139,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.47,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
2333,10139,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.759,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
2334,10139,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.386,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
2335,10139,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.714,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
2336,10139,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.061,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
2337,10139,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.803,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
2338,10139,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.465,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
2339,10139,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.669,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2340,10139,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.539,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
2341,10139,Blank 490,1,F,OHSU_HNSCC_derm002,3,1.027,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
2342,10139,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.418,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2343,10139,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.944,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
2344,10139,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.502,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
2345,10139,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.99,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
2346,10139,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.521,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
2347,10139,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.245,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
2348,10139,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.582,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
2349,10139,Blank 490,1,N,OHSU_HNSCC_derm002,3,1.088,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
2350,10139,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.465,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
2351,10139,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.701,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
2352,10139,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.266,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
2353,10139,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.798,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
2354,10139,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.539,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
2355,10139,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.892,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2356,10139,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.499,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
2357,10139,Blank 490,1,F,OHSU_HNSCC_derm002,4,1.075,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
2358,10139,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.462,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2359,10139,Blank 490,1,H,OHSU_HNSCC_derm002,4,1.04,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
2360,10139,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.587,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
2361,10139,Blank 490,1,J,OHSU_HNSCC_derm002,4,1.064,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
2362,10139,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.448,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
2363,10139,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.281,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
2364,10139,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.567,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
2365,10139,Blank 490,1,N,OHSU_HNSCC_derm002,4,1.251,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
2366,10139,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.46,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
2367,10139,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.703,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
2368,10139,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.415,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
2369,10139,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.867,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
2370,10139,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.469,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
2371,10139,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.973,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2372,10139,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.514,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
2373,10139,Blank 490,1,F,OHSU_HNSCC_derm002,5,1.041,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
2374,10139,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.561,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2375,10139,Blank 490,1,H,OHSU_HNSCC_derm002,5,1.089,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
2376,10139,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.517,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
2377,10139,Blank 490,1,J,OHSU_HNSCC_derm002,5,1.047,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
2378,10139,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.522,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
2379,10139,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.688,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
2380,10139,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.505,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
2381,10139,Blank 490,1,N,OHSU_HNSCC_derm002,5,1.396,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
2382,10139,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.512,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
2383,10139,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.796,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
2384,10139,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.498,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
2385,10139,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.915,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
2386,10139,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.512,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
2387,10139,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.992,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2388,10139,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.489,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
2389,10139,Blank 490,1,F,OHSU_HNSCC_derm002,6,1.082,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
2390,10139,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.538,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2391,10139,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.965,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
2392,10139,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.442,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
2393,10139,Blank 490,1,J,OHSU_HNSCC_derm002,6,1.12,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
2394,10139,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.477,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
2395,10139,Blank 490,1,L,OHSU_HNSCC_derm002,6,1.005,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
2396,10139,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.49,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
2397,10139,Blank 490,1,N,OHSU_HNSCC_derm002,6,1.321,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
2398,10139,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.56,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
2399,10139,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.874,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
2400,10139,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.485,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
2401,10139,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.869,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
2402,10139,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
2403,10139,Blank 490,1,D,OHSU_HNSCC_derm002,7,1.041,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
2404,10139,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.522,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
2405,10139,Blank 490,1,F,OHSU_HNSCC_derm002,7,1.149,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
2406,10139,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.479,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
2407,10139,Blank 490,1,H,OHSU_HNSCC_derm002,7,1.131,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
2408,10139,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
2409,10139,Blank 490,1,J,OHSU_HNSCC_derm002,7,1.14,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
2410,10139,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.533,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
2411,10139,Blank 490,1,L,OHSU_HNSCC_derm002,7,1.113,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
2412,10139,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.547,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
2413,10139,Blank 490,1,N,OHSU_HNSCC_derm002,7,1.398,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
2414,10139,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.511,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
2415,10139,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.877,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
2416,10139,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.444,0,NONE,OHSU_HNSCC_derm002
2417,10139,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.871,0,NONE,OHSU_HNSCC_derm002
2418,10139,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.486,0,NONE,OHSU_HNSCC_derm002
2419,10139,Blank 490,1,D,OHSU_HNSCC_derm002,8,1.177,0,NONE,OHSU_HNSCC_derm002
2420,10139,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.522,0,NONE,OHSU_HNSCC_derm002
2421,10139,Blank 490,1,F,OHSU_HNSCC_derm002,8,1.156,0,NONE,OHSU_HNSCC_derm002
2422,10139,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.42,0,NONE,OHSU_HNSCC_derm002
2423,10139,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
2424,10139,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.546,0,NONE,OHSU_HNSCC_derm002
2425,10139,Blank 490,1,J,OHSU_HNSCC_derm002,8,1.151,0,NONE,OHSU_HNSCC_derm002
2426,10139,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.51,0,NONE,OHSU_HNSCC_derm002
2427,10139,Blank 490,1,L,OHSU_HNSCC_derm002,8,1.384,0,NONE,OHSU_HNSCC_derm002
2428,10139,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.543,0,NONE,OHSU_HNSCC_derm002
2429,10139,Blank 490,1,N,OHSU_HNSCC_derm002,8,1.38,0,NONE,OHSU_HNSCC_derm002
2430,10139,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.529,0,NONE,OHSU_HNSCC_derm002
2431,10139,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.737,0,NONE,OHSU_HNSCC_derm002
2432,10139,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.064,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2433,10139,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.426,10,Sorafenib,OHSU_HNSCC_derm002
2434,10139,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.44,10,Rosmarinic acid,OHSU_HNSCC_derm002
2435,10139,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.776,10,Rapamycin,OHSU_HNSCC_derm002
2436,10139,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.419,10,Vismodegib,OHSU_HNSCC_derm002
2437,10139,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.358,10,PP242,OHSU_HNSCC_derm002
2438,10139,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.413,10,Alectinib,OHSU_HNSCC_derm002
2439,10139,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.452,10,Brigatinib,OHSU_HNSCC_derm002
2440,10139,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.387,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2441,10139,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.563,10,MK-2206,OHSU_HNSCC_derm002
2442,10139,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.43,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2443,10139,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.01,10,Flavopiridol ,OHSU_HNSCC_derm002
2444,10139,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.504,10,Indirubin,OHSU_HNSCC_derm002
2445,10139,Blank 490,1,N,OHSU_HNSCC_derm002,9,1.551,10,PF-533228,OHSU_HNSCC_derm002
2446,10139,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.415,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2447,10139,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.053,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2448,10139,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.218,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2449,10139,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.701,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
2450,10139,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.465,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
2451,10139,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.751,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
2452,10139,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.516,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
2453,10139,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.335,3.3333333333333335,PP242,OHSU_HNSCC_derm002
2454,10139,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.387,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
2455,10139,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.652,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
2456,10139,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.502,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2457,10139,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.644,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
2458,10139,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.479,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2459,10139,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.005,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
2460,10139,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.627,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
2461,10139,Blank 490,1,N,OHSU_HNSCC_derm002,10,1.673,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
2462,10139,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.42,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2463,10139,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.058,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2464,10139,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.218,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2465,10139,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.758,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
2466,10139,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.51,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
2467,10139,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.749,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
2468,10139,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.511,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
2469,10139,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.478,1.1111111111111112,PP242,OHSU_HNSCC_derm002
2470,10139,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.423,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
2471,10139,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.944,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
2472,10139,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.434,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2473,10139,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.756,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
2474,10139,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.454,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2475,10139,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.028,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
2476,10139,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.563,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
2477,10139,Blank 490,1,N,OHSU_HNSCC_derm002,11,1.702,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
2478,10139,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.412,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2479,10139,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.067,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2480,10139,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.254,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2481,10139,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.926,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
2482,10139,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.44,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
2483,10139,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.755,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
2484,10139,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.461,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
2485,10139,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.707,0.3703703703703704,PP242,OHSU_HNSCC_derm002
2486,10139,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.442,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
2487,10139,Blank 490,1,H,OHSU_HNSCC_derm002,12,1.032,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
2488,10139,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.471,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2489,10139,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.864,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
2490,10139,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.416,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2491,10139,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.014,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
2492,10139,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.482,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
2493,10139,Blank 490,1,N,OHSU_HNSCC_derm002,12,1.446,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
2494,10139,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.515,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2495,10139,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.093,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2496,10139,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.274,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2497,10139,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.942,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
2498,10139,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.418,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
2499,10139,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.787,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
2500,10139,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.483,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
2501,10139,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.81,0.1234567901234568,PP242,OHSU_HNSCC_derm002
2502,10139,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.411,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
2503,10139,Blank 490,1,H,OHSU_HNSCC_derm002,13,1.131,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
2504,10139,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.467,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2505,10139,Blank 490,1,J,OHSU_HNSCC_derm002,13,1.068,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
2506,10139,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.428,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2507,10139,Blank 490,1,L,OHSU_HNSCC_derm002,13,1.076,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
2508,10139,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.526,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
2509,10139,Blank 490,1,N,OHSU_HNSCC_derm002,13,1.371,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
2510,10139,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.44,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2511,10139,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.256,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2512,10139,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.363,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2513,10139,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.762,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
2514,10139,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.48,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
2515,10139,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.829,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
2516,10139,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.46,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
2517,10139,Blank 490,1,F,OHSU_HNSCC_derm002,14,1.047,0.0411522633744856,PP242,OHSU_HNSCC_derm002
2518,10139,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.455,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
2519,10139,Blank 490,1,H,OHSU_HNSCC_derm002,14,1.106,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
2520,10139,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.454,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2521,10139,Blank 490,1,J,OHSU_HNSCC_derm002,14,1.107,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
2522,10139,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.453,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2523,10139,Blank 490,1,L,OHSU_HNSCC_derm002,14,1.281,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
2524,10139,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.526,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
2525,10139,Blank 490,1,N,OHSU_HNSCC_derm002,14,1.443,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
2526,10139,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.59,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2527,10139,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.612,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2528,10139,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.427,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
2529,10139,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.842,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
2530,10139,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.476,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
2531,10139,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.853,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
2532,10139,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.633,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
2533,10139,Blank 490,1,F,OHSU_HNSCC_derm002,15,1.119,0.013717421124828532,PP242,OHSU_HNSCC_derm002
2534,10139,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.562,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
2535,10139,Blank 490,1,H,OHSU_HNSCC_derm002,15,1.137,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
2536,10139,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.481,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2537,10139,Blank 490,1,J,OHSU_HNSCC_derm002,15,1.149,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
2538,10139,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.5,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
2539,10139,Blank 490,1,L,OHSU_HNSCC_derm002,15,1.212,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
2540,10139,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.658,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
2541,10139,Blank 490,1,N,OHSU_HNSCC_derm002,15,1.348,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
2542,10139,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.593,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
2543,10139,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.607,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
2544,10139,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.476,0,NONE,OHSU_HNSCC_derm002
2545,10139,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.807,0,NONE,OHSU_HNSCC_derm002
2546,10139,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.536,0,NONE,OHSU_HNSCC_derm002
2547,10139,Blank 490,1,D,OHSU_HNSCC_derm002,16,1.205,0,NONE,OHSU_HNSCC_derm002
2548,10139,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.607,0,NONE,OHSU_HNSCC_derm002
2549,10139,Blank 490,1,F,OHSU_HNSCC_derm002,16,1.146,0,NONE,OHSU_HNSCC_derm002
2550,10139,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.667,0,NONE,OHSU_HNSCC_derm002
2551,10139,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
2552,10139,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.597,0,NONE,OHSU_HNSCC_derm002
2553,10139,Blank 490,1,J,OHSU_HNSCC_derm002,16,1.101,0,NONE,OHSU_HNSCC_derm002
2554,10139,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.568,0,NONE,OHSU_HNSCC_derm002
2555,10139,Blank 490,1,L,OHSU_HNSCC_derm002,16,1.236,0,NONE,OHSU_HNSCC_derm002
2556,10139,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.685,0,NONE,OHSU_HNSCC_derm002
2557,10139,Blank 490,1,N,OHSU_HNSCC_derm002,16,1.296,0,NONE,OHSU_HNSCC_derm002
2558,10139,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.7,0,NONE,OHSU_HNSCC_derm002
2559,10139,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.643,0,NONE,OHSU_HNSCC_derm002
2560,10139,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.21,10,Emodin,OHSU_HNSCC_derm002
2561,10139,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.49,10,Baicalin,OHSU_HNSCC_derm002
2562,10139,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.039,10,NVP-TAE-684,OHSU_HNSCC_derm002
2563,10139,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.088,10,Panobinostat,OHSU_HNSCC_derm002
2564,10139,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.037,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
2565,10139,Blank 490,1,F,OHSU_HNSCC_derm002,17,1.213,10,Fulvestrant,OHSU_HNSCC_derm002
2566,10139,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.72,10,SCH-772984,OHSU_HNSCC_derm002
2567,10139,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.939,10,Trametinib,OHSU_HNSCC_derm002
2568,10139,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.187,10,BEZ235,OHSU_HNSCC_derm002
2569,10139,Blank 490,1,J,OHSU_HNSCC_derm002,17,1.276,10,MLN120B,OHSU_HNSCC_derm002
2570,10139,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.608,10,Ixabepilone,OHSU_HNSCC_derm002
2571,10139,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.78,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
2572,10139,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.834,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2573,10139,Blank 490,1,N,OHSU_HNSCC_derm002,17,1.903,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2574,10139,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.467,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2575,10139,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.859,10,Letrozole,OHSU_HNSCC_derm002
2576,10139,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.33,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
2577,10139,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.69,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
2578,10139,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.54,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
2579,10139,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.102,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
2580,10139,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.143,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
2581,10139,Blank 490,1,F,OHSU_HNSCC_derm002,18,1.104,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
2582,10139,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.795,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
2583,10139,Blank 490,1,H,OHSU_HNSCC_derm002,18,1.081,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
2584,10139,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.214,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
2585,10139,Blank 490,1,J,OHSU_HNSCC_derm002,18,1.26,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
2586,10139,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.617,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
2587,10139,Blank 490,1,L,OHSU_HNSCC_derm002,18,1.144,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
2588,10139,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.993,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2589,10139,Blank 490,1,N,OHSU_HNSCC_derm002,18,1.973,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2590,10139,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.561,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2591,10139,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.783,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
2592,10139,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.437,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
2593,10139,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.838,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
2594,10139,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.643,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
2595,10139,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.21,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
2596,10139,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.303,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
2597,10139,Blank 490,1,F,OHSU_HNSCC_derm002,19,1.174,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
2598,10139,Blank 490,1,G,OHSU_HNSCC_derm002,19,1.038,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
2599,10139,Blank 490,1,H,OHSU_HNSCC_derm002,19,1.27,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
2600,10139,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.205,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
2601,10139,Blank 490,1,J,OHSU_HNSCC_derm002,19,1.215,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
2602,10139,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.79,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
2603,10139,Blank 490,1,L,OHSU_HNSCC_derm002,19,1.065,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
2604,10139,Blank 490,1,M,OHSU_HNSCC_derm002,19,1.097,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2605,10139,Blank 490,1,N,OHSU_HNSCC_derm002,19,2.034,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2606,10139,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.728,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2607,10139,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.78,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
2608,10139,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.536,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
2609,10139,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.701,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
2610,10139,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.786,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
2611,10139,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.561,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
2612,10139,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.486,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
2613,10139,Blank 490,1,F,OHSU_HNSCC_derm002,20,1.188,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
2614,10139,Blank 490,1,G,OHSU_HNSCC_derm002,20,1.178,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
2615,10139,Blank 490,1,H,OHSU_HNSCC_derm002,20,1.185,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
2616,10139,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.32,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
2617,10139,Blank 490,1,J,OHSU_HNSCC_derm002,20,1.244,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
2618,10139,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.813,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
2619,10139,Blank 490,1,L,OHSU_HNSCC_derm002,20,1.028,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
2620,10139,Blank 490,1,M,OHSU_HNSCC_derm002,20,1.155,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2621,10139,Blank 490,1,N,OHSU_HNSCC_derm002,20,1.958,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2622,10139,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.778,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2623,10139,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.731,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
2624,10139,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.558,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
2625,10139,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.781,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
2626,10139,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.8,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
2627,10139,Blank 490,1,D,OHSU_HNSCC_derm002,21,1.146,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
2628,10139,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.625,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
2629,10139,Blank 490,1,F,OHSU_HNSCC_derm002,21,1.188,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
2630,10139,Blank 490,1,G,OHSU_HNSCC_derm002,21,1.278,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
2631,10139,Blank 490,1,H,OHSU_HNSCC_derm002,21,1.313,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
2632,10139,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.52,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
2633,10139,Blank 490,1,J,OHSU_HNSCC_derm002,21,1.184,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
2634,10139,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.954,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
2635,10139,Blank 490,1,L,OHSU_HNSCC_derm002,21,1.109,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
2636,10139,Blank 490,1,M,OHSU_HNSCC_derm002,21,1.381,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2637,10139,Blank 490,1,N,OHSU_HNSCC_derm002,21,1.829,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2638,10139,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.809,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2639,10139,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.793,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
2640,10139,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.778,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
2641,10139,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.687,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
2642,10139,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.912,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
2643,10139,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.97,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
2644,10139,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.852,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
2645,10139,Blank 490,1,F,OHSU_HNSCC_derm002,22,1.147,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
2646,10139,Blank 490,1,G,OHSU_HNSCC_derm002,22,1.358,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
2647,10139,Blank 490,1,H,OHSU_HNSCC_derm002,22,1.297,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
2648,10139,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.833,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
2649,10139,Blank 490,1,J,OHSU_HNSCC_derm002,22,1.159,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
2650,10139,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.968,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
2651,10139,Blank 490,1,L,OHSU_HNSCC_derm002,22,1.206,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
2652,10139,Blank 490,1,M,OHSU_HNSCC_derm002,22,1.242,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2653,10139,Blank 490,1,N,OHSU_HNSCC_derm002,22,1.42,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2654,10139,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.587,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2655,10139,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.915,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
2656,10139,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.73,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
2657,10139,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.737,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
2658,10139,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.857,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
2659,10139,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.794,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
2660,10139,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.806,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
2661,10139,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.854,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
2662,10139,Blank 490,1,G,OHSU_HNSCC_derm002,23,1.057,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
2663,10139,Blank 490,1,H,OHSU_HNSCC_derm002,23,1.127,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
2664,10139,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.9,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
2665,10139,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.82,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
2666,10139,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.855,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
2667,10139,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.864,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
2668,10139,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.936,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
2669,10139,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.915,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
2670,10139,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.471,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
2671,10139,Blank 490,1,P,OHSU_HNSCC_derm002,23,1.024,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
2672,10139,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.674,0,NONE,OHSU_HNSCC_derm002
2673,10139,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.83,0,NONE,OHSU_HNSCC_derm002
2674,10139,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.825,0,NONE,OHSU_HNSCC_derm002
2675,10139,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.776,0,NONE,OHSU_HNSCC_derm002
2676,10139,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.678,0,NONE,OHSU_HNSCC_derm002
2677,10139,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.549,0,NONE,OHSU_HNSCC_derm002
2678,10139,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.763,0,NONE,OHSU_HNSCC_derm002
2679,10139,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.505,0,NONE,OHSU_HNSCC_derm002
2680,10139,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.6,0,NONE,OHSU_HNSCC_derm002
2681,10139,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.613,0,NONE,OHSU_HNSCC_derm002
2682,10139,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.701,0,NONE,OHSU_HNSCC_derm002
2683,10139,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.555,0,NONE,OHSU_HNSCC_derm002
2684,10139,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.718,0,NONE,OHSU_HNSCC_derm002
2685,10139,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.668,0,NONE,OHSU_HNSCC_derm002
2686,10139,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.802,0,NONE,OHSU_HNSCC_derm002
2687,10139,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.924,0,NONE,OHSU_HNSCC_derm002
2688,10139,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.826,10,Coumarin,OHSU_HNSCC_derm002
2689,10139,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.44,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2690,10139,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.214,10,Foretinib (XL-880),OHSU_HNSCC_derm002
2691,10139,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.661,10,Elesclomol,OHSU_HNSCC_derm002
2692,10139,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.744,10,Vemurafenib,OHSU_HNSCC_derm002
2693,10139,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.15,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2694,10139,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.067,10,Ponatinib,OHSU_HNSCC_derm002
2695,10139,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.668,10,Gefitinib,OHSU_HNSCC_derm002
2696,10139,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.89,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
2697,10139,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.768,1,Sunitinib (1mM),OHSU_HNSCC_derm002
2698,10139,Blank 490,2,K,OHSU_HNSCC_derm002,1,1.158,10,Curcumin,OHSU_HNSCC_derm002
2699,10139,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.078,10,PF-562271,OHSU_HNSCC_derm002
2700,10139,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.831,10,STO609,OHSU_HNSCC_derm002
2701,10139,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.576,10,Lenvatinib,OHSU_HNSCC_derm002
2702,10139,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.709,10,Entrectinib,OHSU_HNSCC_derm002
2703,10139,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.784,10,Ethyl Gallate ,OHSU_HNSCC_derm002
2704,10139,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.88,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
2705,10139,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.614,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2706,10139,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.783,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
2707,10139,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.68,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
2708,10139,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.961,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
2709,10139,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.142,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2710,10139,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.466,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
2711,10139,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.576,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
2712,10139,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.867,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
2713,10139,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.701,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
2714,10139,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.946,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
2715,10139,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.747,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
2716,10139,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.764,3.3333333333333335,STO609,OHSU_HNSCC_derm002
2717,10139,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.663,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
2718,10139,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.911,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
2719,10139,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.772,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
2720,10139,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.918,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
2721,10139,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.668,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2722,10139,Blank 490,2,C,OHSU_HNSCC_derm002,3,1.04,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
2723,10139,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.643,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
2724,10139,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.929,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
2725,10139,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.266,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2726,10139,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.785,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
2727,10139,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.648,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
2728,10139,Blank 490,2,I,OHSU_HNSCC_derm002,3,1.028,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
2729,10139,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.76,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
2730,10139,Blank 490,2,K,OHSU_HNSCC_derm002,3,1.011,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
2731,10139,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.839,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
2732,10139,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.96,1.1111111111111112,STO609,OHSU_HNSCC_derm002
2733,10139,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.745,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
2734,10139,Blank 490,2,O,OHSU_HNSCC_derm002,3,1.045,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
2735,10139,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.88,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
2736,10139,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.8,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
2737,10139,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.624,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2738,10139,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.953,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
2739,10139,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.549,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
2740,10139,Blank 490,2,E,OHSU_HNSCC_derm002,4,1.014,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
2741,10139,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.404,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2742,10139,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.97,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
2743,10139,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.669,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
2744,10139,Blank 490,2,I,OHSU_HNSCC_derm002,4,1.086,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
2745,10139,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.737,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
2746,10139,Blank 490,2,K,OHSU_HNSCC_derm002,4,1.063,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
2747,10139,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.762,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
2748,10139,Blank 490,2,M,OHSU_HNSCC_derm002,4,1.157,0.3703703703703704,STO609,OHSU_HNSCC_derm002
2749,10139,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
2750,10139,Blank 490,2,O,OHSU_HNSCC_derm002,4,1.062,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
2751,10139,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.852,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
2752,10139,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.729,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
2753,10139,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.672,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2754,10139,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.933,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
2755,10139,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.66,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
2756,10139,Blank 490,2,E,OHSU_HNSCC_derm002,5,1.073,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
2757,10139,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.506,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2758,10139,Blank 490,2,G,OHSU_HNSCC_derm002,5,1.075,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
2759,10139,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.728,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
2760,10139,Blank 490,2,I,OHSU_HNSCC_derm002,5,1.138,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
2761,10139,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.809,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
2762,10139,Blank 490,2,K,OHSU_HNSCC_derm002,5,1.168,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
2763,10139,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.791,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
2764,10139,Blank 490,2,M,OHSU_HNSCC_derm002,5,1.19,0.1234567901234568,STO609,OHSU_HNSCC_derm002
2765,10139,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.788,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
2766,10139,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.992,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
2767,10139,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.901,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
2768,10139,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.647,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
2769,10139,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.652,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2770,10139,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.942,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
2771,10139,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.621,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
2772,10139,Blank 490,2,E,OHSU_HNSCC_derm002,6,1.062,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
2773,10139,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.697,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2774,10139,Blank 490,2,G,OHSU_HNSCC_derm002,6,1.114,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
2775,10139,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.729,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
2776,10139,Blank 490,2,I,OHSU_HNSCC_derm002,6,1.128,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
2777,10139,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.814,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
2778,10139,Blank 490,2,K,OHSU_HNSCC_derm002,6,1.144,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
2779,10139,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.779,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
2780,10139,Blank 490,2,M,OHSU_HNSCC_derm002,6,1.183,0.0411522633744856,STO609,OHSU_HNSCC_derm002
2781,10139,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.759,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
2782,10139,Blank 490,2,O,OHSU_HNSCC_derm002,6,1.098,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
2783,10139,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.853,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
2784,10139,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.897,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
2785,10139,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.643,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
2786,10139,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.992,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
2787,10139,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.623,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
2788,10139,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.979,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
2789,10139,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.736,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
2790,10139,Blank 490,2,G,OHSU_HNSCC_derm002,7,1.14,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
2791,10139,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.721,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
2792,10139,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.721,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
2793,10139,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.58,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
2794,10139,Blank 490,2,K,OHSU_HNSCC_derm002,7,1.179,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
2795,10139,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.811,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
2796,10139,Blank 490,2,M,OHSU_HNSCC_derm002,7,1.259,0.013717421124828532,STO609,OHSU_HNSCC_derm002
2797,10139,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.812,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
2798,10139,Blank 490,2,O,OHSU_HNSCC_derm002,7,1.141,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
2799,10139,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.836,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
2800,10139,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.951,0,NONE,OHSU_HNSCC_derm002
2801,10139,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.642,0,NONE,OHSU_HNSCC_derm002
2802,10139,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.878,0,NONE,OHSU_HNSCC_derm002
2803,10139,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.759,0,NONE,OHSU_HNSCC_derm002
2804,10139,Blank 490,2,E,OHSU_HNSCC_derm002,8,1.023,0,NONE,OHSU_HNSCC_derm002
2805,10139,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.756,0,NONE,OHSU_HNSCC_derm002
2806,10139,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.691,0,NONE,OHSU_HNSCC_derm002
2807,10139,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
2808,10139,Blank 490,2,I,OHSU_HNSCC_derm002,8,1.005,0,NONE,OHSU_HNSCC_derm002
2809,10139,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.731,0,NONE,OHSU_HNSCC_derm002
2810,10139,Blank 490,2,K,OHSU_HNSCC_derm002,8,1.133,0,NONE,OHSU_HNSCC_derm002
2811,10139,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.792,0,NONE,OHSU_HNSCC_derm002
2812,10139,Blank 490,2,M,OHSU_HNSCC_derm002,8,1.153,0,NONE,OHSU_HNSCC_derm002
2813,10139,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.747,0,NONE,OHSU_HNSCC_derm002
2814,10139,Blank 490,2,O,OHSU_HNSCC_derm002,8,1.062,0,NONE,OHSU_HNSCC_derm002
2815,10139,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.835,0,NONE,OHSU_HNSCC_derm002
2816,10139,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.154,10,GDC-0941,OHSU_HNSCC_derm002
2817,10139,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.598,10,Dovitinib,OHSU_HNSCC_derm002
2818,10139,Blank 490,2,C,OHSU_HNSCC_derm002,9,1.557,10,BI-2536,OHSU_HNSCC_derm002
2819,10139,Blank 490,2,D,OHSU_HNSCC_derm002,9,-0.016,10,TP-0903 ,OHSU_HNSCC_derm002
2820,10139,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.215,10,Belinostat,OHSU_HNSCC_derm002
2821,10139,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.127,10,INK-128,OHSU_HNSCC_derm002
2822,10139,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.242,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2823,10139,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.266,10,Brigatinib,OHSU_HNSCC_derm002
2824,10139,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.267,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2825,10139,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.636,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2826,10139,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.5,10,Pazopanib,OHSU_HNSCC_derm002
2827,10139,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.807,10,AZD4547,OHSU_HNSCC_derm002
2828,10139,Blank 490,2,M,OHSU_HNSCC_derm002,9,1.131,10,Pomalidomide ,OHSU_HNSCC_derm002
2829,10139,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.705,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
2830,10139,Blank 490,2,O,OHSU_HNSCC_derm002,9,1.107,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2831,10139,Blank 490,2,P,OHSU_HNSCC_derm002,9,-0.016,10,Staurosporin,OHSU_HNSCC_derm002
2832,10139,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.148,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
2833,10139,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.74,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
2834,10139,Blank 490,2,C,OHSU_HNSCC_derm002,10,1.673,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
2835,10139,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.0,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
2836,10139,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.561,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
2837,10139,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.132,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
2838,10139,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.506,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2839,10139,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.496,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
2840,10139,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.833,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2841,10139,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.769,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2842,10139,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.697,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
2843,10139,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.838,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
2844,10139,Blank 490,2,M,OHSU_HNSCC_derm002,10,1.17,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
2845,10139,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.784,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
2846,10139,Blank 490,2,O,OHSU_HNSCC_derm002,10,1.102,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2847,10139,Blank 490,2,P,OHSU_HNSCC_derm002,10,-0.002,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
2848,10139,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.223,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
2849,10139,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.743,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
2850,10139,Blank 490,2,C,OHSU_HNSCC_derm002,11,1.52,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
2851,10139,Blank 490,2,D,OHSU_HNSCC_derm002,11,-0.003,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
2852,10139,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.646,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
2853,10139,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.203,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
2854,10139,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.645,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2855,10139,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.613,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
2856,10139,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.902,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2857,10139,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.887,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2858,10139,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.9,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
2859,10139,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.866,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
2860,10139,Blank 490,2,M,OHSU_HNSCC_derm002,11,1.107,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
2861,10139,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.829,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
2862,10139,Blank 490,2,O,OHSU_HNSCC_derm002,11,1.011,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2863,10139,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.008,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
2864,10139,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.33,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
2865,10139,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.87,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
2866,10139,Blank 490,2,C,OHSU_HNSCC_derm002,12,1.196,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
2867,10139,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.571,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
2868,10139,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.724,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
2869,10139,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.279,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
2870,10139,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.743,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2871,10139,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.652,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
2872,10139,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.81,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2873,10139,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.836,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2874,10139,Blank 490,2,K,OHSU_HNSCC_derm002,12,1.059,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
2875,10139,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.784,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
2876,10139,Blank 490,2,M,OHSU_HNSCC_derm002,12,1.117,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
2877,10139,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.817,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
2878,10139,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.999,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2879,10139,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.128,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
2880,10139,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.39,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
2881,10139,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.785,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
2882,10139,Blank 490,2,C,OHSU_HNSCC_derm002,13,1.054,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
2883,10139,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.71,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
2884,10139,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.84,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
2885,10139,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.33,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
2886,10139,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.902,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2887,10139,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.7,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
2888,10139,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.851,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2889,10139,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.795,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2890,10139,Blank 490,2,K,OHSU_HNSCC_derm002,13,1.035,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
2891,10139,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.858,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
2892,10139,Blank 490,2,M,OHSU_HNSCC_derm002,13,1.027,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
2893,10139,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.806,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
2894,10139,Blank 490,2,O,OHSU_HNSCC_derm002,13,1.025,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2895,10139,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.729,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
2896,10139,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.485,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
2897,10139,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.872,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
2898,10139,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.929,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
2899,10139,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.737,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
2900,10139,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.842,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
2901,10139,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.457,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
2902,10139,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.999,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2903,10139,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.718,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
2904,10139,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.982,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2905,10139,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.817,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2906,10139,Blank 490,2,K,OHSU_HNSCC_derm002,14,1.016,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
2907,10139,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.865,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
2908,10139,Blank 490,2,M,OHSU_HNSCC_derm002,14,1.03,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
2909,10139,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.85,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
2910,10139,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.905,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2911,10139,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.627,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
2912,10139,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.746,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
2913,10139,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.705,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
2914,10139,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.986,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
2915,10139,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.559,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
2916,10139,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.737,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
2917,10139,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.525,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
2918,10139,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.967,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
2919,10139,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.768,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
2920,10139,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.913,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
2921,10139,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.75,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
2922,10139,Blank 490,2,K,OHSU_HNSCC_derm002,15,1.048,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
2923,10139,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.89,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
2924,10139,Blank 490,2,M,OHSU_HNSCC_derm002,15,1.057,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
2925,10139,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.875,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
2926,10139,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.958,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
2927,10139,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.56,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
2928,10139,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.976,0,NONE,OHSU_HNSCC_derm002
2929,10139,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.821,0,NONE,OHSU_HNSCC_derm002
2930,10139,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.844,0,NONE,OHSU_HNSCC_derm002
2931,10139,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.734,0,NONE,OHSU_HNSCC_derm002
2932,10139,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.837,0,NONE,OHSU_HNSCC_derm002
2933,10139,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.777,0,NONE,OHSU_HNSCC_derm002
2934,10139,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.862,0,NONE,OHSU_HNSCC_derm002
2935,10139,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
2936,10139,Blank 490,2,I,OHSU_HNSCC_derm002,16,1.015,0,NONE,OHSU_HNSCC_derm002
2937,10139,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.83,0,NONE,OHSU_HNSCC_derm002
2938,10139,Blank 490,2,K,OHSU_HNSCC_derm002,16,1.06,0,NONE,OHSU_HNSCC_derm002
2939,10139,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.893,0,NONE,OHSU_HNSCC_derm002
2940,10139,Blank 490,2,M,OHSU_HNSCC_derm002,16,1.103,0,NONE,OHSU_HNSCC_derm002
2941,10139,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.916,0,NONE,OHSU_HNSCC_derm002
2942,10139,Blank 490,2,O,OHSU_HNSCC_derm002,16,1.06,0,NONE,OHSU_HNSCC_derm002
2943,10139,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.914,0,NONE,OHSU_HNSCC_derm002
2944,10139,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.514,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
2945,10139,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.952,10,Hesperidin,OHSU_HNSCC_derm002
2946,10139,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.693,10,Esculetin,OHSU_HNSCC_derm002
2947,10139,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.123,10,Selinexor ,OHSU_HNSCC_derm002
2948,10139,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.665,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
2949,10139,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.635,10,BMX-IN-1,OHSU_HNSCC_derm002
2950,10139,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.538,1,Dasatinib (1mM),OHSU_HNSCC_derm002
2951,10139,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.569,10,Trametinib,OHSU_HNSCC_derm002
2952,10139,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.288,10,BEZ235,OHSU_HNSCC_derm002
2953,10139,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.079,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
2954,10139,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.892,10,Nilotinib,OHSU_HNSCC_derm002
2955,10139,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.729,10,Enzalutamide,OHSU_HNSCC_derm002
2956,10139,Blank 490,2,M,OHSU_HNSCC_derm002,17,1.028,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
2957,10139,Blank 490,2,N,OHSU_HNSCC_derm002,17,1.119,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
2958,10139,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.012,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
2959,10139,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.476,10,Axitinib,OHSU_HNSCC_derm002
2960,10139,Blank 490,2,A,OHSU_HNSCC_derm002,18,1.004,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
2961,10139,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.779,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
2962,10139,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.791,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
2963,10139,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.228,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
2964,10139,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.803,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
2965,10139,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.698,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
2966,10139,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.497,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
2967,10139,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.74,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
2968,10139,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.302,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
2969,10139,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.096,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
2970,10139,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.926,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
2971,10139,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.915,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
2972,10139,Blank 490,2,M,OHSU_HNSCC_derm002,18,1.004,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
2973,10139,Blank 490,2,N,OHSU_HNSCC_derm002,18,1.318,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
2974,10139,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.017,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
2975,10139,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.584,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
2976,10139,Blank 490,2,A,OHSU_HNSCC_derm002,19,1.0,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
2977,10139,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.806,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
2978,10139,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.804,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
2979,10139,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.239,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
2980,10139,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.862,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
2981,10139,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.78,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
2982,10139,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.604,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
2983,10139,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.823,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
2984,10139,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.285,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
2985,10139,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.109,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
2986,10139,Blank 490,2,K,OHSU_HNSCC_derm002,19,1.042,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
2987,10139,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.852,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
2988,10139,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.997,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
2989,10139,Blank 490,2,N,OHSU_HNSCC_derm002,19,1.29,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
2990,10139,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.018,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
2991,10139,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.704,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
2992,10139,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.956,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
2993,10139,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.851,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
2994,10139,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.83,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
2995,10139,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.433,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
2996,10139,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.896,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
2997,10139,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.772,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
2998,10139,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.803,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
2999,10139,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.831,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
3000,10139,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.34,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
3001,10139,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.175,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
3002,10139,Blank 490,2,K,OHSU_HNSCC_derm002,20,1.135,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
3003,10139,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.9,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
3004,10139,Blank 490,2,M,OHSU_HNSCC_derm002,20,1.016,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
3005,10139,Blank 490,2,N,OHSU_HNSCC_derm002,20,1.339,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
3006,10139,Blank 490,2,O,OHSU_HNSCC_derm002,20,1.074,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
3007,10139,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.881,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
3008,10139,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.82,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
3009,10139,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.737,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
3010,10139,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.826,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
3011,10139,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.625,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
3012,10139,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.828,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
3013,10139,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.813,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
3014,10139,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.872,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
3015,10139,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.915,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
3016,10139,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.457,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
3017,10139,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.429,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
3018,10139,Blank 490,2,K,OHSU_HNSCC_derm002,21,1.082,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
3019,10139,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.974,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
3020,10139,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.975,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
3021,10139,Blank 490,2,N,OHSU_HNSCC_derm002,21,1.251,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
3022,10139,Blank 490,2,O,OHSU_HNSCC_derm002,21,1.154,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
3023,10139,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.952,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
3024,10139,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.76,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
3025,10139,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.708,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
3026,10139,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.911,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
3027,10139,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.699,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
3028,10139,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.949,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
3029,10139,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.844,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
3030,10139,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.911,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
3031,10139,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.944,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
3032,10139,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.659,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
3033,10139,Blank 490,2,J,OHSU_HNSCC_derm002,22,1.058,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
3034,10139,Blank 490,2,K,OHSU_HNSCC_derm002,22,1.055,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
3035,10139,Blank 490,2,L,OHSU_HNSCC_derm002,22,1.008,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
3036,10139,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.955,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
3037,10139,Blank 490,2,N,OHSU_HNSCC_derm002,22,1.237,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
3038,10139,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.833,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
3039,10139,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.801,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
3040,10139,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.554,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
3041,10139,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.871,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
3042,10139,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.884,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
3043,10139,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.812,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
3044,10139,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.79,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
3045,10139,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.777,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
3046,10139,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.81,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
3047,10139,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.864,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
3048,10139,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.824,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
3049,10139,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.995,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
3050,10139,Blank 490,2,K,OHSU_HNSCC_derm002,23,1.003,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
3051,10139,Blank 490,2,L,OHSU_HNSCC_derm002,23,1.018,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
3052,10139,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.949,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
3053,10139,Blank 490,2,N,OHSU_HNSCC_derm002,23,1.202,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
3054,10139,Blank 490,2,O,OHSU_HNSCC_derm002,23,1.046,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
3055,10139,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.773,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
3056,10139,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.601,0,NONE,OHSU_HNSCC_derm002
3057,10139,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.751,0,NONE,OHSU_HNSCC_derm002
3058,10139,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.9,0,NONE,OHSU_HNSCC_derm002
3059,10139,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.915,0,NONE,OHSU_HNSCC_derm002
3060,10139,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.774,0,NONE,OHSU_HNSCC_derm002
3061,10139,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.867,0,NONE,OHSU_HNSCC_derm002
3062,10139,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.81,0,NONE,OHSU_HNSCC_derm002
3063,10139,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.801,0,NONE,OHSU_HNSCC_derm002
3064,10139,Blank 490,2,I,OHSU_HNSCC_derm002,24,1.024,0,NONE,OHSU_HNSCC_derm002
3065,10139,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.826,0,NONE,OHSU_HNSCC_derm002
3066,10139,Blank 490,2,K,OHSU_HNSCC_derm002,24,1.064,0,NONE,OHSU_HNSCC_derm002
3067,10139,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.938,0,NONE,OHSU_HNSCC_derm002
3068,10139,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.919,0,NONE,OHSU_HNSCC_derm002
3069,10139,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.983,0,NONE,OHSU_HNSCC_derm002
3070,10139,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.824,0,NONE,OHSU_HNSCC_derm002
3071,10139,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.77,0,NONE,OHSU_HNSCC_derm002
3072,10139,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.563,10,Thalidomide ,OHSU_HNSCC_derm002
3073,10139,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.564,10,Vandetanib,OHSU_HNSCC_derm002
3074,10139,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.74,10,Oleic acid,OHSU_HNSCC_derm002
3075,10139,Blank 490,3,D,OHSU_HNSCC_derm002,1,-0.005,10,A-674563,OHSU_HNSCC_derm002
3076,10139,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.454,10,Lapatinib,OHSU_HNSCC_derm002
3077,10139,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.787,10,Apocynin (vanillin),OHSU_HNSCC_derm002
3078,10139,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.016,10,AT-7519,OHSU_HNSCC_derm002
3079,10139,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.621,10,Gefitinib,OHSU_HNSCC_derm002
3080,10139,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.721,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
3081,10139,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.056,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3082,10139,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.597,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3083,10139,Blank 490,3,L,OHSU_HNSCC_derm002,1,1.046,10,JQ1,OHSU_HNSCC_derm002
3084,10139,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.934,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3085,10139,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.929,10,Cerdulatinib,OHSU_HNSCC_derm002
3086,10139,Blank 490,3,O,OHSU_HNSCC_derm002,1,-0.002,10,Romidepsin,OHSU_HNSCC_derm002
3087,10139,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.745,10,Gilteritinib,OHSU_HNSCC_derm002
3088,10139,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.717,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
3089,10139,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.614,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
3090,10139,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.811,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
3091,10139,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.579,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
3092,10139,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.596,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
3093,10139,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.806,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
3094,10139,Blank 490,3,G,OHSU_HNSCC_derm002,2,-0.003,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
3095,10139,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.659,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
3096,10139,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.784,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
3097,10139,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.185,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3098,10139,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.686,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3099,10139,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.986,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
3100,10139,Blank 490,3,M,OHSU_HNSCC_derm002,2,1.015,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3101,10139,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.987,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
3102,10139,Blank 490,3,O,OHSU_HNSCC_derm002,2,-0.003,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
3103,10139,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.857,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
3104,10139,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.76,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
3105,10139,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.551,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
3106,10139,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.729,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
3107,10139,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.365,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
3108,10139,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.613,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
3109,10139,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.696,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
3110,10139,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.008,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
3111,10139,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.621,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
3112,10139,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.882,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
3113,10139,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.538,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3114,10139,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.748,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3115,10139,Blank 490,3,L,OHSU_HNSCC_derm002,3,1.058,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
3116,10139,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.958,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3117,10139,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.835,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
3118,10139,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.023,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
3119,10139,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.863,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
3120,10139,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.641,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
3121,10139,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.744,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
3122,10139,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.727,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
3123,10139,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.486,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
3124,10139,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.691,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
3125,10139,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.726,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
3126,10139,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.916,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
3127,10139,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.635,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
3128,10139,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.883,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
3129,10139,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.669,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3130,10139,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.787,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3131,10139,Blank 490,3,L,OHSU_HNSCC_derm002,4,1.07,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
3132,10139,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.844,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3133,10139,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.799,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
3134,10139,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.054,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
3135,10139,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.8,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
3136,10139,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.718,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
3137,10139,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.662,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
3138,10139,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.526,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
3139,10139,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.555,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
3140,10139,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.661,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
3141,10139,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.725,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
3142,10139,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.675,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
3143,10139,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.654,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
3144,10139,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.85,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
3145,10139,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.622,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3146,10139,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.753,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3147,10139,Blank 490,3,L,OHSU_HNSCC_derm002,5,1.046,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
3148,10139,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.883,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3149,10139,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.755,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
3150,10139,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.056,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
3151,10139,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.931,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
3152,10139,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.713,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
3153,10139,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.603,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
3154,10139,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.617,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
3155,10139,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.539,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
3156,10139,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.747,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
3157,10139,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.676,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
3158,10139,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.809,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
3159,10139,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.638,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
3160,10139,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.812,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
3161,10139,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.698,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3162,10139,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.736,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3163,10139,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.9,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
3164,10139,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.886,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3165,10139,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.785,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
3166,10139,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.075,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
3167,10139,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.742,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
3168,10139,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.875,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
3169,10139,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.672,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
3170,10139,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.689,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
3171,10139,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.683,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
3172,10139,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.788,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
3173,10139,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.735,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
3174,10139,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.795,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
3175,10139,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.733,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
3176,10139,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.766,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
3177,10139,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.724,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
3178,10139,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.759,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
3179,10139,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.829,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
3180,10139,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.872,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
3181,10139,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.849,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
3182,10139,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.066,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
3183,10139,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.857,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
3184,10139,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.723,0,NONE,OHSU_HNSCC_derm002
3185,10139,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.596,0,NONE,OHSU_HNSCC_derm002
3186,10139,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.7,0,NONE,OHSU_HNSCC_derm002
3187,10139,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
3188,10139,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.777,0,NONE,OHSU_HNSCC_derm002
3189,10139,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.732,0,NONE,OHSU_HNSCC_derm002
3190,10139,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.811,0,NONE,OHSU_HNSCC_derm002
3191,10139,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
3192,10139,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.692,0,NONE,OHSU_HNSCC_derm002
3193,10139,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.745,0,NONE,OHSU_HNSCC_derm002
3194,10139,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.778,0,NONE,OHSU_HNSCC_derm002
3195,10139,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.676,0,NONE,OHSU_HNSCC_derm002
3196,10139,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.927,0,NONE,OHSU_HNSCC_derm002
3197,10139,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.843,0,NONE,OHSU_HNSCC_derm002
3198,10139,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.744,0,NONE,OHSU_HNSCC_derm002
3199,10139,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.814,0,NONE,OHSU_HNSCC_derm002
3200,10139,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.846,10,Anastrazole,OHSU_HNSCC_derm002
3201,10139,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.588,10,JNJ-28312141 ,OHSU_HNSCC_derm002
3202,10139,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.646,10,Genistein,OHSU_HNSCC_derm002
3203,10139,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.694,10,Abscisic acid,OHSU_HNSCC_derm002
3204,10139,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.537,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3205,10139,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.695,10,Ruxolitinib,OHSU_HNSCC_derm002
3206,10139,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.664,10,TAK-659,OHSU_HNSCC_derm002
3207,10139,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.21,10,Brigatinib,OHSU_HNSCC_derm002
3208,10139,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.665,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3209,10139,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.008,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3210,10139,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.372,10,Vorinostat,OHSU_HNSCC_derm002
3211,10139,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.796,10,Lenalidomide,OHSU_HNSCC_derm002
3212,10139,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.798,10,NVP-ADW742,OHSU_HNSCC_derm002
3213,10139,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.653,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3214,10139,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.821,10,Echinatin,OHSU_HNSCC_derm002
3215,10139,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.035,10,YM-155,OHSU_HNSCC_derm002
3216,10139,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.735,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
3217,10139,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.73,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
3218,10139,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.703,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
3219,10139,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.722,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
3220,10139,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.689,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3221,10139,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.73,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
3222,10139,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.742,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
3223,10139,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.466,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
3224,10139,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.651,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3225,10139,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.479,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3226,10139,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.759,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
3227,10139,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.799,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
3228,10139,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.823,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
3229,10139,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.783,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3230,10139,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.751,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
3231,10139,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.027,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
3232,10139,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.697,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
3233,10139,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.524,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
3234,10139,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.743,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
3235,10139,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.657,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
3236,10139,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.784,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3237,10139,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.765,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
3238,10139,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.809,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
3239,10139,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.662,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
3240,10139,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.7,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3241,10139,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.651,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3242,10139,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.696,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
3243,10139,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.727,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
3244,10139,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.724,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
3245,10139,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.765,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3246,10139,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.838,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
3247,10139,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.024,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
3248,10139,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.645,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
3249,10139,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.593,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
3250,10139,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.606,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
3251,10139,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.717,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
3252,10139,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.718,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3253,10139,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.743,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
3254,10139,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.776,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
3255,10139,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.644,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
3256,10139,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.702,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3257,10139,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.746,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3258,10139,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.675,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
3259,10139,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.79,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
3260,10139,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.872,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
3261,10139,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.763,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3262,10139,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.841,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
3263,10139,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.008,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
3264,10139,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.771,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
3265,10139,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.782,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
3266,10139,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.726,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
3267,10139,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.673,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
3268,10139,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.727,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3269,10139,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.718,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
3270,10139,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.748,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
3271,10139,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.694,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
3272,10139,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.704,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3273,10139,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.737,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3274,10139,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.751,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
3275,10139,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.767,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
3276,10139,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.852,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
3277,10139,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.828,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3278,10139,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.858,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
3279,10139,Blank 490,3,P,OHSU_HNSCC_derm002,13,0.014,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
3280,10139,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.681,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
3281,10139,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.609,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
3282,10139,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.642,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
3283,10139,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.655,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
3284,10139,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.795,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3285,10139,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.721,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
3286,10139,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.797,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
3287,10139,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.746,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
3288,10139,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.676,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3289,10139,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.703,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3290,10139,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.709,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
3291,10139,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
3292,10139,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.812,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
3293,10139,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.785,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3294,10139,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.782,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
3295,10139,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.234,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
3296,10139,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.853,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
3297,10139,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.737,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
3298,10139,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.676,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
3299,10139,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.705,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
3300,10139,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.733,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
3301,10139,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.783,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
3302,10139,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.791,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
3303,10139,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.749,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
3304,10139,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.752,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3305,10139,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.737,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
3306,10139,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.747,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
3307,10139,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.658,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
3308,10139,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.834,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
3309,10139,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.765,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
3310,10139,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.884,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
3311,10139,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.746,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
3312,10139,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.657,0,NONE,OHSU_HNSCC_derm002
3313,10139,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.626,0,NONE,OHSU_HNSCC_derm002
3314,10139,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.691,0,NONE,OHSU_HNSCC_derm002
3315,10139,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.689,0,NONE,OHSU_HNSCC_derm002
3316,10139,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.694,0,NONE,OHSU_HNSCC_derm002
3317,10139,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.798,0,NONE,OHSU_HNSCC_derm002
3318,10139,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.561,0,NONE,OHSU_HNSCC_derm002
3319,10139,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
3320,10139,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.73,0,NONE,OHSU_HNSCC_derm002
3321,10139,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.827,0,NONE,OHSU_HNSCC_derm002
3322,10139,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.738,0,NONE,OHSU_HNSCC_derm002
3323,10139,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.768,0,NONE,OHSU_HNSCC_derm002
3324,10139,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.886,0,NONE,OHSU_HNSCC_derm002
3325,10139,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.821,0,NONE,OHSU_HNSCC_derm002
3326,10139,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.809,0,NONE,OHSU_HNSCC_derm002
3327,10139,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.833,0,NONE,OHSU_HNSCC_derm002
3328,10139,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.562,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3329,10139,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.66,10,Stevioside,OHSU_HNSCC_derm002
3330,10139,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.675,10,Pemetrexed,OHSU_HNSCC_derm002
3331,10139,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.194,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3332,10139,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.653,10,GSK-1838705A,OHSU_HNSCC_derm002
3333,10139,Blank 490,3,F,OHSU_HNSCC_derm002,17,0.019,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3334,10139,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.789,10,Imatinib,OHSU_HNSCC_derm002
3335,10139,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.549,10,Trametinib,OHSU_HNSCC_derm002
3336,10139,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.293,10,BEZ235,OHSU_HNSCC_derm002
3337,10139,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.607,10,Saracatinib,OHSU_HNSCC_derm002
3338,10139,Blank 490,3,K,OHSU_HNSCC_derm002,17,1.113,10,I-BET 762,OHSU_HNSCC_derm002
3339,10139,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.288,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
3340,10139,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.974,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
3341,10139,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.93,10,Crizotinib,OHSU_HNSCC_derm002
3342,10139,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.479,10,MGCD-265,OHSU_HNSCC_derm002
3343,10139,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.441,10,Erlotinib,OHSU_HNSCC_derm002
3344,10139,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.643,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3345,10139,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.63,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
3346,10139,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.721,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
3347,10139,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.22,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3348,10139,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.624,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
3349,10139,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.558,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3350,10139,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.81,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
3351,10139,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.69,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
3352,10139,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.254,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
3353,10139,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.691,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
3354,10139,Blank 490,3,K,OHSU_HNSCC_derm002,18,1.081,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
3355,10139,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.394,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
3356,10139,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.867,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
3357,10139,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.838,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
3358,10139,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.663,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
3359,10139,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.771,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
3360,10139,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.758,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3361,10139,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.563,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
3362,10139,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.667,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
3363,10139,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.24,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3364,10139,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.688,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
3365,10139,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.552,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3366,10139,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.806,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
3367,10139,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.815,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
3368,10139,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.289,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
3369,10139,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.705,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
3370,10139,Blank 490,3,K,OHSU_HNSCC_derm002,19,1.189,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
3371,10139,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.589,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
3372,10139,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.842,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
3373,10139,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.845,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
3374,10139,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.759,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
3375,10139,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.76,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
3376,10139,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.667,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3377,10139,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.685,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
3378,10139,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.687,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
3379,10139,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.249,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3380,10139,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.765,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
3381,10139,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.711,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3382,10139,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.815,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
3383,10139,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.722,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
3384,10139,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.368,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
3385,10139,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.683,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
3386,10139,Blank 490,3,K,OHSU_HNSCC_derm002,20,1.158,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
3387,10139,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.615,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
3388,10139,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.838,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
3389,10139,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.724,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
3390,10139,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.805,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
3391,10139,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.817,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
3392,10139,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.646,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3393,10139,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.654,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
3394,10139,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.706,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
3395,10139,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.289,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3396,10139,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.69,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
3397,10139,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.483,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3398,10139,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.824,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
3399,10139,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.814,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
3400,10139,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.442,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
3401,10139,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.753,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
3402,10139,Blank 490,3,K,OHSU_HNSCC_derm002,21,1.095,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
3403,10139,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.628,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
3404,10139,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.795,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
3405,10139,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.845,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
3406,10139,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.887,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
3407,10139,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.775,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
3408,10139,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.666,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3409,10139,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.702,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
3410,10139,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.684,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
3411,10139,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.313,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3412,10139,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.676,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
3413,10139,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.767,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3414,10139,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.804,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
3415,10139,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.811,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
3416,10139,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.62,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
3417,10139,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.726,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
3418,10139,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.92,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
3419,10139,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.749,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
3420,10139,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.849,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
3421,10139,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.866,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
3422,10139,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.895,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
3423,10139,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.767,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
3424,10139,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.662,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
3425,10139,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.739,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
3426,10139,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.847,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
3427,10139,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.424,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
3428,10139,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.73,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
3429,10139,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.675,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
3430,10139,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.763,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
3431,10139,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.904,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
3432,10139,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.704,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
3433,10139,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.734,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
3434,10139,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.871,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
3435,10139,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.791,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
3436,10139,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.849,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
3437,10139,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.892,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
3438,10139,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.853,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
3439,10139,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.797,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
3440,10139,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.555,0,NONE,OHSU_HNSCC_derm002
3441,10139,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.526,0,NONE,OHSU_HNSCC_derm002
3442,10139,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.785,0,NONE,OHSU_HNSCC_derm002
3443,10139,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.841,0,NONE,OHSU_HNSCC_derm002
3444,10139,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.711,0,NONE,OHSU_HNSCC_derm002
3445,10139,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.855,0,NONE,OHSU_HNSCC_derm002
3446,10139,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.777,0,NONE,OHSU_HNSCC_derm002
3447,10139,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.853,0,NONE,OHSU_HNSCC_derm002
3448,10139,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.927,0,NONE,OHSU_HNSCC_derm002
3449,10139,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.927,0,NONE,OHSU_HNSCC_derm002
3450,10139,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.895,0,NONE,OHSU_HNSCC_derm002
3451,10139,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.983,0,NONE,OHSU_HNSCC_derm002
3452,10139,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.815,0,NONE,OHSU_HNSCC_derm002
3453,10139,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.794,0,NONE,OHSU_HNSCC_derm002
3454,10139,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.817,0,NONE,OHSU_HNSCC_derm002
3455,10139,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.824,0,NONE,OHSU_HNSCC_derm002
3456,10139,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.101,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3457,10139,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.047,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3458,10139,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.412,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3459,10139,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.03,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3460,10139,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.033,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3461,10139,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.011,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3462,10139,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.037,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3463,10139,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.016,10,Gefitinib,OHSU_HNSCC_derm002
3464,10139,Blank 490,4,I,OHSU_HNSCC_derm002,1,-0.057,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
3465,10139,Blank 490,4,J,OHSU_HNSCC_derm002,1,-0.001,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3466,10139,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.045,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3467,10139,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.035,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3468,10139,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.043,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3469,10139,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.017,10,VOLASERTIB x,OHSU_HNSCC_derm002
3470,10139,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.036,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3471,10139,Blank 490,4,P,OHSU_HNSCC_derm002,1,0.018,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3472,10139,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.061,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3473,10139,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.231,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3474,10139,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.526,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3475,10139,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.51,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3476,10139,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.315,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3477,10139,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.098,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3478,10139,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.055,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3479,10139,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.698,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
3480,10139,Blank 490,4,I,OHSU_HNSCC_derm002,2,1.03,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
3481,10139,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.084,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3482,10139,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.569,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3483,10139,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.392,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3484,10139,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.293,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3485,10139,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.922,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
3486,10139,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.11,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3487,10139,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.068,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3488,10139,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.208,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3489,10139,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.624,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3490,10139,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.844,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3491,10139,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.484,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3492,10139,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.65,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3493,10139,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.233,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3494,10139,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.111,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3495,10139,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.672,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
3496,10139,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.913,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
3497,10139,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.266,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3498,10139,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.92,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3499,10139,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.538,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3500,10139,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.667,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3501,10139,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.909,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
3502,10139,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.299,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3503,10139,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.171,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3504,10139,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.303,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3505,10139,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.659,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3506,10139,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.833,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3507,10139,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.55,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3508,10139,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.736,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3509,10139,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.285,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3510,10139,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.099,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3511,10139,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.636,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
3512,10139,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.921,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
3513,10139,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.224,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3514,10139,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.747,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3515,10139,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.485,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3516,10139,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.799,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3517,10139,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.842,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
3518,10139,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.867,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3519,10139,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.257,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3520,10139,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.517,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3521,10139,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.709,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3522,10139,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.791,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3523,10139,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.552,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3524,10139,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.661,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3525,10139,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.355,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3526,10139,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.113,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3527,10139,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.731,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
3528,10139,Blank 490,4,I,OHSU_HNSCC_derm002,5,1.077,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
3529,10139,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.367,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3530,10139,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.734,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3531,10139,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.571,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3532,10139,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.819,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3533,10139,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.804,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
3534,10139,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.456,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3535,10139,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.42,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3536,10139,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.746,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3537,10139,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.788,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3538,10139,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.898,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3539,10139,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.563,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3540,10139,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.875,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3541,10139,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.467,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3542,10139,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.113,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3543,10139,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.757,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
3544,10139,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.89,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
3545,10139,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.519,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3546,10139,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.8,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3547,10139,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.6,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3548,10139,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.864,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3549,10139,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.722,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
3550,10139,Blank 490,4,O,OHSU_HNSCC_derm002,6,1.029,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3551,10139,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.632,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3552,10139,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.716,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
3553,10139,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.736,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
3554,10139,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.953,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
3555,10139,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.621,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
3556,10139,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.79,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
3557,10139,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.652,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
3558,10139,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.123,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
3559,10139,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.665,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
3560,10139,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.926,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
3561,10139,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.762,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
3562,10139,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.895,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
3563,10139,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.726,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
3564,10139,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.983,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
3565,10139,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.709,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
3566,10139,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.955,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3567,10139,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.796,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
3568,10139,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.83,0,NONE,OHSU_HNSCC_derm002
3569,10139,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.762,0,NONE,OHSU_HNSCC_derm002
3570,10139,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.909,0,NONE,OHSU_HNSCC_derm002
3571,10139,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.654,0,NONE,OHSU_HNSCC_derm002
3572,10139,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.885,0,NONE,OHSU_HNSCC_derm002
3573,10139,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.641,0,NONE,OHSU_HNSCC_derm002
3574,10139,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.908,0,NONE,OHSU_HNSCC_derm002
3575,10139,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
3576,10139,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.957,0,NONE,OHSU_HNSCC_derm002
3577,10139,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.866,0,NONE,OHSU_HNSCC_derm002
3578,10139,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.883,0,NONE,OHSU_HNSCC_derm002
3579,10139,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.707,0,NONE,OHSU_HNSCC_derm002
3580,10139,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.993,0,NONE,OHSU_HNSCC_derm002
3581,10139,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
3582,10139,Blank 490,4,O,OHSU_HNSCC_derm002,8,1.002,0,NONE,OHSU_HNSCC_derm002
3583,10139,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.811,0,NONE,OHSU_HNSCC_derm002
3584,10139,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.1,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3585,10139,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.707,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3586,10139,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.07,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
3587,10139,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.28,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3588,10139,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.433,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3589,10139,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.06,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
3590,10139,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.291,10,AZD2014 x ,OHSU_HNSCC_derm002
3591,10139,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.339,10,Brigatinib,OHSU_HNSCC_derm002
3592,10139,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.71,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3593,10139,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.121,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3594,10139,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.658,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3595,10139,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.013,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
3596,10139,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.708,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3597,10139,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.621,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3598,10139,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.778,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3599,10139,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.376,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3600,10139,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.687,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3601,10139,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.786,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3602,10139,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.123,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
3603,10139,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.4,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3604,10139,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.666,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3605,10139,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.1,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
3606,10139,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.324,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
3607,10139,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.539,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
3608,10139,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.807,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3609,10139,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.514,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3610,10139,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.848,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3611,10139,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.354,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
3612,10139,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.872,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3613,10139,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.75,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3614,10139,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.85,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3615,10139,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.678,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3616,10139,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.717,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3617,10139,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.752,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3618,10139,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.223,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
3619,10139,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.555,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3620,10139,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.709,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3621,10139,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.128,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
3622,10139,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.346,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
3623,10139,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.644,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
3624,10139,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.764,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3625,10139,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.621,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3626,10139,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.862,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3627,10139,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.679,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
3628,10139,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.834,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3629,10139,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.667,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3630,10139,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.772,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3631,10139,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.764,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3632,10139,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.622,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3633,10139,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.906,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3634,10139,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.291,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
3635,10139,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.606,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3636,10139,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.763,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3637,10139,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.22,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
3638,10139,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.445,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
3639,10139,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.677,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
3640,10139,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.874,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3641,10139,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.639,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3642,10139,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.808,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3643,10139,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.692,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
3644,10139,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.777,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3645,10139,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.634,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3646,10139,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.753,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3647,10139,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.721,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3648,10139,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.661,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3649,10139,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.929,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3650,10139,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.549,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
3651,10139,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.623,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3652,10139,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.78,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3653,10139,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.446,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
3654,10139,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.602,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
3655,10139,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.745,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
3656,10139,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.8,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3657,10139,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.681,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3658,10139,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.839,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3659,10139,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.773,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
3660,10139,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.728,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3661,10139,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.707,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3662,10139,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.86,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3663,10139,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.697,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3664,10139,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.731,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3665,10139,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.91,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3666,10139,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.565,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
3667,10139,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.674,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3668,10139,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.782,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3669,10139,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.573,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
3670,10139,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.732,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
3671,10139,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.7,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
3672,10139,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.798,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3673,10139,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.779,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3674,10139,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.654,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3675,10139,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.678,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
3676,10139,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.801,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3677,10139,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.807,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3678,10139,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.939,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3679,10139,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.756,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3680,10139,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.837,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
3681,10139,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.867,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
3682,10139,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.72,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
3683,10139,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.664,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3684,10139,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.837,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
3685,10139,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.572,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
3686,10139,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.784,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
3687,10139,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.779,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
3688,10139,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.791,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3689,10139,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.823,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
3690,10139,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.866,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
3691,10139,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.739,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
3692,10139,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.749,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3693,10139,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.721,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
3694,10139,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.963,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
3695,10139,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.826,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
3696,10139,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.778,0,NONE,OHSU_HNSCC_derm002
3697,10139,Blank 490,4,B,OHSU_HNSCC_derm002,16,1.017,0,NONE,OHSU_HNSCC_derm002
3698,10139,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.678,0,NONE,OHSU_HNSCC_derm002
3699,10139,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.587,0,NONE,OHSU_HNSCC_derm002
3700,10139,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.728,0,NONE,OHSU_HNSCC_derm002
3701,10139,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.778,0,NONE,OHSU_HNSCC_derm002
3702,10139,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.821,0,NONE,OHSU_HNSCC_derm002
3703,10139,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
3704,10139,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.883,0,NONE,OHSU_HNSCC_derm002
3705,10139,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.932,0,NONE,OHSU_HNSCC_derm002
3706,10139,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.838,0,NONE,OHSU_HNSCC_derm002
3707,10139,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.698,0,NONE,OHSU_HNSCC_derm002
3708,10139,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.699,0,NONE,OHSU_HNSCC_derm002
3709,10139,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.697,0,NONE,OHSU_HNSCC_derm002
3710,10139,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.964,0,NONE,OHSU_HNSCC_derm002
3711,10139,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.851,0,NONE,OHSU_HNSCC_derm002
3712,10139,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.54,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3713,10139,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.212,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3714,10139,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.068,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3715,10139,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.005,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3716,10139,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.405,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3717,10139,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.355,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3718,10139,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.612,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3719,10139,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.517,10,Trametinib,OHSU_HNSCC_derm002
3720,10139,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.284,10,BEZ235,OHSU_HNSCC_derm002
3721,10139,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.068,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3722,10139,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.674,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3723,10139,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.216,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3724,10139,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.801,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3725,10139,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.797,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3726,10139,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.592,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3727,10139,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.052,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3728,10139,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.882,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3729,10139,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.923,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3730,10139,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.678,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3731,10139,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.017,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3732,10139,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.668,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3733,10139,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.54,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3734,10139,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.777,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3735,10139,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.73,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
3736,10139,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.267,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
3737,10139,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.456,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3738,10139,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.873,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3739,10139,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.463,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3740,10139,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.847,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3741,10139,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.763,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3742,10139,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.845,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3743,10139,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.4,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3744,10139,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.871,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3745,10139,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.904,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3746,10139,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.086,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3747,10139,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.056,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3748,10139,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.076,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3749,10139,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.62,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3750,10139,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.849,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3751,10139,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.76,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
3752,10139,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.339,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
3753,10139,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.552,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3754,10139,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.764,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3755,10139,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.502,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3756,10139,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.898,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3757,10139,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.786,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3758,10139,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.88,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3759,10139,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.666,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3760,10139,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.82,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3761,10139,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.851,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3762,10139,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.195,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3763,10139,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.078,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3764,10139,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.16,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3765,10139,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.633,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3766,10139,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.804,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3767,10139,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.725,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
3768,10139,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.356,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
3769,10139,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.674,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3770,10139,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.718,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3771,10139,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.611,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3772,10139,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.78,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3773,10139,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.876,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3774,10139,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.889,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3775,10139,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.68,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3776,10139,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.92,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3777,10139,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.836,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3778,10139,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.117,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3779,10139,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.031,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3780,10139,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.101,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3781,10139,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.607,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3782,10139,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.854,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3783,10139,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.773,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
3784,10139,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.352,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
3785,10139,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.748,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3786,10139,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.841,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3787,10139,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.649,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3788,10139,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.832,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3789,10139,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.901,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3790,10139,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.867,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3791,10139,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.84,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3792,10139,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.883,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3793,10139,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.928,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3794,10139,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.743,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3795,10139,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.071,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3796,10139,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.583,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3797,10139,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.624,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3798,10139,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.747,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3799,10139,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.736,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
3800,10139,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.58,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
3801,10139,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.75,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3802,10139,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.837,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3803,10139,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.738,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3804,10139,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.852,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3805,10139,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.73,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3806,10139,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.869,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3807,10139,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.785,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3808,10139,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.832,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
3809,10139,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.897,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
3810,10139,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.752,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3811,10139,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.104,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
3812,10139,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.68,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
3813,10139,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.649,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
3814,10139,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.759,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
3815,10139,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.788,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
3816,10139,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.785,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
3817,10139,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.83,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
3818,10139,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.875,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3819,10139,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.773,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
3820,10139,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.801,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
3821,10139,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.767,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3822,10139,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.871,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
3823,10139,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.738,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
3824,10139,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.814,0,NONE,OHSU_HNSCC_derm002
3825,10139,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.793,0,NONE,OHSU_HNSCC_derm002
3826,10139,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.827,0,NONE,OHSU_HNSCC_derm002
3827,10139,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.807,0,NONE,OHSU_HNSCC_derm002
3828,10139,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.738,0,NONE,OHSU_HNSCC_derm002
3829,10139,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.72,0,NONE,OHSU_HNSCC_derm002
3830,10139,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.842,0,NONE,OHSU_HNSCC_derm002
3831,10139,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.754,0,NONE,OHSU_HNSCC_derm002
3832,10139,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.808,0,NONE,OHSU_HNSCC_derm002
3833,10139,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.8,0,NONE,OHSU_HNSCC_derm002
3834,10139,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.912,0,NONE,OHSU_HNSCC_derm002
3835,10139,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.877,0,NONE,OHSU_HNSCC_derm002
3836,10139,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.895,0,NONE,OHSU_HNSCC_derm002
3837,10139,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.875,0,NONE,OHSU_HNSCC_derm002
3838,10139,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.796,0,NONE,OHSU_HNSCC_derm002
3839,10139,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.705,0,NONE,OHSU_HNSCC_derm002
3840,10139,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.491,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3841,10139,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.628,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3842,10139,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.009,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3843,10139,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.049,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3844,10139,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.031,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3845,10139,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.395,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3846,10139,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.604,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3847,10139,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.596,10,Gefitinib,OHSU_HNSCC_derm002
3848,10139,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.036,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
3849,10139,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.011,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3850,10139,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.596,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3851,10139,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.532,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3852,10139,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.076,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3853,10139,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.664,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3854,10139,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.042,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3855,10139,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.026,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3856,10139,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.6,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3857,10139,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.658,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3858,10139,Blank 490,5,C,OHSU_HNSCC_derm002,2,0.012,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3859,10139,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.342,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3860,10139,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.566,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3861,10139,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.454,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3862,10139,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.8,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3863,10139,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.697,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
3864,10139,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.82,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
3865,10139,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.073,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3866,10139,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.728,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3867,10139,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.58,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3868,10139,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.148,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3869,10139,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.618,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3870,10139,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.068,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3871,10139,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.41,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3872,10139,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.577,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3873,10139,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.74,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3874,10139,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.072,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3875,10139,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.591,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3876,10139,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.795,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3877,10139,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.447,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3878,10139,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.819,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3879,10139,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.603,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
3880,10139,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.932,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
3881,10139,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3882,10139,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.745,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3883,10139,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.614,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3884,10139,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.264,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3885,10139,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.747,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3886,10139,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.275,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3887,10139,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.496,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3888,10139,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.691,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3889,10139,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.724,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3890,10139,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.056,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3891,10139,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.648,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3892,10139,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.634,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3893,10139,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.608,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3894,10139,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.676,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3895,10139,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.607,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
3896,10139,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.822,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
3897,10139,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.238,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3898,10139,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.622,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3899,10139,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.627,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3900,10139,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.317,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3901,10139,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.68,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3902,10139,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.306,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3903,10139,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.557,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3904,10139,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.652,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3905,10139,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.734,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3906,10139,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.05,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3907,10139,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.523,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3908,10139,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.626,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3909,10139,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.567,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3910,10139,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.717,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3911,10139,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.637,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
3912,10139,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.85,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
3913,10139,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.487,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3914,10139,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.742,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3915,10139,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.642,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3916,10139,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.329,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3917,10139,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.694,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3918,10139,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.408,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3919,10139,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.631,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3920,10139,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.636,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3921,10139,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.78,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3922,10139,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.076,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3923,10139,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.539,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3924,10139,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.649,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3925,10139,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.635,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3926,10139,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.789,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3927,10139,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.641,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
3928,10139,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.81,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
3929,10139,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.623,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3930,10139,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.63,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3931,10139,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.637,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3932,10139,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.433,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3933,10139,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.682,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3934,10139,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.621,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3935,10139,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.715,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3936,10139,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.727,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3937,10139,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.774,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
3938,10139,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.091,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
3939,10139,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.608,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
3940,10139,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.738,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
3941,10139,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.687,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
3942,10139,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.742,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
3943,10139,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.702,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
3944,10139,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.839,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
3945,10139,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.729,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
3946,10139,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.69,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
3947,10139,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.64,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
3948,10139,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.585,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3949,10139,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.737,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
3950,10139,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.806,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
3951,10139,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.732,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
3952,10139,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.984,0,NONE,OHSU_HNSCC_derm002
3953,10139,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.769,0,NONE,OHSU_HNSCC_derm002
3954,10139,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.775,0,NONE,OHSU_HNSCC_derm002
3955,10139,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.688,0,NONE,OHSU_HNSCC_derm002
3956,10139,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.799,0,NONE,OHSU_HNSCC_derm002
3957,10139,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.761,0,NONE,OHSU_HNSCC_derm002
3958,10139,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.717,0,NONE,OHSU_HNSCC_derm002
3959,10139,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
3960,10139,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.906,0,NONE,OHSU_HNSCC_derm002
3961,10139,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.806,0,NONE,OHSU_HNSCC_derm002
3962,10139,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.813,0,NONE,OHSU_HNSCC_derm002
3963,10139,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.588,0,NONE,OHSU_HNSCC_derm002
3964,10139,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.874,0,NONE,OHSU_HNSCC_derm002
3965,10139,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.758,0,NONE,OHSU_HNSCC_derm002
3966,10139,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.745,0,NONE,OHSU_HNSCC_derm002
3967,10139,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.774,0,NONE,OHSU_HNSCC_derm002
3968,10139,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.007,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
3969,10139,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.699,10,APTO-253 x,OHSU_HNSCC_derm002
3970,10139,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.054,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
3971,10139,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.649,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
3972,10139,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.663,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
3973,10139,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.052,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3974,10139,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.346,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3975,10139,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.325,10,Brigatinib,OHSU_HNSCC_derm002
3976,10139,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.729,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3977,10139,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.041,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
3978,10139,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.019,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
3979,10139,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.078,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
3980,10139,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.496,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
3981,10139,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.644,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3982,10139,Blank 490,5,O,OHSU_HNSCC_derm002,9,-0.006,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
3983,10139,Blank 490,5,P,OHSU_HNSCC_derm002,9,-0.012,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
3984,10139,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.022,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
3985,10139,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.58,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
3986,10139,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.066,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
3987,10139,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.576,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
3988,10139,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.596,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
3989,10139,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.11,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
3990,10139,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.629,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
3991,10139,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.509,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
3992,10139,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.725,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
3993,10139,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.153,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
3994,10139,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.013,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
3995,10139,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.075,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
3996,10139,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.794,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
3997,10139,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.638,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
3998,10139,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.003,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
3999,10139,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.002,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4000,10139,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.044,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
4001,10139,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.745,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
4002,10139,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.082,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
4003,10139,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.654,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
4004,10139,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.664,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
4005,10139,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.135,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4006,10139,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.677,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4007,10139,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.656,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
4008,10139,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.826,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4009,10139,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.124,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
4010,10139,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.153,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4011,10139,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.096,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
4012,10139,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.736,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
4013,10139,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.663,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4014,10139,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.232,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4015,10139,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.102,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4016,10139,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.059,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
4017,10139,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.895,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
4018,10139,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.122,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
4019,10139,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.594,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
4020,10139,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.716,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
4021,10139,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.184,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4022,10139,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.661,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4023,10139,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.658,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
4024,10139,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.746,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4025,10139,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.27,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
4026,10139,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.643,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4027,10139,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.139,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
4028,10139,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.805,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
4029,10139,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.684,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4030,10139,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.726,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4031,10139,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.623,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4032,10139,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.079,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
4033,10139,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.778,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
4034,10139,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.656,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
4035,10139,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.568,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
4036,10139,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.744,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
4037,10139,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.271,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4038,10139,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.635,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4039,10139,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.703,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
4040,10139,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.761,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4041,10139,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.391,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
4042,10139,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.691,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4043,10139,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.516,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
4044,10139,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.691,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
4045,10139,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.722,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4046,10139,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.772,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4047,10139,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.728,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4048,10139,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.05,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
4049,10139,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.788,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
4050,10139,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.547,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
4051,10139,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.718,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
4052,10139,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.69,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
4053,10139,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.367,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4054,10139,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.65,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4055,10139,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.676,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
4056,10139,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.795,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4057,10139,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.481,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
4058,10139,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.709,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4059,10139,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.645,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
4060,10139,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.745,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
4061,10139,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.702,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4062,10139,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.822,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4063,10139,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.86,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4064,10139,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.102,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
4065,10139,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.84,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
4066,10139,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.589,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
4067,10139,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.651,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
4068,10139,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.732,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
4069,10139,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.502,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4070,10139,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.63,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4071,10139,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.794,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
4072,10139,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.77,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4073,10139,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.677,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
4074,10139,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.869,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4075,10139,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.505,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
4076,10139,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.793,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
4077,10139,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.801,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4078,10139,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.831,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4079,10139,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.739,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4080,10139,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.802,0,NONE,OHSU_HNSCC_derm002
4081,10139,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.862,0,NONE,OHSU_HNSCC_derm002
4082,10139,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.708,0,NONE,OHSU_HNSCC_derm002
4083,10139,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.678,0,NONE,OHSU_HNSCC_derm002
4084,10139,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.708,0,NONE,OHSU_HNSCC_derm002
4085,10139,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.727,0,NONE,OHSU_HNSCC_derm002
4086,10139,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.706,0,NONE,OHSU_HNSCC_derm002
4087,10139,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
4088,10139,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.756,0,NONE,OHSU_HNSCC_derm002
4089,10139,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.764,0,NONE,OHSU_HNSCC_derm002
4090,10139,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.603,0,NONE,OHSU_HNSCC_derm002
4091,10139,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.613,0,NONE,OHSU_HNSCC_derm002
4092,10139,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
4093,10139,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.79,0,NONE,OHSU_HNSCC_derm002
4094,10139,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.851,0,NONE,OHSU_HNSCC_derm002
4095,10139,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.648,0,NONE,OHSU_HNSCC_derm002
4096,10139,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.005,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4097,10139,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.062,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4098,10139,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.1,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4099,10139,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.102,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4100,10139,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.612,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4101,10139,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.454,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4102,10139,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.441,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4103,10139,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.573,10,Trametinib,OHSU_HNSCC_derm002
4104,10139,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.219,10,BEZ235,OHSU_HNSCC_derm002
4105,10139,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.177,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4106,10139,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.69,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4107,10139,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.05,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4108,10139,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.703,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4109,10139,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.321,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4110,10139,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.525,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4111,10139,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.364,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4112,10139,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.037,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4113,10139,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.416,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4114,10139,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.123,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4115,10139,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.471,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4116,10139,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.705,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4117,10139,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.673,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4118,10139,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.722,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4119,10139,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.673,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
4120,10139,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.329,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
4121,10139,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.594,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4122,10139,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.631,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4123,10139,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.078,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4124,10139,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.704,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4125,10139,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.647,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4126,10139,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.764,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4127,10139,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.74,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4128,10139,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.678,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4129,10139,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.687,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4130,10139,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.156,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4131,10139,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.587,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4132,10139,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.671,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4133,10139,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.621,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4134,10139,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.682,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4135,10139,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.682,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
4136,10139,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.297,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
4137,10139,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.728,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4138,10139,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.732,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4139,10139,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.128,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4140,10139,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.77,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4141,10139,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.765,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4142,10139,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.834,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4143,10139,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.691,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4144,10139,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.691,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4145,10139,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.803,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4146,10139,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.221,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4147,10139,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.654,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4148,10139,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.694,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4149,10139,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.647,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4150,10139,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.656,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4151,10139,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.647,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
4152,10139,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.307,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
4153,10139,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.626,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4154,10139,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.715,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4155,10139,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.217,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4156,10139,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.676,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4157,10139,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.701,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4158,10139,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.813,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4159,10139,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.737,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4160,10139,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.717,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4161,10139,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.821,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4162,10139,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.308,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4163,10139,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.661,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4164,10139,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.729,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4165,10139,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.684,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4166,10139,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.71,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4167,10139,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.737,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
4168,10139,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.455,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
4169,10139,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.646,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4170,10139,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.697,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4171,10139,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.274,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4172,10139,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.856,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4173,10139,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.75,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4174,10139,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.789,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4175,10139,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.718,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4176,10139,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.871,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4177,10139,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.923,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4178,10139,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4179,10139,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.844,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4180,10139,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.726,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4181,10139,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.709,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4182,10139,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.666,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4183,10139,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.771,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
4184,10139,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.642,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
4185,10139,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.739,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4186,10139,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.773,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4187,10139,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.37,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4188,10139,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.845,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4189,10139,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.825,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4190,10139,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.79,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4191,10139,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.716,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4192,10139,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.951,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4193,10139,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.779,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
4194,10139,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.479,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4195,10139,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.747,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
4196,10139,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.684,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
4197,10139,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.821,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4198,10139,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.837,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
4199,10139,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.856,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
4200,10139,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.79,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
4201,10139,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.861,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
4202,10139,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.696,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
4203,10139,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.554,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
4204,10139,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.835,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
4205,10139,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.758,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4206,10139,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.754,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
4207,10139,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.706,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
4208,10139,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
4209,10139,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.857,0,NONE,OHSU_HNSCC_derm002
4210,10139,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.804,0,NONE,OHSU_HNSCC_derm002
4211,10139,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.84,0,NONE,OHSU_HNSCC_derm002
4212,10139,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.777,0,NONE,OHSU_HNSCC_derm002
4213,10139,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.87,0,NONE,OHSU_HNSCC_derm002
4214,10139,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.882,0,NONE,OHSU_HNSCC_derm002
4215,10139,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.871,0,NONE,OHSU_HNSCC_derm002
4216,10139,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.953,0,NONE,OHSU_HNSCC_derm002
4217,10139,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.922,0,NONE,OHSU_HNSCC_derm002
4218,10139,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.753,0,NONE,OHSU_HNSCC_derm002
4219,10139,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.809,0,NONE,OHSU_HNSCC_derm002
4220,10139,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.796,0,NONE,OHSU_HNSCC_derm002
4221,10139,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.741,0,NONE,OHSU_HNSCC_derm002
4222,10139,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.887,0,NONE,OHSU_HNSCC_derm002
4223,10139,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.883,0,NONE,OHSU_HNSCC_derm002
4224,10139,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.097,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4225,10139,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.297,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4226,10139,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.016,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4227,10139,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.106,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4228,10139,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.02,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4229,10139,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.112,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4230,10139,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.774,10,IMR 1,OHSU_HNSCC_derm002
4231,10139,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.644,10,Gefitinib,OHSU_HNSCC_derm002
4232,10139,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.591,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
4233,10139,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.776,0,DMSO,OHSU_HNSCC_derm002
4234,10139,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.783,0,DMSO ,OHSU_HNSCC_derm002
4235,10139,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.755,0,DMSO,OHSU_HNSCC_derm002
4236,10139,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.807,0,DMSO ,OHSU_HNSCC_derm002
4237,10139,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.666,0,DMSO,OHSU_HNSCC_derm002
4238,10139,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.8,0,DMSO ,OHSU_HNSCC_derm002
4239,10139,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.741,0,DMSO,OHSU_HNSCC_derm002
4240,10139,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.17,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4241,10139,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.421,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4242,10139,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.061,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4243,10139,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.45,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4244,10139,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.739,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4245,10139,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.364,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4246,10139,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.75,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
4247,10139,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.624,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
4248,10139,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.756,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
4249,10139,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.695,0,DMSO,OHSU_HNSCC_derm002
4250,10139,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.844,0,DMSO ,OHSU_HNSCC_derm002
4251,10139,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.713,0,DMSO,OHSU_HNSCC_derm002
4252,10139,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.765,0,DMSO ,OHSU_HNSCC_derm002
4253,10139,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.712,0,DMSO,OHSU_HNSCC_derm002
4254,10139,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.726,0,DMSO ,OHSU_HNSCC_derm002
4255,10139,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.668,0,DMSO,OHSU_HNSCC_derm002
4256,10139,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.589,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4257,10139,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.41,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4258,10139,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.234,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4259,10139,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.511,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4260,10139,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.58,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4261,10139,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.364,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4262,10139,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.734,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
4263,10139,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.574,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
4264,10139,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.781,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
4265,10139,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.669,0,DMSO,OHSU_HNSCC_derm002
4266,10139,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.696,0,DMSO ,OHSU_HNSCC_derm002
4267,10139,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.681,0,DMSO,OHSU_HNSCC_derm002
4268,10139,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.882,0,DMSO ,OHSU_HNSCC_derm002
4269,10139,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.597,0,DMSO,OHSU_HNSCC_derm002
4270,10139,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.847,0,DMSO ,OHSU_HNSCC_derm002
4271,10139,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.659,0,DMSO,OHSU_HNSCC_derm002
4272,10139,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.567,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4273,10139,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.672,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4274,10139,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.313,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4275,10139,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.48,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4276,10139,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.762,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4277,10139,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.452,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4278,10139,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
4279,10139,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.614,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
4280,10139,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.858,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
4281,10139,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.689,0,DMSO,OHSU_HNSCC_derm002
4282,10139,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.728,0,DMSO ,OHSU_HNSCC_derm002
4283,10139,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.607,0,DMSO,OHSU_HNSCC_derm002
4284,10139,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.71,0,DMSO ,OHSU_HNSCC_derm002
4285,10139,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.662,0,DMSO,OHSU_HNSCC_derm002
4286,10139,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.79,0,DMSO ,OHSU_HNSCC_derm002
4287,10139,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.664,0,DMSO,OHSU_HNSCC_derm002
4288,10139,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.783,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4289,10139,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.795,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4290,10139,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.442,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4291,10139,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.516,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4292,10139,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.746,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4293,10139,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.463,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4294,10139,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.693,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
4295,10139,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.604,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
4296,10139,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.917,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
4297,10139,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.646,0,DMSO,OHSU_HNSCC_derm002
4298,10139,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.754,0,DMSO ,OHSU_HNSCC_derm002
4299,10139,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.642,0,DMSO,OHSU_HNSCC_derm002
4300,10139,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.736,0,DMSO ,OHSU_HNSCC_derm002
4301,10139,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.699,0,DMSO,OHSU_HNSCC_derm002
4302,10139,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.808,0,DMSO ,OHSU_HNSCC_derm002
4303,10139,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.762,0,DMSO,OHSU_HNSCC_derm002
4304,10139,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.781,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4305,10139,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.595,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4306,10139,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.527,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4307,10139,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.57,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4308,10139,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.719,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4309,10139,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.582,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4310,10139,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.696,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
4311,10139,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.634,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
4312,10139,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.757,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
4313,10139,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.645,0,DMSO,OHSU_HNSCC_derm002
4314,10139,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.768,0,DMSO ,OHSU_HNSCC_derm002
4315,10139,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.579,0,DMSO,OHSU_HNSCC_derm002
4316,10139,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.788,0,DMSO ,OHSU_HNSCC_derm002
4317,10139,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.561,0,DMSO,OHSU_HNSCC_derm002
4318,10139,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.74,0,DMSO ,OHSU_HNSCC_derm002
4319,10139,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.731,0,DMSO,OHSU_HNSCC_derm002
4320,10139,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.79,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4321,10139,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.536,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
4322,10139,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.707,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
4323,10139,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.551,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
4324,10139,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.739,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
4325,10139,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.623,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
4326,10139,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.757,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
4327,10139,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.642,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
4328,10139,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.774,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
4329,10139,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.691,0,DMSO,OHSU_HNSCC_derm002
4330,10139,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.764,0,DMSO ,OHSU_HNSCC_derm002
4331,10139,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.647,0,DMSO,OHSU_HNSCC_derm002
4332,10139,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.774,0,DMSO ,OHSU_HNSCC_derm002
4333,10139,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.589,0,DMSO,OHSU_HNSCC_derm002
4334,10139,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.855,0,DMSO ,OHSU_HNSCC_derm002
4335,10139,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.72,0,DMSO,OHSU_HNSCC_derm002
4336,10139,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.851,0,NONE,OHSU_HNSCC_derm002
4337,10139,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.771,0,NONE,OHSU_HNSCC_derm002
4338,10139,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.775,0,NONE,OHSU_HNSCC_derm002
4339,10139,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.576,0,NONE,OHSU_HNSCC_derm002
4340,10139,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.671,0,NONE,OHSU_HNSCC_derm002
4341,10139,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.66,0,NONE,OHSU_HNSCC_derm002
4342,10139,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.713,0,NONE,OHSU_HNSCC_derm002
4343,10139,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
4344,10139,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.897,0,NONE,OHSU_HNSCC_derm002
4345,10139,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.746,0,NONE,OHSU_HNSCC_derm002
4346,10139,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.702,0,NONE,OHSU_HNSCC_derm002
4347,10139,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.683,0,NONE,OHSU_HNSCC_derm002
4348,10139,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.753,0,NONE,OHSU_HNSCC_derm002
4349,10139,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.601,0,NONE,OHSU_HNSCC_derm002
4350,10139,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.806,0,NONE,OHSU_HNSCC_derm002
4351,10139,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.792,0,NONE,OHSU_HNSCC_derm002
4352,10139,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.575,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4353,10139,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.015,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4354,10139,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.25,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4355,10139,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.404,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4356,10139,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.562,5,Vandetanib (5mM),OHSU_HNSCC_derm002
4357,10139,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.691,0,DMSO,OHSU_HNSCC_derm002
4358,10139,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.671,0,DMSO ,OHSU_HNSCC_derm002
4359,10139,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.41,10,Brigatinib,OHSU_HNSCC_derm002
4360,10139,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.622,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4361,10139,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.688,0,DMSO,OHSU_HNSCC_derm002
4362,10139,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.751,0,DMSO ,OHSU_HNSCC_derm002
4363,10139,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.645,0,DMSO,OHSU_HNSCC_derm002
4364,10139,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.785,0,DMSO ,OHSU_HNSCC_derm002
4365,10139,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.689,0,DMSO,OHSU_HNSCC_derm002
4366,10139,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.772,0,DMSO ,OHSU_HNSCC_derm002
4367,10139,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.73,0,DMSO,OHSU_HNSCC_derm002
4368,10139,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.712,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4369,10139,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.048,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4370,10139,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.418,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4371,10139,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.452,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4372,10139,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.692,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
4373,10139,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.596,0,DMSO,OHSU_HNSCC_derm002
4374,10139,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.714,0,DMSO ,OHSU_HNSCC_derm002
4375,10139,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.528,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
4376,10139,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.674,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4377,10139,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.727,0,DMSO,OHSU_HNSCC_derm002
4378,10139,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.638,0,DMSO ,OHSU_HNSCC_derm002
4379,10139,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.632,0,DMSO,OHSU_HNSCC_derm002
4380,10139,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.725,0,DMSO ,OHSU_HNSCC_derm002
4381,10139,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.675,0,DMSO,OHSU_HNSCC_derm002
4382,10139,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.661,0,DMSO ,OHSU_HNSCC_derm002
4383,10139,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.73,0,DMSO,OHSU_HNSCC_derm002
4384,10139,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.746,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4385,10139,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.119,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4386,10139,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.468,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4387,10139,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.545,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4388,10139,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.705,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
4389,10139,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.696,0,DMSO,OHSU_HNSCC_derm002
4390,10139,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.735,0,DMSO ,OHSU_HNSCC_derm002
4391,10139,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.592,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
4392,10139,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.796,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4393,10139,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.728,0,DMSO,OHSU_HNSCC_derm002
4394,10139,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.731,0,DMSO ,OHSU_HNSCC_derm002
4395,10139,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.705,0,DMSO,OHSU_HNSCC_derm002
4396,10139,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.693,0,DMSO ,OHSU_HNSCC_derm002
4397,10139,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.678,0,DMSO,OHSU_HNSCC_derm002
4398,10139,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.772,0,DMSO ,OHSU_HNSCC_derm002
4399,10139,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.748,0,DMSO,OHSU_HNSCC_derm002
4400,10139,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.799,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4401,10139,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.268,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4402,10139,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.476,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4403,10139,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.563,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4404,10139,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.693,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
4405,10139,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.621,0,DMSO,OHSU_HNSCC_derm002
4406,10139,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.76,0,DMSO ,OHSU_HNSCC_derm002
4407,10139,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.658,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
4408,10139,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.671,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4409,10139,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.673,0,DMSO,OHSU_HNSCC_derm002
4410,10139,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.757,0,DMSO ,OHSU_HNSCC_derm002
4411,10139,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.726,0,DMSO,OHSU_HNSCC_derm002
4412,10139,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.792,0,DMSO ,OHSU_HNSCC_derm002
4413,10139,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.675,0,DMSO,OHSU_HNSCC_derm002
4414,10139,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.776,0,DMSO ,OHSU_HNSCC_derm002
4415,10139,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.776,0,DMSO,OHSU_HNSCC_derm002
4416,10139,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.768,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4417,10139,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.401,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4418,10139,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.557,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4419,10139,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.542,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4420,10139,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.714,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
4421,10139,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.616,0,DMSO,OHSU_HNSCC_derm002
4422,10139,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.673,0,DMSO ,OHSU_HNSCC_derm002
4423,10139,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.557,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
4424,10139,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.739,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4425,10139,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.756,0,DMSO,OHSU_HNSCC_derm002
4426,10139,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.676,0,DMSO ,OHSU_HNSCC_derm002
4427,10139,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.652,0,DMSO,OHSU_HNSCC_derm002
4428,10139,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.753,0,DMSO ,OHSU_HNSCC_derm002
4429,10139,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.679,0,DMSO,OHSU_HNSCC_derm002
4430,10139,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.827,0,DMSO ,OHSU_HNSCC_derm002
4431,10139,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.822,0,DMSO,OHSU_HNSCC_derm002
4432,10139,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.817,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4433,10139,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.689,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4434,10139,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.573,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4435,10139,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.606,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4436,10139,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.721,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
4437,10139,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.684,0,DMSO,OHSU_HNSCC_derm002
4438,10139,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.656,0,DMSO ,OHSU_HNSCC_derm002
4439,10139,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.654,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
4440,10139,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.714,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4441,10139,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.663,0,DMSO,OHSU_HNSCC_derm002
4442,10139,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.778,0,DMSO ,OHSU_HNSCC_derm002
4443,10139,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.658,0,DMSO,OHSU_HNSCC_derm002
4444,10139,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.811,0,DMSO ,OHSU_HNSCC_derm002
4445,10139,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.701,0,DMSO,OHSU_HNSCC_derm002
4446,10139,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.805,0,DMSO ,OHSU_HNSCC_derm002
4447,10139,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.777,0,DMSO,OHSU_HNSCC_derm002
4448,10139,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.903,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4449,10139,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.706,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
4450,10139,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.641,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
4451,10139,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.585,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
4452,10139,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.677,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
4453,10139,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.709,0,DMSO,OHSU_HNSCC_derm002
4454,10139,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.695,0,DMSO ,OHSU_HNSCC_derm002
4455,10139,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
4456,10139,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.757,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
4457,10139,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.747,0,DMSO,OHSU_HNSCC_derm002
4458,10139,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.795,0,DMSO ,OHSU_HNSCC_derm002
4459,10139,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.737,0,DMSO,OHSU_HNSCC_derm002
4460,10139,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.838,0,DMSO ,OHSU_HNSCC_derm002
4461,10139,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.68,0,DMSO,OHSU_HNSCC_derm002
4462,10139,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.775,0,DMSO ,OHSU_HNSCC_derm002
4463,10139,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.777,0,DMSO,OHSU_HNSCC_derm002
4464,10139,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.844,0,NONE,OHSU_HNSCC_derm002
4465,10139,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.761,0,NONE,OHSU_HNSCC_derm002
4466,10139,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.619,0,NONE,OHSU_HNSCC_derm002
4467,10139,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.589,0,NONE,OHSU_HNSCC_derm002
4468,10139,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.728,0,NONE,OHSU_HNSCC_derm002
4469,10139,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.669,0,NONE,OHSU_HNSCC_derm002
4470,10139,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.677,0,NONE,OHSU_HNSCC_derm002
4471,10139,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
4472,10139,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.817,0,NONE,OHSU_HNSCC_derm002
4473,10139,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.751,0,NONE,OHSU_HNSCC_derm002
4474,10139,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.764,0,NONE,OHSU_HNSCC_derm002
4475,10139,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.616,0,NONE,OHSU_HNSCC_derm002
4476,10139,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.808,0,NONE,OHSU_HNSCC_derm002
4477,10139,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.681,0,NONE,OHSU_HNSCC_derm002
4478,10139,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.786,0,NONE,OHSU_HNSCC_derm002
4479,10139,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.807,0,NONE,OHSU_HNSCC_derm002
4480,10139,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.067,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4481,10139,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.137,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4482,10139,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.601,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4483,10139,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.054,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4484,10139,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.846,10,LY3039478 ,OHSU_HNSCC_derm002
4485,10139,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.546,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4486,10139,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.597,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4487,10139,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.536,10,Trametinib,OHSU_HNSCC_derm002
4488,10139,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.266,10,BEZ235,OHSU_HNSCC_derm002
4489,10139,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.78,0,DMSO,OHSU_HNSCC_derm002
4490,10139,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.793,0,DMSO ,OHSU_HNSCC_derm002
4491,10139,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.764,0,DMSO,OHSU_HNSCC_derm002
4492,10139,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.735,0,DMSO ,OHSU_HNSCC_derm002
4493,10139,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.731,0,DMSO,OHSU_HNSCC_derm002
4494,10139,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.714,0,DMSO ,OHSU_HNSCC_derm002
4495,10139,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.715,0,DMSO,OHSU_HNSCC_derm002
4496,10139,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.246,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4497,10139,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.412,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4498,10139,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.708,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4499,10139,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.063,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4500,10139,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.783,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
4501,10139,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.648,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4502,10139,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.638,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4503,10139,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.671,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
4504,10139,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.259,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
4505,10139,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.768,0,DMSO,OHSU_HNSCC_derm002
4506,10139,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.821,0,DMSO ,OHSU_HNSCC_derm002
4507,10139,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.686,0,DMSO,OHSU_HNSCC_derm002
4508,10139,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.717,0,DMSO ,OHSU_HNSCC_derm002
4509,10139,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.732,0,DMSO,OHSU_HNSCC_derm002
4510,10139,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.709,0,DMSO ,OHSU_HNSCC_derm002
4511,10139,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.782,0,DMSO,OHSU_HNSCC_derm002
4512,10139,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.531,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4513,10139,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.511,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4514,10139,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.599,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4515,10139,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.137,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4516,10139,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.771,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
4517,10139,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.594,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4518,10139,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.616,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4519,10139,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.652,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
4520,10139,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.07,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
4521,10139,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.792,0,DMSO,OHSU_HNSCC_derm002
4522,10139,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.711,0,DMSO ,OHSU_HNSCC_derm002
4523,10139,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.678,0,DMSO,OHSU_HNSCC_derm002
4524,10139,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.754,0,DMSO ,OHSU_HNSCC_derm002
4525,10139,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.689,0,DMSO,OHSU_HNSCC_derm002
4526,10139,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.775,0,DMSO ,OHSU_HNSCC_derm002
4527,10139,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.795,0,DMSO,OHSU_HNSCC_derm002
4528,10139,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.723,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4529,10139,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.641,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4530,10139,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.609,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4531,10139,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.232,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4532,10139,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.666,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
4533,10139,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.621,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4534,10139,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.696,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4535,10139,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.68,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
4536,10139,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.248,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
4537,10139,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.773,0,DMSO,OHSU_HNSCC_derm002
4538,10139,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.747,0,DMSO ,OHSU_HNSCC_derm002
4539,10139,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.664,0,DMSO,OHSU_HNSCC_derm002
4540,10139,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.717,0,DMSO ,OHSU_HNSCC_derm002
4541,10139,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.726,0,DMSO,OHSU_HNSCC_derm002
4542,10139,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.787,0,DMSO ,OHSU_HNSCC_derm002
4543,10139,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.767,0,DMSO,OHSU_HNSCC_derm002
4544,10139,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.683,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4545,10139,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.596,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4546,10139,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.597,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4547,10139,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.39,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4548,10139,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.783,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
4549,10139,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.622,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4550,10139,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.624,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4551,10139,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.702,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
4552,10139,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.27,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
4553,10139,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.746,0,DMSO,OHSU_HNSCC_derm002
4554,10139,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.663,0,DMSO ,OHSU_HNSCC_derm002
4555,10139,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.668,0,DMSO,OHSU_HNSCC_derm002
4556,10139,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.777,0,DMSO ,OHSU_HNSCC_derm002
4557,10139,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.726,0,DMSO,OHSU_HNSCC_derm002
4558,10139,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.82,0,DMSO ,OHSU_HNSCC_derm002
4559,10139,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.822,0,DMSO,OHSU_HNSCC_derm002
4560,10139,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.821,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4561,10139,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.7,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4562,10139,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.664,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4563,10139,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.613,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4564,10139,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.716,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
4565,10139,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.696,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4566,10139,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.622,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4567,10139,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.708,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
4568,10139,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.472,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
4569,10139,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.797,0,DMSO,OHSU_HNSCC_derm002
4570,10139,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.723,0,DMSO ,OHSU_HNSCC_derm002
4571,10139,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.71,0,DMSO,OHSU_HNSCC_derm002
4572,10139,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.745,0,DMSO ,OHSU_HNSCC_derm002
4573,10139,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.642,0,DMSO,OHSU_HNSCC_derm002
4574,10139,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.779,0,DMSO ,OHSU_HNSCC_derm002
4575,10139,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.75,0,DMSO,OHSU_HNSCC_derm002
4576,10139,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.873,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
4577,10139,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.726,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
4578,10139,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.646,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
4579,10139,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.571,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
4580,10139,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.681,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
4581,10139,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.701,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
4582,10139,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.793,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
4583,10139,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.839,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
4584,10139,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.62,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
4585,10139,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.756,0,DMSO,OHSU_HNSCC_derm002
4586,10139,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.807,0,DMSO ,OHSU_HNSCC_derm002
4587,10139,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.705,0,DMSO,OHSU_HNSCC_derm002
4588,10139,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.675,0,DMSO ,OHSU_HNSCC_derm002
4589,10139,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.728,0,DMSO,OHSU_HNSCC_derm002
4590,10139,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.716,0,DMSO ,OHSU_HNSCC_derm002
4591,10139,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.713,0,DMSO,OHSU_HNSCC_derm002
4592,10139,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.793,0,NONE,OHSU_HNSCC_derm002
4593,10139,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.665,0,NONE,OHSU_HNSCC_derm002
4594,10139,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.756,0,NONE,OHSU_HNSCC_derm002
4595,10139,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.803,0,NONE,OHSU_HNSCC_derm002
4596,10139,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.718,0,NONE,OHSU_HNSCC_derm002
4597,10139,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.558,0,NONE,OHSU_HNSCC_derm002
4598,10139,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.798,0,NONE,OHSU_HNSCC_derm002
4599,10139,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.733,0,NONE,OHSU_HNSCC_derm002
4600,10139,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.802,0,NONE,OHSU_HNSCC_derm002
4601,10139,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.83,0,NONE,OHSU_HNSCC_derm002
4602,10139,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.721,0,NONE,OHSU_HNSCC_derm002
4603,10139,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.747,0,NONE,OHSU_HNSCC_derm002
4604,10139,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.509,0,NONE,OHSU_HNSCC_derm002
4605,10139,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.809,0,NONE,OHSU_HNSCC_derm002
4606,10139,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.745,0,NONE,OHSU_HNSCC_derm002
4607,10139,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.783,0,NONE,OHSU_HNSCC_derm002
4608,10314,Blank 490,1,A,OHSU_HNSCC_derm001,1,-0.027,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
4609,10314,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.241,10,Lucitanib ,OHSU_HNSCC_derm001
4610,10314,Blank 490,1,C,OHSU_HNSCC_derm001,1,0.283,10,Resveratrol,OHSU_HNSCC_derm001
4611,10314,Blank 490,1,D,OHSU_HNSCC_derm001,1,-0.015,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4612,10314,Blank 490,1,E,OHSU_HNSCC_derm001,1,0.337,10,Bicalutamide,OHSU_HNSCC_derm001
4613,10314,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.3,10,Methotrexate ,OHSU_HNSCC_derm001
4614,10314,Blank 490,1,G,OHSU_HNSCC_derm001,1,-0.013,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4615,10314,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.221,10,Gefitinib,OHSU_HNSCC_derm001
4616,10314,Blank 490,1,I,OHSU_HNSCC_derm001,1,-0.035,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
4617,10314,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.009,10,Tamatinib/R406,OHSU_HNSCC_derm001
4618,10314,Blank 490,1,K,OHSU_HNSCC_derm001,1,0.038,10,Bosutinib,OHSU_HNSCC_derm001
4619,10314,Blank 490,1,L,OHSU_HNSCC_derm001,1,-0.018,10,PI-103,OHSU_HNSCC_derm001
4620,10314,Blank 490,1,M,OHSU_HNSCC_derm001,1,0.357,10,Glycyrrhizin,OHSU_HNSCC_derm001
4621,10314,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.132,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
4622,10314,Blank 490,1,O,OHSU_HNSCC_derm001,1,0.151,10,GSK-690693,OHSU_HNSCC_derm001
4623,10314,Blank 490,1,P,OHSU_HNSCC_derm001,1,0.198,10,Ibrutinib,OHSU_HNSCC_derm001
4624,10314,Blank 490,1,A,OHSU_HNSCC_derm001,2,-0.02,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
4625,10314,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.233,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
4626,10314,Blank 490,1,C,OHSU_HNSCC_derm001,2,0.266,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
4627,10314,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.067,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4628,10314,Blank 490,1,E,OHSU_HNSCC_derm001,2,0.302,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
4629,10314,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.309,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
4630,10314,Blank 490,1,G,OHSU_HNSCC_derm001,2,0.004,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4631,10314,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.21,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
4632,10314,Blank 490,1,I,OHSU_HNSCC_derm001,2,0.227,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
4633,10314,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.006,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
4634,10314,Blank 490,1,K,OHSU_HNSCC_derm001,2,0.142,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
4635,10314,Blank 490,1,L,OHSU_HNSCC_derm001,2,-0.03,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
4636,10314,Blank 490,1,M,OHSU_HNSCC_derm001,2,0.334,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
4637,10314,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.246,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
4638,10314,Blank 490,1,O,OHSU_HNSCC_derm001,2,0.177,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
4639,10314,Blank 490,1,P,OHSU_HNSCC_derm001,2,0.252,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
4640,10314,Blank 490,1,A,OHSU_HNSCC_derm001,3,-0.011,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
4641,10314,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.225,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
4642,10314,Blank 490,1,C,OHSU_HNSCC_derm001,3,0.273,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
4643,10314,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.115,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4644,10314,Blank 490,1,E,OHSU_HNSCC_derm001,3,0.329,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
4645,10314,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.258,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
4646,10314,Blank 490,1,G,OHSU_HNSCC_derm001,3,0.017,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4647,10314,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.212,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
4648,10314,Blank 490,1,I,OHSU_HNSCC_derm001,3,0.277,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
4649,10314,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.073,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
4650,10314,Blank 490,1,K,OHSU_HNSCC_derm001,3,0.255,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
4651,10314,Blank 490,1,L,OHSU_HNSCC_derm001,3,-0.009,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
4652,10314,Blank 490,1,M,OHSU_HNSCC_derm001,3,0.298,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
4653,10314,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.272,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
4654,10314,Blank 490,1,O,OHSU_HNSCC_derm001,3,0.167,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
4655,10314,Blank 490,1,P,OHSU_HNSCC_derm001,3,0.191,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
4656,10314,Blank 490,1,A,OHSU_HNSCC_derm001,4,-0.006,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
4657,10314,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.245,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
4658,10314,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.282,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
4659,10314,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.101,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4660,10314,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.314,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
4661,10314,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.313,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
4662,10314,Blank 490,1,G,OHSU_HNSCC_derm001,4,0.1,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4663,10314,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.23,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
4664,10314,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.302,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
4665,10314,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.157,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
4666,10314,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.326,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
4667,10314,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.016,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
4668,10314,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.308,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
4669,10314,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.302,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
4670,10314,Blank 490,1,O,OHSU_HNSCC_derm001,4,0.238,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
4671,10314,Blank 490,1,P,OHSU_HNSCC_derm001,4,0.191,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
4672,10314,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.022,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
4673,10314,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.237,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
4674,10314,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.295,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
4675,10314,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.182,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4676,10314,Blank 490,1,E,OHSU_HNSCC_derm001,5,0.367,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
4677,10314,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.26,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
4678,10314,Blank 490,1,G,OHSU_HNSCC_derm001,5,0.22,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4679,10314,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.222,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
4680,10314,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.292,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
4681,10314,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.202,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
4682,10314,Blank 490,1,K,OHSU_HNSCC_derm001,5,0.344,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
4683,10314,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.098,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
4684,10314,Blank 490,1,M,OHSU_HNSCC_derm001,5,0.335,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
4685,10314,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.286,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
4686,10314,Blank 490,1,O,OHSU_HNSCC_derm001,5,0.272,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
4687,10314,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.176,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
4688,10314,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.082,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
4689,10314,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.252,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
4690,10314,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.285,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
4691,10314,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.156,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4692,10314,Blank 490,1,E,OHSU_HNSCC_derm001,6,0.326,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
4693,10314,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.257,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
4694,10314,Blank 490,1,G,OHSU_HNSCC_derm001,6,0.272,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4695,10314,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.214,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
4696,10314,Blank 490,1,I,OHSU_HNSCC_derm001,6,0.305,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
4697,10314,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.232,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
4698,10314,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.296,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
4699,10314,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.147,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
4700,10314,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.327,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
4701,10314,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.252,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
4702,10314,Blank 490,1,O,OHSU_HNSCC_derm001,6,0.302,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
4703,10314,Blank 490,1,P,OHSU_HNSCC_derm001,6,0.221,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
4704,10314,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.115,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
4705,10314,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.258,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
4706,10314,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.289,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
4707,10314,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.155,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
4708,10314,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.314,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
4709,10314,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.276,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
4710,10314,Blank 490,1,G,OHSU_HNSCC_derm001,7,0.271,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
4711,10314,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.27,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
4712,10314,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.324,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
4713,10314,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.216,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
4714,10314,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.384,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
4715,10314,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.201,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
4716,10314,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.15,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
4717,10314,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.255,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
4718,10314,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.265,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
4719,10314,Blank 490,1,P,OHSU_HNSCC_derm001,7,0.254,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
4720,10314,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.344,0,NONE,OHSU_HNSCC_derm001
4721,10314,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.293,0,NONE,OHSU_HNSCC_derm001
4722,10314,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.236,0,NONE,OHSU_HNSCC_derm001
4723,10314,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.242,0,NONE,OHSU_HNSCC_derm001
4724,10314,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.286,0,NONE,OHSU_HNSCC_derm001
4725,10314,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.263,0,NONE,OHSU_HNSCC_derm001
4726,10314,Blank 490,1,G,OHSU_HNSCC_derm001,8,0.299,0,NONE,OHSU_HNSCC_derm001
4727,10314,Blank 490,1,H,OHSU_HNSCC_derm001,8,-0.029,10,F-S-V,OHSU_HNSCC_derm001
4728,10314,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.325,0,NONE,OHSU_HNSCC_derm001
4729,10314,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.291,0,NONE,OHSU_HNSCC_derm001
4730,10314,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.292,0,NONE,OHSU_HNSCC_derm001
4731,10314,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.319,0,NONE,OHSU_HNSCC_derm001
4732,10314,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.33,0,NONE,OHSU_HNSCC_derm001
4733,10314,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.268,0,NONE,OHSU_HNSCC_derm001
4734,10314,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.28,0,NONE,OHSU_HNSCC_derm001
4735,10314,Blank 490,1,P,OHSU_HNSCC_derm001,8,0.303,0,NONE,OHSU_HNSCC_derm001
4736,10314,Blank 490,1,A,OHSU_HNSCC_derm001,9,-0.007,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4737,10314,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.161,10,Sorafenib,OHSU_HNSCC_derm001
4738,10314,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.336,10,Rosmarinic acid,OHSU_HNSCC_derm001
4739,10314,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.069,10,Rapamycin,OHSU_HNSCC_derm001
4740,10314,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.298,10,Vismodegib,OHSU_HNSCC_derm001
4741,10314,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.021,10,PP242,OHSU_HNSCC_derm001
4742,10314,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.172,10,Alectinib,OHSU_HNSCC_derm001
4743,10314,Blank 490,1,H,OHSU_HNSCC_derm001,9,0.144,10,Brigatinib,OHSU_HNSCC_derm001
4744,10314,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.056,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4745,10314,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.104,10,MK-2206,OHSU_HNSCC_derm001
4746,10314,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.231,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4747,10314,Blank 490,1,L,OHSU_HNSCC_derm001,9,-0.004,10,Flavopiridol ,OHSU_HNSCC_derm001
4748,10314,Blank 490,1,M,OHSU_HNSCC_derm001,9,0.42,10,Indirubin,OHSU_HNSCC_derm001
4749,10314,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.199,10,PF-533228,OHSU_HNSCC_derm001
4750,10314,Blank 490,1,O,OHSU_HNSCC_derm001,9,0.342,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4751,10314,Blank 490,1,P,OHSU_HNSCC_derm001,9,-0.023,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4752,10314,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.048,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4753,10314,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.249,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
4754,10314,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.306,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
4755,10314,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.058,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
4756,10314,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.324,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
4757,10314,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.046,3.3333333333333335,PP242,OHSU_HNSCC_derm001
4758,10314,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.146,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
4759,10314,Blank 490,1,H,OHSU_HNSCC_derm001,10,0.202,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
4760,10314,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.223,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4761,10314,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.179,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
4762,10314,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.243,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4763,10314,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.016,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
4764,10314,Blank 490,1,M,OHSU_HNSCC_derm001,10,0.426,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
4765,10314,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.324,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
4766,10314,Blank 490,1,O,OHSU_HNSCC_derm001,10,0.368,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4767,10314,Blank 490,1,P,OHSU_HNSCC_derm001,10,-0.021,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4768,10314,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.02,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4769,10314,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.286,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
4770,10314,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.272,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
4771,10314,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.116,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
4772,10314,Blank 490,1,E,OHSU_HNSCC_derm001,11,0.37,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
4773,10314,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.091,1.1111111111111112,PP242,OHSU_HNSCC_derm001
4774,10314,Blank 490,1,G,OHSU_HNSCC_derm001,11,0.276,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
4775,10314,Blank 490,1,H,OHSU_HNSCC_derm001,11,0.247,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
4776,10314,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.301,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4777,10314,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.232,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
4778,10314,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.312,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4779,10314,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.093,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
4780,10314,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.398,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
4781,10314,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.325,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
4782,10314,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.282,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4783,10314,Blank 490,1,P,OHSU_HNSCC_derm001,11,-0.022,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4784,10314,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.043,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4785,10314,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.303,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
4786,10314,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.313,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
4787,10314,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.126,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
4788,10314,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.361,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
4789,10314,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.15,0.3703703703703704,PP242,OHSU_HNSCC_derm001
4790,10314,Blank 490,1,G,OHSU_HNSCC_derm001,12,0.353,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
4791,10314,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.275,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
4792,10314,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.36,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4793,10314,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.319,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
4794,10314,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.37,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4795,10314,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.103,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
4796,10314,Blank 490,1,M,OHSU_HNSCC_derm001,12,0.464,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
4797,10314,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.373,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
4798,10314,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.271,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4799,10314,Blank 490,1,P,OHSU_HNSCC_derm001,12,-0.008,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4800,10314,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.061,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4801,10314,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.292,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
4802,10314,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.343,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
4803,10314,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.144,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
4804,10314,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.372,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
4805,10314,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.24,0.1234567901234568,PP242,OHSU_HNSCC_derm001
4806,10314,Blank 490,1,G,OHSU_HNSCC_derm001,13,0.422,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
4807,10314,Blank 490,1,H,OHSU_HNSCC_derm001,13,0.314,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
4808,10314,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.35,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4809,10314,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.352,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
4810,10314,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.368,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4811,10314,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.074,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
4812,10314,Blank 490,1,M,OHSU_HNSCC_derm001,13,0.303,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
4813,10314,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.33,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
4814,10314,Blank 490,1,O,OHSU_HNSCC_derm001,13,0.273,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4815,10314,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.018,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4816,10314,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.079,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4817,10314,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.336,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
4818,10314,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.344,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
4819,10314,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.128,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
4820,10314,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.338,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
4821,10314,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.268,0.0411522633744856,PP242,OHSU_HNSCC_derm001
4822,10314,Blank 490,1,G,OHSU_HNSCC_derm001,14,0.313,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
4823,10314,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.284,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
4824,10314,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.303,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4825,10314,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.35,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
4826,10314,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.301,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4827,10314,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.314,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
4828,10314,Blank 490,1,M,OHSU_HNSCC_derm001,14,0.363,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
4829,10314,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.283,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
4830,10314,Blank 490,1,O,OHSU_HNSCC_derm001,14,0.276,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4831,10314,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.118,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4832,10314,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.166,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
4833,10314,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.291,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
4834,10314,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.299,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
4835,10314,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.116,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
4836,10314,Blank 490,1,E,OHSU_HNSCC_derm001,15,0.305,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
4837,10314,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.317,0.013717421124828532,PP242,OHSU_HNSCC_derm001
4838,10314,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.302,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
4839,10314,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.294,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
4840,10314,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.305,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
4841,10314,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.349,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
4842,10314,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.347,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
4843,10314,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.337,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
4844,10314,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.348,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
4845,10314,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.278,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
4846,10314,Blank 490,1,O,OHSU_HNSCC_derm001,15,0.248,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
4847,10314,Blank 490,1,P,OHSU_HNSCC_derm001,15,0.191,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
4848,10314,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.319,0,NONE,OHSU_HNSCC_derm001
4849,10314,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.294,0,NONE,OHSU_HNSCC_derm001
4850,10314,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.275,0,NONE,OHSU_HNSCC_derm001
4851,10314,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.218,0,NONE,OHSU_HNSCC_derm001
4852,10314,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.295,0,NONE,OHSU_HNSCC_derm001
4853,10314,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.287,0,NONE,OHSU_HNSCC_derm001
4854,10314,Blank 490,1,G,OHSU_HNSCC_derm001,16,0.3,0,NONE,OHSU_HNSCC_derm001
4855,10314,Blank 490,1,H,OHSU_HNSCC_derm001,16,0.029,10,F-S-V,OHSU_HNSCC_derm001
4856,10314,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.343,0,NONE,OHSU_HNSCC_derm001
4857,10314,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.307,0,NONE,OHSU_HNSCC_derm001
4858,10314,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.301,0,NONE,OHSU_HNSCC_derm001
4859,10314,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.341,0,NONE,OHSU_HNSCC_derm001
4860,10314,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.381,0,NONE,OHSU_HNSCC_derm001
4861,10314,Blank 490,1,N,OHSU_HNSCC_derm001,16,0.294,0,NONE,OHSU_HNSCC_derm001
4862,10314,Blank 490,1,O,OHSU_HNSCC_derm001,16,0.253,0,NONE,OHSU_HNSCC_derm001
4863,10314,Blank 490,1,P,OHSU_HNSCC_derm001,16,0.298,0,NONE,OHSU_HNSCC_derm001
4864,10314,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.243,10,Emodin,OHSU_HNSCC_derm001
4865,10314,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.24,10,Baicalin,OHSU_HNSCC_derm001
4866,10314,Blank 490,1,C,OHSU_HNSCC_derm001,17,-0.034,10,NVP-TAE-684,OHSU_HNSCC_derm001
4867,10314,Blank 490,1,D,OHSU_HNSCC_derm001,17,-0.034,10,Panobinostat,OHSU_HNSCC_derm001
4868,10314,Blank 490,1,E,OHSU_HNSCC_derm001,17,-0.036,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
4869,10314,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.295,10,Fulvestrant,OHSU_HNSCC_derm001
4870,10314,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.063,10,SCH-772984,OHSU_HNSCC_derm001
4871,10314,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.115,10,Trametinib,OHSU_HNSCC_derm001
4872,10314,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.028,10,BEZ235,OHSU_HNSCC_derm001
4873,10314,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.242,10,MLN120B,OHSU_HNSCC_derm001
4874,10314,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.12,10,Ixabepilone,OHSU_HNSCC_derm001
4875,10314,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.049,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
4876,10314,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.167,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4877,10314,Blank 490,1,N,OHSU_HNSCC_derm001,17,0.069,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4878,10314,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.18,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4879,10314,Blank 490,1,P,OHSU_HNSCC_derm001,17,0.276,10,Letrozole,OHSU_HNSCC_derm001
4880,10314,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.294,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
4881,10314,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.28,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
4882,10314,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.051,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
4883,10314,Blank 490,1,D,OHSU_HNSCC_derm001,18,-0.038,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
4884,10314,Blank 490,1,E,OHSU_HNSCC_derm001,18,-0.023,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
4885,10314,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.278,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
4886,10314,Blank 490,1,G,OHSU_HNSCC_derm001,18,0.107,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
4887,10314,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.118,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
4888,10314,Blank 490,1,I,OHSU_HNSCC_derm001,18,-0.024,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
4889,10314,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.22,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
4890,10314,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.072,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
4891,10314,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.229,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
4892,10314,Blank 490,1,M,OHSU_HNSCC_derm001,18,0.181,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4893,10314,Blank 490,1,N,OHSU_HNSCC_derm001,18,0.098,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4894,10314,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.209,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4895,10314,Blank 490,1,P,OHSU_HNSCC_derm001,18,0.326,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
4896,10314,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.302,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
4897,10314,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.28,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
4898,10314,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.157,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
4899,10314,Blank 490,1,D,OHSU_HNSCC_derm001,19,-0.025,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
4900,10314,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.019,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
4901,10314,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.293,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
4902,10314,Blank 490,1,G,OHSU_HNSCC_derm001,19,0.172,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
4903,10314,Blank 490,1,H,OHSU_HNSCC_derm001,19,0.13,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
4904,10314,Blank 490,1,I,OHSU_HNSCC_derm001,19,-0.015,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
4905,10314,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.232,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
4906,10314,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.078,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
4907,10314,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.247,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
4908,10314,Blank 490,1,M,OHSU_HNSCC_derm001,19,0.189,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4909,10314,Blank 490,1,N,OHSU_HNSCC_derm001,19,0.145,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4910,10314,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.182,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4911,10314,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.318,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
4912,10314,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.308,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
4913,10314,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.288,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
4914,10314,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.231,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
4915,10314,Blank 490,1,D,OHSU_HNSCC_derm001,20,-0.033,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
4916,10314,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.094,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
4917,10314,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.299,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
4918,10314,Blank 490,1,G,OHSU_HNSCC_derm001,20,0.165,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
4919,10314,Blank 490,1,H,OHSU_HNSCC_derm001,20,0.125,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
4920,10314,Blank 490,1,I,OHSU_HNSCC_derm001,20,-0.011,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
4921,10314,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.25,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
4922,10314,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.078,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
4923,10314,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.214,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
4924,10314,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.193,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4925,10314,Blank 490,1,N,OHSU_HNSCC_derm001,20,0.214,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4926,10314,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.207,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4927,10314,Blank 490,1,P,OHSU_HNSCC_derm001,20,0.32,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
4928,10314,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.297,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
4929,10314,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.32,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
4930,10314,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.247,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
4931,10314,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.016,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
4932,10314,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.15,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
4933,10314,Blank 490,1,F,OHSU_HNSCC_derm001,21,0.367,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
4934,10314,Blank 490,1,G,OHSU_HNSCC_derm001,21,0.205,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
4935,10314,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.139,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
4936,10314,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.004,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
4937,10314,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.282,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
4938,10314,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.057,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
4939,10314,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.206,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
4940,10314,Blank 490,1,M,OHSU_HNSCC_derm001,21,0.184,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4941,10314,Blank 490,1,N,OHSU_HNSCC_derm001,21,0.28,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4942,10314,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.199,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4943,10314,Blank 490,1,P,OHSU_HNSCC_derm001,21,0.321,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
4944,10314,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.371,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
4945,10314,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.3,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
4946,10314,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.298,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
4947,10314,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.114,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
4948,10314,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.173,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
4949,10314,Blank 490,1,F,OHSU_HNSCC_derm001,22,0.307,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
4950,10314,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.226,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
4951,10314,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.152,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
4952,10314,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.057,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
4953,10314,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.282,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
4954,10314,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.085,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
4955,10314,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.208,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
4956,10314,Blank 490,1,M,OHSU_HNSCC_derm001,22,0.218,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4957,10314,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.234,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4958,10314,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.218,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4959,10314,Blank 490,1,P,OHSU_HNSCC_derm001,22,0.32,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
4960,10314,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.335,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
4961,10314,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.363,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
4962,10314,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.282,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
4963,10314,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.182,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
4964,10314,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.263,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
4965,10314,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.319,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
4966,10314,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.294,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
4967,10314,Blank 490,1,H,OHSU_HNSCC_derm001,23,0.201,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
4968,10314,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.13,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
4969,10314,Blank 490,1,J,OHSU_HNSCC_derm001,23,0.279,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
4970,10314,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.135,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
4971,10314,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.191,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
4972,10314,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.244,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
4973,10314,Blank 490,1,N,OHSU_HNSCC_derm001,23,0.292,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
4974,10314,Blank 490,1,O,OHSU_HNSCC_derm001,23,0.238,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
4975,10314,Blank 490,1,P,OHSU_HNSCC_derm001,23,0.334,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
4976,10314,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.289,0,NONE,OHSU_HNSCC_derm001
4977,10314,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.352,0,NONE,OHSU_HNSCC_derm001
4978,10314,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.296,0,NONE,OHSU_HNSCC_derm001
4979,10314,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.322,0,NONE,OHSU_HNSCC_derm001
4980,10314,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.318,0,NONE,OHSU_HNSCC_derm001
4981,10314,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.327,0,NONE,OHSU_HNSCC_derm001
4982,10314,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.342,0,NONE,OHSU_HNSCC_derm001
4983,10314,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.35,0,NONE,OHSU_HNSCC_derm001
4984,10314,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.335,0,NONE,OHSU_HNSCC_derm001
4985,10314,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.351,0,NONE,OHSU_HNSCC_derm001
4986,10314,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.324,0,NONE,OHSU_HNSCC_derm001
4987,10314,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.334,0,NONE,OHSU_HNSCC_derm001
4988,10314,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.319,0,NONE,OHSU_HNSCC_derm001
4989,10314,Blank 490,1,N,OHSU_HNSCC_derm001,24,0.3,0,NONE,OHSU_HNSCC_derm001
4990,10314,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.278,0,NONE,OHSU_HNSCC_derm001
4991,10314,Blank 490,1,P,OHSU_HNSCC_derm001,24,0.314,0,NONE,OHSU_HNSCC_derm001
4992,10314,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.223,10,Coumarin,OHSU_HNSCC_derm001
4993,10314,Blank 490,2,B,OHSU_HNSCC_derm001,1,-0.01,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
4994,10314,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.017,10,Foretinib (XL-880),OHSU_HNSCC_derm001
4995,10314,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.257,10,Elesclomol,OHSU_HNSCC_derm001
4996,10314,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.222,10,Vemurafenib,OHSU_HNSCC_derm001
4997,10314,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.006,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
4998,10314,Blank 490,2,G,OHSU_HNSCC_derm001,1,-0.009,10,Ponatinib,OHSU_HNSCC_derm001
4999,10314,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.216,10,Gefitinib,OHSU_HNSCC_derm001
5000,10314,Blank 490,2,I,OHSU_HNSCC_derm001,1,-0.005,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
5001,10314,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.333,1,Sunitinib (1mM),OHSU_HNSCC_derm001
5002,10314,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.357,10,Curcumin,OHSU_HNSCC_derm001
5003,10314,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.025,10,PF-562271,OHSU_HNSCC_derm001
5004,10314,Blank 490,2,M,OHSU_HNSCC_derm001,1,0.209,10,STO609,OHSU_HNSCC_derm001
5005,10314,Blank 490,2,N,OHSU_HNSCC_derm001,1,0.146,10,Lenvatinib,OHSU_HNSCC_derm001
5006,10314,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.015,10,Entrectinib,OHSU_HNSCC_derm001
5007,10314,Blank 490,2,P,OHSU_HNSCC_derm001,1,0.377,10,Ethyl Gallate ,OHSU_HNSCC_derm001
5008,10314,Blank 490,2,A,OHSU_HNSCC_derm001,2,0.202,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
5009,10314,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.214,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5010,10314,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.041,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
5011,10314,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.214,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
5012,10314,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.238,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
5013,10314,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.006,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5014,10314,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.003,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
5015,10314,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.233,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
5016,10314,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.264,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
5017,10314,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.334,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
5018,10314,Blank 490,2,K,OHSU_HNSCC_derm001,2,0.303,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
5019,10314,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.154,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
5020,10314,Blank 490,2,M,OHSU_HNSCC_derm001,2,0.236,3.3333333333333335,STO609,OHSU_HNSCC_derm001
5021,10314,Blank 490,2,N,OHSU_HNSCC_derm001,2,0.193,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
5022,10314,Blank 490,2,O,OHSU_HNSCC_derm001,2,0.204,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
5023,10314,Blank 490,2,P,OHSU_HNSCC_derm001,2,0.364,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
5024,10314,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.382,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
5025,10314,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.238,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5026,10314,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.138,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
5027,10314,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.164,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
5028,10314,Blank 490,2,E,OHSU_HNSCC_derm001,3,0.316,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
5029,10314,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.008,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5030,10314,Blank 490,2,G,OHSU_HNSCC_derm001,3,0.087,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
5031,10314,Blank 490,2,H,OHSU_HNSCC_derm001,3,0.207,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
5032,10314,Blank 490,2,I,OHSU_HNSCC_derm001,3,0.289,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
5033,10314,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.275,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
5034,10314,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.34,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
5035,10314,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.251,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
5036,10314,Blank 490,2,M,OHSU_HNSCC_derm001,3,0.297,1.1111111111111112,STO609,OHSU_HNSCC_derm001
5037,10314,Blank 490,2,N,OHSU_HNSCC_derm001,3,0.212,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
5038,10314,Blank 490,2,O,OHSU_HNSCC_derm001,3,0.289,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
5039,10314,Blank 490,2,P,OHSU_HNSCC_derm001,3,0.312,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
5040,10314,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.338,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
5041,10314,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.208,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5042,10314,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.188,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
5043,10314,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.095,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
5044,10314,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.302,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
5045,10314,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.021,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5046,10314,Blank 490,2,G,OHSU_HNSCC_derm001,4,0.203,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
5047,10314,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.244,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
5048,10314,Blank 490,2,I,OHSU_HNSCC_derm001,4,0.27,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
5049,10314,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.264,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
5050,10314,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.303,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
5051,10314,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.312,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
5052,10314,Blank 490,2,M,OHSU_HNSCC_derm001,4,0.259,0.3703703703703704,STO609,OHSU_HNSCC_derm001
5053,10314,Blank 490,2,N,OHSU_HNSCC_derm001,4,0.258,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
5054,10314,Blank 490,2,O,OHSU_HNSCC_derm001,4,0.291,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
5055,10314,Blank 490,2,P,OHSU_HNSCC_derm001,4,0.313,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
5056,10314,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.319,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
5057,10314,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.18,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5058,10314,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.185,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
5059,10314,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.043,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
5060,10314,Blank 490,2,E,OHSU_HNSCC_derm001,5,0.292,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
5061,10314,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.043,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5062,10314,Blank 490,2,G,OHSU_HNSCC_derm001,5,0.263,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
5063,10314,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.253,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
5064,10314,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.282,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
5065,10314,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.271,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
5066,10314,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.276,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
5067,10314,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.306,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
5068,10314,Blank 490,2,M,OHSU_HNSCC_derm001,5,0.288,0.1234567901234568,STO609,OHSU_HNSCC_derm001
5069,10314,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.252,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
5070,10314,Blank 490,2,O,OHSU_HNSCC_derm001,5,0.293,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
5071,10314,Blank 490,2,P,OHSU_HNSCC_derm001,5,0.338,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
5072,10314,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.329,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
5073,10314,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.2,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5074,10314,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.282,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
5075,10314,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.07,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
5076,10314,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.292,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
5077,10314,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.086,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5078,10314,Blank 490,2,G,OHSU_HNSCC_derm001,6,0.284,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
5079,10314,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.273,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
5080,10314,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.286,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
5081,10314,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.306,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
5082,10314,Blank 490,2,K,OHSU_HNSCC_derm001,6,0.253,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
5083,10314,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.268,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
5084,10314,Blank 490,2,M,OHSU_HNSCC_derm001,6,0.281,0.0411522633744856,STO609,OHSU_HNSCC_derm001
5085,10314,Blank 490,2,N,OHSU_HNSCC_derm001,6,0.267,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
5086,10314,Blank 490,2,O,OHSU_HNSCC_derm001,6,0.248,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
5087,10314,Blank 490,2,P,OHSU_HNSCC_derm001,6,0.347,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
5088,10314,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.321,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
5089,10314,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.202,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
5090,10314,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.242,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
5091,10314,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.079,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
5092,10314,Blank 490,2,E,OHSU_HNSCC_derm001,7,0.291,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
5093,10314,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.197,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
5094,10314,Blank 490,2,G,OHSU_HNSCC_derm001,7,0.268,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
5095,10314,Blank 490,2,H,OHSU_HNSCC_derm001,7,0.315,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
5096,10314,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.062,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
5097,10314,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.066,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
5098,10314,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.281,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
5099,10314,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.302,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
5100,10314,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.23,0.013717421124828532,STO609,OHSU_HNSCC_derm001
5101,10314,Blank 490,2,N,OHSU_HNSCC_derm001,7,0.251,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
5102,10314,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.253,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
5103,10314,Blank 490,2,P,OHSU_HNSCC_derm001,7,0.342,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
5104,10314,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.3,0,NONE,OHSU_HNSCC_derm001
5105,10314,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.278,0,NONE,OHSU_HNSCC_derm001
5106,10314,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.311,0,NONE,OHSU_HNSCC_derm001
5107,10314,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.214,0,NONE,OHSU_HNSCC_derm001
5108,10314,Blank 490,2,E,OHSU_HNSCC_derm001,8,0.28,0,NONE,OHSU_HNSCC_derm001
5109,10314,Blank 490,2,F,OHSU_HNSCC_derm001,8,0.312,0,NONE,OHSU_HNSCC_derm001
5110,10314,Blank 490,2,G,OHSU_HNSCC_derm001,8,0.075,0,NONE,OHSU_HNSCC_derm001
5111,10314,Blank 490,2,H,OHSU_HNSCC_derm001,8,-0.001,10,F-S-V,OHSU_HNSCC_derm001
5112,10314,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.223,0,NONE,OHSU_HNSCC_derm001
5113,10314,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.325,0,NONE,OHSU_HNSCC_derm001
5114,10314,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.303,0,NONE,OHSU_HNSCC_derm001
5115,10314,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.256,0,NONE,OHSU_HNSCC_derm001
5116,10314,Blank 490,2,M,OHSU_HNSCC_derm001,8,0.258,0,NONE,OHSU_HNSCC_derm001
5117,10314,Blank 490,2,N,OHSU_HNSCC_derm001,8,0.266,0,NONE,OHSU_HNSCC_derm001
5118,10314,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.308,0,NONE,OHSU_HNSCC_derm001
5119,10314,Blank 490,2,P,OHSU_HNSCC_derm001,8,0.32,0,NONE,OHSU_HNSCC_derm001
5120,10314,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.032,10,GDC-0941,OHSU_HNSCC_derm001
5121,10314,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.211,10,Dovitinib,OHSU_HNSCC_derm001
5122,10314,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.113,10,BI-2536,OHSU_HNSCC_derm001
5123,10314,Blank 490,2,D,OHSU_HNSCC_derm001,9,-0.002,10,TP-0903 ,OHSU_HNSCC_derm001
5124,10314,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.0,10,Belinostat,OHSU_HNSCC_derm001
5125,10314,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.003,10,INK-128,OHSU_HNSCC_derm001
5126,10314,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.036,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5127,10314,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.063,10,Brigatinib,OHSU_HNSCC_derm001
5128,10314,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.015,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5129,10314,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.022,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5130,10314,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.147,10,Pazopanib,OHSU_HNSCC_derm001
5131,10314,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.135,10,AZD4547,OHSU_HNSCC_derm001
5132,10314,Blank 490,2,M,OHSU_HNSCC_derm001,9,0.244,10,Pomalidomide ,OHSU_HNSCC_derm001
5133,10314,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.172,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
5134,10314,Blank 490,2,O,OHSU_HNSCC_derm001,9,0.269,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5135,10314,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.005,10,Staurosporin,OHSU_HNSCC_derm001
5136,10314,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.052,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
5137,10314,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.234,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
5138,10314,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.158,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
5139,10314,Blank 490,2,D,OHSU_HNSCC_derm001,10,-0.009,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
5140,10314,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.005,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
5141,10314,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.008,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
5142,10314,Blank 490,2,G,OHSU_HNSCC_derm001,10,0.084,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5143,10314,Blank 490,2,H,OHSU_HNSCC_derm001,10,0.158,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
5144,10314,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.214,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5145,10314,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.162,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5146,10314,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.197,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
5147,10314,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.246,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
5148,10314,Blank 490,2,M,OHSU_HNSCC_derm001,10,0.264,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
5149,10314,Blank 490,2,N,OHSU_HNSCC_derm001,10,0.218,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
5150,10314,Blank 490,2,O,OHSU_HNSCC_derm001,10,0.306,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5151,10314,Blank 490,2,P,OHSU_HNSCC_derm001,10,0.011,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
5152,10314,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.127,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
5153,10314,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.239,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
5154,10314,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.234,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
5155,10314,Blank 490,2,D,OHSU_HNSCC_derm001,11,-0.009,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
5156,10314,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.075,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
5157,10314,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.015,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
5158,10314,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.114,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5159,10314,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.293,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
5160,10314,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.301,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5161,10314,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.234,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5162,10314,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.235,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
5163,10314,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.25,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
5164,10314,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.267,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
5165,10314,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.225,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
5166,10314,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.29,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5167,10314,Blank 490,2,P,OHSU_HNSCC_derm001,11,0.013,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
5168,10314,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.107,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
5169,10314,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.26,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
5170,10314,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.219,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
5171,10314,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.112,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
5172,10314,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.142,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
5173,10314,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.026,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
5174,10314,Blank 490,2,G,OHSU_HNSCC_derm001,12,0.125,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5175,10314,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.352,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
5176,10314,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.268,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5177,10314,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.337,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5178,10314,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.236,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
5179,10314,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.282,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
5180,10314,Blank 490,2,M,OHSU_HNSCC_derm001,12,0.288,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
5181,10314,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.256,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
5182,10314,Blank 490,2,O,OHSU_HNSCC_derm001,12,0.282,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5183,10314,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.022,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
5184,10314,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.208,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
5185,10314,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.311,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
5186,10314,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.146,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
5187,10314,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.228,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
5188,10314,Blank 490,2,E,OHSU_HNSCC_derm001,13,0.229,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
5189,10314,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.029,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
5190,10314,Blank 490,2,G,OHSU_HNSCC_derm001,13,0.161,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5191,10314,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.285,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
5192,10314,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.254,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5193,10314,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.32,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5194,10314,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.238,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
5195,10314,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.275,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
5196,10314,Blank 490,2,M,OHSU_HNSCC_derm001,13,0.262,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
5197,10314,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.268,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
5198,10314,Blank 490,2,O,OHSU_HNSCC_derm001,13,0.268,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5199,10314,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.062,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
5200,10314,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.241,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
5201,10314,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.271,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
5202,10314,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.17,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
5203,10314,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.262,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
5204,10314,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.277,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
5205,10314,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.057,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
5206,10314,Blank 490,2,G,OHSU_HNSCC_derm001,14,0.17,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5207,10314,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.315,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
5208,10314,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.263,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5209,10314,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.301,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5210,10314,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.282,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
5211,10314,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.265,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
5212,10314,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.26,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
5213,10314,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.306,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
5214,10314,Blank 490,2,O,OHSU_HNSCC_derm001,14,0.325,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5215,10314,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.073,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
5216,10314,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.285,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
5217,10314,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.318,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
5218,10314,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.251,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
5219,10314,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.26,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
5220,10314,Blank 490,2,E,OHSU_HNSCC_derm001,15,0.296,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
5221,10314,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.099,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
5222,10314,Blank 490,2,G,OHSU_HNSCC_derm001,15,0.176,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
5223,10314,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.301,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
5224,10314,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.279,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5225,10314,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.32,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
5226,10314,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.267,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
5227,10314,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.328,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
5228,10314,Blank 490,2,M,OHSU_HNSCC_derm001,15,0.285,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
5229,10314,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.307,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
5230,10314,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.291,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
5231,10314,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.085,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
5232,10314,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.298,0,NONE,OHSU_HNSCC_derm001
5233,10314,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.278,0,NONE,OHSU_HNSCC_derm001
5234,10314,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.331,0,NONE,OHSU_HNSCC_derm001
5235,10314,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.332,0,NONE,OHSU_HNSCC_derm001
5236,10314,Blank 490,2,E,OHSU_HNSCC_derm001,16,0.297,0,NONE,OHSU_HNSCC_derm001
5237,10314,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.311,0,NONE,OHSU_HNSCC_derm001
5238,10314,Blank 490,2,G,OHSU_HNSCC_derm001,16,0.309,0,NONE,OHSU_HNSCC_derm001
5239,10314,Blank 490,2,H,OHSU_HNSCC_derm001,16,0.001,10,F-S-V,OHSU_HNSCC_derm001
5240,10314,Blank 490,2,I,OHSU_HNSCC_derm001,16,0.302,0,NONE,OHSU_HNSCC_derm001
5241,10314,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.313,0,NONE,OHSU_HNSCC_derm001
5242,10314,Blank 490,2,K,OHSU_HNSCC_derm001,16,0.271,0,NONE,OHSU_HNSCC_derm001
5243,10314,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.306,0,NONE,OHSU_HNSCC_derm001
5244,10314,Blank 490,2,M,OHSU_HNSCC_derm001,16,0.299,0,NONE,OHSU_HNSCC_derm001
5245,10314,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.287,0,NONE,OHSU_HNSCC_derm001
5246,10314,Blank 490,2,O,OHSU_HNSCC_derm001,16,0.316,0,NONE,OHSU_HNSCC_derm001
5247,10314,Blank 490,2,P,OHSU_HNSCC_derm001,16,0.346,0,NONE,OHSU_HNSCC_derm001
5248,10314,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.213,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
5249,10314,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.302,10,Hesperidin,OHSU_HNSCC_derm001
5250,10314,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.282,10,Esculetin,OHSU_HNSCC_derm001
5251,10314,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.012,10,Selinexor ,OHSU_HNSCC_derm001
5252,10314,Blank 490,2,E,OHSU_HNSCC_derm001,17,-0.002,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5253,10314,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.118,10,BMX-IN-1,OHSU_HNSCC_derm001
5254,10314,Blank 490,2,G,OHSU_HNSCC_derm001,17,0.046,1,Dasatinib (1mM),OHSU_HNSCC_derm001
5255,10314,Blank 490,2,H,OHSU_HNSCC_derm001,17,0.122,10,Trametinib,OHSU_HNSCC_derm001
5256,10314,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.001,10,BEZ235,OHSU_HNSCC_derm001
5257,10314,Blank 490,2,J,OHSU_HNSCC_derm001,17,-0.007,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
5258,10314,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.174,10,Nilotinib,OHSU_HNSCC_derm001
5259,10314,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.128,10,Enzalutamide,OHSU_HNSCC_derm001
5260,10314,Blank 490,2,M,OHSU_HNSCC_derm001,17,0.38,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5261,10314,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.1,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
5262,10314,Blank 490,2,O,OHSU_HNSCC_derm001,17,-0.002,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5263,10314,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.178,10,Axitinib,OHSU_HNSCC_derm001
5264,10314,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.253,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
5265,10314,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.325,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
5266,10314,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.308,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
5267,10314,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.012,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
5268,10314,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.251,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5269,10314,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.254,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
5270,10314,Blank 490,2,G,OHSU_HNSCC_derm001,18,0.082,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
5271,10314,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.122,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
5272,10314,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.002,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
5273,10314,Blank 490,2,J,OHSU_HNSCC_derm001,18,-0.011,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
5274,10314,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.231,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
5275,10314,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.169,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
5276,10314,Blank 490,2,M,OHSU_HNSCC_derm001,18,0.345,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5277,10314,Blank 490,2,N,OHSU_HNSCC_derm001,18,0.1,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
5278,10314,Blank 490,2,O,OHSU_HNSCC_derm001,18,-0.005,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5279,10314,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.248,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
5280,10314,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.269,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
5281,10314,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.326,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
5282,10314,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.309,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
5283,10314,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.013,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
5284,10314,Blank 490,2,E,OHSU_HNSCC_derm001,19,0.244,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5285,10314,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.346,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
5286,10314,Blank 490,2,G,OHSU_HNSCC_derm001,19,0.125,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
5287,10314,Blank 490,2,H,OHSU_HNSCC_derm001,19,0.143,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
5288,10314,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.006,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
5289,10314,Blank 490,2,J,OHSU_HNSCC_derm001,19,-0.004,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
5290,10314,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.238,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
5291,10314,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.222,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
5292,10314,Blank 490,2,M,OHSU_HNSCC_derm001,19,0.328,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5293,10314,Blank 490,2,N,OHSU_HNSCC_derm001,19,0.126,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
5294,10314,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.0,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5295,10314,Blank 490,2,P,OHSU_HNSCC_derm001,19,0.303,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
5296,10314,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.296,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
5297,10314,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.298,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
5298,10314,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.278,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
5299,10314,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.019,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
5300,10314,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.265,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5301,10314,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.297,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
5302,10314,Blank 490,2,G,OHSU_HNSCC_derm001,20,0.136,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
5303,10314,Blank 490,2,H,OHSU_HNSCC_derm001,20,0.148,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
5304,10314,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.015,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
5305,10314,Blank 490,2,J,OHSU_HNSCC_derm001,20,-0.003,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
5306,10314,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.297,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
5307,10314,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.276,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
5308,10314,Blank 490,2,M,OHSU_HNSCC_derm001,20,0.322,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5309,10314,Blank 490,2,N,OHSU_HNSCC_derm001,20,0.171,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
5310,10314,Blank 490,2,O,OHSU_HNSCC_derm001,20,0.135,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5311,10314,Blank 490,2,P,OHSU_HNSCC_derm001,20,0.306,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
5312,10314,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.284,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
5313,10314,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.287,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
5314,10314,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.25,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
5315,10314,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.076,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
5316,10314,Blank 490,2,E,OHSU_HNSCC_derm001,21,0.284,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5317,10314,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.335,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
5318,10314,Blank 490,2,G,OHSU_HNSCC_derm001,21,0.24,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
5319,10314,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.189,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
5320,10314,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.031,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
5321,10314,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.004,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
5322,10314,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.289,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
5323,10314,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.251,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
5324,10314,Blank 490,2,M,OHSU_HNSCC_derm001,21,0.283,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5325,10314,Blank 490,2,N,OHSU_HNSCC_derm001,21,0.257,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
5326,10314,Blank 490,2,O,OHSU_HNSCC_derm001,21,0.253,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5327,10314,Blank 490,2,P,OHSU_HNSCC_derm001,21,0.357,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
5328,10314,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.354,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
5329,10314,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.282,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
5330,10314,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.266,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
5331,10314,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.176,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
5332,10314,Blank 490,2,E,OHSU_HNSCC_derm001,22,0.306,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5333,10314,Blank 490,2,F,OHSU_HNSCC_derm001,22,0.321,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
5334,10314,Blank 490,2,G,OHSU_HNSCC_derm001,22,0.256,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
5335,10314,Blank 490,2,H,OHSU_HNSCC_derm001,22,0.18,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
5336,10314,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.065,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
5337,10314,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.008,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
5338,10314,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.296,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
5339,10314,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.238,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
5340,10314,Blank 490,2,M,OHSU_HNSCC_derm001,22,0.308,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5341,10314,Blank 490,2,N,OHSU_HNSCC_derm001,22,0.347,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
5342,10314,Blank 490,2,O,OHSU_HNSCC_derm001,22,0.316,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5343,10314,Blank 490,2,P,OHSU_HNSCC_derm001,22,0.293,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
5344,10314,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.353,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
5345,10314,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.309,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
5346,10314,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.271,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
5347,10314,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.266,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
5348,10314,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.367,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
5349,10314,Blank 490,2,F,OHSU_HNSCC_derm001,23,0.313,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
5350,10314,Blank 490,2,G,OHSU_HNSCC_derm001,23,0.308,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
5351,10314,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.272,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
5352,10314,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.146,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
5353,10314,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.069,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
5354,10314,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.342,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
5355,10314,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.304,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
5356,10314,Blank 490,2,M,OHSU_HNSCC_derm001,23,0.301,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
5357,10314,Blank 490,2,N,OHSU_HNSCC_derm001,23,0.3,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
5358,10314,Blank 490,2,O,OHSU_HNSCC_derm001,23,0.334,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
5359,10314,Blank 490,2,P,OHSU_HNSCC_derm001,23,0.343,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
5360,10314,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.316,0,NONE,OHSU_HNSCC_derm001
5361,10314,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.327,0,NONE,OHSU_HNSCC_derm001
5362,10314,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.312,0,NONE,OHSU_HNSCC_derm001
5363,10314,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.279,0,NONE,OHSU_HNSCC_derm001
5364,10314,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.371,0,NONE,OHSU_HNSCC_derm001
5365,10314,Blank 490,2,F,OHSU_HNSCC_derm001,24,0.375,0,NONE,OHSU_HNSCC_derm001
5366,10314,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.377,0,NONE,OHSU_HNSCC_derm001
5367,10314,Blank 490,2,H,OHSU_HNSCC_derm001,24,0.346,0,NONE,OHSU_HNSCC_derm001
5368,10314,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.339,0,NONE,OHSU_HNSCC_derm001
5369,10314,Blank 490,2,J,OHSU_HNSCC_derm001,24,0.364,0,NONE,OHSU_HNSCC_derm001
5370,10314,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.332,0,NONE,OHSU_HNSCC_derm001
5371,10314,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.296,0,NONE,OHSU_HNSCC_derm001
5372,10314,Blank 490,2,M,OHSU_HNSCC_derm001,24,0.336,0,NONE,OHSU_HNSCC_derm001
5373,10314,Blank 490,2,N,OHSU_HNSCC_derm001,24,0.385,0,NONE,OHSU_HNSCC_derm001
5374,10314,Blank 490,2,O,OHSU_HNSCC_derm001,24,0.344,0,NONE,OHSU_HNSCC_derm001
5375,10314,Blank 490,2,P,OHSU_HNSCC_derm001,24,0.341,0,NONE,OHSU_HNSCC_derm001
5376,10314,Blank 490,3,A,OHSU_HNSCC_derm001,1,0.224,10,Thalidomide ,OHSU_HNSCC_derm001
5377,10314,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.188,10,Vandetanib,OHSU_HNSCC_derm001
5378,10314,Blank 490,3,C,OHSU_HNSCC_derm001,1,0.159,10,Oleic acid,OHSU_HNSCC_derm001
5379,10314,Blank 490,3,D,OHSU_HNSCC_derm001,1,-0.062,10,A-674563,OHSU_HNSCC_derm001
5380,10314,Blank 490,3,E,OHSU_HNSCC_derm001,1,0.029,10,Lapatinib,OHSU_HNSCC_derm001
5381,10314,Blank 490,3,F,OHSU_HNSCC_derm001,1,0.305,10,Apocynin (vanillin),OHSU_HNSCC_derm001
5382,10314,Blank 490,3,G,OHSU_HNSCC_derm001,1,-0.056,10,AT-7519,OHSU_HNSCC_derm001
5383,10314,Blank 490,3,H,OHSU_HNSCC_derm001,1,0.183,10,Gefitinib,OHSU_HNSCC_derm001
5384,10314,Blank 490,3,I,OHSU_HNSCC_derm001,1,0.051,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
5385,10314,Blank 490,3,J,OHSU_HNSCC_derm001,1,-0.02,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5386,10314,Blank 490,3,K,OHSU_HNSCC_derm001,1,0.016,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5387,10314,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.112,10,JQ1,OHSU_HNSCC_derm001
5388,10314,Blank 490,3,M,OHSU_HNSCC_derm001,1,0.805,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5389,10314,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.193,10,Cerdulatinib,OHSU_HNSCC_derm001
5390,10314,Blank 490,3,O,OHSU_HNSCC_derm001,1,-0.056,10,Romidepsin,OHSU_HNSCC_derm001
5391,10314,Blank 490,3,P,OHSU_HNSCC_derm001,1,0.281,10,Gilteritinib,OHSU_HNSCC_derm001
5392,10314,Blank 490,3,A,OHSU_HNSCC_derm001,2,0.241,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
5393,10314,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.147,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
5394,10314,Blank 490,3,C,OHSU_HNSCC_derm001,2,0.208,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
5395,10314,Blank 490,3,D,OHSU_HNSCC_derm001,2,-0.002,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
5396,10314,Blank 490,3,E,OHSU_HNSCC_derm001,2,0.134,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
5397,10314,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.275,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
5398,10314,Blank 490,3,G,OHSU_HNSCC_derm001,2,0.044,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
5399,10314,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.176,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
5400,10314,Blank 490,3,I,OHSU_HNSCC_derm001,2,0.118,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
5401,10314,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.011,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5402,10314,Blank 490,3,K,OHSU_HNSCC_derm001,2,0.187,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5403,10314,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.15,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
5404,10314,Blank 490,3,M,OHSU_HNSCC_derm001,2,0.445,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5405,10314,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.293,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
5406,10314,Blank 490,3,O,OHSU_HNSCC_derm001,2,0.032,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
5407,10314,Blank 490,3,P,OHSU_HNSCC_derm001,2,0.479,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
5408,10314,Blank 490,3,A,OHSU_HNSCC_derm001,3,0.282,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
5409,10314,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.164,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
5410,10314,Blank 490,3,C,OHSU_HNSCC_derm001,3,0.225,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
5411,10314,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.06,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
5412,10314,Blank 490,3,E,OHSU_HNSCC_derm001,3,0.175,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
5413,10314,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.321,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
5414,10314,Blank 490,3,G,OHSU_HNSCC_derm001,3,0.287,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
5415,10314,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.538,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
5416,10314,Blank 490,3,I,OHSU_HNSCC_derm001,3,0.187,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
5417,10314,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.187,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5418,10314,Blank 490,3,K,OHSU_HNSCC_derm001,3,0.125,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5419,10314,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.138,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
5420,10314,Blank 490,3,M,OHSU_HNSCC_derm001,3,0.396,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5421,10314,Blank 490,3,N,OHSU_HNSCC_derm001,3,0.447,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
5422,10314,Blank 490,3,O,OHSU_HNSCC_derm001,3,-0.042,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
5423,10314,Blank 490,3,P,OHSU_HNSCC_derm001,3,0.365,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
5424,10314,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.348,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
5425,10314,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.222,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
5426,10314,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.205,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
5427,10314,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.048,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
5428,10314,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.367,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
5429,10314,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.356,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
5430,10314,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.198,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
5431,10314,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.214,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
5432,10314,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.28,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
5433,10314,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.255,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5434,10314,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.158,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5435,10314,Blank 490,3,L,OHSU_HNSCC_derm001,4,0.352,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
5436,10314,Blank 490,3,M,OHSU_HNSCC_derm001,4,0.322,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5437,10314,Blank 490,3,N,OHSU_HNSCC_derm001,4,0.198,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
5438,10314,Blank 490,3,O,OHSU_HNSCC_derm001,4,-0.011,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
5439,10314,Blank 490,3,P,OHSU_HNSCC_derm001,4,0.463,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
5440,10314,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.306,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
5441,10314,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.205,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
5442,10314,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.245,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
5443,10314,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.135,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
5444,10314,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.184,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
5445,10314,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.304,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
5446,10314,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.296,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
5447,10314,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.188,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
5448,10314,Blank 490,3,I,OHSU_HNSCC_derm001,5,0.231,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
5449,10314,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.114,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5450,10314,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.332,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5451,10314,Blank 490,3,L,OHSU_HNSCC_derm001,5,0.354,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
5452,10314,Blank 490,3,M,OHSU_HNSCC_derm001,5,0.291,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5453,10314,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.229,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
5454,10314,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.023,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
5455,10314,Blank 490,3,P,OHSU_HNSCC_derm001,5,0.468,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
5456,10314,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.281,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
5457,10314,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.261,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
5458,10314,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.231,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
5459,10314,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.17,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
5460,10314,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.259,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
5461,10314,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.224,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
5462,10314,Blank 490,3,G,OHSU_HNSCC_derm001,6,0.502,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
5463,10314,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.242,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
5464,10314,Blank 490,3,I,OHSU_HNSCC_derm001,6,0.23,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
5465,10314,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.138,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5466,10314,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.221,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5467,10314,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.264,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
5468,10314,Blank 490,3,M,OHSU_HNSCC_derm001,6,0.307,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5469,10314,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.218,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
5470,10314,Blank 490,3,O,OHSU_HNSCC_derm001,6,-0.065,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
5471,10314,Blank 490,3,P,OHSU_HNSCC_derm001,6,0.271,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
5472,10314,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.278,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
5473,10314,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.243,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
5474,10314,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.319,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
5475,10314,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.173,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
5476,10314,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.243,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
5477,10314,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.259,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
5478,10314,Blank 490,3,G,OHSU_HNSCC_derm001,7,0.506,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
5479,10314,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.658,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
5480,10314,Blank 490,3,I,OHSU_HNSCC_derm001,7,0.212,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
5481,10314,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.187,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
5482,10314,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.204,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
5483,10314,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.285,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
5484,10314,Blank 490,3,M,OHSU_HNSCC_derm001,7,0.25,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
5485,10314,Blank 490,3,N,OHSU_HNSCC_derm001,7,0.228,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
5486,10314,Blank 490,3,O,OHSU_HNSCC_derm001,7,-0.056,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
5487,10314,Blank 490,3,P,OHSU_HNSCC_derm001,7,0.369,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
5488,10314,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.265,0,NONE,OHSU_HNSCC_derm001
5489,10314,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.227,0,NONE,OHSU_HNSCC_derm001
5490,10314,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.316,0,NONE,OHSU_HNSCC_derm001
5491,10314,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.141,0,NONE,OHSU_HNSCC_derm001
5492,10314,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.337,0,NONE,OHSU_HNSCC_derm001
5493,10314,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.385,0,NONE,OHSU_HNSCC_derm001
5494,10314,Blank 490,3,G,OHSU_HNSCC_derm001,8,0.226,0,NONE,OHSU_HNSCC_derm001
5495,10314,Blank 490,3,H,OHSU_HNSCC_derm001,8,-0.015,10,F-S-V,OHSU_HNSCC_derm001
5496,10314,Blank 490,3,I,OHSU_HNSCC_derm001,8,0.018,0,NONE,OHSU_HNSCC_derm001
5497,10314,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.223,0,NONE,OHSU_HNSCC_derm001
5498,10314,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.227,0,NONE,OHSU_HNSCC_derm001
5499,10314,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.341,0,NONE,OHSU_HNSCC_derm001
5500,10314,Blank 490,3,M,OHSU_HNSCC_derm001,8,0.191,0,NONE,OHSU_HNSCC_derm001
5501,10314,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.204,0,NONE,OHSU_HNSCC_derm001
5502,10314,Blank 490,3,O,OHSU_HNSCC_derm001,8,0.382,0,NONE,OHSU_HNSCC_derm001
5503,10314,Blank 490,3,P,OHSU_HNSCC_derm001,8,0.282,0,NONE,OHSU_HNSCC_derm001
5504,10314,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.248,10,Anastrazole,OHSU_HNSCC_derm001
5505,10314,Blank 490,3,B,OHSU_HNSCC_derm001,9,-0.027,10,JNJ-28312141 ,OHSU_HNSCC_derm001
5506,10314,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.097,10,Genistein,OHSU_HNSCC_derm001
5507,10314,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.133,10,Abscisic acid,OHSU_HNSCC_derm001
5508,10314,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.127,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5509,10314,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.477,10,Ruxolitinib,OHSU_HNSCC_derm001
5510,10314,Blank 490,3,G,OHSU_HNSCC_derm001,9,0.086,10,TAK-659,OHSU_HNSCC_derm001
5511,10314,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.028,10,Brigatinib,OHSU_HNSCC_derm001
5512,10314,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.019,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5513,10314,Blank 490,3,J,OHSU_HNSCC_derm001,9,-0.036,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5514,10314,Blank 490,3,K,OHSU_HNSCC_derm001,9,-0.06,10,Vorinostat,OHSU_HNSCC_derm001
5515,10314,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.219,10,Lenalidomide,OHSU_HNSCC_derm001
5516,10314,Blank 490,3,M,OHSU_HNSCC_derm001,9,-0.022,10,NVP-ADW742,OHSU_HNSCC_derm001
5517,10314,Blank 490,3,N,OHSU_HNSCC_derm001,9,0.175,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5518,10314,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.363,10,Echinatin,OHSU_HNSCC_derm001
5519,10314,Blank 490,3,P,OHSU_HNSCC_derm001,9,0.13,10,YM-155,OHSU_HNSCC_derm001
5520,10314,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.192,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
5521,10314,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.242,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
5522,10314,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.367,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
5523,10314,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.237,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
5524,10314,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.29,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5525,10314,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.513,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
5526,10314,Blank 490,3,G,OHSU_HNSCC_derm001,10,0.316,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
5527,10314,Blank 490,3,H,OHSU_HNSCC_derm001,10,0.337,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
5528,10314,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.18,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5529,10314,Blank 490,3,J,OHSU_HNSCC_derm001,10,0.117,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5530,10314,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.005,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
5531,10314,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.213,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
5532,10314,Blank 490,3,M,OHSU_HNSCC_derm001,10,0.164,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
5533,10314,Blank 490,3,N,OHSU_HNSCC_derm001,10,0.249,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5534,10314,Blank 490,3,O,OHSU_HNSCC_derm001,10,0.419,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
5535,10314,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.044,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
5536,10314,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.264,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
5537,10314,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.247,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
5538,10314,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.373,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
5539,10314,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.231,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
5540,10314,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.198,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5541,10314,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.279,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
5542,10314,Blank 490,3,G,OHSU_HNSCC_derm001,11,0.245,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
5543,10314,Blank 490,3,H,OHSU_HNSCC_derm001,11,0.266,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
5544,10314,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.163,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5545,10314,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.185,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5546,10314,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.043,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
5547,10314,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.2,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
5548,10314,Blank 490,3,M,OHSU_HNSCC_derm001,11,0.171,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
5549,10314,Blank 490,3,N,OHSU_HNSCC_derm001,11,0.217,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5550,10314,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.298,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
5551,10314,Blank 490,3,P,OHSU_HNSCC_derm001,11,-0.039,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
5552,10314,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.312,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
5553,10314,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.264,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
5554,10314,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.191,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
5555,10314,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.184,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
5556,10314,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.158,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5557,10314,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.495,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
5558,10314,Blank 490,3,G,OHSU_HNSCC_derm001,12,0.326,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
5559,10314,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.348,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
5560,10314,Blank 490,3,I,OHSU_HNSCC_derm001,12,0.186,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5561,10314,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.24,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5562,10314,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.171,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
5563,10314,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.234,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
5564,10314,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.235,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
5565,10314,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.315,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5566,10314,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.267,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
5567,10314,Blank 490,3,P,OHSU_HNSCC_derm001,12,0.307,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
5568,10314,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.414,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
5569,10314,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.229,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
5570,10314,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.427,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
5571,10314,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.274,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
5572,10314,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.192,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5573,10314,Blank 490,3,F,OHSU_HNSCC_derm001,13,0.416,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
5574,10314,Blank 490,3,G,OHSU_HNSCC_derm001,13,0.227,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
5575,10314,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.345,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
5576,10314,Blank 490,3,I,OHSU_HNSCC_derm001,13,0.191,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5577,10314,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.306,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5578,10314,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.185,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
5579,10314,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.272,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
5580,10314,Blank 490,3,M,OHSU_HNSCC_derm001,13,0.215,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
5581,10314,Blank 490,3,N,OHSU_HNSCC_derm001,13,0.229,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5582,10314,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.337,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
5583,10314,Blank 490,3,P,OHSU_HNSCC_derm001,13,0.088,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
5584,10314,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.291,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
5585,10314,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.252,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
5586,10314,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.233,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
5587,10314,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.192,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
5588,10314,Blank 490,3,E,OHSU_HNSCC_derm001,14,0.213,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5589,10314,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.248,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
5590,10314,Blank 490,3,G,OHSU_HNSCC_derm001,14,0.276,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
5591,10314,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.52,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
5592,10314,Blank 490,3,I,OHSU_HNSCC_derm001,14,0.175,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5593,10314,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.266,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5594,10314,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.215,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
5595,10314,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.219,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
5596,10314,Blank 490,3,M,OHSU_HNSCC_derm001,14,0.218,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
5597,10314,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.236,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5598,10314,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.347,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
5599,10314,Blank 490,3,P,OHSU_HNSCC_derm001,14,-0.035,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
5600,10314,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.3,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
5601,10314,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.214,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
5602,10314,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.289,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
5603,10314,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.174,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
5604,10314,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.46,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
5605,10314,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.427,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
5606,10314,Blank 490,3,G,OHSU_HNSCC_derm001,15,0.405,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
5607,10314,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.277,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
5608,10314,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.171,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5609,10314,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.333,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
5610,10314,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.187,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
5611,10314,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.173,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
5612,10314,Blank 490,3,M,OHSU_HNSCC_derm001,15,0.202,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
5613,10314,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.261,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
5614,10314,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.54,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
5615,10314,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.121,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
5616,10314,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.277,0,NONE,OHSU_HNSCC_derm001
5617,10314,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.235,0,NONE,OHSU_HNSCC_derm001
5618,10314,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.327,0,NONE,OHSU_HNSCC_derm001
5619,10314,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.172,0,NONE,OHSU_HNSCC_derm001
5620,10314,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.224,0,NONE,OHSU_HNSCC_derm001
5621,10314,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.368,0,NONE,OHSU_HNSCC_derm001
5622,10314,Blank 490,3,G,OHSU_HNSCC_derm001,16,-0.005,0,NONE,OHSU_HNSCC_derm001
5623,10314,Blank 490,3,H,OHSU_HNSCC_derm001,16,0.015,10,F-S-V,OHSU_HNSCC_derm001
5624,10314,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.316,0,NONE,OHSU_HNSCC_derm001
5625,10314,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.248,0,NONE,OHSU_HNSCC_derm001
5626,10314,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.205,0,NONE,OHSU_HNSCC_derm001
5627,10314,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.23,0,NONE,OHSU_HNSCC_derm001
5628,10314,Blank 490,3,M,OHSU_HNSCC_derm001,16,0.204,0,NONE,OHSU_HNSCC_derm001
5629,10314,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.227,0,NONE,OHSU_HNSCC_derm001
5630,10314,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.215,0,NONE,OHSU_HNSCC_derm001
5631,10314,Blank 490,3,P,OHSU_HNSCC_derm001,16,0.332,0,NONE,OHSU_HNSCC_derm001
5632,10314,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.3,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5633,10314,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.229,10,Stevioside,OHSU_HNSCC_derm001
5634,10314,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.203,10,Pemetrexed,OHSU_HNSCC_derm001
5635,10314,Blank 490,3,D,OHSU_HNSCC_derm001,17,-0.022,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5636,10314,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.058,10,GSK-1838705A,OHSU_HNSCC_derm001
5637,10314,Blank 490,3,F,OHSU_HNSCC_derm001,17,-0.05,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5638,10314,Blank 490,3,G,OHSU_HNSCC_derm001,17,0.196,10,Imatinib,OHSU_HNSCC_derm001
5639,10314,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.355,10,Trametinib,OHSU_HNSCC_derm001
5640,10314,Blank 490,3,I,OHSU_HNSCC_derm001,17,-0.046,10,BEZ235,OHSU_HNSCC_derm001
5641,10314,Blank 490,3,J,OHSU_HNSCC_derm001,17,0.158,10,Saracatinib,OHSU_HNSCC_derm001
5642,10314,Blank 490,3,K,OHSU_HNSCC_derm001,17,0.288,10,I-BET 762,OHSU_HNSCC_derm001
5643,10314,Blank 490,3,L,OHSU_HNSCC_derm001,17,-0.068,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
5644,10314,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.222,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
5645,10314,Blank 490,3,N,OHSU_HNSCC_derm001,17,0.115,10,Crizotinib,OHSU_HNSCC_derm001
5646,10314,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.128,10,MGCD-265,OHSU_HNSCC_derm001
5647,10314,Blank 490,3,P,OHSU_HNSCC_derm001,17,0.111,10,Erlotinib,OHSU_HNSCC_derm001
5648,10314,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.507,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5649,10314,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.219,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
5650,10314,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.23,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
5651,10314,Blank 490,3,D,OHSU_HNSCC_derm001,18,-0.003,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5652,10314,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.181,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
5653,10314,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.185,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5654,10314,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.284,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
5655,10314,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.095,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
5656,10314,Blank 490,3,I,OHSU_HNSCC_derm001,18,-0.019,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
5657,10314,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.187,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
5658,10314,Blank 490,3,K,OHSU_HNSCC_derm001,18,0.217,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
5659,10314,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.024,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
5660,10314,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.386,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
5661,10314,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.217,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
5662,10314,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.117,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
5663,10314,Blank 490,3,P,OHSU_HNSCC_derm001,18,0.259,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
5664,10314,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.267,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5665,10314,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.196,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
5666,10314,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.285,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
5667,10314,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.015,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5668,10314,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.15,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
5669,10314,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.546,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5670,10314,Blank 490,3,G,OHSU_HNSCC_derm001,19,0.525,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
5671,10314,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.298,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
5672,10314,Blank 490,3,I,OHSU_HNSCC_derm001,19,-0.037,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
5673,10314,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.257,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
5674,10314,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.344,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
5675,10314,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.147,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
5676,10314,Blank 490,3,M,OHSU_HNSCC_derm001,19,0.348,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
5677,10314,Blank 490,3,N,OHSU_HNSCC_derm001,19,0.252,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
5678,10314,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.195,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
5679,10314,Blank 490,3,P,OHSU_HNSCC_derm001,19,0.208,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
5680,10314,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.313,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5681,10314,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.212,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
5682,10314,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.154,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
5683,10314,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.046,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5684,10314,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.533,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
5685,10314,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.25,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5686,10314,Blank 490,3,G,OHSU_HNSCC_derm001,20,0.281,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
5687,10314,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.32,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
5688,10314,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.164,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
5689,10314,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.226,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
5690,10314,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.248,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
5691,10314,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.148,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
5692,10314,Blank 490,3,M,OHSU_HNSCC_derm001,20,0.254,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
5693,10314,Blank 490,3,N,OHSU_HNSCC_derm001,20,0.235,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
5694,10314,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.262,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
5695,10314,Blank 490,3,P,OHSU_HNSCC_derm001,20,0.294,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
5696,10314,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.278,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5697,10314,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.216,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
5698,10314,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.306,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
5699,10314,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.179,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5700,10314,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.269,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
5701,10314,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.217,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5702,10314,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.251,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
5703,10314,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.183,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
5704,10314,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.065,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
5705,10314,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.211,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
5706,10314,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.306,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
5707,10314,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.144,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
5708,10314,Blank 490,3,M,OHSU_HNSCC_derm001,21,0.212,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
5709,10314,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.301,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
5710,10314,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.213,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
5711,10314,Blank 490,3,P,OHSU_HNSCC_derm001,21,0.229,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
5712,10314,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.441,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5713,10314,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.266,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
5714,10314,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.185,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
5715,10314,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.115,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5716,10314,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.234,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
5717,10314,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.273,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5718,10314,Blank 490,3,G,OHSU_HNSCC_derm001,22,0.363,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
5719,10314,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.241,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
5720,10314,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.106,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
5721,10314,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.225,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
5722,10314,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.249,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
5723,10314,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.175,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
5724,10314,Blank 490,3,M,OHSU_HNSCC_derm001,22,0.238,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
5725,10314,Blank 490,3,N,OHSU_HNSCC_derm001,22,0.259,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
5726,10314,Blank 490,3,O,OHSU_HNSCC_derm001,22,0.222,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
5727,10314,Blank 490,3,P,OHSU_HNSCC_derm001,22,0.252,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
5728,10314,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.256,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
5729,10314,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.277,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
5730,10314,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.234,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
5731,10314,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.113,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
5732,10314,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.353,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
5733,10314,Blank 490,3,F,OHSU_HNSCC_derm001,23,0.241,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
5734,10314,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.241,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
5735,10314,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.202,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
5736,10314,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.223,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
5737,10314,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.213,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
5738,10314,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.242,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
5739,10314,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.239,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
5740,10314,Blank 490,3,M,OHSU_HNSCC_derm001,23,0.22,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
5741,10314,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.25,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
5742,10314,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.313,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
5743,10314,Blank 490,3,P,OHSU_HNSCC_derm001,23,0.246,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
5744,10314,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.344,0,NONE,OHSU_HNSCC_derm001
5745,10314,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.238,0,NONE,OHSU_HNSCC_derm001
5746,10314,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.352,0,NONE,OHSU_HNSCC_derm001
5747,10314,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.194,0,NONE,OHSU_HNSCC_derm001
5748,10314,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.285,0,NONE,OHSU_HNSCC_derm001
5749,10314,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.282,0,NONE,OHSU_HNSCC_derm001
5750,10314,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.245,0,NONE,OHSU_HNSCC_derm001
5751,10314,Blank 490,3,H,OHSU_HNSCC_derm001,24,0.246,0,NONE,OHSU_HNSCC_derm001
5752,10314,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.265,0,NONE,OHSU_HNSCC_derm001
5753,10314,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.276,0,NONE,OHSU_HNSCC_derm001
5754,10314,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.256,0,NONE,OHSU_HNSCC_derm001
5755,10314,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.206,0,NONE,OHSU_HNSCC_derm001
5756,10314,Blank 490,3,M,OHSU_HNSCC_derm001,24,0.243,0,NONE,OHSU_HNSCC_derm001
5757,10314,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.272,0,NONE,OHSU_HNSCC_derm001
5758,10314,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.246,0,NONE,OHSU_HNSCC_derm001
5759,10314,Blank 490,3,P,OHSU_HNSCC_derm001,24,0.242,0,NONE,OHSU_HNSCC_derm001
5760,10320,Blank 490,1,A,OHSU_HNSCC_derm001,1,-0.02,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
5761,10320,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.167,10,Lucitanib ,OHSU_HNSCC_derm001
5762,10320,Blank 490,1,C,OHSU_HNSCC_derm001,1,-0.014,10,Resveratrol,OHSU_HNSCC_derm001
5763,10320,Blank 490,1,D,OHSU_HNSCC_derm001,1,0.084,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5764,10320,Blank 490,1,E,OHSU_HNSCC_derm001,1,-0.016,10,Bicalutamide,OHSU_HNSCC_derm001
5765,10320,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.237,10,Methotrexate ,OHSU_HNSCC_derm001
5766,10320,Blank 490,1,G,OHSU_HNSCC_derm001,1,-0.017,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5767,10320,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.074,10,Gefitinib,OHSU_HNSCC_derm001
5768,10320,Blank 490,1,I,OHSU_HNSCC_derm001,1,-0.016,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
5769,10320,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.091,10,Tamatinib/R406,OHSU_HNSCC_derm001
5770,10320,Blank 490,1,K,OHSU_HNSCC_derm001,1,-0.017,10,Bosutinib,OHSU_HNSCC_derm001
5771,10320,Blank 490,1,L,OHSU_HNSCC_derm001,1,0.023,10,PI-103,OHSU_HNSCC_derm001
5772,10320,Blank 490,1,M,OHSU_HNSCC_derm001,1,-0.014,10,Glycyrrhizin,OHSU_HNSCC_derm001
5773,10320,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.151,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
5774,10320,Blank 490,1,O,OHSU_HNSCC_derm001,1,-0.018,10,GSK-690693,OHSU_HNSCC_derm001
5775,10320,Blank 490,1,P,OHSU_HNSCC_derm001,1,0.15,10,Ibrutinib,OHSU_HNSCC_derm001
5776,10320,Blank 490,1,A,OHSU_HNSCC_derm001,2,-0.02,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
5777,10320,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.188,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
5778,10320,Blank 490,1,C,OHSU_HNSCC_derm001,2,-0.025,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
5779,10320,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.141,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5780,10320,Blank 490,1,E,OHSU_HNSCC_derm001,2,-0.023,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
5781,10320,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.275,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
5782,10320,Blank 490,1,G,OHSU_HNSCC_derm001,2,-0.022,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5783,10320,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.13,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
5784,10320,Blank 490,1,I,OHSU_HNSCC_derm001,2,-0.024,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
5785,10320,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.099,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
5786,10320,Blank 490,1,K,OHSU_HNSCC_derm001,2,-0.023,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
5787,10320,Blank 490,1,L,OHSU_HNSCC_derm001,2,0.031,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
5788,10320,Blank 490,1,M,OHSU_HNSCC_derm001,2,-0.017,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
5789,10320,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.157,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
5790,10320,Blank 490,1,O,OHSU_HNSCC_derm001,2,-0.022,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
5791,10320,Blank 490,1,P,OHSU_HNSCC_derm001,2,0.281,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
5792,10320,Blank 490,1,A,OHSU_HNSCC_derm001,3,-0.019,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
5793,10320,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.207,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
5794,10320,Blank 490,1,C,OHSU_HNSCC_derm001,3,-0.026,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
5795,10320,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.126,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5796,10320,Blank 490,1,E,OHSU_HNSCC_derm001,3,-0.02,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
5797,10320,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.258,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
5798,10320,Blank 490,1,G,OHSU_HNSCC_derm001,3,-0.021,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5799,10320,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.119,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
5800,10320,Blank 490,1,I,OHSU_HNSCC_derm001,3,-0.02,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
5801,10320,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.17,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
5802,10320,Blank 490,1,K,OHSU_HNSCC_derm001,3,-0.019,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
5803,10320,Blank 490,1,L,OHSU_HNSCC_derm001,3,0.033,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
5804,10320,Blank 490,1,M,OHSU_HNSCC_derm001,3,-0.016,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
5805,10320,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.233,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
5806,10320,Blank 490,1,O,OHSU_HNSCC_derm001,3,-0.014,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
5807,10320,Blank 490,1,P,OHSU_HNSCC_derm001,3,0.166,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
5808,10320,Blank 490,1,A,OHSU_HNSCC_derm001,4,0.018,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
5809,10320,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.207,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
5810,10320,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.077,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
5811,10320,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.113,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5812,10320,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.129,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
5813,10320,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.273,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
5814,10320,Blank 490,1,G,OHSU_HNSCC_derm001,4,0.137,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5815,10320,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.187,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
5816,10320,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.116,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
5817,10320,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.243,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
5818,10320,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.219,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
5819,10320,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.068,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
5820,10320,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.166,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
5821,10320,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.242,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
5822,10320,Blank 490,1,O,OHSU_HNSCC_derm001,4,0.197,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
5823,10320,Blank 490,1,P,OHSU_HNSCC_derm001,4,0.175,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
5824,10320,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.108,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
5825,10320,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.235,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
5826,10320,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.241,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
5827,10320,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.128,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5828,10320,Blank 490,1,E,OHSU_HNSCC_derm001,5,0.263,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
5829,10320,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.257,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
5830,10320,Blank 490,1,G,OHSU_HNSCC_derm001,5,0.314,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5831,10320,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.224,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
5832,10320,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.25,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
5833,10320,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.245,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
5834,10320,Blank 490,1,K,OHSU_HNSCC_derm001,5,0.322,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
5835,10320,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.135,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
5836,10320,Blank 490,1,M,OHSU_HNSCC_derm001,5,0.205,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
5837,10320,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.257,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
5838,10320,Blank 490,1,O,OHSU_HNSCC_derm001,5,0.246,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
5839,10320,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.186,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
5840,10320,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.206,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
5841,10320,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.216,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
5842,10320,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.22,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
5843,10320,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.145,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5844,10320,Blank 490,1,E,OHSU_HNSCC_derm001,6,0.27,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
5845,10320,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.287,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
5846,10320,Blank 490,1,G,OHSU_HNSCC_derm001,6,0.289,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5847,10320,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.26,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
5848,10320,Blank 490,1,I,OHSU_HNSCC_derm001,6,0.252,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
5849,10320,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.261,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
5850,10320,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.279,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
5851,10320,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.193,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
5852,10320,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.282,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
5853,10320,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.265,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
5854,10320,Blank 490,1,O,OHSU_HNSCC_derm001,6,0.266,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
5855,10320,Blank 490,1,P,OHSU_HNSCC_derm001,6,0.2,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
5856,10320,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.178,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
5857,10320,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.229,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
5858,10320,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.245,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
5859,10320,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.192,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
5860,10320,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.537,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
5861,10320,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.287,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
5862,10320,Blank 490,1,G,OHSU_HNSCC_derm001,7,0.29,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
5863,10320,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.255,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
5864,10320,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.27,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
5865,10320,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.268,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
5866,10320,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.277,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
5867,10320,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.237,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
5868,10320,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.184,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
5869,10320,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.244,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
5870,10320,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.296,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
5871,10320,Blank 490,1,P,OHSU_HNSCC_derm001,7,0.303,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
5872,10320,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.266,0,NONE,OHSU_HNSCC_derm001
5873,10320,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.24,0,NONE,OHSU_HNSCC_derm001
5874,10320,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.232,0,NONE,OHSU_HNSCC_derm001
5875,10320,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.255,0,NONE,OHSU_HNSCC_derm001
5876,10320,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.285,0,NONE,OHSU_HNSCC_derm001
5877,10320,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.276,0,NONE,OHSU_HNSCC_derm001
5878,10320,Blank 490,1,G,OHSU_HNSCC_derm001,8,0.293,0,NONE,OHSU_HNSCC_derm001
5879,10320,Blank 490,1,H,OHSU_HNSCC_derm001,8,0.001,10,F-S-V,OHSU_HNSCC_derm001
5880,10320,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.29,0,NONE,OHSU_HNSCC_derm001
5881,10320,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.275,0,NONE,OHSU_HNSCC_derm001
5882,10320,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.266,0,NONE,OHSU_HNSCC_derm001
5883,10320,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.281,0,NONE,OHSU_HNSCC_derm001
5884,10320,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.257,0,NONE,OHSU_HNSCC_derm001
5885,10320,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.25,0,NONE,OHSU_HNSCC_derm001
5886,10320,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.247,0,NONE,OHSU_HNSCC_derm001
5887,10320,Blank 490,1,P,OHSU_HNSCC_derm001,8,0.296,0,NONE,OHSU_HNSCC_derm001
5888,10320,Blank 490,1,A,OHSU_HNSCC_derm001,9,0.018,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5889,10320,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.137,10,Sorafenib,OHSU_HNSCC_derm001
5890,10320,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.291,10,Rosmarinic acid,OHSU_HNSCC_derm001
5891,10320,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.136,10,Rapamycin,OHSU_HNSCC_derm001
5892,10320,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.265,10,Vismodegib,OHSU_HNSCC_derm001
5893,10320,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.097,10,PP242,OHSU_HNSCC_derm001
5894,10320,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.179,10,Alectinib,OHSU_HNSCC_derm001
5895,10320,Blank 490,1,H,OHSU_HNSCC_derm001,9,0.045,10,Brigatinib,OHSU_HNSCC_derm001
5896,10320,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.11,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5897,10320,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.092,10,MK-2206,OHSU_HNSCC_derm001
5898,10320,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.1,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5899,10320,Blank 490,1,L,OHSU_HNSCC_derm001,9,0.061,10,Flavopiridol ,OHSU_HNSCC_derm001
5900,10320,Blank 490,1,M,OHSU_HNSCC_derm001,9,0.25,10,Indirubin,OHSU_HNSCC_derm001
5901,10320,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.231,10,PF-533228,OHSU_HNSCC_derm001
5902,10320,Blank 490,1,O,OHSU_HNSCC_derm001,9,0.33,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5903,10320,Blank 490,1,P,OHSU_HNSCC_derm001,9,0.049,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5904,10320,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.028,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5905,10320,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.174,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
5906,10320,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.295,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
5907,10320,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.116,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
5908,10320,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.262,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
5909,10320,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.105,3.3333333333333335,PP242,OHSU_HNSCC_derm001
5910,10320,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.205,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
5911,10320,Blank 490,1,H,OHSU_HNSCC_derm001,10,0.078,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
5912,10320,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.156,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5913,10320,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.145,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
5914,10320,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.157,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5915,10320,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.05,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
5916,10320,Blank 490,1,M,OHSU_HNSCC_derm001,10,0.253,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
5917,10320,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.269,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
5918,10320,Blank 490,1,O,OHSU_HNSCC_derm001,10,0.284,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5919,10320,Blank 490,1,P,OHSU_HNSCC_derm001,10,0.044,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5920,10320,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.032,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5921,10320,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.167,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
5922,10320,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.272,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
5923,10320,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.112,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
5924,10320,Blank 490,1,E,OHSU_HNSCC_derm001,11,0.26,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
5925,10320,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.112,1.1111111111111112,PP242,OHSU_HNSCC_derm001
5926,10320,Blank 490,1,G,OHSU_HNSCC_derm001,11,0.209,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
5927,10320,Blank 490,1,H,OHSU_HNSCC_derm001,11,0.127,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
5928,10320,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.158,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5929,10320,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.143,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
5930,10320,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.163,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5931,10320,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.044,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
5932,10320,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.216,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
5933,10320,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.277,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
5934,10320,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.214,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5935,10320,Blank 490,1,P,OHSU_HNSCC_derm001,11,0.047,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5936,10320,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.024,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5937,10320,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.273,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
5938,10320,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.222,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
5939,10320,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.138,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
5940,10320,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.271,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
5941,10320,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.145,0.3703703703703704,PP242,OHSU_HNSCC_derm001
5942,10320,Blank 490,1,G,OHSU_HNSCC_derm001,12,0.258,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
5943,10320,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.177,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
5944,10320,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.105,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5945,10320,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.358,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
5946,10320,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.164,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5947,10320,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.052,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
5948,10320,Blank 490,1,M,OHSU_HNSCC_derm001,12,0.249,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
5949,10320,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.271,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
5950,10320,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.312,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5951,10320,Blank 490,1,P,OHSU_HNSCC_derm001,12,0.127,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5952,10320,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.056,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5953,10320,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.196,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
5954,10320,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.273,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
5955,10320,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.126,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
5956,10320,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.292,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
5957,10320,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.171,0.1234567901234568,PP242,OHSU_HNSCC_derm001
5958,10320,Blank 490,1,G,OHSU_HNSCC_derm001,13,0.265,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
5959,10320,Blank 490,1,H,OHSU_HNSCC_derm001,13,0.215,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
5960,10320,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.133,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5961,10320,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.185,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
5962,10320,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.218,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5963,10320,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.159,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
5964,10320,Blank 490,1,M,OHSU_HNSCC_derm001,13,0.23,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
5965,10320,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.274,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
5966,10320,Blank 490,1,O,OHSU_HNSCC_derm001,13,0.281,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5967,10320,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.197,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5968,10320,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.114,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5969,10320,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.212,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
5970,10320,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.229,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
5971,10320,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.135,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
5972,10320,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.269,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
5973,10320,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.211,0.0411522633744856,PP242,OHSU_HNSCC_derm001
5974,10320,Blank 490,1,G,OHSU_HNSCC_derm001,14,0.275,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
5975,10320,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.264,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
5976,10320,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.175,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5977,10320,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.215,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
5978,10320,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.24,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5979,10320,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.237,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
5980,10320,Blank 490,1,M,OHSU_HNSCC_derm001,14,0.259,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
5981,10320,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.249,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
5982,10320,Blank 490,1,O,OHSU_HNSCC_derm001,14,0.242,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5983,10320,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.253,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
5984,10320,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.167,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
5985,10320,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.233,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
5986,10320,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.221,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
5987,10320,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.141,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
5988,10320,Blank 490,1,E,OHSU_HNSCC_derm001,15,0.261,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
5989,10320,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.245,0.013717421124828532,PP242,OHSU_HNSCC_derm001
5990,10320,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.271,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
5991,10320,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.277,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
5992,10320,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.186,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
5993,10320,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.251,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
5994,10320,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.285,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
5995,10320,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.258,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
5996,10320,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.244,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
5997,10320,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.23,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
5998,10320,Blank 490,1,O,OHSU_HNSCC_derm001,15,0.299,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
5999,10320,Blank 490,1,P,OHSU_HNSCC_derm001,15,0.253,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
6000,10320,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.21,0,NONE,OHSU_HNSCC_derm001
6001,10320,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.254,0,NONE,OHSU_HNSCC_derm001
6002,10320,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.24,0,NONE,OHSU_HNSCC_derm001
6003,10320,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.27,0,NONE,OHSU_HNSCC_derm001
6004,10320,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.254,0,NONE,OHSU_HNSCC_derm001
6005,10320,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.276,0,NONE,OHSU_HNSCC_derm001
6006,10320,Blank 490,1,G,OHSU_HNSCC_derm001,16,0.306,0,NONE,OHSU_HNSCC_derm001
6007,10320,Blank 490,1,H,OHSU_HNSCC_derm001,16,-0.001,10,F-S-V,OHSU_HNSCC_derm001
6008,10320,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.297,0,NONE,OHSU_HNSCC_derm001
6009,10320,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.294,0,NONE,OHSU_HNSCC_derm001
6010,10320,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.283,0,NONE,OHSU_HNSCC_derm001
6011,10320,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.274,0,NONE,OHSU_HNSCC_derm001
6012,10320,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.251,0,NONE,OHSU_HNSCC_derm001
6013,10320,Blank 490,1,N,OHSU_HNSCC_derm001,16,0.24,0,NONE,OHSU_HNSCC_derm001
6014,10320,Blank 490,1,O,OHSU_HNSCC_derm001,16,0.191,0,NONE,OHSU_HNSCC_derm001
6015,10320,Blank 490,1,P,OHSU_HNSCC_derm001,16,0.263,0,NONE,OHSU_HNSCC_derm001
6016,10320,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.188,10,Emodin,OHSU_HNSCC_derm001
6017,10320,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.186,10,Baicalin,OHSU_HNSCC_derm001
6018,10320,Blank 490,1,C,OHSU_HNSCC_derm001,17,0.014,10,NVP-TAE-684,OHSU_HNSCC_derm001
6019,10320,Blank 490,1,D,OHSU_HNSCC_derm001,17,0.025,10,Panobinostat,OHSU_HNSCC_derm001
6020,10320,Blank 490,1,E,OHSU_HNSCC_derm001,17,0.033,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
6021,10320,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.314,10,Fulvestrant,OHSU_HNSCC_derm001
6022,10320,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.109,10,SCH-772984,OHSU_HNSCC_derm001
6023,10320,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.143,10,Trametinib,OHSU_HNSCC_derm001
6024,10320,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.042,10,BEZ235,OHSU_HNSCC_derm001
6025,10320,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.27,10,MLN120B,OHSU_HNSCC_derm001
6026,10320,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.2,10,Ixabepilone,OHSU_HNSCC_derm001
6027,10320,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.034,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
6028,10320,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.122,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6029,10320,Blank 490,1,N,OHSU_HNSCC_derm001,17,0.148,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6030,10320,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.139,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6031,10320,Blank 490,1,P,OHSU_HNSCC_derm001,17,0.195,10,Letrozole,OHSU_HNSCC_derm001
6032,10320,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.206,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
6033,10320,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.184,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
6034,10320,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.093,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
6035,10320,Blank 490,1,D,OHSU_HNSCC_derm001,18,0.029,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
6036,10320,Blank 490,1,E,OHSU_HNSCC_derm001,18,0.048,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
6037,10320,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.294,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
6038,10320,Blank 490,1,G,OHSU_HNSCC_derm001,18,0.14,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
6039,10320,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.166,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
6040,10320,Blank 490,1,I,OHSU_HNSCC_derm001,18,0.047,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
6041,10320,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.274,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
6042,10320,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.213,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
6043,10320,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.137,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
6044,10320,Blank 490,1,M,OHSU_HNSCC_derm001,18,0.168,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6045,10320,Blank 490,1,N,OHSU_HNSCC_derm001,18,0.129,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6046,10320,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.174,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6047,10320,Blank 490,1,P,OHSU_HNSCC_derm001,18,0.186,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
6048,10320,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.218,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
6049,10320,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.263,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
6050,10320,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.108,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
6051,10320,Blank 490,1,D,OHSU_HNSCC_derm001,19,0.038,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
6052,10320,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.056,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
6053,10320,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.265,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
6054,10320,Blank 490,1,G,OHSU_HNSCC_derm001,19,0.181,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
6055,10320,Blank 490,1,H,OHSU_HNSCC_derm001,19,0.164,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
6056,10320,Blank 490,1,I,OHSU_HNSCC_derm001,19,0.033,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
6057,10320,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.266,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
6058,10320,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.189,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
6059,10320,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.149,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
6060,10320,Blank 490,1,M,OHSU_HNSCC_derm001,19,0.172,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6061,10320,Blank 490,1,N,OHSU_HNSCC_derm001,19,0.149,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6062,10320,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.252,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6063,10320,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.245,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
6064,10320,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.23,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
6065,10320,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.216,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
6066,10320,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.123,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
6067,10320,Blank 490,1,D,OHSU_HNSCC_derm001,20,0.081,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
6068,10320,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.096,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
6069,10320,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.255,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
6070,10320,Blank 490,1,G,OHSU_HNSCC_derm001,20,0.246,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
6071,10320,Blank 490,1,H,OHSU_HNSCC_derm001,20,0.139,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
6072,10320,Blank 490,1,I,OHSU_HNSCC_derm001,20,0.063,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
6073,10320,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.257,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
6074,10320,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.189,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
6075,10320,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.153,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
6076,10320,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.165,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6077,10320,Blank 490,1,N,OHSU_HNSCC_derm001,20,0.18,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6078,10320,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.265,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6079,10320,Blank 490,1,P,OHSU_HNSCC_derm001,20,0.246,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
6080,10320,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.237,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
6081,10320,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.183,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
6082,10320,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.155,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
6083,10320,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.163,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
6084,10320,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.136,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
6085,10320,Blank 490,1,F,OHSU_HNSCC_derm001,21,0.28,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
6086,10320,Blank 490,1,G,OHSU_HNSCC_derm001,21,0.274,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
6087,10320,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.136,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
6088,10320,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.084,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
6089,10320,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.256,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
6090,10320,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.211,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
6091,10320,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.194,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
6092,10320,Blank 490,1,M,OHSU_HNSCC_derm001,21,0.225,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6093,10320,Blank 490,1,N,OHSU_HNSCC_derm001,21,0.243,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6094,10320,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.253,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6095,10320,Blank 490,1,P,OHSU_HNSCC_derm001,21,0.304,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
6096,10320,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.264,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
6097,10320,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.243,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
6098,10320,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.199,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
6099,10320,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.192,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
6100,10320,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.174,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
6101,10320,Blank 490,1,F,OHSU_HNSCC_derm001,22,0.273,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
6102,10320,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.248,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
6103,10320,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.157,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
6104,10320,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.165,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
6105,10320,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.282,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
6106,10320,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.216,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
6107,10320,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.207,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
6108,10320,Blank 490,1,M,OHSU_HNSCC_derm001,22,0.195,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6109,10320,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.23,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6110,10320,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.233,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6111,10320,Blank 490,1,P,OHSU_HNSCC_derm001,22,0.245,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
6112,10320,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.212,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
6113,10320,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.234,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
6114,10320,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.189,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
6115,10320,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.172,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
6116,10320,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.225,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
6117,10320,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.211,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
6118,10320,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.271,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
6119,10320,Blank 490,1,H,OHSU_HNSCC_derm001,23,0.134,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
6120,10320,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.178,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
6121,10320,Blank 490,1,J,OHSU_HNSCC_derm001,23,0.284,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
6122,10320,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.19,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
6123,10320,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.232,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
6124,10320,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.136,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
6125,10320,Blank 490,1,N,OHSU_HNSCC_derm001,23,0.215,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
6126,10320,Blank 490,1,O,OHSU_HNSCC_derm001,23,0.254,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
6127,10320,Blank 490,1,P,OHSU_HNSCC_derm001,23,0.244,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
6128,10320,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.218,0,NONE,OHSU_HNSCC_derm001
6129,10320,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.216,0,NONE,OHSU_HNSCC_derm001
6130,10320,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.17,0,NONE,OHSU_HNSCC_derm001
6131,10320,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.159,0,NONE,OHSU_HNSCC_derm001
6132,10320,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.255,0,NONE,OHSU_HNSCC_derm001
6133,10320,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.171,0,NONE,OHSU_HNSCC_derm001
6134,10320,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.221,0,NONE,OHSU_HNSCC_derm001
6135,10320,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.16,0,NONE,OHSU_HNSCC_derm001
6136,10320,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.227,0,NONE,OHSU_HNSCC_derm001
6137,10320,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.253,0,NONE,OHSU_HNSCC_derm001
6138,10320,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.271,0,NONE,OHSU_HNSCC_derm001
6139,10320,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.206,0,NONE,OHSU_HNSCC_derm001
6140,10320,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.196,0,NONE,OHSU_HNSCC_derm001
6141,10320,Blank 490,1,N,OHSU_HNSCC_derm001,24,0.223,0,NONE,OHSU_HNSCC_derm001
6142,10320,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.21,0,NONE,OHSU_HNSCC_derm001
6143,10320,Blank 490,1,P,OHSU_HNSCC_derm001,24,0.242,0,NONE,OHSU_HNSCC_derm001
6144,10320,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.237,10,Coumarin,OHSU_HNSCC_derm001
6145,10320,Blank 490,2,B,OHSU_HNSCC_derm001,1,0.035,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6146,10320,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.055,10,Foretinib (XL-880),OHSU_HNSCC_derm001
6147,10320,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.203,10,Elesclomol,OHSU_HNSCC_derm001
6148,10320,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.267,10,Vemurafenib,OHSU_HNSCC_derm001
6149,10320,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.032,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6150,10320,Blank 490,2,G,OHSU_HNSCC_derm001,1,0.012,10,Ponatinib,OHSU_HNSCC_derm001
6151,10320,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.085,10,Gefitinib,OHSU_HNSCC_derm001
6152,10320,Blank 490,2,I,OHSU_HNSCC_derm001,1,0.046,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
6153,10320,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.24,1,Sunitinib (1mM),OHSU_HNSCC_derm001
6154,10320,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.269,10,Curcumin,OHSU_HNSCC_derm001
6155,10320,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.056,10,PF-562271,OHSU_HNSCC_derm001
6156,10320,Blank 490,2,M,OHSU_HNSCC_derm001,1,0.198,10,STO609,OHSU_HNSCC_derm001
6157,10320,Blank 490,2,N,OHSU_HNSCC_derm001,1,0.01,10,Lenvatinib,OHSU_HNSCC_derm001
6158,10320,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.054,10,Entrectinib,OHSU_HNSCC_derm001
6159,10320,Blank 490,2,P,OHSU_HNSCC_derm001,1,0.284,10,Ethyl Gallate ,OHSU_HNSCC_derm001
6160,10320,Blank 490,2,A,OHSU_HNSCC_derm001,2,0.201,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
6161,10320,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.087,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6162,10320,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.13,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
6163,10320,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.235,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
6164,10320,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.26,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
6165,10320,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.042,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6166,10320,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.08,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
6167,10320,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.105,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
6168,10320,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.14,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
6169,10320,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.26,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
6170,10320,Blank 490,2,K,OHSU_HNSCC_derm001,2,0.216,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
6171,10320,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.154,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
6172,10320,Blank 490,2,M,OHSU_HNSCC_derm001,2,0.225,3.3333333333333335,STO609,OHSU_HNSCC_derm001
6173,10320,Blank 490,2,N,OHSU_HNSCC_derm001,2,-0.006,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
6174,10320,Blank 490,2,O,OHSU_HNSCC_derm001,2,0.177,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
6175,10320,Blank 490,2,P,OHSU_HNSCC_derm001,2,0.223,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
6176,10320,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.215,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
6177,10320,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.096,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6178,10320,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.211,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
6179,10320,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.2,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
6180,10320,Blank 490,2,E,OHSU_HNSCC_derm001,3,0.224,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
6181,10320,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.053,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6182,10320,Blank 490,2,G,OHSU_HNSCC_derm001,3,0.281,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
6183,10320,Blank 490,2,H,OHSU_HNSCC_derm001,3,0.12,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
6184,10320,Blank 490,2,I,OHSU_HNSCC_derm001,3,0.2,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
6185,10320,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.24,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
6186,10320,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.231,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
6187,10320,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.204,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
6188,10320,Blank 490,2,M,OHSU_HNSCC_derm001,3,0.271,1.1111111111111112,STO609,OHSU_HNSCC_derm001
6189,10320,Blank 490,2,N,OHSU_HNSCC_derm001,3,-0.009,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
6190,10320,Blank 490,2,O,OHSU_HNSCC_derm001,3,0.269,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
6191,10320,Blank 490,2,P,OHSU_HNSCC_derm001,3,0.42,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
6192,10320,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.222,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
6193,10320,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.087,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6194,10320,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.187,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
6195,10320,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.197,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
6196,10320,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.237,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
6197,10320,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.08,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6198,10320,Blank 490,2,G,OHSU_HNSCC_derm001,4,0.271,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
6199,10320,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.142,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
6200,10320,Blank 490,2,I,OHSU_HNSCC_derm001,4,0.23,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
6201,10320,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.264,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
6202,10320,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.24,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
6203,10320,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.234,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
6204,10320,Blank 490,2,M,OHSU_HNSCC_derm001,4,0.277,0.3703703703703704,STO609,OHSU_HNSCC_derm001
6205,10320,Blank 490,2,N,OHSU_HNSCC_derm001,4,-0.04,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
6206,10320,Blank 490,2,O,OHSU_HNSCC_derm001,4,0.269,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
6207,10320,Blank 490,2,P,OHSU_HNSCC_derm001,4,0.338,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
6208,10320,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.238,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
6209,10320,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.117,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6210,10320,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.2,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
6211,10320,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.171,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
6212,10320,Blank 490,2,E,OHSU_HNSCC_derm001,5,0.258,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
6213,10320,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.108,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6214,10320,Blank 490,2,G,OHSU_HNSCC_derm001,5,0.294,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
6215,10320,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.217,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
6216,10320,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.235,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
6217,10320,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.262,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
6218,10320,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.254,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
6219,10320,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.239,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
6220,10320,Blank 490,2,M,OHSU_HNSCC_derm001,5,0.272,0.1234567901234568,STO609,OHSU_HNSCC_derm001
6221,10320,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.019,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
6222,10320,Blank 490,2,O,OHSU_HNSCC_derm001,5,0.287,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
6223,10320,Blank 490,2,P,OHSU_HNSCC_derm001,5,0.251,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
6224,10320,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.228,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
6225,10320,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.108,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6226,10320,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.205,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
6227,10320,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.187,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
6228,10320,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.261,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
6229,10320,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.179,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6230,10320,Blank 490,2,G,OHSU_HNSCC_derm001,6,0.286,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
6231,10320,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.254,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
6232,10320,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.281,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
6233,10320,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.29,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
6234,10320,Blank 490,2,K,OHSU_HNSCC_derm001,6,0.268,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
6235,10320,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.292,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
6236,10320,Blank 490,2,M,OHSU_HNSCC_derm001,6,0.255,0.0411522633744856,STO609,OHSU_HNSCC_derm001
6237,10320,Blank 490,2,N,OHSU_HNSCC_derm001,6,0.042,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
6238,10320,Blank 490,2,O,OHSU_HNSCC_derm001,6,0.286,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
6239,10320,Blank 490,2,P,OHSU_HNSCC_derm001,6,0.243,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
6240,10320,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.198,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
6241,10320,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.156,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
6242,10320,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.202,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
6243,10320,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.179,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
6244,10320,Blank 490,2,E,OHSU_HNSCC_derm001,7,0.26,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
6245,10320,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.258,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
6246,10320,Blank 490,2,G,OHSU_HNSCC_derm001,7,0.312,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
6247,10320,Blank 490,2,H,OHSU_HNSCC_derm001,7,0.283,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
6248,10320,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.243,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
6249,10320,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.224,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
6250,10320,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.288,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
6251,10320,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.282,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
6252,10320,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.297,0.013717421124828532,STO609,OHSU_HNSCC_derm001
6253,10320,Blank 490,2,N,OHSU_HNSCC_derm001,7,-0.007,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
6254,10320,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.308,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
6255,10320,Blank 490,2,P,OHSU_HNSCC_derm001,7,0.259,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
6256,10320,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.211,0,NONE,OHSU_HNSCC_derm001
6257,10320,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.241,0,NONE,OHSU_HNSCC_derm001
6258,10320,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.236,0,NONE,OHSU_HNSCC_derm001
6259,10320,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.219,0,NONE,OHSU_HNSCC_derm001
6260,10320,Blank 490,2,E,OHSU_HNSCC_derm001,8,0.255,0,NONE,OHSU_HNSCC_derm001
6261,10320,Blank 490,2,F,OHSU_HNSCC_derm001,8,0.264,0,NONE,OHSU_HNSCC_derm001
6262,10320,Blank 490,2,G,OHSU_HNSCC_derm001,8,0.215,0,NONE,OHSU_HNSCC_derm001
6263,10320,Blank 490,2,H,OHSU_HNSCC_derm001,8,0.005,10,F-S-V,OHSU_HNSCC_derm001
6264,10320,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.273,0,NONE,OHSU_HNSCC_derm001
6265,10320,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.263,0,NONE,OHSU_HNSCC_derm001
6266,10320,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.277,0,NONE,OHSU_HNSCC_derm001
6267,10320,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.279,0,NONE,OHSU_HNSCC_derm001
6268,10320,Blank 490,2,M,OHSU_HNSCC_derm001,8,0.29,0,NONE,OHSU_HNSCC_derm001
6269,10320,Blank 490,2,N,OHSU_HNSCC_derm001,8,0.058,0,NONE,OHSU_HNSCC_derm001
6270,10320,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.344,0,NONE,OHSU_HNSCC_derm001
6271,10320,Blank 490,2,P,OHSU_HNSCC_derm001,8,0.267,0,NONE,OHSU_HNSCC_derm001
6272,10320,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.028,10,GDC-0941,OHSU_HNSCC_derm001
6273,10320,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.152,10,Dovitinib,OHSU_HNSCC_derm001
6274,10320,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.102,10,BI-2536,OHSU_HNSCC_derm001
6275,10320,Blank 490,2,D,OHSU_HNSCC_derm001,9,0.016,10,TP-0903 ,OHSU_HNSCC_derm001
6276,10320,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.06,10,Belinostat,OHSU_HNSCC_derm001
6277,10320,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.044,10,INK-128,OHSU_HNSCC_derm001
6278,10320,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.068,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6279,10320,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.075,10,Brigatinib,OHSU_HNSCC_derm001
6280,10320,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.103,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6281,10320,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.102,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6282,10320,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.212,10,Pazopanib,OHSU_HNSCC_derm001
6283,10320,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.204,10,AZD4547,OHSU_HNSCC_derm001
6284,10320,Blank 490,2,M,OHSU_HNSCC_derm001,9,0.296,10,Pomalidomide ,OHSU_HNSCC_derm001
6285,10320,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.028,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
6286,10320,Blank 490,2,O,OHSU_HNSCC_derm001,9,0.296,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6287,10320,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.01,10,Staurosporin,OHSU_HNSCC_derm001
6288,10320,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.028,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
6289,10320,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.197,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
6290,10320,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.213,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
6291,10320,Blank 490,2,D,OHSU_HNSCC_derm001,10,0.006,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
6292,10320,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.141,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
6293,10320,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.052,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
6294,10320,Blank 490,2,G,OHSU_HNSCC_derm001,10,0.093,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6295,10320,Blank 490,2,H,OHSU_HNSCC_derm001,10,0.1,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
6296,10320,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.151,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6297,10320,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.176,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6298,10320,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.238,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
6299,10320,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.289,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
6300,10320,Blank 490,2,M,OHSU_HNSCC_derm001,10,0.259,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
6301,10320,Blank 490,2,N,OHSU_HNSCC_derm001,10,0.038,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
6302,10320,Blank 490,2,O,OHSU_HNSCC_derm001,10,0.308,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6303,10320,Blank 490,2,P,OHSU_HNSCC_derm001,10,0.023,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
6304,10320,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.044,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
6305,10320,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.231,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
6306,10320,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.258,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
6307,10320,Blank 490,2,D,OHSU_HNSCC_derm001,11,0.011,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
6308,10320,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.198,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
6309,10320,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.052,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
6310,10320,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.12,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6311,10320,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.195,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
6312,10320,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.16,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6313,10320,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.188,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6314,10320,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.268,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
6315,10320,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.293,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
6316,10320,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.305,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
6317,10320,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.022,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
6318,10320,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.305,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6319,10320,Blank 490,2,P,OHSU_HNSCC_derm001,11,0.004,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
6320,10320,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.086,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
6321,10320,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.233,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
6322,10320,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.237,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
6323,10320,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.182,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
6324,10320,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.198,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
6325,10320,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.059,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
6326,10320,Blank 490,2,G,OHSU_HNSCC_derm001,12,0.122,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6327,10320,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.609,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
6328,10320,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.145,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6329,10320,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.245,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6330,10320,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.259,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
6331,10320,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.31,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
6332,10320,Blank 490,2,M,OHSU_HNSCC_derm001,12,0.338,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
6333,10320,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.061,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
6334,10320,Blank 490,2,O,OHSU_HNSCC_derm001,12,0.286,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6335,10320,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.016,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
6336,10320,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.117,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
6337,10320,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.235,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
6338,10320,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.228,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
6339,10320,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.242,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
6340,10320,Blank 490,2,E,OHSU_HNSCC_derm001,13,0.24,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
6341,10320,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.067,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
6342,10320,Blank 490,2,G,OHSU_HNSCC_derm001,13,0.138,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6343,10320,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.228,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
6344,10320,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.148,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6345,10320,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.256,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6346,10320,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.253,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
6347,10320,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.318,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
6348,10320,Blank 490,2,M,OHSU_HNSCC_derm001,13,0.274,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
6349,10320,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.133,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
6350,10320,Blank 490,2,O,OHSU_HNSCC_derm001,13,0.294,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6351,10320,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.175,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
6352,10320,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.16,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
6353,10320,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.229,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
6354,10320,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.204,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
6355,10320,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.239,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
6356,10320,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.25,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
6357,10320,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.09,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
6358,10320,Blank 490,2,G,OHSU_HNSCC_derm001,14,0.17,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6359,10320,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.248,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
6360,10320,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.157,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6361,10320,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.264,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6362,10320,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.243,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
6363,10320,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.273,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
6364,10320,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.27,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
6365,10320,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.123,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
6366,10320,Blank 490,2,O,OHSU_HNSCC_derm001,14,0.285,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6367,10320,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.169,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
6368,10320,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.197,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
6369,10320,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.248,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
6370,10320,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.206,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
6371,10320,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.241,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
6372,10320,Blank 490,2,E,OHSU_HNSCC_derm001,15,0.249,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
6373,10320,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.128,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
6374,10320,Blank 490,2,G,OHSU_HNSCC_derm001,15,0.201,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
6375,10320,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.282,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
6376,10320,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.204,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6377,10320,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.277,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
6378,10320,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.282,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
6379,10320,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.246,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
6380,10320,Blank 490,2,M,OHSU_HNSCC_derm001,15,0.27,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
6381,10320,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.135,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
6382,10320,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.262,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
6383,10320,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.215,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
6384,10320,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.243,0,NONE,OHSU_HNSCC_derm001
6385,10320,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.251,0,NONE,OHSU_HNSCC_derm001
6386,10320,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.234,0,NONE,OHSU_HNSCC_derm001
6387,10320,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.24,0,NONE,OHSU_HNSCC_derm001
6388,10320,Blank 490,2,E,OHSU_HNSCC_derm001,16,0.29,0,NONE,OHSU_HNSCC_derm001
6389,10320,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.278,0,NONE,OHSU_HNSCC_derm001
6390,10320,Blank 490,2,G,OHSU_HNSCC_derm001,16,0.291,0,NONE,OHSU_HNSCC_derm001
6391,10320,Blank 490,2,H,OHSU_HNSCC_derm001,16,-0.005,10,F-S-V,OHSU_HNSCC_derm001
6392,10320,Blank 490,2,I,OHSU_HNSCC_derm001,16,0.275,0,NONE,OHSU_HNSCC_derm001
6393,10320,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.283,0,NONE,OHSU_HNSCC_derm001
6394,10320,Blank 490,2,K,OHSU_HNSCC_derm001,16,0.263,0,NONE,OHSU_HNSCC_derm001
6395,10320,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.267,0,NONE,OHSU_HNSCC_derm001
6396,10320,Blank 490,2,M,OHSU_HNSCC_derm001,16,0.263,0,NONE,OHSU_HNSCC_derm001
6397,10320,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.157,0,NONE,OHSU_HNSCC_derm001
6398,10320,Blank 490,2,O,OHSU_HNSCC_derm001,16,0.293,0,NONE,OHSU_HNSCC_derm001
6399,10320,Blank 490,2,P,OHSU_HNSCC_derm001,16,0.223,0,NONE,OHSU_HNSCC_derm001
6400,10320,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.241,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
6401,10320,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.224,10,Hesperidin,OHSU_HNSCC_derm001
6402,10320,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.253,10,Esculetin,OHSU_HNSCC_derm001
6403,10320,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.143,10,Selinexor ,OHSU_HNSCC_derm001
6404,10320,Blank 490,2,E,OHSU_HNSCC_derm001,17,0.197,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6405,10320,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.222,10,BMX-IN-1,OHSU_HNSCC_derm001
6406,10320,Blank 490,2,G,OHSU_HNSCC_derm001,17,0.065,1,Dasatinib (1mM),OHSU_HNSCC_derm001
6407,10320,Blank 490,2,H,OHSU_HNSCC_derm001,17,0.136,10,Trametinib,OHSU_HNSCC_derm001
6408,10320,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.045,10,BEZ235,OHSU_HNSCC_derm001
6409,10320,Blank 490,2,J,OHSU_HNSCC_derm001,17,0.015,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
6410,10320,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.174,10,Nilotinib,OHSU_HNSCC_derm001
6411,10320,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.135,10,Enzalutamide,OHSU_HNSCC_derm001
6412,10320,Blank 490,2,M,OHSU_HNSCC_derm001,17,0.32,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6413,10320,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.05,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
6414,10320,Blank 490,2,O,OHSU_HNSCC_derm001,17,0.045,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6415,10320,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.184,10,Axitinib,OHSU_HNSCC_derm001
6416,10320,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.242,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
6417,10320,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.242,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
6418,10320,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.238,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
6419,10320,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.1,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
6420,10320,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.269,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6421,10320,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.236,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
6422,10320,Blank 490,2,G,OHSU_HNSCC_derm001,18,0.077,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
6423,10320,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.182,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
6424,10320,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.044,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
6425,10320,Blank 490,2,J,OHSU_HNSCC_derm001,18,0.027,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
6426,10320,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.229,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
6427,10320,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.179,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
6428,10320,Blank 490,2,M,OHSU_HNSCC_derm001,18,0.293,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6429,10320,Blank 490,2,N,OHSU_HNSCC_derm001,18,0.098,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
6430,10320,Blank 490,2,O,OHSU_HNSCC_derm001,18,0.038,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6431,10320,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.242,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
6432,10320,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.224,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
6433,10320,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.275,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
6434,10320,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.264,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
6435,10320,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.111,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
6436,10320,Blank 490,2,E,OHSU_HNSCC_derm001,19,0.277,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6437,10320,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.246,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
6438,10320,Blank 490,2,G,OHSU_HNSCC_derm001,19,0.101,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
6439,10320,Blank 490,2,H,OHSU_HNSCC_derm001,19,0.126,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
6440,10320,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.049,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
6441,10320,Blank 490,2,J,OHSU_HNSCC_derm001,19,0.029,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
6442,10320,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.265,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
6443,10320,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.228,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
6444,10320,Blank 490,2,M,OHSU_HNSCC_derm001,19,0.279,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6445,10320,Blank 490,2,N,OHSU_HNSCC_derm001,19,0.113,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
6446,10320,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.04,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6447,10320,Blank 490,2,P,OHSU_HNSCC_derm001,19,0.237,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
6448,10320,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.272,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
6449,10320,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.245,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
6450,10320,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.23,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
6451,10320,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.115,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
6452,10320,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.274,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6453,10320,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.25,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
6454,10320,Blank 490,2,G,OHSU_HNSCC_derm001,20,0.19,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
6455,10320,Blank 490,2,H,OHSU_HNSCC_derm001,20,0.123,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
6456,10320,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.052,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
6457,10320,Blank 490,2,J,OHSU_HNSCC_derm001,20,0.038,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
6458,10320,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.299,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
6459,10320,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.266,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
6460,10320,Blank 490,2,M,OHSU_HNSCC_derm001,20,0.262,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6461,10320,Blank 490,2,N,OHSU_HNSCC_derm001,20,0.156,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
6462,10320,Blank 490,2,O,OHSU_HNSCC_derm001,20,0.19,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6463,10320,Blank 490,2,P,OHSU_HNSCC_derm001,20,0.25,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
6464,10320,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.249,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
6465,10320,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.254,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
6466,10320,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.267,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
6467,10320,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.148,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
6468,10320,Blank 490,2,E,OHSU_HNSCC_derm001,21,0.267,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6469,10320,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.259,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
6470,10320,Blank 490,2,G,OHSU_HNSCC_derm001,21,0.234,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
6471,10320,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.161,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
6472,10320,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.086,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
6473,10320,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.062,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
6474,10320,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.274,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
6475,10320,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.244,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
6476,10320,Blank 490,2,M,OHSU_HNSCC_derm001,21,0.277,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6477,10320,Blank 490,2,N,OHSU_HNSCC_derm001,21,0.247,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
6478,10320,Blank 490,2,O,OHSU_HNSCC_derm001,21,0.235,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6479,10320,Blank 490,2,P,OHSU_HNSCC_derm001,21,0.225,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
6480,10320,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.258,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
6481,10320,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.238,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
6482,10320,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.285,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
6483,10320,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.204,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
6484,10320,Blank 490,2,E,OHSU_HNSCC_derm001,22,0.255,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6485,10320,Blank 490,2,F,OHSU_HNSCC_derm001,22,0.232,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
6486,10320,Blank 490,2,G,OHSU_HNSCC_derm001,22,0.216,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
6487,10320,Blank 490,2,H,OHSU_HNSCC_derm001,22,0.149,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
6488,10320,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.15,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
6489,10320,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.095,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
6490,10320,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.286,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
6491,10320,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.264,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
6492,10320,Blank 490,2,M,OHSU_HNSCC_derm001,22,0.228,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6493,10320,Blank 490,2,N,OHSU_HNSCC_derm001,22,0.261,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
6494,10320,Blank 490,2,O,OHSU_HNSCC_derm001,22,0.275,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6495,10320,Blank 490,2,P,OHSU_HNSCC_derm001,22,0.236,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
6496,10320,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.228,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
6497,10320,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.254,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
6498,10320,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.259,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
6499,10320,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.226,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
6500,10320,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.275,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
6501,10320,Blank 490,2,F,OHSU_HNSCC_derm001,23,0.307,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
6502,10320,Blank 490,2,G,OHSU_HNSCC_derm001,23,0.261,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
6503,10320,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.199,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
6504,10320,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.195,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
6505,10320,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.239,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
6506,10320,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.296,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
6507,10320,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.263,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
6508,10320,Blank 490,2,M,OHSU_HNSCC_derm001,23,0.259,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
6509,10320,Blank 490,2,N,OHSU_HNSCC_derm001,23,0.245,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
6510,10320,Blank 490,2,O,OHSU_HNSCC_derm001,23,0.239,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
6511,10320,Blank 490,2,P,OHSU_HNSCC_derm001,23,0.234,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
6512,10320,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.251,0,NONE,OHSU_HNSCC_derm001
6513,10320,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.281,0,NONE,OHSU_HNSCC_derm001
6514,10320,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.233,0,NONE,OHSU_HNSCC_derm001
6515,10320,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.222,0,NONE,OHSU_HNSCC_derm001
6516,10320,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.299,0,NONE,OHSU_HNSCC_derm001
6517,10320,Blank 490,2,F,OHSU_HNSCC_derm001,24,0.261,0,NONE,OHSU_HNSCC_derm001
6518,10320,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.252,0,NONE,OHSU_HNSCC_derm001
6519,10320,Blank 490,2,H,OHSU_HNSCC_derm001,24,0.255,0,NONE,OHSU_HNSCC_derm001
6520,10320,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.232,0,NONE,OHSU_HNSCC_derm001
6521,10320,Blank 490,2,J,OHSU_HNSCC_derm001,24,0.256,0,NONE,OHSU_HNSCC_derm001
6522,10320,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.238,0,NONE,OHSU_HNSCC_derm001
6523,10320,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.278,0,NONE,OHSU_HNSCC_derm001
6524,10320,Blank 490,2,M,OHSU_HNSCC_derm001,24,0.255,0,NONE,OHSU_HNSCC_derm001
6525,10320,Blank 490,2,N,OHSU_HNSCC_derm001,24,0.231,0,NONE,OHSU_HNSCC_derm001
6526,10320,Blank 490,2,O,OHSU_HNSCC_derm001,24,0.256,0,NONE,OHSU_HNSCC_derm001
6527,10320,Blank 490,2,P,OHSU_HNSCC_derm001,24,0.256,0,NONE,OHSU_HNSCC_derm001
6528,10320,Blank 490,3,A,OHSU_HNSCC_derm001,1,0.245,10,Thalidomide ,OHSU_HNSCC_derm001
6529,10320,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.089,10,Vandetanib,OHSU_HNSCC_derm001
6530,10320,Blank 490,3,C,OHSU_HNSCC_derm001,1,0.232,10,Oleic acid,OHSU_HNSCC_derm001
6531,10320,Blank 490,3,D,OHSU_HNSCC_derm001,1,0.018,10,A-674563,OHSU_HNSCC_derm001
6532,10320,Blank 490,3,E,OHSU_HNSCC_derm001,1,0.042,10,Lapatinib,OHSU_HNSCC_derm001
6533,10320,Blank 490,3,F,OHSU_HNSCC_derm001,1,0.255,10,Apocynin (vanillin),OHSU_HNSCC_derm001
6534,10320,Blank 490,3,G,OHSU_HNSCC_derm001,1,0.07,10,AT-7519,OHSU_HNSCC_derm001
6535,10320,Blank 490,3,H,OHSU_HNSCC_derm001,1,0.081,10,Gefitinib,OHSU_HNSCC_derm001
6536,10320,Blank 490,3,I,OHSU_HNSCC_derm001,1,0.056,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
6537,10320,Blank 490,3,J,OHSU_HNSCC_derm001,1,0.051,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6538,10320,Blank 490,3,K,OHSU_HNSCC_derm001,1,0.044,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6539,10320,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.207,10,JQ1,OHSU_HNSCC_derm001
6540,10320,Blank 490,3,M,OHSU_HNSCC_derm001,1,0.371,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6541,10320,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.367,10,Cerdulatinib,OHSU_HNSCC_derm001
6542,10320,Blank 490,3,O,OHSU_HNSCC_derm001,1,-0.003,10,Romidepsin,OHSU_HNSCC_derm001
6543,10320,Blank 490,3,P,OHSU_HNSCC_derm001,1,0.211,10,Gilteritinib,OHSU_HNSCC_derm001
6544,10320,Blank 490,3,A,OHSU_HNSCC_derm001,2,0.253,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
6545,10320,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.122,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
6546,10320,Blank 490,3,C,OHSU_HNSCC_derm001,2,0.196,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
6547,10320,Blank 490,3,D,OHSU_HNSCC_derm001,2,0.19,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
6548,10320,Blank 490,3,E,OHSU_HNSCC_derm001,2,0.1,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
6549,10320,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.264,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
6550,10320,Blank 490,3,G,OHSU_HNSCC_derm001,2,0.07,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
6551,10320,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.119,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
6552,10320,Blank 490,3,I,OHSU_HNSCC_derm001,2,0.127,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
6553,10320,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.086,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6554,10320,Blank 490,3,K,OHSU_HNSCC_derm001,2,0.082,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6555,10320,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.242,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
6556,10320,Blank 490,3,M,OHSU_HNSCC_derm001,2,0.341,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6557,10320,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.396,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
6558,10320,Blank 490,3,O,OHSU_HNSCC_derm001,2,-0.004,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
6559,10320,Blank 490,3,P,OHSU_HNSCC_derm001,2,0.233,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
6560,10320,Blank 490,3,A,OHSU_HNSCC_derm001,3,0.228,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
6561,10320,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.151,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
6562,10320,Blank 490,3,C,OHSU_HNSCC_derm001,3,0.281,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
6563,10320,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.173,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
6564,10320,Blank 490,3,E,OHSU_HNSCC_derm001,3,0.154,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
6565,10320,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.313,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
6566,10320,Blank 490,3,G,OHSU_HNSCC_derm001,3,0.09,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
6567,10320,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.145,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
6568,10320,Blank 490,3,I,OHSU_HNSCC_derm001,3,0.231,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
6569,10320,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.11,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6570,10320,Blank 490,3,K,OHSU_HNSCC_derm001,3,0.152,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6571,10320,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.262,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
6572,10320,Blank 490,3,M,OHSU_HNSCC_derm001,3,0.309,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6573,10320,Blank 490,3,N,OHSU_HNSCC_derm001,3,0.375,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
6574,10320,Blank 490,3,O,OHSU_HNSCC_derm001,3,0.007,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
6575,10320,Blank 490,3,P,OHSU_HNSCC_derm001,3,0.268,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
6576,10320,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.233,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
6577,10320,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.219,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
6578,10320,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.252,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
6579,10320,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.228,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
6580,10320,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.181,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
6581,10320,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.26,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
6582,10320,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.218,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
6583,10320,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.173,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
6584,10320,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.249,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
6585,10320,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.172,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6586,10320,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.18,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6587,10320,Blank 490,3,L,OHSU_HNSCC_derm001,4,0.378,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
6588,10320,Blank 490,3,M,OHSU_HNSCC_derm001,4,0.316,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6589,10320,Blank 490,3,N,OHSU_HNSCC_derm001,4,0.343,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
6590,10320,Blank 490,3,O,OHSU_HNSCC_derm001,4,0.019,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
6591,10320,Blank 490,3,P,OHSU_HNSCC_derm001,4,0.276,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
6592,10320,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.232,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
6593,10320,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.228,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
6594,10320,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.266,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
6595,10320,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.248,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
6596,10320,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.207,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
6597,10320,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.271,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
6598,10320,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.3,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
6599,10320,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.227,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
6600,10320,Blank 490,3,I,OHSU_HNSCC_derm001,5,0.286,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
6601,10320,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.233,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6602,10320,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.242,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6603,10320,Blank 490,3,L,OHSU_HNSCC_derm001,5,0.413,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
6604,10320,Blank 490,3,M,OHSU_HNSCC_derm001,5,0.307,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6605,10320,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.327,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
6606,10320,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.029,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
6607,10320,Blank 490,3,P,OHSU_HNSCC_derm001,5,0.288,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
6608,10320,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.253,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
6609,10320,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.241,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
6610,10320,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.237,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
6611,10320,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.27,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
6612,10320,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.217,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
6613,10320,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.243,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
6614,10320,Blank 490,3,G,OHSU_HNSCC_derm001,6,0.296,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
6615,10320,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.275,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
6616,10320,Blank 490,3,I,OHSU_HNSCC_derm001,6,0.266,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
6617,10320,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.248,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6618,10320,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.27,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6619,10320,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.408,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
6620,10320,Blank 490,3,M,OHSU_HNSCC_derm001,6,0.247,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6621,10320,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.301,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
6622,10320,Blank 490,3,O,OHSU_HNSCC_derm001,6,0.039,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
6623,10320,Blank 490,3,P,OHSU_HNSCC_derm001,6,0.285,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
6624,10320,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.235,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
6625,10320,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.246,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
6626,10320,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.291,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
6627,10320,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.276,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
6628,10320,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.27,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
6629,10320,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.286,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
6630,10320,Blank 490,3,G,OHSU_HNSCC_derm001,7,0.316,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
6631,10320,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.277,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
6632,10320,Blank 490,3,I,OHSU_HNSCC_derm001,7,0.262,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
6633,10320,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.28,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
6634,10320,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.295,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
6635,10320,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.362,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
6636,10320,Blank 490,3,M,OHSU_HNSCC_derm001,7,0.271,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
6637,10320,Blank 490,3,N,OHSU_HNSCC_derm001,7,0.317,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
6638,10320,Blank 490,3,O,OHSU_HNSCC_derm001,7,0.059,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
6639,10320,Blank 490,3,P,OHSU_HNSCC_derm001,7,0.259,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
6640,10320,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.252,0,NONE,OHSU_HNSCC_derm001
6641,10320,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.3,0,NONE,OHSU_HNSCC_derm001
6642,10320,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.269,0,NONE,OHSU_HNSCC_derm001
6643,10320,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.29,0,NONE,OHSU_HNSCC_derm001
6644,10320,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.287,0,NONE,OHSU_HNSCC_derm001
6645,10320,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.29,0,NONE,OHSU_HNSCC_derm001
6646,10320,Blank 490,3,G,OHSU_HNSCC_derm001,8,0.337,0,NONE,OHSU_HNSCC_derm001
6647,10320,Blank 490,3,H,OHSU_HNSCC_derm001,8,0.002,10,F-S-V,OHSU_HNSCC_derm001
6648,10320,Blank 490,3,I,OHSU_HNSCC_derm001,8,0.256,0,NONE,OHSU_HNSCC_derm001
6649,10320,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.283,0,NONE,OHSU_HNSCC_derm001
6650,10320,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.283,0,NONE,OHSU_HNSCC_derm001
6651,10320,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.326,0,NONE,OHSU_HNSCC_derm001
6652,10320,Blank 490,3,M,OHSU_HNSCC_derm001,8,0.284,0,NONE,OHSU_HNSCC_derm001
6653,10320,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.305,0,NONE,OHSU_HNSCC_derm001
6654,10320,Blank 490,3,O,OHSU_HNSCC_derm001,8,0.29,0,NONE,OHSU_HNSCC_derm001
6655,10320,Blank 490,3,P,OHSU_HNSCC_derm001,8,0.312,0,NONE,OHSU_HNSCC_derm001
6656,10320,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.243,10,Anastrazole,OHSU_HNSCC_derm001
6657,10320,Blank 490,3,B,OHSU_HNSCC_derm001,9,0.099,10,JNJ-28312141 ,OHSU_HNSCC_derm001
6658,10320,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.212,10,Genistein,OHSU_HNSCC_derm001
6659,10320,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.271,10,Abscisic acid,OHSU_HNSCC_derm001
6660,10320,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.165,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6661,10320,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.314,10,Ruxolitinib,OHSU_HNSCC_derm001
6662,10320,Blank 490,3,G,OHSU_HNSCC_derm001,9,0.437,10,TAK-659,OHSU_HNSCC_derm001
6663,10320,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.062,10,Brigatinib,OHSU_HNSCC_derm001
6664,10320,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.103,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6665,10320,Blank 490,3,J,OHSU_HNSCC_derm001,9,0.023,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6666,10320,Blank 490,3,K,OHSU_HNSCC_derm001,9,0.145,10,Vorinostat,OHSU_HNSCC_derm001
6667,10320,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.322,10,Lenalidomide,OHSU_HNSCC_derm001
6668,10320,Blank 490,3,M,OHSU_HNSCC_derm001,9,0.037,10,NVP-ADW742,OHSU_HNSCC_derm001
6669,10320,Blank 490,3,N,OHSU_HNSCC_derm001,9,0.241,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6670,10320,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.337,10,Echinatin,OHSU_HNSCC_derm001
6671,10320,Blank 490,3,P,OHSU_HNSCC_derm001,9,-0.015,10,YM-155,OHSU_HNSCC_derm001
6672,10320,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.222,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
6673,10320,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.229,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
6674,10320,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.259,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
6675,10320,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.261,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
6676,10320,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.189,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6677,10320,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.322,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
6678,10320,Blank 490,3,G,OHSU_HNSCC_derm001,10,0.458,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
6679,10320,Blank 490,3,H,OHSU_HNSCC_derm001,10,0.078,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
6680,10320,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.157,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6681,10320,Blank 490,3,J,OHSU_HNSCC_derm001,10,0.287,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6682,10320,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.207,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
6683,10320,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.305,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
6684,10320,Blank 490,3,M,OHSU_HNSCC_derm001,10,0.143,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
6685,10320,Blank 490,3,N,OHSU_HNSCC_derm001,10,0.288,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6686,10320,Blank 490,3,O,OHSU_HNSCC_derm001,10,0.274,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
6687,10320,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.01,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
6688,10320,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.261,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
6689,10320,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.276,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
6690,10320,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.249,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
6691,10320,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.281,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
6692,10320,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.235,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6693,10320,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.323,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
6694,10320,Blank 490,3,G,OHSU_HNSCC_derm001,11,0.368,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
6695,10320,Blank 490,3,H,OHSU_HNSCC_derm001,11,0.132,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
6696,10320,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.162,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6697,10320,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.342,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6698,10320,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.238,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
6699,10320,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.31,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
6700,10320,Blank 490,3,M,OHSU_HNSCC_derm001,11,0.176,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
6701,10320,Blank 490,3,N,OHSU_HNSCC_derm001,11,0.31,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6702,10320,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.264,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
6703,10320,Blank 490,3,P,OHSU_HNSCC_derm001,11,-0.003,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
6704,10320,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.241,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
6705,10320,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.273,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
6706,10320,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.22,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
6707,10320,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.255,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
6708,10320,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.266,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6709,10320,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.313,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
6710,10320,Blank 490,3,G,OHSU_HNSCC_derm001,12,0.35,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
6711,10320,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.21,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
6712,10320,Blank 490,3,I,OHSU_HNSCC_derm001,12,0.155,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6713,10320,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.441,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6714,10320,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.247,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
6715,10320,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.328,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
6716,10320,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.223,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
6717,10320,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.298,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6718,10320,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.292,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
6719,10320,Blank 490,3,P,OHSU_HNSCC_derm001,12,0.002,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
6720,10320,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.225,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
6721,10320,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.278,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
6722,10320,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.26,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
6723,10320,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.261,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
6724,10320,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.278,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6725,10320,Blank 490,3,F,OHSU_HNSCC_derm001,13,0.303,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
6726,10320,Blank 490,3,G,OHSU_HNSCC_derm001,13,0.312,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
6727,10320,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.237,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
6728,10320,Blank 490,3,I,OHSU_HNSCC_derm001,13,0.181,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6729,10320,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.437,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6730,10320,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.273,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
6731,10320,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.352,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
6732,10320,Blank 490,3,M,OHSU_HNSCC_derm001,13,0.259,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
6733,10320,Blank 490,3,N,OHSU_HNSCC_derm001,13,0.327,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6734,10320,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.307,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
6735,10320,Blank 490,3,P,OHSU_HNSCC_derm001,13,0.006,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
6736,10320,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.261,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
6737,10320,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.284,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
6738,10320,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.282,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
6739,10320,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.246,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
6740,10320,Blank 490,3,E,OHSU_HNSCC_derm001,14,0.251,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6741,10320,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.296,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
6742,10320,Blank 490,3,G,OHSU_HNSCC_derm001,14,0.318,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
6743,10320,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.276,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
6744,10320,Blank 490,3,I,OHSU_HNSCC_derm001,14,0.177,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6745,10320,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.371,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6746,10320,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.282,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
6747,10320,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.337,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
6748,10320,Blank 490,3,M,OHSU_HNSCC_derm001,14,0.297,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
6749,10320,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.288,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6750,10320,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.308,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
6751,10320,Blank 490,3,P,OHSU_HNSCC_derm001,14,0.028,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
6752,10320,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.275,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
6753,10320,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.266,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
6754,10320,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.291,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
6755,10320,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.242,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
6756,10320,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.277,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
6757,10320,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.28,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
6758,10320,Blank 490,3,G,OHSU_HNSCC_derm001,15,0.313,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
6759,10320,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.266,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
6760,10320,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.201,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
6761,10320,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.354,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
6762,10320,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.284,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
6763,10320,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.29,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
6764,10320,Blank 490,3,M,OHSU_HNSCC_derm001,15,0.299,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
6765,10320,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.316,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
6766,10320,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.299,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
6767,10320,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.062,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
6768,10320,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.267,0,NONE,OHSU_HNSCC_derm001
6769,10320,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.274,0,NONE,OHSU_HNSCC_derm001
6770,10320,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.27,0,NONE,OHSU_HNSCC_derm001
6771,10320,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.296,0,NONE,OHSU_HNSCC_derm001
6772,10320,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.299,0,NONE,OHSU_HNSCC_derm001
6773,10320,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.309,0,NONE,OHSU_HNSCC_derm001
6774,10320,Blank 490,3,G,OHSU_HNSCC_derm001,16,0.237,0,NONE,OHSU_HNSCC_derm001
6775,10320,Blank 490,3,H,OHSU_HNSCC_derm001,16,-0.002,10,F-S-V,OHSU_HNSCC_derm001
6776,10320,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.301,0,NONE,OHSU_HNSCC_derm001
6777,10320,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.292,0,NONE,OHSU_HNSCC_derm001
6778,10320,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.314,0,NONE,OHSU_HNSCC_derm001
6779,10320,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.315,0,NONE,OHSU_HNSCC_derm001
6780,10320,Blank 490,3,M,OHSU_HNSCC_derm001,16,0.331,0,NONE,OHSU_HNSCC_derm001
6781,10320,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.308,0,NONE,OHSU_HNSCC_derm001
6782,10320,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.267,0,NONE,OHSU_HNSCC_derm001
6783,10320,Blank 490,3,P,OHSU_HNSCC_derm001,16,0.272,0,NONE,OHSU_HNSCC_derm001
6784,10320,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.271,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6785,10320,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.262,10,Stevioside,OHSU_HNSCC_derm001
6786,10320,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.281,10,Pemetrexed,OHSU_HNSCC_derm001
6787,10320,Blank 490,3,D,OHSU_HNSCC_derm001,17,0.033,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6788,10320,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.083,10,GSK-1838705A,OHSU_HNSCC_derm001
6789,10320,Blank 490,3,F,OHSU_HNSCC_derm001,17,0.002,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6790,10320,Blank 490,3,G,OHSU_HNSCC_derm001,17,0.302,10,Imatinib,OHSU_HNSCC_derm001
6791,10320,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.156,10,Trametinib,OHSU_HNSCC_derm001
6792,10320,Blank 490,3,I,OHSU_HNSCC_derm001,17,0.048,10,BEZ235,OHSU_HNSCC_derm001
6793,10320,Blank 490,3,J,OHSU_HNSCC_derm001,17,0.111,10,Saracatinib,OHSU_HNSCC_derm001
6794,10320,Blank 490,3,K,OHSU_HNSCC_derm001,17,0.41,10,I-BET 762,OHSU_HNSCC_derm001
6795,10320,Blank 490,3,L,OHSU_HNSCC_derm001,17,0.116,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
6796,10320,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.319,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
6797,10320,Blank 490,3,N,OHSU_HNSCC_derm001,17,0.324,10,Crizotinib,OHSU_HNSCC_derm001
6798,10320,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.215,10,MGCD-265,OHSU_HNSCC_derm001
6799,10320,Blank 490,3,P,OHSU_HNSCC_derm001,17,0.101,10,Erlotinib,OHSU_HNSCC_derm001
6800,10320,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.272,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6801,10320,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.261,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
6802,10320,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.232,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
6803,10320,Blank 490,3,D,OHSU_HNSCC_derm001,18,0.043,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6804,10320,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.112,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
6805,10320,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.06,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6806,10320,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.318,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
6807,10320,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.161,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
6808,10320,Blank 490,3,I,OHSU_HNSCC_derm001,18,0.058,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
6809,10320,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.216,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
6810,10320,Blank 490,3,K,OHSU_HNSCC_derm001,18,0.445,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
6811,10320,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.144,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
6812,10320,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.377,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
6813,10320,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.363,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
6814,10320,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.232,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
6815,10320,Blank 490,3,P,OHSU_HNSCC_derm001,18,0.116,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
6816,10320,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.281,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6817,10320,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.249,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
6818,10320,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.262,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
6819,10320,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.052,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6820,10320,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.161,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
6821,10320,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.113,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6822,10320,Blank 490,3,G,OHSU_HNSCC_derm001,19,0.312,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
6823,10320,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.19,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
6824,10320,Blank 490,3,I,OHSU_HNSCC_derm001,19,0.048,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
6825,10320,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.268,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
6826,10320,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.456,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
6827,10320,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.149,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
6828,10320,Blank 490,3,M,OHSU_HNSCC_derm001,19,0.316,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
6829,10320,Blank 490,3,N,OHSU_HNSCC_derm001,19,0.373,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
6830,10320,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.243,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
6831,10320,Blank 490,3,P,OHSU_HNSCC_derm001,19,0.154,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
6832,10320,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.251,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6833,10320,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.274,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
6834,10320,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.285,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
6835,10320,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.065,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6836,10320,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.204,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
6837,10320,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.183,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6838,10320,Blank 490,3,G,OHSU_HNSCC_derm001,20,0.307,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
6839,10320,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.137,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
6840,10320,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.091,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
6841,10320,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.268,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
6842,10320,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.413,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
6843,10320,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.177,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
6844,10320,Blank 490,3,M,OHSU_HNSCC_derm001,20,0.305,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
6845,10320,Blank 490,3,N,OHSU_HNSCC_derm001,20,0.307,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
6846,10320,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.262,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
6847,10320,Blank 490,3,P,OHSU_HNSCC_derm001,20,0.15,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
6848,10320,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.247,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6849,10320,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.246,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
6850,10320,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.274,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
6851,10320,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.09,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6852,10320,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.263,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
6853,10320,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.214,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6854,10320,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.287,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
6855,10320,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.156,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
6856,10320,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.127,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
6857,10320,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.327,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
6858,10320,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.374,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
6859,10320,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.204,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
6860,10320,Blank 490,3,M,OHSU_HNSCC_derm001,21,0.33,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
6861,10320,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.315,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
6862,10320,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.285,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
6863,10320,Blank 490,3,P,OHSU_HNSCC_derm001,21,0.213,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
6864,10320,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.266,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6865,10320,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.272,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
6866,10320,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.278,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
6867,10320,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.137,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6868,10320,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.282,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
6869,10320,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.264,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6870,10320,Blank 490,3,G,OHSU_HNSCC_derm001,22,0.343,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
6871,10320,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.18,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
6872,10320,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.179,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
6873,10320,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.313,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
6874,10320,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.349,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
6875,10320,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.244,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
6876,10320,Blank 490,3,M,OHSU_HNSCC_derm001,22,0.321,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
6877,10320,Blank 490,3,N,OHSU_HNSCC_derm001,22,0.283,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
6878,10320,Blank 490,3,O,OHSU_HNSCC_derm001,22,0.271,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
6879,10320,Blank 490,3,P,OHSU_HNSCC_derm001,22,0.239,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
6880,10320,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.269,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
6881,10320,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.243,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
6882,10320,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.256,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
6883,10320,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.175,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
6884,10320,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.276,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
6885,10320,Blank 490,3,F,OHSU_HNSCC_derm001,23,0.275,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
6886,10320,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.274,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
6887,10320,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.192,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
6888,10320,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.247,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
6889,10320,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.305,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
6890,10320,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.268,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
6891,10320,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.26,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
6892,10320,Blank 490,3,M,OHSU_HNSCC_derm001,23,0.3,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
6893,10320,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.313,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
6894,10320,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.263,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
6895,10320,Blank 490,3,P,OHSU_HNSCC_derm001,23,0.276,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
6896,10320,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.292,0,NONE,OHSU_HNSCC_derm001
6897,10320,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.258,0,NONE,OHSU_HNSCC_derm001
6898,10320,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.241,0,NONE,OHSU_HNSCC_derm001
6899,10320,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.236,0,NONE,OHSU_HNSCC_derm001
6900,10320,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.3,0,NONE,OHSU_HNSCC_derm001
6901,10320,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.254,0,NONE,OHSU_HNSCC_derm001
6902,10320,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.26,0,NONE,OHSU_HNSCC_derm001
6903,10320,Blank 490,3,H,OHSU_HNSCC_derm001,24,0.261,0,NONE,OHSU_HNSCC_derm001
6904,10320,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.282,0,NONE,OHSU_HNSCC_derm001
6905,10320,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.282,0,NONE,OHSU_HNSCC_derm001
6906,10320,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.308,0,NONE,OHSU_HNSCC_derm001
6907,10320,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.267,0,NONE,OHSU_HNSCC_derm001
6908,10320,Blank 490,3,M,OHSU_HNSCC_derm001,24,0.283,0,NONE,OHSU_HNSCC_derm001
6909,10320,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.258,0,NONE,OHSU_HNSCC_derm001
6910,10320,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.273,0,NONE,OHSU_HNSCC_derm001
6911,10320,Blank 490,3,P,OHSU_HNSCC_derm001,24,0.307,0,NONE,OHSU_HNSCC_derm001
6912,10320,Blank 490,1,A,OHSU_HNSCC_derm002,1,-0.005,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
6913,10320,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.258,10,Lucitanib ,OHSU_HNSCC_derm002
6914,10320,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.344,10,Resveratrol,OHSU_HNSCC_derm002
6915,10320,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.177,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6916,10320,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.321,10,Bicalutamide,OHSU_HNSCC_derm002
6917,10320,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.458,10,Methotrexate ,OHSU_HNSCC_derm002
6918,10320,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.136,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6919,10320,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.097,10,Gefitinib,OHSU_HNSCC_derm002
6920,10320,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.009,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
6921,10320,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.152,10,Tamatinib/R406,OHSU_HNSCC_derm002
6922,10320,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.116,10,Bosutinib,OHSU_HNSCC_derm002
6923,10320,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.017,10,PI-103,OHSU_HNSCC_derm002
6924,10320,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.345,10,Glycyrrhizin,OHSU_HNSCC_derm002
6925,10320,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.303,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
6926,10320,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.128,10,GSK-690693,OHSU_HNSCC_derm002
6927,10320,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.18,10,Ibrutinib,OHSU_HNSCC_derm002
6928,10320,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.027,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
6929,10320,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.438,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
6930,10320,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.402,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
6931,10320,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.165,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6932,10320,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.389,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
6933,10320,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.541,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
6934,10320,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.252,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6935,10320,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.204,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
6936,10320,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.245,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
6937,10320,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.286,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
6938,10320,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.369,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
6939,10320,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.04,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
6940,10320,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.539,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
6941,10320,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.505,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
6942,10320,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.15,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
6943,10320,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.242,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
6944,10320,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.04,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
6945,10320,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.482,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
6946,10320,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.46,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
6947,10320,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.172,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6948,10320,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.548,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
6949,10320,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.514,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
6950,10320,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.38,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6951,10320,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.266,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
6952,10320,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.436,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
6953,10320,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.392,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
6954,10320,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.532,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
6955,10320,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.082,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
6956,10320,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.59,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
6957,10320,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.549,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
6958,10320,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.256,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
6959,10320,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.274,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
6960,10320,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.089,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
6961,10320,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.473,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
6962,10320,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.507,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
6963,10320,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.165,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6964,10320,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.534,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
6965,10320,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.521,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
6966,10320,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.505,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6967,10320,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.297,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
6968,10320,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.517,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
6969,10320,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.454,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
6970,10320,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.6,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
6971,10320,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.175,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
6972,10320,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.603,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
6973,10320,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.574,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
6974,10320,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.526,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
6975,10320,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.354,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
6976,10320,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.166,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
6977,10320,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.474,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
6978,10320,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.472,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
6979,10320,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.224,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6980,10320,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.532,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
6981,10320,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.524,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
6982,10320,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.555,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6983,10320,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.424,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
6984,10320,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.491,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
6985,10320,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.516,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
6986,10320,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.567,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
6987,10320,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.343,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
6988,10320,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.606,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
6989,10320,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.52,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
6990,10320,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.494,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
6991,10320,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.4,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
6992,10320,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.269,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
6993,10320,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.467,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
6994,10320,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.529,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
6995,10320,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.291,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
6996,10320,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.516,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
6997,10320,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.522,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
6998,10320,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.571,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
6999,10320,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.498,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
7000,10320,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.501,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
7001,10320,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.513,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
7002,10320,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.572,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
7003,10320,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.494,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
7004,10320,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.554,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
7005,10320,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.597,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
7006,10320,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.35,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
7007,10320,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.349,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
7008,10320,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.323,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
7009,10320,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.498,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
7010,10320,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
7011,10320,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.446,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
7012,10320,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.521,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
7013,10320,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.543,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
7014,10320,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.592,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
7015,10320,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.524,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
7016,10320,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.55,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
7017,10320,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.501,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
7018,10320,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.509,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
7019,10320,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.542,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
7020,10320,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.431,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
7021,10320,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.58,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
7022,10320,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.546,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
7023,10320,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.423,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
7024,10320,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.351,0,NONE,OHSU_HNSCC_derm002
7025,10320,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.473,0,NONE,OHSU_HNSCC_derm002
7026,10320,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.529,0,NONE,OHSU_HNSCC_derm002
7027,10320,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.512,0,NONE,OHSU_HNSCC_derm002
7028,10320,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.511,0,NONE,OHSU_HNSCC_derm002
7029,10320,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.502,0,NONE,OHSU_HNSCC_derm002
7030,10320,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.563,0,NONE,OHSU_HNSCC_derm002
7031,10320,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
7032,10320,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.535,0,NONE,OHSU_HNSCC_derm002
7033,10320,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
7034,10320,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.521,0,NONE,OHSU_HNSCC_derm002
7035,10320,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.536,0,NONE,OHSU_HNSCC_derm002
7036,10320,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.565,0,NONE,OHSU_HNSCC_derm002
7037,10320,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.588,0,NONE,OHSU_HNSCC_derm002
7038,10320,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.568,0,NONE,OHSU_HNSCC_derm002
7039,10320,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.386,0,NONE,OHSU_HNSCC_derm002
7040,10320,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.015,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7041,10320,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.285,10,Sorafenib,OHSU_HNSCC_derm002
7042,10320,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.538,10,Rosmarinic acid,OHSU_HNSCC_derm002
7043,10320,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.269,10,Rapamycin,OHSU_HNSCC_derm002
7044,10320,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.487,10,Vismodegib,OHSU_HNSCC_derm002
7045,10320,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.165,10,PP242,OHSU_HNSCC_derm002
7046,10320,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.402,10,Alectinib,OHSU_HNSCC_derm002
7047,10320,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.085,10,Brigatinib,OHSU_HNSCC_derm002
7048,10320,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.23,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7049,10320,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.203,10,MK-2206,OHSU_HNSCC_derm002
7050,10320,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.137,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7051,10320,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.165,10,Flavopiridol ,OHSU_HNSCC_derm002
7052,10320,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.539,10,Indirubin,OHSU_HNSCC_derm002
7053,10320,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.53,10,PF-533228,OHSU_HNSCC_derm002
7054,10320,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.583,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7055,10320,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.075,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7056,10320,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.019,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7057,10320,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.423,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
7058,10320,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.5,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
7059,10320,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.269,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
7060,10320,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.484,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
7061,10320,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.196,3.3333333333333335,PP242,OHSU_HNSCC_derm002
7062,10320,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.353,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
7063,10320,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.137,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
7064,10320,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.251,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7065,10320,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.387,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
7066,10320,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.18,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7067,10320,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.141,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
7068,10320,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.591,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
7069,10320,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.623,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
7070,10320,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.381,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7071,10320,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.065,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7072,10320,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.012,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7073,10320,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.469,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
7074,10320,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.559,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
7075,10320,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.285,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
7076,10320,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.524,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
7077,10320,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.237,1.1111111111111112,PP242,OHSU_HNSCC_derm002
7078,10320,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.397,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
7079,10320,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.322,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
7080,10320,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.251,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7081,10320,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.365,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
7082,10320,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.212,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7083,10320,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.121,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
7084,10320,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.594,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
7085,10320,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.624,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
7086,10320,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.615,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7087,10320,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.058,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7088,10320,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.028,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7089,10320,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.441,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
7090,10320,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.564,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
7091,10320,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.292,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
7092,10320,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.549,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
7093,10320,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.271,0.3703703703703704,PP242,OHSU_HNSCC_derm002
7094,10320,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.497,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
7095,10320,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.431,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
7096,10320,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.228,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7097,10320,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.439,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
7098,10320,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.297,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7099,10320,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.169,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
7100,10320,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.586,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
7101,10320,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.648,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
7102,10320,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.602,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7103,10320,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.097,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7104,10320,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.052,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7105,10320,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.459,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
7106,10320,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.551,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
7107,10320,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.295,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
7108,10320,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.579,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
7109,10320,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.364,0.1234567901234568,PP242,OHSU_HNSCC_derm002
7110,10320,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.54,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
7111,10320,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.457,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
7112,10320,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.267,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7113,10320,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.465,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
7114,10320,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.452,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7115,10320,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.376,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
7116,10320,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.586,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
7117,10320,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.604,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
7118,10320,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.62,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7119,10320,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.181,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7120,10320,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.087,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7121,10320,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.457,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
7122,10320,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.561,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
7123,10320,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.309,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
7124,10320,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.549,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
7125,10320,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.469,0.0411522633744856,PP242,OHSU_HNSCC_derm002
7126,10320,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.591,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
7127,10320,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.5,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
7128,10320,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.379,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7129,10320,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.476,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
7130,10320,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.492,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7131,10320,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.451,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
7132,10320,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.611,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
7133,10320,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.569,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
7134,10320,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.53,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7135,10320,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.38,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7136,10320,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.186,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
7137,10320,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.458,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
7138,10320,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.504,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
7139,10320,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.305,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
7140,10320,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.596,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
7141,10320,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.517,0.013717421124828532,PP242,OHSU_HNSCC_derm002
7142,10320,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.57,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
7143,10320,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.597,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
7144,10320,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.471,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7145,10320,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.537,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
7146,10320,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.528,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
7147,10320,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.475,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
7148,10320,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.555,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
7149,10320,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.567,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
7150,10320,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.572,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
7151,10320,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.451,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
7152,10320,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.363,0,NONE,OHSU_HNSCC_derm002
7153,10320,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.469,0,NONE,OHSU_HNSCC_derm002
7154,10320,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.503,0,NONE,OHSU_HNSCC_derm002
7155,10320,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.536,0,NONE,OHSU_HNSCC_derm002
7156,10320,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
7157,10320,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.579,0,NONE,OHSU_HNSCC_derm002
7158,10320,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.585,0,NONE,OHSU_HNSCC_derm002
7159,10320,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
7160,10320,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.523,0,NONE,OHSU_HNSCC_derm002
7161,10320,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.547,0,NONE,OHSU_HNSCC_derm002
7162,10320,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.512,0,NONE,OHSU_HNSCC_derm002
7163,10320,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.594,0,NONE,OHSU_HNSCC_derm002
7164,10320,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.574,0,NONE,OHSU_HNSCC_derm002
7165,10320,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.576,0,NONE,OHSU_HNSCC_derm002
7166,10320,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.583,0,NONE,OHSU_HNSCC_derm002
7167,10320,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
7168,10320,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.197,10,Emodin,OHSU_HNSCC_derm002
7169,10320,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.364,10,Baicalin,OHSU_HNSCC_derm002
7170,10320,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.031,10,NVP-TAE-684,OHSU_HNSCC_derm002
7171,10320,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.077,10,Panobinostat,OHSU_HNSCC_derm002
7172,10320,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.015,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
7173,10320,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.571,10,Fulvestrant,OHSU_HNSCC_derm002
7174,10320,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.127,10,SCH-772984,OHSU_HNSCC_derm002
7175,10320,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.269,10,Trametinib,OHSU_HNSCC_derm002
7176,10320,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.086,10,BEZ235,OHSU_HNSCC_derm002
7177,10320,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.498,10,MLN120B,OHSU_HNSCC_derm002
7178,10320,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.365,10,Ixabepilone,OHSU_HNSCC_derm002
7179,10320,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.025,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
7180,10320,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.209,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7181,10320,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.186,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7182,10320,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.393,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7183,10320,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.305,10,Letrozole,OHSU_HNSCC_derm002
7184,10320,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.264,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
7185,10320,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.456,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
7186,10320,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.15,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
7187,10320,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
7188,10320,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.047,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
7189,10320,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.54,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
7190,10320,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.21,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
7191,10320,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.297,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
7192,10320,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.122,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
7193,10320,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.537,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
7194,10320,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.34,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
7195,10320,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.216,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
7196,10320,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.332,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7197,10320,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.238,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7198,10320,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.463,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7199,10320,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.315,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
7200,10320,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.327,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
7201,10320,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.508,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
7202,10320,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.188,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
7203,10320,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.149,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
7204,10320,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.1,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
7205,10320,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.588,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
7206,10320,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.302,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
7207,10320,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.273,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
7208,10320,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.108,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
7209,10320,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.554,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
7210,10320,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.363,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
7211,10320,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.314,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
7212,10320,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.353,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7213,10320,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.3,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7214,10320,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.496,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7215,10320,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.354,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
7216,10320,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.331,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
7217,10320,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.483,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
7218,10320,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.314,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
7219,10320,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.398,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
7220,10320,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.193,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
7221,10320,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.527,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
7222,10320,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.571,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
7223,10320,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.265,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
7224,10320,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.156,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
7225,10320,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.57,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
7226,10320,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.373,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
7227,10320,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.37,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
7228,10320,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.38,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7229,10320,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.476,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7230,10320,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.509,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7231,10320,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.327,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
7232,10320,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.315,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
7233,10320,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.489,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
7234,10320,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.385,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
7235,10320,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.518,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
7236,10320,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.302,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
7237,10320,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.561,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
7238,10320,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.591,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
7239,10320,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.282,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
7240,10320,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.219,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
7241,10320,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.531,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
7242,10320,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.361,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
7243,10320,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.428,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
7244,10320,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.481,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7245,10320,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.604,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7246,10320,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.511,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7247,10320,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.396,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
7248,10320,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
7249,10320,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.429,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
7250,10320,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.485,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
7251,10320,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.375,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
7252,10320,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.427,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
7253,10320,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.522,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
7254,10320,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.613,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
7255,10320,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.309,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
7256,10320,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.38,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
7257,10320,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.537,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
7258,10320,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.38,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
7259,10320,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.473,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
7260,10320,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.536,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7261,10320,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.598,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7262,10320,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.515,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7263,10320,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.389,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
7264,10320,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.398,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
7265,10320,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.37,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
7266,10320,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.434,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
7267,10320,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.351,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
7268,10320,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.445,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
7269,10320,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.467,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
7270,10320,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.534,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
7271,10320,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.374,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
7272,10320,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.374,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
7273,10320,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.476,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
7274,10320,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.366,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
7275,10320,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.412,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
7276,10320,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.476,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
7277,10320,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.517,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
7278,10320,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.401,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
7279,10320,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.32,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
7280,10320,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.36,0,NONE,OHSU_HNSCC_derm002
7281,10320,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.341,0,NONE,OHSU_HNSCC_derm002
7282,10320,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.369,0,NONE,OHSU_HNSCC_derm002
7283,10320,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.332,0,NONE,OHSU_HNSCC_derm002
7284,10320,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.338,0,NONE,OHSU_HNSCC_derm002
7285,10320,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
7286,10320,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.345,0,NONE,OHSU_HNSCC_derm002
7287,10320,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.416,0,NONE,OHSU_HNSCC_derm002
7288,10320,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.388,0,NONE,OHSU_HNSCC_derm002
7289,10320,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.537,0,NONE,OHSU_HNSCC_derm002
7290,10320,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.324,0,NONE,OHSU_HNSCC_derm002
7291,10320,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.404,0,NONE,OHSU_HNSCC_derm002
7292,10320,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
7293,10320,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
7294,10320,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.432,0,NONE,OHSU_HNSCC_derm002
7295,10320,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.447,0,NONE,OHSU_HNSCC_derm002
7296,10320,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.359,10,Coumarin,OHSU_HNSCC_derm002
7297,10320,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.035,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7298,10320,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.058,10,Foretinib (XL-880),OHSU_HNSCC_derm002
7299,10320,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.391,10,Elesclomol,OHSU_HNSCC_derm002
7300,10320,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.404,10,Vemurafenib,OHSU_HNSCC_derm002
7301,10320,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.052,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7302,10320,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.037,10,Ponatinib,OHSU_HNSCC_derm002
7303,10320,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.114,10,Gefitinib,OHSU_HNSCC_derm002
7304,10320,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.004,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
7305,10320,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.424,1,Sunitinib (1mM),OHSU_HNSCC_derm002
7306,10320,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.259,10,Curcumin,OHSU_HNSCC_derm002
7307,10320,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.084,10,PF-562271,OHSU_HNSCC_derm002
7308,10320,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.446,10,STO609,OHSU_HNSCC_derm002
7309,10320,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.302,10,Lenvatinib,OHSU_HNSCC_derm002
7310,10320,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.034,10,Entrectinib,OHSU_HNSCC_derm002
7311,10320,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.531,10,Ethyl Gallate ,OHSU_HNSCC_derm002
7312,10320,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.345,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
7313,10320,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.134,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7314,10320,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.224,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
7315,10320,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.459,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
7316,10320,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.372,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
7317,10320,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.094,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7318,10320,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.138,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
7319,10320,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.236,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
7320,10320,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.167,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
7321,10320,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.504,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
7322,10320,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.5,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
7323,10320,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.398,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
7324,10320,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.408,3.3333333333333335,STO609,OHSU_HNSCC_derm002
7325,10320,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.508,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
7326,10320,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.294,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
7327,10320,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.556,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
7328,10320,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.339,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
7329,10320,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.159,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7330,10320,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.365,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
7331,10320,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.39,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
7332,10320,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.551,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
7333,10320,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.141,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7334,10320,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.533,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
7335,10320,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.227,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
7336,10320,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.425,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
7337,10320,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.563,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
7338,10320,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.601,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
7339,10320,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.499,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
7340,10320,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.558,1.1111111111111112,STO609,OHSU_HNSCC_derm002
7341,10320,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.512,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
7342,10320,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.353,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
7343,10320,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.416,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
7344,10320,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.377,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
7345,10320,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.145,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7346,10320,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.46,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
7347,10320,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.407,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
7348,10320,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.519,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
7349,10320,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.22,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7350,10320,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.624,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
7351,10320,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.397,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
7352,10320,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.483,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
7353,10320,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.543,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
7354,10320,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.574,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
7355,10320,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.591,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
7356,10320,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.53,0.3703703703703704,STO609,OHSU_HNSCC_derm002
7357,10320,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.539,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
7358,10320,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.421,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
7359,10320,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.506,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
7360,10320,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.411,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
7361,10320,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.171,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7362,10320,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.512,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
7363,10320,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.415,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
7364,10320,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.61,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
7365,10320,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.313,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7366,10320,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.592,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
7367,10320,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.554,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
7368,10320,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.64,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
7369,10320,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.549,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
7370,10320,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.659,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
7371,10320,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.556,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
7372,10320,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.632,0.1234567901234568,STO609,OHSU_HNSCC_derm002
7373,10320,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.593,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
7374,10320,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.399,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
7375,10320,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.427,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
7376,10320,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.361,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
7377,10320,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.237,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7378,10320,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.472,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
7379,10320,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.402,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
7380,10320,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.574,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
7381,10320,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.412,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7382,10320,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.569,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
7383,10320,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.515,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
7384,10320,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.694,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
7385,10320,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.54,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
7386,10320,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.595,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
7387,10320,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.549,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
7388,10320,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.62,0.0411522633744856,STO609,OHSU_HNSCC_derm002
7389,10320,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.581,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
7390,10320,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.367,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
7391,10320,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.508,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
7392,10320,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.327,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
7393,10320,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.34,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
7394,10320,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.484,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
7395,10320,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.453,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
7396,10320,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.609,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
7397,10320,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.523,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
7398,10320,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.598,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
7399,10320,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.583,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
7400,10320,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
7401,10320,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.562,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
7402,10320,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.639,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
7403,10320,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.51,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
7404,10320,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.66,0.013717421124828532,STO609,OHSU_HNSCC_derm002
7405,10320,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.562,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
7406,10320,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.451,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
7407,10320,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.526,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
7408,10320,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.336,0,NONE,OHSU_HNSCC_derm002
7409,10320,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.445,0,NONE,OHSU_HNSCC_derm002
7410,10320,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.534,0,NONE,OHSU_HNSCC_derm002
7411,10320,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.557,0,NONE,OHSU_HNSCC_derm002
7412,10320,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.603,0,NONE,OHSU_HNSCC_derm002
7413,10320,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.608,0,NONE,OHSU_HNSCC_derm002
7414,10320,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.588,0,NONE,OHSU_HNSCC_derm002
7415,10320,Blank 490,2,H,OHSU_HNSCC_derm002,8,0.002,10,F-S-V,OHSU_HNSCC_derm002
7416,10320,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.538,0,NONE,OHSU_HNSCC_derm002
7417,10320,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.575,0,NONE,OHSU_HNSCC_derm002
7418,10320,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.615,0,NONE,OHSU_HNSCC_derm002
7419,10320,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.501,0,NONE,OHSU_HNSCC_derm002
7420,10320,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.65,0,NONE,OHSU_HNSCC_derm002
7421,10320,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.55,0,NONE,OHSU_HNSCC_derm002
7422,10320,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.524,0,NONE,OHSU_HNSCC_derm002
7423,10320,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.522,0,NONE,OHSU_HNSCC_derm002
7424,10320,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.03,10,GDC-0941,OHSU_HNSCC_derm002
7425,10320,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.224,10,Dovitinib,OHSU_HNSCC_derm002
7426,10320,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.19,10,BI-2536,OHSU_HNSCC_derm002
7427,10320,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.093,10,TP-0903 ,OHSU_HNSCC_derm002
7428,10320,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.22,10,Belinostat,OHSU_HNSCC_derm002
7429,10320,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.056,10,INK-128,OHSU_HNSCC_derm002
7430,10320,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.131,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7431,10320,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.068,10,Brigatinib,OHSU_HNSCC_derm002
7432,10320,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.178,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7433,10320,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.094,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7434,10320,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.378,10,Pazopanib,OHSU_HNSCC_derm002
7435,10320,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.445,10,AZD4547,OHSU_HNSCC_derm002
7436,10320,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.535,10,Pomalidomide ,OHSU_HNSCC_derm002
7437,10320,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.425,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
7438,10320,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.457,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7439,10320,Blank 490,2,P,OHSU_HNSCC_derm002,9,-0.007,10,Staurosporin,OHSU_HNSCC_derm002
7440,10320,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.017,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
7441,10320,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.357,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
7442,10320,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.48,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
7443,10320,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.102,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
7444,10320,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.353,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
7445,10320,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.104,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
7446,10320,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.205,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7447,10320,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.152,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
7448,10320,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.239,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7449,10320,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.265,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7450,10320,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.407,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
7451,10320,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.581,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
7452,10320,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.568,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
7453,10320,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.524,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
7454,10320,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.412,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7455,10320,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.008,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
7456,10320,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.065,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
7457,10320,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.426,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
7458,10320,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.598,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
7459,10320,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.165,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
7460,10320,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.44,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
7461,10320,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.111,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
7462,10320,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.191,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7463,10320,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.315,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
7464,10320,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.235,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7465,10320,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.292,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7466,10320,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.439,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
7467,10320,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.621,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
7468,10320,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.628,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
7469,10320,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.493,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
7470,10320,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.489,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7471,10320,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.02,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
7472,10320,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.156,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
7473,10320,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.444,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
7474,10320,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.544,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
7475,10320,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.535,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
7476,10320,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.454,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
7477,10320,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.121,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
7478,10320,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.213,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7479,10320,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.462,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
7480,10320,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.266,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7481,10320,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.48,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7482,10320,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.51,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
7483,10320,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.601,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
7484,10320,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.598,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
7485,10320,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.601,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
7486,10320,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.473,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7487,10320,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.065,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
7488,10320,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.245,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
7489,10320,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.405,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
7490,10320,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.483,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
7491,10320,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.533,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
7492,10320,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.476,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
7493,10320,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.157,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
7494,10320,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.229,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7495,10320,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.47,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
7496,10320,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.26,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7497,10320,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.593,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7498,10320,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.512,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
7499,10320,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.613,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
7500,10320,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.589,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
7501,10320,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.538,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
7502,10320,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.544,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7503,10320,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.338,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
7504,10320,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.325,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
7505,10320,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.416,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
7506,10320,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.452,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
7507,10320,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.596,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
7508,10320,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.516,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
7509,10320,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.215,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
7510,10320,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.288,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7511,10320,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.553,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
7512,10320,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.313,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7513,10320,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.567,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7514,10320,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.574,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
7515,10320,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.555,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
7516,10320,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.642,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
7517,10320,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.552,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
7518,10320,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.449,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7519,10320,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.486,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
7520,10320,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.337,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
7521,10320,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.398,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
7522,10320,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.462,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
7523,10320,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.587,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
7524,10320,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.548,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
7525,10320,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.29,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
7526,10320,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.34,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
7527,10320,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.565,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
7528,10320,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.425,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7529,10320,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.565,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
7530,10320,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.523,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
7531,10320,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.618,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
7532,10320,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.615,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
7533,10320,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.608,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
7534,10320,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.474,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
7535,10320,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.47,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
7536,10320,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.298,0,NONE,OHSU_HNSCC_derm002
7537,10320,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.402,0,NONE,OHSU_HNSCC_derm002
7538,10320,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.485,0,NONE,OHSU_HNSCC_derm002
7539,10320,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.545,0,NONE,OHSU_HNSCC_derm002
7540,10320,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.535,0,NONE,OHSU_HNSCC_derm002
7541,10320,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.6,0,NONE,OHSU_HNSCC_derm002
7542,10320,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.561,0,NONE,OHSU_HNSCC_derm002
7543,10320,Blank 490,2,H,OHSU_HNSCC_derm002,16,-0.002,10,F-S-V,OHSU_HNSCC_derm002
7544,10320,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.556,0,NONE,OHSU_HNSCC_derm002
7545,10320,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.576,0,NONE,OHSU_HNSCC_derm002
7546,10320,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.6,0,NONE,OHSU_HNSCC_derm002
7547,10320,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.622,0,NONE,OHSU_HNSCC_derm002
7548,10320,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.561,0,NONE,OHSU_HNSCC_derm002
7549,10320,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.597,0,NONE,OHSU_HNSCC_derm002
7550,10320,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.564,0,NONE,OHSU_HNSCC_derm002
7551,10320,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
7552,10320,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.252,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
7553,10320,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.334,10,Hesperidin,OHSU_HNSCC_derm002
7554,10320,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.453,10,Esculetin,OHSU_HNSCC_derm002
7555,10320,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.226,10,Selinexor ,OHSU_HNSCC_derm002
7556,10320,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.332,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7557,10320,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.396,10,BMX-IN-1,OHSU_HNSCC_derm002
7558,10320,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.096,1,Dasatinib (1mM),OHSU_HNSCC_derm002
7559,10320,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.273,10,Trametinib,OHSU_HNSCC_derm002
7560,10320,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.093,10,BEZ235,OHSU_HNSCC_derm002
7561,10320,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.125,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
7562,10320,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.274,10,Nilotinib,OHSU_HNSCC_derm002
7563,10320,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.347,10,Enzalutamide,OHSU_HNSCC_derm002
7564,10320,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.61,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7565,10320,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.139,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
7566,10320,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.154,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7567,10320,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.31,10,Axitinib,OHSU_HNSCC_derm002
7568,10320,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.356,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
7569,10320,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.447,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
7570,10320,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.435,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
7571,10320,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.218,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
7572,10320,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.53,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7573,10320,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.534,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
7574,10320,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.185,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
7575,10320,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.316,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
7576,10320,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.088,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
7577,10320,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.156,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
7578,10320,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.413,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
7579,10320,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.466,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
7580,10320,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.596,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7581,10320,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.196,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
7582,10320,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.147,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7583,10320,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.426,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
7584,10320,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.382,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
7585,10320,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.36,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
7586,10320,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.37,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
7587,10320,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.205,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
7588,10320,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.449,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7589,10320,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.516,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
7590,10320,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.192,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
7591,10320,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.256,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
7592,10320,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.083,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
7593,10320,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.165,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
7594,10320,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.558,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
7595,10320,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.602,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
7596,10320,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.637,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7597,10320,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.238,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
7598,10320,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.133,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7599,10320,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.515,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
7600,10320,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.358,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
7601,10320,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.35,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
7602,10320,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.419,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
7603,10320,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.242,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
7604,10320,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.433,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7605,10320,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.484,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
7606,10320,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.366,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
7607,10320,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.304,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
7608,10320,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.144,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
7609,10320,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.247,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
7610,10320,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.535,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
7611,10320,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.562,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
7612,10320,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.592,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7613,10320,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.389,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
7614,10320,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.371,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7615,10320,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.526,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
7616,10320,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.406,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
7617,10320,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.422,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
7618,10320,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.429,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
7619,10320,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.346,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
7620,10320,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.576,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7621,10320,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.59,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
7622,10320,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.413,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
7623,10320,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.262,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
7624,10320,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.212,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
7625,10320,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.454,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
7626,10320,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.537,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
7627,10320,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.555,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
7628,10320,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.582,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7629,10320,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.661,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
7630,10320,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.492,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7631,10320,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.528,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
7632,10320,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.376,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
7633,10320,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.382,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
7634,10320,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.39,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
7635,10320,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.385,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
7636,10320,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.411,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7637,10320,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.553,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
7638,10320,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.446,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
7639,10320,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.33,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
7640,10320,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.338,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
7641,10320,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.723,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
7642,10320,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.577,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
7643,10320,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.544,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
7644,10320,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.55,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7645,10320,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.674,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
7646,10320,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.488,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7647,10320,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.526,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
7648,10320,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.423,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
7649,10320,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
7650,10320,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.333,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
7651,10320,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.376,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
7652,10320,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.381,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
7653,10320,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.32,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
7654,10320,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.389,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
7655,10320,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.316,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
7656,10320,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.389,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
7657,10320,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.467,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
7658,10320,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.504,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
7659,10320,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.402,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
7660,10320,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.514,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
7661,10320,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.508,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
7662,10320,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.526,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
7663,10320,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.514,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
7664,10320,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.381,0,NONE,OHSU_HNSCC_derm002
7665,10320,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.372,0,NONE,OHSU_HNSCC_derm002
7666,10320,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.369,0,NONE,OHSU_HNSCC_derm002
7667,10320,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.295,0,NONE,OHSU_HNSCC_derm002
7668,10320,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
7669,10320,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.271,0,NONE,OHSU_HNSCC_derm002
7670,10320,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.449,0,NONE,OHSU_HNSCC_derm002
7671,10320,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.441,0,NONE,OHSU_HNSCC_derm002
7672,10320,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.43,0,NONE,OHSU_HNSCC_derm002
7673,10320,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.498,0,NONE,OHSU_HNSCC_derm002
7674,10320,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.458,0,NONE,OHSU_HNSCC_derm002
7675,10320,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.556,0,NONE,OHSU_HNSCC_derm002
7676,10320,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.566,0,NONE,OHSU_HNSCC_derm002
7677,10320,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.576,0,NONE,OHSU_HNSCC_derm002
7678,10320,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.541,0,NONE,OHSU_HNSCC_derm002
7679,10320,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.481,0,NONE,OHSU_HNSCC_derm002
7680,10320,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.357,10,Thalidomide ,OHSU_HNSCC_derm002
7681,10320,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.044,10,Vandetanib,OHSU_HNSCC_derm002
7682,10320,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.459,10,Oleic acid,OHSU_HNSCC_derm002
7683,10320,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.048,10,A-674563,OHSU_HNSCC_derm002
7684,10320,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.014,10,Lapatinib,OHSU_HNSCC_derm002
7685,10320,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.496,10,Apocynin (vanillin),OHSU_HNSCC_derm002
7686,10320,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.141,10,AT-7519,OHSU_HNSCC_derm002
7687,10320,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.127,10,Gefitinib,OHSU_HNSCC_derm002
7688,10320,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.009,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
7689,10320,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.096,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7690,10320,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.06,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7691,10320,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.103,10,JQ1,OHSU_HNSCC_derm002
7692,10320,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.493,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7693,10320,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.562,10,Cerdulatinib,OHSU_HNSCC_derm002
7694,10320,Blank 490,3,O,OHSU_HNSCC_derm002,1,-0.014,10,Romidepsin,OHSU_HNSCC_derm002
7695,10320,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.354,10,Gilteritinib,OHSU_HNSCC_derm002
7696,10320,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.341,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
7697,10320,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.208,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
7698,10320,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.384,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
7699,10320,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.244,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
7700,10320,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.116,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
7701,10320,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.545,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
7702,10320,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.126,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
7703,10320,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.235,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
7704,10320,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.174,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
7705,10320,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.145,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7706,10320,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.144,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7707,10320,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.576,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
7708,10320,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.689,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7709,10320,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.655,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
7710,10320,Blank 490,3,O,OHSU_HNSCC_derm002,2,-0.018,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
7711,10320,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.453,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
7712,10320,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.353,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
7713,10320,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.334,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
7714,10320,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.433,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
7715,10320,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.234,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
7716,10320,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.291,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
7717,10320,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.525,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
7718,10320,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.158,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
7719,10320,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.268,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
7720,10320,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.422,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
7721,10320,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.278,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7722,10320,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.276,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7723,10320,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.661,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
7724,10320,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.69,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7725,10320,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.596,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
7726,10320,Blank 490,3,O,OHSU_HNSCC_derm002,3,-0.008,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
7727,10320,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.498,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
7728,10320,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.404,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
7729,10320,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.428,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
7730,10320,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.416,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
7731,10320,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.285,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
7732,10320,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.374,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
7733,10320,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.551,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
7734,10320,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.569,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
7735,10320,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.406,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
7736,10320,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.467,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
7737,10320,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.408,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7738,10320,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.32,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7739,10320,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.746,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
7740,10320,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.7,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7741,10320,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.595,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
7742,10320,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.026,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
7743,10320,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.506,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
7744,10320,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.452,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
7745,10320,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.426,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
7746,10320,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.453,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
7747,10320,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.375,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
7748,10320,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.495,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
7749,10320,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.541,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
7750,10320,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.626,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
7751,10320,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.514,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
7752,10320,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.55,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
7753,10320,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.497,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7754,10320,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.519,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7755,10320,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.828,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
7756,10320,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.68,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7757,10320,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.651,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
7758,10320,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.058,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
7759,10320,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.594,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
7760,10320,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.413,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
7761,10320,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.431,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
7762,10320,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.447,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
7763,10320,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.431,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
7764,10320,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.502,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
7765,10320,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.563,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
7766,10320,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.584,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
7767,10320,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.542,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
7768,10320,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.567,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
7769,10320,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.56,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7770,10320,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.524,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7771,10320,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.729,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
7772,10320,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.681,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7773,10320,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.647,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
7774,10320,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.079,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
7775,10320,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.54,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
7776,10320,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.423,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
7777,10320,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.461,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
7778,10320,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.479,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
7779,10320,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.433,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
7780,10320,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.595,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
7781,10320,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.58,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
7782,10320,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.642,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
7783,10320,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.621,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
7784,10320,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.593,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
7785,10320,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.535,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
7786,10320,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.578,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
7787,10320,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.668,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
7788,10320,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.648,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
7789,10320,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.669,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
7790,10320,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.072,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
7791,10320,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.595,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
7792,10320,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.382,0,NONE,OHSU_HNSCC_derm002
7793,10320,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.476,0,NONE,OHSU_HNSCC_derm002
7794,10320,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.452,0,NONE,OHSU_HNSCC_derm002
7795,10320,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.519,0,NONE,OHSU_HNSCC_derm002
7796,10320,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.55,0,NONE,OHSU_HNSCC_derm002
7797,10320,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.516,0,NONE,OHSU_HNSCC_derm002
7798,10320,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
7799,10320,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
7800,10320,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.543,0,NONE,OHSU_HNSCC_derm002
7801,10320,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.617,0,NONE,OHSU_HNSCC_derm002
7802,10320,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.532,0,NONE,OHSU_HNSCC_derm002
7803,10320,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.585,0,NONE,OHSU_HNSCC_derm002
7804,10320,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
7805,10320,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.625,0,NONE,OHSU_HNSCC_derm002
7806,10320,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.658,0,NONE,OHSU_HNSCC_derm002
7807,10320,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.536,0,NONE,OHSU_HNSCC_derm002
7808,10320,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.347,10,Anastrazole,OHSU_HNSCC_derm002
7809,10320,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.23,10,JNJ-28312141 ,OHSU_HNSCC_derm002
7810,10320,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.391,10,Genistein,OHSU_HNSCC_derm002
7811,10320,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.522,10,Abscisic acid,OHSU_HNSCC_derm002
7812,10320,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.315,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7813,10320,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.578,10,Ruxolitinib,OHSU_HNSCC_derm002
7814,10320,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.802,10,TAK-659,OHSU_HNSCC_derm002
7815,10320,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.055,10,Brigatinib,OHSU_HNSCC_derm002
7816,10320,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.205,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7817,10320,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.098,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7818,10320,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.531,10,Vorinostat,OHSU_HNSCC_derm002
7819,10320,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.591,10,Lenalidomide,OHSU_HNSCC_derm002
7820,10320,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.061,10,NVP-ADW742,OHSU_HNSCC_derm002
7821,10320,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.508,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7822,10320,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.735,10,Echinatin,OHSU_HNSCC_derm002
7823,10320,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.035,10,YM-155,OHSU_HNSCC_derm002
7824,10320,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.41,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
7825,10320,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.406,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
7826,10320,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.425,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
7827,10320,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.491,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
7828,10320,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.339,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7829,10320,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.583,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
7830,10320,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.801,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
7831,10320,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.128,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
7832,10320,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.261,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7833,10320,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.425,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7834,10320,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.673,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
7835,10320,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.565,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
7836,10320,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.143,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
7837,10320,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.519,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7838,10320,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.58,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
7839,10320,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.031,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
7840,10320,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.437,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
7841,10320,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.484,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
7842,10320,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.495,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
7843,10320,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.501,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
7844,10320,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.441,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7845,10320,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.591,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
7846,10320,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.655,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
7847,10320,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.278,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
7848,10320,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.252,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7849,10320,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.603,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7850,10320,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.483,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
7851,10320,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.618,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
7852,10320,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.255,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
7853,10320,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.606,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7854,10320,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.446,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
7855,10320,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.025,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
7856,10320,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.329,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
7857,10320,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.461,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
7858,10320,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.423,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
7859,10320,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.471,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
7860,10320,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.45,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7861,10320,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.611,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
7862,10320,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.597,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
7863,10320,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.409,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
7864,10320,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.262,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7865,10320,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.677,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7866,10320,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.496,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
7867,10320,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.614,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
7868,10320,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.476,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
7869,10320,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.646,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7870,10320,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.623,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
7871,10320,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.016,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
7872,10320,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
7873,10320,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.558,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
7874,10320,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.426,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
7875,10320,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.466,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
7876,10320,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.448,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7877,10320,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.637,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
7878,10320,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.587,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
7879,10320,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.497,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
7880,10320,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.278,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7881,10320,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.703,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7882,10320,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.495,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
7883,10320,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.604,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
7884,10320,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.593,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
7885,10320,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.637,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7886,10320,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.646,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
7887,10320,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.006,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
7888,10320,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.473,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
7889,10320,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.5,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
7890,10320,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.474,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
7891,10320,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.475,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
7892,10320,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.476,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7893,10320,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.621,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
7894,10320,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.643,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
7895,10320,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.534,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
7896,10320,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.345,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7897,10320,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.651,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7898,10320,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.516,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
7899,10320,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.585,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
7900,10320,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.633,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
7901,10320,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.642,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7902,10320,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.604,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
7903,10320,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.016,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
7904,10320,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.434,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
7905,10320,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.459,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
7906,10320,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.448,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
7907,10320,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.5,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
7908,10320,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.537,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
7909,10320,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.573,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
7910,10320,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.565,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
7911,10320,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.553,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
7912,10320,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.459,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
7913,10320,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.675,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
7914,10320,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.574,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
7915,10320,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.61,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
7916,10320,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.629,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
7917,10320,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.638,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
7918,10320,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.607,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
7919,10320,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.098,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
7920,10320,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.481,0,NONE,OHSU_HNSCC_derm002
7921,10320,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.492,0,NONE,OHSU_HNSCC_derm002
7922,10320,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
7923,10320,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.477,0,NONE,OHSU_HNSCC_derm002
7924,10320,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.552,0,NONE,OHSU_HNSCC_derm002
7925,10320,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.539,0,NONE,OHSU_HNSCC_derm002
7926,10320,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.545,0,NONE,OHSU_HNSCC_derm002
7927,10320,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
7928,10320,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.566,0,NONE,OHSU_HNSCC_derm002
7929,10320,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.57,0,NONE,OHSU_HNSCC_derm002
7930,10320,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.628,0,NONE,OHSU_HNSCC_derm002
7931,10320,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.568,0,NONE,OHSU_HNSCC_derm002
7932,10320,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.667,0,NONE,OHSU_HNSCC_derm002
7933,10320,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.651,0,NONE,OHSU_HNSCC_derm002
7934,10320,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.612,0,NONE,OHSU_HNSCC_derm002
7935,10320,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.498,0,NONE,OHSU_HNSCC_derm002
7936,10320,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.456,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
7937,10320,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.505,10,Stevioside,OHSU_HNSCC_derm002
7938,10320,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.432,10,Pemetrexed,OHSU_HNSCC_derm002
7939,10320,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.03,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
7940,10320,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.082,10,GSK-1838705A,OHSU_HNSCC_derm002
7941,10320,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.013,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
7942,10320,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.473,10,Imatinib,OHSU_HNSCC_derm002
7943,10320,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.284,10,Trametinib,OHSU_HNSCC_derm002
7944,10320,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.083,10,BEZ235,OHSU_HNSCC_derm002
7945,10320,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.191,10,Saracatinib,OHSU_HNSCC_derm002
7946,10320,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.675,10,I-BET 762,OHSU_HNSCC_derm002
7947,10320,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.221,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
7948,10320,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.812,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
7949,10320,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.548,10,Crizotinib,OHSU_HNSCC_derm002
7950,10320,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.385,10,MGCD-265,OHSU_HNSCC_derm002
7951,10320,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.122,10,Erlotinib,OHSU_HNSCC_derm002
7952,10320,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.484,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
7953,10320,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.524,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
7954,10320,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.425,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
7955,10320,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.034,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
7956,10320,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.141,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
7957,10320,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.015,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
7958,10320,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.565,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
7959,10320,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.351,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
7960,10320,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.074,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
7961,10320,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.305,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
7962,10320,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.811,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
7963,10320,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.233,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
7964,10320,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.776,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
7965,10320,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.692,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
7966,10320,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.433,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
7967,10320,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.189,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
7968,10320,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.435,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
7969,10320,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.483,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
7970,10320,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.414,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
7971,10320,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.061,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
7972,10320,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.195,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
7973,10320,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.121,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
7974,10320,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.583,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
7975,10320,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.311,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
7976,10320,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.097,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
7977,10320,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.381,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
7978,10320,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.786,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
7979,10320,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.25,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
7980,10320,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.628,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
7981,10320,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.614,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
7982,10320,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.56,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
7983,10320,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.207,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
7984,10320,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.463,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
7985,10320,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.52,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
7986,10320,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.422,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
7987,10320,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.123,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
7988,10320,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.349,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
7989,10320,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.341,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
7990,10320,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.594,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
7991,10320,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.244,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
7992,10320,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.133,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
7993,10320,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.497,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
7994,10320,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.765,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
7995,10320,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.351,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
7996,10320,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.661,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
7997,10320,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.663,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
7998,10320,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.452,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
7999,10320,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.414,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
8000,10320,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.405,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
8001,10320,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.484,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
8002,10320,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.432,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
8003,10320,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.181,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
8004,10320,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.414,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
8005,10320,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.418,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
8006,10320,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.558,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
8007,10320,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.252,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
8008,10320,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.193,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
8009,10320,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.52,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
8010,10320,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.672,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
8011,10320,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.419,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
8012,10320,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.626,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
8013,10320,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.614,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
8014,10320,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.612,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
8015,10320,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.455,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
8016,10320,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.457,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
8017,10320,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.457,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
8018,10320,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.477,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
8019,10320,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.272,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
8020,10320,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.449,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
8021,10320,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.471,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
8022,10320,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.516,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
8023,10320,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.297,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
8024,10320,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.344,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
8025,10320,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.549,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
8026,10320,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.547,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
8027,10320,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.521,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
8028,10320,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.591,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
8029,10320,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.593,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
8030,10320,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.614,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
8031,10320,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.523,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
8032,10320,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.428,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
8033,10320,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.402,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
8034,10320,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.561,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
8035,10320,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
8036,10320,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.513,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
8037,10320,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.525,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
8038,10320,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.57,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
8039,10320,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.393,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
8040,10320,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.465,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
8041,10320,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.542,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
8042,10320,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.564,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
8043,10320,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.489,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
8044,10320,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.572,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
8045,10320,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.52,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
8046,10320,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.564,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
8047,10320,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.53,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
8048,10320,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.415,0,NONE,OHSU_HNSCC_derm002
8049,10320,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.433,0,NONE,OHSU_HNSCC_derm002
8050,10320,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.512,0,NONE,OHSU_HNSCC_derm002
8051,10320,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
8052,10320,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.515,0,NONE,OHSU_HNSCC_derm002
8053,10320,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.561,0,NONE,OHSU_HNSCC_derm002
8054,10320,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.56,0,NONE,OHSU_HNSCC_derm002
8055,10320,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.526,0,NONE,OHSU_HNSCC_derm002
8056,10320,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.528,0,NONE,OHSU_HNSCC_derm002
8057,10320,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.485,0,NONE,OHSU_HNSCC_derm002
8058,10320,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.448,0,NONE,OHSU_HNSCC_derm002
8059,10320,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.532,0,NONE,OHSU_HNSCC_derm002
8060,10320,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.508,0,NONE,OHSU_HNSCC_derm002
8061,10320,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.521,0,NONE,OHSU_HNSCC_derm002
8062,10320,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.473,0,NONE,OHSU_HNSCC_derm002
8063,10320,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
8064,10320,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.002,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8065,10320,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.015,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8066,10320,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.287,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8067,10320,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.251,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8068,10320,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.008,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8069,10320,Blank 490,4,F,OHSU_HNSCC_derm002,1,-0.003,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8070,10320,Blank 490,4,G,OHSU_HNSCC_derm002,1,-0.034,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8071,10320,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.062,10,Gefitinib,OHSU_HNSCC_derm002
8072,10320,Blank 490,4,I,OHSU_HNSCC_derm002,1,-0.016,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
8073,10320,Blank 490,4,J,OHSU_HNSCC_derm002,1,-0.001,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8074,10320,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.22,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8075,10320,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.159,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8076,10320,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.05,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8077,10320,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.102,10,VOLASERTIB x,OHSU_HNSCC_derm002
8078,10320,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.124,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8079,10320,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.003,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8080,10320,Blank 490,4,A,OHSU_HNSCC_derm002,2,-0.014,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8081,10320,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.12,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8082,10320,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.409,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8083,10320,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.275,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8084,10320,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.114,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8085,10320,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.006,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8086,10320,Blank 490,4,G,OHSU_HNSCC_derm002,2,-0.007,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8087,10320,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.191,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
8088,10320,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.155,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
8089,10320,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.011,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8090,10320,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.222,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8091,10320,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.389,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8092,10320,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.15,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8093,10320,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.282,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
8094,10320,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.295,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8095,10320,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.006,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8096,10320,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.063,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8097,10320,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.324,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8098,10320,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.472,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8099,10320,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.264,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8100,10320,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.252,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8101,10320,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.011,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8102,10320,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.047,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8103,10320,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.22,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
8104,10320,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.374,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
8105,10320,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.079,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8106,10320,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.237,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8107,10320,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.404,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8108,10320,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.34,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8109,10320,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.739,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
8110,10320,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.515,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8111,10320,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.009,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8112,10320,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.117,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8113,10320,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.431,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8114,10320,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.424,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8115,10320,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.295,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8116,10320,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.335,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8117,10320,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.046,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8118,10320,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.067,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8119,10320,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.339,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
8120,10320,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.492,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
8121,10320,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.149,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8122,10320,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.3,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8123,10320,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.442,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8124,10320,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.407,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8125,10320,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.727,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
8126,10320,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.586,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8127,10320,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.03,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8128,10320,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.291,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8129,10320,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.483,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8130,10320,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.443,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8131,10320,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.354,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8132,10320,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.348,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8133,10320,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.162,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8134,10320,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.089,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8135,10320,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
8136,10320,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.555,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
8137,10320,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.291,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8138,10320,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.428,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8139,10320,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.498,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8140,10320,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.569,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8141,10320,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.603,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
8142,10320,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.554,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8143,10320,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.248,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8144,10320,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.393,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8145,10320,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.498,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8146,10320,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.485,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8147,10320,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.395,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8148,10320,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.433,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8149,10320,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.288,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8150,10320,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.109,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8151,10320,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.55,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
8152,10320,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.615,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
8153,10320,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.42,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8154,10320,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.558,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8155,10320,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.531,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8156,10320,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.659,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8157,10320,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.552,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
8158,10320,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.525,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8159,10320,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.404,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8160,10320,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.389,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
8161,10320,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.507,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
8162,10320,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.458,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
8163,10320,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.443,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8164,10320,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.491,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
8165,10320,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.413,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
8166,10320,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.145,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
8167,10320,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.58,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
8168,10320,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.627,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
8169,10320,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.517,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
8170,10320,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.591,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
8171,10320,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.564,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
8172,10320,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.666,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
8173,10320,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.55,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
8174,10320,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.454,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8175,10320,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.467,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
8176,10320,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.474,0,NONE,OHSU_HNSCC_derm002
8177,10320,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.522,0,NONE,OHSU_HNSCC_derm002
8178,10320,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.521,0,NONE,OHSU_HNSCC_derm002
8179,10320,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.434,0,NONE,OHSU_HNSCC_derm002
8180,10320,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.552,0,NONE,OHSU_HNSCC_derm002
8181,10320,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.556,0,NONE,OHSU_HNSCC_derm002
8182,10320,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.584,0,NONE,OHSU_HNSCC_derm002
8183,10320,Blank 490,4,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
8184,10320,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.624,0,NONE,OHSU_HNSCC_derm002
8185,10320,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.592,0,NONE,OHSU_HNSCC_derm002
8186,10320,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.602,0,NONE,OHSU_HNSCC_derm002
8187,10320,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.592,0,NONE,OHSU_HNSCC_derm002
8188,10320,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.619,0,NONE,OHSU_HNSCC_derm002
8189,10320,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.616,0,NONE,OHSU_HNSCC_derm002
8190,10320,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.507,0,NONE,OHSU_HNSCC_derm002
8191,10320,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.62,0,NONE,OHSU_HNSCC_derm002
8192,10320,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.062,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8193,10320,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.143,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8194,10320,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.003,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
8195,10320,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.262,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8196,10320,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.165,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8197,10320,Blank 490,4,F,OHSU_HNSCC_derm002,9,-0.008,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
8198,10320,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.083,10,AZD2014 x ,OHSU_HNSCC_derm002
8199,10320,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.09,10,Brigatinib,OHSU_HNSCC_derm002
8200,10320,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.239,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8201,10320,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.079,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8202,10320,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.224,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8203,10320,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.154,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
8204,10320,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.181,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8205,10320,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.455,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8206,10320,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.051,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8207,10320,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.468,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8208,10320,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.139,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8209,10320,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.202,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8210,10320,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.018,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
8211,10320,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.294,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8212,10320,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.225,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8213,10320,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.002,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
8214,10320,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.109,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
8215,10320,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.149,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
8216,10320,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.261,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8217,10320,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.319,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8218,10320,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.287,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8219,10320,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.482,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
8220,10320,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.279,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8221,10320,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.315,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8222,10320,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.137,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8223,10320,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.483,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8224,10320,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.172,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8225,10320,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.226,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8226,10320,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.03,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
8227,10320,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.401,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8228,10320,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.242,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8229,10320,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.014,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
8230,10320,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.153,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
8231,10320,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.311,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
8232,10320,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.254,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8233,10320,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.372,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8234,10320,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.292,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8235,10320,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.638,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
8236,10320,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.272,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8237,10320,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.507,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8238,10320,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.287,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8239,10320,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.476,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8240,10320,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.284,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8241,10320,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.36,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8242,10320,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.124,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
8243,10320,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.408,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8244,10320,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.326,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8245,10320,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.158,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
8246,10320,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.227,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
8247,10320,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.38,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
8248,10320,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.251,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8249,10320,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.429,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8250,10320,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.332,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8251,10320,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.598,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
8252,10320,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.285,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8253,10320,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.599,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8254,10320,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.361,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8255,10320,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.454,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8256,10320,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.337,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8257,10320,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.444,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8258,10320,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.322,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
8259,10320,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.46,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8260,10320,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.437,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8261,10320,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.314,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
8262,10320,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.295,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
8263,10320,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.483,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
8264,10320,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.261,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8265,10320,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.497,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8266,10320,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.463,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8267,10320,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.623,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
8268,10320,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.303,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8269,10320,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.687,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8270,10320,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.501,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8271,10320,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.541,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8272,10320,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.413,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8273,10320,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.521,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8274,10320,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.449,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
8275,10320,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.492,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8276,10320,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.517,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8277,10320,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.413,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
8278,10320,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.432,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
8279,10320,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.526,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
8280,10320,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.395,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8281,10320,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.533,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8282,10320,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.601,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8283,10320,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.648,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
8284,10320,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.405,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8285,10320,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.604,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8286,10320,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.476,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8287,10320,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.507,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8288,10320,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.388,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
8289,10320,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.551,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
8290,10320,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.436,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
8291,10320,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.462,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8292,10320,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.477,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
8293,10320,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.511,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
8294,10320,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.435,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
8295,10320,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.569,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
8296,10320,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8297,10320,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.547,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
8298,10320,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.591,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
8299,10320,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.616,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
8300,10320,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.46,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8301,10320,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.667,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
8302,10320,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.662,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
8303,10320,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.56,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
8304,10320,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.398,0,NONE,OHSU_HNSCC_derm002
8305,10320,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.505,0,NONE,OHSU_HNSCC_derm002
8306,10320,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.559,0,NONE,OHSU_HNSCC_derm002
8307,10320,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.524,0,NONE,OHSU_HNSCC_derm002
8308,10320,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.532,0,NONE,OHSU_HNSCC_derm002
8309,10320,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.555,0,NONE,OHSU_HNSCC_derm002
8310,10320,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.594,0,NONE,OHSU_HNSCC_derm002
8311,10320,Blank 490,4,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
8312,10320,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.558,0,NONE,OHSU_HNSCC_derm002
8313,10320,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.587,0,NONE,OHSU_HNSCC_derm002
8314,10320,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.601,0,NONE,OHSU_HNSCC_derm002
8315,10320,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.598,0,NONE,OHSU_HNSCC_derm002
8316,10320,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.68,0,NONE,OHSU_HNSCC_derm002
8317,10320,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.694,0,NONE,OHSU_HNSCC_derm002
8318,10320,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.542,0,NONE,OHSU_HNSCC_derm002
8319,10320,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.557,0,NONE,OHSU_HNSCC_derm002
8320,10320,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.073,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8321,10320,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.025,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8322,10320,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.315,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8323,10320,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.022,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8324,10320,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.109,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8325,10320,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.022,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8326,10320,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.216,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8327,10320,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.31,10,Trametinib,OHSU_HNSCC_derm002
8328,10320,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.061,10,BEZ235,OHSU_HNSCC_derm002
8329,10320,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.037,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8330,10320,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.155,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8331,10320,Blank 490,4,L,OHSU_HNSCC_derm002,17,-0.009,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8332,10320,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.177,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8333,10320,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.682,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8334,10320,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.226,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8335,10320,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.043,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8336,10320,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.207,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8337,10320,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.13,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8338,10320,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.115,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8339,10320,Blank 490,4,D,OHSU_HNSCC_derm002,18,-0.009,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8340,10320,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.289,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8341,10320,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.163,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8342,10320,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.302,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8343,10320,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.32,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
8344,10320,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.063,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
8345,10320,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.195,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8346,10320,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.362,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8347,10320,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.027,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8348,10320,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.288,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8349,10320,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.659,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8350,10320,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.306,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8351,10320,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.079,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8352,10320,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.393,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8353,10320,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.246,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8354,10320,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.229,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8355,10320,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.016,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8356,10320,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.421,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8357,10320,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.274,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8358,10320,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.373,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8359,10320,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.312,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
8360,10320,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.068,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
8361,10320,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.246,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8362,10320,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.522,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8363,10320,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.081,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8364,10320,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.318,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8365,10320,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.656,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8366,10320,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.263,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8367,10320,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.174,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8368,10320,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.485,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8369,10320,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.291,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8370,10320,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.317,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8371,10320,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.041,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8372,10320,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.496,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8373,10320,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.359,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8374,10320,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.528,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8375,10320,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.306,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
8376,10320,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.131,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
8377,10320,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.236,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8378,10320,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.578,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8379,10320,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.207,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8380,10320,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.441,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8381,10320,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.69,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8382,10320,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.363,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8383,10320,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.264,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8384,10320,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.476,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8385,10320,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.405,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8386,10320,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.422,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8387,10320,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.055,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8388,10320,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.336,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8389,10320,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.452,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8390,10320,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.537,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8391,10320,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.236,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
8392,10320,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.188,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
8393,10320,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.342,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8394,10320,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.626,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8395,10320,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.386,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8396,10320,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.578,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8397,10320,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.752,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8398,10320,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.483,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8399,10320,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.451,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8400,10320,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.461,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8401,10320,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.44,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8402,10320,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.44,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8403,10320,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.071,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8404,10320,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.57,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8405,10320,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.47,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8406,10320,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.581,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8407,10320,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.287,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
8408,10320,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
8409,10320,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.482,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8410,10320,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.579,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8411,10320,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.503,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8412,10320,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.495,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8413,10320,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.711,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8414,10320,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.586,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8415,10320,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.542,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8416,10320,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.453,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
8417,10320,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.436,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
8418,10320,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.438,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8419,10320,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.112,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
8420,10320,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.528,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8421,10320,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.448,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
8422,10320,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.527,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
8423,10320,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.346,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
8424,10320,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.422,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
8425,10320,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.486,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
8426,10320,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.531,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8427,10320,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.482,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8428,10320,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.584,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
8429,10320,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.43,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8430,10320,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.551,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
8431,10320,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.553,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8432,10320,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.481,0,NONE,OHSU_HNSCC_derm002
8433,10320,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.465,0,NONE,OHSU_HNSCC_derm002
8434,10320,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.445,0,NONE,OHSU_HNSCC_derm002
8435,10320,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.44,0,NONE,OHSU_HNSCC_derm002
8436,10320,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.523,0,NONE,OHSU_HNSCC_derm002
8437,10320,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.503,0,NONE,OHSU_HNSCC_derm002
8438,10320,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.565,0,NONE,OHSU_HNSCC_derm002
8439,10320,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.527,0,NONE,OHSU_HNSCC_derm002
8440,10320,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.505,0,NONE,OHSU_HNSCC_derm002
8441,10320,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.517,0,NONE,OHSU_HNSCC_derm002
8442,10320,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.546,0,NONE,OHSU_HNSCC_derm002
8443,10320,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.55,0,NONE,OHSU_HNSCC_derm002
8444,10320,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.567,0,NONE,OHSU_HNSCC_derm002
8445,10320,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.555,0,NONE,OHSU_HNSCC_derm002
8446,10320,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.538,0,NONE,OHSU_HNSCC_derm002
8447,10320,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.532,0,NONE,OHSU_HNSCC_derm002
8448,10320,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.041,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8449,10320,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.035,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8450,10320,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.006,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8451,10320,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.117,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8452,10320,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.101,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8453,10320,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.115,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8454,10320,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.105,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8455,10320,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.155,10,Gefitinib,OHSU_HNSCC_derm002
8456,10320,Blank 490,5,I,OHSU_HNSCC_derm002,1,-0.019,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
8457,10320,Blank 490,5,J,OHSU_HNSCC_derm002,1,-0.014,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8458,10320,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.465,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8459,10320,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.062,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8460,10320,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.022,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8461,10320,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.208,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8462,10320,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.014,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8463,10320,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.036,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8464,10320,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.102,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8465,10320,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.172,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8466,10320,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.012,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8467,10320,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.26,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8468,10320,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.207,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8469,10320,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.166,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8470,10320,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.282,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8471,10320,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.239,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
8472,10320,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.135,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
8473,10320,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.0,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8474,10320,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.607,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8475,10320,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.173,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8476,10320,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.006,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8477,10320,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.272,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8478,10320,Blank 490,5,O,OHSU_HNSCC_derm002,2,-0.002,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8479,10320,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.118,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8480,10320,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.174,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8481,10320,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.221,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8482,10320,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.045,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8483,10320,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.442,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8484,10320,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.234,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8485,10320,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.192,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8486,10320,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.558,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8487,10320,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.254,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
8488,10320,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.421,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
8489,10320,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.059,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8490,10320,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.611,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8491,10320,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.35,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8492,10320,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.047,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8493,10320,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.237,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8494,10320,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.062,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8495,10320,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.149,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8496,10320,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.125,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8497,10320,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.279,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8498,10320,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.06,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8499,10320,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.523,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8500,10320,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.236,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8501,10320,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.294,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8502,10320,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.535,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8503,10320,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.354,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
8504,10320,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.459,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
8505,10320,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.123,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8506,10320,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.538,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8507,10320,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.462,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8508,10320,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.125,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8509,10320,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.405,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8510,10320,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.11,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8511,10320,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.185,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8512,10320,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.15,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8513,10320,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.471,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8514,10320,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.074,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8515,10320,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.518,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8516,10320,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.354,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8517,10320,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.41,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8518,10320,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.612,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8519,10320,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.514,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
8520,10320,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.599,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
8521,10320,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.34,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8522,10320,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.663,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8523,10320,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.569,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8524,10320,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.24,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8525,10320,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.497,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8526,10320,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.177,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8527,10320,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.319,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8528,10320,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.334,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8529,10320,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.539,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8530,10320,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.091,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8531,10320,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.506,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8532,10320,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.438,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8533,10320,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.448,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8534,10320,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.631,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8535,10320,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.574,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
8536,10320,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.632,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
8537,10320,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.498,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8538,10320,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.681,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8539,10320,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.583,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8540,10320,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.34,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8541,10320,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.609,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8542,10320,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.358,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8543,10320,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.517,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8544,10320,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.241,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8545,10320,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.521,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
8546,10320,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.146,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
8547,10320,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.594,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
8548,10320,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.495,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
8549,10320,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.48,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
8550,10320,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.625,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
8551,10320,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.63,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
8552,10320,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.621,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
8553,10320,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.58,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
8554,10320,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.663,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
8555,10320,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.607,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8556,10320,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.498,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8557,10320,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.587,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
8558,10320,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.526,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
8559,10320,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.541,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
8560,10320,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.482,0,NONE,OHSU_HNSCC_derm002
8561,10320,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.527,0,NONE,OHSU_HNSCC_derm002
8562,10320,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.593,0,NONE,OHSU_HNSCC_derm002
8563,10320,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
8564,10320,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.573,0,NONE,OHSU_HNSCC_derm002
8565,10320,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.557,0,NONE,OHSU_HNSCC_derm002
8566,10320,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.677,0,NONE,OHSU_HNSCC_derm002
8567,10320,Blank 490,5,H,OHSU_HNSCC_derm002,8,0.011,10,F-S-V,OHSU_HNSCC_derm002
8568,10320,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
8569,10320,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.568,0,NONE,OHSU_HNSCC_derm002
8570,10320,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.623,0,NONE,OHSU_HNSCC_derm002
8571,10320,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.633,0,NONE,OHSU_HNSCC_derm002
8572,10320,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.65,0,NONE,OHSU_HNSCC_derm002
8573,10320,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.611,0,NONE,OHSU_HNSCC_derm002
8574,10320,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.622,0,NONE,OHSU_HNSCC_derm002
8575,10320,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.538,0,NONE,OHSU_HNSCC_derm002
8576,10320,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.024,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8577,10320,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.39,10,APTO-253 x,OHSU_HNSCC_derm002
8578,10320,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.022,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8579,10320,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.659,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8580,10320,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.047,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8581,10320,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.004,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8582,10320,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.041,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8583,10320,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.069,10,Brigatinib,OHSU_HNSCC_derm002
8584,10320,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.273,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8585,10320,Blank 490,5,J,OHSU_HNSCC_derm002,9,-0.011,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8586,10320,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.022,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8587,10320,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.041,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8588,10320,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.239,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8589,10320,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.055,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8590,10320,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.004,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8591,10320,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.0,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8592,10320,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.004,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8593,10320,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.447,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
8594,10320,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.048,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8595,10320,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.497,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8596,10320,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.184,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8597,10320,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.012,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8598,10320,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.204,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8599,10320,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.118,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
8600,10320,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.285,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8601,10320,Blank 490,5,J,OHSU_HNSCC_derm002,10,-0.005,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8602,10320,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.057,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8603,10320,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.074,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8604,10320,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.284,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8605,10320,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.146,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8606,10320,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.041,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8607,10320,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.01,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8608,10320,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.023,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8609,10320,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.605,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
8610,10320,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.079,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8611,10320,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.527,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8612,10320,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.268,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8613,10320,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.023,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8614,10320,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.225,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8615,10320,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.248,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
8616,10320,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.264,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8617,10320,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.002,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8618,10320,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.222,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8619,10320,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.089,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8620,10320,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.366,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8621,10320,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.303,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8622,10320,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.162,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8623,10320,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.188,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8624,10320,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.018,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8625,10320,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.583,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
8626,10320,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.114,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8627,10320,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.528,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8628,10320,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.396,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8629,10320,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.029,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8630,10320,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.263,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8631,10320,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.409,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
8632,10320,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.257,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8633,10320,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.077,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8634,10320,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.303,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8635,10320,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.188,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8636,10320,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.345,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8637,10320,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.521,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8638,10320,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.356,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8639,10320,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.416,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8640,10320,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.033,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8641,10320,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.569,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
8642,10320,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.375,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8643,10320,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.494,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8644,10320,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.475,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8645,10320,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.114,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8646,10320,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.255,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8647,10320,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.485,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
8648,10320,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.288,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8649,10320,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.153,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8650,10320,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.506,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8651,10320,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.432,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8652,10320,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.558,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8653,10320,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.706,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8654,10320,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.512,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8655,10320,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.478,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8656,10320,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.061,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8657,10320,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.565,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
8658,10320,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.467,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8659,10320,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.519,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8660,10320,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.528,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8661,10320,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.248,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8662,10320,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.347,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8663,10320,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.573,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
8664,10320,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.431,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8665,10320,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.301,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8666,10320,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.538,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8667,10320,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.509,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8668,10320,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.635,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8669,10320,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.684,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8670,10320,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.547,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8671,10320,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.53,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8672,10320,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.068,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
8673,10320,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.579,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
8674,10320,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.437,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
8675,10320,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.525,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
8676,10320,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.502,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
8677,10320,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.384,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8678,10320,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.483,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8679,10320,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.624,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
8680,10320,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.485,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8681,10320,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.536,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
8682,10320,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.599,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8683,10320,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.471,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
8684,10320,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.668,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
8685,10320,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.668,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8686,10320,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.562,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8687,10320,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.538,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8688,10320,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.473,0,NONE,OHSU_HNSCC_derm002
8689,10320,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.548,0,NONE,OHSU_HNSCC_derm002
8690,10320,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.593,0,NONE,OHSU_HNSCC_derm002
8691,10320,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.55,0,NONE,OHSU_HNSCC_derm002
8692,10320,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.545,0,NONE,OHSU_HNSCC_derm002
8693,10320,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
8694,10320,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.651,0,NONE,OHSU_HNSCC_derm002
8695,10320,Blank 490,5,H,OHSU_HNSCC_derm002,16,-0.011,10,F-S-V,OHSU_HNSCC_derm002
8696,10320,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.627,0,NONE,OHSU_HNSCC_derm002
8697,10320,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.605,0,NONE,OHSU_HNSCC_derm002
8698,10320,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.622,0,NONE,OHSU_HNSCC_derm002
8699,10320,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.532,0,NONE,OHSU_HNSCC_derm002
8700,10320,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.581,0,NONE,OHSU_HNSCC_derm002
8701,10320,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.618,0,NONE,OHSU_HNSCC_derm002
8702,10320,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.567,0,NONE,OHSU_HNSCC_derm002
8703,10320,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.462,0,NONE,OHSU_HNSCC_derm002
8704,10320,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.014,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8705,10320,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.074,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8706,10320,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.017,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8707,10320,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.114,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8708,10320,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.189,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8709,10320,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.11,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8710,10320,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.178,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8711,10320,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.297,10,Trametinib,OHSU_HNSCC_derm002
8712,10320,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.051,10,BEZ235,OHSU_HNSCC_derm002
8713,10320,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.234,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8714,10320,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.22,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8715,10320,Blank 490,5,L,OHSU_HNSCC_derm002,17,-0.014,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8716,10320,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.161,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8717,10320,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.158,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8718,10320,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.428,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8719,10320,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.136,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8720,10320,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.036,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8721,10320,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.349,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8722,10320,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.021,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8723,10320,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.206,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8724,10320,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.316,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8725,10320,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.21,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8726,10320,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.225,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8727,10320,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.305,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
8728,10320,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.063,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
8729,10320,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.38,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8730,10320,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.238,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8731,10320,Blank 490,5,L,OHSU_HNSCC_derm002,18,-0.006,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8732,10320,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.282,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8733,10320,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.242,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8734,10320,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.557,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8735,10320,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.185,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8736,10320,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.239,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8737,10320,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.418,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8738,10320,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.024,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8739,10320,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.303,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8740,10320,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.424,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8741,10320,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.246,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8742,10320,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.256,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8743,10320,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.31,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
8744,10320,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.087,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
8745,10320,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.45,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8746,10320,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.187,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8747,10320,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.014,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8748,10320,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.348,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8749,10320,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.326,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8750,10320,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.623,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8751,10320,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.196,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8752,10320,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.393,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8753,10320,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.518,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8754,10320,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.066,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8755,10320,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.357,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8756,10320,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.507,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8757,10320,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.264,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8758,10320,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.341,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8759,10320,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.181,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
8760,10320,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.105,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
8761,10320,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.484,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8762,10320,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.421,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8763,10320,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.068,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8764,10320,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.44,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8765,10320,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.308,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8766,10320,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.57,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8767,10320,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.199,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8768,10320,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.436,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8769,10320,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.568,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8770,10320,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.153,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8771,10320,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.544,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8772,10320,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.568,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8773,10320,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.411,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8774,10320,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.504,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8775,10320,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.22,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
8776,10320,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.204,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
8777,10320,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.523,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8778,10320,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.523,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8779,10320,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.188,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8780,10320,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.567,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8781,10320,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.52,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8782,10320,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.602,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8783,10320,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.197,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8784,10320,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.484,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8785,10320,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.523,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8786,10320,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.253,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8787,10320,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.541,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8788,10320,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.539,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8789,10320,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.55,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8790,10320,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.661,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8791,10320,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.364,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
8792,10320,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.449,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
8793,10320,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.581,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8794,10320,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.584,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8795,10320,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.355,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8796,10320,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.599,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8797,10320,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.595,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8798,10320,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.552,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8799,10320,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.281,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8800,10320,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.458,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8801,10320,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.532,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
8802,10320,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.362,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8803,10320,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.51,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
8804,10320,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.572,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
8805,10320,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.545,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8806,10320,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.597,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
8807,10320,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
8808,10320,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.53,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
8809,10320,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.539,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
8810,10320,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.599,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
8811,10320,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.431,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
8812,10320,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.627,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
8813,10320,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.61,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8814,10320,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.544,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
8815,10320,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.409,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
8816,10320,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
8817,10320,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.402,0,NONE,OHSU_HNSCC_derm002
8818,10320,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.479,0,NONE,OHSU_HNSCC_derm002
8819,10320,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.508,0,NONE,OHSU_HNSCC_derm002
8820,10320,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.56,0,NONE,OHSU_HNSCC_derm002
8821,10320,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.594,0,NONE,OHSU_HNSCC_derm002
8822,10320,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.519,0,NONE,OHSU_HNSCC_derm002
8823,10320,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.564,0,NONE,OHSU_HNSCC_derm002
8824,10320,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.531,0,NONE,OHSU_HNSCC_derm002
8825,10320,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.518,0,NONE,OHSU_HNSCC_derm002
8826,10320,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.611,0,NONE,OHSU_HNSCC_derm002
8827,10320,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.562,0,NONE,OHSU_HNSCC_derm002
8828,10320,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.629,0,NONE,OHSU_HNSCC_derm002
8829,10320,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.663,0,NONE,OHSU_HNSCC_derm002
8830,10320,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.553,0,NONE,OHSU_HNSCC_derm002
8831,10320,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.51,0,NONE,OHSU_HNSCC_derm002
8832,10320,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.047,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8833,10320,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.017,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8834,10320,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.008,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8835,10320,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.015,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8836,10320,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.046,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8837,10320,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.01,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8838,10320,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.572,10,IMR 1,OHSU_HNSCC_derm002
8839,10320,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.108,10,Gefitinib,OHSU_HNSCC_derm002
8840,10320,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.003,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
8841,10320,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.583,0,DMSO,OHSU_HNSCC_derm002
8842,10320,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.573,0,DMSO ,OHSU_HNSCC_derm002
8843,10320,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.579,0,DMSO,OHSU_HNSCC_derm002
8844,10320,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.599,0,DMSO ,OHSU_HNSCC_derm002
8845,10320,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.62,0,DMSO,OHSU_HNSCC_derm002
8846,10320,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.522,0,DMSO ,OHSU_HNSCC_derm002
8847,10320,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.527,0,DMSO,OHSU_HNSCC_derm002
8848,10320,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.063,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8849,10320,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.071,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8850,10320,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.006,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8851,10320,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.077,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8852,10320,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.085,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8853,10320,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.034,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8854,10320,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.555,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
8855,10320,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.23,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
8856,10320,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.149,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
8857,10320,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.527,0,DMSO,OHSU_HNSCC_derm002
8858,10320,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.593,0,DMSO ,OHSU_HNSCC_derm002
8859,10320,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.616,0,DMSO,OHSU_HNSCC_derm002
8860,10320,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.629,0,DMSO ,OHSU_HNSCC_derm002
8861,10320,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.625,0,DMSO,OHSU_HNSCC_derm002
8862,10320,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.558,0,DMSO ,OHSU_HNSCC_derm002
8863,10320,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.561,0,DMSO,OHSU_HNSCC_derm002
8864,10320,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.177,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8865,10320,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.097,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8866,10320,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.044,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8867,10320,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.145,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8868,10320,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.311,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8869,10320,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.021,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8870,10320,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.602,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
8871,10320,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.262,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
8872,10320,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.429,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
8873,10320,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.528,0,DMSO,OHSU_HNSCC_derm002
8874,10320,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.577,0,DMSO ,OHSU_HNSCC_derm002
8875,10320,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.578,0,DMSO,OHSU_HNSCC_derm002
8876,10320,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.664,0,DMSO ,OHSU_HNSCC_derm002
8877,10320,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.631,0,DMSO,OHSU_HNSCC_derm002
8878,10320,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.63,0,DMSO ,OHSU_HNSCC_derm002
8879,10320,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.55,0,DMSO,OHSU_HNSCC_derm002
8880,10320,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.299,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8881,10320,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.252,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8882,10320,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.123,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8883,10320,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.231,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8884,10320,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.498,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8885,10320,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.15,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8886,10320,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.617,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
8887,10320,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.39,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
8888,10320,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.514,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
8889,10320,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.559,0,DMSO,OHSU_HNSCC_derm002
8890,10320,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.623,0,DMSO ,OHSU_HNSCC_derm002
8891,10320,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.571,0,DMSO,OHSU_HNSCC_derm002
8892,10320,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.631,0,DMSO ,OHSU_HNSCC_derm002
8893,10320,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.575,0,DMSO,OHSU_HNSCC_derm002
8894,10320,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.63,0,DMSO ,OHSU_HNSCC_derm002
8895,10320,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.574,0,DMSO,OHSU_HNSCC_derm002
8896,10320,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.426,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8897,10320,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.352,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8898,10320,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.27,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8899,10320,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.335,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8900,10320,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.575,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8901,10320,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.306,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8902,10320,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.599,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
8903,10320,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.537,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
8904,10320,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.597,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
8905,10320,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.585,0,DMSO,OHSU_HNSCC_derm002
8906,10320,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.594,0,DMSO ,OHSU_HNSCC_derm002
8907,10320,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.568,0,DMSO,OHSU_HNSCC_derm002
8908,10320,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.647,0,DMSO ,OHSU_HNSCC_derm002
8909,10320,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.57,0,DMSO,OHSU_HNSCC_derm002
8910,10320,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.639,0,DMSO ,OHSU_HNSCC_derm002
8911,10320,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.536,0,DMSO,OHSU_HNSCC_derm002
8912,10320,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.5,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8913,10320,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.392,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8914,10320,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.398,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8915,10320,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.378,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8916,10320,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.541,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8917,10320,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.363,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8918,10320,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.607,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
8919,10320,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.592,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
8920,10320,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.594,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
8921,10320,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.581,0,DMSO,OHSU_HNSCC_derm002
8922,10320,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.586,0,DMSO ,OHSU_HNSCC_derm002
8923,10320,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.54,0,DMSO,OHSU_HNSCC_derm002
8924,10320,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.662,0,DMSO ,OHSU_HNSCC_derm002
8925,10320,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.604,0,DMSO,OHSU_HNSCC_derm002
8926,10320,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.603,0,DMSO ,OHSU_HNSCC_derm002
8927,10320,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.532,0,DMSO,OHSU_HNSCC_derm002
8928,10320,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.458,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
8929,10320,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.465,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
8930,10320,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.392,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
8931,10320,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.479,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
8932,10320,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.576,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
8933,10320,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.452,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
8934,10320,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.641,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
8935,10320,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.553,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
8936,10320,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.611,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
8937,10320,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.591,0,DMSO,OHSU_HNSCC_derm002
8938,10320,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.607,0,DMSO ,OHSU_HNSCC_derm002
8939,10320,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.558,0,DMSO,OHSU_HNSCC_derm002
8940,10320,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.632,0,DMSO ,OHSU_HNSCC_derm002
8941,10320,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.629,0,DMSO,OHSU_HNSCC_derm002
8942,10320,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.568,0,DMSO ,OHSU_HNSCC_derm002
8943,10320,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.551,0,DMSO,OHSU_HNSCC_derm002
8944,10320,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.545,0,NONE,OHSU_HNSCC_derm002
8945,10320,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.522,0,NONE,OHSU_HNSCC_derm002
8946,10320,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.508,0,NONE,OHSU_HNSCC_derm002
8947,10320,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.491,0,NONE,OHSU_HNSCC_derm002
8948,10320,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.552,0,NONE,OHSU_HNSCC_derm002
8949,10320,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.552,0,NONE,OHSU_HNSCC_derm002
8950,10320,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.602,0,NONE,OHSU_HNSCC_derm002
8951,10320,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
8952,10320,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.617,0,NONE,OHSU_HNSCC_derm002
8953,10320,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.563,0,NONE,OHSU_HNSCC_derm002
8954,10320,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.604,0,NONE,OHSU_HNSCC_derm002
8955,10320,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
8956,10320,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.634,0,NONE,OHSU_HNSCC_derm002
8957,10320,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.595,0,NONE,OHSU_HNSCC_derm002
8958,10320,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.57,0,NONE,OHSU_HNSCC_derm002
8959,10320,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.579,0,NONE,OHSU_HNSCC_derm002
8960,10320,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.319,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8961,10320,Blank 490,6,B,OHSU_HNSCC_derm002,9,-0.022,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
8962,10320,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.187,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
8963,10320,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.117,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8964,10320,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.183,5,Vandetanib (5mM),OHSU_HNSCC_derm002
8965,10320,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.511,0,DMSO,OHSU_HNSCC_derm002
8966,10320,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.553,0,DMSO ,OHSU_HNSCC_derm002
8967,10320,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.108,10,Brigatinib,OHSU_HNSCC_derm002
8968,10320,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.249,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8969,10320,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.604,0,DMSO,OHSU_HNSCC_derm002
8970,10320,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.583,0,DMSO ,OHSU_HNSCC_derm002
8971,10320,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.549,0,DMSO,OHSU_HNSCC_derm002
8972,10320,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.605,0,DMSO ,OHSU_HNSCC_derm002
8973,10320,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.59,0,DMSO,OHSU_HNSCC_derm002
8974,10320,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.616,0,DMSO ,OHSU_HNSCC_derm002
8975,10320,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.531,0,DMSO,OHSU_HNSCC_derm002
8976,10320,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.464,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8977,10320,Blank 490,6,B,OHSU_HNSCC_derm002,10,-0.002,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
8978,10320,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.292,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
8979,10320,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.139,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8980,10320,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.359,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
8981,10320,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.547,0,DMSO,OHSU_HNSCC_derm002
8982,10320,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.587,0,DMSO ,OHSU_HNSCC_derm002
8983,10320,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.187,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
8984,10320,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.3,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
8985,10320,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.576,0,DMSO,OHSU_HNSCC_derm002
8986,10320,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.564,0,DMSO ,OHSU_HNSCC_derm002
8987,10320,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.552,0,DMSO,OHSU_HNSCC_derm002
8988,10320,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.656,0,DMSO ,OHSU_HNSCC_derm002
8989,10320,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.57,0,DMSO,OHSU_HNSCC_derm002
8990,10320,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.654,0,DMSO ,OHSU_HNSCC_derm002
8991,10320,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.528,0,DMSO,OHSU_HNSCC_derm002
8992,10320,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.496,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
8993,10320,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.003,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
8994,10320,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.302,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
8995,10320,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.218,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
8996,10320,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.465,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
8997,10320,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.547,0,DMSO,OHSU_HNSCC_derm002
8998,10320,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.629,0,DMSO ,OHSU_HNSCC_derm002
8999,10320,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.398,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
9000,10320,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.275,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9001,10320,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.575,0,DMSO,OHSU_HNSCC_derm002
9002,10320,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.575,0,DMSO ,OHSU_HNSCC_derm002
9003,10320,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.603,0,DMSO,OHSU_HNSCC_derm002
9004,10320,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.69,0,DMSO ,OHSU_HNSCC_derm002
9005,10320,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.606,0,DMSO,OHSU_HNSCC_derm002
9006,10320,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.616,0,DMSO ,OHSU_HNSCC_derm002
9007,10320,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.561,0,DMSO,OHSU_HNSCC_derm002
9008,10320,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.453,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9009,10320,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.094,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
9010,10320,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.306,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
9011,10320,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.283,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
9012,10320,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.485,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
9013,10320,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.563,0,DMSO,OHSU_HNSCC_derm002
9014,10320,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.605,0,DMSO ,OHSU_HNSCC_derm002
9015,10320,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.47,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
9016,10320,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.273,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9017,10320,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.611,0,DMSO,OHSU_HNSCC_derm002
9018,10320,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.601,0,DMSO ,OHSU_HNSCC_derm002
9019,10320,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.554,0,DMSO,OHSU_HNSCC_derm002
9020,10320,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.637,0,DMSO ,OHSU_HNSCC_derm002
9021,10320,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.627,0,DMSO,OHSU_HNSCC_derm002
9022,10320,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.632,0,DMSO ,OHSU_HNSCC_derm002
9023,10320,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.555,0,DMSO,OHSU_HNSCC_derm002
9024,10320,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.439,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9025,10320,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.305,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
9026,10320,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.459,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
9027,10320,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.399,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
9028,10320,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.517,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
9029,10320,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.51,0,DMSO,OHSU_HNSCC_derm002
9030,10320,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.59,0,DMSO ,OHSU_HNSCC_derm002
9031,10320,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.502,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
9032,10320,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.302,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9033,10320,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.578,0,DMSO,OHSU_HNSCC_derm002
9034,10320,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.629,0,DMSO ,OHSU_HNSCC_derm002
9035,10320,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.602,0,DMSO,OHSU_HNSCC_derm002
9036,10320,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.629,0,DMSO ,OHSU_HNSCC_derm002
9037,10320,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.615,0,DMSO,OHSU_HNSCC_derm002
9038,10320,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.599,0,DMSO ,OHSU_HNSCC_derm002
9039,10320,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.568,0,DMSO,OHSU_HNSCC_derm002
9040,10320,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.445,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9041,10320,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.436,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
9042,10320,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.507,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
9043,10320,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.448,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
9044,10320,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.534,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
9045,10320,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.567,0,DMSO,OHSU_HNSCC_derm002
9046,10320,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.583,0,DMSO ,OHSU_HNSCC_derm002
9047,10320,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.576,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
9048,10320,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.395,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9049,10320,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.602,0,DMSO,OHSU_HNSCC_derm002
9050,10320,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.631,0,DMSO ,OHSU_HNSCC_derm002
9051,10320,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.647,0,DMSO,OHSU_HNSCC_derm002
9052,10320,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.649,0,DMSO ,OHSU_HNSCC_derm002
9053,10320,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.628,0,DMSO,OHSU_HNSCC_derm002
9054,10320,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.636,0,DMSO ,OHSU_HNSCC_derm002
9055,10320,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.51,0,DMSO,OHSU_HNSCC_derm002
9056,10320,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.484,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9057,10320,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.505,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
9058,10320,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.511,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
9059,10320,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.5,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
9060,10320,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.533,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
9061,10320,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.523,0,DMSO,OHSU_HNSCC_derm002
9062,10320,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.621,0,DMSO ,OHSU_HNSCC_derm002
9063,10320,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.579,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
9064,10320,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.506,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9065,10320,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.597,0,DMSO,OHSU_HNSCC_derm002
9066,10320,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.631,0,DMSO ,OHSU_HNSCC_derm002
9067,10320,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.583,0,DMSO,OHSU_HNSCC_derm002
9068,10320,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.618,0,DMSO ,OHSU_HNSCC_derm002
9069,10320,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.58,0,DMSO,OHSU_HNSCC_derm002
9070,10320,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.559,0,DMSO ,OHSU_HNSCC_derm002
9071,10320,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.529,0,DMSO,OHSU_HNSCC_derm002
9072,10320,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.506,0,NONE,OHSU_HNSCC_derm002
9073,10320,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.513,0,NONE,OHSU_HNSCC_derm002
9074,10320,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.475,0,NONE,OHSU_HNSCC_derm002
9075,10320,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.496,0,NONE,OHSU_HNSCC_derm002
9076,10320,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.53,0,NONE,OHSU_HNSCC_derm002
9077,10320,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.558,0,NONE,OHSU_HNSCC_derm002
9078,10320,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.648,0,NONE,OHSU_HNSCC_derm002
9079,10320,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
9080,10320,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.597,0,NONE,OHSU_HNSCC_derm002
9081,10320,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.643,0,NONE,OHSU_HNSCC_derm002
9082,10320,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
9083,10320,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.579,0,NONE,OHSU_HNSCC_derm002
9084,10320,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.669,0,NONE,OHSU_HNSCC_derm002
9085,10320,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.608,0,NONE,OHSU_HNSCC_derm002
9086,10320,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.602,0,NONE,OHSU_HNSCC_derm002
9087,10320,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.515,0,NONE,OHSU_HNSCC_derm002
9088,10320,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.077,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9089,10320,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.043,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9090,10320,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.486,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9091,10320,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.009,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9092,10320,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.447,10,LY3039478 ,OHSU_HNSCC_derm002
9093,10320,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.146,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9094,10320,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.171,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9095,10320,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.215,10,Trametinib,OHSU_HNSCC_derm002
9096,10320,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.046,10,BEZ235,OHSU_HNSCC_derm002
9097,10320,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.595,0,DMSO,OHSU_HNSCC_derm002
9098,10320,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.599,0,DMSO ,OHSU_HNSCC_derm002
9099,10320,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.602,0,DMSO,OHSU_HNSCC_derm002
9100,10320,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.667,0,DMSO ,OHSU_HNSCC_derm002
9101,10320,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.573,0,DMSO,OHSU_HNSCC_derm002
9102,10320,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.636,0,DMSO ,OHSU_HNSCC_derm002
9103,10320,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.521,0,DMSO,OHSU_HNSCC_derm002
9104,10320,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.086,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9105,10320,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.127,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9106,10320,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.505,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9107,10320,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.015,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9108,10320,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.46,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
9109,10320,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.215,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9110,10320,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.195,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9111,10320,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.324,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
9112,10320,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.052,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
9113,10320,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.596,0,DMSO,OHSU_HNSCC_derm002
9114,10320,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.646,0,DMSO ,OHSU_HNSCC_derm002
9115,10320,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.616,0,DMSO,OHSU_HNSCC_derm002
9116,10320,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.633,0,DMSO ,OHSU_HNSCC_derm002
9117,10320,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.64,0,DMSO,OHSU_HNSCC_derm002
9118,10320,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.566,0,DMSO ,OHSU_HNSCC_derm002
9119,10320,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.538,0,DMSO,OHSU_HNSCC_derm002
9120,10320,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.131,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9121,10320,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.288,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9122,10320,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.508,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9123,10320,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.015,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9124,10320,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.471,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
9125,10320,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.211,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9126,10320,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.207,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9127,10320,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.288,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
9128,10320,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.081,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
9129,10320,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.617,0,DMSO,OHSU_HNSCC_derm002
9130,10320,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.622,0,DMSO ,OHSU_HNSCC_derm002
9131,10320,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.575,0,DMSO,OHSU_HNSCC_derm002
9132,10320,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.638,0,DMSO ,OHSU_HNSCC_derm002
9133,10320,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.619,0,DMSO,OHSU_HNSCC_derm002
9134,10320,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.581,0,DMSO ,OHSU_HNSCC_derm002
9135,10320,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.536,0,DMSO,OHSU_HNSCC_derm002
9136,10320,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.225,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9137,10320,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.403,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9138,10320,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.503,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9139,10320,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.079,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9140,10320,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.485,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
9141,10320,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.381,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9142,10320,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.326,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9143,10320,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.234,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
9144,10320,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.097,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
9145,10320,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.618,0,DMSO,OHSU_HNSCC_derm002
9146,10320,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.559,0,DMSO ,OHSU_HNSCC_derm002
9147,10320,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.604,0,DMSO,OHSU_HNSCC_derm002
9148,10320,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.504,0,DMSO ,OHSU_HNSCC_derm002
9149,10320,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.604,0,DMSO,OHSU_HNSCC_derm002
9150,10320,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.606,0,DMSO ,OHSU_HNSCC_derm002
9151,10320,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.574,0,DMSO,OHSU_HNSCC_derm002
9152,10320,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.398,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9153,10320,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.443,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9154,10320,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.5,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9155,10320,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.31,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9156,10320,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.472,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
9157,10320,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.463,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9158,10320,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.389,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9159,10320,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.259,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
9160,10320,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.128,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
9161,10320,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.582,0,DMSO,OHSU_HNSCC_derm002
9162,10320,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.576,0,DMSO ,OHSU_HNSCC_derm002
9163,10320,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.614,0,DMSO,OHSU_HNSCC_derm002
9164,10320,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.628,0,DMSO ,OHSU_HNSCC_derm002
9165,10320,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.63,0,DMSO,OHSU_HNSCC_derm002
9166,10320,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.566,0,DMSO ,OHSU_HNSCC_derm002
9167,10320,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.551,0,DMSO,OHSU_HNSCC_derm002
9168,10320,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.479,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9169,10320,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.528,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9170,10320,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.494,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9171,10320,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.414,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9172,10320,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.44,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
9173,10320,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.472,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9174,10320,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.388,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9175,10320,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
9176,10320,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.236,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
9177,10320,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.537,0,DMSO,OHSU_HNSCC_derm002
9178,10320,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.547,0,DMSO ,OHSU_HNSCC_derm002
9179,10320,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.601,0,DMSO,OHSU_HNSCC_derm002
9180,10320,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.557,0,DMSO ,OHSU_HNSCC_derm002
9181,10320,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.615,0,DMSO,OHSU_HNSCC_derm002
9182,10320,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.6,0,DMSO ,OHSU_HNSCC_derm002
9183,10320,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.567,0,DMSO,OHSU_HNSCC_derm002
9184,10320,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.497,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
9185,10320,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.492,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
9186,10320,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.539,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
9187,10320,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.511,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
9188,10320,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.464,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
9189,10320,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.548,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
9190,10320,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.473,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
9191,10320,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.444,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
9192,10320,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.426,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
9193,10320,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.51,0,DMSO,OHSU_HNSCC_derm002
9194,10320,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.547,0,DMSO ,OHSU_HNSCC_derm002
9195,10320,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.549,0,DMSO,OHSU_HNSCC_derm002
9196,10320,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.625,0,DMSO ,OHSU_HNSCC_derm002
9197,10320,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.627,0,DMSO,OHSU_HNSCC_derm002
9198,10320,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.585,0,DMSO ,OHSU_HNSCC_derm002
9199,10320,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.564,0,DMSO,OHSU_HNSCC_derm002
9200,10320,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.489,0,NONE,OHSU_HNSCC_derm002
9201,10320,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.505,0,NONE,OHSU_HNSCC_derm002
9202,10320,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.526,0,NONE,OHSU_HNSCC_derm002
9203,10320,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.534,0,NONE,OHSU_HNSCC_derm002
9204,10320,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.52,0,NONE,OHSU_HNSCC_derm002
9205,10320,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.502,0,NONE,OHSU_HNSCC_derm002
9206,10320,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.545,0,NONE,OHSU_HNSCC_derm002
9207,10320,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
9208,10320,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.53,0,NONE,OHSU_HNSCC_derm002
9209,10320,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
9210,10320,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.556,0,NONE,OHSU_HNSCC_derm002
9211,10320,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
9212,10320,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.491,0,NONE,OHSU_HNSCC_derm002
9213,10320,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.257,0,NONE,OHSU_HNSCC_derm002
9214,10320,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.534,0,NONE,OHSU_HNSCC_derm002
9215,10320,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.515,0,NONE,OHSU_HNSCC_derm002
9216,10326,Blank 490,1,A,OHSU_HNSCC_derm002,1,-0.068,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
9217,10326,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.184,10,Lucitanib ,OHSU_HNSCC_derm002
9218,10326,Blank 490,1,C,OHSU_HNSCC_derm002,1,-0.041,10,Resveratrol,OHSU_HNSCC_derm002
9219,10326,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.127,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9220,10326,Blank 490,1,E,OHSU_HNSCC_derm002,1,-0.05,10,Bicalutamide,OHSU_HNSCC_derm002
9221,10326,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.218,10,Methotrexate ,OHSU_HNSCC_derm002
9222,10326,Blank 490,1,G,OHSU_HNSCC_derm002,1,-0.061,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9223,10326,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.129,10,Gefitinib,OHSU_HNSCC_derm002
9224,10326,Blank 490,1,I,OHSU_HNSCC_derm002,1,-0.063,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
9225,10326,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.14,10,Tamatinib/R406,OHSU_HNSCC_derm002
9226,10326,Blank 490,1,K,OHSU_HNSCC_derm002,1,-0.066,10,Bosutinib,OHSU_HNSCC_derm002
9227,10326,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.006,10,PI-103,OHSU_HNSCC_derm002
9228,10326,Blank 490,1,M,OHSU_HNSCC_derm002,1,-0.044,10,Glycyrrhizin,OHSU_HNSCC_derm002
9229,10326,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.211,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
9230,10326,Blank 490,1,O,OHSU_HNSCC_derm002,1,-0.057,10,GSK-690693,OHSU_HNSCC_derm002
9231,10326,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.158,10,Ibrutinib,OHSU_HNSCC_derm002
9232,10326,Blank 490,1,A,OHSU_HNSCC_derm002,2,-0.072,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
9233,10326,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.277,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
9234,10326,Blank 490,1,C,OHSU_HNSCC_derm002,2,-0.047,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
9235,10326,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.2,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9236,10326,Blank 490,1,E,OHSU_HNSCC_derm002,2,-0.058,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
9237,10326,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.391,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
9238,10326,Blank 490,1,G,OHSU_HNSCC_derm002,2,-0.071,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9239,10326,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.246,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
9240,10326,Blank 490,1,I,OHSU_HNSCC_derm002,2,-0.062,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
9241,10326,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.216,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
9242,10326,Blank 490,1,K,OHSU_HNSCC_derm002,2,-0.066,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
9243,10326,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.015,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
9244,10326,Blank 490,1,M,OHSU_HNSCC_derm002,2,-0.052,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
9245,10326,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.38,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
9246,10326,Blank 490,1,O,OHSU_HNSCC_derm002,2,-0.052,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
9247,10326,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.234,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
9248,10326,Blank 490,1,A,OHSU_HNSCC_derm002,3,-0.069,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
9249,10326,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.307,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
9250,10326,Blank 490,1,C,OHSU_HNSCC_derm002,3,-0.057,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
9251,10326,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.208,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9252,10326,Blank 490,1,E,OHSU_HNSCC_derm002,3,-0.042,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
9253,10326,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.36,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
9254,10326,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.023,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9255,10326,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.239,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
9256,10326,Blank 490,1,I,OHSU_HNSCC_derm002,3,-0.043,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
9257,10326,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.351,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
9258,10326,Blank 490,1,K,OHSU_HNSCC_derm002,3,-0.027,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
9259,10326,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.047,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
9260,10326,Blank 490,1,M,OHSU_HNSCC_derm002,3,-0.043,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
9261,10326,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.425,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
9262,10326,Blank 490,1,O,OHSU_HNSCC_derm002,3,-0.05,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
9263,10326,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.211,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
9264,10326,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.016,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
9265,10326,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.252,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
9266,10326,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.124,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
9267,10326,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.212,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9268,10326,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.111,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
9269,10326,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.401,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
9270,10326,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.153,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9271,10326,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.284,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
9272,10326,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.154,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
9273,10326,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.348,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
9274,10326,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.264,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
9275,10326,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.122,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
9276,10326,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.248,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
9277,10326,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.408,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
9278,10326,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.232,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
9279,10326,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.249,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
9280,10326,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.169,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
9281,10326,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
9282,10326,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.298,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
9283,10326,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.245,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9284,10326,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.321,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
9285,10326,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.365,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
9286,10326,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.296,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9287,10326,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.303,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
9288,10326,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.362,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
9289,10326,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.382,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
9290,10326,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.403,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
9291,10326,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.28,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
9292,10326,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.36,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
9293,10326,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.443,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
9294,10326,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.257,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
9295,10326,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.28,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
9296,10326,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.212,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
9297,10326,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.395,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
9298,10326,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.369,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
9299,10326,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.25,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9300,10326,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.338,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
9301,10326,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.343,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
9302,10326,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.394,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9303,10326,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.367,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
9304,10326,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.376,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
9305,10326,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.356,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
9306,10326,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.397,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
9307,10326,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.368,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
9308,10326,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.376,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
9309,10326,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.424,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
9310,10326,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.342,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
9311,10326,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.206,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
9312,10326,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.198,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
9313,10326,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.353,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
9314,10326,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.317,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
9315,10326,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.304,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
9316,10326,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.373,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
9317,10326,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.333,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
9318,10326,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.405,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
9319,10326,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.392,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
9320,10326,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.407,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
9321,10326,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.426,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
9322,10326,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.391,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
9323,10326,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.374,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
9324,10326,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.345,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
9325,10326,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.425,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
9326,10326,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.329,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
9327,10326,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.298,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
9328,10326,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.236,0,NONE,OHSU_HNSCC_derm002
9329,10326,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.356,0,NONE,OHSU_HNSCC_derm002
9330,10326,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
9331,10326,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.395,0,NONE,OHSU_HNSCC_derm002
9332,10326,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.368,0,NONE,OHSU_HNSCC_derm002
9333,10326,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
9334,10326,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.396,0,NONE,OHSU_HNSCC_derm002
9335,10326,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
9336,10326,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.424,0,NONE,OHSU_HNSCC_derm002
9337,10326,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.474,0,NONE,OHSU_HNSCC_derm002
9338,10326,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
9339,10326,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.376,0,NONE,OHSU_HNSCC_derm002
9340,10326,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.434,0,NONE,OHSU_HNSCC_derm002
9341,10326,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
9342,10326,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.372,0,NONE,OHSU_HNSCC_derm002
9343,10326,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.307,0,NONE,OHSU_HNSCC_derm002
9344,10326,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.001,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9345,10326,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.164,10,Sorafenib,OHSU_HNSCC_derm002
9346,10326,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.43,10,Rosmarinic acid,OHSU_HNSCC_derm002
9347,10326,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.271,10,Rapamycin,OHSU_HNSCC_derm002
9348,10326,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.345,10,Vismodegib,OHSU_HNSCC_derm002
9349,10326,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.131,10,PP242,OHSU_HNSCC_derm002
9350,10326,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.182,10,Alectinib,OHSU_HNSCC_derm002
9351,10326,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.167,10,Brigatinib,OHSU_HNSCC_derm002
9352,10326,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.167,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9353,10326,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.245,10,MK-2206,OHSU_HNSCC_derm002
9354,10326,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.265,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9355,10326,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.036,10,Flavopiridol ,OHSU_HNSCC_derm002
9356,10326,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.416,10,Indirubin,OHSU_HNSCC_derm002
9357,10326,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.429,10,PF-533228,OHSU_HNSCC_derm002
9358,10326,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.307,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9359,10326,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.063,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9360,10326,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.009,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9361,10326,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.252,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
9362,10326,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.412,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
9363,10326,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.26,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
9364,10326,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.298,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
9365,10326,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.16,3.3333333333333335,PP242,OHSU_HNSCC_derm002
9366,10326,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.341,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
9367,10326,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.216,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
9368,10326,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.207,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9369,10326,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.402,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
9370,10326,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.265,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9371,10326,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.036,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
9372,10326,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.463,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
9373,10326,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.484,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
9374,10326,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.411,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9375,10326,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.073,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9376,10326,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.027,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9377,10326,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.273,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
9378,10326,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.366,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
9379,10326,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.271,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
9380,10326,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.375,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
9381,10326,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.162,1.1111111111111112,PP242,OHSU_HNSCC_derm002
9382,10326,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.368,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
9383,10326,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.4,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
9384,10326,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.2,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9385,10326,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.321,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
9386,10326,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.25,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9387,10326,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.045,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
9388,10326,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.456,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
9389,10326,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.488,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
9390,10326,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9391,10326,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.218,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9392,10326,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.014,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9393,10326,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.287,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
9394,10326,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.349,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
9395,10326,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.255,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
9396,10326,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.341,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
9397,10326,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.23,0.3703703703703704,PP242,OHSU_HNSCC_derm002
9398,10326,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.391,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
9399,10326,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.379,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
9400,10326,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.219,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9401,10326,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.366,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
9402,10326,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.274,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9403,10326,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.055,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
9404,10326,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.443,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
9405,10326,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.499,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
9406,10326,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.365,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9407,10326,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.332,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9408,10326,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.027,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9409,10326,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.237,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
9410,10326,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.317,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
9411,10326,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.275,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
9412,10326,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.388,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
9413,10326,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.292,0.1234567901234568,PP242,OHSU_HNSCC_derm002
9414,10326,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.409,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
9415,10326,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.395,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
9416,10326,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.238,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9417,10326,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.39,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
9418,10326,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.323,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9419,10326,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.172,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
9420,10326,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.484,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
9421,10326,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.478,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
9422,10326,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.387,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9423,10326,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.37,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9424,10326,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.055,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9425,10326,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.287,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
9426,10326,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.405,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
9427,10326,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.371,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
9428,10326,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.376,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
9429,10326,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.3,0.0411522633744856,PP242,OHSU_HNSCC_derm002
9430,10326,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.398,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
9431,10326,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.387,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
9432,10326,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.273,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9433,10326,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.404,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
9434,10326,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.339,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9435,10326,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.326,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
9436,10326,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.36,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
9437,10326,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.426,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
9438,10326,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.342,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9439,10326,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.225,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9440,10326,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.128,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
9441,10326,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.312,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
9442,10326,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.38,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
9443,10326,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.286,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
9444,10326,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.385,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
9445,10326,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.385,0.013717421124828532,PP242,OHSU_HNSCC_derm002
9446,10326,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.434,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
9447,10326,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.417,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
9448,10326,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.33,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9449,10326,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.399,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
9450,10326,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.361,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
9451,10326,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.383,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
9452,10326,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.449,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
9453,10326,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.445,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
9454,10326,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.402,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
9455,10326,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.384,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
9456,10326,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.26,0,NONE,OHSU_HNSCC_derm002
9457,10326,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.325,0,NONE,OHSU_HNSCC_derm002
9458,10326,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.369,0,NONE,OHSU_HNSCC_derm002
9459,10326,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.404,0,NONE,OHSU_HNSCC_derm002
9460,10326,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.38,0,NONE,OHSU_HNSCC_derm002
9461,10326,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.41,0,NONE,OHSU_HNSCC_derm002
9462,10326,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.413,0,NONE,OHSU_HNSCC_derm002
9463,10326,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
9464,10326,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.369,0,NONE,OHSU_HNSCC_derm002
9465,10326,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.408,0,NONE,OHSU_HNSCC_derm002
9466,10326,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.389,0,NONE,OHSU_HNSCC_derm002
9467,10326,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
9468,10326,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.386,0,NONE,OHSU_HNSCC_derm002
9469,10326,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.433,0,NONE,OHSU_HNSCC_derm002
9470,10326,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
9471,10326,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.308,0,NONE,OHSU_HNSCC_derm002
9472,10326,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.224,10,Emodin,OHSU_HNSCC_derm002
9473,10326,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.32,10,Baicalin,OHSU_HNSCC_derm002
9474,10326,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.108,10,NVP-TAE-684,OHSU_HNSCC_derm002
9475,10326,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.029,10,Panobinostat,OHSU_HNSCC_derm002
9476,10326,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.025,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
9477,10326,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.353,10,Fulvestrant,OHSU_HNSCC_derm002
9478,10326,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.383,10,SCH-772984,OHSU_HNSCC_derm002
9479,10326,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.315,10,Trametinib,OHSU_HNSCC_derm002
9480,10326,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.167,10,BEZ235,OHSU_HNSCC_derm002
9481,10326,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.344,10,MLN120B,OHSU_HNSCC_derm002
9482,10326,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.163,10,Ixabepilone,OHSU_HNSCC_derm002
9483,10326,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.023,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
9484,10326,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.402,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9485,10326,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.37,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9486,10326,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.157,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9487,10326,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.229,10,Letrozole,OHSU_HNSCC_derm002
9488,10326,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.252,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
9489,10326,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.321,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
9490,10326,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.262,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
9491,10326,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.035,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
9492,10326,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.071,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
9493,10326,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.348,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
9494,10326,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.377,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
9495,10326,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.332,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
9496,10326,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.119,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
9497,10326,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.383,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
9498,10326,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.163,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
9499,10326,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.217,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
9500,10326,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.415,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9501,10326,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.427,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9502,10326,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.159,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9503,10326,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.366,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
9504,10326,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.238,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
9505,10326,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
9506,10326,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.371,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
9507,10326,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.063,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
9508,10326,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.107,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
9509,10326,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.357,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
9510,10326,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
9511,10326,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.249,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
9512,10326,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.116,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
9513,10326,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.41,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
9514,10326,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.157,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
9515,10326,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.229,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
9516,10326,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.394,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9517,10326,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.431,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9518,10326,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.197,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9519,10326,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.271,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
9520,10326,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.235,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
9521,10326,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.308,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
9522,10326,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.34,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
9523,10326,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.121,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
9524,10326,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.181,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
9525,10326,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.386,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
9526,10326,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.378,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
9527,10326,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.345,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
9528,10326,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.144,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
9529,10326,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.396,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
9530,10326,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
9531,10326,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.27,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
9532,10326,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.397,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9533,10326,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.339,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9534,10326,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.137,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9535,10326,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.322,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
9536,10326,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.224,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
9537,10326,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.364,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
9538,10326,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.377,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
9539,10326,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.2,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
9540,10326,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.24,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
9541,10326,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.393,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
9542,10326,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.382,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
9543,10326,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.354,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
9544,10326,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.218,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
9545,10326,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.383,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
9546,10326,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.171,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
9547,10326,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.248,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
9548,10326,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.316,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9549,10326,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.241,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9550,10326,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.186,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9551,10326,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.331,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
9552,10326,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.2,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
9553,10326,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.353,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
9554,10326,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.357,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
9555,10326,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.266,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
9556,10326,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.247,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
9557,10326,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.381,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
9558,10326,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.395,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
9559,10326,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.319,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
9560,10326,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.255,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
9561,10326,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
9562,10326,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.187,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
9563,10326,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.334,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
9564,10326,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.395,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9565,10326,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.318,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9566,10326,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.153,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9567,10326,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.222,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
9568,10326,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.206,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
9569,10326,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.286,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
9570,10326,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
9571,10326,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.335,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
9572,10326,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.232,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
9573,10326,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.304,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
9574,10326,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.249,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
9575,10326,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.239,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
9576,10326,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.267,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
9577,10326,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.292,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
9578,10326,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.208,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
9579,10326,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.33,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
9580,10326,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.378,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
9581,10326,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.278,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
9582,10326,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.156,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
9583,10326,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.32,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
9584,10326,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.23,0,NONE,OHSU_HNSCC_derm002
9585,10326,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.228,0,NONE,OHSU_HNSCC_derm002
9586,10326,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.309,0,NONE,OHSU_HNSCC_derm002
9587,10326,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.241,0,NONE,OHSU_HNSCC_derm002
9588,10326,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.235,0,NONE,OHSU_HNSCC_derm002
9589,10326,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.351,0,NONE,OHSU_HNSCC_derm002
9590,10326,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.351,0,NONE,OHSU_HNSCC_derm002
9591,10326,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.29,0,NONE,OHSU_HNSCC_derm002
9592,10326,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.393,0,NONE,OHSU_HNSCC_derm002
9593,10326,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.34,0,NONE,OHSU_HNSCC_derm002
9594,10326,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.182,0,NONE,OHSU_HNSCC_derm002
9595,10326,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.287,0,NONE,OHSU_HNSCC_derm002
9596,10326,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.209,0,NONE,OHSU_HNSCC_derm002
9597,10326,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.278,0,NONE,OHSU_HNSCC_derm002
9598,10326,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.253,0,NONE,OHSU_HNSCC_derm002
9599,10326,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.316,0,NONE,OHSU_HNSCC_derm002
9600,10326,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.271,10,Coumarin,OHSU_HNSCC_derm002
9601,10326,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.058,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9602,10326,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.044,10,Foretinib (XL-880),OHSU_HNSCC_derm002
9603,10326,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.294,10,Elesclomol,OHSU_HNSCC_derm002
9604,10326,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.357,10,Vemurafenib,OHSU_HNSCC_derm002
9605,10326,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.1,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9606,10326,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.017,10,Ponatinib,OHSU_HNSCC_derm002
9607,10326,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.159,10,Gefitinib,OHSU_HNSCC_derm002
9608,10326,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.043,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
9609,10326,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.379,1,Sunitinib (1mM),OHSU_HNSCC_derm002
9610,10326,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.303,10,Curcumin,OHSU_HNSCC_derm002
9611,10326,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.075,10,PF-562271,OHSU_HNSCC_derm002
9612,10326,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.327,10,STO609,OHSU_HNSCC_derm002
9613,10326,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.271,10,Lenvatinib,OHSU_HNSCC_derm002
9614,10326,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.03,10,Entrectinib,OHSU_HNSCC_derm002
9615,10326,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.364,10,Ethyl Gallate ,OHSU_HNSCC_derm002
9616,10326,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.358,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
9617,10326,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.151,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9618,10326,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.18,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
9619,10326,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.326,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
9620,10326,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.255,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
9621,10326,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.11,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9622,10326,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.029,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
9623,10326,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.188,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
9624,10326,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.21,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
9625,10326,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.358,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
9626,10326,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.344,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
9627,10326,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.375,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
9628,10326,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.243,3.3333333333333335,STO609,OHSU_HNSCC_derm002
9629,10326,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.271,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
9630,10326,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.268,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
9631,10326,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.379,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
9632,10326,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
9633,10326,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.149,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9634,10326,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.339,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
9635,10326,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.231,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
9636,10326,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.425,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
9637,10326,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.135,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9638,10326,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.279,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
9639,10326,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.226,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
9640,10326,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.327,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
9641,10326,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.385,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
9642,10326,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.377,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
9643,10326,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.407,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
9644,10326,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.395,1.1111111111111112,STO609,OHSU_HNSCC_derm002
9645,10326,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.295,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
9646,10326,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.35,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
9647,10326,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.409,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
9648,10326,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.372,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
9649,10326,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.16,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9650,10326,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.346,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
9651,10326,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.093,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
9652,10326,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.377,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
9653,10326,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.167,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9654,10326,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.453,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
9655,10326,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.305,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
9656,10326,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.414,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
9657,10326,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.431,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
9658,10326,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.432,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
9659,10326,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.409,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
9660,10326,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.398,0.3703703703703704,STO609,OHSU_HNSCC_derm002
9661,10326,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.381,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
9662,10326,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.352,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
9663,10326,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.391,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
9664,10326,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.394,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
9665,10326,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.162,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9666,10326,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.344,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
9667,10326,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.049,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
9668,10326,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.372,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
9669,10326,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.205,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9670,10326,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
9671,10326,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.353,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
9672,10326,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.406,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
9673,10326,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.412,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
9674,10326,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.481,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
9675,10326,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.321,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
9676,10326,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.467,0.1234567901234568,STO609,OHSU_HNSCC_derm002
9677,10326,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.426,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
9678,10326,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.366,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
9679,10326,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.381,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
9680,10326,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.302,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
9681,10326,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.218,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9682,10326,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.298,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
9683,10326,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.058,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
9684,10326,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.383,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
9685,10326,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.281,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9686,10326,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.49,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
9687,10326,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.401,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
9688,10326,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.44,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
9689,10326,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.361,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
9690,10326,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.39,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
9691,10326,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.442,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
9692,10326,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.446,0.0411522633744856,STO609,OHSU_HNSCC_derm002
9693,10326,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.425,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
9694,10326,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.34,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
9695,10326,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.393,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
9696,10326,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.282,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
9697,10326,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.278,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
9698,10326,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.307,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
9699,10326,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.141,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
9700,10326,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.408,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
9701,10326,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.38,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
9702,10326,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.462,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
9703,10326,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.445,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
9704,10326,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.416,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
9705,10326,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.289,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
9706,10326,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
9707,10326,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.431,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
9708,10326,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.453,0.013717421124828532,STO609,OHSU_HNSCC_derm002
9709,10326,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.434,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
9710,10326,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.313,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
9711,10326,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.38,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
9712,10326,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.353,0,NONE,OHSU_HNSCC_derm002
9713,10326,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.273,0,NONE,OHSU_HNSCC_derm002
9714,10326,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.37,0,NONE,OHSU_HNSCC_derm002
9715,10326,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.356,0,NONE,OHSU_HNSCC_derm002
9716,10326,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.351,0,NONE,OHSU_HNSCC_derm002
9717,10326,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
9718,10326,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.337,0,NONE,OHSU_HNSCC_derm002
9719,10326,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
9720,10326,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
9721,10326,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.406,0,NONE,OHSU_HNSCC_derm002
9722,10326,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.399,0,NONE,OHSU_HNSCC_derm002
9723,10326,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
9724,10326,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.457,0,NONE,OHSU_HNSCC_derm002
9725,10326,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.431,0,NONE,OHSU_HNSCC_derm002
9726,10326,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.343,0,NONE,OHSU_HNSCC_derm002
9727,10326,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.409,0,NONE,OHSU_HNSCC_derm002
9728,10326,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.031,10,GDC-0941,OHSU_HNSCC_derm002
9729,10326,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.271,10,Dovitinib,OHSU_HNSCC_derm002
9730,10326,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.365,10,BI-2536,OHSU_HNSCC_derm002
9731,10326,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.022,10,TP-0903 ,OHSU_HNSCC_derm002
9732,10326,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.078,10,Belinostat,OHSU_HNSCC_derm002
9733,10326,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.041,10,INK-128,OHSU_HNSCC_derm002
9734,10326,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.185,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9735,10326,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.114,10,Brigatinib,OHSU_HNSCC_derm002
9736,10326,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.224,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9737,10326,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.117,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9738,10326,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.245,10,Pazopanib,OHSU_HNSCC_derm002
9739,10326,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.44,10,AZD4547,OHSU_HNSCC_derm002
9740,10326,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.414,10,Pomalidomide ,OHSU_HNSCC_derm002
9741,10326,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.241,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
9742,10326,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.264,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9743,10326,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.003,10,Staurosporin,OHSU_HNSCC_derm002
9744,10326,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.04,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
9745,10326,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.253,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
9746,10326,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.501,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
9747,10326,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.021,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
9748,10326,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.165,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
9749,10326,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.057,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
9750,10326,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.239,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9751,10326,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.279,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
9752,10326,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.213,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9753,10326,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.194,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9754,10326,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.317,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
9755,10326,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.465,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
9756,10326,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.423,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
9757,10326,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.316,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
9758,10326,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.312,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9759,10326,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.0,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
9760,10326,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.104,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
9761,10326,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.353,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
9762,10326,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.444,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
9763,10326,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.055,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
9764,10326,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.211,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
9765,10326,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.066,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
9766,10326,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.259,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9767,10326,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.384,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
9768,10326,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.214,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9769,10326,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.307,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9770,10326,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
9771,10326,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.435,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
9772,10326,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.443,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
9773,10326,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.331,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
9774,10326,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.433,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9775,10326,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.006,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
9776,10326,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.13,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
9777,10326,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.264,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
9778,10326,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.387,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
9779,10326,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.337,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
9780,10326,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.29,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
9781,10326,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.096,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
9782,10326,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.279,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9783,10326,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.414,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
9784,10326,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.189,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9785,10326,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.351,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9786,10326,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.377,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
9787,10326,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.438,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
9788,10326,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.458,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
9789,10326,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.384,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
9790,10326,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.332,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9791,10326,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.059,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
9792,10326,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.22,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
9793,10326,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
9794,10326,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.33,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
9795,10326,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.404,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
9796,10326,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.332,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
9797,10326,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.128,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
9798,10326,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.371,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9799,10326,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.41,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
9800,10326,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.29,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9801,10326,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.397,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9802,10326,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.382,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
9803,10326,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.391,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
9804,10326,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.464,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
9805,10326,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.418,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
9806,10326,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.303,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9807,10326,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.176,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
9808,10326,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.207,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
9809,10326,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.309,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
9810,10326,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.276,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
9811,10326,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.385,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
9812,10326,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.357,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
9813,10326,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.156,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
9814,10326,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.395,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9815,10326,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.404,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
9816,10326,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.25,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9817,10326,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.407,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9818,10326,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.403,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
9819,10326,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.445,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
9820,10326,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.455,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
9821,10326,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.367,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
9822,10326,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.373,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9823,10326,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.361,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
9824,10326,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.309,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
9825,10326,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.306,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
9826,10326,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.266,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
9827,10326,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.352,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
9828,10326,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.456,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
9829,10326,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.188,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
9830,10326,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.38,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
9831,10326,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.42,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
9832,10326,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.341,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
9833,10326,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.412,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
9834,10326,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.424,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
9835,10326,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.388,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
9836,10326,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.447,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
9837,10326,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.425,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
9838,10326,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.261,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
9839,10326,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.379,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
9840,10326,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.342,0,NONE,OHSU_HNSCC_derm002
9841,10326,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.312,0,NONE,OHSU_HNSCC_derm002
9842,10326,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.29,0,NONE,OHSU_HNSCC_derm002
9843,10326,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.367,0,NONE,OHSU_HNSCC_derm002
9844,10326,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.382,0,NONE,OHSU_HNSCC_derm002
9845,10326,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
9846,10326,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
9847,10326,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
9848,10326,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.373,0,NONE,OHSU_HNSCC_derm002
9849,10326,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
9850,10326,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
9851,10326,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.506,0,NONE,OHSU_HNSCC_derm002
9852,10326,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.399,0,NONE,OHSU_HNSCC_derm002
9853,10326,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.396,0,NONE,OHSU_HNSCC_derm002
9854,10326,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.298,0,NONE,OHSU_HNSCC_derm002
9855,10326,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.38,0,NONE,OHSU_HNSCC_derm002
9856,10326,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.316,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
9857,10326,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.238,10,Hesperidin,OHSU_HNSCC_derm002
9858,10326,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.31,10,Esculetin,OHSU_HNSCC_derm002
9859,10326,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.072,10,Selinexor ,OHSU_HNSCC_derm002
9860,10326,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.313,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9861,10326,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.245,10,BMX-IN-1,OHSU_HNSCC_derm002
9862,10326,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.039,1,Dasatinib (1mM),OHSU_HNSCC_derm002
9863,10326,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.396,10,Trametinib,OHSU_HNSCC_derm002
9864,10326,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.129,10,BEZ235,OHSU_HNSCC_derm002
9865,10326,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.023,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
9866,10326,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.279,10,Nilotinib,OHSU_HNSCC_derm002
9867,10326,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.283,10,Enzalutamide,OHSU_HNSCC_derm002
9868,10326,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.54,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9869,10326,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.347,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
9870,10326,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.05,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9871,10326,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.323,10,Axitinib,OHSU_HNSCC_derm002
9872,10326,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.267,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
9873,10326,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.286,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
9874,10326,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.271,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
9875,10326,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.088,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
9876,10326,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.294,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9877,10326,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.171,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
9878,10326,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.064,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
9879,10326,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.334,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
9880,10326,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.124,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
9881,10326,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.018,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
9882,10326,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.35,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
9883,10326,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.345,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
9884,10326,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.424,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9885,10326,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.433,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
9886,10326,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.047,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9887,10326,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.337,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
9888,10326,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.223,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
9889,10326,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.253,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
9890,10326,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.362,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
9891,10326,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.088,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
9892,10326,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.322,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9893,10326,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.331,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
9894,10326,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.07,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
9895,10326,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.409,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
9896,10326,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.1,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
9897,10326,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.028,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
9898,10326,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.393,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
9899,10326,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.406,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
9900,10326,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.41,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9901,10326,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.321,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
9902,10326,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.049,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9903,10326,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.385,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
9904,10326,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.268,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
9905,10326,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.308,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
9906,10326,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.299,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
9907,10326,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.16,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
9908,10326,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.255,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9909,10326,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.295,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
9910,10326,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.195,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
9911,10326,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.345,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
9912,10326,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.141,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
9913,10326,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.047,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
9914,10326,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.43,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
9915,10326,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.364,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
9916,10326,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.444,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9917,10326,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.473,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
9918,10326,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.191,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9919,10326,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.387,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
9920,10326,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.303,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
9921,10326,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.256,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
9922,10326,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.372,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
9923,10326,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.312,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
9924,10326,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.305,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9925,10326,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.371,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
9926,10326,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.329,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
9927,10326,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.353,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
9928,10326,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.157,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
9929,10326,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.103,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
9930,10326,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.389,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
9931,10326,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.354,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
9932,10326,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.443,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9933,10326,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.506,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
9934,10326,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.299,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9935,10326,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.363,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
9936,10326,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.268,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
9937,10326,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.204,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
9938,10326,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.273,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
9939,10326,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.255,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
9940,10326,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.307,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9941,10326,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.297,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
9942,10326,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.271,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
9943,10326,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.355,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
9944,10326,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.146,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
9945,10326,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.315,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
9946,10326,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.393,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
9947,10326,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.316,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
9948,10326,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.368,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9949,10326,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.317,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
9950,10326,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.376,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9951,10326,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.332,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
9952,10326,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.264,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
9953,10326,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.226,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
9954,10326,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.252,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
9955,10326,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.224,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
9956,10326,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.287,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
9957,10326,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.296,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
9958,10326,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.367,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
9959,10326,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.375,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
9960,10326,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.289,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
9961,10326,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.271,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
9962,10326,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.256,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
9963,10326,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.295,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
9964,10326,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.329,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
9965,10326,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.387,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
9966,10326,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.35,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
9967,10326,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.342,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
9968,10326,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.277,0,NONE,OHSU_HNSCC_derm002
9969,10326,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.265,0,NONE,OHSU_HNSCC_derm002
9970,10326,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.286,0,NONE,OHSU_HNSCC_derm002
9971,10326,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.283,0,NONE,OHSU_HNSCC_derm002
9972,10326,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
9973,10326,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.304,0,NONE,OHSU_HNSCC_derm002
9974,10326,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.328,0,NONE,OHSU_HNSCC_derm002
9975,10326,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
9976,10326,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.338,0,NONE,OHSU_HNSCC_derm002
9977,10326,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.305,0,NONE,OHSU_HNSCC_derm002
9978,10326,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.346,0,NONE,OHSU_HNSCC_derm002
9979,10326,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
9980,10326,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.319,0,NONE,OHSU_HNSCC_derm002
9981,10326,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.386,0,NONE,OHSU_HNSCC_derm002
9982,10326,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.368,0,NONE,OHSU_HNSCC_derm002
9983,10326,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.358,0,NONE,OHSU_HNSCC_derm002
9984,10326,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.322,10,Thalidomide ,OHSU_HNSCC_derm002
9985,10326,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.167,10,Vandetanib,OHSU_HNSCC_derm002
9986,10326,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.321,10,Oleic acid,OHSU_HNSCC_derm002
9987,10326,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.017,10,A-674563,OHSU_HNSCC_derm002
9988,10326,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.133,10,Lapatinib,OHSU_HNSCC_derm002
9989,10326,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.33,10,Apocynin (vanillin),OHSU_HNSCC_derm002
9990,10326,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.135,10,AT-7519,OHSU_HNSCC_derm002
9991,10326,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.163,10,Gefitinib,OHSU_HNSCC_derm002
9992,10326,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.1,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
9993,10326,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.115,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
9994,10326,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.018,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
9995,10326,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.474,10,JQ1,OHSU_HNSCC_derm002
9996,10326,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.582,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
9997,10326,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.358,10,Cerdulatinib,OHSU_HNSCC_derm002
9998,10326,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.004,10,Romidepsin,OHSU_HNSCC_derm002
9999,10326,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.289,10,Gilteritinib,OHSU_HNSCC_derm002
10000,10326,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.277,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
10001,10326,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.365,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
10002,10326,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.392,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
10003,10326,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.349,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
10004,10326,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.196,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
10005,10326,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.415,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
10006,10326,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.029,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
10007,10326,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.251,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
10008,10326,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.344,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
10009,10326,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.189,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10010,10326,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.146,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10011,10326,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.629,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
10012,10326,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.439,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10013,10326,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.497,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
10014,10326,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.0,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
10015,10326,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.405,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
10016,10326,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
10017,10326,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.341,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
10018,10326,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.355,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
10019,10326,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.377,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
10020,10326,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.238,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
10021,10326,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.341,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
10022,10326,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.049,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
10023,10326,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.251,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
10024,10326,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.408,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
10025,10326,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.298,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10026,10326,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.238,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10027,10326,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.621,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
10028,10326,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.432,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10029,10326,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.529,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
10030,10326,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.006,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
10031,10326,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.451,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
10032,10326,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.377,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
10033,10326,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.339,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
10034,10326,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.376,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
10035,10326,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.364,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
10036,10326,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.242,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
10037,10326,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.346,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
10038,10326,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.281,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
10039,10326,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.274,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
10040,10326,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.437,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
10041,10326,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.333,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10042,10326,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.267,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10043,10326,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.729,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
10044,10326,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.414,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10045,10326,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.448,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
10046,10326,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.011,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
10047,10326,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.43,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
10048,10326,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.336,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
10049,10326,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.326,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
10050,10326,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.348,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
10051,10326,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.349,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
10052,10326,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.327,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
10053,10326,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.392,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
10054,10326,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.364,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
10055,10326,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.351,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
10056,10326,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.4,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
10057,10326,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.394,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10058,10326,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.341,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10059,10326,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.649,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
10060,10326,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.5,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10061,10326,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.465,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
10062,10326,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.03,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
10063,10326,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.418,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
10064,10326,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.305,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
10065,10326,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.307,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
10066,10326,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.386,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
10067,10326,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.33,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
10068,10326,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.321,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
10069,10326,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.403,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
10070,10326,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.365,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
10071,10326,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.408,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
10072,10326,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.435,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
10073,10326,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.383,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10074,10326,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.353,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10075,10326,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.556,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
10076,10326,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.449,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10077,10326,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.465,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
10078,10326,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.041,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
10079,10326,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.415,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
10080,10326,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.318,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
10081,10326,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.379,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
10082,10326,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.351,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
10083,10326,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.35,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
10084,10326,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.359,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
10085,10326,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.401,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
10086,10326,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.417,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
10087,10326,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.445,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
10088,10326,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.43,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
10089,10326,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.413,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
10090,10326,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.414,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
10091,10326,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.499,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
10092,10326,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.471,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
10093,10326,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.448,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
10094,10326,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.046,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
10095,10326,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.45,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
10096,10326,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.346,0,NONE,OHSU_HNSCC_derm002
10097,10326,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.4,0,NONE,OHSU_HNSCC_derm002
10098,10326,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.308,0,NONE,OHSU_HNSCC_derm002
10099,10326,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.348,0,NONE,OHSU_HNSCC_derm002
10100,10326,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
10101,10326,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.403,0,NONE,OHSU_HNSCC_derm002
10102,10326,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.43,0,NONE,OHSU_HNSCC_derm002
10103,10326,Blank 490,3,H,OHSU_HNSCC_derm002,8,0.0,10,F-S-V,OHSU_HNSCC_derm002
10104,10326,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.456,0,NONE,OHSU_HNSCC_derm002
10105,10326,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.447,0,NONE,OHSU_HNSCC_derm002
10106,10326,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.449,0,NONE,OHSU_HNSCC_derm002
10107,10326,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.442,0,NONE,OHSU_HNSCC_derm002
10108,10326,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.465,0,NONE,OHSU_HNSCC_derm002
10109,10326,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.416,0,NONE,OHSU_HNSCC_derm002
10110,10326,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.393,0,NONE,OHSU_HNSCC_derm002
10111,10326,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.455,0,NONE,OHSU_HNSCC_derm002
10112,10326,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.34,10,Anastrazole,OHSU_HNSCC_derm002
10113,10326,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.219,10,JNJ-28312141 ,OHSU_HNSCC_derm002
10114,10326,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.283,10,Genistein,OHSU_HNSCC_derm002
10115,10326,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.34,10,Abscisic acid,OHSU_HNSCC_derm002
10116,10326,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.214,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10117,10326,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.454,10,Ruxolitinib,OHSU_HNSCC_derm002
10118,10326,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.452,10,TAK-659,OHSU_HNSCC_derm002
10119,10326,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.1,10,Brigatinib,OHSU_HNSCC_derm002
10120,10326,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.194,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10121,10326,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.068,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10122,10326,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.155,10,Vorinostat,OHSU_HNSCC_derm002
10123,10326,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.443,10,Lenalidomide,OHSU_HNSCC_derm002
10124,10326,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.196,10,NVP-ADW742,OHSU_HNSCC_derm002
10125,10326,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.446,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10126,10326,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.453,10,Echinatin,OHSU_HNSCC_derm002
10127,10326,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.017,10,YM-155,OHSU_HNSCC_derm002
10128,10326,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.328,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
10129,10326,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.404,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
10130,10326,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.349,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
10131,10326,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.331,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
10132,10326,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.268,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10133,10326,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.452,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
10134,10326,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.512,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
10135,10326,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.206,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
10136,10326,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.223,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10137,10326,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.542,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10138,10326,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.218,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
10139,10326,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.466,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
10140,10326,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.403,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
10141,10326,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.429,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10142,10326,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.428,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
10143,10326,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.018,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
10144,10326,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.306,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
10145,10326,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.424,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
10146,10326,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.451,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
10147,10326,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.335,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
10148,10326,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.231,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10149,10326,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.42,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
10150,10326,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.493,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
10151,10326,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.396,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
10152,10326,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.259,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10153,10326,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.557,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10154,10326,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.318,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
10155,10326,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.418,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
10156,10326,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.362,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
10157,10326,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.424,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10158,10326,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.399,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
10159,10326,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.003,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
10160,10326,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.276,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
10161,10326,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.421,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
10162,10326,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.412,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
10163,10326,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.377,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
10164,10326,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.272,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10165,10326,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.412,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
10166,10326,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.456,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
10167,10326,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.367,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
10168,10326,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.257,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10169,10326,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.532,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10170,10326,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.372,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
10171,10326,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.422,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
10172,10326,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.388,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
10173,10326,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.43,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10174,10326,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.428,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
10175,10326,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.015,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
10176,10326,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
10177,10326,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.347,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
10178,10326,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.397,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
10179,10326,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.359,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
10180,10326,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.306,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10181,10326,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.35,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
10182,10326,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.456,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
10183,10326,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.417,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
10184,10326,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.258,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10185,10326,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.514,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10186,10326,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.377,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
10187,10326,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.434,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
10188,10326,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.455,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
10189,10326,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.42,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10190,10326,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.415,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
10191,10326,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.004,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
10192,10326,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.283,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
10193,10326,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.441,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
10194,10326,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.38,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
10195,10326,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.378,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
10196,10326,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.26,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10197,10326,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.393,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
10198,10326,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.415,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
10199,10326,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.411,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
10200,10326,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.299,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10201,10326,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.485,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10202,10326,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.353,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
10203,10326,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.426,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
10204,10326,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.444,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
10205,10326,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.444,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10206,10326,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.434,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
10207,10326,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.0,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
10208,10326,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.339,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
10209,10326,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.369,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
10210,10326,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.336,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
10211,10326,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.34,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
10212,10326,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.366,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
10213,10326,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.373,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
10214,10326,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.417,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
10215,10326,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.418,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
10216,10326,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.35,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10217,10326,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.467,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
10218,10326,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
10219,10326,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.432,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
10220,10326,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.468,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
10221,10326,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.439,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
10222,10326,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.422,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
10223,10326,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.001,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
10224,10326,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.246,0,NONE,OHSU_HNSCC_derm002
10225,10326,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.364,0,NONE,OHSU_HNSCC_derm002
10226,10326,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.381,0,NONE,OHSU_HNSCC_derm002
10227,10326,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.323,0,NONE,OHSU_HNSCC_derm002
10228,10326,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.32,0,NONE,OHSU_HNSCC_derm002
10229,10326,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.378,0,NONE,OHSU_HNSCC_derm002
10230,10326,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.406,0,NONE,OHSU_HNSCC_derm002
10231,10326,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.0,10,F-S-V,OHSU_HNSCC_derm002
10232,10326,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.423,0,NONE,OHSU_HNSCC_derm002
10233,10326,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.428,0,NONE,OHSU_HNSCC_derm002
10234,10326,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.445,0,NONE,OHSU_HNSCC_derm002
10235,10326,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.465,0,NONE,OHSU_HNSCC_derm002
10236,10326,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.489,0,NONE,OHSU_HNSCC_derm002
10237,10326,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.439,0,NONE,OHSU_HNSCC_derm002
10238,10326,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.434,0,NONE,OHSU_HNSCC_derm002
10239,10326,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.419,0,NONE,OHSU_HNSCC_derm002
10240,10326,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.343,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10241,10326,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.392,10,Stevioside,OHSU_HNSCC_derm002
10242,10326,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.305,10,Pemetrexed,OHSU_HNSCC_derm002
10243,10326,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.044,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10244,10326,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.22,10,GSK-1838705A,OHSU_HNSCC_derm002
10245,10326,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.013,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10246,10326,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.406,10,Imatinib,OHSU_HNSCC_derm002
10247,10326,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.346,10,Trametinib,OHSU_HNSCC_derm002
10248,10326,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.144,10,BEZ235,OHSU_HNSCC_derm002
10249,10326,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.08,10,Saracatinib,OHSU_HNSCC_derm002
10250,10326,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.662,10,I-BET 762,OHSU_HNSCC_derm002
10251,10326,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.175,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
10252,10326,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.532,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
10253,10326,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.416,10,Crizotinib,OHSU_HNSCC_derm002
10254,10326,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.269,10,MGCD-265,OHSU_HNSCC_derm002
10255,10326,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.176,10,Erlotinib,OHSU_HNSCC_derm002
10256,10326,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.296,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10257,10326,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.378,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
10258,10326,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.366,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
10259,10326,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.047,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10260,10326,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.238,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
10261,10326,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.095,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10262,10326,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.431,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
10263,10326,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.403,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
10264,10326,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.13,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
10265,10326,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
10266,10326,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.682,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
10267,10326,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.174,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
10268,10326,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.499,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
10269,10326,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.5,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
10270,10326,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.29,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
10271,10326,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.217,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
10272,10326,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.337,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10273,10326,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.448,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
10274,10326,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.335,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
10275,10326,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.085,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10276,10326,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.252,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
10277,10326,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.208,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10278,10326,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.393,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
10279,10326,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.413,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
10280,10326,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.126,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
10281,10326,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.398,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
10282,10326,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.653,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
10283,10326,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.209,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
10284,10326,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.489,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
10285,10326,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.424,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
10286,10326,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.445,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
10287,10326,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.316,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
10288,10326,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.388,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10289,10326,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.39,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
10290,10326,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.313,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
10291,10326,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.133,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10292,10326,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.294,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
10293,10326,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.244,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10294,10326,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.41,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
10295,10326,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.374,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
10296,10326,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.155,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
10297,10326,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.473,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
10298,10326,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.567,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
10299,10326,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.227,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
10300,10326,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.44,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
10301,10326,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.441,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
10302,10326,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.397,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
10303,10326,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.341,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
10304,10326,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.337,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10305,10326,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.37,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
10306,10326,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.381,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
10307,10326,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.214,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10308,10326,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.321,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
10309,10326,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.292,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10310,10326,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.391,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
10311,10326,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.362,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
10312,10326,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.179,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
10313,10326,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.449,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
10314,10326,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.509,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
10315,10326,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.252,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
10316,10326,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.46,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
10317,10326,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.407,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
10318,10326,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.364,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
10319,10326,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.395,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
10320,10326,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.369,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10321,10326,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.343,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
10322,10326,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.367,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
10323,10326,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.223,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10324,10326,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
10325,10326,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.307,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10326,10326,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.409,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
10327,10326,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.37,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
10328,10326,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.26,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
10329,10326,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.401,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
10330,10326,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.389,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
10331,10326,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.333,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
10332,10326,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.39,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
10333,10326,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.419,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
10334,10326,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.438,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
10335,10326,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
10336,10326,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.378,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
10337,10326,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.38,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
10338,10326,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.388,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
10339,10326,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.332,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
10340,10326,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.362,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
10341,10326,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.347,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
10342,10326,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.389,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
10343,10326,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.412,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
10344,10326,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.341,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
10345,10326,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.365,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
10346,10326,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.371,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
10347,10326,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.296,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
10348,10326,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.345,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
10349,10326,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.333,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
10350,10326,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.374,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
10351,10326,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.373,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
10352,10326,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.303,0,NONE,OHSU_HNSCC_derm002
10353,10326,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.314,0,NONE,OHSU_HNSCC_derm002
10354,10326,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.296,0,NONE,OHSU_HNSCC_derm002
10355,10326,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.394,0,NONE,OHSU_HNSCC_derm002
10356,10326,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.365,0,NONE,OHSU_HNSCC_derm002
10357,10326,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.321,0,NONE,OHSU_HNSCC_derm002
10358,10326,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
10359,10326,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
10360,10326,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.383,0,NONE,OHSU_HNSCC_derm002
10361,10326,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.411,0,NONE,OHSU_HNSCC_derm002
10362,10326,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.21,0,NONE,OHSU_HNSCC_derm002
10363,10326,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
10364,10326,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.333,0,NONE,OHSU_HNSCC_derm002
10365,10326,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
10366,10326,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.341,0,NONE,OHSU_HNSCC_derm002
10367,10326,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.419,0,NONE,OHSU_HNSCC_derm002
10368,10326,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.028,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10369,10326,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.115,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10370,10326,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.399,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10371,10326,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.113,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10372,10326,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.037,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10373,10326,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.03,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10374,10326,Blank 490,4,G,OHSU_HNSCC_derm002,1,-0.014,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10375,10326,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.192,10,Gefitinib,OHSU_HNSCC_derm002
10376,10326,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.01,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
10377,10326,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.013,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10378,10326,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.141,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10379,10326,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.101,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10380,10326,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.099,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10381,10326,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.301,10,VOLASERTIB x,OHSU_HNSCC_derm002
10382,10326,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.062,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10383,10326,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.007,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10384,10326,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.044,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10385,10326,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.178,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10386,10326,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.399,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10387,10326,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.175,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10388,10326,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.131,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10389,10326,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.061,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10390,10326,Blank 490,4,G,OHSU_HNSCC_derm002,2,-0.003,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10391,10326,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.281,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
10392,10326,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.322,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
10393,10326,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.022,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10394,10326,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.179,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10395,10326,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.174,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10396,10326,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.218,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10397,10326,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.569,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
10398,10326,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.375,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10399,10326,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.007,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10400,10326,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.088,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10401,10326,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.24,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10402,10326,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.413,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10403,10326,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.222,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10404,10326,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.139,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10405,10326,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.078,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10406,10326,Blank 490,4,G,OHSU_HNSCC_derm002,3,-0.001,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10407,10326,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.29,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
10408,10326,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.457,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
10409,10326,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.085,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10410,10326,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.204,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10411,10326,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.216,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10412,10326,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.252,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10413,10326,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.637,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
10414,10326,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.407,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10415,10326,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.01,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10416,10326,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.152,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10417,10326,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.293,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10418,10326,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.432,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10419,10326,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.261,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10420,10326,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.2,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10421,10326,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.121,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10422,10326,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.023,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10423,10326,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.296,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
10424,10326,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.382,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
10425,10326,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.138,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10426,10326,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.274,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10427,10326,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.297,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10428,10326,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.413,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10429,10326,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.554,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
10430,10326,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.435,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10431,10326,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.092,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10432,10326,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.267,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10433,10326,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.272,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10434,10326,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.423,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10435,10326,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.288,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10436,10326,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.245,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10437,10326,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.149,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10438,10326,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.049,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10439,10326,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.306,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
10440,10326,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.53,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
10441,10326,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.23,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10442,10326,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.36,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10443,10326,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.369,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10444,10326,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.466,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10445,10326,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.44,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
10446,10326,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.414,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10447,10326,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.299,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10448,10326,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.302,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10449,10326,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.359,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10450,10326,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.411,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10451,10326,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.345,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10452,10326,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.312,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10453,10326,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.215,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10454,10326,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.051,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10455,10326,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.408,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
10456,10326,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.439,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
10457,10326,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.331,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10458,10326,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.386,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10459,10326,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.408,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10460,10326,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.417,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10461,10326,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.343,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
10462,10326,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.407,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10463,10326,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.341,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10464,10326,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.375,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
10465,10326,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.411,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
10466,10326,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.411,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
10467,10326,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.387,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
10468,10326,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.357,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
10469,10326,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.269,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
10470,10326,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.055,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
10471,10326,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.453,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
10472,10326,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.469,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
10473,10326,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.382,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
10474,10326,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.405,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
10475,10326,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.483,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
10476,10326,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.494,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
10477,10326,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.393,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
10478,10326,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.382,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10479,10326,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.397,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
10480,10326,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.342,0,NONE,OHSU_HNSCC_derm002
10481,10326,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.392,0,NONE,OHSU_HNSCC_derm002
10482,10326,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.416,0,NONE,OHSU_HNSCC_derm002
10483,10326,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.402,0,NONE,OHSU_HNSCC_derm002
10484,10326,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.367,0,NONE,OHSU_HNSCC_derm002
10485,10326,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
10486,10326,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.452,0,NONE,OHSU_HNSCC_derm002
10487,10326,Blank 490,4,H,OHSU_HNSCC_derm002,8,0.004,10,F-S-V,OHSU_HNSCC_derm002
10488,10326,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
10489,10326,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.461,0,NONE,OHSU_HNSCC_derm002
10490,10326,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.476,0,NONE,OHSU_HNSCC_derm002
10491,10326,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.463,0,NONE,OHSU_HNSCC_derm002
10492,10326,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.514,0,NONE,OHSU_HNSCC_derm002
10493,10326,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.478,0,NONE,OHSU_HNSCC_derm002
10494,10326,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.474,0,NONE,OHSU_HNSCC_derm002
10495,10326,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.377,0,NONE,OHSU_HNSCC_derm002
10496,10326,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.12,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10497,10326,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.183,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10498,10326,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.016,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
10499,10326,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.232,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10500,10326,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.15,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10501,10326,Blank 490,4,F,OHSU_HNSCC_derm002,9,-0.001,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
10502,10326,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.068,10,AZD2014 x ,OHSU_HNSCC_derm002
10503,10326,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.137,10,Brigatinib,OHSU_HNSCC_derm002
10504,10326,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.194,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10505,10326,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.049,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10506,10326,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.248,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10507,10326,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.012,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
10508,10326,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.134,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10509,10326,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.35,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10510,10326,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.185,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10511,10326,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.195,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10512,10326,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.163,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10513,10326,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.185,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10514,10326,Blank 490,4,C,OHSU_HNSCC_derm002,10,-0.006,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
10515,10326,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.363,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10516,10326,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.195,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10517,10326,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.013,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
10518,10326,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.09,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
10519,10326,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.291,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
10520,10326,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.213,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10521,10326,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.209,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10522,10326,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.318,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10523,10326,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.25,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
10524,10326,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.25,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10525,10326,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.29,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10526,10326,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.227,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10527,10326,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.27,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10528,10326,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.187,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10529,10326,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.218,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10530,10326,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.012,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
10531,10326,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.339,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10532,10326,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.229,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10533,10326,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.025,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
10534,10326,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.121,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
10535,10326,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.388,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
10536,10326,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.266,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10537,10326,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.217,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10538,10326,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.348,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10539,10326,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.341,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
10540,10326,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.254,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10541,10326,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.312,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10542,10326,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.235,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10543,10326,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.284,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10544,10326,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.243,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10545,10326,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.307,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10546,10326,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.124,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
10547,10326,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.353,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10548,10326,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.295,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10549,10326,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.087,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
10550,10326,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.179,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
10551,10326,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.436,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
10552,10326,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.265,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10553,10326,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.259,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10554,10326,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.355,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10555,10326,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.419,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
10556,10326,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.263,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10557,10326,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.371,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10558,10326,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.279,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10559,10326,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.374,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10560,10326,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.284,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10561,10326,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.321,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10562,10326,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.284,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
10563,10326,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.415,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10564,10326,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.261,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10565,10326,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.232,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
10566,10326,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.248,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
10567,10326,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.423,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
10568,10326,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.274,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10569,10326,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.4,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10570,10326,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.44,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10571,10326,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.453,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
10572,10326,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.279,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10573,10326,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.398,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10574,10326,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.332,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10575,10326,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.408,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10576,10326,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.31,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10577,10326,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.372,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10578,10326,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.337,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
10579,10326,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.421,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10580,10326,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.337,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10581,10326,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.311,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
10582,10326,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.331,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
10583,10326,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.41,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
10584,10326,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.357,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10585,10326,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.423,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10586,10326,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.358,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10587,10326,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.381,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
10588,10326,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.322,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10589,10326,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.487,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10590,10326,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.358,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10591,10326,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.439,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10592,10326,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.301,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
10593,10326,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.394,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
10594,10326,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.433,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
10595,10326,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.409,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10596,10326,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.331,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
10597,10326,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.337,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
10598,10326,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.398,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
10599,10326,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.46,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
10600,10326,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.377,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10601,10326,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.415,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
10602,10326,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.43,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
10603,10326,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.479,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
10604,10326,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.364,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10605,10326,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.403,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
10606,10326,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.401,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
10607,10326,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.4,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
10608,10326,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.376,0,NONE,OHSU_HNSCC_derm002
10609,10326,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.42,0,NONE,OHSU_HNSCC_derm002
10610,10326,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.442,0,NONE,OHSU_HNSCC_derm002
10611,10326,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.412,0,NONE,OHSU_HNSCC_derm002
10612,10326,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.4,0,NONE,OHSU_HNSCC_derm002
10613,10326,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.413,0,NONE,OHSU_HNSCC_derm002
10614,10326,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.432,0,NONE,OHSU_HNSCC_derm002
10615,10326,Blank 490,4,H,OHSU_HNSCC_derm002,16,-0.004,10,F-S-V,OHSU_HNSCC_derm002
10616,10326,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.473,0,NONE,OHSU_HNSCC_derm002
10617,10326,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.462,0,NONE,OHSU_HNSCC_derm002
10618,10326,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
10619,10326,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.446,0,NONE,OHSU_HNSCC_derm002
10620,10326,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.492,0,NONE,OHSU_HNSCC_derm002
10621,10326,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.481,0,NONE,OHSU_HNSCC_derm002
10622,10326,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.441,0,NONE,OHSU_HNSCC_derm002
10623,10326,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.341,0,NONE,OHSU_HNSCC_derm002
10624,10326,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.127,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10625,10326,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.01,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10626,10326,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.071,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10627,10326,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.009,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10628,10326,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.002,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10629,10326,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.094,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10630,10326,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.176,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10631,10326,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.381,10,Trametinib,OHSU_HNSCC_derm002
10632,10326,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.106,10,BEZ235,OHSU_HNSCC_derm002
10633,10326,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.09,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10634,10326,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.411,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10635,10326,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.003,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10636,10326,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.155,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10637,10326,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.504,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10638,10326,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.166,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10639,10326,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.196,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10640,10326,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.232,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10641,10326,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.124,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10642,10326,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.029,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10643,10326,Blank 490,4,D,OHSU_HNSCC_derm002,18,-0.003,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10644,10326,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.023,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10645,10326,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.17,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10646,10326,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.308,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10647,10326,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.397,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
10648,10326,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.149,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
10649,10326,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.169,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10650,10326,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.456,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10651,10326,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.034,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10652,10326,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.278,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10653,10326,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.505,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10654,10326,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.29,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10655,10326,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.167,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10656,10326,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.419,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10657,10326,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.28,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10658,10326,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.04,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10659,10326,Blank 490,4,D,OHSU_HNSCC_derm002,19,-0.033,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10660,10326,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.041,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10661,10326,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.212,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10662,10326,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.35,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10663,10326,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.374,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
10664,10326,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.124,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
10665,10326,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.218,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10666,10326,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.455,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10667,10326,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.031,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10668,10326,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.273,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10669,10326,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.483,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10670,10326,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.337,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10671,10326,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.188,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10672,10326,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.422,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10673,10326,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.336,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10674,10326,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.069,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10675,10326,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.005,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10676,10326,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.03,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10677,10326,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.075,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10678,10326,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.467,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10679,10326,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.451,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
10680,10326,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.161,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
10681,10326,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.254,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10682,10326,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.43,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10683,10326,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.07,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10684,10326,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.35,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10685,10326,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.498,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10686,10326,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.37,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10687,10326,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.246,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10688,10326,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.415,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10689,10326,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.296,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10690,10326,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.111,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10691,10326,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.026,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10692,10326,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.063,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10693,10326,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.294,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10694,10326,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.452,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10695,10326,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.426,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
10696,10326,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.196,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
10697,10326,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.335,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10698,10326,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.419,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10699,10326,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.234,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10700,10326,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.389,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10701,10326,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.444,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10702,10326,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.43,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10703,10326,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.286,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10704,10326,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.387,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10705,10326,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.377,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10706,10326,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.306,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10707,10326,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.03,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10708,10326,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.398,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10709,10326,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.347,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10710,10326,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.393,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10711,10326,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.362,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
10712,10326,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
10713,10326,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.323,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10714,10326,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.43,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10715,10326,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.372,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10716,10326,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.438,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10717,10326,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.425,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10718,10326,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10719,10326,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.362,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10720,10326,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.392,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
10721,10326,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.341,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
10722,10326,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.345,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10723,10326,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.047,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
10724,10326,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.357,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
10725,10326,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.289,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
10726,10326,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.379,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
10727,10326,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.421,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
10728,10326,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.41,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
10729,10326,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.418,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
10730,10326,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.482,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10731,10326,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.375,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
10732,10326,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.416,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
10733,10326,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.414,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10734,10326,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.408,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
10735,10326,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.368,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
10736,10326,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.311,0,NONE,OHSU_HNSCC_derm002
10737,10326,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.341,0,NONE,OHSU_HNSCC_derm002
10738,10326,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.377,0,NONE,OHSU_HNSCC_derm002
10739,10326,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.368,0,NONE,OHSU_HNSCC_derm002
10740,10326,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.364,0,NONE,OHSU_HNSCC_derm002
10741,10326,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.361,0,NONE,OHSU_HNSCC_derm002
10742,10326,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
10743,10326,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.364,0,NONE,OHSU_HNSCC_derm002
10744,10326,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.42,0,NONE,OHSU_HNSCC_derm002
10745,10326,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.415,0,NONE,OHSU_HNSCC_derm002
10746,10326,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.428,0,NONE,OHSU_HNSCC_derm002
10747,10326,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.371,0,NONE,OHSU_HNSCC_derm002
10748,10326,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.388,0,NONE,OHSU_HNSCC_derm002
10749,10326,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
10750,10326,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.37,0,NONE,OHSU_HNSCC_derm002
10751,10326,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
10752,10326,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.152,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10753,10326,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.003,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10754,10326,Blank 490,5,C,OHSU_HNSCC_derm002,1,0.003,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10755,10326,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.046,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10756,10326,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.067,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10757,10326,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.059,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10758,10326,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.49,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10759,10326,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.216,10,Gefitinib,OHSU_HNSCC_derm002
10760,10326,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.045,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
10761,10326,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.021,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10762,10326,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.526,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10763,10326,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.173,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10764,10326,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.028,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10765,10326,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.297,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10766,10326,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.056,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10767,10326,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.097,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10768,10326,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.163,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10769,10326,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.176,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10770,10326,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.003,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10771,10326,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.31,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10772,10326,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.179,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10773,10326,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.086,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10774,10326,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.393,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10775,10326,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.25,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
10776,10326,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.315,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
10777,10326,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.008,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10778,10326,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.432,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10779,10326,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.211,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10780,10326,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.031,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10781,10326,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.28,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10782,10326,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.074,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10783,10326,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.131,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10784,10326,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.201,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10785,10326,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.23,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10786,10326,Blank 490,5,C,OHSU_HNSCC_derm002,3,-0.002,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10787,10326,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.395,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10788,10326,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.263,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10789,10326,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.077,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10790,10326,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.432,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10791,10326,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
10792,10326,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.404,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
10793,10326,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.07,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10794,10326,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.459,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10795,10326,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.263,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10796,10326,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.061,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10797,10326,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.384,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10798,10326,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.113,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10799,10326,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.178,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10800,10326,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.2,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10801,10326,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.291,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10802,10326,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.028,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10803,10326,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.453,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10804,10326,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.356,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10805,10326,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.182,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10806,10326,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.451,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10807,10326,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.336,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
10808,10326,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.459,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
10809,10326,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.13,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10810,10326,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.465,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10811,10326,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.311,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10812,10326,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.153,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10813,10326,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.33,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10814,10326,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.146,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10815,10326,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.201,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10816,10326,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.238,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10817,10326,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.321,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10818,10326,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.053,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10819,10326,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.448,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10820,10326,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.362,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10821,10326,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.357,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10822,10326,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.444,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10823,10326,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.387,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
10824,10326,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.48,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
10825,10326,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.265,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10826,10326,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.464,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10827,10326,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.346,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10828,10326,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.218,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10829,10326,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.395,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10830,10326,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.204,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10831,10326,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.348,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10832,10326,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.276,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10833,10326,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.393,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10834,10326,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.046,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10835,10326,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.465,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10836,10326,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.366,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10837,10326,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.436,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10838,10326,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.489,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10839,10326,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.449,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
10840,10326,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.458,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
10841,10326,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.337,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10842,10326,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.453,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10843,10326,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.411,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10844,10326,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.375,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10845,10326,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.487,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10846,10326,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.291,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10847,10326,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.278,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10848,10326,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.238,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10849,10326,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.436,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
10850,10326,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.056,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
10851,10326,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.488,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
10852,10326,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.405,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
10853,10326,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.428,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
10854,10326,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.472,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
10855,10326,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.466,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
10856,10326,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.463,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
10857,10326,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.495,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
10858,10326,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.492,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
10859,10326,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.382,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
10860,10326,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.437,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10861,10326,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.446,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
10862,10326,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.355,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
10863,10326,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.346,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
10864,10326,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
10865,10326,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.42,0,NONE,OHSU_HNSCC_derm002
10866,10326,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.46,0,NONE,OHSU_HNSCC_derm002
10867,10326,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.437,0,NONE,OHSU_HNSCC_derm002
10868,10326,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.415,0,NONE,OHSU_HNSCC_derm002
10869,10326,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.433,0,NONE,OHSU_HNSCC_derm002
10870,10326,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.467,0,NONE,OHSU_HNSCC_derm002
10871,10326,Blank 490,5,H,OHSU_HNSCC_derm002,8,0.0,10,F-S-V,OHSU_HNSCC_derm002
10872,10326,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
10873,10326,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
10874,10326,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.434,0,NONE,OHSU_HNSCC_derm002
10875,10326,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.499,0,NONE,OHSU_HNSCC_derm002
10876,10326,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.471,0,NONE,OHSU_HNSCC_derm002
10877,10326,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.475,0,NONE,OHSU_HNSCC_derm002
10878,10326,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
10879,10326,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.394,0,NONE,OHSU_HNSCC_derm002
10880,10326,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.022,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10881,10326,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.217,10,APTO-253 x,OHSU_HNSCC_derm002
10882,10326,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.022,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10883,10326,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.483,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10884,10326,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.227,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10885,10326,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.028,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10886,10326,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.059,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10887,10326,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.087,10,Brigatinib,OHSU_HNSCC_derm002
10888,10326,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.234,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10889,10326,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.028,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10890,10326,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.022,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10891,10326,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.023,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10892,10326,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.234,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10893,10326,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.256,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10894,10326,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.021,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10895,10326,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.004,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10896,10326,Blank 490,5,A,OHSU_HNSCC_derm002,10,-0.007,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10897,10326,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.166,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
10898,10326,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.033,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10899,10326,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.423,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10900,10326,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.256,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10901,10326,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.041,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10902,10326,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.239,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10903,10326,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.23,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
10904,10326,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.229,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10905,10326,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.081,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10906,10326,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.027,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10907,10326,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.046,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10908,10326,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.256,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10909,10326,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.306,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10910,10326,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.008,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10911,10326,Blank 490,5,P,OHSU_HNSCC_derm002,10,-0.008,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10912,10326,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.008,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10913,10326,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.313,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
10914,10326,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.054,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10915,10326,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.489,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10916,10326,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.275,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10917,10326,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.06,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10918,10326,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.258,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10919,10326,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.409,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
10920,10326,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.268,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10921,10326,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.07,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10922,10326,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.123,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10923,10326,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.072,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10924,10326,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.344,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10925,10326,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.309,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10926,10326,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.111,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10927,10326,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.096,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10928,10326,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.032,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10929,10326,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.363,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
10930,10326,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.091,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10931,10326,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.45,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10932,10326,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.286,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10933,10326,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.108,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10934,10326,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.264,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10935,10326,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.38,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
10936,10326,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.246,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10937,10326,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.144,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10938,10326,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.291,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10939,10326,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.089,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10940,10326,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.368,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10941,10326,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.345,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10942,10326,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.313,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10943,10326,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.307,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10944,10326,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.047,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10945,10326,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.415,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
10946,10326,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.171,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10947,10326,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.458,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10948,10326,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.285,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10949,10326,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.186,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10950,10326,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.259,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10951,10326,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.414,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
10952,10326,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.316,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10953,10326,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.149,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10954,10326,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.424,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10955,10326,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.171,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10956,10326,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.48,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10957,10326,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.364,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10958,10326,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.387,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10959,10326,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.409,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10960,10326,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.056,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10961,10326,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.44,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
10962,10326,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.297,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10963,10326,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.438,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10964,10326,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.402,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10965,10326,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.314,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10966,10326,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.353,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10967,10326,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.464,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
10968,10326,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.381,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10969,10326,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.275,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10970,10326,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.431,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10971,10326,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.284,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10972,10326,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.448,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10973,10326,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.408,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10974,10326,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.397,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10975,10326,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.397,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10976,10326,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.073,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
10977,10326,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.409,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
10978,10326,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.429,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
10979,10326,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.455,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
10980,10326,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.398,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
10981,10326,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.313,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
10982,10326,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.365,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
10983,10326,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.471,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
10984,10326,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.439,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
10985,10326,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.393,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
10986,10326,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.472,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10987,10326,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.417,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
10988,10326,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.487,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
10989,10326,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.442,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
10990,10326,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.443,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10991,10326,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.442,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
10992,10326,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.347,0,NONE,OHSU_HNSCC_derm002
10993,10326,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
10994,10326,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.46,0,NONE,OHSU_HNSCC_derm002
10995,10326,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.405,0,NONE,OHSU_HNSCC_derm002
10996,10326,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.425,0,NONE,OHSU_HNSCC_derm002
10997,10326,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.448,0,NONE,OHSU_HNSCC_derm002
10998,10326,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.493,0,NONE,OHSU_HNSCC_derm002
10999,10326,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.0,10,F-S-V,OHSU_HNSCC_derm002
11000,10326,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.46,0,NONE,OHSU_HNSCC_derm002
11001,10326,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.49,0,NONE,OHSU_HNSCC_derm002
11002,10326,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.458,0,NONE,OHSU_HNSCC_derm002
11003,10326,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
11004,10326,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.429,0,NONE,OHSU_HNSCC_derm002
11005,10326,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.443,0,NONE,OHSU_HNSCC_derm002
11006,10326,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.432,0,NONE,OHSU_HNSCC_derm002
11007,10326,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
11008,10326,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.014,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11009,10326,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.02,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11010,10326,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.025,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11011,10326,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.14,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11012,10326,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.338,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11013,10326,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.121,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11014,10326,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.316,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11015,10326,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.399,10,Trametinib,OHSU_HNSCC_derm002
11016,10326,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.118,10,BEZ235,OHSU_HNSCC_derm002
11017,10326,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.161,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11018,10326,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.257,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11019,10326,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.011,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11020,10326,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.113,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11021,10326,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.151,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11022,10326,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.376,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11023,10326,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.162,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11024,10326,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.014,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11025,10326,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.108,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11026,10326,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.043,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11027,10326,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.264,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11028,10326,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.326,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11029,10326,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.273,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11030,10326,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.382,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11031,10326,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.423,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
11032,10326,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.184,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
11033,10326,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.226,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11034,10326,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.244,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11035,10326,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.047,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11036,10326,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.242,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11037,10326,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.272,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11038,10326,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.361,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11039,10326,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.232,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11040,10326,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.124,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11041,10326,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.286,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11042,10326,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.058,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11043,10326,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.311,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11044,10326,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.337,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11045,10326,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.288,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11046,10326,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.41,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11047,10326,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.465,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
11048,10326,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.168,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
11049,10326,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.311,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11050,10326,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.339,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11051,10326,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.039,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11052,10326,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.311,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11053,10326,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.277,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11054,10326,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.467,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11055,10326,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.22,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11056,10326,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.329,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11057,10326,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.43,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11058,10326,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.096,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11059,10326,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.381,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11060,10326,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.419,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11061,10326,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.3,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11062,10326,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.424,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11063,10326,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.427,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
11064,10326,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.202,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
11065,10326,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.394,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11066,10326,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.35,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11067,10326,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.101,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11068,10326,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.369,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11069,10326,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.365,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11070,10326,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.439,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11071,10326,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.232,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11072,10326,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.398,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11073,10326,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.441,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11074,10326,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.193,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11075,10326,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.428,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11076,10326,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.43,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11077,10326,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.394,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11078,10326,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.384,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11079,10326,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.44,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
11080,10326,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.215,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
11081,10326,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.44,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11082,10326,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.361,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11083,10326,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.166,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11084,10326,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.39,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11085,10326,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.403,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11086,10326,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.474,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11087,10326,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.291,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11088,10326,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.421,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11089,10326,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.446,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11090,10326,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.268,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11091,10326,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.405,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11092,10326,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.428,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11093,10326,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.379,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11094,10326,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.404,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11095,10326,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.453,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
11096,10326,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.315,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
11097,10326,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.497,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11098,10326,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.397,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11099,10326,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.27,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11100,10326,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11101,10326,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.326,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11102,10326,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.422,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11103,10326,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.245,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11104,10326,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.379,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11105,10326,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.415,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
11106,10326,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.323,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11107,10326,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.379,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
11108,10326,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.415,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
11109,10326,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.398,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11110,10326,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.422,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
11111,10326,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.38,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
11112,10326,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
11113,10326,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.447,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
11114,10326,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.397,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
11115,10326,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.352,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
11116,10326,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.36,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
11117,10326,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.42,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11118,10326,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.408,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
11119,10326,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.272,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
11120,10326,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.329,0,NONE,OHSU_HNSCC_derm002
11121,10326,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
11122,10326,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.389,0,NONE,OHSU_HNSCC_derm002
11123,10326,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.396,0,NONE,OHSU_HNSCC_derm002
11124,10326,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.383,0,NONE,OHSU_HNSCC_derm002
11125,10326,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
11126,10326,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
11127,10326,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.436,0,NONE,OHSU_HNSCC_derm002
11128,10326,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
11129,10326,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.43,0,NONE,OHSU_HNSCC_derm002
11130,10326,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.385,0,NONE,OHSU_HNSCC_derm002
11131,10326,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
11132,10326,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.39,0,NONE,OHSU_HNSCC_derm002
11133,10326,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
11134,10326,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.442,0,NONE,OHSU_HNSCC_derm002
11135,10326,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.385,0,NONE,OHSU_HNSCC_derm002
11136,10326,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.07,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11137,10326,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.006,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11138,10326,Blank 490,6,C,OHSU_HNSCC_derm002,1,-0.007,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11139,10326,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.098,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11140,10326,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.05,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11141,10326,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.005,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11142,10326,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.433,10,IMR 1,OHSU_HNSCC_derm002
11143,10326,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.246,10,Gefitinib,OHSU_HNSCC_derm002
11144,10326,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.178,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
11145,10326,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.423,0,DMSO,OHSU_HNSCC_derm002
11146,10326,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.398,0,DMSO ,OHSU_HNSCC_derm002
11147,10326,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.374,0,DMSO,OHSU_HNSCC_derm002
11148,10326,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.401,0,DMSO ,OHSU_HNSCC_derm002
11149,10326,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.391,0,DMSO,OHSU_HNSCC_derm002
11150,10326,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.431,0,DMSO ,OHSU_HNSCC_derm002
11151,10326,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.389,0,DMSO,OHSU_HNSCC_derm002
11152,10326,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.095,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11153,10326,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.024,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11154,10326,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.019,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11155,10326,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.196,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11156,10326,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.133,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11157,10326,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.009,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11158,10326,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.436,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
11159,10326,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.221,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
11160,10326,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.357,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
11161,10326,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.379,0,DMSO,OHSU_HNSCC_derm002
11162,10326,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.401,0,DMSO ,OHSU_HNSCC_derm002
11163,10326,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.405,0,DMSO,OHSU_HNSCC_derm002
11164,10326,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.408,0,DMSO ,OHSU_HNSCC_derm002
11165,10326,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.44,0,DMSO,OHSU_HNSCC_derm002
11166,10326,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.449,0,DMSO ,OHSU_HNSCC_derm002
11167,10326,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.4,0,DMSO,OHSU_HNSCC_derm002
11168,10326,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.162,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11169,10326,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.033,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11170,10326,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.078,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11171,10326,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.195,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11172,10326,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.323,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11173,10326,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.011,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11174,10326,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.405,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
11175,10326,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.271,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
11176,10326,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.405,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
11177,10326,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.461,0,DMSO,OHSU_HNSCC_derm002
11178,10326,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.428,0,DMSO ,OHSU_HNSCC_derm002
11179,10326,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.412,0,DMSO,OHSU_HNSCC_derm002
11180,10326,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.495,0,DMSO ,OHSU_HNSCC_derm002
11181,10326,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.412,0,DMSO,OHSU_HNSCC_derm002
11182,10326,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.468,0,DMSO ,OHSU_HNSCC_derm002
11183,10326,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.43,0,DMSO,OHSU_HNSCC_derm002
11184,10326,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.231,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11185,10326,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.149,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11186,10326,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.179,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11187,10326,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.238,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11188,10326,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.325,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11189,10326,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.092,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11190,10326,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.433,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
11191,10326,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.311,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
11192,10326,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.402,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
11193,10326,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.41,0,DMSO,OHSU_HNSCC_derm002
11194,10326,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.424,0,DMSO ,OHSU_HNSCC_derm002
11195,10326,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.397,0,DMSO,OHSU_HNSCC_derm002
11196,10326,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.443,0,DMSO ,OHSU_HNSCC_derm002
11197,10326,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.48,0,DMSO,OHSU_HNSCC_derm002
11198,10326,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.424,0,DMSO ,OHSU_HNSCC_derm002
11199,10326,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.424,0,DMSO,OHSU_HNSCC_derm002
11200,10326,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.299,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11201,10326,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.275,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11202,10326,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.266,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11203,10326,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.273,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11204,10326,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.39,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11205,10326,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.267,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11206,10326,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.446,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
11207,10326,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.364,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
11208,10326,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.422,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
11209,10326,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.415,0,DMSO,OHSU_HNSCC_derm002
11210,10326,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.435,0,DMSO ,OHSU_HNSCC_derm002
11211,10326,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.433,0,DMSO,OHSU_HNSCC_derm002
11212,10326,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.437,0,DMSO ,OHSU_HNSCC_derm002
11213,10326,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.426,0,DMSO,OHSU_HNSCC_derm002
11214,10326,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.422,0,DMSO ,OHSU_HNSCC_derm002
11215,10326,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.388,0,DMSO,OHSU_HNSCC_derm002
11216,10326,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.324,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11217,10326,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.409,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11218,10326,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.337,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11219,10326,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.325,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11220,10326,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.386,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11221,10326,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.385,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11222,10326,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.431,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
11223,10326,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.403,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
11224,10326,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.417,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
11225,10326,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.402,0,DMSO,OHSU_HNSCC_derm002
11226,10326,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.43,0,DMSO ,OHSU_HNSCC_derm002
11227,10326,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.445,0,DMSO,OHSU_HNSCC_derm002
11228,10326,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.451,0,DMSO ,OHSU_HNSCC_derm002
11229,10326,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.424,0,DMSO,OHSU_HNSCC_derm002
11230,10326,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.417,0,DMSO ,OHSU_HNSCC_derm002
11231,10326,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.37,0,DMSO,OHSU_HNSCC_derm002
11232,10326,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.342,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11233,10326,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.385,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
11234,10326,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.38,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
11235,10326,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.315,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
11236,10326,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.383,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
11237,10326,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.397,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
11238,10326,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.44,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
11239,10326,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
11240,10326,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.441,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
11241,10326,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.426,0,DMSO,OHSU_HNSCC_derm002
11242,10326,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.422,0,DMSO ,OHSU_HNSCC_derm002
11243,10326,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.418,0,DMSO,OHSU_HNSCC_derm002
11244,10326,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.514,0,DMSO ,OHSU_HNSCC_derm002
11245,10326,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.454,0,DMSO,OHSU_HNSCC_derm002
11246,10326,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.411,0,DMSO ,OHSU_HNSCC_derm002
11247,10326,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.433,0,DMSO,OHSU_HNSCC_derm002
11248,10326,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.337,0,NONE,OHSU_HNSCC_derm002
11249,10326,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.382,0,NONE,OHSU_HNSCC_derm002
11250,10326,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.365,0,NONE,OHSU_HNSCC_derm002
11251,10326,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
11252,10326,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.381,0,NONE,OHSU_HNSCC_derm002
11253,10326,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
11254,10326,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.421,0,NONE,OHSU_HNSCC_derm002
11255,10326,Blank 490,6,H,OHSU_HNSCC_derm002,8,0.002,10,F-S-V,OHSU_HNSCC_derm002
11256,10326,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.44,0,NONE,OHSU_HNSCC_derm002
11257,10326,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
11258,10326,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.418,0,NONE,OHSU_HNSCC_derm002
11259,10326,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.419,0,NONE,OHSU_HNSCC_derm002
11260,10326,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.465,0,NONE,OHSU_HNSCC_derm002
11261,10326,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.447,0,NONE,OHSU_HNSCC_derm002
11262,10326,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.462,0,NONE,OHSU_HNSCC_derm002
11263,10326,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.453,0,NONE,OHSU_HNSCC_derm002
11264,10326,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.23,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11265,10326,Blank 490,6,B,OHSU_HNSCC_derm002,9,-0.013,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11266,10326,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.086,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11267,10326,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.154,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11268,10326,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.322,5,Vandetanib (5mM),OHSU_HNSCC_derm002
11269,10326,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.376,0,DMSO,OHSU_HNSCC_derm002
11270,10326,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.467,0,DMSO ,OHSU_HNSCC_derm002
11271,10326,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.196,10,Brigatinib,OHSU_HNSCC_derm002
11272,10326,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.199,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11273,10326,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.396,0,DMSO,OHSU_HNSCC_derm002
11274,10326,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.446,0,DMSO ,OHSU_HNSCC_derm002
11275,10326,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.425,0,DMSO,OHSU_HNSCC_derm002
11276,10326,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.488,0,DMSO ,OHSU_HNSCC_derm002
11277,10326,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.475,0,DMSO,OHSU_HNSCC_derm002
11278,10326,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.426,0,DMSO ,OHSU_HNSCC_derm002
11279,10326,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.439,0,DMSO,OHSU_HNSCC_derm002
11280,10326,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.319,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11281,10326,Blank 490,6,B,OHSU_HNSCC_derm002,10,-0.015,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11282,10326,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.18,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11283,10326,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.169,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11284,10326,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.375,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
11285,10326,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.411,0,DMSO,OHSU_HNSCC_derm002
11286,10326,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.453,0,DMSO ,OHSU_HNSCC_derm002
11287,10326,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.332,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
11288,10326,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.225,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11289,10326,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.458,0,DMSO,OHSU_HNSCC_derm002
11290,10326,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.428,0,DMSO ,OHSU_HNSCC_derm002
11291,10326,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.442,0,DMSO,OHSU_HNSCC_derm002
11292,10326,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.477,0,DMSO ,OHSU_HNSCC_derm002
11293,10326,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.494,0,DMSO,OHSU_HNSCC_derm002
11294,10326,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.451,0,DMSO ,OHSU_HNSCC_derm002
11295,10326,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.42,0,DMSO,OHSU_HNSCC_derm002
11296,10326,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.355,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11297,10326,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.004,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11298,10326,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.268,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11299,10326,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.216,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11300,10326,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.364,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
11301,10326,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.404,0,DMSO,OHSU_HNSCC_derm002
11302,10326,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.444,0,DMSO ,OHSU_HNSCC_derm002
11303,10326,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.455,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
11304,10326,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.253,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11305,10326,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.435,0,DMSO,OHSU_HNSCC_derm002
11306,10326,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.455,0,DMSO ,OHSU_HNSCC_derm002
11307,10326,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.432,0,DMSO,OHSU_HNSCC_derm002
11308,10326,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.463,0,DMSO ,OHSU_HNSCC_derm002
11309,10326,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.461,0,DMSO,OHSU_HNSCC_derm002
11310,10326,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.456,0,DMSO ,OHSU_HNSCC_derm002
11311,10326,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.46,0,DMSO,OHSU_HNSCC_derm002
11312,10326,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.365,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11313,10326,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.063,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11314,10326,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.3,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11315,10326,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.232,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11316,10326,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.35,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
11317,10326,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.396,0,DMSO,OHSU_HNSCC_derm002
11318,10326,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.45,0,DMSO ,OHSU_HNSCC_derm002
11319,10326,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.428,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
11320,10326,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.335,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11321,10326,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.431,0,DMSO,OHSU_HNSCC_derm002
11322,10326,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.433,0,DMSO ,OHSU_HNSCC_derm002
11323,10326,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.474,0,DMSO,OHSU_HNSCC_derm002
11324,10326,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.454,0,DMSO ,OHSU_HNSCC_derm002
11325,10326,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.372,0,DMSO,OHSU_HNSCC_derm002
11326,10326,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.449,0,DMSO ,OHSU_HNSCC_derm002
11327,10326,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.477,0,DMSO,OHSU_HNSCC_derm002
11328,10326,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.336,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11329,10326,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.188,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11330,10326,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.333,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11331,10326,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.314,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11332,10326,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.365,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
11333,10326,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.418,0,DMSO,OHSU_HNSCC_derm002
11334,10326,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.44,0,DMSO ,OHSU_HNSCC_derm002
11335,10326,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.418,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
11336,10326,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.294,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11337,10326,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.458,0,DMSO,OHSU_HNSCC_derm002
11338,10326,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.437,0,DMSO ,OHSU_HNSCC_derm002
11339,10326,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.436,0,DMSO,OHSU_HNSCC_derm002
11340,10326,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.495,0,DMSO ,OHSU_HNSCC_derm002
11341,10326,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.44,0,DMSO,OHSU_HNSCC_derm002
11342,10326,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.462,0,DMSO ,OHSU_HNSCC_derm002
11343,10326,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.444,0,DMSO,OHSU_HNSCC_derm002
11344,10326,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.338,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11345,10326,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.3,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11346,10326,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.293,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11347,10326,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.341,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11348,10326,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.348,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
11349,10326,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.397,0,DMSO,OHSU_HNSCC_derm002
11350,10326,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.446,0,DMSO ,OHSU_HNSCC_derm002
11351,10326,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.433,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
11352,10326,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.293,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11353,10326,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.422,0,DMSO,OHSU_HNSCC_derm002
11354,10326,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.449,0,DMSO ,OHSU_HNSCC_derm002
11355,10326,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.438,0,DMSO,OHSU_HNSCC_derm002
11356,10326,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.429,0,DMSO ,OHSU_HNSCC_derm002
11357,10326,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.466,0,DMSO,OHSU_HNSCC_derm002
11358,10326,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.493,0,DMSO ,OHSU_HNSCC_derm002
11359,10326,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.451,0,DMSO,OHSU_HNSCC_derm002
11360,10326,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.369,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11361,10326,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.375,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
11362,10326,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.401,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
11363,10326,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.373,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
11364,10326,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.406,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
11365,10326,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.404,0,DMSO,OHSU_HNSCC_derm002
11366,10326,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.445,0,DMSO ,OHSU_HNSCC_derm002
11367,10326,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
11368,10326,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.324,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
11369,10326,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.43,0,DMSO,OHSU_HNSCC_derm002
11370,10326,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.435,0,DMSO ,OHSU_HNSCC_derm002
11371,10326,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.467,0,DMSO,OHSU_HNSCC_derm002
11372,10326,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.46,0,DMSO ,OHSU_HNSCC_derm002
11373,10326,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.455,0,DMSO,OHSU_HNSCC_derm002
11374,10326,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.436,0,DMSO ,OHSU_HNSCC_derm002
11375,10326,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.385,0,DMSO,OHSU_HNSCC_derm002
11376,10326,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.356,0,NONE,OHSU_HNSCC_derm002
11377,10326,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
11378,10326,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.41,0,NONE,OHSU_HNSCC_derm002
11379,10326,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.389,0,NONE,OHSU_HNSCC_derm002
11380,10326,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
11381,10326,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.39,0,NONE,OHSU_HNSCC_derm002
11382,10326,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.441,0,NONE,OHSU_HNSCC_derm002
11383,10326,Blank 490,6,H,OHSU_HNSCC_derm002,16,-0.002,10,F-S-V,OHSU_HNSCC_derm002
11384,10326,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.484,0,NONE,OHSU_HNSCC_derm002
11385,10326,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.471,0,NONE,OHSU_HNSCC_derm002
11386,10326,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.442,0,NONE,OHSU_HNSCC_derm002
11387,10326,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.44,0,NONE,OHSU_HNSCC_derm002
11388,10326,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.437,0,NONE,OHSU_HNSCC_derm002
11389,10326,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.449,0,NONE,OHSU_HNSCC_derm002
11390,10326,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.405,0,NONE,OHSU_HNSCC_derm002
11391,10326,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
11392,10326,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.066,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11393,10326,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.048,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11394,10326,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.398,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11395,10326,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.017,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11396,10326,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.476,10,LY3039478 ,OHSU_HNSCC_derm002
11397,10326,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.209,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11398,10326,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.237,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11399,10326,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.384,10,Trametinib,OHSU_HNSCC_derm002
11400,10326,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.115,10,BEZ235,OHSU_HNSCC_derm002
11401,10326,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.376,0,DMSO,OHSU_HNSCC_derm002
11402,10326,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.464,0,DMSO ,OHSU_HNSCC_derm002
11403,10326,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.442,0,DMSO,OHSU_HNSCC_derm002
11404,10326,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.416,0,DMSO ,OHSU_HNSCC_derm002
11405,10326,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.488,0,DMSO,OHSU_HNSCC_derm002
11406,10326,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.42,0,DMSO ,OHSU_HNSCC_derm002
11407,10326,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.452,0,DMSO,OHSU_HNSCC_derm002
11408,10326,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.136,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11409,10326,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.118,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11410,10326,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.385,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11411,10326,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.021,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11412,10326,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.486,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
11413,10326,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.241,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11414,10326,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.272,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11415,10326,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.433,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
11416,10326,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.119,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
11417,10326,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.435,0,DMSO,OHSU_HNSCC_derm002
11418,10326,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.43,0,DMSO ,OHSU_HNSCC_derm002
11419,10326,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.425,0,DMSO,OHSU_HNSCC_derm002
11420,10326,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.448,0,DMSO ,OHSU_HNSCC_derm002
11421,10326,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.445,0,DMSO,OHSU_HNSCC_derm002
11422,10326,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.414,0,DMSO ,OHSU_HNSCC_derm002
11423,10326,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.469,0,DMSO,OHSU_HNSCC_derm002
11424,10326,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.19,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11425,10326,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.195,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11426,10326,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.415,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11427,10326,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.02,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11428,10326,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.469,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
11429,10326,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.198,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11430,10326,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.308,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11431,10326,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
11432,10326,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.148,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
11433,10326,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.447,0,DMSO,OHSU_HNSCC_derm002
11434,10326,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.444,0,DMSO ,OHSU_HNSCC_derm002
11435,10326,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.439,0,DMSO,OHSU_HNSCC_derm002
11436,10326,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.463,0,DMSO ,OHSU_HNSCC_derm002
11437,10326,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.445,0,DMSO,OHSU_HNSCC_derm002
11438,10326,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.483,0,DMSO ,OHSU_HNSCC_derm002
11439,10326,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.44,0,DMSO,OHSU_HNSCC_derm002
11440,10326,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.254,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11441,10326,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.268,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11442,10326,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.387,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11443,10326,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.134,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11444,10326,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.46,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
11445,10326,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.262,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11446,10326,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.395,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11447,10326,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.385,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
11448,10326,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.152,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
11449,10326,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.408,0,DMSO,OHSU_HNSCC_derm002
11450,10326,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.439,0,DMSO ,OHSU_HNSCC_derm002
11451,10326,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.439,0,DMSO,OHSU_HNSCC_derm002
11452,10326,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.456,0,DMSO ,OHSU_HNSCC_derm002
11453,10326,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.432,0,DMSO,OHSU_HNSCC_derm002
11454,10326,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.482,0,DMSO ,OHSU_HNSCC_derm002
11455,10326,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.431,0,DMSO,OHSU_HNSCC_derm002
11456,10326,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.305,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11457,10326,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.291,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11458,10326,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.389,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11459,10326,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.318,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11460,10326,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.463,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
11461,10326,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.265,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11462,10326,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.397,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11463,10326,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.383,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
11464,10326,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.17,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
11465,10326,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.437,0,DMSO,OHSU_HNSCC_derm002
11466,10326,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.453,0,DMSO ,OHSU_HNSCC_derm002
11467,10326,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.449,0,DMSO,OHSU_HNSCC_derm002
11468,10326,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.468,0,DMSO ,OHSU_HNSCC_derm002
11469,10326,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.466,0,DMSO,OHSU_HNSCC_derm002
11470,10326,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.436,0,DMSO ,OHSU_HNSCC_derm002
11471,10326,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.481,0,DMSO,OHSU_HNSCC_derm002
11472,10326,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.324,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11473,10326,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.268,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11474,10326,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.412,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11475,10326,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.407,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11476,10326,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.482,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
11477,10326,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.329,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11478,10326,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.436,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11479,10326,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.432,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
11480,10326,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.215,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
11481,10326,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.455,0,DMSO,OHSU_HNSCC_derm002
11482,10326,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.451,0,DMSO ,OHSU_HNSCC_derm002
11483,10326,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.439,0,DMSO,OHSU_HNSCC_derm002
11484,10326,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.473,0,DMSO ,OHSU_HNSCC_derm002
11485,10326,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.427,0,DMSO,OHSU_HNSCC_derm002
11486,10326,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.436,0,DMSO ,OHSU_HNSCC_derm002
11487,10326,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.444,0,DMSO,OHSU_HNSCC_derm002
11488,10326,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.359,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
11489,10326,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.335,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
11490,10326,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.374,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
11491,10326,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.325,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
11492,10326,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.483,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
11493,10326,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.344,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
11494,10326,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.413,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
11495,10326,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.404,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
11496,10326,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.319,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
11497,10326,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.402,0,DMSO,OHSU_HNSCC_derm002
11498,10326,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.464,0,DMSO ,OHSU_HNSCC_derm002
11499,10326,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.444,0,DMSO,OHSU_HNSCC_derm002
11500,10326,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.436,0,DMSO ,OHSU_HNSCC_derm002
11501,10326,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.411,0,DMSO,OHSU_HNSCC_derm002
11502,10326,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.364,0,DMSO ,OHSU_HNSCC_derm002
11503,10326,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.444,0,DMSO,OHSU_HNSCC_derm002
11504,10326,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.353,0,NONE,OHSU_HNSCC_derm002
11505,10326,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.375,0,NONE,OHSU_HNSCC_derm002
11506,10326,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
11507,10326,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
11508,10326,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
11509,10326,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.393,0,NONE,OHSU_HNSCC_derm002
11510,10326,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
11511,10326,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.408,0,NONE,OHSU_HNSCC_derm002
11512,10326,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
11513,10326,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.471,0,NONE,OHSU_HNSCC_derm002
11514,10326,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.4,0,NONE,OHSU_HNSCC_derm002
11515,10326,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
11516,10326,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.418,0,NONE,OHSU_HNSCC_derm002
11517,10326,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
11518,10326,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
11519,10326,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.453,0,NONE,OHSU_HNSCC_derm002
11520,10326,Blank 490,1,A,OHSU_HNSCC_derm001,1,0.014,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
11521,10326,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.344,10,Lucitanib ,OHSU_HNSCC_derm001
11522,10326,Blank 490,1,C,OHSU_HNSCC_derm001,1,0.315,10,Resveratrol,OHSU_HNSCC_derm001
11523,10326,Blank 490,1,D,OHSU_HNSCC_derm001,1,0.203,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11524,10326,Blank 490,1,E,OHSU_HNSCC_derm001,1,0.251,10,Bicalutamide,OHSU_HNSCC_derm001
11525,10326,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.456,10,Methotrexate ,OHSU_HNSCC_derm001
11526,10326,Blank 490,1,G,OHSU_HNSCC_derm001,1,0.205,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11527,10326,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.14,10,Gefitinib,OHSU_HNSCC_derm001
11528,10326,Blank 490,1,I,OHSU_HNSCC_derm001,1,0.204,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
11529,10326,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.237,10,Tamatinib/R406,OHSU_HNSCC_derm001
11530,10326,Blank 490,1,K,OHSU_HNSCC_derm001,1,0.12,10,Bosutinib,OHSU_HNSCC_derm001
11531,10326,Blank 490,1,L,OHSU_HNSCC_derm001,1,0.026,10,PI-103,OHSU_HNSCC_derm001
11532,10326,Blank 490,1,M,OHSU_HNSCC_derm001,1,0.295,10,Glycyrrhizin,OHSU_HNSCC_derm001
11533,10326,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.396,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
11534,10326,Blank 490,1,O,OHSU_HNSCC_derm001,1,0.153,10,GSK-690693,OHSU_HNSCC_derm001
11535,10326,Blank 490,1,P,OHSU_HNSCC_derm001,1,0.224,10,Ibrutinib,OHSU_HNSCC_derm001
11536,10326,Blank 490,1,A,OHSU_HNSCC_derm001,2,0.044,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
11537,10326,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.454,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
11538,10326,Blank 490,1,C,OHSU_HNSCC_derm001,2,0.476,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
11539,10326,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.267,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11540,10326,Blank 490,1,E,OHSU_HNSCC_derm001,2,0.528,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
11541,10326,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.543,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
11542,10326,Blank 490,1,G,OHSU_HNSCC_derm001,2,0.297,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11543,10326,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.245,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
11544,10326,Blank 490,1,I,OHSU_HNSCC_derm001,2,0.44,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
11545,10326,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.323,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
11546,10326,Blank 490,1,K,OHSU_HNSCC_derm001,2,0.279,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
11547,10326,Blank 490,1,L,OHSU_HNSCC_derm001,2,0.041,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
11548,10326,Blank 490,1,M,OHSU_HNSCC_derm001,2,0.509,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
11549,10326,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.5,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
11550,10326,Blank 490,1,O,OHSU_HNSCC_derm001,2,0.306,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
11551,10326,Blank 490,1,P,OHSU_HNSCC_derm001,2,0.34,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
11552,10326,Blank 490,1,A,OHSU_HNSCC_derm001,3,0.072,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
11553,10326,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.525,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
11554,10326,Blank 490,1,C,OHSU_HNSCC_derm001,3,0.534,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
11555,10326,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.289,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11556,10326,Blank 490,1,E,OHSU_HNSCC_derm001,3,0.561,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
11557,10326,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.537,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
11558,10326,Blank 490,1,G,OHSU_HNSCC_derm001,3,0.336,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11559,10326,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.271,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
11560,10326,Blank 490,1,I,OHSU_HNSCC_derm001,3,0.536,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
11561,10326,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.395,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
11562,10326,Blank 490,1,K,OHSU_HNSCC_derm001,3,0.454,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
11563,10326,Blank 490,1,L,OHSU_HNSCC_derm001,3,0.093,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
11564,10326,Blank 490,1,M,OHSU_HNSCC_derm001,3,0.556,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
11565,10326,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.549,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
11566,10326,Blank 490,1,O,OHSU_HNSCC_derm001,3,0.42,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
11567,10326,Blank 490,1,P,OHSU_HNSCC_derm001,3,0.32,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
11568,10326,Blank 490,1,A,OHSU_HNSCC_derm001,4,0.12,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
11569,10326,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.505,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
11570,10326,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.554,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
11571,10326,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.257,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11572,10326,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.562,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
11573,10326,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.55,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
11574,10326,Blank 490,1,G,OHSU_HNSCC_derm001,4,0.373,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11575,10326,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.323,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
11576,10326,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.54,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
11577,10326,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.461,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
11578,10326,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.548,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
11579,10326,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.185,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
11580,10326,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.49,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
11581,10326,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.482,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
11582,10326,Blank 490,1,O,OHSU_HNSCC_derm001,4,0.479,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
11583,10326,Blank 490,1,P,OHSU_HNSCC_derm001,4,0.358,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
11584,10326,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.175,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
11585,10326,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.496,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
11586,10326,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.504,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
11587,10326,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.269,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11588,10326,Blank 490,1,E,OHSU_HNSCC_derm001,5,0.553,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
11589,10326,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.551,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
11590,10326,Blank 490,1,G,OHSU_HNSCC_derm001,5,0.475,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11591,10326,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.366,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
11592,10326,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.503,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
11593,10326,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.484,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
11594,10326,Blank 490,1,K,OHSU_HNSCC_derm001,5,0.565,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
11595,10326,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.362,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
11596,10326,Blank 490,1,M,OHSU_HNSCC_derm001,5,0.546,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
11597,10326,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.512,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
11598,10326,Blank 490,1,O,OHSU_HNSCC_derm001,5,0.552,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
11599,10326,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.436,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
11600,10326,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.332,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
11601,10326,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.496,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
11602,10326,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.528,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
11603,10326,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.345,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11604,10326,Blank 490,1,E,OHSU_HNSCC_derm001,6,0.567,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
11605,10326,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.535,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
11606,10326,Blank 490,1,G,OHSU_HNSCC_derm001,6,0.458,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11607,10326,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.441,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
11608,10326,Blank 490,1,I,OHSU_HNSCC_derm001,6,0.536,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
11609,10326,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.496,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
11610,10326,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.559,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
11611,10326,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.488,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
11612,10326,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.519,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
11613,10326,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.521,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
11614,10326,Blank 490,1,O,OHSU_HNSCC_derm001,6,0.596,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
11615,10326,Blank 490,1,P,OHSU_HNSCC_derm001,6,0.433,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
11616,10326,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.334,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
11617,10326,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.473,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
11618,10326,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.52,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
11619,10326,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.382,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
11620,10326,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.558,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
11621,10326,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.494,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
11622,10326,Blank 490,1,G,OHSU_HNSCC_derm001,7,0.501,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
11623,10326,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.507,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
11624,10326,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.515,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
11625,10326,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.484,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
11626,10326,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.553,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
11627,10326,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.511,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
11628,10326,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.419,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
11629,10326,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.509,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
11630,10326,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.58,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
11631,10326,Blank 490,1,P,OHSU_HNSCC_derm001,7,0.468,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
11632,10326,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.366,0,NONE,OHSU_HNSCC_derm001
11633,10326,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.513,0,NONE,OHSU_HNSCC_derm001
11634,10326,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.544,0,NONE,OHSU_HNSCC_derm001
11635,10326,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.491,0,NONE,OHSU_HNSCC_derm001
11636,10326,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.573,0,NONE,OHSU_HNSCC_derm001
11637,10326,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.514,0,NONE,OHSU_HNSCC_derm001
11638,10326,Blank 490,1,G,OHSU_HNSCC_derm001,8,0.529,0,NONE,OHSU_HNSCC_derm001
11639,10326,Blank 490,1,H,OHSU_HNSCC_derm001,8,0.004,10,F-S-V,OHSU_HNSCC_derm001
11640,10326,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.496,0,NONE,OHSU_HNSCC_derm001
11641,10326,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.482,0,NONE,OHSU_HNSCC_derm001
11642,10326,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.552,0,NONE,OHSU_HNSCC_derm001
11643,10326,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.505,0,NONE,OHSU_HNSCC_derm001
11644,10326,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.522,0,NONE,OHSU_HNSCC_derm001
11645,10326,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.483,0,NONE,OHSU_HNSCC_derm001
11646,10326,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.559,0,NONE,OHSU_HNSCC_derm001
11647,10326,Blank 490,1,P,OHSU_HNSCC_derm001,8,0.545,0,NONE,OHSU_HNSCC_derm001
11648,10326,Blank 490,1,A,OHSU_HNSCC_derm001,9,0.013,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11649,10326,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.296,10,Sorafenib,OHSU_HNSCC_derm001
11650,10326,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.558,10,Rosmarinic acid,OHSU_HNSCC_derm001
11651,10326,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.319,10,Rapamycin,OHSU_HNSCC_derm001
11652,10326,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.493,10,Vismodegib,OHSU_HNSCC_derm001
11653,10326,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.17,10,PP242,OHSU_HNSCC_derm001
11654,10326,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.307,10,Alectinib,OHSU_HNSCC_derm001
11655,10326,Blank 490,1,H,OHSU_HNSCC_derm001,9,0.229,10,Brigatinib,OHSU_HNSCC_derm001
11656,10326,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.207,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11657,10326,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.263,10,MK-2206,OHSU_HNSCC_derm001
11658,10326,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.287,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11659,10326,Blank 490,1,L,OHSU_HNSCC_derm001,9,0.029,10,Flavopiridol ,OHSU_HNSCC_derm001
11660,10326,Blank 490,1,M,OHSU_HNSCC_derm001,9,0.476,10,Indirubin,OHSU_HNSCC_derm001
11661,10326,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.503,10,PF-533228,OHSU_HNSCC_derm001
11662,10326,Blank 490,1,O,OHSU_HNSCC_derm001,9,0.514,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11663,10326,Blank 490,1,P,OHSU_HNSCC_derm001,9,0.065,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11664,10326,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.013,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11665,10326,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.462,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
11666,10326,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.532,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
11667,10326,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.355,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
11668,10326,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.517,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
11669,10326,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.192,3.3333333333333335,PP242,OHSU_HNSCC_derm001
11670,10326,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.455,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
11671,10326,Blank 490,1,H,OHSU_HNSCC_derm001,10,0.318,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
11672,10326,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.255,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11673,10326,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.315,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
11674,10326,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.32,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11675,10326,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.029,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
11676,10326,Blank 490,1,M,OHSU_HNSCC_derm001,10,0.53,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
11677,10326,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.523,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
11678,10326,Blank 490,1,O,OHSU_HNSCC_derm001,10,0.523,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11679,10326,Blank 490,1,P,OHSU_HNSCC_derm001,10,0.137,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11680,10326,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.014,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11681,10326,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.48,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
11682,10326,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.528,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
11683,10326,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.338,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
11684,10326,Blank 490,1,E,OHSU_HNSCC_derm001,11,0.536,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
11685,10326,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.222,1.1111111111111112,PP242,OHSU_HNSCC_derm001
11686,10326,Blank 490,1,G,OHSU_HNSCC_derm001,11,0.489,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
11687,10326,Blank 490,1,H,OHSU_HNSCC_derm001,11,0.446,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
11688,10326,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.269,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11689,10326,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.381,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
11690,10326,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.321,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11691,10326,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.027,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
11692,10326,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.51,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
11693,10326,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.545,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
11694,10326,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.531,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11695,10326,Blank 490,1,P,OHSU_HNSCC_derm001,11,0.416,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11696,10326,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.012,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11697,10326,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.49,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
11698,10326,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.515,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
11699,10326,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.267,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
11700,10326,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.536,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
11701,10326,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.313,0.3703703703703704,PP242,OHSU_HNSCC_derm001
11702,10326,Blank 490,1,G,OHSU_HNSCC_derm001,12,0.48,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
11703,10326,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.452,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
11704,10326,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.274,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11705,10326,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.428,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
11706,10326,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.343,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11707,10326,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.032,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
11708,10326,Blank 490,1,M,OHSU_HNSCC_derm001,12,0.553,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
11709,10326,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.565,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
11710,10326,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.546,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11711,10326,Blank 490,1,P,OHSU_HNSCC_derm001,12,0.502,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11712,10326,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.025,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11713,10326,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.492,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
11714,10326,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.502,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
11715,10326,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.323,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
11716,10326,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.527,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
11717,10326,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.378,0.1234567901234568,PP242,OHSU_HNSCC_derm001
11718,10326,Blank 490,1,G,OHSU_HNSCC_derm001,13,0.556,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
11719,10326,Blank 490,1,H,OHSU_HNSCC_derm001,13,0.501,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
11720,10326,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.312,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11721,10326,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.478,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
11722,10326,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.38,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11723,10326,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.136,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
11724,10326,Blank 490,1,M,OHSU_HNSCC_derm001,13,0.516,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
11725,10326,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.542,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
11726,10326,Blank 490,1,O,OHSU_HNSCC_derm001,13,0.597,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11727,10326,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.317,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11728,10326,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.042,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11729,10326,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.492,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
11730,10326,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.524,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
11731,10326,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.359,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
11732,10326,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.571,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
11733,10326,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.477,0.0411522633744856,PP242,OHSU_HNSCC_derm001
11734,10326,Blank 490,1,G,OHSU_HNSCC_derm001,14,0.512,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
11735,10326,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.459,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
11736,10326,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.314,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11737,10326,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.507,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
11738,10326,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.448,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11739,10326,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.446,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
11740,10326,Blank 490,1,M,OHSU_HNSCC_derm001,14,0.416,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
11741,10326,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.562,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
11742,10326,Blank 490,1,O,OHSU_HNSCC_derm001,14,0.595,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11743,10326,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.545,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11744,10326,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.162,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
11745,10326,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.511,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
11746,10326,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.522,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
11747,10326,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.368,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
11748,10326,Blank 490,1,E,OHSU_HNSCC_derm001,15,0.527,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
11749,10326,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.514,0.013717421124828532,PP242,OHSU_HNSCC_derm001
11750,10326,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.554,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
11751,10326,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.501,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
11752,10326,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.38,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
11753,10326,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.521,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
11754,10326,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.466,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
11755,10326,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.512,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
11756,10326,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.5,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
11757,10326,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.501,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
11758,10326,Blank 490,1,O,OHSU_HNSCC_derm001,15,0.522,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
11759,10326,Blank 490,1,P,OHSU_HNSCC_derm001,15,0.561,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
11760,10326,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.341,0,NONE,OHSU_HNSCC_derm001
11761,10326,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.467,0,NONE,OHSU_HNSCC_derm001
11762,10326,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.488,0,NONE,OHSU_HNSCC_derm001
11763,10326,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.52,0,NONE,OHSU_HNSCC_derm001
11764,10326,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.504,0,NONE,OHSU_HNSCC_derm001
11765,10326,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.509,0,NONE,OHSU_HNSCC_derm001
11766,10326,Blank 490,1,G,OHSU_HNSCC_derm001,16,0.55,0,NONE,OHSU_HNSCC_derm001
11767,10326,Blank 490,1,H,OHSU_HNSCC_derm001,16,-0.004,10,F-S-V,OHSU_HNSCC_derm001
11768,10326,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.505,0,NONE,OHSU_HNSCC_derm001
11769,10326,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.448,0,NONE,OHSU_HNSCC_derm001
11770,10326,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.55,0,NONE,OHSU_HNSCC_derm001
11771,10326,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.519,0,NONE,OHSU_HNSCC_derm001
11772,10326,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.512,0,NONE,OHSU_HNSCC_derm001
11773,10326,Blank 490,1,N,OHSU_HNSCC_derm001,16,0.522,0,NONE,OHSU_HNSCC_derm001
11774,10326,Blank 490,1,O,OHSU_HNSCC_derm001,16,0.57,0,NONE,OHSU_HNSCC_derm001
11775,10326,Blank 490,1,P,OHSU_HNSCC_derm001,16,0.326,0,NONE,OHSU_HNSCC_derm001
11776,10326,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.303,10,Emodin,OHSU_HNSCC_derm001
11777,10326,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.475,10,Baicalin,OHSU_HNSCC_derm001
11778,10326,Blank 490,1,C,OHSU_HNSCC_derm001,17,0.223,10,NVP-TAE-684,OHSU_HNSCC_derm001
11779,10326,Blank 490,1,D,OHSU_HNSCC_derm001,17,0.041,10,Panobinostat,OHSU_HNSCC_derm001
11780,10326,Blank 490,1,E,OHSU_HNSCC_derm001,17,0.077,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
11781,10326,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.537,10,Fulvestrant,OHSU_HNSCC_derm001
11782,10326,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.399,10,SCH-772984,OHSU_HNSCC_derm001
11783,10326,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.378,10,Trametinib,OHSU_HNSCC_derm001
11784,10326,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.126,10,BEZ235,OHSU_HNSCC_derm001
11785,10326,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.468,10,MLN120B,OHSU_HNSCC_derm001
11786,10326,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.302,10,Ixabepilone,OHSU_HNSCC_derm001
11787,10326,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.011,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
11788,10326,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.398,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11789,10326,Blank 490,1,N,OHSU_HNSCC_derm001,17,0.381,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11790,10326,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.252,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11791,10326,Blank 490,1,P,OHSU_HNSCC_derm001,17,0.499,10,Letrozole,OHSU_HNSCC_derm001
11792,10326,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.331,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
11793,10326,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.48,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
11794,10326,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.448,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
11795,10326,Blank 490,1,D,OHSU_HNSCC_derm001,18,0.05,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
11796,10326,Blank 490,1,E,OHSU_HNSCC_derm001,18,0.12,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
11797,10326,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.501,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
11798,10326,Blank 490,1,G,OHSU_HNSCC_derm001,18,0.361,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
11799,10326,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.389,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
11800,10326,Blank 490,1,I,OHSU_HNSCC_derm001,18,0.114,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
11801,10326,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.466,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
11802,10326,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.31,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
11803,10326,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.267,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
11804,10326,Blank 490,1,M,OHSU_HNSCC_derm001,18,0.416,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11805,10326,Blank 490,1,N,OHSU_HNSCC_derm001,18,0.408,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11806,10326,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.279,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11807,10326,Blank 490,1,P,OHSU_HNSCC_derm001,18,0.459,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
11808,10326,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.353,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
11809,10326,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.495,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
11810,10326,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.472,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
11811,10326,Blank 490,1,D,OHSU_HNSCC_derm001,19,0.073,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
11812,10326,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.138,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
11813,10326,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.533,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
11814,10326,Blank 490,1,G,OHSU_HNSCC_derm001,19,0.392,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
11815,10326,Blank 490,1,H,OHSU_HNSCC_derm001,19,0.415,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
11816,10326,Blank 490,1,I,OHSU_HNSCC_derm001,19,0.14,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
11817,10326,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.522,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
11818,10326,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.316,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
11819,10326,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.32,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
11820,10326,Blank 490,1,M,OHSU_HNSCC_derm001,19,0.434,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11821,10326,Blank 490,1,N,OHSU_HNSCC_derm001,19,0.407,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11822,10326,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.297,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11823,10326,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.491,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
11824,10326,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.364,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
11825,10326,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.508,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
11826,10326,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.468,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
11827,10326,Blank 490,1,D,OHSU_HNSCC_derm001,20,0.151,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
11828,10326,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.239,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
11829,10326,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.509,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
11830,10326,Blank 490,1,G,OHSU_HNSCC_derm001,20,0.486,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
11831,10326,Blank 490,1,H,OHSU_HNSCC_derm001,20,0.435,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
11832,10326,Blank 490,1,I,OHSU_HNSCC_derm001,20,0.159,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
11833,10326,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.535,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
11834,10326,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.34,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
11835,10326,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.343,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
11836,10326,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.465,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11837,10326,Blank 490,1,N,OHSU_HNSCC_derm001,20,0.387,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11838,10326,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.317,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11839,10326,Blank 490,1,P,OHSU_HNSCC_derm001,20,0.324,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
11840,10326,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.354,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
11841,10326,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.497,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
11842,10326,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.457,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
11843,10326,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.32,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
11844,10326,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.348,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
11845,10326,Blank 490,1,F,OHSU_HNSCC_derm001,21,0.558,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
11846,10326,Blank 490,1,G,OHSU_HNSCC_derm001,21,0.482,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
11847,10326,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.429,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
11848,10326,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.201,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
11849,10326,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.508,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
11850,10326,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.362,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
11851,10326,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.398,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
11852,10326,Blank 490,1,M,OHSU_HNSCC_derm001,21,0.422,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11853,10326,Blank 490,1,N,OHSU_HNSCC_derm001,21,0.465,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11854,10326,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.308,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11855,10326,Blank 490,1,P,OHSU_HNSCC_derm001,21,0.506,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
11856,10326,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.36,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
11857,10326,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.484,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
11858,10326,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.507,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
11859,10326,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.402,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
11860,10326,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.429,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
11861,10326,Blank 490,1,F,OHSU_HNSCC_derm001,22,0.527,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
11862,10326,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.508,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
11863,10326,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.384,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
11864,10326,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.329,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
11865,10326,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.501,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
11866,10326,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.393,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
11867,10326,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.439,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
11868,10326,Blank 490,1,M,OHSU_HNSCC_derm001,22,0.468,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11869,10326,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.528,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11870,10326,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.308,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11871,10326,Blank 490,1,P,OHSU_HNSCC_derm001,22,0.384,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
11872,10326,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.349,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
11873,10326,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.458,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
11874,10326,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.502,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
11875,10326,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.453,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
11876,10326,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.477,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
11877,10326,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.507,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
11878,10326,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.515,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
11879,10326,Blank 490,1,H,OHSU_HNSCC_derm001,23,0.435,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
11880,10326,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.377,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
11881,10326,Blank 490,1,J,OHSU_HNSCC_derm001,23,0.473,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
11882,10326,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.372,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
11883,10326,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.412,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
11884,10326,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.473,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
11885,10326,Blank 490,1,N,OHSU_HNSCC_derm001,23,0.487,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
11886,10326,Blank 490,1,O,OHSU_HNSCC_derm001,23,0.365,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
11887,10326,Blank 490,1,P,OHSU_HNSCC_derm001,23,0.309,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
11888,10326,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.325,0,NONE,OHSU_HNSCC_derm001
11889,10326,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.342,0,NONE,OHSU_HNSCC_derm001
11890,10326,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.317,0,NONE,OHSU_HNSCC_derm001
11891,10326,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.293,0,NONE,OHSU_HNSCC_derm001
11892,10326,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.296,0,NONE,OHSU_HNSCC_derm001
11893,10326,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.263,0,NONE,OHSU_HNSCC_derm001
11894,10326,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.344,0,NONE,OHSU_HNSCC_derm001
11895,10326,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.272,0,NONE,OHSU_HNSCC_derm001
11896,10326,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.319,0,NONE,OHSU_HNSCC_derm001
11897,10326,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.289,0,NONE,OHSU_HNSCC_derm001
11898,10326,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.351,0,NONE,OHSU_HNSCC_derm001
11899,10326,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.37,0,NONE,OHSU_HNSCC_derm001
11900,10326,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.385,0,NONE,OHSU_HNSCC_derm001
11901,10326,Blank 490,1,N,OHSU_HNSCC_derm001,24,0.311,0,NONE,OHSU_HNSCC_derm001
11902,10326,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.383,0,NONE,OHSU_HNSCC_derm001
11903,10326,Blank 490,1,P,OHSU_HNSCC_derm001,24,0.375,0,NONE,OHSU_HNSCC_derm001
11904,10326,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.37,10,Coumarin,OHSU_HNSCC_derm001
11905,10326,Blank 490,2,B,OHSU_HNSCC_derm001,1,0.103,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11906,10326,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.095,10,Foretinib (XL-880),OHSU_HNSCC_derm001
11907,10326,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.387,10,Elesclomol,OHSU_HNSCC_derm001
11908,10326,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.339,10,Vemurafenib,OHSU_HNSCC_derm001
11909,10326,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.072,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11910,10326,Blank 490,2,G,OHSU_HNSCC_derm001,1,0.01,10,Ponatinib,OHSU_HNSCC_derm001
11911,10326,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.161,10,Gefitinib,OHSU_HNSCC_derm001
11912,10326,Blank 490,2,I,OHSU_HNSCC_derm001,1,0.183,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
11913,10326,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.431,1,Sunitinib (1mM),OHSU_HNSCC_derm001
11914,10326,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.362,10,Curcumin,OHSU_HNSCC_derm001
11915,10326,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.078,10,PF-562271,OHSU_HNSCC_derm001
11916,10326,Blank 490,2,M,OHSU_HNSCC_derm001,1,0.349,10,STO609,OHSU_HNSCC_derm001
11917,10326,Blank 490,2,N,OHSU_HNSCC_derm001,1,0.344,10,Lenvatinib,OHSU_HNSCC_derm001
11918,10326,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.095,10,Entrectinib,OHSU_HNSCC_derm001
11919,10326,Blank 490,2,P,OHSU_HNSCC_derm001,1,0.445,10,Ethyl Gallate ,OHSU_HNSCC_derm001
11920,10326,Blank 490,2,A,OHSU_HNSCC_derm001,2,0.347,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
11921,10326,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.179,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11922,10326,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.267,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
11923,10326,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.423,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
11924,10326,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.378,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
11925,10326,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.09,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11926,10326,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.047,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
11927,10326,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.251,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
11928,10326,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.259,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
11929,10326,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.45,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
11930,10326,Blank 490,2,K,OHSU_HNSCC_derm001,2,0.393,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
11931,10326,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.432,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
11932,10326,Blank 490,2,M,OHSU_HNSCC_derm001,2,0.385,3.3333333333333335,STO609,OHSU_HNSCC_derm001
11933,10326,Blank 490,2,N,OHSU_HNSCC_derm001,2,0.495,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
11934,10326,Blank 490,2,O,OHSU_HNSCC_derm001,2,0.433,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
11935,10326,Blank 490,2,P,OHSU_HNSCC_derm001,2,0.421,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
11936,10326,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.378,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
11937,10326,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.165,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11938,10326,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.457,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
11939,10326,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.418,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
11940,10326,Blank 490,2,E,OHSU_HNSCC_derm001,3,0.51,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
11941,10326,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.124,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11942,10326,Blank 490,2,G,OHSU_HNSCC_derm001,3,0.402,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
11943,10326,Blank 490,2,H,OHSU_HNSCC_derm001,3,0.289,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
11944,10326,Blank 490,2,I,OHSU_HNSCC_derm001,3,0.504,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
11945,10326,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.508,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
11946,10326,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.52,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
11947,10326,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.525,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
11948,10326,Blank 490,2,M,OHSU_HNSCC_derm001,3,0.373,1.1111111111111112,STO609,OHSU_HNSCC_derm001
11949,10326,Blank 490,2,N,OHSU_HNSCC_derm001,3,0.529,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
11950,10326,Blank 490,2,O,OHSU_HNSCC_derm001,3,0.483,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
11951,10326,Blank 490,2,P,OHSU_HNSCC_derm001,3,0.442,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
11952,10326,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.398,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
11953,10326,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.212,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11954,10326,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.459,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
11955,10326,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.362,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
11956,10326,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.525,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
11957,10326,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.164,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11958,10326,Blank 490,2,G,OHSU_HNSCC_derm001,4,0.567,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
11959,10326,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.355,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
11960,10326,Blank 490,2,I,OHSU_HNSCC_derm001,4,0.506,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
11961,10326,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.529,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
11962,10326,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.53,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
11963,10326,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.563,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
11964,10326,Blank 490,2,M,OHSU_HNSCC_derm001,4,0.579,0.3703703703703704,STO609,OHSU_HNSCC_derm001
11965,10326,Blank 490,2,N,OHSU_HNSCC_derm001,4,0.538,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
11966,10326,Blank 490,2,O,OHSU_HNSCC_derm001,4,0.48,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
11967,10326,Blank 490,2,P,OHSU_HNSCC_derm001,4,0.5,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
11968,10326,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.395,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
11969,10326,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.207,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11970,10326,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.469,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
11971,10326,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.131,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
11972,10326,Blank 490,2,E,OHSU_HNSCC_derm001,5,0.554,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
11973,10326,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.252,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11974,10326,Blank 490,2,G,OHSU_HNSCC_derm001,5,0.553,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
11975,10326,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.45,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
11976,10326,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.521,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
11977,10326,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.466,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
11978,10326,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.561,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
11979,10326,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.559,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
11980,10326,Blank 490,2,M,OHSU_HNSCC_derm001,5,0.554,0.1234567901234568,STO609,OHSU_HNSCC_derm001
11981,10326,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.545,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
11982,10326,Blank 490,2,O,OHSU_HNSCC_derm001,5,0.536,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
11983,10326,Blank 490,2,P,OHSU_HNSCC_derm001,5,0.517,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
11984,10326,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.407,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
11985,10326,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.229,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
11986,10326,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.459,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
11987,10326,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.162,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
11988,10326,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.551,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
11989,10326,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.357,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
11990,10326,Blank 490,2,G,OHSU_HNSCC_derm001,6,0.57,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
11991,10326,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.461,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
11992,10326,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.525,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
11993,10326,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.493,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
11994,10326,Blank 490,2,K,OHSU_HNSCC_derm001,6,0.565,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
11995,10326,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.565,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
11996,10326,Blank 490,2,M,OHSU_HNSCC_derm001,6,0.616,0.0411522633744856,STO609,OHSU_HNSCC_derm001
11997,10326,Blank 490,2,N,OHSU_HNSCC_derm001,6,0.557,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
11998,10326,Blank 490,2,O,OHSU_HNSCC_derm001,6,0.482,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
11999,10326,Blank 490,2,P,OHSU_HNSCC_derm001,6,0.484,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
12000,10326,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.381,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
12001,10326,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.316,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
12002,10326,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.428,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
12003,10326,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.37,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
12004,10326,Blank 490,2,E,OHSU_HNSCC_derm001,7,0.553,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
12005,10326,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.471,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
12006,10326,Blank 490,2,G,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
12007,10326,Blank 490,2,H,OHSU_HNSCC_derm001,7,0.453,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
12008,10326,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.354,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
12009,10326,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.285,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
12010,10326,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.536,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
12011,10326,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.582,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
12012,10326,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.575,0.013717421124828532,STO609,OHSU_HNSCC_derm001
12013,10326,Blank 490,2,N,OHSU_HNSCC_derm001,7,0.561,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
12014,10326,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.548,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
12015,10326,Blank 490,2,P,OHSU_HNSCC_derm001,7,0.519,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
12016,10326,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.383,0,NONE,OHSU_HNSCC_derm001
12017,10326,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.432,0,NONE,OHSU_HNSCC_derm001
12018,10326,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.438,0,NONE,OHSU_HNSCC_derm001
12019,10326,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.485,0,NONE,OHSU_HNSCC_derm001
12020,10326,Blank 490,2,E,OHSU_HNSCC_derm001,8,0.575,0,NONE,OHSU_HNSCC_derm001
12021,10326,Blank 490,2,F,OHSU_HNSCC_derm001,8,0.531,0,NONE,OHSU_HNSCC_derm001
12022,10326,Blank 490,2,G,OHSU_HNSCC_derm001,8,0.283,0,NONE,OHSU_HNSCC_derm001
12023,10326,Blank 490,2,H,OHSU_HNSCC_derm001,8,0.002,10,F-S-V,OHSU_HNSCC_derm001
12024,10326,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.37,0,NONE,OHSU_HNSCC_derm001
12025,10326,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.51,0,NONE,OHSU_HNSCC_derm001
12026,10326,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.56,0,NONE,OHSU_HNSCC_derm001
12027,10326,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.53,0,NONE,OHSU_HNSCC_derm001
12028,10326,Blank 490,2,M,OHSU_HNSCC_derm001,8,0.559,0,NONE,OHSU_HNSCC_derm001
12029,10326,Blank 490,2,N,OHSU_HNSCC_derm001,8,0.55,0,NONE,OHSU_HNSCC_derm001
12030,10326,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.574,0,NONE,OHSU_HNSCC_derm001
12031,10326,Blank 490,2,P,OHSU_HNSCC_derm001,8,0.534,0,NONE,OHSU_HNSCC_derm001
12032,10326,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.06,10,GDC-0941,OHSU_HNSCC_derm001
12033,10326,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.383,10,Dovitinib,OHSU_HNSCC_derm001
12034,10326,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.536,10,BI-2536,OHSU_HNSCC_derm001
12035,10326,Blank 490,2,D,OHSU_HNSCC_derm001,9,0.027,10,TP-0903 ,OHSU_HNSCC_derm001
12036,10326,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.103,10,Belinostat,OHSU_HNSCC_derm001
12037,10326,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.057,10,INK-128,OHSU_HNSCC_derm001
12038,10326,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.198,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12039,10326,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.203,10,Brigatinib,OHSU_HNSCC_derm001
12040,10326,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.21,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12041,10326,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.165,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12042,10326,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.406,10,Pazopanib,OHSU_HNSCC_derm001
12043,10326,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.491,10,AZD4547,OHSU_HNSCC_derm001
12044,10326,Blank 490,2,M,OHSU_HNSCC_derm001,9,0.569,10,Pomalidomide ,OHSU_HNSCC_derm001
12045,10326,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.438,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
12046,10326,Blank 490,2,O,OHSU_HNSCC_derm001,9,0.482,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12047,10326,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.009,10,Staurosporin,OHSU_HNSCC_derm001
12048,10326,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.056,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
12049,10326,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.421,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
12050,10326,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.593,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
12051,10326,Blank 490,2,D,OHSU_HNSCC_derm001,10,0.021,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
12052,10326,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.225,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
12053,10326,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.074,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
12054,10326,Blank 490,2,G,OHSU_HNSCC_derm001,10,0.28,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12055,10326,Blank 490,2,H,OHSU_HNSCC_derm001,10,0.357,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
12056,10326,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.247,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12057,10326,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.21,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12058,10326,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.432,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
12059,10326,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.539,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
12060,10326,Blank 490,2,M,OHSU_HNSCC_derm001,10,0.564,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
12061,10326,Blank 490,2,N,OHSU_HNSCC_derm001,10,0.485,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
12062,10326,Blank 490,2,O,OHSU_HNSCC_derm001,10,0.482,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12063,10326,Blank 490,2,P,OHSU_HNSCC_derm001,10,0.013,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
12064,10326,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.105,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
12065,10326,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.457,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
12066,10326,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.587,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
12067,10326,Blank 490,2,D,OHSU_HNSCC_derm001,11,0.035,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
12068,10326,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.349,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
12069,10326,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.09,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
12070,10326,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.31,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12071,10326,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.458,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
12072,10326,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.305,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12073,10326,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.312,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12074,10326,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.498,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
12075,10326,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.556,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
12076,10326,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.605,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
12077,10326,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.518,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
12078,10326,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.544,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12079,10326,Blank 490,2,P,OHSU_HNSCC_derm001,11,0.015,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
12080,10326,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.2,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
12081,10326,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.449,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
12082,10326,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.559,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
12083,10326,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.283,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
12084,10326,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.435,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
12085,10326,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.119,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
12086,10326,Blank 490,2,G,OHSU_HNSCC_derm001,12,0.364,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12087,10326,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.432,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
12088,10326,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.314,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12089,10326,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.39,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12090,10326,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.527,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
12091,10326,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.536,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
12092,10326,Blank 490,2,M,OHSU_HNSCC_derm001,12,0.575,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
12093,10326,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.555,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
12094,10326,Blank 490,2,O,OHSU_HNSCC_derm001,12,0.533,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12095,10326,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.038,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
12096,10326,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.285,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
12097,10326,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.458,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
12098,10326,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.493,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
12099,10326,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.484,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
12100,10326,Blank 490,2,E,OHSU_HNSCC_derm001,13,0.53,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
12101,10326,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.151,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
12102,10326,Blank 490,2,G,OHSU_HNSCC_derm001,13,0.374,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12103,10326,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.517,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
12104,10326,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.352,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12105,10326,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.446,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12106,10326,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.579,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
12107,10326,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.555,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
12108,10326,Blank 490,2,M,OHSU_HNSCC_derm001,13,0.548,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
12109,10326,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.562,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
12110,10326,Blank 490,2,O,OHSU_HNSCC_derm001,13,0.532,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12111,10326,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.16,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
12112,10326,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.346,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
12113,10326,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.447,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
12114,10326,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.438,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
12115,10326,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.523,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
12116,10326,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.539,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
12117,10326,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.207,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
12118,10326,Blank 490,2,G,OHSU_HNSCC_derm001,14,0.391,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12119,10326,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.532,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
12120,10326,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.356,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12121,10326,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.466,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12122,10326,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.527,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
12123,10326,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.549,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
12124,10326,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.58,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
12125,10326,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.534,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
12126,10326,Blank 490,2,O,OHSU_HNSCC_derm001,14,0.493,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12127,10326,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.378,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
12128,10326,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.388,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
12129,10326,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.41,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
12130,10326,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.442,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
12131,10326,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.508,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
12132,10326,Blank 490,2,E,OHSU_HNSCC_derm001,15,0.547,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
12133,10326,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.291,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
12134,10326,Blank 490,2,G,OHSU_HNSCC_derm001,15,0.41,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
12135,10326,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.513,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
12136,10326,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.375,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12137,10326,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.521,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
12138,10326,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.536,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
12139,10326,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.553,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
12140,10326,Blank 490,2,M,OHSU_HNSCC_derm001,15,0.584,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
12141,10326,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.576,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
12142,10326,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.543,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
12143,10326,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.391,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
12144,10326,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.394,0,NONE,OHSU_HNSCC_derm001
12145,10326,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.424,0,NONE,OHSU_HNSCC_derm001
12146,10326,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.474,0,NONE,OHSU_HNSCC_derm001
12147,10326,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.509,0,NONE,OHSU_HNSCC_derm001
12148,10326,Blank 490,2,E,OHSU_HNSCC_derm001,16,0.572,0,NONE,OHSU_HNSCC_derm001
12149,10326,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.54,0,NONE,OHSU_HNSCC_derm001
12150,10326,Blank 490,2,G,OHSU_HNSCC_derm001,16,0.522,0,NONE,OHSU_HNSCC_derm001
12151,10326,Blank 490,2,H,OHSU_HNSCC_derm001,16,-0.002,10,F-S-V,OHSU_HNSCC_derm001
12152,10326,Blank 490,2,I,OHSU_HNSCC_derm001,16,0.582,0,NONE,OHSU_HNSCC_derm001
12153,10326,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.528,0,NONE,OHSU_HNSCC_derm001
12154,10326,Blank 490,2,K,OHSU_HNSCC_derm001,16,0.587,0,NONE,OHSU_HNSCC_derm001
12155,10326,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.552,0,NONE,OHSU_HNSCC_derm001
12156,10326,Blank 490,2,M,OHSU_HNSCC_derm001,16,0.584,0,NONE,OHSU_HNSCC_derm001
12157,10326,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.527,0,NONE,OHSU_HNSCC_derm001
12158,10326,Blank 490,2,O,OHSU_HNSCC_derm001,16,0.539,0,NONE,OHSU_HNSCC_derm001
12159,10326,Blank 490,2,P,OHSU_HNSCC_derm001,16,0.472,0,NONE,OHSU_HNSCC_derm001
12160,10326,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.424,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
12161,10326,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.439,10,Hesperidin,OHSU_HNSCC_derm001
12162,10326,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.484,10,Esculetin,OHSU_HNSCC_derm001
12163,10326,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.077,10,Selinexor ,OHSU_HNSCC_derm001
12164,10326,Blank 490,2,E,OHSU_HNSCC_derm001,17,0.447,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12165,10326,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.385,10,BMX-IN-1,OHSU_HNSCC_derm001
12166,10326,Blank 490,2,G,OHSU_HNSCC_derm001,17,0.052,1,Dasatinib (1mM),OHSU_HNSCC_derm001
12167,10326,Blank 490,2,H,OHSU_HNSCC_derm001,17,0.381,10,Trametinib,OHSU_HNSCC_derm001
12168,10326,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.13,10,BEZ235,OHSU_HNSCC_derm001
12169,10326,Blank 490,2,J,OHSU_HNSCC_derm001,17,0.032,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
12170,10326,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.442,10,Nilotinib,OHSU_HNSCC_derm001
12171,10326,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.402,10,Enzalutamide,OHSU_HNSCC_derm001
12172,10326,Blank 490,2,M,OHSU_HNSCC_derm001,17,0.649,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12173,10326,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.342,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
12174,10326,Blank 490,2,O,OHSU_HNSCC_derm001,17,0.048,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12175,10326,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.331,10,Axitinib,OHSU_HNSCC_derm001
12176,10326,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.432,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
12177,10326,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.38,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
12178,10326,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.419,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
12179,10326,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.08,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
12180,10326,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.487,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12181,10326,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.525,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
12182,10326,Blank 490,2,G,OHSU_HNSCC_derm001,18,0.062,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
12183,10326,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.416,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
12184,10326,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.129,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
12185,10326,Blank 490,2,J,OHSU_HNSCC_derm001,18,0.041,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
12186,10326,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.534,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
12187,10326,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.428,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
12188,10326,Blank 490,2,M,OHSU_HNSCC_derm001,18,0.594,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12189,10326,Blank 490,2,N,OHSU_HNSCC_derm001,18,0.409,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
12190,10326,Blank 490,2,O,OHSU_HNSCC_derm001,18,0.034,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12191,10326,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.4,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
12192,10326,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.437,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
12193,10326,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.412,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
12194,10326,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.486,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
12195,10326,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.093,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
12196,10326,Blank 490,2,E,OHSU_HNSCC_derm001,19,0.525,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12197,10326,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.561,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
12198,10326,Blank 490,2,G,OHSU_HNSCC_derm001,19,0.078,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
12199,10326,Blank 490,2,H,OHSU_HNSCC_derm001,19,0.423,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
12200,10326,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.125,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
12201,10326,Blank 490,2,J,OHSU_HNSCC_derm001,19,0.064,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
12202,10326,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.544,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
12203,10326,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.525,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
12204,10326,Blank 490,2,M,OHSU_HNSCC_derm001,19,0.55,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12205,10326,Blank 490,2,N,OHSU_HNSCC_derm001,19,0.435,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
12206,10326,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.044,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12207,10326,Blank 490,2,P,OHSU_HNSCC_derm001,19,0.463,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
12208,10326,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.385,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
12209,10326,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.39,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
12210,10326,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.456,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
12211,10326,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.165,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
12212,10326,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.537,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12213,10326,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.532,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
12214,10326,Blank 490,2,G,OHSU_HNSCC_derm001,20,0.232,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
12215,10326,Blank 490,2,H,OHSU_HNSCC_derm001,20,0.449,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
12216,10326,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.155,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
12217,10326,Blank 490,2,J,OHSU_HNSCC_derm001,20,0.083,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
12218,10326,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.541,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
12219,10326,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.553,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
12220,10326,Blank 490,2,M,OHSU_HNSCC_derm001,20,0.541,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12221,10326,Blank 490,2,N,OHSU_HNSCC_derm001,20,0.48,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
12222,10326,Blank 490,2,O,OHSU_HNSCC_derm001,20,0.279,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12223,10326,Blank 490,2,P,OHSU_HNSCC_derm001,20,0.501,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
12224,10326,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.399,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
12225,10326,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.366,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
12226,10326,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.463,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
12227,10326,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.435,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
12228,10326,Blank 490,2,E,OHSU_HNSCC_derm001,21,0.548,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12229,10326,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.528,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
12230,10326,Blank 490,2,G,OHSU_HNSCC_derm001,21,0.519,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
12231,10326,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.389,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
12232,10326,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.193,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
12233,10326,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.183,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
12234,10326,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.529,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
12235,10326,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.537,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
12236,10326,Blank 490,2,M,OHSU_HNSCC_derm001,21,0.565,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12237,10326,Blank 490,2,N,OHSU_HNSCC_derm001,21,0.471,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
12238,10326,Blank 490,2,O,OHSU_HNSCC_derm001,21,0.532,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12239,10326,Blank 490,2,P,OHSU_HNSCC_derm001,21,0.42,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
12240,10326,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.436,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
12241,10326,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.374,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
12242,10326,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.449,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
12243,10326,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.487,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
12244,10326,Blank 490,2,E,OHSU_HNSCC_derm001,22,0.494,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12245,10326,Blank 490,2,F,OHSU_HNSCC_derm001,22,0.486,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
12246,10326,Blank 490,2,G,OHSU_HNSCC_derm001,22,0.432,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
12247,10326,Blank 490,2,H,OHSU_HNSCC_derm001,22,0.428,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
12248,10326,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.281,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
12249,10326,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.384,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
12250,10326,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.52,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
12251,10326,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.502,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
12252,10326,Blank 490,2,M,OHSU_HNSCC_derm001,22,0.535,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12253,10326,Blank 490,2,N,OHSU_HNSCC_derm001,22,0.542,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
12254,10326,Blank 490,2,O,OHSU_HNSCC_derm001,22,0.543,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12255,10326,Blank 490,2,P,OHSU_HNSCC_derm001,22,0.405,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
12256,10326,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.437,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
12257,10326,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.416,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
12258,10326,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.446,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
12259,10326,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.45,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
12260,10326,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.502,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
12261,10326,Blank 490,2,F,OHSU_HNSCC_derm001,23,0.45,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
12262,10326,Blank 490,2,G,OHSU_HNSCC_derm001,23,0.357,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
12263,10326,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.39,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
12264,10326,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.318,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
12265,10326,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.445,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
12266,10326,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.48,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
12267,10326,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.471,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
12268,10326,Blank 490,2,M,OHSU_HNSCC_derm001,23,0.497,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
12269,10326,Blank 490,2,N,OHSU_HNSCC_derm001,23,0.522,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
12270,10326,Blank 490,2,O,OHSU_HNSCC_derm001,23,0.523,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
12271,10326,Blank 490,2,P,OHSU_HNSCC_derm001,23,0.461,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
12272,10326,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.401,0,NONE,OHSU_HNSCC_derm001
12273,10326,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.456,0,NONE,OHSU_HNSCC_derm001
12274,10326,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.414,0,NONE,OHSU_HNSCC_derm001
12275,10326,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.383,0,NONE,OHSU_HNSCC_derm001
12276,10326,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.467,0,NONE,OHSU_HNSCC_derm001
12277,10326,Blank 490,2,F,OHSU_HNSCC_derm001,24,0.478,0,NONE,OHSU_HNSCC_derm001
12278,10326,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.452,0,NONE,OHSU_HNSCC_derm001
12279,10326,Blank 490,2,H,OHSU_HNSCC_derm001,24,0.457,0,NONE,OHSU_HNSCC_derm001
12280,10326,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.426,0,NONE,OHSU_HNSCC_derm001
12281,10326,Blank 490,2,J,OHSU_HNSCC_derm001,24,0.432,0,NONE,OHSU_HNSCC_derm001
12282,10326,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.448,0,NONE,OHSU_HNSCC_derm001
12283,10326,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.445,0,NONE,OHSU_HNSCC_derm001
12284,10326,Blank 490,2,M,OHSU_HNSCC_derm001,24,0.475,0,NONE,OHSU_HNSCC_derm001
12285,10326,Blank 490,2,N,OHSU_HNSCC_derm001,24,0.463,0,NONE,OHSU_HNSCC_derm001
12286,10326,Blank 490,2,O,OHSU_HNSCC_derm001,24,0.465,0,NONE,OHSU_HNSCC_derm001
12287,10326,Blank 490,2,P,OHSU_HNSCC_derm001,24,0.491,0,NONE,OHSU_HNSCC_derm001
12288,10326,Blank 490,3,A,OHSU_HNSCC_derm001,1,0.369,10,Thalidomide ,OHSU_HNSCC_derm001
12289,10326,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.199,10,Vandetanib,OHSU_HNSCC_derm001
12290,10326,Blank 490,3,C,OHSU_HNSCC_derm001,1,0.452,10,Oleic acid,OHSU_HNSCC_derm001
12291,10326,Blank 490,3,D,OHSU_HNSCC_derm001,1,0.027,10,A-674563,OHSU_HNSCC_derm001
12292,10326,Blank 490,3,E,OHSU_HNSCC_derm001,1,0.164,10,Lapatinib,OHSU_HNSCC_derm001
12293,10326,Blank 490,3,F,OHSU_HNSCC_derm001,1,0.409,10,Apocynin (vanillin),OHSU_HNSCC_derm001
12294,10326,Blank 490,3,G,OHSU_HNSCC_derm001,1,0.034,10,AT-7519,OHSU_HNSCC_derm001
12295,10326,Blank 490,3,H,OHSU_HNSCC_derm001,1,0.203,10,Gefitinib,OHSU_HNSCC_derm001
12296,10326,Blank 490,3,I,OHSU_HNSCC_derm001,1,0.169,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
12297,10326,Blank 490,3,J,OHSU_HNSCC_derm001,1,0.173,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12298,10326,Blank 490,3,K,OHSU_HNSCC_derm001,1,0.078,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12299,10326,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.427,10,JQ1,OHSU_HNSCC_derm001
12300,10326,Blank 490,3,M,OHSU_HNSCC_derm001,1,0.596,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12301,10326,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.433,10,Cerdulatinib,OHSU_HNSCC_derm001
12302,10326,Blank 490,3,O,OHSU_HNSCC_derm001,1,0.004,10,Romidepsin,OHSU_HNSCC_derm001
12303,10326,Blank 490,3,P,OHSU_HNSCC_derm001,1,0.404,10,Gilteritinib,OHSU_HNSCC_derm001
12304,10326,Blank 490,3,A,OHSU_HNSCC_derm001,2,0.37,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
12305,10326,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.317,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
12306,10326,Blank 490,3,C,OHSU_HNSCC_derm001,2,0.345,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
12307,10326,Blank 490,3,D,OHSU_HNSCC_derm001,2,0.359,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
12308,10326,Blank 490,3,E,OHSU_HNSCC_derm001,2,0.238,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
12309,10326,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.444,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
12310,10326,Blank 490,3,G,OHSU_HNSCC_derm001,2,0.032,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
12311,10326,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.243,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
12312,10326,Blank 490,3,I,OHSU_HNSCC_derm001,2,0.355,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
12313,10326,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.262,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12314,10326,Blank 490,3,K,OHSU_HNSCC_derm001,2,0.214,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12315,10326,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.533,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
12316,10326,Blank 490,3,M,OHSU_HNSCC_derm001,2,0.577,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12317,10326,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.171,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
12318,10326,Blank 490,3,O,OHSU_HNSCC_derm001,2,0.006,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
12319,10326,Blank 490,3,P,OHSU_HNSCC_derm001,2,0.457,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
12320,10326,Blank 490,3,A,OHSU_HNSCC_derm001,3,0.37,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
12321,10326,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.317,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
12322,10326,Blank 490,3,C,OHSU_HNSCC_derm001,3,0.398,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
12323,10326,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.382,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
12324,10326,Blank 490,3,E,OHSU_HNSCC_derm001,3,0.305,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
12325,10326,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.433,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
12326,10326,Blank 490,3,G,OHSU_HNSCC_derm001,3,0.036,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
12327,10326,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.255,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
12328,10326,Blank 490,3,I,OHSU_HNSCC_derm001,3,0.48,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
12329,10326,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.336,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12330,10326,Blank 490,3,K,OHSU_HNSCC_derm001,3,0.31,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12331,10326,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.059,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
12332,10326,Blank 490,3,M,OHSU_HNSCC_derm001,3,0.575,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12333,10326,Blank 490,3,N,OHSU_HNSCC_derm001,3,0.109,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
12334,10326,Blank 490,3,O,OHSU_HNSCC_derm001,3,0.013,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
12335,10326,Blank 490,3,P,OHSU_HNSCC_derm001,3,0.486,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
12336,10326,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.423,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
12337,10326,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.377,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
12338,10326,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.428,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
12339,10326,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.394,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
12340,10326,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.334,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
12341,10326,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.504,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
12342,10326,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.356,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
12343,10326,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.361,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
12344,10326,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.473,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
12345,10326,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.399,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12346,10326,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.363,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12347,10326,Blank 490,3,L,OHSU_HNSCC_derm001,4,0.66,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
12348,10326,Blank 490,3,M,OHSU_HNSCC_derm001,4,0.543,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12349,10326,Blank 490,3,N,OHSU_HNSCC_derm001,4,0.481,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
12350,10326,Blank 490,3,O,OHSU_HNSCC_derm001,4,0.018,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
12351,10326,Blank 490,3,P,OHSU_HNSCC_derm001,4,0.493,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
12352,10326,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.425,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
12353,10326,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.367,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
12354,10326,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.446,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
12355,10326,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.431,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
12356,10326,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.444,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
12357,10326,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.499,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
12358,10326,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.441,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
12359,10326,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.411,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
12360,10326,Blank 490,3,I,OHSU_HNSCC_derm001,5,0.522,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
12361,10326,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.407,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12362,10326,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.377,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12363,10326,Blank 490,3,L,OHSU_HNSCC_derm001,5,0.647,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
12364,10326,Blank 490,3,M,OHSU_HNSCC_derm001,5,0.06,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12365,10326,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.513,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
12366,10326,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.024,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
12367,10326,Blank 490,3,P,OHSU_HNSCC_derm001,5,0.458,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
12368,10326,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.374,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
12369,10326,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.405,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
12370,10326,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.392,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
12371,10326,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.434,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
12372,10326,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.463,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
12373,10326,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.487,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
12374,10326,Blank 490,3,G,OHSU_HNSCC_derm001,6,0.514,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
12375,10326,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.459,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
12376,10326,Blank 490,3,I,OHSU_HNSCC_derm001,6,0.5,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
12377,10326,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.459,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12378,10326,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.501,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12379,10326,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.089,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
12380,10326,Blank 490,3,M,OHSU_HNSCC_derm001,6,0.534,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12381,10326,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.518,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
12382,10326,Blank 490,3,O,OHSU_HNSCC_derm001,6,0.063,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
12383,10326,Blank 490,3,P,OHSU_HNSCC_derm001,6,0.434,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
12384,10326,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.411,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
12385,10326,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.379,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
12386,10326,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.429,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
12387,10326,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.433,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
12388,10326,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.496,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
12389,10326,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
12390,10326,Blank 490,3,G,OHSU_HNSCC_derm001,7,0.522,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
12391,10326,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.482,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
12392,10326,Blank 490,3,I,OHSU_HNSCC_derm001,7,0.487,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
12393,10326,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.445,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
12394,10326,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.328,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
12395,10326,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
12396,10326,Blank 490,3,M,OHSU_HNSCC_derm001,7,0.518,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
12397,10326,Blank 490,3,N,OHSU_HNSCC_derm001,7,0.511,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
12398,10326,Blank 490,3,O,OHSU_HNSCC_derm001,7,0.062,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
12399,10326,Blank 490,3,P,OHSU_HNSCC_derm001,7,0.419,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
12400,10326,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.418,0,NONE,OHSU_HNSCC_derm001
12401,10326,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.382,0,NONE,OHSU_HNSCC_derm001
12402,10326,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.43,0,NONE,OHSU_HNSCC_derm001
12403,10326,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.423,0,NONE,OHSU_HNSCC_derm001
12404,10326,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.525,0,NONE,OHSU_HNSCC_derm001
12405,10326,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.498,0,NONE,OHSU_HNSCC_derm001
12406,10326,Blank 490,3,G,OHSU_HNSCC_derm001,8,0.467,0,NONE,OHSU_HNSCC_derm001
12407,10326,Blank 490,3,H,OHSU_HNSCC_derm001,8,-0.002,10,F-S-V,OHSU_HNSCC_derm001
12408,10326,Blank 490,3,I,OHSU_HNSCC_derm001,8,0.26,0,NONE,OHSU_HNSCC_derm001
12409,10326,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.428,0,NONE,OHSU_HNSCC_derm001
12410,10326,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.53,0,NONE,OHSU_HNSCC_derm001
12411,10326,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.519,0,NONE,OHSU_HNSCC_derm001
12412,10326,Blank 490,3,M,OHSU_HNSCC_derm001,8,0.522,0,NONE,OHSU_HNSCC_derm001
12413,10326,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.503,0,NONE,OHSU_HNSCC_derm001
12414,10326,Blank 490,3,O,OHSU_HNSCC_derm001,8,0.487,0,NONE,OHSU_HNSCC_derm001
12415,10326,Blank 490,3,P,OHSU_HNSCC_derm001,8,0.459,0,NONE,OHSU_HNSCC_derm001
12416,10326,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.405,10,Anastrazole,OHSU_HNSCC_derm001
12417,10326,Blank 490,3,B,OHSU_HNSCC_derm001,9,0.268,10,JNJ-28312141 ,OHSU_HNSCC_derm001
12418,10326,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.375,10,Genistein,OHSU_HNSCC_derm001
12419,10326,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.463,10,Abscisic acid,OHSU_HNSCC_derm001
12420,10326,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.388,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12421,10326,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.495,10,Ruxolitinib,OHSU_HNSCC_derm001
12422,10326,Blank 490,3,G,OHSU_HNSCC_derm001,9,0.492,10,TAK-659,OHSU_HNSCC_derm001
12423,10326,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.154,10,Brigatinib,OHSU_HNSCC_derm001
12424,10326,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.21,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12425,10326,Blank 490,3,J,OHSU_HNSCC_derm001,9,0.009,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12426,10326,Blank 490,3,K,OHSU_HNSCC_derm001,9,0.187,10,Vorinostat,OHSU_HNSCC_derm001
12427,10326,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.489,10,Lenalidomide,OHSU_HNSCC_derm001
12428,10326,Blank 490,3,M,OHSU_HNSCC_derm001,9,0.371,10,NVP-ADW742,OHSU_HNSCC_derm001
12429,10326,Blank 490,3,N,OHSU_HNSCC_derm001,9,0.441,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12430,10326,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.57,10,Echinatin,OHSU_HNSCC_derm001
12431,10326,Blank 490,3,P,OHSU_HNSCC_derm001,9,-0.02,10,YM-155,OHSU_HNSCC_derm001
12432,10326,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.392,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
12433,10326,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.441,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
12434,10326,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.412,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
12435,10326,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.446,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
12436,10326,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.449,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12437,10326,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.538,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
12438,10326,Blank 490,3,G,OHSU_HNSCC_derm001,10,0.543,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
12439,10326,Blank 490,3,H,OHSU_HNSCC_derm001,10,0.305,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
12440,10326,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.234,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12441,10326,Blank 490,3,J,OHSU_HNSCC_derm001,10,0.45,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12442,10326,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.293,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
12443,10326,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.5,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
12444,10326,Blank 490,3,M,OHSU_HNSCC_derm001,10,0.447,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
12445,10326,Blank 490,3,N,OHSU_HNSCC_derm001,10,0.504,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12446,10326,Blank 490,3,O,OHSU_HNSCC_derm001,10,0.5,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
12447,10326,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.02,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
12448,10326,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.389,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
12449,10326,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.429,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
12450,10326,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.405,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
12451,10326,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.465,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
12452,10326,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.483,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12453,10326,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.507,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
12454,10326,Blank 490,3,G,OHSU_HNSCC_derm001,11,0.53,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
12455,10326,Blank 490,3,H,OHSU_HNSCC_derm001,11,0.46,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
12456,10326,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.254,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12457,10326,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.488,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12458,10326,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.395,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
12459,10326,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.534,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
12460,10326,Blank 490,3,M,OHSU_HNSCC_derm001,11,0.429,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
12461,10326,Blank 490,3,N,OHSU_HNSCC_derm001,11,0.463,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12462,10326,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.523,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
12463,10326,Blank 490,3,P,OHSU_HNSCC_derm001,11,-0.017,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
12464,10326,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.421,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
12465,10326,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.451,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
12466,10326,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.403,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
12467,10326,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.456,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
12468,10326,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.458,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12469,10326,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.485,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
12470,10326,Blank 490,3,G,OHSU_HNSCC_derm001,12,0.548,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
12471,10326,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.479,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
12472,10326,Blank 490,3,I,OHSU_HNSCC_derm001,12,0.262,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12473,10326,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.496,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12474,10326,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.474,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
12475,10326,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.525,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
12476,10326,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.501,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
12477,10326,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.524,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12478,10326,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.515,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
12479,10326,Blank 490,3,P,OHSU_HNSCC_derm001,12,-0.009,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
12480,10326,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.402,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
12481,10326,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.438,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
12482,10326,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.397,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
12483,10326,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.465,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
12484,10326,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.48,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12485,10326,Blank 490,3,F,OHSU_HNSCC_derm001,13,0.511,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
12486,10326,Blank 490,3,G,OHSU_HNSCC_derm001,13,0.512,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
12487,10326,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.51,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
12488,10326,Blank 490,3,I,OHSU_HNSCC_derm001,13,0.257,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12489,10326,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.518,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12490,10326,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.504,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
12491,10326,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.519,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
12492,10326,Blank 490,3,M,OHSU_HNSCC_derm001,13,0.53,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
12493,10326,Blank 490,3,N,OHSU_HNSCC_derm001,13,0.496,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12494,10326,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.505,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
12495,10326,Blank 490,3,P,OHSU_HNSCC_derm001,13,-0.006,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
12496,10326,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.361,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
12497,10326,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.415,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
12498,10326,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.431,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
12499,10326,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.452,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
12500,10326,Blank 490,3,E,OHSU_HNSCC_derm001,14,0.49,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12501,10326,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.509,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
12502,10326,Blank 490,3,G,OHSU_HNSCC_derm001,14,0.473,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
12503,10326,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.468,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
12504,10326,Blank 490,3,I,OHSU_HNSCC_derm001,14,0.348,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12505,10326,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.518,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12506,10326,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.538,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
12507,10326,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.52,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
12508,10326,Blank 490,3,M,OHSU_HNSCC_derm001,14,0.57,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
12509,10326,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.522,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12510,10326,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.494,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
12511,10326,Blank 490,3,P,OHSU_HNSCC_derm001,14,0.001,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
12512,10326,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.377,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
12513,10326,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.42,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
12514,10326,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.445,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
12515,10326,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.464,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
12516,10326,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.492,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
12517,10326,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.521,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
12518,10326,Blank 490,3,G,OHSU_HNSCC_derm001,15,0.522,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
12519,10326,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.486,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
12520,10326,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.353,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
12521,10326,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.523,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
12522,10326,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.546,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
12523,10326,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.529,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
12524,10326,Blank 490,3,M,OHSU_HNSCC_derm001,15,0.541,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
12525,10326,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.52,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
12526,10326,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.502,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
12527,10326,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.011,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
12528,10326,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.395,0,NONE,OHSU_HNSCC_derm001
12529,10326,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.404,0,NONE,OHSU_HNSCC_derm001
12530,10326,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.417,0,NONE,OHSU_HNSCC_derm001
12531,10326,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.445,0,NONE,OHSU_HNSCC_derm001
12532,10326,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.497,0,NONE,OHSU_HNSCC_derm001
12533,10326,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.507,0,NONE,OHSU_HNSCC_derm001
12534,10326,Blank 490,3,G,OHSU_HNSCC_derm001,16,0.336,0,NONE,OHSU_HNSCC_derm001
12535,10326,Blank 490,3,H,OHSU_HNSCC_derm001,16,0.002,10,F-S-V,OHSU_HNSCC_derm001
12536,10326,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.524,0,NONE,OHSU_HNSCC_derm001
12537,10326,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.49,0,NONE,OHSU_HNSCC_derm001
12538,10326,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.514,0,NONE,OHSU_HNSCC_derm001
12539,10326,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.564,0,NONE,OHSU_HNSCC_derm001
12540,10326,Blank 490,3,M,OHSU_HNSCC_derm001,16,0.535,0,NONE,OHSU_HNSCC_derm001
12541,10326,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.524,0,NONE,OHSU_HNSCC_derm001
12542,10326,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.527,0,NONE,OHSU_HNSCC_derm001
12543,10326,Blank 490,3,P,OHSU_HNSCC_derm001,16,0.447,0,NONE,OHSU_HNSCC_derm001
12544,10326,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.387,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12545,10326,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.401,10,Stevioside,OHSU_HNSCC_derm001
12546,10326,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.423,10,Pemetrexed,OHSU_HNSCC_derm001
12547,10326,Blank 490,3,D,OHSU_HNSCC_derm001,17,0.08,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12548,10326,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.328,10,GSK-1838705A,OHSU_HNSCC_derm001
12549,10326,Blank 490,3,F,OHSU_HNSCC_derm001,17,-0.002,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12550,10326,Blank 490,3,G,OHSU_HNSCC_derm001,17,0.513,10,Imatinib,OHSU_HNSCC_derm001
12551,10326,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.362,10,Trametinib,OHSU_HNSCC_derm001
12552,10326,Blank 490,3,I,OHSU_HNSCC_derm001,17,0.118,10,BEZ235,OHSU_HNSCC_derm001
12553,10326,Blank 490,3,J,OHSU_HNSCC_derm001,17,0.127,10,Saracatinib,OHSU_HNSCC_derm001
12554,10326,Blank 490,3,K,OHSU_HNSCC_derm001,17,0.626,10,I-BET 762,OHSU_HNSCC_derm001
12555,10326,Blank 490,3,L,OHSU_HNSCC_derm001,17,0.227,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
12556,10326,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.561,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
12557,10326,Blank 490,3,N,OHSU_HNSCC_derm001,17,0.486,10,Crizotinib,OHSU_HNSCC_derm001
12558,10326,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.331,10,MGCD-265,OHSU_HNSCC_derm001
12559,10326,Blank 490,3,P,OHSU_HNSCC_derm001,17,0.206,10,Erlotinib,OHSU_HNSCC_derm001
12560,10326,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.398,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12561,10326,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.422,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
12562,10326,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.409,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
12563,10326,Blank 490,3,D,OHSU_HNSCC_derm001,18,0.082,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12564,10326,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.414,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
12565,10326,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.174,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12566,10326,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.513,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
12567,10326,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.401,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
12568,10326,Blank 490,3,I,OHSU_HNSCC_derm001,18,0.127,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
12569,10326,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.292,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
12570,10326,Blank 490,3,K,OHSU_HNSCC_derm001,18,0.676,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
12571,10326,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.227,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
12572,10326,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.541,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
12573,10326,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.559,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
12574,10326,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.402,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
12575,10326,Blank 490,3,P,OHSU_HNSCC_derm001,18,0.247,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
12576,10326,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.384,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12577,10326,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.433,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
12578,10326,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.435,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
12579,10326,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.126,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12580,10326,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.409,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
12581,10326,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.291,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12582,10326,Blank 490,3,G,OHSU_HNSCC_derm001,19,0.52,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
12583,10326,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.411,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
12584,10326,Blank 490,3,I,OHSU_HNSCC_derm001,19,0.131,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
12585,10326,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.479,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
12586,10326,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.679,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
12587,10326,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.222,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
12588,10326,Blank 490,3,M,OHSU_HNSCC_derm001,19,0.534,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
12589,10326,Blank 490,3,N,OHSU_HNSCC_derm001,19,0.545,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
12590,10326,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.433,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
12591,10326,Blank 490,3,P,OHSU_HNSCC_derm001,19,0.28,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
12592,10326,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.367,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12593,10326,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.378,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
12594,10326,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.419,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
12595,10326,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.204,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12596,10326,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.462,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
12597,10326,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.313,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12598,10326,Blank 490,3,G,OHSU_HNSCC_derm001,20,0.524,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
12599,10326,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.403,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
12600,10326,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.167,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
12601,10326,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.495,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
12602,10326,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.673,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
12603,10326,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.298,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
12604,10326,Blank 490,3,M,OHSU_HNSCC_derm001,20,0.535,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
12605,10326,Blank 490,3,N,OHSU_HNSCC_derm001,20,0.538,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
12606,10326,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.498,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
12607,10326,Blank 490,3,P,OHSU_HNSCC_derm001,20,0.313,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
12608,10326,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.367,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12609,10326,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.413,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
12610,10326,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.428,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
12611,10326,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.257,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12612,10326,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.519,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
12613,10326,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.408,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12614,10326,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.505,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
12615,10326,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.408,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
12616,10326,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.198,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
12617,10326,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.516,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
12618,10326,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.572,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
12619,10326,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.277,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
12620,10326,Blank 490,3,M,OHSU_HNSCC_derm001,21,0.524,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
12621,10326,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.512,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
12622,10326,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.498,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
12623,10326,Blank 490,3,P,OHSU_HNSCC_derm001,21,0.368,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
12624,10326,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.349,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12625,10326,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.387,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
12626,10326,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.389,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
12627,10326,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.313,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12628,10326,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.486,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
12629,10326,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.435,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12630,10326,Blank 490,3,G,OHSU_HNSCC_derm001,22,0.489,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
12631,10326,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.384,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
12632,10326,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.3,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
12633,10326,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.487,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
12634,10326,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.554,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
12635,10326,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.42,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
12636,10326,Blank 490,3,M,OHSU_HNSCC_derm001,22,0.523,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
12637,10326,Blank 490,3,N,OHSU_HNSCC_derm001,22,0.541,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
12638,10326,Blank 490,3,O,OHSU_HNSCC_derm001,22,0.498,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
12639,10326,Blank 490,3,P,OHSU_HNSCC_derm001,22,0.47,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
12640,10326,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.368,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
12641,10326,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.293,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
12642,10326,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.449,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
12643,10326,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.384,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
12644,10326,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.479,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
12645,10326,Blank 490,3,F,OHSU_HNSCC_derm001,23,0.466,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
12646,10326,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.463,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
12647,10326,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.451,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
12648,10326,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.373,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
12649,10326,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.487,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
12650,10326,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.487,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
12651,10326,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.454,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
12652,10326,Blank 490,3,M,OHSU_HNSCC_derm001,23,0.492,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
12653,10326,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.482,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
12654,10326,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.52,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
12655,10326,Blank 490,3,P,OHSU_HNSCC_derm001,23,0.423,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
12656,10326,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.402,0,NONE,OHSU_HNSCC_derm001
12657,10326,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.411,0,NONE,OHSU_HNSCC_derm001
12658,10326,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.415,0,NONE,OHSU_HNSCC_derm001
12659,10326,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.398,0,NONE,OHSU_HNSCC_derm001
12660,10326,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.423,0,NONE,OHSU_HNSCC_derm001
12661,10326,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.435,0,NONE,OHSU_HNSCC_derm001
12662,10326,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.414,0,NONE,OHSU_HNSCC_derm001
12663,10326,Blank 490,3,H,OHSU_HNSCC_derm001,24,0.437,0,NONE,OHSU_HNSCC_derm001
12664,10326,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.417,0,NONE,OHSU_HNSCC_derm001
12665,10326,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.426,0,NONE,OHSU_HNSCC_derm001
12666,10326,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.415,0,NONE,OHSU_HNSCC_derm001
12667,10326,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.466,0,NONE,OHSU_HNSCC_derm001
12668,10326,Blank 490,3,M,OHSU_HNSCC_derm001,24,0.429,0,NONE,OHSU_HNSCC_derm001
12669,10326,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.468,0,NONE,OHSU_HNSCC_derm001
12670,10326,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.451,0,NONE,OHSU_HNSCC_derm001
12671,10326,Blank 490,3,P,OHSU_HNSCC_derm001,24,0.45,0,NONE,OHSU_HNSCC_derm001
12672,10326,Blank 490,1,A,OHSU_HNSCC_derm002,1,-0.068,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
12673,10326,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.184,10,Lucitanib ,OHSU_HNSCC_derm002
12674,10326,Blank 490,1,C,OHSU_HNSCC_derm002,1,-0.041,10,Resveratrol,OHSU_HNSCC_derm002
12675,10326,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.127,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12676,10326,Blank 490,1,E,OHSU_HNSCC_derm002,1,-0.05,10,Bicalutamide,OHSU_HNSCC_derm002
12677,10326,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.218,10,Methotrexate ,OHSU_HNSCC_derm002
12678,10326,Blank 490,1,G,OHSU_HNSCC_derm002,1,-0.061,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12679,10326,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.129,10,Gefitinib,OHSU_HNSCC_derm002
12680,10326,Blank 490,1,I,OHSU_HNSCC_derm002,1,-0.063,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
12681,10326,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.14,10,Tamatinib/R406,OHSU_HNSCC_derm002
12682,10326,Blank 490,1,K,OHSU_HNSCC_derm002,1,-0.066,10,Bosutinib,OHSU_HNSCC_derm002
12683,10326,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.006,10,PI-103,OHSU_HNSCC_derm002
12684,10326,Blank 490,1,M,OHSU_HNSCC_derm002,1,-0.044,10,Glycyrrhizin,OHSU_HNSCC_derm002
12685,10326,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.211,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
12686,10326,Blank 490,1,O,OHSU_HNSCC_derm002,1,-0.057,10,GSK-690693,OHSU_HNSCC_derm002
12687,10326,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.158,10,Ibrutinib,OHSU_HNSCC_derm002
12688,10326,Blank 490,1,A,OHSU_HNSCC_derm002,2,-0.072,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
12689,10326,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.277,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
12690,10326,Blank 490,1,C,OHSU_HNSCC_derm002,2,-0.047,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
12691,10326,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.2,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12692,10326,Blank 490,1,E,OHSU_HNSCC_derm002,2,-0.058,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
12693,10326,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.391,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
12694,10326,Blank 490,1,G,OHSU_HNSCC_derm002,2,-0.071,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12695,10326,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.246,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
12696,10326,Blank 490,1,I,OHSU_HNSCC_derm002,2,-0.062,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
12697,10326,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.216,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
12698,10326,Blank 490,1,K,OHSU_HNSCC_derm002,2,-0.066,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
12699,10326,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.015,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
12700,10326,Blank 490,1,M,OHSU_HNSCC_derm002,2,-0.052,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
12701,10326,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.38,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
12702,10326,Blank 490,1,O,OHSU_HNSCC_derm002,2,-0.052,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
12703,10326,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.234,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
12704,10326,Blank 490,1,A,OHSU_HNSCC_derm002,3,-0.069,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
12705,10326,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.307,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
12706,10326,Blank 490,1,C,OHSU_HNSCC_derm002,3,-0.057,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
12707,10326,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.208,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12708,10326,Blank 490,1,E,OHSU_HNSCC_derm002,3,-0.042,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
12709,10326,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.36,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
12710,10326,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.023,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12711,10326,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.239,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
12712,10326,Blank 490,1,I,OHSU_HNSCC_derm002,3,-0.043,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
12713,10326,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.351,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
12714,10326,Blank 490,1,K,OHSU_HNSCC_derm002,3,-0.027,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
12715,10326,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.047,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
12716,10326,Blank 490,1,M,OHSU_HNSCC_derm002,3,-0.043,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
12717,10326,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.425,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
12718,10326,Blank 490,1,O,OHSU_HNSCC_derm002,3,-0.05,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
12719,10326,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.211,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
12720,10326,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.016,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
12721,10326,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.252,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
12722,10326,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.124,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
12723,10326,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.212,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12724,10326,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.111,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
12725,10326,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.401,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
12726,10326,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.153,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12727,10326,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.284,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
12728,10326,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.154,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
12729,10326,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.348,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
12730,10326,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.264,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
12731,10326,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.122,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
12732,10326,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.248,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
12733,10326,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.408,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
12734,10326,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.232,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
12735,10326,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.249,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
12736,10326,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.169,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
12737,10326,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
12738,10326,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.298,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
12739,10326,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.245,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12740,10326,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.321,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
12741,10326,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.365,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
12742,10326,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.296,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12743,10326,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.303,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
12744,10326,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.362,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
12745,10326,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.382,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
12746,10326,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.403,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
12747,10326,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.28,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
12748,10326,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.36,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
12749,10326,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.443,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
12750,10326,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.257,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
12751,10326,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.28,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
12752,10326,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.212,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
12753,10326,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.395,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
12754,10326,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.369,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
12755,10326,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.25,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12756,10326,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.338,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
12757,10326,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.343,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
12758,10326,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.394,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12759,10326,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.367,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
12760,10326,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.376,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
12761,10326,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.356,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
12762,10326,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.397,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
12763,10326,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.368,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
12764,10326,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.376,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
12765,10326,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.424,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
12766,10326,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.342,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
12767,10326,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.206,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
12768,10326,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.198,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
12769,10326,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.353,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
12770,10326,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.317,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
12771,10326,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.304,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
12772,10326,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.373,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
12773,10326,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.333,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
12774,10326,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.405,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
12775,10326,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.392,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
12776,10326,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.407,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
12777,10326,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.426,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
12778,10326,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.391,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
12779,10326,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.374,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
12780,10326,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.345,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
12781,10326,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.425,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
12782,10326,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.329,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
12783,10326,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.298,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
12784,10326,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.236,0,NONE,OHSU_HNSCC_derm002
12785,10326,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.356,0,NONE,OHSU_HNSCC_derm002
12786,10326,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
12787,10326,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.395,0,NONE,OHSU_HNSCC_derm002
12788,10326,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.368,0,NONE,OHSU_HNSCC_derm002
12789,10326,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
12790,10326,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.396,0,NONE,OHSU_HNSCC_derm002
12791,10326,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
12792,10326,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.424,0,NONE,OHSU_HNSCC_derm002
12793,10326,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.474,0,NONE,OHSU_HNSCC_derm002
12794,10326,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
12795,10326,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.376,0,NONE,OHSU_HNSCC_derm002
12796,10326,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.434,0,NONE,OHSU_HNSCC_derm002
12797,10326,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
12798,10326,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.372,0,NONE,OHSU_HNSCC_derm002
12799,10326,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.307,0,NONE,OHSU_HNSCC_derm002
12800,10326,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.001,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12801,10326,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.164,10,Sorafenib,OHSU_HNSCC_derm002
12802,10326,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.43,10,Rosmarinic acid,OHSU_HNSCC_derm002
12803,10326,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.271,10,Rapamycin,OHSU_HNSCC_derm002
12804,10326,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.345,10,Vismodegib,OHSU_HNSCC_derm002
12805,10326,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.131,10,PP242,OHSU_HNSCC_derm002
12806,10326,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.182,10,Alectinib,OHSU_HNSCC_derm002
12807,10326,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.167,10,Brigatinib,OHSU_HNSCC_derm002
12808,10326,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.167,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12809,10326,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.245,10,MK-2206,OHSU_HNSCC_derm002
12810,10326,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.265,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12811,10326,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.036,10,Flavopiridol ,OHSU_HNSCC_derm002
12812,10326,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.416,10,Indirubin,OHSU_HNSCC_derm002
12813,10326,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.429,10,PF-533228,OHSU_HNSCC_derm002
12814,10326,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.307,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12815,10326,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.063,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12816,10326,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.009,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12817,10326,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.252,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
12818,10326,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.412,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
12819,10326,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.26,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
12820,10326,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.298,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
12821,10326,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.16,3.3333333333333335,PP242,OHSU_HNSCC_derm002
12822,10326,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.341,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
12823,10326,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.216,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
12824,10326,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.207,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12825,10326,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.402,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
12826,10326,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.265,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12827,10326,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.036,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
12828,10326,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.463,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
12829,10326,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.484,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
12830,10326,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.411,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12831,10326,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.073,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12832,10326,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.027,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12833,10326,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.273,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
12834,10326,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.366,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
12835,10326,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.271,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
12836,10326,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.375,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
12837,10326,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.162,1.1111111111111112,PP242,OHSU_HNSCC_derm002
12838,10326,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.368,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
12839,10326,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.4,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
12840,10326,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.2,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12841,10326,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.321,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
12842,10326,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.25,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12843,10326,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.045,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
12844,10326,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.456,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
12845,10326,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.488,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
12846,10326,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12847,10326,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.218,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12848,10326,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.014,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12849,10326,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.287,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
12850,10326,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.349,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
12851,10326,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.255,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
12852,10326,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.341,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
12853,10326,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.23,0.3703703703703704,PP242,OHSU_HNSCC_derm002
12854,10326,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.391,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
12855,10326,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.379,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
12856,10326,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.219,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12857,10326,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.366,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
12858,10326,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.274,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12859,10326,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.055,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
12860,10326,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.443,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
12861,10326,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.499,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
12862,10326,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.365,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12863,10326,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.332,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12864,10326,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.027,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12865,10326,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.237,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
12866,10326,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.317,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
12867,10326,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.275,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
12868,10326,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.388,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
12869,10326,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.292,0.1234567901234568,PP242,OHSU_HNSCC_derm002
12870,10326,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.409,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
12871,10326,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.395,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
12872,10326,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.238,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12873,10326,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.39,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
12874,10326,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.323,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12875,10326,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.172,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
12876,10326,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.484,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
12877,10326,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.478,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
12878,10326,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.387,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12879,10326,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.37,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12880,10326,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.055,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12881,10326,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.287,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
12882,10326,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.405,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
12883,10326,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.371,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
12884,10326,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.376,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
12885,10326,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.3,0.0411522633744856,PP242,OHSU_HNSCC_derm002
12886,10326,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.398,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
12887,10326,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.387,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
12888,10326,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.273,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12889,10326,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.404,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
12890,10326,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.339,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12891,10326,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.326,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
12892,10326,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.36,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
12893,10326,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.426,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
12894,10326,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.342,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12895,10326,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.225,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12896,10326,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.128,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
12897,10326,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.312,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
12898,10326,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.38,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
12899,10326,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.286,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
12900,10326,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.385,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
12901,10326,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.385,0.013717421124828532,PP242,OHSU_HNSCC_derm002
12902,10326,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.434,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
12903,10326,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.417,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
12904,10326,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.33,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
12905,10326,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.399,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
12906,10326,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.361,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
12907,10326,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.383,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
12908,10326,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.449,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
12909,10326,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.445,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
12910,10326,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.402,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
12911,10326,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.384,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
12912,10326,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.26,0,NONE,OHSU_HNSCC_derm002
12913,10326,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.325,0,NONE,OHSU_HNSCC_derm002
12914,10326,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.369,0,NONE,OHSU_HNSCC_derm002
12915,10326,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.404,0,NONE,OHSU_HNSCC_derm002
12916,10326,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.38,0,NONE,OHSU_HNSCC_derm002
12917,10326,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.41,0,NONE,OHSU_HNSCC_derm002
12918,10326,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.413,0,NONE,OHSU_HNSCC_derm002
12919,10326,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
12920,10326,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.369,0,NONE,OHSU_HNSCC_derm002
12921,10326,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.408,0,NONE,OHSU_HNSCC_derm002
12922,10326,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.389,0,NONE,OHSU_HNSCC_derm002
12923,10326,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
12924,10326,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.386,0,NONE,OHSU_HNSCC_derm002
12925,10326,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.433,0,NONE,OHSU_HNSCC_derm002
12926,10326,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
12927,10326,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.308,0,NONE,OHSU_HNSCC_derm002
12928,10326,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.224,10,Emodin,OHSU_HNSCC_derm002
12929,10326,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.32,10,Baicalin,OHSU_HNSCC_derm002
12930,10326,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.108,10,NVP-TAE-684,OHSU_HNSCC_derm002
12931,10326,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.029,10,Panobinostat,OHSU_HNSCC_derm002
12932,10326,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.025,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
12933,10326,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.353,10,Fulvestrant,OHSU_HNSCC_derm002
12934,10326,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.383,10,SCH-772984,OHSU_HNSCC_derm002
12935,10326,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.315,10,Trametinib,OHSU_HNSCC_derm002
12936,10326,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.167,10,BEZ235,OHSU_HNSCC_derm002
12937,10326,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.344,10,MLN120B,OHSU_HNSCC_derm002
12938,10326,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.163,10,Ixabepilone,OHSU_HNSCC_derm002
12939,10326,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.023,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
12940,10326,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.402,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
12941,10326,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.37,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
12942,10326,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.157,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
12943,10326,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.229,10,Letrozole,OHSU_HNSCC_derm002
12944,10326,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.252,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
12945,10326,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.321,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
12946,10326,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.262,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
12947,10326,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.035,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
12948,10326,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.071,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
12949,10326,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.348,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
12950,10326,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.377,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
12951,10326,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.332,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
12952,10326,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.119,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
12953,10326,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.383,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
12954,10326,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.163,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
12955,10326,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.217,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
12956,10326,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.415,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
12957,10326,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.427,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
12958,10326,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.159,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
12959,10326,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.366,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
12960,10326,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.238,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
12961,10326,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
12962,10326,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.371,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
12963,10326,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.063,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
12964,10326,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.107,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
12965,10326,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.357,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
12966,10326,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
12967,10326,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.249,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
12968,10326,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.116,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
12969,10326,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.41,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
12970,10326,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.157,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
12971,10326,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.229,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
12972,10326,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.394,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
12973,10326,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.431,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
12974,10326,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.197,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
12975,10326,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.271,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
12976,10326,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.235,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
12977,10326,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.308,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
12978,10326,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.34,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
12979,10326,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.121,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
12980,10326,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.181,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
12981,10326,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.386,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
12982,10326,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.378,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
12983,10326,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.345,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
12984,10326,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.144,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
12985,10326,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.396,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
12986,10326,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
12987,10326,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.27,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
12988,10326,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.397,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
12989,10326,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.339,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
12990,10326,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.137,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
12991,10326,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.322,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
12992,10326,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.224,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
12993,10326,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.364,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
12994,10326,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.377,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
12995,10326,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.2,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
12996,10326,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.24,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
12997,10326,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.393,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
12998,10326,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.382,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
12999,10326,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.354,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
13000,10326,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.218,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
13001,10326,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.383,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
13002,10326,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.171,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
13003,10326,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.248,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
13004,10326,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.316,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
13005,10326,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.241,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
13006,10326,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.186,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
13007,10326,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.331,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
13008,10326,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.2,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
13009,10326,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.353,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
13010,10326,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.357,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
13011,10326,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.266,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
13012,10326,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.247,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
13013,10326,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.381,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
13014,10326,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.395,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
13015,10326,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.319,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
13016,10326,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.255,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
13017,10326,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
13018,10326,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.187,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
13019,10326,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.334,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
13020,10326,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.395,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
13021,10326,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.318,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
13022,10326,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.153,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
13023,10326,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.222,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
13024,10326,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.206,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
13025,10326,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.286,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
13026,10326,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
13027,10326,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.335,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
13028,10326,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.232,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
13029,10326,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.304,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
13030,10326,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.249,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
13031,10326,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.239,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
13032,10326,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.267,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
13033,10326,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.292,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
13034,10326,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.208,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
13035,10326,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.33,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
13036,10326,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.378,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
13037,10326,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.278,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
13038,10326,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.156,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
13039,10326,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.32,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
13040,10326,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.23,0,NONE,OHSU_HNSCC_derm002
13041,10326,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.228,0,NONE,OHSU_HNSCC_derm002
13042,10326,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.309,0,NONE,OHSU_HNSCC_derm002
13043,10326,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.241,0,NONE,OHSU_HNSCC_derm002
13044,10326,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.235,0,NONE,OHSU_HNSCC_derm002
13045,10326,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.351,0,NONE,OHSU_HNSCC_derm002
13046,10326,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.351,0,NONE,OHSU_HNSCC_derm002
13047,10326,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.29,0,NONE,OHSU_HNSCC_derm002
13048,10326,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.393,0,NONE,OHSU_HNSCC_derm002
13049,10326,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.34,0,NONE,OHSU_HNSCC_derm002
13050,10326,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.182,0,NONE,OHSU_HNSCC_derm002
13051,10326,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.287,0,NONE,OHSU_HNSCC_derm002
13052,10326,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.209,0,NONE,OHSU_HNSCC_derm002
13053,10326,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.278,0,NONE,OHSU_HNSCC_derm002
13054,10326,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.253,0,NONE,OHSU_HNSCC_derm002
13055,10326,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.316,0,NONE,OHSU_HNSCC_derm002
13056,10326,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.271,10,Coumarin,OHSU_HNSCC_derm002
13057,10326,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.058,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13058,10326,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.044,10,Foretinib (XL-880),OHSU_HNSCC_derm002
13059,10326,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.294,10,Elesclomol,OHSU_HNSCC_derm002
13060,10326,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.357,10,Vemurafenib,OHSU_HNSCC_derm002
13061,10326,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.1,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13062,10326,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.017,10,Ponatinib,OHSU_HNSCC_derm002
13063,10326,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.159,10,Gefitinib,OHSU_HNSCC_derm002
13064,10326,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.043,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
13065,10326,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.379,1,Sunitinib (1mM),OHSU_HNSCC_derm002
13066,10326,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.303,10,Curcumin,OHSU_HNSCC_derm002
13067,10326,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.075,10,PF-562271,OHSU_HNSCC_derm002
13068,10326,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.327,10,STO609,OHSU_HNSCC_derm002
13069,10326,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.271,10,Lenvatinib,OHSU_HNSCC_derm002
13070,10326,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.03,10,Entrectinib,OHSU_HNSCC_derm002
13071,10326,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.364,10,Ethyl Gallate ,OHSU_HNSCC_derm002
13072,10326,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.358,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
13073,10326,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.151,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13074,10326,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.18,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
13075,10326,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.326,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
13076,10326,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.255,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
13077,10326,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.11,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13078,10326,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.029,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
13079,10326,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.188,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
13080,10326,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.21,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
13081,10326,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.358,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
13082,10326,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.344,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
13083,10326,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.375,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
13084,10326,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.243,3.3333333333333335,STO609,OHSU_HNSCC_derm002
13085,10326,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.271,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
13086,10326,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.268,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
13087,10326,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.379,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
13088,10326,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
13089,10326,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.149,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13090,10326,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.339,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
13091,10326,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.231,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
13092,10326,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.425,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
13093,10326,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.135,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13094,10326,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.279,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
13095,10326,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.226,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
13096,10326,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.327,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
13097,10326,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.385,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
13098,10326,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.377,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
13099,10326,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.407,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
13100,10326,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.395,1.1111111111111112,STO609,OHSU_HNSCC_derm002
13101,10326,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.295,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
13102,10326,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.35,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
13103,10326,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.409,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
13104,10326,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.372,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
13105,10326,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.16,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13106,10326,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.346,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
13107,10326,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.093,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
13108,10326,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.377,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
13109,10326,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.167,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13110,10326,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.453,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
13111,10326,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.305,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
13112,10326,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.414,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
13113,10326,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.431,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
13114,10326,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.432,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
13115,10326,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.409,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
13116,10326,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.398,0.3703703703703704,STO609,OHSU_HNSCC_derm002
13117,10326,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.381,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
13118,10326,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.352,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
13119,10326,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.391,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
13120,10326,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.394,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
13121,10326,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.162,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13122,10326,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.344,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
13123,10326,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.049,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
13124,10326,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.372,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
13125,10326,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.205,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13126,10326,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
13127,10326,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.353,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
13128,10326,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.406,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
13129,10326,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.412,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
13130,10326,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.481,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
13131,10326,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.321,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
13132,10326,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.467,0.1234567901234568,STO609,OHSU_HNSCC_derm002
13133,10326,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.426,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
13134,10326,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.366,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
13135,10326,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.381,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
13136,10326,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.302,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
13137,10326,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.218,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13138,10326,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.298,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
13139,10326,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.058,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
13140,10326,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.383,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
13141,10326,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.281,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13142,10326,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.49,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
13143,10326,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.401,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
13144,10326,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.44,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
13145,10326,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.361,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
13146,10326,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.39,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
13147,10326,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.442,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
13148,10326,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.446,0.0411522633744856,STO609,OHSU_HNSCC_derm002
13149,10326,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.425,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
13150,10326,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.34,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
13151,10326,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.393,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
13152,10326,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.282,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
13153,10326,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.278,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
13154,10326,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.307,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
13155,10326,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.141,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
13156,10326,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.408,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
13157,10326,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.38,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
13158,10326,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.462,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
13159,10326,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.445,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
13160,10326,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.416,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
13161,10326,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.289,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
13162,10326,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
13163,10326,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.431,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
13164,10326,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.453,0.013717421124828532,STO609,OHSU_HNSCC_derm002
13165,10326,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.434,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
13166,10326,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.313,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
13167,10326,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.38,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
13168,10326,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.353,0,NONE,OHSU_HNSCC_derm002
13169,10326,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.273,0,NONE,OHSU_HNSCC_derm002
13170,10326,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.37,0,NONE,OHSU_HNSCC_derm002
13171,10326,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.356,0,NONE,OHSU_HNSCC_derm002
13172,10326,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.351,0,NONE,OHSU_HNSCC_derm002
13173,10326,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
13174,10326,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.337,0,NONE,OHSU_HNSCC_derm002
13175,10326,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
13176,10326,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
13177,10326,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.406,0,NONE,OHSU_HNSCC_derm002
13178,10326,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.399,0,NONE,OHSU_HNSCC_derm002
13179,10326,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
13180,10326,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.457,0,NONE,OHSU_HNSCC_derm002
13181,10326,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.431,0,NONE,OHSU_HNSCC_derm002
13182,10326,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.343,0,NONE,OHSU_HNSCC_derm002
13183,10326,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.409,0,NONE,OHSU_HNSCC_derm002
13184,10326,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.031,10,GDC-0941,OHSU_HNSCC_derm002
13185,10326,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.271,10,Dovitinib,OHSU_HNSCC_derm002
13186,10326,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.365,10,BI-2536,OHSU_HNSCC_derm002
13187,10326,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.022,10,TP-0903 ,OHSU_HNSCC_derm002
13188,10326,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.078,10,Belinostat,OHSU_HNSCC_derm002
13189,10326,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.041,10,INK-128,OHSU_HNSCC_derm002
13190,10326,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.185,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13191,10326,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.114,10,Brigatinib,OHSU_HNSCC_derm002
13192,10326,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.224,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13193,10326,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.117,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13194,10326,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.245,10,Pazopanib,OHSU_HNSCC_derm002
13195,10326,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.44,10,AZD4547,OHSU_HNSCC_derm002
13196,10326,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.414,10,Pomalidomide ,OHSU_HNSCC_derm002
13197,10326,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.241,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
13198,10326,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.264,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13199,10326,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.003,10,Staurosporin,OHSU_HNSCC_derm002
13200,10326,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.04,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
13201,10326,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.253,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
13202,10326,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.501,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
13203,10326,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.021,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
13204,10326,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.165,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
13205,10326,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.057,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
13206,10326,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.239,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13207,10326,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.279,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
13208,10326,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.213,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13209,10326,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.194,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13210,10326,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.317,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
13211,10326,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.465,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
13212,10326,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.423,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
13213,10326,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.316,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
13214,10326,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.312,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13215,10326,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.0,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
13216,10326,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.104,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
13217,10326,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.353,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
13218,10326,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.444,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
13219,10326,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.055,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
13220,10326,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.211,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
13221,10326,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.066,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
13222,10326,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.259,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13223,10326,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.384,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
13224,10326,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.214,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13225,10326,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.307,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13226,10326,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
13227,10326,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.435,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
13228,10326,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.443,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
13229,10326,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.331,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
13230,10326,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.433,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13231,10326,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.006,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
13232,10326,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.13,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
13233,10326,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.264,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
13234,10326,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.387,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
13235,10326,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.337,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
13236,10326,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.29,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
13237,10326,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.096,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
13238,10326,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.279,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13239,10326,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.414,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
13240,10326,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.189,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13241,10326,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.351,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13242,10326,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.377,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
13243,10326,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.438,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
13244,10326,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.458,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
13245,10326,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.384,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
13246,10326,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.332,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13247,10326,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.059,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
13248,10326,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.22,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
13249,10326,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
13250,10326,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.33,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
13251,10326,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.404,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
13252,10326,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.332,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
13253,10326,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.128,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
13254,10326,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.371,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13255,10326,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.41,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
13256,10326,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.29,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13257,10326,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.397,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13258,10326,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.382,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
13259,10326,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.391,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
13260,10326,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.464,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
13261,10326,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.418,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
13262,10326,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.303,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13263,10326,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.176,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
13264,10326,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.207,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
13265,10326,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.309,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
13266,10326,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.276,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
13267,10326,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.385,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
13268,10326,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.357,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
13269,10326,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.156,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
13270,10326,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.395,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13271,10326,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.404,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
13272,10326,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.25,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13273,10326,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.407,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13274,10326,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.403,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
13275,10326,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.445,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
13276,10326,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.455,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
13277,10326,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.367,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
13278,10326,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.373,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13279,10326,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.361,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
13280,10326,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.309,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
13281,10326,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.306,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
13282,10326,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.266,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
13283,10326,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.352,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
13284,10326,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.456,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
13285,10326,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.188,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
13286,10326,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.38,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
13287,10326,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.42,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
13288,10326,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.341,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13289,10326,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.412,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
13290,10326,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.424,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
13291,10326,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.388,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
13292,10326,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.447,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
13293,10326,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.425,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
13294,10326,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.261,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
13295,10326,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.379,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
13296,10326,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.342,0,NONE,OHSU_HNSCC_derm002
13297,10326,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.312,0,NONE,OHSU_HNSCC_derm002
13298,10326,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.29,0,NONE,OHSU_HNSCC_derm002
13299,10326,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.367,0,NONE,OHSU_HNSCC_derm002
13300,10326,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.382,0,NONE,OHSU_HNSCC_derm002
13301,10326,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
13302,10326,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
13303,10326,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
13304,10326,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.373,0,NONE,OHSU_HNSCC_derm002
13305,10326,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
13306,10326,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
13307,10326,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.506,0,NONE,OHSU_HNSCC_derm002
13308,10326,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.399,0,NONE,OHSU_HNSCC_derm002
13309,10326,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.396,0,NONE,OHSU_HNSCC_derm002
13310,10326,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.298,0,NONE,OHSU_HNSCC_derm002
13311,10326,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.38,0,NONE,OHSU_HNSCC_derm002
13312,10326,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.316,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
13313,10326,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.238,10,Hesperidin,OHSU_HNSCC_derm002
13314,10326,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.31,10,Esculetin,OHSU_HNSCC_derm002
13315,10326,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.072,10,Selinexor ,OHSU_HNSCC_derm002
13316,10326,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.313,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13317,10326,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.245,10,BMX-IN-1,OHSU_HNSCC_derm002
13318,10326,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.039,1,Dasatinib (1mM),OHSU_HNSCC_derm002
13319,10326,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.396,10,Trametinib,OHSU_HNSCC_derm002
13320,10326,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.129,10,BEZ235,OHSU_HNSCC_derm002
13321,10326,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.023,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
13322,10326,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.279,10,Nilotinib,OHSU_HNSCC_derm002
13323,10326,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.283,10,Enzalutamide,OHSU_HNSCC_derm002
13324,10326,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.54,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13325,10326,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.347,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
13326,10326,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.05,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13327,10326,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.323,10,Axitinib,OHSU_HNSCC_derm002
13328,10326,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.267,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
13329,10326,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.286,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
13330,10326,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.271,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
13331,10326,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.088,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
13332,10326,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.294,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13333,10326,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.171,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
13334,10326,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.064,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
13335,10326,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.334,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
13336,10326,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.124,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
13337,10326,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.018,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
13338,10326,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.35,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
13339,10326,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.345,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
13340,10326,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.424,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13341,10326,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.433,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
13342,10326,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.047,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13343,10326,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.337,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
13344,10326,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.223,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
13345,10326,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.253,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
13346,10326,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.362,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
13347,10326,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.088,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
13348,10326,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.322,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13349,10326,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.331,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
13350,10326,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.07,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
13351,10326,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.409,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
13352,10326,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.1,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
13353,10326,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.028,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
13354,10326,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.393,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
13355,10326,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.406,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
13356,10326,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.41,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13357,10326,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.321,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
13358,10326,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.049,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13359,10326,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.385,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
13360,10326,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.268,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
13361,10326,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.308,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
13362,10326,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.299,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
13363,10326,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.16,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
13364,10326,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.255,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13365,10326,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.295,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
13366,10326,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.195,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
13367,10326,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.345,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
13368,10326,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.141,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
13369,10326,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.047,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
13370,10326,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.43,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
13371,10326,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.364,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
13372,10326,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.444,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13373,10326,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.473,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
13374,10326,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.191,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13375,10326,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.387,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
13376,10326,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.303,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
13377,10326,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.256,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
13378,10326,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.372,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
13379,10326,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.312,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
13380,10326,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.305,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13381,10326,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.371,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
13382,10326,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.329,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
13383,10326,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.353,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
13384,10326,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.157,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
13385,10326,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.103,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
13386,10326,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.389,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
13387,10326,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.354,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
13388,10326,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.443,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13389,10326,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.506,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
13390,10326,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.299,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13391,10326,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.363,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
13392,10326,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.268,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
13393,10326,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.204,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
13394,10326,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.273,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
13395,10326,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.255,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
13396,10326,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.307,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13397,10326,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.297,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
13398,10326,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.271,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
13399,10326,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.355,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
13400,10326,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.146,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
13401,10326,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.315,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
13402,10326,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.393,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
13403,10326,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.316,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
13404,10326,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.368,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13405,10326,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.317,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
13406,10326,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.376,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13407,10326,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.332,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
13408,10326,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.264,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
13409,10326,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.226,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
13410,10326,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.252,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
13411,10326,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.224,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
13412,10326,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.287,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
13413,10326,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.296,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
13414,10326,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.367,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
13415,10326,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.375,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
13416,10326,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.289,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
13417,10326,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.271,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
13418,10326,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.256,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
13419,10326,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.295,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
13420,10326,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.329,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
13421,10326,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.387,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
13422,10326,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.35,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
13423,10326,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.342,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
13424,10326,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.277,0,NONE,OHSU_HNSCC_derm002
13425,10326,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.265,0,NONE,OHSU_HNSCC_derm002
13426,10326,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.286,0,NONE,OHSU_HNSCC_derm002
13427,10326,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.283,0,NONE,OHSU_HNSCC_derm002
13428,10326,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
13429,10326,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.304,0,NONE,OHSU_HNSCC_derm002
13430,10326,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.328,0,NONE,OHSU_HNSCC_derm002
13431,10326,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
13432,10326,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.338,0,NONE,OHSU_HNSCC_derm002
13433,10326,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.305,0,NONE,OHSU_HNSCC_derm002
13434,10326,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.346,0,NONE,OHSU_HNSCC_derm002
13435,10326,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
13436,10326,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.319,0,NONE,OHSU_HNSCC_derm002
13437,10326,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.386,0,NONE,OHSU_HNSCC_derm002
13438,10326,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.368,0,NONE,OHSU_HNSCC_derm002
13439,10326,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.358,0,NONE,OHSU_HNSCC_derm002
13440,10326,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.322,10,Thalidomide ,OHSU_HNSCC_derm002
13441,10326,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.167,10,Vandetanib,OHSU_HNSCC_derm002
13442,10326,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.321,10,Oleic acid,OHSU_HNSCC_derm002
13443,10326,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.017,10,A-674563,OHSU_HNSCC_derm002
13444,10326,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.133,10,Lapatinib,OHSU_HNSCC_derm002
13445,10326,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.33,10,Apocynin (vanillin),OHSU_HNSCC_derm002
13446,10326,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.135,10,AT-7519,OHSU_HNSCC_derm002
13447,10326,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.163,10,Gefitinib,OHSU_HNSCC_derm002
13448,10326,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.1,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
13449,10326,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.115,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13450,10326,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.018,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13451,10326,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.474,10,JQ1,OHSU_HNSCC_derm002
13452,10326,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.582,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13453,10326,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.358,10,Cerdulatinib,OHSU_HNSCC_derm002
13454,10326,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.004,10,Romidepsin,OHSU_HNSCC_derm002
13455,10326,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.289,10,Gilteritinib,OHSU_HNSCC_derm002
13456,10326,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.277,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
13457,10326,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.365,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
13458,10326,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.392,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
13459,10326,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.349,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
13460,10326,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.196,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
13461,10326,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.415,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
13462,10326,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.029,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
13463,10326,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.251,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
13464,10326,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.344,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
13465,10326,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.189,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13466,10326,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.146,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13467,10326,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.629,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
13468,10326,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.439,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13469,10326,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.497,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
13470,10326,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.0,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
13471,10326,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.405,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
13472,10326,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
13473,10326,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.341,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
13474,10326,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.355,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
13475,10326,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.377,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
13476,10326,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.238,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
13477,10326,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.341,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
13478,10326,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.049,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
13479,10326,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.251,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
13480,10326,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.408,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
13481,10326,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.298,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13482,10326,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.238,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13483,10326,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.621,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
13484,10326,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.432,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13485,10326,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.529,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
13486,10326,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.006,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
13487,10326,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.451,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
13488,10326,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.377,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
13489,10326,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.339,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
13490,10326,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.376,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
13491,10326,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.364,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
13492,10326,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.242,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
13493,10326,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.346,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
13494,10326,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.281,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
13495,10326,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.274,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
13496,10326,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.437,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
13497,10326,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.333,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13498,10326,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.267,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13499,10326,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.729,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
13500,10326,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.414,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13501,10326,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.448,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
13502,10326,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.011,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
13503,10326,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.43,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
13504,10326,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.336,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
13505,10326,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.326,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
13506,10326,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.348,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
13507,10326,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.349,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
13508,10326,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.327,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
13509,10326,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.392,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
13510,10326,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.364,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
13511,10326,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.351,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
13512,10326,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.4,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
13513,10326,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.394,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13514,10326,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.341,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13515,10326,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.649,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
13516,10326,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.5,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13517,10326,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.465,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
13518,10326,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.03,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
13519,10326,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.418,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
13520,10326,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.305,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
13521,10326,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.307,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
13522,10326,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.386,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
13523,10326,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.33,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
13524,10326,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.321,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
13525,10326,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.403,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
13526,10326,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.365,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
13527,10326,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.408,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
13528,10326,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.435,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
13529,10326,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.383,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13530,10326,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.353,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13531,10326,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.556,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
13532,10326,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.449,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13533,10326,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.465,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
13534,10326,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.041,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
13535,10326,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.415,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
13536,10326,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.318,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
13537,10326,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.379,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
13538,10326,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.351,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
13539,10326,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.35,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
13540,10326,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.359,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
13541,10326,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.401,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
13542,10326,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.417,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
13543,10326,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.445,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
13544,10326,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.43,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
13545,10326,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.413,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
13546,10326,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.414,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
13547,10326,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.499,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
13548,10326,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.471,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
13549,10326,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.448,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
13550,10326,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.046,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
13551,10326,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.45,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
13552,10326,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.346,0,NONE,OHSU_HNSCC_derm002
13553,10326,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.4,0,NONE,OHSU_HNSCC_derm002
13554,10326,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.308,0,NONE,OHSU_HNSCC_derm002
13555,10326,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.348,0,NONE,OHSU_HNSCC_derm002
13556,10326,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
13557,10326,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.403,0,NONE,OHSU_HNSCC_derm002
13558,10326,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.43,0,NONE,OHSU_HNSCC_derm002
13559,10326,Blank 490,3,H,OHSU_HNSCC_derm002,8,0.0,10,F-S-V,OHSU_HNSCC_derm002
13560,10326,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.456,0,NONE,OHSU_HNSCC_derm002
13561,10326,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.447,0,NONE,OHSU_HNSCC_derm002
13562,10326,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.449,0,NONE,OHSU_HNSCC_derm002
13563,10326,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.442,0,NONE,OHSU_HNSCC_derm002
13564,10326,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.465,0,NONE,OHSU_HNSCC_derm002
13565,10326,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.416,0,NONE,OHSU_HNSCC_derm002
13566,10326,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.393,0,NONE,OHSU_HNSCC_derm002
13567,10326,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.455,0,NONE,OHSU_HNSCC_derm002
13568,10326,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.34,10,Anastrazole,OHSU_HNSCC_derm002
13569,10326,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.219,10,JNJ-28312141 ,OHSU_HNSCC_derm002
13570,10326,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.283,10,Genistein,OHSU_HNSCC_derm002
13571,10326,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.34,10,Abscisic acid,OHSU_HNSCC_derm002
13572,10326,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.214,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13573,10326,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.454,10,Ruxolitinib,OHSU_HNSCC_derm002
13574,10326,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.452,10,TAK-659,OHSU_HNSCC_derm002
13575,10326,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.1,10,Brigatinib,OHSU_HNSCC_derm002
13576,10326,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.194,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13577,10326,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.068,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13578,10326,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.155,10,Vorinostat,OHSU_HNSCC_derm002
13579,10326,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.443,10,Lenalidomide,OHSU_HNSCC_derm002
13580,10326,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.196,10,NVP-ADW742,OHSU_HNSCC_derm002
13581,10326,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.446,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13582,10326,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.453,10,Echinatin,OHSU_HNSCC_derm002
13583,10326,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.017,10,YM-155,OHSU_HNSCC_derm002
13584,10326,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.328,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
13585,10326,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.404,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
13586,10326,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.349,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
13587,10326,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.331,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
13588,10326,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.268,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13589,10326,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.452,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
13590,10326,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.512,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
13591,10326,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.206,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
13592,10326,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.223,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13593,10326,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.542,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13594,10326,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.218,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
13595,10326,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.466,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
13596,10326,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.403,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
13597,10326,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.429,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13598,10326,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.428,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
13599,10326,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.018,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
13600,10326,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.306,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
13601,10326,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.424,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
13602,10326,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.451,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
13603,10326,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.335,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
13604,10326,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.231,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13605,10326,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.42,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
13606,10326,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.493,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
13607,10326,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.396,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
13608,10326,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.259,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13609,10326,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.557,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13610,10326,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.318,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
13611,10326,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.418,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
13612,10326,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.362,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
13613,10326,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.424,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13614,10326,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.399,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
13615,10326,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.003,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
13616,10326,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.276,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
13617,10326,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.421,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
13618,10326,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.412,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
13619,10326,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.377,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
13620,10326,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.272,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13621,10326,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.412,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
13622,10326,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.456,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
13623,10326,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.367,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
13624,10326,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.257,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13625,10326,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.532,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13626,10326,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.372,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
13627,10326,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.422,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
13628,10326,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.388,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
13629,10326,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.43,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13630,10326,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.428,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
13631,10326,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.015,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
13632,10326,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
13633,10326,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.347,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
13634,10326,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.397,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
13635,10326,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.359,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
13636,10326,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.306,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13637,10326,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.35,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
13638,10326,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.456,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
13639,10326,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.417,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
13640,10326,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.258,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13641,10326,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.514,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13642,10326,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.377,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
13643,10326,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.434,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
13644,10326,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.455,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
13645,10326,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.42,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13646,10326,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.415,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
13647,10326,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.004,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
13648,10326,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.283,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
13649,10326,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.441,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
13650,10326,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.38,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
13651,10326,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.378,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
13652,10326,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.26,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13653,10326,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.393,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
13654,10326,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.415,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
13655,10326,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.411,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
13656,10326,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.299,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13657,10326,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.485,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13658,10326,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.353,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
13659,10326,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.426,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
13660,10326,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.444,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
13661,10326,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.444,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13662,10326,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.434,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
13663,10326,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.0,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
13664,10326,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.339,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
13665,10326,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.369,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
13666,10326,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.336,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
13667,10326,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.34,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
13668,10326,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.366,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
13669,10326,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.373,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
13670,10326,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.417,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
13671,10326,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.418,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
13672,10326,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.35,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13673,10326,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.467,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
13674,10326,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
13675,10326,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.432,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
13676,10326,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.468,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
13677,10326,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.439,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
13678,10326,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.422,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
13679,10326,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.001,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
13680,10326,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.246,0,NONE,OHSU_HNSCC_derm002
13681,10326,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.364,0,NONE,OHSU_HNSCC_derm002
13682,10326,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.381,0,NONE,OHSU_HNSCC_derm002
13683,10326,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.323,0,NONE,OHSU_HNSCC_derm002
13684,10326,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.32,0,NONE,OHSU_HNSCC_derm002
13685,10326,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.378,0,NONE,OHSU_HNSCC_derm002
13686,10326,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.406,0,NONE,OHSU_HNSCC_derm002
13687,10326,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.0,10,F-S-V,OHSU_HNSCC_derm002
13688,10326,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.423,0,NONE,OHSU_HNSCC_derm002
13689,10326,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.428,0,NONE,OHSU_HNSCC_derm002
13690,10326,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.445,0,NONE,OHSU_HNSCC_derm002
13691,10326,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.465,0,NONE,OHSU_HNSCC_derm002
13692,10326,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.489,0,NONE,OHSU_HNSCC_derm002
13693,10326,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.439,0,NONE,OHSU_HNSCC_derm002
13694,10326,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.434,0,NONE,OHSU_HNSCC_derm002
13695,10326,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.419,0,NONE,OHSU_HNSCC_derm002
13696,10326,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.343,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13697,10326,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.392,10,Stevioside,OHSU_HNSCC_derm002
13698,10326,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.305,10,Pemetrexed,OHSU_HNSCC_derm002
13699,10326,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.044,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13700,10326,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.22,10,GSK-1838705A,OHSU_HNSCC_derm002
13701,10326,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.013,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13702,10326,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.406,10,Imatinib,OHSU_HNSCC_derm002
13703,10326,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.346,10,Trametinib,OHSU_HNSCC_derm002
13704,10326,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.144,10,BEZ235,OHSU_HNSCC_derm002
13705,10326,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.08,10,Saracatinib,OHSU_HNSCC_derm002
13706,10326,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.662,10,I-BET 762,OHSU_HNSCC_derm002
13707,10326,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.175,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
13708,10326,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.532,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
13709,10326,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.416,10,Crizotinib,OHSU_HNSCC_derm002
13710,10326,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.269,10,MGCD-265,OHSU_HNSCC_derm002
13711,10326,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.176,10,Erlotinib,OHSU_HNSCC_derm002
13712,10326,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.296,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13713,10326,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.378,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
13714,10326,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.366,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
13715,10326,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.047,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13716,10326,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.238,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
13717,10326,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.095,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13718,10326,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.431,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
13719,10326,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.403,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
13720,10326,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.13,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
13721,10326,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
13722,10326,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.682,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
13723,10326,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.174,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
13724,10326,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.499,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
13725,10326,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.5,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
13726,10326,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.29,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
13727,10326,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.217,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
13728,10326,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.337,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13729,10326,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.448,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
13730,10326,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.335,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
13731,10326,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.085,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13732,10326,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.252,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
13733,10326,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.208,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13734,10326,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.393,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
13735,10326,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.413,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
13736,10326,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.126,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
13737,10326,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.398,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
13738,10326,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.653,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
13739,10326,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.209,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
13740,10326,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.489,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
13741,10326,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.424,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
13742,10326,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.445,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
13743,10326,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.316,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
13744,10326,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.388,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13745,10326,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.39,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
13746,10326,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.313,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
13747,10326,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.133,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13748,10326,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.294,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
13749,10326,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.244,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13750,10326,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.41,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
13751,10326,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.374,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
13752,10326,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.155,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
13753,10326,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.473,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
13754,10326,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.567,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
13755,10326,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.227,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
13756,10326,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.44,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
13757,10326,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.441,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
13758,10326,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.397,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
13759,10326,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.341,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
13760,10326,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.337,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13761,10326,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.37,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
13762,10326,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.381,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
13763,10326,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.214,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13764,10326,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.321,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
13765,10326,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.292,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13766,10326,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.391,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
13767,10326,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.362,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
13768,10326,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.179,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
13769,10326,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.449,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
13770,10326,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.509,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
13771,10326,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.252,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
13772,10326,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.46,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
13773,10326,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.407,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
13774,10326,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.364,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
13775,10326,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.395,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
13776,10326,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.369,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13777,10326,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.343,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
13778,10326,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.367,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
13779,10326,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.223,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13780,10326,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
13781,10326,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.307,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13782,10326,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.409,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
13783,10326,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.37,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
13784,10326,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.26,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
13785,10326,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.401,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
13786,10326,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.389,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
13787,10326,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.333,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
13788,10326,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.39,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
13789,10326,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.419,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
13790,10326,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.438,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
13791,10326,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
13792,10326,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.378,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
13793,10326,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.38,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
13794,10326,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.388,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
13795,10326,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.332,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
13796,10326,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.362,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
13797,10326,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.347,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
13798,10326,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.389,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
13799,10326,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.412,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
13800,10326,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.341,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
13801,10326,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.365,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
13802,10326,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.371,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
13803,10326,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.296,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
13804,10326,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.345,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
13805,10326,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.333,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
13806,10326,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.374,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
13807,10326,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.373,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
13808,10326,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.303,0,NONE,OHSU_HNSCC_derm002
13809,10326,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.314,0,NONE,OHSU_HNSCC_derm002
13810,10326,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.296,0,NONE,OHSU_HNSCC_derm002
13811,10326,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.394,0,NONE,OHSU_HNSCC_derm002
13812,10326,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.365,0,NONE,OHSU_HNSCC_derm002
13813,10326,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.321,0,NONE,OHSU_HNSCC_derm002
13814,10326,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
13815,10326,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
13816,10326,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.383,0,NONE,OHSU_HNSCC_derm002
13817,10326,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.411,0,NONE,OHSU_HNSCC_derm002
13818,10326,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.21,0,NONE,OHSU_HNSCC_derm002
13819,10326,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
13820,10326,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.333,0,NONE,OHSU_HNSCC_derm002
13821,10326,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
13822,10326,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.341,0,NONE,OHSU_HNSCC_derm002
13823,10326,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.419,0,NONE,OHSU_HNSCC_derm002
13824,10326,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.028,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13825,10326,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.115,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13826,10326,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.399,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13827,10326,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.113,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13828,10326,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.037,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13829,10326,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.03,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13830,10326,Blank 490,4,G,OHSU_HNSCC_derm002,1,-0.014,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13831,10326,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.192,10,Gefitinib,OHSU_HNSCC_derm002
13832,10326,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.01,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
13833,10326,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.013,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13834,10326,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.141,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13835,10326,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.101,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13836,10326,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.099,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13837,10326,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.301,10,VOLASERTIB x,OHSU_HNSCC_derm002
13838,10326,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.062,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13839,10326,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.007,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13840,10326,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.044,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13841,10326,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.178,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13842,10326,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.399,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13843,10326,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.175,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13844,10326,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.131,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13845,10326,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.061,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13846,10326,Blank 490,4,G,OHSU_HNSCC_derm002,2,-0.003,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13847,10326,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.281,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
13848,10326,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.322,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
13849,10326,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.022,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13850,10326,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.179,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13851,10326,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.174,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13852,10326,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.218,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13853,10326,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.569,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
13854,10326,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.375,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13855,10326,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.007,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13856,10326,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.088,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13857,10326,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.24,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13858,10326,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.413,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13859,10326,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.222,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13860,10326,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.139,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13861,10326,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.078,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13862,10326,Blank 490,4,G,OHSU_HNSCC_derm002,3,-0.001,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13863,10326,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.29,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
13864,10326,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.457,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
13865,10326,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.085,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13866,10326,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.204,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13867,10326,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.216,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13868,10326,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.252,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13869,10326,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.637,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
13870,10326,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.407,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13871,10326,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.01,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13872,10326,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.152,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13873,10326,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.293,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13874,10326,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.432,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13875,10326,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.261,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13876,10326,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.2,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13877,10326,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.121,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13878,10326,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.023,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13879,10326,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.296,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
13880,10326,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.382,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
13881,10326,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.138,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13882,10326,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.274,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13883,10326,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.297,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13884,10326,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.413,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13885,10326,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.554,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
13886,10326,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.435,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13887,10326,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.092,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13888,10326,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.267,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13889,10326,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.272,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13890,10326,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.423,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13891,10326,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.288,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13892,10326,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.245,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13893,10326,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.149,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13894,10326,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.049,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13895,10326,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.306,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
13896,10326,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.53,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
13897,10326,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.23,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13898,10326,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.36,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13899,10326,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.369,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13900,10326,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.466,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13901,10326,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.44,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
13902,10326,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.414,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13903,10326,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.299,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13904,10326,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.302,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13905,10326,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.359,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13906,10326,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.411,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13907,10326,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.345,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13908,10326,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.312,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13909,10326,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.215,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13910,10326,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.051,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13911,10326,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.408,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
13912,10326,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.439,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
13913,10326,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.331,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13914,10326,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.386,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13915,10326,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.408,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13916,10326,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.417,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13917,10326,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.343,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
13918,10326,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.407,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13919,10326,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.341,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13920,10326,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.375,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
13921,10326,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.411,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
13922,10326,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.411,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
13923,10326,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.387,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
13924,10326,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.357,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
13925,10326,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.269,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
13926,10326,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.055,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
13927,10326,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.453,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
13928,10326,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.469,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
13929,10326,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.382,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
13930,10326,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.405,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
13931,10326,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.483,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
13932,10326,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.494,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
13933,10326,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.393,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
13934,10326,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.382,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
13935,10326,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.397,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
13936,10326,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.342,0,NONE,OHSU_HNSCC_derm002
13937,10326,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.392,0,NONE,OHSU_HNSCC_derm002
13938,10326,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.416,0,NONE,OHSU_HNSCC_derm002
13939,10326,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.402,0,NONE,OHSU_HNSCC_derm002
13940,10326,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.367,0,NONE,OHSU_HNSCC_derm002
13941,10326,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
13942,10326,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.452,0,NONE,OHSU_HNSCC_derm002
13943,10326,Blank 490,4,H,OHSU_HNSCC_derm002,8,0.004,10,F-S-V,OHSU_HNSCC_derm002
13944,10326,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.448,0,NONE,OHSU_HNSCC_derm002
13945,10326,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.461,0,NONE,OHSU_HNSCC_derm002
13946,10326,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.476,0,NONE,OHSU_HNSCC_derm002
13947,10326,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.463,0,NONE,OHSU_HNSCC_derm002
13948,10326,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.514,0,NONE,OHSU_HNSCC_derm002
13949,10326,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.478,0,NONE,OHSU_HNSCC_derm002
13950,10326,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.474,0,NONE,OHSU_HNSCC_derm002
13951,10326,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.377,0,NONE,OHSU_HNSCC_derm002
13952,10326,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.12,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
13953,10326,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.183,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
13954,10326,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.016,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
13955,10326,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.232,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
13956,10326,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.15,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
13957,10326,Blank 490,4,F,OHSU_HNSCC_derm002,9,-0.001,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
13958,10326,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.068,10,AZD2014 x ,OHSU_HNSCC_derm002
13959,10326,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.137,10,Brigatinib,OHSU_HNSCC_derm002
13960,10326,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.194,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13961,10326,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.049,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
13962,10326,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.248,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
13963,10326,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.012,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
13964,10326,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.134,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
13965,10326,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.35,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
13966,10326,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.185,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
13967,10326,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.195,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
13968,10326,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.163,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
13969,10326,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.185,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
13970,10326,Blank 490,4,C,OHSU_HNSCC_derm002,10,-0.006,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
13971,10326,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.363,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
13972,10326,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.195,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
13973,10326,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.013,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
13974,10326,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.09,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
13975,10326,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.291,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
13976,10326,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.213,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13977,10326,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.209,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
13978,10326,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.318,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
13979,10326,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.25,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
13980,10326,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.25,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
13981,10326,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.29,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
13982,10326,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.227,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
13983,10326,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.27,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
13984,10326,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.187,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
13985,10326,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.218,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
13986,10326,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.012,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
13987,10326,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.339,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
13988,10326,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.229,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
13989,10326,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.025,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
13990,10326,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.121,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
13991,10326,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.388,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
13992,10326,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.266,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
13993,10326,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.217,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
13994,10326,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.348,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
13995,10326,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.341,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
13996,10326,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.254,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
13997,10326,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.312,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
13998,10326,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.235,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
13999,10326,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.284,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
14000,10326,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.243,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
14001,10326,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.307,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
14002,10326,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.124,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
14003,10326,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.353,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14004,10326,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.295,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
14005,10326,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.087,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
14006,10326,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.179,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
14007,10326,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.436,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
14008,10326,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.265,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14009,10326,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.259,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
14010,10326,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.355,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
14011,10326,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.419,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
14012,10326,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.263,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14013,10326,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.371,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
14014,10326,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.279,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
14015,10326,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.374,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
14016,10326,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.284,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
14017,10326,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.321,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
14018,10326,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.284,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
14019,10326,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.415,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14020,10326,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.261,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
14021,10326,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.232,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
14022,10326,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.248,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
14023,10326,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.423,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
14024,10326,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.274,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14025,10326,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.4,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
14026,10326,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.44,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
14027,10326,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.453,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
14028,10326,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.279,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14029,10326,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.398,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
14030,10326,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.332,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
14031,10326,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.408,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
14032,10326,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.31,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
14033,10326,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.372,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
14034,10326,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.337,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
14035,10326,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.421,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14036,10326,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.337,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
14037,10326,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.311,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
14038,10326,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.331,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
14039,10326,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.41,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
14040,10326,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.357,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14041,10326,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.423,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
14042,10326,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.358,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
14043,10326,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.381,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
14044,10326,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.322,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14045,10326,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.487,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
14046,10326,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.358,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
14047,10326,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.439,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
14048,10326,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.301,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
14049,10326,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.394,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
14050,10326,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.433,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
14051,10326,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.409,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14052,10326,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.331,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
14053,10326,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.337,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
14054,10326,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.398,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
14055,10326,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.46,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
14056,10326,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.377,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14057,10326,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.415,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
14058,10326,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.43,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
14059,10326,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.479,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
14060,10326,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.364,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14061,10326,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.403,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
14062,10326,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.401,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
14063,10326,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.4,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
14064,10326,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.376,0,NONE,OHSU_HNSCC_derm002
14065,10326,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.42,0,NONE,OHSU_HNSCC_derm002
14066,10326,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.442,0,NONE,OHSU_HNSCC_derm002
14067,10326,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.412,0,NONE,OHSU_HNSCC_derm002
14068,10326,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.4,0,NONE,OHSU_HNSCC_derm002
14069,10326,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.413,0,NONE,OHSU_HNSCC_derm002
14070,10326,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.432,0,NONE,OHSU_HNSCC_derm002
14071,10326,Blank 490,4,H,OHSU_HNSCC_derm002,16,-0.004,10,F-S-V,OHSU_HNSCC_derm002
14072,10326,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.473,0,NONE,OHSU_HNSCC_derm002
14073,10326,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.462,0,NONE,OHSU_HNSCC_derm002
14074,10326,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.427,0,NONE,OHSU_HNSCC_derm002
14075,10326,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.446,0,NONE,OHSU_HNSCC_derm002
14076,10326,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.492,0,NONE,OHSU_HNSCC_derm002
14077,10326,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.481,0,NONE,OHSU_HNSCC_derm002
14078,10326,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.441,0,NONE,OHSU_HNSCC_derm002
14079,10326,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.341,0,NONE,OHSU_HNSCC_derm002
14080,10326,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.127,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14081,10326,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.01,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14082,10326,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.071,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14083,10326,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.009,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14084,10326,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.002,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14085,10326,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.094,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14086,10326,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.176,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14087,10326,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.381,10,Trametinib,OHSU_HNSCC_derm002
14088,10326,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.106,10,BEZ235,OHSU_HNSCC_derm002
14089,10326,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.09,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14090,10326,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.411,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14091,10326,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.003,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14092,10326,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.155,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14093,10326,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.504,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14094,10326,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.166,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14095,10326,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.196,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14096,10326,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.232,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14097,10326,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.124,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14098,10326,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.029,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14099,10326,Blank 490,4,D,OHSU_HNSCC_derm002,18,-0.003,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14100,10326,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.023,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14101,10326,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.17,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14102,10326,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.308,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14103,10326,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.397,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
14104,10326,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.149,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
14105,10326,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.169,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14106,10326,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.456,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14107,10326,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.034,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14108,10326,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.278,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14109,10326,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.505,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14110,10326,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.29,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14111,10326,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.167,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14112,10326,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.419,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14113,10326,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.28,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14114,10326,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.04,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14115,10326,Blank 490,4,D,OHSU_HNSCC_derm002,19,-0.033,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14116,10326,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.041,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14117,10326,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.212,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14118,10326,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.35,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14119,10326,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.374,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
14120,10326,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.124,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
14121,10326,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.218,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14122,10326,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.455,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14123,10326,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.031,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14124,10326,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.273,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14125,10326,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.483,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14126,10326,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.337,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14127,10326,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.188,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14128,10326,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.422,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14129,10326,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.336,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14130,10326,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.069,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14131,10326,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.005,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14132,10326,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.03,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14133,10326,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.075,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14134,10326,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.467,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14135,10326,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.451,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
14136,10326,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.161,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
14137,10326,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.254,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14138,10326,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.43,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14139,10326,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.07,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14140,10326,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.35,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14141,10326,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.498,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14142,10326,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.37,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14143,10326,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.246,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14144,10326,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.415,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14145,10326,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.296,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14146,10326,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.111,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14147,10326,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.026,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14148,10326,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.063,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14149,10326,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.294,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14150,10326,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.452,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14151,10326,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.426,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
14152,10326,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.196,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
14153,10326,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.335,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14154,10326,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.419,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14155,10326,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.234,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14156,10326,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.389,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14157,10326,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.444,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14158,10326,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.43,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14159,10326,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.286,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14160,10326,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.387,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14161,10326,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.377,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14162,10326,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.306,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14163,10326,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.03,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14164,10326,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.398,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14165,10326,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.347,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14166,10326,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.393,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14167,10326,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.362,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
14168,10326,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
14169,10326,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.323,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14170,10326,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.43,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14171,10326,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.372,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14172,10326,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.438,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14173,10326,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.425,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14174,10326,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14175,10326,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.362,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14176,10326,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.392,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
14177,10326,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.341,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
14178,10326,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.345,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14179,10326,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.047,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
14180,10326,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.357,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14181,10326,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.289,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
14182,10326,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.379,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
14183,10326,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.421,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
14184,10326,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.41,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
14185,10326,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.418,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
14186,10326,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.482,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14187,10326,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.375,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14188,10326,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.416,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
14189,10326,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.414,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14190,10326,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.408,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
14191,10326,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.368,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14192,10326,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.311,0,NONE,OHSU_HNSCC_derm002
14193,10326,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.341,0,NONE,OHSU_HNSCC_derm002
14194,10326,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.377,0,NONE,OHSU_HNSCC_derm002
14195,10326,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.368,0,NONE,OHSU_HNSCC_derm002
14196,10326,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.364,0,NONE,OHSU_HNSCC_derm002
14197,10326,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.361,0,NONE,OHSU_HNSCC_derm002
14198,10326,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
14199,10326,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.364,0,NONE,OHSU_HNSCC_derm002
14200,10326,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.42,0,NONE,OHSU_HNSCC_derm002
14201,10326,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.415,0,NONE,OHSU_HNSCC_derm002
14202,10326,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.428,0,NONE,OHSU_HNSCC_derm002
14203,10326,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.371,0,NONE,OHSU_HNSCC_derm002
14204,10326,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.388,0,NONE,OHSU_HNSCC_derm002
14205,10326,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
14206,10326,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.37,0,NONE,OHSU_HNSCC_derm002
14207,10326,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
14208,10326,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.152,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14209,10326,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.003,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14210,10326,Blank 490,5,C,OHSU_HNSCC_derm002,1,0.003,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14211,10326,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.046,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14212,10326,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.067,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14213,10326,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.059,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14214,10326,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.49,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14215,10326,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.216,10,Gefitinib,OHSU_HNSCC_derm002
14216,10326,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.045,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
14217,10326,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.021,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14218,10326,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.526,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14219,10326,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.173,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14220,10326,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.028,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14221,10326,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.297,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14222,10326,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.056,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14223,10326,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.097,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14224,10326,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.163,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14225,10326,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.176,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14226,10326,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.003,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14227,10326,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.31,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14228,10326,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.179,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14229,10326,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.086,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14230,10326,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.393,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14231,10326,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.25,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
14232,10326,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.315,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
14233,10326,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.008,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14234,10326,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.432,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14235,10326,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.211,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14236,10326,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.031,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14237,10326,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.28,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14238,10326,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.074,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14239,10326,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.131,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14240,10326,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.201,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14241,10326,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.23,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14242,10326,Blank 490,5,C,OHSU_HNSCC_derm002,3,-0.002,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14243,10326,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.395,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14244,10326,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.263,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14245,10326,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.077,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14246,10326,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.432,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14247,10326,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.31,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
14248,10326,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.404,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
14249,10326,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.07,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14250,10326,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.459,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14251,10326,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.263,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14252,10326,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.061,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14253,10326,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.384,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14254,10326,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.113,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14255,10326,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.178,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14256,10326,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.2,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14257,10326,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.291,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14258,10326,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.028,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14259,10326,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.453,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14260,10326,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.356,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14261,10326,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.182,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14262,10326,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.451,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14263,10326,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.336,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
14264,10326,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.459,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
14265,10326,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.13,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14266,10326,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.465,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14267,10326,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.311,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14268,10326,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.153,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14269,10326,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.33,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14270,10326,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.146,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14271,10326,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.201,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14272,10326,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.238,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14273,10326,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.321,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14274,10326,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.053,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14275,10326,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.448,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14276,10326,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.362,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14277,10326,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.357,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14278,10326,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.444,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14279,10326,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.387,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
14280,10326,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.48,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
14281,10326,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.265,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14282,10326,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.464,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14283,10326,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.346,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14284,10326,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.218,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14285,10326,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.395,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14286,10326,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.204,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14287,10326,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.348,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14288,10326,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.276,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14289,10326,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.393,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14290,10326,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.046,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14291,10326,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.465,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14292,10326,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.366,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14293,10326,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.436,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14294,10326,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.489,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14295,10326,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.449,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
14296,10326,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.458,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
14297,10326,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.337,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14298,10326,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.453,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14299,10326,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.411,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14300,10326,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.375,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14301,10326,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.487,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14302,10326,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.291,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14303,10326,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.278,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14304,10326,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.238,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14305,10326,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.436,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
14306,10326,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.056,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
14307,10326,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.488,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
14308,10326,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.405,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
14309,10326,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.428,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
14310,10326,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.472,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
14311,10326,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.466,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
14312,10326,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.463,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
14313,10326,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.495,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
14314,10326,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.492,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
14315,10326,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.382,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14316,10326,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.437,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14317,10326,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.446,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
14318,10326,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.355,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
14319,10326,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.346,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
14320,10326,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.361,0,NONE,OHSU_HNSCC_derm002
14321,10326,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.42,0,NONE,OHSU_HNSCC_derm002
14322,10326,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.46,0,NONE,OHSU_HNSCC_derm002
14323,10326,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.437,0,NONE,OHSU_HNSCC_derm002
14324,10326,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.415,0,NONE,OHSU_HNSCC_derm002
14325,10326,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.433,0,NONE,OHSU_HNSCC_derm002
14326,10326,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.467,0,NONE,OHSU_HNSCC_derm002
14327,10326,Blank 490,5,H,OHSU_HNSCC_derm002,8,0.0,10,F-S-V,OHSU_HNSCC_derm002
14328,10326,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
14329,10326,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
14330,10326,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.434,0,NONE,OHSU_HNSCC_derm002
14331,10326,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.499,0,NONE,OHSU_HNSCC_derm002
14332,10326,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.471,0,NONE,OHSU_HNSCC_derm002
14333,10326,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.475,0,NONE,OHSU_HNSCC_derm002
14334,10326,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
14335,10326,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.394,0,NONE,OHSU_HNSCC_derm002
14336,10326,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.022,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14337,10326,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.217,10,APTO-253 x,OHSU_HNSCC_derm002
14338,10326,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.022,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14339,10326,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.483,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14340,10326,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.227,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14341,10326,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.028,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14342,10326,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.059,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14343,10326,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.087,10,Brigatinib,OHSU_HNSCC_derm002
14344,10326,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.234,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14345,10326,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.028,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14346,10326,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.022,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14347,10326,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.023,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14348,10326,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.234,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14349,10326,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.256,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14350,10326,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.021,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14351,10326,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.004,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14352,10326,Blank 490,5,A,OHSU_HNSCC_derm002,10,-0.007,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14353,10326,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.166,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
14354,10326,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.033,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14355,10326,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.423,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14356,10326,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.256,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14357,10326,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.041,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14358,10326,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.239,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14359,10326,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.23,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
14360,10326,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.229,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14361,10326,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.081,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14362,10326,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.027,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14363,10326,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.046,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14364,10326,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.256,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14365,10326,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.306,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14366,10326,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.008,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14367,10326,Blank 490,5,P,OHSU_HNSCC_derm002,10,-0.008,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14368,10326,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.008,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14369,10326,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.313,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
14370,10326,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.054,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14371,10326,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.489,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14372,10326,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.275,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14373,10326,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.06,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14374,10326,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.258,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14375,10326,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.409,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
14376,10326,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.268,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14377,10326,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.07,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14378,10326,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.123,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14379,10326,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.072,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14380,10326,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.344,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14381,10326,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.309,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14382,10326,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.111,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14383,10326,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.096,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14384,10326,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.032,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14385,10326,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.363,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
14386,10326,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.091,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14387,10326,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.45,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14388,10326,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.286,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14389,10326,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.108,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14390,10326,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.264,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14391,10326,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.38,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
14392,10326,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.246,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14393,10326,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.144,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14394,10326,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.291,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14395,10326,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.089,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14396,10326,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.368,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14397,10326,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.345,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14398,10326,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.313,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14399,10326,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.307,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14400,10326,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.047,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14401,10326,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.415,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
14402,10326,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.171,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14403,10326,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.458,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14404,10326,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.285,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14405,10326,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.186,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14406,10326,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.259,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14407,10326,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.414,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
14408,10326,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.316,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14409,10326,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.149,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14410,10326,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.424,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14411,10326,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.171,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14412,10326,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.48,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14413,10326,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.364,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14414,10326,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.387,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14415,10326,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.409,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14416,10326,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.056,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14417,10326,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.44,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
14418,10326,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.297,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14419,10326,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.438,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14420,10326,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.402,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14421,10326,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.314,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14422,10326,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.353,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14423,10326,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.464,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
14424,10326,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.381,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14425,10326,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.275,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14426,10326,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.431,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14427,10326,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.284,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14428,10326,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.448,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14429,10326,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.408,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14430,10326,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.397,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14431,10326,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.397,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14432,10326,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.073,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
14433,10326,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.409,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
14434,10326,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.429,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
14435,10326,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.455,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
14436,10326,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.398,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
14437,10326,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.313,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14438,10326,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.365,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14439,10326,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.471,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
14440,10326,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.439,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14441,10326,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.393,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
14442,10326,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.472,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14443,10326,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.417,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
14444,10326,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.487,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
14445,10326,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.442,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14446,10326,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.443,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14447,10326,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.442,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14448,10326,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.347,0,NONE,OHSU_HNSCC_derm002
14449,10326,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
14450,10326,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.46,0,NONE,OHSU_HNSCC_derm002
14451,10326,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.405,0,NONE,OHSU_HNSCC_derm002
14452,10326,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.425,0,NONE,OHSU_HNSCC_derm002
14453,10326,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.448,0,NONE,OHSU_HNSCC_derm002
14454,10326,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.493,0,NONE,OHSU_HNSCC_derm002
14455,10326,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.0,10,F-S-V,OHSU_HNSCC_derm002
14456,10326,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.46,0,NONE,OHSU_HNSCC_derm002
14457,10326,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.49,0,NONE,OHSU_HNSCC_derm002
14458,10326,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.458,0,NONE,OHSU_HNSCC_derm002
14459,10326,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.422,0,NONE,OHSU_HNSCC_derm002
14460,10326,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.429,0,NONE,OHSU_HNSCC_derm002
14461,10326,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.443,0,NONE,OHSU_HNSCC_derm002
14462,10326,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.432,0,NONE,OHSU_HNSCC_derm002
14463,10326,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
14464,10326,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.014,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14465,10326,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.02,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14466,10326,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.025,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14467,10326,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.14,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14468,10326,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.338,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14469,10326,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.121,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14470,10326,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.316,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14471,10326,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.399,10,Trametinib,OHSU_HNSCC_derm002
14472,10326,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.118,10,BEZ235,OHSU_HNSCC_derm002
14473,10326,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.161,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14474,10326,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.257,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14475,10326,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.011,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14476,10326,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.113,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14477,10326,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.151,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14478,10326,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.376,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14479,10326,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.162,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14480,10326,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.014,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14481,10326,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.108,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14482,10326,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.043,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14483,10326,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.264,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14484,10326,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.326,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14485,10326,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.273,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14486,10326,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.382,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14487,10326,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.423,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
14488,10326,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.184,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
14489,10326,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.226,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14490,10326,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.244,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14491,10326,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.047,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14492,10326,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.242,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14493,10326,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.272,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14494,10326,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.361,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14495,10326,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.232,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14496,10326,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.124,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14497,10326,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.286,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14498,10326,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.058,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14499,10326,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.311,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14500,10326,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.337,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14501,10326,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.288,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14502,10326,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.41,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14503,10326,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.465,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
14504,10326,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.168,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
14505,10326,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.311,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14506,10326,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.339,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14507,10326,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.039,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14508,10326,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.311,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14509,10326,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.277,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14510,10326,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.467,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14511,10326,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.22,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14512,10326,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.329,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14513,10326,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.43,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14514,10326,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.096,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14515,10326,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.381,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14516,10326,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.419,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14517,10326,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.3,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14518,10326,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.424,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14519,10326,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.427,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
14520,10326,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.202,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
14521,10326,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.394,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14522,10326,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.35,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14523,10326,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.101,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14524,10326,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.369,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14525,10326,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.365,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14526,10326,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.439,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14527,10326,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.232,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14528,10326,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.398,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14529,10326,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.441,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14530,10326,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.193,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14531,10326,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.428,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14532,10326,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.43,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14533,10326,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.394,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14534,10326,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.384,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14535,10326,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.44,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
14536,10326,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.215,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
14537,10326,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.44,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14538,10326,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.361,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14539,10326,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.166,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14540,10326,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.39,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14541,10326,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.403,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14542,10326,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.474,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14543,10326,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.291,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14544,10326,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.421,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14545,10326,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.446,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14546,10326,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.268,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14547,10326,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.405,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14548,10326,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.428,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14549,10326,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.379,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14550,10326,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.404,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14551,10326,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.453,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
14552,10326,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.315,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
14553,10326,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.497,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14554,10326,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.397,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14555,10326,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.27,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14556,10326,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14557,10326,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.326,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14558,10326,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.422,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14559,10326,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.245,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14560,10326,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.379,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14561,10326,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.415,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
14562,10326,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.323,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14563,10326,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.379,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
14564,10326,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.415,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
14565,10326,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.398,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14566,10326,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.422,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
14567,10326,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.38,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
14568,10326,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
14569,10326,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.447,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
14570,10326,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.397,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
14571,10326,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.352,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
14572,10326,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.36,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
14573,10326,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.42,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14574,10326,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.408,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
14575,10326,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.272,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
14576,10326,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.329,0,NONE,OHSU_HNSCC_derm002
14577,10326,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.355,0,NONE,OHSU_HNSCC_derm002
14578,10326,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.389,0,NONE,OHSU_HNSCC_derm002
14579,10326,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.396,0,NONE,OHSU_HNSCC_derm002
14580,10326,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.383,0,NONE,OHSU_HNSCC_derm002
14581,10326,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
14582,10326,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
14583,10326,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.436,0,NONE,OHSU_HNSCC_derm002
14584,10326,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
14585,10326,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.43,0,NONE,OHSU_HNSCC_derm002
14586,10326,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.385,0,NONE,OHSU_HNSCC_derm002
14587,10326,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
14588,10326,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.39,0,NONE,OHSU_HNSCC_derm002
14589,10326,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
14590,10326,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.442,0,NONE,OHSU_HNSCC_derm002
14591,10326,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.385,0,NONE,OHSU_HNSCC_derm002
14592,10326,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.07,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14593,10326,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.006,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14594,10326,Blank 490,6,C,OHSU_HNSCC_derm002,1,-0.007,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14595,10326,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.098,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14596,10326,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.05,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14597,10326,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.005,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14598,10326,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.433,10,IMR 1,OHSU_HNSCC_derm002
14599,10326,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.246,10,Gefitinib,OHSU_HNSCC_derm002
14600,10326,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.178,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
14601,10326,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.423,0,DMSO,OHSU_HNSCC_derm002
14602,10326,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.398,0,DMSO ,OHSU_HNSCC_derm002
14603,10326,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.374,0,DMSO,OHSU_HNSCC_derm002
14604,10326,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.401,0,DMSO ,OHSU_HNSCC_derm002
14605,10326,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.391,0,DMSO,OHSU_HNSCC_derm002
14606,10326,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.431,0,DMSO ,OHSU_HNSCC_derm002
14607,10326,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.389,0,DMSO,OHSU_HNSCC_derm002
14608,10326,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.095,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14609,10326,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.024,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14610,10326,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.019,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14611,10326,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.196,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14612,10326,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.133,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14613,10326,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.009,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14614,10326,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.436,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
14615,10326,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.221,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
14616,10326,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.357,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
14617,10326,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.379,0,DMSO,OHSU_HNSCC_derm002
14618,10326,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.401,0,DMSO ,OHSU_HNSCC_derm002
14619,10326,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.405,0,DMSO,OHSU_HNSCC_derm002
14620,10326,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.408,0,DMSO ,OHSU_HNSCC_derm002
14621,10326,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.44,0,DMSO,OHSU_HNSCC_derm002
14622,10326,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.449,0,DMSO ,OHSU_HNSCC_derm002
14623,10326,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.4,0,DMSO,OHSU_HNSCC_derm002
14624,10326,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.162,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14625,10326,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.033,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14626,10326,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.078,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14627,10326,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.195,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14628,10326,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.323,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14629,10326,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.011,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14630,10326,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.405,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
14631,10326,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.271,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
14632,10326,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.405,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
14633,10326,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.461,0,DMSO,OHSU_HNSCC_derm002
14634,10326,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.428,0,DMSO ,OHSU_HNSCC_derm002
14635,10326,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.412,0,DMSO,OHSU_HNSCC_derm002
14636,10326,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.495,0,DMSO ,OHSU_HNSCC_derm002
14637,10326,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.412,0,DMSO,OHSU_HNSCC_derm002
14638,10326,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.468,0,DMSO ,OHSU_HNSCC_derm002
14639,10326,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.43,0,DMSO,OHSU_HNSCC_derm002
14640,10326,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.231,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14641,10326,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.149,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14642,10326,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.179,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14643,10326,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.238,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14644,10326,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.325,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14645,10326,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.092,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14646,10326,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.433,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
14647,10326,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.311,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
14648,10326,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.402,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
14649,10326,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.41,0,DMSO,OHSU_HNSCC_derm002
14650,10326,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.424,0,DMSO ,OHSU_HNSCC_derm002
14651,10326,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.397,0,DMSO,OHSU_HNSCC_derm002
14652,10326,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.443,0,DMSO ,OHSU_HNSCC_derm002
14653,10326,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.48,0,DMSO,OHSU_HNSCC_derm002
14654,10326,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.424,0,DMSO ,OHSU_HNSCC_derm002
14655,10326,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.424,0,DMSO,OHSU_HNSCC_derm002
14656,10326,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.299,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14657,10326,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.275,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14658,10326,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.266,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14659,10326,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.273,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14660,10326,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.39,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14661,10326,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.267,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14662,10326,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.446,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
14663,10326,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.364,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
14664,10326,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.422,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
14665,10326,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.415,0,DMSO,OHSU_HNSCC_derm002
14666,10326,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.435,0,DMSO ,OHSU_HNSCC_derm002
14667,10326,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.433,0,DMSO,OHSU_HNSCC_derm002
14668,10326,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.437,0,DMSO ,OHSU_HNSCC_derm002
14669,10326,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.426,0,DMSO,OHSU_HNSCC_derm002
14670,10326,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.422,0,DMSO ,OHSU_HNSCC_derm002
14671,10326,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.388,0,DMSO,OHSU_HNSCC_derm002
14672,10326,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.324,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14673,10326,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.409,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14674,10326,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.337,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14675,10326,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.325,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14676,10326,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.386,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14677,10326,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.385,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14678,10326,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.431,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
14679,10326,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.403,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
14680,10326,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.417,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
14681,10326,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.402,0,DMSO,OHSU_HNSCC_derm002
14682,10326,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.43,0,DMSO ,OHSU_HNSCC_derm002
14683,10326,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.445,0,DMSO,OHSU_HNSCC_derm002
14684,10326,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.451,0,DMSO ,OHSU_HNSCC_derm002
14685,10326,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.424,0,DMSO,OHSU_HNSCC_derm002
14686,10326,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.417,0,DMSO ,OHSU_HNSCC_derm002
14687,10326,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.37,0,DMSO,OHSU_HNSCC_derm002
14688,10326,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.342,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14689,10326,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.385,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
14690,10326,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.38,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
14691,10326,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.315,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
14692,10326,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.383,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
14693,10326,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.397,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
14694,10326,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.44,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
14695,10326,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
14696,10326,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.441,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
14697,10326,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.426,0,DMSO,OHSU_HNSCC_derm002
14698,10326,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.422,0,DMSO ,OHSU_HNSCC_derm002
14699,10326,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.418,0,DMSO,OHSU_HNSCC_derm002
14700,10326,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.514,0,DMSO ,OHSU_HNSCC_derm002
14701,10326,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.454,0,DMSO,OHSU_HNSCC_derm002
14702,10326,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.411,0,DMSO ,OHSU_HNSCC_derm002
14703,10326,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.433,0,DMSO,OHSU_HNSCC_derm002
14704,10326,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.337,0,NONE,OHSU_HNSCC_derm002
14705,10326,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.382,0,NONE,OHSU_HNSCC_derm002
14706,10326,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.365,0,NONE,OHSU_HNSCC_derm002
14707,10326,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
14708,10326,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.381,0,NONE,OHSU_HNSCC_derm002
14709,10326,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.388,0,NONE,OHSU_HNSCC_derm002
14710,10326,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.421,0,NONE,OHSU_HNSCC_derm002
14711,10326,Blank 490,6,H,OHSU_HNSCC_derm002,8,0.002,10,F-S-V,OHSU_HNSCC_derm002
14712,10326,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.44,0,NONE,OHSU_HNSCC_derm002
14713,10326,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.454,0,NONE,OHSU_HNSCC_derm002
14714,10326,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.418,0,NONE,OHSU_HNSCC_derm002
14715,10326,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.419,0,NONE,OHSU_HNSCC_derm002
14716,10326,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.465,0,NONE,OHSU_HNSCC_derm002
14717,10326,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.447,0,NONE,OHSU_HNSCC_derm002
14718,10326,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.462,0,NONE,OHSU_HNSCC_derm002
14719,10326,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.453,0,NONE,OHSU_HNSCC_derm002
14720,10326,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.23,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14721,10326,Blank 490,6,B,OHSU_HNSCC_derm002,9,-0.013,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14722,10326,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.086,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14723,10326,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.154,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14724,10326,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.322,5,Vandetanib (5mM),OHSU_HNSCC_derm002
14725,10326,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.376,0,DMSO,OHSU_HNSCC_derm002
14726,10326,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.467,0,DMSO ,OHSU_HNSCC_derm002
14727,10326,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.196,10,Brigatinib,OHSU_HNSCC_derm002
14728,10326,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.199,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14729,10326,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.396,0,DMSO,OHSU_HNSCC_derm002
14730,10326,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.446,0,DMSO ,OHSU_HNSCC_derm002
14731,10326,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.425,0,DMSO,OHSU_HNSCC_derm002
14732,10326,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.488,0,DMSO ,OHSU_HNSCC_derm002
14733,10326,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.475,0,DMSO,OHSU_HNSCC_derm002
14734,10326,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.426,0,DMSO ,OHSU_HNSCC_derm002
14735,10326,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.439,0,DMSO,OHSU_HNSCC_derm002
14736,10326,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.319,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14737,10326,Blank 490,6,B,OHSU_HNSCC_derm002,10,-0.015,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14738,10326,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.18,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14739,10326,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.169,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14740,10326,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.375,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
14741,10326,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.411,0,DMSO,OHSU_HNSCC_derm002
14742,10326,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.453,0,DMSO ,OHSU_HNSCC_derm002
14743,10326,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.332,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
14744,10326,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.225,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14745,10326,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.458,0,DMSO,OHSU_HNSCC_derm002
14746,10326,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.428,0,DMSO ,OHSU_HNSCC_derm002
14747,10326,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.442,0,DMSO,OHSU_HNSCC_derm002
14748,10326,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.477,0,DMSO ,OHSU_HNSCC_derm002
14749,10326,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.494,0,DMSO,OHSU_HNSCC_derm002
14750,10326,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.451,0,DMSO ,OHSU_HNSCC_derm002
14751,10326,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.42,0,DMSO,OHSU_HNSCC_derm002
14752,10326,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.355,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14753,10326,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.004,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14754,10326,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.268,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14755,10326,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.216,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14756,10326,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.364,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
14757,10326,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.404,0,DMSO,OHSU_HNSCC_derm002
14758,10326,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.444,0,DMSO ,OHSU_HNSCC_derm002
14759,10326,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.455,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
14760,10326,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.253,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14761,10326,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.435,0,DMSO,OHSU_HNSCC_derm002
14762,10326,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.455,0,DMSO ,OHSU_HNSCC_derm002
14763,10326,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.432,0,DMSO,OHSU_HNSCC_derm002
14764,10326,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.463,0,DMSO ,OHSU_HNSCC_derm002
14765,10326,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.461,0,DMSO,OHSU_HNSCC_derm002
14766,10326,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.456,0,DMSO ,OHSU_HNSCC_derm002
14767,10326,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.46,0,DMSO,OHSU_HNSCC_derm002
14768,10326,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.365,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14769,10326,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.063,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14770,10326,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.3,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14771,10326,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.232,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14772,10326,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.35,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
14773,10326,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.396,0,DMSO,OHSU_HNSCC_derm002
14774,10326,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.45,0,DMSO ,OHSU_HNSCC_derm002
14775,10326,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.428,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
14776,10326,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.335,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14777,10326,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.431,0,DMSO,OHSU_HNSCC_derm002
14778,10326,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.433,0,DMSO ,OHSU_HNSCC_derm002
14779,10326,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.474,0,DMSO,OHSU_HNSCC_derm002
14780,10326,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.454,0,DMSO ,OHSU_HNSCC_derm002
14781,10326,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.372,0,DMSO,OHSU_HNSCC_derm002
14782,10326,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.449,0,DMSO ,OHSU_HNSCC_derm002
14783,10326,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.477,0,DMSO,OHSU_HNSCC_derm002
14784,10326,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.336,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14785,10326,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.188,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14786,10326,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.333,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14787,10326,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.314,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14788,10326,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.365,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
14789,10326,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.418,0,DMSO,OHSU_HNSCC_derm002
14790,10326,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.44,0,DMSO ,OHSU_HNSCC_derm002
14791,10326,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.418,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
14792,10326,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.294,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14793,10326,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.458,0,DMSO,OHSU_HNSCC_derm002
14794,10326,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.437,0,DMSO ,OHSU_HNSCC_derm002
14795,10326,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.436,0,DMSO,OHSU_HNSCC_derm002
14796,10326,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.495,0,DMSO ,OHSU_HNSCC_derm002
14797,10326,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.44,0,DMSO,OHSU_HNSCC_derm002
14798,10326,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.462,0,DMSO ,OHSU_HNSCC_derm002
14799,10326,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.444,0,DMSO,OHSU_HNSCC_derm002
14800,10326,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.338,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14801,10326,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.3,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14802,10326,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.293,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14803,10326,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.341,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14804,10326,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.348,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
14805,10326,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.397,0,DMSO,OHSU_HNSCC_derm002
14806,10326,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.446,0,DMSO ,OHSU_HNSCC_derm002
14807,10326,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.433,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
14808,10326,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.293,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14809,10326,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.422,0,DMSO,OHSU_HNSCC_derm002
14810,10326,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.449,0,DMSO ,OHSU_HNSCC_derm002
14811,10326,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.438,0,DMSO,OHSU_HNSCC_derm002
14812,10326,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.429,0,DMSO ,OHSU_HNSCC_derm002
14813,10326,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.466,0,DMSO,OHSU_HNSCC_derm002
14814,10326,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.493,0,DMSO ,OHSU_HNSCC_derm002
14815,10326,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.451,0,DMSO,OHSU_HNSCC_derm002
14816,10326,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.369,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14817,10326,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.375,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
14818,10326,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.401,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
14819,10326,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.373,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
14820,10326,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.406,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
14821,10326,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.404,0,DMSO,OHSU_HNSCC_derm002
14822,10326,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.445,0,DMSO ,OHSU_HNSCC_derm002
14823,10326,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
14824,10326,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.324,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
14825,10326,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.43,0,DMSO,OHSU_HNSCC_derm002
14826,10326,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.435,0,DMSO ,OHSU_HNSCC_derm002
14827,10326,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.467,0,DMSO,OHSU_HNSCC_derm002
14828,10326,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.46,0,DMSO ,OHSU_HNSCC_derm002
14829,10326,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.455,0,DMSO,OHSU_HNSCC_derm002
14830,10326,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.436,0,DMSO ,OHSU_HNSCC_derm002
14831,10326,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.385,0,DMSO,OHSU_HNSCC_derm002
14832,10326,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.356,0,NONE,OHSU_HNSCC_derm002
14833,10326,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
14834,10326,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.41,0,NONE,OHSU_HNSCC_derm002
14835,10326,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.389,0,NONE,OHSU_HNSCC_derm002
14836,10326,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.371,0,NONE,OHSU_HNSCC_derm002
14837,10326,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.39,0,NONE,OHSU_HNSCC_derm002
14838,10326,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.441,0,NONE,OHSU_HNSCC_derm002
14839,10326,Blank 490,6,H,OHSU_HNSCC_derm002,16,-0.002,10,F-S-V,OHSU_HNSCC_derm002
14840,10326,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.484,0,NONE,OHSU_HNSCC_derm002
14841,10326,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.471,0,NONE,OHSU_HNSCC_derm002
14842,10326,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.442,0,NONE,OHSU_HNSCC_derm002
14843,10326,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.44,0,NONE,OHSU_HNSCC_derm002
14844,10326,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.437,0,NONE,OHSU_HNSCC_derm002
14845,10326,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.449,0,NONE,OHSU_HNSCC_derm002
14846,10326,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.405,0,NONE,OHSU_HNSCC_derm002
14847,10326,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
14848,10326,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.066,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14849,10326,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.048,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14850,10326,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.398,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14851,10326,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.017,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14852,10326,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.476,10,LY3039478 ,OHSU_HNSCC_derm002
14853,10326,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.209,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14854,10326,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.237,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14855,10326,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.384,10,Trametinib,OHSU_HNSCC_derm002
14856,10326,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.115,10,BEZ235,OHSU_HNSCC_derm002
14857,10326,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.376,0,DMSO,OHSU_HNSCC_derm002
14858,10326,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.464,0,DMSO ,OHSU_HNSCC_derm002
14859,10326,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.442,0,DMSO,OHSU_HNSCC_derm002
14860,10326,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.416,0,DMSO ,OHSU_HNSCC_derm002
14861,10326,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.488,0,DMSO,OHSU_HNSCC_derm002
14862,10326,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.42,0,DMSO ,OHSU_HNSCC_derm002
14863,10326,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.452,0,DMSO,OHSU_HNSCC_derm002
14864,10326,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.136,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14865,10326,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.118,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14866,10326,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.385,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14867,10326,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.021,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14868,10326,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.486,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
14869,10326,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.241,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14870,10326,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.272,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14871,10326,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.433,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
14872,10326,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.119,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
14873,10326,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.435,0,DMSO,OHSU_HNSCC_derm002
14874,10326,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.43,0,DMSO ,OHSU_HNSCC_derm002
14875,10326,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.425,0,DMSO,OHSU_HNSCC_derm002
14876,10326,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.448,0,DMSO ,OHSU_HNSCC_derm002
14877,10326,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.445,0,DMSO,OHSU_HNSCC_derm002
14878,10326,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.414,0,DMSO ,OHSU_HNSCC_derm002
14879,10326,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.469,0,DMSO,OHSU_HNSCC_derm002
14880,10326,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.19,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14881,10326,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.195,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14882,10326,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.415,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14883,10326,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.02,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14884,10326,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.469,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
14885,10326,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.198,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14886,10326,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.308,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14887,10326,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
14888,10326,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.148,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
14889,10326,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.447,0,DMSO,OHSU_HNSCC_derm002
14890,10326,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.444,0,DMSO ,OHSU_HNSCC_derm002
14891,10326,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.439,0,DMSO,OHSU_HNSCC_derm002
14892,10326,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.463,0,DMSO ,OHSU_HNSCC_derm002
14893,10326,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.445,0,DMSO,OHSU_HNSCC_derm002
14894,10326,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.483,0,DMSO ,OHSU_HNSCC_derm002
14895,10326,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.44,0,DMSO,OHSU_HNSCC_derm002
14896,10326,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.254,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14897,10326,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.268,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14898,10326,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.387,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14899,10326,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.134,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14900,10326,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.46,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
14901,10326,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.262,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14902,10326,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.395,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14903,10326,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.385,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
14904,10326,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.152,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
14905,10326,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.408,0,DMSO,OHSU_HNSCC_derm002
14906,10326,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.439,0,DMSO ,OHSU_HNSCC_derm002
14907,10326,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.439,0,DMSO,OHSU_HNSCC_derm002
14908,10326,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.456,0,DMSO ,OHSU_HNSCC_derm002
14909,10326,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.432,0,DMSO,OHSU_HNSCC_derm002
14910,10326,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.482,0,DMSO ,OHSU_HNSCC_derm002
14911,10326,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.431,0,DMSO,OHSU_HNSCC_derm002
14912,10326,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.305,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14913,10326,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.291,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14914,10326,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.389,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14915,10326,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.318,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14916,10326,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.463,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
14917,10326,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.265,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14918,10326,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.397,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14919,10326,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.383,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
14920,10326,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.17,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
14921,10326,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.437,0,DMSO,OHSU_HNSCC_derm002
14922,10326,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.453,0,DMSO ,OHSU_HNSCC_derm002
14923,10326,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.449,0,DMSO,OHSU_HNSCC_derm002
14924,10326,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.468,0,DMSO ,OHSU_HNSCC_derm002
14925,10326,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.466,0,DMSO,OHSU_HNSCC_derm002
14926,10326,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.436,0,DMSO ,OHSU_HNSCC_derm002
14927,10326,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.481,0,DMSO,OHSU_HNSCC_derm002
14928,10326,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.324,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14929,10326,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.268,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14930,10326,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.412,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14931,10326,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.407,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14932,10326,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.482,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
14933,10326,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.329,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14934,10326,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.436,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14935,10326,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.432,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
14936,10326,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.215,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
14937,10326,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.455,0,DMSO,OHSU_HNSCC_derm002
14938,10326,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.451,0,DMSO ,OHSU_HNSCC_derm002
14939,10326,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.439,0,DMSO,OHSU_HNSCC_derm002
14940,10326,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.473,0,DMSO ,OHSU_HNSCC_derm002
14941,10326,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.427,0,DMSO,OHSU_HNSCC_derm002
14942,10326,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.436,0,DMSO ,OHSU_HNSCC_derm002
14943,10326,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.444,0,DMSO,OHSU_HNSCC_derm002
14944,10326,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.359,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
14945,10326,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.335,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
14946,10326,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.374,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
14947,10326,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.325,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
14948,10326,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.483,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
14949,10326,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.344,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
14950,10326,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.413,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
14951,10326,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.404,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
14952,10326,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.319,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
14953,10326,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.402,0,DMSO,OHSU_HNSCC_derm002
14954,10326,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.464,0,DMSO ,OHSU_HNSCC_derm002
14955,10326,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.444,0,DMSO,OHSU_HNSCC_derm002
14956,10326,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.436,0,DMSO ,OHSU_HNSCC_derm002
14957,10326,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.411,0,DMSO,OHSU_HNSCC_derm002
14958,10326,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.364,0,DMSO ,OHSU_HNSCC_derm002
14959,10326,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.444,0,DMSO,OHSU_HNSCC_derm002
14960,10326,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.353,0,NONE,OHSU_HNSCC_derm002
14961,10326,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.375,0,NONE,OHSU_HNSCC_derm002
14962,10326,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
14963,10326,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.354,0,NONE,OHSU_HNSCC_derm002
14964,10326,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
14965,10326,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.393,0,NONE,OHSU_HNSCC_derm002
14966,10326,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
14967,10326,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.408,0,NONE,OHSU_HNSCC_derm002
14968,10326,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
14969,10326,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.471,0,NONE,OHSU_HNSCC_derm002
14970,10326,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.4,0,NONE,OHSU_HNSCC_derm002
14971,10326,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.405,0,NONE,OHSU_HNSCC_derm002
14972,10326,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.418,0,NONE,OHSU_HNSCC_derm002
14973,10326,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
14974,10326,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
14975,10326,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.453,0,NONE,OHSU_HNSCC_derm002
14976,10328,490.0,1,A,OHSU_HNSCC_derm001,1,0.18,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
14977,10328,490.0,1,B,OHSU_HNSCC_derm001,1,0.327,10,Lucitanib ,OHSU_HNSCC_derm001
14978,10328,490.0,1,C,OHSU_HNSCC_derm001,1,0.434,10,Resveratrol,OHSU_HNSCC_derm001
14979,10328,490.0,1,D,OHSU_HNSCC_derm001,1,0.421,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
14980,10328,490.0,1,E,OHSU_HNSCC_derm001,1,0.407,10,Bicalutamide,OHSU_HNSCC_derm001
14981,10328,490.0,1,F,OHSU_HNSCC_derm001,1,0.415,10,Methotrexate ,OHSU_HNSCC_derm001
14982,10328,490.0,1,G,OHSU_HNSCC_derm001,1,0.254,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
14983,10328,490.0,1,H,OHSU_HNSCC_derm001,1,0.309,10,Gefitinib,OHSU_HNSCC_derm001
14984,10328,490.0,1,I,OHSU_HNSCC_derm001,1,0.299,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
14985,10328,490.0,1,J,OHSU_HNSCC_derm001,1,0.274,10,Tamatinib/R406,OHSU_HNSCC_derm001
14986,10328,490.0,1,K,OHSU_HNSCC_derm001,1,0.298,10,Bosutinib,OHSU_HNSCC_derm001
14987,10328,490.0,1,L,OHSU_HNSCC_derm001,1,0.193,10,PI-103,OHSU_HNSCC_derm001
14988,10328,490.0,1,M,OHSU_HNSCC_derm001,1,0.411,10,Glycyrrhizin,OHSU_HNSCC_derm001
14989,10328,490.0,1,N,OHSU_HNSCC_derm001,1,0.388,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
14990,10328,490.0,1,O,OHSU_HNSCC_derm001,1,0.227,10,GSK-690693,OHSU_HNSCC_derm001
14991,10328,490.0,1,P,OHSU_HNSCC_derm001,1,0.336,10,Ibrutinib,OHSU_HNSCC_derm001
14992,10328,490.0,1,A,OHSU_HNSCC_derm001,2,0.204,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
14993,10328,490.0,1,B,OHSU_HNSCC_derm001,2,0.449,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
14994,10328,490.0,1,C,OHSU_HNSCC_derm001,2,0.515,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
14995,10328,490.0,1,D,OHSU_HNSCC_derm001,2,0.354,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
14996,10328,490.0,1,E,OHSU_HNSCC_derm001,2,0.444,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
14997,10328,490.0,1,F,OHSU_HNSCC_derm001,2,0.465,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
14998,10328,490.0,1,G,OHSU_HNSCC_derm001,2,0.355,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
14999,10328,490.0,1,H,OHSU_HNSCC_derm001,2,0.396,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
15000,10328,490.0,1,I,OHSU_HNSCC_derm001,2,0.388,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
15001,10328,490.0,1,J,OHSU_HNSCC_derm001,2,0.32,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
15002,10328,490.0,1,K,OHSU_HNSCC_derm001,2,0.566,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
15003,10328,490.0,1,L,OHSU_HNSCC_derm001,2,0.199,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
15004,10328,490.0,1,M,OHSU_HNSCC_derm001,2,0.452,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
15005,10328,490.0,1,N,OHSU_HNSCC_derm001,2,0.481,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
15006,10328,490.0,1,O,OHSU_HNSCC_derm001,2,0.339,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
15007,10328,490.0,1,P,OHSU_HNSCC_derm001,2,0.399,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
15008,10328,490.0,1,A,OHSU_HNSCC_derm001,3,0.219,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
15009,10328,490.0,1,B,OHSU_HNSCC_derm001,3,0.457,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
15010,10328,490.0,1,C,OHSU_HNSCC_derm001,3,0.484,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
15011,10328,490.0,1,D,OHSU_HNSCC_derm001,3,0.362,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
15012,10328,490.0,1,E,OHSU_HNSCC_derm001,3,0.498,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
15013,10328,490.0,1,F,OHSU_HNSCC_derm001,3,0.477,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
15014,10328,490.0,1,G,OHSU_HNSCC_derm001,3,0.394,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
15015,10328,490.0,1,H,OHSU_HNSCC_derm001,3,0.415,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
15016,10328,490.0,1,I,OHSU_HNSCC_derm001,3,0.45,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
15017,10328,490.0,1,J,OHSU_HNSCC_derm001,3,0.395,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
15018,10328,490.0,1,K,OHSU_HNSCC_derm001,3,0.646,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
15019,10328,490.0,1,L,OHSU_HNSCC_derm001,3,0.221,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
15020,10328,490.0,1,M,OHSU_HNSCC_derm001,3,0.538,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
15021,10328,490.0,1,N,OHSU_HNSCC_derm001,3,0.49,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
15022,10328,490.0,1,O,OHSU_HNSCC_derm001,3,0.387,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
15023,10328,490.0,1,P,OHSU_HNSCC_derm001,3,0.337,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
15024,10328,490.0,1,A,OHSU_HNSCC_derm001,4,0.248,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
15025,10328,490.0,1,B,OHSU_HNSCC_derm001,4,0.481,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
15026,10328,490.0,1,C,OHSU_HNSCC_derm001,4,0.481,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
15027,10328,490.0,1,D,OHSU_HNSCC_derm001,4,0.376,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
15028,10328,490.0,1,E,OHSU_HNSCC_derm001,4,0.465,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
15029,10328,490.0,1,F,OHSU_HNSCC_derm001,4,0.491,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
15030,10328,490.0,1,G,OHSU_HNSCC_derm001,4,0.391,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
15031,10328,490.0,1,H,OHSU_HNSCC_derm001,4,0.416,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
15032,10328,490.0,1,I,OHSU_HNSCC_derm001,4,0.429,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
15033,10328,490.0,1,J,OHSU_HNSCC_derm001,4,0.436,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
15034,10328,490.0,1,K,OHSU_HNSCC_derm001,4,0.631,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
15035,10328,490.0,1,L,OHSU_HNSCC_derm001,4,0.254,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
15036,10328,490.0,1,M,OHSU_HNSCC_derm001,4,0.464,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
15037,10328,490.0,1,N,OHSU_HNSCC_derm001,4,0.479,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
15038,10328,490.0,1,O,OHSU_HNSCC_derm001,4,0.434,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
15039,10328,490.0,1,P,OHSU_HNSCC_derm001,4,0.36,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
15040,10328,490.0,1,A,OHSU_HNSCC_derm001,5,0.32,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
15041,10328,490.0,1,B,OHSU_HNSCC_derm001,5,0.44,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
15042,10328,490.0,1,C,OHSU_HNSCC_derm001,5,0.535,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
15043,10328,490.0,1,D,OHSU_HNSCC_derm001,5,0.376,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
15044,10328,490.0,1,E,OHSU_HNSCC_derm001,5,0.462,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
15045,10328,490.0,1,F,OHSU_HNSCC_derm001,5,0.476,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
15046,10328,490.0,1,G,OHSU_HNSCC_derm001,5,0.454,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
15047,10328,490.0,1,H,OHSU_HNSCC_derm001,5,0.417,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
15048,10328,490.0,1,I,OHSU_HNSCC_derm001,5,0.469,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
15049,10328,490.0,1,J,OHSU_HNSCC_derm001,5,0.416,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
15050,10328,490.0,1,K,OHSU_HNSCC_derm001,5,0.56,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
15051,10328,490.0,1,L,OHSU_HNSCC_derm001,5,0.324,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
15052,10328,490.0,1,M,OHSU_HNSCC_derm001,5,0.499,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
15053,10328,490.0,1,N,OHSU_HNSCC_derm001,5,0.484,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
15054,10328,490.0,1,O,OHSU_HNSCC_derm001,5,0.485,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
15055,10328,490.0,1,P,OHSU_HNSCC_derm001,5,0.422,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
15056,10328,490.0,1,A,OHSU_HNSCC_derm001,6,0.354,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
15057,10328,490.0,1,B,OHSU_HNSCC_derm001,6,0.438,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
15058,10328,490.0,1,C,OHSU_HNSCC_derm001,6,0.499,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
15059,10328,490.0,1,D,OHSU_HNSCC_derm001,6,0.377,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
15060,10328,490.0,1,E,OHSU_HNSCC_derm001,6,0.473,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
15061,10328,490.0,1,F,OHSU_HNSCC_derm001,6,0.409,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
15062,10328,490.0,1,G,OHSU_HNSCC_derm001,6,0.481,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
15063,10328,490.0,1,H,OHSU_HNSCC_derm001,6,0.441,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
15064,10328,490.0,1,I,OHSU_HNSCC_derm001,6,0.455,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
15065,10328,490.0,1,J,OHSU_HNSCC_derm001,6,0.424,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
15066,10328,490.0,1,K,OHSU_HNSCC_derm001,6,0.52,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
15067,10328,490.0,1,L,OHSU_HNSCC_derm001,6,0.386,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
15068,10328,490.0,1,M,OHSU_HNSCC_derm001,6,0.468,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
15069,10328,490.0,1,N,OHSU_HNSCC_derm001,6,0.483,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
15070,10328,490.0,1,O,OHSU_HNSCC_derm001,6,0.463,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
15071,10328,490.0,1,P,OHSU_HNSCC_derm001,6,0.416,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
15072,10328,490.0,1,A,OHSU_HNSCC_derm001,7,0.45,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
15073,10328,490.0,1,B,OHSU_HNSCC_derm001,7,0.453,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
15074,10328,490.0,1,C,OHSU_HNSCC_derm001,7,0.498,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
15075,10328,490.0,1,D,OHSU_HNSCC_derm001,7,0.417,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
15076,10328,490.0,1,E,OHSU_HNSCC_derm001,7,0.465,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
15077,10328,490.0,1,F,OHSU_HNSCC_derm001,7,0.486,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
15078,10328,490.0,1,G,OHSU_HNSCC_derm001,7,0.448,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
15079,10328,490.0,1,H,OHSU_HNSCC_derm001,7,0.426,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
15080,10328,490.0,1,I,OHSU_HNSCC_derm001,7,0.489,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
15081,10328,490.0,1,J,OHSU_HNSCC_derm001,7,0.446,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
15082,10328,490.0,1,K,OHSU_HNSCC_derm001,7,0.496,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
15083,10328,490.0,1,L,OHSU_HNSCC_derm001,7,0.44,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
15084,10328,490.0,1,M,OHSU_HNSCC_derm001,7,0.404,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
15085,10328,490.0,1,N,OHSU_HNSCC_derm001,7,0.481,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
15086,10328,490.0,1,O,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
15087,10328,490.0,1,P,OHSU_HNSCC_derm001,7,0.461,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
15088,10328,490.0,1,A,OHSU_HNSCC_derm001,8,0.415,0,NONE,OHSU_HNSCC_derm001
15089,10328,490.0,1,B,OHSU_HNSCC_derm001,8,0.456,0,NONE,OHSU_HNSCC_derm001
15090,10328,490.0,1,C,OHSU_HNSCC_derm001,8,0.452,0,NONE,OHSU_HNSCC_derm001
15091,10328,490.0,1,D,OHSU_HNSCC_derm001,8,0.496,0,NONE,OHSU_HNSCC_derm001
15092,10328,490.0,1,E,OHSU_HNSCC_derm001,8,0.489,0,NONE,OHSU_HNSCC_derm001
15093,10328,490.0,1,F,OHSU_HNSCC_derm001,8,0.445,0,NONE,OHSU_HNSCC_derm001
15094,10328,490.0,1,G,OHSU_HNSCC_derm001,8,0.485,0,NONE,OHSU_HNSCC_derm001
15095,10328,490.0,1,H,OHSU_HNSCC_derm001,8,0.172,10,F-S-V,OHSU_HNSCC_derm001
15096,10328,490.0,1,I,OHSU_HNSCC_derm001,8,0.446,0,NONE,OHSU_HNSCC_derm001
15097,10328,490.0,1,J,OHSU_HNSCC_derm001,8,0.468,0,NONE,OHSU_HNSCC_derm001
15098,10328,490.0,1,K,OHSU_HNSCC_derm001,8,0.473,0,NONE,OHSU_HNSCC_derm001
15099,10328,490.0,1,L,OHSU_HNSCC_derm001,8,0.461,0,NONE,OHSU_HNSCC_derm001
15100,10328,490.0,1,M,OHSU_HNSCC_derm001,8,0.461,0,NONE,OHSU_HNSCC_derm001
15101,10328,490.0,1,N,OHSU_HNSCC_derm001,8,0.472,0,NONE,OHSU_HNSCC_derm001
15102,10328,490.0,1,O,OHSU_HNSCC_derm001,8,0.49,0,NONE,OHSU_HNSCC_derm001
15103,10328,490.0,1,P,OHSU_HNSCC_derm001,8,0.441,0,NONE,OHSU_HNSCC_derm001
15104,10328,490.0,1,A,OHSU_HNSCC_derm001,9,0.205,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15105,10328,490.0,1,B,OHSU_HNSCC_derm001,9,0.345,10,Sorafenib,OHSU_HNSCC_derm001
15106,10328,490.0,1,C,OHSU_HNSCC_derm001,9,0.552,10,Rosmarinic acid,OHSU_HNSCC_derm001
15107,10328,490.0,1,D,OHSU_HNSCC_derm001,9,0.358,10,Rapamycin,OHSU_HNSCC_derm001
15108,10328,490.0,1,E,OHSU_HNSCC_derm001,9,0.422,10,Vismodegib,OHSU_HNSCC_derm001
15109,10328,490.0,1,F,OHSU_HNSCC_derm001,9,0.293,10,PP242,OHSU_HNSCC_derm001
15110,10328,490.0,1,G,OHSU_HNSCC_derm001,9,0.355,10,Alectinib,OHSU_HNSCC_derm001
15111,10328,490.0,1,H,OHSU_HNSCC_derm001,9,0.25,10,Brigatinib,OHSU_HNSCC_derm001
15112,10328,490.0,1,I,OHSU_HNSCC_derm001,9,0.33,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15113,10328,490.0,1,J,OHSU_HNSCC_derm001,9,0.426,10,MK-2206,OHSU_HNSCC_derm001
15114,10328,490.0,1,K,OHSU_HNSCC_derm001,9,0.371,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15115,10328,490.0,1,L,OHSU_HNSCC_derm001,9,0.195,10,Flavopiridol ,OHSU_HNSCC_derm001
15116,10328,490.0,1,M,OHSU_HNSCC_derm001,9,0.523,10,Indirubin,OHSU_HNSCC_derm001
15117,10328,490.0,1,N,OHSU_HNSCC_derm001,9,0.626,10,PF-533228,OHSU_HNSCC_derm001
15118,10328,490.0,1,O,OHSU_HNSCC_derm001,9,0.497,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15119,10328,490.0,1,P,OHSU_HNSCC_derm001,9,0.181,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15120,10328,490.0,1,A,OHSU_HNSCC_derm001,10,0.237,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15121,10328,490.0,1,B,OHSU_HNSCC_derm001,10,0.418,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
15122,10328,490.0,1,C,OHSU_HNSCC_derm001,10,0.499,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
15123,10328,490.0,1,D,OHSU_HNSCC_derm001,10,0.362,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
15124,10328,490.0,1,E,OHSU_HNSCC_derm001,10,0.452,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
15125,10328,490.0,1,F,OHSU_HNSCC_derm001,10,0.262,3.3333333333333335,PP242,OHSU_HNSCC_derm001
15126,10328,490.0,1,G,OHSU_HNSCC_derm001,10,0.406,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
15127,10328,490.0,1,H,OHSU_HNSCC_derm001,10,0.292,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
15128,10328,490.0,1,I,OHSU_HNSCC_derm001,10,0.387,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15129,10328,490.0,1,J,OHSU_HNSCC_derm001,10,0.422,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
15130,10328,490.0,1,K,OHSU_HNSCC_derm001,10,0.429,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15131,10328,490.0,1,L,OHSU_HNSCC_derm001,10,0.188,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
15132,10328,490.0,1,M,OHSU_HNSCC_derm001,10,0.512,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
15133,10328,490.0,1,N,OHSU_HNSCC_derm001,10,0.655,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
15134,10328,490.0,1,O,OHSU_HNSCC_derm001,10,0.484,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15135,10328,490.0,1,P,OHSU_HNSCC_derm001,10,0.182,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15136,10328,490.0,1,A,OHSU_HNSCC_derm001,11,0.225,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15137,10328,490.0,1,B,OHSU_HNSCC_derm001,11,0.403,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
15138,10328,490.0,1,C,OHSU_HNSCC_derm001,11,0.476,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
15139,10328,490.0,1,D,OHSU_HNSCC_derm001,11,0.341,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
15140,10328,490.0,1,E,OHSU_HNSCC_derm001,11,0.457,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
15141,10328,490.0,1,F,OHSU_HNSCC_derm001,11,0.274,1.1111111111111112,PP242,OHSU_HNSCC_derm001
15142,10328,490.0,1,G,OHSU_HNSCC_derm001,11,0.41,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
15143,10328,490.0,1,H,OHSU_HNSCC_derm001,11,0.407,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
15144,10328,490.0,1,I,OHSU_HNSCC_derm001,11,0.4,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15145,10328,490.0,1,J,OHSU_HNSCC_derm001,11,0.414,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
15146,10328,490.0,1,K,OHSU_HNSCC_derm001,11,0.422,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15147,10328,490.0,1,L,OHSU_HNSCC_derm001,11,0.184,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
15148,10328,490.0,1,M,OHSU_HNSCC_derm001,11,0.515,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
15149,10328,490.0,1,N,OHSU_HNSCC_derm001,11,0.627,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
15150,10328,490.0,1,O,OHSU_HNSCC_derm001,11,0.476,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15151,10328,490.0,1,P,OHSU_HNSCC_derm001,11,0.221,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15152,10328,490.0,1,A,OHSU_HNSCC_derm001,12,0.231,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15153,10328,490.0,1,B,OHSU_HNSCC_derm001,12,0.408,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
15154,10328,490.0,1,C,OHSU_HNSCC_derm001,12,0.522,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
15155,10328,490.0,1,D,OHSU_HNSCC_derm001,12,0.365,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
15156,10328,490.0,1,E,OHSU_HNSCC_derm001,12,0.472,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
15157,10328,490.0,1,F,OHSU_HNSCC_derm001,12,0.301,0.3703703703703704,PP242,OHSU_HNSCC_derm001
15158,10328,490.0,1,G,OHSU_HNSCC_derm001,12,0.454,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
15159,10328,490.0,1,H,OHSU_HNSCC_derm001,12,0.429,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
15160,10328,490.0,1,I,OHSU_HNSCC_derm001,12,0.395,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15161,10328,490.0,1,J,OHSU_HNSCC_derm001,12,0.432,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
15162,10328,490.0,1,K,OHSU_HNSCC_derm001,12,0.417,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15163,10328,490.0,1,L,OHSU_HNSCC_derm001,12,0.19,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
15164,10328,490.0,1,M,OHSU_HNSCC_derm001,12,0.514,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
15165,10328,490.0,1,N,OHSU_HNSCC_derm001,12,0.582,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
15166,10328,490.0,1,O,OHSU_HNSCC_derm001,12,0.489,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15167,10328,490.0,1,P,OHSU_HNSCC_derm001,12,0.263,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15168,10328,490.0,1,A,OHSU_HNSCC_derm001,13,0.244,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15169,10328,490.0,1,B,OHSU_HNSCC_derm001,13,0.443,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
15170,10328,490.0,1,C,OHSU_HNSCC_derm001,13,0.477,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
15171,10328,490.0,1,D,OHSU_HNSCC_derm001,13,0.363,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
15172,10328,490.0,1,E,OHSU_HNSCC_derm001,13,0.467,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
15173,10328,490.0,1,F,OHSU_HNSCC_derm001,13,0.406,0.1234567901234568,PP242,OHSU_HNSCC_derm001
15174,10328,490.0,1,G,OHSU_HNSCC_derm001,13,0.468,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
15175,10328,490.0,1,H,OHSU_HNSCC_derm001,13,0.438,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
15176,10328,490.0,1,I,OHSU_HNSCC_derm001,13,0.39,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15177,10328,490.0,1,J,OHSU_HNSCC_derm001,13,0.442,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
15178,10328,490.0,1,K,OHSU_HNSCC_derm001,13,0.443,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15179,10328,490.0,1,L,OHSU_HNSCC_derm001,13,0.237,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
15180,10328,490.0,1,M,OHSU_HNSCC_derm001,13,0.542,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
15181,10328,490.0,1,N,OHSU_HNSCC_derm001,13,0.56,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
15182,10328,490.0,1,O,OHSU_HNSCC_derm001,13,0.509,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15183,10328,490.0,1,P,OHSU_HNSCC_derm001,13,0.359,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15184,10328,490.0,1,A,OHSU_HNSCC_derm001,14,0.275,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15185,10328,490.0,1,B,OHSU_HNSCC_derm001,14,0.479,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
15186,10328,490.0,1,C,OHSU_HNSCC_derm001,14,0.468,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
15187,10328,490.0,1,D,OHSU_HNSCC_derm001,14,0.373,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
15188,10328,490.0,1,E,OHSU_HNSCC_derm001,14,0.456,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
15189,10328,490.0,1,F,OHSU_HNSCC_derm001,14,0.435,0.0411522633744856,PP242,OHSU_HNSCC_derm001
15190,10328,490.0,1,G,OHSU_HNSCC_derm001,14,0.463,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
15191,10328,490.0,1,H,OHSU_HNSCC_derm001,14,0.437,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
15192,10328,490.0,1,I,OHSU_HNSCC_derm001,14,0.382,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15193,10328,490.0,1,J,OHSU_HNSCC_derm001,14,0.438,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
15194,10328,490.0,1,K,OHSU_HNSCC_derm001,14,0.445,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15195,10328,490.0,1,L,OHSU_HNSCC_derm001,14,0.337,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
15196,10328,490.0,1,M,OHSU_HNSCC_derm001,14,0.511,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
15197,10328,490.0,1,N,OHSU_HNSCC_derm001,14,0.545,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
15198,10328,490.0,1,O,OHSU_HNSCC_derm001,14,0.494,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15199,10328,490.0,1,P,OHSU_HNSCC_derm001,14,0.425,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15200,10328,490.0,1,A,OHSU_HNSCC_derm001,15,0.359,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
15201,10328,490.0,1,B,OHSU_HNSCC_derm001,15,0.451,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
15202,10328,490.0,1,C,OHSU_HNSCC_derm001,15,0.468,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
15203,10328,490.0,1,D,OHSU_HNSCC_derm001,15,0.365,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
15204,10328,490.0,1,E,OHSU_HNSCC_derm001,15,0.466,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
15205,10328,490.0,1,F,OHSU_HNSCC_derm001,15,0.428,0.013717421124828532,PP242,OHSU_HNSCC_derm001
15206,10328,490.0,1,G,OHSU_HNSCC_derm001,15,0.463,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
15207,10328,490.0,1,H,OHSU_HNSCC_derm001,15,0.442,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
15208,10328,490.0,1,I,OHSU_HNSCC_derm001,15,0.386,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15209,10328,490.0,1,J,OHSU_HNSCC_derm001,15,0.462,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
15210,10328,490.0,1,K,OHSU_HNSCC_derm001,15,0.464,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
15211,10328,490.0,1,L,OHSU_HNSCC_derm001,15,0.418,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
15212,10328,490.0,1,M,OHSU_HNSCC_derm001,15,0.499,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
15213,10328,490.0,1,N,OHSU_HNSCC_derm001,15,0.481,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
15214,10328,490.0,1,O,OHSU_HNSCC_derm001,15,0.497,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
15215,10328,490.0,1,P,OHSU_HNSCC_derm001,15,0.478,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
15216,10328,490.0,1,A,OHSU_HNSCC_derm001,16,0.445,0,NONE,OHSU_HNSCC_derm001
15217,10328,490.0,1,B,OHSU_HNSCC_derm001,16,0.472,0,NONE,OHSU_HNSCC_derm001
15218,10328,490.0,1,C,OHSU_HNSCC_derm001,16,0.455,0,NONE,OHSU_HNSCC_derm001
15219,10328,490.0,1,D,OHSU_HNSCC_derm001,16,0.477,0,NONE,OHSU_HNSCC_derm001
15220,10328,490.0,1,E,OHSU_HNSCC_derm001,16,0.437,0,NONE,OHSU_HNSCC_derm001
15221,10328,490.0,1,F,OHSU_HNSCC_derm001,16,0.475,0,NONE,OHSU_HNSCC_derm001
15222,10328,490.0,1,G,OHSU_HNSCC_derm001,16,0.447,0,NONE,OHSU_HNSCC_derm001
15223,10328,490.0,1,H,OHSU_HNSCC_derm001,16,0.18,10,F-S-V,OHSU_HNSCC_derm001
15224,10328,490.0,1,I,OHSU_HNSCC_derm001,16,0.472,0,NONE,OHSU_HNSCC_derm001
15225,10328,490.0,1,J,OHSU_HNSCC_derm001,16,0.474,0,NONE,OHSU_HNSCC_derm001
15226,10328,490.0,1,K,OHSU_HNSCC_derm001,16,0.422,0,NONE,OHSU_HNSCC_derm001
15227,10328,490.0,1,L,OHSU_HNSCC_derm001,16,0.464,0,NONE,OHSU_HNSCC_derm001
15228,10328,490.0,1,M,OHSU_HNSCC_derm001,16,0.49,0,NONE,OHSU_HNSCC_derm001
15229,10328,490.0,1,N,OHSU_HNSCC_derm001,16,0.464,0,NONE,OHSU_HNSCC_derm001
15230,10328,490.0,1,O,OHSU_HNSCC_derm001,16,0.494,0,NONE,OHSU_HNSCC_derm001
15231,10328,490.0,1,P,OHSU_HNSCC_derm001,16,0.495,0,NONE,OHSU_HNSCC_derm001
15232,10328,490.0,1,A,OHSU_HNSCC_derm001,17,0.381,10,Emodin,OHSU_HNSCC_derm001
15233,10328,490.0,1,B,OHSU_HNSCC_derm001,17,0.445,10,Baicalin,OHSU_HNSCC_derm001
15234,10328,490.0,1,C,OHSU_HNSCC_derm001,17,0.201,10,NVP-TAE-684,OHSU_HNSCC_derm001
15235,10328,490.0,1,D,OHSU_HNSCC_derm001,17,0.216,10,Panobinostat,OHSU_HNSCC_derm001
15236,10328,490.0,1,E,OHSU_HNSCC_derm001,17,0.238,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
15237,10328,490.0,1,F,OHSU_HNSCC_derm001,17,0.452,10,Fulvestrant,OHSU_HNSCC_derm001
15238,10328,490.0,1,G,OHSU_HNSCC_derm001,17,0.322,10,SCH-772984,OHSU_HNSCC_derm001
15239,10328,490.0,1,H,OHSU_HNSCC_derm001,17,0.349,10,Trametinib,OHSU_HNSCC_derm001
15240,10328,490.0,1,I,OHSU_HNSCC_derm001,17,0.214,10,BEZ235,OHSU_HNSCC_derm001
15241,10328,490.0,1,J,OHSU_HNSCC_derm001,17,0.432,10,MLN120B,OHSU_HNSCC_derm001
15242,10328,490.0,1,K,OHSU_HNSCC_derm001,17,0.331,10,Ixabepilone,OHSU_HNSCC_derm001
15243,10328,490.0,1,L,OHSU_HNSCC_derm001,17,0.196,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
15244,10328,490.0,1,M,OHSU_HNSCC_derm001,17,0.347,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15245,10328,490.0,1,N,OHSU_HNSCC_derm001,17,0.459,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15246,10328,490.0,1,O,OHSU_HNSCC_derm001,17,0.429,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15247,10328,490.0,1,P,OHSU_HNSCC_derm001,17,0.504,10,Letrozole,OHSU_HNSCC_derm001
15248,10328,490.0,1,A,OHSU_HNSCC_derm001,18,0.407,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
15249,10328,490.0,1,B,OHSU_HNSCC_derm001,18,0.469,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
15250,10328,490.0,1,C,OHSU_HNSCC_derm001,18,0.331,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
15251,10328,490.0,1,D,OHSU_HNSCC_derm001,18,0.215,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
15252,10328,490.0,1,E,OHSU_HNSCC_derm001,18,0.257,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
15253,10328,490.0,1,F,OHSU_HNSCC_derm001,18,0.428,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
15254,10328,490.0,1,G,OHSU_HNSCC_derm001,18,0.371,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
15255,10328,490.0,1,H,OHSU_HNSCC_derm001,18,0.36,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
15256,10328,490.0,1,I,OHSU_HNSCC_derm001,18,0.214,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
15257,10328,490.0,1,J,OHSU_HNSCC_derm001,18,0.467,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
15258,10328,490.0,1,K,OHSU_HNSCC_derm001,18,0.329,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
15259,10328,490.0,1,L,OHSU_HNSCC_derm001,18,0.373,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
15260,10328,490.0,1,M,OHSU_HNSCC_derm001,18,0.381,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15261,10328,490.0,1,N,OHSU_HNSCC_derm001,18,0.486,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15262,10328,490.0,1,O,OHSU_HNSCC_derm001,18,0.416,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15263,10328,490.0,1,P,OHSU_HNSCC_derm001,18,0.474,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
15264,10328,490.0,1,A,OHSU_HNSCC_derm001,19,0.412,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
15265,10328,490.0,1,B,OHSU_HNSCC_derm001,19,0.464,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
15266,10328,490.0,1,C,OHSU_HNSCC_derm001,19,0.46,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
15267,10328,490.0,1,D,OHSU_HNSCC_derm001,19,0.235,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
15268,10328,490.0,1,E,OHSU_HNSCC_derm001,19,0.277,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
15269,10328,490.0,1,F,OHSU_HNSCC_derm001,19,0.452,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
15270,10328,490.0,1,G,OHSU_HNSCC_derm001,19,0.362,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
15271,10328,490.0,1,H,OHSU_HNSCC_derm001,19,0.353,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
15272,10328,490.0,1,I,OHSU_HNSCC_derm001,19,0.215,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
15273,10328,490.0,1,J,OHSU_HNSCC_derm001,19,0.48,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
15274,10328,490.0,1,K,OHSU_HNSCC_derm001,19,0.346,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
15275,10328,490.0,1,L,OHSU_HNSCC_derm001,19,0.367,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
15276,10328,490.0,1,M,OHSU_HNSCC_derm001,19,0.424,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15277,10328,490.0,1,N,OHSU_HNSCC_derm001,19,0.536,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15278,10328,490.0,1,O,OHSU_HNSCC_derm001,19,0.423,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15279,10328,490.0,1,P,OHSU_HNSCC_derm001,19,0.476,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
15280,10328,490.0,1,A,OHSU_HNSCC_derm001,20,0.414,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
15281,10328,490.0,1,B,OHSU_HNSCC_derm001,20,0.443,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
15282,10328,490.0,1,C,OHSU_HNSCC_derm001,20,0.498,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
15283,10328,490.0,1,D,OHSU_HNSCC_derm001,20,0.313,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
15284,10328,490.0,1,E,OHSU_HNSCC_derm001,20,0.308,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
15285,10328,490.0,1,F,OHSU_HNSCC_derm001,20,0.465,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
15286,10328,490.0,1,G,OHSU_HNSCC_derm001,20,0.388,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
15287,10328,490.0,1,H,OHSU_HNSCC_derm001,20,0.353,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
15288,10328,490.0,1,I,OHSU_HNSCC_derm001,20,0.234,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
15289,10328,490.0,1,J,OHSU_HNSCC_derm001,20,0.475,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
15290,10328,490.0,1,K,OHSU_HNSCC_derm001,20,0.33,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
15291,10328,490.0,1,L,OHSU_HNSCC_derm001,20,0.372,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
15292,10328,490.0,1,M,OHSU_HNSCC_derm001,20,0.412,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15293,10328,490.0,1,N,OHSU_HNSCC_derm001,20,0.467,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15294,10328,490.0,1,O,OHSU_HNSCC_derm001,20,0.453,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15295,10328,490.0,1,P,OHSU_HNSCC_derm001,20,0.505,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
15296,10328,490.0,1,A,OHSU_HNSCC_derm001,21,0.414,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
15297,10328,490.0,1,B,OHSU_HNSCC_derm001,21,0.476,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
15298,10328,490.0,1,C,OHSU_HNSCC_derm001,21,0.479,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
15299,10328,490.0,1,D,OHSU_HNSCC_derm001,21,0.323,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
15300,10328,490.0,1,E,OHSU_HNSCC_derm001,21,0.356,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
15301,10328,490.0,1,F,OHSU_HNSCC_derm001,21,0.445,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
15302,10328,490.0,1,G,OHSU_HNSCC_derm001,21,0.441,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
15303,10328,490.0,1,H,OHSU_HNSCC_derm001,21,0.377,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
15304,10328,490.0,1,I,OHSU_HNSCC_derm001,21,0.261,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
15305,10328,490.0,1,J,OHSU_HNSCC_derm001,21,0.454,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
15306,10328,490.0,1,K,OHSU_HNSCC_derm001,21,0.335,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
15307,10328,490.0,1,L,OHSU_HNSCC_derm001,21,0.393,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
15308,10328,490.0,1,M,OHSU_HNSCC_derm001,21,0.421,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15309,10328,490.0,1,N,OHSU_HNSCC_derm001,21,0.451,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15310,10328,490.0,1,O,OHSU_HNSCC_derm001,21,0.455,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15311,10328,490.0,1,P,OHSU_HNSCC_derm001,21,0.491,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
15312,10328,490.0,1,A,OHSU_HNSCC_derm001,22,0.406,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
15313,10328,490.0,1,B,OHSU_HNSCC_derm001,22,0.433,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
15314,10328,490.0,1,C,OHSU_HNSCC_derm001,22,0.484,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
15315,10328,490.0,1,D,OHSU_HNSCC_derm001,22,0.332,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
15316,10328,490.0,1,E,OHSU_HNSCC_derm001,22,0.398,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
15317,10328,490.0,1,F,OHSU_HNSCC_derm001,22,0.482,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
15318,10328,490.0,1,G,OHSU_HNSCC_derm001,22,0.453,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
15319,10328,490.0,1,H,OHSU_HNSCC_derm001,22,0.38,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
15320,10328,490.0,1,I,OHSU_HNSCC_derm001,22,0.339,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
15321,10328,490.0,1,J,OHSU_HNSCC_derm001,22,0.476,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
15322,10328,490.0,1,K,OHSU_HNSCC_derm001,22,0.367,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
15323,10328,490.0,1,L,OHSU_HNSCC_derm001,22,0.421,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
15324,10328,490.0,1,M,OHSU_HNSCC_derm001,22,0.452,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15325,10328,490.0,1,N,OHSU_HNSCC_derm001,22,0.505,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15326,10328,490.0,1,O,OHSU_HNSCC_derm001,22,0.427,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15327,10328,490.0,1,P,OHSU_HNSCC_derm001,22,0.512,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
15328,10328,490.0,1,A,OHSU_HNSCC_derm001,23,0.391,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
15329,10328,490.0,1,B,OHSU_HNSCC_derm001,23,0.5,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
15330,10328,490.0,1,C,OHSU_HNSCC_derm001,23,0.499,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
15331,10328,490.0,1,D,OHSU_HNSCC_derm001,23,0.411,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
15332,10328,490.0,1,E,OHSU_HNSCC_derm001,23,0.466,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
15333,10328,490.0,1,F,OHSU_HNSCC_derm001,23,0.455,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
15334,10328,490.0,1,G,OHSU_HNSCC_derm001,23,0.483,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
15335,10328,490.0,1,H,OHSU_HNSCC_derm001,23,0.448,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
15336,10328,490.0,1,I,OHSU_HNSCC_derm001,23,0.425,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
15337,10328,490.0,1,J,OHSU_HNSCC_derm001,23,0.446,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
15338,10328,490.0,1,K,OHSU_HNSCC_derm001,23,0.378,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
15339,10328,490.0,1,L,OHSU_HNSCC_derm001,23,0.437,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
15340,10328,490.0,1,M,OHSU_HNSCC_derm001,23,0.478,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
15341,10328,490.0,1,N,OHSU_HNSCC_derm001,23,0.499,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
15342,10328,490.0,1,O,OHSU_HNSCC_derm001,23,0.461,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
15343,10328,490.0,1,P,OHSU_HNSCC_derm001,23,0.475,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
15344,10328,490.0,1,A,OHSU_HNSCC_derm001,24,0.349,0,NONE,OHSU_HNSCC_derm001
15345,10328,490.0,1,B,OHSU_HNSCC_derm001,24,0.371,0,NONE,OHSU_HNSCC_derm001
15346,10328,490.0,1,C,OHSU_HNSCC_derm001,24,0.42,0,NONE,OHSU_HNSCC_derm001
15347,10328,490.0,1,D,OHSU_HNSCC_derm001,24,0.355,0,NONE,OHSU_HNSCC_derm001
15348,10328,490.0,1,E,OHSU_HNSCC_derm001,24,0.375,0,NONE,OHSU_HNSCC_derm001
15349,10328,490.0,1,F,OHSU_HNSCC_derm001,24,0.356,0,NONE,OHSU_HNSCC_derm001
15350,10328,490.0,1,G,OHSU_HNSCC_derm001,24,0.383,0,NONE,OHSU_HNSCC_derm001
15351,10328,490.0,1,H,OHSU_HNSCC_derm001,24,0.341,0,NONE,OHSU_HNSCC_derm001
15352,10328,490.0,1,I,OHSU_HNSCC_derm001,24,0.346,0,NONE,OHSU_HNSCC_derm001
15353,10328,490.0,1,J,OHSU_HNSCC_derm001,24,0.358,0,NONE,OHSU_HNSCC_derm001
15354,10328,490.0,1,K,OHSU_HNSCC_derm001,24,0.418,0,NONE,OHSU_HNSCC_derm001
15355,10328,490.0,1,L,OHSU_HNSCC_derm001,24,0.358,0,NONE,OHSU_HNSCC_derm001
15356,10328,490.0,1,M,OHSU_HNSCC_derm001,24,0.338,0,NONE,OHSU_HNSCC_derm001
15357,10328,490.0,1,N,OHSU_HNSCC_derm001,24,0.367,0,NONE,OHSU_HNSCC_derm001
15358,10328,490.0,1,O,OHSU_HNSCC_derm001,24,0.343,0,NONE,OHSU_HNSCC_derm001
15359,10328,490.0,1,P,OHSU_HNSCC_derm001,24,0.4,0,NONE,OHSU_HNSCC_derm001
15360,10328,490.0,2,A,OHSU_HNSCC_derm001,1,0.341,10,Coumarin,OHSU_HNSCC_derm001
15361,10328,490.0,2,B,OHSU_HNSCC_derm001,1,0.195,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15362,10328,490.0,2,C,OHSU_HNSCC_derm001,1,0.196,10,Foretinib (XL-880),OHSU_HNSCC_derm001
15363,10328,490.0,2,D,OHSU_HNSCC_derm001,1,0.441,10,Elesclomol,OHSU_HNSCC_derm001
15364,10328,490.0,2,E,OHSU_HNSCC_derm001,1,0.323,10,Vemurafenib,OHSU_HNSCC_derm001
15365,10328,490.0,2,F,OHSU_HNSCC_derm001,1,0.218,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15366,10328,490.0,2,G,OHSU_HNSCC_derm001,1,0.17,10,Ponatinib,OHSU_HNSCC_derm001
15367,10328,490.0,2,H,OHSU_HNSCC_derm001,1,0.297,10,Gefitinib,OHSU_HNSCC_derm001
15368,10328,490.0,2,I,OHSU_HNSCC_derm001,1,0.175,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
15369,10328,490.0,2,J,OHSU_HNSCC_derm001,1,0.352,1,Sunitinib (1mM),OHSU_HNSCC_derm001
15370,10328,490.0,2,K,OHSU_HNSCC_derm001,1,0.351,10,Curcumin,OHSU_HNSCC_derm001
15371,10328,490.0,2,L,OHSU_HNSCC_derm001,1,0.219,10,PF-562271,OHSU_HNSCC_derm001
15372,10328,490.0,2,M,OHSU_HNSCC_derm001,1,0.381,10,STO609,OHSU_HNSCC_derm001
15373,10328,490.0,2,N,OHSU_HNSCC_derm001,1,0.311,10,Lenvatinib,OHSU_HNSCC_derm001
15374,10328,490.0,2,O,OHSU_HNSCC_derm001,1,0.218,10,Entrectinib,OHSU_HNSCC_derm001
15375,10328,490.0,2,P,OHSU_HNSCC_derm001,1,0.482,10,Ethyl Gallate ,OHSU_HNSCC_derm001
15376,10328,490.0,2,A,OHSU_HNSCC_derm001,2,0.368,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
15377,10328,490.0,2,B,OHSU_HNSCC_derm001,2,0.388,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15378,10328,490.0,2,C,OHSU_HNSCC_derm001,2,0.286,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
15379,10328,490.0,2,D,OHSU_HNSCC_derm001,2,0.44,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
15380,10328,490.0,2,E,OHSU_HNSCC_derm001,2,0.422,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
15381,10328,490.0,2,F,OHSU_HNSCC_derm001,2,0.215,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15382,10328,490.0,2,G,OHSU_HNSCC_derm001,2,0.206,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
15383,10328,490.0,2,H,OHSU_HNSCC_derm001,2,0.352,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
15384,10328,490.0,2,I,OHSU_HNSCC_derm001,2,0.379,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
15385,10328,490.0,2,J,OHSU_HNSCC_derm001,2,0.473,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
15386,10328,490.0,2,K,OHSU_HNSCC_derm001,2,0.446,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
15387,10328,490.0,2,L,OHSU_HNSCC_derm001,2,0.382,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
15388,10328,490.0,2,M,OHSU_HNSCC_derm001,2,0.394,3.3333333333333335,STO609,OHSU_HNSCC_derm001
15389,10328,490.0,2,N,OHSU_HNSCC_derm001,2,0.383,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
15390,10328,490.0,2,O,OHSU_HNSCC_derm001,2,0.446,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
15391,10328,490.0,2,P,OHSU_HNSCC_derm001,2,0.504,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
15392,10328,490.0,2,A,OHSU_HNSCC_derm001,3,0.386,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
15393,10328,490.0,2,B,OHSU_HNSCC_derm001,3,0.364,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15394,10328,490.0,2,C,OHSU_HNSCC_derm001,3,0.403,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
15395,10328,490.0,2,D,OHSU_HNSCC_derm001,3,0.357,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
15396,10328,490.0,2,E,OHSU_HNSCC_derm001,3,0.445,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
15397,10328,490.0,2,F,OHSU_HNSCC_derm001,3,0.247,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15398,10328,490.0,2,G,OHSU_HNSCC_derm001,3,0.427,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
15399,10328,490.0,2,H,OHSU_HNSCC_derm001,3,0.382,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
15400,10328,490.0,2,I,OHSU_HNSCC_derm001,3,0.441,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
15401,10328,490.0,2,J,OHSU_HNSCC_derm001,3,0.468,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
15402,10328,490.0,2,K,OHSU_HNSCC_derm001,3,0.462,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
15403,10328,490.0,2,L,OHSU_HNSCC_derm001,3,0.479,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
15404,10328,490.0,2,M,OHSU_HNSCC_derm001,3,0.478,1.1111111111111112,STO609,OHSU_HNSCC_derm001
15405,10328,490.0,2,N,OHSU_HNSCC_derm001,3,0.427,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
15406,10328,490.0,2,O,OHSU_HNSCC_derm001,3,0.466,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
15407,10328,490.0,2,P,OHSU_HNSCC_derm001,3,0.448,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
15408,10328,490.0,2,A,OHSU_HNSCC_derm001,4,0.37,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
15409,10328,490.0,2,B,OHSU_HNSCC_derm001,4,0.35,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15410,10328,490.0,2,C,OHSU_HNSCC_derm001,4,0.407,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
15411,10328,490.0,2,D,OHSU_HNSCC_derm001,4,0.308,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
15412,10328,490.0,2,E,OHSU_HNSCC_derm001,4,0.474,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
15413,10328,490.0,2,F,OHSU_HNSCC_derm001,4,0.275,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15414,10328,490.0,2,G,OHSU_HNSCC_derm001,4,0.389,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
15415,10328,490.0,2,H,OHSU_HNSCC_derm001,4,0.412,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
15416,10328,490.0,2,I,OHSU_HNSCC_derm001,4,0.409,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
15417,10328,490.0,2,J,OHSU_HNSCC_derm001,4,0.439,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
15418,10328,490.0,2,K,OHSU_HNSCC_derm001,4,0.453,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
15419,10328,490.0,2,L,OHSU_HNSCC_derm001,4,0.517,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
15420,10328,490.0,2,M,OHSU_HNSCC_derm001,4,0.466,0.3703703703703704,STO609,OHSU_HNSCC_derm001
15421,10328,490.0,2,N,OHSU_HNSCC_derm001,4,0.436,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
15422,10328,490.0,2,O,OHSU_HNSCC_derm001,4,0.455,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
15423,10328,490.0,2,P,OHSU_HNSCC_derm001,4,0.507,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
15424,10328,490.0,2,A,OHSU_HNSCC_derm001,5,0.372,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
15425,10328,490.0,2,B,OHSU_HNSCC_derm001,5,0.363,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15426,10328,490.0,2,C,OHSU_HNSCC_derm001,5,0.424,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
15427,10328,490.0,2,D,OHSU_HNSCC_derm001,5,0.242,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
15428,10328,490.0,2,E,OHSU_HNSCC_derm001,5,0.477,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
15429,10328,490.0,2,F,OHSU_HNSCC_derm001,5,0.308,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15430,10328,490.0,2,G,OHSU_HNSCC_derm001,5,0.468,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
15431,10328,490.0,2,H,OHSU_HNSCC_derm001,5,0.424,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
15432,10328,490.0,2,I,OHSU_HNSCC_derm001,5,0.441,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
15433,10328,490.0,2,J,OHSU_HNSCC_derm001,5,0.451,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
15434,10328,490.0,2,K,OHSU_HNSCC_derm001,5,0.5,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
15435,10328,490.0,2,L,OHSU_HNSCC_derm001,5,0.552,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
15436,10328,490.0,2,M,OHSU_HNSCC_derm001,5,0.488,0.1234567901234568,STO609,OHSU_HNSCC_derm001
15437,10328,490.0,2,N,OHSU_HNSCC_derm001,5,0.444,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
15438,10328,490.0,2,O,OHSU_HNSCC_derm001,5,0.442,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
15439,10328,490.0,2,P,OHSU_HNSCC_derm001,5,0.446,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
15440,10328,490.0,2,A,OHSU_HNSCC_derm001,6,0.35,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
15441,10328,490.0,2,B,OHSU_HNSCC_derm001,6,0.351,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15442,10328,490.0,2,C,OHSU_HNSCC_derm001,6,0.415,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
15443,10328,490.0,2,D,OHSU_HNSCC_derm001,6,0.241,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
15444,10328,490.0,2,E,OHSU_HNSCC_derm001,6,0.487,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
15445,10328,490.0,2,F,OHSU_HNSCC_derm001,6,0.417,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15446,10328,490.0,2,G,OHSU_HNSCC_derm001,6,0.455,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
15447,10328,490.0,2,H,OHSU_HNSCC_derm001,6,0.435,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
15448,10328,490.0,2,I,OHSU_HNSCC_derm001,6,0.454,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
15449,10328,490.0,2,J,OHSU_HNSCC_derm001,6,0.41,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
15450,10328,490.0,2,K,OHSU_HNSCC_derm001,6,0.495,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
15451,10328,490.0,2,L,OHSU_HNSCC_derm001,6,0.496,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
15452,10328,490.0,2,M,OHSU_HNSCC_derm001,6,0.503,0.0411522633744856,STO609,OHSU_HNSCC_derm001
15453,10328,490.0,2,N,OHSU_HNSCC_derm001,6,0.418,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
15454,10328,490.0,2,O,OHSU_HNSCC_derm001,6,0.545,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
15455,10328,490.0,2,P,OHSU_HNSCC_derm001,6,0.42,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
15456,10328,490.0,2,A,OHSU_HNSCC_derm001,7,0.377,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
15457,10328,490.0,2,B,OHSU_HNSCC_derm001,7,0.356,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
15458,10328,490.0,2,C,OHSU_HNSCC_derm001,7,0.438,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
15459,10328,490.0,2,D,OHSU_HNSCC_derm001,7,0.3,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
15460,10328,490.0,2,E,OHSU_HNSCC_derm001,7,0.502,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
15461,10328,490.0,2,F,OHSU_HNSCC_derm001,7,0.434,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
15462,10328,490.0,2,G,OHSU_HNSCC_derm001,7,0.46,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
15463,10328,490.0,2,H,OHSU_HNSCC_derm001,7,0.452,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
15464,10328,490.0,2,I,OHSU_HNSCC_derm001,7,0.375,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
15465,10328,490.0,2,J,OHSU_HNSCC_derm001,7,0.368,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
15466,10328,490.0,2,K,OHSU_HNSCC_derm001,7,0.471,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
15467,10328,490.0,2,L,OHSU_HNSCC_derm001,7,0.498,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
15468,10328,490.0,2,M,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,STO609,OHSU_HNSCC_derm001
15469,10328,490.0,2,N,OHSU_HNSCC_derm001,7,0.498,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
15470,10328,490.0,2,O,OHSU_HNSCC_derm001,7,0.516,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
15471,10328,490.0,2,P,OHSU_HNSCC_derm001,7,0.54,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
15472,10328,490.0,2,A,OHSU_HNSCC_derm001,8,0.386,0,NONE,OHSU_HNSCC_derm001
15473,10328,490.0,2,B,OHSU_HNSCC_derm001,8,0.414,0,NONE,OHSU_HNSCC_derm001
15474,10328,490.0,2,C,OHSU_HNSCC_derm001,8,0.466,0,NONE,OHSU_HNSCC_derm001
15475,10328,490.0,2,D,OHSU_HNSCC_derm001,8,0.46,0,NONE,OHSU_HNSCC_derm001
15476,10328,490.0,2,E,OHSU_HNSCC_derm001,8,0.469,0,NONE,OHSU_HNSCC_derm001
15477,10328,490.0,2,F,OHSU_HNSCC_derm001,8,0.489,0,NONE,OHSU_HNSCC_derm001
15478,10328,490.0,2,G,OHSU_HNSCC_derm001,8,0.398,0,NONE,OHSU_HNSCC_derm001
15479,10328,490.0,2,H,OHSU_HNSCC_derm001,8,0.174,10,F-S-V,OHSU_HNSCC_derm001
15480,10328,490.0,2,I,OHSU_HNSCC_derm001,8,0.396,0,NONE,OHSU_HNSCC_derm001
15481,10328,490.0,2,J,OHSU_HNSCC_derm001,8,0.454,0,NONE,OHSU_HNSCC_derm001
15482,10328,490.0,2,K,OHSU_HNSCC_derm001,8,0.474,0,NONE,OHSU_HNSCC_derm001
15483,10328,490.0,2,L,OHSU_HNSCC_derm001,8,0.462,0,NONE,OHSU_HNSCC_derm001
15484,10328,490.0,2,M,OHSU_HNSCC_derm001,8,0.453,0,NONE,OHSU_HNSCC_derm001
15485,10328,490.0,2,N,OHSU_HNSCC_derm001,8,0.484,0,NONE,OHSU_HNSCC_derm001
15486,10328,490.0,2,O,OHSU_HNSCC_derm001,8,0.527,0,NONE,OHSU_HNSCC_derm001
15487,10328,490.0,2,P,OHSU_HNSCC_derm001,8,0.407,0,NONE,OHSU_HNSCC_derm001
15488,10328,490.0,2,A,OHSU_HNSCC_derm001,9,0.197,10,GDC-0941,OHSU_HNSCC_derm001
15489,10328,490.0,2,B,OHSU_HNSCC_derm001,9,0.546,10,Dovitinib,OHSU_HNSCC_derm001
15490,10328,490.0,2,C,OHSU_HNSCC_derm001,9,0.438,10,BI-2536,OHSU_HNSCC_derm001
15491,10328,490.0,2,D,OHSU_HNSCC_derm001,9,0.18,10,TP-0903 ,OHSU_HNSCC_derm001
15492,10328,490.0,2,E,OHSU_HNSCC_derm001,9,0.229,10,Belinostat,OHSU_HNSCC_derm001
15493,10328,490.0,2,F,OHSU_HNSCC_derm001,9,0.199,10,INK-128,OHSU_HNSCC_derm001
15494,10328,490.0,2,G,OHSU_HNSCC_derm001,9,0.264,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15495,10328,490.0,2,H,OHSU_HNSCC_derm001,9,0.216,10,Brigatinib,OHSU_HNSCC_derm001
15496,10328,490.0,2,I,OHSU_HNSCC_derm001,9,0.314,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15497,10328,490.0,2,J,OHSU_HNSCC_derm001,9,0.307,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15498,10328,490.0,2,K,OHSU_HNSCC_derm001,9,0.358,10,Pazopanib,OHSU_HNSCC_derm001
15499,10328,490.0,2,L,OHSU_HNSCC_derm001,9,0.524,10,AZD4547,OHSU_HNSCC_derm001
15500,10328,490.0,2,M,OHSU_HNSCC_derm001,9,0.499,10,Pomalidomide ,OHSU_HNSCC_derm001
15501,10328,490.0,2,N,OHSU_HNSCC_derm001,9,0.385,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
15502,10328,490.0,2,O,OHSU_HNSCC_derm001,9,0.424,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15503,10328,490.0,2,P,OHSU_HNSCC_derm001,9,0.175,10,Staurosporin,OHSU_HNSCC_derm001
15504,10328,490.0,2,A,OHSU_HNSCC_derm001,10,0.203,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
15505,10328,490.0,2,B,OHSU_HNSCC_derm001,10,0.567,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
15506,10328,490.0,2,C,OHSU_HNSCC_derm001,10,0.628,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
15507,10328,490.0,2,D,OHSU_HNSCC_derm001,10,0.182,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
15508,10328,490.0,2,E,OHSU_HNSCC_derm001,10,0.277,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
15509,10328,490.0,2,F,OHSU_HNSCC_derm001,10,0.206,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
15510,10328,490.0,2,G,OHSU_HNSCC_derm001,10,0.332,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15511,10328,490.0,2,H,OHSU_HNSCC_derm001,10,0.311,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
15512,10328,490.0,2,I,OHSU_HNSCC_derm001,10,0.415,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15513,10328,490.0,2,J,OHSU_HNSCC_derm001,10,0.504,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15514,10328,490.0,2,K,OHSU_HNSCC_derm001,10,0.389,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
15515,10328,490.0,2,L,OHSU_HNSCC_derm001,10,0.478,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
15516,10328,490.0,2,M,OHSU_HNSCC_derm001,10,0.543,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
15517,10328,490.0,2,N,OHSU_HNSCC_derm001,10,0.433,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
15518,10328,490.0,2,O,OHSU_HNSCC_derm001,10,0.49,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15519,10328,490.0,2,P,OHSU_HNSCC_derm001,10,0.175,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
15520,10328,490.0,2,A,OHSU_HNSCC_derm001,11,0.234,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
15521,10328,490.0,2,B,OHSU_HNSCC_derm001,11,0.524,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
15522,10328,490.0,2,C,OHSU_HNSCC_derm001,11,0.68,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
15523,10328,490.0,2,D,OHSU_HNSCC_derm001,11,0.176,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
15524,10328,490.0,2,E,OHSU_HNSCC_derm001,11,0.322,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
15525,10328,490.0,2,F,OHSU_HNSCC_derm001,11,0.218,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
15526,10328,490.0,2,G,OHSU_HNSCC_derm001,11,0.349,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15527,10328,490.0,2,H,OHSU_HNSCC_derm001,11,0.384,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
15528,10328,490.0,2,I,OHSU_HNSCC_derm001,11,0.373,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15529,10328,490.0,2,J,OHSU_HNSCC_derm001,11,0.538,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15530,10328,490.0,2,K,OHSU_HNSCC_derm001,11,0.407,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
15531,10328,490.0,2,L,OHSU_HNSCC_derm001,11,0.515,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
15532,10328,490.0,2,M,OHSU_HNSCC_derm001,11,0.471,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
15533,10328,490.0,2,N,OHSU_HNSCC_derm001,11,0.414,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
15534,10328,490.0,2,O,OHSU_HNSCC_derm001,11,0.469,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15535,10328,490.0,2,P,OHSU_HNSCC_derm001,11,0.172,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
15536,10328,490.0,2,A,OHSU_HNSCC_derm001,12,0.245,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
15537,10328,490.0,2,B,OHSU_HNSCC_derm001,12,0.444,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
15538,10328,490.0,2,C,OHSU_HNSCC_derm001,12,0.617,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
15539,10328,490.0,2,D,OHSU_HNSCC_derm001,12,0.279,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
15540,10328,490.0,2,E,OHSU_HNSCC_derm001,12,0.38,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
15541,10328,490.0,2,F,OHSU_HNSCC_derm001,12,0.229,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
15542,10328,490.0,2,G,OHSU_HNSCC_derm001,12,0.35,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15543,10328,490.0,2,H,OHSU_HNSCC_derm001,12,0.465,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
15544,10328,490.0,2,I,OHSU_HNSCC_derm001,12,0.397,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15545,10328,490.0,2,J,OHSU_HNSCC_derm001,12,0.534,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15546,10328,490.0,2,K,OHSU_HNSCC_derm001,12,0.406,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
15547,10328,490.0,2,L,OHSU_HNSCC_derm001,12,0.5,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
15548,10328,490.0,2,M,OHSU_HNSCC_derm001,12,0.471,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
15549,10328,490.0,2,N,OHSU_HNSCC_derm001,12,0.462,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
15550,10328,490.0,2,O,OHSU_HNSCC_derm001,12,0.466,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15551,10328,490.0,2,P,OHSU_HNSCC_derm001,12,0.198,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
15552,10328,490.0,2,A,OHSU_HNSCC_derm001,13,0.293,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
15553,10328,490.0,2,B,OHSU_HNSCC_derm001,13,0.437,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
15554,10328,490.0,2,C,OHSU_HNSCC_derm001,13,0.498,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
15555,10328,490.0,2,D,OHSU_HNSCC_derm001,13,0.44,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
15556,10328,490.0,2,E,OHSU_HNSCC_derm001,13,0.441,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
15557,10328,490.0,2,F,OHSU_HNSCC_derm001,13,0.254,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
15558,10328,490.0,2,G,OHSU_HNSCC_derm001,13,0.362,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15559,10328,490.0,2,H,OHSU_HNSCC_derm001,13,0.431,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
15560,10328,490.0,2,I,OHSU_HNSCC_derm001,13,0.367,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15561,10328,490.0,2,J,OHSU_HNSCC_derm001,13,0.523,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15562,10328,490.0,2,K,OHSU_HNSCC_derm001,13,0.502,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
15563,10328,490.0,2,L,OHSU_HNSCC_derm001,13,0.535,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
15564,10328,490.0,2,M,OHSU_HNSCC_derm001,13,0.501,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
15565,10328,490.0,2,N,OHSU_HNSCC_derm001,13,0.465,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
15566,10328,490.0,2,O,OHSU_HNSCC_derm001,13,0.464,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15567,10328,490.0,2,P,OHSU_HNSCC_derm001,13,0.248,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
15568,10328,490.0,2,A,OHSU_HNSCC_derm001,14,0.322,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
15569,10328,490.0,2,B,OHSU_HNSCC_derm001,14,0.404,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
15570,10328,490.0,2,C,OHSU_HNSCC_derm001,14,0.489,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
15571,10328,490.0,2,D,OHSU_HNSCC_derm001,14,0.449,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
15572,10328,490.0,2,E,OHSU_HNSCC_derm001,14,0.451,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
15573,10328,490.0,2,F,OHSU_HNSCC_derm001,14,0.302,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
15574,10328,490.0,2,G,OHSU_HNSCC_derm001,14,0.404,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15575,10328,490.0,2,H,OHSU_HNSCC_derm001,14,0.465,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
15576,10328,490.0,2,I,OHSU_HNSCC_derm001,14,0.381,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15577,10328,490.0,2,J,OHSU_HNSCC_derm001,14,0.491,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15578,10328,490.0,2,K,OHSU_HNSCC_derm001,14,0.461,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
15579,10328,490.0,2,L,OHSU_HNSCC_derm001,14,0.472,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
15580,10328,490.0,2,M,OHSU_HNSCC_derm001,14,0.435,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
15581,10328,490.0,2,N,OHSU_HNSCC_derm001,14,0.459,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
15582,10328,490.0,2,O,OHSU_HNSCC_derm001,14,0.455,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15583,10328,490.0,2,P,OHSU_HNSCC_derm001,14,0.316,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
15584,10328,490.0,2,A,OHSU_HNSCC_derm001,15,0.304,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
15585,10328,490.0,2,B,OHSU_HNSCC_derm001,15,0.426,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
15586,10328,490.0,2,C,OHSU_HNSCC_derm001,15,0.455,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
15587,10328,490.0,2,D,OHSU_HNSCC_derm001,15,0.488,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
15588,10328,490.0,2,E,OHSU_HNSCC_derm001,15,0.455,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
15589,10328,490.0,2,F,OHSU_HNSCC_derm001,15,0.319,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
15590,10328,490.0,2,G,OHSU_HNSCC_derm001,15,0.402,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
15591,10328,490.0,2,H,OHSU_HNSCC_derm001,15,0.462,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
15592,10328,490.0,2,I,OHSU_HNSCC_derm001,15,0.424,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15593,10328,490.0,2,J,OHSU_HNSCC_derm001,15,0.475,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
15594,10328,490.0,2,K,OHSU_HNSCC_derm001,15,0.455,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
15595,10328,490.0,2,L,OHSU_HNSCC_derm001,15,0.504,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
15596,10328,490.0,2,M,OHSU_HNSCC_derm001,15,0.502,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
15597,10328,490.0,2,N,OHSU_HNSCC_derm001,15,0.49,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
15598,10328,490.0,2,O,OHSU_HNSCC_derm001,15,0.489,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
15599,10328,490.0,2,P,OHSU_HNSCC_derm001,15,0.298,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
15600,10328,490.0,2,A,OHSU_HNSCC_derm001,16,0.363,0,NONE,OHSU_HNSCC_derm001
15601,10328,490.0,2,B,OHSU_HNSCC_derm001,16,0.428,0,NONE,OHSU_HNSCC_derm001
15602,10328,490.0,2,C,OHSU_HNSCC_derm001,16,0.452,0,NONE,OHSU_HNSCC_derm001
15603,10328,490.0,2,D,OHSU_HNSCC_derm001,16,0.478,0,NONE,OHSU_HNSCC_derm001
15604,10328,490.0,2,E,OHSU_HNSCC_derm001,16,0.475,0,NONE,OHSU_HNSCC_derm001
15605,10328,490.0,2,F,OHSU_HNSCC_derm001,16,0.434,0,NONE,OHSU_HNSCC_derm001
15606,10328,490.0,2,G,OHSU_HNSCC_derm001,16,0.479,0,NONE,OHSU_HNSCC_derm001
15607,10328,490.0,2,H,OHSU_HNSCC_derm001,16,0.175,10,F-S-V,OHSU_HNSCC_derm001
15608,10328,490.0,2,I,OHSU_HNSCC_derm001,16,0.477,0,NONE,OHSU_HNSCC_derm001
15609,10328,490.0,2,J,OHSU_HNSCC_derm001,16,0.459,0,NONE,OHSU_HNSCC_derm001
15610,10328,490.0,2,K,OHSU_HNSCC_derm001,16,0.504,0,NONE,OHSU_HNSCC_derm001
15611,10328,490.0,2,L,OHSU_HNSCC_derm001,16,0.463,0,NONE,OHSU_HNSCC_derm001
15612,10328,490.0,2,M,OHSU_HNSCC_derm001,16,0.466,0,NONE,OHSU_HNSCC_derm001
15613,10328,490.0,2,N,OHSU_HNSCC_derm001,16,0.518,0,NONE,OHSU_HNSCC_derm001
15614,10328,490.0,2,O,OHSU_HNSCC_derm001,16,0.499,0,NONE,OHSU_HNSCC_derm001
15615,10328,490.0,2,P,OHSU_HNSCC_derm001,16,0.499,0,NONE,OHSU_HNSCC_derm001
15616,10328,490.0,2,A,OHSU_HNSCC_derm001,17,0.446,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
15617,10328,490.0,2,B,OHSU_HNSCC_derm001,17,0.447,10,Hesperidin,OHSU_HNSCC_derm001
15618,10328,490.0,2,C,OHSU_HNSCC_derm001,17,0.457,10,Esculetin,OHSU_HNSCC_derm001
15619,10328,490.0,2,D,OHSU_HNSCC_derm001,17,0.309,10,Selinexor ,OHSU_HNSCC_derm001
15620,10328,490.0,2,E,OHSU_HNSCC_derm001,17,0.31,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15621,10328,490.0,2,F,OHSU_HNSCC_derm001,17,0.342,10,BMX-IN-1,OHSU_HNSCC_derm001
15622,10328,490.0,2,G,OHSU_HNSCC_derm001,17,0.26,1,Dasatinib (1mM),OHSU_HNSCC_derm001
15623,10328,490.0,2,H,OHSU_HNSCC_derm001,17,0.333,10,Trametinib,OHSU_HNSCC_derm001
15624,10328,490.0,2,I,OHSU_HNSCC_derm001,17,0.21,10,BEZ235,OHSU_HNSCC_derm001
15625,10328,490.0,2,J,OHSU_HNSCC_derm001,17,0.176,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
15626,10328,490.0,2,K,OHSU_HNSCC_derm001,17,0.328,10,Nilotinib,OHSU_HNSCC_derm001
15627,10328,490.0,2,L,OHSU_HNSCC_derm001,17,0.436,10,Enzalutamide,OHSU_HNSCC_derm001
15628,10328,490.0,2,M,OHSU_HNSCC_derm001,17,0.599,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15629,10328,490.0,2,N,OHSU_HNSCC_derm001,17,0.422,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
15630,10328,490.0,2,O,OHSU_HNSCC_derm001,17,0.176,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15631,10328,490.0,2,P,OHSU_HNSCC_derm001,17,0.379,10,Axitinib,OHSU_HNSCC_derm001
15632,10328,490.0,2,A,OHSU_HNSCC_derm001,18,0.483,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
15633,10328,490.0,2,B,OHSU_HNSCC_derm001,18,0.43,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
15634,10328,490.0,2,C,OHSU_HNSCC_derm001,18,0.488,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
15635,10328,490.0,2,D,OHSU_HNSCC_derm001,18,0.283,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
15636,10328,490.0,2,E,OHSU_HNSCC_derm001,18,0.413,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15637,10328,490.0,2,F,OHSU_HNSCC_derm001,18,0.407,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
15638,10328,490.0,2,G,OHSU_HNSCC_derm001,18,0.317,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
15639,10328,490.0,2,H,OHSU_HNSCC_derm001,18,0.367,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
15640,10328,490.0,2,I,OHSU_HNSCC_derm001,18,0.212,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
15641,10328,490.0,2,J,OHSU_HNSCC_derm001,18,0.177,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
15642,10328,490.0,2,K,OHSU_HNSCC_derm001,18,0.459,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
15643,10328,490.0,2,L,OHSU_HNSCC_derm001,18,0.425,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
15644,10328,490.0,2,M,OHSU_HNSCC_derm001,18,0.554,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15645,10328,490.0,2,N,OHSU_HNSCC_derm001,18,0.427,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
15646,10328,490.0,2,O,OHSU_HNSCC_derm001,18,0.175,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15647,10328,490.0,2,P,OHSU_HNSCC_derm001,18,0.395,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
15648,10328,490.0,2,A,OHSU_HNSCC_derm001,19,0.461,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
15649,10328,490.0,2,B,OHSU_HNSCC_derm001,19,0.449,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
15650,10328,490.0,2,C,OHSU_HNSCC_derm001,19,0.447,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
15651,10328,490.0,2,D,OHSU_HNSCC_derm001,19,0.296,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
15652,10328,490.0,2,E,OHSU_HNSCC_derm001,19,0.465,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15653,10328,490.0,2,F,OHSU_HNSCC_derm001,19,0.408,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
15654,10328,490.0,2,G,OHSU_HNSCC_derm001,19,0.282,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
15655,10328,490.0,2,H,OHSU_HNSCC_derm001,19,0.349,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
15656,10328,490.0,2,I,OHSU_HNSCC_derm001,19,0.22,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
15657,10328,490.0,2,J,OHSU_HNSCC_derm001,19,0.194,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
15658,10328,490.0,2,K,OHSU_HNSCC_derm001,19,0.425,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
15659,10328,490.0,2,L,OHSU_HNSCC_derm001,19,0.524,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
15660,10328,490.0,2,M,OHSU_HNSCC_derm001,19,0.54,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15661,10328,490.0,2,N,OHSU_HNSCC_derm001,19,0.451,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
15662,10328,490.0,2,O,OHSU_HNSCC_derm001,19,0.186,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15663,10328,490.0,2,P,OHSU_HNSCC_derm001,19,0.47,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
15664,10328,490.0,2,A,OHSU_HNSCC_derm001,20,0.373,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
15665,10328,490.0,2,B,OHSU_HNSCC_derm001,20,0.438,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
15666,10328,490.0,2,C,OHSU_HNSCC_derm001,20,0.397,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
15667,10328,490.0,2,D,OHSU_HNSCC_derm001,20,0.312,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
15668,10328,490.0,2,E,OHSU_HNSCC_derm001,20,0.468,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15669,10328,490.0,2,F,OHSU_HNSCC_derm001,20,0.459,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
15670,10328,490.0,2,G,OHSU_HNSCC_derm001,20,0.455,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
15671,10328,490.0,2,H,OHSU_HNSCC_derm001,20,0.363,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
15672,10328,490.0,2,I,OHSU_HNSCC_derm001,20,0.232,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
15673,10328,490.0,2,J,OHSU_HNSCC_derm001,20,0.221,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
15674,10328,490.0,2,K,OHSU_HNSCC_derm001,20,0.471,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
15675,10328,490.0,2,L,OHSU_HNSCC_derm001,20,0.506,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
15676,10328,490.0,2,M,OHSU_HNSCC_derm001,20,0.491,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15677,10328,490.0,2,N,OHSU_HNSCC_derm001,20,0.496,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
15678,10328,490.0,2,O,OHSU_HNSCC_derm001,20,0.323,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15679,10328,490.0,2,P,OHSU_HNSCC_derm001,20,0.415,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
15680,10328,490.0,2,A,OHSU_HNSCC_derm001,21,0.403,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
15681,10328,490.0,2,B,OHSU_HNSCC_derm001,21,0.402,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
15682,10328,490.0,2,C,OHSU_HNSCC_derm001,21,0.466,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
15683,10328,490.0,2,D,OHSU_HNSCC_derm001,21,0.326,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
15684,10328,490.0,2,E,OHSU_HNSCC_derm001,21,0.442,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15685,10328,490.0,2,F,OHSU_HNSCC_derm001,21,0.461,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
15686,10328,490.0,2,G,OHSU_HNSCC_derm001,21,0.455,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
15687,10328,490.0,2,H,OHSU_HNSCC_derm001,21,0.375,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
15688,10328,490.0,2,I,OHSU_HNSCC_derm001,21,0.256,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
15689,10328,490.0,2,J,OHSU_HNSCC_derm001,21,0.251,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
15690,10328,490.0,2,K,OHSU_HNSCC_derm001,21,0.506,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
15691,10328,490.0,2,L,OHSU_HNSCC_derm001,21,0.479,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
15692,10328,490.0,2,M,OHSU_HNSCC_derm001,21,0.486,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15693,10328,490.0,2,N,OHSU_HNSCC_derm001,21,0.528,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
15694,10328,490.0,2,O,OHSU_HNSCC_derm001,21,0.452,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15695,10328,490.0,2,P,OHSU_HNSCC_derm001,21,0.5,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
15696,10328,490.0,2,A,OHSU_HNSCC_derm001,22,0.42,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
15697,10328,490.0,2,B,OHSU_HNSCC_derm001,22,0.457,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
15698,10328,490.0,2,C,OHSU_HNSCC_derm001,22,0.447,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
15699,10328,490.0,2,D,OHSU_HNSCC_derm001,22,0.379,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
15700,10328,490.0,2,E,OHSU_HNSCC_derm001,22,0.445,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15701,10328,490.0,2,F,OHSU_HNSCC_derm001,22,0.478,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
15702,10328,490.0,2,G,OHSU_HNSCC_derm001,22,0.467,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
15703,10328,490.0,2,H,OHSU_HNSCC_derm001,22,0.416,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
15704,10328,490.0,2,I,OHSU_HNSCC_derm001,22,0.322,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
15705,10328,490.0,2,J,OHSU_HNSCC_derm001,22,0.274,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
15706,10328,490.0,2,K,OHSU_HNSCC_derm001,22,0.476,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
15707,10328,490.0,2,L,OHSU_HNSCC_derm001,22,0.475,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
15708,10328,490.0,2,M,OHSU_HNSCC_derm001,22,0.444,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15709,10328,490.0,2,N,OHSU_HNSCC_derm001,22,0.546,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
15710,10328,490.0,2,O,OHSU_HNSCC_derm001,22,0.482,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15711,10328,490.0,2,P,OHSU_HNSCC_derm001,22,0.412,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
15712,10328,490.0,2,A,OHSU_HNSCC_derm001,23,0.374,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
15713,10328,490.0,2,B,OHSU_HNSCC_derm001,23,0.442,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
15714,10328,490.0,2,C,OHSU_HNSCC_derm001,23,0.42,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
15715,10328,490.0,2,D,OHSU_HNSCC_derm001,23,0.418,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
15716,10328,490.0,2,E,OHSU_HNSCC_derm001,23,0.472,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
15717,10328,490.0,2,F,OHSU_HNSCC_derm001,23,0.468,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
15718,10328,490.0,2,G,OHSU_HNSCC_derm001,23,0.418,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
15719,10328,490.0,2,H,OHSU_HNSCC_derm001,23,0.361,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
15720,10328,490.0,2,I,OHSU_HNSCC_derm001,23,0.346,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
15721,10328,490.0,2,J,OHSU_HNSCC_derm001,23,0.467,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
15722,10328,490.0,2,K,OHSU_HNSCC_derm001,23,0.456,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
15723,10328,490.0,2,L,OHSU_HNSCC_derm001,23,0.456,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
15724,10328,490.0,2,M,OHSU_HNSCC_derm001,23,0.498,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
15725,10328,490.0,2,N,OHSU_HNSCC_derm001,23,0.45,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
15726,10328,490.0,2,O,OHSU_HNSCC_derm001,23,0.511,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
15727,10328,490.0,2,P,OHSU_HNSCC_derm001,23,0.374,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
15728,10328,490.0,2,A,OHSU_HNSCC_derm001,24,0.429,0,NONE,OHSU_HNSCC_derm001
15729,10328,490.0,2,B,OHSU_HNSCC_derm001,24,0.37,0,NONE,OHSU_HNSCC_derm001
15730,10328,490.0,2,C,OHSU_HNSCC_derm001,24,0.411,0,NONE,OHSU_HNSCC_derm001
15731,10328,490.0,2,D,OHSU_HNSCC_derm001,24,0.384,0,NONE,OHSU_HNSCC_derm001
15732,10328,490.0,2,E,OHSU_HNSCC_derm001,24,0.401,0,NONE,OHSU_HNSCC_derm001
15733,10328,490.0,2,F,OHSU_HNSCC_derm001,24,0.396,0,NONE,OHSU_HNSCC_derm001
15734,10328,490.0,2,G,OHSU_HNSCC_derm001,24,0.388,0,NONE,OHSU_HNSCC_derm001
15735,10328,490.0,2,H,OHSU_HNSCC_derm001,24,0.41,0,NONE,OHSU_HNSCC_derm001
15736,10328,490.0,2,I,OHSU_HNSCC_derm001,24,0.363,0,NONE,OHSU_HNSCC_derm001
15737,10328,490.0,2,J,OHSU_HNSCC_derm001,24,0.386,0,NONE,OHSU_HNSCC_derm001
15738,10328,490.0,2,K,OHSU_HNSCC_derm001,24,0.423,0,NONE,OHSU_HNSCC_derm001
15739,10328,490.0,2,L,OHSU_HNSCC_derm001,24,0.402,0,NONE,OHSU_HNSCC_derm001
15740,10328,490.0,2,M,OHSU_HNSCC_derm001,24,0.4,0,NONE,OHSU_HNSCC_derm001
15741,10328,490.0,2,N,OHSU_HNSCC_derm001,24,0.425,0,NONE,OHSU_HNSCC_derm001
15742,10328,490.0,2,O,OHSU_HNSCC_derm001,24,0.438,0,NONE,OHSU_HNSCC_derm001
15743,10328,490.0,2,P,OHSU_HNSCC_derm001,24,0.445,0,NONE,OHSU_HNSCC_derm001
15744,10328,490.0,3,A,OHSU_HNSCC_derm001,1,0.394,10,Thalidomide ,OHSU_HNSCC_derm001
15745,10328,490.0,3,B,OHSU_HNSCC_derm001,1,0.32,10,Vandetanib,OHSU_HNSCC_derm001
15746,10328,490.0,3,C,OHSU_HNSCC_derm001,1,0.443,10,Oleic acid,OHSU_HNSCC_derm001
15747,10328,490.0,3,D,OHSU_HNSCC_derm001,1,0.177,10,A-674563,OHSU_HNSCC_derm001
15748,10328,490.0,3,E,OHSU_HNSCC_derm001,1,0.231,10,Lapatinib,OHSU_HNSCC_derm001
15749,10328,490.0,3,F,OHSU_HNSCC_derm001,1,0.462,10,Apocynin (vanillin),OHSU_HNSCC_derm001
15750,10328,490.0,3,G,OHSU_HNSCC_derm001,1,0.186,10,AT-7519,OHSU_HNSCC_derm001
15751,10328,490.0,3,H,OHSU_HNSCC_derm001,1,0.328,10,Gefitinib,OHSU_HNSCC_derm001
15752,10328,490.0,3,I,OHSU_HNSCC_derm001,1,0.225,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
15753,10328,490.0,3,J,OHSU_HNSCC_derm001,1,0.221,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15754,10328,490.0,3,K,OHSU_HNSCC_derm001,1,0.223,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15755,10328,490.0,3,L,OHSU_HNSCC_derm001,1,0.412,10,JQ1,OHSU_HNSCC_derm001
15756,10328,490.0,3,M,OHSU_HNSCC_derm001,1,0.611,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15757,10328,490.0,3,N,OHSU_HNSCC_derm001,1,0.257,10,Cerdulatinib,OHSU_HNSCC_derm001
15758,10328,490.0,3,O,OHSU_HNSCC_derm001,1,0.183,10,Romidepsin,OHSU_HNSCC_derm001
15759,10328,490.0,3,P,OHSU_HNSCC_derm001,1,0.412,10,Gilteritinib,OHSU_HNSCC_derm001
15760,10328,490.0,3,A,OHSU_HNSCC_derm001,2,0.404,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
15761,10328,490.0,3,B,OHSU_HNSCC_derm001,2,0.387,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
15762,10328,490.0,3,C,OHSU_HNSCC_derm001,2,0.47,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
15763,10328,490.0,3,D,OHSU_HNSCC_derm001,2,0.394,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
15764,10328,490.0,3,E,OHSU_HNSCC_derm001,2,0.313,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
15765,10328,490.0,3,F,OHSU_HNSCC_derm001,2,0.465,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
15766,10328,490.0,3,G,OHSU_HNSCC_derm001,2,0.185,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
15767,10328,490.0,3,H,OHSU_HNSCC_derm001,2,0.381,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
15768,10328,490.0,3,I,OHSU_HNSCC_derm001,2,0.382,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
15769,10328,490.0,3,J,OHSU_HNSCC_derm001,2,0.28,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15770,10328,490.0,3,K,OHSU_HNSCC_derm001,2,0.339,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15771,10328,490.0,3,L,OHSU_HNSCC_derm001,2,0.511,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
15772,10328,490.0,3,M,OHSU_HNSCC_derm001,2,0.624,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15773,10328,490.0,3,N,OHSU_HNSCC_derm001,2,0.872,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
15774,10328,490.0,3,O,OHSU_HNSCC_derm001,2,0.185,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
15775,10328,490.0,3,P,OHSU_HNSCC_derm001,2,0.44,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
15776,10328,490.0,3,A,OHSU_HNSCC_derm001,3,0.445,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
15777,10328,490.0,3,B,OHSU_HNSCC_derm001,3,0.434,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
15778,10328,490.0,3,C,OHSU_HNSCC_derm001,3,0.452,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
15779,10328,490.0,3,D,OHSU_HNSCC_derm001,3,0.388,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
15780,10328,490.0,3,E,OHSU_HNSCC_derm001,3,0.363,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
15781,10328,490.0,3,F,OHSU_HNSCC_derm001,3,0.447,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
15782,10328,490.0,3,G,OHSU_HNSCC_derm001,3,0.192,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
15783,10328,490.0,3,H,OHSU_HNSCC_derm001,3,0.39,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
15784,10328,490.0,3,I,OHSU_HNSCC_derm001,3,0.436,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
15785,10328,490.0,3,J,OHSU_HNSCC_derm001,3,0.319,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15786,10328,490.0,3,K,OHSU_HNSCC_derm001,3,0.373,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15787,10328,490.0,3,L,OHSU_HNSCC_derm001,3,0.563,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
15788,10328,490.0,3,M,OHSU_HNSCC_derm001,3,0.596,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15789,10328,490.0,3,N,OHSU_HNSCC_derm001,3,0.772,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
15790,10328,490.0,3,O,OHSU_HNSCC_derm001,3,0.185,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
15791,10328,490.0,3,P,OHSU_HNSCC_derm001,3,0.437,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
15792,10328,490.0,3,A,OHSU_HNSCC_derm001,4,0.403,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
15793,10328,490.0,3,B,OHSU_HNSCC_derm001,4,0.416,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
15794,10328,490.0,3,C,OHSU_HNSCC_derm001,4,0.418,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
15795,10328,490.0,3,D,OHSU_HNSCC_derm001,4,0.392,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
15796,10328,490.0,3,E,OHSU_HNSCC_derm001,4,0.382,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
15797,10328,490.0,3,F,OHSU_HNSCC_derm001,4,0.448,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
15798,10328,490.0,3,G,OHSU_HNSCC_derm001,4,0.331,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
15799,10328,490.0,3,H,OHSU_HNSCC_derm001,4,0.408,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
15800,10328,490.0,3,I,OHSU_HNSCC_derm001,4,0.464,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
15801,10328,490.0,3,J,OHSU_HNSCC_derm001,4,0.379,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15802,10328,490.0,3,K,OHSU_HNSCC_derm001,4,0.396,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15803,10328,490.0,3,L,OHSU_HNSCC_derm001,4,0.648,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
15804,10328,490.0,3,M,OHSU_HNSCC_derm001,4,0.515,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15805,10328,490.0,3,N,OHSU_HNSCC_derm001,4,0.609,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
15806,10328,490.0,3,O,OHSU_HNSCC_derm001,4,0.197,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
15807,10328,490.0,3,P,OHSU_HNSCC_derm001,4,0.414,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
15808,10328,490.0,3,A,OHSU_HNSCC_derm001,5,0.392,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
15809,10328,490.0,3,B,OHSU_HNSCC_derm001,5,0.463,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
15810,10328,490.0,3,C,OHSU_HNSCC_derm001,5,0.451,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
15811,10328,490.0,3,D,OHSU_HNSCC_derm001,5,0.405,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
15812,10328,490.0,3,E,OHSU_HNSCC_derm001,5,0.412,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
15813,10328,490.0,3,F,OHSU_HNSCC_derm001,5,0.443,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
15814,10328,490.0,3,G,OHSU_HNSCC_derm001,5,0.428,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
15815,10328,490.0,3,H,OHSU_HNSCC_derm001,5,0.43,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
15816,10328,490.0,3,I,OHSU_HNSCC_derm001,5,0.468,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
15817,10328,490.0,3,J,OHSU_HNSCC_derm001,5,0.391,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15818,10328,490.0,3,K,OHSU_HNSCC_derm001,5,0.435,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15819,10328,490.0,3,L,OHSU_HNSCC_derm001,5,0.694,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
15820,10328,490.0,3,M,OHSU_HNSCC_derm001,5,0.491,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15821,10328,490.0,3,N,OHSU_HNSCC_derm001,5,0.528,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
15822,10328,490.0,3,O,OHSU_HNSCC_derm001,5,0.204,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
15823,10328,490.0,3,P,OHSU_HNSCC_derm001,5,0.506,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
15824,10328,490.0,3,A,OHSU_HNSCC_derm001,6,0.369,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
15825,10328,490.0,3,B,OHSU_HNSCC_derm001,6,0.485,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
15826,10328,490.0,3,C,OHSU_HNSCC_derm001,6,0.427,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
15827,10328,490.0,3,D,OHSU_HNSCC_derm001,6,0.413,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
15828,10328,490.0,3,E,OHSU_HNSCC_derm001,6,0.458,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
15829,10328,490.0,3,F,OHSU_HNSCC_derm001,6,0.47,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
15830,10328,490.0,3,G,OHSU_HNSCC_derm001,6,0.455,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
15831,10328,490.0,3,H,OHSU_HNSCC_derm001,6,0.435,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
15832,10328,490.0,3,I,OHSU_HNSCC_derm001,6,0.451,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
15833,10328,490.0,3,J,OHSU_HNSCC_derm001,6,0.442,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15834,10328,490.0,3,K,OHSU_HNSCC_derm001,6,0.462,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15835,10328,490.0,3,L,OHSU_HNSCC_derm001,6,0.604,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
15836,10328,490.0,3,M,OHSU_HNSCC_derm001,6,0.54,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15837,10328,490.0,3,N,OHSU_HNSCC_derm001,6,0.549,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
15838,10328,490.0,3,O,OHSU_HNSCC_derm001,6,0.21,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
15839,10328,490.0,3,P,OHSU_HNSCC_derm001,6,0.52,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
15840,10328,490.0,3,A,OHSU_HNSCC_derm001,7,0.354,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
15841,10328,490.0,3,B,OHSU_HNSCC_derm001,7,0.454,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
15842,10328,490.0,3,C,OHSU_HNSCC_derm001,7,0.444,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
15843,10328,490.0,3,D,OHSU_HNSCC_derm001,7,0.455,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
15844,10328,490.0,3,E,OHSU_HNSCC_derm001,7,0.438,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
15845,10328,490.0,3,F,OHSU_HNSCC_derm001,7,0.48,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
15846,10328,490.0,3,G,OHSU_HNSCC_derm001,7,0.501,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
15847,10328,490.0,3,H,OHSU_HNSCC_derm001,7,0.474,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
15848,10328,490.0,3,I,OHSU_HNSCC_derm001,7,0.455,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
15849,10328,490.0,3,J,OHSU_HNSCC_derm001,7,0.443,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
15850,10328,490.0,3,K,OHSU_HNSCC_derm001,7,0.481,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
15851,10328,490.0,3,L,OHSU_HNSCC_derm001,7,0.534,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
15852,10328,490.0,3,M,OHSU_HNSCC_derm001,7,0.52,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
15853,10328,490.0,3,N,OHSU_HNSCC_derm001,7,0.52,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
15854,10328,490.0,3,O,OHSU_HNSCC_derm001,7,0.207,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
15855,10328,490.0,3,P,OHSU_HNSCC_derm001,7,0.487,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
15856,10328,490.0,3,A,OHSU_HNSCC_derm001,8,0.389,0,NONE,OHSU_HNSCC_derm001
15857,10328,490.0,3,B,OHSU_HNSCC_derm001,8,0.417,0,NONE,OHSU_HNSCC_derm001
15858,10328,490.0,3,C,OHSU_HNSCC_derm001,8,0.446,0,NONE,OHSU_HNSCC_derm001
15859,10328,490.0,3,D,OHSU_HNSCC_derm001,8,0.425,0,NONE,OHSU_HNSCC_derm001
15860,10328,490.0,3,E,OHSU_HNSCC_derm001,8,0.428,0,NONE,OHSU_HNSCC_derm001
15861,10328,490.0,3,F,OHSU_HNSCC_derm001,8,0.491,0,NONE,OHSU_HNSCC_derm001
15862,10328,490.0,3,G,OHSU_HNSCC_derm001,8,0.497,0,NONE,OHSU_HNSCC_derm001
15863,10328,490.0,3,H,OHSU_HNSCC_derm001,8,0.173,10,F-S-V,OHSU_HNSCC_derm001
15864,10328,490.0,3,I,OHSU_HNSCC_derm001,8,0.349,0,NONE,OHSU_HNSCC_derm001
15865,10328,490.0,3,J,OHSU_HNSCC_derm001,8,0.484,0,NONE,OHSU_HNSCC_derm001
15866,10328,490.0,3,K,OHSU_HNSCC_derm001,8,0.488,0,NONE,OHSU_HNSCC_derm001
15867,10328,490.0,3,L,OHSU_HNSCC_derm001,8,0.48,0,NONE,OHSU_HNSCC_derm001
15868,10328,490.0,3,M,OHSU_HNSCC_derm001,8,0.525,0,NONE,OHSU_HNSCC_derm001
15869,10328,490.0,3,N,OHSU_HNSCC_derm001,8,0.495,0,NONE,OHSU_HNSCC_derm001
15870,10328,490.0,3,O,OHSU_HNSCC_derm001,8,0.484,0,NONE,OHSU_HNSCC_derm001
15871,10328,490.0,3,P,OHSU_HNSCC_derm001,8,0.481,0,NONE,OHSU_HNSCC_derm001
15872,10328,490.0,3,A,OHSU_HNSCC_derm001,9,0.361,10,Anastrazole,OHSU_HNSCC_derm001
15873,10328,490.0,3,B,OHSU_HNSCC_derm001,9,0.376,10,JNJ-28312141 ,OHSU_HNSCC_derm001
15874,10328,490.0,3,C,OHSU_HNSCC_derm001,9,0.45,10,Genistein,OHSU_HNSCC_derm001
15875,10328,490.0,3,D,OHSU_HNSCC_derm001,9,0.445,10,Abscisic acid,OHSU_HNSCC_derm001
15876,10328,490.0,3,E,OHSU_HNSCC_derm001,9,0.428,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15877,10328,490.0,3,F,OHSU_HNSCC_derm001,9,0.563,10,Ruxolitinib,OHSU_HNSCC_derm001
15878,10328,490.0,3,G,OHSU_HNSCC_derm001,9,0.57,10,TAK-659,OHSU_HNSCC_derm001
15879,10328,490.0,3,H,OHSU_HNSCC_derm001,9,0.216,10,Brigatinib,OHSU_HNSCC_derm001
15880,10328,490.0,3,I,OHSU_HNSCC_derm001,9,0.359,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15881,10328,490.0,3,J,OHSU_HNSCC_derm001,9,0.266,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15882,10328,490.0,3,K,OHSU_HNSCC_derm001,9,0.318,10,Vorinostat,OHSU_HNSCC_derm001
15883,10328,490.0,3,L,OHSU_HNSCC_derm001,9,0.472,10,Lenalidomide,OHSU_HNSCC_derm001
15884,10328,490.0,3,M,OHSU_HNSCC_derm001,9,0.223,10,NVP-ADW742,OHSU_HNSCC_derm001
15885,10328,490.0,3,N,OHSU_HNSCC_derm001,9,0.465,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15886,10328,490.0,3,O,OHSU_HNSCC_derm001,9,0.663,10,Echinatin,OHSU_HNSCC_derm001
15887,10328,490.0,3,P,OHSU_HNSCC_derm001,9,0.163,10,YM-155,OHSU_HNSCC_derm001
15888,10328,490.0,3,A,OHSU_HNSCC_derm001,10,0.374,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
15889,10328,490.0,3,B,OHSU_HNSCC_derm001,10,0.621,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
15890,10328,490.0,3,C,OHSU_HNSCC_derm001,10,0.459,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
15891,10328,490.0,3,D,OHSU_HNSCC_derm001,10,0.414,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
15892,10328,490.0,3,E,OHSU_HNSCC_derm001,10,0.437,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15893,10328,490.0,3,F,OHSU_HNSCC_derm001,10,0.525,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
15894,10328,490.0,3,G,OHSU_HNSCC_derm001,10,0.595,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
15895,10328,490.0,3,H,OHSU_HNSCC_derm001,10,0.28,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
15896,10328,490.0,3,I,OHSU_HNSCC_derm001,10,0.418,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15897,10328,490.0,3,J,OHSU_HNSCC_derm001,10,0.573,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15898,10328,490.0,3,K,OHSU_HNSCC_derm001,10,0.345,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
15899,10328,490.0,3,L,OHSU_HNSCC_derm001,10,0.483,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
15900,10328,490.0,3,M,OHSU_HNSCC_derm001,10,0.419,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
15901,10328,490.0,3,N,OHSU_HNSCC_derm001,10,0.467,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15902,10328,490.0,3,O,OHSU_HNSCC_derm001,10,0.505,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
15903,10328,490.0,3,P,OHSU_HNSCC_derm001,10,0.163,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
15904,10328,490.0,3,A,OHSU_HNSCC_derm001,11,0.372,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
15905,10328,490.0,3,B,OHSU_HNSCC_derm001,11,0.531,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
15906,10328,490.0,3,C,OHSU_HNSCC_derm001,11,0.438,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
15907,10328,490.0,3,D,OHSU_HNSCC_derm001,11,0.436,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
15908,10328,490.0,3,E,OHSU_HNSCC_derm001,11,0.43,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15909,10328,490.0,3,F,OHSU_HNSCC_derm001,11,0.472,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
15910,10328,490.0,3,G,OHSU_HNSCC_derm001,11,0.589,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
15911,10328,490.0,3,H,OHSU_HNSCC_derm001,11,0.392,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
15912,10328,490.0,3,I,OHSU_HNSCC_derm001,11,0.371,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15913,10328,490.0,3,J,OHSU_HNSCC_derm001,11,0.678,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15914,10328,490.0,3,K,OHSU_HNSCC_derm001,11,0.369,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
15915,10328,490.0,3,L,OHSU_HNSCC_derm001,11,0.446,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
15916,10328,490.0,3,M,OHSU_HNSCC_derm001,11,0.415,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
15917,10328,490.0,3,N,OHSU_HNSCC_derm001,11,0.509,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15918,10328,490.0,3,O,OHSU_HNSCC_derm001,11,0.506,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
15919,10328,490.0,3,P,OHSU_HNSCC_derm001,11,0.165,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
15920,10328,490.0,3,A,OHSU_HNSCC_derm001,12,0.367,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
15921,10328,490.0,3,B,OHSU_HNSCC_derm001,12,0.496,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
15922,10328,490.0,3,C,OHSU_HNSCC_derm001,12,0.422,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
15923,10328,490.0,3,D,OHSU_HNSCC_derm001,12,0.47,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
15924,10328,490.0,3,E,OHSU_HNSCC_derm001,12,0.443,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15925,10328,490.0,3,F,OHSU_HNSCC_derm001,12,0.474,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
15926,10328,490.0,3,G,OHSU_HNSCC_derm001,12,0.504,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
15927,10328,490.0,3,H,OHSU_HNSCC_derm001,12,0.434,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
15928,10328,490.0,3,I,OHSU_HNSCC_derm001,12,0.378,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15929,10328,490.0,3,J,OHSU_HNSCC_derm001,12,0.757,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15930,10328,490.0,3,K,OHSU_HNSCC_derm001,12,0.404,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
15931,10328,490.0,3,L,OHSU_HNSCC_derm001,12,0.457,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
15932,10328,490.0,3,M,OHSU_HNSCC_derm001,12,0.479,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
15933,10328,490.0,3,N,OHSU_HNSCC_derm001,12,0.503,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15934,10328,490.0,3,O,OHSU_HNSCC_derm001,12,0.461,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
15935,10328,490.0,3,P,OHSU_HNSCC_derm001,12,0.172,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
15936,10328,490.0,3,A,OHSU_HNSCC_derm001,13,0.354,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
15937,10328,490.0,3,B,OHSU_HNSCC_derm001,13,0.473,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
15938,10328,490.0,3,C,OHSU_HNSCC_derm001,13,0.435,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
15939,10328,490.0,3,D,OHSU_HNSCC_derm001,13,0.409,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
15940,10328,490.0,3,E,OHSU_HNSCC_derm001,13,0.473,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15941,10328,490.0,3,F,OHSU_HNSCC_derm001,13,0.449,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
15942,10328,490.0,3,G,OHSU_HNSCC_derm001,13,0.466,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
15943,10328,490.0,3,H,OHSU_HNSCC_derm001,13,0.442,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
15944,10328,490.0,3,I,OHSU_HNSCC_derm001,13,0.397,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15945,10328,490.0,3,J,OHSU_HNSCC_derm001,13,0.7,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15946,10328,490.0,3,K,OHSU_HNSCC_derm001,13,0.471,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
15947,10328,490.0,3,L,OHSU_HNSCC_derm001,13,0.503,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
15948,10328,490.0,3,M,OHSU_HNSCC_derm001,13,0.495,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
15949,10328,490.0,3,N,OHSU_HNSCC_derm001,13,0.492,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15950,10328,490.0,3,O,OHSU_HNSCC_derm001,13,0.49,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
15951,10328,490.0,3,P,OHSU_HNSCC_derm001,13,0.176,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
15952,10328,490.0,3,A,OHSU_HNSCC_derm001,14,0.399,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
15953,10328,490.0,3,B,OHSU_HNSCC_derm001,14,0.45,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
15954,10328,490.0,3,C,OHSU_HNSCC_derm001,14,0.438,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
15955,10328,490.0,3,D,OHSU_HNSCC_derm001,14,0.458,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
15956,10328,490.0,3,E,OHSU_HNSCC_derm001,14,0.466,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15957,10328,490.0,3,F,OHSU_HNSCC_derm001,14,0.481,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
15958,10328,490.0,3,G,OHSU_HNSCC_derm001,14,0.492,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
15959,10328,490.0,3,H,OHSU_HNSCC_derm001,14,0.426,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
15960,10328,490.0,3,I,OHSU_HNSCC_derm001,14,0.397,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15961,10328,490.0,3,J,OHSU_HNSCC_derm001,14,0.588,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15962,10328,490.0,3,K,OHSU_HNSCC_derm001,14,0.48,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
15963,10328,490.0,3,L,OHSU_HNSCC_derm001,14,0.48,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
15964,10328,490.0,3,M,OHSU_HNSCC_derm001,14,0.509,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
15965,10328,490.0,3,N,OHSU_HNSCC_derm001,14,0.459,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15966,10328,490.0,3,O,OHSU_HNSCC_derm001,14,0.521,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
15967,10328,490.0,3,P,OHSU_HNSCC_derm001,14,0.184,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
15968,10328,490.0,3,A,OHSU_HNSCC_derm001,15,0.372,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
15969,10328,490.0,3,B,OHSU_HNSCC_derm001,15,0.43,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
15970,10328,490.0,3,C,OHSU_HNSCC_derm001,15,0.399,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
15971,10328,490.0,3,D,OHSU_HNSCC_derm001,15,0.441,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
15972,10328,490.0,3,E,OHSU_HNSCC_derm001,15,0.484,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
15973,10328,490.0,3,F,OHSU_HNSCC_derm001,15,0.482,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
15974,10328,490.0,3,G,OHSU_HNSCC_derm001,15,0.472,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
15975,10328,490.0,3,H,OHSU_HNSCC_derm001,15,0.439,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
15976,10328,490.0,3,I,OHSU_HNSCC_derm001,15,0.379,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
15977,10328,490.0,3,J,OHSU_HNSCC_derm001,15,0.554,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
15978,10328,490.0,3,K,OHSU_HNSCC_derm001,15,0.495,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
15979,10328,490.0,3,L,OHSU_HNSCC_derm001,15,0.48,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
15980,10328,490.0,3,M,OHSU_HNSCC_derm001,15,0.48,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
15981,10328,490.0,3,N,OHSU_HNSCC_derm001,15,0.491,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
15982,10328,490.0,3,O,OHSU_HNSCC_derm001,15,0.492,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
15983,10328,490.0,3,P,OHSU_HNSCC_derm001,15,0.198,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
15984,10328,490.0,3,A,OHSU_HNSCC_derm001,16,0.368,0,NONE,OHSU_HNSCC_derm001
15985,10328,490.0,3,B,OHSU_HNSCC_derm001,16,0.449,0,NONE,OHSU_HNSCC_derm001
15986,10328,490.0,3,C,OHSU_HNSCC_derm001,16,0.417,0,NONE,OHSU_HNSCC_derm001
15987,10328,490.0,3,D,OHSU_HNSCC_derm001,16,0.452,0,NONE,OHSU_HNSCC_derm001
15988,10328,490.0,3,E,OHSU_HNSCC_derm001,16,0.466,0,NONE,OHSU_HNSCC_derm001
15989,10328,490.0,3,F,OHSU_HNSCC_derm001,16,0.443,0,NONE,OHSU_HNSCC_derm001
15990,10328,490.0,3,G,OHSU_HNSCC_derm001,16,0.317,0,NONE,OHSU_HNSCC_derm001
15991,10328,490.0,3,H,OHSU_HNSCC_derm001,16,0.178,10,F-S-V,OHSU_HNSCC_derm001
15992,10328,490.0,3,I,OHSU_HNSCC_derm001,16,0.461,0,NONE,OHSU_HNSCC_derm001
15993,10328,490.0,3,J,OHSU_HNSCC_derm001,16,0.455,0,NONE,OHSU_HNSCC_derm001
15994,10328,490.0,3,K,OHSU_HNSCC_derm001,16,0.502,0,NONE,OHSU_HNSCC_derm001
15995,10328,490.0,3,L,OHSU_HNSCC_derm001,16,0.492,0,NONE,OHSU_HNSCC_derm001
15996,10328,490.0,3,M,OHSU_HNSCC_derm001,16,0.518,0,NONE,OHSU_HNSCC_derm001
15997,10328,490.0,3,N,OHSU_HNSCC_derm001,16,0.493,0,NONE,OHSU_HNSCC_derm001
15998,10328,490.0,3,O,OHSU_HNSCC_derm001,16,0.506,0,NONE,OHSU_HNSCC_derm001
15999,10328,490.0,3,P,OHSU_HNSCC_derm001,16,0.491,0,NONE,OHSU_HNSCC_derm001
16000,10328,490.0,3,A,OHSU_HNSCC_derm001,17,0.362,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16001,10328,490.0,3,B,OHSU_HNSCC_derm001,17,0.431,10,Stevioside,OHSU_HNSCC_derm001
16002,10328,490.0,3,C,OHSU_HNSCC_derm001,17,0.428,10,Pemetrexed,OHSU_HNSCC_derm001
16003,10328,490.0,3,D,OHSU_HNSCC_derm001,17,0.224,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16004,10328,490.0,3,E,OHSU_HNSCC_derm001,17,0.202,10,GSK-1838705A,OHSU_HNSCC_derm001
16005,10328,490.0,3,F,OHSU_HNSCC_derm001,17,0.175,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16006,10328,490.0,3,G,OHSU_HNSCC_derm001,17,0.474,10,Imatinib,OHSU_HNSCC_derm001
16007,10328,490.0,3,H,OHSU_HNSCC_derm001,17,0.338,10,Trametinib,OHSU_HNSCC_derm001
16008,10328,490.0,3,I,OHSU_HNSCC_derm001,17,0.205,10,BEZ235,OHSU_HNSCC_derm001
16009,10328,490.0,3,J,OHSU_HNSCC_derm001,17,0.405,10,Saracatinib,OHSU_HNSCC_derm001
16010,10328,490.0,3,K,OHSU_HNSCC_derm001,17,0.625,10,I-BET 762,OHSU_HNSCC_derm001
16011,10328,490.0,3,L,OHSU_HNSCC_derm001,17,0.26,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
16012,10328,490.0,3,M,OHSU_HNSCC_derm001,17,0.471,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
16013,10328,490.0,3,N,OHSU_HNSCC_derm001,17,0.446,10,Crizotinib,OHSU_HNSCC_derm001
16014,10328,490.0,3,O,OHSU_HNSCC_derm001,17,0.398,10,MGCD-265,OHSU_HNSCC_derm001
16015,10328,490.0,3,P,OHSU_HNSCC_derm001,17,0.329,10,Erlotinib,OHSU_HNSCC_derm001
16016,10328,490.0,3,A,OHSU_HNSCC_derm001,18,0.369,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16017,10328,490.0,3,B,OHSU_HNSCC_derm001,18,0.447,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
16018,10328,490.0,3,C,OHSU_HNSCC_derm001,18,0.438,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
16019,10328,490.0,3,D,OHSU_HNSCC_derm001,18,0.249,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16020,10328,490.0,3,E,OHSU_HNSCC_derm001,18,0.349,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
16021,10328,490.0,3,F,OHSU_HNSCC_derm001,18,0.321,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16022,10328,490.0,3,G,OHSU_HNSCC_derm001,18,0.488,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
16023,10328,490.0,3,H,OHSU_HNSCC_derm001,18,0.366,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
16024,10328,490.0,3,I,OHSU_HNSCC_derm001,18,0.216,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
16025,10328,490.0,3,J,OHSU_HNSCC_derm001,18,0.46,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
16026,10328,490.0,3,K,OHSU_HNSCC_derm001,18,0.717,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
16027,10328,490.0,3,L,OHSU_HNSCC_derm001,18,0.331,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
16028,10328,490.0,3,M,OHSU_HNSCC_derm001,18,0.58,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
16029,10328,490.0,3,N,OHSU_HNSCC_derm001,18,0.471,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
16030,10328,490.0,3,O,OHSU_HNSCC_derm001,18,0.433,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
16031,10328,490.0,3,P,OHSU_HNSCC_derm001,18,0.359,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
16032,10328,490.0,3,A,OHSU_HNSCC_derm001,19,0.373,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16033,10328,490.0,3,B,OHSU_HNSCC_derm001,19,0.444,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
16034,10328,490.0,3,C,OHSU_HNSCC_derm001,19,0.432,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
16035,10328,490.0,3,D,OHSU_HNSCC_derm001,19,0.28,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16036,10328,490.0,3,E,OHSU_HNSCC_derm001,19,0.37,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
16037,10328,490.0,3,F,OHSU_HNSCC_derm001,19,0.352,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16038,10328,490.0,3,G,OHSU_HNSCC_derm001,19,0.465,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
16039,10328,490.0,3,H,OHSU_HNSCC_derm001,19,0.377,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
16040,10328,490.0,3,I,OHSU_HNSCC_derm001,19,0.214,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
16041,10328,490.0,3,J,OHSU_HNSCC_derm001,19,0.472,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
16042,10328,490.0,3,K,OHSU_HNSCC_derm001,19,0.728,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
16043,10328,490.0,3,L,OHSU_HNSCC_derm001,19,0.393,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
16044,10328,490.0,3,M,OHSU_HNSCC_derm001,19,0.475,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
16045,10328,490.0,3,N,OHSU_HNSCC_derm001,19,0.464,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
16046,10328,490.0,3,O,OHSU_HNSCC_derm001,19,0.463,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
16047,10328,490.0,3,P,OHSU_HNSCC_derm001,19,0.433,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
16048,10328,490.0,3,A,OHSU_HNSCC_derm001,20,0.387,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16049,10328,490.0,3,B,OHSU_HNSCC_derm001,20,0.414,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
16050,10328,490.0,3,C,OHSU_HNSCC_derm001,20,0.461,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
16051,10328,490.0,3,D,OHSU_HNSCC_derm001,20,0.294,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16052,10328,490.0,3,E,OHSU_HNSCC_derm001,20,0.397,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
16053,10328,490.0,3,F,OHSU_HNSCC_derm001,20,0.389,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16054,10328,490.0,3,G,OHSU_HNSCC_derm001,20,0.486,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
16055,10328,490.0,3,H,OHSU_HNSCC_derm001,20,0.351,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
16056,10328,490.0,3,I,OHSU_HNSCC_derm001,20,0.247,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
16057,10328,490.0,3,J,OHSU_HNSCC_derm001,20,0.489,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
16058,10328,490.0,3,K,OHSU_HNSCC_derm001,20,0.637,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
16059,10328,490.0,3,L,OHSU_HNSCC_derm001,20,0.392,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
16060,10328,490.0,3,M,OHSU_HNSCC_derm001,20,0.5,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
16061,10328,490.0,3,N,OHSU_HNSCC_derm001,20,0.509,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
16062,10328,490.0,3,O,OHSU_HNSCC_derm001,20,0.468,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
16063,10328,490.0,3,P,OHSU_HNSCC_derm001,20,0.449,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
16064,10328,490.0,3,A,OHSU_HNSCC_derm001,21,0.406,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16065,10328,490.0,3,B,OHSU_HNSCC_derm001,21,0.419,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
16066,10328,490.0,3,C,OHSU_HNSCC_derm001,21,0.431,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
16067,10328,490.0,3,D,OHSU_HNSCC_derm001,21,0.318,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16068,10328,490.0,3,E,OHSU_HNSCC_derm001,21,0.423,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
16069,10328,490.0,3,F,OHSU_HNSCC_derm001,21,0.389,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16070,10328,490.0,3,G,OHSU_HNSCC_derm001,21,0.44,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
16071,10328,490.0,3,H,OHSU_HNSCC_derm001,21,0.366,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
16072,10328,490.0,3,I,OHSU_HNSCC_derm001,21,0.266,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
16073,10328,490.0,3,J,OHSU_HNSCC_derm001,21,0.492,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
16074,10328,490.0,3,K,OHSU_HNSCC_derm001,21,0.59,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
16075,10328,490.0,3,L,OHSU_HNSCC_derm001,21,0.378,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
16076,10328,490.0,3,M,OHSU_HNSCC_derm001,21,0.443,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
16077,10328,490.0,3,N,OHSU_HNSCC_derm001,21,0.474,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
16078,10328,490.0,3,O,OHSU_HNSCC_derm001,21,0.491,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
16079,10328,490.0,3,P,OHSU_HNSCC_derm001,21,0.412,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
16080,10328,490.0,3,A,OHSU_HNSCC_derm001,22,0.402,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16081,10328,490.0,3,B,OHSU_HNSCC_derm001,22,0.381,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
16082,10328,490.0,3,C,OHSU_HNSCC_derm001,22,0.42,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
16083,10328,490.0,3,D,OHSU_HNSCC_derm001,22,0.351,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16084,10328,490.0,3,E,OHSU_HNSCC_derm001,22,0.449,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
16085,10328,490.0,3,F,OHSU_HNSCC_derm001,22,0.413,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16086,10328,490.0,3,G,OHSU_HNSCC_derm001,22,0.437,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
16087,10328,490.0,3,H,OHSU_HNSCC_derm001,22,0.396,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
16088,10328,490.0,3,I,OHSU_HNSCC_derm001,22,0.356,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
16089,10328,490.0,3,J,OHSU_HNSCC_derm001,22,0.457,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
16090,10328,490.0,3,K,OHSU_HNSCC_derm001,22,0.48,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
16091,10328,490.0,3,L,OHSU_HNSCC_derm001,22,0.419,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
16092,10328,490.0,3,M,OHSU_HNSCC_derm001,22,0.497,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
16093,10328,490.0,3,N,OHSU_HNSCC_derm001,22,0.505,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
16094,10328,490.0,3,O,OHSU_HNSCC_derm001,22,0.497,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
16095,10328,490.0,3,P,OHSU_HNSCC_derm001,22,0.435,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
16096,10328,490.0,3,A,OHSU_HNSCC_derm001,23,0.385,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
16097,10328,490.0,3,B,OHSU_HNSCC_derm001,23,0.401,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
16098,10328,490.0,3,C,OHSU_HNSCC_derm001,23,0.49,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
16099,10328,490.0,3,D,OHSU_HNSCC_derm001,23,0.418,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
16100,10328,490.0,3,E,OHSU_HNSCC_derm001,23,0.48,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
16101,10328,490.0,3,F,OHSU_HNSCC_derm001,23,0.462,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
16102,10328,490.0,3,G,OHSU_HNSCC_derm001,23,0.434,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
16103,10328,490.0,3,H,OHSU_HNSCC_derm001,23,0.43,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
16104,10328,490.0,3,I,OHSU_HNSCC_derm001,23,0.469,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
16105,10328,490.0,3,J,OHSU_HNSCC_derm001,23,0.486,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
16106,10328,490.0,3,K,OHSU_HNSCC_derm001,23,0.524,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
16107,10328,490.0,3,L,OHSU_HNSCC_derm001,23,0.446,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
16108,10328,490.0,3,M,OHSU_HNSCC_derm001,23,0.49,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
16109,10328,490.0,3,N,OHSU_HNSCC_derm001,23,0.52,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
16110,10328,490.0,3,O,OHSU_HNSCC_derm001,23,0.439,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
16111,10328,490.0,3,P,OHSU_HNSCC_derm001,23,0.432,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
16112,10328,490.0,3,A,OHSU_HNSCC_derm001,24,0.405,0,NONE,OHSU_HNSCC_derm001
16113,10328,490.0,3,B,OHSU_HNSCC_derm001,24,0.402,0,NONE,OHSU_HNSCC_derm001
16114,10328,490.0,3,C,OHSU_HNSCC_derm001,24,0.413,0,NONE,OHSU_HNSCC_derm001
16115,10328,490.0,3,D,OHSU_HNSCC_derm001,24,0.417,0,NONE,OHSU_HNSCC_derm001
16116,10328,490.0,3,E,OHSU_HNSCC_derm001,24,0.486,0,NONE,OHSU_HNSCC_derm001
16117,10328,490.0,3,F,OHSU_HNSCC_derm001,24,0.391,0,NONE,OHSU_HNSCC_derm001
16118,10328,490.0,3,G,OHSU_HNSCC_derm001,24,0.423,0,NONE,OHSU_HNSCC_derm001
16119,10328,490.0,3,H,OHSU_HNSCC_derm001,24,0.407,0,NONE,OHSU_HNSCC_derm001
16120,10328,490.0,3,I,OHSU_HNSCC_derm001,24,0.406,0,NONE,OHSU_HNSCC_derm001
16121,10328,490.0,3,J,OHSU_HNSCC_derm001,24,0.469,0,NONE,OHSU_HNSCC_derm001
16122,10328,490.0,3,K,OHSU_HNSCC_derm001,24,0.501,0,NONE,OHSU_HNSCC_derm001
16123,10328,490.0,3,L,OHSU_HNSCC_derm001,24,0.438,0,NONE,OHSU_HNSCC_derm001
16124,10328,490.0,3,M,OHSU_HNSCC_derm001,24,0.47,0,NONE,OHSU_HNSCC_derm001
16125,10328,490.0,3,N,OHSU_HNSCC_derm001,24,0.504,0,NONE,OHSU_HNSCC_derm001
16126,10328,490.0,3,O,OHSU_HNSCC_derm001,24,0.471,0,NONE,OHSU_HNSCC_derm001
16127,10328,490.0,3,P,OHSU_HNSCC_derm001,24,0.452,0,NONE,OHSU_HNSCC_derm001
16128,10328,Blank 490,1,A,OHSU_HNSCC_derm001,1,0.004,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
16129,10328,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.151,10,Lucitanib ,OHSU_HNSCC_derm001
16130,10328,Blank 490,1,C,OHSU_HNSCC_derm001,1,0.258,10,Resveratrol,OHSU_HNSCC_derm001
16131,10328,Blank 490,1,D,OHSU_HNSCC_derm001,1,0.245,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16132,10328,Blank 490,1,E,OHSU_HNSCC_derm001,1,0.231,10,Bicalutamide,OHSU_HNSCC_derm001
16133,10328,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.239,10,Methotrexate ,OHSU_HNSCC_derm001
16134,10328,Blank 490,1,G,OHSU_HNSCC_derm001,1,0.077,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16135,10328,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.133,10,Gefitinib,OHSU_HNSCC_derm001
16136,10328,Blank 490,1,I,OHSU_HNSCC_derm001,1,0.123,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
16137,10328,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.098,10,Tamatinib/R406,OHSU_HNSCC_derm001
16138,10328,Blank 490,1,K,OHSU_HNSCC_derm001,1,0.122,10,Bosutinib,OHSU_HNSCC_derm001
16139,10328,Blank 490,1,L,OHSU_HNSCC_derm001,1,0.017,10,PI-103,OHSU_HNSCC_derm001
16140,10328,Blank 490,1,M,OHSU_HNSCC_derm001,1,0.235,10,Glycyrrhizin,OHSU_HNSCC_derm001
16141,10328,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.211,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
16142,10328,Blank 490,1,O,OHSU_HNSCC_derm001,1,0.051,10,GSK-690693,OHSU_HNSCC_derm001
16143,10328,Blank 490,1,P,OHSU_HNSCC_derm001,1,0.16,10,Ibrutinib,OHSU_HNSCC_derm001
16144,10328,Blank 490,1,A,OHSU_HNSCC_derm001,2,0.028,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
16145,10328,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.273,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
16146,10328,Blank 490,1,C,OHSU_HNSCC_derm001,2,0.339,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
16147,10328,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.178,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16148,10328,Blank 490,1,E,OHSU_HNSCC_derm001,2,0.268,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
16149,10328,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.288,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
16150,10328,Blank 490,1,G,OHSU_HNSCC_derm001,2,0.178,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16151,10328,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.22,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
16152,10328,Blank 490,1,I,OHSU_HNSCC_derm001,2,0.211,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
16153,10328,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.143,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
16154,10328,Blank 490,1,K,OHSU_HNSCC_derm001,2,0.39,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
16155,10328,Blank 490,1,L,OHSU_HNSCC_derm001,2,0.022,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
16156,10328,Blank 490,1,M,OHSU_HNSCC_derm001,2,0.276,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
16157,10328,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.305,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
16158,10328,Blank 490,1,O,OHSU_HNSCC_derm001,2,0.163,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
16159,10328,Blank 490,1,P,OHSU_HNSCC_derm001,2,0.222,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
16160,10328,Blank 490,1,A,OHSU_HNSCC_derm001,3,0.043,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
16161,10328,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.28,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
16162,10328,Blank 490,1,C,OHSU_HNSCC_derm001,3,0.308,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
16163,10328,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.186,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16164,10328,Blank 490,1,E,OHSU_HNSCC_derm001,3,0.321,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
16165,10328,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.301,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
16166,10328,Blank 490,1,G,OHSU_HNSCC_derm001,3,0.218,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16167,10328,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.239,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
16168,10328,Blank 490,1,I,OHSU_HNSCC_derm001,3,0.274,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
16169,10328,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.218,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
16170,10328,Blank 490,1,K,OHSU_HNSCC_derm001,3,0.47,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
16171,10328,Blank 490,1,L,OHSU_HNSCC_derm001,3,0.045,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
16172,10328,Blank 490,1,M,OHSU_HNSCC_derm001,3,0.362,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
16173,10328,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.313,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
16174,10328,Blank 490,1,O,OHSU_HNSCC_derm001,3,0.21,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
16175,10328,Blank 490,1,P,OHSU_HNSCC_derm001,3,0.161,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
16176,10328,Blank 490,1,A,OHSU_HNSCC_derm001,4,0.072,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
16177,10328,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.305,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
16178,10328,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.304,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
16179,10328,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.2,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16180,10328,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.289,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
16181,10328,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.315,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
16182,10328,Blank 490,1,G,OHSU_HNSCC_derm001,4,0.215,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16183,10328,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.24,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
16184,10328,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.253,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
16185,10328,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.26,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
16186,10328,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.455,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
16187,10328,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.078,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
16188,10328,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.288,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
16189,10328,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.303,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
16190,10328,Blank 490,1,O,OHSU_HNSCC_derm001,4,0.258,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
16191,10328,Blank 490,1,P,OHSU_HNSCC_derm001,4,0.184,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
16192,10328,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.143,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
16193,10328,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.264,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
16194,10328,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.358,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
16195,10328,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.2,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16196,10328,Blank 490,1,E,OHSU_HNSCC_derm001,5,0.286,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
16197,10328,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.3,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
16198,10328,Blank 490,1,G,OHSU_HNSCC_derm001,5,0.277,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16199,10328,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.24,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
16200,10328,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.293,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
16201,10328,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.24,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
16202,10328,Blank 490,1,K,OHSU_HNSCC_derm001,5,0.384,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
16203,10328,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.148,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
16204,10328,Blank 490,1,M,OHSU_HNSCC_derm001,5,0.323,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
16205,10328,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.308,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
16206,10328,Blank 490,1,O,OHSU_HNSCC_derm001,5,0.309,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
16207,10328,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.246,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
16208,10328,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.177,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
16209,10328,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.262,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
16210,10328,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.323,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
16211,10328,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.201,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16212,10328,Blank 490,1,E,OHSU_HNSCC_derm001,6,0.296,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
16213,10328,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.233,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
16214,10328,Blank 490,1,G,OHSU_HNSCC_derm001,6,0.304,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16215,10328,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.265,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
16216,10328,Blank 490,1,I,OHSU_HNSCC_derm001,6,0.278,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
16217,10328,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.248,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
16218,10328,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.344,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
16219,10328,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.209,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
16220,10328,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.292,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
16221,10328,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.307,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
16222,10328,Blank 490,1,O,OHSU_HNSCC_derm001,6,0.287,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
16223,10328,Blank 490,1,P,OHSU_HNSCC_derm001,6,0.24,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
16224,10328,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.273,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
16225,10328,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.276,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
16226,10328,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.322,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
16227,10328,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.241,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
16228,10328,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.288,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
16229,10328,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.31,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
16230,10328,Blank 490,1,G,OHSU_HNSCC_derm001,7,0.272,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
16231,10328,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.25,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
16232,10328,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.313,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
16233,10328,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.27,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
16234,10328,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.32,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
16235,10328,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.263,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
16236,10328,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.228,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
16237,10328,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.304,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
16238,10328,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.34,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
16239,10328,Blank 490,1,P,OHSU_HNSCC_derm001,7,0.285,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
16240,10328,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.239,0,NONE,OHSU_HNSCC_derm001
16241,10328,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.279,0,NONE,OHSU_HNSCC_derm001
16242,10328,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.275,0,NONE,OHSU_HNSCC_derm001
16243,10328,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.319,0,NONE,OHSU_HNSCC_derm001
16244,10328,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.313,0,NONE,OHSU_HNSCC_derm001
16245,10328,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.269,0,NONE,OHSU_HNSCC_derm001
16246,10328,Blank 490,1,G,OHSU_HNSCC_derm001,8,0.309,0,NONE,OHSU_HNSCC_derm001
16247,10328,Blank 490,1,H,OHSU_HNSCC_derm001,8,-0.004,10,F-S-V,OHSU_HNSCC_derm001
16248,10328,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.269,0,NONE,OHSU_HNSCC_derm001
16249,10328,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.292,0,NONE,OHSU_HNSCC_derm001
16250,10328,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.297,0,NONE,OHSU_HNSCC_derm001
16251,10328,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.285,0,NONE,OHSU_HNSCC_derm001
16252,10328,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.285,0,NONE,OHSU_HNSCC_derm001
16253,10328,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.296,0,NONE,OHSU_HNSCC_derm001
16254,10328,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.314,0,NONE,OHSU_HNSCC_derm001
16255,10328,Blank 490,1,P,OHSU_HNSCC_derm001,8,0.265,0,NONE,OHSU_HNSCC_derm001
16256,10328,Blank 490,1,A,OHSU_HNSCC_derm001,9,0.029,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16257,10328,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.169,10,Sorafenib,OHSU_HNSCC_derm001
16258,10328,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.375,10,Rosmarinic acid,OHSU_HNSCC_derm001
16259,10328,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.182,10,Rapamycin,OHSU_HNSCC_derm001
16260,10328,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.246,10,Vismodegib,OHSU_HNSCC_derm001
16261,10328,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.117,10,PP242,OHSU_HNSCC_derm001
16262,10328,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.179,10,Alectinib,OHSU_HNSCC_derm001
16263,10328,Blank 490,1,H,OHSU_HNSCC_derm001,9,0.074,10,Brigatinib,OHSU_HNSCC_derm001
16264,10328,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.154,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16265,10328,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.25,10,MK-2206,OHSU_HNSCC_derm001
16266,10328,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.195,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16267,10328,Blank 490,1,L,OHSU_HNSCC_derm001,9,0.019,10,Flavopiridol ,OHSU_HNSCC_derm001
16268,10328,Blank 490,1,M,OHSU_HNSCC_derm001,9,0.347,10,Indirubin,OHSU_HNSCC_derm001
16269,10328,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.45,10,PF-533228,OHSU_HNSCC_derm001
16270,10328,Blank 490,1,O,OHSU_HNSCC_derm001,9,0.32,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16271,10328,Blank 490,1,P,OHSU_HNSCC_derm001,9,0.004,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16272,10328,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.061,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16273,10328,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.241,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
16274,10328,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.323,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
16275,10328,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.186,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
16276,10328,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.275,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
16277,10328,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.086,3.3333333333333335,PP242,OHSU_HNSCC_derm001
16278,10328,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.229,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
16279,10328,Blank 490,1,H,OHSU_HNSCC_derm001,10,0.116,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
16280,10328,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.211,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16281,10328,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.246,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
16282,10328,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.253,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16283,10328,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.012,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
16284,10328,Blank 490,1,M,OHSU_HNSCC_derm001,10,0.336,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
16285,10328,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.478,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
16286,10328,Blank 490,1,O,OHSU_HNSCC_derm001,10,0.308,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16287,10328,Blank 490,1,P,OHSU_HNSCC_derm001,10,0.005,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16288,10328,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.049,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16289,10328,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.227,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
16290,10328,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.3,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
16291,10328,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.165,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
16292,10328,Blank 490,1,E,OHSU_HNSCC_derm001,11,0.281,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
16293,10328,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.098,1.1111111111111112,PP242,OHSU_HNSCC_derm001
16294,10328,Blank 490,1,G,OHSU_HNSCC_derm001,11,0.234,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
16295,10328,Blank 490,1,H,OHSU_HNSCC_derm001,11,0.231,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
16296,10328,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.223,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16297,10328,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.238,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
16298,10328,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.246,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16299,10328,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.008,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
16300,10328,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.339,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
16301,10328,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.451,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
16302,10328,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.3,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16303,10328,Blank 490,1,P,OHSU_HNSCC_derm001,11,0.045,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16304,10328,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.054,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16305,10328,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.232,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
16306,10328,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.345,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
16307,10328,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.189,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
16308,10328,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.296,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
16309,10328,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.125,0.3703703703703704,PP242,OHSU_HNSCC_derm001
16310,10328,Blank 490,1,G,OHSU_HNSCC_derm001,12,0.277,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
16311,10328,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.253,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
16312,10328,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.219,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16313,10328,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.256,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
16314,10328,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.24,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16315,10328,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.014,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
16316,10328,Blank 490,1,M,OHSU_HNSCC_derm001,12,0.338,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
16317,10328,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.406,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
16318,10328,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.313,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16319,10328,Blank 490,1,P,OHSU_HNSCC_derm001,12,0.087,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16320,10328,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.067,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16321,10328,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.266,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
16322,10328,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.3,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
16323,10328,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.187,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
16324,10328,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.29,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
16325,10328,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.23,0.1234567901234568,PP242,OHSU_HNSCC_derm001
16326,10328,Blank 490,1,G,OHSU_HNSCC_derm001,13,0.292,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
16327,10328,Blank 490,1,H,OHSU_HNSCC_derm001,13,0.262,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
16328,10328,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.213,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16329,10328,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.265,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
16330,10328,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.267,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16331,10328,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.061,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
16332,10328,Blank 490,1,M,OHSU_HNSCC_derm001,13,0.366,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
16333,10328,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.384,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
16334,10328,Blank 490,1,O,OHSU_HNSCC_derm001,13,0.333,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16335,10328,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.183,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16336,10328,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.099,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16337,10328,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.303,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
16338,10328,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.292,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
16339,10328,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.197,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
16340,10328,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.279,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
16341,10328,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.259,0.0411522633744856,PP242,OHSU_HNSCC_derm001
16342,10328,Blank 490,1,G,OHSU_HNSCC_derm001,14,0.287,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
16343,10328,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.26,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
16344,10328,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.206,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16345,10328,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.261,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
16346,10328,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.269,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16347,10328,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.161,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
16348,10328,Blank 490,1,M,OHSU_HNSCC_derm001,14,0.335,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
16349,10328,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.369,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
16350,10328,Blank 490,1,O,OHSU_HNSCC_derm001,14,0.317,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16351,10328,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.249,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16352,10328,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.183,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
16353,10328,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.275,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
16354,10328,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.292,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
16355,10328,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.189,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
16356,10328,Blank 490,1,E,OHSU_HNSCC_derm001,15,0.289,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
16357,10328,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.252,0.013717421124828532,PP242,OHSU_HNSCC_derm001
16358,10328,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.287,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
16359,10328,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.266,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
16360,10328,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.21,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16361,10328,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.285,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
16362,10328,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.288,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
16363,10328,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.242,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
16364,10328,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.322,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
16365,10328,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.304,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
16366,10328,Blank 490,1,O,OHSU_HNSCC_derm001,15,0.32,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
16367,10328,Blank 490,1,P,OHSU_HNSCC_derm001,15,0.302,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
16368,10328,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.269,0,NONE,OHSU_HNSCC_derm001
16369,10328,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.296,0,NONE,OHSU_HNSCC_derm001
16370,10328,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.279,0,NONE,OHSU_HNSCC_derm001
16371,10328,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.301,0,NONE,OHSU_HNSCC_derm001
16372,10328,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.261,0,NONE,OHSU_HNSCC_derm001
16373,10328,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.298,0,NONE,OHSU_HNSCC_derm001
16374,10328,Blank 490,1,G,OHSU_HNSCC_derm001,16,0.271,0,NONE,OHSU_HNSCC_derm001
16375,10328,Blank 490,1,H,OHSU_HNSCC_derm001,16,0.004,10,F-S-V,OHSU_HNSCC_derm001
16376,10328,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.295,0,NONE,OHSU_HNSCC_derm001
16377,10328,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.298,0,NONE,OHSU_HNSCC_derm001
16378,10328,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.246,0,NONE,OHSU_HNSCC_derm001
16379,10328,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.287,0,NONE,OHSU_HNSCC_derm001
16380,10328,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.314,0,NONE,OHSU_HNSCC_derm001
16381,10328,Blank 490,1,N,OHSU_HNSCC_derm001,16,0.288,0,NONE,OHSU_HNSCC_derm001
16382,10328,Blank 490,1,O,OHSU_HNSCC_derm001,16,0.318,0,NONE,OHSU_HNSCC_derm001
16383,10328,Blank 490,1,P,OHSU_HNSCC_derm001,16,0.319,0,NONE,OHSU_HNSCC_derm001
16384,10328,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.205,10,Emodin,OHSU_HNSCC_derm001
16385,10328,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.269,10,Baicalin,OHSU_HNSCC_derm001
16386,10328,Blank 490,1,C,OHSU_HNSCC_derm001,17,0.024,10,NVP-TAE-684,OHSU_HNSCC_derm001
16387,10328,Blank 490,1,D,OHSU_HNSCC_derm001,17,0.04,10,Panobinostat,OHSU_HNSCC_derm001
16388,10328,Blank 490,1,E,OHSU_HNSCC_derm001,17,0.062,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
16389,10328,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.276,10,Fulvestrant,OHSU_HNSCC_derm001
16390,10328,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.146,10,SCH-772984,OHSU_HNSCC_derm001
16391,10328,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.173,10,Trametinib,OHSU_HNSCC_derm001
16392,10328,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.038,10,BEZ235,OHSU_HNSCC_derm001
16393,10328,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.255,10,MLN120B,OHSU_HNSCC_derm001
16394,10328,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.155,10,Ixabepilone,OHSU_HNSCC_derm001
16395,10328,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.02,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
16396,10328,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.171,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16397,10328,Blank 490,1,N,OHSU_HNSCC_derm001,17,0.283,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16398,10328,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.252,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16399,10328,Blank 490,1,P,OHSU_HNSCC_derm001,17,0.328,10,Letrozole,OHSU_HNSCC_derm001
16400,10328,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.231,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
16401,10328,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.293,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
16402,10328,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.154,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
16403,10328,Blank 490,1,D,OHSU_HNSCC_derm001,18,0.039,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
16404,10328,Blank 490,1,E,OHSU_HNSCC_derm001,18,0.081,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
16405,10328,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.252,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
16406,10328,Blank 490,1,G,OHSU_HNSCC_derm001,18,0.195,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
16407,10328,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.184,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
16408,10328,Blank 490,1,I,OHSU_HNSCC_derm001,18,0.038,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
16409,10328,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.291,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
16410,10328,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.152,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
16411,10328,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.197,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
16412,10328,Blank 490,1,M,OHSU_HNSCC_derm001,18,0.205,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16413,10328,Blank 490,1,N,OHSU_HNSCC_derm001,18,0.31,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16414,10328,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.24,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16415,10328,Blank 490,1,P,OHSU_HNSCC_derm001,18,0.298,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
16416,10328,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.236,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
16417,10328,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.287,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
16418,10328,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.283,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
16419,10328,Blank 490,1,D,OHSU_HNSCC_derm001,19,0.059,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
16420,10328,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.101,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
16421,10328,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.275,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
16422,10328,Blank 490,1,G,OHSU_HNSCC_derm001,19,0.186,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
16423,10328,Blank 490,1,H,OHSU_HNSCC_derm001,19,0.177,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
16424,10328,Blank 490,1,I,OHSU_HNSCC_derm001,19,0.039,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
16425,10328,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.304,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
16426,10328,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.17,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
16427,10328,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.191,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
16428,10328,Blank 490,1,M,OHSU_HNSCC_derm001,19,0.248,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16429,10328,Blank 490,1,N,OHSU_HNSCC_derm001,19,0.36,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16430,10328,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.247,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16431,10328,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.3,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
16432,10328,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.237,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
16433,10328,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.267,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
16434,10328,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.322,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
16435,10328,Blank 490,1,D,OHSU_HNSCC_derm001,20,0.137,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
16436,10328,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.132,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
16437,10328,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.289,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
16438,10328,Blank 490,1,G,OHSU_HNSCC_derm001,20,0.212,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
16439,10328,Blank 490,1,H,OHSU_HNSCC_derm001,20,0.177,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
16440,10328,Blank 490,1,I,OHSU_HNSCC_derm001,20,0.057,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
16441,10328,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.299,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
16442,10328,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.154,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
16443,10328,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.195,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
16444,10328,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.236,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16445,10328,Blank 490,1,N,OHSU_HNSCC_derm001,20,0.29,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16446,10328,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.277,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16447,10328,Blank 490,1,P,OHSU_HNSCC_derm001,20,0.329,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
16448,10328,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.238,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
16449,10328,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.3,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
16450,10328,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.303,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
16451,10328,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.147,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
16452,10328,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.18,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
16453,10328,Blank 490,1,F,OHSU_HNSCC_derm001,21,0.269,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
16454,10328,Blank 490,1,G,OHSU_HNSCC_derm001,21,0.265,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
16455,10328,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.201,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
16456,10328,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.084,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
16457,10328,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.278,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
16458,10328,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.159,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
16459,10328,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.217,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
16460,10328,Blank 490,1,M,OHSU_HNSCC_derm001,21,0.245,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16461,10328,Blank 490,1,N,OHSU_HNSCC_derm001,21,0.275,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16462,10328,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.279,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16463,10328,Blank 490,1,P,OHSU_HNSCC_derm001,21,0.315,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
16464,10328,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.229,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
16465,10328,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.256,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
16466,10328,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.308,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
16467,10328,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.156,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
16468,10328,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.221,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
16469,10328,Blank 490,1,F,OHSU_HNSCC_derm001,22,0.306,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
16470,10328,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.277,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
16471,10328,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.204,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
16472,10328,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.163,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
16473,10328,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.3,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
16474,10328,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.191,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
16475,10328,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.245,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
16476,10328,Blank 490,1,M,OHSU_HNSCC_derm001,22,0.276,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16477,10328,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.328,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16478,10328,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.251,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16479,10328,Blank 490,1,P,OHSU_HNSCC_derm001,22,0.336,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
16480,10328,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.214,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
16481,10328,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.324,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
16482,10328,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.323,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
16483,10328,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.235,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
16484,10328,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.29,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
16485,10328,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.279,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
16486,10328,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.307,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
16487,10328,Blank 490,1,H,OHSU_HNSCC_derm001,23,0.272,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
16488,10328,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.249,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
16489,10328,Blank 490,1,J,OHSU_HNSCC_derm001,23,0.27,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
16490,10328,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.202,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
16491,10328,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.261,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
16492,10328,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.302,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
16493,10328,Blank 490,1,N,OHSU_HNSCC_derm001,23,0.323,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
16494,10328,Blank 490,1,O,OHSU_HNSCC_derm001,23,0.284,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
16495,10328,Blank 490,1,P,OHSU_HNSCC_derm001,23,0.299,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
16496,10328,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.172,0,NONE,OHSU_HNSCC_derm001
16497,10328,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.195,0,NONE,OHSU_HNSCC_derm001
16498,10328,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.244,0,NONE,OHSU_HNSCC_derm001
16499,10328,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.179,0,NONE,OHSU_HNSCC_derm001
16500,10328,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.199,0,NONE,OHSU_HNSCC_derm001
16501,10328,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.18,0,NONE,OHSU_HNSCC_derm001
16502,10328,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.207,0,NONE,OHSU_HNSCC_derm001
16503,10328,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.165,0,NONE,OHSU_HNSCC_derm001
16504,10328,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.17,0,NONE,OHSU_HNSCC_derm001
16505,10328,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.181,0,NONE,OHSU_HNSCC_derm001
16506,10328,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.242,0,NONE,OHSU_HNSCC_derm001
16507,10328,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.181,0,NONE,OHSU_HNSCC_derm001
16508,10328,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.162,0,NONE,OHSU_HNSCC_derm001
16509,10328,Blank 490,1,N,OHSU_HNSCC_derm001,24,0.19,0,NONE,OHSU_HNSCC_derm001
16510,10328,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.167,0,NONE,OHSU_HNSCC_derm001
16511,10328,Blank 490,1,P,OHSU_HNSCC_derm001,24,0.223,0,NONE,OHSU_HNSCC_derm001
16512,10328,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.166,10,Coumarin,OHSU_HNSCC_derm001
16513,10328,Blank 490,2,B,OHSU_HNSCC_derm001,1,0.021,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16514,10328,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.022,10,Foretinib (XL-880),OHSU_HNSCC_derm001
16515,10328,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.267,10,Elesclomol,OHSU_HNSCC_derm001
16516,10328,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.148,10,Vemurafenib,OHSU_HNSCC_derm001
16517,10328,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.043,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16518,10328,Blank 490,2,G,OHSU_HNSCC_derm001,1,-0.004,10,Ponatinib,OHSU_HNSCC_derm001
16519,10328,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.123,10,Gefitinib,OHSU_HNSCC_derm001
16520,10328,Blank 490,2,I,OHSU_HNSCC_derm001,1,0.0,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
16521,10328,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.178,1,Sunitinib (1mM),OHSU_HNSCC_derm001
16522,10328,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.177,10,Curcumin,OHSU_HNSCC_derm001
16523,10328,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.045,10,PF-562271,OHSU_HNSCC_derm001
16524,10328,Blank 490,2,M,OHSU_HNSCC_derm001,1,0.207,10,STO609,OHSU_HNSCC_derm001
16525,10328,Blank 490,2,N,OHSU_HNSCC_derm001,1,0.136,10,Lenvatinib,OHSU_HNSCC_derm001
16526,10328,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.043,10,Entrectinib,OHSU_HNSCC_derm001
16527,10328,Blank 490,2,P,OHSU_HNSCC_derm001,1,0.307,10,Ethyl Gallate ,OHSU_HNSCC_derm001
16528,10328,Blank 490,2,A,OHSU_HNSCC_derm001,2,0.193,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
16529,10328,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.213,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16530,10328,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.112,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
16531,10328,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.265,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
16532,10328,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.247,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
16533,10328,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.041,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16534,10328,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.031,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
16535,10328,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.178,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
16536,10328,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.204,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
16537,10328,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.299,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
16538,10328,Blank 490,2,K,OHSU_HNSCC_derm001,2,0.272,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
16539,10328,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.207,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
16540,10328,Blank 490,2,M,OHSU_HNSCC_derm001,2,0.22,3.3333333333333335,STO609,OHSU_HNSCC_derm001
16541,10328,Blank 490,2,N,OHSU_HNSCC_derm001,2,0.209,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
16542,10328,Blank 490,2,O,OHSU_HNSCC_derm001,2,0.271,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
16543,10328,Blank 490,2,P,OHSU_HNSCC_derm001,2,0.33,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
16544,10328,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.211,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
16545,10328,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.19,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16546,10328,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.229,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
16547,10328,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.182,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
16548,10328,Blank 490,2,E,OHSU_HNSCC_derm001,3,0.271,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
16549,10328,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.073,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16550,10328,Blank 490,2,G,OHSU_HNSCC_derm001,3,0.253,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
16551,10328,Blank 490,2,H,OHSU_HNSCC_derm001,3,0.208,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
16552,10328,Blank 490,2,I,OHSU_HNSCC_derm001,3,0.267,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
16553,10328,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.294,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
16554,10328,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.287,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
16555,10328,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.305,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
16556,10328,Blank 490,2,M,OHSU_HNSCC_derm001,3,0.304,1.1111111111111112,STO609,OHSU_HNSCC_derm001
16557,10328,Blank 490,2,N,OHSU_HNSCC_derm001,3,0.253,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
16558,10328,Blank 490,2,O,OHSU_HNSCC_derm001,3,0.291,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
16559,10328,Blank 490,2,P,OHSU_HNSCC_derm001,3,0.273,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
16560,10328,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.195,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
16561,10328,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.175,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16562,10328,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.232,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
16563,10328,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.133,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
16564,10328,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.299,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
16565,10328,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.101,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16566,10328,Blank 490,2,G,OHSU_HNSCC_derm001,4,0.215,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
16567,10328,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.237,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
16568,10328,Blank 490,2,I,OHSU_HNSCC_derm001,4,0.234,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
16569,10328,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.265,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
16570,10328,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.278,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
16571,10328,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.343,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
16572,10328,Blank 490,2,M,OHSU_HNSCC_derm001,4,0.291,0.3703703703703704,STO609,OHSU_HNSCC_derm001
16573,10328,Blank 490,2,N,OHSU_HNSCC_derm001,4,0.261,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
16574,10328,Blank 490,2,O,OHSU_HNSCC_derm001,4,0.28,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
16575,10328,Blank 490,2,P,OHSU_HNSCC_derm001,4,0.333,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
16576,10328,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.197,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
16577,10328,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.188,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16578,10328,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.249,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
16579,10328,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.068,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
16580,10328,Blank 490,2,E,OHSU_HNSCC_derm001,5,0.302,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
16581,10328,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.133,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16582,10328,Blank 490,2,G,OHSU_HNSCC_derm001,5,0.294,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
16583,10328,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.249,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
16584,10328,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.267,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
16585,10328,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.277,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
16586,10328,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.325,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
16587,10328,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.378,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
16588,10328,Blank 490,2,M,OHSU_HNSCC_derm001,5,0.314,0.1234567901234568,STO609,OHSU_HNSCC_derm001
16589,10328,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.27,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
16590,10328,Blank 490,2,O,OHSU_HNSCC_derm001,5,0.267,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
16591,10328,Blank 490,2,P,OHSU_HNSCC_derm001,5,0.272,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
16592,10328,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.176,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
16593,10328,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.177,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16594,10328,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.241,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
16595,10328,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.067,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
16596,10328,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.313,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
16597,10328,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.242,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16598,10328,Blank 490,2,G,OHSU_HNSCC_derm001,6,0.28,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
16599,10328,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.26,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
16600,10328,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.28,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
16601,10328,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.236,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
16602,10328,Blank 490,2,K,OHSU_HNSCC_derm001,6,0.321,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
16603,10328,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.321,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
16604,10328,Blank 490,2,M,OHSU_HNSCC_derm001,6,0.328,0.0411522633744856,STO609,OHSU_HNSCC_derm001
16605,10328,Blank 490,2,N,OHSU_HNSCC_derm001,6,0.243,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
16606,10328,Blank 490,2,O,OHSU_HNSCC_derm001,6,0.371,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
16607,10328,Blank 490,2,P,OHSU_HNSCC_derm001,6,0.246,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
16608,10328,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.203,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
16609,10328,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.182,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
16610,10328,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.264,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
16611,10328,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.126,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
16612,10328,Blank 490,2,E,OHSU_HNSCC_derm001,7,0.327,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
16613,10328,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.259,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
16614,10328,Blank 490,2,G,OHSU_HNSCC_derm001,7,0.286,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
16615,10328,Blank 490,2,H,OHSU_HNSCC_derm001,7,0.277,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
16616,10328,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.2,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
16617,10328,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.194,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
16618,10328,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.296,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
16619,10328,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.323,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
16620,10328,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.342,0.013717421124828532,STO609,OHSU_HNSCC_derm001
16621,10328,Blank 490,2,N,OHSU_HNSCC_derm001,7,0.324,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
16622,10328,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.341,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
16623,10328,Blank 490,2,P,OHSU_HNSCC_derm001,7,0.365,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
16624,10328,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.211,0,NONE,OHSU_HNSCC_derm001
16625,10328,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.239,0,NONE,OHSU_HNSCC_derm001
16626,10328,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.292,0,NONE,OHSU_HNSCC_derm001
16627,10328,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.285,0,NONE,OHSU_HNSCC_derm001
16628,10328,Blank 490,2,E,OHSU_HNSCC_derm001,8,0.295,0,NONE,OHSU_HNSCC_derm001
16629,10328,Blank 490,2,F,OHSU_HNSCC_derm001,8,0.314,0,NONE,OHSU_HNSCC_derm001
16630,10328,Blank 490,2,G,OHSU_HNSCC_derm001,8,0.223,0,NONE,OHSU_HNSCC_derm001
16631,10328,Blank 490,2,H,OHSU_HNSCC_derm001,8,-0.001,10,F-S-V,OHSU_HNSCC_derm001
16632,10328,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.221,0,NONE,OHSU_HNSCC_derm001
16633,10328,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.28,0,NONE,OHSU_HNSCC_derm001
16634,10328,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.3,0,NONE,OHSU_HNSCC_derm001
16635,10328,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.287,0,NONE,OHSU_HNSCC_derm001
16636,10328,Blank 490,2,M,OHSU_HNSCC_derm001,8,0.279,0,NONE,OHSU_HNSCC_derm001
16637,10328,Blank 490,2,N,OHSU_HNSCC_derm001,8,0.31,0,NONE,OHSU_HNSCC_derm001
16638,10328,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.353,0,NONE,OHSU_HNSCC_derm001
16639,10328,Blank 490,2,P,OHSU_HNSCC_derm001,8,0.232,0,NONE,OHSU_HNSCC_derm001
16640,10328,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.022,10,GDC-0941,OHSU_HNSCC_derm001
16641,10328,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.371,10,Dovitinib,OHSU_HNSCC_derm001
16642,10328,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.263,10,BI-2536,OHSU_HNSCC_derm001
16643,10328,Blank 490,2,D,OHSU_HNSCC_derm001,9,0.006,10,TP-0903 ,OHSU_HNSCC_derm001
16644,10328,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.054,10,Belinostat,OHSU_HNSCC_derm001
16645,10328,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.024,10,INK-128,OHSU_HNSCC_derm001
16646,10328,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.089,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16647,10328,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.041,10,Brigatinib,OHSU_HNSCC_derm001
16648,10328,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.139,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16649,10328,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.132,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16650,10328,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.184,10,Pazopanib,OHSU_HNSCC_derm001
16651,10328,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.35,10,AZD4547,OHSU_HNSCC_derm001
16652,10328,Blank 490,2,M,OHSU_HNSCC_derm001,9,0.324,10,Pomalidomide ,OHSU_HNSCC_derm001
16653,10328,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.21,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
16654,10328,Blank 490,2,O,OHSU_HNSCC_derm001,9,0.25,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16655,10328,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.0,10,Staurosporin,OHSU_HNSCC_derm001
16656,10328,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.029,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
16657,10328,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.392,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
16658,10328,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.454,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
16659,10328,Blank 490,2,D,OHSU_HNSCC_derm001,10,0.008,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
16660,10328,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.103,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
16661,10328,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.031,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
16662,10328,Blank 490,2,G,OHSU_HNSCC_derm001,10,0.157,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16663,10328,Blank 490,2,H,OHSU_HNSCC_derm001,10,0.137,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
16664,10328,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.24,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16665,10328,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.33,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16666,10328,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.214,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
16667,10328,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.304,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
16668,10328,Blank 490,2,M,OHSU_HNSCC_derm001,10,0.369,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
16669,10328,Blank 490,2,N,OHSU_HNSCC_derm001,10,0.258,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
16670,10328,Blank 490,2,O,OHSU_HNSCC_derm001,10,0.316,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16671,10328,Blank 490,2,P,OHSU_HNSCC_derm001,10,0.001,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
16672,10328,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.06,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
16673,10328,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.35,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
16674,10328,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.505,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
16675,10328,Blank 490,2,D,OHSU_HNSCC_derm001,11,0.002,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
16676,10328,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.148,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
16677,10328,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.043,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
16678,10328,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.175,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16679,10328,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.21,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
16680,10328,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.198,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16681,10328,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.364,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16682,10328,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.233,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
16683,10328,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.341,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
16684,10328,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.296,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
16685,10328,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.239,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
16686,10328,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.294,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16687,10328,Blank 490,2,P,OHSU_HNSCC_derm001,11,-0.002,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
16688,10328,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.07,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
16689,10328,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.269,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
16690,10328,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.443,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
16691,10328,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.105,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
16692,10328,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.206,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
16693,10328,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.055,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
16694,10328,Blank 490,2,G,OHSU_HNSCC_derm001,12,0.176,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16695,10328,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.29,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
16696,10328,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.223,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16697,10328,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.359,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16698,10328,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.232,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
16699,10328,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.325,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
16700,10328,Blank 490,2,M,OHSU_HNSCC_derm001,12,0.297,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
16701,10328,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.287,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
16702,10328,Blank 490,2,O,OHSU_HNSCC_derm001,12,0.291,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16703,10328,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.023,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
16704,10328,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.119,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
16705,10328,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.262,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
16706,10328,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.323,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
16707,10328,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.266,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
16708,10328,Blank 490,2,E,OHSU_HNSCC_derm001,13,0.266,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
16709,10328,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.079,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
16710,10328,Blank 490,2,G,OHSU_HNSCC_derm001,13,0.187,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16711,10328,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.257,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
16712,10328,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.193,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16713,10328,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.348,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16714,10328,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.327,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
16715,10328,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.36,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
16716,10328,Blank 490,2,M,OHSU_HNSCC_derm001,13,0.327,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
16717,10328,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.29,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
16718,10328,Blank 490,2,O,OHSU_HNSCC_derm001,13,0.29,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16719,10328,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.074,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
16720,10328,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.148,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
16721,10328,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.229,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
16722,10328,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.314,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
16723,10328,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.275,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
16724,10328,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.277,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
16725,10328,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.128,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
16726,10328,Blank 490,2,G,OHSU_HNSCC_derm001,14,0.23,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16727,10328,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.291,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
16728,10328,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.206,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16729,10328,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.317,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16730,10328,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.286,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
16731,10328,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.298,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
16732,10328,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.261,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
16733,10328,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.285,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
16734,10328,Blank 490,2,O,OHSU_HNSCC_derm001,14,0.281,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16735,10328,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.142,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
16736,10328,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.13,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
16737,10328,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.251,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
16738,10328,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.28,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
16739,10328,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.314,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
16740,10328,Blank 490,2,E,OHSU_HNSCC_derm001,15,0.281,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
16741,10328,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.144,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
16742,10328,Blank 490,2,G,OHSU_HNSCC_derm001,15,0.228,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
16743,10328,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.287,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
16744,10328,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.25,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
16745,10328,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.3,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
16746,10328,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.281,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
16747,10328,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.329,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
16748,10328,Blank 490,2,M,OHSU_HNSCC_derm001,15,0.327,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
16749,10328,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.316,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
16750,10328,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.314,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
16751,10328,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.124,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
16752,10328,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.189,0,NONE,OHSU_HNSCC_derm001
16753,10328,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.253,0,NONE,OHSU_HNSCC_derm001
16754,10328,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.278,0,NONE,OHSU_HNSCC_derm001
16755,10328,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.303,0,NONE,OHSU_HNSCC_derm001
16756,10328,Blank 490,2,E,OHSU_HNSCC_derm001,16,0.301,0,NONE,OHSU_HNSCC_derm001
16757,10328,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.259,0,NONE,OHSU_HNSCC_derm001
16758,10328,Blank 490,2,G,OHSU_HNSCC_derm001,16,0.304,0,NONE,OHSU_HNSCC_derm001
16759,10328,Blank 490,2,H,OHSU_HNSCC_derm001,16,0.001,10,F-S-V,OHSU_HNSCC_derm001
16760,10328,Blank 490,2,I,OHSU_HNSCC_derm001,16,0.303,0,NONE,OHSU_HNSCC_derm001
16761,10328,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.285,0,NONE,OHSU_HNSCC_derm001
16762,10328,Blank 490,2,K,OHSU_HNSCC_derm001,16,0.329,0,NONE,OHSU_HNSCC_derm001
16763,10328,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.289,0,NONE,OHSU_HNSCC_derm001
16764,10328,Blank 490,2,M,OHSU_HNSCC_derm001,16,0.291,0,NONE,OHSU_HNSCC_derm001
16765,10328,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.343,0,NONE,OHSU_HNSCC_derm001
16766,10328,Blank 490,2,O,OHSU_HNSCC_derm001,16,0.325,0,NONE,OHSU_HNSCC_derm001
16767,10328,Blank 490,2,P,OHSU_HNSCC_derm001,16,0.324,0,NONE,OHSU_HNSCC_derm001
16768,10328,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.271,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
16769,10328,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.272,10,Hesperidin,OHSU_HNSCC_derm001
16770,10328,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.283,10,Esculetin,OHSU_HNSCC_derm001
16771,10328,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.134,10,Selinexor ,OHSU_HNSCC_derm001
16772,10328,Blank 490,2,E,OHSU_HNSCC_derm001,17,0.135,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16773,10328,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.167,10,BMX-IN-1,OHSU_HNSCC_derm001
16774,10328,Blank 490,2,G,OHSU_HNSCC_derm001,17,0.086,1,Dasatinib (1mM),OHSU_HNSCC_derm001
16775,10328,Blank 490,2,H,OHSU_HNSCC_derm001,17,0.159,10,Trametinib,OHSU_HNSCC_derm001
16776,10328,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.036,10,BEZ235,OHSU_HNSCC_derm001
16777,10328,Blank 490,2,J,OHSU_HNSCC_derm001,17,0.002,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
16778,10328,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.153,10,Nilotinib,OHSU_HNSCC_derm001
16779,10328,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.262,10,Enzalutamide,OHSU_HNSCC_derm001
16780,10328,Blank 490,2,M,OHSU_HNSCC_derm001,17,0.424,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16781,10328,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.248,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
16782,10328,Blank 490,2,O,OHSU_HNSCC_derm001,17,0.002,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16783,10328,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.204,10,Axitinib,OHSU_HNSCC_derm001
16784,10328,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.308,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
16785,10328,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.256,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
16786,10328,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.314,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
16787,10328,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.108,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
16788,10328,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.239,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16789,10328,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.232,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
16790,10328,Blank 490,2,G,OHSU_HNSCC_derm001,18,0.142,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
16791,10328,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.193,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
16792,10328,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.037,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
16793,10328,Blank 490,2,J,OHSU_HNSCC_derm001,18,0.002,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
16794,10328,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.285,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
16795,10328,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.251,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
16796,10328,Blank 490,2,M,OHSU_HNSCC_derm001,18,0.38,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16797,10328,Blank 490,2,N,OHSU_HNSCC_derm001,18,0.253,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
16798,10328,Blank 490,2,O,OHSU_HNSCC_derm001,18,0.001,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16799,10328,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.221,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
16800,10328,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.286,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
16801,10328,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.274,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
16802,10328,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.273,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
16803,10328,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.121,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
16804,10328,Blank 490,2,E,OHSU_HNSCC_derm001,19,0.291,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16805,10328,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.233,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
16806,10328,Blank 490,2,G,OHSU_HNSCC_derm001,19,0.107,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
16807,10328,Blank 490,2,H,OHSU_HNSCC_derm001,19,0.175,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
16808,10328,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.046,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
16809,10328,Blank 490,2,J,OHSU_HNSCC_derm001,19,0.02,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
16810,10328,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.25,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
16811,10328,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.35,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
16812,10328,Blank 490,2,M,OHSU_HNSCC_derm001,19,0.366,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16813,10328,Blank 490,2,N,OHSU_HNSCC_derm001,19,0.276,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
16814,10328,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.011,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16815,10328,Blank 490,2,P,OHSU_HNSCC_derm001,19,0.296,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
16816,10328,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.198,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
16817,10328,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.263,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
16818,10328,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.223,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
16819,10328,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.138,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
16820,10328,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.294,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16821,10328,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.284,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
16822,10328,Blank 490,2,G,OHSU_HNSCC_derm001,20,0.281,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
16823,10328,Blank 490,2,H,OHSU_HNSCC_derm001,20,0.189,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
16824,10328,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.057,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
16825,10328,Blank 490,2,J,OHSU_HNSCC_derm001,20,0.046,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
16826,10328,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.297,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
16827,10328,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.332,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
16828,10328,Blank 490,2,M,OHSU_HNSCC_derm001,20,0.317,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16829,10328,Blank 490,2,N,OHSU_HNSCC_derm001,20,0.321,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
16830,10328,Blank 490,2,O,OHSU_HNSCC_derm001,20,0.148,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16831,10328,Blank 490,2,P,OHSU_HNSCC_derm001,20,0.241,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
16832,10328,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.229,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
16833,10328,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.228,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
16834,10328,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.292,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
16835,10328,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.151,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
16836,10328,Blank 490,2,E,OHSU_HNSCC_derm001,21,0.267,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16837,10328,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.286,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
16838,10328,Blank 490,2,G,OHSU_HNSCC_derm001,21,0.281,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
16839,10328,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.201,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
16840,10328,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.081,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
16841,10328,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.076,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
16842,10328,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.332,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
16843,10328,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.304,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
16844,10328,Blank 490,2,M,OHSU_HNSCC_derm001,21,0.312,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16845,10328,Blank 490,2,N,OHSU_HNSCC_derm001,21,0.353,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
16846,10328,Blank 490,2,O,OHSU_HNSCC_derm001,21,0.278,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16847,10328,Blank 490,2,P,OHSU_HNSCC_derm001,21,0.325,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
16848,10328,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.245,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
16849,10328,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.282,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
16850,10328,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.272,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
16851,10328,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.204,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
16852,10328,Blank 490,2,E,OHSU_HNSCC_derm001,22,0.271,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16853,10328,Blank 490,2,F,OHSU_HNSCC_derm001,22,0.304,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
16854,10328,Blank 490,2,G,OHSU_HNSCC_derm001,22,0.292,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
16855,10328,Blank 490,2,H,OHSU_HNSCC_derm001,22,0.242,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
16856,10328,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.147,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
16857,10328,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.099,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
16858,10328,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.301,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
16859,10328,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.301,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
16860,10328,Blank 490,2,M,OHSU_HNSCC_derm001,22,0.269,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16861,10328,Blank 490,2,N,OHSU_HNSCC_derm001,22,0.372,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
16862,10328,Blank 490,2,O,OHSU_HNSCC_derm001,22,0.307,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16863,10328,Blank 490,2,P,OHSU_HNSCC_derm001,22,0.238,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
16864,10328,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.199,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
16865,10328,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.267,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
16866,10328,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.246,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
16867,10328,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.243,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
16868,10328,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.297,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
16869,10328,Blank 490,2,F,OHSU_HNSCC_derm001,23,0.293,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
16870,10328,Blank 490,2,G,OHSU_HNSCC_derm001,23,0.244,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
16871,10328,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.187,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
16872,10328,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.172,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
16873,10328,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.293,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
16874,10328,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.282,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
16875,10328,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.282,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
16876,10328,Blank 490,2,M,OHSU_HNSCC_derm001,23,0.323,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
16877,10328,Blank 490,2,N,OHSU_HNSCC_derm001,23,0.275,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
16878,10328,Blank 490,2,O,OHSU_HNSCC_derm001,23,0.337,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
16879,10328,Blank 490,2,P,OHSU_HNSCC_derm001,23,0.199,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
16880,10328,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.255,0,NONE,OHSU_HNSCC_derm001
16881,10328,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.196,0,NONE,OHSU_HNSCC_derm001
16882,10328,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.236,0,NONE,OHSU_HNSCC_derm001
16883,10328,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.21,0,NONE,OHSU_HNSCC_derm001
16884,10328,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.226,0,NONE,OHSU_HNSCC_derm001
16885,10328,Blank 490,2,F,OHSU_HNSCC_derm001,24,0.221,0,NONE,OHSU_HNSCC_derm001
16886,10328,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.213,0,NONE,OHSU_HNSCC_derm001
16887,10328,Blank 490,2,H,OHSU_HNSCC_derm001,24,0.236,0,NONE,OHSU_HNSCC_derm001
16888,10328,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.188,0,NONE,OHSU_HNSCC_derm001
16889,10328,Blank 490,2,J,OHSU_HNSCC_derm001,24,0.211,0,NONE,OHSU_HNSCC_derm001
16890,10328,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.248,0,NONE,OHSU_HNSCC_derm001
16891,10328,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.228,0,NONE,OHSU_HNSCC_derm001
16892,10328,Blank 490,2,M,OHSU_HNSCC_derm001,24,0.225,0,NONE,OHSU_HNSCC_derm001
16893,10328,Blank 490,2,N,OHSU_HNSCC_derm001,24,0.25,0,NONE,OHSU_HNSCC_derm001
16894,10328,Blank 490,2,O,OHSU_HNSCC_derm001,24,0.263,0,NONE,OHSU_HNSCC_derm001
16895,10328,Blank 490,2,P,OHSU_HNSCC_derm001,24,0.27,0,NONE,OHSU_HNSCC_derm001
16896,10328,Blank 490,3,A,OHSU_HNSCC_derm001,1,0.219,10,Thalidomide ,OHSU_HNSCC_derm001
16897,10328,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.144,10,Vandetanib,OHSU_HNSCC_derm001
16898,10328,Blank 490,3,C,OHSU_HNSCC_derm001,1,0.268,10,Oleic acid,OHSU_HNSCC_derm001
16899,10328,Blank 490,3,D,OHSU_HNSCC_derm001,1,0.001,10,A-674563,OHSU_HNSCC_derm001
16900,10328,Blank 490,3,E,OHSU_HNSCC_derm001,1,0.056,10,Lapatinib,OHSU_HNSCC_derm001
16901,10328,Blank 490,3,F,OHSU_HNSCC_derm001,1,0.286,10,Apocynin (vanillin),OHSU_HNSCC_derm001
16902,10328,Blank 490,3,G,OHSU_HNSCC_derm001,1,0.01,10,AT-7519,OHSU_HNSCC_derm001
16903,10328,Blank 490,3,H,OHSU_HNSCC_derm001,1,0.152,10,Gefitinib,OHSU_HNSCC_derm001
16904,10328,Blank 490,3,I,OHSU_HNSCC_derm001,1,0.049,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
16905,10328,Blank 490,3,J,OHSU_HNSCC_derm001,1,0.045,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16906,10328,Blank 490,3,K,OHSU_HNSCC_derm001,1,0.047,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16907,10328,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.236,10,JQ1,OHSU_HNSCC_derm001
16908,10328,Blank 490,3,M,OHSU_HNSCC_derm001,1,0.436,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16909,10328,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.082,10,Cerdulatinib,OHSU_HNSCC_derm001
16910,10328,Blank 490,3,O,OHSU_HNSCC_derm001,1,0.007,10,Romidepsin,OHSU_HNSCC_derm001
16911,10328,Blank 490,3,P,OHSU_HNSCC_derm001,1,0.236,10,Gilteritinib,OHSU_HNSCC_derm001
16912,10328,Blank 490,3,A,OHSU_HNSCC_derm001,2,0.229,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
16913,10328,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.211,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
16914,10328,Blank 490,3,C,OHSU_HNSCC_derm001,2,0.295,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
16915,10328,Blank 490,3,D,OHSU_HNSCC_derm001,2,0.218,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
16916,10328,Blank 490,3,E,OHSU_HNSCC_derm001,2,0.138,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
16917,10328,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.289,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
16918,10328,Blank 490,3,G,OHSU_HNSCC_derm001,2,0.009,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
16919,10328,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.206,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
16920,10328,Blank 490,3,I,OHSU_HNSCC_derm001,2,0.206,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
16921,10328,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.105,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16922,10328,Blank 490,3,K,OHSU_HNSCC_derm001,2,0.163,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16923,10328,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.335,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
16924,10328,Blank 490,3,M,OHSU_HNSCC_derm001,2,0.449,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16925,10328,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.697,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
16926,10328,Blank 490,3,O,OHSU_HNSCC_derm001,2,0.01,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
16927,10328,Blank 490,3,P,OHSU_HNSCC_derm001,2,0.264,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
16928,10328,Blank 490,3,A,OHSU_HNSCC_derm001,3,0.269,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
16929,10328,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.259,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
16930,10328,Blank 490,3,C,OHSU_HNSCC_derm001,3,0.276,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
16931,10328,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.213,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
16932,10328,Blank 490,3,E,OHSU_HNSCC_derm001,3,0.188,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
16933,10328,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.271,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
16934,10328,Blank 490,3,G,OHSU_HNSCC_derm001,3,0.016,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
16935,10328,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.215,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
16936,10328,Blank 490,3,I,OHSU_HNSCC_derm001,3,0.26,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
16937,10328,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.143,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16938,10328,Blank 490,3,K,OHSU_HNSCC_derm001,3,0.198,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16939,10328,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.388,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
16940,10328,Blank 490,3,M,OHSU_HNSCC_derm001,3,0.421,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16941,10328,Blank 490,3,N,OHSU_HNSCC_derm001,3,0.597,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
16942,10328,Blank 490,3,O,OHSU_HNSCC_derm001,3,0.009,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
16943,10328,Blank 490,3,P,OHSU_HNSCC_derm001,3,0.262,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
16944,10328,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.227,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
16945,10328,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.241,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
16946,10328,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.242,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
16947,10328,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.217,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
16948,10328,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.206,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
16949,10328,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.272,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
16950,10328,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.155,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
16951,10328,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.232,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
16952,10328,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.288,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
16953,10328,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.204,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16954,10328,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.22,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16955,10328,Blank 490,3,L,OHSU_HNSCC_derm001,4,0.472,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
16956,10328,Blank 490,3,M,OHSU_HNSCC_derm001,4,0.339,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16957,10328,Blank 490,3,N,OHSU_HNSCC_derm001,4,0.433,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
16958,10328,Blank 490,3,O,OHSU_HNSCC_derm001,4,0.021,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
16959,10328,Blank 490,3,P,OHSU_HNSCC_derm001,4,0.239,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
16960,10328,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.216,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
16961,10328,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.287,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
16962,10328,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.275,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
16963,10328,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.229,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
16964,10328,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.237,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
16965,10328,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.267,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
16966,10328,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.253,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
16967,10328,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.254,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
16968,10328,Blank 490,3,I,OHSU_HNSCC_derm001,5,0.292,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
16969,10328,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.216,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16970,10328,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.259,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16971,10328,Blank 490,3,L,OHSU_HNSCC_derm001,5,0.518,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
16972,10328,Blank 490,3,M,OHSU_HNSCC_derm001,5,0.316,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16973,10328,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.352,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
16974,10328,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.029,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
16975,10328,Blank 490,3,P,OHSU_HNSCC_derm001,5,0.33,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
16976,10328,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.193,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
16977,10328,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.309,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
16978,10328,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.251,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
16979,10328,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.237,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
16980,10328,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.282,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
16981,10328,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.295,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
16982,10328,Blank 490,3,G,OHSU_HNSCC_derm001,6,0.279,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
16983,10328,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.259,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
16984,10328,Blank 490,3,I,OHSU_HNSCC_derm001,6,0.275,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
16985,10328,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.266,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
16986,10328,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.287,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
16987,10328,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.428,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
16988,10328,Blank 490,3,M,OHSU_HNSCC_derm001,6,0.365,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
16989,10328,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.373,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
16990,10328,Blank 490,3,O,OHSU_HNSCC_derm001,6,0.034,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
16991,10328,Blank 490,3,P,OHSU_HNSCC_derm001,6,0.344,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
16992,10328,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.179,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
16993,10328,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.278,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
16994,10328,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.269,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
16995,10328,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.279,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
16996,10328,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.262,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
16997,10328,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.305,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
16998,10328,Blank 490,3,G,OHSU_HNSCC_derm001,7,0.326,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
16999,10328,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.298,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
17000,10328,Blank 490,3,I,OHSU_HNSCC_derm001,7,0.279,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
17001,10328,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.268,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
17002,10328,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.305,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
17003,10328,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.358,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
17004,10328,Blank 490,3,M,OHSU_HNSCC_derm001,7,0.344,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
17005,10328,Blank 490,3,N,OHSU_HNSCC_derm001,7,0.344,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
17006,10328,Blank 490,3,O,OHSU_HNSCC_derm001,7,0.031,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
17007,10328,Blank 490,3,P,OHSU_HNSCC_derm001,7,0.311,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
17008,10328,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.213,0,NONE,OHSU_HNSCC_derm001
17009,10328,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.241,0,NONE,OHSU_HNSCC_derm001
17010,10328,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.27,0,NONE,OHSU_HNSCC_derm001
17011,10328,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.249,0,NONE,OHSU_HNSCC_derm001
17012,10328,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.253,0,NONE,OHSU_HNSCC_derm001
17013,10328,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.315,0,NONE,OHSU_HNSCC_derm001
17014,10328,Blank 490,3,G,OHSU_HNSCC_derm001,8,0.322,0,NONE,OHSU_HNSCC_derm001
17015,10328,Blank 490,3,H,OHSU_HNSCC_derm001,8,-0.003,10,F-S-V,OHSU_HNSCC_derm001
17016,10328,Blank 490,3,I,OHSU_HNSCC_derm001,8,0.174,0,NONE,OHSU_HNSCC_derm001
17017,10328,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.308,0,NONE,OHSU_HNSCC_derm001
17018,10328,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.312,0,NONE,OHSU_HNSCC_derm001
17019,10328,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.305,0,NONE,OHSU_HNSCC_derm001
17020,10328,Blank 490,3,M,OHSU_HNSCC_derm001,8,0.35,0,NONE,OHSU_HNSCC_derm001
17021,10328,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.319,0,NONE,OHSU_HNSCC_derm001
17022,10328,Blank 490,3,O,OHSU_HNSCC_derm001,8,0.309,0,NONE,OHSU_HNSCC_derm001
17023,10328,Blank 490,3,P,OHSU_HNSCC_derm001,8,0.305,0,NONE,OHSU_HNSCC_derm001
17024,10328,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.186,10,Anastrazole,OHSU_HNSCC_derm001
17025,10328,Blank 490,3,B,OHSU_HNSCC_derm001,9,0.201,10,JNJ-28312141 ,OHSU_HNSCC_derm001
17026,10328,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.274,10,Genistein,OHSU_HNSCC_derm001
17027,10328,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.27,10,Abscisic acid,OHSU_HNSCC_derm001
17028,10328,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.252,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17029,10328,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.387,10,Ruxolitinib,OHSU_HNSCC_derm001
17030,10328,Blank 490,3,G,OHSU_HNSCC_derm001,9,0.394,10,TAK-659,OHSU_HNSCC_derm001
17031,10328,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.041,10,Brigatinib,OHSU_HNSCC_derm001
17032,10328,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.183,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17033,10328,Blank 490,3,J,OHSU_HNSCC_derm001,9,0.091,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17034,10328,Blank 490,3,K,OHSU_HNSCC_derm001,9,0.142,10,Vorinostat,OHSU_HNSCC_derm001
17035,10328,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.296,10,Lenalidomide,OHSU_HNSCC_derm001
17036,10328,Blank 490,3,M,OHSU_HNSCC_derm001,9,0.047,10,NVP-ADW742,OHSU_HNSCC_derm001
17037,10328,Blank 490,3,N,OHSU_HNSCC_derm001,9,0.29,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17038,10328,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.487,10,Echinatin,OHSU_HNSCC_derm001
17039,10328,Blank 490,3,P,OHSU_HNSCC_derm001,9,-0.013,10,YM-155,OHSU_HNSCC_derm001
17040,10328,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.199,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
17041,10328,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.446,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
17042,10328,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.283,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
17043,10328,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.238,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
17044,10328,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.261,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17045,10328,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.35,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
17046,10328,Blank 490,3,G,OHSU_HNSCC_derm001,10,0.419,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
17047,10328,Blank 490,3,H,OHSU_HNSCC_derm001,10,0.104,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
17048,10328,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.242,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17049,10328,Blank 490,3,J,OHSU_HNSCC_derm001,10,0.398,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17050,10328,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.169,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
17051,10328,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.307,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
17052,10328,Blank 490,3,M,OHSU_HNSCC_derm001,10,0.243,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
17053,10328,Blank 490,3,N,OHSU_HNSCC_derm001,10,0.291,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17054,10328,Blank 490,3,O,OHSU_HNSCC_derm001,10,0.33,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
17055,10328,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.012,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
17056,10328,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.196,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
17057,10328,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.356,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
17058,10328,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.262,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
17059,10328,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.26,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
17060,10328,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.255,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17061,10328,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.297,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
17062,10328,Blank 490,3,G,OHSU_HNSCC_derm001,11,0.413,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
17063,10328,Blank 490,3,H,OHSU_HNSCC_derm001,11,0.216,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
17064,10328,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.196,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17065,10328,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.502,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17066,10328,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.193,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
17067,10328,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.271,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
17068,10328,Blank 490,3,M,OHSU_HNSCC_derm001,11,0.239,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
17069,10328,Blank 490,3,N,OHSU_HNSCC_derm001,11,0.333,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17070,10328,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.33,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
17071,10328,Blank 490,3,P,OHSU_HNSCC_derm001,11,-0.01,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
17072,10328,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.192,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
17073,10328,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.321,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
17074,10328,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.247,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
17075,10328,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.294,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
17076,10328,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.267,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17077,10328,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.298,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
17078,10328,Blank 490,3,G,OHSU_HNSCC_derm001,12,0.328,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
17079,10328,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.258,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
17080,10328,Blank 490,3,I,OHSU_HNSCC_derm001,12,0.203,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17081,10328,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.582,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17082,10328,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.229,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
17083,10328,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.281,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
17084,10328,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.303,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
17085,10328,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.327,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17086,10328,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.285,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
17087,10328,Blank 490,3,P,OHSU_HNSCC_derm001,12,-0.004,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
17088,10328,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.178,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
17089,10328,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.298,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
17090,10328,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.259,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
17091,10328,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.233,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
17092,10328,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.298,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17093,10328,Blank 490,3,F,OHSU_HNSCC_derm001,13,0.273,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
17094,10328,Blank 490,3,G,OHSU_HNSCC_derm001,13,0.291,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
17095,10328,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.267,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
17096,10328,Blank 490,3,I,OHSU_HNSCC_derm001,13,0.221,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17097,10328,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.524,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17098,10328,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.295,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
17099,10328,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.327,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
17100,10328,Blank 490,3,M,OHSU_HNSCC_derm001,13,0.32,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
17101,10328,Blank 490,3,N,OHSU_HNSCC_derm001,13,0.317,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17102,10328,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.314,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
17103,10328,Blank 490,3,P,OHSU_HNSCC_derm001,13,0.0,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
17104,10328,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.223,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
17105,10328,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.274,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
17106,10328,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.263,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
17107,10328,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.282,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
17108,10328,Blank 490,3,E,OHSU_HNSCC_derm001,14,0.291,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17109,10328,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.306,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
17110,10328,Blank 490,3,G,OHSU_HNSCC_derm001,14,0.316,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
17111,10328,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.25,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
17112,10328,Blank 490,3,I,OHSU_HNSCC_derm001,14,0.221,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17113,10328,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.412,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17114,10328,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.304,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
17115,10328,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.304,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
17116,10328,Blank 490,3,M,OHSU_HNSCC_derm001,14,0.334,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
17117,10328,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.283,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17118,10328,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.346,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
17119,10328,Blank 490,3,P,OHSU_HNSCC_derm001,14,0.009,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
17120,10328,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.196,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
17121,10328,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.254,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
17122,10328,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.224,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
17123,10328,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.265,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
17124,10328,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.308,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
17125,10328,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.306,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
17126,10328,Blank 490,3,G,OHSU_HNSCC_derm001,15,0.296,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
17127,10328,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.264,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
17128,10328,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.204,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17129,10328,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.379,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
17130,10328,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.319,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
17131,10328,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.304,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
17132,10328,Blank 490,3,M,OHSU_HNSCC_derm001,15,0.304,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
17133,10328,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.315,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
17134,10328,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.316,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
17135,10328,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.023,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
17136,10328,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.193,0,NONE,OHSU_HNSCC_derm001
17137,10328,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.273,0,NONE,OHSU_HNSCC_derm001
17138,10328,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.241,0,NONE,OHSU_HNSCC_derm001
17139,10328,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.276,0,NONE,OHSU_HNSCC_derm001
17140,10328,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.29,0,NONE,OHSU_HNSCC_derm001
17141,10328,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.267,0,NONE,OHSU_HNSCC_derm001
17142,10328,Blank 490,3,G,OHSU_HNSCC_derm001,16,0.141,0,NONE,OHSU_HNSCC_derm001
17143,10328,Blank 490,3,H,OHSU_HNSCC_derm001,16,0.003,10,F-S-V,OHSU_HNSCC_derm001
17144,10328,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.285,0,NONE,OHSU_HNSCC_derm001
17145,10328,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.279,0,NONE,OHSU_HNSCC_derm001
17146,10328,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.327,0,NONE,OHSU_HNSCC_derm001
17147,10328,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.317,0,NONE,OHSU_HNSCC_derm001
17148,10328,Blank 490,3,M,OHSU_HNSCC_derm001,16,0.342,0,NONE,OHSU_HNSCC_derm001
17149,10328,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.317,0,NONE,OHSU_HNSCC_derm001
17150,10328,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.331,0,NONE,OHSU_HNSCC_derm001
17151,10328,Blank 490,3,P,OHSU_HNSCC_derm001,16,0.315,0,NONE,OHSU_HNSCC_derm001
17152,10328,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.187,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17153,10328,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.256,10,Stevioside,OHSU_HNSCC_derm001
17154,10328,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.253,10,Pemetrexed,OHSU_HNSCC_derm001
17155,10328,Blank 490,3,D,OHSU_HNSCC_derm001,17,0.049,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17156,10328,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.026,10,GSK-1838705A,OHSU_HNSCC_derm001
17157,10328,Blank 490,3,F,OHSU_HNSCC_derm001,17,-0.001,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17158,10328,Blank 490,3,G,OHSU_HNSCC_derm001,17,0.298,10,Imatinib,OHSU_HNSCC_derm001
17159,10328,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.162,10,Trametinib,OHSU_HNSCC_derm001
17160,10328,Blank 490,3,I,OHSU_HNSCC_derm001,17,0.03,10,BEZ235,OHSU_HNSCC_derm001
17161,10328,Blank 490,3,J,OHSU_HNSCC_derm001,17,0.23,10,Saracatinib,OHSU_HNSCC_derm001
17162,10328,Blank 490,3,K,OHSU_HNSCC_derm001,17,0.45,10,I-BET 762,OHSU_HNSCC_derm001
17163,10328,Blank 490,3,L,OHSU_HNSCC_derm001,17,0.085,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
17164,10328,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.296,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
17165,10328,Blank 490,3,N,OHSU_HNSCC_derm001,17,0.27,10,Crizotinib,OHSU_HNSCC_derm001
17166,10328,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.222,10,MGCD-265,OHSU_HNSCC_derm001
17167,10328,Blank 490,3,P,OHSU_HNSCC_derm001,17,0.154,10,Erlotinib,OHSU_HNSCC_derm001
17168,10328,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.194,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17169,10328,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.271,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
17170,10328,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.262,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
17171,10328,Blank 490,3,D,OHSU_HNSCC_derm001,18,0.074,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17172,10328,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.173,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
17173,10328,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.145,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17174,10328,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.312,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
17175,10328,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.19,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
17176,10328,Blank 490,3,I,OHSU_HNSCC_derm001,18,0.041,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
17177,10328,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.285,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
17178,10328,Blank 490,3,K,OHSU_HNSCC_derm001,18,0.541,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
17179,10328,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.156,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
17180,10328,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.405,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
17181,10328,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.295,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
17182,10328,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.257,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
17183,10328,Blank 490,3,P,OHSU_HNSCC_derm001,18,0.184,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
17184,10328,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.198,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17185,10328,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.269,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
17186,10328,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.256,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
17187,10328,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.104,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17188,10328,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.194,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
17189,10328,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.176,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17190,10328,Blank 490,3,G,OHSU_HNSCC_derm001,19,0.289,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
17191,10328,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.201,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
17192,10328,Blank 490,3,I,OHSU_HNSCC_derm001,19,0.038,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
17193,10328,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.296,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
17194,10328,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.552,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
17195,10328,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.218,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
17196,10328,Blank 490,3,M,OHSU_HNSCC_derm001,19,0.3,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
17197,10328,Blank 490,3,N,OHSU_HNSCC_derm001,19,0.288,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
17198,10328,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.287,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
17199,10328,Blank 490,3,P,OHSU_HNSCC_derm001,19,0.258,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
17200,10328,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.211,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17201,10328,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.239,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
17202,10328,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.285,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
17203,10328,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.118,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17204,10328,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.222,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
17205,10328,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.214,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17206,10328,Blank 490,3,G,OHSU_HNSCC_derm001,20,0.311,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
17207,10328,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.175,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
17208,10328,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.071,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
17209,10328,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.314,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
17210,10328,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.462,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
17211,10328,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.216,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
17212,10328,Blank 490,3,M,OHSU_HNSCC_derm001,20,0.324,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
17213,10328,Blank 490,3,N,OHSU_HNSCC_derm001,20,0.333,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
17214,10328,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.292,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
17215,10328,Blank 490,3,P,OHSU_HNSCC_derm001,20,0.273,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
17216,10328,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.23,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17217,10328,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.243,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
17218,10328,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.256,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
17219,10328,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.142,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17220,10328,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.248,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
17221,10328,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.213,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17222,10328,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.265,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
17223,10328,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.191,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
17224,10328,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.091,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
17225,10328,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.316,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
17226,10328,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.414,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
17227,10328,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.202,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
17228,10328,Blank 490,3,M,OHSU_HNSCC_derm001,21,0.268,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
17229,10328,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.299,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
17230,10328,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.315,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
17231,10328,Blank 490,3,P,OHSU_HNSCC_derm001,21,0.237,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
17232,10328,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.226,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17233,10328,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.206,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
17234,10328,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.245,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
17235,10328,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.176,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17236,10328,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.273,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
17237,10328,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.238,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17238,10328,Blank 490,3,G,OHSU_HNSCC_derm001,22,0.261,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
17239,10328,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.22,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
17240,10328,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.18,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
17241,10328,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.281,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
17242,10328,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.304,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
17243,10328,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.244,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
17244,10328,Blank 490,3,M,OHSU_HNSCC_derm001,22,0.321,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
17245,10328,Blank 490,3,N,OHSU_HNSCC_derm001,22,0.329,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
17246,10328,Blank 490,3,O,OHSU_HNSCC_derm001,22,0.322,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
17247,10328,Blank 490,3,P,OHSU_HNSCC_derm001,22,0.26,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
17248,10328,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.209,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
17249,10328,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.226,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
17250,10328,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.315,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
17251,10328,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.242,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
17252,10328,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.305,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
17253,10328,Blank 490,3,F,OHSU_HNSCC_derm001,23,0.286,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
17254,10328,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.258,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
17255,10328,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.254,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
17256,10328,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.293,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
17257,10328,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.311,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
17258,10328,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.349,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
17259,10328,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.27,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
17260,10328,Blank 490,3,M,OHSU_HNSCC_derm001,23,0.315,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
17261,10328,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.344,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
17262,10328,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.264,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
17263,10328,Blank 490,3,P,OHSU_HNSCC_derm001,23,0.257,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
17264,10328,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.23,0,NONE,OHSU_HNSCC_derm001
17265,10328,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.226,0,NONE,OHSU_HNSCC_derm001
17266,10328,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.237,0,NONE,OHSU_HNSCC_derm001
17267,10328,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.241,0,NONE,OHSU_HNSCC_derm001
17268,10328,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.31,0,NONE,OHSU_HNSCC_derm001
17269,10328,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.215,0,NONE,OHSU_HNSCC_derm001
17270,10328,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.247,0,NONE,OHSU_HNSCC_derm001
17271,10328,Blank 490,3,H,OHSU_HNSCC_derm001,24,0.231,0,NONE,OHSU_HNSCC_derm001
17272,10328,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.23,0,NONE,OHSU_HNSCC_derm001
17273,10328,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.293,0,NONE,OHSU_HNSCC_derm001
17274,10328,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.326,0,NONE,OHSU_HNSCC_derm001
17275,10328,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.262,0,NONE,OHSU_HNSCC_derm001
17276,10328,Blank 490,3,M,OHSU_HNSCC_derm001,24,0.294,0,NONE,OHSU_HNSCC_derm001
17277,10328,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.329,0,NONE,OHSU_HNSCC_derm001
17278,10328,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.296,0,NONE,OHSU_HNSCC_derm001
17279,10328,Blank 490,3,P,OHSU_HNSCC_derm001,24,0.276,0,NONE,OHSU_HNSCC_derm001
17280,10329,Blank 490,1,A,OHSU_HNSCC_derm001,1,0.004,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
17281,10329,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.231,10,Lucitanib ,OHSU_HNSCC_derm001
17282,10329,Blank 490,1,C,OHSU_HNSCC_derm001,1,0.24,10,Resveratrol,OHSU_HNSCC_derm001
17283,10329,Blank 490,1,D,OHSU_HNSCC_derm001,1,0.115,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17284,10329,Blank 490,1,E,OHSU_HNSCC_derm001,1,0.263,10,Bicalutamide,OHSU_HNSCC_derm001
17285,10329,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.239,10,Methotrexate ,OHSU_HNSCC_derm001
17286,10329,Blank 490,1,G,OHSU_HNSCC_derm001,1,0.022,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17287,10329,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.102,10,Gefitinib,OHSU_HNSCC_derm001
17288,10329,Blank 490,1,I,OHSU_HNSCC_derm001,1,0.09,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
17289,10329,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.1,10,Tamatinib/R406,OHSU_HNSCC_derm001
17290,10329,Blank 490,1,K,OHSU_HNSCC_derm001,1,0.055,10,Bosutinib,OHSU_HNSCC_derm001
17291,10329,Blank 490,1,L,OHSU_HNSCC_derm001,1,0.024,10,PI-103,OHSU_HNSCC_derm001
17292,10329,Blank 490,1,M,OHSU_HNSCC_derm001,1,0.324,10,Glycyrrhizin,OHSU_HNSCC_derm001
17293,10329,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.207,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
17294,10329,Blank 490,1,O,OHSU_HNSCC_derm001,1,0.136,10,GSK-690693,OHSU_HNSCC_derm001
17295,10329,Blank 490,1,P,OHSU_HNSCC_derm001,1,0.103,10,Ibrutinib,OHSU_HNSCC_derm001
17296,10329,Blank 490,1,A,OHSU_HNSCC_derm001,2,0.009,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
17297,10329,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.285,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
17298,10329,Blank 490,1,C,OHSU_HNSCC_derm001,2,0.276,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
17299,10329,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.1,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17300,10329,Blank 490,1,E,OHSU_HNSCC_derm001,2,0.265,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
17301,10329,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.353,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
17302,10329,Blank 490,1,G,OHSU_HNSCC_derm001,2,0.12,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17303,10329,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.138,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
17304,10329,Blank 490,1,I,OHSU_HNSCC_derm001,2,0.208,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
17305,10329,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.148,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
17306,10329,Blank 490,1,K,OHSU_HNSCC_derm001,2,0.197,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
17307,10329,Blank 490,1,L,OHSU_HNSCC_derm001,2,0.038,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
17308,10329,Blank 490,1,M,OHSU_HNSCC_derm001,2,0.333,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
17309,10329,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.318,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
17310,10329,Blank 490,1,O,OHSU_HNSCC_derm001,2,0.153,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
17311,10329,Blank 490,1,P,OHSU_HNSCC_derm001,2,0.13,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
17312,10329,Blank 490,1,A,OHSU_HNSCC_derm001,3,0.012,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
17313,10329,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.247,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
17314,10329,Blank 490,1,C,OHSU_HNSCC_derm001,3,0.395,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
17315,10329,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.146,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17316,10329,Blank 490,1,E,OHSU_HNSCC_derm001,3,0.353,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
17317,10329,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.3,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
17318,10329,Blank 490,1,G,OHSU_HNSCC_derm001,3,0.214,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17319,10329,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.154,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
17320,10329,Blank 490,1,I,OHSU_HNSCC_derm001,3,0.265,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
17321,10329,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.286,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
17322,10329,Blank 490,1,K,OHSU_HNSCC_derm001,3,0.412,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
17323,10329,Blank 490,1,L,OHSU_HNSCC_derm001,3,0.049,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
17324,10329,Blank 490,1,M,OHSU_HNSCC_derm001,3,0.381,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
17325,10329,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.464,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
17326,10329,Blank 490,1,O,OHSU_HNSCC_derm001,3,0.237,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
17327,10329,Blank 490,1,P,OHSU_HNSCC_derm001,3,0.133,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
17328,10329,Blank 490,1,A,OHSU_HNSCC_derm001,4,0.045,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
17329,10329,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.366,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
17330,10329,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.315,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
17331,10329,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.138,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17332,10329,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.317,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
17333,10329,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.318,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
17334,10329,Blank 490,1,G,OHSU_HNSCC_derm001,4,0.249,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17335,10329,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.17,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
17336,10329,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.293,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
17337,10329,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.308,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
17338,10329,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.514,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
17339,10329,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.084,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
17340,10329,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.403,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
17341,10329,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.455,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
17342,10329,Blank 490,1,O,OHSU_HNSCC_derm001,4,0.329,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
17343,10329,Blank 490,1,P,OHSU_HNSCC_derm001,4,0.157,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
17344,10329,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.12,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
17345,10329,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.277,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
17346,10329,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.345,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
17347,10329,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.156,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17348,10329,Blank 490,1,E,OHSU_HNSCC_derm001,5,0.341,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
17349,10329,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.319,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
17350,10329,Blank 490,1,G,OHSU_HNSCC_derm001,5,0.316,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17351,10329,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.214,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
17352,10329,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.322,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
17353,10329,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.336,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
17354,10329,Blank 490,1,K,OHSU_HNSCC_derm001,5,0.466,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
17355,10329,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.216,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
17356,10329,Blank 490,1,M,OHSU_HNSCC_derm001,5,0.374,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
17357,10329,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.394,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
17358,10329,Blank 490,1,O,OHSU_HNSCC_derm001,5,0.293,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
17359,10329,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.205,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
17360,10329,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.224,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
17361,10329,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.359,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
17362,10329,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.308,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
17363,10329,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.151,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17364,10329,Blank 490,1,E,OHSU_HNSCC_derm001,6,0.328,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
17365,10329,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.357,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
17366,10329,Blank 490,1,G,OHSU_HNSCC_derm001,6,0.363,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17367,10329,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.274,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
17368,10329,Blank 490,1,I,OHSU_HNSCC_derm001,6,0.366,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
17369,10329,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.361,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
17370,10329,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.448,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
17371,10329,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.331,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
17372,10329,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.422,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
17373,10329,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.424,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
17374,10329,Blank 490,1,O,OHSU_HNSCC_derm001,6,0.427,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
17375,10329,Blank 490,1,P,OHSU_HNSCC_derm001,6,0.221,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
17376,10329,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.254,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
17377,10329,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.263,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
17378,10329,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.328,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
17379,10329,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.211,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
17380,10329,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.343,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
17381,10329,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.321,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
17382,10329,Blank 490,1,G,OHSU_HNSCC_derm001,7,0.396,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
17383,10329,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.295,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
17384,10329,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.362,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
17385,10329,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.388,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
17386,10329,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.408,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
17387,10329,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.385,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
17388,10329,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.334,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
17389,10329,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.419,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
17390,10329,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.348,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
17391,10329,Blank 490,1,P,OHSU_HNSCC_derm001,7,0.282,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
17392,10329,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.265,0,NONE,OHSU_HNSCC_derm001
17393,10329,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.28,0,NONE,OHSU_HNSCC_derm001
17394,10329,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.359,0,NONE,OHSU_HNSCC_derm001
17395,10329,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.359,0,NONE,OHSU_HNSCC_derm001
17396,10329,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.365,0,NONE,OHSU_HNSCC_derm001
17397,10329,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.337,0,NONE,OHSU_HNSCC_derm001
17398,10329,Blank 490,1,G,OHSU_HNSCC_derm001,8,0.362,0,NONE,OHSU_HNSCC_derm001
17399,10329,Blank 490,1,H,OHSU_HNSCC_derm001,8,0.002,10,F-S-V,OHSU_HNSCC_derm001
17400,10329,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.357,0,NONE,OHSU_HNSCC_derm001
17401,10329,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.369,0,NONE,OHSU_HNSCC_derm001
17402,10329,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.387,0,NONE,OHSU_HNSCC_derm001
17403,10329,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.406,0,NONE,OHSU_HNSCC_derm001
17404,10329,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.377,0,NONE,OHSU_HNSCC_derm001
17405,10329,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.403,0,NONE,OHSU_HNSCC_derm001
17406,10329,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.394,0,NONE,OHSU_HNSCC_derm001
17407,10329,Blank 490,1,P,OHSU_HNSCC_derm001,8,0.329,0,NONE,OHSU_HNSCC_derm001
17408,10329,Blank 490,1,A,OHSU_HNSCC_derm001,9,0.014,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17409,10329,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.25,10,Sorafenib,OHSU_HNSCC_derm001
17410,10329,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.451,10,Rosmarinic acid,OHSU_HNSCC_derm001
17411,10329,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.207,10,Rapamycin,OHSU_HNSCC_derm001
17412,10329,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.317,10,Vismodegib,OHSU_HNSCC_derm001
17413,10329,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.086,10,PP242,OHSU_HNSCC_derm001
17414,10329,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.221,10,Alectinib,OHSU_HNSCC_derm001
17415,10329,Blank 490,1,H,OHSU_HNSCC_derm001,9,0.023,10,Brigatinib,OHSU_HNSCC_derm001
17416,10329,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.104,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17417,10329,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.218,10,MK-2206,OHSU_HNSCC_derm001
17418,10329,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.167,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17419,10329,Blank 490,1,L,OHSU_HNSCC_derm001,9,0.03,10,Flavopiridol ,OHSU_HNSCC_derm001
17420,10329,Blank 490,1,M,OHSU_HNSCC_derm001,9,0.399,10,Indirubin,OHSU_HNSCC_derm001
17421,10329,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.477,10,PF-533228,OHSU_HNSCC_derm001
17422,10329,Blank 490,1,O,OHSU_HNSCC_derm001,9,0.453,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17423,10329,Blank 490,1,P,OHSU_HNSCC_derm001,9,0.037,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17424,10329,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.025,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17425,10329,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.356,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
17426,10329,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.373,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
17427,10329,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.213,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
17428,10329,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.333,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
17429,10329,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.097,3.3333333333333335,PP242,OHSU_HNSCC_derm001
17430,10329,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.195,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
17431,10329,Blank 490,1,H,OHSU_HNSCC_derm001,10,0.03,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
17432,10329,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.143,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17433,10329,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.26,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
17434,10329,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.207,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17435,10329,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.041,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
17436,10329,Blank 490,1,M,OHSU_HNSCC_derm001,10,0.452,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
17437,10329,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.613,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
17438,10329,Blank 490,1,O,OHSU_HNSCC_derm001,10,0.426,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17439,10329,Blank 490,1,P,OHSU_HNSCC_derm001,10,0.053,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17440,10329,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.023,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17441,10329,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.362,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
17442,10329,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.346,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
17443,10329,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.212,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
17444,10329,Blank 490,1,E,OHSU_HNSCC_derm001,11,0.322,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
17445,10329,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.111,1.1111111111111112,PP242,OHSU_HNSCC_derm001
17446,10329,Blank 490,1,G,OHSU_HNSCC_derm001,11,0.36,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
17447,10329,Blank 490,1,H,OHSU_HNSCC_derm001,11,0.132,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
17448,10329,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.168,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17449,10329,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.274,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
17450,10329,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.212,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17451,10329,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.043,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
17452,10329,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.511,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
17453,10329,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.56,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
17454,10329,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.394,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17455,10329,Blank 490,1,P,OHSU_HNSCC_derm001,11,0.06,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17456,10329,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.024,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17457,10329,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.283,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
17458,10329,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.325,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
17459,10329,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.205,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
17460,10329,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.341,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
17461,10329,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.162,0.3703703703703704,PP242,OHSU_HNSCC_derm001
17462,10329,Blank 490,1,G,OHSU_HNSCC_derm001,12,0.401,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
17463,10329,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.255,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
17464,10329,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.165,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17465,10329,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.289,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
17466,10329,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.211,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17467,10329,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.059,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
17468,10329,Blank 490,1,M,OHSU_HNSCC_derm001,12,0.466,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
17469,10329,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.519,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
17470,10329,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.354,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17471,10329,Blank 490,1,P,OHSU_HNSCC_derm001,12,0.074,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17472,10329,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.03,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17473,10329,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.365,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
17474,10329,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.398,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
17475,10329,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.204,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
17476,10329,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.361,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
17477,10329,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.234,0.1234567901234568,PP242,OHSU_HNSCC_derm001
17478,10329,Blank 490,1,G,OHSU_HNSCC_derm001,13,0.357,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
17479,10329,Blank 490,1,H,OHSU_HNSCC_derm001,13,0.271,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
17480,10329,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.179,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17481,10329,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.31,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
17482,10329,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.238,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17483,10329,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.087,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
17484,10329,Blank 490,1,M,OHSU_HNSCC_derm001,13,0.486,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
17485,10329,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.496,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
17486,10329,Blank 490,1,O,OHSU_HNSCC_derm001,13,0.422,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17487,10329,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.08,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17488,10329,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.059,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17489,10329,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.35,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
17490,10329,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.402,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
17491,10329,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.223,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
17492,10329,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.343,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
17493,10329,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.307,0.0411522633744856,PP242,OHSU_HNSCC_derm001
17494,10329,Blank 490,1,G,OHSU_HNSCC_derm001,14,0.398,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
17495,10329,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.326,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
17496,10329,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.174,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17497,10329,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.367,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
17498,10329,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.278,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17499,10329,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.171,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
17500,10329,Blank 490,1,M,OHSU_HNSCC_derm001,14,0.474,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
17501,10329,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.47,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
17502,10329,Blank 490,1,O,OHSU_HNSCC_derm001,14,0.358,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17503,10329,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.128,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17504,10329,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.157,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
17505,10329,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.234,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
17506,10329,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.331,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
17507,10329,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.232,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
17508,10329,Blank 490,1,E,OHSU_HNSCC_derm001,15,0.348,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
17509,10329,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.336,0.013717421124828532,PP242,OHSU_HNSCC_derm001
17510,10329,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.372,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
17511,10329,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.342,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
17512,10329,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.204,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17513,10329,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.38,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
17514,10329,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.339,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
17515,10329,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.247,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
17516,10329,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.423,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
17517,10329,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.488,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
17518,10329,Blank 490,1,O,OHSU_HNSCC_derm001,15,0.399,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
17519,10329,Blank 490,1,P,OHSU_HNSCC_derm001,15,0.275,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
17520,10329,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.332,0,NONE,OHSU_HNSCC_derm001
17521,10329,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.267,0,NONE,OHSU_HNSCC_derm001
17522,10329,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.451,0,NONE,OHSU_HNSCC_derm001
17523,10329,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.328,0,NONE,OHSU_HNSCC_derm001
17524,10329,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.376,0,NONE,OHSU_HNSCC_derm001
17525,10329,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.331,0,NONE,OHSU_HNSCC_derm001
17526,10329,Blank 490,1,G,OHSU_HNSCC_derm001,16,0.386,0,NONE,OHSU_HNSCC_derm001
17527,10329,Blank 490,1,H,OHSU_HNSCC_derm001,16,-0.002,10,F-S-V,OHSU_HNSCC_derm001
17528,10329,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.387,0,NONE,OHSU_HNSCC_derm001
17529,10329,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.369,0,NONE,OHSU_HNSCC_derm001
17530,10329,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.386,0,NONE,OHSU_HNSCC_derm001
17531,10329,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.397,0,NONE,OHSU_HNSCC_derm001
17532,10329,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.428,0,NONE,OHSU_HNSCC_derm001
17533,10329,Blank 490,1,N,OHSU_HNSCC_derm001,16,0.399,0,NONE,OHSU_HNSCC_derm001
17534,10329,Blank 490,1,O,OHSU_HNSCC_derm001,16,0.423,0,NONE,OHSU_HNSCC_derm001
17535,10329,Blank 490,1,P,OHSU_HNSCC_derm001,16,0.296,0,NONE,OHSU_HNSCC_derm001
17536,10329,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.17,10,Emodin,OHSU_HNSCC_derm001
17537,10329,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.244,10,Baicalin,OHSU_HNSCC_derm001
17538,10329,Blank 490,1,C,OHSU_HNSCC_derm001,17,0.023,10,NVP-TAE-684,OHSU_HNSCC_derm001
17539,10329,Blank 490,1,D,OHSU_HNSCC_derm001,17,0.035,10,Panobinostat,OHSU_HNSCC_derm001
17540,10329,Blank 490,1,E,OHSU_HNSCC_derm001,17,0.032,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
17541,10329,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.409,10,Fulvestrant,OHSU_HNSCC_derm001
17542,10329,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.082,10,SCH-772984,OHSU_HNSCC_derm001
17543,10329,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.141,10,Trametinib,OHSU_HNSCC_derm001
17544,10329,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.042,10,BEZ235,OHSU_HNSCC_derm001
17545,10329,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.334,10,MLN120B,OHSU_HNSCC_derm001
17546,10329,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.14,10,Ixabepilone,OHSU_HNSCC_derm001
17547,10329,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.023,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
17548,10329,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.142,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17549,10329,Blank 490,1,N,OHSU_HNSCC_derm001,17,0.098,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17550,10329,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.351,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17551,10329,Blank 490,1,P,OHSU_HNSCC_derm001,17,0.297,10,Letrozole,OHSU_HNSCC_derm001
17552,10329,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.223,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
17553,10329,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.333,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
17554,10329,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.048,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
17555,10329,Blank 490,1,D,OHSU_HNSCC_derm001,18,0.036,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
17556,10329,Blank 490,1,E,OHSU_HNSCC_derm001,18,0.058,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
17557,10329,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.375,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
17558,10329,Blank 490,1,G,OHSU_HNSCC_derm001,18,0.114,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
17559,10329,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.137,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
17560,10329,Blank 490,1,I,OHSU_HNSCC_derm001,18,0.053,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
17561,10329,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.373,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
17562,10329,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.164,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
17563,10329,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.14,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
17564,10329,Blank 490,1,M,OHSU_HNSCC_derm001,18,0.192,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17565,10329,Blank 490,1,N,OHSU_HNSCC_derm001,18,0.124,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17566,10329,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.337,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17567,10329,Blank 490,1,P,OHSU_HNSCC_derm001,18,0.327,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
17568,10329,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.256,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
17569,10329,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.256,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
17570,10329,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.148,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
17571,10329,Blank 490,1,D,OHSU_HNSCC_derm001,19,0.036,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
17572,10329,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.065,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
17573,10329,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.367,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
17574,10329,Blank 490,1,G,OHSU_HNSCC_derm001,19,0.135,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
17575,10329,Blank 490,1,H,OHSU_HNSCC_derm001,19,0.132,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
17576,10329,Blank 490,1,I,OHSU_HNSCC_derm001,19,0.059,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
17577,10329,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.327,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
17578,10329,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.178,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
17579,10329,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.196,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
17580,10329,Blank 490,1,M,OHSU_HNSCC_derm001,19,0.209,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17581,10329,Blank 490,1,N,OHSU_HNSCC_derm001,19,0.154,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17582,10329,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.407,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17583,10329,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.335,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
17584,10329,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.28,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
17585,10329,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.301,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
17586,10329,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.233,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
17587,10329,Blank 490,1,D,OHSU_HNSCC_derm001,20,0.081,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
17588,10329,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.103,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
17589,10329,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.357,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
17590,10329,Blank 490,1,G,OHSU_HNSCC_derm001,20,0.157,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
17591,10329,Blank 490,1,H,OHSU_HNSCC_derm001,20,0.134,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
17592,10329,Blank 490,1,I,OHSU_HNSCC_derm001,20,0.07,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
17593,10329,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.371,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
17594,10329,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.173,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
17595,10329,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.186,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
17596,10329,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.191,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17597,10329,Blank 490,1,N,OHSU_HNSCC_derm001,20,0.211,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17598,10329,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.384,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17599,10329,Blank 490,1,P,OHSU_HNSCC_derm001,20,0.307,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
17600,10329,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.271,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
17601,10329,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.305,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
17602,10329,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.345,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
17603,10329,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.174,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
17604,10329,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.156,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
17605,10329,Blank 490,1,F,OHSU_HNSCC_derm001,21,0.356,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
17606,10329,Blank 490,1,G,OHSU_HNSCC_derm001,21,0.207,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
17607,10329,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.148,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
17608,10329,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.138,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
17609,10329,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.353,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
17610,10329,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.175,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
17611,10329,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.192,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
17612,10329,Blank 490,1,M,OHSU_HNSCC_derm001,21,0.249,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17613,10329,Blank 490,1,N,OHSU_HNSCC_derm001,21,0.295,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17614,10329,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.398,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17615,10329,Blank 490,1,P,OHSU_HNSCC_derm001,21,0.319,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
17616,10329,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.293,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
17617,10329,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.298,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
17618,10329,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.367,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
17619,10329,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.271,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
17620,10329,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.257,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
17621,10329,Blank 490,1,F,OHSU_HNSCC_derm001,22,0.372,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
17622,10329,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.264,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
17623,10329,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.155,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
17624,10329,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.23,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
17625,10329,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.35,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
17626,10329,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.207,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
17627,10329,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.247,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
17628,10329,Blank 490,1,M,OHSU_HNSCC_derm001,22,0.288,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17629,10329,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.346,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17630,10329,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.407,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17631,10329,Blank 490,1,P,OHSU_HNSCC_derm001,22,0.31,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
17632,10329,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.272,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
17633,10329,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.291,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
17634,10329,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.318,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
17635,10329,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.344,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
17636,10329,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.321,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
17637,10329,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.383,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
17638,10329,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.315,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
17639,10329,Blank 490,1,H,OHSU_HNSCC_derm001,23,0.185,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
17640,10329,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.34,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
17641,10329,Blank 490,1,J,OHSU_HNSCC_derm001,23,0.397,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
17642,10329,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.249,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
17643,10329,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.228,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
17644,10329,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.29,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
17645,10329,Blank 490,1,N,OHSU_HNSCC_derm001,23,0.316,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
17646,10329,Blank 490,1,O,OHSU_HNSCC_derm001,23,0.374,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
17647,10329,Blank 490,1,P,OHSU_HNSCC_derm001,23,0.289,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
17648,10329,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.255,0,NONE,OHSU_HNSCC_derm001
17649,10329,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.28,0,NONE,OHSU_HNSCC_derm001
17650,10329,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.312,0,NONE,OHSU_HNSCC_derm001
17651,10329,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.311,0,NONE,OHSU_HNSCC_derm001
17652,10329,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.305,0,NONE,OHSU_HNSCC_derm001
17653,10329,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.279,0,NONE,OHSU_HNSCC_derm001
17654,10329,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.328,0,NONE,OHSU_HNSCC_derm001
17655,10329,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.291,0,NONE,OHSU_HNSCC_derm001
17656,10329,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.303,0,NONE,OHSU_HNSCC_derm001
17657,10329,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.341,0,NONE,OHSU_HNSCC_derm001
17658,10329,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.298,0,NONE,OHSU_HNSCC_derm001
17659,10329,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.327,0,NONE,OHSU_HNSCC_derm001
17660,10329,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.345,0,NONE,OHSU_HNSCC_derm001
17661,10329,Blank 490,1,N,OHSU_HNSCC_derm001,24,0.348,0,NONE,OHSU_HNSCC_derm001
17662,10329,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.331,0,NONE,OHSU_HNSCC_derm001
17663,10329,Blank 490,1,P,OHSU_HNSCC_derm001,24,0.304,0,NONE,OHSU_HNSCC_derm001
17664,10329,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.263,10,Coumarin,OHSU_HNSCC_derm001
17665,10329,Blank 490,2,B,OHSU_HNSCC_derm001,1,0.015,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17666,10329,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.027,10,Foretinib (XL-880),OHSU_HNSCC_derm001
17667,10329,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.368,10,Elesclomol,OHSU_HNSCC_derm001
17668,10329,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.222,10,Vemurafenib,OHSU_HNSCC_derm001
17669,10329,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.029,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17670,10329,Blank 490,2,G,OHSU_HNSCC_derm001,1,0.01,10,Ponatinib,OHSU_HNSCC_derm001
17671,10329,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.126,10,Gefitinib,OHSU_HNSCC_derm001
17672,10329,Blank 490,2,I,OHSU_HNSCC_derm001,1,0.017,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
17673,10329,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.367,1,Sunitinib (1mM),OHSU_HNSCC_derm001
17674,10329,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.324,10,Curcumin,OHSU_HNSCC_derm001
17675,10329,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.07,10,PF-562271,OHSU_HNSCC_derm001
17676,10329,Blank 490,2,M,OHSU_HNSCC_derm001,1,0.273,10,STO609,OHSU_HNSCC_derm001
17677,10329,Blank 490,2,N,OHSU_HNSCC_derm001,1,0.203,10,Lenvatinib,OHSU_HNSCC_derm001
17678,10329,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.021,10,Entrectinib,OHSU_HNSCC_derm001
17679,10329,Blank 490,2,P,OHSU_HNSCC_derm001,1,0.416,10,Ethyl Gallate ,OHSU_HNSCC_derm001
17680,10329,Blank 490,2,A,OHSU_HNSCC_derm001,2,0.289,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
17681,10329,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.075,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17682,10329,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.139,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
17683,10329,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.319,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
17684,10329,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.376,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
17685,10329,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.031,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17686,10329,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.029,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
17687,10329,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.193,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
17688,10329,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.221,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
17689,10329,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.508,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
17690,10329,Blank 490,2,K,OHSU_HNSCC_derm001,2,0.286,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
17691,10329,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.194,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
17692,10329,Blank 490,2,M,OHSU_HNSCC_derm001,2,0.264,3.3333333333333335,STO609,OHSU_HNSCC_derm001
17693,10329,Blank 490,2,N,OHSU_HNSCC_derm001,2,0.262,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
17694,10329,Blank 490,2,O,OHSU_HNSCC_derm001,2,0.21,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
17695,10329,Blank 490,2,P,OHSU_HNSCC_derm001,2,0.351,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
17696,10329,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.311,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
17697,10329,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.117,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17698,10329,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.224,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
17699,10329,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.171,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
17700,10329,Blank 490,2,E,OHSU_HNSCC_derm001,3,0.438,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
17701,10329,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.049,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17702,10329,Blank 490,2,G,OHSU_HNSCC_derm001,3,0.244,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
17703,10329,Blank 490,2,H,OHSU_HNSCC_derm001,3,0.173,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
17704,10329,Blank 490,2,I,OHSU_HNSCC_derm001,3,0.341,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
17705,10329,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.419,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
17706,10329,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.361,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
17707,10329,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.379,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
17708,10329,Blank 490,2,M,OHSU_HNSCC_derm001,3,0.313,1.1111111111111112,STO609,OHSU_HNSCC_derm001
17709,10329,Blank 490,2,N,OHSU_HNSCC_derm001,3,0.402,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
17710,10329,Blank 490,2,O,OHSU_HNSCC_derm001,3,0.339,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
17711,10329,Blank 490,2,P,OHSU_HNSCC_derm001,3,0.307,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
17712,10329,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.287,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
17713,10329,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.16,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17714,10329,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.245,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
17715,10329,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.082,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
17716,10329,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.355,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
17717,10329,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.088,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17718,10329,Blank 490,2,G,OHSU_HNSCC_derm001,4,0.329,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
17719,10329,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.19,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
17720,10329,Blank 490,2,I,OHSU_HNSCC_derm001,4,0.357,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
17721,10329,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.373,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
17722,10329,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.377,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
17723,10329,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.417,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
17724,10329,Blank 490,2,M,OHSU_HNSCC_derm001,4,0.385,0.3703703703703704,STO609,OHSU_HNSCC_derm001
17725,10329,Blank 490,2,N,OHSU_HNSCC_derm001,4,0.395,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
17726,10329,Blank 490,2,O,OHSU_HNSCC_derm001,4,0.327,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
17727,10329,Blank 490,2,P,OHSU_HNSCC_derm001,4,0.315,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
17728,10329,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.302,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
17729,10329,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.147,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17730,10329,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.318,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
17731,10329,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.063,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
17732,10329,Blank 490,2,E,OHSU_HNSCC_derm001,5,0.359,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
17733,10329,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.148,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17734,10329,Blank 490,2,G,OHSU_HNSCC_derm001,5,0.32,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
17735,10329,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.271,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
17736,10329,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.421,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
17737,10329,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.387,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
17738,10329,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.384,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
17739,10329,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.419,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
17740,10329,Blank 490,2,M,OHSU_HNSCC_derm001,5,0.426,0.1234567901234568,STO609,OHSU_HNSCC_derm001
17741,10329,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.44,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
17742,10329,Blank 490,2,O,OHSU_HNSCC_derm001,5,0.299,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
17743,10329,Blank 490,2,P,OHSU_HNSCC_derm001,5,0.339,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
17744,10329,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.284,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
17745,10329,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.145,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17746,10329,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.362,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
17747,10329,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.057,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
17748,10329,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.38,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
17749,10329,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.271,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17750,10329,Blank 490,2,G,OHSU_HNSCC_derm001,6,0.341,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
17751,10329,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.309,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
17752,10329,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.409,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
17753,10329,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.401,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
17754,10329,Blank 490,2,K,OHSU_HNSCC_derm001,6,0.416,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
17755,10329,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.485,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
17756,10329,Blank 490,2,M,OHSU_HNSCC_derm001,6,0.389,0.0411522633744856,STO609,OHSU_HNSCC_derm001
17757,10329,Blank 490,2,N,OHSU_HNSCC_derm001,6,0.436,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
17758,10329,Blank 490,2,O,OHSU_HNSCC_derm001,6,0.346,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
17759,10329,Blank 490,2,P,OHSU_HNSCC_derm001,6,0.323,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
17760,10329,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.269,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
17761,10329,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.212,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
17762,10329,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.402,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
17763,10329,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.097,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
17764,10329,Blank 490,2,E,OHSU_HNSCC_derm001,7,0.363,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
17765,10329,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.354,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
17766,10329,Blank 490,2,G,OHSU_HNSCC_derm001,7,0.351,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
17767,10329,Blank 490,2,H,OHSU_HNSCC_derm001,7,0.365,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
17768,10329,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.103,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
17769,10329,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.145,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
17770,10329,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.407,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
17771,10329,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.498,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
17772,10329,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.434,0.013717421124828532,STO609,OHSU_HNSCC_derm001
17773,10329,Blank 490,2,N,OHSU_HNSCC_derm001,7,0.449,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
17774,10329,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.37,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
17775,10329,Blank 490,2,P,OHSU_HNSCC_derm001,7,0.347,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
17776,10329,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.304,0,NONE,OHSU_HNSCC_derm001
17777,10329,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.383,0,NONE,OHSU_HNSCC_derm001
17778,10329,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.372,0,NONE,OHSU_HNSCC_derm001
17779,10329,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.333,0,NONE,OHSU_HNSCC_derm001
17780,10329,Blank 490,2,E,OHSU_HNSCC_derm001,8,0.376,0,NONE,OHSU_HNSCC_derm001
17781,10329,Blank 490,2,F,OHSU_HNSCC_derm001,8,0.355,0,NONE,OHSU_HNSCC_derm001
17782,10329,Blank 490,2,G,OHSU_HNSCC_derm001,8,0.135,0,NONE,OHSU_HNSCC_derm001
17783,10329,Blank 490,2,H,OHSU_HNSCC_derm001,8,0.003,10,F-S-V,OHSU_HNSCC_derm001
17784,10329,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.307,0,NONE,OHSU_HNSCC_derm001
17785,10329,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.403,0,NONE,OHSU_HNSCC_derm001
17786,10329,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.385,0,NONE,OHSU_HNSCC_derm001
17787,10329,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.441,0,NONE,OHSU_HNSCC_derm001
17788,10329,Blank 490,2,M,OHSU_HNSCC_derm001,8,0.391,0,NONE,OHSU_HNSCC_derm001
17789,10329,Blank 490,2,N,OHSU_HNSCC_derm001,8,0.408,0,NONE,OHSU_HNSCC_derm001
17790,10329,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.384,0,NONE,OHSU_HNSCC_derm001
17791,10329,Blank 490,2,P,OHSU_HNSCC_derm001,8,0.312,0,NONE,OHSU_HNSCC_derm001
17792,10329,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.024,10,GDC-0941,OHSU_HNSCC_derm001
17793,10329,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.46,10,Dovitinib,OHSU_HNSCC_derm001
17794,10329,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.124,10,BI-2536,OHSU_HNSCC_derm001
17795,10329,Blank 490,2,D,OHSU_HNSCC_derm001,9,0.042,10,TP-0903 ,OHSU_HNSCC_derm001
17796,10329,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.062,10,Belinostat,OHSU_HNSCC_derm001
17797,10329,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.016,10,INK-128,OHSU_HNSCC_derm001
17798,10329,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.076,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17799,10329,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.039,10,Brigatinib,OHSU_HNSCC_derm001
17800,10329,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.078,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17801,10329,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.09,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17802,10329,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.223,10,Pazopanib,OHSU_HNSCC_derm001
17803,10329,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.444,10,AZD4547,OHSU_HNSCC_derm001
17804,10329,Blank 490,2,M,OHSU_HNSCC_derm001,9,0.394,10,Pomalidomide ,OHSU_HNSCC_derm001
17805,10329,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.213,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
17806,10329,Blank 490,2,O,OHSU_HNSCC_derm001,9,0.335,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17807,10329,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.0,10,Staurosporin,OHSU_HNSCC_derm001
17808,10329,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.033,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
17809,10329,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.487,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
17810,10329,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.278,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
17811,10329,Blank 490,2,D,OHSU_HNSCC_derm001,10,0.041,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
17812,10329,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.115,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
17813,10329,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.041,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
17814,10329,Blank 490,2,G,OHSU_HNSCC_derm001,10,0.107,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17815,10329,Blank 490,2,H,OHSU_HNSCC_derm001,10,0.046,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
17816,10329,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.166,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17817,10329,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.193,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17818,10329,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.27,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
17819,10329,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.49,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
17820,10329,Blank 490,2,M,OHSU_HNSCC_derm001,10,0.361,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
17821,10329,Blank 490,2,N,OHSU_HNSCC_derm001,10,0.239,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
17822,10329,Blank 490,2,O,OHSU_HNSCC_derm001,10,0.331,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17823,10329,Blank 490,2,P,OHSU_HNSCC_derm001,10,0.004,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
17824,10329,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.059,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
17825,10329,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.565,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
17826,10329,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.33,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
17827,10329,Blank 490,2,D,OHSU_HNSCC_derm001,11,0.019,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
17828,10329,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.215,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
17829,10329,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.056,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
17830,10329,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.124,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17831,10329,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.175,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
17832,10329,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.179,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17833,10329,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.266,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17834,10329,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.312,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
17835,10329,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.458,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
17836,10329,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.401,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
17837,10329,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.303,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
17838,10329,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.34,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17839,10329,Blank 490,2,P,OHSU_HNSCC_derm001,11,0.011,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
17840,10329,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.083,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
17841,10329,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.437,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
17842,10329,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.506,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
17843,10329,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.114,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
17844,10329,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.298,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
17845,10329,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.076,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
17846,10329,Blank 490,2,G,OHSU_HNSCC_derm001,12,0.128,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17847,10329,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.326,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
17848,10329,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.179,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17849,10329,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.313,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17850,10329,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.365,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
17851,10329,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.435,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
17852,10329,Blank 490,2,M,OHSU_HNSCC_derm001,12,0.411,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
17853,10329,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.374,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
17854,10329,Blank 490,2,O,OHSU_HNSCC_derm001,12,0.389,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17855,10329,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.02,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
17856,10329,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.125,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
17857,10329,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.418,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
17858,10329,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.44,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
17859,10329,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.348,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
17860,10329,Blank 490,2,E,OHSU_HNSCC_derm001,13,0.322,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
17861,10329,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.093,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
17862,10329,Blank 490,2,G,OHSU_HNSCC_derm001,13,0.143,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17863,10329,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.35,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
17864,10329,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.173,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17865,10329,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.356,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17866,10329,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.38,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
17867,10329,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.42,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
17868,10329,Blank 490,2,M,OHSU_HNSCC_derm001,13,0.364,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
17869,10329,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.388,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
17870,10329,Blank 490,2,O,OHSU_HNSCC_derm001,13,0.384,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17871,10329,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.038,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
17872,10329,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.206,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
17873,10329,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.41,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
17874,10329,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.457,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
17875,10329,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.414,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
17876,10329,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.368,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
17877,10329,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.145,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
17878,10329,Blank 490,2,G,OHSU_HNSCC_derm001,14,0.171,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17879,10329,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.379,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
17880,10329,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.181,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17881,10329,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.384,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17882,10329,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.422,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
17883,10329,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.412,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
17884,10329,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.433,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
17885,10329,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.413,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
17886,10329,Blank 490,2,O,OHSU_HNSCC_derm001,14,0.323,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17887,10329,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.078,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
17888,10329,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.238,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
17889,10329,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.337,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
17890,10329,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.411,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
17891,10329,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.371,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
17892,10329,Blank 490,2,E,OHSU_HNSCC_derm001,15,0.345,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
17893,10329,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.187,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
17894,10329,Blank 490,2,G,OHSU_HNSCC_derm001,15,0.197,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
17895,10329,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.406,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
17896,10329,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.207,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
17897,10329,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.359,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
17898,10329,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.437,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
17899,10329,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.427,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
17900,10329,Blank 490,2,M,OHSU_HNSCC_derm001,15,0.421,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
17901,10329,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.487,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
17902,10329,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.33,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
17903,10329,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.084,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
17904,10329,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.259,0,NONE,OHSU_HNSCC_derm001
17905,10329,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.377,0,NONE,OHSU_HNSCC_derm001
17906,10329,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.406,0,NONE,OHSU_HNSCC_derm001
17907,10329,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.377,0,NONE,OHSU_HNSCC_derm001
17908,10329,Blank 490,2,E,OHSU_HNSCC_derm001,16,0.358,0,NONE,OHSU_HNSCC_derm001
17909,10329,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.349,0,NONE,OHSU_HNSCC_derm001
17910,10329,Blank 490,2,G,OHSU_HNSCC_derm001,16,0.389,0,NONE,OHSU_HNSCC_derm001
17911,10329,Blank 490,2,H,OHSU_HNSCC_derm001,16,-0.003,10,F-S-V,OHSU_HNSCC_derm001
17912,10329,Blank 490,2,I,OHSU_HNSCC_derm001,16,0.369,0,NONE,OHSU_HNSCC_derm001
17913,10329,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.381,0,NONE,OHSU_HNSCC_derm001
17914,10329,Blank 490,2,K,OHSU_HNSCC_derm001,16,0.401,0,NONE,OHSU_HNSCC_derm001
17915,10329,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.404,0,NONE,OHSU_HNSCC_derm001
17916,10329,Blank 490,2,M,OHSU_HNSCC_derm001,16,0.416,0,NONE,OHSU_HNSCC_derm001
17917,10329,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.469,0,NONE,OHSU_HNSCC_derm001
17918,10329,Blank 490,2,O,OHSU_HNSCC_derm001,16,0.376,0,NONE,OHSU_HNSCC_derm001
17919,10329,Blank 490,2,P,OHSU_HNSCC_derm001,16,0.326,0,NONE,OHSU_HNSCC_derm001
17920,10329,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.344,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
17921,10329,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.404,10,Hesperidin,OHSU_HNSCC_derm001
17922,10329,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.388,10,Esculetin,OHSU_HNSCC_derm001
17923,10329,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.166,10,Selinexor ,OHSU_HNSCC_derm001
17924,10329,Blank 490,2,E,OHSU_HNSCC_derm001,17,0.094,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
17925,10329,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.209,10,BMX-IN-1,OHSU_HNSCC_derm001
17926,10329,Blank 490,2,G,OHSU_HNSCC_derm001,17,0.062,1,Dasatinib (1mM),OHSU_HNSCC_derm001
17927,10329,Blank 490,2,H,OHSU_HNSCC_derm001,17,0.14,10,Trametinib,OHSU_HNSCC_derm001
17928,10329,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.044,10,BEZ235,OHSU_HNSCC_derm001
17929,10329,Blank 490,2,J,OHSU_HNSCC_derm001,17,0.016,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
17930,10329,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.207,10,Nilotinib,OHSU_HNSCC_derm001
17931,10329,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.355,10,Enzalutamide,OHSU_HNSCC_derm001
17932,10329,Blank 490,2,M,OHSU_HNSCC_derm001,17,0.528,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
17933,10329,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.04,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
17934,10329,Blank 490,2,O,OHSU_HNSCC_derm001,17,0.028,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
17935,10329,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.237,10,Axitinib,OHSU_HNSCC_derm001
17936,10329,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.347,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
17937,10329,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.419,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
17938,10329,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.376,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
17939,10329,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.141,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
17940,10329,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.354,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
17941,10329,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.29,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
17942,10329,Blank 490,2,G,OHSU_HNSCC_derm001,18,0.077,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
17943,10329,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.165,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
17944,10329,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.044,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
17945,10329,Blank 490,2,J,OHSU_HNSCC_derm001,18,0.003,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
17946,10329,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.342,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
17947,10329,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.373,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
17948,10329,Blank 490,2,M,OHSU_HNSCC_derm001,18,0.475,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
17949,10329,Blank 490,2,N,OHSU_HNSCC_derm001,18,0.06,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
17950,10329,Blank 490,2,O,OHSU_HNSCC_derm001,18,0.028,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
17951,10329,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.304,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
17952,10329,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.313,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
17953,10329,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.434,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
17954,10329,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.412,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
17955,10329,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.164,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
17956,10329,Blank 490,2,E,OHSU_HNSCC_derm001,19,0.388,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
17957,10329,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.311,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
17958,10329,Blank 490,2,G,OHSU_HNSCC_derm001,19,0.112,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
17959,10329,Blank 490,2,H,OHSU_HNSCC_derm001,19,0.149,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
17960,10329,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.037,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
17961,10329,Blank 490,2,J,OHSU_HNSCC_derm001,19,0.013,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
17962,10329,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.345,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
17963,10329,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.394,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
17964,10329,Blank 490,2,M,OHSU_HNSCC_derm001,19,0.426,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
17965,10329,Blank 490,2,N,OHSU_HNSCC_derm001,19,0.067,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
17966,10329,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.035,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
17967,10329,Blank 490,2,P,OHSU_HNSCC_derm001,19,0.346,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
17968,10329,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.283,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
17969,10329,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.319,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
17970,10329,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.405,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
17971,10329,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.183,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
17972,10329,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.371,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
17973,10329,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.333,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
17974,10329,Blank 490,2,G,OHSU_HNSCC_derm001,20,0.216,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
17975,10329,Blank 490,2,H,OHSU_HNSCC_derm001,20,0.157,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
17976,10329,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.065,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
17977,10329,Blank 490,2,J,OHSU_HNSCC_derm001,20,0.039,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
17978,10329,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.373,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
17979,10329,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.406,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
17980,10329,Blank 490,2,M,OHSU_HNSCC_derm001,20,0.419,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
17981,10329,Blank 490,2,N,OHSU_HNSCC_derm001,20,0.126,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
17982,10329,Blank 490,2,O,OHSU_HNSCC_derm001,20,0.091,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
17983,10329,Blank 490,2,P,OHSU_HNSCC_derm001,20,0.343,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
17984,10329,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.286,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
17985,10329,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.377,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
17986,10329,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.402,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
17987,10329,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.272,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
17988,10329,Blank 490,2,E,OHSU_HNSCC_derm001,21,0.377,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
17989,10329,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.391,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
17990,10329,Blank 490,2,G,OHSU_HNSCC_derm001,21,0.297,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
17991,10329,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.19,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
17992,10329,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.145,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
17993,10329,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.083,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
17994,10329,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.385,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
17995,10329,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.44,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
17996,10329,Blank 490,2,M,OHSU_HNSCC_derm001,21,0.419,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
17997,10329,Blank 490,2,N,OHSU_HNSCC_derm001,21,0.211,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
17998,10329,Blank 490,2,O,OHSU_HNSCC_derm001,21,0.171,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
17999,10329,Blank 490,2,P,OHSU_HNSCC_derm001,21,0.336,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
18000,10329,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.27,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
18001,10329,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.397,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
18002,10329,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.367,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
18003,10329,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.269,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
18004,10329,Blank 490,2,E,OHSU_HNSCC_derm001,22,0.407,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
18005,10329,Blank 490,2,F,OHSU_HNSCC_derm001,22,0.357,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
18006,10329,Blank 490,2,G,OHSU_HNSCC_derm001,22,0.358,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
18007,10329,Blank 490,2,H,OHSU_HNSCC_derm001,22,0.166,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
18008,10329,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.242,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
18009,10329,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.16,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
18010,10329,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.488,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
18011,10329,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.433,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
18012,10329,Blank 490,2,M,OHSU_HNSCC_derm001,22,0.415,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
18013,10329,Blank 490,2,N,OHSU_HNSCC_derm001,22,0.301,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
18014,10329,Blank 490,2,O,OHSU_HNSCC_derm001,22,0.281,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
18015,10329,Blank 490,2,P,OHSU_HNSCC_derm001,22,0.348,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
18016,10329,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.296,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
18017,10329,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.297,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
18018,10329,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.391,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
18019,10329,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.383,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
18020,10329,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.367,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
18021,10329,Blank 490,2,F,OHSU_HNSCC_derm001,23,0.395,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
18022,10329,Blank 490,2,G,OHSU_HNSCC_derm001,23,0.37,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
18023,10329,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.176,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
18024,10329,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.303,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
18025,10329,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.355,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
18026,10329,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.427,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
18027,10329,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.406,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
18028,10329,Blank 490,2,M,OHSU_HNSCC_derm001,23,0.336,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
18029,10329,Blank 490,2,N,OHSU_HNSCC_derm001,23,0.306,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
18030,10329,Blank 490,2,O,OHSU_HNSCC_derm001,23,0.328,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
18031,10329,Blank 490,2,P,OHSU_HNSCC_derm001,23,0.321,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
18032,10329,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.236,0,NONE,OHSU_HNSCC_derm001
18033,10329,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.275,0,NONE,OHSU_HNSCC_derm001
18034,10329,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.322,0,NONE,OHSU_HNSCC_derm001
18035,10329,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.302,0,NONE,OHSU_HNSCC_derm001
18036,10329,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.284,0,NONE,OHSU_HNSCC_derm001
18037,10329,Blank 490,2,F,OHSU_HNSCC_derm001,24,0.308,0,NONE,OHSU_HNSCC_derm001
18038,10329,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.323,0,NONE,OHSU_HNSCC_derm001
18039,10329,Blank 490,2,H,OHSU_HNSCC_derm001,24,0.371,0,NONE,OHSU_HNSCC_derm001
18040,10329,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.306,0,NONE,OHSU_HNSCC_derm001
18041,10329,Blank 490,2,J,OHSU_HNSCC_derm001,24,0.345,0,NONE,OHSU_HNSCC_derm001
18042,10329,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.348,0,NONE,OHSU_HNSCC_derm001
18043,10329,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.317,0,NONE,OHSU_HNSCC_derm001
18044,10329,Blank 490,2,M,OHSU_HNSCC_derm001,24,0.356,0,NONE,OHSU_HNSCC_derm001
18045,10329,Blank 490,2,N,OHSU_HNSCC_derm001,24,0.381,0,NONE,OHSU_HNSCC_derm001
18046,10329,Blank 490,2,O,OHSU_HNSCC_derm001,24,0.383,0,NONE,OHSU_HNSCC_derm001
18047,10329,Blank 490,2,P,OHSU_HNSCC_derm001,24,0.343,0,NONE,OHSU_HNSCC_derm001
18048,10329,Blank 490,3,A,OHSU_HNSCC_derm001,1,-0.069,10,Thalidomide ,OHSU_HNSCC_derm001
18049,10329,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.081,10,Vandetanib,OHSU_HNSCC_derm001
18050,10329,Blank 490,3,C,OHSU_HNSCC_derm001,1,-0.067,10,Oleic acid,OHSU_HNSCC_derm001
18051,10329,Blank 490,3,D,OHSU_HNSCC_derm001,1,0.015,10,A-674563,OHSU_HNSCC_derm001
18052,10329,Blank 490,3,E,OHSU_HNSCC_derm001,1,-0.065,10,Lapatinib,OHSU_HNSCC_derm001
18053,10329,Blank 490,3,F,OHSU_HNSCC_derm001,1,0.303,10,Apocynin (vanillin),OHSU_HNSCC_derm001
18054,10329,Blank 490,3,G,OHSU_HNSCC_derm001,1,-0.066,10,AT-7519,OHSU_HNSCC_derm001
18055,10329,Blank 490,3,H,OHSU_HNSCC_derm001,1,0.118,10,Gefitinib,OHSU_HNSCC_derm001
18056,10329,Blank 490,3,I,OHSU_HNSCC_derm001,1,-0.065,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
18057,10329,Blank 490,3,J,OHSU_HNSCC_derm001,1,0.042,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18058,10329,Blank 490,3,K,OHSU_HNSCC_derm001,1,-0.064,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18059,10329,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.194,10,JQ1,OHSU_HNSCC_derm001
18060,10329,Blank 490,3,M,OHSU_HNSCC_derm001,1,-0.063,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18061,10329,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.619,10,Cerdulatinib,OHSU_HNSCC_derm001
18062,10329,Blank 490,3,O,OHSU_HNSCC_derm001,1,-0.064,10,Romidepsin,OHSU_HNSCC_derm001
18063,10329,Blank 490,3,P,OHSU_HNSCC_derm001,1,0.279,10,Gilteritinib,OHSU_HNSCC_derm001
18064,10329,Blank 490,3,A,OHSU_HNSCC_derm001,2,-0.066,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
18065,10329,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.152,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
18066,10329,Blank 490,3,C,OHSU_HNSCC_derm001,2,-0.069,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
18067,10329,Blank 490,3,D,OHSU_HNSCC_derm001,2,0.122,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
18068,10329,Blank 490,3,E,OHSU_HNSCC_derm001,2,-0.066,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
18069,10329,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.384,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
18070,10329,Blank 490,3,G,OHSU_HNSCC_derm001,2,-0.068,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
18071,10329,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.177,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
18072,10329,Blank 490,3,I,OHSU_HNSCC_derm001,2,-0.069,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
18073,10329,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.079,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18074,10329,Blank 490,3,K,OHSU_HNSCC_derm001,2,-0.068,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18075,10329,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.211,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
18076,10329,Blank 490,3,M,OHSU_HNSCC_derm001,2,-0.066,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18077,10329,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.712,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
18078,10329,Blank 490,3,O,OHSU_HNSCC_derm001,2,-0.068,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
18079,10329,Blank 490,3,P,OHSU_HNSCC_derm001,2,0.322,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
18080,10329,Blank 490,3,A,OHSU_HNSCC_derm001,3,-0.071,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
18081,10329,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.194,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
18082,10329,Blank 490,3,C,OHSU_HNSCC_derm001,3,-0.067,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
18083,10329,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.149,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
18084,10329,Blank 490,3,E,OHSU_HNSCC_derm001,3,-0.065,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
18085,10329,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.342,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
18086,10329,Blank 490,3,G,OHSU_HNSCC_derm001,3,-0.052,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
18087,10329,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.173,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
18088,10329,Blank 490,3,I,OHSU_HNSCC_derm001,3,-0.074,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
18089,10329,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.125,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18090,10329,Blank 490,3,K,OHSU_HNSCC_derm001,3,-0.057,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18091,10329,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.264,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
18092,10329,Blank 490,3,M,OHSU_HNSCC_derm001,3,-0.034,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18093,10329,Blank 490,3,N,OHSU_HNSCC_derm001,3,0.61,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
18094,10329,Blank 490,3,O,OHSU_HNSCC_derm001,3,-0.061,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
18095,10329,Blank 490,3,P,OHSU_HNSCC_derm001,3,0.369,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
18096,10329,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.124,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
18097,10329,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.278,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
18098,10329,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.211,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
18099,10329,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.179,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
18100,10329,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.079,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
18101,10329,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.316,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
18102,10329,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.082,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
18103,10329,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.184,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
18104,10329,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.087,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
18105,10329,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.166,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18106,10329,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.104,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18107,10329,Blank 490,3,L,OHSU_HNSCC_derm001,4,0.351,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
18108,10329,Blank 490,3,M,OHSU_HNSCC_derm001,4,0.275,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18109,10329,Blank 490,3,N,OHSU_HNSCC_derm001,4,0.466,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
18110,10329,Blank 490,3,O,OHSU_HNSCC_derm001,4,0.003,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
18111,10329,Blank 490,3,P,OHSU_HNSCC_derm001,4,0.365,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
18112,10329,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.256,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
18113,10329,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.324,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
18114,10329,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.32,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
18115,10329,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.247,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
18116,10329,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.241,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
18117,10329,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.367,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
18118,10329,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.203,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
18119,10329,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.24,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
18120,10329,Blank 490,3,I,OHSU_HNSCC_derm001,5,0.396,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
18121,10329,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.23,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18122,10329,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.203,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18123,10329,Blank 490,3,L,OHSU_HNSCC_derm001,5,0.455,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
18124,10329,Blank 490,3,M,OHSU_HNSCC_derm001,5,0.38,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18125,10329,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.446,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
18126,10329,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.047,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
18127,10329,Blank 490,3,P,OHSU_HNSCC_derm001,5,0.334,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
18128,10329,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.293,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
18129,10329,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.296,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
18130,10329,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.383,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
18131,10329,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.27,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
18132,10329,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.284,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
18133,10329,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.348,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
18134,10329,Blank 490,3,G,OHSU_HNSCC_derm001,6,0.254,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
18135,10329,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.291,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
18136,10329,Blank 490,3,I,OHSU_HNSCC_derm001,6,0.334,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
18137,10329,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.278,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18138,10329,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.279,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18139,10329,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.454,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
18140,10329,Blank 490,3,M,OHSU_HNSCC_derm001,6,0.409,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18141,10329,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.408,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
18142,10329,Blank 490,3,O,OHSU_HNSCC_derm001,6,0.031,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
18143,10329,Blank 490,3,P,OHSU_HNSCC_derm001,6,0.344,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
18144,10329,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.289,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
18145,10329,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.325,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
18146,10329,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.364,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
18147,10329,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.29,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
18148,10329,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.349,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
18149,10329,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.369,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
18150,10329,Blank 490,3,G,OHSU_HNSCC_derm001,7,0.306,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
18151,10329,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.355,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
18152,10329,Blank 490,3,I,OHSU_HNSCC_derm001,7,0.365,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
18153,10329,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.35,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
18154,10329,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.357,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
18155,10329,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.448,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
18156,10329,Blank 490,3,M,OHSU_HNSCC_derm001,7,0.386,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
18157,10329,Blank 490,3,N,OHSU_HNSCC_derm001,7,0.41,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
18158,10329,Blank 490,3,O,OHSU_HNSCC_derm001,7,0.03,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
18159,10329,Blank 490,3,P,OHSU_HNSCC_derm001,7,0.348,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
18160,10329,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.262,0,NONE,OHSU_HNSCC_derm001
18161,10329,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.365,0,NONE,OHSU_HNSCC_derm001
18162,10329,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.392,0,NONE,OHSU_HNSCC_derm001
18163,10329,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.327,0,NONE,OHSU_HNSCC_derm001
18164,10329,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.335,0,NONE,OHSU_HNSCC_derm001
18165,10329,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.365,0,NONE,OHSU_HNSCC_derm001
18166,10329,Blank 490,3,G,OHSU_HNSCC_derm001,8,0.371,0,NONE,OHSU_HNSCC_derm001
18167,10329,Blank 490,3,H,OHSU_HNSCC_derm001,8,0.003,10,F-S-V,OHSU_HNSCC_derm001
18168,10329,Blank 490,3,I,OHSU_HNSCC_derm001,8,0.165,0,NONE,OHSU_HNSCC_derm001
18169,10329,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.412,0,NONE,OHSU_HNSCC_derm001
18170,10329,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.419,0,NONE,OHSU_HNSCC_derm001
18171,10329,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.408,0,NONE,OHSU_HNSCC_derm001
18172,10329,Blank 490,3,M,OHSU_HNSCC_derm001,8,0.402,0,NONE,OHSU_HNSCC_derm001
18173,10329,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.363,0,NONE,OHSU_HNSCC_derm001
18174,10329,Blank 490,3,O,OHSU_HNSCC_derm001,8,0.347,0,NONE,OHSU_HNSCC_derm001
18175,10329,Blank 490,3,P,OHSU_HNSCC_derm001,8,0.333,0,NONE,OHSU_HNSCC_derm001
18176,10329,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.282,10,Anastrazole,OHSU_HNSCC_derm001
18177,10329,Blank 490,3,B,OHSU_HNSCC_derm001,9,0.221,10,JNJ-28312141 ,OHSU_HNSCC_derm001
18178,10329,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.396,10,Genistein,OHSU_HNSCC_derm001
18179,10329,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.385,10,Abscisic acid,OHSU_HNSCC_derm001
18180,10329,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.254,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18181,10329,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.38,10,Ruxolitinib,OHSU_HNSCC_derm001
18182,10329,Blank 490,3,G,OHSU_HNSCC_derm001,9,0.374,10,TAK-659,OHSU_HNSCC_derm001
18183,10329,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.028,10,Brigatinib,OHSU_HNSCC_derm001
18184,10329,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.109,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18185,10329,Blank 490,3,J,OHSU_HNSCC_derm001,9,0.021,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18186,10329,Blank 490,3,K,OHSU_HNSCC_derm001,9,0.202,10,Vorinostat,OHSU_HNSCC_derm001
18187,10329,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.363,10,Lenalidomide,OHSU_HNSCC_derm001
18188,10329,Blank 490,3,M,OHSU_HNSCC_derm001,9,0.02,10,NVP-ADW742,OHSU_HNSCC_derm001
18189,10329,Blank 490,3,N,OHSU_HNSCC_derm001,9,0.384,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18190,10329,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.527,10,Echinatin,OHSU_HNSCC_derm001
18191,10329,Blank 490,3,P,OHSU_HNSCC_derm001,9,-0.013,10,YM-155,OHSU_HNSCC_derm001
18192,10329,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.275,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
18193,10329,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.491,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
18194,10329,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.394,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
18195,10329,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.327,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
18196,10329,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.291,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18197,10329,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.394,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
18198,10329,Blank 490,3,G,OHSU_HNSCC_derm001,10,0.435,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
18199,10329,Blank 490,3,H,OHSU_HNSCC_derm001,10,0.034,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
18200,10329,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.145,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18201,10329,Blank 490,3,J,OHSU_HNSCC_derm001,10,0.243,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18202,10329,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.251,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
18203,10329,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.378,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
18204,10329,Blank 490,3,M,OHSU_HNSCC_derm001,10,0.218,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
18205,10329,Blank 490,3,N,OHSU_HNSCC_derm001,10,0.418,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18206,10329,Blank 490,3,O,OHSU_HNSCC_derm001,10,0.441,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
18207,10329,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.007,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
18208,10329,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.275,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
18209,10329,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.462,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
18210,10329,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.407,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
18211,10329,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.394,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
18212,10329,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.35,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18213,10329,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.361,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
18214,10329,Blank 490,3,G,OHSU_HNSCC_derm001,11,0.416,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
18215,10329,Blank 490,3,H,OHSU_HNSCC_derm001,11,0.151,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
18216,10329,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.185,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18217,10329,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.377,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18218,10329,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.288,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
18219,10329,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.359,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
18220,10329,Blank 490,3,M,OHSU_HNSCC_derm001,11,0.358,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
18221,10329,Blank 490,3,N,OHSU_HNSCC_derm001,11,0.407,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18222,10329,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.384,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
18223,10329,Blank 490,3,P,OHSU_HNSCC_derm001,11,0.004,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
18224,10329,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.264,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
18225,10329,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.429,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
18226,10329,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.383,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
18227,10329,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.318,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
18228,10329,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.373,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18229,10329,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.353,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
18230,10329,Blank 490,3,G,OHSU_HNSCC_derm001,12,0.416,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
18231,10329,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.278,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
18232,10329,Blank 490,3,I,OHSU_HNSCC_derm001,12,0.176,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18233,10329,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.552,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18234,10329,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.34,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
18235,10329,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.404,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
18236,10329,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.411,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
18237,10329,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.389,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18238,10329,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.372,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
18239,10329,Blank 490,3,P,OHSU_HNSCC_derm001,12,0.009,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
18240,10329,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.293,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
18241,10329,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.42,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
18242,10329,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.407,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
18243,10329,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.359,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
18244,10329,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.351,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18245,10329,Blank 490,3,F,OHSU_HNSCC_derm001,13,0.388,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
18246,10329,Blank 490,3,G,OHSU_HNSCC_derm001,13,0.395,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
18247,10329,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.314,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
18248,10329,Blank 490,3,I,OHSU_HNSCC_derm001,13,0.184,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18249,10329,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.581,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18250,10329,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.407,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
18251,10329,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.399,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
18252,10329,Blank 490,3,M,OHSU_HNSCC_derm001,13,0.431,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
18253,10329,Blank 490,3,N,OHSU_HNSCC_derm001,13,0.427,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18254,10329,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.376,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
18255,10329,Blank 490,3,P,OHSU_HNSCC_derm001,13,0.039,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
18256,10329,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.303,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
18257,10329,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.391,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
18258,10329,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.396,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
18259,10329,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.333,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
18260,10329,Blank 490,3,E,OHSU_HNSCC_derm001,14,0.366,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18261,10329,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.342,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
18262,10329,Blank 490,3,G,OHSU_HNSCC_derm001,14,0.375,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
18263,10329,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.347,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
18264,10329,Blank 490,3,I,OHSU_HNSCC_derm001,14,0.19,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18265,10329,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.499,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18266,10329,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.395,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
18267,10329,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.41,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
18268,10329,Blank 490,3,M,OHSU_HNSCC_derm001,14,0.442,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
18269,10329,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.373,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18270,10329,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.392,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
18271,10329,Blank 490,3,P,OHSU_HNSCC_derm001,14,0.069,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
18272,10329,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.29,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
18273,10329,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.387,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
18274,10329,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.379,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
18275,10329,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.349,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
18276,10329,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.376,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
18277,10329,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.342,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
18278,10329,Blank 490,3,G,OHSU_HNSCC_derm001,15,0.381,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
18279,10329,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.375,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
18280,10329,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.218,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
18281,10329,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.471,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
18282,10329,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.388,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
18283,10329,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.411,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
18284,10329,Blank 490,3,M,OHSU_HNSCC_derm001,15,0.431,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
18285,10329,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.378,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
18286,10329,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.362,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
18287,10329,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.139,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
18288,10329,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.291,0,NONE,OHSU_HNSCC_derm001
18289,10329,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.37,0,NONE,OHSU_HNSCC_derm001
18290,10329,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.361,0,NONE,OHSU_HNSCC_derm001
18291,10329,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.353,0,NONE,OHSU_HNSCC_derm001
18292,10329,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.335,0,NONE,OHSU_HNSCC_derm001
18293,10329,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.332,0,NONE,OHSU_HNSCC_derm001
18294,10329,Blank 490,3,G,OHSU_HNSCC_derm001,16,0.09,0,NONE,OHSU_HNSCC_derm001
18295,10329,Blank 490,3,H,OHSU_HNSCC_derm001,16,-0.003,10,F-S-V,OHSU_HNSCC_derm001
18296,10329,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.384,0,NONE,OHSU_HNSCC_derm001
18297,10329,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.369,0,NONE,OHSU_HNSCC_derm001
18298,10329,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.395,0,NONE,OHSU_HNSCC_derm001
18299,10329,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.41,0,NONE,OHSU_HNSCC_derm001
18300,10329,Blank 490,3,M,OHSU_HNSCC_derm001,16,0.428,0,NONE,OHSU_HNSCC_derm001
18301,10329,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.368,0,NONE,OHSU_HNSCC_derm001
18302,10329,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.417,0,NONE,OHSU_HNSCC_derm001
18303,10329,Blank 490,3,P,OHSU_HNSCC_derm001,16,0.346,0,NONE,OHSU_HNSCC_derm001
18304,10329,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.266,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18305,10329,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.374,10,Stevioside,OHSU_HNSCC_derm001
18306,10329,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.368,10,Pemetrexed,OHSU_HNSCC_derm001
18307,10329,Blank 490,3,D,OHSU_HNSCC_derm001,17,0.041,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18308,10329,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.065,10,GSK-1838705A,OHSU_HNSCC_derm001
18309,10329,Blank 490,3,F,OHSU_HNSCC_derm001,17,0.001,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18310,10329,Blank 490,3,G,OHSU_HNSCC_derm001,17,0.435,10,Imatinib,OHSU_HNSCC_derm001
18311,10329,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.145,10,Trametinib,OHSU_HNSCC_derm001
18312,10329,Blank 490,3,I,OHSU_HNSCC_derm001,17,0.042,10,BEZ235,OHSU_HNSCC_derm001
18313,10329,Blank 490,3,J,OHSU_HNSCC_derm001,17,0.094,10,Saracatinib,OHSU_HNSCC_derm001
18314,10329,Blank 490,3,K,OHSU_HNSCC_derm001,17,0.349,10,I-BET 762,OHSU_HNSCC_derm001
18315,10329,Blank 490,3,L,OHSU_HNSCC_derm001,17,0.066,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
18316,10329,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.307,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
18317,10329,Blank 490,3,N,OHSU_HNSCC_derm001,17,0.161,10,Crizotinib,OHSU_HNSCC_derm001
18318,10329,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.362,10,MGCD-265,OHSU_HNSCC_derm001
18319,10329,Blank 490,3,P,OHSU_HNSCC_derm001,17,0.105,10,Erlotinib,OHSU_HNSCC_derm001
18320,10329,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.283,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18321,10329,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.396,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
18322,10329,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.405,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
18323,10329,Blank 490,3,D,OHSU_HNSCC_derm001,18,0.041,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18324,10329,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.135,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
18325,10329,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.095,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18326,10329,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.423,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
18327,10329,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.158,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
18328,10329,Blank 490,3,I,OHSU_HNSCC_derm001,18,0.051,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
18329,10329,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.114,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
18330,10329,Blank 490,3,K,OHSU_HNSCC_derm001,18,0.469,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
18331,10329,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.086,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
18332,10329,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.443,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
18333,10329,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.335,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
18334,10329,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.451,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
18335,10329,Blank 490,3,P,OHSU_HNSCC_derm001,18,0.143,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
18336,10329,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.284,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18337,10329,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.37,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
18338,10329,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.377,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
18339,10329,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.049,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18340,10329,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.226,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
18341,10329,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.127,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18342,10329,Blank 490,3,G,OHSU_HNSCC_derm001,19,0.434,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
18343,10329,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.132,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
18344,10329,Blank 490,3,I,OHSU_HNSCC_derm001,19,0.056,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
18345,10329,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.282,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
18346,10329,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.527,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
18347,10329,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.141,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
18348,10329,Blank 490,3,M,OHSU_HNSCC_derm001,19,0.385,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
18349,10329,Blank 490,3,N,OHSU_HNSCC_derm001,19,0.354,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
18350,10329,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.382,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
18351,10329,Blank 490,3,P,OHSU_HNSCC_derm001,19,0.169,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
18352,10329,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.264,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18353,10329,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.356,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
18354,10329,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.371,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
18355,10329,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.105,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18356,10329,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.259,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
18357,10329,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.169,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18358,10329,Blank 490,3,G,OHSU_HNSCC_derm001,20,0.432,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
18359,10329,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.142,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
18360,10329,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.096,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
18361,10329,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.388,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
18362,10329,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.51,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
18363,10329,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.165,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
18364,10329,Blank 490,3,M,OHSU_HNSCC_derm001,20,0.406,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
18365,10329,Blank 490,3,N,OHSU_HNSCC_derm001,20,0.401,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
18366,10329,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.366,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
18367,10329,Blank 490,3,P,OHSU_HNSCC_derm001,20,0.199,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
18368,10329,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.252,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18369,10329,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.358,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
18370,10329,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.406,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
18371,10329,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.154,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18372,10329,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.318,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
18373,10329,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.229,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18374,10329,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.418,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
18375,10329,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.142,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
18376,10329,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.158,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
18377,10329,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.436,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
18378,10329,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.428,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
18379,10329,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.176,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
18380,10329,Blank 490,3,M,OHSU_HNSCC_derm001,21,0.381,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
18381,10329,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.409,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
18382,10329,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.351,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
18383,10329,Blank 490,3,P,OHSU_HNSCC_derm001,21,0.261,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
18384,10329,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.272,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18385,10329,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.334,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
18386,10329,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.395,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
18387,10329,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.26,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18388,10329,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.339,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
18389,10329,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.296,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18390,10329,Blank 490,3,G,OHSU_HNSCC_derm001,22,0.411,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
18391,10329,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.179,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
18392,10329,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.263,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
18393,10329,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.434,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
18394,10329,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.387,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
18395,10329,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.213,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
18396,10329,Blank 490,3,M,OHSU_HNSCC_derm001,22,0.409,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
18397,10329,Blank 490,3,N,OHSU_HNSCC_derm001,22,0.403,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
18398,10329,Blank 490,3,O,OHSU_HNSCC_derm001,22,0.353,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
18399,10329,Blank 490,3,P,OHSU_HNSCC_derm001,22,0.303,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
18400,10329,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.268,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
18401,10329,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.338,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
18402,10329,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.354,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
18403,10329,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.287,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
18404,10329,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.359,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
18405,10329,Blank 490,3,F,OHSU_HNSCC_derm001,23,0.333,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
18406,10329,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.394,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
18407,10329,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.211,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
18408,10329,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.315,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
18409,10329,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.398,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
18410,10329,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.38,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
18411,10329,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.308,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
18412,10329,Blank 490,3,M,OHSU_HNSCC_derm001,23,0.355,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
18413,10329,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.357,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
18414,10329,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.352,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
18415,10329,Blank 490,3,P,OHSU_HNSCC_derm001,23,0.279,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
18416,10329,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.254,0,NONE,OHSU_HNSCC_derm001
18417,10329,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.322,0,NONE,OHSU_HNSCC_derm001
18418,10329,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.353,0,NONE,OHSU_HNSCC_derm001
18419,10329,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.334,0,NONE,OHSU_HNSCC_derm001
18420,10329,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.337,0,NONE,OHSU_HNSCC_derm001
18421,10329,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.345,0,NONE,OHSU_HNSCC_derm001
18422,10329,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.375,0,NONE,OHSU_HNSCC_derm001
18423,10329,Blank 490,3,H,OHSU_HNSCC_derm001,24,0.334,0,NONE,OHSU_HNSCC_derm001
18424,10329,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.319,0,NONE,OHSU_HNSCC_derm001
18425,10329,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.324,0,NONE,OHSU_HNSCC_derm001
18426,10329,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.376,0,NONE,OHSU_HNSCC_derm001
18427,10329,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.366,0,NONE,OHSU_HNSCC_derm001
18428,10329,Blank 490,3,M,OHSU_HNSCC_derm001,24,0.353,0,NONE,OHSU_HNSCC_derm001
18429,10329,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.365,0,NONE,OHSU_HNSCC_derm001
18430,10329,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.324,0,NONE,OHSU_HNSCC_derm001
18431,10329,Blank 490,3,P,OHSU_HNSCC_derm001,24,0.298,0,NONE,OHSU_HNSCC_derm001
18432,10336,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.034,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
18433,10336,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.635,10,Lucitanib ,OHSU_HNSCC_derm002
18434,10336,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.522,10,Resveratrol,OHSU_HNSCC_derm002
18435,10336,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.546,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18436,10336,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.523,10,Bicalutamide,OHSU_HNSCC_derm002
18437,10336,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.823,10,Methotrexate ,OHSU_HNSCC_derm002
18438,10336,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.322,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18439,10336,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.634,10,Gefitinib,OHSU_HNSCC_derm002
18440,10336,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.586,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
18441,10336,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.391,10,Tamatinib/R406,OHSU_HNSCC_derm002
18442,10336,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.514,10,Bosutinib,OHSU_HNSCC_derm002
18443,10336,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.097,10,PI-103,OHSU_HNSCC_derm002
18444,10336,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.64,10,Glycyrrhizin,OHSU_HNSCC_derm002
18445,10336,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.637,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
18446,10336,Blank 490,1,O,OHSU_HNSCC_derm002,1,1.027,10,GSK-690693,OHSU_HNSCC_derm002
18447,10336,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.941,10,Ibrutinib,OHSU_HNSCC_derm002
18448,10336,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.095,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
18449,10336,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.656,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
18450,10336,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.442,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
18451,10336,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.697,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18452,10336,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.687,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
18453,10336,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.769,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
18454,10336,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.517,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18455,10336,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.705,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
18456,10336,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.498,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
18457,10336,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.618,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
18458,10336,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.572,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
18459,10336,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.152,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
18460,10336,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.652,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
18461,10336,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.732,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
18462,10336,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.887,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
18463,10336,Blank 490,1,P,OHSU_HNSCC_derm002,2,1.005,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
18464,10336,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.109,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
18465,10336,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.664,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
18466,10336,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.599,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
18467,10336,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.795,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18468,10336,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.658,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
18469,10336,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.697,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
18470,10336,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.789,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18471,10336,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.657,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
18472,10336,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.67,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
18473,10336,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.787,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
18474,10336,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.654,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
18475,10336,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.311,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
18476,10336,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.712,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
18477,10336,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.828,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
18478,10336,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.823,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
18479,10336,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.827,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
18480,10336,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.196,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
18481,10336,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.552,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
18482,10336,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.704,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
18483,10336,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.7,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18484,10336,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.682,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
18485,10336,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.725,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
18486,10336,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.687,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18487,10336,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.708,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
18488,10336,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.792,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
18489,10336,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.788,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
18490,10336,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.652,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
18491,10336,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
18492,10336,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.785,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
18493,10336,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.954,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
18494,10336,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.788,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
18495,10336,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.799,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
18496,10336,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.403,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
18497,10336,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.616,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
18498,10336,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.53,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
18499,10336,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.729,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18500,10336,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.76,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
18501,10336,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.735,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
18502,10336,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.639,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18503,10336,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.64,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
18504,10336,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.626,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
18505,10336,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.676,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
18506,10336,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.586,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
18507,10336,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.824,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
18508,10336,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.798,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
18509,10336,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.767,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
18510,10336,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.793,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
18511,10336,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.888,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
18512,10336,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.598,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
18513,10336,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.665,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
18514,10336,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.663,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
18515,10336,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.766,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18516,10336,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.661,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
18517,10336,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.817,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
18518,10336,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.759,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18519,10336,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.699,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
18520,10336,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
18521,10336,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.736,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
18522,10336,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.722,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
18523,10336,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.785,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
18524,10336,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.691,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
18525,10336,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.84,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
18526,10336,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.809,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
18527,10336,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.776,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
18528,10336,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.602,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
18529,10336,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.582,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
18530,10336,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.651,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
18531,10336,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.772,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
18532,10336,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.782,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
18533,10336,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.758,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
18534,10336,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.72,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
18535,10336,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.691,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
18536,10336,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.71,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
18537,10336,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.744,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
18538,10336,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.6,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
18539,10336,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.713,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
18540,10336,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.839,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
18541,10336,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.885,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
18542,10336,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.806,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
18543,10336,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.802,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
18544,10336,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
18545,10336,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.632,0,NONE,OHSU_HNSCC_derm002
18546,10336,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.603,0,NONE,OHSU_HNSCC_derm002
18547,10336,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
18548,10336,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
18549,10336,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
18550,10336,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.717,0,NONE,OHSU_HNSCC_derm002
18551,10336,Blank 490,1,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
18552,10336,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.698,0,NONE,OHSU_HNSCC_derm002
18553,10336,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
18554,10336,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.693,0,NONE,OHSU_HNSCC_derm002
18555,10336,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.61,0,NONE,OHSU_HNSCC_derm002
18556,10336,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.777,0,NONE,OHSU_HNSCC_derm002
18557,10336,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.729,0,NONE,OHSU_HNSCC_derm002
18558,10336,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.799,0,NONE,OHSU_HNSCC_derm002
18559,10336,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.929,0,NONE,OHSU_HNSCC_derm002
18560,10336,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.396,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18561,10336,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.639,10,Sorafenib,OHSU_HNSCC_derm002
18562,10336,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.693,10,Rosmarinic acid,OHSU_HNSCC_derm002
18563,10336,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.701,10,Rapamycin,OHSU_HNSCC_derm002
18564,10336,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.821,10,Vismodegib,OHSU_HNSCC_derm002
18565,10336,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.182,10,PP242,OHSU_HNSCC_derm002
18566,10336,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.613,10,Alectinib,OHSU_HNSCC_derm002
18567,10336,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.836,10,Brigatinib,OHSU_HNSCC_derm002
18568,10336,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.819,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18569,10336,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.825,10,MK-2206,OHSU_HNSCC_derm002
18570,10336,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.726,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18571,10336,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.414,10,Flavopiridol ,OHSU_HNSCC_derm002
18572,10336,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.803,10,Indirubin,OHSU_HNSCC_derm002
18573,10336,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.731,10,PF-533228,OHSU_HNSCC_derm002
18574,10336,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.789,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18575,10336,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.2,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18576,10336,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.489,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18577,10336,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.618,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
18578,10336,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.732,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
18579,10336,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.696,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
18580,10336,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.854,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
18581,10336,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.361,3.3333333333333335,PP242,OHSU_HNSCC_derm002
18582,10336,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.766,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
18583,10336,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.769,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
18584,10336,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.741,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18585,10336,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.893,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
18586,10336,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.84,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18587,10336,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.387,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
18588,10336,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.809,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
18589,10336,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.798,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
18590,10336,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.875,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18591,10336,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.15,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18592,10336,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.562,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18593,10336,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.654,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
18594,10336,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.58,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
18595,10336,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.716,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
18596,10336,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.671,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
18597,10336,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.543,1.1111111111111112,PP242,OHSU_HNSCC_derm002
18598,10336,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.805,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
18599,10336,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.774,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
18600,10336,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.629,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18601,10336,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.887,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
18602,10336,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.606,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18603,10336,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.311,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
18604,10336,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.887,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
18605,10336,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.722,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
18606,10336,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.797,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18607,10336,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.126,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18608,10336,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.428,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18609,10336,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.593,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
18610,10336,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.647,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
18611,10336,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.785,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
18612,10336,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.826,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
18613,10336,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.848,0.3703703703703704,PP242,OHSU_HNSCC_derm002
18614,10336,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.841,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
18615,10336,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.78,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
18616,10336,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.593,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18617,10336,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.877,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
18618,10336,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.75,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18619,10336,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.322,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
18620,10336,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.783,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
18621,10336,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.799,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
18622,10336,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.822,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18623,10336,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.399,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18624,10336,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.656,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18625,10336,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.707,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
18626,10336,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.689,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
18627,10336,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.761,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
18628,10336,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.841,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
18629,10336,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.8,0.1234567901234568,PP242,OHSU_HNSCC_derm002
18630,10336,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.805,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
18631,10336,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.767,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
18632,10336,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.668,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18633,10336,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.846,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
18634,10336,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.641,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18635,10336,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.701,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
18636,10336,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.871,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
18637,10336,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.742,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
18638,10336,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.837,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18639,10336,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.539,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18640,10336,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.535,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18641,10336,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.593,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
18642,10336,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.728,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
18643,10336,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.75,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
18644,10336,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.71,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
18645,10336,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.793,0.0411522633744856,PP242,OHSU_HNSCC_derm002
18646,10336,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.763,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
18647,10336,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.694,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
18648,10336,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.677,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18649,10336,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.746,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
18650,10336,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.673,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18651,10336,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.736,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
18652,10336,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.778,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
18653,10336,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.847,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
18654,10336,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.846,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18655,10336,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.74,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18656,10336,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.567,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
18657,10336,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
18658,10336,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.702,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
18659,10336,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.778,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
18660,10336,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.712,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
18661,10336,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.739,0.013717421124828532,PP242,OHSU_HNSCC_derm002
18662,10336,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.758,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
18663,10336,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.707,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
18664,10336,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.63,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18665,10336,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.691,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
18666,10336,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.703,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
18667,10336,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.772,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
18668,10336,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.771,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
18669,10336,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.884,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
18670,10336,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.848,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
18671,10336,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.949,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
18672,10336,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.593,0,NONE,OHSU_HNSCC_derm002
18673,10336,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.668,0,NONE,OHSU_HNSCC_derm002
18674,10336,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.716,0,NONE,OHSU_HNSCC_derm002
18675,10336,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.781,0,NONE,OHSU_HNSCC_derm002
18676,10336,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.852,0,NONE,OHSU_HNSCC_derm002
18677,10336,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.799,0,NONE,OHSU_HNSCC_derm002
18678,10336,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.773,0,NONE,OHSU_HNSCC_derm002
18679,10336,Blank 490,1,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
18680,10336,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.641,0,NONE,OHSU_HNSCC_derm002
18681,10336,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.856,0,NONE,OHSU_HNSCC_derm002
18682,10336,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.733,0,NONE,OHSU_HNSCC_derm002
18683,10336,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.757,0,NONE,OHSU_HNSCC_derm002
18684,10336,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.763,0,NONE,OHSU_HNSCC_derm002
18685,10336,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.841,0,NONE,OHSU_HNSCC_derm002
18686,10336,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.925,0,NONE,OHSU_HNSCC_derm002
18687,10336,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.945,0,NONE,OHSU_HNSCC_derm002
18688,10336,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.581,10,Emodin,OHSU_HNSCC_derm002
18689,10336,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.554,10,Baicalin,OHSU_HNSCC_derm002
18690,10336,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.009,10,NVP-TAE-684,OHSU_HNSCC_derm002
18691,10336,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.104,10,Panobinostat,OHSU_HNSCC_derm002
18692,10336,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.102,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
18693,10336,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.861,10,Fulvestrant,OHSU_HNSCC_derm002
18694,10336,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.937,10,SCH-772984,OHSU_HNSCC_derm002
18695,10336,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.862,10,Trametinib,OHSU_HNSCC_derm002
18696,10336,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.552,10,BEZ235,OHSU_HNSCC_derm002
18697,10336,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.743,10,MLN120B,OHSU_HNSCC_derm002
18698,10336,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.126,10,Ixabepilone,OHSU_HNSCC_derm002
18699,10336,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.663,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
18700,10336,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.963,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18701,10336,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.825,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18702,10336,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.784,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18703,10336,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.944,10,Letrozole,OHSU_HNSCC_derm002
18704,10336,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.594,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
18705,10336,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.654,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
18706,10336,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.762,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
18707,10336,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.113,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
18708,10336,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.434,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
18709,10336,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.76,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
18710,10336,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.849,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
18711,10336,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.788,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
18712,10336,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.312,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
18713,10336,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.696,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
18714,10336,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.126,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
18715,10336,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.763,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
18716,10336,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.699,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18717,10336,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.875,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18718,10336,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.843,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18719,10336,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.845,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
18720,10336,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.666,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
18721,10336,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.653,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
18722,10336,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.708,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
18723,10336,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.188,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
18724,10336,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.583,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
18725,10336,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.894,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
18726,10336,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.847,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
18727,10336,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.776,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
18728,10336,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.317,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
18729,10336,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.829,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
18730,10336,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.149,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
18731,10336,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.706,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
18732,10336,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.717,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18733,10336,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.998,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18734,10336,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.796,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18735,10336,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.866,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
18736,10336,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.595,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
18737,10336,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.677,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
18738,10336,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.677,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
18739,10336,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.47,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
18740,10336,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.871,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
18741,10336,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.803,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
18742,10336,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.879,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
18743,10336,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.862,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
18744,10336,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.469,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
18745,10336,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.614,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
18746,10336,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.164,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
18747,10336,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.825,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
18748,10336,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.757,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18749,10336,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.917,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18750,10336,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.711,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18751,10336,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.907,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
18752,10336,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.595,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
18753,10336,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.664,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
18754,10336,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.698,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
18755,10336,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.748,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
18756,10336,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.921,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
18757,10336,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.756,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
18758,10336,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.798,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
18759,10336,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.861,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
18760,10336,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.699,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
18761,10336,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.745,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
18762,10336,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.279,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
18763,10336,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.726,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
18764,10336,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.803,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18765,10336,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.908,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18766,10336,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.727,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18767,10336,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.824,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
18768,10336,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.586,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
18769,10336,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.673,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
18770,10336,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.783,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
18771,10336,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.888,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
18772,10336,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.934,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
18773,10336,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.924,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
18774,10336,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.796,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
18775,10336,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.844,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
18776,10336,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.985,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
18777,10336,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.771,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
18778,10336,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.409,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
18779,10336,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.78,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
18780,10336,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.832,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18781,10336,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.894,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18782,10336,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.802,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18783,10336,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.901,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
18784,10336,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.556,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
18785,10336,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.674,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
18786,10336,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
18787,10336,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.79,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
18788,10336,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.735,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
18789,10336,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.795,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
18790,10336,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.781,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
18791,10336,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.765,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
18792,10336,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.799,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
18793,10336,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.636,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
18794,10336,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.517,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
18795,10336,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.708,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
18796,10336,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.704,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
18797,10336,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.756,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
18798,10336,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.853,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
18799,10336,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.862,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
18800,10336,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
18801,10336,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.626,0,NONE,OHSU_HNSCC_derm002
18802,10336,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.642,0,NONE,OHSU_HNSCC_derm002
18803,10336,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.73,0,NONE,OHSU_HNSCC_derm002
18804,10336,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.671,0,NONE,OHSU_HNSCC_derm002
18805,10336,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.679,0,NONE,OHSU_HNSCC_derm002
18806,10336,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.694,0,NONE,OHSU_HNSCC_derm002
18807,10336,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.677,0,NONE,OHSU_HNSCC_derm002
18808,10336,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.681,0,NONE,OHSU_HNSCC_derm002
18809,10336,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.745,0,NONE,OHSU_HNSCC_derm002
18810,10336,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.735,0,NONE,OHSU_HNSCC_derm002
18811,10336,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.778,0,NONE,OHSU_HNSCC_derm002
18812,10336,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.772,0,NONE,OHSU_HNSCC_derm002
18813,10336,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.796,0,NONE,OHSU_HNSCC_derm002
18814,10336,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.781,0,NONE,OHSU_HNSCC_derm002
18815,10336,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.844,0,NONE,OHSU_HNSCC_derm002
18816,10336,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.68,10,Coumarin,OHSU_HNSCC_derm002
18817,10336,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.825,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18818,10336,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.61,10,Foretinib (XL-880),OHSU_HNSCC_derm002
18819,10336,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.736,10,Elesclomol,OHSU_HNSCC_derm002
18820,10336,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.786,10,Vemurafenib,OHSU_HNSCC_derm002
18821,10336,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.096,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18822,10336,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.016,10,Ponatinib,OHSU_HNSCC_derm002
18823,10336,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.745,10,Gefitinib,OHSU_HNSCC_derm002
18824,10336,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.744,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
18825,10336,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.69,1,Sunitinib (1mM),OHSU_HNSCC_derm002
18826,10336,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.836,10,Curcumin,OHSU_HNSCC_derm002
18827,10336,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.608,10,PF-562271,OHSU_HNSCC_derm002
18828,10336,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.76,10,STO609,OHSU_HNSCC_derm002
18829,10336,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.828,10,Lenvatinib,OHSU_HNSCC_derm002
18830,10336,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.738,10,Entrectinib,OHSU_HNSCC_derm002
18831,10336,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.994,10,Ethyl Gallate ,OHSU_HNSCC_derm002
18832,10336,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.893,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
18833,10336,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.899,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18834,10336,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.7,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
18835,10336,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.794,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
18836,10336,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.679,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
18837,10336,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.111,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18838,10336,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.701,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
18839,10336,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.768,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
18840,10336,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.752,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
18841,10336,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.696,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
18842,10336,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.876,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
18843,10336,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.579,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
18844,10336,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.692,3.3333333333333335,STO609,OHSU_HNSCC_derm002
18845,10336,Blank 490,2,N,OHSU_HNSCC_derm002,2,1.137,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
18846,10336,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.98,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
18847,10336,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.917,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
18848,10336,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.826,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
18849,10336,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.789,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18850,10336,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.678,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
18851,10336,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.573,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
18852,10336,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.759,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
18853,10336,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18854,10336,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.966,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
18855,10336,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.7,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
18856,10336,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.727,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
18857,10336,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.768,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
18858,10336,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.808,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
18859,10336,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.725,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
18860,10336,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.893,1.1111111111111112,STO609,OHSU_HNSCC_derm002
18861,10336,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.734,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
18862,10336,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.931,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
18863,10336,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.895,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
18864,10336,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.709,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
18865,10336,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.819,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18866,10336,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.772,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
18867,10336,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.693,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
18868,10336,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.758,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
18869,10336,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.387,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18870,10336,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.824,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
18871,10336,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.674,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
18872,10336,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.888,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
18873,10336,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.563,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
18874,10336,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.792,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
18875,10336,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.745,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
18876,10336,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.774,0.3703703703703704,STO609,OHSU_HNSCC_derm002
18877,10336,Blank 490,2,N,OHSU_HNSCC_derm002,4,1.002,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
18878,10336,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.912,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
18879,10336,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.99,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
18880,10336,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.871,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
18881,10336,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.874,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18882,10336,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.773,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
18883,10336,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.739,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
18884,10336,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.744,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
18885,10336,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.717,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18886,10336,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.717,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
18887,10336,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.663,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
18888,10336,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.763,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
18889,10336,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.816,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
18890,10336,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.796,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
18891,10336,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.717,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
18892,10336,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.799,0.1234567901234568,STO609,OHSU_HNSCC_derm002
18893,10336,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.701,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
18894,10336,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.872,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
18895,10336,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.924,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
18896,10336,Blank 490,2,A,OHSU_HNSCC_derm002,6,1.052,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
18897,10336,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.866,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18898,10336,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.701,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
18899,10336,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.77,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
18900,10336,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.841,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
18901,10336,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.783,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18902,10336,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.734,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
18903,10336,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.694,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
18904,10336,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.637,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
18905,10336,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.568,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
18906,10336,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.796,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
18907,10336,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.798,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
18908,10336,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.9,0.0411522633744856,STO609,OHSU_HNSCC_derm002
18909,10336,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.911,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
18910,10336,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.856,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
18911,10336,Blank 490,2,P,OHSU_HNSCC_derm002,6,1.022,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
18912,10336,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.861,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
18913,10336,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.822,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
18914,10336,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.768,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
18915,10336,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.666,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
18916,10336,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.669,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
18917,10336,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.846,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
18918,10336,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.627,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
18919,10336,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.713,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
18920,10336,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.8,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
18921,10336,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.866,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
18922,10336,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.881,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
18923,10336,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.77,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
18924,10336,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.667,0.013717421124828532,STO609,OHSU_HNSCC_derm002
18925,10336,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.77,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
18926,10336,Blank 490,2,O,OHSU_HNSCC_derm002,7,1.034,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
18927,10336,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.824,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
18928,10336,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.728,0,NONE,OHSU_HNSCC_derm002
18929,10336,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.711,0,NONE,OHSU_HNSCC_derm002
18930,10336,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.649,0,NONE,OHSU_HNSCC_derm002
18931,10336,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.76,0,NONE,OHSU_HNSCC_derm002
18932,10336,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.869,0,NONE,OHSU_HNSCC_derm002
18933,10336,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.639,0,NONE,OHSU_HNSCC_derm002
18934,10336,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.891,0,NONE,OHSU_HNSCC_derm002
18935,10336,Blank 490,2,H,OHSU_HNSCC_derm002,8,0.005,10,F-S-V,OHSU_HNSCC_derm002
18936,10336,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.712,0,NONE,OHSU_HNSCC_derm002
18937,10336,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.594,0,NONE,OHSU_HNSCC_derm002
18938,10336,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
18939,10336,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.787,0,NONE,OHSU_HNSCC_derm002
18940,10336,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.839,0,NONE,OHSU_HNSCC_derm002
18941,10336,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.842,0,NONE,OHSU_HNSCC_derm002
18942,10336,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.804,0,NONE,OHSU_HNSCC_derm002
18943,10336,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.846,0,NONE,OHSU_HNSCC_derm002
18944,10336,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.337,10,GDC-0941,OHSU_HNSCC_derm002
18945,10336,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.773,10,Dovitinib,OHSU_HNSCC_derm002
18946,10336,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.524,10,BI-2536,OHSU_HNSCC_derm002
18947,10336,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.264,10,TP-0903 ,OHSU_HNSCC_derm002
18948,10336,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.203,10,Belinostat,OHSU_HNSCC_derm002
18949,10336,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.218,10,INK-128,OHSU_HNSCC_derm002
18950,10336,Blank 490,2,G,OHSU_HNSCC_derm002,9,1.044,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
18951,10336,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.931,10,Brigatinib,OHSU_HNSCC_derm002
18952,10336,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.639,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18953,10336,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.66,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
18954,10336,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.697,10,Pazopanib,OHSU_HNSCC_derm002
18955,10336,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.875,10,AZD4547,OHSU_HNSCC_derm002
18956,10336,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.851,10,Pomalidomide ,OHSU_HNSCC_derm002
18957,10336,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.906,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
18958,10336,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.851,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
18959,10336,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.029,10,Staurosporin,OHSU_HNSCC_derm002
18960,10336,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.295,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
18961,10336,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.803,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
18962,10336,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.81,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
18963,10336,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.228,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
18964,10336,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.553,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
18965,10336,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.232,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
18966,10336,Blank 490,2,G,OHSU_HNSCC_derm002,10,1.0,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
18967,10336,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.855,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
18968,10336,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.724,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18969,10336,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.68,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
18970,10336,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.788,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
18971,10336,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.963,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
18972,10336,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.773,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
18973,10336,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.831,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
18974,10336,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.885,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
18975,10336,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.006,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
18976,10336,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.386,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
18977,10336,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.913,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
18978,10336,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.555,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
18979,10336,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.454,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
18980,10336,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.952,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
18981,10336,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.333,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
18982,10336,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.877,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
18983,10336,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.738,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
18984,10336,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.827,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
18985,10336,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.723,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
18986,10336,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.608,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
18987,10336,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.85,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
18988,10336,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.667,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
18989,10336,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.834,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
18990,10336,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.978,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
18991,10336,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.058,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
18992,10336,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.719,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
18993,10336,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.786,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
18994,10336,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.346,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
18995,10336,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.869,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
18996,10336,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.855,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
18997,10336,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.353,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
18998,10336,Blank 490,2,G,OHSU_HNSCC_derm002,12,1.024,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
18999,10336,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.769,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
19000,10336,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.899,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19001,10336,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.664,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
19002,10336,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.777,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
19003,10336,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.909,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
19004,10336,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.841,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
19005,10336,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.957,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
19006,10336,Blank 490,2,O,OHSU_HNSCC_derm002,12,1.138,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
19007,10336,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.182,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
19008,10336,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.731,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
19009,10336,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.981,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
19010,10336,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.287,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
19011,10336,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.87,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
19012,10336,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.783,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
19013,10336,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.552,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
19014,10336,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.819,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
19015,10336,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.837,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
19016,10336,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.664,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19017,10336,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.679,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
19018,10336,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.777,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
19019,10336,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.878,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
19020,10336,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.726,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
19021,10336,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.855,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
19022,10336,Blank 490,2,O,OHSU_HNSCC_derm002,13,1.069,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
19023,10336,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.409,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
19024,10336,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.928,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
19025,10336,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.998,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
19026,10336,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.29,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
19027,10336,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.861,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
19028,10336,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.653,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
19029,10336,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.695,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
19030,10336,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.865,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
19031,10336,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.828,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
19032,10336,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.661,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19033,10336,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.841,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
19034,10336,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.803,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
19035,10336,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
19036,10336,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.858,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
19037,10336,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.869,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
19038,10336,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.823,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
19039,10336,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.586,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
19040,10336,Blank 490,2,A,OHSU_HNSCC_derm002,15,1.019,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
19041,10336,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.89,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
19042,10336,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.526,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
19043,10336,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.644,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
19044,10336,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.735,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
19045,10336,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.823,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
19046,10336,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.819,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
19047,10336,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.724,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
19048,10336,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.649,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19049,10336,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.656,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
19050,10336,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.806,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
19051,10336,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.841,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
19052,10336,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.653,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
19053,10336,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.708,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
19054,10336,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.851,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
19055,10336,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.766,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
19056,10336,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.993,0,NONE,OHSU_HNSCC_derm002
19057,10336,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.866,0,NONE,OHSU_HNSCC_derm002
19058,10336,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.912,0,NONE,OHSU_HNSCC_derm002
19059,10336,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.792,0,NONE,OHSU_HNSCC_derm002
19060,10336,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.75,0,NONE,OHSU_HNSCC_derm002
19061,10336,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.859,0,NONE,OHSU_HNSCC_derm002
19062,10336,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.829,0,NONE,OHSU_HNSCC_derm002
19063,10336,Blank 490,2,H,OHSU_HNSCC_derm002,16,-0.005,10,F-S-V,OHSU_HNSCC_derm002
19064,10336,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.796,0,NONE,OHSU_HNSCC_derm002
19065,10336,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.715,0,NONE,OHSU_HNSCC_derm002
19066,10336,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.837,0,NONE,OHSU_HNSCC_derm002
19067,10336,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.743,0,NONE,OHSU_HNSCC_derm002
19068,10336,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.932,0,NONE,OHSU_HNSCC_derm002
19069,10336,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.791,0,NONE,OHSU_HNSCC_derm002
19070,10336,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.887,0,NONE,OHSU_HNSCC_derm002
19071,10336,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.872,0,NONE,OHSU_HNSCC_derm002
19072,10336,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.434,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
19073,10336,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.903,10,Hesperidin,OHSU_HNSCC_derm002
19074,10336,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.722,10,Esculetin,OHSU_HNSCC_derm002
19075,10336,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.682,10,Selinexor ,OHSU_HNSCC_derm002
19076,10336,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.871,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19077,10336,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.873,10,BMX-IN-1,OHSU_HNSCC_derm002
19078,10336,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.9,1,Dasatinib (1mM),OHSU_HNSCC_derm002
19079,10336,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.876,10,Trametinib,OHSU_HNSCC_derm002
19080,10336,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.399,10,BEZ235,OHSU_HNSCC_derm002
19081,10336,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.019,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
19082,10336,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.727,10,Nilotinib,OHSU_HNSCC_derm002
19083,10336,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.899,10,Enzalutamide,OHSU_HNSCC_derm002
19084,10336,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.812,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19085,10336,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.779,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
19086,10336,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.431,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19087,10336,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.757,10,Axitinib,OHSU_HNSCC_derm002
19088,10336,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.356,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
19089,10336,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.722,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
19090,10336,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.786,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
19091,10336,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.541,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
19092,10336,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.853,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19093,10336,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.743,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
19094,10336,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.853,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
19095,10336,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.904,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
19096,10336,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.334,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
19097,10336,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.037,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
19098,10336,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.7,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
19099,10336,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.893,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
19100,10336,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.828,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19101,10336,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.891,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
19102,10336,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.348,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19103,10336,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.994,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
19104,10336,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.536,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
19105,10336,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.752,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
19106,10336,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.702,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
19107,10336,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.652,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
19108,10336,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.797,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19109,10336,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.754,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
19110,10336,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.907,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
19111,10336,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.914,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
19112,10336,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.325,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
19113,10336,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.026,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
19114,10336,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.638,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
19115,10336,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.818,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
19116,10336,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.692,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19117,10336,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.805,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
19118,10336,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19119,10336,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.857,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
19120,10336,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
19121,10336,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.619,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
19122,10336,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.79,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
19123,10336,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.735,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
19124,10336,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.814,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19125,10336,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.852,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
19126,10336,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.884,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
19127,10336,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.84,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
19128,10336,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.475,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
19129,10336,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.014,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
19130,10336,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.667,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
19131,10336,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.88,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
19132,10336,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.763,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19133,10336,Blank 490,2,N,OHSU_HNSCC_derm002,20,1.203,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
19134,10336,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.879,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19135,10336,Blank 490,2,P,OHSU_HNSCC_derm002,20,1.068,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
19136,10336,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.603,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
19137,10336,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.742,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
19138,10336,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.733,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
19139,10336,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.828,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
19140,10336,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.816,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19141,10336,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.771,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
19142,10336,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.858,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
19143,10336,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.896,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
19144,10336,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.612,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
19145,10336,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.341,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
19146,10336,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.745,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
19147,10336,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.802,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
19148,10336,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.793,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19149,10336,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.842,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
19150,10336,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.935,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19151,10336,Blank 490,2,P,OHSU_HNSCC_derm002,21,1.009,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
19152,10336,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.8,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
19153,10336,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.716,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
19154,10336,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.696,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
19155,10336,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.767,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
19156,10336,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.718,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19157,10336,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.819,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
19158,10336,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.805,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
19159,10336,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.91,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
19160,10336,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.921,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
19161,10336,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.401,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
19162,10336,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.649,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
19163,10336,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.839,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
19164,10336,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.864,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19165,10336,Blank 490,2,N,OHSU_HNSCC_derm002,22,1.07,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
19166,10336,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.889,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19167,10336,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.968,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
19168,10336,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.777,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
19169,10336,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.931,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
19170,10336,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
19171,10336,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.786,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
19172,10336,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.801,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
19173,10336,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.747,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
19174,10336,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.769,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
19175,10336,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.812,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
19176,10336,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.8,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
19177,10336,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.715,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
19178,10336,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.699,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
19179,10336,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.772,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
19180,10336,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.862,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
19181,10336,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.971,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
19182,10336,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.85,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
19183,10336,Blank 490,2,P,OHSU_HNSCC_derm002,23,1.156,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
19184,10336,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.608,0,NONE,OHSU_HNSCC_derm002
19185,10336,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.832,0,NONE,OHSU_HNSCC_derm002
19186,10336,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.854,0,NONE,OHSU_HNSCC_derm002
19187,10336,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.739,0,NONE,OHSU_HNSCC_derm002
19188,10336,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.944,0,NONE,OHSU_HNSCC_derm002
19189,10336,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.625,0,NONE,OHSU_HNSCC_derm002
19190,10336,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.829,0,NONE,OHSU_HNSCC_derm002
19191,10336,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.845,0,NONE,OHSU_HNSCC_derm002
19192,10336,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.881,0,NONE,OHSU_HNSCC_derm002
19193,10336,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.777,0,NONE,OHSU_HNSCC_derm002
19194,10336,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.864,0,NONE,OHSU_HNSCC_derm002
19195,10336,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.98,0,NONE,OHSU_HNSCC_derm002
19196,10336,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.874,0,NONE,OHSU_HNSCC_derm002
19197,10336,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.842,0,NONE,OHSU_HNSCC_derm002
19198,10336,Blank 490,2,O,OHSU_HNSCC_derm002,24,1.002,0,NONE,OHSU_HNSCC_derm002
19199,10336,Blank 490,2,P,OHSU_HNSCC_derm002,24,1.01,0,NONE,OHSU_HNSCC_derm002
19200,10336,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.937,10,Thalidomide ,OHSU_HNSCC_derm002
19201,10336,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.868,10,Vandetanib,OHSU_HNSCC_derm002
19202,10336,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.777,10,Oleic acid,OHSU_HNSCC_derm002
19203,10336,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.2,10,A-674563,OHSU_HNSCC_derm002
19204,10336,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.781,10,Lapatinib,OHSU_HNSCC_derm002
19205,10336,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.826,10,Apocynin (vanillin),OHSU_HNSCC_derm002
19206,10336,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.358,10,AT-7519,OHSU_HNSCC_derm002
19207,10336,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.867,10,Gefitinib,OHSU_HNSCC_derm002
19208,10336,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.986,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
19209,10336,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.103,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19210,10336,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.289,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19211,10336,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.157,10,JQ1,OHSU_HNSCC_derm002
19212,10336,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.565,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19213,10336,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.402,10,Cerdulatinib,OHSU_HNSCC_derm002
19214,10336,Blank 490,3,O,OHSU_HNSCC_derm002,1,-0.014,10,Romidepsin,OHSU_HNSCC_derm002
19215,10336,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.119,10,Gilteritinib,OHSU_HNSCC_derm002
19216,10336,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.831,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
19217,10336,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.894,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
19218,10336,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.689,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
19219,10336,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.772,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
19220,10336,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.723,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
19221,10336,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.857,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
19222,10336,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.284,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
19223,10336,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.732,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
19224,10336,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.787,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
19225,10336,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.777,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19226,10336,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.787,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19227,10336,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.698,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
19228,10336,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.767,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19229,10336,Blank 490,3,N,OHSU_HNSCC_derm002,2,1.098,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
19230,10336,Blank 490,3,O,OHSU_HNSCC_derm002,2,-0.009,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
19231,10336,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.961,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
19232,10336,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.918,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
19233,10336,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.882,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
19234,10336,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.731,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
19235,10336,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.766,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
19236,10336,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.867,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
19237,10336,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.769,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
19238,10336,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.358,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
19239,10336,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.794,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
19240,10336,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.795,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
19241,10336,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.814,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19242,10336,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.831,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19243,10336,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.835,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
19244,10336,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.935,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19245,10336,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.922,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
19246,10336,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.026,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
19247,10336,Blank 490,3,P,OHSU_HNSCC_derm002,3,1.084,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
19248,10336,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.963,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
19249,10336,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.802,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
19250,10336,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.767,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
19251,10336,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
19252,10336,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.889,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
19253,10336,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.733,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
19254,10336,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.735,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
19255,10336,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.761,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
19256,10336,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.739,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
19257,10336,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.536,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19258,10336,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.792,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19259,10336,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.852,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
19260,10336,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.838,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19261,10336,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.827,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
19262,10336,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.103,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
19263,10336,Blank 490,3,P,OHSU_HNSCC_derm002,4,1.049,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
19264,10336,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.918,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
19265,10336,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.817,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
19266,10336,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.743,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
19267,10336,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.826,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
19268,10336,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.943,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
19269,10336,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.763,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
19270,10336,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.844,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
19271,10336,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.797,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
19272,10336,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.739,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
19273,10336,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.677,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19274,10336,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.758,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19275,10336,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.87,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
19276,10336,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.904,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19277,10336,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.84,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
19278,10336,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.12,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
19279,10336,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.957,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
19280,10336,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.871,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
19281,10336,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.844,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
19282,10336,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.632,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
19283,10336,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.706,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
19284,10336,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.899,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
19285,10336,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.773,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
19286,10336,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.856,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
19287,10336,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.805,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
19288,10336,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.839,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
19289,10336,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.862,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19290,10336,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.868,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19291,10336,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.894,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
19292,10336,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.924,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19293,10336,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.889,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
19294,10336,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.117,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
19295,10336,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.892,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
19296,10336,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.834,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
19297,10336,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.923,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
19298,10336,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.78,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
19299,10336,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.81,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
19300,10336,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.813,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
19301,10336,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.803,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
19302,10336,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.9,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
19303,10336,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.677,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
19304,10336,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.814,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
19305,10336,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.679,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
19306,10336,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.838,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
19307,10336,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.728,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
19308,10336,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.907,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
19309,10336,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.967,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
19310,10336,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.117,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
19311,10336,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.913,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
19312,10336,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.917,0,NONE,OHSU_HNSCC_derm002
19313,10336,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.903,0,NONE,OHSU_HNSCC_derm002
19314,10336,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
19315,10336,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.667,0,NONE,OHSU_HNSCC_derm002
19316,10336,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.824,0,NONE,OHSU_HNSCC_derm002
19317,10336,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.782,0,NONE,OHSU_HNSCC_derm002
19318,10336,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.872,0,NONE,OHSU_HNSCC_derm002
19319,10336,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.013,10,F-S-V,OHSU_HNSCC_derm002
19320,10336,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.72,0,NONE,OHSU_HNSCC_derm002
19321,10336,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.8,0,NONE,OHSU_HNSCC_derm002
19322,10336,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.664,0,NONE,OHSU_HNSCC_derm002
19323,10336,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.761,0,NONE,OHSU_HNSCC_derm002
19324,10336,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.94,0,NONE,OHSU_HNSCC_derm002
19325,10336,Blank 490,3,N,OHSU_HNSCC_derm002,8,1.031,0,NONE,OHSU_HNSCC_derm002
19326,10336,Blank 490,3,O,OHSU_HNSCC_derm002,8,1.017,0,NONE,OHSU_HNSCC_derm002
19327,10336,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.876,0,NONE,OHSU_HNSCC_derm002
19328,10336,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.852,10,Anastrazole,OHSU_HNSCC_derm002
19329,10336,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.245,10,JNJ-28312141 ,OHSU_HNSCC_derm002
19330,10336,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.758,10,Genistein,OHSU_HNSCC_derm002
19331,10336,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.798,10,Abscisic acid,OHSU_HNSCC_derm002
19332,10336,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.654,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19333,10336,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.762,10,Ruxolitinib,OHSU_HNSCC_derm002
19334,10336,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.946,10,TAK-659,OHSU_HNSCC_derm002
19335,10336,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.961,10,Brigatinib,OHSU_HNSCC_derm002
19336,10336,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.76,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19337,10336,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.047,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19338,10336,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.599,10,Vorinostat,OHSU_HNSCC_derm002
19339,10336,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.722,10,Lenalidomide,OHSU_HNSCC_derm002
19340,10336,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.82,10,NVP-ADW742,OHSU_HNSCC_derm002
19341,10336,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.987,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19342,10336,Blank 490,3,O,OHSU_HNSCC_derm002,9,1.101,10,Echinatin,OHSU_HNSCC_derm002
19343,10336,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.026,10,YM-155,OHSU_HNSCC_derm002
19344,10336,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.948,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
19345,10336,Blank 490,3,B,OHSU_HNSCC_derm002,10,1.062,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
19346,10336,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.735,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
19347,10336,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.814,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
19348,10336,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.545,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19349,10336,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.896,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
19350,10336,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.934,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
19351,10336,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.85,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
19352,10336,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.77,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19353,10336,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.694,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19354,10336,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.928,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
19355,10336,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.813,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
19356,10336,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.861,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
19357,10336,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.915,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19358,10336,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.982,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
19359,10336,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.014,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
19360,10336,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.897,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
19361,10336,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.917,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
19362,10336,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.771,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
19363,10336,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.696,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
19364,10336,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.572,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19365,10336,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.856,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
19366,10336,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.93,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
19367,10336,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.932,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
19368,10336,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.946,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19369,10336,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.766,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19370,10336,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.955,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
19371,10336,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.751,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
19372,10336,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.808,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
19373,10336,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.815,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19374,10336,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.939,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
19375,10336,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.013,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
19376,10336,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.847,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
19377,10336,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.94,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
19378,10336,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.708,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
19379,10336,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.722,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
19380,10336,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.63,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19381,10336,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.771,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
19382,10336,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.861,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
19383,10336,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.768,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
19384,10336,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.774,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19385,10336,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.812,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19386,10336,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.86,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
19387,10336,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.791,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
19388,10336,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.83,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
19389,10336,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.913,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19390,10336,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.951,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
19391,10336,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.012,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
19392,10336,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.843,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
19393,10336,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.806,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
19394,10336,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.711,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
19395,10336,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.754,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
19396,10336,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.747,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19397,10336,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.88,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
19398,10336,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.89,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
19399,10336,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.782,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
19400,10336,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.83,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19401,10336,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.789,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19402,10336,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.876,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
19403,10336,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.817,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
19404,10336,Blank 490,3,M,OHSU_HNSCC_derm002,13,1.063,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
19405,10336,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.867,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19406,10336,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.94,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
19407,10336,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.002,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
19408,10336,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.87,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
19409,10336,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.973,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
19410,10336,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.866,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
19411,10336,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.726,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
19412,10336,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.776,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19413,10336,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.836,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
19414,10336,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.855,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
19415,10336,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.736,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
19416,10336,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.688,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19417,10336,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.786,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19418,10336,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.871,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
19419,10336,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.715,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
19420,10336,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.779,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
19421,10336,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.846,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19422,10336,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.85,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
19423,10336,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.053,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
19424,10336,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.903,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
19425,10336,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.879,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
19426,10336,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.779,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
19427,10336,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.696,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
19428,10336,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.921,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
19429,10336,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.822,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
19430,10336,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.829,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
19431,10336,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.835,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
19432,10336,Blank 490,3,I,OHSU_HNSCC_derm002,15,1.019,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19433,10336,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.901,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
19434,10336,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.72,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
19435,10336,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.677,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
19436,10336,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.819,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
19437,10336,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.795,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
19438,10336,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.942,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
19439,10336,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.131,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
19440,10336,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.919,0,NONE,OHSU_HNSCC_derm002
19441,10336,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.915,0,NONE,OHSU_HNSCC_derm002
19442,10336,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.876,0,NONE,OHSU_HNSCC_derm002
19443,10336,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.806,0,NONE,OHSU_HNSCC_derm002
19444,10336,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.734,0,NONE,OHSU_HNSCC_derm002
19445,10336,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.836,0,NONE,OHSU_HNSCC_derm002
19446,10336,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.659,0,NONE,OHSU_HNSCC_derm002
19447,10336,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.013,10,F-S-V,OHSU_HNSCC_derm002
19448,10336,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.762,0,NONE,OHSU_HNSCC_derm002
19449,10336,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.724,0,NONE,OHSU_HNSCC_derm002
19450,10336,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.825,0,NONE,OHSU_HNSCC_derm002
19451,10336,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.874,0,NONE,OHSU_HNSCC_derm002
19452,10336,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.832,0,NONE,OHSU_HNSCC_derm002
19453,10336,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.895,0,NONE,OHSU_HNSCC_derm002
19454,10336,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.932,0,NONE,OHSU_HNSCC_derm002
19455,10336,Blank 490,3,P,OHSU_HNSCC_derm002,16,1.075,0,NONE,OHSU_HNSCC_derm002
19456,10336,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.903,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19457,10336,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.852,10,Stevioside,OHSU_HNSCC_derm002
19458,10336,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.704,10,Pemetrexed,OHSU_HNSCC_derm002
19459,10336,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.411,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19460,10336,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.788,10,GSK-1838705A,OHSU_HNSCC_derm002
19461,10336,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.016,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19462,10336,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.816,10,Imatinib,OHSU_HNSCC_derm002
19463,10336,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.953,10,Trametinib,OHSU_HNSCC_derm002
19464,10336,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.283,10,BEZ235,OHSU_HNSCC_derm002
19465,10336,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.965,10,Saracatinib,OHSU_HNSCC_derm002
19466,10336,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.83,10,I-BET 762,OHSU_HNSCC_derm002
19467,10336,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.95,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
19468,10336,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.582,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
19469,10336,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.848,10,Crizotinib,OHSU_HNSCC_derm002
19470,10336,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.913,10,MGCD-265,OHSU_HNSCC_derm002
19471,10336,Blank 490,3,P,OHSU_HNSCC_derm002,17,1.129,10,Erlotinib,OHSU_HNSCC_derm002
19472,10336,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.894,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19473,10336,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.891,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
19474,10336,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.863,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
19475,10336,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.548,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19476,10336,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.849,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
19477,10336,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.809,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19478,10336,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.764,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
19479,10336,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.932,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
19480,10336,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.275,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
19481,10336,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.987,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
19482,10336,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.883,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
19483,10336,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.774,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
19484,10336,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.688,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
19485,10336,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.827,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
19486,10336,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.852,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
19487,10336,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.979,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
19488,10336,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.942,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19489,10336,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.915,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
19490,10336,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.76,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
19491,10336,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.683,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19492,10336,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.801,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
19493,10336,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.861,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19494,10336,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.889,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
19495,10336,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.917,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
19496,10336,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.332,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
19497,10336,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.871,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
19498,10336,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.962,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
19499,10336,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.802,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
19500,10336,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.848,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
19501,10336,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.967,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
19502,10336,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.958,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
19503,10336,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.94,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
19504,10336,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.864,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19505,10336,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.904,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
19506,10336,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.742,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
19507,10336,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.781,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19508,10336,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.956,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
19509,10336,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.871,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19510,10336,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.851,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
19511,10336,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.84,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
19512,10336,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.51,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
19513,10336,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.842,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
19514,10336,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.975,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
19515,10336,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.906,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
19516,10336,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.948,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
19517,10336,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.896,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
19518,10336,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.938,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
19519,10336,Blank 490,3,P,OHSU_HNSCC_derm002,20,1.027,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
19520,10336,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.831,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19521,10336,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.768,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
19522,10336,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.728,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
19523,10336,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.97,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19524,10336,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.85,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
19525,10336,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.779,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19526,10336,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.838,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
19527,10336,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.922,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
19528,10336,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.707,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
19529,10336,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.942,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
19530,10336,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.782,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
19531,10336,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.852,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
19532,10336,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.86,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
19533,10336,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.921,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
19534,10336,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.787,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
19535,10336,Blank 490,3,P,OHSU_HNSCC_derm002,21,1.07,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
19536,10336,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.803,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19537,10336,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.94,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
19538,10336,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.937,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
19539,10336,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.936,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19540,10336,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.951,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
19541,10336,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.9,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19542,10336,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.844,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
19543,10336,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.785,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
19544,10336,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.887,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
19545,10336,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.755,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
19546,10336,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.877,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
19547,10336,Blank 490,3,L,OHSU_HNSCC_derm002,22,1.053,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
19548,10336,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.867,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
19549,10336,Blank 490,3,N,OHSU_HNSCC_derm002,22,1.07,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
19550,10336,Blank 490,3,O,OHSU_HNSCC_derm002,22,1.054,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
19551,10336,Blank 490,3,P,OHSU_HNSCC_derm002,22,1.105,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
19552,10336,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.884,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
19553,10336,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.931,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
19554,10336,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.818,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
19555,10336,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.827,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
19556,10336,Blank 490,3,E,OHSU_HNSCC_derm002,23,1.041,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
19557,10336,Blank 490,3,F,OHSU_HNSCC_derm002,23,1.056,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
19558,10336,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.913,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
19559,10336,Blank 490,3,H,OHSU_HNSCC_derm002,23,1.083,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
19560,10336,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.662,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
19561,10336,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.99,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
19562,10336,Blank 490,3,K,OHSU_HNSCC_derm002,23,1.004,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
19563,10336,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.968,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
19564,10336,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.979,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
19565,10336,Blank 490,3,N,OHSU_HNSCC_derm002,23,1.227,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
19566,10336,Blank 490,3,O,OHSU_HNSCC_derm002,23,1.067,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
19567,10336,Blank 490,3,P,OHSU_HNSCC_derm002,23,1.066,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
19568,10336,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.78,0,NONE,OHSU_HNSCC_derm002
19569,10336,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.958,0,NONE,OHSU_HNSCC_derm002
19570,10336,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.87,0,NONE,OHSU_HNSCC_derm002
19571,10336,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.882,0,NONE,OHSU_HNSCC_derm002
19572,10336,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.875,0,NONE,OHSU_HNSCC_derm002
19573,10336,Blank 490,3,F,OHSU_HNSCC_derm002,24,1.006,0,NONE,OHSU_HNSCC_derm002
19574,10336,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.705,0,NONE,OHSU_HNSCC_derm002
19575,10336,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.827,0,NONE,OHSU_HNSCC_derm002
19576,10336,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.906,0,NONE,OHSU_HNSCC_derm002
19577,10336,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.862,0,NONE,OHSU_HNSCC_derm002
19578,10336,Blank 490,3,K,OHSU_HNSCC_derm002,24,1.085,0,NONE,OHSU_HNSCC_derm002
19579,10336,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.946,0,NONE,OHSU_HNSCC_derm002
19580,10336,Blank 490,3,M,OHSU_HNSCC_derm002,24,1.129,0,NONE,OHSU_HNSCC_derm002
19581,10336,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.918,0,NONE,OHSU_HNSCC_derm002
19582,10336,Blank 490,3,O,OHSU_HNSCC_derm002,24,1.074,0,NONE,OHSU_HNSCC_derm002
19583,10336,Blank 490,3,P,OHSU_HNSCC_derm002,24,1.008,0,NONE,OHSU_HNSCC_derm002
19584,10336,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.128,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19585,10336,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.744,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19586,10336,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.585,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19587,10336,Blank 490,4,D,OHSU_HNSCC_derm002,1,1.054,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19588,10336,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.109,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19589,10336,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.26,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19590,10336,Blank 490,4,G,OHSU_HNSCC_derm002,1,-0.001,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19591,10336,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.115,10,Gefitinib,OHSU_HNSCC_derm002
19592,10336,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.546,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
19593,10336,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.001,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19594,10336,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.552,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19595,10336,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.207,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19596,10336,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.594,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19597,10336,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.432,10,VOLASERTIB x,OHSU_HNSCC_derm002
19598,10336,Blank 490,4,O,OHSU_HNSCC_derm002,1,1.135,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19599,10336,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.001,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19600,10336,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.245,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19601,10336,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.964,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19602,10336,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.945,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19603,10336,Blank 490,4,D,OHSU_HNSCC_derm002,2,1.138,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19604,10336,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.27,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19605,10336,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.254,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19606,10336,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.048,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19607,10336,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.975,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
19608,10336,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.958,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
19609,10336,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.684,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19610,10336,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.918,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19611,10336,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.555,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19612,10336,Blank 490,4,M,OHSU_HNSCC_derm002,2,1.068,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19613,10336,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.922,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
19614,10336,Blank 490,4,O,OHSU_HNSCC_derm002,2,1.065,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19615,10336,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.187,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19616,10336,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.638,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19617,10336,Blank 490,4,B,OHSU_HNSCC_derm002,3,1.051,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19618,10336,Blank 490,4,C,OHSU_HNSCC_derm002,3,1.009,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19619,10336,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.909,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19620,10336,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.845,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19621,10336,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.395,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19622,10336,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.161,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19623,10336,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.808,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
19624,10336,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.853,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
19625,10336,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.899,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19626,10336,Blank 490,4,K,OHSU_HNSCC_derm002,3,1.163,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19627,10336,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.964,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19628,10336,Blank 490,4,M,OHSU_HNSCC_derm002,3,1.027,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19629,10336,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.682,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
19630,10336,Blank 490,4,O,OHSU_HNSCC_derm002,3,1.141,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19631,10336,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.54,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19632,10336,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.678,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19633,10336,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.973,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19634,10336,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.78,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19635,10336,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.724,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19636,10336,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.943,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19637,10336,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.464,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19638,10336,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.162,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19639,10336,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.849,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
19640,10336,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.873,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
19641,10336,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.947,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19642,10336,Blank 490,4,K,OHSU_HNSCC_derm002,4,1.003,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19643,10336,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.966,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19644,10336,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.832,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19645,10336,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.569,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
19646,10336,Blank 490,4,O,OHSU_HNSCC_derm002,4,1.191,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19647,10336,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.964,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19648,10336,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.92,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19649,10336,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.833,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19650,10336,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.836,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19651,10336,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.914,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19652,10336,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.927,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19653,10336,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.773,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19654,10336,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.151,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19655,10336,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.838,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
19656,10336,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.936,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
19657,10336,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.922,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19658,10336,Blank 490,4,K,OHSU_HNSCC_derm002,5,1.015,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19659,10336,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.9,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19660,10336,Blank 490,4,M,OHSU_HNSCC_derm002,5,1.084,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19661,10336,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
19662,10336,Blank 490,4,O,OHSU_HNSCC_derm002,5,1.112,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19663,10336,Blank 490,4,P,OHSU_HNSCC_derm002,5,1.069,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19664,10336,Blank 490,4,A,OHSU_HNSCC_derm002,6,1.234,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19665,10336,Blank 490,4,B,OHSU_HNSCC_derm002,6,1.024,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19666,10336,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.746,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19667,10336,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.791,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19668,10336,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.888,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19669,10336,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.851,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19670,10336,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.184,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19671,10336,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.85,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
19672,10336,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.929,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
19673,10336,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.888,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19674,10336,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.969,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19675,10336,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.971,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19676,10336,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.878,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19677,10336,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.57,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
19678,10336,Blank 490,4,O,OHSU_HNSCC_derm002,6,1.16,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19679,10336,Blank 490,4,P,OHSU_HNSCC_derm002,6,1.315,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19680,10336,Blank 490,4,A,OHSU_HNSCC_derm002,7,1.168,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
19681,10336,Blank 490,4,B,OHSU_HNSCC_derm002,7,1.16,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
19682,10336,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.805,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
19683,10336,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.76,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
19684,10336,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.89,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
19685,10336,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.916,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
19686,10336,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.223,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
19687,10336,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.855,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
19688,10336,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.844,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
19689,10336,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.696,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
19690,10336,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.955,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
19691,10336,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.95,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
19692,10336,Blank 490,4,M,OHSU_HNSCC_derm002,7,1.137,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
19693,10336,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.901,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
19694,10336,Blank 490,4,O,OHSU_HNSCC_derm002,7,1.159,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19695,10336,Blank 490,4,P,OHSU_HNSCC_derm002,7,1.219,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
19696,10336,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.963,0,NONE,OHSU_HNSCC_derm002
19697,10336,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.965,0,NONE,OHSU_HNSCC_derm002
19698,10336,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.835,0,NONE,OHSU_HNSCC_derm002
19699,10336,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.917,0,NONE,OHSU_HNSCC_derm002
19700,10336,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.935,0,NONE,OHSU_HNSCC_derm002
19701,10336,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.885,0,NONE,OHSU_HNSCC_derm002
19702,10336,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.977,0,NONE,OHSU_HNSCC_derm002
19703,10336,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
19704,10336,Blank 490,4,I,OHSU_HNSCC_derm002,8,1.16,0,NONE,OHSU_HNSCC_derm002
19705,10336,Blank 490,4,J,OHSU_HNSCC_derm002,8,1.06,0,NONE,OHSU_HNSCC_derm002
19706,10336,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.883,0,NONE,OHSU_HNSCC_derm002
19707,10336,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.998,0,NONE,OHSU_HNSCC_derm002
19708,10336,Blank 490,4,M,OHSU_HNSCC_derm002,8,1.102,0,NONE,OHSU_HNSCC_derm002
19709,10336,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.905,0,NONE,OHSU_HNSCC_derm002
19710,10336,Blank 490,4,O,OHSU_HNSCC_derm002,8,1.108,0,NONE,OHSU_HNSCC_derm002
19711,10336,Blank 490,4,P,OHSU_HNSCC_derm002,8,1.121,0,NONE,OHSU_HNSCC_derm002
19712,10336,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.445,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19713,10336,Blank 490,4,B,OHSU_HNSCC_derm002,9,1.087,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19714,10336,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.117,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
19715,10336,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.676,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19716,10336,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.922,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19717,10336,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.068,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
19718,10336,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.324,10,AZD2014 x ,OHSU_HNSCC_derm002
19719,10336,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.99,10,Brigatinib,OHSU_HNSCC_derm002
19720,10336,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.97,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19721,10336,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.221,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19722,10336,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.771,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19723,10336,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.001,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
19724,10336,Blank 490,4,M,OHSU_HNSCC_derm002,9,1.043,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19725,10336,Blank 490,4,N,OHSU_HNSCC_derm002,9,1.063,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19726,10336,Blank 490,4,O,OHSU_HNSCC_derm002,9,1.019,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19727,10336,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.576,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19728,10336,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.65,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19729,10336,Blank 490,4,B,OHSU_HNSCC_derm002,10,1.182,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19730,10336,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.226,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
19731,10336,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.795,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19732,10336,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.884,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19733,10336,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.296,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
19734,10336,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.426,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
19735,10336,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.944,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
19736,10336,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.928,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19737,10336,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.76,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19738,10336,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.9,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19739,10336,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.028,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
19740,10336,Blank 490,4,M,OHSU_HNSCC_derm002,10,1.211,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19741,10336,Blank 490,4,N,OHSU_HNSCC_derm002,10,1.137,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19742,10336,Blank 490,4,O,OHSU_HNSCC_derm002,10,1.04,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19743,10336,Blank 490,4,P,OHSU_HNSCC_derm002,10,1.147,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19744,10336,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.745,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19745,10336,Blank 490,4,B,OHSU_HNSCC_derm002,11,1.086,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19746,10336,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.285,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
19747,10336,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.933,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19748,10336,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.953,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19749,10336,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.506,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
19750,10336,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.474,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
19751,10336,Blank 490,4,H,OHSU_HNSCC_derm002,11,1.001,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
19752,10336,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.813,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19753,10336,Blank 490,4,J,OHSU_HNSCC_derm002,11,1.066,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19754,10336,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.866,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19755,10336,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.101,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
19756,10336,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.929,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19757,10336,Blank 490,4,N,OHSU_HNSCC_derm002,11,1.003,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19758,10336,Blank 490,4,O,OHSU_HNSCC_derm002,11,1.179,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19759,10336,Blank 490,4,P,OHSU_HNSCC_derm002,11,1.186,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19760,10336,Blank 490,4,A,OHSU_HNSCC_derm002,12,1.127,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19761,10336,Blank 490,4,B,OHSU_HNSCC_derm002,12,1.1,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19762,10336,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.775,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
19763,10336,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.809,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19764,10336,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.889,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19765,10336,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.926,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
19766,10336,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.829,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
19767,10336,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.869,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
19768,10336,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.834,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19769,10336,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.905,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19770,10336,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.922,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19771,10336,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.744,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
19772,10336,Blank 490,4,M,OHSU_HNSCC_derm002,12,1.172,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19773,10336,Blank 490,4,N,OHSU_HNSCC_derm002,12,1.002,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19774,10336,Blank 490,4,O,OHSU_HNSCC_derm002,12,1.124,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19775,10336,Blank 490,4,P,OHSU_HNSCC_derm002,12,1.2,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19776,10336,Blank 490,4,A,OHSU_HNSCC_derm002,13,1.145,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19777,10336,Blank 490,4,B,OHSU_HNSCC_derm002,13,1.033,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19778,10336,Blank 490,4,C,OHSU_HNSCC_derm002,13,1.099,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
19779,10336,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.688,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19780,10336,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.929,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19781,10336,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.851,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
19782,10336,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.932,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
19783,10336,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.861,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
19784,10336,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.836,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19785,10336,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.928,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19786,10336,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.897,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19787,10336,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.874,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
19788,10336,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.885,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19789,10336,Blank 490,4,N,OHSU_HNSCC_derm002,13,1.065,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19790,10336,Blank 490,4,O,OHSU_HNSCC_derm002,13,1.267,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19791,10336,Blank 490,4,P,OHSU_HNSCC_derm002,13,1.072,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19792,10336,Blank 490,4,A,OHSU_HNSCC_derm002,14,1.041,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19793,10336,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.997,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19794,10336,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.929,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
19795,10336,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.829,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19796,10336,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.978,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19797,10336,Blank 490,4,F,OHSU_HNSCC_derm002,14,1.029,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
19798,10336,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.966,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
19799,10336,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.902,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
19800,10336,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.899,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19801,10336,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.907,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19802,10336,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.754,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19803,10336,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.804,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
19804,10336,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.91,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19805,10336,Blank 490,4,N,OHSU_HNSCC_derm002,14,1.153,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19806,10336,Blank 490,4,O,OHSU_HNSCC_derm002,14,1.121,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19807,10336,Blank 490,4,P,OHSU_HNSCC_derm002,14,1.339,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19808,10336,Blank 490,4,A,OHSU_HNSCC_derm002,15,1.117,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
19809,10336,Blank 490,4,B,OHSU_HNSCC_derm002,15,1.051,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
19810,10336,Blank 490,4,C,OHSU_HNSCC_derm002,15,1.127,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
19811,10336,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.87,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19812,10336,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.992,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
19813,10336,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.926,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
19814,10336,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.935,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
19815,10336,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.88,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
19816,10336,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.981,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
19817,10336,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.823,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
19818,10336,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.949,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
19819,10336,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.806,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
19820,10336,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.958,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19821,10336,Blank 490,4,N,OHSU_HNSCC_derm002,15,1.004,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
19822,10336,Blank 490,4,O,OHSU_HNSCC_derm002,15,1.132,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
19823,10336,Blank 490,4,P,OHSU_HNSCC_derm002,15,1.048,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
19824,10336,Blank 490,4,A,OHSU_HNSCC_derm002,16,1.176,0,NONE,OHSU_HNSCC_derm002
19825,10336,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.973,0,NONE,OHSU_HNSCC_derm002
19826,10336,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.829,0,NONE,OHSU_HNSCC_derm002
19827,10336,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.845,0,NONE,OHSU_HNSCC_derm002
19828,10336,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.919,0,NONE,OHSU_HNSCC_derm002
19829,10336,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.933,0,NONE,OHSU_HNSCC_derm002
19830,10336,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.87,0,NONE,OHSU_HNSCC_derm002
19831,10336,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
19832,10336,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.882,0,NONE,OHSU_HNSCC_derm002
19833,10336,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.897,0,NONE,OHSU_HNSCC_derm002
19834,10336,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.784,0,NONE,OHSU_HNSCC_derm002
19835,10336,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.729,0,NONE,OHSU_HNSCC_derm002
19836,10336,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.851,0,NONE,OHSU_HNSCC_derm002
19837,10336,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.962,0,NONE,OHSU_HNSCC_derm002
19838,10336,Blank 490,4,O,OHSU_HNSCC_derm002,16,1.02,0,NONE,OHSU_HNSCC_derm002
19839,10336,Blank 490,4,P,OHSU_HNSCC_derm002,16,1.201,0,NONE,OHSU_HNSCC_derm002
19840,10336,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.943,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19841,10336,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.234,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19842,10336,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.172,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19843,10336,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.015,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19844,10336,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.113,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19845,10336,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.883,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19846,10336,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.987,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19847,10336,Blank 490,4,H,OHSU_HNSCC_derm002,17,1.092,10,Trametinib,OHSU_HNSCC_derm002
19848,10336,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.272,10,BEZ235,OHSU_HNSCC_derm002
19849,10336,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.175,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19850,10336,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.907,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19851,10336,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.962,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19852,10336,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.87,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19853,10336,Blank 490,4,N,OHSU_HNSCC_derm002,17,1.145,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19854,10336,Blank 490,4,O,OHSU_HNSCC_derm002,17,1.019,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19855,10336,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.516,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19856,10336,Blank 490,4,A,OHSU_HNSCC_derm002,18,1.0,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19857,10336,Blank 490,4,B,OHSU_HNSCC_derm002,18,1.162,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19858,10336,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.846,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19859,10336,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.014,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19860,10336,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.397,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19861,10336,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.956,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19862,10336,Blank 490,4,G,OHSU_HNSCC_derm002,18,1.078,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19863,10336,Blank 490,4,H,OHSU_HNSCC_derm002,18,1.033,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
19864,10336,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.369,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
19865,10336,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.582,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19866,10336,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.884,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19867,10336,Blank 490,4,L,OHSU_HNSCC_derm002,18,1.107,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19868,10336,Blank 490,4,M,OHSU_HNSCC_derm002,18,1.009,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19869,10336,Blank 490,4,N,OHSU_HNSCC_derm002,18,1.16,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19870,10336,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.971,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19871,10336,Blank 490,4,P,OHSU_HNSCC_derm002,18,1.257,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19872,10336,Blank 490,4,A,OHSU_HNSCC_derm002,19,1.043,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19873,10336,Blank 490,4,B,OHSU_HNSCC_derm002,19,1.116,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19874,10336,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.859,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19875,10336,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.103,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19876,10336,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.966,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19877,10336,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.535,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19878,10336,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.766,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19879,10336,Blank 490,4,H,OHSU_HNSCC_derm002,19,1.059,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
19880,10336,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.277,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
19881,10336,Blank 490,4,J,OHSU_HNSCC_derm002,19,1.103,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19882,10336,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.902,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19883,10336,Blank 490,4,L,OHSU_HNSCC_derm002,19,1.086,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19884,10336,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.849,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19885,10336,Blank 490,4,N,OHSU_HNSCC_derm002,19,1.024,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19886,10336,Blank 490,4,O,OHSU_HNSCC_derm002,19,1.028,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19887,10336,Blank 490,4,P,OHSU_HNSCC_derm002,19,1.097,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19888,10336,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.96,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19889,10336,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.989,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19890,10336,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.875,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19891,10336,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.124,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19892,10336,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.517,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19893,10336,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.895,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19894,10336,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.847,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19895,10336,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.937,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
19896,10336,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.527,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
19897,10336,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.999,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19898,10336,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.818,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19899,10336,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.913,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19900,10336,Blank 490,4,M,OHSU_HNSCC_derm002,20,1.049,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19901,10336,Blank 490,4,N,OHSU_HNSCC_derm002,20,1.055,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19902,10336,Blank 490,4,O,OHSU_HNSCC_derm002,20,1.036,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19903,10336,Blank 490,4,P,OHSU_HNSCC_derm002,20,1.092,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19904,10336,Blank 490,4,A,OHSU_HNSCC_derm002,21,1.072,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19905,10336,Blank 490,4,B,OHSU_HNSCC_derm002,21,1.109,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19906,10336,Blank 490,4,C,OHSU_HNSCC_derm002,21,1.016,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19907,10336,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.146,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19908,10336,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.838,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19909,10336,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.882,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19910,10336,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.897,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19911,10336,Blank 490,4,H,OHSU_HNSCC_derm002,21,1.067,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
19912,10336,Blank 490,4,I,OHSU_HNSCC_derm002,21,1.161,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
19913,10336,Blank 490,4,J,OHSU_HNSCC_derm002,21,1.143,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19914,10336,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.863,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19915,10336,Blank 490,4,L,OHSU_HNSCC_derm002,21,1.119,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19916,10336,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.895,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19917,10336,Blank 490,4,N,OHSU_HNSCC_derm002,21,1.147,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19918,10336,Blank 490,4,O,OHSU_HNSCC_derm002,21,1.162,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19919,10336,Blank 490,4,P,OHSU_HNSCC_derm002,21,1.279,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19920,10336,Blank 490,4,A,OHSU_HNSCC_derm002,22,1.042,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19921,10336,Blank 490,4,B,OHSU_HNSCC_derm002,22,1.032,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19922,10336,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.878,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19923,10336,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.131,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19924,10336,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.851,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19925,10336,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.945,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19926,10336,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.896,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19927,10336,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.976,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
19928,10336,Blank 490,4,I,OHSU_HNSCC_derm002,22,1.074,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
19929,10336,Blank 490,4,J,OHSU_HNSCC_derm002,22,1.008,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19930,10336,Blank 490,4,K,OHSU_HNSCC_derm002,22,1.112,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19931,10336,Blank 490,4,L,OHSU_HNSCC_derm002,22,1.076,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19932,10336,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.882,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19933,10336,Blank 490,4,N,OHSU_HNSCC_derm002,22,1.302,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19934,10336,Blank 490,4,O,OHSU_HNSCC_derm002,22,1.185,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19935,10336,Blank 490,4,P,OHSU_HNSCC_derm002,22,1.295,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19936,10336,Blank 490,4,A,OHSU_HNSCC_derm002,23,1.035,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
19937,10336,Blank 490,4,B,OHSU_HNSCC_derm002,23,1.125,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
19938,10336,Blank 490,4,C,OHSU_HNSCC_derm002,23,1.137,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19939,10336,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.179,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
19940,10336,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.867,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
19941,10336,Blank 490,4,F,OHSU_HNSCC_derm002,23,1.154,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
19942,10336,Blank 490,4,G,OHSU_HNSCC_derm002,23,1.073,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
19943,10336,Blank 490,4,H,OHSU_HNSCC_derm002,23,1.096,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
19944,10336,Blank 490,4,I,OHSU_HNSCC_derm002,23,1.026,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
19945,10336,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.855,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
19946,10336,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.932,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19947,10336,Blank 490,4,L,OHSU_HNSCC_derm002,23,1.344,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
19948,10336,Blank 490,4,M,OHSU_HNSCC_derm002,23,1.2,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
19949,10336,Blank 490,4,N,OHSU_HNSCC_derm002,23,1.035,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
19950,10336,Blank 490,4,O,OHSU_HNSCC_derm002,23,1.111,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
19951,10336,Blank 490,4,P,OHSU_HNSCC_derm002,23,1.153,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
19952,10336,Blank 490,4,A,OHSU_HNSCC_derm002,24,1.058,0,NONE,OHSU_HNSCC_derm002
19953,10336,Blank 490,4,B,OHSU_HNSCC_derm002,24,1.155,0,NONE,OHSU_HNSCC_derm002
19954,10336,Blank 490,4,C,OHSU_HNSCC_derm002,24,1.15,0,NONE,OHSU_HNSCC_derm002
19955,10336,Blank 490,4,D,OHSU_HNSCC_derm002,24,1.068,0,NONE,OHSU_HNSCC_derm002
19956,10336,Blank 490,4,E,OHSU_HNSCC_derm002,24,1.007,0,NONE,OHSU_HNSCC_derm002
19957,10336,Blank 490,4,F,OHSU_HNSCC_derm002,24,1.059,0,NONE,OHSU_HNSCC_derm002
19958,10336,Blank 490,4,G,OHSU_HNSCC_derm002,24,1.075,0,NONE,OHSU_HNSCC_derm002
19959,10336,Blank 490,4,H,OHSU_HNSCC_derm002,24,1.212,0,NONE,OHSU_HNSCC_derm002
19960,10336,Blank 490,4,I,OHSU_HNSCC_derm002,24,1.2,0,NONE,OHSU_HNSCC_derm002
19961,10336,Blank 490,4,J,OHSU_HNSCC_derm002,24,1.036,0,NONE,OHSU_HNSCC_derm002
19962,10336,Blank 490,4,K,OHSU_HNSCC_derm002,24,1.102,0,NONE,OHSU_HNSCC_derm002
19963,10336,Blank 490,4,L,OHSU_HNSCC_derm002,24,1.055,0,NONE,OHSU_HNSCC_derm002
19964,10336,Blank 490,4,M,OHSU_HNSCC_derm002,24,1.149,0,NONE,OHSU_HNSCC_derm002
19965,10336,Blank 490,4,N,OHSU_HNSCC_derm002,24,1.287,0,NONE,OHSU_HNSCC_derm002
19966,10336,Blank 490,4,O,OHSU_HNSCC_derm002,24,1.169,0,NONE,OHSU_HNSCC_derm002
19967,10336,Blank 490,4,P,OHSU_HNSCC_derm002,24,1.037,0,NONE,OHSU_HNSCC_derm002
19968,10336,Blank 490,5,A,OHSU_HNSCC_derm002,1,1.006,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19969,10336,Blank 490,5,B,OHSU_HNSCC_derm002,1,1.151,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
19970,10336,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.008,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
19971,10336,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.772,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
19972,10336,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.269,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
19973,10336,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.863,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
19974,10336,Blank 490,5,G,OHSU_HNSCC_derm002,1,1.146,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
19975,10336,Blank 490,5,H,OHSU_HNSCC_derm002,1,1.055,10,Gefitinib,OHSU_HNSCC_derm002
19976,10336,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.412,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
19977,10336,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.003,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
19978,10336,Blank 490,5,K,OHSU_HNSCC_derm002,1,1.049,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19979,10336,Blank 490,5,L,OHSU_HNSCC_derm002,1,1.181,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
19980,10336,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.379,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
19981,10336,Blank 490,5,N,OHSU_HNSCC_derm002,1,1.142,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
19982,10336,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.202,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
19983,10336,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.181,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
19984,10336,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.962,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
19985,10336,Blank 490,5,B,OHSU_HNSCC_derm002,2,1.134,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
19986,10336,Blank 490,5,C,OHSU_HNSCC_derm002,2,0.006,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
19987,10336,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.854,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
19988,10336,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.919,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
19989,10336,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.897,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
19990,10336,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.93,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
19991,10336,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.939,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
19992,10336,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.937,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
19993,10336,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.435,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
19994,10336,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.922,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
19995,10336,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.872,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
19996,10336,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.569,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
19997,10336,Blank 490,5,N,OHSU_HNSCC_derm002,2,1.024,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
19998,10336,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.243,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
19999,10336,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.492,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20000,10336,Blank 490,5,A,OHSU_HNSCC_derm002,3,1.001,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20001,10336,Blank 490,5,B,OHSU_HNSCC_derm002,3,1.129,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
20002,10336,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.098,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
20003,10336,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.888,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
20004,10336,Blank 490,5,E,OHSU_HNSCC_derm002,3,1.117,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
20005,10336,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.91,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
20006,10336,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.853,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
20007,10336,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.894,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
20008,10336,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.884,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
20009,10336,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.782,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
20010,10336,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.812,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
20011,10336,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.917,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20012,10336,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.947,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20013,10336,Blank 490,5,N,OHSU_HNSCC_derm002,3,1.071,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
20014,10336,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.38,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
20015,10336,Blank 490,5,P,OHSU_HNSCC_derm002,3,1.089,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20016,10336,Blank 490,5,A,OHSU_HNSCC_derm002,4,1.102,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20017,10336,Blank 490,5,B,OHSU_HNSCC_derm002,4,1.04,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
20018,10336,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.123,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
20019,10336,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.798,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
20020,10336,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.968,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
20021,10336,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.855,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
20022,10336,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.974,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
20023,10336,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.872,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
20024,10336,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.87,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
20025,10336,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.929,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
20026,10336,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.887,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
20027,10336,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.894,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20028,10336,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.978,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20029,10336,Blank 490,5,N,OHSU_HNSCC_derm002,4,1.083,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
20030,10336,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.501,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
20031,10336,Blank 490,5,P,OHSU_HNSCC_derm002,4,1.352,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20032,10336,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.833,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20033,10336,Blank 490,5,B,OHSU_HNSCC_derm002,5,1.142,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
20034,10336,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.146,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
20035,10336,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.793,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
20036,10336,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.912,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
20037,10336,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.852,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
20038,10336,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.956,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
20039,10336,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.886,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
20040,10336,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.878,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
20041,10336,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.987,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
20042,10336,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.971,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
20043,10336,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.913,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20044,10336,Blank 490,5,M,OHSU_HNSCC_derm002,5,1.11,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20045,10336,Blank 490,5,N,OHSU_HNSCC_derm002,5,1.108,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
20046,10336,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.822,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
20047,10336,Blank 490,5,P,OHSU_HNSCC_derm002,5,1.166,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20048,10336,Blank 490,5,A,OHSU_HNSCC_derm002,6,1.129,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20049,10336,Blank 490,5,B,OHSU_HNSCC_derm002,6,1.082,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
20050,10336,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.173,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
20051,10336,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.735,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
20052,10336,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.856,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
20053,10336,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.777,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
20054,10336,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.898,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
20055,10336,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.665,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
20056,10336,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.719,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
20057,10336,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.914,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
20058,10336,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.927,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
20059,10336,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.998,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20060,10336,Blank 490,5,M,OHSU_HNSCC_derm002,6,1.018,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20061,10336,Blank 490,5,N,OHSU_HNSCC_derm002,6,1.1,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
20062,10336,Blank 490,5,O,OHSU_HNSCC_derm002,6,1.02,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
20063,10336,Blank 490,5,P,OHSU_HNSCC_derm002,6,1.084,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20064,10336,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.959,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20065,10336,Blank 490,5,B,OHSU_HNSCC_derm002,7,1.063,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
20066,10336,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.269,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
20067,10336,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.851,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
20068,10336,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.793,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
20069,10336,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.889,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
20070,10336,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.883,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
20071,10336,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.859,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
20072,10336,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.894,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
20073,10336,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.839,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
20074,10336,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.878,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
20075,10336,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.854,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20076,10336,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.896,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20077,10336,Blank 490,5,N,OHSU_HNSCC_derm002,7,1.1,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
20078,10336,Blank 490,5,O,OHSU_HNSCC_derm002,7,1.103,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
20079,10336,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.979,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
20080,10336,Blank 490,5,A,OHSU_HNSCC_derm002,8,1.064,0,NONE,OHSU_HNSCC_derm002
20081,10336,Blank 490,5,B,OHSU_HNSCC_derm002,8,1.079,0,NONE,OHSU_HNSCC_derm002
20082,10336,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.87,0,NONE,OHSU_HNSCC_derm002
20083,10336,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.893,0,NONE,OHSU_HNSCC_derm002
20084,10336,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.886,0,NONE,OHSU_HNSCC_derm002
20085,10336,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
20086,10336,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.922,0,NONE,OHSU_HNSCC_derm002
20087,10336,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.006,10,F-S-V,OHSU_HNSCC_derm002
20088,10336,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.892,0,NONE,OHSU_HNSCC_derm002
20089,10336,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.797,0,NONE,OHSU_HNSCC_derm002
20090,10336,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.888,0,NONE,OHSU_HNSCC_derm002
20091,10336,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
20092,10336,Blank 490,5,M,OHSU_HNSCC_derm002,8,1.087,0,NONE,OHSU_HNSCC_derm002
20093,10336,Blank 490,5,N,OHSU_HNSCC_derm002,8,1.015,0,NONE,OHSU_HNSCC_derm002
20094,10336,Blank 490,5,O,OHSU_HNSCC_derm002,8,1.118,0,NONE,OHSU_HNSCC_derm002
20095,10336,Blank 490,5,P,OHSU_HNSCC_derm002,8,1.139,0,NONE,OHSU_HNSCC_derm002
20096,10336,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.001,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20097,10336,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.719,10,APTO-253 x,OHSU_HNSCC_derm002
20098,10336,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.064,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20099,10336,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.8,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20100,10336,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.967,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20101,10336,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.238,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20102,10336,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.24,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20103,10336,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.007,10,Brigatinib,OHSU_HNSCC_derm002
20104,10336,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.945,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20105,10336,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.118,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20106,10336,Blank 490,5,K,OHSU_HNSCC_derm002,9,-0.002,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20107,10336,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.163,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20108,10336,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.98,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20109,10336,Blank 490,5,N,OHSU_HNSCC_derm002,9,1.044,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20110,10336,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.008,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20111,10336,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.004,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20112,10336,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.024,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20113,10336,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.82,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
20114,10336,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.11,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20115,10336,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.788,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20116,10336,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.88,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20117,10336,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.665,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20118,10336,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.915,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20119,10336,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.934,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
20120,10336,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.921,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20121,10336,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.283,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20122,10336,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.391,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20123,10336,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.172,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20124,10336,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.983,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20125,10336,Blank 490,5,N,OHSU_HNSCC_derm002,10,1.14,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20126,10336,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.561,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20127,10336,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.108,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20128,10336,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.09,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20129,10336,Blank 490,5,B,OHSU_HNSCC_derm002,11,1.007,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
20130,10336,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.129,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20131,10336,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.874,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20132,10336,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.885,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20133,10336,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.913,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20134,10336,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.901,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20135,10336,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.969,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
20136,10336,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.895,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20137,10336,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.419,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20138,10336,Blank 490,5,K,OHSU_HNSCC_derm002,11,1.041,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20139,10336,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.204,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20140,10336,Blank 490,5,M,OHSU_HNSCC_derm002,11,1.021,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20141,10336,Blank 490,5,N,OHSU_HNSCC_derm002,11,1.04,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20142,10336,Blank 490,5,O,OHSU_HNSCC_derm002,11,1.076,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20143,10336,Blank 490,5,P,OHSU_HNSCC_derm002,11,1.307,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20144,10336,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.117,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20145,10336,Blank 490,5,B,OHSU_HNSCC_derm002,12,1.131,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
20146,10336,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.299,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20147,10336,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.797,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20148,10336,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.929,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20149,10336,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.941,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20150,10336,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.837,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20151,10336,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.879,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
20152,10336,Blank 490,5,I,OHSU_HNSCC_derm002,12,1.044,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20153,10336,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.339,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20154,10336,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.945,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20155,10336,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.385,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20156,10336,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.942,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20157,10336,Blank 490,5,N,OHSU_HNSCC_derm002,12,1.027,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20158,10336,Blank 490,5,O,OHSU_HNSCC_derm002,12,1.07,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20159,10336,Blank 490,5,P,OHSU_HNSCC_derm002,12,1.282,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20160,10336,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.126,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20161,10336,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.873,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
20162,10336,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.842,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20163,10336,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.824,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20164,10336,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.737,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20165,10336,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.935,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20166,10336,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.801,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20167,10336,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.834,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
20168,10336,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.894,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20169,10336,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.591,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20170,10336,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.87,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20171,10336,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.832,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20172,10336,Blank 490,5,M,OHSU_HNSCC_derm002,13,1.015,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20173,10336,Blank 490,5,N,OHSU_HNSCC_derm002,13,1.026,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20174,10336,Blank 490,5,O,OHSU_HNSCC_derm002,13,1.044,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20175,10336,Blank 490,5,P,OHSU_HNSCC_derm002,13,1.201,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20176,10336,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.138,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20177,10336,Blank 490,5,B,OHSU_HNSCC_derm002,14,1.065,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
20178,10336,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.919,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20179,10336,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.877,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20180,10336,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.909,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20181,10336,Blank 490,5,F,OHSU_HNSCC_derm002,14,1.047,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20182,10336,Blank 490,5,G,OHSU_HNSCC_derm002,14,1.053,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20183,10336,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.894,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
20184,10336,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.915,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20185,10336,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.981,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20186,10336,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.903,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20187,10336,Blank 490,5,L,OHSU_HNSCC_derm002,14,1.025,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20188,10336,Blank 490,5,M,OHSU_HNSCC_derm002,14,1.008,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20189,10336,Blank 490,5,N,OHSU_HNSCC_derm002,14,1.132,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20190,10336,Blank 490,5,O,OHSU_HNSCC_derm002,14,1.006,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20191,10336,Blank 490,5,P,OHSU_HNSCC_derm002,14,1.248,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20192,10336,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.174,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
20193,10336,Blank 490,5,B,OHSU_HNSCC_derm002,15,1.122,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
20194,10336,Blank 490,5,C,OHSU_HNSCC_derm002,15,1.112,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
20195,10336,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.796,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
20196,10336,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.899,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
20197,10336,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.998,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20198,10336,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.954,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20199,10336,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.934,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
20200,10336,Blank 490,5,I,OHSU_HNSCC_derm002,15,1.035,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20201,10336,Blank 490,5,J,OHSU_HNSCC_derm002,15,1.119,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
20202,10336,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.863,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20203,10336,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.955,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
20204,10336,Blank 490,5,M,OHSU_HNSCC_derm002,15,1.068,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
20205,10336,Blank 490,5,N,OHSU_HNSCC_derm002,15,1.124,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20206,10336,Blank 490,5,O,OHSU_HNSCC_derm002,15,1.043,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20207,10336,Blank 490,5,P,OHSU_HNSCC_derm002,15,1.092,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20208,10336,Blank 490,5,A,OHSU_HNSCC_derm002,16,1.001,0,NONE,OHSU_HNSCC_derm002
20209,10336,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.958,0,NONE,OHSU_HNSCC_derm002
20210,10336,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.869,0,NONE,OHSU_HNSCC_derm002
20211,10336,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.792,0,NONE,OHSU_HNSCC_derm002
20212,10336,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.801,0,NONE,OHSU_HNSCC_derm002
20213,10336,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.773,0,NONE,OHSU_HNSCC_derm002
20214,10336,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.88,0,NONE,OHSU_HNSCC_derm002
20215,10336,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.006,10,F-S-V,OHSU_HNSCC_derm002
20216,10336,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.642,0,NONE,OHSU_HNSCC_derm002
20217,10336,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.801,0,NONE,OHSU_HNSCC_derm002
20218,10336,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.867,0,NONE,OHSU_HNSCC_derm002
20219,10336,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.88,0,NONE,OHSU_HNSCC_derm002
20220,10336,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.935,0,NONE,OHSU_HNSCC_derm002
20221,10336,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.832,0,NONE,OHSU_HNSCC_derm002
20222,10336,Blank 490,5,O,OHSU_HNSCC_derm002,16,1.096,0,NONE,OHSU_HNSCC_derm002
20223,10336,Blank 490,5,P,OHSU_HNSCC_derm002,16,1.132,0,NONE,OHSU_HNSCC_derm002
20224,10336,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.007,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20225,10336,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.005,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20226,10336,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.473,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20227,10336,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.911,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20228,10336,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.851,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20229,10336,Blank 490,5,F,OHSU_HNSCC_derm002,17,1.068,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20230,10336,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.985,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20231,10336,Blank 490,5,H,OHSU_HNSCC_derm002,17,1.008,10,Trametinib,OHSU_HNSCC_derm002
20232,10336,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.233,10,BEZ235,OHSU_HNSCC_derm002
20233,10336,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.679,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20234,10336,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.838,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20235,10336,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.34,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20236,10336,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.984,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20237,10336,Blank 490,5,N,OHSU_HNSCC_derm002,17,1.102,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20238,10336,Blank 490,5,O,OHSU_HNSCC_derm002,17,1.03,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20239,10336,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.977,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20240,10336,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.286,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20241,10336,Blank 490,5,B,OHSU_HNSCC_derm002,18,1.012,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20242,10336,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.702,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20243,10336,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.894,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20244,10336,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.998,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20245,10336,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.955,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20246,10336,Blank 490,5,G,OHSU_HNSCC_derm002,18,1.028,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20247,10336,Blank 490,5,H,OHSU_HNSCC_derm002,18,1.102,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
20248,10336,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.347,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
20249,10336,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.994,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20250,10336,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.818,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20251,10336,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.906,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20252,10336,Blank 490,5,M,OHSU_HNSCC_derm002,18,1.022,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20253,10336,Blank 490,5,N,OHSU_HNSCC_derm002,18,1.057,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20254,10336,Blank 490,5,O,OHSU_HNSCC_derm002,18,1.271,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20255,10336,Blank 490,5,P,OHSU_HNSCC_derm002,18,1.23,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20256,10336,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.999,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20257,10336,Blank 490,5,B,OHSU_HNSCC_derm002,19,1.059,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20258,10336,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.819,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20259,10336,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.844,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20260,10336,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.821,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20261,10336,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.91,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20262,10336,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.923,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20263,10336,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.979,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
20264,10336,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.277,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
20265,10336,Blank 490,5,J,OHSU_HNSCC_derm002,19,1.163,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20266,10336,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.818,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20267,10336,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.917,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20268,10336,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.91,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20269,10336,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.937,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20270,10336,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.875,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20271,10336,Blank 490,5,P,OHSU_HNSCC_derm002,19,1.284,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20272,10336,Blank 490,5,A,OHSU_HNSCC_derm002,20,1.076,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20273,10336,Blank 490,5,B,OHSU_HNSCC_derm002,20,1.109,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20274,10336,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.952,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20275,10336,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.82,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20276,10336,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.9,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20277,10336,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.958,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20278,10336,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.963,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20279,10336,Blank 490,5,H,OHSU_HNSCC_derm002,20,1.073,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
20280,10336,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.625,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
20281,10336,Blank 490,5,J,OHSU_HNSCC_derm002,20,1.192,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20282,10336,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.868,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20283,10336,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.924,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20284,10336,Blank 490,5,M,OHSU_HNSCC_derm002,20,1.059,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20285,10336,Blank 490,5,N,OHSU_HNSCC_derm002,20,1.181,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20286,10336,Blank 490,5,O,OHSU_HNSCC_derm002,20,1.109,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20287,10336,Blank 490,5,P,OHSU_HNSCC_derm002,20,1.136,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20288,10336,Blank 490,5,A,OHSU_HNSCC_derm002,21,1.038,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20289,10336,Blank 490,5,B,OHSU_HNSCC_derm002,21,1.156,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20290,10336,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.972,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20291,10336,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.948,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20292,10336,Blank 490,5,E,OHSU_HNSCC_derm002,21,1.137,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20293,10336,Blank 490,5,F,OHSU_HNSCC_derm002,21,1.016,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20294,10336,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.931,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20295,10336,Blank 490,5,H,OHSU_HNSCC_derm002,21,1.017,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
20296,10336,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.766,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
20297,10336,Blank 490,5,J,OHSU_HNSCC_derm002,21,1.132,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20298,10336,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.914,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20299,10336,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.983,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20300,10336,Blank 490,5,M,OHSU_HNSCC_derm002,21,1.047,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20301,10336,Blank 490,5,N,OHSU_HNSCC_derm002,21,1.129,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20302,10336,Blank 490,5,O,OHSU_HNSCC_derm002,21,1.06,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20303,10336,Blank 490,5,P,OHSU_HNSCC_derm002,21,1.137,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20304,10336,Blank 490,5,A,OHSU_HNSCC_derm002,22,1.055,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20305,10336,Blank 490,5,B,OHSU_HNSCC_derm002,22,1.135,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20306,10336,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.961,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20307,10336,Blank 490,5,D,OHSU_HNSCC_derm002,22,1.06,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20308,10336,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.774,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20309,10336,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.893,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20310,10336,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.991,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20311,10336,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.994,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
20312,10336,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.956,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
20313,10336,Blank 490,5,J,OHSU_HNSCC_derm002,22,1.079,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20314,10336,Blank 490,5,K,OHSU_HNSCC_derm002,22,1.032,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20315,10336,Blank 490,5,L,OHSU_HNSCC_derm002,22,1.053,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20316,10336,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.944,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20317,10336,Blank 490,5,N,OHSU_HNSCC_derm002,22,1.27,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20318,10336,Blank 490,5,O,OHSU_HNSCC_derm002,22,1.04,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20319,10336,Blank 490,5,P,OHSU_HNSCC_derm002,22,1.158,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20320,10336,Blank 490,5,A,OHSU_HNSCC_derm002,23,1.023,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20321,10336,Blank 490,5,B,OHSU_HNSCC_derm002,23,1.109,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
20322,10336,Blank 490,5,C,OHSU_HNSCC_derm002,23,1.092,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20323,10336,Blank 490,5,D,OHSU_HNSCC_derm002,23,1.147,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
20324,10336,Blank 490,5,E,OHSU_HNSCC_derm002,23,1.052,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
20325,10336,Blank 490,5,F,OHSU_HNSCC_derm002,23,1.181,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20326,10336,Blank 490,5,G,OHSU_HNSCC_derm002,23,1.037,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
20327,10336,Blank 490,5,H,OHSU_HNSCC_derm002,23,1.102,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
20328,10336,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.78,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
20329,10336,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.984,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
20330,10336,Blank 490,5,K,OHSU_HNSCC_derm002,23,1.243,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
20331,10336,Blank 490,5,L,OHSU_HNSCC_derm002,23,1.077,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
20332,10336,Blank 490,5,M,OHSU_HNSCC_derm002,23,1.086,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
20333,10336,Blank 490,5,N,OHSU_HNSCC_derm002,23,1.26,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20334,10336,Blank 490,5,O,OHSU_HNSCC_derm002,23,1.044,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
20335,10336,Blank 490,5,P,OHSU_HNSCC_derm002,23,1.051,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
20336,10336,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.961,0,NONE,OHSU_HNSCC_derm002
20337,10336,Blank 490,5,B,OHSU_HNSCC_derm002,24,1.001,0,NONE,OHSU_HNSCC_derm002
20338,10336,Blank 490,5,C,OHSU_HNSCC_derm002,24,1.205,0,NONE,OHSU_HNSCC_derm002
20339,10336,Blank 490,5,D,OHSU_HNSCC_derm002,24,1.075,0,NONE,OHSU_HNSCC_derm002
20340,10336,Blank 490,5,E,OHSU_HNSCC_derm002,24,1.039,0,NONE,OHSU_HNSCC_derm002
20341,10336,Blank 490,5,F,OHSU_HNSCC_derm002,24,1.136,0,NONE,OHSU_HNSCC_derm002
20342,10336,Blank 490,5,G,OHSU_HNSCC_derm002,24,1.11,0,NONE,OHSU_HNSCC_derm002
20343,10336,Blank 490,5,H,OHSU_HNSCC_derm002,24,1.128,0,NONE,OHSU_HNSCC_derm002
20344,10336,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.986,0,NONE,OHSU_HNSCC_derm002
20345,10336,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.961,0,NONE,OHSU_HNSCC_derm002
20346,10336,Blank 490,5,K,OHSU_HNSCC_derm002,24,1.099,0,NONE,OHSU_HNSCC_derm002
20347,10336,Blank 490,5,L,OHSU_HNSCC_derm002,24,1.134,0,NONE,OHSU_HNSCC_derm002
20348,10336,Blank 490,5,M,OHSU_HNSCC_derm002,24,1.227,0,NONE,OHSU_HNSCC_derm002
20349,10336,Blank 490,5,N,OHSU_HNSCC_derm002,24,1.153,0,NONE,OHSU_HNSCC_derm002
20350,10336,Blank 490,5,O,OHSU_HNSCC_derm002,24,1.118,0,NONE,OHSU_HNSCC_derm002
20351,10336,Blank 490,5,P,OHSU_HNSCC_derm002,24,1.153,0,NONE,OHSU_HNSCC_derm002
20352,10336,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.972,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20353,10336,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.703,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20354,10336,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.092,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20355,10336,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.986,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20356,10336,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.081,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20357,10336,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.516,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20358,10336,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.97,10,IMR 1,OHSU_HNSCC_derm002
20359,10336,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.71,10,Gefitinib,OHSU_HNSCC_derm002
20360,10336,Blank 490,6,I,OHSU_HNSCC_derm002,1,1.081,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
20361,10336,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.959,0,DMSO,OHSU_HNSCC_derm002
20362,10336,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.997,0,DMSO ,OHSU_HNSCC_derm002
20363,10336,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.886,0,DMSO,OHSU_HNSCC_derm002
20364,10336,Blank 490,6,M,OHSU_HNSCC_derm002,1,1.053,0,DMSO ,OHSU_HNSCC_derm002
20365,10336,Blank 490,6,N,OHSU_HNSCC_derm002,1,1.016,0,DMSO,OHSU_HNSCC_derm002
20366,10336,Blank 490,6,O,OHSU_HNSCC_derm002,1,1.003,0,DMSO ,OHSU_HNSCC_derm002
20367,10336,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.988,0,DMSO,OHSU_HNSCC_derm002
20368,10336,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.955,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20369,10336,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.738,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20370,10336,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.399,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20371,10336,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.735,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20372,10336,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.934,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20373,10336,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.774,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20374,10336,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.782,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
20375,10336,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.844,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
20376,10336,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.982,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
20377,10336,Blank 490,6,J,OHSU_HNSCC_derm002,2,1.017,0,DMSO,OHSU_HNSCC_derm002
20378,10336,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.788,0,DMSO ,OHSU_HNSCC_derm002
20379,10336,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.892,0,DMSO,OHSU_HNSCC_derm002
20380,10336,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.845,0,DMSO ,OHSU_HNSCC_derm002
20381,10336,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.94,0,DMSO,OHSU_HNSCC_derm002
20382,10336,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.91,0,DMSO ,OHSU_HNSCC_derm002
20383,10336,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.969,0,DMSO,OHSU_HNSCC_derm002
20384,10336,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.963,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20385,10336,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.685,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20386,10336,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.869,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20387,10336,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.798,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20388,10336,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.86,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20389,10336,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.8,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20390,10336,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.764,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
20391,10336,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.828,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
20392,10336,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.751,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
20393,10336,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.769,0,DMSO,OHSU_HNSCC_derm002
20394,10336,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.701,0,DMSO ,OHSU_HNSCC_derm002
20395,10336,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.844,0,DMSO,OHSU_HNSCC_derm002
20396,10336,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.912,0,DMSO ,OHSU_HNSCC_derm002
20397,10336,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.861,0,DMSO,OHSU_HNSCC_derm002
20398,10336,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.858,0,DMSO ,OHSU_HNSCC_derm002
20399,10336,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.989,0,DMSO,OHSU_HNSCC_derm002
20400,10336,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.926,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20401,10336,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.786,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20402,10336,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.833,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20403,10336,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.811,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20404,10336,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.929,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20405,10336,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.937,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20406,10336,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.91,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
20407,10336,Blank 490,6,H,OHSU_HNSCC_derm002,4,1.224,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
20408,10336,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.895,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
20409,10336,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.868,0,DMSO,OHSU_HNSCC_derm002
20410,10336,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.833,0,DMSO ,OHSU_HNSCC_derm002
20411,10336,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.816,0,DMSO,OHSU_HNSCC_derm002
20412,10336,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.904,0,DMSO ,OHSU_HNSCC_derm002
20413,10336,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.962,0,DMSO,OHSU_HNSCC_derm002
20414,10336,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.91,0,DMSO ,OHSU_HNSCC_derm002
20415,10336,Blank 490,6,P,OHSU_HNSCC_derm002,4,1.116,0,DMSO,OHSU_HNSCC_derm002
20416,10336,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.91,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20417,10336,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.786,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20418,10336,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.92,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20419,10336,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.759,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20420,10336,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.924,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20421,10336,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.909,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20422,10336,Blank 490,6,G,OHSU_HNSCC_derm002,5,1.018,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
20423,10336,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.873,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
20424,10336,Blank 490,6,I,OHSU_HNSCC_derm002,5,1.09,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
20425,10336,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.901,0,DMSO,OHSU_HNSCC_derm002
20426,10336,Blank 490,6,K,OHSU_HNSCC_derm002,5,1.032,0,DMSO ,OHSU_HNSCC_derm002
20427,10336,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.896,0,DMSO,OHSU_HNSCC_derm002
20428,10336,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.981,0,DMSO ,OHSU_HNSCC_derm002
20429,10336,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.775,0,DMSO,OHSU_HNSCC_derm002
20430,10336,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.848,0,DMSO ,OHSU_HNSCC_derm002
20431,10336,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.966,0,DMSO,OHSU_HNSCC_derm002
20432,10336,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.886,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20433,10336,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.724,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20434,10336,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.749,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20435,10336,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.787,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20436,10336,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.84,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20437,10336,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.906,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20438,10336,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.835,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
20439,10336,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.937,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
20440,10336,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.781,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
20441,10336,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.796,0,DMSO,OHSU_HNSCC_derm002
20442,10336,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.951,0,DMSO ,OHSU_HNSCC_derm002
20443,10336,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.733,0,DMSO,OHSU_HNSCC_derm002
20444,10336,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.923,0,DMSO ,OHSU_HNSCC_derm002
20445,10336,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.822,0,DMSO,OHSU_HNSCC_derm002
20446,10336,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.963,0,DMSO ,OHSU_HNSCC_derm002
20447,10336,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.975,0,DMSO,OHSU_HNSCC_derm002
20448,10336,Blank 490,6,A,OHSU_HNSCC_derm002,7,1.021,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20449,10336,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.747,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
20450,10336,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.844,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
20451,10336,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.764,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
20452,10336,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.992,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
20453,10336,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.849,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
20454,10336,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.869,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
20455,10336,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.912,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
20456,10336,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.952,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
20457,10336,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.801,0,DMSO,OHSU_HNSCC_derm002
20458,10336,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.797,0,DMSO ,OHSU_HNSCC_derm002
20459,10336,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.829,0,DMSO,OHSU_HNSCC_derm002
20460,10336,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.933,0,DMSO ,OHSU_HNSCC_derm002
20461,10336,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.852,0,DMSO,OHSU_HNSCC_derm002
20462,10336,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.968,0,DMSO ,OHSU_HNSCC_derm002
20463,10336,Blank 490,6,P,OHSU_HNSCC_derm002,7,1.014,0,DMSO,OHSU_HNSCC_derm002
20464,10336,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.82,0,NONE,OHSU_HNSCC_derm002
20465,10336,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
20466,10336,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.91,0,NONE,OHSU_HNSCC_derm002
20467,10336,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.836,0,NONE,OHSU_HNSCC_derm002
20468,10336,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.936,0,NONE,OHSU_HNSCC_derm002
20469,10336,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.918,0,NONE,OHSU_HNSCC_derm002
20470,10336,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.964,0,NONE,OHSU_HNSCC_derm002
20471,10336,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
20472,10336,Blank 490,6,I,OHSU_HNSCC_derm002,8,1.258,0,NONE,OHSU_HNSCC_derm002
20473,10336,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.981,0,NONE,OHSU_HNSCC_derm002
20474,10336,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.89,0,NONE,OHSU_HNSCC_derm002
20475,10336,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
20476,10336,Blank 490,6,M,OHSU_HNSCC_derm002,8,1.044,0,NONE,OHSU_HNSCC_derm002
20477,10336,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.927,0,NONE,OHSU_HNSCC_derm002
20478,10336,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.905,0,NONE,OHSU_HNSCC_derm002
20479,10336,Blank 490,6,P,OHSU_HNSCC_derm002,8,1.087,0,NONE,OHSU_HNSCC_derm002
20480,10336,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.917,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20481,10336,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.043,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20482,10336,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.771,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20483,10336,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.862,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20484,10336,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.886,5,Vandetanib (5mM),OHSU_HNSCC_derm002
20485,10336,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.94,0,DMSO,OHSU_HNSCC_derm002
20486,10336,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.981,0,DMSO ,OHSU_HNSCC_derm002
20487,10336,Blank 490,6,H,OHSU_HNSCC_derm002,9,1.014,10,Brigatinib,OHSU_HNSCC_derm002
20488,10336,Blank 490,6,I,OHSU_HNSCC_derm002,9,1.012,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20489,10336,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.931,0,DMSO,OHSU_HNSCC_derm002
20490,10336,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.993,0,DMSO ,OHSU_HNSCC_derm002
20491,10336,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.864,0,DMSO,OHSU_HNSCC_derm002
20492,10336,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.974,0,DMSO ,OHSU_HNSCC_derm002
20493,10336,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.888,0,DMSO,OHSU_HNSCC_derm002
20494,10336,Blank 490,6,O,OHSU_HNSCC_derm002,9,1.048,0,DMSO ,OHSU_HNSCC_derm002
20495,10336,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.951,0,DMSO,OHSU_HNSCC_derm002
20496,10336,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.966,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20497,10336,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.106,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20498,10336,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.9,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20499,10336,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.786,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20500,10336,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.95,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
20501,10336,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.887,0,DMSO,OHSU_HNSCC_derm002
20502,10336,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.911,0,DMSO ,OHSU_HNSCC_derm002
20503,10336,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.88,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
20504,10336,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.957,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20505,10336,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.92,0,DMSO,OHSU_HNSCC_derm002
20506,10336,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.987,0,DMSO ,OHSU_HNSCC_derm002
20507,10336,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.845,0,DMSO,OHSU_HNSCC_derm002
20508,10336,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.887,0,DMSO ,OHSU_HNSCC_derm002
20509,10336,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.845,0,DMSO,OHSU_HNSCC_derm002
20510,10336,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.919,0,DMSO ,OHSU_HNSCC_derm002
20511,10336,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.99,0,DMSO,OHSU_HNSCC_derm002
20512,10336,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.95,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20513,10336,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.322,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20514,10336,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.876,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20515,10336,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.854,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20516,10336,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.898,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
20517,10336,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.942,0,DMSO,OHSU_HNSCC_derm002
20518,10336,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.98,0,DMSO ,OHSU_HNSCC_derm002
20519,10336,Blank 490,6,H,OHSU_HNSCC_derm002,11,1.004,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
20520,10336,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.998,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20521,10336,Blank 490,6,J,OHSU_HNSCC_derm002,11,1.013,0,DMSO,OHSU_HNSCC_derm002
20522,10336,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.873,0,DMSO ,OHSU_HNSCC_derm002
20523,10336,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.862,0,DMSO,OHSU_HNSCC_derm002
20524,10336,Blank 490,6,M,OHSU_HNSCC_derm002,11,1.004,0,DMSO ,OHSU_HNSCC_derm002
20525,10336,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.934,0,DMSO,OHSU_HNSCC_derm002
20526,10336,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.911,0,DMSO ,OHSU_HNSCC_derm002
20527,10336,Blank 490,6,P,OHSU_HNSCC_derm002,11,1.09,0,DMSO,OHSU_HNSCC_derm002
20528,10336,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.974,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20529,10336,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.721,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20530,10336,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.897,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20531,10336,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.828,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20532,10336,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.991,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
20533,10336,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.899,0,DMSO,OHSU_HNSCC_derm002
20534,10336,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.983,0,DMSO ,OHSU_HNSCC_derm002
20535,10336,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.946,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
20536,10336,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.972,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20537,10336,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.849,0,DMSO,OHSU_HNSCC_derm002
20538,10336,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.923,0,DMSO ,OHSU_HNSCC_derm002
20539,10336,Blank 490,6,L,OHSU_HNSCC_derm002,12,1.03,0,DMSO,OHSU_HNSCC_derm002
20540,10336,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.941,0,DMSO ,OHSU_HNSCC_derm002
20541,10336,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.846,0,DMSO,OHSU_HNSCC_derm002
20542,10336,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.851,0,DMSO ,OHSU_HNSCC_derm002
20543,10336,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.898,0,DMSO,OHSU_HNSCC_derm002
20544,10336,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.883,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20545,10336,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.776,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20546,10336,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.817,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20547,10336,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.794,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20548,10336,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.909,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
20549,10336,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.902,0,DMSO,OHSU_HNSCC_derm002
20550,10336,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.971,0,DMSO ,OHSU_HNSCC_derm002
20551,10336,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.886,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
20552,10336,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.919,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20553,10336,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.828,0,DMSO,OHSU_HNSCC_derm002
20554,10336,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.925,0,DMSO ,OHSU_HNSCC_derm002
20555,10336,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.849,0,DMSO,OHSU_HNSCC_derm002
20556,10336,Blank 490,6,M,OHSU_HNSCC_derm002,13,1.068,0,DMSO ,OHSU_HNSCC_derm002
20557,10336,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.889,0,DMSO,OHSU_HNSCC_derm002
20558,10336,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.865,0,DMSO ,OHSU_HNSCC_derm002
20559,10336,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.969,0,DMSO,OHSU_HNSCC_derm002
20560,10336,Blank 490,6,A,OHSU_HNSCC_derm002,14,1.135,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20561,10336,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.776,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20562,10336,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.798,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20563,10336,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.838,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20564,10336,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.878,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
20565,10336,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.938,0,DMSO,OHSU_HNSCC_derm002
20566,10336,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.941,0,DMSO ,OHSU_HNSCC_derm002
20567,10336,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.984,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
20568,10336,Blank 490,6,I,OHSU_HNSCC_derm002,14,1.046,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20569,10336,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.959,0,DMSO,OHSU_HNSCC_derm002
20570,10336,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.991,0,DMSO ,OHSU_HNSCC_derm002
20571,10336,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.931,0,DMSO,OHSU_HNSCC_derm002
20572,10336,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.917,0,DMSO ,OHSU_HNSCC_derm002
20573,10336,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.903,0,DMSO,OHSU_HNSCC_derm002
20574,10336,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.935,0,DMSO ,OHSU_HNSCC_derm002
20575,10336,Blank 490,6,P,OHSU_HNSCC_derm002,14,1.055,0,DMSO,OHSU_HNSCC_derm002
20576,10336,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.998,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20577,10336,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.738,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
20578,10336,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.794,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
20579,10336,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.939,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
20580,10336,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.972,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
20581,10336,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.918,0,DMSO,OHSU_HNSCC_derm002
20582,10336,Blank 490,6,G,OHSU_HNSCC_derm002,15,1.008,0,DMSO ,OHSU_HNSCC_derm002
20583,10336,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.892,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
20584,10336,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.962,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
20585,10336,Blank 490,6,J,OHSU_HNSCC_derm002,15,1.017,0,DMSO,OHSU_HNSCC_derm002
20586,10336,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.937,0,DMSO ,OHSU_HNSCC_derm002
20587,10336,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.837,0,DMSO,OHSU_HNSCC_derm002
20588,10336,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.998,0,DMSO ,OHSU_HNSCC_derm002
20589,10336,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.853,0,DMSO,OHSU_HNSCC_derm002
20590,10336,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.88,0,DMSO ,OHSU_HNSCC_derm002
20591,10336,Blank 490,6,P,OHSU_HNSCC_derm002,15,1.0,0,DMSO,OHSU_HNSCC_derm002
20592,10336,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.87,0,NONE,OHSU_HNSCC_derm002
20593,10336,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.747,0,NONE,OHSU_HNSCC_derm002
20594,10336,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.876,0,NONE,OHSU_HNSCC_derm002
20595,10336,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.794,0,NONE,OHSU_HNSCC_derm002
20596,10336,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.933,0,NONE,OHSU_HNSCC_derm002
20597,10336,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.881,0,NONE,OHSU_HNSCC_derm002
20598,10336,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.978,0,NONE,OHSU_HNSCC_derm002
20599,10336,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
20600,10336,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.97,0,NONE,OHSU_HNSCC_derm002
20601,10336,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.883,0,NONE,OHSU_HNSCC_derm002
20602,10336,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.901,0,NONE,OHSU_HNSCC_derm002
20603,10336,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.875,0,NONE,OHSU_HNSCC_derm002
20604,10336,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.872,0,NONE,OHSU_HNSCC_derm002
20605,10336,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.929,0,NONE,OHSU_HNSCC_derm002
20606,10336,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.815,0,NONE,OHSU_HNSCC_derm002
20607,10336,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.891,0,NONE,OHSU_HNSCC_derm002
20608,10336,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.496,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20609,10336,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.668,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20610,10336,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.78,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20611,10336,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.112,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20612,10336,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.893,10,LY3039478 ,OHSU_HNSCC_derm002
20613,10336,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.807,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20614,10336,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.941,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20615,10336,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.955,10,Trametinib,OHSU_HNSCC_derm002
20616,10336,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.264,10,BEZ235,OHSU_HNSCC_derm002
20617,10336,Blank 490,6,J,OHSU_HNSCC_derm002,17,1.011,0,DMSO,OHSU_HNSCC_derm002
20618,10336,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.831,0,DMSO ,OHSU_HNSCC_derm002
20619,10336,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.851,0,DMSO,OHSU_HNSCC_derm002
20620,10336,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.83,0,DMSO ,OHSU_HNSCC_derm002
20621,10336,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.889,0,DMSO,OHSU_HNSCC_derm002
20622,10336,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.896,0,DMSO ,OHSU_HNSCC_derm002
20623,10336,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.953,0,DMSO,OHSU_HNSCC_derm002
20624,10336,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.961,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20625,10336,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.824,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20626,10336,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.887,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20627,10336,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.158,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20628,10336,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.933,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
20629,10336,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.905,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20630,10336,Blank 490,6,G,OHSU_HNSCC_derm002,18,1.028,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20631,10336,Blank 490,6,H,OHSU_HNSCC_derm002,18,1.059,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
20632,10336,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.327,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
20633,10336,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.942,0,DMSO,OHSU_HNSCC_derm002
20634,10336,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.914,0,DMSO ,OHSU_HNSCC_derm002
20635,10336,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.95,0,DMSO,OHSU_HNSCC_derm002
20636,10336,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.917,0,DMSO ,OHSU_HNSCC_derm002
20637,10336,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.878,0,DMSO,OHSU_HNSCC_derm002
20638,10336,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.84,0,DMSO ,OHSU_HNSCC_derm002
20639,10336,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.95,0,DMSO,OHSU_HNSCC_derm002
20640,10336,Blank 490,6,A,OHSU_HNSCC_derm002,19,1.007,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20641,10336,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.83,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20642,10336,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.809,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20643,10336,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.354,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20644,10336,Blank 490,6,E,OHSU_HNSCC_derm002,19,1.026,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
20645,10336,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.94,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20646,10336,Blank 490,6,G,OHSU_HNSCC_derm002,19,1.002,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20647,10336,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.985,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
20648,10336,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.356,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
20649,10336,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.977,0,DMSO,OHSU_HNSCC_derm002
20650,10336,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.865,0,DMSO ,OHSU_HNSCC_derm002
20651,10336,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.938,0,DMSO,OHSU_HNSCC_derm002
20652,10336,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.931,0,DMSO ,OHSU_HNSCC_derm002
20653,10336,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.837,0,DMSO,OHSU_HNSCC_derm002
20654,10336,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.758,0,DMSO ,OHSU_HNSCC_derm002
20655,10336,Blank 490,6,P,OHSU_HNSCC_derm002,19,1.135,0,DMSO,OHSU_HNSCC_derm002
20656,10336,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.913,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20657,10336,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.776,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20658,10336,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.769,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20659,10336,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.845,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20660,10336,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.876,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
20661,10336,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.963,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20662,10336,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.922,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20663,10336,Blank 490,6,H,OHSU_HNSCC_derm002,20,1.051,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
20664,10336,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.327,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
20665,10336,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.772,0,DMSO,OHSU_HNSCC_derm002
20666,10336,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.901,0,DMSO ,OHSU_HNSCC_derm002
20667,10336,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.918,0,DMSO,OHSU_HNSCC_derm002
20668,10336,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.874,0,DMSO ,OHSU_HNSCC_derm002
20669,10336,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.741,0,DMSO,OHSU_HNSCC_derm002
20670,10336,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.755,0,DMSO ,OHSU_HNSCC_derm002
20671,10336,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.97,0,DMSO,OHSU_HNSCC_derm002
20672,10336,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.872,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20673,10336,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.816,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20674,10336,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.805,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20675,10336,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.907,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20676,10336,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.927,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
20677,10336,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.939,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20678,10336,Blank 490,6,G,OHSU_HNSCC_derm002,21,1.026,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20679,10336,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.954,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
20680,10336,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.484,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
20681,10336,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.93,0,DMSO,OHSU_HNSCC_derm002
20682,10336,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.821,0,DMSO ,OHSU_HNSCC_derm002
20683,10336,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.792,0,DMSO,OHSU_HNSCC_derm002
20684,10336,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.946,0,DMSO ,OHSU_HNSCC_derm002
20685,10336,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.982,0,DMSO,OHSU_HNSCC_derm002
20686,10336,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.939,0,DMSO ,OHSU_HNSCC_derm002
20687,10336,Blank 490,6,P,OHSU_HNSCC_derm002,21,1.072,0,DMSO,OHSU_HNSCC_derm002
20688,10336,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.919,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20689,10336,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.854,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20690,10336,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.808,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20691,10336,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.888,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20692,10336,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.9,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
20693,10336,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.839,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20694,10336,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.919,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20695,10336,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.925,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
20696,10336,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.801,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
20697,10336,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.852,0,DMSO,OHSU_HNSCC_derm002
20698,10336,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.803,0,DMSO ,OHSU_HNSCC_derm002
20699,10336,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.828,0,DMSO,OHSU_HNSCC_derm002
20700,10336,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.871,0,DMSO ,OHSU_HNSCC_derm002
20701,10336,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.91,0,DMSO,OHSU_HNSCC_derm002
20702,10336,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.884,0,DMSO ,OHSU_HNSCC_derm002
20703,10336,Blank 490,6,P,OHSU_HNSCC_derm002,22,1.04,0,DMSO,OHSU_HNSCC_derm002
20704,10336,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.861,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
20705,10336,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.855,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
20706,10336,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.807,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
20707,10336,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.891,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
20708,10336,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.768,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
20709,10336,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.894,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
20710,10336,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.835,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
20711,10336,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.845,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
20712,10336,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.869,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
20713,10336,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.833,0,DMSO,OHSU_HNSCC_derm002
20714,10336,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.743,0,DMSO ,OHSU_HNSCC_derm002
20715,10336,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.803,0,DMSO,OHSU_HNSCC_derm002
20716,10336,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.813,0,DMSO ,OHSU_HNSCC_derm002
20717,10336,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.835,0,DMSO,OHSU_HNSCC_derm002
20718,10336,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.878,0,DMSO ,OHSU_HNSCC_derm002
20719,10336,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.98,0,DMSO,OHSU_HNSCC_derm002
20720,10336,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.947,0,NONE,OHSU_HNSCC_derm002
20721,10336,Blank 490,6,B,OHSU_HNSCC_derm002,24,1.079,0,NONE,OHSU_HNSCC_derm002
20722,10336,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.927,0,NONE,OHSU_HNSCC_derm002
20723,10336,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.916,0,NONE,OHSU_HNSCC_derm002
20724,10336,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.905,0,NONE,OHSU_HNSCC_derm002
20725,10336,Blank 490,6,F,OHSU_HNSCC_derm002,24,1.088,0,NONE,OHSU_HNSCC_derm002
20726,10336,Blank 490,6,G,OHSU_HNSCC_derm002,24,1.061,0,NONE,OHSU_HNSCC_derm002
20727,10336,Blank 490,6,H,OHSU_HNSCC_derm002,24,1.067,0,NONE,OHSU_HNSCC_derm002
20728,10336,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.991,0,NONE,OHSU_HNSCC_derm002
20729,10336,Blank 490,6,J,OHSU_HNSCC_derm002,24,1.068,0,NONE,OHSU_HNSCC_derm002
20730,10336,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.954,0,NONE,OHSU_HNSCC_derm002
20731,10336,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.911,0,NONE,OHSU_HNSCC_derm002
20732,10336,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.995,0,NONE,OHSU_HNSCC_derm002
20733,10336,Blank 490,6,N,OHSU_HNSCC_derm002,24,1.139,0,NONE,OHSU_HNSCC_derm002
20734,10336,Blank 490,6,O,OHSU_HNSCC_derm002,24,1.014,0,NONE,OHSU_HNSCC_derm002
20735,10336,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.995,0,NONE,OHSU_HNSCC_derm002
20736,10336,Blank 490,1,A,OHSU_HNSCC_derm001,1,0.066,10;10, JQ1;BEZ235,OHSU_HNSCC_derm001
20737,10336,Blank 490,1,B,OHSU_HNSCC_derm001,1,0.689,10,Lucitanib ,OHSU_HNSCC_derm001
20738,10336,Blank 490,1,C,OHSU_HNSCC_derm001,1,0.756,10,Resveratrol,OHSU_HNSCC_derm001
20739,10336,Blank 490,1,D,OHSU_HNSCC_derm001,1,0.516,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20740,10336,Blank 490,1,E,OHSU_HNSCC_derm001,1,0.819,10,Bicalutamide,OHSU_HNSCC_derm001
20741,10336,Blank 490,1,F,OHSU_HNSCC_derm001,1,0.897,10,Methotrexate ,OHSU_HNSCC_derm001
20742,10336,Blank 490,1,G,OHSU_HNSCC_derm001,1,0.662,10,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20743,10336,Blank 490,1,H,OHSU_HNSCC_derm001,1,0.893,10,Gefitinib,OHSU_HNSCC_derm001
20744,10336,Blank 490,1,I,OHSU_HNSCC_derm001,1,0.791,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
20745,10336,Blank 490,1,J,OHSU_HNSCC_derm001,1,0.752,10,Tamatinib/R406,OHSU_HNSCC_derm001
20746,10336,Blank 490,1,K,OHSU_HNSCC_derm001,1,0.777,10,Bosutinib,OHSU_HNSCC_derm001
20747,10336,Blank 490,1,L,OHSU_HNSCC_derm001,1,0.056,10,PI-103,OHSU_HNSCC_derm001
20748,10336,Blank 490,1,M,OHSU_HNSCC_derm001,1,0.931,10,Glycyrrhizin,OHSU_HNSCC_derm001
20749,10336,Blank 490,1,N,OHSU_HNSCC_derm001,1,0.925,10,Luteolin (direct interaction),OHSU_HNSCC_derm001
20750,10336,Blank 490,1,O,OHSU_HNSCC_derm001,1,0.74,10,GSK-690693,OHSU_HNSCC_derm001
20751,10336,Blank 490,1,P,OHSU_HNSCC_derm001,1,1.064,10,Ibrutinib,OHSU_HNSCC_derm001
20752,10336,Blank 490,1,A,OHSU_HNSCC_derm001,2,0.073,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm001
20753,10336,Blank 490,1,B,OHSU_HNSCC_derm001,2,0.71,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm001
20754,10336,Blank 490,1,C,OHSU_HNSCC_derm001,2,0.804,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm001
20755,10336,Blank 490,1,D,OHSU_HNSCC_derm001,2,0.779,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20756,10336,Blank 490,1,E,OHSU_HNSCC_derm001,2,0.89,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm001
20757,10336,Blank 490,1,F,OHSU_HNSCC_derm001,2,0.731,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm001
20758,10336,Blank 490,1,G,OHSU_HNSCC_derm001,2,0.803,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20759,10336,Blank 490,1,H,OHSU_HNSCC_derm001,2,0.95,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
20760,10336,Blank 490,1,I,OHSU_HNSCC_derm001,2,0.936,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
20761,10336,Blank 490,1,J,OHSU_HNSCC_derm001,2,0.896,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm001
20762,10336,Blank 490,1,K,OHSU_HNSCC_derm001,2,0.975,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm001
20763,10336,Blank 490,1,L,OHSU_HNSCC_derm001,2,0.144,3.3333333333333335,PI-103,OHSU_HNSCC_derm001
20764,10336,Blank 490,1,M,OHSU_HNSCC_derm001,2,1.113,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm001
20765,10336,Blank 490,1,N,OHSU_HNSCC_derm001,2,0.987,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm001
20766,10336,Blank 490,1,O,OHSU_HNSCC_derm001,2,1.032,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm001
20767,10336,Blank 490,1,P,OHSU_HNSCC_derm001,2,1.065,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm001
20768,10336,Blank 490,1,A,OHSU_HNSCC_derm001,3,0.154,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm001
20769,10336,Blank 490,1,B,OHSU_HNSCC_derm001,3,0.784,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm001
20770,10336,Blank 490,1,C,OHSU_HNSCC_derm001,3,0.839,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm001
20771,10336,Blank 490,1,D,OHSU_HNSCC_derm001,3,0.867,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20772,10336,Blank 490,1,E,OHSU_HNSCC_derm001,3,0.989,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm001
20773,10336,Blank 490,1,F,OHSU_HNSCC_derm001,3,0.969,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm001
20774,10336,Blank 490,1,G,OHSU_HNSCC_derm001,3,1.012,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20775,10336,Blank 490,1,H,OHSU_HNSCC_derm001,3,0.998,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
20776,10336,Blank 490,1,I,OHSU_HNSCC_derm001,3,0.987,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
20777,10336,Blank 490,1,J,OHSU_HNSCC_derm001,3,0.975,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm001
20778,10336,Blank 490,1,K,OHSU_HNSCC_derm001,3,0.872,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm001
20779,10336,Blank 490,1,L,OHSU_HNSCC_derm001,3,0.367,1.1111111111111112,PI-103,OHSU_HNSCC_derm001
20780,10336,Blank 490,1,M,OHSU_HNSCC_derm001,3,1.139,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm001
20781,10336,Blank 490,1,N,OHSU_HNSCC_derm001,3,0.956,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm001
20782,10336,Blank 490,1,O,OHSU_HNSCC_derm001,3,1.125,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm001
20783,10336,Blank 490,1,P,OHSU_HNSCC_derm001,3,1.081,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm001
20784,10336,Blank 490,1,A,OHSU_HNSCC_derm001,4,0.268,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm001
20785,10336,Blank 490,1,B,OHSU_HNSCC_derm001,4,0.748,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm001
20786,10336,Blank 490,1,C,OHSU_HNSCC_derm001,4,0.801,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm001
20787,10336,Blank 490,1,D,OHSU_HNSCC_derm001,4,0.84,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20788,10336,Blank 490,1,E,OHSU_HNSCC_derm001,4,0.964,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm001
20789,10336,Blank 490,1,F,OHSU_HNSCC_derm001,4,0.668,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm001
20790,10336,Blank 490,1,G,OHSU_HNSCC_derm001,4,1.107,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20791,10336,Blank 490,1,H,OHSU_HNSCC_derm001,4,0.892,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
20792,10336,Blank 490,1,I,OHSU_HNSCC_derm001,4,0.963,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
20793,10336,Blank 490,1,J,OHSU_HNSCC_derm001,4,0.872,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm001
20794,10336,Blank 490,1,K,OHSU_HNSCC_derm001,4,0.907,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm001
20795,10336,Blank 490,1,L,OHSU_HNSCC_derm001,4,0.659,0.3703703703703704,PI-103,OHSU_HNSCC_derm001
20796,10336,Blank 490,1,M,OHSU_HNSCC_derm001,4,0.998,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm001
20797,10336,Blank 490,1,N,OHSU_HNSCC_derm001,4,0.983,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm001
20798,10336,Blank 490,1,O,OHSU_HNSCC_derm001,4,1.038,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm001
20799,10336,Blank 490,1,P,OHSU_HNSCC_derm001,4,1.063,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm001
20800,10336,Blank 490,1,A,OHSU_HNSCC_derm001,5,0.51,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm001
20801,10336,Blank 490,1,B,OHSU_HNSCC_derm001,5,0.765,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm001
20802,10336,Blank 490,1,C,OHSU_HNSCC_derm001,5,0.792,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm001
20803,10336,Blank 490,1,D,OHSU_HNSCC_derm001,5,0.814,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20804,10336,Blank 490,1,E,OHSU_HNSCC_derm001,5,1.025,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm001
20805,10336,Blank 490,1,F,OHSU_HNSCC_derm001,5,0.99,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm001
20806,10336,Blank 490,1,G,OHSU_HNSCC_derm001,5,1.109,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20807,10336,Blank 490,1,H,OHSU_HNSCC_derm001,5,0.994,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
20808,10336,Blank 490,1,I,OHSU_HNSCC_derm001,5,0.879,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
20809,10336,Blank 490,1,J,OHSU_HNSCC_derm001,5,0.811,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm001
20810,10336,Blank 490,1,K,OHSU_HNSCC_derm001,5,1.015,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm001
20811,10336,Blank 490,1,L,OHSU_HNSCC_derm001,5,0.667,0.1234567901234568,PI-103,OHSU_HNSCC_derm001
20812,10336,Blank 490,1,M,OHSU_HNSCC_derm001,5,1.07,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm001
20813,10336,Blank 490,1,N,OHSU_HNSCC_derm001,5,0.946,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm001
20814,10336,Blank 490,1,O,OHSU_HNSCC_derm001,5,1.112,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm001
20815,10336,Blank 490,1,P,OHSU_HNSCC_derm001,5,0.82,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm001
20816,10336,Blank 490,1,A,OHSU_HNSCC_derm001,6,0.771,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm001
20817,10336,Blank 490,1,B,OHSU_HNSCC_derm001,6,0.728,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm001
20818,10336,Blank 490,1,C,OHSU_HNSCC_derm001,6,0.879,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm001
20819,10336,Blank 490,1,D,OHSU_HNSCC_derm001,6,0.884,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20820,10336,Blank 490,1,E,OHSU_HNSCC_derm001,6,1.05,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm001
20821,10336,Blank 490,1,F,OHSU_HNSCC_derm001,6,0.852,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm001
20822,10336,Blank 490,1,G,OHSU_HNSCC_derm001,6,1.083,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20823,10336,Blank 490,1,H,OHSU_HNSCC_derm001,6,0.962,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
20824,10336,Blank 490,1,I,OHSU_HNSCC_derm001,6,1.023,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
20825,10336,Blank 490,1,J,OHSU_HNSCC_derm001,6,0.859,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm001
20826,10336,Blank 490,1,K,OHSU_HNSCC_derm001,6,0.967,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm001
20827,10336,Blank 490,1,L,OHSU_HNSCC_derm001,6,0.726,0.0411522633744856,PI-103,OHSU_HNSCC_derm001
20828,10336,Blank 490,1,M,OHSU_HNSCC_derm001,6,0.885,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm001
20829,10336,Blank 490,1,N,OHSU_HNSCC_derm001,6,0.99,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm001
20830,10336,Blank 490,1,O,OHSU_HNSCC_derm001,6,1.058,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm001
20831,10336,Blank 490,1,P,OHSU_HNSCC_derm001,6,1.118,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm001
20832,10336,Blank 490,1,A,OHSU_HNSCC_derm001,7,0.741,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm001
20833,10336,Blank 490,1,B,OHSU_HNSCC_derm001,7,0.673,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm001
20834,10336,Blank 490,1,C,OHSU_HNSCC_derm001,7,0.713,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm001
20835,10336,Blank 490,1,D,OHSU_HNSCC_derm001,7,0.785,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm001
20836,10336,Blank 490,1,E,OHSU_HNSCC_derm001,7,0.833,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm001
20837,10336,Blank 490,1,F,OHSU_HNSCC_derm001,7,0.946,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm001
20838,10336,Blank 490,1,G,OHSU_HNSCC_derm001,7,1.062,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm001
20839,10336,Blank 490,1,H,OHSU_HNSCC_derm001,7,0.921,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
20840,10336,Blank 490,1,I,OHSU_HNSCC_derm001,7,0.902,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
20841,10336,Blank 490,1,J,OHSU_HNSCC_derm001,7,0.879,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm001
20842,10336,Blank 490,1,K,OHSU_HNSCC_derm001,7,0.818,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm001
20843,10336,Blank 490,1,L,OHSU_HNSCC_derm001,7,0.683,0.013717421124828532,PI-103,OHSU_HNSCC_derm001
20844,10336,Blank 490,1,M,OHSU_HNSCC_derm001,7,0.966,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm001
20845,10336,Blank 490,1,N,OHSU_HNSCC_derm001,7,0.939,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm001
20846,10336,Blank 490,1,O,OHSU_HNSCC_derm001,7,0.983,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm001
20847,10336,Blank 490,1,P,OHSU_HNSCC_derm001,7,1.077,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm001
20848,10336,Blank 490,1,A,OHSU_HNSCC_derm001,8,0.716,0,NONE,OHSU_HNSCC_derm001
20849,10336,Blank 490,1,B,OHSU_HNSCC_derm001,8,0.708,0,NONE,OHSU_HNSCC_derm001
20850,10336,Blank 490,1,C,OHSU_HNSCC_derm001,8,0.871,0,NONE,OHSU_HNSCC_derm001
20851,10336,Blank 490,1,D,OHSU_HNSCC_derm001,8,0.764,0,NONE,OHSU_HNSCC_derm001
20852,10336,Blank 490,1,E,OHSU_HNSCC_derm001,8,0.941,0,NONE,OHSU_HNSCC_derm001
20853,10336,Blank 490,1,F,OHSU_HNSCC_derm001,8,0.736,0,NONE,OHSU_HNSCC_derm001
20854,10336,Blank 490,1,G,OHSU_HNSCC_derm001,8,1.085,0,NONE,OHSU_HNSCC_derm001
20855,10336,Blank 490,1,H,OHSU_HNSCC_derm001,8,0.004,10,F-S-V,OHSU_HNSCC_derm001
20856,10336,Blank 490,1,I,OHSU_HNSCC_derm001,8,0.908,0,NONE,OHSU_HNSCC_derm001
20857,10336,Blank 490,1,J,OHSU_HNSCC_derm001,8,0.842,0,NONE,OHSU_HNSCC_derm001
20858,10336,Blank 490,1,K,OHSU_HNSCC_derm001,8,0.867,0,NONE,OHSU_HNSCC_derm001
20859,10336,Blank 490,1,L,OHSU_HNSCC_derm001,8,0.676,0,NONE,OHSU_HNSCC_derm001
20860,10336,Blank 490,1,M,OHSU_HNSCC_derm001,8,0.943,0,NONE,OHSU_HNSCC_derm001
20861,10336,Blank 490,1,N,OHSU_HNSCC_derm001,8,0.963,0,NONE,OHSU_HNSCC_derm001
20862,10336,Blank 490,1,O,OHSU_HNSCC_derm001,8,0.959,0,NONE,OHSU_HNSCC_derm001
20863,10336,Blank 490,1,P,OHSU_HNSCC_derm001,8,1.093,0,NONE,OHSU_HNSCC_derm001
20864,10336,Blank 490,1,A,OHSU_HNSCC_derm001,9,0.317,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20865,10336,Blank 490,1,B,OHSU_HNSCC_derm001,9,0.722,10,Sorafenib,OHSU_HNSCC_derm001
20866,10336,Blank 490,1,C,OHSU_HNSCC_derm001,9,0.929,10,Rosmarinic acid,OHSU_HNSCC_derm001
20867,10336,Blank 490,1,D,OHSU_HNSCC_derm001,9,0.752,10,Rapamycin,OHSU_HNSCC_derm001
20868,10336,Blank 490,1,E,OHSU_HNSCC_derm001,9,0.902,10,Vismodegib,OHSU_HNSCC_derm001
20869,10336,Blank 490,1,F,OHSU_HNSCC_derm001,9,0.241,10,PP242,OHSU_HNSCC_derm001
20870,10336,Blank 490,1,G,OHSU_HNSCC_derm001,9,0.84,10,Alectinib,OHSU_HNSCC_derm001
20871,10336,Blank 490,1,H,OHSU_HNSCC_derm001,9,1.006,10,Brigatinib,OHSU_HNSCC_derm001
20872,10336,Blank 490,1,I,OHSU_HNSCC_derm001,9,0.887,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20873,10336,Blank 490,1,J,OHSU_HNSCC_derm001,9,0.766,10,MK-2206,OHSU_HNSCC_derm001
20874,10336,Blank 490,1,K,OHSU_HNSCC_derm001,9,0.943,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20875,10336,Blank 490,1,L,OHSU_HNSCC_derm001,9,0.383,10,Flavopiridol ,OHSU_HNSCC_derm001
20876,10336,Blank 490,1,M,OHSU_HNSCC_derm001,9,1.08,10,Indirubin,OHSU_HNSCC_derm001
20877,10336,Blank 490,1,N,OHSU_HNSCC_derm001,9,0.984,10,PF-533228,OHSU_HNSCC_derm001
20878,10336,Blank 490,1,O,OHSU_HNSCC_derm001,9,1.119,10,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20879,10336,Blank 490,1,P,OHSU_HNSCC_derm001,9,0.248,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20880,10336,Blank 490,1,A,OHSU_HNSCC_derm001,10,0.683,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20881,10336,Blank 490,1,B,OHSU_HNSCC_derm001,10,0.736,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm001
20882,10336,Blank 490,1,C,OHSU_HNSCC_derm001,10,0.851,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm001
20883,10336,Blank 490,1,D,OHSU_HNSCC_derm001,10,0.7,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm001
20884,10336,Blank 490,1,E,OHSU_HNSCC_derm001,10,0.915,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm001
20885,10336,Blank 490,1,F,OHSU_HNSCC_derm001,10,0.461,3.3333333333333335,PP242,OHSU_HNSCC_derm001
20886,10336,Blank 490,1,G,OHSU_HNSCC_derm001,10,0.965,3.3333333333333335,Alectinib,OHSU_HNSCC_derm001
20887,10336,Blank 490,1,H,OHSU_HNSCC_derm001,10,1.048,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
20888,10336,Blank 490,1,I,OHSU_HNSCC_derm001,10,0.979,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20889,10336,Blank 490,1,J,OHSU_HNSCC_derm001,10,0.945,3.3333333333333335,MK-2206,OHSU_HNSCC_derm001
20890,10336,Blank 490,1,K,OHSU_HNSCC_derm001,10,0.876,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20891,10336,Blank 490,1,L,OHSU_HNSCC_derm001,10,0.319,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm001
20892,10336,Blank 490,1,M,OHSU_HNSCC_derm001,10,1.045,3.3333333333333335,Indirubin,OHSU_HNSCC_derm001
20893,10336,Blank 490,1,N,OHSU_HNSCC_derm001,10,0.852,3.3333333333333335,PF-533228,OHSU_HNSCC_derm001
20894,10336,Blank 490,1,O,OHSU_HNSCC_derm001,10,1.069,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20895,10336,Blank 490,1,P,OHSU_HNSCC_derm001,10,0.234,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20896,10336,Blank 490,1,A,OHSU_HNSCC_derm001,11,0.549,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20897,10336,Blank 490,1,B,OHSU_HNSCC_derm001,11,0.704,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm001
20898,10336,Blank 490,1,C,OHSU_HNSCC_derm001,11,0.751,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm001
20899,10336,Blank 490,1,D,OHSU_HNSCC_derm001,11,0.789,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm001
20900,10336,Blank 490,1,E,OHSU_HNSCC_derm001,11,1.029,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm001
20901,10336,Blank 490,1,F,OHSU_HNSCC_derm001,11,0.672,1.1111111111111112,PP242,OHSU_HNSCC_derm001
20902,10336,Blank 490,1,G,OHSU_HNSCC_derm001,11,1.008,1.1111111111111112,Alectinib,OHSU_HNSCC_derm001
20903,10336,Blank 490,1,H,OHSU_HNSCC_derm001,11,1.039,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
20904,10336,Blank 490,1,I,OHSU_HNSCC_derm001,11,0.938,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20905,10336,Blank 490,1,J,OHSU_HNSCC_derm001,11,0.873,1.1111111111111112,MK-2206,OHSU_HNSCC_derm001
20906,10336,Blank 490,1,K,OHSU_HNSCC_derm001,11,0.795,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20907,10336,Blank 490,1,L,OHSU_HNSCC_derm001,11,0.282,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm001
20908,10336,Blank 490,1,M,OHSU_HNSCC_derm001,11,0.799,1.1111111111111112,Indirubin,OHSU_HNSCC_derm001
20909,10336,Blank 490,1,N,OHSU_HNSCC_derm001,11,0.977,1.1111111111111112,PF-533228,OHSU_HNSCC_derm001
20910,10336,Blank 490,1,O,OHSU_HNSCC_derm001,11,0.986,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20911,10336,Blank 490,1,P,OHSU_HNSCC_derm001,11,0.299,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20912,10336,Blank 490,1,A,OHSU_HNSCC_derm001,12,0.638,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20913,10336,Blank 490,1,B,OHSU_HNSCC_derm001,12,0.752,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm001
20914,10336,Blank 490,1,C,OHSU_HNSCC_derm001,12,0.81,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm001
20915,10336,Blank 490,1,D,OHSU_HNSCC_derm001,12,0.782,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm001
20916,10336,Blank 490,1,E,OHSU_HNSCC_derm001,12,0.869,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm001
20917,10336,Blank 490,1,F,OHSU_HNSCC_derm001,12,0.842,0.3703703703703704,PP242,OHSU_HNSCC_derm001
20918,10336,Blank 490,1,G,OHSU_HNSCC_derm001,12,1.099,0.3703703703703704,Alectinib,OHSU_HNSCC_derm001
20919,10336,Blank 490,1,H,OHSU_HNSCC_derm001,12,0.851,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
20920,10336,Blank 490,1,I,OHSU_HNSCC_derm001,12,0.905,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20921,10336,Blank 490,1,J,OHSU_HNSCC_derm001,12,0.853,0.3703703703703704,MK-2206,OHSU_HNSCC_derm001
20922,10336,Blank 490,1,K,OHSU_HNSCC_derm001,12,0.904,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20923,10336,Blank 490,1,L,OHSU_HNSCC_derm001,12,0.308,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm001
20924,10336,Blank 490,1,M,OHSU_HNSCC_derm001,12,1.033,0.3703703703703704,Indirubin,OHSU_HNSCC_derm001
20925,10336,Blank 490,1,N,OHSU_HNSCC_derm001,12,0.977,0.3703703703703704,PF-533228,OHSU_HNSCC_derm001
20926,10336,Blank 490,1,O,OHSU_HNSCC_derm001,12,0.93,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20927,10336,Blank 490,1,P,OHSU_HNSCC_derm001,12,0.556,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20928,10336,Blank 490,1,A,OHSU_HNSCC_derm001,13,0.754,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20929,10336,Blank 490,1,B,OHSU_HNSCC_derm001,13,0.74,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm001
20930,10336,Blank 490,1,C,OHSU_HNSCC_derm001,13,0.792,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm001
20931,10336,Blank 490,1,D,OHSU_HNSCC_derm001,13,0.825,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm001
20932,10336,Blank 490,1,E,OHSU_HNSCC_derm001,13,0.956,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm001
20933,10336,Blank 490,1,F,OHSU_HNSCC_derm001,13,0.924,0.1234567901234568,PP242,OHSU_HNSCC_derm001
20934,10336,Blank 490,1,G,OHSU_HNSCC_derm001,13,1.105,0.1234567901234568,Alectinib,OHSU_HNSCC_derm001
20935,10336,Blank 490,1,H,OHSU_HNSCC_derm001,13,1.043,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
20936,10336,Blank 490,1,I,OHSU_HNSCC_derm001,13,0.956,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20937,10336,Blank 490,1,J,OHSU_HNSCC_derm001,13,0.902,0.1234567901234568,MK-2206,OHSU_HNSCC_derm001
20938,10336,Blank 490,1,K,OHSU_HNSCC_derm001,13,0.881,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20939,10336,Blank 490,1,L,OHSU_HNSCC_derm001,13,0.759,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm001
20940,10336,Blank 490,1,M,OHSU_HNSCC_derm001,13,1.051,0.1234567901234568,Indirubin,OHSU_HNSCC_derm001
20941,10336,Blank 490,1,N,OHSU_HNSCC_derm001,13,0.947,0.1234567901234568,PF-533228,OHSU_HNSCC_derm001
20942,10336,Blank 490,1,O,OHSU_HNSCC_derm001,13,1.136,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20943,10336,Blank 490,1,P,OHSU_HNSCC_derm001,13,0.933,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20944,10336,Blank 490,1,A,OHSU_HNSCC_derm001,14,0.709,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20945,10336,Blank 490,1,B,OHSU_HNSCC_derm001,14,0.725,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm001
20946,10336,Blank 490,1,C,OHSU_HNSCC_derm001,14,0.877,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm001
20947,10336,Blank 490,1,D,OHSU_HNSCC_derm001,14,0.697,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm001
20948,10336,Blank 490,1,E,OHSU_HNSCC_derm001,14,0.83,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm001
20949,10336,Blank 490,1,F,OHSU_HNSCC_derm001,14,0.953,0.0411522633744856,PP242,OHSU_HNSCC_derm001
20950,10336,Blank 490,1,G,OHSU_HNSCC_derm001,14,1.013,0.0411522633744856,Alectinib,OHSU_HNSCC_derm001
20951,10336,Blank 490,1,H,OHSU_HNSCC_derm001,14,0.941,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
20952,10336,Blank 490,1,I,OHSU_HNSCC_derm001,14,0.878,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20953,10336,Blank 490,1,J,OHSU_HNSCC_derm001,14,0.835,0.0411522633744856,MK-2206,OHSU_HNSCC_derm001
20954,10336,Blank 490,1,K,OHSU_HNSCC_derm001,14,0.808,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20955,10336,Blank 490,1,L,OHSU_HNSCC_derm001,14,0.761,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm001
20956,10336,Blank 490,1,M,OHSU_HNSCC_derm001,14,1.01,0.0411522633744856,Indirubin,OHSU_HNSCC_derm001
20957,10336,Blank 490,1,N,OHSU_HNSCC_derm001,14,0.98,0.0411522633744856,PF-533228,OHSU_HNSCC_derm001
20958,10336,Blank 490,1,O,OHSU_HNSCC_derm001,14,1.017,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20959,10336,Blank 490,1,P,OHSU_HNSCC_derm001,14,0.927,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20960,10336,Blank 490,1,A,OHSU_HNSCC_derm001,15,0.707,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm001
20961,10336,Blank 490,1,B,OHSU_HNSCC_derm001,15,0.759,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm001
20962,10336,Blank 490,1,C,OHSU_HNSCC_derm001,15,0.877,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm001
20963,10336,Blank 490,1,D,OHSU_HNSCC_derm001,15,0.782,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm001
20964,10336,Blank 490,1,E,OHSU_HNSCC_derm001,15,1.045,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm001
20965,10336,Blank 490,1,F,OHSU_HNSCC_derm001,15,0.955,0.013717421124828532,PP242,OHSU_HNSCC_derm001
20966,10336,Blank 490,1,G,OHSU_HNSCC_derm001,15,0.917,0.013717421124828532,Alectinib,OHSU_HNSCC_derm001
20967,10336,Blank 490,1,H,OHSU_HNSCC_derm001,15,0.814,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
20968,10336,Blank 490,1,I,OHSU_HNSCC_derm001,15,0.831,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
20969,10336,Blank 490,1,J,OHSU_HNSCC_derm001,15,0.78,0.013717421124828532,MK-2206,OHSU_HNSCC_derm001
20970,10336,Blank 490,1,K,OHSU_HNSCC_derm001,15,0.872,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm001
20971,10336,Blank 490,1,L,OHSU_HNSCC_derm001,15,0.722,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm001
20972,10336,Blank 490,1,M,OHSU_HNSCC_derm001,15,0.946,0.013717421124828532,Indirubin,OHSU_HNSCC_derm001
20973,10336,Blank 490,1,N,OHSU_HNSCC_derm001,15,0.996,0.013717421124828532,PF-533228,OHSU_HNSCC_derm001
20974,10336,Blank 490,1,O,OHSU_HNSCC_derm001,15,1.009,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm001
20975,10336,Blank 490,1,P,OHSU_HNSCC_derm001,15,1.095,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm001
20976,10336,Blank 490,1,A,OHSU_HNSCC_derm001,16,0.765,0,NONE,OHSU_HNSCC_derm001
20977,10336,Blank 490,1,B,OHSU_HNSCC_derm001,16,0.79,0,NONE,OHSU_HNSCC_derm001
20978,10336,Blank 490,1,C,OHSU_HNSCC_derm001,16,0.875,0,NONE,OHSU_HNSCC_derm001
20979,10336,Blank 490,1,D,OHSU_HNSCC_derm001,16,0.985,0,NONE,OHSU_HNSCC_derm001
20980,10336,Blank 490,1,E,OHSU_HNSCC_derm001,16,0.71,0,NONE,OHSU_HNSCC_derm001
20981,10336,Blank 490,1,F,OHSU_HNSCC_derm001,16,0.888,0,NONE,OHSU_HNSCC_derm001
20982,10336,Blank 490,1,G,OHSU_HNSCC_derm001,16,1.019,0,NONE,OHSU_HNSCC_derm001
20983,10336,Blank 490,1,H,OHSU_HNSCC_derm001,16,-0.004,10,F-S-V,OHSU_HNSCC_derm001
20984,10336,Blank 490,1,I,OHSU_HNSCC_derm001,16,0.83,0,NONE,OHSU_HNSCC_derm001
20985,10336,Blank 490,1,J,OHSU_HNSCC_derm001,16,0.814,0,NONE,OHSU_HNSCC_derm001
20986,10336,Blank 490,1,K,OHSU_HNSCC_derm001,16,0.891,0,NONE,OHSU_HNSCC_derm001
20987,10336,Blank 490,1,L,OHSU_HNSCC_derm001,16,0.628,0,NONE,OHSU_HNSCC_derm001
20988,10336,Blank 490,1,M,OHSU_HNSCC_derm001,16,0.938,0,NONE,OHSU_HNSCC_derm001
20989,10336,Blank 490,1,N,OHSU_HNSCC_derm001,16,1.075,0,NONE,OHSU_HNSCC_derm001
20990,10336,Blank 490,1,O,OHSU_HNSCC_derm001,16,1.018,0,NONE,OHSU_HNSCC_derm001
20991,10336,Blank 490,1,P,OHSU_HNSCC_derm001,16,1.081,0,NONE,OHSU_HNSCC_derm001
20992,10336,Blank 490,1,A,OHSU_HNSCC_derm001,17,0.685,10,Emodin,OHSU_HNSCC_derm001
20993,10336,Blank 490,1,B,OHSU_HNSCC_derm001,17,0.756,10,Baicalin,OHSU_HNSCC_derm001
20994,10336,Blank 490,1,C,OHSU_HNSCC_derm001,17,0.421,10,NVP-TAE-684,OHSU_HNSCC_derm001
20995,10336,Blank 490,1,D,OHSU_HNSCC_derm001,17,0.086,10,Panobinostat,OHSU_HNSCC_derm001
20996,10336,Blank 490,1,E,OHSU_HNSCC_derm001,17,0.162,10;10,PP242;Gefitinib,OHSU_HNSCC_derm001
20997,10336,Blank 490,1,F,OHSU_HNSCC_derm001,17,0.873,10,Fulvestrant,OHSU_HNSCC_derm001
20998,10336,Blank 490,1,G,OHSU_HNSCC_derm001,17,0.968,10,SCH-772984,OHSU_HNSCC_derm001
20999,10336,Blank 490,1,H,OHSU_HNSCC_derm001,17,0.916,10,Trametinib,OHSU_HNSCC_derm001
21000,10336,Blank 490,1,I,OHSU_HNSCC_derm001,17,0.273,10,BEZ235,OHSU_HNSCC_derm001
21001,10336,Blank 490,1,J,OHSU_HNSCC_derm001,17,0.923,10,MLN120B,OHSU_HNSCC_derm001
21002,10336,Blank 490,1,K,OHSU_HNSCC_derm001,17,0.46,10,Ixabepilone,OHSU_HNSCC_derm001
21003,10336,Blank 490,1,L,OHSU_HNSCC_derm001,17,0.573,10,Canertinib (CI-1033),OHSU_HNSCC_derm001
21004,10336,Blank 490,1,M,OHSU_HNSCC_derm001,17,0.946,10,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21005,10336,Blank 490,1,N,OHSU_HNSCC_derm001,17,1.036,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21006,10336,Blank 490,1,O,OHSU_HNSCC_derm001,17,0.965,10,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21007,10336,Blank 490,1,P,OHSU_HNSCC_derm001,17,1.047,10,Letrozole,OHSU_HNSCC_derm001
21008,10336,Blank 490,1,A,OHSU_HNSCC_derm001,18,0.702,3.3333333333333335,Emodin,OHSU_HNSCC_derm001
21009,10336,Blank 490,1,B,OHSU_HNSCC_derm001,18,0.737,3.3333333333333335,Baicalin,OHSU_HNSCC_derm001
21010,10336,Blank 490,1,C,OHSU_HNSCC_derm001,18,0.844,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm001
21011,10336,Blank 490,1,D,OHSU_HNSCC_derm001,18,0.115,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm001
21012,10336,Blank 490,1,E,OHSU_HNSCC_derm001,18,0.216,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm001
21013,10336,Blank 490,1,F,OHSU_HNSCC_derm001,18,0.752,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm001
21014,10336,Blank 490,1,G,OHSU_HNSCC_derm001,18,1.012,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm001
21015,10336,Blank 490,1,H,OHSU_HNSCC_derm001,18,0.935,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
21016,10336,Blank 490,1,I,OHSU_HNSCC_derm001,18,0.288,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
21017,10336,Blank 490,1,J,OHSU_HNSCC_derm001,18,0.967,3.3333333333333335,MLN120B,OHSU_HNSCC_derm001
21018,10336,Blank 490,1,K,OHSU_HNSCC_derm001,18,0.365,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm001
21019,10336,Blank 490,1,L,OHSU_HNSCC_derm001,18,0.785,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm001
21020,10336,Blank 490,1,M,OHSU_HNSCC_derm001,18,1.006,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21021,10336,Blank 490,1,N,OHSU_HNSCC_derm001,18,1.169,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21022,10336,Blank 490,1,O,OHSU_HNSCC_derm001,18,0.902,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21023,10336,Blank 490,1,P,OHSU_HNSCC_derm001,18,1.064,3.3333333333333335,Letrozole,OHSU_HNSCC_derm001
21024,10336,Blank 490,1,A,OHSU_HNSCC_derm001,19,0.669,1.1111111111111112,Emodin,OHSU_HNSCC_derm001
21025,10336,Blank 490,1,B,OHSU_HNSCC_derm001,19,0.654,1.1111111111111112,Baicalin,OHSU_HNSCC_derm001
21026,10336,Blank 490,1,C,OHSU_HNSCC_derm001,19,0.867,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm001
21027,10336,Blank 490,1,D,OHSU_HNSCC_derm001,19,0.174,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm001
21028,10336,Blank 490,1,E,OHSU_HNSCC_derm001,19,0.565,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm001
21029,10336,Blank 490,1,F,OHSU_HNSCC_derm001,19,0.88,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm001
21030,10336,Blank 490,1,G,OHSU_HNSCC_derm001,19,1.022,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm001
21031,10336,Blank 490,1,H,OHSU_HNSCC_derm001,19,1.048,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
21032,10336,Blank 490,1,I,OHSU_HNSCC_derm001,19,0.291,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
21033,10336,Blank 490,1,J,OHSU_HNSCC_derm001,19,0.94,1.1111111111111112,MLN120B,OHSU_HNSCC_derm001
21034,10336,Blank 490,1,K,OHSU_HNSCC_derm001,19,0.422,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm001
21035,10336,Blank 490,1,L,OHSU_HNSCC_derm001,19,0.73,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm001
21036,10336,Blank 490,1,M,OHSU_HNSCC_derm001,19,1.074,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21037,10336,Blank 490,1,N,OHSU_HNSCC_derm001,19,1.163,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21038,10336,Blank 490,1,O,OHSU_HNSCC_derm001,19,0.994,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21039,10336,Blank 490,1,P,OHSU_HNSCC_derm001,19,0.938,1.1111111111111112,Letrozole,OHSU_HNSCC_derm001
21040,10336,Blank 490,1,A,OHSU_HNSCC_derm001,20,0.666,0.3703703703703704,Emodin,OHSU_HNSCC_derm001
21041,10336,Blank 490,1,B,OHSU_HNSCC_derm001,20,0.71,0.3703703703703704,Baicalin,OHSU_HNSCC_derm001
21042,10336,Blank 490,1,C,OHSU_HNSCC_derm001,20,0.799,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm001
21043,10336,Blank 490,1,D,OHSU_HNSCC_derm001,20,0.445,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm001
21044,10336,Blank 490,1,E,OHSU_HNSCC_derm001,20,0.853,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm001
21045,10336,Blank 490,1,F,OHSU_HNSCC_derm001,20,0.932,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm001
21046,10336,Blank 490,1,G,OHSU_HNSCC_derm001,20,1.063,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm001
21047,10336,Blank 490,1,H,OHSU_HNSCC_derm001,20,1.059,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
21048,10336,Blank 490,1,I,OHSU_HNSCC_derm001,20,0.413,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
21049,10336,Blank 490,1,J,OHSU_HNSCC_derm001,20,0.912,0.3703703703703704,MLN120B,OHSU_HNSCC_derm001
21050,10336,Blank 490,1,K,OHSU_HNSCC_derm001,20,0.392,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm001
21051,10336,Blank 490,1,L,OHSU_HNSCC_derm001,20,0.833,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm001
21052,10336,Blank 490,1,M,OHSU_HNSCC_derm001,20,0.995,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21053,10336,Blank 490,1,N,OHSU_HNSCC_derm001,20,1.22,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21054,10336,Blank 490,1,O,OHSU_HNSCC_derm001,20,0.902,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21055,10336,Blank 490,1,P,OHSU_HNSCC_derm001,20,1.107,0.3703703703703704,Letrozole,OHSU_HNSCC_derm001
21056,10336,Blank 490,1,A,OHSU_HNSCC_derm001,21,0.698,0.1234567901234568,Emodin,OHSU_HNSCC_derm001
21057,10336,Blank 490,1,B,OHSU_HNSCC_derm001,21,0.696,0.1234567901234568,Baicalin,OHSU_HNSCC_derm001
21058,10336,Blank 490,1,C,OHSU_HNSCC_derm001,21,0.639,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm001
21059,10336,Blank 490,1,D,OHSU_HNSCC_derm001,21,0.847,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm001
21060,10336,Blank 490,1,E,OHSU_HNSCC_derm001,21,0.806,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm001
21061,10336,Blank 490,1,F,OHSU_HNSCC_derm001,21,1.056,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm001
21062,10336,Blank 490,1,G,OHSU_HNSCC_derm001,21,1.03,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm001
21063,10336,Blank 490,1,H,OHSU_HNSCC_derm001,21,0.995,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
21064,10336,Blank 490,1,I,OHSU_HNSCC_derm001,21,0.618,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
21065,10336,Blank 490,1,J,OHSU_HNSCC_derm001,21,0.898,0.1234567901234568,MLN120B,OHSU_HNSCC_derm001
21066,10336,Blank 490,1,K,OHSU_HNSCC_derm001,21,0.46,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm001
21067,10336,Blank 490,1,L,OHSU_HNSCC_derm001,21,0.749,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm001
21068,10336,Blank 490,1,M,OHSU_HNSCC_derm001,21,1.035,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21069,10336,Blank 490,1,N,OHSU_HNSCC_derm001,21,1.129,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21070,10336,Blank 490,1,O,OHSU_HNSCC_derm001,21,0.954,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21071,10336,Blank 490,1,P,OHSU_HNSCC_derm001,21,1.13,0.1234567901234568,Letrozole,OHSU_HNSCC_derm001
21072,10336,Blank 490,1,A,OHSU_HNSCC_derm001,22,0.732,0.0411522633744856,Emodin,OHSU_HNSCC_derm001
21073,10336,Blank 490,1,B,OHSU_HNSCC_derm001,22,0.709,0.0411522633744856,Baicalin,OHSU_HNSCC_derm001
21074,10336,Blank 490,1,C,OHSU_HNSCC_derm001,22,0.804,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm001
21075,10336,Blank 490,1,D,OHSU_HNSCC_derm001,22,0.884,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm001
21076,10336,Blank 490,1,E,OHSU_HNSCC_derm001,22,0.929,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm001
21077,10336,Blank 490,1,F,OHSU_HNSCC_derm001,22,1.043,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm001
21078,10336,Blank 490,1,G,OHSU_HNSCC_derm001,22,0.903,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm001
21079,10336,Blank 490,1,H,OHSU_HNSCC_derm001,22,0.946,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
21080,10336,Blank 490,1,I,OHSU_HNSCC_derm001,22,0.8,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
21081,10336,Blank 490,1,J,OHSU_HNSCC_derm001,22,0.936,0.0411522633744856,MLN120B,OHSU_HNSCC_derm001
21082,10336,Blank 490,1,K,OHSU_HNSCC_derm001,22,0.491,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm001
21083,10336,Blank 490,1,L,OHSU_HNSCC_derm001,22,0.763,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm001
21084,10336,Blank 490,1,M,OHSU_HNSCC_derm001,22,1.056,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21085,10336,Blank 490,1,N,OHSU_HNSCC_derm001,22,0.959,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21086,10336,Blank 490,1,O,OHSU_HNSCC_derm001,22,0.959,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21087,10336,Blank 490,1,P,OHSU_HNSCC_derm001,22,1.09,0.0411522633744856,Letrozole,OHSU_HNSCC_derm001
21088,10336,Blank 490,1,A,OHSU_HNSCC_derm001,23,0.742,0.013717421124828532,Emodin,OHSU_HNSCC_derm001
21089,10336,Blank 490,1,B,OHSU_HNSCC_derm001,23,0.765,0.013717421124828532,Baicalin,OHSU_HNSCC_derm001
21090,10336,Blank 490,1,C,OHSU_HNSCC_derm001,23,0.744,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm001
21091,10336,Blank 490,1,D,OHSU_HNSCC_derm001,23,0.797,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm001
21092,10336,Blank 490,1,E,OHSU_HNSCC_derm001,23,0.986,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm001
21093,10336,Blank 490,1,F,OHSU_HNSCC_derm001,23,0.984,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm001
21094,10336,Blank 490,1,G,OHSU_HNSCC_derm001,23,0.973,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm001
21095,10336,Blank 490,1,H,OHSU_HNSCC_derm001,23,1.004,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
21096,10336,Blank 490,1,I,OHSU_HNSCC_derm001,23,0.824,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
21097,10336,Blank 490,1,J,OHSU_HNSCC_derm001,23,1.007,0.013717421124828532,MLN120B,OHSU_HNSCC_derm001
21098,10336,Blank 490,1,K,OHSU_HNSCC_derm001,23,0.639,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm001
21099,10336,Blank 490,1,L,OHSU_HNSCC_derm001,23,0.76,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm001
21100,10336,Blank 490,1,M,OHSU_HNSCC_derm001,23,0.98,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm001
21101,10336,Blank 490,1,N,OHSU_HNSCC_derm001,23,1.071,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm001
21102,10336,Blank 490,1,O,OHSU_HNSCC_derm001,23,1.031,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm001
21103,10336,Blank 490,1,P,OHSU_HNSCC_derm001,23,1.106,0.013717421124828532,Letrozole,OHSU_HNSCC_derm001
21104,10336,Blank 490,1,A,OHSU_HNSCC_derm001,24,0.79,0,NONE,OHSU_HNSCC_derm001
21105,10336,Blank 490,1,B,OHSU_HNSCC_derm001,24,0.721,0,NONE,OHSU_HNSCC_derm001
21106,10336,Blank 490,1,C,OHSU_HNSCC_derm001,24,0.869,0,NONE,OHSU_HNSCC_derm001
21107,10336,Blank 490,1,D,OHSU_HNSCC_derm001,24,0.915,0,NONE,OHSU_HNSCC_derm001
21108,10336,Blank 490,1,E,OHSU_HNSCC_derm001,24,0.915,0,NONE,OHSU_HNSCC_derm001
21109,10336,Blank 490,1,F,OHSU_HNSCC_derm001,24,0.934,0,NONE,OHSU_HNSCC_derm001
21110,10336,Blank 490,1,G,OHSU_HNSCC_derm001,24,0.906,0,NONE,OHSU_HNSCC_derm001
21111,10336,Blank 490,1,H,OHSU_HNSCC_derm001,24,0.922,0,NONE,OHSU_HNSCC_derm001
21112,10336,Blank 490,1,I,OHSU_HNSCC_derm001,24,0.791,0,NONE,OHSU_HNSCC_derm001
21113,10336,Blank 490,1,J,OHSU_HNSCC_derm001,24,0.966,0,NONE,OHSU_HNSCC_derm001
21114,10336,Blank 490,1,K,OHSU_HNSCC_derm001,24,0.836,0,NONE,OHSU_HNSCC_derm001
21115,10336,Blank 490,1,L,OHSU_HNSCC_derm001,24,0.731,0,NONE,OHSU_HNSCC_derm001
21116,10336,Blank 490,1,M,OHSU_HNSCC_derm001,24,0.941,0,NONE,OHSU_HNSCC_derm001
21117,10336,Blank 490,1,N,OHSU_HNSCC_derm001,24,1.002,0,NONE,OHSU_HNSCC_derm001
21118,10336,Blank 490,1,O,OHSU_HNSCC_derm001,24,0.925,0,NONE,OHSU_HNSCC_derm001
21119,10336,Blank 490,1,P,OHSU_HNSCC_derm001,24,1.078,0,NONE,OHSU_HNSCC_derm001
21120,10336,Blank 490,2,A,OHSU_HNSCC_derm001,1,0.875,10,Coumarin,OHSU_HNSCC_derm001
21121,10336,Blank 490,2,B,OHSU_HNSCC_derm001,1,0.501,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21122,10336,Blank 490,2,C,OHSU_HNSCC_derm001,1,0.492,10,Foretinib (XL-880),OHSU_HNSCC_derm001
21123,10336,Blank 490,2,D,OHSU_HNSCC_derm001,1,0.776,10,Elesclomol,OHSU_HNSCC_derm001
21124,10336,Blank 490,2,E,OHSU_HNSCC_derm001,1,0.864,10,Vemurafenib,OHSU_HNSCC_derm001
21125,10336,Blank 490,2,F,OHSU_HNSCC_derm001,1,0.086,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21126,10336,Blank 490,2,G,OHSU_HNSCC_derm001,1,0.038,10,Ponatinib,OHSU_HNSCC_derm001
21127,10336,Blank 490,2,H,OHSU_HNSCC_derm001,1,0.815,10,Gefitinib,OHSU_HNSCC_derm001
21128,10336,Blank 490,2,I,OHSU_HNSCC_derm001,1,0.793,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
21129,10336,Blank 490,2,J,OHSU_HNSCC_derm001,1,0.964,1,Sunitinib (1mM),OHSU_HNSCC_derm001
21130,10336,Blank 490,2,K,OHSU_HNSCC_derm001,1,0.887,10,Curcumin,OHSU_HNSCC_derm001
21131,10336,Blank 490,2,L,OHSU_HNSCC_derm001,1,0.5,10,PF-562271,OHSU_HNSCC_derm001
21132,10336,Blank 490,2,M,OHSU_HNSCC_derm001,1,1.005,10,STO609,OHSU_HNSCC_derm001
21133,10336,Blank 490,2,N,OHSU_HNSCC_derm001,1,1.023,10,Lenvatinib,OHSU_HNSCC_derm001
21134,10336,Blank 490,2,O,OHSU_HNSCC_derm001,1,0.84,10,Entrectinib,OHSU_HNSCC_derm001
21135,10336,Blank 490,2,P,OHSU_HNSCC_derm001,1,1.088,10,Ethyl Gallate ,OHSU_HNSCC_derm001
21136,10336,Blank 490,2,A,OHSU_HNSCC_derm001,2,1.029,3.3333333333333335,Coumarin,OHSU_HNSCC_derm001
21137,10336,Blank 490,2,B,OHSU_HNSCC_derm001,2,0.775,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21138,10336,Blank 490,2,C,OHSU_HNSCC_derm001,2,0.713,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm001
21139,10336,Blank 490,2,D,OHSU_HNSCC_derm001,2,0.736,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm001
21140,10336,Blank 490,2,E,OHSU_HNSCC_derm001,2,0.875,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm001
21141,10336,Blank 490,2,F,OHSU_HNSCC_derm001,2,0.218,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21142,10336,Blank 490,2,G,OHSU_HNSCC_derm001,2,0.812,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm001
21143,10336,Blank 490,2,H,OHSU_HNSCC_derm001,2,0.916,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
21144,10336,Blank 490,2,I,OHSU_HNSCC_derm001,2,0.808,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
21145,10336,Blank 490,2,J,OHSU_HNSCC_derm001,2,0.89,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm001
21146,10336,Blank 490,2,K,OHSU_HNSCC_derm001,2,1.003,3.3333333333333335,Curcumin,OHSU_HNSCC_derm001
21147,10336,Blank 490,2,L,OHSU_HNSCC_derm001,2,0.604,3.3333333333333335,PF-562271,OHSU_HNSCC_derm001
21148,10336,Blank 490,2,M,OHSU_HNSCC_derm001,2,1.059,3.3333333333333335,STO609,OHSU_HNSCC_derm001
21149,10336,Blank 490,2,N,OHSU_HNSCC_derm001,2,1.102,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm001
21150,10336,Blank 490,2,O,OHSU_HNSCC_derm001,2,1.061,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm001
21151,10336,Blank 490,2,P,OHSU_HNSCC_derm001,2,1.153,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm001
21152,10336,Blank 490,2,A,OHSU_HNSCC_derm001,3,0.991,1.1111111111111112,Coumarin,OHSU_HNSCC_derm001
21153,10336,Blank 490,2,B,OHSU_HNSCC_derm001,3,0.749,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21154,10336,Blank 490,2,C,OHSU_HNSCC_derm001,3,0.893,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm001
21155,10336,Blank 490,2,D,OHSU_HNSCC_derm001,3,0.76,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm001
21156,10336,Blank 490,2,E,OHSU_HNSCC_derm001,3,1.112,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm001
21157,10336,Blank 490,2,F,OHSU_HNSCC_derm001,3,0.221,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21158,10336,Blank 490,2,G,OHSU_HNSCC_derm001,3,1.177,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm001
21159,10336,Blank 490,2,H,OHSU_HNSCC_derm001,3,1.0,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
21160,10336,Blank 490,2,I,OHSU_HNSCC_derm001,3,1.056,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
21161,10336,Blank 490,2,J,OHSU_HNSCC_derm001,3,0.933,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm001
21162,10336,Blank 490,2,K,OHSU_HNSCC_derm001,3,0.9,1.1111111111111112,Curcumin,OHSU_HNSCC_derm001
21163,10336,Blank 490,2,L,OHSU_HNSCC_derm001,3,0.746,1.1111111111111112,PF-562271,OHSU_HNSCC_derm001
21164,10336,Blank 490,2,M,OHSU_HNSCC_derm001,3,1.176,1.1111111111111112,STO609,OHSU_HNSCC_derm001
21165,10336,Blank 490,2,N,OHSU_HNSCC_derm001,3,1.125,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm001
21166,10336,Blank 490,2,O,OHSU_HNSCC_derm001,3,1.027,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm001
21167,10336,Blank 490,2,P,OHSU_HNSCC_derm001,3,1.026,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm001
21168,10336,Blank 490,2,A,OHSU_HNSCC_derm001,4,0.862,0.3703703703703704,Coumarin,OHSU_HNSCC_derm001
21169,10336,Blank 490,2,B,OHSU_HNSCC_derm001,4,0.704,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21170,10336,Blank 490,2,C,OHSU_HNSCC_derm001,4,0.92,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm001
21171,10336,Blank 490,2,D,OHSU_HNSCC_derm001,4,0.708,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm001
21172,10336,Blank 490,2,E,OHSU_HNSCC_derm001,4,0.849,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm001
21173,10336,Blank 490,2,F,OHSU_HNSCC_derm001,4,0.406,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21174,10336,Blank 490,2,G,OHSU_HNSCC_derm001,4,1.055,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm001
21175,10336,Blank 490,2,H,OHSU_HNSCC_derm001,4,0.972,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
21176,10336,Blank 490,2,I,OHSU_HNSCC_derm001,4,1.065,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
21177,10336,Blank 490,2,J,OHSU_HNSCC_derm001,4,0.828,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm001
21178,10336,Blank 490,2,K,OHSU_HNSCC_derm001,4,0.787,0.3703703703703704,Curcumin,OHSU_HNSCC_derm001
21179,10336,Blank 490,2,L,OHSU_HNSCC_derm001,4,0.816,0.3703703703703704,PF-562271,OHSU_HNSCC_derm001
21180,10336,Blank 490,2,M,OHSU_HNSCC_derm001,4,1.167,0.3703703703703704,STO609,OHSU_HNSCC_derm001
21181,10336,Blank 490,2,N,OHSU_HNSCC_derm001,4,1.086,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm001
21182,10336,Blank 490,2,O,OHSU_HNSCC_derm001,4,1.109,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm001
21183,10336,Blank 490,2,P,OHSU_HNSCC_derm001,4,1.041,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm001
21184,10336,Blank 490,2,A,OHSU_HNSCC_derm001,5,0.835,0.1234567901234568,Coumarin,OHSU_HNSCC_derm001
21185,10336,Blank 490,2,B,OHSU_HNSCC_derm001,5,0.627,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21186,10336,Blank 490,2,C,OHSU_HNSCC_derm001,5,0.87,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm001
21187,10336,Blank 490,2,D,OHSU_HNSCC_derm001,5,0.78,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm001
21188,10336,Blank 490,2,E,OHSU_HNSCC_derm001,5,1.097,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm001
21189,10336,Blank 490,2,F,OHSU_HNSCC_derm001,5,0.638,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21190,10336,Blank 490,2,G,OHSU_HNSCC_derm001,5,1.046,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm001
21191,10336,Blank 490,2,H,OHSU_HNSCC_derm001,5,0.876,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
21192,10336,Blank 490,2,I,OHSU_HNSCC_derm001,5,0.936,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
21193,10336,Blank 490,2,J,OHSU_HNSCC_derm001,5,0.751,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm001
21194,10336,Blank 490,2,K,OHSU_HNSCC_derm001,5,0.859,0.1234567901234568,Curcumin,OHSU_HNSCC_derm001
21195,10336,Blank 490,2,L,OHSU_HNSCC_derm001,5,0.748,0.1234567901234568,PF-562271,OHSU_HNSCC_derm001
21196,10336,Blank 490,2,M,OHSU_HNSCC_derm001,5,1.067,0.1234567901234568,STO609,OHSU_HNSCC_derm001
21197,10336,Blank 490,2,N,OHSU_HNSCC_derm001,5,0.965,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm001
21198,10336,Blank 490,2,O,OHSU_HNSCC_derm001,5,1.241,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm001
21199,10336,Blank 490,2,P,OHSU_HNSCC_derm001,5,1.102,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm001
21200,10336,Blank 490,2,A,OHSU_HNSCC_derm001,6,0.898,0.0411522633744856,Coumarin,OHSU_HNSCC_derm001
21201,10336,Blank 490,2,B,OHSU_HNSCC_derm001,6,0.699,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21202,10336,Blank 490,2,C,OHSU_HNSCC_derm001,6,0.937,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm001
21203,10336,Blank 490,2,D,OHSU_HNSCC_derm001,6,0.842,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm001
21204,10336,Blank 490,2,E,OHSU_HNSCC_derm001,6,0.971,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm001
21205,10336,Blank 490,2,F,OHSU_HNSCC_derm001,6,0.966,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21206,10336,Blank 490,2,G,OHSU_HNSCC_derm001,6,1.144,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm001
21207,10336,Blank 490,2,H,OHSU_HNSCC_derm001,6,0.916,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
21208,10336,Blank 490,2,I,OHSU_HNSCC_derm001,6,0.97,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
21209,10336,Blank 490,2,J,OHSU_HNSCC_derm001,6,0.928,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm001
21210,10336,Blank 490,2,K,OHSU_HNSCC_derm001,6,1.032,0.0411522633744856,Curcumin,OHSU_HNSCC_derm001
21211,10336,Blank 490,2,L,OHSU_HNSCC_derm001,6,0.808,0.0411522633744856,PF-562271,OHSU_HNSCC_derm001
21212,10336,Blank 490,2,M,OHSU_HNSCC_derm001,6,1.103,0.0411522633744856,STO609,OHSU_HNSCC_derm001
21213,10336,Blank 490,2,N,OHSU_HNSCC_derm001,6,1.08,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm001
21214,10336,Blank 490,2,O,OHSU_HNSCC_derm001,6,1.227,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm001
21215,10336,Blank 490,2,P,OHSU_HNSCC_derm001,6,1.008,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm001
21216,10336,Blank 490,2,A,OHSU_HNSCC_derm001,7,0.731,0.013717421124828532,Coumarin,OHSU_HNSCC_derm001
21217,10336,Blank 490,2,B,OHSU_HNSCC_derm001,7,0.679,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm001
21218,10336,Blank 490,2,C,OHSU_HNSCC_derm001,7,0.807,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm001
21219,10336,Blank 490,2,D,OHSU_HNSCC_derm001,7,0.886,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm001
21220,10336,Blank 490,2,E,OHSU_HNSCC_derm001,7,1.041,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm001
21221,10336,Blank 490,2,F,OHSU_HNSCC_derm001,7,0.842,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm001
21222,10336,Blank 490,2,G,OHSU_HNSCC_derm001,7,1.076,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm001
21223,10336,Blank 490,2,H,OHSU_HNSCC_derm001,7,1.002,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
21224,10336,Blank 490,2,I,OHSU_HNSCC_derm001,7,0.741,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
21225,10336,Blank 490,2,J,OHSU_HNSCC_derm001,7,0.844,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm001
21226,10336,Blank 490,2,K,OHSU_HNSCC_derm001,7,0.836,0.013717421124828532,Curcumin,OHSU_HNSCC_derm001
21227,10336,Blank 490,2,L,OHSU_HNSCC_derm001,7,0.767,0.013717421124828532,PF-562271,OHSU_HNSCC_derm001
21228,10336,Blank 490,2,M,OHSU_HNSCC_derm001,7,0.976,0.013717421124828532,STO609,OHSU_HNSCC_derm001
21229,10336,Blank 490,2,N,OHSU_HNSCC_derm001,7,1.031,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm001
21230,10336,Blank 490,2,O,OHSU_HNSCC_derm001,7,0.977,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm001
21231,10336,Blank 490,2,P,OHSU_HNSCC_derm001,7,1.094,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm001
21232,10336,Blank 490,2,A,OHSU_HNSCC_derm001,8,0.778,0,NONE,OHSU_HNSCC_derm001
21233,10336,Blank 490,2,B,OHSU_HNSCC_derm001,8,0.693,0,NONE,OHSU_HNSCC_derm001
21234,10336,Blank 490,2,C,OHSU_HNSCC_derm001,8,0.885,0,NONE,OHSU_HNSCC_derm001
21235,10336,Blank 490,2,D,OHSU_HNSCC_derm001,8,0.745,0,NONE,OHSU_HNSCC_derm001
21236,10336,Blank 490,2,E,OHSU_HNSCC_derm001,8,1.03,0,NONE,OHSU_HNSCC_derm001
21237,10336,Blank 490,2,F,OHSU_HNSCC_derm001,8,1.009,0,NONE,OHSU_HNSCC_derm001
21238,10336,Blank 490,2,G,OHSU_HNSCC_derm001,8,1.026,0,NONE,OHSU_HNSCC_derm001
21239,10336,Blank 490,2,H,OHSU_HNSCC_derm001,8,0.005,10,F-S-V,OHSU_HNSCC_derm001
21240,10336,Blank 490,2,I,OHSU_HNSCC_derm001,8,0.799,0,NONE,OHSU_HNSCC_derm001
21241,10336,Blank 490,2,J,OHSU_HNSCC_derm001,8,0.823,0,NONE,OHSU_HNSCC_derm001
21242,10336,Blank 490,2,K,OHSU_HNSCC_derm001,8,0.852,0,NONE,OHSU_HNSCC_derm001
21243,10336,Blank 490,2,L,OHSU_HNSCC_derm001,8,0.736,0,NONE,OHSU_HNSCC_derm001
21244,10336,Blank 490,2,M,OHSU_HNSCC_derm001,8,1.051,0,NONE,OHSU_HNSCC_derm001
21245,10336,Blank 490,2,N,OHSU_HNSCC_derm001,8,1.137,0,NONE,OHSU_HNSCC_derm001
21246,10336,Blank 490,2,O,OHSU_HNSCC_derm001,8,0.97,0,NONE,OHSU_HNSCC_derm001
21247,10336,Blank 490,2,P,OHSU_HNSCC_derm001,8,1.082,0,NONE,OHSU_HNSCC_derm001
21248,10336,Blank 490,2,A,OHSU_HNSCC_derm001,9,0.289,10,GDC-0941,OHSU_HNSCC_derm001
21249,10336,Blank 490,2,B,OHSU_HNSCC_derm001,9,0.734,10,Dovitinib,OHSU_HNSCC_derm001
21250,10336,Blank 490,2,C,OHSU_HNSCC_derm001,9,0.727,10,BI-2536,OHSU_HNSCC_derm001
21251,10336,Blank 490,2,D,OHSU_HNSCC_derm001,9,0.346,10,TP-0903 ,OHSU_HNSCC_derm001
21252,10336,Blank 490,2,E,OHSU_HNSCC_derm001,9,0.208,10,Belinostat,OHSU_HNSCC_derm001
21253,10336,Blank 490,2,F,OHSU_HNSCC_derm001,9,0.157,10,INK-128,OHSU_HNSCC_derm001
21254,10336,Blank 490,2,G,OHSU_HNSCC_derm001,9,0.991,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21255,10336,Blank 490,2,H,OHSU_HNSCC_derm001,9,0.949,10,Brigatinib,OHSU_HNSCC_derm001
21256,10336,Blank 490,2,I,OHSU_HNSCC_derm001,9,0.784,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21257,10336,Blank 490,2,J,OHSU_HNSCC_derm001,9,0.754,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21258,10336,Blank 490,2,K,OHSU_HNSCC_derm001,9,0.943,10,Pazopanib,OHSU_HNSCC_derm001
21259,10336,Blank 490,2,L,OHSU_HNSCC_derm001,9,0.842,10,AZD4547,OHSU_HNSCC_derm001
21260,10336,Blank 490,2,M,OHSU_HNSCC_derm001,9,1.041,10,Pomalidomide ,OHSU_HNSCC_derm001
21261,10336,Blank 490,2,N,OHSU_HNSCC_derm001,9,0.894,10,Idelasib (GS-1101),OHSU_HNSCC_derm001
21262,10336,Blank 490,2,O,OHSU_HNSCC_derm001,9,1.133,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21263,10336,Blank 490,2,P,OHSU_HNSCC_derm001,9,0.0,10,Staurosporin,OHSU_HNSCC_derm001
21264,10336,Blank 490,2,A,OHSU_HNSCC_derm001,10,0.188,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm001
21265,10336,Blank 490,2,B,OHSU_HNSCC_derm001,10,0.809,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm001
21266,10336,Blank 490,2,C,OHSU_HNSCC_derm001,10,0.913,3.3333333333333335,BI-2536,OHSU_HNSCC_derm001
21267,10336,Blank 490,2,D,OHSU_HNSCC_derm001,10,0.332,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm001
21268,10336,Blank 490,2,E,OHSU_HNSCC_derm001,10,0.494,3.3333333333333335,Belinostat,OHSU_HNSCC_derm001
21269,10336,Blank 490,2,F,OHSU_HNSCC_derm001,10,0.213,3.3333333333333335,INK-128,OHSU_HNSCC_derm001
21270,10336,Blank 490,2,G,OHSU_HNSCC_derm001,10,1.03,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21271,10336,Blank 490,2,H,OHSU_HNSCC_derm001,10,1.078,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
21272,10336,Blank 490,2,I,OHSU_HNSCC_derm001,10,0.938,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21273,10336,Blank 490,2,J,OHSU_HNSCC_derm001,10,0.938,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21274,10336,Blank 490,2,K,OHSU_HNSCC_derm001,10,0.848,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm001
21275,10336,Blank 490,2,L,OHSU_HNSCC_derm001,10,0.744,3.3333333333333335,AZD4547,OHSU_HNSCC_derm001
21276,10336,Blank 490,2,M,OHSU_HNSCC_derm001,10,1.047,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm001
21277,10336,Blank 490,2,N,OHSU_HNSCC_derm001,10,1.052,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm001
21278,10336,Blank 490,2,O,OHSU_HNSCC_derm001,10,1.048,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21279,10336,Blank 490,2,P,OHSU_HNSCC_derm001,10,-0.001,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm001
21280,10336,Blank 490,2,A,OHSU_HNSCC_derm001,11,0.668,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm001
21281,10336,Blank 490,2,B,OHSU_HNSCC_derm001,11,0.688,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm001
21282,10336,Blank 490,2,C,OHSU_HNSCC_derm001,11,0.882,1.1111111111111112,BI-2536,OHSU_HNSCC_derm001
21283,10336,Blank 490,2,D,OHSU_HNSCC_derm001,11,0.286,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm001
21284,10336,Blank 490,2,E,OHSU_HNSCC_derm001,11,0.861,1.1111111111111112,Belinostat,OHSU_HNSCC_derm001
21285,10336,Blank 490,2,F,OHSU_HNSCC_derm001,11,0.282,1.1111111111111112,INK-128,OHSU_HNSCC_derm001
21286,10336,Blank 490,2,G,OHSU_HNSCC_derm001,11,0.958,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21287,10336,Blank 490,2,H,OHSU_HNSCC_derm001,11,0.988,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
21288,10336,Blank 490,2,I,OHSU_HNSCC_derm001,11,0.945,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21289,10336,Blank 490,2,J,OHSU_HNSCC_derm001,11,0.858,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21290,10336,Blank 490,2,K,OHSU_HNSCC_derm001,11,0.933,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm001
21291,10336,Blank 490,2,L,OHSU_HNSCC_derm001,11,0.837,1.1111111111111112,AZD4547,OHSU_HNSCC_derm001
21292,10336,Blank 490,2,M,OHSU_HNSCC_derm001,11,0.956,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm001
21293,10336,Blank 490,2,N,OHSU_HNSCC_derm001,11,0.96,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm001
21294,10336,Blank 490,2,O,OHSU_HNSCC_derm001,11,0.992,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21295,10336,Blank 490,2,P,OHSU_HNSCC_derm001,11,0.009,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm001
21296,10336,Blank 490,2,A,OHSU_HNSCC_derm001,12,0.733,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm001
21297,10336,Blank 490,2,B,OHSU_HNSCC_derm001,12,0.661,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm001
21298,10336,Blank 490,2,C,OHSU_HNSCC_derm001,12,0.628,0.3703703703703704,BI-2536,OHSU_HNSCC_derm001
21299,10336,Blank 490,2,D,OHSU_HNSCC_derm001,12,0.829,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm001
21300,10336,Blank 490,2,E,OHSU_HNSCC_derm001,12,0.841,0.3703703703703704,Belinostat,OHSU_HNSCC_derm001
21301,10336,Blank 490,2,F,OHSU_HNSCC_derm001,12,0.45,0.3703703703703704,INK-128,OHSU_HNSCC_derm001
21302,10336,Blank 490,2,G,OHSU_HNSCC_derm001,12,1.164,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21303,10336,Blank 490,2,H,OHSU_HNSCC_derm001,12,0.924,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
21304,10336,Blank 490,2,I,OHSU_HNSCC_derm001,12,0.938,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21305,10336,Blank 490,2,J,OHSU_HNSCC_derm001,12,0.82,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21306,10336,Blank 490,2,K,OHSU_HNSCC_derm001,12,0.918,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm001
21307,10336,Blank 490,2,L,OHSU_HNSCC_derm001,12,0.85,0.3703703703703704,AZD4547,OHSU_HNSCC_derm001
21308,10336,Blank 490,2,M,OHSU_HNSCC_derm001,12,1.034,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm001
21309,10336,Blank 490,2,N,OHSU_HNSCC_derm001,12,0.917,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm001
21310,10336,Blank 490,2,O,OHSU_HNSCC_derm001,12,1.047,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21311,10336,Blank 490,2,P,OHSU_HNSCC_derm001,12,0.348,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm001
21312,10336,Blank 490,2,A,OHSU_HNSCC_derm001,13,0.776,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm001
21313,10336,Blank 490,2,B,OHSU_HNSCC_derm001,13,0.706,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm001
21314,10336,Blank 490,2,C,OHSU_HNSCC_derm001,13,0.558,0.1234567901234568,BI-2536,OHSU_HNSCC_derm001
21315,10336,Blank 490,2,D,OHSU_HNSCC_derm001,13,0.866,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm001
21316,10336,Blank 490,2,E,OHSU_HNSCC_derm001,13,1.084,0.1234567901234568,Belinostat,OHSU_HNSCC_derm001
21317,10336,Blank 490,2,F,OHSU_HNSCC_derm001,13,0.443,0.1234567901234568,INK-128,OHSU_HNSCC_derm001
21318,10336,Blank 490,2,G,OHSU_HNSCC_derm001,13,1.135,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21319,10336,Blank 490,2,H,OHSU_HNSCC_derm001,13,0.95,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
21320,10336,Blank 490,2,I,OHSU_HNSCC_derm001,13,0.899,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21321,10336,Blank 490,2,J,OHSU_HNSCC_derm001,13,0.948,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21322,10336,Blank 490,2,K,OHSU_HNSCC_derm001,13,0.876,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm001
21323,10336,Blank 490,2,L,OHSU_HNSCC_derm001,13,0.92,0.1234567901234568,AZD4547,OHSU_HNSCC_derm001
21324,10336,Blank 490,2,M,OHSU_HNSCC_derm001,13,1.132,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm001
21325,10336,Blank 490,2,N,OHSU_HNSCC_derm001,13,0.975,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm001
21326,10336,Blank 490,2,O,OHSU_HNSCC_derm001,13,1.084,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21327,10336,Blank 490,2,P,OHSU_HNSCC_derm001,13,0.981,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm001
21328,10336,Blank 490,2,A,OHSU_HNSCC_derm001,14,0.705,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm001
21329,10336,Blank 490,2,B,OHSU_HNSCC_derm001,14,0.738,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm001
21330,10336,Blank 490,2,C,OHSU_HNSCC_derm001,14,0.528,0.0411522633744856,BI-2536,OHSU_HNSCC_derm001
21331,10336,Blank 490,2,D,OHSU_HNSCC_derm001,14,0.925,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm001
21332,10336,Blank 490,2,E,OHSU_HNSCC_derm001,14,0.774,0.0411522633744856,Belinostat,OHSU_HNSCC_derm001
21333,10336,Blank 490,2,F,OHSU_HNSCC_derm001,14,0.691,0.0411522633744856,INK-128,OHSU_HNSCC_derm001
21334,10336,Blank 490,2,G,OHSU_HNSCC_derm001,14,1.038,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21335,10336,Blank 490,2,H,OHSU_HNSCC_derm001,14,0.909,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
21336,10336,Blank 490,2,I,OHSU_HNSCC_derm001,14,0.887,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21337,10336,Blank 490,2,J,OHSU_HNSCC_derm001,14,0.864,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21338,10336,Blank 490,2,K,OHSU_HNSCC_derm001,14,0.87,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm001
21339,10336,Blank 490,2,L,OHSU_HNSCC_derm001,14,0.886,0.0411522633744856,AZD4547,OHSU_HNSCC_derm001
21340,10336,Blank 490,2,M,OHSU_HNSCC_derm001,14,0.964,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm001
21341,10336,Blank 490,2,N,OHSU_HNSCC_derm001,14,0.852,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm001
21342,10336,Blank 490,2,O,OHSU_HNSCC_derm001,14,1.129,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21343,10336,Blank 490,2,P,OHSU_HNSCC_derm001,14,0.783,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm001
21344,10336,Blank 490,2,A,OHSU_HNSCC_derm001,15,0.76,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm001
21345,10336,Blank 490,2,B,OHSU_HNSCC_derm001,15,0.723,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm001
21346,10336,Blank 490,2,C,OHSU_HNSCC_derm001,15,0.798,0.013717421124828532,BI-2536,OHSU_HNSCC_derm001
21347,10336,Blank 490,2,D,OHSU_HNSCC_derm001,15,0.794,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm001
21348,10336,Blank 490,2,E,OHSU_HNSCC_derm001,15,1.034,0.013717421124828532,Belinostat,OHSU_HNSCC_derm001
21349,10336,Blank 490,2,F,OHSU_HNSCC_derm001,15,0.887,0.013717421124828532,INK-128,OHSU_HNSCC_derm001
21350,10336,Blank 490,2,G,OHSU_HNSCC_derm001,15,1.066,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm001
21351,10336,Blank 490,2,H,OHSU_HNSCC_derm001,15,0.998,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
21352,10336,Blank 490,2,I,OHSU_HNSCC_derm001,15,0.877,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21353,10336,Blank 490,2,J,OHSU_HNSCC_derm001,15,0.883,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm001
21354,10336,Blank 490,2,K,OHSU_HNSCC_derm001,15,0.792,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm001
21355,10336,Blank 490,2,L,OHSU_HNSCC_derm001,15,0.683,0.013717421124828532,AZD4547,OHSU_HNSCC_derm001
21356,10336,Blank 490,2,M,OHSU_HNSCC_derm001,15,1.079,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm001
21357,10336,Blank 490,2,N,OHSU_HNSCC_derm001,15,0.938,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm001
21358,10336,Blank 490,2,O,OHSU_HNSCC_derm001,15,0.931,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm001
21359,10336,Blank 490,2,P,OHSU_HNSCC_derm001,15,0.785,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm001
21360,10336,Blank 490,2,A,OHSU_HNSCC_derm001,16,0.741,0,NONE,OHSU_HNSCC_derm001
21361,10336,Blank 490,2,B,OHSU_HNSCC_derm001,16,0.769,0,NONE,OHSU_HNSCC_derm001
21362,10336,Blank 490,2,C,OHSU_HNSCC_derm001,16,0.857,0,NONE,OHSU_HNSCC_derm001
21363,10336,Blank 490,2,D,OHSU_HNSCC_derm001,16,0.856,0,NONE,OHSU_HNSCC_derm001
21364,10336,Blank 490,2,E,OHSU_HNSCC_derm001,16,1.107,0,NONE,OHSU_HNSCC_derm001
21365,10336,Blank 490,2,F,OHSU_HNSCC_derm001,16,0.73,0,NONE,OHSU_HNSCC_derm001
21366,10336,Blank 490,2,G,OHSU_HNSCC_derm001,16,1.055,0,NONE,OHSU_HNSCC_derm001
21367,10336,Blank 490,2,H,OHSU_HNSCC_derm001,16,-0.005,10,F-S-V,OHSU_HNSCC_derm001
21368,10336,Blank 490,2,I,OHSU_HNSCC_derm001,16,1.049,0,NONE,OHSU_HNSCC_derm001
21369,10336,Blank 490,2,J,OHSU_HNSCC_derm001,16,0.926,0,NONE,OHSU_HNSCC_derm001
21370,10336,Blank 490,2,K,OHSU_HNSCC_derm001,16,1.064,0,NONE,OHSU_HNSCC_derm001
21371,10336,Blank 490,2,L,OHSU_HNSCC_derm001,16,0.87,0,NONE,OHSU_HNSCC_derm001
21372,10336,Blank 490,2,M,OHSU_HNSCC_derm001,16,1.165,0,NONE,OHSU_HNSCC_derm001
21373,10336,Blank 490,2,N,OHSU_HNSCC_derm001,16,0.996,0,NONE,OHSU_HNSCC_derm001
21374,10336,Blank 490,2,O,OHSU_HNSCC_derm001,16,1.0,0,NONE,OHSU_HNSCC_derm001
21375,10336,Blank 490,2,P,OHSU_HNSCC_derm001,16,1.068,0,NONE,OHSU_HNSCC_derm001
21376,10336,Blank 490,2,A,OHSU_HNSCC_derm001,17,0.533,10,Tozasertib (VX-680),OHSU_HNSCC_derm001
21377,10336,Blank 490,2,B,OHSU_HNSCC_derm001,17,0.703,10,Hesperidin,OHSU_HNSCC_derm001
21378,10336,Blank 490,2,C,OHSU_HNSCC_derm001,17,0.806,10,Esculetin,OHSU_HNSCC_derm001
21379,10336,Blank 490,2,D,OHSU_HNSCC_derm001,17,0.43,10,Selinexor ,OHSU_HNSCC_derm001
21380,10336,Blank 490,2,E,OHSU_HNSCC_derm001,17,0.796,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21381,10336,Blank 490,2,F,OHSU_HNSCC_derm001,17,0.936,10,BMX-IN-1,OHSU_HNSCC_derm001
21382,10336,Blank 490,2,G,OHSU_HNSCC_derm001,17,1.03,1,Dasatinib (1mM),OHSU_HNSCC_derm001
21383,10336,Blank 490,2,H,OHSU_HNSCC_derm001,17,1.032,10,Trametinib,OHSU_HNSCC_derm001
21384,10336,Blank 490,2,I,OHSU_HNSCC_derm001,17,0.289,10,BEZ235,OHSU_HNSCC_derm001
21385,10336,Blank 490,2,J,OHSU_HNSCC_derm001,17,0.093,10,Bortezomib (Velcade),OHSU_HNSCC_derm001
21386,10336,Blank 490,2,K,OHSU_HNSCC_derm001,17,0.826,10,Nilotinib,OHSU_HNSCC_derm001
21387,10336,Blank 490,2,L,OHSU_HNSCC_derm001,17,0.821,10,Enzalutamide,OHSU_HNSCC_derm001
21388,10336,Blank 490,2,M,OHSU_HNSCC_derm001,17,1.1,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21389,10336,Blank 490,2,N,OHSU_HNSCC_derm001,17,0.918,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm001
21390,10336,Blank 490,2,O,OHSU_HNSCC_derm001,17,0.413,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21391,10336,Blank 490,2,P,OHSU_HNSCC_derm001,17,0.607,10,Axitinib,OHSU_HNSCC_derm001
21392,10336,Blank 490,2,A,OHSU_HNSCC_derm001,18,0.488,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm001
21393,10336,Blank 490,2,B,OHSU_HNSCC_derm001,18,0.709,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm001
21394,10336,Blank 490,2,C,OHSU_HNSCC_derm001,18,0.875,3.3333333333333335,Esculetin,OHSU_HNSCC_derm001
21395,10336,Blank 490,2,D,OHSU_HNSCC_derm001,18,0.421,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm001
21396,10336,Blank 490,2,E,OHSU_HNSCC_derm001,18,0.991,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21397,10336,Blank 490,2,F,OHSU_HNSCC_derm001,18,0.959,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm001
21398,10336,Blank 490,2,G,OHSU_HNSCC_derm001,18,1.015,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm001
21399,10336,Blank 490,2,H,OHSU_HNSCC_derm001,18,0.983,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
21400,10336,Blank 490,2,I,OHSU_HNSCC_derm001,18,0.29,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
21401,10336,Blank 490,2,J,OHSU_HNSCC_derm001,18,0.048,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm001
21402,10336,Blank 490,2,K,OHSU_HNSCC_derm001,18,0.8,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm001
21403,10336,Blank 490,2,L,OHSU_HNSCC_derm001,18,0.813,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm001
21404,10336,Blank 490,2,M,OHSU_HNSCC_derm001,18,1.081,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21405,10336,Blank 490,2,N,OHSU_HNSCC_derm001,18,1.009,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm001
21406,10336,Blank 490,2,O,OHSU_HNSCC_derm001,18,0.394,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21407,10336,Blank 490,2,P,OHSU_HNSCC_derm001,18,0.873,3.3333333333333335,Axitinib,OHSU_HNSCC_derm001
21408,10336,Blank 490,2,A,OHSU_HNSCC_derm001,19,0.468,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm001
21409,10336,Blank 490,2,B,OHSU_HNSCC_derm001,19,0.698,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm001
21410,10336,Blank 490,2,C,OHSU_HNSCC_derm001,19,0.841,1.1111111111111112,Esculetin,OHSU_HNSCC_derm001
21411,10336,Blank 490,2,D,OHSU_HNSCC_derm001,19,0.43,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm001
21412,10336,Blank 490,2,E,OHSU_HNSCC_derm001,19,1.091,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21413,10336,Blank 490,2,F,OHSU_HNSCC_derm001,19,0.969,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm001
21414,10336,Blank 490,2,G,OHSU_HNSCC_derm001,19,1.023,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm001
21415,10336,Blank 490,2,H,OHSU_HNSCC_derm001,19,1.134,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
21416,10336,Blank 490,2,I,OHSU_HNSCC_derm001,19,0.272,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
21417,10336,Blank 490,2,J,OHSU_HNSCC_derm001,19,0.101,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm001
21418,10336,Blank 490,2,K,OHSU_HNSCC_derm001,19,0.932,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm001
21419,10336,Blank 490,2,L,OHSU_HNSCC_derm001,19,0.827,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm001
21420,10336,Blank 490,2,M,OHSU_HNSCC_derm001,19,1.059,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21421,10336,Blank 490,2,N,OHSU_HNSCC_derm001,19,1.102,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm001
21422,10336,Blank 490,2,O,OHSU_HNSCC_derm001,19,0.382,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21423,10336,Blank 490,2,P,OHSU_HNSCC_derm001,19,1.089,1.1111111111111112,Axitinib,OHSU_HNSCC_derm001
21424,10336,Blank 490,2,A,OHSU_HNSCC_derm001,20,0.6,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm001
21425,10336,Blank 490,2,B,OHSU_HNSCC_derm001,20,0.741,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm001
21426,10336,Blank 490,2,C,OHSU_HNSCC_derm001,20,0.813,0.3703703703703704,Esculetin,OHSU_HNSCC_derm001
21427,10336,Blank 490,2,D,OHSU_HNSCC_derm001,20,0.611,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm001
21428,10336,Blank 490,2,E,OHSU_HNSCC_derm001,20,0.873,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21429,10336,Blank 490,2,F,OHSU_HNSCC_derm001,20,0.852,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm001
21430,10336,Blank 490,2,G,OHSU_HNSCC_derm001,20,1.095,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm001
21431,10336,Blank 490,2,H,OHSU_HNSCC_derm001,20,1.009,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
21432,10336,Blank 490,2,I,OHSU_HNSCC_derm001,20,0.315,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
21433,10336,Blank 490,2,J,OHSU_HNSCC_derm001,20,0.087,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm001
21434,10336,Blank 490,2,K,OHSU_HNSCC_derm001,20,0.878,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm001
21435,10336,Blank 490,2,L,OHSU_HNSCC_derm001,20,0.927,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm001
21436,10336,Blank 490,2,M,OHSU_HNSCC_derm001,20,1.115,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21437,10336,Blank 490,2,N,OHSU_HNSCC_derm001,20,1.274,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm001
21438,10336,Blank 490,2,O,OHSU_HNSCC_derm001,20,1.003,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21439,10336,Blank 490,2,P,OHSU_HNSCC_derm001,20,1.114,0.3703703703703704,Axitinib,OHSU_HNSCC_derm001
21440,10336,Blank 490,2,A,OHSU_HNSCC_derm001,21,0.656,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm001
21441,10336,Blank 490,2,B,OHSU_HNSCC_derm001,21,0.749,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm001
21442,10336,Blank 490,2,C,OHSU_HNSCC_derm001,21,0.752,0.1234567901234568,Esculetin,OHSU_HNSCC_derm001
21443,10336,Blank 490,2,D,OHSU_HNSCC_derm001,21,0.838,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm001
21444,10336,Blank 490,2,E,OHSU_HNSCC_derm001,21,1.05,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21445,10336,Blank 490,2,F,OHSU_HNSCC_derm001,21,0.937,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm001
21446,10336,Blank 490,2,G,OHSU_HNSCC_derm001,21,1.109,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm001
21447,10336,Blank 490,2,H,OHSU_HNSCC_derm001,21,0.994,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
21448,10336,Blank 490,2,I,OHSU_HNSCC_derm001,21,0.614,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
21449,10336,Blank 490,2,J,OHSU_HNSCC_derm001,21,0.118,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm001
21450,10336,Blank 490,2,K,OHSU_HNSCC_derm001,21,0.73,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm001
21451,10336,Blank 490,2,L,OHSU_HNSCC_derm001,21,0.782,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm001
21452,10336,Blank 490,2,M,OHSU_HNSCC_derm001,21,1.139,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21453,10336,Blank 490,2,N,OHSU_HNSCC_derm001,21,1.272,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm001
21454,10336,Blank 490,2,O,OHSU_HNSCC_derm001,21,1.061,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21455,10336,Blank 490,2,P,OHSU_HNSCC_derm001,21,1.124,0.1234567901234568,Axitinib,OHSU_HNSCC_derm001
21456,10336,Blank 490,2,A,OHSU_HNSCC_derm001,22,0.703,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm001
21457,10336,Blank 490,2,B,OHSU_HNSCC_derm001,22,0.713,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm001
21458,10336,Blank 490,2,C,OHSU_HNSCC_derm001,22,0.822,0.0411522633744856,Esculetin,OHSU_HNSCC_derm001
21459,10336,Blank 490,2,D,OHSU_HNSCC_derm001,22,0.898,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm001
21460,10336,Blank 490,2,E,OHSU_HNSCC_derm001,22,1.007,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21461,10336,Blank 490,2,F,OHSU_HNSCC_derm001,22,1.064,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm001
21462,10336,Blank 490,2,G,OHSU_HNSCC_derm001,22,1.093,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm001
21463,10336,Blank 490,2,H,OHSU_HNSCC_derm001,22,1.014,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
21464,10336,Blank 490,2,I,OHSU_HNSCC_derm001,22,0.825,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
21465,10336,Blank 490,2,J,OHSU_HNSCC_derm001,22,0.215,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm001
21466,10336,Blank 490,2,K,OHSU_HNSCC_derm001,22,0.879,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm001
21467,10336,Blank 490,2,L,OHSU_HNSCC_derm001,22,0.778,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm001
21468,10336,Blank 490,2,M,OHSU_HNSCC_derm001,22,1.135,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21469,10336,Blank 490,2,N,OHSU_HNSCC_derm001,22,1.147,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm001
21470,10336,Blank 490,2,O,OHSU_HNSCC_derm001,22,1.04,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21471,10336,Blank 490,2,P,OHSU_HNSCC_derm001,22,1.157,0.0411522633744856,Axitinib,OHSU_HNSCC_derm001
21472,10336,Blank 490,2,A,OHSU_HNSCC_derm001,23,0.667,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm001
21473,10336,Blank 490,2,B,OHSU_HNSCC_derm001,23,0.733,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm001
21474,10336,Blank 490,2,C,OHSU_HNSCC_derm001,23,0.828,0.013717421124828532,Esculetin,OHSU_HNSCC_derm001
21475,10336,Blank 490,2,D,OHSU_HNSCC_derm001,23,0.883,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm001
21476,10336,Blank 490,2,E,OHSU_HNSCC_derm001,23,0.924,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm001
21477,10336,Blank 490,2,F,OHSU_HNSCC_derm001,23,1.053,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm001
21478,10336,Blank 490,2,G,OHSU_HNSCC_derm001,23,1.047,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm001
21479,10336,Blank 490,2,H,OHSU_HNSCC_derm001,23,0.972,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
21480,10336,Blank 490,2,I,OHSU_HNSCC_derm001,23,0.861,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
21481,10336,Blank 490,2,J,OHSU_HNSCC_derm001,23,0.706,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm001
21482,10336,Blank 490,2,K,OHSU_HNSCC_derm001,23,0.848,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm001
21483,10336,Blank 490,2,L,OHSU_HNSCC_derm001,23,0.786,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm001
21484,10336,Blank 490,2,M,OHSU_HNSCC_derm001,23,1.112,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm001
21485,10336,Blank 490,2,N,OHSU_HNSCC_derm001,23,1.226,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm001
21486,10336,Blank 490,2,O,OHSU_HNSCC_derm001,23,1.006,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm001
21487,10336,Blank 490,2,P,OHSU_HNSCC_derm001,23,1.087,0.013717421124828532,Axitinib,OHSU_HNSCC_derm001
21488,10336,Blank 490,2,A,OHSU_HNSCC_derm001,24,0.854,0,NONE,OHSU_HNSCC_derm001
21489,10336,Blank 490,2,B,OHSU_HNSCC_derm001,24,0.708,0,NONE,OHSU_HNSCC_derm001
21490,10336,Blank 490,2,C,OHSU_HNSCC_derm001,24,0.854,0,NONE,OHSU_HNSCC_derm001
21491,10336,Blank 490,2,D,OHSU_HNSCC_derm001,24,0.869,0,NONE,OHSU_HNSCC_derm001
21492,10336,Blank 490,2,E,OHSU_HNSCC_derm001,24,0.974,0,NONE,OHSU_HNSCC_derm001
21493,10336,Blank 490,2,F,OHSU_HNSCC_derm001,24,1.049,0,NONE,OHSU_HNSCC_derm001
21494,10336,Blank 490,2,G,OHSU_HNSCC_derm001,24,0.962,0,NONE,OHSU_HNSCC_derm001
21495,10336,Blank 490,2,H,OHSU_HNSCC_derm001,24,1.011,0,NONE,OHSU_HNSCC_derm001
21496,10336,Blank 490,2,I,OHSU_HNSCC_derm001,24,0.963,0,NONE,OHSU_HNSCC_derm001
21497,10336,Blank 490,2,J,OHSU_HNSCC_derm001,24,1.01,0,NONE,OHSU_HNSCC_derm001
21498,10336,Blank 490,2,K,OHSU_HNSCC_derm001,24,0.984,0,NONE,OHSU_HNSCC_derm001
21499,10336,Blank 490,2,L,OHSU_HNSCC_derm001,24,0.872,0,NONE,OHSU_HNSCC_derm001
21500,10336,Blank 490,2,M,OHSU_HNSCC_derm001,24,1.052,0,NONE,OHSU_HNSCC_derm001
21501,10336,Blank 490,2,N,OHSU_HNSCC_derm001,24,1.077,0,NONE,OHSU_HNSCC_derm001
21502,10336,Blank 490,2,O,OHSU_HNSCC_derm001,24,1.043,0,NONE,OHSU_HNSCC_derm001
21503,10336,Blank 490,2,P,OHSU_HNSCC_derm001,24,1.059,0,NONE,OHSU_HNSCC_derm001
21504,10336,Blank 490,3,A,OHSU_HNSCC_derm001,1,0.882,10,Thalidomide ,OHSU_HNSCC_derm001
21505,10336,Blank 490,3,B,OHSU_HNSCC_derm001,1,0.976,10,Vandetanib,OHSU_HNSCC_derm001
21506,10336,Blank 490,3,C,OHSU_HNSCC_derm001,1,0.863,10,Oleic acid,OHSU_HNSCC_derm001
21507,10336,Blank 490,3,D,OHSU_HNSCC_derm001,1,0.125,10,A-674563,OHSU_HNSCC_derm001
21508,10336,Blank 490,3,E,OHSU_HNSCC_derm001,1,0.871,10,Lapatinib,OHSU_HNSCC_derm001
21509,10336,Blank 490,3,F,OHSU_HNSCC_derm001,1,1.016,10,Apocynin (vanillin),OHSU_HNSCC_derm001
21510,10336,Blank 490,3,G,OHSU_HNSCC_derm001,1,0.239,10,AT-7519,OHSU_HNSCC_derm001
21511,10336,Blank 490,3,H,OHSU_HNSCC_derm001,1,1.0,10,Gefitinib,OHSU_HNSCC_derm001
21512,10336,Blank 490,3,I,OHSU_HNSCC_derm001,1,0.893,10,Ceritinib (LDK378),OHSU_HNSCC_derm001
21513,10336,Blank 490,3,J,OHSU_HNSCC_derm001,1,0.444,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21514,10336,Blank 490,3,K,OHSU_HNSCC_derm001,1,0.731,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21515,10336,Blank 490,3,L,OHSU_HNSCC_derm001,1,0.794,10,JQ1,OHSU_HNSCC_derm001
21516,10336,Blank 490,3,M,OHSU_HNSCC_derm001,1,1.188,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21517,10336,Blank 490,3,N,OHSU_HNSCC_derm001,1,0.953,10,Cerdulatinib,OHSU_HNSCC_derm001
21518,10336,Blank 490,3,O,OHSU_HNSCC_derm001,1,-0.003,10,Romidepsin,OHSU_HNSCC_derm001
21519,10336,Blank 490,3,P,OHSU_HNSCC_derm001,1,1.04,10,Gilteritinib,OHSU_HNSCC_derm001
21520,10336,Blank 490,3,A,OHSU_HNSCC_derm001,2,0.933,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm001
21521,10336,Blank 490,3,B,OHSU_HNSCC_derm001,2,0.727,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm001
21522,10336,Blank 490,3,C,OHSU_HNSCC_derm001,2,0.819,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm001
21523,10336,Blank 490,3,D,OHSU_HNSCC_derm001,2,0.609,3.3333333333333335,A-674563,OHSU_HNSCC_derm001
21524,10336,Blank 490,3,E,OHSU_HNSCC_derm001,2,0.883,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm001
21525,10336,Blank 490,3,F,OHSU_HNSCC_derm001,2,0.907,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm001
21526,10336,Blank 490,3,G,OHSU_HNSCC_derm001,2,0.305,3.3333333333333335,AT-7519,OHSU_HNSCC_derm001
21527,10336,Blank 490,3,H,OHSU_HNSCC_derm001,2,0.918,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm001
21528,10336,Blank 490,3,I,OHSU_HNSCC_derm001,2,0.882,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm001
21529,10336,Blank 490,3,J,OHSU_HNSCC_derm001,2,0.769,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21530,10336,Blank 490,3,K,OHSU_HNSCC_derm001,2,1.017,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21531,10336,Blank 490,3,L,OHSU_HNSCC_derm001,2,0.809,3.3333333333333335,JQ1,OHSU_HNSCC_derm001
21532,10336,Blank 490,3,M,OHSU_HNSCC_derm001,2,1.194,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21533,10336,Blank 490,3,N,OHSU_HNSCC_derm001,2,0.967,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm001
21534,10336,Blank 490,3,O,OHSU_HNSCC_derm001,2,0.0,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm001
21535,10336,Blank 490,3,P,OHSU_HNSCC_derm001,2,1.05,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm001
21536,10336,Blank 490,3,A,OHSU_HNSCC_derm001,3,0.905,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm001
21537,10336,Blank 490,3,B,OHSU_HNSCC_derm001,3,0.672,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm001
21538,10336,Blank 490,3,C,OHSU_HNSCC_derm001,3,0.906,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm001
21539,10336,Blank 490,3,D,OHSU_HNSCC_derm001,3,0.843,1.1111111111111112,A-674563,OHSU_HNSCC_derm001
21540,10336,Blank 490,3,E,OHSU_HNSCC_derm001,3,0.978,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm001
21541,10336,Blank 490,3,F,OHSU_HNSCC_derm001,3,0.839,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm001
21542,10336,Blank 490,3,G,OHSU_HNSCC_derm001,3,0.412,1.1111111111111112,AT-7519,OHSU_HNSCC_derm001
21543,10336,Blank 490,3,H,OHSU_HNSCC_derm001,3,0.928,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm001
21544,10336,Blank 490,3,I,OHSU_HNSCC_derm001,3,0.868,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm001
21545,10336,Blank 490,3,J,OHSU_HNSCC_derm001,3,0.812,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21546,10336,Blank 490,3,K,OHSU_HNSCC_derm001,3,0.903,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21547,10336,Blank 490,3,L,OHSU_HNSCC_derm001,3,0.926,1.1111111111111112,JQ1,OHSU_HNSCC_derm001
21548,10336,Blank 490,3,M,OHSU_HNSCC_derm001,3,1.235,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21549,10336,Blank 490,3,N,OHSU_HNSCC_derm001,3,1.092,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm001
21550,10336,Blank 490,3,O,OHSU_HNSCC_derm001,3,0.005,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm001
21551,10336,Blank 490,3,P,OHSU_HNSCC_derm001,3,1.008,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm001
21552,10336,Blank 490,3,A,OHSU_HNSCC_derm001,4,0.946,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm001
21553,10336,Blank 490,3,B,OHSU_HNSCC_derm001,4,0.69,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm001
21554,10336,Blank 490,3,C,OHSU_HNSCC_derm001,4,0.897,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm001
21555,10336,Blank 490,3,D,OHSU_HNSCC_derm001,4,0.836,0.3703703703703704,A-674563,OHSU_HNSCC_derm001
21556,10336,Blank 490,3,E,OHSU_HNSCC_derm001,4,0.887,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm001
21557,10336,Blank 490,3,F,OHSU_HNSCC_derm001,4,0.899,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm001
21558,10336,Blank 490,3,G,OHSU_HNSCC_derm001,4,0.986,0.3703703703703704,AT-7519,OHSU_HNSCC_derm001
21559,10336,Blank 490,3,H,OHSU_HNSCC_derm001,4,0.909,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm001
21560,10336,Blank 490,3,I,OHSU_HNSCC_derm001,4,0.939,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm001
21561,10336,Blank 490,3,J,OHSU_HNSCC_derm001,4,0.849,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21562,10336,Blank 490,3,K,OHSU_HNSCC_derm001,4,0.992,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21563,10336,Blank 490,3,L,OHSU_HNSCC_derm001,4,1.012,0.3703703703703704,JQ1,OHSU_HNSCC_derm001
21564,10336,Blank 490,3,M,OHSU_HNSCC_derm001,4,1.053,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21565,10336,Blank 490,3,N,OHSU_HNSCC_derm001,4,1.007,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm001
21566,10336,Blank 490,3,O,OHSU_HNSCC_derm001,4,0.069,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm001
21567,10336,Blank 490,3,P,OHSU_HNSCC_derm001,4,1.049,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm001
21568,10336,Blank 490,3,A,OHSU_HNSCC_derm001,5,0.888,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm001
21569,10336,Blank 490,3,B,OHSU_HNSCC_derm001,5,0.655,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm001
21570,10336,Blank 490,3,C,OHSU_HNSCC_derm001,5,0.956,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm001
21571,10336,Blank 490,3,D,OHSU_HNSCC_derm001,5,0.766,0.1234567901234568,A-674563,OHSU_HNSCC_derm001
21572,10336,Blank 490,3,E,OHSU_HNSCC_derm001,5,0.97,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm001
21573,10336,Blank 490,3,F,OHSU_HNSCC_derm001,5,0.88,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm001
21574,10336,Blank 490,3,G,OHSU_HNSCC_derm001,5,0.905,0.1234567901234568,AT-7519,OHSU_HNSCC_derm001
21575,10336,Blank 490,3,H,OHSU_HNSCC_derm001,5,0.919,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm001
21576,10336,Blank 490,3,I,OHSU_HNSCC_derm001,5,1.03,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm001
21577,10336,Blank 490,3,J,OHSU_HNSCC_derm001,5,0.728,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21578,10336,Blank 490,3,K,OHSU_HNSCC_derm001,5,0.912,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21579,10336,Blank 490,3,L,OHSU_HNSCC_derm001,5,1.005,0.1234567901234568,JQ1,OHSU_HNSCC_derm001
21580,10336,Blank 490,3,M,OHSU_HNSCC_derm001,5,1.184,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21581,10336,Blank 490,3,N,OHSU_HNSCC_derm001,5,0.947,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm001
21582,10336,Blank 490,3,O,OHSU_HNSCC_derm001,5,0.132,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm001
21583,10336,Blank 490,3,P,OHSU_HNSCC_derm001,5,1.001,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm001
21584,10336,Blank 490,3,A,OHSU_HNSCC_derm001,6,0.941,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm001
21585,10336,Blank 490,3,B,OHSU_HNSCC_derm001,6,0.757,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm001
21586,10336,Blank 490,3,C,OHSU_HNSCC_derm001,6,0.88,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm001
21587,10336,Blank 490,3,D,OHSU_HNSCC_derm001,6,0.793,0.0411522633744856,A-674563,OHSU_HNSCC_derm001
21588,10336,Blank 490,3,E,OHSU_HNSCC_derm001,6,0.968,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm001
21589,10336,Blank 490,3,F,OHSU_HNSCC_derm001,6,0.928,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm001
21590,10336,Blank 490,3,G,OHSU_HNSCC_derm001,6,1.004,0.0411522633744856,AT-7519,OHSU_HNSCC_derm001
21591,10336,Blank 490,3,H,OHSU_HNSCC_derm001,6,0.907,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm001
21592,10336,Blank 490,3,I,OHSU_HNSCC_derm001,6,1.026,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm001
21593,10336,Blank 490,3,J,OHSU_HNSCC_derm001,6,0.921,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21594,10336,Blank 490,3,K,OHSU_HNSCC_derm001,6,0.921,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21595,10336,Blank 490,3,L,OHSU_HNSCC_derm001,6,0.865,0.0411522633744856,JQ1,OHSU_HNSCC_derm001
21596,10336,Blank 490,3,M,OHSU_HNSCC_derm001,6,1.148,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21597,10336,Blank 490,3,N,OHSU_HNSCC_derm001,6,0.926,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm001
21598,10336,Blank 490,3,O,OHSU_HNSCC_derm001,6,0.122,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm001
21599,10336,Blank 490,3,P,OHSU_HNSCC_derm001,6,1.078,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm001
21600,10336,Blank 490,3,A,OHSU_HNSCC_derm001,7,0.872,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm001
21601,10336,Blank 490,3,B,OHSU_HNSCC_derm001,7,0.738,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm001
21602,10336,Blank 490,3,C,OHSU_HNSCC_derm001,7,0.902,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm001
21603,10336,Blank 490,3,D,OHSU_HNSCC_derm001,7,0.861,0.013717421124828532,A-674563,OHSU_HNSCC_derm001
21604,10336,Blank 490,3,E,OHSU_HNSCC_derm001,7,0.843,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm001
21605,10336,Blank 490,3,F,OHSU_HNSCC_derm001,7,0.974,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm001
21606,10336,Blank 490,3,G,OHSU_HNSCC_derm001,7,1.05,0.013717421124828532,AT-7519,OHSU_HNSCC_derm001
21607,10336,Blank 490,3,H,OHSU_HNSCC_derm001,7,0.966,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm001
21608,10336,Blank 490,3,I,OHSU_HNSCC_derm001,7,1.002,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm001
21609,10336,Blank 490,3,J,OHSU_HNSCC_derm001,7,0.845,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm001
21610,10336,Blank 490,3,K,OHSU_HNSCC_derm001,7,0.78,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm001
21611,10336,Blank 490,3,L,OHSU_HNSCC_derm001,7,0.827,0.013717421124828532,JQ1,OHSU_HNSCC_derm001
21612,10336,Blank 490,3,M,OHSU_HNSCC_derm001,7,1.095,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm001
21613,10336,Blank 490,3,N,OHSU_HNSCC_derm001,7,1.028,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm001
21614,10336,Blank 490,3,O,OHSU_HNSCC_derm001,7,0.124,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm001
21615,10336,Blank 490,3,P,OHSU_HNSCC_derm001,7,1.051,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm001
21616,10336,Blank 490,3,A,OHSU_HNSCC_derm001,8,0.931,0,NONE,OHSU_HNSCC_derm001
21617,10336,Blank 490,3,B,OHSU_HNSCC_derm001,8,0.718,0,NONE,OHSU_HNSCC_derm001
21618,10336,Blank 490,3,C,OHSU_HNSCC_derm001,8,0.855,0,NONE,OHSU_HNSCC_derm001
21619,10336,Blank 490,3,D,OHSU_HNSCC_derm001,8,0.861,0,NONE,OHSU_HNSCC_derm001
21620,10336,Blank 490,3,E,OHSU_HNSCC_derm001,8,0.928,0,NONE,OHSU_HNSCC_derm001
21621,10336,Blank 490,3,F,OHSU_HNSCC_derm001,8,0.86,0,NONE,OHSU_HNSCC_derm001
21622,10336,Blank 490,3,G,OHSU_HNSCC_derm001,8,1.089,0,NONE,OHSU_HNSCC_derm001
21623,10336,Blank 490,3,H,OHSU_HNSCC_derm001,8,0.0,10,F-S-V,OHSU_HNSCC_derm001
21624,10336,Blank 490,3,I,OHSU_HNSCC_derm001,8,1.105,0,NONE,OHSU_HNSCC_derm001
21625,10336,Blank 490,3,J,OHSU_HNSCC_derm001,8,0.744,0,NONE,OHSU_HNSCC_derm001
21626,10336,Blank 490,3,K,OHSU_HNSCC_derm001,8,0.888,0,NONE,OHSU_HNSCC_derm001
21627,10336,Blank 490,3,L,OHSU_HNSCC_derm001,8,0.749,0,NONE,OHSU_HNSCC_derm001
21628,10336,Blank 490,3,M,OHSU_HNSCC_derm001,8,1.038,0,NONE,OHSU_HNSCC_derm001
21629,10336,Blank 490,3,N,OHSU_HNSCC_derm001,8,0.995,0,NONE,OHSU_HNSCC_derm001
21630,10336,Blank 490,3,O,OHSU_HNSCC_derm001,8,1.087,0,NONE,OHSU_HNSCC_derm001
21631,10336,Blank 490,3,P,OHSU_HNSCC_derm001,8,1.101,0,NONE,OHSU_HNSCC_derm001
21632,10336,Blank 490,3,A,OHSU_HNSCC_derm001,9,0.841,10,Anastrazole,OHSU_HNSCC_derm001
21633,10336,Blank 490,3,B,OHSU_HNSCC_derm001,9,0.612,10,JNJ-28312141 ,OHSU_HNSCC_derm001
21634,10336,Blank 490,3,C,OHSU_HNSCC_derm001,9,0.9,10,Genistein,OHSU_HNSCC_derm001
21635,10336,Blank 490,3,D,OHSU_HNSCC_derm001,9,0.806,10,Abscisic acid,OHSU_HNSCC_derm001
21636,10336,Blank 490,3,E,OHSU_HNSCC_derm001,9,0.608,10,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21637,10336,Blank 490,3,F,OHSU_HNSCC_derm001,9,0.956,10,Ruxolitinib,OHSU_HNSCC_derm001
21638,10336,Blank 490,3,G,OHSU_HNSCC_derm001,9,1.033,10,TAK-659,OHSU_HNSCC_derm001
21639,10336,Blank 490,3,H,OHSU_HNSCC_derm001,9,0.936,10,Brigatinib,OHSU_HNSCC_derm001
21640,10336,Blank 490,3,I,OHSU_HNSCC_derm001,9,0.812,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21641,10336,Blank 490,3,J,OHSU_HNSCC_derm001,9,0.52,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21642,10336,Blank 490,3,K,OHSU_HNSCC_derm001,9,0.581,10,Vorinostat,OHSU_HNSCC_derm001
21643,10336,Blank 490,3,L,OHSU_HNSCC_derm001,9,0.741,10,Lenalidomide,OHSU_HNSCC_derm001
21644,10336,Blank 490,3,M,OHSU_HNSCC_derm001,9,1.061,10,NVP-ADW742,OHSU_HNSCC_derm001
21645,10336,Blank 490,3,N,OHSU_HNSCC_derm001,9,1.008,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21646,10336,Blank 490,3,O,OHSU_HNSCC_derm001,9,0.982,10,Echinatin,OHSU_HNSCC_derm001
21647,10336,Blank 490,3,P,OHSU_HNSCC_derm001,9,-0.012,10,YM-155,OHSU_HNSCC_derm001
21648,10336,Blank 490,3,A,OHSU_HNSCC_derm001,10,0.847,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm001
21649,10336,Blank 490,3,B,OHSU_HNSCC_derm001,10,0.819,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm001
21650,10336,Blank 490,3,C,OHSU_HNSCC_derm001,10,0.888,3.3333333333333335,Genistein,OHSU_HNSCC_derm001
21651,10336,Blank 490,3,D,OHSU_HNSCC_derm001,10,0.797,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm001
21652,10336,Blank 490,3,E,OHSU_HNSCC_derm001,10,0.616,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21653,10336,Blank 490,3,F,OHSU_HNSCC_derm001,10,0.994,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm001
21654,10336,Blank 490,3,G,OHSU_HNSCC_derm001,10,1.048,3.3333333333333335,TAK-659,OHSU_HNSCC_derm001
21655,10336,Blank 490,3,H,OHSU_HNSCC_derm001,10,1.008,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm001
21656,10336,Blank 490,3,I,OHSU_HNSCC_derm001,10,0.927,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21657,10336,Blank 490,3,J,OHSU_HNSCC_derm001,10,1.003,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21658,10336,Blank 490,3,K,OHSU_HNSCC_derm001,10,0.897,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm001
21659,10336,Blank 490,3,L,OHSU_HNSCC_derm001,10,0.879,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm001
21660,10336,Blank 490,3,M,OHSU_HNSCC_derm001,10,1.021,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm001
21661,10336,Blank 490,3,N,OHSU_HNSCC_derm001,10,1.107,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21662,10336,Blank 490,3,O,OHSU_HNSCC_derm001,10,1.049,3.3333333333333335,Echinatin,OHSU_HNSCC_derm001
21663,10336,Blank 490,3,P,OHSU_HNSCC_derm001,10,-0.009,3.3333333333333335,YM-155,OHSU_HNSCC_derm001
21664,10336,Blank 490,3,A,OHSU_HNSCC_derm001,11,0.827,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm001
21665,10336,Blank 490,3,B,OHSU_HNSCC_derm001,11,0.704,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm001
21666,10336,Blank 490,3,C,OHSU_HNSCC_derm001,11,0.775,1.1111111111111112,Genistein,OHSU_HNSCC_derm001
21667,10336,Blank 490,3,D,OHSU_HNSCC_derm001,11,0.818,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm001
21668,10336,Blank 490,3,E,OHSU_HNSCC_derm001,11,0.677,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21669,10336,Blank 490,3,F,OHSU_HNSCC_derm001,11,0.968,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm001
21670,10336,Blank 490,3,G,OHSU_HNSCC_derm001,11,1.079,1.1111111111111112,TAK-659,OHSU_HNSCC_derm001
21671,10336,Blank 490,3,H,OHSU_HNSCC_derm001,11,1.032,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm001
21672,10336,Blank 490,3,I,OHSU_HNSCC_derm001,11,0.916,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21673,10336,Blank 490,3,J,OHSU_HNSCC_derm001,11,0.807,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21674,10336,Blank 490,3,K,OHSU_HNSCC_derm001,11,0.907,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm001
21675,10336,Blank 490,3,L,OHSU_HNSCC_derm001,11,0.828,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm001
21676,10336,Blank 490,3,M,OHSU_HNSCC_derm001,11,1.069,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm001
21677,10336,Blank 490,3,N,OHSU_HNSCC_derm001,11,1.001,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21678,10336,Blank 490,3,O,OHSU_HNSCC_derm001,11,0.922,1.1111111111111112,Echinatin,OHSU_HNSCC_derm001
21679,10336,Blank 490,3,P,OHSU_HNSCC_derm001,11,0.002,1.1111111111111112,YM-155,OHSU_HNSCC_derm001
21680,10336,Blank 490,3,A,OHSU_HNSCC_derm001,12,0.841,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm001
21681,10336,Blank 490,3,B,OHSU_HNSCC_derm001,12,0.701,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm001
21682,10336,Blank 490,3,C,OHSU_HNSCC_derm001,12,0.826,0.3703703703703704,Genistein,OHSU_HNSCC_derm001
21683,10336,Blank 490,3,D,OHSU_HNSCC_derm001,12,0.822,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm001
21684,10336,Blank 490,3,E,OHSU_HNSCC_derm001,12,0.699,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21685,10336,Blank 490,3,F,OHSU_HNSCC_derm001,12,0.918,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm001
21686,10336,Blank 490,3,G,OHSU_HNSCC_derm001,12,1.082,0.3703703703703704,TAK-659,OHSU_HNSCC_derm001
21687,10336,Blank 490,3,H,OHSU_HNSCC_derm001,12,0.984,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm001
21688,10336,Blank 490,3,I,OHSU_HNSCC_derm001,12,1.073,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21689,10336,Blank 490,3,J,OHSU_HNSCC_derm001,12,0.726,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21690,10336,Blank 490,3,K,OHSU_HNSCC_derm001,12,0.922,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm001
21691,10336,Blank 490,3,L,OHSU_HNSCC_derm001,12,0.781,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm001
21692,10336,Blank 490,3,M,OHSU_HNSCC_derm001,12,0.975,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm001
21693,10336,Blank 490,3,N,OHSU_HNSCC_derm001,12,0.974,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21694,10336,Blank 490,3,O,OHSU_HNSCC_derm001,12,0.992,0.3703703703703704,Echinatin,OHSU_HNSCC_derm001
21695,10336,Blank 490,3,P,OHSU_HNSCC_derm001,12,0.017,0.3703703703703704,YM-155,OHSU_HNSCC_derm001
21696,10336,Blank 490,3,A,OHSU_HNSCC_derm001,13,0.864,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm001
21697,10336,Blank 490,3,B,OHSU_HNSCC_derm001,13,0.711,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm001
21698,10336,Blank 490,3,C,OHSU_HNSCC_derm001,13,0.785,0.1234567901234568,Genistein,OHSU_HNSCC_derm001
21699,10336,Blank 490,3,D,OHSU_HNSCC_derm001,13,0.837,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm001
21700,10336,Blank 490,3,E,OHSU_HNSCC_derm001,13,0.776,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21701,10336,Blank 490,3,F,OHSU_HNSCC_derm001,13,1.032,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm001
21702,10336,Blank 490,3,G,OHSU_HNSCC_derm001,13,1.118,0.1234567901234568,TAK-659,OHSU_HNSCC_derm001
21703,10336,Blank 490,3,H,OHSU_HNSCC_derm001,13,0.939,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm001
21704,10336,Blank 490,3,I,OHSU_HNSCC_derm001,13,1.062,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21705,10336,Blank 490,3,J,OHSU_HNSCC_derm001,13,0.959,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21706,10336,Blank 490,3,K,OHSU_HNSCC_derm001,13,0.875,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm001
21707,10336,Blank 490,3,L,OHSU_HNSCC_derm001,13,0.804,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm001
21708,10336,Blank 490,3,M,OHSU_HNSCC_derm001,13,1.055,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm001
21709,10336,Blank 490,3,N,OHSU_HNSCC_derm001,13,1.001,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21710,10336,Blank 490,3,O,OHSU_HNSCC_derm001,13,0.898,0.1234567901234568,Echinatin,OHSU_HNSCC_derm001
21711,10336,Blank 490,3,P,OHSU_HNSCC_derm001,13,0.034,0.1234567901234568,YM-155,OHSU_HNSCC_derm001
21712,10336,Blank 490,3,A,OHSU_HNSCC_derm001,14,0.881,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm001
21713,10336,Blank 490,3,B,OHSU_HNSCC_derm001,14,0.693,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm001
21714,10336,Blank 490,3,C,OHSU_HNSCC_derm001,14,0.765,0.0411522633744856,Genistein,OHSU_HNSCC_derm001
21715,10336,Blank 490,3,D,OHSU_HNSCC_derm001,14,0.83,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm001
21716,10336,Blank 490,3,E,OHSU_HNSCC_derm001,14,1.014,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21717,10336,Blank 490,3,F,OHSU_HNSCC_derm001,14,0.975,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm001
21718,10336,Blank 490,3,G,OHSU_HNSCC_derm001,14,1.077,0.0411522633744856,TAK-659,OHSU_HNSCC_derm001
21719,10336,Blank 490,3,H,OHSU_HNSCC_derm001,14,0.966,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm001
21720,10336,Blank 490,3,I,OHSU_HNSCC_derm001,14,1.069,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21721,10336,Blank 490,3,J,OHSU_HNSCC_derm001,14,0.888,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21722,10336,Blank 490,3,K,OHSU_HNSCC_derm001,14,0.931,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm001
21723,10336,Blank 490,3,L,OHSU_HNSCC_derm001,14,0.818,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm001
21724,10336,Blank 490,3,M,OHSU_HNSCC_derm001,14,1.042,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm001
21725,10336,Blank 490,3,N,OHSU_HNSCC_derm001,14,0.993,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21726,10336,Blank 490,3,O,OHSU_HNSCC_derm001,14,0.933,0.0411522633744856,Echinatin,OHSU_HNSCC_derm001
21727,10336,Blank 490,3,P,OHSU_HNSCC_derm001,14,0.09,0.0411522633744856,YM-155,OHSU_HNSCC_derm001
21728,10336,Blank 490,3,A,OHSU_HNSCC_derm001,15,0.811,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm001
21729,10336,Blank 490,3,B,OHSU_HNSCC_derm001,15,0.699,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm001
21730,10336,Blank 490,3,C,OHSU_HNSCC_derm001,15,0.823,0.013717421124828532,Genistein,OHSU_HNSCC_derm001
21731,10336,Blank 490,3,D,OHSU_HNSCC_derm001,15,0.819,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm001
21732,10336,Blank 490,3,E,OHSU_HNSCC_derm001,15,0.927,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm001
21733,10336,Blank 490,3,F,OHSU_HNSCC_derm001,15,0.926,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm001
21734,10336,Blank 490,3,G,OHSU_HNSCC_derm001,15,1.008,0.013717421124828532,TAK-659,OHSU_HNSCC_derm001
21735,10336,Blank 490,3,H,OHSU_HNSCC_derm001,15,0.945,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm001
21736,10336,Blank 490,3,I,OHSU_HNSCC_derm001,15,0.886,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm001
21737,10336,Blank 490,3,J,OHSU_HNSCC_derm001,15,0.811,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm001
21738,10336,Blank 490,3,K,OHSU_HNSCC_derm001,15,0.864,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm001
21739,10336,Blank 490,3,L,OHSU_HNSCC_derm001,15,0.801,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm001
21740,10336,Blank 490,3,M,OHSU_HNSCC_derm001,15,1.097,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm001
21741,10336,Blank 490,3,N,OHSU_HNSCC_derm001,15,0.96,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm001
21742,10336,Blank 490,3,O,OHSU_HNSCC_derm001,15,0.953,0.013717421124828532,Echinatin,OHSU_HNSCC_derm001
21743,10336,Blank 490,3,P,OHSU_HNSCC_derm001,15,0.263,0.013717421124828532,YM-155,OHSU_HNSCC_derm001
21744,10336,Blank 490,3,A,OHSU_HNSCC_derm001,16,0.817,0,NONE,OHSU_HNSCC_derm001
21745,10336,Blank 490,3,B,OHSU_HNSCC_derm001,16,0.748,0,NONE,OHSU_HNSCC_derm001
21746,10336,Blank 490,3,C,OHSU_HNSCC_derm001,16,0.761,0,NONE,OHSU_HNSCC_derm001
21747,10336,Blank 490,3,D,OHSU_HNSCC_derm001,16,0.938,0,NONE,OHSU_HNSCC_derm001
21748,10336,Blank 490,3,E,OHSU_HNSCC_derm001,16,0.922,0,NONE,OHSU_HNSCC_derm001
21749,10336,Blank 490,3,F,OHSU_HNSCC_derm001,16,0.944,0,NONE,OHSU_HNSCC_derm001
21750,10336,Blank 490,3,G,OHSU_HNSCC_derm001,16,0.67,0,NONE,OHSU_HNSCC_derm001
21751,10336,Blank 490,3,H,OHSU_HNSCC_derm001,16,0.0,10,F-S-V,OHSU_HNSCC_derm001
21752,10336,Blank 490,3,I,OHSU_HNSCC_derm001,16,0.936,0,NONE,OHSU_HNSCC_derm001
21753,10336,Blank 490,3,J,OHSU_HNSCC_derm001,16,0.959,0,NONE,OHSU_HNSCC_derm001
21754,10336,Blank 490,3,K,OHSU_HNSCC_derm001,16,0.955,0,NONE,OHSU_HNSCC_derm001
21755,10336,Blank 490,3,L,OHSU_HNSCC_derm001,16,0.765,0,NONE,OHSU_HNSCC_derm001
21756,10336,Blank 490,3,M,OHSU_HNSCC_derm001,16,1.058,0,NONE,OHSU_HNSCC_derm001
21757,10336,Blank 490,3,N,OHSU_HNSCC_derm001,16,0.998,0,NONE,OHSU_HNSCC_derm001
21758,10336,Blank 490,3,O,OHSU_HNSCC_derm001,16,0.956,0,NONE,OHSU_HNSCC_derm001
21759,10336,Blank 490,3,P,OHSU_HNSCC_derm001,16,1.095,0,NONE,OHSU_HNSCC_derm001
21760,10336,Blank 490,3,A,OHSU_HNSCC_derm001,17,0.85,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21761,10336,Blank 490,3,B,OHSU_HNSCC_derm001,17,0.7,10,Stevioside,OHSU_HNSCC_derm001
21762,10336,Blank 490,3,C,OHSU_HNSCC_derm001,17,0.764,10,Pemetrexed,OHSU_HNSCC_derm001
21763,10336,Blank 490,3,D,OHSU_HNSCC_derm001,17,0.251,10,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21764,10336,Blank 490,3,E,OHSU_HNSCC_derm001,17,0.846,10,GSK-1838705A,OHSU_HNSCC_derm001
21765,10336,Blank 490,3,F,OHSU_HNSCC_derm001,17,0.007,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21766,10336,Blank 490,3,G,OHSU_HNSCC_derm001,17,1.054,10,Imatinib,OHSU_HNSCC_derm001
21767,10336,Blank 490,3,H,OHSU_HNSCC_derm001,17,0.981,10,Trametinib,OHSU_HNSCC_derm001
21768,10336,Blank 490,3,I,OHSU_HNSCC_derm001,17,0.232,10,BEZ235,OHSU_HNSCC_derm001
21769,10336,Blank 490,3,J,OHSU_HNSCC_derm001,17,1.072,10,Saracatinib,OHSU_HNSCC_derm001
21770,10336,Blank 490,3,K,OHSU_HNSCC_derm001,17,1.016,10,I-BET 762,OHSU_HNSCC_derm001
21771,10336,Blank 490,3,L,OHSU_HNSCC_derm001,17,0.824,10,Neratinib (HKI-272),OHSU_HNSCC_derm001
21772,10336,Blank 490,3,M,OHSU_HNSCC_derm001,17,0.629,10,Ginsenoside Rb2,OHSU_HNSCC_derm001
21773,10336,Blank 490,3,N,OHSU_HNSCC_derm001,17,1.011,10,Crizotinib,OHSU_HNSCC_derm001
21774,10336,Blank 490,3,O,OHSU_HNSCC_derm001,17,0.86,10,MGCD-265,OHSU_HNSCC_derm001
21775,10336,Blank 490,3,P,OHSU_HNSCC_derm001,17,1.057,10,Erlotinib,OHSU_HNSCC_derm001
21776,10336,Blank 490,3,A,OHSU_HNSCC_derm001,18,0.798,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21777,10336,Blank 490,3,B,OHSU_HNSCC_derm001,18,0.647,3.3333333333333335,Stevioside,OHSU_HNSCC_derm001
21778,10336,Blank 490,3,C,OHSU_HNSCC_derm001,18,0.731,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm001
21779,10336,Blank 490,3,D,OHSU_HNSCC_derm001,18,0.398,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21780,10336,Blank 490,3,E,OHSU_HNSCC_derm001,18,0.992,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm001
21781,10336,Blank 490,3,F,OHSU_HNSCC_derm001,18,0.891,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21782,10336,Blank 490,3,G,OHSU_HNSCC_derm001,18,0.982,3.3333333333333335,Imatinib,OHSU_HNSCC_derm001
21783,10336,Blank 490,3,H,OHSU_HNSCC_derm001,18,0.968,3.3333333333333335,Trametinib,OHSU_HNSCC_derm001
21784,10336,Blank 490,3,I,OHSU_HNSCC_derm001,18,0.297,3.3333333333333335,BEZ235,OHSU_HNSCC_derm001
21785,10336,Blank 490,3,J,OHSU_HNSCC_derm001,18,0.868,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm001
21786,10336,Blank 490,3,K,OHSU_HNSCC_derm001,18,1.071,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm001
21787,10336,Blank 490,3,L,OHSU_HNSCC_derm001,18,0.897,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm001
21788,10336,Blank 490,3,M,OHSU_HNSCC_derm001,18,0.834,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm001
21789,10336,Blank 490,3,N,OHSU_HNSCC_derm001,18,0.918,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm001
21790,10336,Blank 490,3,O,OHSU_HNSCC_derm001,18,0.855,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm001
21791,10336,Blank 490,3,P,OHSU_HNSCC_derm001,18,1.097,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm001
21792,10336,Blank 490,3,A,OHSU_HNSCC_derm001,19,0.83,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21793,10336,Blank 490,3,B,OHSU_HNSCC_derm001,19,0.709,1.1111111111111112,Stevioside,OHSU_HNSCC_derm001
21794,10336,Blank 490,3,C,OHSU_HNSCC_derm001,19,0.736,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm001
21795,10336,Blank 490,3,D,OHSU_HNSCC_derm001,19,0.658,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21796,10336,Blank 490,3,E,OHSU_HNSCC_derm001,19,0.9,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm001
21797,10336,Blank 490,3,F,OHSU_HNSCC_derm001,19,0.965,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21798,10336,Blank 490,3,G,OHSU_HNSCC_derm001,19,1.056,1.1111111111111112,Imatinib,OHSU_HNSCC_derm001
21799,10336,Blank 490,3,H,OHSU_HNSCC_derm001,19,0.966,1.1111111111111112,Trametinib,OHSU_HNSCC_derm001
21800,10336,Blank 490,3,I,OHSU_HNSCC_derm001,19,0.292,1.1111111111111112,BEZ235,OHSU_HNSCC_derm001
21801,10336,Blank 490,3,J,OHSU_HNSCC_derm001,19,0.874,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm001
21802,10336,Blank 490,3,K,OHSU_HNSCC_derm001,19,0.975,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm001
21803,10336,Blank 490,3,L,OHSU_HNSCC_derm001,19,0.747,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm001
21804,10336,Blank 490,3,M,OHSU_HNSCC_derm001,19,1.044,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm001
21805,10336,Blank 490,3,N,OHSU_HNSCC_derm001,19,1.087,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm001
21806,10336,Blank 490,3,O,OHSU_HNSCC_derm001,19,0.955,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm001
21807,10336,Blank 490,3,P,OHSU_HNSCC_derm001,19,1.139,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm001
21808,10336,Blank 490,3,A,OHSU_HNSCC_derm001,20,0.778,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21809,10336,Blank 490,3,B,OHSU_HNSCC_derm001,20,0.769,0.3703703703703704,Stevioside,OHSU_HNSCC_derm001
21810,10336,Blank 490,3,C,OHSU_HNSCC_derm001,20,0.782,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm001
21811,10336,Blank 490,3,D,OHSU_HNSCC_derm001,20,0.729,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21812,10336,Blank 490,3,E,OHSU_HNSCC_derm001,20,0.844,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm001
21813,10336,Blank 490,3,F,OHSU_HNSCC_derm001,20,0.978,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21814,10336,Blank 490,3,G,OHSU_HNSCC_derm001,20,1.021,0.3703703703703704,Imatinib,OHSU_HNSCC_derm001
21815,10336,Blank 490,3,H,OHSU_HNSCC_derm001,20,0.989,0.3703703703703704,Trametinib,OHSU_HNSCC_derm001
21816,10336,Blank 490,3,I,OHSU_HNSCC_derm001,20,0.439,0.3703703703703704,BEZ235,OHSU_HNSCC_derm001
21817,10336,Blank 490,3,J,OHSU_HNSCC_derm001,20,0.918,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm001
21818,10336,Blank 490,3,K,OHSU_HNSCC_derm001,20,0.925,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm001
21819,10336,Blank 490,3,L,OHSU_HNSCC_derm001,20,0.842,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm001
21820,10336,Blank 490,3,M,OHSU_HNSCC_derm001,20,1.033,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm001
21821,10336,Blank 490,3,N,OHSU_HNSCC_derm001,20,1.131,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm001
21822,10336,Blank 490,3,O,OHSU_HNSCC_derm001,20,0.962,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm001
21823,10336,Blank 490,3,P,OHSU_HNSCC_derm001,20,1.064,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm001
21824,10336,Blank 490,3,A,OHSU_HNSCC_derm001,21,0.956,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21825,10336,Blank 490,3,B,OHSU_HNSCC_derm001,21,0.737,0.1234567901234568,Stevioside,OHSU_HNSCC_derm001
21826,10336,Blank 490,3,C,OHSU_HNSCC_derm001,21,0.768,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm001
21827,10336,Blank 490,3,D,OHSU_HNSCC_derm001,21,0.734,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21828,10336,Blank 490,3,E,OHSU_HNSCC_derm001,21,0.863,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm001
21829,10336,Blank 490,3,F,OHSU_HNSCC_derm001,21,0.918,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21830,10336,Blank 490,3,G,OHSU_HNSCC_derm001,21,0.929,0.1234567901234568,Imatinib,OHSU_HNSCC_derm001
21831,10336,Blank 490,3,H,OHSU_HNSCC_derm001,21,0.976,0.1234567901234568,Trametinib,OHSU_HNSCC_derm001
21832,10336,Blank 490,3,I,OHSU_HNSCC_derm001,21,0.615,0.1234567901234568,BEZ235,OHSU_HNSCC_derm001
21833,10336,Blank 490,3,J,OHSU_HNSCC_derm001,21,0.802,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm001
21834,10336,Blank 490,3,K,OHSU_HNSCC_derm001,21,0.845,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm001
21835,10336,Blank 490,3,L,OHSU_HNSCC_derm001,21,0.703,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm001
21836,10336,Blank 490,3,M,OHSU_HNSCC_derm001,21,1.032,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm001
21837,10336,Blank 490,3,N,OHSU_HNSCC_derm001,21,0.939,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm001
21838,10336,Blank 490,3,O,OHSU_HNSCC_derm001,21,0.885,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm001
21839,10336,Blank 490,3,P,OHSU_HNSCC_derm001,21,1.252,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm001
21840,10336,Blank 490,3,A,OHSU_HNSCC_derm001,22,0.822,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21841,10336,Blank 490,3,B,OHSU_HNSCC_derm001,22,0.711,0.0411522633744856,Stevioside,OHSU_HNSCC_derm001
21842,10336,Blank 490,3,C,OHSU_HNSCC_derm001,22,0.842,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm001
21843,10336,Blank 490,3,D,OHSU_HNSCC_derm001,22,0.805,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21844,10336,Blank 490,3,E,OHSU_HNSCC_derm001,22,0.925,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm001
21845,10336,Blank 490,3,F,OHSU_HNSCC_derm001,22,0.818,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21846,10336,Blank 490,3,G,OHSU_HNSCC_derm001,22,1.011,0.0411522633744856,Imatinib,OHSU_HNSCC_derm001
21847,10336,Blank 490,3,H,OHSU_HNSCC_derm001,22,0.884,0.0411522633744856,Trametinib,OHSU_HNSCC_derm001
21848,10336,Blank 490,3,I,OHSU_HNSCC_derm001,22,0.733,0.0411522633744856,BEZ235,OHSU_HNSCC_derm001
21849,10336,Blank 490,3,J,OHSU_HNSCC_derm001,22,0.887,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm001
21850,10336,Blank 490,3,K,OHSU_HNSCC_derm001,22,0.93,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm001
21851,10336,Blank 490,3,L,OHSU_HNSCC_derm001,22,0.887,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm001
21852,10336,Blank 490,3,M,OHSU_HNSCC_derm001,22,1.086,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm001
21853,10336,Blank 490,3,N,OHSU_HNSCC_derm001,22,1.08,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm001
21854,10336,Blank 490,3,O,OHSU_HNSCC_derm001,22,1.008,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm001
21855,10336,Blank 490,3,P,OHSU_HNSCC_derm001,22,1.091,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm001
21856,10336,Blank 490,3,A,OHSU_HNSCC_derm001,23,0.891,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm001
21857,10336,Blank 490,3,B,OHSU_HNSCC_derm001,23,0.779,0.013717421124828532,Stevioside,OHSU_HNSCC_derm001
21858,10336,Blank 490,3,C,OHSU_HNSCC_derm001,23,0.885,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm001
21859,10336,Blank 490,3,D,OHSU_HNSCC_derm001,23,0.893,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm001
21860,10336,Blank 490,3,E,OHSU_HNSCC_derm001,23,0.886,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm001
21861,10336,Blank 490,3,F,OHSU_HNSCC_derm001,23,1.01,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm001
21862,10336,Blank 490,3,G,OHSU_HNSCC_derm001,23,0.997,0.013717421124828532,Imatinib,OHSU_HNSCC_derm001
21863,10336,Blank 490,3,H,OHSU_HNSCC_derm001,23,0.938,0.013717421124828532,Trametinib,OHSU_HNSCC_derm001
21864,10336,Blank 490,3,I,OHSU_HNSCC_derm001,23,0.799,0.013717421124828532,BEZ235,OHSU_HNSCC_derm001
21865,10336,Blank 490,3,J,OHSU_HNSCC_derm001,23,0.842,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm001
21866,10336,Blank 490,3,K,OHSU_HNSCC_derm001,23,0.872,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm001
21867,10336,Blank 490,3,L,OHSU_HNSCC_derm001,23,0.846,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm001
21868,10336,Blank 490,3,M,OHSU_HNSCC_derm001,23,1.07,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm001
21869,10336,Blank 490,3,N,OHSU_HNSCC_derm001,23,0.955,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm001
21870,10336,Blank 490,3,O,OHSU_HNSCC_derm001,23,0.976,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm001
21871,10336,Blank 490,3,P,OHSU_HNSCC_derm001,23,1.118,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm001
21872,10336,Blank 490,3,A,OHSU_HNSCC_derm001,24,0.949,0,NONE,OHSU_HNSCC_derm001
21873,10336,Blank 490,3,B,OHSU_HNSCC_derm001,24,0.819,0,NONE,OHSU_HNSCC_derm001
21874,10336,Blank 490,3,C,OHSU_HNSCC_derm001,24,0.851,0,NONE,OHSU_HNSCC_derm001
21875,10336,Blank 490,3,D,OHSU_HNSCC_derm001,24,0.86,0,NONE,OHSU_HNSCC_derm001
21876,10336,Blank 490,3,E,OHSU_HNSCC_derm001,24,0.972,0,NONE,OHSU_HNSCC_derm001
21877,10336,Blank 490,3,F,OHSU_HNSCC_derm001,24,0.967,0,NONE,OHSU_HNSCC_derm001
21878,10336,Blank 490,3,G,OHSU_HNSCC_derm001,24,0.966,0,NONE,OHSU_HNSCC_derm001
21879,10336,Blank 490,3,H,OHSU_HNSCC_derm001,24,1.053,0,NONE,OHSU_HNSCC_derm001
21880,10336,Blank 490,3,I,OHSU_HNSCC_derm001,24,0.842,0,NONE,OHSU_HNSCC_derm001
21881,10336,Blank 490,3,J,OHSU_HNSCC_derm001,24,0.988,0,NONE,OHSU_HNSCC_derm001
21882,10336,Blank 490,3,K,OHSU_HNSCC_derm001,24,0.869,0,NONE,OHSU_HNSCC_derm001
21883,10336,Blank 490,3,L,OHSU_HNSCC_derm001,24,0.917,0,NONE,OHSU_HNSCC_derm001
21884,10336,Blank 490,3,M,OHSU_HNSCC_derm001,24,1.137,0,NONE,OHSU_HNSCC_derm001
21885,10336,Blank 490,3,N,OHSU_HNSCC_derm001,24,0.998,0,NONE,OHSU_HNSCC_derm001
21886,10336,Blank 490,3,O,OHSU_HNSCC_derm001,24,0.955,0,NONE,OHSU_HNSCC_derm001
21887,10336,Blank 490,3,P,OHSU_HNSCC_derm001,24,1.136,0,NONE,OHSU_HNSCC_derm001
21888,10336,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.034,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
21889,10336,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.635,10,Lucitanib ,OHSU_HNSCC_derm002
21890,10336,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.522,10,Resveratrol,OHSU_HNSCC_derm002
21891,10336,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.546,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21892,10336,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.523,10,Bicalutamide,OHSU_HNSCC_derm002
21893,10336,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.823,10,Methotrexate ,OHSU_HNSCC_derm002
21894,10336,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.322,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21895,10336,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.634,10,Gefitinib,OHSU_HNSCC_derm002
21896,10336,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.586,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
21897,10336,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.391,10,Tamatinib/R406,OHSU_HNSCC_derm002
21898,10336,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.514,10,Bosutinib,OHSU_HNSCC_derm002
21899,10336,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.097,10,PI-103,OHSU_HNSCC_derm002
21900,10336,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.64,10,Glycyrrhizin,OHSU_HNSCC_derm002
21901,10336,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.637,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
21902,10336,Blank 490,1,O,OHSU_HNSCC_derm002,1,1.027,10,GSK-690693,OHSU_HNSCC_derm002
21903,10336,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.941,10,Ibrutinib,OHSU_HNSCC_derm002
21904,10336,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.095,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
21905,10336,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.656,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
21906,10336,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.442,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
21907,10336,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.697,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21908,10336,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.687,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
21909,10336,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.769,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
21910,10336,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.517,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21911,10336,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.705,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
21912,10336,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.498,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
21913,10336,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.618,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
21914,10336,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.572,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
21915,10336,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.152,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
21916,10336,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.652,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
21917,10336,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.732,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
21918,10336,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.887,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
21919,10336,Blank 490,1,P,OHSU_HNSCC_derm002,2,1.005,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
21920,10336,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.109,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
21921,10336,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.664,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
21922,10336,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.599,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
21923,10336,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.795,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21924,10336,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.658,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
21925,10336,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.697,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
21926,10336,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.789,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21927,10336,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.657,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
21928,10336,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.67,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
21929,10336,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.787,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
21930,10336,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.654,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
21931,10336,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.311,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
21932,10336,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.712,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
21933,10336,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.828,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
21934,10336,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.823,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
21935,10336,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.827,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
21936,10336,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.196,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
21937,10336,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.552,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
21938,10336,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.704,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
21939,10336,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.7,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21940,10336,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.682,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
21941,10336,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.725,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
21942,10336,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.687,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21943,10336,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.708,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
21944,10336,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.792,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
21945,10336,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.788,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
21946,10336,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.652,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
21947,10336,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
21948,10336,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.785,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
21949,10336,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.954,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
21950,10336,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.788,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
21951,10336,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.799,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
21952,10336,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.403,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
21953,10336,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.616,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
21954,10336,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.53,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
21955,10336,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.729,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21956,10336,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.76,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
21957,10336,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.735,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
21958,10336,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.639,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21959,10336,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.64,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
21960,10336,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.626,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
21961,10336,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.676,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
21962,10336,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.586,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
21963,10336,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.824,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
21964,10336,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.798,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
21965,10336,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.767,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
21966,10336,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.793,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
21967,10336,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.888,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
21968,10336,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.598,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
21969,10336,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.665,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
21970,10336,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.663,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
21971,10336,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.766,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21972,10336,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.661,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
21973,10336,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.817,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
21974,10336,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.759,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21975,10336,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.699,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
21976,10336,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
21977,10336,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.736,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
21978,10336,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.722,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
21979,10336,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.785,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
21980,10336,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.691,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
21981,10336,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.84,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
21982,10336,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.809,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
21983,10336,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.776,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
21984,10336,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.602,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
21985,10336,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.582,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
21986,10336,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.651,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
21987,10336,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.772,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
21988,10336,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.782,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
21989,10336,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.758,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
21990,10336,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.72,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
21991,10336,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.691,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
21992,10336,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.71,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
21993,10336,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.744,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
21994,10336,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.6,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
21995,10336,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.713,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
21996,10336,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.839,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
21997,10336,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.885,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
21998,10336,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.806,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
21999,10336,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.802,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
22000,10336,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
22001,10336,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.632,0,NONE,OHSU_HNSCC_derm002
22002,10336,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.603,0,NONE,OHSU_HNSCC_derm002
22003,10336,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
22004,10336,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
22005,10336,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
22006,10336,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.717,0,NONE,OHSU_HNSCC_derm002
22007,10336,Blank 490,1,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
22008,10336,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.698,0,NONE,OHSU_HNSCC_derm002
22009,10336,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
22010,10336,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.693,0,NONE,OHSU_HNSCC_derm002
22011,10336,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.61,0,NONE,OHSU_HNSCC_derm002
22012,10336,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.777,0,NONE,OHSU_HNSCC_derm002
22013,10336,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.729,0,NONE,OHSU_HNSCC_derm002
22014,10336,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.799,0,NONE,OHSU_HNSCC_derm002
22015,10336,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.929,0,NONE,OHSU_HNSCC_derm002
22016,10336,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.396,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22017,10336,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.639,10,Sorafenib,OHSU_HNSCC_derm002
22018,10336,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.693,10,Rosmarinic acid,OHSU_HNSCC_derm002
22019,10336,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.701,10,Rapamycin,OHSU_HNSCC_derm002
22020,10336,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.821,10,Vismodegib,OHSU_HNSCC_derm002
22021,10336,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.182,10,PP242,OHSU_HNSCC_derm002
22022,10336,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.613,10,Alectinib,OHSU_HNSCC_derm002
22023,10336,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.836,10,Brigatinib,OHSU_HNSCC_derm002
22024,10336,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.819,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22025,10336,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.825,10,MK-2206,OHSU_HNSCC_derm002
22026,10336,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.726,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22027,10336,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.414,10,Flavopiridol ,OHSU_HNSCC_derm002
22028,10336,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.803,10,Indirubin,OHSU_HNSCC_derm002
22029,10336,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.731,10,PF-533228,OHSU_HNSCC_derm002
22030,10336,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.789,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22031,10336,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.2,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22032,10336,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.489,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22033,10336,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.618,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
22034,10336,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.732,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
22035,10336,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.696,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
22036,10336,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.854,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
22037,10336,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.361,3.3333333333333335,PP242,OHSU_HNSCC_derm002
22038,10336,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.766,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
22039,10336,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.769,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
22040,10336,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.741,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22041,10336,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.893,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
22042,10336,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.84,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22043,10336,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.387,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
22044,10336,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.809,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
22045,10336,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.798,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
22046,10336,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.875,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22047,10336,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.15,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22048,10336,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.562,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22049,10336,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.654,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
22050,10336,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.58,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
22051,10336,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.716,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
22052,10336,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.671,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
22053,10336,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.543,1.1111111111111112,PP242,OHSU_HNSCC_derm002
22054,10336,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.805,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
22055,10336,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.774,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
22056,10336,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.629,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22057,10336,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.887,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
22058,10336,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.606,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22059,10336,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.311,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
22060,10336,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.887,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
22061,10336,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.722,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
22062,10336,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.797,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22063,10336,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.126,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22064,10336,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.428,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22065,10336,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.593,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
22066,10336,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.647,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
22067,10336,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.785,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
22068,10336,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.826,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
22069,10336,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.848,0.3703703703703704,PP242,OHSU_HNSCC_derm002
22070,10336,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.841,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
22071,10336,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.78,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
22072,10336,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.593,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22073,10336,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.877,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
22074,10336,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.75,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22075,10336,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.322,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
22076,10336,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.783,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
22077,10336,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.799,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
22078,10336,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.822,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22079,10336,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.399,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22080,10336,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.656,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22081,10336,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.707,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
22082,10336,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.689,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
22083,10336,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.761,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
22084,10336,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.841,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
22085,10336,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.8,0.1234567901234568,PP242,OHSU_HNSCC_derm002
22086,10336,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.805,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
22087,10336,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.767,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
22088,10336,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.668,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22089,10336,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.846,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
22090,10336,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.641,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22091,10336,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.701,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
22092,10336,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.871,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
22093,10336,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.742,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
22094,10336,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.837,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22095,10336,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.539,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22096,10336,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.535,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22097,10336,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.593,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
22098,10336,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.728,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
22099,10336,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.75,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
22100,10336,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.71,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
22101,10336,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.793,0.0411522633744856,PP242,OHSU_HNSCC_derm002
22102,10336,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.763,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
22103,10336,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.694,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
22104,10336,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.677,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22105,10336,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.746,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
22106,10336,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.673,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22107,10336,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.736,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
22108,10336,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.778,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
22109,10336,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.847,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
22110,10336,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.846,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22111,10336,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.74,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22112,10336,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.567,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
22113,10336,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
22114,10336,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.702,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
22115,10336,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.778,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
22116,10336,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.712,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
22117,10336,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.739,0.013717421124828532,PP242,OHSU_HNSCC_derm002
22118,10336,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.758,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
22119,10336,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.707,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
22120,10336,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.63,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22121,10336,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.691,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
22122,10336,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.703,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
22123,10336,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.772,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
22124,10336,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.771,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
22125,10336,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.884,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
22126,10336,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.848,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
22127,10336,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.949,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
22128,10336,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.593,0,NONE,OHSU_HNSCC_derm002
22129,10336,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.668,0,NONE,OHSU_HNSCC_derm002
22130,10336,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.716,0,NONE,OHSU_HNSCC_derm002
22131,10336,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.781,0,NONE,OHSU_HNSCC_derm002
22132,10336,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.852,0,NONE,OHSU_HNSCC_derm002
22133,10336,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.799,0,NONE,OHSU_HNSCC_derm002
22134,10336,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.773,0,NONE,OHSU_HNSCC_derm002
22135,10336,Blank 490,1,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
22136,10336,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.641,0,NONE,OHSU_HNSCC_derm002
22137,10336,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.856,0,NONE,OHSU_HNSCC_derm002
22138,10336,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.733,0,NONE,OHSU_HNSCC_derm002
22139,10336,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.757,0,NONE,OHSU_HNSCC_derm002
22140,10336,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.763,0,NONE,OHSU_HNSCC_derm002
22141,10336,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.841,0,NONE,OHSU_HNSCC_derm002
22142,10336,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.925,0,NONE,OHSU_HNSCC_derm002
22143,10336,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.945,0,NONE,OHSU_HNSCC_derm002
22144,10336,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.581,10,Emodin,OHSU_HNSCC_derm002
22145,10336,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.554,10,Baicalin,OHSU_HNSCC_derm002
22146,10336,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.009,10,NVP-TAE-684,OHSU_HNSCC_derm002
22147,10336,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.104,10,Panobinostat,OHSU_HNSCC_derm002
22148,10336,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.102,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
22149,10336,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.861,10,Fulvestrant,OHSU_HNSCC_derm002
22150,10336,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.937,10,SCH-772984,OHSU_HNSCC_derm002
22151,10336,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.862,10,Trametinib,OHSU_HNSCC_derm002
22152,10336,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.552,10,BEZ235,OHSU_HNSCC_derm002
22153,10336,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.743,10,MLN120B,OHSU_HNSCC_derm002
22154,10336,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.126,10,Ixabepilone,OHSU_HNSCC_derm002
22155,10336,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.663,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
22156,10336,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.963,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22157,10336,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.825,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22158,10336,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.784,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22159,10336,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.944,10,Letrozole,OHSU_HNSCC_derm002
22160,10336,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.594,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
22161,10336,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.654,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
22162,10336,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.762,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
22163,10336,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.113,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
22164,10336,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.434,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
22165,10336,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.76,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
22166,10336,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.849,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
22167,10336,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.788,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
22168,10336,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.312,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
22169,10336,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.696,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
22170,10336,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.126,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
22171,10336,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.763,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
22172,10336,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.699,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22173,10336,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.875,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22174,10336,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.843,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22175,10336,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.845,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
22176,10336,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.666,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
22177,10336,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.653,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
22178,10336,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.708,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
22179,10336,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.188,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
22180,10336,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.583,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
22181,10336,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.894,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
22182,10336,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.847,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
22183,10336,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.776,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
22184,10336,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.317,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
22185,10336,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.829,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
22186,10336,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.149,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
22187,10336,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.706,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
22188,10336,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.717,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22189,10336,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.998,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22190,10336,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.796,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22191,10336,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.866,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
22192,10336,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.595,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
22193,10336,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.677,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
22194,10336,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.677,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
22195,10336,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.47,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
22196,10336,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.871,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
22197,10336,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.803,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
22198,10336,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.879,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
22199,10336,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.862,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
22200,10336,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.469,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
22201,10336,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.614,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
22202,10336,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.164,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
22203,10336,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.825,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
22204,10336,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.757,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22205,10336,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.917,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22206,10336,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.711,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22207,10336,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.907,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
22208,10336,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.595,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
22209,10336,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.664,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
22210,10336,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.698,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
22211,10336,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.748,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
22212,10336,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.921,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
22213,10336,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.756,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
22214,10336,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.798,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
22215,10336,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.861,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
22216,10336,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.699,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
22217,10336,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.745,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
22218,10336,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.279,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
22219,10336,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.726,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
22220,10336,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.803,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22221,10336,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.908,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22222,10336,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.727,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22223,10336,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.824,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
22224,10336,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.586,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
22225,10336,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.673,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
22226,10336,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.783,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
22227,10336,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.888,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
22228,10336,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.934,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
22229,10336,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.924,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
22230,10336,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.796,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
22231,10336,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.844,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
22232,10336,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.985,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
22233,10336,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.771,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
22234,10336,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.409,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
22235,10336,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.78,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
22236,10336,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.832,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22237,10336,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.894,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22238,10336,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.802,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22239,10336,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.901,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
22240,10336,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.556,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
22241,10336,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.674,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
22242,10336,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
22243,10336,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.79,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
22244,10336,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.735,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
22245,10336,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.795,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
22246,10336,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.781,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
22247,10336,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.765,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
22248,10336,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.799,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
22249,10336,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.636,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
22250,10336,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.517,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
22251,10336,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.708,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
22252,10336,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.704,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
22253,10336,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.756,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
22254,10336,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.853,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
22255,10336,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.862,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
22256,10336,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
22257,10336,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.626,0,NONE,OHSU_HNSCC_derm002
22258,10336,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.642,0,NONE,OHSU_HNSCC_derm002
22259,10336,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.73,0,NONE,OHSU_HNSCC_derm002
22260,10336,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.671,0,NONE,OHSU_HNSCC_derm002
22261,10336,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.679,0,NONE,OHSU_HNSCC_derm002
22262,10336,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.694,0,NONE,OHSU_HNSCC_derm002
22263,10336,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.677,0,NONE,OHSU_HNSCC_derm002
22264,10336,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.681,0,NONE,OHSU_HNSCC_derm002
22265,10336,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.745,0,NONE,OHSU_HNSCC_derm002
22266,10336,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.735,0,NONE,OHSU_HNSCC_derm002
22267,10336,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.778,0,NONE,OHSU_HNSCC_derm002
22268,10336,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.772,0,NONE,OHSU_HNSCC_derm002
22269,10336,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.796,0,NONE,OHSU_HNSCC_derm002
22270,10336,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.781,0,NONE,OHSU_HNSCC_derm002
22271,10336,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.844,0,NONE,OHSU_HNSCC_derm002
22272,10336,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.68,10,Coumarin,OHSU_HNSCC_derm002
22273,10336,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.825,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22274,10336,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.61,10,Foretinib (XL-880),OHSU_HNSCC_derm002
22275,10336,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.736,10,Elesclomol,OHSU_HNSCC_derm002
22276,10336,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.786,10,Vemurafenib,OHSU_HNSCC_derm002
22277,10336,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.096,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22278,10336,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.016,10,Ponatinib,OHSU_HNSCC_derm002
22279,10336,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.745,10,Gefitinib,OHSU_HNSCC_derm002
22280,10336,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.744,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
22281,10336,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.69,1,Sunitinib (1mM),OHSU_HNSCC_derm002
22282,10336,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.836,10,Curcumin,OHSU_HNSCC_derm002
22283,10336,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.608,10,PF-562271,OHSU_HNSCC_derm002
22284,10336,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.76,10,STO609,OHSU_HNSCC_derm002
22285,10336,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.828,10,Lenvatinib,OHSU_HNSCC_derm002
22286,10336,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.738,10,Entrectinib,OHSU_HNSCC_derm002
22287,10336,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.994,10,Ethyl Gallate ,OHSU_HNSCC_derm002
22288,10336,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.893,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
22289,10336,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.899,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22290,10336,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.7,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
22291,10336,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.794,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
22292,10336,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.679,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
22293,10336,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.111,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22294,10336,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.701,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
22295,10336,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.768,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
22296,10336,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.752,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
22297,10336,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.696,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
22298,10336,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.876,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
22299,10336,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.579,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
22300,10336,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.692,3.3333333333333335,STO609,OHSU_HNSCC_derm002
22301,10336,Blank 490,2,N,OHSU_HNSCC_derm002,2,1.137,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
22302,10336,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.98,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
22303,10336,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.917,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
22304,10336,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.826,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
22305,10336,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.789,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22306,10336,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.678,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
22307,10336,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.573,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
22308,10336,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.759,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
22309,10336,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22310,10336,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.966,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
22311,10336,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.7,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
22312,10336,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.727,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
22313,10336,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.768,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
22314,10336,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.808,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
22315,10336,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.725,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
22316,10336,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.893,1.1111111111111112,STO609,OHSU_HNSCC_derm002
22317,10336,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.734,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
22318,10336,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.931,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
22319,10336,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.895,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
22320,10336,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.709,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
22321,10336,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.819,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22322,10336,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.772,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
22323,10336,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.693,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
22324,10336,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.758,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
22325,10336,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.387,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22326,10336,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.824,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
22327,10336,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.674,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
22328,10336,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.888,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
22329,10336,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.563,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
22330,10336,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.792,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
22331,10336,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.745,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
22332,10336,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.774,0.3703703703703704,STO609,OHSU_HNSCC_derm002
22333,10336,Blank 490,2,N,OHSU_HNSCC_derm002,4,1.002,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
22334,10336,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.912,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
22335,10336,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.99,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
22336,10336,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.871,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
22337,10336,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.874,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22338,10336,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.773,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
22339,10336,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.739,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
22340,10336,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.744,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
22341,10336,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.717,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22342,10336,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.717,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
22343,10336,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.663,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
22344,10336,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.763,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
22345,10336,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.816,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
22346,10336,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.796,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
22347,10336,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.717,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
22348,10336,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.799,0.1234567901234568,STO609,OHSU_HNSCC_derm002
22349,10336,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.701,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
22350,10336,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.872,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
22351,10336,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.924,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
22352,10336,Blank 490,2,A,OHSU_HNSCC_derm002,6,1.052,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
22353,10336,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.866,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22354,10336,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.701,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
22355,10336,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.77,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
22356,10336,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.841,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
22357,10336,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.783,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22358,10336,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.734,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
22359,10336,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.694,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
22360,10336,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.637,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
22361,10336,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.568,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
22362,10336,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.796,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
22363,10336,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.798,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
22364,10336,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.9,0.0411522633744856,STO609,OHSU_HNSCC_derm002
22365,10336,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.911,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
22366,10336,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.856,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
22367,10336,Blank 490,2,P,OHSU_HNSCC_derm002,6,1.022,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
22368,10336,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.861,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
22369,10336,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.822,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
22370,10336,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.768,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
22371,10336,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.666,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
22372,10336,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.669,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
22373,10336,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.846,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
22374,10336,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.627,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
22375,10336,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.713,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
22376,10336,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.8,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
22377,10336,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.866,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
22378,10336,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.881,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
22379,10336,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.77,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
22380,10336,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.667,0.013717421124828532,STO609,OHSU_HNSCC_derm002
22381,10336,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.77,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
22382,10336,Blank 490,2,O,OHSU_HNSCC_derm002,7,1.034,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
22383,10336,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.824,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
22384,10336,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.728,0,NONE,OHSU_HNSCC_derm002
22385,10336,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.711,0,NONE,OHSU_HNSCC_derm002
22386,10336,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.649,0,NONE,OHSU_HNSCC_derm002
22387,10336,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.76,0,NONE,OHSU_HNSCC_derm002
22388,10336,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.869,0,NONE,OHSU_HNSCC_derm002
22389,10336,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.639,0,NONE,OHSU_HNSCC_derm002
22390,10336,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.891,0,NONE,OHSU_HNSCC_derm002
22391,10336,Blank 490,2,H,OHSU_HNSCC_derm002,8,0.005,10,F-S-V,OHSU_HNSCC_derm002
22392,10336,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.712,0,NONE,OHSU_HNSCC_derm002
22393,10336,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.594,0,NONE,OHSU_HNSCC_derm002
22394,10336,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.754,0,NONE,OHSU_HNSCC_derm002
22395,10336,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.787,0,NONE,OHSU_HNSCC_derm002
22396,10336,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.839,0,NONE,OHSU_HNSCC_derm002
22397,10336,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.842,0,NONE,OHSU_HNSCC_derm002
22398,10336,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.804,0,NONE,OHSU_HNSCC_derm002
22399,10336,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.846,0,NONE,OHSU_HNSCC_derm002
22400,10336,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.337,10,GDC-0941,OHSU_HNSCC_derm002
22401,10336,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.773,10,Dovitinib,OHSU_HNSCC_derm002
22402,10336,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.524,10,BI-2536,OHSU_HNSCC_derm002
22403,10336,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.264,10,TP-0903 ,OHSU_HNSCC_derm002
22404,10336,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.203,10,Belinostat,OHSU_HNSCC_derm002
22405,10336,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.218,10,INK-128,OHSU_HNSCC_derm002
22406,10336,Blank 490,2,G,OHSU_HNSCC_derm002,9,1.044,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22407,10336,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.931,10,Brigatinib,OHSU_HNSCC_derm002
22408,10336,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.639,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22409,10336,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.66,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22410,10336,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.697,10,Pazopanib,OHSU_HNSCC_derm002
22411,10336,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.875,10,AZD4547,OHSU_HNSCC_derm002
22412,10336,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.851,10,Pomalidomide ,OHSU_HNSCC_derm002
22413,10336,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.906,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
22414,10336,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.851,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22415,10336,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.029,10,Staurosporin,OHSU_HNSCC_derm002
22416,10336,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.295,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
22417,10336,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.803,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
22418,10336,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.81,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
22419,10336,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.228,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
22420,10336,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.553,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
22421,10336,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.232,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
22422,10336,Blank 490,2,G,OHSU_HNSCC_derm002,10,1.0,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22423,10336,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.855,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
22424,10336,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.724,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22425,10336,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.68,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22426,10336,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.788,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
22427,10336,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.963,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
22428,10336,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.773,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
22429,10336,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.831,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
22430,10336,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.885,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22431,10336,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.006,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
22432,10336,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.386,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
22433,10336,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.913,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
22434,10336,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.555,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
22435,10336,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.454,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
22436,10336,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.952,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
22437,10336,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.333,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
22438,10336,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.877,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22439,10336,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.738,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
22440,10336,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.827,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22441,10336,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.723,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22442,10336,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.608,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
22443,10336,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.85,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
22444,10336,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.667,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
22445,10336,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.834,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
22446,10336,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.978,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22447,10336,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.058,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
22448,10336,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.719,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
22449,10336,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.786,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
22450,10336,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.346,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
22451,10336,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.869,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
22452,10336,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.855,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
22453,10336,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.353,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
22454,10336,Blank 490,2,G,OHSU_HNSCC_derm002,12,1.024,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22455,10336,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.769,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
22456,10336,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.899,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22457,10336,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.664,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22458,10336,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.777,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
22459,10336,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.909,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
22460,10336,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.841,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
22461,10336,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.957,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
22462,10336,Blank 490,2,O,OHSU_HNSCC_derm002,12,1.138,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22463,10336,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.182,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
22464,10336,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.731,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
22465,10336,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.981,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
22466,10336,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.287,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
22467,10336,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.87,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
22468,10336,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.783,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
22469,10336,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.552,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
22470,10336,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.819,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22471,10336,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.837,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
22472,10336,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.664,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22473,10336,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.679,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22474,10336,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.777,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
22475,10336,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.878,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
22476,10336,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.726,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
22477,10336,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.855,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
22478,10336,Blank 490,2,O,OHSU_HNSCC_derm002,13,1.069,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22479,10336,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.409,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
22480,10336,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.928,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
22481,10336,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.998,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
22482,10336,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.29,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
22483,10336,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.861,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
22484,10336,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.653,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
22485,10336,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.695,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
22486,10336,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.865,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22487,10336,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.828,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
22488,10336,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.661,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22489,10336,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.841,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22490,10336,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.803,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
22491,10336,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.741,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
22492,10336,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.858,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
22493,10336,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.869,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
22494,10336,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.823,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22495,10336,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.586,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
22496,10336,Blank 490,2,A,OHSU_HNSCC_derm002,15,1.019,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
22497,10336,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.89,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
22498,10336,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.526,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
22499,10336,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.644,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
22500,10336,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.735,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
22501,10336,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.823,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
22502,10336,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.819,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
22503,10336,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.724,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
22504,10336,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.649,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22505,10336,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.656,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
22506,10336,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.806,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
22507,10336,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.841,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
22508,10336,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.653,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
22509,10336,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.708,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
22510,10336,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.851,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
22511,10336,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.766,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
22512,10336,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.993,0,NONE,OHSU_HNSCC_derm002
22513,10336,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.866,0,NONE,OHSU_HNSCC_derm002
22514,10336,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.912,0,NONE,OHSU_HNSCC_derm002
22515,10336,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.792,0,NONE,OHSU_HNSCC_derm002
22516,10336,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.75,0,NONE,OHSU_HNSCC_derm002
22517,10336,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.859,0,NONE,OHSU_HNSCC_derm002
22518,10336,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.829,0,NONE,OHSU_HNSCC_derm002
22519,10336,Blank 490,2,H,OHSU_HNSCC_derm002,16,-0.005,10,F-S-V,OHSU_HNSCC_derm002
22520,10336,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.796,0,NONE,OHSU_HNSCC_derm002
22521,10336,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.715,0,NONE,OHSU_HNSCC_derm002
22522,10336,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.837,0,NONE,OHSU_HNSCC_derm002
22523,10336,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.743,0,NONE,OHSU_HNSCC_derm002
22524,10336,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.932,0,NONE,OHSU_HNSCC_derm002
22525,10336,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.791,0,NONE,OHSU_HNSCC_derm002
22526,10336,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.887,0,NONE,OHSU_HNSCC_derm002
22527,10336,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.872,0,NONE,OHSU_HNSCC_derm002
22528,10336,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.434,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
22529,10336,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.903,10,Hesperidin,OHSU_HNSCC_derm002
22530,10336,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.722,10,Esculetin,OHSU_HNSCC_derm002
22531,10336,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.682,10,Selinexor ,OHSU_HNSCC_derm002
22532,10336,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.871,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22533,10336,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.873,10,BMX-IN-1,OHSU_HNSCC_derm002
22534,10336,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.9,1,Dasatinib (1mM),OHSU_HNSCC_derm002
22535,10336,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.876,10,Trametinib,OHSU_HNSCC_derm002
22536,10336,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.399,10,BEZ235,OHSU_HNSCC_derm002
22537,10336,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.019,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
22538,10336,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.727,10,Nilotinib,OHSU_HNSCC_derm002
22539,10336,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.899,10,Enzalutamide,OHSU_HNSCC_derm002
22540,10336,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.812,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22541,10336,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.779,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
22542,10336,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.431,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22543,10336,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.757,10,Axitinib,OHSU_HNSCC_derm002
22544,10336,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.356,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
22545,10336,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.722,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
22546,10336,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.786,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
22547,10336,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.541,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
22548,10336,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.853,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22549,10336,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.743,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
22550,10336,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.853,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
22551,10336,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.904,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
22552,10336,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.334,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
22553,10336,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.037,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
22554,10336,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.7,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
22555,10336,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.893,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
22556,10336,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.828,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22557,10336,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.891,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
22558,10336,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.348,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22559,10336,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.994,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
22560,10336,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.536,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
22561,10336,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.752,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
22562,10336,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.702,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
22563,10336,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.652,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
22564,10336,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.797,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22565,10336,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.754,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
22566,10336,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.907,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
22567,10336,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.914,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
22568,10336,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.325,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
22569,10336,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.026,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
22570,10336,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.638,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
22571,10336,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.818,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
22572,10336,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.692,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22573,10336,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.805,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
22574,10336,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22575,10336,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.857,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
22576,10336,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
22577,10336,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.619,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
22578,10336,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.79,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
22579,10336,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.735,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
22580,10336,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.814,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22581,10336,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.852,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
22582,10336,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.884,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
22583,10336,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.84,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
22584,10336,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.475,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
22585,10336,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.014,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
22586,10336,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.667,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
22587,10336,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.88,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
22588,10336,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.763,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22589,10336,Blank 490,2,N,OHSU_HNSCC_derm002,20,1.203,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
22590,10336,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.879,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22591,10336,Blank 490,2,P,OHSU_HNSCC_derm002,20,1.068,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
22592,10336,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.603,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
22593,10336,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.742,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
22594,10336,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.733,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
22595,10336,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.828,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
22596,10336,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.816,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22597,10336,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.771,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
22598,10336,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.858,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
22599,10336,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.896,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
22600,10336,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.612,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
22601,10336,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.341,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
22602,10336,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.745,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
22603,10336,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.802,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
22604,10336,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.793,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22605,10336,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.842,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
22606,10336,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.935,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22607,10336,Blank 490,2,P,OHSU_HNSCC_derm002,21,1.009,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
22608,10336,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.8,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
22609,10336,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.716,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
22610,10336,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.696,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
22611,10336,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.767,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
22612,10336,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.718,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22613,10336,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.819,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
22614,10336,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.805,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
22615,10336,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.91,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
22616,10336,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.921,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
22617,10336,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.401,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
22618,10336,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.649,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
22619,10336,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.839,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
22620,10336,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.864,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22621,10336,Blank 490,2,N,OHSU_HNSCC_derm002,22,1.07,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
22622,10336,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.889,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22623,10336,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.968,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
22624,10336,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.777,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
22625,10336,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.931,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
22626,10336,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.741,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
22627,10336,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.786,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
22628,10336,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.801,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
22629,10336,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.747,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
22630,10336,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.769,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
22631,10336,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.812,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
22632,10336,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.8,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
22633,10336,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.715,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
22634,10336,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.699,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
22635,10336,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.772,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
22636,10336,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.862,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
22637,10336,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.971,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
22638,10336,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.85,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
22639,10336,Blank 490,2,P,OHSU_HNSCC_derm002,23,1.156,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
22640,10336,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.608,0,NONE,OHSU_HNSCC_derm002
22641,10336,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.832,0,NONE,OHSU_HNSCC_derm002
22642,10336,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.854,0,NONE,OHSU_HNSCC_derm002
22643,10336,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.739,0,NONE,OHSU_HNSCC_derm002
22644,10336,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.944,0,NONE,OHSU_HNSCC_derm002
22645,10336,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.625,0,NONE,OHSU_HNSCC_derm002
22646,10336,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.829,0,NONE,OHSU_HNSCC_derm002
22647,10336,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.845,0,NONE,OHSU_HNSCC_derm002
22648,10336,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.881,0,NONE,OHSU_HNSCC_derm002
22649,10336,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.777,0,NONE,OHSU_HNSCC_derm002
22650,10336,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.864,0,NONE,OHSU_HNSCC_derm002
22651,10336,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.98,0,NONE,OHSU_HNSCC_derm002
22652,10336,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.874,0,NONE,OHSU_HNSCC_derm002
22653,10336,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.842,0,NONE,OHSU_HNSCC_derm002
22654,10336,Blank 490,2,O,OHSU_HNSCC_derm002,24,1.002,0,NONE,OHSU_HNSCC_derm002
22655,10336,Blank 490,2,P,OHSU_HNSCC_derm002,24,1.01,0,NONE,OHSU_HNSCC_derm002
22656,10336,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.937,10,Thalidomide ,OHSU_HNSCC_derm002
22657,10336,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.868,10,Vandetanib,OHSU_HNSCC_derm002
22658,10336,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.777,10,Oleic acid,OHSU_HNSCC_derm002
22659,10336,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.2,10,A-674563,OHSU_HNSCC_derm002
22660,10336,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.781,10,Lapatinib,OHSU_HNSCC_derm002
22661,10336,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.826,10,Apocynin (vanillin),OHSU_HNSCC_derm002
22662,10336,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.358,10,AT-7519,OHSU_HNSCC_derm002
22663,10336,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.867,10,Gefitinib,OHSU_HNSCC_derm002
22664,10336,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.986,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
22665,10336,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.103,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22666,10336,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.289,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22667,10336,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.157,10,JQ1,OHSU_HNSCC_derm002
22668,10336,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.565,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22669,10336,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.402,10,Cerdulatinib,OHSU_HNSCC_derm002
22670,10336,Blank 490,3,O,OHSU_HNSCC_derm002,1,-0.014,10,Romidepsin,OHSU_HNSCC_derm002
22671,10336,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.119,10,Gilteritinib,OHSU_HNSCC_derm002
22672,10336,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.831,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
22673,10336,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.894,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
22674,10336,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.689,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
22675,10336,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.772,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
22676,10336,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.723,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
22677,10336,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.857,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
22678,10336,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.284,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
22679,10336,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.732,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
22680,10336,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.787,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
22681,10336,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.777,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22682,10336,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.787,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22683,10336,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.698,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
22684,10336,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.767,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22685,10336,Blank 490,3,N,OHSU_HNSCC_derm002,2,1.098,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
22686,10336,Blank 490,3,O,OHSU_HNSCC_derm002,2,-0.009,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
22687,10336,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.961,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
22688,10336,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.918,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
22689,10336,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.882,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
22690,10336,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.731,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
22691,10336,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.766,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
22692,10336,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.867,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
22693,10336,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.769,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
22694,10336,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.358,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
22695,10336,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.794,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
22696,10336,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.795,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
22697,10336,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.814,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22698,10336,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.831,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22699,10336,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.835,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
22700,10336,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.935,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22701,10336,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.922,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
22702,10336,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.026,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
22703,10336,Blank 490,3,P,OHSU_HNSCC_derm002,3,1.084,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
22704,10336,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.963,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
22705,10336,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.802,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
22706,10336,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.767,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
22707,10336,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
22708,10336,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.889,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
22709,10336,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.733,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
22710,10336,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.735,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
22711,10336,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.761,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
22712,10336,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.739,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
22713,10336,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.536,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22714,10336,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.792,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22715,10336,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.852,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
22716,10336,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.838,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22717,10336,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.827,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
22718,10336,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.103,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
22719,10336,Blank 490,3,P,OHSU_HNSCC_derm002,4,1.049,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
22720,10336,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.918,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
22721,10336,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.817,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
22722,10336,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.743,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
22723,10336,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.826,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
22724,10336,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.943,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
22725,10336,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.763,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
22726,10336,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.844,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
22727,10336,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.797,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
22728,10336,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.739,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
22729,10336,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.677,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22730,10336,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.758,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22731,10336,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.87,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
22732,10336,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.904,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22733,10336,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.84,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
22734,10336,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.12,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
22735,10336,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.957,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
22736,10336,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.871,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
22737,10336,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.844,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
22738,10336,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.632,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
22739,10336,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.706,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
22740,10336,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.899,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
22741,10336,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.773,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
22742,10336,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.856,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
22743,10336,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.805,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
22744,10336,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.839,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
22745,10336,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.862,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22746,10336,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.868,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22747,10336,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.894,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
22748,10336,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.924,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22749,10336,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.889,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
22750,10336,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.117,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
22751,10336,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.892,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
22752,10336,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.834,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
22753,10336,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.923,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
22754,10336,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.78,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
22755,10336,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.81,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
22756,10336,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.813,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
22757,10336,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.803,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
22758,10336,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.9,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
22759,10336,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.677,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
22760,10336,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.814,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
22761,10336,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.679,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
22762,10336,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.838,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
22763,10336,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.728,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
22764,10336,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.907,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
22765,10336,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.967,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
22766,10336,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.117,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
22767,10336,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.913,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
22768,10336,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.917,0,NONE,OHSU_HNSCC_derm002
22769,10336,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.903,0,NONE,OHSU_HNSCC_derm002
22770,10336,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
22771,10336,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.667,0,NONE,OHSU_HNSCC_derm002
22772,10336,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.824,0,NONE,OHSU_HNSCC_derm002
22773,10336,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.782,0,NONE,OHSU_HNSCC_derm002
22774,10336,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.872,0,NONE,OHSU_HNSCC_derm002
22775,10336,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.013,10,F-S-V,OHSU_HNSCC_derm002
22776,10336,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.72,0,NONE,OHSU_HNSCC_derm002
22777,10336,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.8,0,NONE,OHSU_HNSCC_derm002
22778,10336,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.664,0,NONE,OHSU_HNSCC_derm002
22779,10336,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.761,0,NONE,OHSU_HNSCC_derm002
22780,10336,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.94,0,NONE,OHSU_HNSCC_derm002
22781,10336,Blank 490,3,N,OHSU_HNSCC_derm002,8,1.031,0,NONE,OHSU_HNSCC_derm002
22782,10336,Blank 490,3,O,OHSU_HNSCC_derm002,8,1.017,0,NONE,OHSU_HNSCC_derm002
22783,10336,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.876,0,NONE,OHSU_HNSCC_derm002
22784,10336,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.852,10,Anastrazole,OHSU_HNSCC_derm002
22785,10336,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.245,10,JNJ-28312141 ,OHSU_HNSCC_derm002
22786,10336,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.758,10,Genistein,OHSU_HNSCC_derm002
22787,10336,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.798,10,Abscisic acid,OHSU_HNSCC_derm002
22788,10336,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.654,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22789,10336,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.762,10,Ruxolitinib,OHSU_HNSCC_derm002
22790,10336,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.946,10,TAK-659,OHSU_HNSCC_derm002
22791,10336,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.961,10,Brigatinib,OHSU_HNSCC_derm002
22792,10336,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.76,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22793,10336,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.047,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22794,10336,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.599,10,Vorinostat,OHSU_HNSCC_derm002
22795,10336,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.722,10,Lenalidomide,OHSU_HNSCC_derm002
22796,10336,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.82,10,NVP-ADW742,OHSU_HNSCC_derm002
22797,10336,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.987,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22798,10336,Blank 490,3,O,OHSU_HNSCC_derm002,9,1.101,10,Echinatin,OHSU_HNSCC_derm002
22799,10336,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.026,10,YM-155,OHSU_HNSCC_derm002
22800,10336,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.948,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
22801,10336,Blank 490,3,B,OHSU_HNSCC_derm002,10,1.062,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
22802,10336,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.735,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
22803,10336,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.814,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
22804,10336,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.545,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22805,10336,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.896,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
22806,10336,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.934,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
22807,10336,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.85,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
22808,10336,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.77,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22809,10336,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.694,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22810,10336,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.928,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
22811,10336,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.813,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
22812,10336,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.861,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
22813,10336,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.915,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22814,10336,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.982,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
22815,10336,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.014,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
22816,10336,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.897,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
22817,10336,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.917,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
22818,10336,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.771,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
22819,10336,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.696,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
22820,10336,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.572,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22821,10336,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.856,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
22822,10336,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.93,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
22823,10336,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.932,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
22824,10336,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.946,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22825,10336,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.766,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22826,10336,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.955,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
22827,10336,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.751,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
22828,10336,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.808,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
22829,10336,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.815,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22830,10336,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.939,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
22831,10336,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.013,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
22832,10336,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.847,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
22833,10336,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.94,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
22834,10336,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.708,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
22835,10336,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.722,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
22836,10336,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.63,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22837,10336,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.771,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
22838,10336,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.861,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
22839,10336,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.768,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
22840,10336,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.774,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22841,10336,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.812,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22842,10336,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.86,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
22843,10336,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.791,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
22844,10336,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.83,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
22845,10336,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.913,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22846,10336,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.951,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
22847,10336,Blank 490,3,P,OHSU_HNSCC_derm002,12,-0.012,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
22848,10336,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.843,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
22849,10336,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.806,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
22850,10336,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.711,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
22851,10336,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.754,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
22852,10336,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.747,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22853,10336,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.88,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
22854,10336,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.89,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
22855,10336,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.782,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
22856,10336,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.83,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22857,10336,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.789,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22858,10336,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.876,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
22859,10336,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.817,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
22860,10336,Blank 490,3,M,OHSU_HNSCC_derm002,13,1.063,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
22861,10336,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.867,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22862,10336,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.94,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
22863,10336,Blank 490,3,P,OHSU_HNSCC_derm002,13,-0.002,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
22864,10336,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.87,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
22865,10336,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.973,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
22866,10336,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.866,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
22867,10336,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.726,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
22868,10336,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.776,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22869,10336,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.836,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
22870,10336,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.855,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
22871,10336,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.736,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
22872,10336,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.688,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22873,10336,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.786,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22874,10336,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.871,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
22875,10336,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.715,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
22876,10336,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.779,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
22877,10336,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.846,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22878,10336,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.85,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
22879,10336,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.053,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
22880,10336,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.903,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
22881,10336,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.879,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
22882,10336,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.779,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
22883,10336,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.696,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
22884,10336,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.921,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
22885,10336,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.822,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
22886,10336,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.829,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
22887,10336,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.835,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
22888,10336,Blank 490,3,I,OHSU_HNSCC_derm002,15,1.019,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
22889,10336,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.901,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
22890,10336,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.72,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
22891,10336,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.677,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
22892,10336,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.819,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
22893,10336,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.795,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
22894,10336,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.942,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
22895,10336,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.131,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
22896,10336,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.919,0,NONE,OHSU_HNSCC_derm002
22897,10336,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.915,0,NONE,OHSU_HNSCC_derm002
22898,10336,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.876,0,NONE,OHSU_HNSCC_derm002
22899,10336,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.806,0,NONE,OHSU_HNSCC_derm002
22900,10336,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.734,0,NONE,OHSU_HNSCC_derm002
22901,10336,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.836,0,NONE,OHSU_HNSCC_derm002
22902,10336,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.659,0,NONE,OHSU_HNSCC_derm002
22903,10336,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.013,10,F-S-V,OHSU_HNSCC_derm002
22904,10336,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.762,0,NONE,OHSU_HNSCC_derm002
22905,10336,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.724,0,NONE,OHSU_HNSCC_derm002
22906,10336,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.825,0,NONE,OHSU_HNSCC_derm002
22907,10336,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.874,0,NONE,OHSU_HNSCC_derm002
22908,10336,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.832,0,NONE,OHSU_HNSCC_derm002
22909,10336,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.895,0,NONE,OHSU_HNSCC_derm002
22910,10336,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.932,0,NONE,OHSU_HNSCC_derm002
22911,10336,Blank 490,3,P,OHSU_HNSCC_derm002,16,1.075,0,NONE,OHSU_HNSCC_derm002
22912,10336,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.903,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22913,10336,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.852,10,Stevioside,OHSU_HNSCC_derm002
22914,10336,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.704,10,Pemetrexed,OHSU_HNSCC_derm002
22915,10336,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.411,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22916,10336,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.788,10,GSK-1838705A,OHSU_HNSCC_derm002
22917,10336,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.016,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22918,10336,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.816,10,Imatinib,OHSU_HNSCC_derm002
22919,10336,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.953,10,Trametinib,OHSU_HNSCC_derm002
22920,10336,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.283,10,BEZ235,OHSU_HNSCC_derm002
22921,10336,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.965,10,Saracatinib,OHSU_HNSCC_derm002
22922,10336,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.83,10,I-BET 762,OHSU_HNSCC_derm002
22923,10336,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.95,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
22924,10336,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.582,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
22925,10336,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.848,10,Crizotinib,OHSU_HNSCC_derm002
22926,10336,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.913,10,MGCD-265,OHSU_HNSCC_derm002
22927,10336,Blank 490,3,P,OHSU_HNSCC_derm002,17,1.129,10,Erlotinib,OHSU_HNSCC_derm002
22928,10336,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.894,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22929,10336,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.891,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
22930,10336,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.863,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
22931,10336,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.548,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22932,10336,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.849,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
22933,10336,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.809,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22934,10336,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.764,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
22935,10336,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.932,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
22936,10336,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.275,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
22937,10336,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.987,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
22938,10336,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.883,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
22939,10336,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.774,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
22940,10336,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.688,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
22941,10336,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.827,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
22942,10336,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.852,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
22943,10336,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.979,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
22944,10336,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.942,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22945,10336,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.915,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
22946,10336,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.76,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
22947,10336,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.683,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22948,10336,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.801,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
22949,10336,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.861,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22950,10336,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.889,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
22951,10336,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.917,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
22952,10336,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.332,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
22953,10336,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.871,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
22954,10336,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.962,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
22955,10336,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.802,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
22956,10336,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.848,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
22957,10336,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.967,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
22958,10336,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.958,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
22959,10336,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.94,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
22960,10336,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.864,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22961,10336,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.904,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
22962,10336,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.742,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
22963,10336,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.781,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22964,10336,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.956,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
22965,10336,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.871,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22966,10336,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.851,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
22967,10336,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.84,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
22968,10336,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.51,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
22969,10336,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.842,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
22970,10336,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.975,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
22971,10336,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.906,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
22972,10336,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.948,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
22973,10336,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.896,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
22974,10336,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.938,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
22975,10336,Blank 490,3,P,OHSU_HNSCC_derm002,20,1.027,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
22976,10336,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.831,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22977,10336,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.768,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
22978,10336,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.728,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
22979,10336,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.97,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22980,10336,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.85,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
22981,10336,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.779,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22982,10336,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.838,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
22983,10336,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.922,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
22984,10336,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.707,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
22985,10336,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.942,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
22986,10336,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.782,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
22987,10336,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.852,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
22988,10336,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.86,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
22989,10336,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.921,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
22990,10336,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.787,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
22991,10336,Blank 490,3,P,OHSU_HNSCC_derm002,21,1.07,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
22992,10336,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.803,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
22993,10336,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.94,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
22994,10336,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.937,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
22995,10336,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.936,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
22996,10336,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.951,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
22997,10336,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.9,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
22998,10336,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.844,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
22999,10336,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.785,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
23000,10336,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.887,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
23001,10336,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.755,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
23002,10336,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.877,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
23003,10336,Blank 490,3,L,OHSU_HNSCC_derm002,22,1.053,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
23004,10336,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.867,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
23005,10336,Blank 490,3,N,OHSU_HNSCC_derm002,22,1.07,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
23006,10336,Blank 490,3,O,OHSU_HNSCC_derm002,22,1.054,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
23007,10336,Blank 490,3,P,OHSU_HNSCC_derm002,22,1.105,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
23008,10336,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.884,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
23009,10336,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.931,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
23010,10336,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.818,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
23011,10336,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.827,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
23012,10336,Blank 490,3,E,OHSU_HNSCC_derm002,23,1.041,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
23013,10336,Blank 490,3,F,OHSU_HNSCC_derm002,23,1.056,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
23014,10336,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.913,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
23015,10336,Blank 490,3,H,OHSU_HNSCC_derm002,23,1.083,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
23016,10336,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.662,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
23017,10336,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.99,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
23018,10336,Blank 490,3,K,OHSU_HNSCC_derm002,23,1.004,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
23019,10336,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.968,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
23020,10336,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.979,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
23021,10336,Blank 490,3,N,OHSU_HNSCC_derm002,23,1.227,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
23022,10336,Blank 490,3,O,OHSU_HNSCC_derm002,23,1.067,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
23023,10336,Blank 490,3,P,OHSU_HNSCC_derm002,23,1.066,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
23024,10336,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.78,0,NONE,OHSU_HNSCC_derm002
23025,10336,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.958,0,NONE,OHSU_HNSCC_derm002
23026,10336,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.87,0,NONE,OHSU_HNSCC_derm002
23027,10336,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.882,0,NONE,OHSU_HNSCC_derm002
23028,10336,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.875,0,NONE,OHSU_HNSCC_derm002
23029,10336,Blank 490,3,F,OHSU_HNSCC_derm002,24,1.006,0,NONE,OHSU_HNSCC_derm002
23030,10336,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.705,0,NONE,OHSU_HNSCC_derm002
23031,10336,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.827,0,NONE,OHSU_HNSCC_derm002
23032,10336,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.906,0,NONE,OHSU_HNSCC_derm002
23033,10336,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.862,0,NONE,OHSU_HNSCC_derm002
23034,10336,Blank 490,3,K,OHSU_HNSCC_derm002,24,1.085,0,NONE,OHSU_HNSCC_derm002
23035,10336,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.946,0,NONE,OHSU_HNSCC_derm002
23036,10336,Blank 490,3,M,OHSU_HNSCC_derm002,24,1.129,0,NONE,OHSU_HNSCC_derm002
23037,10336,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.918,0,NONE,OHSU_HNSCC_derm002
23038,10336,Blank 490,3,O,OHSU_HNSCC_derm002,24,1.074,0,NONE,OHSU_HNSCC_derm002
23039,10336,Blank 490,3,P,OHSU_HNSCC_derm002,24,1.008,0,NONE,OHSU_HNSCC_derm002
23040,10336,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.128,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23041,10336,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.744,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23042,10336,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.585,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23043,10336,Blank 490,4,D,OHSU_HNSCC_derm002,1,1.054,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23044,10336,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.109,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23045,10336,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.26,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23046,10336,Blank 490,4,G,OHSU_HNSCC_derm002,1,-0.001,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23047,10336,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.115,10,Gefitinib,OHSU_HNSCC_derm002
23048,10336,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.546,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
23049,10336,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.001,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23050,10336,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.552,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23051,10336,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.207,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23052,10336,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.594,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23053,10336,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.432,10,VOLASERTIB x,OHSU_HNSCC_derm002
23054,10336,Blank 490,4,O,OHSU_HNSCC_derm002,1,1.135,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23055,10336,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.001,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23056,10336,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.245,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23057,10336,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.964,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23058,10336,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.945,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23059,10336,Blank 490,4,D,OHSU_HNSCC_derm002,2,1.138,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23060,10336,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.27,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23061,10336,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.254,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23062,10336,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.048,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23063,10336,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.975,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
23064,10336,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.958,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
23065,10336,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.684,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23066,10336,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.918,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23067,10336,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.555,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23068,10336,Blank 490,4,M,OHSU_HNSCC_derm002,2,1.068,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23069,10336,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.922,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
23070,10336,Blank 490,4,O,OHSU_HNSCC_derm002,2,1.065,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23071,10336,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.187,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23072,10336,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.638,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23073,10336,Blank 490,4,B,OHSU_HNSCC_derm002,3,1.051,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23074,10336,Blank 490,4,C,OHSU_HNSCC_derm002,3,1.009,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23075,10336,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.909,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23076,10336,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.845,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23077,10336,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.395,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23078,10336,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.161,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23079,10336,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.808,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
23080,10336,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.853,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
23081,10336,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.899,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23082,10336,Blank 490,4,K,OHSU_HNSCC_derm002,3,1.163,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23083,10336,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.964,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23084,10336,Blank 490,4,M,OHSU_HNSCC_derm002,3,1.027,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23085,10336,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.682,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
23086,10336,Blank 490,4,O,OHSU_HNSCC_derm002,3,1.141,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23087,10336,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.54,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23088,10336,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.678,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23089,10336,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.973,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23090,10336,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.78,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23091,10336,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.724,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23092,10336,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.943,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23093,10336,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.464,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23094,10336,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.162,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23095,10336,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.849,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
23096,10336,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.873,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
23097,10336,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.947,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23098,10336,Blank 490,4,K,OHSU_HNSCC_derm002,4,1.003,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23099,10336,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.966,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23100,10336,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.832,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23101,10336,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.569,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
23102,10336,Blank 490,4,O,OHSU_HNSCC_derm002,4,1.191,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23103,10336,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.964,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23104,10336,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.92,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23105,10336,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.833,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23106,10336,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.836,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23107,10336,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.914,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23108,10336,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.927,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23109,10336,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.773,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23110,10336,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.151,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23111,10336,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.838,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
23112,10336,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.936,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
23113,10336,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.922,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23114,10336,Blank 490,4,K,OHSU_HNSCC_derm002,5,1.015,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23115,10336,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.9,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23116,10336,Blank 490,4,M,OHSU_HNSCC_derm002,5,1.084,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23117,10336,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
23118,10336,Blank 490,4,O,OHSU_HNSCC_derm002,5,1.112,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23119,10336,Blank 490,4,P,OHSU_HNSCC_derm002,5,1.069,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23120,10336,Blank 490,4,A,OHSU_HNSCC_derm002,6,1.234,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23121,10336,Blank 490,4,B,OHSU_HNSCC_derm002,6,1.024,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23122,10336,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.746,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23123,10336,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.791,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23124,10336,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.888,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23125,10336,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.851,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23126,10336,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.184,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23127,10336,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.85,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
23128,10336,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.929,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
23129,10336,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.888,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23130,10336,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.969,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23131,10336,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.971,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23132,10336,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.878,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23133,10336,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.57,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
23134,10336,Blank 490,4,O,OHSU_HNSCC_derm002,6,1.16,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23135,10336,Blank 490,4,P,OHSU_HNSCC_derm002,6,1.315,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23136,10336,Blank 490,4,A,OHSU_HNSCC_derm002,7,1.168,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
23137,10336,Blank 490,4,B,OHSU_HNSCC_derm002,7,1.16,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
23138,10336,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.805,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
23139,10336,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.76,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23140,10336,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.89,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
23141,10336,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.916,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
23142,10336,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.223,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
23143,10336,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.855,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
23144,10336,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.844,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
23145,10336,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.696,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
23146,10336,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.955,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
23147,10336,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.95,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
23148,10336,Blank 490,4,M,OHSU_HNSCC_derm002,7,1.137,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
23149,10336,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.901,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
23150,10336,Blank 490,4,O,OHSU_HNSCC_derm002,7,1.159,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23151,10336,Blank 490,4,P,OHSU_HNSCC_derm002,7,1.219,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
23152,10336,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.963,0,NONE,OHSU_HNSCC_derm002
23153,10336,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.965,0,NONE,OHSU_HNSCC_derm002
23154,10336,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.835,0,NONE,OHSU_HNSCC_derm002
23155,10336,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.917,0,NONE,OHSU_HNSCC_derm002
23156,10336,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.935,0,NONE,OHSU_HNSCC_derm002
23157,10336,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.885,0,NONE,OHSU_HNSCC_derm002
23158,10336,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.977,0,NONE,OHSU_HNSCC_derm002
23159,10336,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
23160,10336,Blank 490,4,I,OHSU_HNSCC_derm002,8,1.16,0,NONE,OHSU_HNSCC_derm002
23161,10336,Blank 490,4,J,OHSU_HNSCC_derm002,8,1.06,0,NONE,OHSU_HNSCC_derm002
23162,10336,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.883,0,NONE,OHSU_HNSCC_derm002
23163,10336,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.998,0,NONE,OHSU_HNSCC_derm002
23164,10336,Blank 490,4,M,OHSU_HNSCC_derm002,8,1.102,0,NONE,OHSU_HNSCC_derm002
23165,10336,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.905,0,NONE,OHSU_HNSCC_derm002
23166,10336,Blank 490,4,O,OHSU_HNSCC_derm002,8,1.108,0,NONE,OHSU_HNSCC_derm002
23167,10336,Blank 490,4,P,OHSU_HNSCC_derm002,8,1.121,0,NONE,OHSU_HNSCC_derm002
23168,10336,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.445,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23169,10336,Blank 490,4,B,OHSU_HNSCC_derm002,9,1.087,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23170,10336,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.117,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
23171,10336,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.676,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23172,10336,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.922,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23173,10336,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.068,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
23174,10336,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.324,10,AZD2014 x ,OHSU_HNSCC_derm002
23175,10336,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.99,10,Brigatinib,OHSU_HNSCC_derm002
23176,10336,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.97,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23177,10336,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.221,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23178,10336,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.771,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23179,10336,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.001,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
23180,10336,Blank 490,4,M,OHSU_HNSCC_derm002,9,1.043,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23181,10336,Blank 490,4,N,OHSU_HNSCC_derm002,9,1.063,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23182,10336,Blank 490,4,O,OHSU_HNSCC_derm002,9,1.019,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23183,10336,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.576,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23184,10336,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.65,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23185,10336,Blank 490,4,B,OHSU_HNSCC_derm002,10,1.182,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23186,10336,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.226,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
23187,10336,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.795,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23188,10336,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.884,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23189,10336,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.296,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
23190,10336,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.426,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
23191,10336,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.944,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
23192,10336,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.928,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23193,10336,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.76,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23194,10336,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.9,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23195,10336,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.028,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
23196,10336,Blank 490,4,M,OHSU_HNSCC_derm002,10,1.211,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23197,10336,Blank 490,4,N,OHSU_HNSCC_derm002,10,1.137,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23198,10336,Blank 490,4,O,OHSU_HNSCC_derm002,10,1.04,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23199,10336,Blank 490,4,P,OHSU_HNSCC_derm002,10,1.147,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23200,10336,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.745,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23201,10336,Blank 490,4,B,OHSU_HNSCC_derm002,11,1.086,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23202,10336,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.285,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
23203,10336,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.933,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23204,10336,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.953,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23205,10336,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.506,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
23206,10336,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.474,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
23207,10336,Blank 490,4,H,OHSU_HNSCC_derm002,11,1.001,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
23208,10336,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.813,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23209,10336,Blank 490,4,J,OHSU_HNSCC_derm002,11,1.066,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23210,10336,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.866,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23211,10336,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.101,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
23212,10336,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.929,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23213,10336,Blank 490,4,N,OHSU_HNSCC_derm002,11,1.003,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23214,10336,Blank 490,4,O,OHSU_HNSCC_derm002,11,1.179,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23215,10336,Blank 490,4,P,OHSU_HNSCC_derm002,11,1.186,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23216,10336,Blank 490,4,A,OHSU_HNSCC_derm002,12,1.127,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23217,10336,Blank 490,4,B,OHSU_HNSCC_derm002,12,1.1,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23218,10336,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.775,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
23219,10336,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.809,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23220,10336,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.889,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23221,10336,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.926,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
23222,10336,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.829,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
23223,10336,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.869,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
23224,10336,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.834,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23225,10336,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.905,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23226,10336,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.922,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23227,10336,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.744,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
23228,10336,Blank 490,4,M,OHSU_HNSCC_derm002,12,1.172,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23229,10336,Blank 490,4,N,OHSU_HNSCC_derm002,12,1.002,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23230,10336,Blank 490,4,O,OHSU_HNSCC_derm002,12,1.124,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23231,10336,Blank 490,4,P,OHSU_HNSCC_derm002,12,1.2,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23232,10336,Blank 490,4,A,OHSU_HNSCC_derm002,13,1.145,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23233,10336,Blank 490,4,B,OHSU_HNSCC_derm002,13,1.033,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23234,10336,Blank 490,4,C,OHSU_HNSCC_derm002,13,1.099,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
23235,10336,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.688,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23236,10336,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.929,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23237,10336,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.851,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
23238,10336,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.932,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
23239,10336,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.861,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
23240,10336,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.836,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23241,10336,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.928,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23242,10336,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.897,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23243,10336,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.874,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
23244,10336,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.885,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23245,10336,Blank 490,4,N,OHSU_HNSCC_derm002,13,1.065,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23246,10336,Blank 490,4,O,OHSU_HNSCC_derm002,13,1.267,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23247,10336,Blank 490,4,P,OHSU_HNSCC_derm002,13,1.072,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23248,10336,Blank 490,4,A,OHSU_HNSCC_derm002,14,1.041,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23249,10336,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.997,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23250,10336,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.929,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
23251,10336,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.829,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23252,10336,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.978,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23253,10336,Blank 490,4,F,OHSU_HNSCC_derm002,14,1.029,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
23254,10336,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.966,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
23255,10336,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.902,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
23256,10336,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.899,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23257,10336,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.907,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23258,10336,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.754,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23259,10336,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.804,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
23260,10336,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.91,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23261,10336,Blank 490,4,N,OHSU_HNSCC_derm002,14,1.153,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23262,10336,Blank 490,4,O,OHSU_HNSCC_derm002,14,1.121,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23263,10336,Blank 490,4,P,OHSU_HNSCC_derm002,14,1.339,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23264,10336,Blank 490,4,A,OHSU_HNSCC_derm002,15,1.117,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
23265,10336,Blank 490,4,B,OHSU_HNSCC_derm002,15,1.051,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
23266,10336,Blank 490,4,C,OHSU_HNSCC_derm002,15,1.127,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
23267,10336,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.87,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23268,10336,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.992,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
23269,10336,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.926,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
23270,10336,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.935,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
23271,10336,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.88,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
23272,10336,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.981,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23273,10336,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.823,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
23274,10336,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.949,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
23275,10336,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.806,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
23276,10336,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.958,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23277,10336,Blank 490,4,N,OHSU_HNSCC_derm002,15,1.004,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
23278,10336,Blank 490,4,O,OHSU_HNSCC_derm002,15,1.132,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
23279,10336,Blank 490,4,P,OHSU_HNSCC_derm002,15,1.048,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
23280,10336,Blank 490,4,A,OHSU_HNSCC_derm002,16,1.176,0,NONE,OHSU_HNSCC_derm002
23281,10336,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.973,0,NONE,OHSU_HNSCC_derm002
23282,10336,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.829,0,NONE,OHSU_HNSCC_derm002
23283,10336,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.845,0,NONE,OHSU_HNSCC_derm002
23284,10336,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.919,0,NONE,OHSU_HNSCC_derm002
23285,10336,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.933,0,NONE,OHSU_HNSCC_derm002
23286,10336,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.87,0,NONE,OHSU_HNSCC_derm002
23287,10336,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
23288,10336,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.882,0,NONE,OHSU_HNSCC_derm002
23289,10336,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.897,0,NONE,OHSU_HNSCC_derm002
23290,10336,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.784,0,NONE,OHSU_HNSCC_derm002
23291,10336,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.729,0,NONE,OHSU_HNSCC_derm002
23292,10336,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.851,0,NONE,OHSU_HNSCC_derm002
23293,10336,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.962,0,NONE,OHSU_HNSCC_derm002
23294,10336,Blank 490,4,O,OHSU_HNSCC_derm002,16,1.02,0,NONE,OHSU_HNSCC_derm002
23295,10336,Blank 490,4,P,OHSU_HNSCC_derm002,16,1.201,0,NONE,OHSU_HNSCC_derm002
23296,10336,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.943,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23297,10336,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.234,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23298,10336,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.172,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23299,10336,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.015,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23300,10336,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.113,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23301,10336,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.883,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23302,10336,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.987,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23303,10336,Blank 490,4,H,OHSU_HNSCC_derm002,17,1.092,10,Trametinib,OHSU_HNSCC_derm002
23304,10336,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.272,10,BEZ235,OHSU_HNSCC_derm002
23305,10336,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.175,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23306,10336,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.907,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23307,10336,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.962,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23308,10336,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.87,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23309,10336,Blank 490,4,N,OHSU_HNSCC_derm002,17,1.145,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23310,10336,Blank 490,4,O,OHSU_HNSCC_derm002,17,1.019,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23311,10336,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.516,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23312,10336,Blank 490,4,A,OHSU_HNSCC_derm002,18,1.0,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23313,10336,Blank 490,4,B,OHSU_HNSCC_derm002,18,1.162,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23314,10336,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.846,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23315,10336,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.014,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23316,10336,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.397,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23317,10336,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.956,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23318,10336,Blank 490,4,G,OHSU_HNSCC_derm002,18,1.078,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23319,10336,Blank 490,4,H,OHSU_HNSCC_derm002,18,1.033,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
23320,10336,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.369,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
23321,10336,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.582,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23322,10336,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.884,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23323,10336,Blank 490,4,L,OHSU_HNSCC_derm002,18,1.107,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23324,10336,Blank 490,4,M,OHSU_HNSCC_derm002,18,1.009,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23325,10336,Blank 490,4,N,OHSU_HNSCC_derm002,18,1.16,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23326,10336,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.971,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23327,10336,Blank 490,4,P,OHSU_HNSCC_derm002,18,1.257,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23328,10336,Blank 490,4,A,OHSU_HNSCC_derm002,19,1.043,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23329,10336,Blank 490,4,B,OHSU_HNSCC_derm002,19,1.116,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23330,10336,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.859,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23331,10336,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.103,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23332,10336,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.966,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23333,10336,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.535,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23334,10336,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.766,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23335,10336,Blank 490,4,H,OHSU_HNSCC_derm002,19,1.059,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
23336,10336,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.277,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
23337,10336,Blank 490,4,J,OHSU_HNSCC_derm002,19,1.103,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23338,10336,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.902,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23339,10336,Blank 490,4,L,OHSU_HNSCC_derm002,19,1.086,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23340,10336,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.849,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23341,10336,Blank 490,4,N,OHSU_HNSCC_derm002,19,1.024,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23342,10336,Blank 490,4,O,OHSU_HNSCC_derm002,19,1.028,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23343,10336,Blank 490,4,P,OHSU_HNSCC_derm002,19,1.097,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23344,10336,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.96,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23345,10336,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.989,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23346,10336,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.875,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23347,10336,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.124,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23348,10336,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.517,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23349,10336,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.895,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23350,10336,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.847,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23351,10336,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.937,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
23352,10336,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.527,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
23353,10336,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.999,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23354,10336,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.818,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23355,10336,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.913,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23356,10336,Blank 490,4,M,OHSU_HNSCC_derm002,20,1.049,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23357,10336,Blank 490,4,N,OHSU_HNSCC_derm002,20,1.055,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23358,10336,Blank 490,4,O,OHSU_HNSCC_derm002,20,1.036,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23359,10336,Blank 490,4,P,OHSU_HNSCC_derm002,20,1.092,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23360,10336,Blank 490,4,A,OHSU_HNSCC_derm002,21,1.072,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23361,10336,Blank 490,4,B,OHSU_HNSCC_derm002,21,1.109,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23362,10336,Blank 490,4,C,OHSU_HNSCC_derm002,21,1.016,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23363,10336,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.146,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23364,10336,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.838,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23365,10336,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.882,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23366,10336,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.897,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23367,10336,Blank 490,4,H,OHSU_HNSCC_derm002,21,1.067,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
23368,10336,Blank 490,4,I,OHSU_HNSCC_derm002,21,1.161,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
23369,10336,Blank 490,4,J,OHSU_HNSCC_derm002,21,1.143,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23370,10336,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.863,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23371,10336,Blank 490,4,L,OHSU_HNSCC_derm002,21,1.119,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23372,10336,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.895,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23373,10336,Blank 490,4,N,OHSU_HNSCC_derm002,21,1.147,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23374,10336,Blank 490,4,O,OHSU_HNSCC_derm002,21,1.162,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23375,10336,Blank 490,4,P,OHSU_HNSCC_derm002,21,1.279,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23376,10336,Blank 490,4,A,OHSU_HNSCC_derm002,22,1.042,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23377,10336,Blank 490,4,B,OHSU_HNSCC_derm002,22,1.032,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23378,10336,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.878,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23379,10336,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.131,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23380,10336,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.851,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23381,10336,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.945,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23382,10336,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.896,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23383,10336,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.976,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
23384,10336,Blank 490,4,I,OHSU_HNSCC_derm002,22,1.074,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
23385,10336,Blank 490,4,J,OHSU_HNSCC_derm002,22,1.008,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23386,10336,Blank 490,4,K,OHSU_HNSCC_derm002,22,1.112,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23387,10336,Blank 490,4,L,OHSU_HNSCC_derm002,22,1.076,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23388,10336,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.882,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23389,10336,Blank 490,4,N,OHSU_HNSCC_derm002,22,1.302,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23390,10336,Blank 490,4,O,OHSU_HNSCC_derm002,22,1.185,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23391,10336,Blank 490,4,P,OHSU_HNSCC_derm002,22,1.295,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23392,10336,Blank 490,4,A,OHSU_HNSCC_derm002,23,1.035,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
23393,10336,Blank 490,4,B,OHSU_HNSCC_derm002,23,1.125,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
23394,10336,Blank 490,4,C,OHSU_HNSCC_derm002,23,1.137,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23395,10336,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.179,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
23396,10336,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.867,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23397,10336,Blank 490,4,F,OHSU_HNSCC_derm002,23,1.154,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
23398,10336,Blank 490,4,G,OHSU_HNSCC_derm002,23,1.073,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
23399,10336,Blank 490,4,H,OHSU_HNSCC_derm002,23,1.096,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
23400,10336,Blank 490,4,I,OHSU_HNSCC_derm002,23,1.026,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
23401,10336,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.855,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
23402,10336,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.932,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23403,10336,Blank 490,4,L,OHSU_HNSCC_derm002,23,1.344,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23404,10336,Blank 490,4,M,OHSU_HNSCC_derm002,23,1.2,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
23405,10336,Blank 490,4,N,OHSU_HNSCC_derm002,23,1.035,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23406,10336,Blank 490,4,O,OHSU_HNSCC_derm002,23,1.111,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
23407,10336,Blank 490,4,P,OHSU_HNSCC_derm002,23,1.153,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23408,10336,Blank 490,4,A,OHSU_HNSCC_derm002,24,1.058,0,NONE,OHSU_HNSCC_derm002
23409,10336,Blank 490,4,B,OHSU_HNSCC_derm002,24,1.155,0,NONE,OHSU_HNSCC_derm002
23410,10336,Blank 490,4,C,OHSU_HNSCC_derm002,24,1.15,0,NONE,OHSU_HNSCC_derm002
23411,10336,Blank 490,4,D,OHSU_HNSCC_derm002,24,1.068,0,NONE,OHSU_HNSCC_derm002
23412,10336,Blank 490,4,E,OHSU_HNSCC_derm002,24,1.007,0,NONE,OHSU_HNSCC_derm002
23413,10336,Blank 490,4,F,OHSU_HNSCC_derm002,24,1.059,0,NONE,OHSU_HNSCC_derm002
23414,10336,Blank 490,4,G,OHSU_HNSCC_derm002,24,1.075,0,NONE,OHSU_HNSCC_derm002
23415,10336,Blank 490,4,H,OHSU_HNSCC_derm002,24,1.212,0,NONE,OHSU_HNSCC_derm002
23416,10336,Blank 490,4,I,OHSU_HNSCC_derm002,24,1.2,0,NONE,OHSU_HNSCC_derm002
23417,10336,Blank 490,4,J,OHSU_HNSCC_derm002,24,1.036,0,NONE,OHSU_HNSCC_derm002
23418,10336,Blank 490,4,K,OHSU_HNSCC_derm002,24,1.102,0,NONE,OHSU_HNSCC_derm002
23419,10336,Blank 490,4,L,OHSU_HNSCC_derm002,24,1.055,0,NONE,OHSU_HNSCC_derm002
23420,10336,Blank 490,4,M,OHSU_HNSCC_derm002,24,1.149,0,NONE,OHSU_HNSCC_derm002
23421,10336,Blank 490,4,N,OHSU_HNSCC_derm002,24,1.287,0,NONE,OHSU_HNSCC_derm002
23422,10336,Blank 490,4,O,OHSU_HNSCC_derm002,24,1.169,0,NONE,OHSU_HNSCC_derm002
23423,10336,Blank 490,4,P,OHSU_HNSCC_derm002,24,1.037,0,NONE,OHSU_HNSCC_derm002
23424,10336,Blank 490,5,A,OHSU_HNSCC_derm002,1,1.006,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23425,10336,Blank 490,5,B,OHSU_HNSCC_derm002,1,1.151,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23426,10336,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.008,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23427,10336,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.772,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23428,10336,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.269,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23429,10336,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.863,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23430,10336,Blank 490,5,G,OHSU_HNSCC_derm002,1,1.146,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23431,10336,Blank 490,5,H,OHSU_HNSCC_derm002,1,1.055,10,Gefitinib,OHSU_HNSCC_derm002
23432,10336,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.412,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
23433,10336,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.003,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23434,10336,Blank 490,5,K,OHSU_HNSCC_derm002,1,1.049,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23435,10336,Blank 490,5,L,OHSU_HNSCC_derm002,1,1.181,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23436,10336,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.379,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23437,10336,Blank 490,5,N,OHSU_HNSCC_derm002,1,1.142,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23438,10336,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.202,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23439,10336,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.181,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23440,10336,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.962,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23441,10336,Blank 490,5,B,OHSU_HNSCC_derm002,2,1.134,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23442,10336,Blank 490,5,C,OHSU_HNSCC_derm002,2,0.006,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23443,10336,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.854,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23444,10336,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.919,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23445,10336,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.897,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23446,10336,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.93,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23447,10336,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.939,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
23448,10336,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.937,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
23449,10336,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.435,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23450,10336,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.922,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23451,10336,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.872,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23452,10336,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.569,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23453,10336,Blank 490,5,N,OHSU_HNSCC_derm002,2,1.024,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23454,10336,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.243,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23455,10336,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.492,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23456,10336,Blank 490,5,A,OHSU_HNSCC_derm002,3,1.001,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23457,10336,Blank 490,5,B,OHSU_HNSCC_derm002,3,1.129,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23458,10336,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.098,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23459,10336,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.888,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23460,10336,Blank 490,5,E,OHSU_HNSCC_derm002,3,1.117,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23461,10336,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.91,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23462,10336,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.853,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23463,10336,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.894,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
23464,10336,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.884,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
23465,10336,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.782,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23466,10336,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.812,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23467,10336,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.917,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23468,10336,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.947,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23469,10336,Blank 490,5,N,OHSU_HNSCC_derm002,3,1.071,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23470,10336,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.38,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23471,10336,Blank 490,5,P,OHSU_HNSCC_derm002,3,1.089,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23472,10336,Blank 490,5,A,OHSU_HNSCC_derm002,4,1.102,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23473,10336,Blank 490,5,B,OHSU_HNSCC_derm002,4,1.04,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23474,10336,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.123,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23475,10336,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.798,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23476,10336,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.968,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23477,10336,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.855,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23478,10336,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.974,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23479,10336,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.872,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
23480,10336,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.87,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
23481,10336,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.929,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23482,10336,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.887,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23483,10336,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.894,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23484,10336,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.978,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23485,10336,Blank 490,5,N,OHSU_HNSCC_derm002,4,1.083,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23486,10336,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.501,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23487,10336,Blank 490,5,P,OHSU_HNSCC_derm002,4,1.352,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23488,10336,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.833,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23489,10336,Blank 490,5,B,OHSU_HNSCC_derm002,5,1.142,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23490,10336,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.146,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23491,10336,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.793,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23492,10336,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.912,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23493,10336,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.852,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23494,10336,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.956,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23495,10336,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.886,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
23496,10336,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.878,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
23497,10336,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.987,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23498,10336,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.971,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23499,10336,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.913,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23500,10336,Blank 490,5,M,OHSU_HNSCC_derm002,5,1.11,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23501,10336,Blank 490,5,N,OHSU_HNSCC_derm002,5,1.108,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23502,10336,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.822,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23503,10336,Blank 490,5,P,OHSU_HNSCC_derm002,5,1.166,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23504,10336,Blank 490,5,A,OHSU_HNSCC_derm002,6,1.129,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23505,10336,Blank 490,5,B,OHSU_HNSCC_derm002,6,1.082,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23506,10336,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.173,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23507,10336,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.735,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23508,10336,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.856,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23509,10336,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.777,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23510,10336,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.898,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23511,10336,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.665,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
23512,10336,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.719,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
23513,10336,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.914,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23514,10336,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.927,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23515,10336,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.998,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23516,10336,Blank 490,5,M,OHSU_HNSCC_derm002,6,1.018,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23517,10336,Blank 490,5,N,OHSU_HNSCC_derm002,6,1.1,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23518,10336,Blank 490,5,O,OHSU_HNSCC_derm002,6,1.02,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23519,10336,Blank 490,5,P,OHSU_HNSCC_derm002,6,1.084,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23520,10336,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.959,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23521,10336,Blank 490,5,B,OHSU_HNSCC_derm002,7,1.063,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
23522,10336,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.269,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
23523,10336,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.851,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
23524,10336,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.793,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
23525,10336,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.889,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
23526,10336,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.883,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
23527,10336,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.859,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
23528,10336,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.894,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
23529,10336,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.839,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
23530,10336,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.878,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
23531,10336,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.854,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23532,10336,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.896,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23533,10336,Blank 490,5,N,OHSU_HNSCC_derm002,7,1.1,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
23534,10336,Blank 490,5,O,OHSU_HNSCC_derm002,7,1.103,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
23535,10336,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.979,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
23536,10336,Blank 490,5,A,OHSU_HNSCC_derm002,8,1.064,0,NONE,OHSU_HNSCC_derm002
23537,10336,Blank 490,5,B,OHSU_HNSCC_derm002,8,1.079,0,NONE,OHSU_HNSCC_derm002
23538,10336,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.87,0,NONE,OHSU_HNSCC_derm002
23539,10336,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.893,0,NONE,OHSU_HNSCC_derm002
23540,10336,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.886,0,NONE,OHSU_HNSCC_derm002
23541,10336,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
23542,10336,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.922,0,NONE,OHSU_HNSCC_derm002
23543,10336,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.006,10,F-S-V,OHSU_HNSCC_derm002
23544,10336,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.892,0,NONE,OHSU_HNSCC_derm002
23545,10336,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.797,0,NONE,OHSU_HNSCC_derm002
23546,10336,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.888,0,NONE,OHSU_HNSCC_derm002
23547,10336,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
23548,10336,Blank 490,5,M,OHSU_HNSCC_derm002,8,1.087,0,NONE,OHSU_HNSCC_derm002
23549,10336,Blank 490,5,N,OHSU_HNSCC_derm002,8,1.015,0,NONE,OHSU_HNSCC_derm002
23550,10336,Blank 490,5,O,OHSU_HNSCC_derm002,8,1.118,0,NONE,OHSU_HNSCC_derm002
23551,10336,Blank 490,5,P,OHSU_HNSCC_derm002,8,1.139,0,NONE,OHSU_HNSCC_derm002
23552,10336,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.001,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23553,10336,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.719,10,APTO-253 x,OHSU_HNSCC_derm002
23554,10336,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.064,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23555,10336,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.8,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23556,10336,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.967,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23557,10336,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.238,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23558,10336,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.24,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23559,10336,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.007,10,Brigatinib,OHSU_HNSCC_derm002
23560,10336,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.945,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23561,10336,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.118,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23562,10336,Blank 490,5,K,OHSU_HNSCC_derm002,9,-0.002,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23563,10336,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.163,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23564,10336,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.98,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23565,10336,Blank 490,5,N,OHSU_HNSCC_derm002,9,1.044,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23566,10336,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.008,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23567,10336,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.004,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23568,10336,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.024,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23569,10336,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.82,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
23570,10336,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.11,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23571,10336,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.788,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23572,10336,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.88,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23573,10336,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.665,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23574,10336,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.915,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23575,10336,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.934,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
23576,10336,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.921,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23577,10336,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.283,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23578,10336,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.391,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23579,10336,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.172,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23580,10336,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.983,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23581,10336,Blank 490,5,N,OHSU_HNSCC_derm002,10,1.14,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23582,10336,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.561,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23583,10336,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.108,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23584,10336,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.09,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23585,10336,Blank 490,5,B,OHSU_HNSCC_derm002,11,1.007,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
23586,10336,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.129,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23587,10336,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.874,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23588,10336,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.885,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23589,10336,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.913,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23590,10336,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.901,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23591,10336,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.969,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
23592,10336,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.895,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23593,10336,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.419,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23594,10336,Blank 490,5,K,OHSU_HNSCC_derm002,11,1.041,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23595,10336,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.204,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23596,10336,Blank 490,5,M,OHSU_HNSCC_derm002,11,1.021,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23597,10336,Blank 490,5,N,OHSU_HNSCC_derm002,11,1.04,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23598,10336,Blank 490,5,O,OHSU_HNSCC_derm002,11,1.076,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23599,10336,Blank 490,5,P,OHSU_HNSCC_derm002,11,1.307,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23600,10336,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.117,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23601,10336,Blank 490,5,B,OHSU_HNSCC_derm002,12,1.131,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
23602,10336,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.299,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23603,10336,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.797,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23604,10336,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.929,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23605,10336,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.941,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23606,10336,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.837,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23607,10336,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.879,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
23608,10336,Blank 490,5,I,OHSU_HNSCC_derm002,12,1.044,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23609,10336,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.339,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23610,10336,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.945,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23611,10336,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.385,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23612,10336,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.942,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23613,10336,Blank 490,5,N,OHSU_HNSCC_derm002,12,1.027,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23614,10336,Blank 490,5,O,OHSU_HNSCC_derm002,12,1.07,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23615,10336,Blank 490,5,P,OHSU_HNSCC_derm002,12,1.282,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23616,10336,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.126,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23617,10336,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.873,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
23618,10336,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.842,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23619,10336,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.824,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23620,10336,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.737,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23621,10336,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.935,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23622,10336,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.801,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23623,10336,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.834,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
23624,10336,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.894,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23625,10336,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.591,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23626,10336,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.87,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23627,10336,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.832,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23628,10336,Blank 490,5,M,OHSU_HNSCC_derm002,13,1.015,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23629,10336,Blank 490,5,N,OHSU_HNSCC_derm002,13,1.026,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23630,10336,Blank 490,5,O,OHSU_HNSCC_derm002,13,1.044,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23631,10336,Blank 490,5,P,OHSU_HNSCC_derm002,13,1.201,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23632,10336,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.138,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23633,10336,Blank 490,5,B,OHSU_HNSCC_derm002,14,1.065,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
23634,10336,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.919,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23635,10336,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.877,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23636,10336,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.909,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23637,10336,Blank 490,5,F,OHSU_HNSCC_derm002,14,1.047,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23638,10336,Blank 490,5,G,OHSU_HNSCC_derm002,14,1.053,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23639,10336,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.894,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
23640,10336,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.915,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23641,10336,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.981,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23642,10336,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.903,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23643,10336,Blank 490,5,L,OHSU_HNSCC_derm002,14,1.025,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23644,10336,Blank 490,5,M,OHSU_HNSCC_derm002,14,1.008,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23645,10336,Blank 490,5,N,OHSU_HNSCC_derm002,14,1.132,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23646,10336,Blank 490,5,O,OHSU_HNSCC_derm002,14,1.006,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23647,10336,Blank 490,5,P,OHSU_HNSCC_derm002,14,1.248,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23648,10336,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.174,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
23649,10336,Blank 490,5,B,OHSU_HNSCC_derm002,15,1.122,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
23650,10336,Blank 490,5,C,OHSU_HNSCC_derm002,15,1.112,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
23651,10336,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.796,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
23652,10336,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.899,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
23653,10336,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.998,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23654,10336,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.954,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23655,10336,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.934,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
23656,10336,Blank 490,5,I,OHSU_HNSCC_derm002,15,1.035,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23657,10336,Blank 490,5,J,OHSU_HNSCC_derm002,15,1.119,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
23658,10336,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.863,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23659,10336,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.955,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
23660,10336,Blank 490,5,M,OHSU_HNSCC_derm002,15,1.068,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
23661,10336,Blank 490,5,N,OHSU_HNSCC_derm002,15,1.124,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23662,10336,Blank 490,5,O,OHSU_HNSCC_derm002,15,1.043,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23663,10336,Blank 490,5,P,OHSU_HNSCC_derm002,15,1.092,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23664,10336,Blank 490,5,A,OHSU_HNSCC_derm002,16,1.001,0,NONE,OHSU_HNSCC_derm002
23665,10336,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.958,0,NONE,OHSU_HNSCC_derm002
23666,10336,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.869,0,NONE,OHSU_HNSCC_derm002
23667,10336,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.792,0,NONE,OHSU_HNSCC_derm002
23668,10336,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.801,0,NONE,OHSU_HNSCC_derm002
23669,10336,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.773,0,NONE,OHSU_HNSCC_derm002
23670,10336,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.88,0,NONE,OHSU_HNSCC_derm002
23671,10336,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.006,10,F-S-V,OHSU_HNSCC_derm002
23672,10336,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.642,0,NONE,OHSU_HNSCC_derm002
23673,10336,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.801,0,NONE,OHSU_HNSCC_derm002
23674,10336,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.867,0,NONE,OHSU_HNSCC_derm002
23675,10336,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.88,0,NONE,OHSU_HNSCC_derm002
23676,10336,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.935,0,NONE,OHSU_HNSCC_derm002
23677,10336,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.832,0,NONE,OHSU_HNSCC_derm002
23678,10336,Blank 490,5,O,OHSU_HNSCC_derm002,16,1.096,0,NONE,OHSU_HNSCC_derm002
23679,10336,Blank 490,5,P,OHSU_HNSCC_derm002,16,1.132,0,NONE,OHSU_HNSCC_derm002
23680,10336,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.007,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23681,10336,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.005,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23682,10336,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.473,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23683,10336,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.911,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23684,10336,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.851,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23685,10336,Blank 490,5,F,OHSU_HNSCC_derm002,17,1.068,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23686,10336,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.985,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23687,10336,Blank 490,5,H,OHSU_HNSCC_derm002,17,1.008,10,Trametinib,OHSU_HNSCC_derm002
23688,10336,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.233,10,BEZ235,OHSU_HNSCC_derm002
23689,10336,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.679,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23690,10336,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.838,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23691,10336,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.34,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23692,10336,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.984,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23693,10336,Blank 490,5,N,OHSU_HNSCC_derm002,17,1.102,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23694,10336,Blank 490,5,O,OHSU_HNSCC_derm002,17,1.03,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23695,10336,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.977,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23696,10336,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.286,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23697,10336,Blank 490,5,B,OHSU_HNSCC_derm002,18,1.012,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23698,10336,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.702,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23699,10336,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.894,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23700,10336,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.998,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23701,10336,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.955,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23702,10336,Blank 490,5,G,OHSU_HNSCC_derm002,18,1.028,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23703,10336,Blank 490,5,H,OHSU_HNSCC_derm002,18,1.102,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
23704,10336,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.347,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
23705,10336,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.994,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23706,10336,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.818,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23707,10336,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.906,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23708,10336,Blank 490,5,M,OHSU_HNSCC_derm002,18,1.022,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23709,10336,Blank 490,5,N,OHSU_HNSCC_derm002,18,1.057,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23710,10336,Blank 490,5,O,OHSU_HNSCC_derm002,18,1.271,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23711,10336,Blank 490,5,P,OHSU_HNSCC_derm002,18,1.23,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23712,10336,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.999,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23713,10336,Blank 490,5,B,OHSU_HNSCC_derm002,19,1.059,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23714,10336,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.819,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23715,10336,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.844,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23716,10336,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.821,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23717,10336,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.91,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23718,10336,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.923,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23719,10336,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.979,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
23720,10336,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.277,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
23721,10336,Blank 490,5,J,OHSU_HNSCC_derm002,19,1.163,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23722,10336,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.818,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23723,10336,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.917,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23724,10336,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.91,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23725,10336,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.937,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23726,10336,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.875,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23727,10336,Blank 490,5,P,OHSU_HNSCC_derm002,19,1.284,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23728,10336,Blank 490,5,A,OHSU_HNSCC_derm002,20,1.076,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23729,10336,Blank 490,5,B,OHSU_HNSCC_derm002,20,1.109,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23730,10336,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.952,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23731,10336,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.82,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23732,10336,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.9,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23733,10336,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.958,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23734,10336,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.963,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23735,10336,Blank 490,5,H,OHSU_HNSCC_derm002,20,1.073,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
23736,10336,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.625,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
23737,10336,Blank 490,5,J,OHSU_HNSCC_derm002,20,1.192,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23738,10336,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.868,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23739,10336,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.924,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23740,10336,Blank 490,5,M,OHSU_HNSCC_derm002,20,1.059,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23741,10336,Blank 490,5,N,OHSU_HNSCC_derm002,20,1.181,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23742,10336,Blank 490,5,O,OHSU_HNSCC_derm002,20,1.109,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23743,10336,Blank 490,5,P,OHSU_HNSCC_derm002,20,1.136,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23744,10336,Blank 490,5,A,OHSU_HNSCC_derm002,21,1.038,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23745,10336,Blank 490,5,B,OHSU_HNSCC_derm002,21,1.156,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23746,10336,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.972,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23747,10336,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.948,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23748,10336,Blank 490,5,E,OHSU_HNSCC_derm002,21,1.137,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23749,10336,Blank 490,5,F,OHSU_HNSCC_derm002,21,1.016,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23750,10336,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.931,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23751,10336,Blank 490,5,H,OHSU_HNSCC_derm002,21,1.017,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
23752,10336,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.766,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
23753,10336,Blank 490,5,J,OHSU_HNSCC_derm002,21,1.132,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23754,10336,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.914,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23755,10336,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.983,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23756,10336,Blank 490,5,M,OHSU_HNSCC_derm002,21,1.047,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23757,10336,Blank 490,5,N,OHSU_HNSCC_derm002,21,1.129,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23758,10336,Blank 490,5,O,OHSU_HNSCC_derm002,21,1.06,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23759,10336,Blank 490,5,P,OHSU_HNSCC_derm002,21,1.137,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23760,10336,Blank 490,5,A,OHSU_HNSCC_derm002,22,1.055,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23761,10336,Blank 490,5,B,OHSU_HNSCC_derm002,22,1.135,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23762,10336,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.961,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23763,10336,Blank 490,5,D,OHSU_HNSCC_derm002,22,1.06,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23764,10336,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.774,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23765,10336,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.893,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23766,10336,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.991,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23767,10336,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.994,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
23768,10336,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.956,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
23769,10336,Blank 490,5,J,OHSU_HNSCC_derm002,22,1.079,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23770,10336,Blank 490,5,K,OHSU_HNSCC_derm002,22,1.032,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23771,10336,Blank 490,5,L,OHSU_HNSCC_derm002,22,1.053,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23772,10336,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.944,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23773,10336,Blank 490,5,N,OHSU_HNSCC_derm002,22,1.27,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23774,10336,Blank 490,5,O,OHSU_HNSCC_derm002,22,1.04,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23775,10336,Blank 490,5,P,OHSU_HNSCC_derm002,22,1.158,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23776,10336,Blank 490,5,A,OHSU_HNSCC_derm002,23,1.023,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23777,10336,Blank 490,5,B,OHSU_HNSCC_derm002,23,1.109,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
23778,10336,Blank 490,5,C,OHSU_HNSCC_derm002,23,1.092,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23779,10336,Blank 490,5,D,OHSU_HNSCC_derm002,23,1.147,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
23780,10336,Blank 490,5,E,OHSU_HNSCC_derm002,23,1.052,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
23781,10336,Blank 490,5,F,OHSU_HNSCC_derm002,23,1.181,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23782,10336,Blank 490,5,G,OHSU_HNSCC_derm002,23,1.037,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
23783,10336,Blank 490,5,H,OHSU_HNSCC_derm002,23,1.102,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
23784,10336,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.78,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
23785,10336,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.984,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
23786,10336,Blank 490,5,K,OHSU_HNSCC_derm002,23,1.243,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
23787,10336,Blank 490,5,L,OHSU_HNSCC_derm002,23,1.077,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
23788,10336,Blank 490,5,M,OHSU_HNSCC_derm002,23,1.086,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
23789,10336,Blank 490,5,N,OHSU_HNSCC_derm002,23,1.26,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23790,10336,Blank 490,5,O,OHSU_HNSCC_derm002,23,1.044,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
23791,10336,Blank 490,5,P,OHSU_HNSCC_derm002,23,1.051,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
23792,10336,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.961,0,NONE,OHSU_HNSCC_derm002
23793,10336,Blank 490,5,B,OHSU_HNSCC_derm002,24,1.001,0,NONE,OHSU_HNSCC_derm002
23794,10336,Blank 490,5,C,OHSU_HNSCC_derm002,24,1.205,0,NONE,OHSU_HNSCC_derm002
23795,10336,Blank 490,5,D,OHSU_HNSCC_derm002,24,1.075,0,NONE,OHSU_HNSCC_derm002
23796,10336,Blank 490,5,E,OHSU_HNSCC_derm002,24,1.039,0,NONE,OHSU_HNSCC_derm002
23797,10336,Blank 490,5,F,OHSU_HNSCC_derm002,24,1.136,0,NONE,OHSU_HNSCC_derm002
23798,10336,Blank 490,5,G,OHSU_HNSCC_derm002,24,1.11,0,NONE,OHSU_HNSCC_derm002
23799,10336,Blank 490,5,H,OHSU_HNSCC_derm002,24,1.128,0,NONE,OHSU_HNSCC_derm002
23800,10336,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.986,0,NONE,OHSU_HNSCC_derm002
23801,10336,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.961,0,NONE,OHSU_HNSCC_derm002
23802,10336,Blank 490,5,K,OHSU_HNSCC_derm002,24,1.099,0,NONE,OHSU_HNSCC_derm002
23803,10336,Blank 490,5,L,OHSU_HNSCC_derm002,24,1.134,0,NONE,OHSU_HNSCC_derm002
23804,10336,Blank 490,5,M,OHSU_HNSCC_derm002,24,1.227,0,NONE,OHSU_HNSCC_derm002
23805,10336,Blank 490,5,N,OHSU_HNSCC_derm002,24,1.153,0,NONE,OHSU_HNSCC_derm002
23806,10336,Blank 490,5,O,OHSU_HNSCC_derm002,24,1.118,0,NONE,OHSU_HNSCC_derm002
23807,10336,Blank 490,5,P,OHSU_HNSCC_derm002,24,1.153,0,NONE,OHSU_HNSCC_derm002
23808,10336,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.972,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23809,10336,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.703,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23810,10336,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.092,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23811,10336,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.986,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23812,10336,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.081,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23813,10336,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.516,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23814,10336,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.97,10,IMR 1,OHSU_HNSCC_derm002
23815,10336,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.71,10,Gefitinib,OHSU_HNSCC_derm002
23816,10336,Blank 490,6,I,OHSU_HNSCC_derm002,1,1.081,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
23817,10336,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.959,0,DMSO,OHSU_HNSCC_derm002
23818,10336,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.997,0,DMSO ,OHSU_HNSCC_derm002
23819,10336,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.886,0,DMSO,OHSU_HNSCC_derm002
23820,10336,Blank 490,6,M,OHSU_HNSCC_derm002,1,1.053,0,DMSO ,OHSU_HNSCC_derm002
23821,10336,Blank 490,6,N,OHSU_HNSCC_derm002,1,1.016,0,DMSO,OHSU_HNSCC_derm002
23822,10336,Blank 490,6,O,OHSU_HNSCC_derm002,1,1.003,0,DMSO ,OHSU_HNSCC_derm002
23823,10336,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.988,0,DMSO,OHSU_HNSCC_derm002
23824,10336,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.955,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23825,10336,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.738,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23826,10336,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.399,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23827,10336,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.735,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23828,10336,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.934,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23829,10336,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.774,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23830,10336,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.782,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
23831,10336,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.844,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
23832,10336,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.982,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
23833,10336,Blank 490,6,J,OHSU_HNSCC_derm002,2,1.017,0,DMSO,OHSU_HNSCC_derm002
23834,10336,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.788,0,DMSO ,OHSU_HNSCC_derm002
23835,10336,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.892,0,DMSO,OHSU_HNSCC_derm002
23836,10336,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.845,0,DMSO ,OHSU_HNSCC_derm002
23837,10336,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.94,0,DMSO,OHSU_HNSCC_derm002
23838,10336,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.91,0,DMSO ,OHSU_HNSCC_derm002
23839,10336,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.969,0,DMSO,OHSU_HNSCC_derm002
23840,10336,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.963,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23841,10336,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.685,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23842,10336,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.869,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23843,10336,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.798,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23844,10336,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.86,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23845,10336,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.8,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23846,10336,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.764,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
23847,10336,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.828,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
23848,10336,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.751,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
23849,10336,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.769,0,DMSO,OHSU_HNSCC_derm002
23850,10336,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.701,0,DMSO ,OHSU_HNSCC_derm002
23851,10336,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.844,0,DMSO,OHSU_HNSCC_derm002
23852,10336,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.912,0,DMSO ,OHSU_HNSCC_derm002
23853,10336,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.861,0,DMSO,OHSU_HNSCC_derm002
23854,10336,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.858,0,DMSO ,OHSU_HNSCC_derm002
23855,10336,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.989,0,DMSO,OHSU_HNSCC_derm002
23856,10336,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.926,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23857,10336,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.786,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23858,10336,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.833,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23859,10336,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.811,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23860,10336,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.929,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23861,10336,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.937,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23862,10336,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.91,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
23863,10336,Blank 490,6,H,OHSU_HNSCC_derm002,4,1.224,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
23864,10336,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.895,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
23865,10336,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.868,0,DMSO,OHSU_HNSCC_derm002
23866,10336,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.833,0,DMSO ,OHSU_HNSCC_derm002
23867,10336,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.816,0,DMSO,OHSU_HNSCC_derm002
23868,10336,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.904,0,DMSO ,OHSU_HNSCC_derm002
23869,10336,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.962,0,DMSO,OHSU_HNSCC_derm002
23870,10336,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.91,0,DMSO ,OHSU_HNSCC_derm002
23871,10336,Blank 490,6,P,OHSU_HNSCC_derm002,4,1.116,0,DMSO,OHSU_HNSCC_derm002
23872,10336,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.91,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23873,10336,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.786,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23874,10336,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.92,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23875,10336,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.759,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23876,10336,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.924,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23877,10336,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.909,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23878,10336,Blank 490,6,G,OHSU_HNSCC_derm002,5,1.018,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
23879,10336,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.873,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
23880,10336,Blank 490,6,I,OHSU_HNSCC_derm002,5,1.09,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
23881,10336,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.901,0,DMSO,OHSU_HNSCC_derm002
23882,10336,Blank 490,6,K,OHSU_HNSCC_derm002,5,1.032,0,DMSO ,OHSU_HNSCC_derm002
23883,10336,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.896,0,DMSO,OHSU_HNSCC_derm002
23884,10336,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.981,0,DMSO ,OHSU_HNSCC_derm002
23885,10336,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.775,0,DMSO,OHSU_HNSCC_derm002
23886,10336,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.848,0,DMSO ,OHSU_HNSCC_derm002
23887,10336,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.966,0,DMSO,OHSU_HNSCC_derm002
23888,10336,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.886,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23889,10336,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.724,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23890,10336,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.749,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23891,10336,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.787,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23892,10336,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.84,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23893,10336,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.906,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23894,10336,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.835,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
23895,10336,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.937,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
23896,10336,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.781,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
23897,10336,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.796,0,DMSO,OHSU_HNSCC_derm002
23898,10336,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.951,0,DMSO ,OHSU_HNSCC_derm002
23899,10336,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.733,0,DMSO,OHSU_HNSCC_derm002
23900,10336,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.923,0,DMSO ,OHSU_HNSCC_derm002
23901,10336,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.822,0,DMSO,OHSU_HNSCC_derm002
23902,10336,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.963,0,DMSO ,OHSU_HNSCC_derm002
23903,10336,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.975,0,DMSO,OHSU_HNSCC_derm002
23904,10336,Blank 490,6,A,OHSU_HNSCC_derm002,7,1.021,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
23905,10336,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.747,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
23906,10336,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.844,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
23907,10336,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.764,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
23908,10336,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.992,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
23909,10336,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.849,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
23910,10336,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.869,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
23911,10336,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.912,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
23912,10336,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.952,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
23913,10336,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.801,0,DMSO,OHSU_HNSCC_derm002
23914,10336,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.797,0,DMSO ,OHSU_HNSCC_derm002
23915,10336,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.829,0,DMSO,OHSU_HNSCC_derm002
23916,10336,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.933,0,DMSO ,OHSU_HNSCC_derm002
23917,10336,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.852,0,DMSO,OHSU_HNSCC_derm002
23918,10336,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.968,0,DMSO ,OHSU_HNSCC_derm002
23919,10336,Blank 490,6,P,OHSU_HNSCC_derm002,7,1.014,0,DMSO,OHSU_HNSCC_derm002
23920,10336,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.82,0,NONE,OHSU_HNSCC_derm002
23921,10336,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
23922,10336,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.91,0,NONE,OHSU_HNSCC_derm002
23923,10336,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.836,0,NONE,OHSU_HNSCC_derm002
23924,10336,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.936,0,NONE,OHSU_HNSCC_derm002
23925,10336,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.918,0,NONE,OHSU_HNSCC_derm002
23926,10336,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.964,0,NONE,OHSU_HNSCC_derm002
23927,10336,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
23928,10336,Blank 490,6,I,OHSU_HNSCC_derm002,8,1.258,0,NONE,OHSU_HNSCC_derm002
23929,10336,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.981,0,NONE,OHSU_HNSCC_derm002
23930,10336,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.89,0,NONE,OHSU_HNSCC_derm002
23931,10336,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.858,0,NONE,OHSU_HNSCC_derm002
23932,10336,Blank 490,6,M,OHSU_HNSCC_derm002,8,1.044,0,NONE,OHSU_HNSCC_derm002
23933,10336,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.927,0,NONE,OHSU_HNSCC_derm002
23934,10336,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.905,0,NONE,OHSU_HNSCC_derm002
23935,10336,Blank 490,6,P,OHSU_HNSCC_derm002,8,1.087,0,NONE,OHSU_HNSCC_derm002
23936,10336,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.917,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23937,10336,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.043,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
23938,10336,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.771,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
23939,10336,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.862,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23940,10336,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.886,5,Vandetanib (5mM),OHSU_HNSCC_derm002
23941,10336,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.94,0,DMSO,OHSU_HNSCC_derm002
23942,10336,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.981,0,DMSO ,OHSU_HNSCC_derm002
23943,10336,Blank 490,6,H,OHSU_HNSCC_derm002,9,1.014,10,Brigatinib,OHSU_HNSCC_derm002
23944,10336,Blank 490,6,I,OHSU_HNSCC_derm002,9,1.012,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23945,10336,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.931,0,DMSO,OHSU_HNSCC_derm002
23946,10336,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.993,0,DMSO ,OHSU_HNSCC_derm002
23947,10336,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.864,0,DMSO,OHSU_HNSCC_derm002
23948,10336,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.974,0,DMSO ,OHSU_HNSCC_derm002
23949,10336,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.888,0,DMSO,OHSU_HNSCC_derm002
23950,10336,Blank 490,6,O,OHSU_HNSCC_derm002,9,1.048,0,DMSO ,OHSU_HNSCC_derm002
23951,10336,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.951,0,DMSO,OHSU_HNSCC_derm002
23952,10336,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.966,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23953,10336,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.106,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
23954,10336,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.9,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
23955,10336,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.786,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23956,10336,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.95,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
23957,10336,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.887,0,DMSO,OHSU_HNSCC_derm002
23958,10336,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.911,0,DMSO ,OHSU_HNSCC_derm002
23959,10336,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.88,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
23960,10336,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.957,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23961,10336,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.92,0,DMSO,OHSU_HNSCC_derm002
23962,10336,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.987,0,DMSO ,OHSU_HNSCC_derm002
23963,10336,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.845,0,DMSO,OHSU_HNSCC_derm002
23964,10336,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.887,0,DMSO ,OHSU_HNSCC_derm002
23965,10336,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.845,0,DMSO,OHSU_HNSCC_derm002
23966,10336,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.919,0,DMSO ,OHSU_HNSCC_derm002
23967,10336,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.99,0,DMSO,OHSU_HNSCC_derm002
23968,10336,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.95,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23969,10336,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.322,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
23970,10336,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.876,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
23971,10336,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.854,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23972,10336,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.898,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
23973,10336,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.942,0,DMSO,OHSU_HNSCC_derm002
23974,10336,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.98,0,DMSO ,OHSU_HNSCC_derm002
23975,10336,Blank 490,6,H,OHSU_HNSCC_derm002,11,1.004,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
23976,10336,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.998,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23977,10336,Blank 490,6,J,OHSU_HNSCC_derm002,11,1.013,0,DMSO,OHSU_HNSCC_derm002
23978,10336,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.873,0,DMSO ,OHSU_HNSCC_derm002
23979,10336,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.862,0,DMSO,OHSU_HNSCC_derm002
23980,10336,Blank 490,6,M,OHSU_HNSCC_derm002,11,1.004,0,DMSO ,OHSU_HNSCC_derm002
23981,10336,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.934,0,DMSO,OHSU_HNSCC_derm002
23982,10336,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.911,0,DMSO ,OHSU_HNSCC_derm002
23983,10336,Blank 490,6,P,OHSU_HNSCC_derm002,11,1.09,0,DMSO,OHSU_HNSCC_derm002
23984,10336,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.974,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
23985,10336,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.721,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
23986,10336,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.897,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
23987,10336,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.828,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
23988,10336,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.991,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
23989,10336,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.899,0,DMSO,OHSU_HNSCC_derm002
23990,10336,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.983,0,DMSO ,OHSU_HNSCC_derm002
23991,10336,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.946,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
23992,10336,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.972,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
23993,10336,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.849,0,DMSO,OHSU_HNSCC_derm002
23994,10336,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.923,0,DMSO ,OHSU_HNSCC_derm002
23995,10336,Blank 490,6,L,OHSU_HNSCC_derm002,12,1.03,0,DMSO,OHSU_HNSCC_derm002
23996,10336,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.941,0,DMSO ,OHSU_HNSCC_derm002
23997,10336,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.846,0,DMSO,OHSU_HNSCC_derm002
23998,10336,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.851,0,DMSO ,OHSU_HNSCC_derm002
23999,10336,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.898,0,DMSO,OHSU_HNSCC_derm002
24000,10336,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.883,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24001,10336,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.776,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
24002,10336,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.817,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
24003,10336,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.794,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
24004,10336,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.909,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
24005,10336,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.902,0,DMSO,OHSU_HNSCC_derm002
24006,10336,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.971,0,DMSO ,OHSU_HNSCC_derm002
24007,10336,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.886,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
24008,10336,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.919,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24009,10336,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.828,0,DMSO,OHSU_HNSCC_derm002
24010,10336,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.925,0,DMSO ,OHSU_HNSCC_derm002
24011,10336,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.849,0,DMSO,OHSU_HNSCC_derm002
24012,10336,Blank 490,6,M,OHSU_HNSCC_derm002,13,1.068,0,DMSO ,OHSU_HNSCC_derm002
24013,10336,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.889,0,DMSO,OHSU_HNSCC_derm002
24014,10336,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.865,0,DMSO ,OHSU_HNSCC_derm002
24015,10336,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.969,0,DMSO,OHSU_HNSCC_derm002
24016,10336,Blank 490,6,A,OHSU_HNSCC_derm002,14,1.135,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24017,10336,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.776,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
24018,10336,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.798,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
24019,10336,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.838,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
24020,10336,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.878,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
24021,10336,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.938,0,DMSO,OHSU_HNSCC_derm002
24022,10336,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.941,0,DMSO ,OHSU_HNSCC_derm002
24023,10336,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.984,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
24024,10336,Blank 490,6,I,OHSU_HNSCC_derm002,14,1.046,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24025,10336,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.959,0,DMSO,OHSU_HNSCC_derm002
24026,10336,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.991,0,DMSO ,OHSU_HNSCC_derm002
24027,10336,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.931,0,DMSO,OHSU_HNSCC_derm002
24028,10336,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.917,0,DMSO ,OHSU_HNSCC_derm002
24029,10336,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.903,0,DMSO,OHSU_HNSCC_derm002
24030,10336,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.935,0,DMSO ,OHSU_HNSCC_derm002
24031,10336,Blank 490,6,P,OHSU_HNSCC_derm002,14,1.055,0,DMSO,OHSU_HNSCC_derm002
24032,10336,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.998,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24033,10336,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.738,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
24034,10336,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.794,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
24035,10336,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.939,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
24036,10336,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.972,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
24037,10336,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.918,0,DMSO,OHSU_HNSCC_derm002
24038,10336,Blank 490,6,G,OHSU_HNSCC_derm002,15,1.008,0,DMSO ,OHSU_HNSCC_derm002
24039,10336,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.892,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
24040,10336,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.962,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24041,10336,Blank 490,6,J,OHSU_HNSCC_derm002,15,1.017,0,DMSO,OHSU_HNSCC_derm002
24042,10336,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.937,0,DMSO ,OHSU_HNSCC_derm002
24043,10336,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.837,0,DMSO,OHSU_HNSCC_derm002
24044,10336,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.998,0,DMSO ,OHSU_HNSCC_derm002
24045,10336,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.853,0,DMSO,OHSU_HNSCC_derm002
24046,10336,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.88,0,DMSO ,OHSU_HNSCC_derm002
24047,10336,Blank 490,6,P,OHSU_HNSCC_derm002,15,1.0,0,DMSO,OHSU_HNSCC_derm002
24048,10336,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.87,0,NONE,OHSU_HNSCC_derm002
24049,10336,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.747,0,NONE,OHSU_HNSCC_derm002
24050,10336,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.876,0,NONE,OHSU_HNSCC_derm002
24051,10336,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.794,0,NONE,OHSU_HNSCC_derm002
24052,10336,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.933,0,NONE,OHSU_HNSCC_derm002
24053,10336,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.881,0,NONE,OHSU_HNSCC_derm002
24054,10336,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.978,0,NONE,OHSU_HNSCC_derm002
24055,10336,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
24056,10336,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.97,0,NONE,OHSU_HNSCC_derm002
24057,10336,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.883,0,NONE,OHSU_HNSCC_derm002
24058,10336,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.901,0,NONE,OHSU_HNSCC_derm002
24059,10336,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.875,0,NONE,OHSU_HNSCC_derm002
24060,10336,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.872,0,NONE,OHSU_HNSCC_derm002
24061,10336,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.929,0,NONE,OHSU_HNSCC_derm002
24062,10336,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.815,0,NONE,OHSU_HNSCC_derm002
24063,10336,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.891,0,NONE,OHSU_HNSCC_derm002
24064,10336,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.496,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24065,10336,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.668,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24066,10336,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.78,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24067,10336,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.112,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24068,10336,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.893,10,LY3039478 ,OHSU_HNSCC_derm002
24069,10336,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.807,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24070,10336,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.941,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24071,10336,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.955,10,Trametinib,OHSU_HNSCC_derm002
24072,10336,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.264,10,BEZ235,OHSU_HNSCC_derm002
24073,10336,Blank 490,6,J,OHSU_HNSCC_derm002,17,1.011,0,DMSO,OHSU_HNSCC_derm002
24074,10336,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.831,0,DMSO ,OHSU_HNSCC_derm002
24075,10336,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.851,0,DMSO,OHSU_HNSCC_derm002
24076,10336,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.83,0,DMSO ,OHSU_HNSCC_derm002
24077,10336,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.889,0,DMSO,OHSU_HNSCC_derm002
24078,10336,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.896,0,DMSO ,OHSU_HNSCC_derm002
24079,10336,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.953,0,DMSO,OHSU_HNSCC_derm002
24080,10336,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.961,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24081,10336,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.824,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24082,10336,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.887,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24083,10336,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.158,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24084,10336,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.933,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
24085,10336,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.905,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24086,10336,Blank 490,6,G,OHSU_HNSCC_derm002,18,1.028,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24087,10336,Blank 490,6,H,OHSU_HNSCC_derm002,18,1.059,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
24088,10336,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.327,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
24089,10336,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.942,0,DMSO,OHSU_HNSCC_derm002
24090,10336,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.914,0,DMSO ,OHSU_HNSCC_derm002
24091,10336,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.95,0,DMSO,OHSU_HNSCC_derm002
24092,10336,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.917,0,DMSO ,OHSU_HNSCC_derm002
24093,10336,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.878,0,DMSO,OHSU_HNSCC_derm002
24094,10336,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.84,0,DMSO ,OHSU_HNSCC_derm002
24095,10336,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.95,0,DMSO,OHSU_HNSCC_derm002
24096,10336,Blank 490,6,A,OHSU_HNSCC_derm002,19,1.007,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24097,10336,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.83,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24098,10336,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.809,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24099,10336,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.354,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24100,10336,Blank 490,6,E,OHSU_HNSCC_derm002,19,1.026,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
24101,10336,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.94,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24102,10336,Blank 490,6,G,OHSU_HNSCC_derm002,19,1.002,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24103,10336,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.985,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
24104,10336,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.356,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
24105,10336,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.977,0,DMSO,OHSU_HNSCC_derm002
24106,10336,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.865,0,DMSO ,OHSU_HNSCC_derm002
24107,10336,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.938,0,DMSO,OHSU_HNSCC_derm002
24108,10336,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.931,0,DMSO ,OHSU_HNSCC_derm002
24109,10336,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.837,0,DMSO,OHSU_HNSCC_derm002
24110,10336,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.758,0,DMSO ,OHSU_HNSCC_derm002
24111,10336,Blank 490,6,P,OHSU_HNSCC_derm002,19,1.135,0,DMSO,OHSU_HNSCC_derm002
24112,10336,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.913,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24113,10336,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.776,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24114,10336,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.769,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24115,10336,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.845,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24116,10336,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.876,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
24117,10336,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.963,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24118,10336,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.922,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24119,10336,Blank 490,6,H,OHSU_HNSCC_derm002,20,1.051,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
24120,10336,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.327,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
24121,10336,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.772,0,DMSO,OHSU_HNSCC_derm002
24122,10336,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.901,0,DMSO ,OHSU_HNSCC_derm002
24123,10336,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.918,0,DMSO,OHSU_HNSCC_derm002
24124,10336,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.874,0,DMSO ,OHSU_HNSCC_derm002
24125,10336,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.741,0,DMSO,OHSU_HNSCC_derm002
24126,10336,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.755,0,DMSO ,OHSU_HNSCC_derm002
24127,10336,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.97,0,DMSO,OHSU_HNSCC_derm002
24128,10336,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.872,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24129,10336,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.816,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24130,10336,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.805,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24131,10336,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.907,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24132,10336,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.927,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
24133,10336,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.939,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24134,10336,Blank 490,6,G,OHSU_HNSCC_derm002,21,1.026,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24135,10336,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.954,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
24136,10336,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.484,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
24137,10336,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.93,0,DMSO,OHSU_HNSCC_derm002
24138,10336,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.821,0,DMSO ,OHSU_HNSCC_derm002
24139,10336,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.792,0,DMSO,OHSU_HNSCC_derm002
24140,10336,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.946,0,DMSO ,OHSU_HNSCC_derm002
24141,10336,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.982,0,DMSO,OHSU_HNSCC_derm002
24142,10336,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.939,0,DMSO ,OHSU_HNSCC_derm002
24143,10336,Blank 490,6,P,OHSU_HNSCC_derm002,21,1.072,0,DMSO,OHSU_HNSCC_derm002
24144,10336,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.919,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24145,10336,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.854,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24146,10336,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.808,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24147,10336,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.888,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24148,10336,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.9,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
24149,10336,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.839,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24150,10336,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.919,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24151,10336,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.925,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
24152,10336,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.801,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
24153,10336,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.852,0,DMSO,OHSU_HNSCC_derm002
24154,10336,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.803,0,DMSO ,OHSU_HNSCC_derm002
24155,10336,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.828,0,DMSO,OHSU_HNSCC_derm002
24156,10336,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.871,0,DMSO ,OHSU_HNSCC_derm002
24157,10336,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.91,0,DMSO,OHSU_HNSCC_derm002
24158,10336,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.884,0,DMSO ,OHSU_HNSCC_derm002
24159,10336,Blank 490,6,P,OHSU_HNSCC_derm002,22,1.04,0,DMSO,OHSU_HNSCC_derm002
24160,10336,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.861,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
24161,10336,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.855,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
24162,10336,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.807,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
24163,10336,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.891,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
24164,10336,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.768,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
24165,10336,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.894,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
24166,10336,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.835,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
24167,10336,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.845,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
24168,10336,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.869,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
24169,10336,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.833,0,DMSO,OHSU_HNSCC_derm002
24170,10336,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.743,0,DMSO ,OHSU_HNSCC_derm002
24171,10336,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.803,0,DMSO,OHSU_HNSCC_derm002
24172,10336,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.813,0,DMSO ,OHSU_HNSCC_derm002
24173,10336,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.835,0,DMSO,OHSU_HNSCC_derm002
24174,10336,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.878,0,DMSO ,OHSU_HNSCC_derm002
24175,10336,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.98,0,DMSO,OHSU_HNSCC_derm002
24176,10336,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.947,0,NONE,OHSU_HNSCC_derm002
24177,10336,Blank 490,6,B,OHSU_HNSCC_derm002,24,1.079,0,NONE,OHSU_HNSCC_derm002
24178,10336,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.927,0,NONE,OHSU_HNSCC_derm002
24179,10336,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.916,0,NONE,OHSU_HNSCC_derm002
24180,10336,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.905,0,NONE,OHSU_HNSCC_derm002
24181,10336,Blank 490,6,F,OHSU_HNSCC_derm002,24,1.088,0,NONE,OHSU_HNSCC_derm002
24182,10336,Blank 490,6,G,OHSU_HNSCC_derm002,24,1.061,0,NONE,OHSU_HNSCC_derm002
24183,10336,Blank 490,6,H,OHSU_HNSCC_derm002,24,1.067,0,NONE,OHSU_HNSCC_derm002
24184,10336,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.991,0,NONE,OHSU_HNSCC_derm002
24185,10336,Blank 490,6,J,OHSU_HNSCC_derm002,24,1.068,0,NONE,OHSU_HNSCC_derm002
24186,10336,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.954,0,NONE,OHSU_HNSCC_derm002
24187,10336,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.911,0,NONE,OHSU_HNSCC_derm002
24188,10336,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.995,0,NONE,OHSU_HNSCC_derm002
24189,10336,Blank 490,6,N,OHSU_HNSCC_derm002,24,1.139,0,NONE,OHSU_HNSCC_derm002
24190,10336,Blank 490,6,O,OHSU_HNSCC_derm002,24,1.014,0,NONE,OHSU_HNSCC_derm002
24191,10336,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.995,0,NONE,OHSU_HNSCC_derm002
24192,10348,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.019,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
24193,10348,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.523,10,Lucitanib ,OHSU_HNSCC_derm002
24194,10348,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.556,10,Resveratrol,OHSU_HNSCC_derm002
24195,10348,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.177,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24196,10348,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.543,10,Bicalutamide,OHSU_HNSCC_derm002
24197,10348,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.471,10,Methotrexate ,OHSU_HNSCC_derm002
24198,10348,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.117,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24199,10348,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.198,10,Gefitinib,OHSU_HNSCC_derm002
24200,10348,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.15,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
24201,10348,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.232,10,Tamatinib/R406,OHSU_HNSCC_derm002
24202,10348,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.182,10,Bosutinib,OHSU_HNSCC_derm002
24203,10348,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.063,10,PI-103,OHSU_HNSCC_derm002
24204,10348,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.553,10,Glycyrrhizin,OHSU_HNSCC_derm002
24205,10348,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.476,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
24206,10348,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.209,10,GSK-690693,OHSU_HNSCC_derm002
24207,10348,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.133,10,Ibrutinib,OHSU_HNSCC_derm002
24208,10348,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.034,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
24209,10348,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.573,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
24210,10348,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.502,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
24211,10348,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.193,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24212,10348,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.519,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
24213,10348,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.628,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
24214,10348,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.2,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24215,10348,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.235,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
24216,10348,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.312,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
24217,10348,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.322,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
24218,10348,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.209,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
24219,10348,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.074,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
24220,10348,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.561,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
24221,10348,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.533,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
24222,10348,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.252,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
24223,10348,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.242,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
24224,10348,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.059,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
24225,10348,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.575,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
24226,10348,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.606,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
24227,10348,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.255,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24228,10348,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.635,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
24229,10348,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.621,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
24230,10348,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.4,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24231,10348,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.336,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
24232,10348,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.546,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
24233,10348,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.544,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
24234,10348,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.315,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
24235,10348,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.104,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
24236,10348,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.573,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
24237,10348,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.597,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
24238,10348,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.292,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
24239,10348,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.288,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
24240,10348,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.095,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
24241,10348,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.487,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
24242,10348,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.592,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
24243,10348,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.262,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24244,10348,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.641,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
24245,10348,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.608,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
24246,10348,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.559,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24247,10348,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.34,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
24248,10348,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.585,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
24249,10348,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.554,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
24250,10348,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.542,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
24251,10348,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.171,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
24252,10348,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
24253,10348,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.612,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
24254,10348,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.312,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
24255,10348,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.329,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
24256,10348,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.214,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
24257,10348,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.418,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
24258,10348,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.655,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
24259,10348,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24260,10348,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.596,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
24261,10348,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.668,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
24262,10348,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.539,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24263,10348,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.357,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
24264,10348,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.655,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
24265,10348,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.631,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
24266,10348,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.697,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
24267,10348,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.326,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
24268,10348,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.648,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
24269,10348,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.624,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
24270,10348,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.432,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
24271,10348,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.397,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
24272,10348,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.405,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
24273,10348,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.563,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
24274,10348,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.639,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
24275,10348,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.351,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24276,10348,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.651,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
24277,10348,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.663,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
24278,10348,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.653,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24279,10348,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.505,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
24280,10348,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.611,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
24281,10348,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.583,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
24282,10348,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
24283,10348,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.523,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
24284,10348,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.617,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
24285,10348,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.62,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
24286,10348,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.446,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
24287,10348,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.45,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
24288,10348,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.431,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
24289,10348,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
24290,10348,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.618,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
24291,10348,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.417,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
24292,10348,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.627,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
24293,10348,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.608,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
24294,10348,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.654,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
24295,10348,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.597,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
24296,10348,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.614,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
24297,10348,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.686,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
24298,10348,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.632,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
24299,10348,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.617,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
24300,10348,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
24301,10348,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.657,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
24302,10348,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.524,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
24303,10348,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.47,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
24304,10348,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.479,0,NONE,OHSU_HNSCC_derm002
24305,10348,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.486,0,NONE,OHSU_HNSCC_derm002
24306,10348,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.689,0,NONE,OHSU_HNSCC_derm002
24307,10348,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.628,0,NONE,OHSU_HNSCC_derm002
24308,10348,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.665,0,NONE,OHSU_HNSCC_derm002
24309,10348,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.655,0,NONE,OHSU_HNSCC_derm002
24310,10348,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.669,0,NONE,OHSU_HNSCC_derm002
24311,10348,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
24312,10348,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
24313,10348,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.614,0,NONE,OHSU_HNSCC_derm002
24314,10348,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.61,0,NONE,OHSU_HNSCC_derm002
24315,10348,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.695,0,NONE,OHSU_HNSCC_derm002
24316,10348,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.596,0,NONE,OHSU_HNSCC_derm002
24317,10348,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.654,0,NONE,OHSU_HNSCC_derm002
24318,10348,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.548,0,NONE,OHSU_HNSCC_derm002
24319,10348,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.427,0,NONE,OHSU_HNSCC_derm002
24320,10348,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.052,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24321,10348,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.522,10,Sorafenib,OHSU_HNSCC_derm002
24322,10348,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.754,10,Rosmarinic acid,OHSU_HNSCC_derm002
24323,10348,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.331,10,Rapamycin,OHSU_HNSCC_derm002
24324,10348,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.58,10,Vismodegib,OHSU_HNSCC_derm002
24325,10348,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.131,10,PP242,OHSU_HNSCC_derm002
24326,10348,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.133,10,Alectinib,OHSU_HNSCC_derm002
24327,10348,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.059,10,Brigatinib,OHSU_HNSCC_derm002
24328,10348,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.187,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24329,10348,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.225,10,MK-2206,OHSU_HNSCC_derm002
24330,10348,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.186,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24331,10348,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.131,10,Flavopiridol ,OHSU_HNSCC_derm002
24332,10348,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.624,10,Indirubin,OHSU_HNSCC_derm002
24333,10348,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.515,10,PF-533228,OHSU_HNSCC_derm002
24334,10348,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.543,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24335,10348,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.117,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24336,10348,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.066,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24337,10348,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.648,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
24338,10348,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.657,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
24339,10348,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.333,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
24340,10348,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.627,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
24341,10348,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.217,3.3333333333333335,PP242,OHSU_HNSCC_derm002
24342,10348,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.408,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
24343,10348,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.098,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
24344,10348,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.253,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24345,10348,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.316,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
24346,10348,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.248,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24347,10348,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.116,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
24348,10348,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.734,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
24349,10348,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.67,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
24350,10348,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.44,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24351,10348,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.124,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24352,10348,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.063,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24353,10348,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.706,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
24354,10348,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.657,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
24355,10348,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.36,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
24356,10348,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.626,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
24357,10348,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.222,1.1111111111111112,PP242,OHSU_HNSCC_derm002
24358,10348,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.552,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
24359,10348,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.386,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
24360,10348,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.314,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24361,10348,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.41,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
24362,10348,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.264,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24363,10348,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.108,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
24364,10348,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.684,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
24365,10348,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.794,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
24366,10348,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.496,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24367,10348,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.109,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24368,10348,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.057,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24369,10348,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.585,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
24370,10348,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.633,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
24371,10348,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.361,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
24372,10348,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.648,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
24373,10348,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.336,0.3703703703703704,PP242,OHSU_HNSCC_derm002
24374,10348,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.516,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
24375,10348,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.525,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
24376,10348,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.277,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24377,10348,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.493,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
24378,10348,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.333,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24379,10348,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.158,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
24380,10348,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.675,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
24381,10348,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.786,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
24382,10348,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.459,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24383,10348,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.173,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24384,10348,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.068,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24385,10348,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.611,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
24386,10348,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.553,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
24387,10348,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
24388,10348,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.741,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
24389,10348,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.477,0.1234567901234568,PP242,OHSU_HNSCC_derm002
24390,10348,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.618,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
24391,10348,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.595,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
24392,10348,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.274,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24393,10348,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.541,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
24394,10348,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.321,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24395,10348,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.369,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
24396,10348,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
24397,10348,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.735,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
24398,10348,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.541,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24399,10348,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.272,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24400,10348,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.099,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24401,10348,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.602,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
24402,10348,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.674,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
24403,10348,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.341,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
24404,10348,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.523,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
24405,10348,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.569,0.0411522633744856,PP242,OHSU_HNSCC_derm002
24406,10348,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.685,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
24407,10348,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.698,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
24408,10348,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.293,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24409,10348,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.587,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
24410,10348,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.449,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24411,10348,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.495,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
24412,10348,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.659,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
24413,10348,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.626,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
24414,10348,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.584,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24415,10348,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.365,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24416,10348,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.225,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
24417,10348,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.529,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
24418,10348,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.623,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
24419,10348,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.409,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
24420,10348,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.584,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
24421,10348,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.637,0.013717421124828532,PP242,OHSU_HNSCC_derm002
24422,10348,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.63,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
24423,10348,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.645,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
24424,10348,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.358,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24425,10348,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.599,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
24426,10348,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.483,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
24427,10348,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.531,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
24428,10348,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.657,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
24429,10348,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
24430,10348,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.601,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
24431,10348,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.459,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
24432,10348,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.485,0,NONE,OHSU_HNSCC_derm002
24433,10348,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.609,0,NONE,OHSU_HNSCC_derm002
24434,10348,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.683,0,NONE,OHSU_HNSCC_derm002
24435,10348,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.608,0,NONE,OHSU_HNSCC_derm002
24436,10348,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.583,0,NONE,OHSU_HNSCC_derm002
24437,10348,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.66,0,NONE,OHSU_HNSCC_derm002
24438,10348,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
24439,10348,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
24440,10348,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
24441,10348,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.588,0,NONE,OHSU_HNSCC_derm002
24442,10348,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.613,0,NONE,OHSU_HNSCC_derm002
24443,10348,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.624,0,NONE,OHSU_HNSCC_derm002
24444,10348,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.631,0,NONE,OHSU_HNSCC_derm002
24445,10348,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.711,0,NONE,OHSU_HNSCC_derm002
24446,10348,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.517,0,NONE,OHSU_HNSCC_derm002
24447,10348,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.537,0,NONE,OHSU_HNSCC_derm002
24448,10348,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.378,10,Emodin,OHSU_HNSCC_derm002
24449,10348,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.482,10,Baicalin,OHSU_HNSCC_derm002
24450,10348,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.033,10,NVP-TAE-684,OHSU_HNSCC_derm002
24451,10348,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.025,10,Panobinostat,OHSU_HNSCC_derm002
24452,10348,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.047,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
24453,10348,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.602,10,Fulvestrant,OHSU_HNSCC_derm002
24454,10348,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.152,10,SCH-772984,OHSU_HNSCC_derm002
24455,10348,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.202,10,Trametinib,OHSU_HNSCC_derm002
24456,10348,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.126,10,BEZ235,OHSU_HNSCC_derm002
24457,10348,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.541,10,MLN120B,OHSU_HNSCC_derm002
24458,10348,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.368,10,Ixabepilone,OHSU_HNSCC_derm002
24459,10348,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.002,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
24460,10348,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.225,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24461,10348,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.101,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24462,10348,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.491,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24463,10348,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.525,10,Letrozole,OHSU_HNSCC_derm002
24464,10348,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.425,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
24465,10348,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.6,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
24466,10348,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.232,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
24467,10348,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.026,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
24468,10348,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.084,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
24469,10348,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.647,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
24470,10348,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.21,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
24471,10348,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
24472,10348,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.137,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
24473,10348,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.638,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
24474,10348,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.415,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
24475,10348,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.2,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
24476,10348,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.232,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24477,10348,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.152,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24478,10348,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.576,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24479,10348,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.52,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
24480,10348,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.478,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
24481,10348,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.463,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
24482,10348,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.426,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
24483,10348,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.035,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
24484,10348,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.13,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
24485,10348,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.563,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
24486,10348,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.218,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
24487,10348,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.212,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
24488,10348,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.128,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
24489,10348,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.593,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
24490,10348,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.416,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
24491,10348,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.318,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
24492,10348,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.278,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24493,10348,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.155,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24494,10348,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.499,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24495,10348,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.561,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
24496,10348,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.498,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
24497,10348,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.503,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
24498,10348,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.472,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
24499,10348,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.071,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
24500,10348,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.202,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
24501,10348,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.538,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
24502,10348,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.28,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
24503,10348,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.209,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
24504,10348,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.19,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
24505,10348,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.688,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
24506,10348,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.418,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
24507,10348,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.332,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
24508,10348,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.312,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24509,10348,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.262,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24510,10348,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24511,10348,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.502,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
24512,10348,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.447,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
24513,10348,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.532,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
24514,10348,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.522,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
24515,10348,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.154,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
24516,10348,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.265,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
24517,10348,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.62,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
24518,10348,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.359,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
24519,10348,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.206,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
24520,10348,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.226,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
24521,10348,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.652,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
24522,10348,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.46,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
24523,10348,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.428,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
24524,10348,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.339,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24525,10348,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.425,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24526,10348,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.539,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24527,10348,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.518,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
24528,10348,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.459,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
24529,10348,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.515,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
24530,10348,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.591,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
24531,10348,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
24532,10348,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.43,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
24533,10348,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.608,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
24534,10348,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.468,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
24535,10348,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.258,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
24536,10348,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.368,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
24537,10348,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.539,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
24538,10348,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.349,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
24539,10348,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.473,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
24540,10348,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.402,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24541,10348,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.625,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24542,10348,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.512,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24543,10348,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.508,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
24544,10348,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.486,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
24545,10348,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.52,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
24546,10348,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.531,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
24547,10348,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
24548,10348,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.49,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
24549,10348,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.574,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
24550,10348,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.51,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
24551,10348,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.216,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
24552,10348,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.471,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
24553,10348,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.476,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
24554,10348,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.417,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
24555,10348,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.459,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
24556,10348,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.339,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
24557,10348,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.44,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
24558,10348,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.506,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
24559,10348,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.526,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
24560,10348,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.503,0,NONE,OHSU_HNSCC_derm002
24561,10348,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.519,0,NONE,OHSU_HNSCC_derm002
24562,10348,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.522,0,NONE,OHSU_HNSCC_derm002
24563,10348,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.545,0,NONE,OHSU_HNSCC_derm002
24564,10348,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
24565,10348,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.534,0,NONE,OHSU_HNSCC_derm002
24566,10348,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.49,0,NONE,OHSU_HNSCC_derm002
24567,10348,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
24568,10348,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
24569,10348,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.574,0,NONE,OHSU_HNSCC_derm002
24570,10348,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.524,0,NONE,OHSU_HNSCC_derm002
24571,10348,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.47,0,NONE,OHSU_HNSCC_derm002
24572,10348,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
24573,10348,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
24574,10348,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.539,0,NONE,OHSU_HNSCC_derm002
24575,10348,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.513,0,NONE,OHSU_HNSCC_derm002
24576,10348,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.648,10,Coumarin,OHSU_HNSCC_derm002
24577,10348,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.098,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24578,10348,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.084,10,Foretinib (XL-880),OHSU_HNSCC_derm002
24579,10348,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.406,10,Elesclomol,OHSU_HNSCC_derm002
24580,10348,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.704,10,Vemurafenib,OHSU_HNSCC_derm002
24581,10348,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.043,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24582,10348,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.006,10,Ponatinib,OHSU_HNSCC_derm002
24583,10348,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.23,10,Gefitinib,OHSU_HNSCC_derm002
24584,10348,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.108,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
24585,10348,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.557,1,Sunitinib (1mM),OHSU_HNSCC_derm002
24586,10348,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.626,10,Curcumin,OHSU_HNSCC_derm002
24587,10348,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.133,10,PF-562271,OHSU_HNSCC_derm002
24588,10348,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.591,10,STO609,OHSU_HNSCC_derm002
24589,10348,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.438,10,Lenvatinib,OHSU_HNSCC_derm002
24590,10348,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.087,10,Entrectinib,OHSU_HNSCC_derm002
24591,10348,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.678,10,Ethyl Gallate ,OHSU_HNSCC_derm002
24592,10348,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.554,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
24593,10348,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.187,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24594,10348,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.318,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
24595,10348,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.141,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
24596,10348,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.701,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
24597,10348,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.06,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24598,10348,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.13,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
24599,10348,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
24600,10348,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.359,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
24601,10348,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.706,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
24602,10348,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.57,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
24603,10348,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.458,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
24604,10348,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.568,3.3333333333333335,STO609,OHSU_HNSCC_derm002
24605,10348,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.627,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
24606,10348,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.391,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
24607,10348,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.57,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
24608,10348,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.619,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
24609,10348,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.246,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24610,10348,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.512,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
24611,10348,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.142,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
24612,10348,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.732,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
24613,10348,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.097,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24614,10348,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.542,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
24615,10348,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.321,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
24616,10348,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.528,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
24617,10348,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.669,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
24618,10348,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.664,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
24619,10348,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.641,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
24620,10348,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.66,1.1111111111111112,STO609,OHSU_HNSCC_derm002
24621,10348,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.607,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
24622,10348,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.538,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
24623,10348,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.617,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
24624,10348,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.562,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
24625,10348,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.245,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24626,10348,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.577,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
24627,10348,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.11,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
24628,10348,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.677,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
24629,10348,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.17,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24630,10348,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.726,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
24631,10348,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.342,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
24632,10348,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.621,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
24633,10348,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.625,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
24634,10348,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.618,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
24635,10348,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.688,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
24636,10348,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.642,0.3703703703703704,STO609,OHSU_HNSCC_derm002
24637,10348,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.606,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
24638,10348,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.617,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
24639,10348,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.57,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
24640,10348,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.581,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
24641,10348,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.259,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24642,10348,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.524,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
24643,10348,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.062,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
24644,10348,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.658,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
24645,10348,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.263,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24646,10348,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.765,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
24647,10348,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.441,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
24648,10348,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.643,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
24649,10348,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.581,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
24650,10348,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.629,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
24651,10348,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.7,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
24652,10348,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.713,0.1234567901234568,STO609,OHSU_HNSCC_derm002
24653,10348,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.68,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
24654,10348,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.631,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
24655,10348,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.61,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
24656,10348,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.571,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
24657,10348,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.226,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24658,10348,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.549,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
24659,10348,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.087,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
24660,10348,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.695,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
24661,10348,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.416,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24662,10348,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.766,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
24663,10348,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.557,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
24664,10348,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.589,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
24665,10348,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.635,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
24666,10348,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.6,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
24667,10348,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
24668,10348,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.733,0.0411522633744856,STO609,OHSU_HNSCC_derm002
24669,10348,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
24670,10348,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.585,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
24671,10348,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.622,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
24672,10348,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.554,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
24673,10348,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.313,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
24674,10348,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.541,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
24675,10348,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.211,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
24676,10348,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.641,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
24677,10348,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.562,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
24678,10348,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.738,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
24679,10348,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.586,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
24680,10348,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.245,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
24681,10348,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.313,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
24682,10348,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.655,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
24683,10348,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.665,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
24684,10348,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.668,0.013717421124828532,STO609,OHSU_HNSCC_derm002
24685,10348,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.654,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
24686,10348,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.602,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
24687,10348,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.557,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
24688,10348,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.551,0,NONE,OHSU_HNSCC_derm002
24689,10348,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
24690,10348,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
24691,10348,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.63,0,NONE,OHSU_HNSCC_derm002
24692,10348,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.625,0,NONE,OHSU_HNSCC_derm002
24693,10348,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.64,0,NONE,OHSU_HNSCC_derm002
24694,10348,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
24695,10348,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
24696,10348,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.579,0,NONE,OHSU_HNSCC_derm002
24697,10348,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.633,0,NONE,OHSU_HNSCC_derm002
24698,10348,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.671,0,NONE,OHSU_HNSCC_derm002
24699,10348,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.658,0,NONE,OHSU_HNSCC_derm002
24700,10348,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.676,0,NONE,OHSU_HNSCC_derm002
24701,10348,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.616,0,NONE,OHSU_HNSCC_derm002
24702,10348,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
24703,10348,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.582,0,NONE,OHSU_HNSCC_derm002
24704,10348,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.071,10,GDC-0941,OHSU_HNSCC_derm002
24705,10348,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.376,10,Dovitinib,OHSU_HNSCC_derm002
24706,10348,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.089,10,BI-2536,OHSU_HNSCC_derm002
24707,10348,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.104,10,TP-0903 ,OHSU_HNSCC_derm002
24708,10348,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.046,10,Belinostat,OHSU_HNSCC_derm002
24709,10348,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.064,10,INK-128,OHSU_HNSCC_derm002
24710,10348,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.137,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24711,10348,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.04,10,Brigatinib,OHSU_HNSCC_derm002
24712,10348,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.117,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24713,10348,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.119,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24714,10348,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.651,10,Pazopanib,OHSU_HNSCC_derm002
24715,10348,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.512,10,AZD4547,OHSU_HNSCC_derm002
24716,10348,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.673,10,Pomalidomide ,OHSU_HNSCC_derm002
24717,10348,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.434,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
24718,10348,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.679,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24719,10348,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.009,10,Staurosporin,OHSU_HNSCC_derm002
24720,10348,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.064,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
24721,10348,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.419,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
24722,10348,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.191,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
24723,10348,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.097,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
24724,10348,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.102,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
24725,10348,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.094,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
24726,10348,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.168,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24727,10348,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.108,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
24728,10348,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.285,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24729,10348,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.282,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24730,10348,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.694,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
24731,10348,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.633,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
24732,10348,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.698,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
24733,10348,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.544,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
24734,10348,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.581,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24735,10348,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.022,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
24736,10348,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.136,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
24737,10348,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.45,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
24738,10348,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.356,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
24739,10348,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.108,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
24740,10348,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.234,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
24741,10348,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.117,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
24742,10348,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.176,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24743,10348,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.36,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
24744,10348,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.299,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24745,10348,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.344,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24746,10348,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.679,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
24747,10348,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.646,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
24748,10348,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.684,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
24749,10348,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.644,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
24750,10348,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.551,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24751,10348,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.024,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
24752,10348,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.259,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
24753,10348,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.419,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
24754,10348,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.446,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
24755,10348,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.409,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
24756,10348,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.363,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
24757,10348,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.144,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
24758,10348,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.18,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24759,10348,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.577,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
24760,10348,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.328,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24761,10348,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.413,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24762,10348,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.67,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
24763,10348,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.666,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
24764,10348,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.683,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
24765,10348,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.688,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
24766,10348,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.561,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24767,10348,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.042,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
24768,10348,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.384,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
24769,10348,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.64,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
24770,10348,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.554,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
24771,10348,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.618,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
24772,10348,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.528,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
24773,10348,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.173,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
24774,10348,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.2,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24775,10348,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.63,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
24776,10348,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24777,10348,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.485,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24778,10348,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.696,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
24779,10348,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.676,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
24780,10348,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.69,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
24781,10348,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.665,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
24782,10348,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.638,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24783,10348,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.093,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
24784,10348,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.464,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
24785,10348,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.535,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
24786,10348,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.568,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
24787,10348,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.653,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
24788,10348,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.61,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
24789,10348,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.275,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
24790,10348,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.241,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24791,10348,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.649,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
24792,10348,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.326,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24793,10348,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.534,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24794,10348,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.65,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
24795,10348,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.696,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
24796,10348,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.666,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
24797,10348,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.713,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
24798,10348,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.606,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24799,10348,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.169,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
24800,10348,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.497,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
24801,10348,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.465,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
24802,10348,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.577,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
24803,10348,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.665,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
24804,10348,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.653,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
24805,10348,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.359,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
24806,10348,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.271,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
24807,10348,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
24808,10348,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.399,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
24809,10348,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.581,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
24810,10348,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.674,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
24811,10348,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.639,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
24812,10348,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.684,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
24813,10348,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.646,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
24814,10348,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.545,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
24815,10348,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.179,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
24816,10348,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.52,0,NONE,OHSU_HNSCC_derm002
24817,10348,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.529,0,NONE,OHSU_HNSCC_derm002
24818,10348,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.614,0,NONE,OHSU_HNSCC_derm002
24819,10348,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.58,0,NONE,OHSU_HNSCC_derm002
24820,10348,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.635,0,NONE,OHSU_HNSCC_derm002
24821,10348,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.612,0,NONE,OHSU_HNSCC_derm002
24822,10348,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.693,0,NONE,OHSU_HNSCC_derm002
24823,10348,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
24824,10348,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.646,0,NONE,OHSU_HNSCC_derm002
24825,10348,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.655,0,NONE,OHSU_HNSCC_derm002
24826,10348,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.631,0,NONE,OHSU_HNSCC_derm002
24827,10348,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.675,0,NONE,OHSU_HNSCC_derm002
24828,10348,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.652,0,NONE,OHSU_HNSCC_derm002
24829,10348,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.694,0,NONE,OHSU_HNSCC_derm002
24830,10348,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
24831,10348,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.59,0,NONE,OHSU_HNSCC_derm002
24832,10348,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.392,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
24833,10348,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.419,10,Hesperidin,OHSU_HNSCC_derm002
24834,10348,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.502,10,Esculetin,OHSU_HNSCC_derm002
24835,10348,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.172,10,Selinexor ,OHSU_HNSCC_derm002
24836,10348,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.109,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24837,10348,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.287,10,BMX-IN-1,OHSU_HNSCC_derm002
24838,10348,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.093,1,Dasatinib (1mM),OHSU_HNSCC_derm002
24839,10348,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.206,10,Trametinib,OHSU_HNSCC_derm002
24840,10348,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.135,10,BEZ235,OHSU_HNSCC_derm002
24841,10348,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.055,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
24842,10348,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.663,10,Nilotinib,OHSU_HNSCC_derm002
24843,10348,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.444,10,Enzalutamide,OHSU_HNSCC_derm002
24844,10348,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.778,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24845,10348,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.085,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
24846,10348,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.138,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24847,10348,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.426,10,Axitinib,OHSU_HNSCC_derm002
24848,10348,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.481,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
24849,10348,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.526,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
24850,10348,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.578,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
24851,10348,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
24852,10348,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.548,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24853,10348,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.453,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
24854,10348,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.098,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
24855,10348,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.218,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
24856,10348,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.132,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
24857,10348,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.067,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
24858,10348,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.737,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
24859,10348,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.491,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
24860,10348,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.664,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24861,10348,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.11,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
24862,10348,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24863,10348,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.45,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
24864,10348,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.552,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
24865,10348,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.594,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
24866,10348,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.522,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
24867,10348,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.258,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
24868,10348,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.595,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24869,10348,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.564,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
24870,10348,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.124,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
24871,10348,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.206,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
24872,10348,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.124,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
24873,10348,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.078,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
24874,10348,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.787,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
24875,10348,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.587,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
24876,10348,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.685,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24877,10348,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.119,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
24878,10348,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.116,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24879,10348,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.542,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
24880,10348,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.536,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
24881,10348,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
24882,10348,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.649,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
24883,10348,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.289,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
24884,10348,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.619,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24885,10348,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.582,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
24886,10348,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.346,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
24887,10348,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.213,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
24888,10348,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
24889,10348,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.116,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
24890,10348,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.709,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
24891,10348,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.659,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
24892,10348,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.709,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24893,10348,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.183,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
24894,10348,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.391,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24895,10348,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.55,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
24896,10348,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.521,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
24897,10348,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.539,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
24898,10348,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.611,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
24899,10348,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.378,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
24900,10348,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.591,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24901,10348,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.606,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
24902,10348,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.401,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
24903,10348,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.223,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
24904,10348,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.218,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
24905,10348,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.227,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
24906,10348,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.718,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
24907,10348,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.68,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
24908,10348,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.678,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24909,10348,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.225,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
24910,10348,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.519,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24911,10348,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.62,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
24912,10348,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.501,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
24913,10348,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.529,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
24914,10348,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.52,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
24915,10348,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.536,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
24916,10348,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.59,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24917,10348,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.663,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
24918,10348,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.513,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
24919,10348,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.248,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
24920,10348,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.331,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
24921,10348,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.504,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
24922,10348,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.747,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
24923,10348,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.636,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
24924,10348,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.758,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24925,10348,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.484,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
24926,10348,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.591,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24927,10348,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.624,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
24928,10348,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.577,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
24929,10348,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.555,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
24930,10348,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.587,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
24931,10348,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.542,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
24932,10348,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.572,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
24933,10348,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.609,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
24934,10348,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.601,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
24935,10348,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.28,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
24936,10348,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.429,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
24937,10348,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.596,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
24938,10348,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.616,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
24939,10348,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.566,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
24940,10348,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.674,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
24941,10348,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.593,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
24942,10348,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.627,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
24943,10348,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.555,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
24944,10348,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.543,0,NONE,OHSU_HNSCC_derm002
24945,10348,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.522,0,NONE,OHSU_HNSCC_derm002
24946,10348,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.528,0,NONE,OHSU_HNSCC_derm002
24947,10348,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.559,0,NONE,OHSU_HNSCC_derm002
24948,10348,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.574,0,NONE,OHSU_HNSCC_derm002
24949,10348,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.598,0,NONE,OHSU_HNSCC_derm002
24950,10348,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
24951,10348,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.592,0,NONE,OHSU_HNSCC_derm002
24952,10348,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
24953,10348,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.559,0,NONE,OHSU_HNSCC_derm002
24954,10348,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.562,0,NONE,OHSU_HNSCC_derm002
24955,10348,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.589,0,NONE,OHSU_HNSCC_derm002
24956,10348,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.614,0,NONE,OHSU_HNSCC_derm002
24957,10348,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.644,0,NONE,OHSU_HNSCC_derm002
24958,10348,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.588,0,NONE,OHSU_HNSCC_derm002
24959,10348,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.646,0,NONE,OHSU_HNSCC_derm002
24960,10348,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.434,10,Thalidomide ,OHSU_HNSCC_derm002
24961,10348,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.108,10,Vandetanib,OHSU_HNSCC_derm002
24962,10348,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.542,10,Oleic acid,OHSU_HNSCC_derm002
24963,10348,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.067,10,A-674563,OHSU_HNSCC_derm002
24964,10348,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.147,10,Lapatinib,OHSU_HNSCC_derm002
24965,10348,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.517,10,Apocynin (vanillin),OHSU_HNSCC_derm002
24966,10348,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.112,10,AT-7519,OHSU_HNSCC_derm002
24967,10348,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.219,10,Gefitinib,OHSU_HNSCC_derm002
24968,10348,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.03,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
24969,10348,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.106,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
24970,10348,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.053,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
24971,10348,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.11,10,JQ1,OHSU_HNSCC_derm002
24972,10348,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.684,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
24973,10348,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.34,10,Cerdulatinib,OHSU_HNSCC_derm002
24974,10348,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.004,10,Romidepsin,OHSU_HNSCC_derm002
24975,10348,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.442,10,Gilteritinib,OHSU_HNSCC_derm002
24976,10348,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.492,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
24977,10348,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.218,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
24978,10348,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.585,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
24979,10348,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.336,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
24980,10348,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.214,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
24981,10348,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.501,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
24982,10348,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.117,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
24983,10348,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.263,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
24984,10348,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
24985,10348,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.182,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
24986,10348,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.168,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
24987,10348,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.169,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
24988,10348,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.689,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
24989,10348,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.653,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
24990,10348,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.001,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
24991,10348,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.427,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
24992,10348,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.555,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
24993,10348,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.261,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
24994,10348,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.469,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
24995,10348,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.346,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
24996,10348,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.288,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
24997,10348,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.465,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
24998,10348,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.118,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
24999,10348,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.259,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
25000,10348,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.467,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
25001,10348,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.252,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
25002,10348,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
25003,10348,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.204,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
25004,10348,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.689,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
25005,10348,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.639,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
25006,10348,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.006,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
25007,10348,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.481,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
25008,10348,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.47,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
25009,10348,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.349,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
25010,10348,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.487,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
25011,10348,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.325,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
25012,10348,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.308,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
25013,10348,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.52,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
25014,10348,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.321,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
25015,10348,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.303,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
25016,10348,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.529,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
25017,10348,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.29,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
25018,10348,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.238,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
25019,10348,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.277,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
25020,10348,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.604,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
25021,10348,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.564,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
25022,10348,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.012,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
25023,10348,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.527,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
25024,10348,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.46,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
25025,10348,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.403,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
25026,10348,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.559,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
25027,10348,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.404,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
25028,10348,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.377,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
25029,10348,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.49,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
25030,10348,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.528,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
25031,10348,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.402,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
25032,10348,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.566,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
25033,10348,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.395,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
25034,10348,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.315,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
25035,10348,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.36,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
25036,10348,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.648,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
25037,10348,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.58,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
25038,10348,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.03,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
25039,10348,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.596,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
25040,10348,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.458,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
25041,10348,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.432,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
25042,10348,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.551,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
25043,10348,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.445,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
25044,10348,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.448,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
25045,10348,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.499,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
25046,10348,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.596,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
25047,10348,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.468,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
25048,10348,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.624,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
25049,10348,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.457,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
25050,10348,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.423,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
25051,10348,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.526,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
25052,10348,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.59,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
25053,10348,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.578,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
25054,10348,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.035,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
25055,10348,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.522,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
25056,10348,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.479,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
25057,10348,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.413,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
25058,10348,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.558,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
25059,10348,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.487,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
25060,10348,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.508,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
25061,10348,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.48,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
25062,10348,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.596,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
25063,10348,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.557,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
25064,10348,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.647,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
25065,10348,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.508,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
25066,10348,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.512,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
25067,10348,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.609,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
25068,10348,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.628,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
25069,10348,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.534,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
25070,10348,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.042,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
25071,10348,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.495,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
25072,10348,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.435,0,NONE,OHSU_HNSCC_derm002
25073,10348,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.5,0,NONE,OHSU_HNSCC_derm002
25074,10348,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.542,0,NONE,OHSU_HNSCC_derm002
25075,10348,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.464,0,NONE,OHSU_HNSCC_derm002
25076,10348,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.547,0,NONE,OHSU_HNSCC_derm002
25077,10348,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.535,0,NONE,OHSU_HNSCC_derm002
25078,10348,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.567,0,NONE,OHSU_HNSCC_derm002
25079,10348,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
25080,10348,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.433,0,NONE,OHSU_HNSCC_derm002
25081,10348,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.568,0,NONE,OHSU_HNSCC_derm002
25082,10348,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.641,0,NONE,OHSU_HNSCC_derm002
25083,10348,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.589,0,NONE,OHSU_HNSCC_derm002
25084,10348,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.628,0,NONE,OHSU_HNSCC_derm002
25085,10348,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.532,0,NONE,OHSU_HNSCC_derm002
25086,10348,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.593,0,NONE,OHSU_HNSCC_derm002
25087,10348,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.494,0,NONE,OHSU_HNSCC_derm002
25088,10348,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.44,10,Anastrazole,OHSU_HNSCC_derm002
25089,10348,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.15,10,JNJ-28312141 ,OHSU_HNSCC_derm002
25090,10348,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.545,10,Genistein,OHSU_HNSCC_derm002
25091,10348,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.479,10,Abscisic acid,OHSU_HNSCC_derm002
25092,10348,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.419,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25093,10348,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.533,10,Ruxolitinib,OHSU_HNSCC_derm002
25094,10348,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.428,10,TAK-659,OHSU_HNSCC_derm002
25095,10348,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.046,10,Brigatinib,OHSU_HNSCC_derm002
25096,10348,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.164,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25097,10348,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.056,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25098,10348,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.083,10,Vorinostat,OHSU_HNSCC_derm002
25099,10348,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.557,10,Lenalidomide,OHSU_HNSCC_derm002
25100,10348,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.11,10,NVP-ADW742,OHSU_HNSCC_derm002
25101,10348,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.585,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25102,10348,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.702,10,Echinatin,OHSU_HNSCC_derm002
25103,10348,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.009,10,YM-155,OHSU_HNSCC_derm002
25104,10348,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.431,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
25105,10348,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.401,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
25106,10348,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.562,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
25107,10348,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.511,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
25108,10348,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.469,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25109,10348,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.561,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
25110,10348,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.602,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
25111,10348,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.085,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
25112,10348,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.268,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25113,10348,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.167,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25114,10348,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.17,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
25115,10348,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.527,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
25116,10348,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.267,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
25117,10348,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.509,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25118,10348,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.619,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
25119,10348,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.01,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
25120,10348,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.394,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
25121,10348,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.4,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
25122,10348,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.547,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
25123,10348,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.473,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
25124,10348,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.468,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25125,10348,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.541,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
25126,10348,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.62,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
25127,10348,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.295,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
25128,10348,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.281,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25129,10348,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.305,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25130,10348,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
25131,10348,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.538,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
25132,10348,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.344,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
25133,10348,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.611,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25134,10348,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.583,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
25135,10348,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.006,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
25136,10348,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.443,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
25137,10348,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.496,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
25138,10348,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.544,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
25139,10348,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.508,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
25140,10348,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.508,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25141,10348,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.561,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
25142,10348,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.594,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
25143,10348,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.458,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
25144,10348,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.303,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25145,10348,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.473,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25146,10348,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.414,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
25147,10348,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.6,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
25148,10348,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.463,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
25149,10348,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.577,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25150,10348,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.601,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
25151,10348,Blank 490,3,P,OHSU_HNSCC_derm002,12,0.0,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
25152,10348,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.443,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
25153,10348,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.472,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
25154,10348,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.545,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
25155,10348,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.46,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
25156,10348,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.519,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25157,10348,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.53,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
25158,10348,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.577,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
25159,10348,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.545,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
25160,10348,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.282,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25161,10348,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.55,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25162,10348,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.53,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
25163,10348,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.592,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
25164,10348,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.609,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
25165,10348,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.609,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25166,10348,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.58,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
25167,10348,Blank 490,3,P,OHSU_HNSCC_derm002,13,0.021,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
25168,10348,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.479,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
25169,10348,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.486,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
25170,10348,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.531,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
25171,10348,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.476,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
25172,10348,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.511,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25173,10348,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.523,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
25174,10348,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.527,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
25175,10348,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.608,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
25176,10348,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.31,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25177,10348,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.56,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25178,10348,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.533,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
25179,10348,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.556,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
25180,10348,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.627,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
25181,10348,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.592,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25182,10348,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.592,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
25183,10348,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.025,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
25184,10348,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.37,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
25185,10348,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.455,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
25186,10348,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.526,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
25187,10348,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.484,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
25188,10348,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.509,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
25189,10348,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.527,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
25190,10348,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.593,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
25191,10348,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.577,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
25192,10348,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.327,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25193,10348,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.509,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
25194,10348,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.573,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
25195,10348,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.574,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
25196,10348,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.586,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
25197,10348,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.57,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
25198,10348,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.611,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
25199,10348,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.078,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
25200,10348,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.424,0,NONE,OHSU_HNSCC_derm002
25201,10348,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.534,0,NONE,OHSU_HNSCC_derm002
25202,10348,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.538,0,NONE,OHSU_HNSCC_derm002
25203,10348,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.453,0,NONE,OHSU_HNSCC_derm002
25204,10348,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.54,0,NONE,OHSU_HNSCC_derm002
25205,10348,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.574,0,NONE,OHSU_HNSCC_derm002
25206,10348,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.172,0,NONE,OHSU_HNSCC_derm002
25207,10348,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
25208,10348,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.605,0,NONE,OHSU_HNSCC_derm002
25209,10348,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.594,0,NONE,OHSU_HNSCC_derm002
25210,10348,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.569,0,NONE,OHSU_HNSCC_derm002
25211,10348,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
25212,10348,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.592,0,NONE,OHSU_HNSCC_derm002
25213,10348,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.535,0,NONE,OHSU_HNSCC_derm002
25214,10348,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.619,0,NONE,OHSU_HNSCC_derm002
25215,10348,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.563,0,NONE,OHSU_HNSCC_derm002
25216,10348,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.476,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25217,10348,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.552,10,Stevioside,OHSU_HNSCC_derm002
25218,10348,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.541,10,Pemetrexed,OHSU_HNSCC_derm002
25219,10348,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.052,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25220,10348,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.028,10,GSK-1838705A,OHSU_HNSCC_derm002
25221,10348,Blank 490,3,F,OHSU_HNSCC_derm002,17,0.011,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25222,10348,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.649,10,Imatinib,OHSU_HNSCC_derm002
25223,10348,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.173,10,Trametinib,OHSU_HNSCC_derm002
25224,10348,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.102,10,BEZ235,OHSU_HNSCC_derm002
25225,10348,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.125,10,Saracatinib,OHSU_HNSCC_derm002
25226,10348,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.211,10,I-BET 762,OHSU_HNSCC_derm002
25227,10348,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.2,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
25228,10348,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.519,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
25229,10348,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.503,10,Crizotinib,OHSU_HNSCC_derm002
25230,10348,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.362,10,MGCD-265,OHSU_HNSCC_derm002
25231,10348,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.168,10,Erlotinib,OHSU_HNSCC_derm002
25232,10348,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.464,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25233,10348,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.547,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
25234,10348,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.53,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
25235,10348,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.06,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25236,10348,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.258,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
25237,10348,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.082,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25238,10348,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.554,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
25239,10348,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.177,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
25240,10348,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.111,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
25241,10348,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.175,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
25242,10348,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.251,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
25243,10348,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.204,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
25244,10348,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.586,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
25245,10348,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.604,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
25246,10348,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.434,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
25247,10348,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.195,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
25248,10348,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.481,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25249,10348,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.509,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
25250,10348,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.517,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
25251,10348,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.09,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25252,10348,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.266,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
25253,10348,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.189,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25254,10348,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.595,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
25255,10348,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.186,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
25256,10348,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.12,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
25257,10348,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.338,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
25258,10348,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
25259,10348,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.224,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
25260,10348,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.567,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
25261,10348,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.574,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
25262,10348,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.456,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
25263,10348,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.241,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
25264,10348,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.468,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25265,10348,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.498,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
25266,10348,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.493,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
25267,10348,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.129,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25268,10348,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.366,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
25269,10348,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.251,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25270,10348,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.522,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
25271,10348,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.181,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
25272,10348,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.162,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
25273,10348,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.453,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
25274,10348,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.459,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
25275,10348,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.258,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
25276,10348,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.587,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
25277,10348,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.593,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
25278,10348,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.588,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
25279,10348,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.257,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
25280,10348,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.444,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25281,10348,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.529,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
25282,10348,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.503,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
25283,10348,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.196,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25284,10348,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.422,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
25285,10348,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.304,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25286,10348,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.551,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
25287,10348,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.167,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
25288,10348,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.212,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
25289,10348,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.507,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
25290,10348,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.583,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
25291,10348,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.319,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
25292,10348,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.574,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
25293,10348,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.627,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
25294,10348,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.564,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
25295,10348,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.365,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
25296,10348,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.482,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25297,10348,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.489,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
25298,10348,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.509,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
25299,10348,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.301,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25300,10348,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.492,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
25301,10348,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.373,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25302,10348,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.562,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
25303,10348,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.217,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
25304,10348,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.348,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
25305,10348,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.571,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
25306,10348,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.569,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
25307,10348,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.411,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
25308,10348,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.611,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
25309,10348,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.645,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
25310,10348,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.597,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
25311,10348,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.384,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
25312,10348,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.466,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
25313,10348,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.484,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
25314,10348,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.524,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
25315,10348,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.401,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
25316,10348,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.533,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
25317,10348,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.469,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
25318,10348,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.602,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
25319,10348,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.25,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
25320,10348,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.468,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
25321,10348,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.676,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
25322,10348,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.615,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
25323,10348,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.501,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
25324,10348,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.611,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
25325,10348,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.591,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
25326,10348,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.526,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
25327,10348,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.438,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
25328,10348,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
25329,10348,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.408,0,NONE,OHSU_HNSCC_derm002
25330,10348,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.449,0,NONE,OHSU_HNSCC_derm002
25331,10348,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.505,0,NONE,OHSU_HNSCC_derm002
25332,10348,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.475,0,NONE,OHSU_HNSCC_derm002
25333,10348,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.424,0,NONE,OHSU_HNSCC_derm002
25334,10348,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.511,0,NONE,OHSU_HNSCC_derm002
25335,10348,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.544,0,NONE,OHSU_HNSCC_derm002
25336,10348,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.464,0,NONE,OHSU_HNSCC_derm002
25337,10348,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.438,0,NONE,OHSU_HNSCC_derm002
25338,10348,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.476,0,NONE,OHSU_HNSCC_derm002
25339,10348,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.487,0,NONE,OHSU_HNSCC_derm002
25340,10348,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.452,0,NONE,OHSU_HNSCC_derm002
25341,10348,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.489,0,NONE,OHSU_HNSCC_derm002
25342,10348,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.519,0,NONE,OHSU_HNSCC_derm002
25343,10348,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.482,0,NONE,OHSU_HNSCC_derm002
25344,10348,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.031,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25345,10348,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.084,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25346,10348,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.009,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25347,10348,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.027,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25348,10348,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.013,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25349,10348,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.012,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25350,10348,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.001,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25351,10348,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.025,10,Gefitinib,OHSU_HNSCC_derm002
25352,10348,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.011,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
25353,10348,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.034,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25354,10348,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.037,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25355,10348,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.038,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25356,10348,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.02,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25357,10348,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.013,10,VOLASERTIB x,OHSU_HNSCC_derm002
25358,10348,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.009,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25359,10348,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.006,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25360,10348,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.063,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25361,10348,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.19,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25362,10348,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.538,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25363,10348,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.48,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25364,10348,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.043,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25365,10348,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.046,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25366,10348,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.003,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25367,10348,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.34,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
25368,10348,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.342,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
25369,10348,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.048,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25370,10348,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.115,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25371,10348,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.066,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25372,10348,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.232,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25373,10348,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.174,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
25374,10348,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.401,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25375,10348,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.037,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25376,10348,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.146,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25377,10348,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.309,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25378,10348,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.674,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25379,10348,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.493,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25380,10348,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.118,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25381,10348,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.075,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25382,10348,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.014,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25383,10348,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.37,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
25384,10348,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.604,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
25385,10348,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.144,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25386,10348,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.238,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25387,10348,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.182,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25388,10348,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.318,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25389,10348,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.318,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
25390,10348,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.512,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25391,10348,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.069,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25392,10348,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.182,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25393,10348,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.464,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25394,10348,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.717,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25395,10348,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.531,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25396,10348,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.207,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25397,10348,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.099,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25398,10348,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.026,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25399,10348,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.343,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
25400,10348,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
25401,10348,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.18,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25402,10348,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.268,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25403,10348,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.322,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25404,10348,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.367,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25405,10348,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.54,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
25406,10348,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.603,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25407,10348,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.121,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25408,10348,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.414,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25409,10348,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.497,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25410,10348,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.781,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25411,10348,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.511,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25412,10348,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.281,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25413,10348,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.149,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25414,10348,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.035,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25415,10348,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.424,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
25416,10348,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.7,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
25417,10348,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.297,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25418,10348,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.415,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25419,10348,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.431,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25420,10348,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.538,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25421,10348,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.705,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
25422,10348,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.768,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25423,10348,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.209,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25424,10348,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.546,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25425,10348,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.606,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25426,10348,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.746,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25427,10348,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.657,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25428,10348,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.493,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25429,10348,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.316,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25430,10348,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.038,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25431,10348,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.595,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
25432,10348,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.701,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
25433,10348,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.454,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25434,10348,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.644,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25435,10348,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.635,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25436,10348,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.58,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25437,10348,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.694,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
25438,10348,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.651,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25439,10348,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.398,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25440,10348,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.503,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
25441,10348,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.61,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
25442,10348,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.817,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
25443,10348,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.671,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
25444,10348,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.608,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
25445,10348,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.423,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
25446,10348,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.038,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
25447,10348,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.642,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
25448,10348,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.682,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
25449,10348,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.572,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
25450,10348,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.673,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
25451,10348,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.743,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
25452,10348,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.74,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
25453,10348,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.843,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
25454,10348,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.615,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25455,10348,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.514,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
25456,10348,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.609,0,NONE,OHSU_HNSCC_derm002
25457,10348,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.705,0,NONE,OHSU_HNSCC_derm002
25458,10348,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.737,0,NONE,OHSU_HNSCC_derm002
25459,10348,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.674,0,NONE,OHSU_HNSCC_derm002
25460,10348,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.701,0,NONE,OHSU_HNSCC_derm002
25461,10348,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.744,0,NONE,OHSU_HNSCC_derm002
25462,10348,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.746,0,NONE,OHSU_HNSCC_derm002
25463,10348,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
25464,10348,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.721,0,NONE,OHSU_HNSCC_derm002
25465,10348,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.679,0,NONE,OHSU_HNSCC_derm002
25466,10348,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.68,0,NONE,OHSU_HNSCC_derm002
25467,10348,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.795,0,NONE,OHSU_HNSCC_derm002
25468,10348,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.784,0,NONE,OHSU_HNSCC_derm002
25469,10348,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.743,0,NONE,OHSU_HNSCC_derm002
25470,10348,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
25471,10348,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.635,0,NONE,OHSU_HNSCC_derm002
25472,10348,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.026,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25473,10348,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.251,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25474,10348,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.056,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
25475,10348,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.74,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25476,10348,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.194,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25477,10348,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.039,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
25478,10348,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.133,10,AZD2014 x ,OHSU_HNSCC_derm002
25479,10348,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.063,10,Brigatinib,OHSU_HNSCC_derm002
25480,10348,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.189,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25481,10348,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.04,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25482,10348,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.255,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25483,10348,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.031,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
25484,10348,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.133,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25485,10348,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.397,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25486,10348,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.169,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25487,10348,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.076,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25488,10348,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.106,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25489,10348,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.317,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25490,10348,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.066,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
25491,10348,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.828,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25492,10348,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.254,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25493,10348,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.069,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
25494,10348,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.163,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
25495,10348,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.157,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
25496,10348,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.335,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25497,10348,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.085,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25498,10348,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.324,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25499,10348,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.09,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
25500,10348,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.251,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25501,10348,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.411,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25502,10348,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.307,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25503,10348,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.225,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25504,10348,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.195,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25505,10348,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.308,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25506,10348,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.096,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
25507,10348,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.82,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25508,10348,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.266,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25509,10348,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.089,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
25510,10348,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.179,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
25511,10348,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.413,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
25512,10348,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.323,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25513,10348,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.121,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25514,10348,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.342,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25515,10348,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.197,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
25516,10348,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.318,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25517,10348,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.471,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25518,10348,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.3,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25519,10348,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.354,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25520,10348,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.314,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25521,10348,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.327,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25522,10348,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.215,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
25523,10348,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.817,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25524,10348,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.361,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25525,10348,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.116,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
25526,10348,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.286,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
25527,10348,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.649,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
25528,10348,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.362,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25529,10348,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.215,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25530,10348,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.422,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25531,10348,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.46,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
25532,10348,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.394,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25533,10348,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.545,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25534,10348,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.454,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25535,10348,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.477,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25536,10348,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.434,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25537,10348,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.415,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25538,10348,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.355,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
25539,10348,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.726,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25540,10348,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.399,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25541,10348,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.252,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
25542,10348,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.439,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
25543,10348,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
25544,10348,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25545,10348,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.4,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25546,10348,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.449,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25547,10348,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.659,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
25548,10348,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.358,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25549,10348,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.621,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25550,10348,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.626,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25551,10348,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.583,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25552,10348,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.542,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25553,10348,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.541,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25554,10348,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.621,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
25555,10348,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.79,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25556,10348,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.532,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25557,10348,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.417,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
25558,10348,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.563,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
25559,10348,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.756,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
25560,10348,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.33,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25561,10348,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.585,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25562,10348,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.558,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25563,10348,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.718,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
25564,10348,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.328,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25565,10348,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.667,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25566,10348,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.58,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25567,10348,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.633,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25568,10348,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.545,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
25569,10348,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.571,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
25570,10348,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.76,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
25571,10348,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.74,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25572,10348,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.653,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
25573,10348,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.574,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
25574,10348,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.669,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
25575,10348,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.759,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
25576,10348,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.421,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25577,10348,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.654,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
25578,10348,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.659,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
25579,10348,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.711,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
25580,10348,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.487,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25581,10348,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.768,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
25582,10348,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.629,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
25583,10348,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.651,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
25584,10348,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
25585,10348,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.678,0,NONE,OHSU_HNSCC_derm002
25586,10348,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.794,0,NONE,OHSU_HNSCC_derm002
25587,10348,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.71,0,NONE,OHSU_HNSCC_derm002
25588,10348,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.75,0,NONE,OHSU_HNSCC_derm002
25589,10348,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.739,0,NONE,OHSU_HNSCC_derm002
25590,10348,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
25591,10348,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
25592,10348,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
25593,10348,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.74,0,NONE,OHSU_HNSCC_derm002
25594,10348,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.742,0,NONE,OHSU_HNSCC_derm002
25595,10348,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.811,0,NONE,OHSU_HNSCC_derm002
25596,10348,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.815,0,NONE,OHSU_HNSCC_derm002
25597,10348,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.802,0,NONE,OHSU_HNSCC_derm002
25598,10348,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.632,0,NONE,OHSU_HNSCC_derm002
25599,10348,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.633,0,NONE,OHSU_HNSCC_derm002
25600,10348,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.138,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25601,10348,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.035,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25602,10348,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.384,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25603,10348,Blank 490,4,D,OHSU_HNSCC_derm002,17,0.0,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25604,10348,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.181,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25605,10348,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.147,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25606,10348,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.123,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25607,10348,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.238,10,Trametinib,OHSU_HNSCC_derm002
25608,10348,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.092,10,BEZ235,OHSU_HNSCC_derm002
25609,10348,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.04,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25610,10348,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.197,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25611,10348,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.048,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25612,10348,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.338,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25613,10348,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.781,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25614,10348,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.312,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25615,10348,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.09,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25616,10348,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.245,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25617,10348,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.185,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25618,10348,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.259,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25619,10348,Blank 490,4,D,OHSU_HNSCC_derm002,18,-0.005,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25620,10348,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.271,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25621,10348,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.211,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25622,10348,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.277,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25623,10348,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.252,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
25624,10348,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
25625,10348,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.058,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25626,10348,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.38,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25627,10348,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.073,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25628,10348,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.389,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25629,10348,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.914,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25630,10348,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.292,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25631,10348,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.201,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25632,10348,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.442,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25633,10348,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.252,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25634,10348,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.351,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25635,10348,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.006,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25636,10348,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.054,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25637,10348,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.294,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25638,10348,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.382,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25639,10348,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.247,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
25640,10348,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.13,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
25641,10348,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.11,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25642,10348,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.48,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25643,10348,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.098,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25644,10348,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.416,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25645,10348,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.902,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25646,10348,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.369,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25647,10348,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.255,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25648,10348,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.581,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25649,10348,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.326,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25650,10348,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.42,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25651,10348,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.028,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25652,10348,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.096,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25653,10348,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.4,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25654,10348,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.44,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25655,10348,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.227,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
25656,10348,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
25657,10348,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.194,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25658,10348,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.579,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25659,10348,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.181,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25660,10348,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.431,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25661,10348,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.718,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25662,10348,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.392,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25663,10348,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.301,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25664,10348,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.657,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25665,10348,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.361,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25666,10348,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.443,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25667,10348,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.025,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25668,10348,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.596,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25669,10348,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.556,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25670,10348,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.534,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25671,10348,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.229,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
25672,10348,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.212,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
25673,10348,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.293,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25674,10348,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.655,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25675,10348,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.358,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25676,10348,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.476,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25677,10348,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.71,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25678,10348,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.464,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25679,10348,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.415,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25680,10348,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.601,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25681,10348,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.472,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25682,10348,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.54,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25683,10348,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.017,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25684,10348,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.067,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25685,10348,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.587,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25686,10348,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.684,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25687,10348,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.281,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
25688,10348,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.443,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
25689,10348,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.462,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25690,10348,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.837,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25691,10348,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.475,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25692,10348,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.598,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25693,10348,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.698,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25694,10348,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.573,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25695,10348,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.553,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25696,10348,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.659,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
25697,10348,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.422,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
25698,10348,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.46,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25699,10348,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.038,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
25700,10348,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.611,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
25701,10348,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.625,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
25702,10348,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.659,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
25703,10348,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.276,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
25704,10348,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.513,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
25705,10348,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.681,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
25706,10348,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.626,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25707,10348,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.613,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
25708,10348,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.566,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
25709,10348,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.639,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25710,10348,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.609,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
25711,10348,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.55,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
25712,10348,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.583,0,NONE,OHSU_HNSCC_derm002
25713,10348,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.586,0,NONE,OHSU_HNSCC_derm002
25714,10348,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.62,0,NONE,OHSU_HNSCC_derm002
25715,10348,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.66,0,NONE,OHSU_HNSCC_derm002
25716,10348,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.661,0,NONE,OHSU_HNSCC_derm002
25717,10348,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.597,0,NONE,OHSU_HNSCC_derm002
25718,10348,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.643,0,NONE,OHSU_HNSCC_derm002
25719,10348,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.593,0,NONE,OHSU_HNSCC_derm002
25720,10348,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.617,0,NONE,OHSU_HNSCC_derm002
25721,10348,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.563,0,NONE,OHSU_HNSCC_derm002
25722,10348,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.5,0,NONE,OHSU_HNSCC_derm002
25723,10348,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.682,0,NONE,OHSU_HNSCC_derm002
25724,10348,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
25725,10348,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.69,0,NONE,OHSU_HNSCC_derm002
25726,10348,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.672,0,NONE,OHSU_HNSCC_derm002
25727,10348,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.662,0,NONE,OHSU_HNSCC_derm002
25728,10348,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.165,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25729,10348,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.167,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25730,10348,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.01,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25731,10348,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.02,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25732,10348,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.021,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25733,10348,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.022,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25734,10348,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.202,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25735,10348,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.183,10,Gefitinib,OHSU_HNSCC_derm002
25736,10348,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.022,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
25737,10348,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.062,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25738,10348,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.133,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25739,10348,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.047,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25740,10348,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.045,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25741,10348,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.108,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25742,10348,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.043,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25743,10348,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.035,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25744,10348,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.239,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25745,10348,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.257,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25746,10348,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.001,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25747,10348,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.233,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25748,10348,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.124,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25749,10348,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.114,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25750,10348,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.345,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25751,10348,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.315,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
25752,10348,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.35,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
25753,10348,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.049,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25754,10348,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.66,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25755,10348,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.225,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25756,10348,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.066,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25757,10348,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.269,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25758,10348,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.075,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25759,10348,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.056,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25760,10348,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.295,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25761,10348,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.273,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25762,10348,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.012,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25763,10348,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.471,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25764,10348,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.22,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25765,10348,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.118,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25766,10348,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.416,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25767,10348,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.364,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
25768,10348,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.484,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
25769,10348,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.132,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25770,10348,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.669,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25771,10348,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.34,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25772,10348,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.08,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25773,10348,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.347,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25774,10348,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.087,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25775,10348,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.102,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25776,10348,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.289,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25777,10348,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.38,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25778,10348,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.026,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25779,10348,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.641,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25780,10348,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.278,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25781,10348,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.307,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25782,10348,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.538,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25783,10348,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.464,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
25784,10348,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
25785,10348,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.196,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25786,10348,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.654,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25787,10348,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.461,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25788,10348,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.134,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25789,10348,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.4,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25790,10348,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.149,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25791,10348,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.197,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25792,10348,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.289,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25793,10348,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.443,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25794,10348,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.039,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25795,10348,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.719,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25796,10348,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.446,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25797,10348,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.443,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25798,10348,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.668,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25799,10348,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.465,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
25800,10348,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.67,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
25801,10348,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.354,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25802,10348,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.703,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25803,10348,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.601,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25804,10348,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.279,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25805,10348,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.502,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25806,10348,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.252,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25807,10348,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.303,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25808,10348,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.363,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25809,10348,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.609,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25810,10348,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.042,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25811,10348,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.78,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25812,10348,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.542,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25813,10348,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.58,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25814,10348,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.736,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25815,10348,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.594,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
25816,10348,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.742,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
25817,10348,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.58,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25818,10348,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.754,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25819,10348,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.635,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25820,10348,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.413,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25821,10348,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.669,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25822,10348,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.449,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25823,10348,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.506,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25824,10348,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.34,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25825,10348,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.587,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
25826,10348,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.05,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
25827,10348,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.786,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
25828,10348,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.613,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
25829,10348,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.698,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
25830,10348,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.74,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
25831,10348,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.657,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
25832,10348,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.684,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
25833,10348,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.684,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
25834,10348,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.751,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
25835,10348,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.776,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25836,10348,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.604,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25837,10348,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.735,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
25838,10348,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.605,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
25839,10348,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.618,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
25840,10348,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.66,0,NONE,OHSU_HNSCC_derm002
25841,10348,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.663,0,NONE,OHSU_HNSCC_derm002
25842,10348,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.74,0,NONE,OHSU_HNSCC_derm002
25843,10348,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.796,0,NONE,OHSU_HNSCC_derm002
25844,10348,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.733,0,NONE,OHSU_HNSCC_derm002
25845,10348,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.677,0,NONE,OHSU_HNSCC_derm002
25846,10348,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.723,0,NONE,OHSU_HNSCC_derm002
25847,10348,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
25848,10348,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.712,0,NONE,OHSU_HNSCC_derm002
25849,10348,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.752,0,NONE,OHSU_HNSCC_derm002
25850,10348,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.748,0,NONE,OHSU_HNSCC_derm002
25851,10348,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.747,0,NONE,OHSU_HNSCC_derm002
25852,10348,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.805,0,NONE,OHSU_HNSCC_derm002
25853,10348,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.766,0,NONE,OHSU_HNSCC_derm002
25854,10348,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.648,0,NONE,OHSU_HNSCC_derm002
25855,10348,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.746,0,NONE,OHSU_HNSCC_derm002
25856,10348,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.004,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25857,10348,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.491,10,APTO-253 x,OHSU_HNSCC_derm002
25858,10348,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.027,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25859,10348,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.935,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25860,10348,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.175,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25861,10348,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.049,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25862,10348,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.042,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25863,10348,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.044,10,Brigatinib,OHSU_HNSCC_derm002
25864,10348,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.234,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25865,10348,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.033,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25866,10348,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.013,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25867,10348,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.03,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25868,10348,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.241,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25869,10348,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.159,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25870,10348,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.016,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25871,10348,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.005,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25872,10348,Blank 490,5,A,OHSU_HNSCC_derm002,10,-0.007,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25873,10348,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.45,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
25874,10348,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.032,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25875,10348,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.828,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25876,10348,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.295,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25877,10348,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.074,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25878,10348,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.262,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25879,10348,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.107,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
25880,10348,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.325,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25881,10348,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.089,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25882,10348,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.084,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25883,10348,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.05,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25884,10348,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.372,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25885,10348,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.311,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25886,10348,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.043,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25887,10348,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.058,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25888,10348,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.004,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25889,10348,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.618,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
25890,10348,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.028,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25891,10348,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.799,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25892,10348,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.342,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25893,10348,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.066,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25894,10348,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.314,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25895,10348,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.396,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
25896,10348,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.369,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25897,10348,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.087,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25898,10348,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.287,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25899,10348,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.044,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25900,10348,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.334,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25901,10348,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.314,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25902,10348,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.229,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25903,10348,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.216,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25904,10348,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.021,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25905,10348,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.659,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
25906,10348,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.052,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25907,10348,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.796,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25908,10348,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.472,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25909,10348,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.095,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25910,10348,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.363,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25911,10348,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.676,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
25912,10348,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.38,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25913,10348,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.137,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25914,10348,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.442,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25915,10348,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.039,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25916,10348,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.455,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25917,10348,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.442,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25918,10348,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.418,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25919,10348,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.424,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25920,10348,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.024,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25921,10348,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.619,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
25922,10348,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.101,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25923,10348,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.795,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25924,10348,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.519,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25925,10348,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.166,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25926,10348,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.345,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25927,10348,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.754,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
25928,10348,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.353,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25929,10348,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.232,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25930,10348,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.613,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25931,10348,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.12,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25932,10348,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.564,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25933,10348,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.544,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25934,10348,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.529,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25935,10348,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.561,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25936,10348,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.034,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25937,10348,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.676,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
25938,10348,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.301,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25939,10348,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.775,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25940,10348,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.631,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25941,10348,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.386,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25942,10348,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.362,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25943,10348,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.766,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
25944,10348,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.391,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25945,10348,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.414,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25946,10348,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.755,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25947,10348,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.29,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25948,10348,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.724,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25949,10348,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.644,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25950,10348,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.605,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25951,10348,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.653,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25952,10348,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.036,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
25953,10348,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
25954,10348,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.629,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
25955,10348,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.829,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
25956,10348,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.673,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
25957,10348,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.472,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25958,10348,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.497,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
25959,10348,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.789,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
25960,10348,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.505,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
25961,10348,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.576,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
25962,10348,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.843,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25963,10348,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.522,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
25964,10348,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.813,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
25965,10348,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.772,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25966,10348,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.692,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25967,10348,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.624,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25968,10348,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.636,0,NONE,OHSU_HNSCC_derm002
25969,10348,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.673,0,NONE,OHSU_HNSCC_derm002
25970,10348,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
25971,10348,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.808,0,NONE,OHSU_HNSCC_derm002
25972,10348,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.73,0,NONE,OHSU_HNSCC_derm002
25973,10348,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.753,0,NONE,OHSU_HNSCC_derm002
25974,10348,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.785,0,NONE,OHSU_HNSCC_derm002
25975,10348,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
25976,10348,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.804,0,NONE,OHSU_HNSCC_derm002
25977,10348,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.757,0,NONE,OHSU_HNSCC_derm002
25978,10348,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.79,0,NONE,OHSU_HNSCC_derm002
25979,10348,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.727,0,NONE,OHSU_HNSCC_derm002
25980,10348,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.701,0,NONE,OHSU_HNSCC_derm002
25981,10348,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.687,0,NONE,OHSU_HNSCC_derm002
25982,10348,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.609,0,NONE,OHSU_HNSCC_derm002
25983,10348,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.373,0,NONE,OHSU_HNSCC_derm002
25984,10348,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.006,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25985,10348,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.011,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
25986,10348,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.063,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25987,10348,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.267,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
25988,10348,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.293,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
25989,10348,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.203,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
25990,10348,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.183,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
25991,10348,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.229,10,Trametinib,OHSU_HNSCC_derm002
25992,10348,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.101,10,BEZ235,OHSU_HNSCC_derm002
25993,10348,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.085,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
25994,10348,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.316,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
25995,10348,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.043,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
25996,10348,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.304,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
25997,10348,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.155,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
25998,10348,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.508,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
25999,10348,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.142,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26000,10348,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.058,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26001,10348,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.126,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26002,10348,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.071,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26003,10348,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.334,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26004,10348,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.366,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26005,10348,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.309,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26006,10348,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.179,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26007,10348,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.26,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
26008,10348,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.138,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
26009,10348,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.155,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26010,10348,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.373,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26011,10348,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.077,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26012,10348,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.492,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26013,10348,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.279,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26014,10348,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.601,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26015,10348,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.201,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26016,10348,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.361,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26017,10348,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.519,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26018,10348,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.089,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26019,10348,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.483,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26020,10348,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.514,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26021,10348,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.352,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26022,10348,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.349,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26023,10348,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.263,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
26024,10348,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.166,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
26025,10348,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.344,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26026,10348,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.249,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26027,10348,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.084,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26028,10348,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.521,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26029,10348,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.366,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26030,10348,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.721,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26031,10348,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.284,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26032,10348,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.573,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26033,10348,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.77,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26034,10348,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.103,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26035,10348,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.544,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26036,10348,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.649,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26037,10348,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.404,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26038,10348,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.425,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26039,10348,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.261,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
26040,10348,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.186,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
26041,10348,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.483,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26042,10348,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.441,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26043,10348,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.156,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26044,10348,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.577,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26045,10348,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.371,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26046,10348,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.62,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26047,10348,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.301,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26048,10348,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.735,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26049,10348,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.798,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26050,10348,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.187,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26051,10348,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.627,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26052,10348,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.765,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26053,10348,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.489,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26054,10348,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.544,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26055,10348,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.291,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
26056,10348,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.273,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
26057,10348,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.685,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26058,10348,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.528,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26059,10348,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.269,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26060,10348,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.599,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26061,10348,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.44,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26062,10348,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.7,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26063,10348,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.297,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26064,10348,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.738,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26065,10348,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.822,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26066,10348,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.344,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26067,10348,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.625,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26068,10348,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.742,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26069,10348,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.545,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26070,10348,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.668,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26071,10348,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.319,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
26072,10348,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.54,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
26073,10348,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.627,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26074,10348,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.669,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26075,10348,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.381,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26076,10348,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.681,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26077,10348,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.586,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26078,10348,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.738,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26079,10348,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.31,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26080,10348,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.673,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26081,10348,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.746,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
26082,10348,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.46,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26083,10348,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.728,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
26084,10348,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.722,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
26085,10348,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.663,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26086,10348,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.572,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
26087,10348,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.33,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
26088,10348,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.631,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
26089,10348,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.798,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
26090,10348,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.717,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
26091,10348,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.548,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
26092,10348,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.735,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
26093,10348,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.718,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26094,10348,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.713,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
26095,10348,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.429,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
26096,10348,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
26097,10348,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.663,0,NONE,OHSU_HNSCC_derm002
26098,10348,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.679,0,NONE,OHSU_HNSCC_derm002
26099,10348,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.715,0,NONE,OHSU_HNSCC_derm002
26100,10348,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.654,0,NONE,OHSU_HNSCC_derm002
26101,10348,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.698,0,NONE,OHSU_HNSCC_derm002
26102,10348,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.683,0,NONE,OHSU_HNSCC_derm002
26103,10348,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.756,0,NONE,OHSU_HNSCC_derm002
26104,10348,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.684,0,NONE,OHSU_HNSCC_derm002
26105,10348,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.688,0,NONE,OHSU_HNSCC_derm002
26106,10348,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.639,0,NONE,OHSU_HNSCC_derm002
26107,10348,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.739,0,NONE,OHSU_HNSCC_derm002
26108,10348,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.78,0,NONE,OHSU_HNSCC_derm002
26109,10348,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.721,0,NONE,OHSU_HNSCC_derm002
26110,10348,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.688,0,NONE,OHSU_HNSCC_derm002
26111,10348,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.687,0,NONE,OHSU_HNSCC_derm002
26112,10348,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.163,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26113,10348,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.056,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26114,10348,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.03,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26115,10348,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.104,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26116,10348,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.023,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26117,10348,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.07,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26118,10348,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.424,10,IMR 1,OHSU_HNSCC_derm002
26119,10348,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.246,10,Gefitinib,OHSU_HNSCC_derm002
26120,10348,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.027,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
26121,10348,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.654,0,DMSO,OHSU_HNSCC_derm002
26122,10348,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.652,0,DMSO ,OHSU_HNSCC_derm002
26123,10348,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.625,0,DMSO,OHSU_HNSCC_derm002
26124,10348,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.676,0,DMSO ,OHSU_HNSCC_derm002
26125,10348,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.659,0,DMSO,OHSU_HNSCC_derm002
26126,10348,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.576,0,DMSO ,OHSU_HNSCC_derm002
26127,10348,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.526,0,DMSO,OHSU_HNSCC_derm002
26128,10348,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.139,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26129,10348,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.052,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26130,10348,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.049,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26131,10348,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.203,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26132,10348,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.163,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26133,10348,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.081,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26134,10348,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.683,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
26135,10348,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
26136,10348,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.317,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
26137,10348,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.658,0,DMSO,OHSU_HNSCC_derm002
26138,10348,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.665,0,DMSO ,OHSU_HNSCC_derm002
26139,10348,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.664,0,DMSO,OHSU_HNSCC_derm002
26140,10348,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.646,0,DMSO ,OHSU_HNSCC_derm002
26141,10348,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.648,0,DMSO,OHSU_HNSCC_derm002
26142,10348,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.745,0,DMSO ,OHSU_HNSCC_derm002
26143,10348,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.57,0,DMSO,OHSU_HNSCC_derm002
26144,10348,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.279,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26145,10348,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.075,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26146,10348,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.099,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26147,10348,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.272,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26148,10348,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.396,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26149,10348,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.088,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26150,10348,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.762,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
26151,10348,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.307,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
26152,10348,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.516,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
26153,10348,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.594,0,DMSO,OHSU_HNSCC_derm002
26154,10348,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.668,0,DMSO ,OHSU_HNSCC_derm002
26155,10348,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.665,0,DMSO,OHSU_HNSCC_derm002
26156,10348,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.761,0,DMSO ,OHSU_HNSCC_derm002
26157,10348,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.669,0,DMSO,OHSU_HNSCC_derm002
26158,10348,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.691,0,DMSO ,OHSU_HNSCC_derm002
26159,10348,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.589,0,DMSO,OHSU_HNSCC_derm002
26160,10348,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.338,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26161,10348,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.2,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26162,10348,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.158,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26163,10348,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.294,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26164,10348,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.449,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26165,10348,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.142,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26166,10348,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.669,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
26167,10348,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.351,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
26168,10348,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.597,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
26169,10348,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.667,0,DMSO,OHSU_HNSCC_derm002
26170,10348,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.714,0,DMSO ,OHSU_HNSCC_derm002
26171,10348,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.648,0,DMSO,OHSU_HNSCC_derm002
26172,10348,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.737,0,DMSO ,OHSU_HNSCC_derm002
26173,10348,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.718,0,DMSO,OHSU_HNSCC_derm002
26174,10348,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.686,0,DMSO ,OHSU_HNSCC_derm002
26175,10348,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.603,0,DMSO,OHSU_HNSCC_derm002
26176,10348,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.468,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26177,10348,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.323,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26178,10348,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.303,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26179,10348,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.305,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26180,10348,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.559,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26181,10348,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.255,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26182,10348,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.699,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
26183,10348,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.428,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
26184,10348,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.622,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
26185,10348,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.648,0,DMSO,OHSU_HNSCC_derm002
26186,10348,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.686,0,DMSO ,OHSU_HNSCC_derm002
26187,10348,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.695,0,DMSO,OHSU_HNSCC_derm002
26188,10348,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.731,0,DMSO ,OHSU_HNSCC_derm002
26189,10348,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.678,0,DMSO,OHSU_HNSCC_derm002
26190,10348,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.726,0,DMSO ,OHSU_HNSCC_derm002
26191,10348,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.559,0,DMSO,OHSU_HNSCC_derm002
26192,10348,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.573,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26193,10348,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.441,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26194,10348,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.476,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26195,10348,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.423,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26196,10348,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.626,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26197,10348,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.421,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26198,10348,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
26199,10348,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.517,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
26200,10348,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.651,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
26201,10348,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.632,0,DMSO,OHSU_HNSCC_derm002
26202,10348,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.712,0,DMSO ,OHSU_HNSCC_derm002
26203,10348,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.658,0,DMSO,OHSU_HNSCC_derm002
26204,10348,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.689,0,DMSO ,OHSU_HNSCC_derm002
26205,10348,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.664,0,DMSO,OHSU_HNSCC_derm002
26206,10348,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.744,0,DMSO ,OHSU_HNSCC_derm002
26207,10348,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.584,0,DMSO,OHSU_HNSCC_derm002
26208,10348,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.695,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26209,10348,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.54,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
26210,10348,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.62,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
26211,10348,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.509,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
26212,10348,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.66,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
26213,10348,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.548,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
26214,10348,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.718,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
26215,10348,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.555,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
26216,10348,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.658,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
26217,10348,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.632,0,DMSO,OHSU_HNSCC_derm002
26218,10348,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.652,0,DMSO ,OHSU_HNSCC_derm002
26219,10348,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.668,0,DMSO,OHSU_HNSCC_derm002
26220,10348,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.726,0,DMSO ,OHSU_HNSCC_derm002
26221,10348,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.706,0,DMSO,OHSU_HNSCC_derm002
26222,10348,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.692,0,DMSO ,OHSU_HNSCC_derm002
26223,10348,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.576,0,DMSO,OHSU_HNSCC_derm002
26224,10348,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
26225,10348,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.578,0,NONE,OHSU_HNSCC_derm002
26226,10348,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.725,0,NONE,OHSU_HNSCC_derm002
26227,10348,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.644,0,NONE,OHSU_HNSCC_derm002
26228,10348,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.69,0,NONE,OHSU_HNSCC_derm002
26229,10348,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.684,0,NONE,OHSU_HNSCC_derm002
26230,10348,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.654,0,NONE,OHSU_HNSCC_derm002
26231,10348,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
26232,10348,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.627,0,NONE,OHSU_HNSCC_derm002
26233,10348,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.642,0,NONE,OHSU_HNSCC_derm002
26234,10348,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
26235,10348,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.641,0,NONE,OHSU_HNSCC_derm002
26236,10348,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.713,0,NONE,OHSU_HNSCC_derm002
26237,10348,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.699,0,NONE,OHSU_HNSCC_derm002
26238,10348,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
26239,10348,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.591,0,NONE,OHSU_HNSCC_derm002
26240,10348,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.59,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26241,10348,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.02,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26242,10348,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.298,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26243,10348,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.206,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26244,10348,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.295,5,Vandetanib (5mM),OHSU_HNSCC_derm002
26245,10348,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.662,0,DMSO,OHSU_HNSCC_derm002
26246,10348,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.702,0,DMSO ,OHSU_HNSCC_derm002
26247,10348,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.043,10,Brigatinib,OHSU_HNSCC_derm002
26248,10348,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.2,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26249,10348,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.634,0,DMSO,OHSU_HNSCC_derm002
26250,10348,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.72,0,DMSO ,OHSU_HNSCC_derm002
26251,10348,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.618,0,DMSO,OHSU_HNSCC_derm002
26252,10348,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.742,0,DMSO ,OHSU_HNSCC_derm002
26253,10348,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.699,0,DMSO,OHSU_HNSCC_derm002
26254,10348,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.696,0,DMSO ,OHSU_HNSCC_derm002
26255,10348,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.573,0,DMSO,OHSU_HNSCC_derm002
26256,10348,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.717,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26257,10348,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.033,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26258,10348,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.349,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26259,10348,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.242,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26260,10348,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.38,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
26261,10348,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.693,0,DMSO,OHSU_HNSCC_derm002
26262,10348,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.692,0,DMSO ,OHSU_HNSCC_derm002
26263,10348,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.128,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
26264,10348,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.282,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26265,10348,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.65,0,DMSO,OHSU_HNSCC_derm002
26266,10348,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.706,0,DMSO ,OHSU_HNSCC_derm002
26267,10348,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.65,0,DMSO,OHSU_HNSCC_derm002
26268,10348,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.747,0,DMSO ,OHSU_HNSCC_derm002
26269,10348,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.687,0,DMSO,OHSU_HNSCC_derm002
26270,10348,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.695,0,DMSO ,OHSU_HNSCC_derm002
26271,10348,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.544,0,DMSO,OHSU_HNSCC_derm002
26272,10348,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.809,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26273,10348,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.06,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26274,10348,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.461,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26275,10348,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.254,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26276,10348,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.456,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
26277,10348,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.665,0,DMSO,OHSU_HNSCC_derm002
26278,10348,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.712,0,DMSO ,OHSU_HNSCC_derm002
26279,10348,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.449,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
26280,10348,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.284,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26281,10348,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.667,0,DMSO,OHSU_HNSCC_derm002
26282,10348,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.675,0,DMSO ,OHSU_HNSCC_derm002
26283,10348,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.684,0,DMSO,OHSU_HNSCC_derm002
26284,10348,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.705,0,DMSO ,OHSU_HNSCC_derm002
26285,10348,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.688,0,DMSO,OHSU_HNSCC_derm002
26286,10348,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.675,0,DMSO ,OHSU_HNSCC_derm002
26287,10348,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.554,0,DMSO,OHSU_HNSCC_derm002
26288,10348,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.728,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26289,10348,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.117,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26290,10348,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.522,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26291,10348,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.284,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26292,10348,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.612,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
26293,10348,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.661,0,DMSO,OHSU_HNSCC_derm002
26294,10348,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.711,0,DMSO ,OHSU_HNSCC_derm002
26295,10348,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.581,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
26296,10348,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.306,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26297,10348,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.599,0,DMSO,OHSU_HNSCC_derm002
26298,10348,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.735,0,DMSO ,OHSU_HNSCC_derm002
26299,10348,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.691,0,DMSO,OHSU_HNSCC_derm002
26300,10348,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.751,0,DMSO ,OHSU_HNSCC_derm002
26301,10348,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.688,0,DMSO,OHSU_HNSCC_derm002
26302,10348,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.717,0,DMSO ,OHSU_HNSCC_derm002
26303,10348,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.566,0,DMSO,OHSU_HNSCC_derm002
26304,10348,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.688,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26305,10348,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.253,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26306,10348,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.553,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26307,10348,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.413,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26308,10348,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.62,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
26309,10348,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.655,0,DMSO,OHSU_HNSCC_derm002
26310,10348,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.675,0,DMSO ,OHSU_HNSCC_derm002
26311,10348,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.581,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
26312,10348,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.313,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26313,10348,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.673,0,DMSO,OHSU_HNSCC_derm002
26314,10348,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.716,0,DMSO ,OHSU_HNSCC_derm002
26315,10348,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.702,0,DMSO,OHSU_HNSCC_derm002
26316,10348,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.715,0,DMSO ,OHSU_HNSCC_derm002
26317,10348,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.699,0,DMSO,OHSU_HNSCC_derm002
26318,10348,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.702,0,DMSO ,OHSU_HNSCC_derm002
26319,10348,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.534,0,DMSO,OHSU_HNSCC_derm002
26320,10348,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.726,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26321,10348,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.462,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26322,10348,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.632,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26323,10348,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.505,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26324,10348,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.656,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
26325,10348,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.707,0,DMSO,OHSU_HNSCC_derm002
26326,10348,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.686,0,DMSO ,OHSU_HNSCC_derm002
26327,10348,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.62,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
26328,10348,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.321,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26329,10348,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.686,0,DMSO,OHSU_HNSCC_derm002
26330,10348,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.721,0,DMSO ,OHSU_HNSCC_derm002
26331,10348,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.714,0,DMSO,OHSU_HNSCC_derm002
26332,10348,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.738,0,DMSO ,OHSU_HNSCC_derm002
26333,10348,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.732,0,DMSO,OHSU_HNSCC_derm002
26334,10348,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.683,0,DMSO ,OHSU_HNSCC_derm002
26335,10348,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.566,0,DMSO,OHSU_HNSCC_derm002
26336,10348,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.652,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26337,10348,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.551,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
26338,10348,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.76,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
26339,10348,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.59,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
26340,10348,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.709,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
26341,10348,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.673,0,DMSO,OHSU_HNSCC_derm002
26342,10348,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.738,0,DMSO ,OHSU_HNSCC_derm002
26343,10348,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.629,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
26344,10348,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.388,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26345,10348,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.731,0,DMSO,OHSU_HNSCC_derm002
26346,10348,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.716,0,DMSO ,OHSU_HNSCC_derm002
26347,10348,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.657,0,DMSO,OHSU_HNSCC_derm002
26348,10348,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.759,0,DMSO ,OHSU_HNSCC_derm002
26349,10348,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.659,0,DMSO,OHSU_HNSCC_derm002
26350,10348,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.701,0,DMSO ,OHSU_HNSCC_derm002
26351,10348,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.551,0,DMSO,OHSU_HNSCC_derm002
26352,10348,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.602,0,NONE,OHSU_HNSCC_derm002
26353,10348,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.693,0,NONE,OHSU_HNSCC_derm002
26354,10348,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.753,0,NONE,OHSU_HNSCC_derm002
26355,10348,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.652,0,NONE,OHSU_HNSCC_derm002
26356,10348,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.643,0,NONE,OHSU_HNSCC_derm002
26357,10348,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.674,0,NONE,OHSU_HNSCC_derm002
26358,10348,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.691,0,NONE,OHSU_HNSCC_derm002
26359,10348,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
26360,10348,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.671,0,NONE,OHSU_HNSCC_derm002
26361,10348,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.682,0,NONE,OHSU_HNSCC_derm002
26362,10348,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.755,0,NONE,OHSU_HNSCC_derm002
26363,10348,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.733,0,NONE,OHSU_HNSCC_derm002
26364,10348,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
26365,10348,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.679,0,NONE,OHSU_HNSCC_derm002
26366,10348,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.654,0,NONE,OHSU_HNSCC_derm002
26367,10348,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.531,0,NONE,OHSU_HNSCC_derm002
26368,10348,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.125,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26369,10348,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.145,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26370,10348,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.643,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26371,10348,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.053,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26372,10348,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.449,10,LY3039478 ,OHSU_HNSCC_derm002
26373,10348,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.175,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26374,10348,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.136,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26375,10348,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.177,10,Trametinib,OHSU_HNSCC_derm002
26376,10348,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.083,10,BEZ235,OHSU_HNSCC_derm002
26377,10348,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.659,0,DMSO,OHSU_HNSCC_derm002
26378,10348,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.677,0,DMSO ,OHSU_HNSCC_derm002
26379,10348,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.719,0,DMSO,OHSU_HNSCC_derm002
26380,10348,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.692,0,DMSO ,OHSU_HNSCC_derm002
26381,10348,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.747,0,DMSO,OHSU_HNSCC_derm002
26382,10348,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.671,0,DMSO ,OHSU_HNSCC_derm002
26383,10348,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.545,0,DMSO,OHSU_HNSCC_derm002
26384,10348,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.181,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26385,10348,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.298,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26386,10348,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.711,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26387,10348,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.047,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26388,10348,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.494,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
26389,10348,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.224,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26390,10348,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.133,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26391,10348,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.176,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
26392,10348,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.092,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
26393,10348,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.697,0,DMSO,OHSU_HNSCC_derm002
26394,10348,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.714,0,DMSO ,OHSU_HNSCC_derm002
26395,10348,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.737,0,DMSO,OHSU_HNSCC_derm002
26396,10348,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.713,0,DMSO ,OHSU_HNSCC_derm002
26397,10348,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.687,0,DMSO,OHSU_HNSCC_derm002
26398,10348,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.682,0,DMSO ,OHSU_HNSCC_derm002
26399,10348,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.579,0,DMSO,OHSU_HNSCC_derm002
26400,10348,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.223,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26401,10348,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.395,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26402,10348,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.693,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26403,10348,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.064,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26404,10348,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.509,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
26405,10348,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.236,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26406,10348,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.197,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26407,10348,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.166,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
26408,10348,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.119,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
26409,10348,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.694,0,DMSO,OHSU_HNSCC_derm002
26410,10348,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.759,0,DMSO ,OHSU_HNSCC_derm002
26411,10348,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.766,0,DMSO,OHSU_HNSCC_derm002
26412,10348,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.72,0,DMSO ,OHSU_HNSCC_derm002
26413,10348,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.745,0,DMSO,OHSU_HNSCC_derm002
26414,10348,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.694,0,DMSO ,OHSU_HNSCC_derm002
26415,10348,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.552,0,DMSO,OHSU_HNSCC_derm002
26416,10348,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.293,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26417,10348,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.485,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26418,10348,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.727,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26419,10348,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.126,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26420,10348,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.487,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
26421,10348,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.409,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26422,10348,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.209,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26423,10348,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.209,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
26424,10348,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.123,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
26425,10348,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.738,0,DMSO,OHSU_HNSCC_derm002
26426,10348,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.702,0,DMSO ,OHSU_HNSCC_derm002
26427,10348,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.684,0,DMSO,OHSU_HNSCC_derm002
26428,10348,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.736,0,DMSO ,OHSU_HNSCC_derm002
26429,10348,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.735,0,DMSO,OHSU_HNSCC_derm002
26430,10348,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.692,0,DMSO ,OHSU_HNSCC_derm002
26431,10348,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.598,0,DMSO,OHSU_HNSCC_derm002
26432,10348,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.402,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26433,10348,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.588,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26434,10348,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.72,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26435,10348,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.278,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26436,10348,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.468,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
26437,10348,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.492,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26438,10348,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.246,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26439,10348,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.234,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
26440,10348,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.151,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
26441,10348,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.738,0,DMSO,OHSU_HNSCC_derm002
26442,10348,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.715,0,DMSO ,OHSU_HNSCC_derm002
26443,10348,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.747,0,DMSO,OHSU_HNSCC_derm002
26444,10348,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.788,0,DMSO ,OHSU_HNSCC_derm002
26445,10348,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.722,0,DMSO,OHSU_HNSCC_derm002
26446,10348,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.665,0,DMSO ,OHSU_HNSCC_derm002
26447,10348,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.629,0,DMSO,OHSU_HNSCC_derm002
26448,10348,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.524,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26449,10348,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.552,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26450,10348,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.703,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26451,10348,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.489,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26452,10348,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.54,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
26453,10348,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.53,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26454,10348,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.395,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26455,10348,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.243,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
26456,10348,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.285,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
26457,10348,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.692,0,DMSO,OHSU_HNSCC_derm002
26458,10348,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.703,0,DMSO ,OHSU_HNSCC_derm002
26459,10348,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.717,0,DMSO,OHSU_HNSCC_derm002
26460,10348,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.719,0,DMSO ,OHSU_HNSCC_derm002
26461,10348,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.754,0,DMSO,OHSU_HNSCC_derm002
26462,10348,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.658,0,DMSO ,OHSU_HNSCC_derm002
26463,10348,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.606,0,DMSO,OHSU_HNSCC_derm002
26464,10348,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.532,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
26465,10348,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.593,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
26466,10348,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.675,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
26467,10348,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.575,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
26468,10348,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.499,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
26469,10348,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.495,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
26470,10348,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.398,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
26471,10348,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.293,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
26472,10348,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.43,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
26473,10348,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.713,0,DMSO,OHSU_HNSCC_derm002
26474,10348,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.703,0,DMSO ,OHSU_HNSCC_derm002
26475,10348,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.716,0,DMSO,OHSU_HNSCC_derm002
26476,10348,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.692,0,DMSO ,OHSU_HNSCC_derm002
26477,10348,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.702,0,DMSO,OHSU_HNSCC_derm002
26478,10348,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.646,0,DMSO ,OHSU_HNSCC_derm002
26479,10348,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.623,0,DMSO,OHSU_HNSCC_derm002
26480,10348,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.531,0,NONE,OHSU_HNSCC_derm002
26481,10348,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.593,0,NONE,OHSU_HNSCC_derm002
26482,10348,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.549,0,NONE,OHSU_HNSCC_derm002
26483,10348,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.55,0,NONE,OHSU_HNSCC_derm002
26484,10348,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.647,0,NONE,OHSU_HNSCC_derm002
26485,10348,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
26486,10348,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.578,0,NONE,OHSU_HNSCC_derm002
26487,10348,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.603,0,NONE,OHSU_HNSCC_derm002
26488,10348,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.598,0,NONE,OHSU_HNSCC_derm002
26489,10348,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.638,0,NONE,OHSU_HNSCC_derm002
26490,10348,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
26491,10348,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
26492,10348,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
26493,10348,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.685,0,NONE,OHSU_HNSCC_derm002
26494,10348,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
26495,10348,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.599,0,NONE,OHSU_HNSCC_derm002
26496,10348,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.019,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
26497,10348,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.523,10,Lucitanib ,OHSU_HNSCC_derm002
26498,10348,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.556,10,Resveratrol,OHSU_HNSCC_derm002
26499,10348,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.177,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26500,10348,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.543,10,Bicalutamide,OHSU_HNSCC_derm002
26501,10348,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.471,10,Methotrexate ,OHSU_HNSCC_derm002
26502,10348,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.117,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26503,10348,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.198,10,Gefitinib,OHSU_HNSCC_derm002
26504,10348,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.15,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
26505,10348,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.232,10,Tamatinib/R406,OHSU_HNSCC_derm002
26506,10348,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.182,10,Bosutinib,OHSU_HNSCC_derm002
26507,10348,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.063,10,PI-103,OHSU_HNSCC_derm002
26508,10348,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.553,10,Glycyrrhizin,OHSU_HNSCC_derm002
26509,10348,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.476,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
26510,10348,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.209,10,GSK-690693,OHSU_HNSCC_derm002
26511,10348,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.133,10,Ibrutinib,OHSU_HNSCC_derm002
26512,10348,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.034,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
26513,10348,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.573,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
26514,10348,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.502,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
26515,10348,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.193,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26516,10348,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.519,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
26517,10348,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.628,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
26518,10348,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.2,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26519,10348,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.235,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
26520,10348,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.312,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
26521,10348,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.322,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
26522,10348,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.209,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
26523,10348,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.074,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
26524,10348,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.561,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
26525,10348,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.533,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
26526,10348,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.252,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
26527,10348,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.242,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
26528,10348,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.059,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
26529,10348,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.575,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
26530,10348,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.606,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
26531,10348,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.255,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26532,10348,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.635,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
26533,10348,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.621,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
26534,10348,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.4,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26535,10348,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.336,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
26536,10348,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.546,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
26537,10348,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.544,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
26538,10348,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.315,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
26539,10348,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.104,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
26540,10348,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.573,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
26541,10348,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.597,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
26542,10348,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.292,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
26543,10348,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.288,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
26544,10348,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.095,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
26545,10348,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.487,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
26546,10348,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.592,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
26547,10348,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.262,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26548,10348,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.641,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
26549,10348,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.608,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
26550,10348,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.559,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26551,10348,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.34,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
26552,10348,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.585,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
26553,10348,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.554,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
26554,10348,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.542,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
26555,10348,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.171,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
26556,10348,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
26557,10348,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.612,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
26558,10348,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.312,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
26559,10348,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.329,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
26560,10348,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.214,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
26561,10348,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.418,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
26562,10348,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.655,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
26563,10348,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26564,10348,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.596,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
26565,10348,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.668,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
26566,10348,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.539,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26567,10348,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.357,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
26568,10348,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.655,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
26569,10348,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.631,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
26570,10348,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.697,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
26571,10348,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.326,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
26572,10348,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.648,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
26573,10348,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.624,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
26574,10348,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.432,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
26575,10348,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.397,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
26576,10348,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.405,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
26577,10348,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.563,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
26578,10348,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.639,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
26579,10348,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.351,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26580,10348,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.651,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
26581,10348,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.663,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
26582,10348,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.653,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26583,10348,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.505,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
26584,10348,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.611,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
26585,10348,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.583,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
26586,10348,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
26587,10348,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.523,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
26588,10348,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.617,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
26589,10348,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.62,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
26590,10348,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.446,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
26591,10348,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.45,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
26592,10348,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.431,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
26593,10348,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.525,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
26594,10348,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.618,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
26595,10348,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.417,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
26596,10348,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.627,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
26597,10348,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.608,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
26598,10348,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.654,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
26599,10348,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.597,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
26600,10348,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.614,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
26601,10348,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.686,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
26602,10348,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.632,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
26603,10348,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.617,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
26604,10348,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
26605,10348,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.657,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
26606,10348,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.524,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
26607,10348,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.47,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
26608,10348,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.479,0,NONE,OHSU_HNSCC_derm002
26609,10348,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.486,0,NONE,OHSU_HNSCC_derm002
26610,10348,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.689,0,NONE,OHSU_HNSCC_derm002
26611,10348,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.628,0,NONE,OHSU_HNSCC_derm002
26612,10348,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.665,0,NONE,OHSU_HNSCC_derm002
26613,10348,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.655,0,NONE,OHSU_HNSCC_derm002
26614,10348,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.669,0,NONE,OHSU_HNSCC_derm002
26615,10348,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
26616,10348,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
26617,10348,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.614,0,NONE,OHSU_HNSCC_derm002
26618,10348,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.61,0,NONE,OHSU_HNSCC_derm002
26619,10348,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.695,0,NONE,OHSU_HNSCC_derm002
26620,10348,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.596,0,NONE,OHSU_HNSCC_derm002
26621,10348,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.654,0,NONE,OHSU_HNSCC_derm002
26622,10348,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.548,0,NONE,OHSU_HNSCC_derm002
26623,10348,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.427,0,NONE,OHSU_HNSCC_derm002
26624,10348,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.052,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26625,10348,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.522,10,Sorafenib,OHSU_HNSCC_derm002
26626,10348,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.754,10,Rosmarinic acid,OHSU_HNSCC_derm002
26627,10348,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.331,10,Rapamycin,OHSU_HNSCC_derm002
26628,10348,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.58,10,Vismodegib,OHSU_HNSCC_derm002
26629,10348,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.131,10,PP242,OHSU_HNSCC_derm002
26630,10348,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.133,10,Alectinib,OHSU_HNSCC_derm002
26631,10348,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.059,10,Brigatinib,OHSU_HNSCC_derm002
26632,10348,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.187,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26633,10348,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.225,10,MK-2206,OHSU_HNSCC_derm002
26634,10348,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.186,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26635,10348,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.131,10,Flavopiridol ,OHSU_HNSCC_derm002
26636,10348,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.624,10,Indirubin,OHSU_HNSCC_derm002
26637,10348,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.515,10,PF-533228,OHSU_HNSCC_derm002
26638,10348,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.543,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26639,10348,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.117,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26640,10348,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.066,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26641,10348,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.648,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
26642,10348,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.657,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
26643,10348,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.333,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
26644,10348,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.627,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
26645,10348,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.217,3.3333333333333335,PP242,OHSU_HNSCC_derm002
26646,10348,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.408,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
26647,10348,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.098,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
26648,10348,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.253,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26649,10348,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.316,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
26650,10348,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.248,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26651,10348,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.116,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
26652,10348,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.734,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
26653,10348,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.67,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
26654,10348,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.44,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26655,10348,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.124,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26656,10348,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.063,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26657,10348,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.706,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
26658,10348,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.657,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
26659,10348,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.36,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
26660,10348,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.626,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
26661,10348,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.222,1.1111111111111112,PP242,OHSU_HNSCC_derm002
26662,10348,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.552,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
26663,10348,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.386,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
26664,10348,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.314,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26665,10348,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.41,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
26666,10348,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.264,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26667,10348,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.108,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
26668,10348,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.684,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
26669,10348,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.794,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
26670,10348,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.496,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26671,10348,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.109,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26672,10348,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.057,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26673,10348,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.585,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
26674,10348,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.633,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
26675,10348,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.361,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
26676,10348,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.648,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
26677,10348,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.336,0.3703703703703704,PP242,OHSU_HNSCC_derm002
26678,10348,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.516,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
26679,10348,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.525,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
26680,10348,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.277,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26681,10348,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.493,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
26682,10348,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.333,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26683,10348,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.158,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
26684,10348,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.675,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
26685,10348,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.786,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
26686,10348,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.459,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26687,10348,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.173,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26688,10348,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.068,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26689,10348,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.611,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
26690,10348,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.553,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
26691,10348,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
26692,10348,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.741,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
26693,10348,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.477,0.1234567901234568,PP242,OHSU_HNSCC_derm002
26694,10348,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.618,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
26695,10348,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.595,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
26696,10348,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.274,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26697,10348,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.541,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
26698,10348,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.321,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26699,10348,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.369,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
26700,10348,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
26701,10348,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.735,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
26702,10348,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.541,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26703,10348,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.272,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26704,10348,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.099,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26705,10348,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.602,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
26706,10348,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.674,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
26707,10348,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.341,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
26708,10348,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.523,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
26709,10348,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.569,0.0411522633744856,PP242,OHSU_HNSCC_derm002
26710,10348,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.685,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
26711,10348,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.698,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
26712,10348,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.293,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26713,10348,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.587,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
26714,10348,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.449,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26715,10348,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.495,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
26716,10348,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.659,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
26717,10348,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.626,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
26718,10348,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.584,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26719,10348,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.365,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26720,10348,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.225,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
26721,10348,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.529,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
26722,10348,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.623,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
26723,10348,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.409,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
26724,10348,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.584,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
26725,10348,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.637,0.013717421124828532,PP242,OHSU_HNSCC_derm002
26726,10348,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.63,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
26727,10348,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.645,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
26728,10348,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.358,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
26729,10348,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.599,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
26730,10348,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.483,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
26731,10348,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.531,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
26732,10348,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.657,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
26733,10348,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
26734,10348,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.601,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
26735,10348,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.459,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
26736,10348,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.485,0,NONE,OHSU_HNSCC_derm002
26737,10348,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.609,0,NONE,OHSU_HNSCC_derm002
26738,10348,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.683,0,NONE,OHSU_HNSCC_derm002
26739,10348,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.608,0,NONE,OHSU_HNSCC_derm002
26740,10348,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.583,0,NONE,OHSU_HNSCC_derm002
26741,10348,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.66,0,NONE,OHSU_HNSCC_derm002
26742,10348,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
26743,10348,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
26744,10348,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
26745,10348,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.588,0,NONE,OHSU_HNSCC_derm002
26746,10348,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.613,0,NONE,OHSU_HNSCC_derm002
26747,10348,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.624,0,NONE,OHSU_HNSCC_derm002
26748,10348,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.631,0,NONE,OHSU_HNSCC_derm002
26749,10348,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.711,0,NONE,OHSU_HNSCC_derm002
26750,10348,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.517,0,NONE,OHSU_HNSCC_derm002
26751,10348,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.537,0,NONE,OHSU_HNSCC_derm002
26752,10348,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.378,10,Emodin,OHSU_HNSCC_derm002
26753,10348,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.482,10,Baicalin,OHSU_HNSCC_derm002
26754,10348,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.033,10,NVP-TAE-684,OHSU_HNSCC_derm002
26755,10348,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.025,10,Panobinostat,OHSU_HNSCC_derm002
26756,10348,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.047,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
26757,10348,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.602,10,Fulvestrant,OHSU_HNSCC_derm002
26758,10348,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.152,10,SCH-772984,OHSU_HNSCC_derm002
26759,10348,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.202,10,Trametinib,OHSU_HNSCC_derm002
26760,10348,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.126,10,BEZ235,OHSU_HNSCC_derm002
26761,10348,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.541,10,MLN120B,OHSU_HNSCC_derm002
26762,10348,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.368,10,Ixabepilone,OHSU_HNSCC_derm002
26763,10348,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.002,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
26764,10348,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.225,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26765,10348,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.101,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26766,10348,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.491,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26767,10348,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.525,10,Letrozole,OHSU_HNSCC_derm002
26768,10348,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.425,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
26769,10348,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.6,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
26770,10348,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.232,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
26771,10348,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.026,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
26772,10348,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.084,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
26773,10348,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.647,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
26774,10348,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.21,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
26775,10348,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
26776,10348,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.137,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
26777,10348,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.638,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
26778,10348,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.415,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
26779,10348,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.2,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
26780,10348,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.232,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26781,10348,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.152,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26782,10348,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.576,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26783,10348,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.52,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
26784,10348,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.478,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
26785,10348,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.463,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
26786,10348,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.426,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
26787,10348,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.035,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
26788,10348,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.13,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
26789,10348,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.563,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
26790,10348,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.218,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
26791,10348,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.212,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
26792,10348,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.128,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
26793,10348,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.593,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
26794,10348,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.416,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
26795,10348,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.318,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
26796,10348,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.278,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26797,10348,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.155,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26798,10348,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.499,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26799,10348,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.561,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
26800,10348,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.498,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
26801,10348,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.503,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
26802,10348,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.472,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
26803,10348,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.071,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
26804,10348,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.202,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
26805,10348,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.538,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
26806,10348,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.28,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
26807,10348,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.209,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
26808,10348,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.19,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
26809,10348,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.688,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
26810,10348,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.418,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
26811,10348,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.332,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
26812,10348,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.312,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26813,10348,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.262,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26814,10348,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26815,10348,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.502,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
26816,10348,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.447,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
26817,10348,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.532,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
26818,10348,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.522,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
26819,10348,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.154,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
26820,10348,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.265,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
26821,10348,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.62,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
26822,10348,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.359,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
26823,10348,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.206,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
26824,10348,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.226,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
26825,10348,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.652,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
26826,10348,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.46,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
26827,10348,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.428,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
26828,10348,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.339,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26829,10348,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.425,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26830,10348,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.539,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26831,10348,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.518,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
26832,10348,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.459,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
26833,10348,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.515,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
26834,10348,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.591,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
26835,10348,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.326,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
26836,10348,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.43,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
26837,10348,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.608,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
26838,10348,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.468,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
26839,10348,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.258,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
26840,10348,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.368,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
26841,10348,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.539,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
26842,10348,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.349,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
26843,10348,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.473,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
26844,10348,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.402,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26845,10348,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.625,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26846,10348,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.512,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26847,10348,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.508,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
26848,10348,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.486,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
26849,10348,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.52,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
26850,10348,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.531,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
26851,10348,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
26852,10348,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.49,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
26853,10348,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.574,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
26854,10348,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.51,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
26855,10348,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.216,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
26856,10348,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.471,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
26857,10348,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.476,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
26858,10348,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.417,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
26859,10348,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.459,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
26860,10348,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.339,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
26861,10348,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.44,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
26862,10348,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.506,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
26863,10348,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.526,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
26864,10348,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.503,0,NONE,OHSU_HNSCC_derm002
26865,10348,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.519,0,NONE,OHSU_HNSCC_derm002
26866,10348,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.522,0,NONE,OHSU_HNSCC_derm002
26867,10348,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.545,0,NONE,OHSU_HNSCC_derm002
26868,10348,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
26869,10348,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.534,0,NONE,OHSU_HNSCC_derm002
26870,10348,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.49,0,NONE,OHSU_HNSCC_derm002
26871,10348,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
26872,10348,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
26873,10348,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.574,0,NONE,OHSU_HNSCC_derm002
26874,10348,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.524,0,NONE,OHSU_HNSCC_derm002
26875,10348,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.47,0,NONE,OHSU_HNSCC_derm002
26876,10348,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.497,0,NONE,OHSU_HNSCC_derm002
26877,10348,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
26878,10348,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.539,0,NONE,OHSU_HNSCC_derm002
26879,10348,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.513,0,NONE,OHSU_HNSCC_derm002
26880,10348,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.648,10,Coumarin,OHSU_HNSCC_derm002
26881,10348,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.098,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26882,10348,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.084,10,Foretinib (XL-880),OHSU_HNSCC_derm002
26883,10348,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.406,10,Elesclomol,OHSU_HNSCC_derm002
26884,10348,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.704,10,Vemurafenib,OHSU_HNSCC_derm002
26885,10348,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.043,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26886,10348,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.006,10,Ponatinib,OHSU_HNSCC_derm002
26887,10348,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.23,10,Gefitinib,OHSU_HNSCC_derm002
26888,10348,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.108,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
26889,10348,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.557,1,Sunitinib (1mM),OHSU_HNSCC_derm002
26890,10348,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.626,10,Curcumin,OHSU_HNSCC_derm002
26891,10348,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.133,10,PF-562271,OHSU_HNSCC_derm002
26892,10348,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.591,10,STO609,OHSU_HNSCC_derm002
26893,10348,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.438,10,Lenvatinib,OHSU_HNSCC_derm002
26894,10348,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.087,10,Entrectinib,OHSU_HNSCC_derm002
26895,10348,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.678,10,Ethyl Gallate ,OHSU_HNSCC_derm002
26896,10348,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.554,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
26897,10348,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.187,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26898,10348,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.318,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
26899,10348,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.141,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
26900,10348,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.701,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
26901,10348,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.06,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26902,10348,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.13,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
26903,10348,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
26904,10348,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.359,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
26905,10348,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.706,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
26906,10348,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.57,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
26907,10348,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.458,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
26908,10348,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.568,3.3333333333333335,STO609,OHSU_HNSCC_derm002
26909,10348,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.627,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
26910,10348,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.391,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
26911,10348,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.57,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
26912,10348,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.619,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
26913,10348,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.246,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26914,10348,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.512,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
26915,10348,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.142,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
26916,10348,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.732,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
26917,10348,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.097,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26918,10348,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.542,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
26919,10348,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.321,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
26920,10348,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.528,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
26921,10348,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.669,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
26922,10348,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.664,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
26923,10348,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.641,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
26924,10348,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.66,1.1111111111111112,STO609,OHSU_HNSCC_derm002
26925,10348,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.607,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
26926,10348,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.538,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
26927,10348,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.617,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
26928,10348,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.562,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
26929,10348,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.245,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26930,10348,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.577,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
26931,10348,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.11,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
26932,10348,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.677,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
26933,10348,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.17,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26934,10348,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.726,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
26935,10348,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.342,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
26936,10348,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.621,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
26937,10348,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.625,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
26938,10348,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.618,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
26939,10348,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.688,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
26940,10348,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.642,0.3703703703703704,STO609,OHSU_HNSCC_derm002
26941,10348,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.606,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
26942,10348,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.617,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
26943,10348,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.57,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
26944,10348,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.581,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
26945,10348,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.259,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26946,10348,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.524,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
26947,10348,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.062,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
26948,10348,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.658,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
26949,10348,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.263,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26950,10348,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.765,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
26951,10348,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.441,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
26952,10348,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.643,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
26953,10348,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.581,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
26954,10348,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.629,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
26955,10348,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.7,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
26956,10348,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.713,0.1234567901234568,STO609,OHSU_HNSCC_derm002
26957,10348,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.68,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
26958,10348,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.631,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
26959,10348,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.61,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
26960,10348,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.571,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
26961,10348,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.226,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26962,10348,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.549,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
26963,10348,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.087,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
26964,10348,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.695,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
26965,10348,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.416,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26966,10348,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.766,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
26967,10348,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.557,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
26968,10348,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.589,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
26969,10348,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.635,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
26970,10348,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.6,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
26971,10348,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
26972,10348,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.733,0.0411522633744856,STO609,OHSU_HNSCC_derm002
26973,10348,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
26974,10348,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.585,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
26975,10348,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.622,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
26976,10348,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.554,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
26977,10348,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.313,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
26978,10348,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.541,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
26979,10348,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.211,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
26980,10348,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.641,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
26981,10348,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.562,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
26982,10348,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.738,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
26983,10348,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.586,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
26984,10348,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.245,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
26985,10348,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.313,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
26986,10348,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.655,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
26987,10348,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.665,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
26988,10348,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.668,0.013717421124828532,STO609,OHSU_HNSCC_derm002
26989,10348,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.654,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
26990,10348,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.602,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
26991,10348,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.557,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
26992,10348,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.551,0,NONE,OHSU_HNSCC_derm002
26993,10348,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.577,0,NONE,OHSU_HNSCC_derm002
26994,10348,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
26995,10348,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.63,0,NONE,OHSU_HNSCC_derm002
26996,10348,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.625,0,NONE,OHSU_HNSCC_derm002
26997,10348,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.64,0,NONE,OHSU_HNSCC_derm002
26998,10348,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.373,0,NONE,OHSU_HNSCC_derm002
26999,10348,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.002,10,F-S-V,OHSU_HNSCC_derm002
27000,10348,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.579,0,NONE,OHSU_HNSCC_derm002
27001,10348,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.633,0,NONE,OHSU_HNSCC_derm002
27002,10348,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.671,0,NONE,OHSU_HNSCC_derm002
27003,10348,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.658,0,NONE,OHSU_HNSCC_derm002
27004,10348,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.676,0,NONE,OHSU_HNSCC_derm002
27005,10348,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.616,0,NONE,OHSU_HNSCC_derm002
27006,10348,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.612,0,NONE,OHSU_HNSCC_derm002
27007,10348,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.582,0,NONE,OHSU_HNSCC_derm002
27008,10348,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.071,10,GDC-0941,OHSU_HNSCC_derm002
27009,10348,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.376,10,Dovitinib,OHSU_HNSCC_derm002
27010,10348,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.089,10,BI-2536,OHSU_HNSCC_derm002
27011,10348,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.104,10,TP-0903 ,OHSU_HNSCC_derm002
27012,10348,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.046,10,Belinostat,OHSU_HNSCC_derm002
27013,10348,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.064,10,INK-128,OHSU_HNSCC_derm002
27014,10348,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.137,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27015,10348,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.04,10,Brigatinib,OHSU_HNSCC_derm002
27016,10348,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.117,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27017,10348,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.119,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27018,10348,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.651,10,Pazopanib,OHSU_HNSCC_derm002
27019,10348,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.512,10,AZD4547,OHSU_HNSCC_derm002
27020,10348,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.673,10,Pomalidomide ,OHSU_HNSCC_derm002
27021,10348,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.434,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
27022,10348,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.679,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27023,10348,Blank 490,2,P,OHSU_HNSCC_derm002,9,0.009,10,Staurosporin,OHSU_HNSCC_derm002
27024,10348,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.064,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
27025,10348,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.419,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
27026,10348,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.191,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
27027,10348,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.097,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
27028,10348,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.102,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
27029,10348,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.094,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
27030,10348,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.168,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27031,10348,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.108,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
27032,10348,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.285,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27033,10348,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.282,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27034,10348,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.694,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
27035,10348,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.633,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
27036,10348,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.698,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
27037,10348,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.544,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
27038,10348,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.581,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27039,10348,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.022,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
27040,10348,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.136,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
27041,10348,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.45,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
27042,10348,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.356,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
27043,10348,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.108,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
27044,10348,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.234,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
27045,10348,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.117,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
27046,10348,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.176,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27047,10348,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.36,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
27048,10348,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.299,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27049,10348,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.344,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27050,10348,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.679,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
27051,10348,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.646,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
27052,10348,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.684,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
27053,10348,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.644,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
27054,10348,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.551,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27055,10348,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.024,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
27056,10348,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.259,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
27057,10348,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.419,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
27058,10348,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.446,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
27059,10348,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.409,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
27060,10348,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.363,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
27061,10348,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.144,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
27062,10348,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.18,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27063,10348,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.577,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
27064,10348,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.328,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27065,10348,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.413,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27066,10348,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.67,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
27067,10348,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.666,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
27068,10348,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.683,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
27069,10348,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.688,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
27070,10348,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.561,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27071,10348,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.042,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
27072,10348,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.384,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
27073,10348,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.64,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
27074,10348,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.554,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
27075,10348,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.618,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
27076,10348,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.528,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
27077,10348,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.173,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
27078,10348,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.2,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27079,10348,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.63,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
27080,10348,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27081,10348,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.485,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27082,10348,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.696,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
27083,10348,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.676,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
27084,10348,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.69,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
27085,10348,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.665,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
27086,10348,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.638,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27087,10348,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.093,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
27088,10348,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.464,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
27089,10348,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.535,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
27090,10348,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.568,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
27091,10348,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.653,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
27092,10348,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.61,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
27093,10348,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.275,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
27094,10348,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.241,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27095,10348,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.649,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
27096,10348,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.326,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27097,10348,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.534,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27098,10348,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.65,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
27099,10348,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.696,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
27100,10348,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.666,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
27101,10348,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.713,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
27102,10348,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.606,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27103,10348,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.169,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
27104,10348,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.497,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
27105,10348,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.465,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
27106,10348,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.577,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
27107,10348,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.665,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
27108,10348,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.653,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
27109,10348,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.359,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
27110,10348,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.271,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
27111,10348,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
27112,10348,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.399,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27113,10348,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.581,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
27114,10348,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.674,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
27115,10348,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.639,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
27116,10348,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.684,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
27117,10348,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.646,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
27118,10348,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.545,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
27119,10348,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.179,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
27120,10348,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.52,0,NONE,OHSU_HNSCC_derm002
27121,10348,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.529,0,NONE,OHSU_HNSCC_derm002
27122,10348,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.614,0,NONE,OHSU_HNSCC_derm002
27123,10348,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.58,0,NONE,OHSU_HNSCC_derm002
27124,10348,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.635,0,NONE,OHSU_HNSCC_derm002
27125,10348,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.612,0,NONE,OHSU_HNSCC_derm002
27126,10348,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.693,0,NONE,OHSU_HNSCC_derm002
27127,10348,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.002,10,F-S-V,OHSU_HNSCC_derm002
27128,10348,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.646,0,NONE,OHSU_HNSCC_derm002
27129,10348,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.655,0,NONE,OHSU_HNSCC_derm002
27130,10348,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.631,0,NONE,OHSU_HNSCC_derm002
27131,10348,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.675,0,NONE,OHSU_HNSCC_derm002
27132,10348,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.652,0,NONE,OHSU_HNSCC_derm002
27133,10348,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.694,0,NONE,OHSU_HNSCC_derm002
27134,10348,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
27135,10348,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.59,0,NONE,OHSU_HNSCC_derm002
27136,10348,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.392,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
27137,10348,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.419,10,Hesperidin,OHSU_HNSCC_derm002
27138,10348,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.502,10,Esculetin,OHSU_HNSCC_derm002
27139,10348,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.172,10,Selinexor ,OHSU_HNSCC_derm002
27140,10348,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.109,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27141,10348,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.287,10,BMX-IN-1,OHSU_HNSCC_derm002
27142,10348,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.093,1,Dasatinib (1mM),OHSU_HNSCC_derm002
27143,10348,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.206,10,Trametinib,OHSU_HNSCC_derm002
27144,10348,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.135,10,BEZ235,OHSU_HNSCC_derm002
27145,10348,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.055,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
27146,10348,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.663,10,Nilotinib,OHSU_HNSCC_derm002
27147,10348,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.444,10,Enzalutamide,OHSU_HNSCC_derm002
27148,10348,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.778,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27149,10348,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.085,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
27150,10348,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.138,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27151,10348,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.426,10,Axitinib,OHSU_HNSCC_derm002
27152,10348,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.481,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
27153,10348,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.526,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
27154,10348,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.578,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
27155,10348,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.208,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
27156,10348,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.548,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27157,10348,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.453,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
27158,10348,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.098,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
27159,10348,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.218,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
27160,10348,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.132,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
27161,10348,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.067,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
27162,10348,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.737,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
27163,10348,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.491,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
27164,10348,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.664,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27165,10348,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.11,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
27166,10348,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27167,10348,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.45,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
27168,10348,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.552,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
27169,10348,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.594,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
27170,10348,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.522,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
27171,10348,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.258,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
27172,10348,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.595,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27173,10348,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.564,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
27174,10348,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.124,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
27175,10348,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.206,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
27176,10348,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.124,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
27177,10348,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.078,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
27178,10348,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.787,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
27179,10348,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.587,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
27180,10348,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.685,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27181,10348,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.119,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
27182,10348,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.116,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27183,10348,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.542,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
27184,10348,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.536,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
27185,10348,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.581,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
27186,10348,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.649,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
27187,10348,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.289,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
27188,10348,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.619,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27189,10348,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.582,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
27190,10348,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.346,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
27191,10348,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.213,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
27192,10348,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
27193,10348,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.116,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
27194,10348,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.709,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
27195,10348,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.659,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
27196,10348,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.709,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27197,10348,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.183,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
27198,10348,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.391,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27199,10348,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.55,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
27200,10348,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.521,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
27201,10348,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.539,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
27202,10348,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.611,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
27203,10348,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.378,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
27204,10348,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.591,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27205,10348,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.606,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
27206,10348,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.401,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
27207,10348,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.223,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
27208,10348,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.218,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
27209,10348,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.227,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
27210,10348,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.718,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
27211,10348,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.68,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
27212,10348,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.678,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27213,10348,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.225,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
27214,10348,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.519,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27215,10348,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.62,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
27216,10348,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.501,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
27217,10348,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.529,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
27218,10348,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.52,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
27219,10348,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.536,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
27220,10348,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.59,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27221,10348,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.663,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
27222,10348,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.513,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
27223,10348,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.248,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
27224,10348,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.331,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
27225,10348,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.504,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
27226,10348,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.747,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
27227,10348,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.636,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
27228,10348,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.758,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27229,10348,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.484,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
27230,10348,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.591,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27231,10348,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.624,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
27232,10348,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.577,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
27233,10348,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.555,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
27234,10348,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.587,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
27235,10348,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.542,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
27236,10348,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.572,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
27237,10348,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.609,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
27238,10348,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.601,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
27239,10348,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.28,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
27240,10348,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.429,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
27241,10348,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.596,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
27242,10348,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.616,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
27243,10348,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.566,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
27244,10348,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.674,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
27245,10348,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.593,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
27246,10348,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.627,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
27247,10348,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.555,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
27248,10348,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.543,0,NONE,OHSU_HNSCC_derm002
27249,10348,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.522,0,NONE,OHSU_HNSCC_derm002
27250,10348,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.528,0,NONE,OHSU_HNSCC_derm002
27251,10348,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.559,0,NONE,OHSU_HNSCC_derm002
27252,10348,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.574,0,NONE,OHSU_HNSCC_derm002
27253,10348,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.598,0,NONE,OHSU_HNSCC_derm002
27254,10348,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
27255,10348,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.592,0,NONE,OHSU_HNSCC_derm002
27256,10348,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
27257,10348,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.559,0,NONE,OHSU_HNSCC_derm002
27258,10348,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.562,0,NONE,OHSU_HNSCC_derm002
27259,10348,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.589,0,NONE,OHSU_HNSCC_derm002
27260,10348,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.614,0,NONE,OHSU_HNSCC_derm002
27261,10348,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.644,0,NONE,OHSU_HNSCC_derm002
27262,10348,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.588,0,NONE,OHSU_HNSCC_derm002
27263,10348,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.646,0,NONE,OHSU_HNSCC_derm002
27264,10348,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.434,10,Thalidomide ,OHSU_HNSCC_derm002
27265,10348,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.108,10,Vandetanib,OHSU_HNSCC_derm002
27266,10348,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.542,10,Oleic acid,OHSU_HNSCC_derm002
27267,10348,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.067,10,A-674563,OHSU_HNSCC_derm002
27268,10348,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.147,10,Lapatinib,OHSU_HNSCC_derm002
27269,10348,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.517,10,Apocynin (vanillin),OHSU_HNSCC_derm002
27270,10348,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.112,10,AT-7519,OHSU_HNSCC_derm002
27271,10348,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.219,10,Gefitinib,OHSU_HNSCC_derm002
27272,10348,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.03,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
27273,10348,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.106,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27274,10348,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.053,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27275,10348,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.11,10,JQ1,OHSU_HNSCC_derm002
27276,10348,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.684,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27277,10348,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.34,10,Cerdulatinib,OHSU_HNSCC_derm002
27278,10348,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.004,10,Romidepsin,OHSU_HNSCC_derm002
27279,10348,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.442,10,Gilteritinib,OHSU_HNSCC_derm002
27280,10348,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.492,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
27281,10348,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.218,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
27282,10348,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.585,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
27283,10348,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.336,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
27284,10348,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.214,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
27285,10348,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.501,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
27286,10348,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.117,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
27287,10348,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.263,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
27288,10348,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
27289,10348,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.182,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27290,10348,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.168,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27291,10348,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.169,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
27292,10348,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.689,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27293,10348,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.653,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
27294,10348,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.001,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
27295,10348,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.427,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
27296,10348,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.555,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
27297,10348,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.261,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
27298,10348,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.469,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
27299,10348,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.346,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
27300,10348,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.288,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
27301,10348,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.465,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
27302,10348,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.118,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
27303,10348,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.259,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
27304,10348,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.467,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
27305,10348,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.252,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27306,10348,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27307,10348,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.204,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
27308,10348,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.689,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27309,10348,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.639,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
27310,10348,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.006,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
27311,10348,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.481,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
27312,10348,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.47,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
27313,10348,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.349,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
27314,10348,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.487,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
27315,10348,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.325,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
27316,10348,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.308,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
27317,10348,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.52,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
27318,10348,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.321,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
27319,10348,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.303,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
27320,10348,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.529,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
27321,10348,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.29,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27322,10348,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.238,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27323,10348,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.277,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
27324,10348,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.604,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27325,10348,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.564,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
27326,10348,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.012,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
27327,10348,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.527,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
27328,10348,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.46,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
27329,10348,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.403,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
27330,10348,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.559,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
27331,10348,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.404,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
27332,10348,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.377,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
27333,10348,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.49,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
27334,10348,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.528,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
27335,10348,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.402,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
27336,10348,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.566,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
27337,10348,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.395,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27338,10348,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.315,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27339,10348,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.36,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
27340,10348,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.648,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27341,10348,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.58,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
27342,10348,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.03,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
27343,10348,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.596,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
27344,10348,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.458,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
27345,10348,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.432,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
27346,10348,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.551,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
27347,10348,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.445,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
27348,10348,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.448,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
27349,10348,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.499,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
27350,10348,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.596,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
27351,10348,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.468,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
27352,10348,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.624,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
27353,10348,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.457,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27354,10348,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.423,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27355,10348,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.526,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
27356,10348,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.59,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27357,10348,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.578,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
27358,10348,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.035,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
27359,10348,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.522,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
27360,10348,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.479,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
27361,10348,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.413,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
27362,10348,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.558,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
27363,10348,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.487,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
27364,10348,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.508,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
27365,10348,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.48,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
27366,10348,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.596,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
27367,10348,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.557,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
27368,10348,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.647,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
27369,10348,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.508,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
27370,10348,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.512,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
27371,10348,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.609,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
27372,10348,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.628,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
27373,10348,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.534,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
27374,10348,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.042,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
27375,10348,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.495,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
27376,10348,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.435,0,NONE,OHSU_HNSCC_derm002
27377,10348,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.5,0,NONE,OHSU_HNSCC_derm002
27378,10348,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.542,0,NONE,OHSU_HNSCC_derm002
27379,10348,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.464,0,NONE,OHSU_HNSCC_derm002
27380,10348,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.547,0,NONE,OHSU_HNSCC_derm002
27381,10348,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.535,0,NONE,OHSU_HNSCC_derm002
27382,10348,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.567,0,NONE,OHSU_HNSCC_derm002
27383,10348,Blank 490,3,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
27384,10348,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.433,0,NONE,OHSU_HNSCC_derm002
27385,10348,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.568,0,NONE,OHSU_HNSCC_derm002
27386,10348,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.641,0,NONE,OHSU_HNSCC_derm002
27387,10348,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.589,0,NONE,OHSU_HNSCC_derm002
27388,10348,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.628,0,NONE,OHSU_HNSCC_derm002
27389,10348,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.532,0,NONE,OHSU_HNSCC_derm002
27390,10348,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.593,0,NONE,OHSU_HNSCC_derm002
27391,10348,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.494,0,NONE,OHSU_HNSCC_derm002
27392,10348,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.44,10,Anastrazole,OHSU_HNSCC_derm002
27393,10348,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.15,10,JNJ-28312141 ,OHSU_HNSCC_derm002
27394,10348,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.545,10,Genistein,OHSU_HNSCC_derm002
27395,10348,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.479,10,Abscisic acid,OHSU_HNSCC_derm002
27396,10348,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.419,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27397,10348,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.533,10,Ruxolitinib,OHSU_HNSCC_derm002
27398,10348,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.428,10,TAK-659,OHSU_HNSCC_derm002
27399,10348,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.046,10,Brigatinib,OHSU_HNSCC_derm002
27400,10348,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.164,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27401,10348,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.056,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27402,10348,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.083,10,Vorinostat,OHSU_HNSCC_derm002
27403,10348,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.557,10,Lenalidomide,OHSU_HNSCC_derm002
27404,10348,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.11,10,NVP-ADW742,OHSU_HNSCC_derm002
27405,10348,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.585,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27406,10348,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.702,10,Echinatin,OHSU_HNSCC_derm002
27407,10348,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.009,10,YM-155,OHSU_HNSCC_derm002
27408,10348,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.431,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
27409,10348,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.401,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
27410,10348,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.562,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
27411,10348,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.511,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
27412,10348,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.469,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27413,10348,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.561,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
27414,10348,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.602,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
27415,10348,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.085,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
27416,10348,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.268,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27417,10348,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.167,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27418,10348,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.17,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
27419,10348,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.527,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
27420,10348,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.267,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
27421,10348,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.509,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27422,10348,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.619,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
27423,10348,Blank 490,3,P,OHSU_HNSCC_derm002,10,-0.01,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
27424,10348,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.394,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
27425,10348,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.4,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
27426,10348,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.547,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
27427,10348,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.473,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
27428,10348,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.468,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27429,10348,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.541,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
27430,10348,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.62,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
27431,10348,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.295,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
27432,10348,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.281,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27433,10348,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.305,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27434,10348,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.325,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
27435,10348,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.538,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
27436,10348,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.344,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
27437,10348,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.611,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27438,10348,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.583,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
27439,10348,Blank 490,3,P,OHSU_HNSCC_derm002,11,-0.006,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
27440,10348,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.443,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
27441,10348,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.496,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
27442,10348,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.544,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
27443,10348,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.508,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
27444,10348,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.508,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27445,10348,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.561,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
27446,10348,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.594,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
27447,10348,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.458,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
27448,10348,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.303,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27449,10348,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.473,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27450,10348,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.414,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
27451,10348,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.6,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
27452,10348,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.463,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
27453,10348,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.577,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27454,10348,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.601,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
27455,10348,Blank 490,3,P,OHSU_HNSCC_derm002,12,0.0,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
27456,10348,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.443,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
27457,10348,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.472,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
27458,10348,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.545,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
27459,10348,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.46,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
27460,10348,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.519,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27461,10348,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.53,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
27462,10348,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.577,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
27463,10348,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.545,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
27464,10348,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.282,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27465,10348,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.55,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27466,10348,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.53,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
27467,10348,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.592,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
27468,10348,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.609,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
27469,10348,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.609,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27470,10348,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.58,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
27471,10348,Blank 490,3,P,OHSU_HNSCC_derm002,13,0.021,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
27472,10348,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.479,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
27473,10348,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.486,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
27474,10348,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.531,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
27475,10348,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.476,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
27476,10348,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.511,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27477,10348,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.523,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
27478,10348,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.527,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
27479,10348,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.608,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
27480,10348,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.31,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27481,10348,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.56,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27482,10348,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.533,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
27483,10348,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.556,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
27484,10348,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.627,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
27485,10348,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.592,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27486,10348,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.592,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
27487,10348,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.025,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
27488,10348,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.37,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
27489,10348,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.455,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
27490,10348,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.526,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
27491,10348,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.484,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
27492,10348,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.509,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
27493,10348,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.527,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
27494,10348,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.593,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
27495,10348,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.577,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
27496,10348,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.327,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27497,10348,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.509,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
27498,10348,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.573,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
27499,10348,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.574,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
27500,10348,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.586,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
27501,10348,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.57,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
27502,10348,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.611,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
27503,10348,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.078,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
27504,10348,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.424,0,NONE,OHSU_HNSCC_derm002
27505,10348,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.534,0,NONE,OHSU_HNSCC_derm002
27506,10348,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.538,0,NONE,OHSU_HNSCC_derm002
27507,10348,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.453,0,NONE,OHSU_HNSCC_derm002
27508,10348,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.54,0,NONE,OHSU_HNSCC_derm002
27509,10348,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.574,0,NONE,OHSU_HNSCC_derm002
27510,10348,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.172,0,NONE,OHSU_HNSCC_derm002
27511,10348,Blank 490,3,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
27512,10348,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.605,0,NONE,OHSU_HNSCC_derm002
27513,10348,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.594,0,NONE,OHSU_HNSCC_derm002
27514,10348,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.569,0,NONE,OHSU_HNSCC_derm002
27515,10348,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.61,0,NONE,OHSU_HNSCC_derm002
27516,10348,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.592,0,NONE,OHSU_HNSCC_derm002
27517,10348,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.535,0,NONE,OHSU_HNSCC_derm002
27518,10348,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.619,0,NONE,OHSU_HNSCC_derm002
27519,10348,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.563,0,NONE,OHSU_HNSCC_derm002
27520,10348,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.476,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27521,10348,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.552,10,Stevioside,OHSU_HNSCC_derm002
27522,10348,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.541,10,Pemetrexed,OHSU_HNSCC_derm002
27523,10348,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.052,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27524,10348,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.028,10,GSK-1838705A,OHSU_HNSCC_derm002
27525,10348,Blank 490,3,F,OHSU_HNSCC_derm002,17,0.011,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27526,10348,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.649,10,Imatinib,OHSU_HNSCC_derm002
27527,10348,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.173,10,Trametinib,OHSU_HNSCC_derm002
27528,10348,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.102,10,BEZ235,OHSU_HNSCC_derm002
27529,10348,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.125,10,Saracatinib,OHSU_HNSCC_derm002
27530,10348,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.211,10,I-BET 762,OHSU_HNSCC_derm002
27531,10348,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.2,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
27532,10348,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.519,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
27533,10348,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.503,10,Crizotinib,OHSU_HNSCC_derm002
27534,10348,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.362,10,MGCD-265,OHSU_HNSCC_derm002
27535,10348,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.168,10,Erlotinib,OHSU_HNSCC_derm002
27536,10348,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.464,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27537,10348,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.547,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
27538,10348,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.53,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
27539,10348,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.06,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27540,10348,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.258,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
27541,10348,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.082,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27542,10348,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.554,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
27543,10348,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.177,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
27544,10348,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.111,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
27545,10348,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.175,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
27546,10348,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.251,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
27547,10348,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.204,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
27548,10348,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.586,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
27549,10348,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.604,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
27550,10348,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.434,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
27551,10348,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.195,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
27552,10348,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.481,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27553,10348,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.509,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
27554,10348,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.517,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
27555,10348,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.09,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27556,10348,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.266,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
27557,10348,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.189,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27558,10348,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.595,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
27559,10348,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.186,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
27560,10348,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.12,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
27561,10348,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.338,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
27562,10348,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.341,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
27563,10348,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.224,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
27564,10348,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.567,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
27565,10348,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.574,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
27566,10348,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.456,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
27567,10348,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.241,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
27568,10348,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.468,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27569,10348,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.498,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
27570,10348,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.493,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
27571,10348,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.129,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27572,10348,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.366,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
27573,10348,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.251,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27574,10348,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.522,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
27575,10348,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.181,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
27576,10348,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.162,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
27577,10348,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.453,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
27578,10348,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.459,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
27579,10348,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.258,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
27580,10348,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.587,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
27581,10348,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.593,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
27582,10348,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.588,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
27583,10348,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.257,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
27584,10348,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.444,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27585,10348,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.529,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
27586,10348,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.503,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
27587,10348,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.196,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27588,10348,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.422,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
27589,10348,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.304,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27590,10348,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.551,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
27591,10348,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.167,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
27592,10348,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.212,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
27593,10348,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.507,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
27594,10348,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.583,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
27595,10348,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.319,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
27596,10348,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.574,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
27597,10348,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.627,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
27598,10348,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.564,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
27599,10348,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.365,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
27600,10348,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.482,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27601,10348,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.489,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
27602,10348,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.509,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
27603,10348,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.301,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27604,10348,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.492,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
27605,10348,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.373,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27606,10348,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.562,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
27607,10348,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.217,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
27608,10348,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.348,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
27609,10348,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.571,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
27610,10348,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.569,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
27611,10348,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.411,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
27612,10348,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.611,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
27613,10348,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.645,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
27614,10348,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.597,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
27615,10348,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.384,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
27616,10348,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.466,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
27617,10348,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.484,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
27618,10348,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.524,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
27619,10348,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.401,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
27620,10348,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.533,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
27621,10348,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.469,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
27622,10348,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.602,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
27623,10348,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.25,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
27624,10348,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.468,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
27625,10348,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.676,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
27626,10348,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.615,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
27627,10348,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.501,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
27628,10348,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.611,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
27629,10348,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.591,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
27630,10348,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.526,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
27631,10348,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.438,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
27632,10348,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
27633,10348,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.408,0,NONE,OHSU_HNSCC_derm002
27634,10348,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.449,0,NONE,OHSU_HNSCC_derm002
27635,10348,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.505,0,NONE,OHSU_HNSCC_derm002
27636,10348,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.475,0,NONE,OHSU_HNSCC_derm002
27637,10348,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.424,0,NONE,OHSU_HNSCC_derm002
27638,10348,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.511,0,NONE,OHSU_HNSCC_derm002
27639,10348,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.544,0,NONE,OHSU_HNSCC_derm002
27640,10348,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.464,0,NONE,OHSU_HNSCC_derm002
27641,10348,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.438,0,NONE,OHSU_HNSCC_derm002
27642,10348,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.476,0,NONE,OHSU_HNSCC_derm002
27643,10348,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.487,0,NONE,OHSU_HNSCC_derm002
27644,10348,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.452,0,NONE,OHSU_HNSCC_derm002
27645,10348,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.489,0,NONE,OHSU_HNSCC_derm002
27646,10348,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.519,0,NONE,OHSU_HNSCC_derm002
27647,10348,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.482,0,NONE,OHSU_HNSCC_derm002
27648,10348,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.031,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27649,10348,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.084,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27650,10348,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.009,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27651,10348,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.027,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27652,10348,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.013,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27653,10348,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.012,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27654,10348,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.001,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27655,10348,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.025,10,Gefitinib,OHSU_HNSCC_derm002
27656,10348,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.011,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
27657,10348,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.034,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27658,10348,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.037,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27659,10348,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.038,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27660,10348,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.02,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27661,10348,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.013,10,VOLASERTIB x,OHSU_HNSCC_derm002
27662,10348,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.009,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27663,10348,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.006,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27664,10348,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.063,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27665,10348,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.19,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27666,10348,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.538,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27667,10348,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.48,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27668,10348,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.043,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27669,10348,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.046,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27670,10348,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.003,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27671,10348,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.34,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
27672,10348,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.342,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
27673,10348,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.048,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27674,10348,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.115,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27675,10348,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.066,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27676,10348,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.232,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27677,10348,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.174,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
27678,10348,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.401,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27679,10348,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.037,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27680,10348,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.146,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27681,10348,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.309,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27682,10348,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.674,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27683,10348,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.493,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27684,10348,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.118,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27685,10348,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.075,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27686,10348,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.014,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27687,10348,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.37,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
27688,10348,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.604,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
27689,10348,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.144,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27690,10348,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.238,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27691,10348,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.182,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27692,10348,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.318,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27693,10348,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.318,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
27694,10348,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.512,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27695,10348,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.069,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27696,10348,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.182,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27697,10348,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.464,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27698,10348,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.717,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27699,10348,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.531,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27700,10348,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.207,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27701,10348,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.099,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27702,10348,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.026,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27703,10348,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.343,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
27704,10348,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
27705,10348,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.18,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27706,10348,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.268,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27707,10348,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.322,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27708,10348,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.367,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27709,10348,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.54,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
27710,10348,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.603,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27711,10348,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.121,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27712,10348,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.414,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27713,10348,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.497,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27714,10348,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.781,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27715,10348,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.511,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27716,10348,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.281,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27717,10348,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.149,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27718,10348,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.035,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27719,10348,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.424,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
27720,10348,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.7,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
27721,10348,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.297,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27722,10348,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.415,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27723,10348,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.431,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27724,10348,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.538,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27725,10348,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.705,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
27726,10348,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.768,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27727,10348,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.209,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27728,10348,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.546,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27729,10348,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.606,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27730,10348,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.746,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27731,10348,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.657,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27732,10348,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.493,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27733,10348,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.316,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27734,10348,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.038,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27735,10348,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.595,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
27736,10348,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.701,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
27737,10348,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.454,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27738,10348,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.644,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27739,10348,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.635,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27740,10348,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.58,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27741,10348,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.694,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
27742,10348,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.651,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27743,10348,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.398,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27744,10348,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.503,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
27745,10348,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.61,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
27746,10348,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.817,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
27747,10348,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.671,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
27748,10348,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.608,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
27749,10348,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.423,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
27750,10348,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.038,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
27751,10348,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.642,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
27752,10348,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.682,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
27753,10348,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.572,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
27754,10348,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.673,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
27755,10348,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.743,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
27756,10348,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.74,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
27757,10348,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.843,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
27758,10348,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.615,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27759,10348,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.514,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
27760,10348,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.609,0,NONE,OHSU_HNSCC_derm002
27761,10348,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.705,0,NONE,OHSU_HNSCC_derm002
27762,10348,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.737,0,NONE,OHSU_HNSCC_derm002
27763,10348,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.674,0,NONE,OHSU_HNSCC_derm002
27764,10348,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.701,0,NONE,OHSU_HNSCC_derm002
27765,10348,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.744,0,NONE,OHSU_HNSCC_derm002
27766,10348,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.746,0,NONE,OHSU_HNSCC_derm002
27767,10348,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.003,10,F-S-V,OHSU_HNSCC_derm002
27768,10348,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.721,0,NONE,OHSU_HNSCC_derm002
27769,10348,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.679,0,NONE,OHSU_HNSCC_derm002
27770,10348,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.68,0,NONE,OHSU_HNSCC_derm002
27771,10348,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.795,0,NONE,OHSU_HNSCC_derm002
27772,10348,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.784,0,NONE,OHSU_HNSCC_derm002
27773,10348,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.743,0,NONE,OHSU_HNSCC_derm002
27774,10348,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
27775,10348,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.635,0,NONE,OHSU_HNSCC_derm002
27776,10348,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.026,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27777,10348,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.251,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27778,10348,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.056,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
27779,10348,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.74,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27780,10348,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.194,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27781,10348,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.039,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
27782,10348,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.133,10,AZD2014 x ,OHSU_HNSCC_derm002
27783,10348,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.063,10,Brigatinib,OHSU_HNSCC_derm002
27784,10348,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.189,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27785,10348,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.04,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27786,10348,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.255,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27787,10348,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.031,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
27788,10348,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.133,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27789,10348,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.397,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27790,10348,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.169,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27791,10348,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.076,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27792,10348,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.106,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27793,10348,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.317,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27794,10348,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.066,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
27795,10348,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.828,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27796,10348,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.254,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27797,10348,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.069,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
27798,10348,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.163,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
27799,10348,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.157,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
27800,10348,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.335,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27801,10348,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.085,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27802,10348,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.324,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27803,10348,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.09,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
27804,10348,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.251,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27805,10348,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.411,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27806,10348,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.307,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27807,10348,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.225,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27808,10348,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.195,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27809,10348,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.308,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27810,10348,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.096,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
27811,10348,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.82,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27812,10348,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.266,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27813,10348,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.089,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
27814,10348,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.179,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
27815,10348,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.413,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
27816,10348,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.323,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27817,10348,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.121,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27818,10348,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.342,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27819,10348,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.197,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
27820,10348,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.318,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27821,10348,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.471,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27822,10348,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.3,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27823,10348,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.354,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27824,10348,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.314,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27825,10348,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.327,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27826,10348,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.215,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
27827,10348,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.817,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27828,10348,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.361,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27829,10348,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.116,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
27830,10348,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.286,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
27831,10348,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.649,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
27832,10348,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.362,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27833,10348,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.215,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27834,10348,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.422,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27835,10348,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.46,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
27836,10348,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.394,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27837,10348,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.545,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27838,10348,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.454,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27839,10348,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.477,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27840,10348,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.434,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27841,10348,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.415,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27842,10348,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.355,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
27843,10348,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.726,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27844,10348,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.399,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27845,10348,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.252,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
27846,10348,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.439,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
27847,10348,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.692,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
27848,10348,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.335,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27849,10348,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.4,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27850,10348,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.449,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27851,10348,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.659,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
27852,10348,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.358,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27853,10348,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.621,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27854,10348,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.626,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27855,10348,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.583,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27856,10348,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.542,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27857,10348,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.541,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27858,10348,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.621,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
27859,10348,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.79,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27860,10348,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.532,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27861,10348,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.417,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
27862,10348,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.563,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
27863,10348,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.756,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
27864,10348,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.33,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27865,10348,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.585,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27866,10348,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.558,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27867,10348,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.718,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
27868,10348,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.328,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27869,10348,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.667,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27870,10348,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.58,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27871,10348,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.633,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27872,10348,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.545,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
27873,10348,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.571,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
27874,10348,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.76,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
27875,10348,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.74,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27876,10348,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.653,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
27877,10348,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.574,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
27878,10348,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.669,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
27879,10348,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.759,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
27880,10348,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.421,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
27881,10348,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.654,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
27882,10348,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.659,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
27883,10348,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.711,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
27884,10348,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.487,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
27885,10348,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.768,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
27886,10348,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.629,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
27887,10348,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.651,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
27888,10348,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
27889,10348,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.678,0,NONE,OHSU_HNSCC_derm002
27890,10348,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.794,0,NONE,OHSU_HNSCC_derm002
27891,10348,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.71,0,NONE,OHSU_HNSCC_derm002
27892,10348,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.75,0,NONE,OHSU_HNSCC_derm002
27893,10348,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.739,0,NONE,OHSU_HNSCC_derm002
27894,10348,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
27895,10348,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.003,10,F-S-V,OHSU_HNSCC_derm002
27896,10348,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
27897,10348,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.74,0,NONE,OHSU_HNSCC_derm002
27898,10348,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.742,0,NONE,OHSU_HNSCC_derm002
27899,10348,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.811,0,NONE,OHSU_HNSCC_derm002
27900,10348,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.815,0,NONE,OHSU_HNSCC_derm002
27901,10348,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.802,0,NONE,OHSU_HNSCC_derm002
27902,10348,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.632,0,NONE,OHSU_HNSCC_derm002
27903,10348,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.633,0,NONE,OHSU_HNSCC_derm002
27904,10348,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.138,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27905,10348,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.035,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27906,10348,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.384,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27907,10348,Blank 490,4,D,OHSU_HNSCC_derm002,17,0.0,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27908,10348,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.181,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27909,10348,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.147,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27910,10348,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.123,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27911,10348,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.238,10,Trametinib,OHSU_HNSCC_derm002
27912,10348,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.092,10,BEZ235,OHSU_HNSCC_derm002
27913,10348,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.04,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27914,10348,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.197,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27915,10348,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.048,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27916,10348,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.338,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27917,10348,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.781,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27918,10348,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.312,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27919,10348,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.09,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27920,10348,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.245,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27921,10348,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.185,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27922,10348,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.259,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27923,10348,Blank 490,4,D,OHSU_HNSCC_derm002,18,-0.005,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27924,10348,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.271,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27925,10348,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.211,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27926,10348,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.277,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27927,10348,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.252,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
27928,10348,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
27929,10348,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.058,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27930,10348,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.38,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27931,10348,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.073,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27932,10348,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.389,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27933,10348,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.914,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27934,10348,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.292,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27935,10348,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.201,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27936,10348,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.442,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27937,10348,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.252,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27938,10348,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.351,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27939,10348,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.006,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27940,10348,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.054,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27941,10348,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.294,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27942,10348,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.382,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27943,10348,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.247,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
27944,10348,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.13,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
27945,10348,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.11,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27946,10348,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.48,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27947,10348,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.098,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27948,10348,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.416,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27949,10348,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.902,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27950,10348,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.369,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27951,10348,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.255,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27952,10348,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.581,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27953,10348,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.326,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27954,10348,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.42,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27955,10348,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.028,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27956,10348,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.096,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27957,10348,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.4,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27958,10348,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.44,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27959,10348,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.227,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
27960,10348,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.166,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
27961,10348,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.194,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27962,10348,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.579,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27963,10348,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.181,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27964,10348,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.431,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27965,10348,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.718,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27966,10348,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.392,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27967,10348,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.301,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27968,10348,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.657,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27969,10348,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.361,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27970,10348,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.443,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27971,10348,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.025,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27972,10348,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.596,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27973,10348,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.556,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27974,10348,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.534,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27975,10348,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.229,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
27976,10348,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.212,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
27977,10348,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.293,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27978,10348,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.655,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27979,10348,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.358,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27980,10348,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.476,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27981,10348,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.71,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27982,10348,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.464,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27983,10348,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.415,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
27984,10348,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.601,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
27985,10348,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.472,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
27986,10348,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.54,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
27987,10348,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.017,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
27988,10348,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.067,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
27989,10348,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.587,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
27990,10348,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.684,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
27991,10348,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.281,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
27992,10348,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.443,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
27993,10348,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.462,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
27994,10348,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.837,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27995,10348,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.475,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
27996,10348,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.598,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
27997,10348,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.698,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
27998,10348,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.573,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
27999,10348,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.553,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28000,10348,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.659,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
28001,10348,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.422,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
28002,10348,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.46,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28003,10348,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.038,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
28004,10348,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.611,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28005,10348,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.625,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
28006,10348,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.659,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
28007,10348,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.276,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
28008,10348,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.513,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
28009,10348,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.681,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
28010,10348,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.626,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28011,10348,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.613,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28012,10348,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.566,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
28013,10348,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.639,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28014,10348,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.609,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
28015,10348,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.55,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28016,10348,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.583,0,NONE,OHSU_HNSCC_derm002
28017,10348,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.586,0,NONE,OHSU_HNSCC_derm002
28018,10348,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.62,0,NONE,OHSU_HNSCC_derm002
28019,10348,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.66,0,NONE,OHSU_HNSCC_derm002
28020,10348,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.661,0,NONE,OHSU_HNSCC_derm002
28021,10348,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.597,0,NONE,OHSU_HNSCC_derm002
28022,10348,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.643,0,NONE,OHSU_HNSCC_derm002
28023,10348,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.593,0,NONE,OHSU_HNSCC_derm002
28024,10348,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.617,0,NONE,OHSU_HNSCC_derm002
28025,10348,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.563,0,NONE,OHSU_HNSCC_derm002
28026,10348,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.5,0,NONE,OHSU_HNSCC_derm002
28027,10348,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.682,0,NONE,OHSU_HNSCC_derm002
28028,10348,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
28029,10348,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.69,0,NONE,OHSU_HNSCC_derm002
28030,10348,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.672,0,NONE,OHSU_HNSCC_derm002
28031,10348,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.662,0,NONE,OHSU_HNSCC_derm002
28032,10348,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.165,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28033,10348,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.167,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28034,10348,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.01,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28035,10348,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.02,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28036,10348,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.021,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28037,10348,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.022,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28038,10348,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.202,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28039,10348,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.183,10,Gefitinib,OHSU_HNSCC_derm002
28040,10348,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.022,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
28041,10348,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.062,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28042,10348,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.133,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28043,10348,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.047,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28044,10348,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.045,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28045,10348,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.108,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28046,10348,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.043,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28047,10348,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.035,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28048,10348,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.239,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28049,10348,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.257,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28050,10348,Blank 490,5,C,OHSU_HNSCC_derm002,2,-0.001,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28051,10348,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.233,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28052,10348,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.124,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28053,10348,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.114,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28054,10348,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.345,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28055,10348,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.315,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
28056,10348,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.35,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
28057,10348,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.049,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28058,10348,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.66,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28059,10348,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.225,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28060,10348,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.066,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28061,10348,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.269,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28062,10348,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.075,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28063,10348,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.056,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28064,10348,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.295,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28065,10348,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.273,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28066,10348,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.012,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28067,10348,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.471,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28068,10348,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.22,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28069,10348,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.118,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28070,10348,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.416,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28071,10348,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.364,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
28072,10348,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.484,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
28073,10348,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.132,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28074,10348,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.669,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28075,10348,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.34,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28076,10348,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.08,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28077,10348,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.347,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28078,10348,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.087,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28079,10348,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.102,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28080,10348,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.289,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28081,10348,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.38,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28082,10348,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.026,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28083,10348,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.641,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28084,10348,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.278,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28085,10348,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.307,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28086,10348,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.538,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28087,10348,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.464,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
28088,10348,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
28089,10348,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.196,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28090,10348,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.654,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28091,10348,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.461,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28092,10348,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.134,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28093,10348,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.4,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28094,10348,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.149,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28095,10348,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.197,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28096,10348,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.289,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28097,10348,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.443,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28098,10348,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.039,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28099,10348,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.719,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28100,10348,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.446,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28101,10348,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.443,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28102,10348,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.668,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28103,10348,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.465,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
28104,10348,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.67,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
28105,10348,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.354,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28106,10348,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.703,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28107,10348,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.601,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28108,10348,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.279,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28109,10348,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.502,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28110,10348,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.252,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28111,10348,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.303,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28112,10348,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.363,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28113,10348,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.609,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28114,10348,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.042,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28115,10348,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.78,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28116,10348,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.542,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28117,10348,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.58,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28118,10348,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.736,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28119,10348,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.594,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
28120,10348,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.742,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
28121,10348,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.58,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28122,10348,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.754,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28123,10348,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.635,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28124,10348,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.413,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28125,10348,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.669,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28126,10348,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.449,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28127,10348,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.506,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28128,10348,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.34,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28129,10348,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.587,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
28130,10348,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.05,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
28131,10348,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.786,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
28132,10348,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.613,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
28133,10348,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.698,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
28134,10348,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.74,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
28135,10348,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.657,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
28136,10348,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.684,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
28137,10348,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.684,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
28138,10348,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.751,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
28139,10348,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.776,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28140,10348,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.604,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28141,10348,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.735,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
28142,10348,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.605,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
28143,10348,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.618,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
28144,10348,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.66,0,NONE,OHSU_HNSCC_derm002
28145,10348,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.663,0,NONE,OHSU_HNSCC_derm002
28146,10348,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.74,0,NONE,OHSU_HNSCC_derm002
28147,10348,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.796,0,NONE,OHSU_HNSCC_derm002
28148,10348,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.733,0,NONE,OHSU_HNSCC_derm002
28149,10348,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.677,0,NONE,OHSU_HNSCC_derm002
28150,10348,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.723,0,NONE,OHSU_HNSCC_derm002
28151,10348,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.005,10,F-S-V,OHSU_HNSCC_derm002
28152,10348,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.712,0,NONE,OHSU_HNSCC_derm002
28153,10348,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.752,0,NONE,OHSU_HNSCC_derm002
28154,10348,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.748,0,NONE,OHSU_HNSCC_derm002
28155,10348,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.747,0,NONE,OHSU_HNSCC_derm002
28156,10348,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.805,0,NONE,OHSU_HNSCC_derm002
28157,10348,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.766,0,NONE,OHSU_HNSCC_derm002
28158,10348,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.648,0,NONE,OHSU_HNSCC_derm002
28159,10348,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.746,0,NONE,OHSU_HNSCC_derm002
28160,10348,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.004,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28161,10348,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.491,10,APTO-253 x,OHSU_HNSCC_derm002
28162,10348,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.027,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28163,10348,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.935,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28164,10348,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.175,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28165,10348,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.049,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28166,10348,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.042,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28167,10348,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.044,10,Brigatinib,OHSU_HNSCC_derm002
28168,10348,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.234,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28169,10348,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.033,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28170,10348,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.013,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28171,10348,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.03,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28172,10348,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.241,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28173,10348,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.159,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28174,10348,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.016,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28175,10348,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.005,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28176,10348,Blank 490,5,A,OHSU_HNSCC_derm002,10,-0.007,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28177,10348,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.45,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
28178,10348,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.032,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28179,10348,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.828,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28180,10348,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.295,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28181,10348,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.074,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28182,10348,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.262,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28183,10348,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.107,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
28184,10348,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.325,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28185,10348,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.089,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28186,10348,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.084,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28187,10348,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.05,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28188,10348,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.372,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28189,10348,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.311,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28190,10348,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.043,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28191,10348,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.058,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28192,10348,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.004,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28193,10348,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.618,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
28194,10348,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.028,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28195,10348,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.799,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28196,10348,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.342,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28197,10348,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.066,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28198,10348,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.314,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28199,10348,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.396,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
28200,10348,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.369,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28201,10348,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.087,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28202,10348,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.287,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28203,10348,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.044,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28204,10348,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.334,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28205,10348,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.314,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28206,10348,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.229,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28207,10348,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.216,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28208,10348,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.021,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28209,10348,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.659,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
28210,10348,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.052,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28211,10348,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.796,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28212,10348,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.472,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28213,10348,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.095,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28214,10348,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.363,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28215,10348,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.676,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
28216,10348,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.38,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28217,10348,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.137,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28218,10348,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.442,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28219,10348,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.039,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28220,10348,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.455,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28221,10348,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.442,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28222,10348,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.418,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28223,10348,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.424,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28224,10348,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.024,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28225,10348,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.619,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
28226,10348,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.101,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28227,10348,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.795,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28228,10348,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.519,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28229,10348,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.166,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28230,10348,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.345,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28231,10348,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.754,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
28232,10348,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.353,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28233,10348,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.232,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28234,10348,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.613,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28235,10348,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.12,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28236,10348,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.564,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28237,10348,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.544,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28238,10348,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.529,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28239,10348,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.561,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28240,10348,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.034,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28241,10348,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.676,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
28242,10348,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.301,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28243,10348,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.775,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28244,10348,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.631,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28245,10348,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.386,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28246,10348,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.362,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28247,10348,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.766,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
28248,10348,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.391,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28249,10348,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.414,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28250,10348,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.755,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28251,10348,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.29,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28252,10348,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.724,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28253,10348,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.644,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28254,10348,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.605,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28255,10348,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.653,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28256,10348,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.036,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
28257,10348,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
28258,10348,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.629,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
28259,10348,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.829,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
28260,10348,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.673,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
28261,10348,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.472,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28262,10348,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.497,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28263,10348,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.789,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
28264,10348,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.505,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28265,10348,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.576,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
28266,10348,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.843,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28267,10348,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.522,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
28268,10348,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.813,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
28269,10348,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.772,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28270,10348,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.692,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28271,10348,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.624,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28272,10348,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.636,0,NONE,OHSU_HNSCC_derm002
28273,10348,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.673,0,NONE,OHSU_HNSCC_derm002
28274,10348,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.744,0,NONE,OHSU_HNSCC_derm002
28275,10348,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.808,0,NONE,OHSU_HNSCC_derm002
28276,10348,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.73,0,NONE,OHSU_HNSCC_derm002
28277,10348,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.753,0,NONE,OHSU_HNSCC_derm002
28278,10348,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.785,0,NONE,OHSU_HNSCC_derm002
28279,10348,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.005,10,F-S-V,OHSU_HNSCC_derm002
28280,10348,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.804,0,NONE,OHSU_HNSCC_derm002
28281,10348,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.757,0,NONE,OHSU_HNSCC_derm002
28282,10348,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.79,0,NONE,OHSU_HNSCC_derm002
28283,10348,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.727,0,NONE,OHSU_HNSCC_derm002
28284,10348,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.701,0,NONE,OHSU_HNSCC_derm002
28285,10348,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.687,0,NONE,OHSU_HNSCC_derm002
28286,10348,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.609,0,NONE,OHSU_HNSCC_derm002
28287,10348,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.373,0,NONE,OHSU_HNSCC_derm002
28288,10348,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.006,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28289,10348,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.011,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28290,10348,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.063,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28291,10348,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.267,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28292,10348,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.293,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28293,10348,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.203,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28294,10348,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.183,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28295,10348,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.229,10,Trametinib,OHSU_HNSCC_derm002
28296,10348,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.101,10,BEZ235,OHSU_HNSCC_derm002
28297,10348,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.085,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28298,10348,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.316,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28299,10348,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.043,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28300,10348,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.304,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28301,10348,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.155,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28302,10348,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.508,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28303,10348,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.142,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28304,10348,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.058,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28305,10348,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.126,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28306,10348,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.071,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28307,10348,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.334,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28308,10348,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.366,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28309,10348,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.309,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28310,10348,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.179,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28311,10348,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.26,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
28312,10348,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.138,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
28313,10348,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.155,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28314,10348,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.373,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28315,10348,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.077,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28316,10348,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.492,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28317,10348,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.279,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28318,10348,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.601,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28319,10348,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.201,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28320,10348,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.361,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28321,10348,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.519,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28322,10348,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.089,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28323,10348,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.483,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28324,10348,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.514,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28325,10348,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.352,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28326,10348,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.349,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28327,10348,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.263,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
28328,10348,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.166,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
28329,10348,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.344,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28330,10348,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.249,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28331,10348,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.084,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28332,10348,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.521,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28333,10348,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.366,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28334,10348,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.721,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28335,10348,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.284,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28336,10348,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.573,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28337,10348,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.77,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28338,10348,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.103,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28339,10348,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.544,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28340,10348,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.649,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28341,10348,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.404,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28342,10348,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.425,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28343,10348,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.261,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
28344,10348,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.186,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
28345,10348,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.483,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28346,10348,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.441,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28347,10348,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.156,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28348,10348,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.577,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28349,10348,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.371,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28350,10348,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.62,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28351,10348,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.301,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28352,10348,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.735,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28353,10348,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.798,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28354,10348,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.187,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28355,10348,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.627,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28356,10348,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.765,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28357,10348,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.489,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28358,10348,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.544,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28359,10348,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.291,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
28360,10348,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.273,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
28361,10348,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.685,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28362,10348,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.528,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28363,10348,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.269,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28364,10348,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.599,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28365,10348,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.44,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28366,10348,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.7,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28367,10348,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.297,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28368,10348,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.738,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28369,10348,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.822,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28370,10348,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.344,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28371,10348,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.625,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28372,10348,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.742,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28373,10348,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.545,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28374,10348,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.668,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28375,10348,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.319,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
28376,10348,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.54,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
28377,10348,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.627,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28378,10348,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.669,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28379,10348,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.381,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28380,10348,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.681,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28381,10348,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.586,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28382,10348,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.738,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28383,10348,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.31,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28384,10348,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.673,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28385,10348,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.746,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
28386,10348,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.46,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28387,10348,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.728,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
28388,10348,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.722,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
28389,10348,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.663,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28390,10348,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.572,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
28391,10348,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.33,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
28392,10348,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.631,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
28393,10348,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.798,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
28394,10348,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.717,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
28395,10348,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.548,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
28396,10348,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.735,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
28397,10348,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.718,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28398,10348,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.713,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
28399,10348,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.429,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
28400,10348,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
28401,10348,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.663,0,NONE,OHSU_HNSCC_derm002
28402,10348,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.679,0,NONE,OHSU_HNSCC_derm002
28403,10348,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.715,0,NONE,OHSU_HNSCC_derm002
28404,10348,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.654,0,NONE,OHSU_HNSCC_derm002
28405,10348,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.698,0,NONE,OHSU_HNSCC_derm002
28406,10348,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.683,0,NONE,OHSU_HNSCC_derm002
28407,10348,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.756,0,NONE,OHSU_HNSCC_derm002
28408,10348,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.684,0,NONE,OHSU_HNSCC_derm002
28409,10348,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.688,0,NONE,OHSU_HNSCC_derm002
28410,10348,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.639,0,NONE,OHSU_HNSCC_derm002
28411,10348,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.739,0,NONE,OHSU_HNSCC_derm002
28412,10348,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.78,0,NONE,OHSU_HNSCC_derm002
28413,10348,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.721,0,NONE,OHSU_HNSCC_derm002
28414,10348,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.688,0,NONE,OHSU_HNSCC_derm002
28415,10348,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.687,0,NONE,OHSU_HNSCC_derm002
28416,10348,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.163,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28417,10348,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.056,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28418,10348,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.03,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28419,10348,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.104,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28420,10348,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.023,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28421,10348,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.07,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28422,10348,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.424,10,IMR 1,OHSU_HNSCC_derm002
28423,10348,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.246,10,Gefitinib,OHSU_HNSCC_derm002
28424,10348,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.027,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
28425,10348,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.654,0,DMSO,OHSU_HNSCC_derm002
28426,10348,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.652,0,DMSO ,OHSU_HNSCC_derm002
28427,10348,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.625,0,DMSO,OHSU_HNSCC_derm002
28428,10348,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.676,0,DMSO ,OHSU_HNSCC_derm002
28429,10348,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.659,0,DMSO,OHSU_HNSCC_derm002
28430,10348,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.576,0,DMSO ,OHSU_HNSCC_derm002
28431,10348,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.526,0,DMSO,OHSU_HNSCC_derm002
28432,10348,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.139,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28433,10348,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.052,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28434,10348,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.049,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28435,10348,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.203,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28436,10348,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.163,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28437,10348,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.081,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28438,10348,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.683,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
28439,10348,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.295,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
28440,10348,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.317,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
28441,10348,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.658,0,DMSO,OHSU_HNSCC_derm002
28442,10348,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.665,0,DMSO ,OHSU_HNSCC_derm002
28443,10348,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.664,0,DMSO,OHSU_HNSCC_derm002
28444,10348,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.646,0,DMSO ,OHSU_HNSCC_derm002
28445,10348,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.648,0,DMSO,OHSU_HNSCC_derm002
28446,10348,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.745,0,DMSO ,OHSU_HNSCC_derm002
28447,10348,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.57,0,DMSO,OHSU_HNSCC_derm002
28448,10348,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.279,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28449,10348,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.075,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28450,10348,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.099,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28451,10348,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.272,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28452,10348,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.396,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28453,10348,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.088,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28454,10348,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.762,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
28455,10348,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.307,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
28456,10348,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.516,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
28457,10348,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.594,0,DMSO,OHSU_HNSCC_derm002
28458,10348,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.668,0,DMSO ,OHSU_HNSCC_derm002
28459,10348,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.665,0,DMSO,OHSU_HNSCC_derm002
28460,10348,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.761,0,DMSO ,OHSU_HNSCC_derm002
28461,10348,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.669,0,DMSO,OHSU_HNSCC_derm002
28462,10348,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.691,0,DMSO ,OHSU_HNSCC_derm002
28463,10348,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.589,0,DMSO,OHSU_HNSCC_derm002
28464,10348,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.338,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28465,10348,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.2,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28466,10348,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.158,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28467,10348,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.294,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28468,10348,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.449,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28469,10348,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.142,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28470,10348,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.669,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
28471,10348,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.351,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
28472,10348,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.597,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
28473,10348,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.667,0,DMSO,OHSU_HNSCC_derm002
28474,10348,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.714,0,DMSO ,OHSU_HNSCC_derm002
28475,10348,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.648,0,DMSO,OHSU_HNSCC_derm002
28476,10348,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.737,0,DMSO ,OHSU_HNSCC_derm002
28477,10348,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.718,0,DMSO,OHSU_HNSCC_derm002
28478,10348,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.686,0,DMSO ,OHSU_HNSCC_derm002
28479,10348,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.603,0,DMSO,OHSU_HNSCC_derm002
28480,10348,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.468,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28481,10348,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.323,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28482,10348,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.303,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28483,10348,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.305,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28484,10348,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.559,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28485,10348,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.255,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28486,10348,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.699,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
28487,10348,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.428,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
28488,10348,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.622,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
28489,10348,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.648,0,DMSO,OHSU_HNSCC_derm002
28490,10348,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.686,0,DMSO ,OHSU_HNSCC_derm002
28491,10348,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.695,0,DMSO,OHSU_HNSCC_derm002
28492,10348,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.731,0,DMSO ,OHSU_HNSCC_derm002
28493,10348,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.678,0,DMSO,OHSU_HNSCC_derm002
28494,10348,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.726,0,DMSO ,OHSU_HNSCC_derm002
28495,10348,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.559,0,DMSO,OHSU_HNSCC_derm002
28496,10348,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.573,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28497,10348,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.441,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28498,10348,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.476,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28499,10348,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.423,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28500,10348,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.626,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28501,10348,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.421,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28502,10348,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.671,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
28503,10348,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.517,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
28504,10348,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.651,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
28505,10348,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.632,0,DMSO,OHSU_HNSCC_derm002
28506,10348,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.712,0,DMSO ,OHSU_HNSCC_derm002
28507,10348,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.658,0,DMSO,OHSU_HNSCC_derm002
28508,10348,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.689,0,DMSO ,OHSU_HNSCC_derm002
28509,10348,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.664,0,DMSO,OHSU_HNSCC_derm002
28510,10348,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.744,0,DMSO ,OHSU_HNSCC_derm002
28511,10348,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.584,0,DMSO,OHSU_HNSCC_derm002
28512,10348,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.695,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28513,10348,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.54,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
28514,10348,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.62,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
28515,10348,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.509,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
28516,10348,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.66,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
28517,10348,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.548,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
28518,10348,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.718,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
28519,10348,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.555,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
28520,10348,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.658,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
28521,10348,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.632,0,DMSO,OHSU_HNSCC_derm002
28522,10348,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.652,0,DMSO ,OHSU_HNSCC_derm002
28523,10348,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.668,0,DMSO,OHSU_HNSCC_derm002
28524,10348,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.726,0,DMSO ,OHSU_HNSCC_derm002
28525,10348,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.706,0,DMSO,OHSU_HNSCC_derm002
28526,10348,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.692,0,DMSO ,OHSU_HNSCC_derm002
28527,10348,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.576,0,DMSO,OHSU_HNSCC_derm002
28528,10348,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
28529,10348,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.578,0,NONE,OHSU_HNSCC_derm002
28530,10348,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.725,0,NONE,OHSU_HNSCC_derm002
28531,10348,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.644,0,NONE,OHSU_HNSCC_derm002
28532,10348,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.69,0,NONE,OHSU_HNSCC_derm002
28533,10348,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.684,0,NONE,OHSU_HNSCC_derm002
28534,10348,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.654,0,NONE,OHSU_HNSCC_derm002
28535,10348,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
28536,10348,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.627,0,NONE,OHSU_HNSCC_derm002
28537,10348,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.642,0,NONE,OHSU_HNSCC_derm002
28538,10348,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
28539,10348,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.641,0,NONE,OHSU_HNSCC_derm002
28540,10348,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.713,0,NONE,OHSU_HNSCC_derm002
28541,10348,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.699,0,NONE,OHSU_HNSCC_derm002
28542,10348,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.704,0,NONE,OHSU_HNSCC_derm002
28543,10348,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.591,0,NONE,OHSU_HNSCC_derm002
28544,10348,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.59,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28545,10348,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.02,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28546,10348,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.298,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28547,10348,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.206,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28548,10348,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.295,5,Vandetanib (5mM),OHSU_HNSCC_derm002
28549,10348,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.662,0,DMSO,OHSU_HNSCC_derm002
28550,10348,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.702,0,DMSO ,OHSU_HNSCC_derm002
28551,10348,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.043,10,Brigatinib,OHSU_HNSCC_derm002
28552,10348,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.2,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28553,10348,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.634,0,DMSO,OHSU_HNSCC_derm002
28554,10348,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.72,0,DMSO ,OHSU_HNSCC_derm002
28555,10348,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.618,0,DMSO,OHSU_HNSCC_derm002
28556,10348,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.742,0,DMSO ,OHSU_HNSCC_derm002
28557,10348,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.699,0,DMSO,OHSU_HNSCC_derm002
28558,10348,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.696,0,DMSO ,OHSU_HNSCC_derm002
28559,10348,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.573,0,DMSO,OHSU_HNSCC_derm002
28560,10348,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.717,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28561,10348,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.033,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28562,10348,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.349,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28563,10348,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.242,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28564,10348,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.38,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
28565,10348,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.693,0,DMSO,OHSU_HNSCC_derm002
28566,10348,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.692,0,DMSO ,OHSU_HNSCC_derm002
28567,10348,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.128,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
28568,10348,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.282,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28569,10348,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.65,0,DMSO,OHSU_HNSCC_derm002
28570,10348,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.706,0,DMSO ,OHSU_HNSCC_derm002
28571,10348,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.65,0,DMSO,OHSU_HNSCC_derm002
28572,10348,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.747,0,DMSO ,OHSU_HNSCC_derm002
28573,10348,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.687,0,DMSO,OHSU_HNSCC_derm002
28574,10348,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.695,0,DMSO ,OHSU_HNSCC_derm002
28575,10348,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.544,0,DMSO,OHSU_HNSCC_derm002
28576,10348,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.809,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28577,10348,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.06,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28578,10348,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.461,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28579,10348,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.254,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28580,10348,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.456,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
28581,10348,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.665,0,DMSO,OHSU_HNSCC_derm002
28582,10348,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.712,0,DMSO ,OHSU_HNSCC_derm002
28583,10348,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.449,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
28584,10348,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.284,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28585,10348,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.667,0,DMSO,OHSU_HNSCC_derm002
28586,10348,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.675,0,DMSO ,OHSU_HNSCC_derm002
28587,10348,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.684,0,DMSO,OHSU_HNSCC_derm002
28588,10348,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.705,0,DMSO ,OHSU_HNSCC_derm002
28589,10348,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.688,0,DMSO,OHSU_HNSCC_derm002
28590,10348,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.675,0,DMSO ,OHSU_HNSCC_derm002
28591,10348,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.554,0,DMSO,OHSU_HNSCC_derm002
28592,10348,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.728,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28593,10348,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.117,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28594,10348,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.522,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28595,10348,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.284,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28596,10348,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.612,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
28597,10348,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.661,0,DMSO,OHSU_HNSCC_derm002
28598,10348,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.711,0,DMSO ,OHSU_HNSCC_derm002
28599,10348,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.581,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
28600,10348,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.306,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28601,10348,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.599,0,DMSO,OHSU_HNSCC_derm002
28602,10348,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.735,0,DMSO ,OHSU_HNSCC_derm002
28603,10348,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.691,0,DMSO,OHSU_HNSCC_derm002
28604,10348,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.751,0,DMSO ,OHSU_HNSCC_derm002
28605,10348,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.688,0,DMSO,OHSU_HNSCC_derm002
28606,10348,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.717,0,DMSO ,OHSU_HNSCC_derm002
28607,10348,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.566,0,DMSO,OHSU_HNSCC_derm002
28608,10348,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.688,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28609,10348,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.253,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28610,10348,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.553,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28611,10348,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.413,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28612,10348,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.62,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
28613,10348,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.655,0,DMSO,OHSU_HNSCC_derm002
28614,10348,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.675,0,DMSO ,OHSU_HNSCC_derm002
28615,10348,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.581,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
28616,10348,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.313,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28617,10348,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.673,0,DMSO,OHSU_HNSCC_derm002
28618,10348,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.716,0,DMSO ,OHSU_HNSCC_derm002
28619,10348,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.702,0,DMSO,OHSU_HNSCC_derm002
28620,10348,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.715,0,DMSO ,OHSU_HNSCC_derm002
28621,10348,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.699,0,DMSO,OHSU_HNSCC_derm002
28622,10348,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.702,0,DMSO ,OHSU_HNSCC_derm002
28623,10348,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.534,0,DMSO,OHSU_HNSCC_derm002
28624,10348,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.726,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28625,10348,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.462,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28626,10348,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.632,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28627,10348,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.505,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28628,10348,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.656,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
28629,10348,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.707,0,DMSO,OHSU_HNSCC_derm002
28630,10348,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.686,0,DMSO ,OHSU_HNSCC_derm002
28631,10348,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.62,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
28632,10348,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.321,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28633,10348,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.686,0,DMSO,OHSU_HNSCC_derm002
28634,10348,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.721,0,DMSO ,OHSU_HNSCC_derm002
28635,10348,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.714,0,DMSO,OHSU_HNSCC_derm002
28636,10348,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.738,0,DMSO ,OHSU_HNSCC_derm002
28637,10348,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.732,0,DMSO,OHSU_HNSCC_derm002
28638,10348,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.683,0,DMSO ,OHSU_HNSCC_derm002
28639,10348,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.566,0,DMSO,OHSU_HNSCC_derm002
28640,10348,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.652,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28641,10348,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.551,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
28642,10348,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.76,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
28643,10348,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.59,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
28644,10348,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.709,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
28645,10348,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.673,0,DMSO,OHSU_HNSCC_derm002
28646,10348,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.738,0,DMSO ,OHSU_HNSCC_derm002
28647,10348,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.629,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
28648,10348,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.388,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28649,10348,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.731,0,DMSO,OHSU_HNSCC_derm002
28650,10348,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.716,0,DMSO ,OHSU_HNSCC_derm002
28651,10348,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.657,0,DMSO,OHSU_HNSCC_derm002
28652,10348,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.759,0,DMSO ,OHSU_HNSCC_derm002
28653,10348,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.659,0,DMSO,OHSU_HNSCC_derm002
28654,10348,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.701,0,DMSO ,OHSU_HNSCC_derm002
28655,10348,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.551,0,DMSO,OHSU_HNSCC_derm002
28656,10348,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.602,0,NONE,OHSU_HNSCC_derm002
28657,10348,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.693,0,NONE,OHSU_HNSCC_derm002
28658,10348,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.753,0,NONE,OHSU_HNSCC_derm002
28659,10348,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.652,0,NONE,OHSU_HNSCC_derm002
28660,10348,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.643,0,NONE,OHSU_HNSCC_derm002
28661,10348,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.674,0,NONE,OHSU_HNSCC_derm002
28662,10348,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.691,0,NONE,OHSU_HNSCC_derm002
28663,10348,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
28664,10348,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.671,0,NONE,OHSU_HNSCC_derm002
28665,10348,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.682,0,NONE,OHSU_HNSCC_derm002
28666,10348,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.755,0,NONE,OHSU_HNSCC_derm002
28667,10348,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.733,0,NONE,OHSU_HNSCC_derm002
28668,10348,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
28669,10348,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.679,0,NONE,OHSU_HNSCC_derm002
28670,10348,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.654,0,NONE,OHSU_HNSCC_derm002
28671,10348,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.531,0,NONE,OHSU_HNSCC_derm002
28672,10348,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.125,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28673,10348,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.145,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28674,10348,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.643,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28675,10348,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.053,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28676,10348,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.449,10,LY3039478 ,OHSU_HNSCC_derm002
28677,10348,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.175,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28678,10348,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.136,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28679,10348,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.177,10,Trametinib,OHSU_HNSCC_derm002
28680,10348,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.083,10,BEZ235,OHSU_HNSCC_derm002
28681,10348,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.659,0,DMSO,OHSU_HNSCC_derm002
28682,10348,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.677,0,DMSO ,OHSU_HNSCC_derm002
28683,10348,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.719,0,DMSO,OHSU_HNSCC_derm002
28684,10348,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.692,0,DMSO ,OHSU_HNSCC_derm002
28685,10348,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.747,0,DMSO,OHSU_HNSCC_derm002
28686,10348,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.671,0,DMSO ,OHSU_HNSCC_derm002
28687,10348,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.545,0,DMSO,OHSU_HNSCC_derm002
28688,10348,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.181,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28689,10348,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.298,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28690,10348,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.711,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28691,10348,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.047,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28692,10348,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.494,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
28693,10348,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.224,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28694,10348,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.133,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28695,10348,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.176,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
28696,10348,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.092,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
28697,10348,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.697,0,DMSO,OHSU_HNSCC_derm002
28698,10348,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.714,0,DMSO ,OHSU_HNSCC_derm002
28699,10348,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.737,0,DMSO,OHSU_HNSCC_derm002
28700,10348,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.713,0,DMSO ,OHSU_HNSCC_derm002
28701,10348,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.687,0,DMSO,OHSU_HNSCC_derm002
28702,10348,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.682,0,DMSO ,OHSU_HNSCC_derm002
28703,10348,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.579,0,DMSO,OHSU_HNSCC_derm002
28704,10348,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.223,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28705,10348,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.395,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28706,10348,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.693,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28707,10348,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.064,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28708,10348,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.509,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
28709,10348,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.236,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28710,10348,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.197,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28711,10348,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.166,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
28712,10348,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.119,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
28713,10348,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.694,0,DMSO,OHSU_HNSCC_derm002
28714,10348,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.759,0,DMSO ,OHSU_HNSCC_derm002
28715,10348,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.766,0,DMSO,OHSU_HNSCC_derm002
28716,10348,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.72,0,DMSO ,OHSU_HNSCC_derm002
28717,10348,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.745,0,DMSO,OHSU_HNSCC_derm002
28718,10348,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.694,0,DMSO ,OHSU_HNSCC_derm002
28719,10348,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.552,0,DMSO,OHSU_HNSCC_derm002
28720,10348,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.293,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28721,10348,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.485,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28722,10348,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.727,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28723,10348,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.126,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28724,10348,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.487,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
28725,10348,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.409,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28726,10348,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.209,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28727,10348,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.209,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
28728,10348,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.123,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
28729,10348,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.738,0,DMSO,OHSU_HNSCC_derm002
28730,10348,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.702,0,DMSO ,OHSU_HNSCC_derm002
28731,10348,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.684,0,DMSO,OHSU_HNSCC_derm002
28732,10348,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.736,0,DMSO ,OHSU_HNSCC_derm002
28733,10348,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.735,0,DMSO,OHSU_HNSCC_derm002
28734,10348,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.692,0,DMSO ,OHSU_HNSCC_derm002
28735,10348,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.598,0,DMSO,OHSU_HNSCC_derm002
28736,10348,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.402,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28737,10348,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.588,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28738,10348,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.72,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28739,10348,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.278,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28740,10348,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.468,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
28741,10348,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.492,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28742,10348,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.246,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28743,10348,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.234,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
28744,10348,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.151,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
28745,10348,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.738,0,DMSO,OHSU_HNSCC_derm002
28746,10348,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.715,0,DMSO ,OHSU_HNSCC_derm002
28747,10348,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.747,0,DMSO,OHSU_HNSCC_derm002
28748,10348,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.788,0,DMSO ,OHSU_HNSCC_derm002
28749,10348,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.722,0,DMSO,OHSU_HNSCC_derm002
28750,10348,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.665,0,DMSO ,OHSU_HNSCC_derm002
28751,10348,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.629,0,DMSO,OHSU_HNSCC_derm002
28752,10348,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.524,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28753,10348,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.552,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28754,10348,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.703,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28755,10348,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.489,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28756,10348,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.54,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
28757,10348,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.53,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28758,10348,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.395,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28759,10348,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.243,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
28760,10348,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.285,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
28761,10348,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.692,0,DMSO,OHSU_HNSCC_derm002
28762,10348,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.703,0,DMSO ,OHSU_HNSCC_derm002
28763,10348,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.717,0,DMSO,OHSU_HNSCC_derm002
28764,10348,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.719,0,DMSO ,OHSU_HNSCC_derm002
28765,10348,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.754,0,DMSO,OHSU_HNSCC_derm002
28766,10348,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.658,0,DMSO ,OHSU_HNSCC_derm002
28767,10348,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.606,0,DMSO,OHSU_HNSCC_derm002
28768,10348,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.532,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
28769,10348,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.593,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
28770,10348,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.675,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
28771,10348,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.575,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
28772,10348,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.499,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
28773,10348,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.495,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
28774,10348,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.398,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
28775,10348,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.293,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
28776,10348,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.43,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
28777,10348,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.713,0,DMSO,OHSU_HNSCC_derm002
28778,10348,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.703,0,DMSO ,OHSU_HNSCC_derm002
28779,10348,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.716,0,DMSO,OHSU_HNSCC_derm002
28780,10348,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.692,0,DMSO ,OHSU_HNSCC_derm002
28781,10348,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.702,0,DMSO,OHSU_HNSCC_derm002
28782,10348,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.646,0,DMSO ,OHSU_HNSCC_derm002
28783,10348,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.623,0,DMSO,OHSU_HNSCC_derm002
28784,10348,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.531,0,NONE,OHSU_HNSCC_derm002
28785,10348,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.593,0,NONE,OHSU_HNSCC_derm002
28786,10348,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.549,0,NONE,OHSU_HNSCC_derm002
28787,10348,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.55,0,NONE,OHSU_HNSCC_derm002
28788,10348,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.647,0,NONE,OHSU_HNSCC_derm002
28789,10348,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
28790,10348,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.578,0,NONE,OHSU_HNSCC_derm002
28791,10348,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.603,0,NONE,OHSU_HNSCC_derm002
28792,10348,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.598,0,NONE,OHSU_HNSCC_derm002
28793,10348,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.638,0,NONE,OHSU_HNSCC_derm002
28794,10348,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
28795,10348,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
28796,10348,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
28797,10348,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.685,0,NONE,OHSU_HNSCC_derm002
28798,10348,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.577,0,NONE,OHSU_HNSCC_derm002
28799,10348,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.599,0,NONE,OHSU_HNSCC_derm002
28800,20003,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.125,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
28801,20003,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.445,10,Lucitanib ,OHSU_HNSCC_derm002
28802,20003,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.488,10,Resveratrol,OHSU_HNSCC_derm002
28803,20003,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.378,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28804,20003,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.554,10,Bicalutamide,OHSU_HNSCC_derm002
28805,20003,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.439,10,Methotrexate ,OHSU_HNSCC_derm002
28806,20003,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.363,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28807,20003,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.361,10,Gefitinib,OHSU_HNSCC_derm002
28808,20003,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.259,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
28809,20003,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.445,10,Tamatinib/R406,OHSU_HNSCC_derm002
28810,20003,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.375,10,Bosutinib,OHSU_HNSCC_derm002
28811,20003,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.181,10,PI-103,OHSU_HNSCC_derm002
28812,20003,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.361,10,Glycyrrhizin,OHSU_HNSCC_derm002
28813,20003,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.501,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
28814,20003,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.451,10,GSK-690693,OHSU_HNSCC_derm002
28815,20003,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.421,10,Ibrutinib,OHSU_HNSCC_derm002
28816,20003,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.144,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
28817,20003,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.565,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
28818,20003,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.614,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
28819,20003,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.532,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28820,20003,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.559,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
28821,20003,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.577,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
28822,20003,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.542,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28823,20003,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.495,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
28824,20003,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.45,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
28825,20003,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.446,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
28826,20003,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.507,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
28827,20003,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.203,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
28828,20003,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.487,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
28829,20003,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.535,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
28830,20003,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.446,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
28831,20003,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.391,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
28832,20003,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.227,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
28833,20003,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.519,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
28834,20003,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.616,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
28835,20003,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.538,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28836,20003,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.656,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
28837,20003,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.626,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
28838,20003,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.62,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28839,20003,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.509,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
28840,20003,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.591,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
28841,20003,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.518,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
28842,20003,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.655,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
28843,20003,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.282,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
28844,20003,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.633,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
28845,20003,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.573,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
28846,20003,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.531,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
28847,20003,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.404,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
28848,20003,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.267,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
28849,20003,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.504,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
28850,20003,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.67,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
28851,20003,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.53,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28852,20003,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.641,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
28853,20003,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.59,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
28854,20003,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.591,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28855,20003,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.571,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
28856,20003,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.587,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
28857,20003,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.582,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
28858,20003,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.715,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
28859,20003,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.332,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
28860,20003,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.664,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
28861,20003,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.589,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
28862,20003,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.611,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
28863,20003,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.345,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
28864,20003,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.364,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
28865,20003,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.502,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
28866,20003,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.54,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
28867,20003,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.545,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28868,20003,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.654,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
28869,20003,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.633,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
28870,20003,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.585,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28871,20003,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.575,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
28872,20003,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.537,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
28873,20003,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.55,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
28874,20003,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.734,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
28875,20003,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.446,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
28876,20003,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.64,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
28877,20003,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.584,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
28878,20003,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.601,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
28879,20003,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.485,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
28880,20003,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.483,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
28881,20003,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.567,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
28882,20003,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.633,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
28883,20003,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.564,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28884,20003,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.652,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
28885,20003,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.626,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
28886,20003,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.586,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28887,20003,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.614,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
28888,20003,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.505,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
28889,20003,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.523,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
28890,20003,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.645,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
28891,20003,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.532,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
28892,20003,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.606,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
28893,20003,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.613,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
28894,20003,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.669,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
28895,20003,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.412,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
28896,20003,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.449,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
28897,20003,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.539,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
28898,20003,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.621,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
28899,20003,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.588,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
28900,20003,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.653,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
28901,20003,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.597,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
28902,20003,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.629,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
28903,20003,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.595,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
28904,20003,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.566,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
28905,20003,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.49,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
28906,20003,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.653,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
28907,20003,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.573,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
28908,20003,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.526,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
28909,20003,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.538,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
28910,20003,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.644,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
28911,20003,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.361,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
28912,20003,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.446,0,NONE,OHSU_HNSCC_derm002
28913,20003,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.547,0,NONE,OHSU_HNSCC_derm002
28914,20003,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.659,0,NONE,OHSU_HNSCC_derm002
28915,20003,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.624,0,NONE,OHSU_HNSCC_derm002
28916,20003,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.624,0,NONE,OHSU_HNSCC_derm002
28917,20003,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.592,0,NONE,OHSU_HNSCC_derm002
28918,20003,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.615,0,NONE,OHSU_HNSCC_derm002
28919,20003,Blank 490,1,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
28920,20003,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.561,0,NONE,OHSU_HNSCC_derm002
28921,20003,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.595,0,NONE,OHSU_HNSCC_derm002
28922,20003,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.619,0,NONE,OHSU_HNSCC_derm002
28923,20003,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
28924,20003,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.593,0,NONE,OHSU_HNSCC_derm002
28925,20003,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.598,0,NONE,OHSU_HNSCC_derm002
28926,20003,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.67,0,NONE,OHSU_HNSCC_derm002
28927,20003,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.392,0,NONE,OHSU_HNSCC_derm002
28928,20003,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.232,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
28929,20003,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.329,10,Sorafenib,OHSU_HNSCC_derm002
28930,20003,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.68,10,Rosmarinic acid,OHSU_HNSCC_derm002
28931,20003,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.518,10,Rapamycin,OHSU_HNSCC_derm002
28932,20003,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.546,10,Vismodegib,OHSU_HNSCC_derm002
28933,20003,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.395,10,PP242,OHSU_HNSCC_derm002
28934,20003,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.419,10,Alectinib,OHSU_HNSCC_derm002
28935,20003,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.272,10,Brigatinib,OHSU_HNSCC_derm002
28936,20003,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.477,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28937,20003,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.381,10,MK-2206,OHSU_HNSCC_derm002
28938,20003,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.562,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
28939,20003,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.078,10,Flavopiridol ,OHSU_HNSCC_derm002
28940,20003,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.642,10,Indirubin,OHSU_HNSCC_derm002
28941,20003,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.474,10,PF-533228,OHSU_HNSCC_derm002
28942,20003,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.72,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
28943,20003,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.146,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
28944,20003,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.331,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
28945,20003,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.444,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
28946,20003,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.658,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
28947,20003,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.528,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
28948,20003,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.586,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
28949,20003,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.384,3.3333333333333335,PP242,OHSU_HNSCC_derm002
28950,20003,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.47,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
28951,20003,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.426,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
28952,20003,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.476,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28953,20003,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.424,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
28954,20003,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.594,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
28955,20003,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.063,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
28956,20003,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.583,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
28957,20003,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.617,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
28958,20003,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.687,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
28959,20003,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.101,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
28960,20003,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.314,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
28961,20003,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.47,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
28962,20003,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.606,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
28963,20003,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.475,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
28964,20003,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.619,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
28965,20003,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.56,1.1111111111111112,PP242,OHSU_HNSCC_derm002
28966,20003,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.499,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
28967,20003,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.591,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
28968,20003,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.448,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28969,20003,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.464,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
28970,20003,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.572,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
28971,20003,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.075,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
28972,20003,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.593,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
28973,20003,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.643,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
28974,20003,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.529,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
28975,20003,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.134,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
28976,20003,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.293,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
28977,20003,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.499,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
28978,20003,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.663,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
28979,20003,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.55,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
28980,20003,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.609,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
28981,20003,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.601,0.3703703703703704,PP242,OHSU_HNSCC_derm002
28982,20003,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.596,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
28983,20003,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.634,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
28984,20003,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.474,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
28985,20003,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.475,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
28986,20003,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.616,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
28987,20003,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.094,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
28988,20003,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.666,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
28989,20003,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.585,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
28990,20003,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.646,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
28991,20003,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.158,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
28992,20003,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.324,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
28993,20003,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.515,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
28994,20003,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.657,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
28995,20003,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.55,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
28996,20003,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.593,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
28997,20003,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.558,0.1234567901234568,PP242,OHSU_HNSCC_derm002
28998,20003,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.572,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
28999,20003,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.672,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
29000,20003,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.462,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29001,20003,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.522,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
29002,20003,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.611,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
29003,20003,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.341,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
29004,20003,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.617,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
29005,20003,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.557,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
29006,20003,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.635,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
29007,20003,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.187,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
29008,20003,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.356,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
29009,20003,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.538,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
29010,20003,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.587,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
29011,20003,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.515,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
29012,20003,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.611,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
29013,20003,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.596,0.0411522633744856,PP242,OHSU_HNSCC_derm002
29014,20003,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.604,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
29015,20003,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.613,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
29016,20003,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.488,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29017,20003,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.537,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
29018,20003,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.675,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
29019,20003,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.519,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
29020,20003,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.568,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
29021,20003,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.606,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
29022,20003,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.617,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
29023,20003,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.328,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
29024,20003,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.4,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
29025,20003,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.572,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
29026,20003,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.578,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
29027,20003,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.569,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
29028,20003,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.598,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
29029,20003,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.601,0.013717421124828532,PP242,OHSU_HNSCC_derm002
29030,20003,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.605,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
29031,20003,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.622,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
29032,20003,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.517,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29033,20003,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.488,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
29034,20003,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.568,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
29035,20003,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.547,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
29036,20003,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.586,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
29037,20003,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.638,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
29038,20003,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.674,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
29039,20003,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.332,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
29040,20003,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.462,0,NONE,OHSU_HNSCC_derm002
29041,20003,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.585,0,NONE,OHSU_HNSCC_derm002
29042,20003,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.592,0,NONE,OHSU_HNSCC_derm002
29043,20003,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.6,0,NONE,OHSU_HNSCC_derm002
29044,20003,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.593,0,NONE,OHSU_HNSCC_derm002
29045,20003,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.615,0,NONE,OHSU_HNSCC_derm002
29046,20003,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.603,0,NONE,OHSU_HNSCC_derm002
29047,20003,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
29048,20003,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.58,0,NONE,OHSU_HNSCC_derm002
29049,20003,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.546,0,NONE,OHSU_HNSCC_derm002
29050,20003,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.632,0,NONE,OHSU_HNSCC_derm002
29051,20003,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.601,0,NONE,OHSU_HNSCC_derm002
29052,20003,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.579,0,NONE,OHSU_HNSCC_derm002
29053,20003,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.568,0,NONE,OHSU_HNSCC_derm002
29054,20003,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.66,0,NONE,OHSU_HNSCC_derm002
29055,20003,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.392,0,NONE,OHSU_HNSCC_derm002
29056,20003,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.315,10,Emodin,OHSU_HNSCC_derm002
29057,20003,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.508,10,Baicalin,OHSU_HNSCC_derm002
29058,20003,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.181,10,NVP-TAE-684,OHSU_HNSCC_derm002
29059,20003,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.115,10,Panobinostat,OHSU_HNSCC_derm002
29060,20003,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.276,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
29061,20003,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.622,10,Fulvestrant,OHSU_HNSCC_derm002
29062,20003,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.655,10,SCH-772984,OHSU_HNSCC_derm002
29063,20003,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.616,10,Trametinib,OHSU_HNSCC_derm002
29064,20003,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.337,10,BEZ235,OHSU_HNSCC_derm002
29065,20003,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.543,10,MLN120B,OHSU_HNSCC_derm002
29066,20003,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.441,10,Ixabepilone,OHSU_HNSCC_derm002
29067,20003,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.269,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
29068,20003,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.514,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29069,20003,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.408,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29070,20003,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.415,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29071,20003,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.391,10,Letrozole,OHSU_HNSCC_derm002
29072,20003,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.377,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
29073,20003,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.532,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
29074,20003,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.399,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
29075,20003,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.115,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
29076,20003,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.355,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
29077,20003,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.593,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
29078,20003,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.708,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
29079,20003,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.636,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
29080,20003,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.306,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
29081,20003,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.589,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
29082,20003,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.454,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
29083,20003,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.473,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
29084,20003,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.596,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29085,20003,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.484,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29086,20003,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.409,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29087,20003,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.428,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
29088,20003,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.407,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
29089,20003,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.578,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
29090,20003,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.535,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
29091,20003,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.175,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
29092,20003,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.528,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
29093,20003,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.623,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
29094,20003,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.649,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
29095,20003,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.625,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
29096,20003,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.305,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
29097,20003,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.582,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
29098,20003,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.464,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
29099,20003,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.495,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
29100,20003,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.587,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29101,20003,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.541,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29102,20003,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.417,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29103,20003,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.382,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
29104,20003,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.429,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
29105,20003,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.586,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
29106,20003,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.596,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
29107,20003,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.358,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
29108,20003,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.522,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
29109,20003,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.612,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
29110,20003,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.67,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
29111,20003,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.61,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
29112,20003,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.316,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
29113,20003,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.55,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
29114,20003,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.423,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
29115,20003,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.477,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
29116,20003,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.568,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29117,20003,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.575,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29118,20003,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.487,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29119,20003,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.378,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
29120,20003,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.413,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
29121,20003,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.564,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
29122,20003,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.629,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
29123,20003,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.447,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
29124,20003,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.577,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
29125,20003,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.559,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
29126,20003,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.642,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
29127,20003,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.615,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
29128,20003,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.397,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
29129,20003,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.533,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
29130,20003,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.474,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
29131,20003,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.505,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
29132,20003,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.622,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29133,20003,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.684,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29134,20003,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.508,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29135,20003,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.473,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
29136,20003,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.471,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
29137,20003,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.584,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
29138,20003,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.622,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
29139,20003,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.54,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
29140,20003,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.589,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
29141,20003,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.62,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
29142,20003,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.628,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
29143,20003,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.674,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
29144,20003,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.497,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
29145,20003,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.543,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
29146,20003,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.474,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
29147,20003,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.57,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
29148,20003,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.598,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29149,20003,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.61,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29150,20003,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.484,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29151,20003,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.391,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
29152,20003,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.422,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
29153,20003,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.586,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
29154,20003,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.601,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
29155,20003,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.564,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
29156,20003,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.615,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
29157,20003,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.614,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
29158,20003,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.564,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
29159,20003,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.592,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
29160,20003,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.529,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
29161,20003,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.552,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
29162,20003,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.481,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
29163,20003,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.497,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
29164,20003,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.574,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
29165,20003,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.565,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
29166,20003,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.398,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
29167,20003,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.569,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
29168,20003,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.387,0,NONE,OHSU_HNSCC_derm002
29169,20003,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.375,0,NONE,OHSU_HNSCC_derm002
29170,20003,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.46,0,NONE,OHSU_HNSCC_derm002
29171,20003,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.456,0,NONE,OHSU_HNSCC_derm002
29172,20003,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.441,0,NONE,OHSU_HNSCC_derm002
29173,20003,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
29174,20003,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.347,0,NONE,OHSU_HNSCC_derm002
29175,20003,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.393,0,NONE,OHSU_HNSCC_derm002
29176,20003,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.543,0,NONE,OHSU_HNSCC_derm002
29177,20003,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.514,0,NONE,OHSU_HNSCC_derm002
29178,20003,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.358,0,NONE,OHSU_HNSCC_derm002
29179,20003,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.404,0,NONE,OHSU_HNSCC_derm002
29180,20003,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.53,0,NONE,OHSU_HNSCC_derm002
29181,20003,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.553,0,NONE,OHSU_HNSCC_derm002
29182,20003,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.395,0,NONE,OHSU_HNSCC_derm002
29183,20003,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.496,0,NONE,OHSU_HNSCC_derm002
29184,20003,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.546,10,Coumarin,OHSU_HNSCC_derm002
29185,20003,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.264,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29186,20003,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.338,10,Foretinib (XL-880),OHSU_HNSCC_derm002
29187,20003,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.294,10,Elesclomol,OHSU_HNSCC_derm002
29188,20003,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.476,10,Vemurafenib,OHSU_HNSCC_derm002
29189,20003,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.189,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29190,20003,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.088,10,Ponatinib,OHSU_HNSCC_derm002
29191,20003,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.431,10,Gefitinib,OHSU_HNSCC_derm002
29192,20003,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.18,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
29193,20003,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.671,1,Sunitinib (1mM),OHSU_HNSCC_derm002
29194,20003,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.518,10,Curcumin,OHSU_HNSCC_derm002
29195,20003,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.086,10,PF-562271,OHSU_HNSCC_derm002
29196,20003,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.38,10,STO609,OHSU_HNSCC_derm002
29197,20003,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.311,10,Lenvatinib,OHSU_HNSCC_derm002
29198,20003,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.493,10,Entrectinib,OHSU_HNSCC_derm002
29199,20003,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.484,10,Ethyl Gallate ,OHSU_HNSCC_derm002
29200,20003,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.543,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
29201,20003,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.568,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29202,20003,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.55,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
29203,20003,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.286,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
29204,20003,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.628,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
29205,20003,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.235,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29206,20003,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.377,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
29207,20003,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.423,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
29208,20003,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.493,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
29209,20003,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.669,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
29210,20003,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.601,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
29211,20003,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.424,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
29212,20003,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.593,3.3333333333333335,STO609,OHSU_HNSCC_derm002
29213,20003,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.361,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
29214,20003,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.547,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
29215,20003,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.398,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
29216,20003,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.524,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
29217,20003,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.521,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29218,20003,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.79,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
29219,20003,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.274,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
29220,20003,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.759,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
29221,20003,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.239,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29222,20003,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.667,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
29223,20003,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.405,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
29224,20003,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.635,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
29225,20003,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.663,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
29226,20003,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.738,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
29227,20003,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.603,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
29228,20003,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.546,1.1111111111111112,STO609,OHSU_HNSCC_derm002
29229,20003,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.476,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
29230,20003,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.62,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
29231,20003,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.43,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
29232,20003,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.515,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
29233,20003,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.523,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29234,20003,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.683,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
29235,20003,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.278,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
29236,20003,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.638,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
29237,20003,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.366,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29238,20003,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.676,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
29239,20003,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.489,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
29240,20003,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.568,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
29241,20003,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.572,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
29242,20003,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.659,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
29243,20003,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.558,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
29244,20003,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.575,0.3703703703703704,STO609,OHSU_HNSCC_derm002
29245,20003,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.433,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
29246,20003,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.713,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
29247,20003,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.383,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
29248,20003,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.547,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
29249,20003,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.515,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29250,20003,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.734,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
29251,20003,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.288,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
29252,20003,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.733,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
29253,20003,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.446,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29254,20003,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.702,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
29255,20003,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.517,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
29256,20003,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.579,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
29257,20003,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.554,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
29258,20003,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.664,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
29259,20003,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.606,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
29260,20003,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.489,0.1234567901234568,STO609,OHSU_HNSCC_derm002
29261,20003,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.416,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
29262,20003,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.553,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
29263,20003,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.353,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
29264,20003,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.631,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
29265,20003,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.504,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29266,20003,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.699,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
29267,20003,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.388,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
29268,20003,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.71,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
29269,20003,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.599,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29270,20003,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.73,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
29271,20003,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.509,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
29272,20003,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.61,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
29273,20003,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.569,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
29274,20003,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.582,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
29275,20003,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.568,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
29276,20003,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.551,0.0411522633744856,STO609,OHSU_HNSCC_derm002
29277,20003,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.446,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
29278,20003,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.676,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
29279,20003,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.357,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
29280,20003,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.538,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
29281,20003,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.557,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
29282,20003,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.73,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
29283,20003,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.51,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
29284,20003,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.765,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
29285,20003,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.632,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
29286,20003,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.653,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
29287,20003,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.548,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
29288,20003,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.597,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
29289,20003,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.67,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
29290,20003,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.631,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
29291,20003,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.656,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
29292,20003,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.554,0.013717421124828532,STO609,OHSU_HNSCC_derm002
29293,20003,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.435,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
29294,20003,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.646,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
29295,20003,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.408,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
29296,20003,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.49,0,NONE,OHSU_HNSCC_derm002
29297,20003,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.634,0,NONE,OHSU_HNSCC_derm002
29298,20003,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.768,0,NONE,OHSU_HNSCC_derm002
29299,20003,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.659,0,NONE,OHSU_HNSCC_derm002
29300,20003,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.717,0,NONE,OHSU_HNSCC_derm002
29301,20003,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.653,0,NONE,OHSU_HNSCC_derm002
29302,20003,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.663,0,NONE,OHSU_HNSCC_derm002
29303,20003,Blank 490,2,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
29304,20003,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.588,0,NONE,OHSU_HNSCC_derm002
29305,20003,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.578,0,NONE,OHSU_HNSCC_derm002
29306,20003,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.653,0,NONE,OHSU_HNSCC_derm002
29307,20003,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.588,0,NONE,OHSU_HNSCC_derm002
29308,20003,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.549,0,NONE,OHSU_HNSCC_derm002
29309,20003,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.453,0,NONE,OHSU_HNSCC_derm002
29310,20003,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.543,0,NONE,OHSU_HNSCC_derm002
29311,20003,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.4,0,NONE,OHSU_HNSCC_derm002
29312,20003,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.283,10,GDC-0941,OHSU_HNSCC_derm002
29313,20003,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.703,10,Dovitinib,OHSU_HNSCC_derm002
29314,20003,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.402,10,BI-2536,OHSU_HNSCC_derm002
29315,20003,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.06,10,TP-0903 ,OHSU_HNSCC_derm002
29316,20003,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.145,10,Belinostat,OHSU_HNSCC_derm002
29317,20003,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.294,10,INK-128,OHSU_HNSCC_derm002
29318,20003,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.43,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29319,20003,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.264,10,Brigatinib,OHSU_HNSCC_derm002
29320,20003,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.64,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29321,20003,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.249,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29322,20003,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.422,10,Pazopanib,OHSU_HNSCC_derm002
29323,20003,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.598,10,AZD4547,OHSU_HNSCC_derm002
29324,20003,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.535,10,Pomalidomide ,OHSU_HNSCC_derm002
29325,20003,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.392,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
29326,20003,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.705,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29327,20003,Blank 490,2,P,OHSU_HNSCC_derm002,9,-0.005,10,Staurosporin,OHSU_HNSCC_derm002
29328,20003,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.299,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
29329,20003,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.721,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
29330,20003,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.618,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
29331,20003,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.061,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
29332,20003,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.25,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
29333,20003,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.347,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
29334,20003,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.445,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29335,20003,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.419,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
29336,20003,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.502,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29337,20003,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.477,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29338,20003,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.432,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
29339,20003,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.589,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
29340,20003,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.515,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
29341,20003,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.468,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
29342,20003,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.682,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29343,20003,Blank 490,2,P,OHSU_HNSCC_derm002,10,0.003,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
29344,20003,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.293,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
29345,20003,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.743,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
29346,20003,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.72,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
29347,20003,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.065,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
29348,20003,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.445,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
29349,20003,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.369,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
29350,20003,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.529,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29351,20003,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.446,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
29352,20003,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.533,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29353,20003,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.542,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29354,20003,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.531,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
29355,20003,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.544,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
29356,20003,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.555,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
29357,20003,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.471,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
29358,20003,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.617,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29359,20003,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.017,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
29360,20003,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.416,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
29361,20003,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.659,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
29362,20003,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.73,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
29363,20003,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.287,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
29364,20003,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.556,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
29365,20003,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.358,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
29366,20003,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.544,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29367,20003,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.567,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
29368,20003,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.525,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29369,20003,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.545,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29370,20003,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.59,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
29371,20003,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.576,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
29372,20003,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.571,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
29373,20003,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.498,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
29374,20003,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.767,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29375,20003,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.128,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
29376,20003,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.393,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
29377,20003,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.629,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
29378,20003,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.701,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
29379,20003,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.513,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
29380,20003,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.587,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
29381,20003,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.345,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
29382,20003,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.568,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29383,20003,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.568,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
29384,20003,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.474,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29385,20003,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.57,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29386,20003,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.649,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
29387,20003,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.576,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
29388,20003,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.573,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
29389,20003,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.526,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
29390,20003,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.709,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29391,20003,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.288,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
29392,20003,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.534,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
29393,20003,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.647,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
29394,20003,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.635,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
29395,20003,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.632,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
29396,20003,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.648,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
29397,20003,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.4,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
29398,20003,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.633,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29399,20003,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.553,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
29400,20003,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.516,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29401,20003,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.543,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29402,20003,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.573,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
29403,20003,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.585,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
29404,20003,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.595,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
29405,20003,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.525,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
29406,20003,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.747,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29407,20003,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.46,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
29408,20003,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.59,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
29409,20003,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.614,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
29410,20003,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.676,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
29411,20003,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.635,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
29412,20003,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.662,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
29413,20003,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.466,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
29414,20003,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.636,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
29415,20003,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.554,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
29416,20003,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.568,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29417,20003,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.584,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
29418,20003,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.625,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
29419,20003,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.609,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
29420,20003,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.556,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
29421,20003,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.532,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
29422,20003,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.724,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
29423,20003,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.474,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
29424,20003,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
29425,20003,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.601,0,NONE,OHSU_HNSCC_derm002
29426,20003,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.727,0,NONE,OHSU_HNSCC_derm002
29427,20003,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.615,0,NONE,OHSU_HNSCC_derm002
29428,20003,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.651,0,NONE,OHSU_HNSCC_derm002
29429,20003,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.659,0,NONE,OHSU_HNSCC_derm002
29430,20003,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.596,0,NONE,OHSU_HNSCC_derm002
29431,20003,Blank 490,2,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
29432,20003,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.604,0,NONE,OHSU_HNSCC_derm002
29433,20003,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.526,0,NONE,OHSU_HNSCC_derm002
29434,20003,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.63,0,NONE,OHSU_HNSCC_derm002
29435,20003,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.508,0,NONE,OHSU_HNSCC_derm002
29436,20003,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.625,0,NONE,OHSU_HNSCC_derm002
29437,20003,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.617,0,NONE,OHSU_HNSCC_derm002
29438,20003,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.606,0,NONE,OHSU_HNSCC_derm002
29439,20003,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.388,0,NONE,OHSU_HNSCC_derm002
29440,20003,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.531,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
29441,20003,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.622,10,Hesperidin,OHSU_HNSCC_derm002
29442,20003,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.695,10,Esculetin,OHSU_HNSCC_derm002
29443,20003,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.18,10,Selinexor ,OHSU_HNSCC_derm002
29444,20003,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.487,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29445,20003,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.455,10,BMX-IN-1,OHSU_HNSCC_derm002
29446,20003,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.407,1,Dasatinib (1mM),OHSU_HNSCC_derm002
29447,20003,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.571,10,Trametinib,OHSU_HNSCC_derm002
29448,20003,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.341,10,BEZ235,OHSU_HNSCC_derm002
29449,20003,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.134,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
29450,20003,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.44,10,Nilotinib,OHSU_HNSCC_derm002
29451,20003,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.478,10,Enzalutamide,OHSU_HNSCC_derm002
29452,20003,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.665,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29453,20003,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.316,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
29454,20003,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.076,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29455,20003,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.278,10,Axitinib,OHSU_HNSCC_derm002
29456,20003,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.468,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
29457,20003,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.642,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
29458,20003,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.67,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
29459,20003,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.2,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
29460,20003,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.691,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29461,20003,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.607,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
29462,20003,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.478,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
29463,20003,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.595,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
29464,20003,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.349,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
29465,20003,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.192,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
29466,20003,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.555,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
29467,20003,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.528,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
29468,20003,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.625,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29469,20003,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.425,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
29470,20003,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.082,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29471,20003,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.356,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
29472,20003,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.443,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
29473,20003,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.573,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
29474,20003,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.741,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
29475,20003,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.252,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
29476,20003,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.638,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29477,20003,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.673,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
29478,20003,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.495,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
29479,20003,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.654,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
29480,20003,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.306,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
29481,20003,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.245,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
29482,20003,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.613,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
29483,20003,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.557,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
29484,20003,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.613,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29485,20003,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.42,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
29486,20003,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.134,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29487,20003,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.456,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
29488,20003,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.458,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
29489,20003,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.588,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
29490,20003,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.653,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
29491,20003,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.455,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
29492,20003,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.638,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29493,20003,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.66,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
29494,20003,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.53,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
29495,20003,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.599,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
29496,20003,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.331,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
29497,20003,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.341,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
29498,20003,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.651,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
29499,20003,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.616,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
29500,20003,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.593,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29501,20003,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.524,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
29502,20003,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.484,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29503,20003,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.423,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
29504,20003,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.423,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
29505,20003,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.612,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
29506,20003,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.731,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
29507,20003,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.575,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
29508,20003,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.664,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29509,20003,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.659,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
29510,20003,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.64,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
29511,20003,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.665,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
29512,20003,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.39,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
29513,20003,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.555,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
29514,20003,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.588,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
29515,20003,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.558,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
29516,20003,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.565,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29517,20003,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.658,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
29518,20003,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.678,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29519,20003,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.45,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
29520,20003,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.454,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
29521,20003,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.557,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
29522,20003,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.667,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
29523,20003,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.654,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
29524,20003,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.637,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29525,20003,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.65,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
29526,20003,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.67,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
29527,20003,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.665,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
29528,20003,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.486,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
29529,20003,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.568,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
29530,20003,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.648,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
29531,20003,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.585,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
29532,20003,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.572,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29533,20003,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.705,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
29534,20003,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.727,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29535,20003,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.439,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
29536,20003,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.38,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
29537,20003,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.552,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
29538,20003,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.639,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
29539,20003,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.648,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
29540,20003,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.642,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
29541,20003,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.672,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
29542,20003,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.7,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
29543,20003,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.616,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
29544,20003,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.515,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
29545,20003,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.524,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
29546,20003,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.595,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
29547,20003,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.617,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
29548,20003,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.571,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
29549,20003,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.691,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
29550,20003,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.455,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
29551,20003,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.607,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
29552,20003,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.494,0,NONE,OHSU_HNSCC_derm002
29553,20003,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.365,0,NONE,OHSU_HNSCC_derm002
29554,20003,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
29555,20003,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.431,0,NONE,OHSU_HNSCC_derm002
29556,20003,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.387,0,NONE,OHSU_HNSCC_derm002
29557,20003,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.376,0,NONE,OHSU_HNSCC_derm002
29558,20003,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.314,0,NONE,OHSU_HNSCC_derm002
29559,20003,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
29560,20003,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.468,0,NONE,OHSU_HNSCC_derm002
29561,20003,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.402,0,NONE,OHSU_HNSCC_derm002
29562,20003,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.346,0,NONE,OHSU_HNSCC_derm002
29563,20003,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.33,0,NONE,OHSU_HNSCC_derm002
29564,20003,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.536,0,NONE,OHSU_HNSCC_derm002
29565,20003,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
29566,20003,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.424,0,NONE,OHSU_HNSCC_derm002
29567,20003,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.54,0,NONE,OHSU_HNSCC_derm002
29568,20003,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.482,10,Thalidomide ,OHSU_HNSCC_derm002
29569,20003,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.379,10,Vandetanib,OHSU_HNSCC_derm002
29570,20003,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.523,10,Oleic acid,OHSU_HNSCC_derm002
29571,20003,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.063,10,A-674563,OHSU_HNSCC_derm002
29572,20003,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.284,10,Lapatinib,OHSU_HNSCC_derm002
29573,20003,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.496,10,Apocynin (vanillin),OHSU_HNSCC_derm002
29574,20003,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.051,10,AT-7519,OHSU_HNSCC_derm002
29575,20003,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.374,10,Gefitinib,OHSU_HNSCC_derm002
29576,20003,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.145,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
29577,20003,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.293,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29578,20003,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.243,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29579,20003,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.398,10,JQ1,OHSU_HNSCC_derm002
29580,20003,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.68,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29581,20003,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.512,10,Cerdulatinib,OHSU_HNSCC_derm002
29582,20003,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.002,10,Romidepsin,OHSU_HNSCC_derm002
29583,20003,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.62,10,Gilteritinib,OHSU_HNSCC_derm002
29584,20003,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.387,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
29585,20003,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.425,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
29586,20003,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.538,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
29587,20003,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.443,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
29588,20003,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.418,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
29589,20003,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.62,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
29590,20003,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.085,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
29591,20003,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.533,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
29592,20003,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.557,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
29593,20003,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.384,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29594,20003,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.506,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29595,20003,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.497,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
29596,20003,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.731,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29597,20003,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.764,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
29598,20003,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.011,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
29599,20003,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.596,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
29600,20003,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.478,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
29601,20003,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.407,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
29602,20003,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.669,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
29603,20003,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.572,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
29604,20003,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.666,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
29605,20003,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.7,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
29606,20003,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.179,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
29607,20003,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.572,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
29608,20003,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.657,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
29609,20003,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.46,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29610,20003,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.589,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29611,20003,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.554,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
29612,20003,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.787,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29613,20003,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.713,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
29614,20003,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.046,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
29615,20003,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.548,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
29616,20003,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.479,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
29617,20003,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.474,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
29618,20003,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.563,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
29619,20003,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.637,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
29620,20003,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.535,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
29621,20003,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.701,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
29622,20003,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.482,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
29623,20003,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.573,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
29624,20003,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.555,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
29625,20003,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.498,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29626,20003,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.638,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29627,20003,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.73,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
29628,20003,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.667,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29629,20003,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.657,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
29630,20003,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.084,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
29631,20003,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.648,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
29632,20003,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.468,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
29633,20003,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.452,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
29634,20003,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.6,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
29635,20003,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.701,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
29636,20003,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.706,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
29637,20003,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.657,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
29638,20003,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.624,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
29639,20003,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.705,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
29640,20003,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.591,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
29641,20003,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.534,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29642,20003,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.76,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29643,20003,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.7,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
29644,20003,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.664,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29645,20003,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.684,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
29646,20003,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.112,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
29647,20003,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.543,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
29648,20003,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.387,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
29649,20003,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.518,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
29650,20003,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.651,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
29651,20003,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.683,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
29652,20003,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.778,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
29653,20003,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.707,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
29654,20003,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.757,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
29655,20003,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.681,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
29656,20003,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.617,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
29657,20003,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.605,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29658,20003,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.722,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29659,20003,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.731,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
29660,20003,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.695,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29661,20003,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.634,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
29662,20003,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.135,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
29663,20003,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.605,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
29664,20003,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.379,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
29665,20003,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.512,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
29666,20003,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.686,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
29667,20003,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.686,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
29668,20003,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.743,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
29669,20003,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.651,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
29670,20003,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.781,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
29671,20003,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.682,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
29672,20003,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.653,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
29673,20003,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.589,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
29674,20003,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.718,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
29675,20003,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.765,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
29676,20003,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.717,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
29677,20003,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.736,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
29678,20003,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.139,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
29679,20003,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.648,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
29680,20003,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.359,0,NONE,OHSU_HNSCC_derm002
29681,20003,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.504,0,NONE,OHSU_HNSCC_derm002
29682,20003,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.728,0,NONE,OHSU_HNSCC_derm002
29683,20003,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.694,0,NONE,OHSU_HNSCC_derm002
29684,20003,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.703,0,NONE,OHSU_HNSCC_derm002
29685,20003,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.637,0,NONE,OHSU_HNSCC_derm002
29686,20003,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.753,0,NONE,OHSU_HNSCC_derm002
29687,20003,Blank 490,3,H,OHSU_HNSCC_derm002,8,0.002,10,F-S-V,OHSU_HNSCC_derm002
29688,20003,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.595,0,NONE,OHSU_HNSCC_derm002
29689,20003,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.568,0,NONE,OHSU_HNSCC_derm002
29690,20003,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.707,0,NONE,OHSU_HNSCC_derm002
29691,20003,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.646,0,NONE,OHSU_HNSCC_derm002
29692,20003,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.756,0,NONE,OHSU_HNSCC_derm002
29693,20003,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.594,0,NONE,OHSU_HNSCC_derm002
29694,20003,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.77,0,NONE,OHSU_HNSCC_derm002
29695,20003,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.594,0,NONE,OHSU_HNSCC_derm002
29696,20003,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.376,10,Anastrazole,OHSU_HNSCC_derm002
29697,20003,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.238,10,JNJ-28312141 ,OHSU_HNSCC_derm002
29698,20003,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.666,10,Genistein,OHSU_HNSCC_derm002
29699,20003,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.73,10,Abscisic acid,OHSU_HNSCC_derm002
29700,20003,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.638,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29701,20003,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.774,10,Ruxolitinib,OHSU_HNSCC_derm002
29702,20003,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.617,10,TAK-659,OHSU_HNSCC_derm002
29703,20003,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.318,10,Brigatinib,OHSU_HNSCC_derm002
29704,20003,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.559,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29705,20003,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.042,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29706,20003,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.287,10,Vorinostat,OHSU_HNSCC_derm002
29707,20003,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.686,10,Lenalidomide,OHSU_HNSCC_derm002
29708,20003,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.518,10,NVP-ADW742,OHSU_HNSCC_derm002
29709,20003,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.606,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29710,20003,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.667,10,Echinatin,OHSU_HNSCC_derm002
29711,20003,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.003,10,YM-155,OHSU_HNSCC_derm002
29712,20003,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.487,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
29713,20003,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.575,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
29714,20003,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.684,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
29715,20003,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.655,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
29716,20003,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.719,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29717,20003,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.757,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
29718,20003,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.68,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
29719,20003,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.435,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
29720,20003,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.588,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29721,20003,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.33,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29722,20003,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.391,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
29723,20003,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.693,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
29724,20003,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.619,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
29725,20003,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.579,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29726,20003,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.608,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
29727,20003,Blank 490,3,P,OHSU_HNSCC_derm002,10,0.066,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
29728,20003,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.425,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
29729,20003,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.63,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
29730,20003,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.696,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
29731,20003,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.739,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
29732,20003,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.721,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29733,20003,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.758,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
29734,20003,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.647,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
29735,20003,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.607,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
29736,20003,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.562,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29737,20003,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.557,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29738,20003,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.535,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
29739,20003,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.671,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
29740,20003,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.595,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
29741,20003,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.661,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29742,20003,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.641,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
29743,20003,Blank 490,3,P,OHSU_HNSCC_derm002,11,0.169,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
29744,20003,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.435,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
29745,20003,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.545,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
29746,20003,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.723,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
29747,20003,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.661,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
29748,20003,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.702,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29749,20003,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.636,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
29750,20003,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.671,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
29751,20003,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.68,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
29752,20003,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.544,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29753,20003,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.712,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29754,20003,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.531,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
29755,20003,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.584,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
29756,20003,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.611,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
29757,20003,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.686,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29758,20003,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.779,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
29759,20003,Blank 490,3,P,OHSU_HNSCC_derm002,12,0.186,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
29760,20003,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.417,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
29761,20003,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.6,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
29762,20003,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.755,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
29763,20003,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.659,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
29764,20003,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.691,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29765,20003,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.645,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
29766,20003,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.69,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
29767,20003,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.737,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
29768,20003,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.548,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29769,20003,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.716,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29770,20003,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.732,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
29771,20003,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.696,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
29772,20003,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.631,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
29773,20003,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.627,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29774,20003,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.75,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
29775,20003,Blank 490,3,P,OHSU_HNSCC_derm002,13,0.281,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
29776,20003,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.463,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
29777,20003,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.53,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
29778,20003,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.658,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
29779,20003,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.652,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
29780,20003,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.65,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29781,20003,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.648,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
29782,20003,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.671,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
29783,20003,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.738,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
29784,20003,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.564,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29785,20003,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.723,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29786,20003,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.652,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
29787,20003,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.706,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
29788,20003,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.648,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
29789,20003,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.632,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29790,20003,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.745,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
29791,20003,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.388,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
29792,20003,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.385,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
29793,20003,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.481,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
29794,20003,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.681,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
29795,20003,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.652,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
29796,20003,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.664,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
29797,20003,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.597,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
29798,20003,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.698,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
29799,20003,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.673,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
29800,20003,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.59,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
29801,20003,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.691,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
29802,20003,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.702,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
29803,20003,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.675,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
29804,20003,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.674,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
29805,20003,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.644,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
29806,20003,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.715,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
29807,20003,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.369,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
29808,20003,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.438,0,NONE,OHSU_HNSCC_derm002
29809,20003,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.569,0,NONE,OHSU_HNSCC_derm002
29810,20003,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.642,0,NONE,OHSU_HNSCC_derm002
29811,20003,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.636,0,NONE,OHSU_HNSCC_derm002
29812,20003,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.661,0,NONE,OHSU_HNSCC_derm002
29813,20003,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.653,0,NONE,OHSU_HNSCC_derm002
29814,20003,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.648,0,NONE,OHSU_HNSCC_derm002
29815,20003,Blank 490,3,H,OHSU_HNSCC_derm002,16,-0.002,10,F-S-V,OHSU_HNSCC_derm002
29816,20003,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.63,0,NONE,OHSU_HNSCC_derm002
29817,20003,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.603,0,NONE,OHSU_HNSCC_derm002
29818,20003,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.657,0,NONE,OHSU_HNSCC_derm002
29819,20003,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.698,0,NONE,OHSU_HNSCC_derm002
29820,20003,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.692,0,NONE,OHSU_HNSCC_derm002
29821,20003,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.626,0,NONE,OHSU_HNSCC_derm002
29822,20003,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.712,0,NONE,OHSU_HNSCC_derm002
29823,20003,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.567,0,NONE,OHSU_HNSCC_derm002
29824,20003,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.46,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29825,20003,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.5,10,Stevioside,OHSU_HNSCC_derm002
29826,20003,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.676,10,Pemetrexed,OHSU_HNSCC_derm002
29827,20003,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.304,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29828,20003,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.421,10,GSK-1838705A,OHSU_HNSCC_derm002
29829,20003,Blank 490,3,F,OHSU_HNSCC_derm002,17,0.024,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29830,20003,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.633,10,Imatinib,OHSU_HNSCC_derm002
29831,20003,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.722,10,Trametinib,OHSU_HNSCC_derm002
29832,20003,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.335,10,BEZ235,OHSU_HNSCC_derm002
29833,20003,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.385,10,Saracatinib,OHSU_HNSCC_derm002
29834,20003,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.552,10,I-BET 762,OHSU_HNSCC_derm002
29835,20003,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.559,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
29836,20003,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.376,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
29837,20003,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.545,10,Crizotinib,OHSU_HNSCC_derm002
29838,20003,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.436,10,MGCD-265,OHSU_HNSCC_derm002
29839,20003,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.545,10,Erlotinib,OHSU_HNSCC_derm002
29840,20003,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.454,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29841,20003,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.502,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
29842,20003,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.621,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
29843,20003,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.328,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29844,20003,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.52,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
29845,20003,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.337,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29846,20003,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.691,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
29847,20003,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.727,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
29848,20003,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.349,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
29849,20003,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.507,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
29850,20003,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.717,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
29851,20003,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.55,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
29852,20003,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.747,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
29853,20003,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.6,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
29854,20003,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.433,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
29855,20003,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.472,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
29856,20003,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29857,20003,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.508,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
29858,20003,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.648,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
29859,20003,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.346,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29860,20003,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.535,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
29861,20003,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.408,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29862,20003,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.64,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
29863,20003,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.659,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
29864,20003,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.369,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
29865,20003,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.513,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
29866,20003,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.68,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
29867,20003,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.513,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
29868,20003,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.658,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
29869,20003,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.696,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
29870,20003,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.785,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
29871,20003,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.571,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
29872,20003,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.409,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29873,20003,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.546,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
29874,20003,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.627,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
29875,20003,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.406,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29876,20003,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.57,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
29877,20003,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.54,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29878,20003,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.696,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
29879,20003,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.663,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
29880,20003,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.393,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
29881,20003,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.572,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
29882,20003,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.7,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
29883,20003,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.543,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
29884,20003,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.644,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
29885,20003,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.653,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
29886,20003,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.542,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
29887,20003,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.508,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
29888,20003,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.443,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29889,20003,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.534,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
29890,20003,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.624,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
29891,20003,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.475,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29892,20003,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.646,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
29893,20003,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.602,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29894,20003,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.65,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
29895,20003,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.711,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
29896,20003,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.423,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
29897,20003,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.609,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
29898,20003,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.677,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
29899,20003,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.6,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
29900,20003,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.618,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
29901,20003,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.653,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
29902,20003,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.425,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
29903,20003,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.579,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
29904,20003,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.488,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29905,20003,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.438,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
29906,20003,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.608,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
29907,20003,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.552,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29908,20003,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.667,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
29909,20003,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.631,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29910,20003,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.693,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
29911,20003,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.699,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
29912,20003,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.561,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
29913,20003,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.621,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
29914,20003,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.732,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
29915,20003,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.632,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
29916,20003,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.619,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
29917,20003,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.676,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
29918,20003,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.635,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
29919,20003,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.555,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
29920,20003,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.473,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
29921,20003,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.454,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
29922,20003,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.612,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
29923,20003,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.566,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
29924,20003,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.615,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
29925,20003,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.604,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
29926,20003,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.682,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
29927,20003,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.683,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
29928,20003,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.574,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
29929,20003,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.596,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
29930,20003,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.596,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
29931,20003,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.601,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
29932,20003,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.677,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
29933,20003,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.646,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
29934,20003,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.666,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
29935,20003,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.584,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
29936,20003,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.488,0,NONE,OHSU_HNSCC_derm002
29937,20003,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.518,0,NONE,OHSU_HNSCC_derm002
29938,20003,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.638,0,NONE,OHSU_HNSCC_derm002
29939,20003,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.537,0,NONE,OHSU_HNSCC_derm002
29940,20003,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.568,0,NONE,OHSU_HNSCC_derm002
29941,20003,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.516,0,NONE,OHSU_HNSCC_derm002
29942,20003,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.513,0,NONE,OHSU_HNSCC_derm002
29943,20003,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.507,0,NONE,OHSU_HNSCC_derm002
29944,20003,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.64,0,NONE,OHSU_HNSCC_derm002
29945,20003,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.627,0,NONE,OHSU_HNSCC_derm002
29946,20003,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.57,0,NONE,OHSU_HNSCC_derm002
29947,20003,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.61,0,NONE,OHSU_HNSCC_derm002
29948,20003,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.435,0,NONE,OHSU_HNSCC_derm002
29949,20003,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.628,0,NONE,OHSU_HNSCC_derm002
29950,20003,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.584,0,NONE,OHSU_HNSCC_derm002
29951,20003,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.583,0,NONE,OHSU_HNSCC_derm002
29952,20003,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.169,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
29953,20003,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.212,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
29954,20003,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.068,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
29955,20003,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.062,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
29956,20003,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.053,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
29957,20003,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.03,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
29958,20003,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.036,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
29959,20003,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.093,10,Gefitinib,OHSU_HNSCC_derm002
29960,20003,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.049,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
29961,20003,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.075,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
29962,20003,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.08,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
29963,20003,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.068,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
29964,20003,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.068,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
29965,20003,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.059,10,VOLASERTIB x,OHSU_HNSCC_derm002
29966,20003,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.121,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
29967,20003,Blank 490,4,P,OHSU_HNSCC_derm002,1,0.139,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
29968,20003,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.247,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
29969,20003,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.431,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
29970,20003,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.429,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
29971,20003,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.545,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
29972,20003,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.147,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
29973,20003,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.04,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
29974,20003,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.067,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
29975,20003,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.122,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
29976,20003,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.618,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
29977,20003,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.246,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
29978,20003,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.353,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
29979,20003,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.248,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
29980,20003,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.434,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
29981,20003,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.365,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
29982,20003,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.559,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
29983,20003,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.209,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
29984,20003,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.366,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
29985,20003,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.355,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
29986,20003,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.736,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
29987,20003,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.521,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
29988,20003,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.322,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
29989,20003,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.299,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
29990,20003,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.167,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
29991,20003,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.563,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
29992,20003,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.63,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
29993,20003,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.324,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
29994,20003,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.488,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
29995,20003,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.376,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
29996,20003,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.542,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
29997,20003,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.556,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
29998,20003,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.672,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
29999,20003,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.219,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
30000,20003,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.332,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
30001,20003,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.614,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
30002,20003,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.623,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
30003,20003,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.572,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30004,20003,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.462,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
30005,20003,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.322,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
30006,20003,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.139,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
30007,20003,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.555,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
30008,20003,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.647,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
30009,20003,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.383,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
30010,20003,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.529,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
30011,20003,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.534,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
30012,20003,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.559,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
30013,20003,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.615,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
30014,20003,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.685,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30015,20003,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.297,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
30016,20003,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.409,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
30017,20003,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.712,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
30018,20003,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.67,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
30019,20003,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.624,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30020,20003,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.563,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
30021,20003,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.474,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
30022,20003,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.153,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
30023,20003,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.629,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
30024,20003,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.715,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
30025,20003,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.509,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
30026,20003,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.624,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
30027,20003,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.622,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
30028,20003,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.643,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
30029,20003,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.609,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
30030,20003,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.666,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30031,20003,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.4,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
30032,20003,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.488,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
30033,20003,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.718,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
30034,20003,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.67,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
30035,20003,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.672,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30036,20003,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.694,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
30037,20003,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.545,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
30038,20003,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.177,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
30039,20003,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.635,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
30040,20003,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.621,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
30041,20003,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.546,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
30042,20003,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.676,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
30043,20003,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.708,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
30044,20003,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.663,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
30045,20003,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.576,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
30046,20003,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.593,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30047,20003,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.544,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
30048,20003,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.611,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
30049,20003,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.722,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
30050,20003,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.661,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
30051,20003,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.713,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30052,20003,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.693,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
30053,20003,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.639,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
30054,20003,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.184,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
30055,20003,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.666,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
30056,20003,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.684,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
30057,20003,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.624,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
30058,20003,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.768,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
30059,20003,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.668,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
30060,20003,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.732,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
30061,20003,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.615,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
30062,20003,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.744,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30063,20003,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.527,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
30064,20003,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.424,0,NONE,OHSU_HNSCC_derm002
30065,20003,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.723,0,NONE,OHSU_HNSCC_derm002
30066,20003,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.613,0,NONE,OHSU_HNSCC_derm002
30067,20003,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.709,0,NONE,OHSU_HNSCC_derm002
30068,20003,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.738,0,NONE,OHSU_HNSCC_derm002
30069,20003,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.708,0,NONE,OHSU_HNSCC_derm002
30070,20003,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.682,0,NONE,OHSU_HNSCC_derm002
30071,20003,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
30072,20003,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.676,0,NONE,OHSU_HNSCC_derm002
30073,20003,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.645,0,NONE,OHSU_HNSCC_derm002
30074,20003,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.724,0,NONE,OHSU_HNSCC_derm002
30075,20003,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.667,0,NONE,OHSU_HNSCC_derm002
30076,20003,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.693,0,NONE,OHSU_HNSCC_derm002
30077,20003,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.698,0,NONE,OHSU_HNSCC_derm002
30078,20003,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.71,0,NONE,OHSU_HNSCC_derm002
30079,20003,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.622,0,NONE,OHSU_HNSCC_derm002
30080,20003,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.127,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30081,20003,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.582,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30082,20003,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.198,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
30083,20003,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.488,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30084,20003,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.534,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30085,20003,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.202,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
30086,20003,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.401,10,AZD2014 x ,OHSU_HNSCC_derm002
30087,20003,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.359,10,Brigatinib,OHSU_HNSCC_derm002
30088,20003,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.592,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30089,20003,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.137,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30090,20003,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.575,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30091,20003,Blank 490,4,L,OHSU_HNSCC_derm002,9,0.012,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
30092,20003,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.449,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30093,20003,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.55,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30094,20003,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.372,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30095,20003,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.226,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30096,20003,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.243,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30097,20003,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.629,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30098,20003,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.228,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
30099,20003,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.559,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30100,20003,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.576,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30101,20003,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.242,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
30102,20003,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.417,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
30103,20003,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.466,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
30104,20003,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.593,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30105,20003,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.244,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30106,20003,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.672,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30107,20003,Blank 490,4,L,OHSU_HNSCC_derm002,10,-0.004,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
30108,20003,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.568,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30109,20003,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.632,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30110,20003,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.523,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30111,20003,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.371,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30112,20003,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.343,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30113,20003,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.587,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30114,20003,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.308,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
30115,20003,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.661,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30116,20003,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.603,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30117,20003,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.284,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
30118,20003,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.4,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
30119,20003,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.599,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
30120,20003,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.555,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30121,20003,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.344,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30122,20003,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.703,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30123,20003,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.034,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
30124,20003,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.571,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30125,20003,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.59,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30126,20003,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.566,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30127,20003,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.419,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30128,20003,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.382,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30129,20003,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.68,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30130,20003,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.413,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
30131,20003,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.655,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30132,20003,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.62,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30133,20003,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.398,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
30134,20003,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.463,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
30135,20003,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.622,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
30136,20003,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.612,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30137,20003,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.482,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30138,20003,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.669,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30139,20003,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.126,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
30140,20003,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.556,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30141,20003,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.574,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30142,20003,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.631,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30143,20003,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.509,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30144,20003,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.526,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30145,20003,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.691,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30146,20003,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.506,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
30147,20003,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.682,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30148,20003,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.655,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30149,20003,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.523,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
30150,20003,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.503,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
30151,20003,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.636,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
30152,20003,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.607,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30153,20003,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.576,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30154,20003,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.68,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30155,20003,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.345,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
30156,20003,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.553,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30157,20003,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.664,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30158,20003,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.559,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30159,20003,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.544,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30160,20003,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.432,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30161,20003,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.685,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30162,20003,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.555,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
30163,20003,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.671,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30164,20003,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.708,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30165,20003,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.636,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
30166,20003,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.618,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
30167,20003,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.696,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
30168,20003,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.587,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30169,20003,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.722,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30170,20003,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.7,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30171,20003,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.502,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
30172,20003,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.51,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30173,20003,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.648,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30174,20003,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.773,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30175,20003,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.558,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30176,20003,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.512,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
30177,20003,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.819,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
30178,20003,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.65,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
30179,20003,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.643,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30180,20003,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.758,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
30181,20003,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.731,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
30182,20003,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.701,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
30183,20003,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.654,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
30184,20003,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.64,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30185,20003,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.672,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
30186,20003,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.757,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
30187,20003,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.736,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
30188,20003,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.616,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30189,20003,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.681,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
30190,20003,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.691,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
30191,20003,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.566,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
30192,20003,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.6,0,NONE,OHSU_HNSCC_derm002
30193,20003,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.755,0,NONE,OHSU_HNSCC_derm002
30194,20003,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.638,0,NONE,OHSU_HNSCC_derm002
30195,20003,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
30196,20003,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.758,0,NONE,OHSU_HNSCC_derm002
30197,20003,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.614,0,NONE,OHSU_HNSCC_derm002
30198,20003,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.726,0,NONE,OHSU_HNSCC_derm002
30199,20003,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
30200,20003,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.701,0,NONE,OHSU_HNSCC_derm002
30201,20003,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.731,0,NONE,OHSU_HNSCC_derm002
30202,20003,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.763,0,NONE,OHSU_HNSCC_derm002
30203,20003,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.74,0,NONE,OHSU_HNSCC_derm002
30204,20003,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.672,0,NONE,OHSU_HNSCC_derm002
30205,20003,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.656,0,NONE,OHSU_HNSCC_derm002
30206,20003,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
30207,20003,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.575,0,NONE,OHSU_HNSCC_derm002
30208,20003,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.356,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30209,20003,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.196,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30210,20003,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.635,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30211,20003,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.001,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30212,20003,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.099,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30213,20003,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.327,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30214,20003,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.379,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30215,20003,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.686,10,Trametinib,OHSU_HNSCC_derm002
30216,20003,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.339,10,BEZ235,OHSU_HNSCC_derm002
30217,20003,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.113,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30218,20003,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.576,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30219,20003,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.288,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30220,20003,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.49,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30221,20003,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.611,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30222,20003,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.468,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30223,20003,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.23,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30224,20003,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.537,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30225,20003,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.479,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30226,20003,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.58,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30227,20003,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.04,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30228,20003,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.487,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30229,20003,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.524,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30230,20003,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.632,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30231,20003,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.713,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
30232,20003,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.372,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
30233,20003,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.208,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30234,20003,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.7,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30235,20003,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.464,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30236,20003,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.589,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30237,20003,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.734,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30238,20003,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.579,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30239,20003,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.384,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30240,20003,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.57,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30241,20003,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.493,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30242,20003,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.118,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30243,20003,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.087,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30244,20003,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.152,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30245,20003,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.577,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30246,20003,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.648,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30247,20003,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.677,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
30248,20003,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.378,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
30249,20003,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.33,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30250,20003,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.697,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30251,20003,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.488,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30252,20003,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.617,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30253,20003,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.768,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30254,20003,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.521,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30255,20003,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.455,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30256,20003,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.609,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30257,20003,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.492,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30258,20003,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.141,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30259,20003,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.109,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30260,20003,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.727,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30261,20003,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.557,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30262,20003,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.728,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30263,20003,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.71,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
30264,20003,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.432,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
30265,20003,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.425,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30266,20003,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.727,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30267,20003,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.516,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30268,20003,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.613,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30269,20003,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.676,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30270,20003,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.556,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30271,20003,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.525,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30272,20003,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.476,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30273,20003,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.29,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30274,20003,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.171,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30275,20003,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.123,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30276,20003,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.678,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30277,20003,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.647,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30278,20003,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.739,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30279,20003,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.678,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
30280,20003,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.458,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
30281,20003,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.552,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30282,20003,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.749,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30283,20003,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.644,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30284,20003,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.642,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30285,20003,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.691,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30286,20003,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.73,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30287,20003,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.603,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30288,20003,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.487,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30289,20003,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.102,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30290,20003,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.478,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30291,20003,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.093,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30292,20003,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.619,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30293,20003,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.665,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30294,20003,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.757,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30295,20003,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.709,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
30296,20003,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.531,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
30297,20003,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.626,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30298,20003,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.689,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30299,20003,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.506,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30300,20003,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.661,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30301,20003,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.729,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30302,20003,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.768,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30303,20003,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.59,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30304,20003,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.508,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
30305,20003,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.136,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
30306,20003,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.519,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30307,20003,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.136,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
30308,20003,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.625,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30309,20003,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.688,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
30310,20003,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.634,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
30311,20003,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.643,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
30312,20003,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.618,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
30313,20003,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.705,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
30314,20003,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.705,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30315,20003,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.74,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30316,20003,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.731,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
30317,20003,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.697,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30318,20003,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.607,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
30319,20003,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.666,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30320,20003,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.58,0,NONE,OHSU_HNSCC_derm002
30321,20003,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.606,0,NONE,OHSU_HNSCC_derm002
30322,20003,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.526,0,NONE,OHSU_HNSCC_derm002
30323,20003,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.605,0,NONE,OHSU_HNSCC_derm002
30324,20003,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.554,0,NONE,OHSU_HNSCC_derm002
30325,20003,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.589,0,NONE,OHSU_HNSCC_derm002
30326,20003,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.645,0,NONE,OHSU_HNSCC_derm002
30327,20003,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.571,0,NONE,OHSU_HNSCC_derm002
30328,20003,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.647,0,NONE,OHSU_HNSCC_derm002
30329,20003,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.534,0,NONE,OHSU_HNSCC_derm002
30330,20003,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.591,0,NONE,OHSU_HNSCC_derm002
30331,20003,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.573,0,NONE,OHSU_HNSCC_derm002
30332,20003,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.69,0,NONE,OHSU_HNSCC_derm002
30333,20003,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.726,0,NONE,OHSU_HNSCC_derm002
30334,20003,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.302,0,NONE,OHSU_HNSCC_derm002
30335,20003,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.113,0,NONE,OHSU_HNSCC_derm002
30336,20003,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.543,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30337,20003,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.425,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30338,20003,Blank 490,5,C,OHSU_HNSCC_derm002,1,0.021,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30339,20003,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.278,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30340,20003,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.159,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30341,20003,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.408,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30342,20003,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.326,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30343,20003,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.242,10,Gefitinib,OHSU_HNSCC_derm002
30344,20003,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.142,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
30345,20003,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.169,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30346,20003,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.528,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30347,20003,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.288,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30348,20003,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.236,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30349,20003,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.468,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30350,20003,Blank 490,5,O,OHSU_HNSCC_derm002,1,0.242,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30351,20003,Blank 490,5,P,OHSU_HNSCC_derm002,1,0.114,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30352,20003,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.437,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30353,20003,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.594,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30354,20003,Blank 490,5,C,OHSU_HNSCC_derm002,2,0.039,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30355,20003,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.341,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30356,20003,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.351,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30357,20003,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.56,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30358,20003,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.645,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30359,20003,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.611,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
30360,20003,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.594,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
30361,20003,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.262,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30362,20003,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.691,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30363,20003,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.542,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30364,20003,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.355,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30365,20003,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.55,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30366,20003,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.329,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30367,20003,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.205,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30368,20003,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.375,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30369,20003,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.53,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30370,20003,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.119,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30371,20003,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.646,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30372,20003,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.503,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30373,20003,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.55,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30374,20003,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.704,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30375,20003,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.529,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
30376,20003,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.646,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
30377,20003,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.301,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30378,20003,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.656,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30379,20003,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.577,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30380,20003,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.343,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30381,20003,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.509,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30382,20003,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.42,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30383,20003,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.308,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30384,20003,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.393,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30385,20003,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.593,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30386,20003,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.161,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30387,20003,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.76,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30388,20003,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.518,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30389,20003,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.552,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30390,20003,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.706,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30391,20003,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.626,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
30392,20003,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.675,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
30393,20003,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.379,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30394,20003,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.693,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30395,20003,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.586,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30396,20003,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.392,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30397,20003,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.539,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30398,20003,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.439,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30399,20003,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.395,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30400,20003,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.471,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30401,20003,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.691,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30402,20003,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.165,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30403,20003,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.618,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30404,20003,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.634,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30405,20003,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.733,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30406,20003,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.714,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30407,20003,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.639,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
30408,20003,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.71,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
30409,20003,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.538,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30410,20003,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.706,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30411,20003,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.624,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30412,20003,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.452,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30413,20003,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.677,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30414,20003,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.416,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30415,20003,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.48,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30416,20003,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.47,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30417,20003,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.684,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30418,20003,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.179,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30419,20003,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.737,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30420,20003,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.747,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30421,20003,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.751,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30422,20003,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.769,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30423,20003,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.639,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
30424,20003,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.727,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
30425,20003,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.639,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30426,20003,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.793,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30427,20003,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.713,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30428,20003,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.546,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30429,20003,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.63,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30430,20003,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.565,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30431,20003,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.563,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30432,20003,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.459,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30433,20003,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.666,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
30434,20003,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.221,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
30435,20003,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.722,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
30436,20003,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.778,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
30437,20003,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.79,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
30438,20003,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.75,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
30439,20003,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.767,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
30440,20003,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.684,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
30441,20003,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.676,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
30442,20003,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.665,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
30443,20003,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.671,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30444,20003,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.603,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30445,20003,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.602,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
30446,20003,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.675,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
30447,20003,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.53,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
30448,20003,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.55,0,NONE,OHSU_HNSCC_derm002
30449,20003,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.705,0,NONE,OHSU_HNSCC_derm002
30450,20003,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.871,0,NONE,OHSU_HNSCC_derm002
30451,20003,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.706,0,NONE,OHSU_HNSCC_derm002
30452,20003,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.756,0,NONE,OHSU_HNSCC_derm002
30453,20003,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.737,0,NONE,OHSU_HNSCC_derm002
30454,20003,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.739,0,NONE,OHSU_HNSCC_derm002
30455,20003,Blank 490,5,H,OHSU_HNSCC_derm002,8,0.006,10,F-S-V,OHSU_HNSCC_derm002
30456,20003,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.733,0,NONE,OHSU_HNSCC_derm002
30457,20003,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.589,0,NONE,OHSU_HNSCC_derm002
30458,20003,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.73,0,NONE,OHSU_HNSCC_derm002
30459,20003,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.697,0,NONE,OHSU_HNSCC_derm002
30460,20003,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.693,0,NONE,OHSU_HNSCC_derm002
30461,20003,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.597,0,NONE,OHSU_HNSCC_derm002
30462,20003,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.61,0,NONE,OHSU_HNSCC_derm002
30463,20003,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.558,0,NONE,OHSU_HNSCC_derm002
30464,20003,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.01,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30465,20003,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.58,10,APTO-253 x,OHSU_HNSCC_derm002
30466,20003,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.091,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30467,20003,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.875,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30468,20003,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.499,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30469,20003,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.296,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30470,20003,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.123,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30471,20003,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.327,10,Brigatinib,OHSU_HNSCC_derm002
30472,20003,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.648,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30473,20003,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.125,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30474,20003,Blank 490,5,K,OHSU_HNSCC_derm002,9,0.048,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30475,20003,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.082,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30476,20003,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.527,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30477,20003,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.409,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30478,20003,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.061,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30479,20003,Blank 490,5,P,OHSU_HNSCC_derm002,9,0.09,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30480,20003,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.037,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30481,20003,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.451,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
30482,20003,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.165,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30483,20003,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.7,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30484,20003,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.613,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30485,20003,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.339,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30486,20003,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.535,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30487,20003,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.492,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
30488,20003,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.599,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30489,20003,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.292,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30490,20003,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.332,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30491,20003,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.104,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30492,20003,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.581,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30493,20003,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.542,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30494,20003,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.287,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30495,20003,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.105,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30496,20003,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.078,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30497,20003,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.638,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
30498,20003,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.159,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30499,20003,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.652,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30500,20003,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.68,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30501,20003,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.317,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30502,20003,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.602,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30503,20003,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.634,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
30504,20003,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.552,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30505,20003,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.333,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30506,20003,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.454,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30507,20003,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.128,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30508,20003,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.647,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30509,20003,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.634,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30510,20003,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.446,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30511,20003,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.368,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30512,20003,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.087,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30513,20003,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.729,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
30514,20003,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.262,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30515,20003,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.711,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30516,20003,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.688,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30517,20003,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.398,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30518,20003,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.587,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30519,20003,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.66,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
30520,20003,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.604,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30521,20003,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.391,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30522,20003,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.566,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30523,20003,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.227,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30524,20003,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.593,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30525,20003,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.617,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30526,20003,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.568,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30527,20003,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.546,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30528,20003,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.09,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30529,20003,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.725,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
30530,20003,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.628,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30531,20003,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.731,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30532,20003,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.729,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30533,20003,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.491,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30534,20003,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.632,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30535,20003,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.732,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
30536,20003,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.604,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30537,20003,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.432,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30538,20003,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.786,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30539,20003,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.449,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30540,20003,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.638,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30541,20003,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.605,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30542,20003,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.567,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30543,20003,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.628,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30544,20003,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.116,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30545,20003,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.742,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
30546,20003,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.698,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30547,20003,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.81,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30548,20003,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.698,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30549,20003,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.631,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30550,20003,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.575,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30551,20003,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.752,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
30552,20003,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.594,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30553,20003,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.585,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30554,20003,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.805,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30555,20003,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.584,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30556,20003,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.643,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30557,20003,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.554,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30558,20003,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.663,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30559,20003,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.615,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30560,20003,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.119,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
30561,20003,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.68,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
30562,20003,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.746,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
30563,20003,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.584,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
30564,20003,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.627,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
30565,20003,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.663,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30566,20003,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.651,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30567,20003,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.71,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
30568,20003,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.656,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30569,20003,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.623,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
30570,20003,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.778,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30571,20003,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.548,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
30572,20003,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.668,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
30573,20003,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.611,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30574,20003,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.609,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30575,20003,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.622,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30576,20003,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.548,0,NONE,OHSU_HNSCC_derm002
30577,20003,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.789,0,NONE,OHSU_HNSCC_derm002
30578,20003,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.729,0,NONE,OHSU_HNSCC_derm002
30579,20003,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.701,0,NONE,OHSU_HNSCC_derm002
30580,20003,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.85,0,NONE,OHSU_HNSCC_derm002
30581,20003,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.762,0,NONE,OHSU_HNSCC_derm002
30582,20003,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.74,0,NONE,OHSU_HNSCC_derm002
30583,20003,Blank 490,5,H,OHSU_HNSCC_derm002,16,-0.006,10,F-S-V,OHSU_HNSCC_derm002
30584,20003,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.754,0,NONE,OHSU_HNSCC_derm002
30585,20003,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.676,0,NONE,OHSU_HNSCC_derm002
30586,20003,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.766,0,NONE,OHSU_HNSCC_derm002
30587,20003,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.717,0,NONE,OHSU_HNSCC_derm002
30588,20003,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.637,0,NONE,OHSU_HNSCC_derm002
30589,20003,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.56,0,NONE,OHSU_HNSCC_derm002
30590,20003,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.67,0,NONE,OHSU_HNSCC_derm002
30591,20003,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.552,0,NONE,OHSU_HNSCC_derm002
30592,20003,Blank 490,5,A,OHSU_HNSCC_derm002,17,0.013,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30593,20003,Blank 490,5,B,OHSU_HNSCC_derm002,17,0.035,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30594,20003,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.317,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30595,20003,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.388,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30596,20003,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.71,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30597,20003,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.594,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30598,20003,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.582,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30599,20003,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.626,10,Trametinib,OHSU_HNSCC_derm002
30600,20003,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.37,10,BEZ235,OHSU_HNSCC_derm002
30601,20003,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.24,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30602,20003,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.672,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30603,20003,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.132,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30604,20003,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.345,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30605,20003,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.522,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30606,20003,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.664,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30607,20003,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.363,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30608,20003,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.237,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30609,20003,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.391,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30610,20003,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.387,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30611,20003,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.503,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30612,20003,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.717,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30613,20003,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.615,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30614,20003,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.647,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30615,20003,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.69,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
30616,20003,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.381,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
30617,20003,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.356,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30618,20003,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.596,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30619,20003,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.255,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30620,20003,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.481,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30621,20003,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.549,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30622,20003,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.667,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30623,20003,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.511,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30624,20003,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.372,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30625,20003,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.733,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30626,20003,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.366,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30627,20003,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.607,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30628,20003,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.704,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30629,20003,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.703,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30630,20003,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.682,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30631,20003,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.759,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
30632,20003,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.429,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
30633,20003,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.497,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30634,20003,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.589,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30635,20003,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.333,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30636,20003,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.574,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30637,20003,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.527,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30638,20003,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.683,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30639,20003,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.485,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30640,20003,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.536,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30641,20003,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.67,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30642,20003,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.406,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30643,20003,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.672,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30644,20003,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.796,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30645,20003,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.673,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30646,20003,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.677,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30647,20003,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.683,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
30648,20003,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.448,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
30649,20003,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.577,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30650,20003,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.704,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30651,20003,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.366,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30652,20003,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.666,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30653,20003,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.578,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30654,20003,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.627,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30655,20003,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.499,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30656,20003,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.565,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30657,20003,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.741,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30658,20003,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.51,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30659,20003,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.775,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30660,20003,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.702,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30661,20003,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.712,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30662,20003,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.754,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30663,20003,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.71,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
30664,20003,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.485,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
30665,20003,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.616,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30666,20003,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.717,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30667,20003,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.514,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30668,20003,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.666,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30669,20003,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.65,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30670,20003,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.619,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30671,20003,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.498,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30672,20003,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.531,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30673,20003,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.593,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30674,20003,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.573,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30675,20003,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.781,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30676,20003,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.751,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30677,20003,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.831,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30678,20003,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.748,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30679,20003,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.754,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
30680,20003,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.612,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
30681,20003,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.625,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30682,20003,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.757,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30683,20003,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.629,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30684,20003,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.658,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30685,20003,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.683,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30686,20003,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.643,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30687,20003,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.555,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30688,20003,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.534,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30689,20003,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.733,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
30690,20003,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.52,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30691,20003,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.754,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
30692,20003,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.797,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
30693,20003,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.767,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30694,20003,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.765,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
30695,20003,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.826,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
30696,20003,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.764,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
30697,20003,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.72,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
30698,20003,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.714,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
30699,20003,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.667,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
30700,20003,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.631,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
30701,20003,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.681,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30702,20003,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.589,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
30703,20003,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.544,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
30704,20003,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.483,0,NONE,OHSU_HNSCC_derm002
30705,20003,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.535,0,NONE,OHSU_HNSCC_derm002
30706,20003,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.567,0,NONE,OHSU_HNSCC_derm002
30707,20003,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.51,0,NONE,OHSU_HNSCC_derm002
30708,20003,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.53,0,NONE,OHSU_HNSCC_derm002
30709,20003,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.588,0,NONE,OHSU_HNSCC_derm002
30710,20003,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.529,0,NONE,OHSU_HNSCC_derm002
30711,20003,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.54,0,NONE,OHSU_HNSCC_derm002
30712,20003,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.606,0,NONE,OHSU_HNSCC_derm002
30713,20003,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.795,0,NONE,OHSU_HNSCC_derm002
30714,20003,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.597,0,NONE,OHSU_HNSCC_derm002
30715,20003,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.649,0,NONE,OHSU_HNSCC_derm002
30716,20003,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.711,0,NONE,OHSU_HNSCC_derm002
30717,20003,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.708,0,NONE,OHSU_HNSCC_derm002
30718,20003,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.663,0,NONE,OHSU_HNSCC_derm002
30719,20003,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.544,0,NONE,OHSU_HNSCC_derm002
30720,20003,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.302,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30721,20003,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.425,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30722,20003,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.199,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30723,20003,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.346,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30724,20003,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.145,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30725,20003,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.433,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30726,20003,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.636,10,IMR 1,OHSU_HNSCC_derm002
30727,20003,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.452,10,Gefitinib,OHSU_HNSCC_derm002
30728,20003,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.298,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
30729,20003,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.698,0,DMSO,OHSU_HNSCC_derm002
30730,20003,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.645,0,DMSO ,OHSU_HNSCC_derm002
30731,20003,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.646,0,DMSO,OHSU_HNSCC_derm002
30732,20003,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.722,0,DMSO ,OHSU_HNSCC_derm002
30733,20003,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.637,0,DMSO,OHSU_HNSCC_derm002
30734,20003,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.78,0,DMSO ,OHSU_HNSCC_derm002
30735,20003,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.659,0,DMSO,OHSU_HNSCC_derm002
30736,20003,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.36,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30737,20003,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.408,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30738,20003,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.218,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30739,20003,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.57,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30740,20003,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.4,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30741,20003,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.442,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30742,20003,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.673,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
30743,20003,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.563,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
30744,20003,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.623,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
30745,20003,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.717,0,DMSO,OHSU_HNSCC_derm002
30746,20003,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.619,0,DMSO ,OHSU_HNSCC_derm002
30747,20003,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.73,0,DMSO,OHSU_HNSCC_derm002
30748,20003,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.646,0,DMSO ,OHSU_HNSCC_derm002
30749,20003,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.635,0,DMSO,OHSU_HNSCC_derm002
30750,20003,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.598,0,DMSO ,OHSU_HNSCC_derm002
30751,20003,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.646,0,DMSO,OHSU_HNSCC_derm002
30752,20003,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.462,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30753,20003,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.4,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30754,20003,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.321,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30755,20003,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.629,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30756,20003,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.71,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30757,20003,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.482,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30758,20003,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.74,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
30759,20003,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.541,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
30760,20003,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.698,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
30761,20003,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.634,0,DMSO,OHSU_HNSCC_derm002
30762,20003,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.749,0,DMSO ,OHSU_HNSCC_derm002
30763,20003,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.691,0,DMSO,OHSU_HNSCC_derm002
30764,20003,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.748,0,DMSO ,OHSU_HNSCC_derm002
30765,20003,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.661,0,DMSO,OHSU_HNSCC_derm002
30766,20003,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.736,0,DMSO ,OHSU_HNSCC_derm002
30767,20003,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.68,0,DMSO,OHSU_HNSCC_derm002
30768,20003,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.497,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30769,20003,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.532,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30770,20003,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.403,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30771,20003,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.635,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30772,20003,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.699,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30773,20003,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.439,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30774,20003,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.688,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
30775,20003,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.545,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
30776,20003,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.621,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
30777,20003,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.693,0,DMSO,OHSU_HNSCC_derm002
30778,20003,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.64,0,DMSO ,OHSU_HNSCC_derm002
30779,20003,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.69,0,DMSO,OHSU_HNSCC_derm002
30780,20003,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.653,0,DMSO ,OHSU_HNSCC_derm002
30781,20003,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.643,0,DMSO,OHSU_HNSCC_derm002
30782,20003,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.712,0,DMSO ,OHSU_HNSCC_derm002
30783,20003,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.652,0,DMSO,OHSU_HNSCC_derm002
30784,20003,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.546,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30785,20003,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.658,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30786,20003,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.586,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30787,20003,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.603,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30788,20003,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.715,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30789,20003,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.577,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30790,20003,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.736,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
30791,20003,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.58,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
30792,20003,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.668,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
30793,20003,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.627,0,DMSO,OHSU_HNSCC_derm002
30794,20003,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.689,0,DMSO ,OHSU_HNSCC_derm002
30795,20003,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.666,0,DMSO,OHSU_HNSCC_derm002
30796,20003,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.681,0,DMSO ,OHSU_HNSCC_derm002
30797,20003,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.596,0,DMSO,OHSU_HNSCC_derm002
30798,20003,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.719,0,DMSO ,OHSU_HNSCC_derm002
30799,20003,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.648,0,DMSO,OHSU_HNSCC_derm002
30800,20003,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.506,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30801,20003,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.661,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30802,20003,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.636,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30803,20003,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.675,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30804,20003,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.788,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30805,20003,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.601,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30806,20003,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.701,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
30807,20003,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.617,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
30808,20003,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.669,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
30809,20003,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.69,0,DMSO,OHSU_HNSCC_derm002
30810,20003,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.785,0,DMSO ,OHSU_HNSCC_derm002
30811,20003,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.699,0,DMSO,OHSU_HNSCC_derm002
30812,20003,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.716,0,DMSO ,OHSU_HNSCC_derm002
30813,20003,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.671,0,DMSO,OHSU_HNSCC_derm002
30814,20003,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.728,0,DMSO ,OHSU_HNSCC_derm002
30815,20003,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.697,0,DMSO,OHSU_HNSCC_derm002
30816,20003,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.568,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30817,20003,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.682,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
30818,20003,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.723,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
30819,20003,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.686,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
30820,20003,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.705,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
30821,20003,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.648,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
30822,20003,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.712,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
30823,20003,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.67,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
30824,20003,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.657,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
30825,20003,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.704,0,DMSO,OHSU_HNSCC_derm002
30826,20003,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.684,0,DMSO ,OHSU_HNSCC_derm002
30827,20003,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.685,0,DMSO,OHSU_HNSCC_derm002
30828,20003,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.656,0,DMSO ,OHSU_HNSCC_derm002
30829,20003,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.583,0,DMSO,OHSU_HNSCC_derm002
30830,20003,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.722,0,DMSO ,OHSU_HNSCC_derm002
30831,20003,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.703,0,DMSO,OHSU_HNSCC_derm002
30832,20003,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.602,0,NONE,OHSU_HNSCC_derm002
30833,20003,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.722,0,NONE,OHSU_HNSCC_derm002
30834,20003,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.79,0,NONE,OHSU_HNSCC_derm002
30835,20003,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.731,0,NONE,OHSU_HNSCC_derm002
30836,20003,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.691,0,NONE,OHSU_HNSCC_derm002
30837,20003,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.652,0,NONE,OHSU_HNSCC_derm002
30838,20003,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.739,0,NONE,OHSU_HNSCC_derm002
30839,20003,Blank 490,6,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
30840,20003,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.729,0,NONE,OHSU_HNSCC_derm002
30841,20003,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.689,0,NONE,OHSU_HNSCC_derm002
30842,20003,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.715,0,NONE,OHSU_HNSCC_derm002
30843,20003,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.744,0,NONE,OHSU_HNSCC_derm002
30844,20003,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.669,0,NONE,OHSU_HNSCC_derm002
30845,20003,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.639,0,NONE,OHSU_HNSCC_derm002
30846,20003,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.752,0,NONE,OHSU_HNSCC_derm002
30847,20003,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.72,0,NONE,OHSU_HNSCC_derm002
30848,20003,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.539,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30849,20003,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.128,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30850,20003,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.322,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30851,20003,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.469,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30852,20003,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.588,5,Vandetanib (5mM),OHSU_HNSCC_derm002
30853,20003,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.669,0,DMSO,OHSU_HNSCC_derm002
30854,20003,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.69,0,DMSO ,OHSU_HNSCC_derm002
30855,20003,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.347,10,Brigatinib,OHSU_HNSCC_derm002
30856,20003,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.596,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30857,20003,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.719,0,DMSO,OHSU_HNSCC_derm002
30858,20003,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.708,0,DMSO ,OHSU_HNSCC_derm002
30859,20003,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.676,0,DMSO,OHSU_HNSCC_derm002
30860,20003,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.663,0,DMSO ,OHSU_HNSCC_derm002
30861,20003,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.698,0,DMSO,OHSU_HNSCC_derm002
30862,20003,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.744,0,DMSO ,OHSU_HNSCC_derm002
30863,20003,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.66,0,DMSO,OHSU_HNSCC_derm002
30864,20003,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.471,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30865,20003,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.169,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30866,20003,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.46,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30867,20003,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.56,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30868,20003,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.659,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
30869,20003,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.624,0,DMSO,OHSU_HNSCC_derm002
30870,20003,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.629,0,DMSO ,OHSU_HNSCC_derm002
30871,20003,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.486,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
30872,20003,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.611,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30873,20003,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.683,0,DMSO,OHSU_HNSCC_derm002
30874,20003,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.759,0,DMSO ,OHSU_HNSCC_derm002
30875,20003,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.704,0,DMSO,OHSU_HNSCC_derm002
30876,20003,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.692,0,DMSO ,OHSU_HNSCC_derm002
30877,20003,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.679,0,DMSO,OHSU_HNSCC_derm002
30878,20003,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.687,0,DMSO ,OHSU_HNSCC_derm002
30879,20003,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.7,0,DMSO,OHSU_HNSCC_derm002
30880,20003,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.594,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30881,20003,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.226,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30882,20003,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.527,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30883,20003,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.568,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30884,20003,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.694,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
30885,20003,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.622,0,DMSO,OHSU_HNSCC_derm002
30886,20003,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.67,0,DMSO ,OHSU_HNSCC_derm002
30887,20003,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.67,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
30888,20003,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.623,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30889,20003,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.697,0,DMSO,OHSU_HNSCC_derm002
30890,20003,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.709,0,DMSO ,OHSU_HNSCC_derm002
30891,20003,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.725,0,DMSO,OHSU_HNSCC_derm002
30892,20003,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.623,0,DMSO ,OHSU_HNSCC_derm002
30893,20003,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.71,0,DMSO,OHSU_HNSCC_derm002
30894,20003,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.739,0,DMSO ,OHSU_HNSCC_derm002
30895,20003,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.629,0,DMSO,OHSU_HNSCC_derm002
30896,20003,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.633,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30897,20003,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.358,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30898,20003,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.608,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30899,20003,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.627,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30900,20003,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.752,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
30901,20003,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.592,0,DMSO,OHSU_HNSCC_derm002
30902,20003,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.684,0,DMSO ,OHSU_HNSCC_derm002
30903,20003,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.667,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
30904,20003,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.576,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30905,20003,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.721,0,DMSO,OHSU_HNSCC_derm002
30906,20003,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.752,0,DMSO ,OHSU_HNSCC_derm002
30907,20003,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.753,0,DMSO,OHSU_HNSCC_derm002
30908,20003,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.691,0,DMSO ,OHSU_HNSCC_derm002
30909,20003,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.64,0,DMSO,OHSU_HNSCC_derm002
30910,20003,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.728,0,DMSO ,OHSU_HNSCC_derm002
30911,20003,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.72,0,DMSO,OHSU_HNSCC_derm002
30912,20003,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.64,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30913,20003,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.41,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30914,20003,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.713,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30915,20003,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.73,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30916,20003,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.741,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
30917,20003,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.617,0,DMSO,OHSU_HNSCC_derm002
30918,20003,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.693,0,DMSO ,OHSU_HNSCC_derm002
30919,20003,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.691,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
30920,20003,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.565,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30921,20003,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.658,0,DMSO,OHSU_HNSCC_derm002
30922,20003,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.743,0,DMSO ,OHSU_HNSCC_derm002
30923,20003,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.783,0,DMSO,OHSU_HNSCC_derm002
30924,20003,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.708,0,DMSO ,OHSU_HNSCC_derm002
30925,20003,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.698,0,DMSO,OHSU_HNSCC_derm002
30926,20003,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.702,0,DMSO ,OHSU_HNSCC_derm002
30927,20003,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.671,0,DMSO,OHSU_HNSCC_derm002
30928,20003,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.548,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30929,20003,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.516,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30930,20003,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.772,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30931,20003,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.686,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30932,20003,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.727,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
30933,20003,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.66,0,DMSO,OHSU_HNSCC_derm002
30934,20003,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.643,0,DMSO ,OHSU_HNSCC_derm002
30935,20003,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.659,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
30936,20003,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.591,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30937,20003,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.695,0,DMSO,OHSU_HNSCC_derm002
30938,20003,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.753,0,DMSO ,OHSU_HNSCC_derm002
30939,20003,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.718,0,DMSO,OHSU_HNSCC_derm002
30940,20003,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.646,0,DMSO ,OHSU_HNSCC_derm002
30941,20003,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.633,0,DMSO,OHSU_HNSCC_derm002
30942,20003,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.748,0,DMSO ,OHSU_HNSCC_derm002
30943,20003,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.666,0,DMSO,OHSU_HNSCC_derm002
30944,20003,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.616,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30945,20003,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.671,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
30946,20003,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.75,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
30947,20003,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.642,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
30948,20003,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.666,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
30949,20003,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.655,0,DMSO,OHSU_HNSCC_derm002
30950,20003,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.642,0,DMSO ,OHSU_HNSCC_derm002
30951,20003,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.644,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
30952,20003,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.66,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
30953,20003,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.67,0,DMSO,OHSU_HNSCC_derm002
30954,20003,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.738,0,DMSO ,OHSU_HNSCC_derm002
30955,20003,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.764,0,DMSO,OHSU_HNSCC_derm002
30956,20003,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.719,0,DMSO ,OHSU_HNSCC_derm002
30957,20003,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.699,0,DMSO,OHSU_HNSCC_derm002
30958,20003,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.698,0,DMSO ,OHSU_HNSCC_derm002
30959,20003,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.716,0,DMSO,OHSU_HNSCC_derm002
30960,20003,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.51,0,NONE,OHSU_HNSCC_derm002
30961,20003,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.647,0,NONE,OHSU_HNSCC_derm002
30962,20003,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.701,0,NONE,OHSU_HNSCC_derm002
30963,20003,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.735,0,NONE,OHSU_HNSCC_derm002
30964,20003,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.714,0,NONE,OHSU_HNSCC_derm002
30965,20003,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.691,0,NONE,OHSU_HNSCC_derm002
30966,20003,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.71,0,NONE,OHSU_HNSCC_derm002
30967,20003,Blank 490,6,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
30968,20003,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.725,0,NONE,OHSU_HNSCC_derm002
30969,20003,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.688,0,NONE,OHSU_HNSCC_derm002
30970,20003,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.752,0,NONE,OHSU_HNSCC_derm002
30971,20003,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.741,0,NONE,OHSU_HNSCC_derm002
30972,20003,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.759,0,NONE,OHSU_HNSCC_derm002
30973,20003,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.669,0,NONE,OHSU_HNSCC_derm002
30974,20003,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.758,0,NONE,OHSU_HNSCC_derm002
30975,20003,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.678,0,NONE,OHSU_HNSCC_derm002
30976,20003,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.238,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30977,20003,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.233,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30978,20003,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.765,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
30979,20003,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.247,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
30980,20003,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.648,10,LY3039478 ,OHSU_HNSCC_derm002
30981,20003,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.474,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
30982,20003,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.512,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
30983,20003,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.68,10,Trametinib,OHSU_HNSCC_derm002
30984,20003,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.348,10,BEZ235,OHSU_HNSCC_derm002
30985,20003,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.727,0,DMSO,OHSU_HNSCC_derm002
30986,20003,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.715,0,DMSO ,OHSU_HNSCC_derm002
30987,20003,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.725,0,DMSO,OHSU_HNSCC_derm002
30988,20003,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.681,0,DMSO ,OHSU_HNSCC_derm002
30989,20003,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.709,0,DMSO,OHSU_HNSCC_derm002
30990,20003,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.715,0,DMSO ,OHSU_HNSCC_derm002
30991,20003,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.685,0,DMSO,OHSU_HNSCC_derm002
30992,20003,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.374,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
30993,20003,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.37,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
30994,20003,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.681,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
30995,20003,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.267,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
30996,20003,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.671,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
30997,20003,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.556,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
30998,20003,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.558,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
30999,20003,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.664,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
31000,20003,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.336,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
31001,20003,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.681,0,DMSO,OHSU_HNSCC_derm002
31002,20003,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.694,0,DMSO ,OHSU_HNSCC_derm002
31003,20003,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.713,0,DMSO,OHSU_HNSCC_derm002
31004,20003,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.711,0,DMSO ,OHSU_HNSCC_derm002
31005,20003,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.697,0,DMSO,OHSU_HNSCC_derm002
31006,20003,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.699,0,DMSO ,OHSU_HNSCC_derm002
31007,20003,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.651,0,DMSO,OHSU_HNSCC_derm002
31008,20003,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.437,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
31009,20003,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.491,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
31010,20003,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.723,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
31011,20003,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.335,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
31012,20003,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.755,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
31013,20003,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.555,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
31014,20003,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.556,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
31015,20003,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.73,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
31016,20003,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.416,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
31017,20003,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.703,0,DMSO,OHSU_HNSCC_derm002
31018,20003,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.728,0,DMSO ,OHSU_HNSCC_derm002
31019,20003,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.712,0,DMSO,OHSU_HNSCC_derm002
31020,20003,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.607,0,DMSO ,OHSU_HNSCC_derm002
31021,20003,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.69,0,DMSO,OHSU_HNSCC_derm002
31022,20003,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.717,0,DMSO ,OHSU_HNSCC_derm002
31023,20003,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.667,0,DMSO,OHSU_HNSCC_derm002
31024,20003,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.492,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
31025,20003,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.512,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
31026,20003,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.706,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
31027,20003,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.368,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
31028,20003,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.728,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
31029,20003,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.589,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
31030,20003,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.639,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
31031,20003,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.788,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
31032,20003,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.374,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
31033,20003,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.687,0,DMSO,OHSU_HNSCC_derm002
31034,20003,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.723,0,DMSO ,OHSU_HNSCC_derm002
31035,20003,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.706,0,DMSO,OHSU_HNSCC_derm002
31036,20003,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.718,0,DMSO ,OHSU_HNSCC_derm002
31037,20003,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.688,0,DMSO,OHSU_HNSCC_derm002
31038,20003,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.729,0,DMSO ,OHSU_HNSCC_derm002
31039,20003,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.613,0,DMSO,OHSU_HNSCC_derm002
31040,20003,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.546,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
31041,20003,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.562,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
31042,20003,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.726,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
31043,20003,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.578,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
31044,20003,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.71,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
31045,20003,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.658,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
31046,20003,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.691,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
31047,20003,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.679,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
31048,20003,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.395,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
31049,20003,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.69,0,DMSO,OHSU_HNSCC_derm002
31050,20003,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.766,0,DMSO ,OHSU_HNSCC_derm002
31051,20003,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.757,0,DMSO,OHSU_HNSCC_derm002
31052,20003,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.689,0,DMSO ,OHSU_HNSCC_derm002
31053,20003,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.637,0,DMSO,OHSU_HNSCC_derm002
31054,20003,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.743,0,DMSO ,OHSU_HNSCC_derm002
31055,20003,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.686,0,DMSO,OHSU_HNSCC_derm002
31056,20003,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.648,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
31057,20003,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.579,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
31058,20003,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.733,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
31059,20003,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.675,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
31060,20003,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.738,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
31061,20003,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.674,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
31062,20003,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.689,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
31063,20003,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.718,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
31064,20003,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.503,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
31065,20003,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.663,0,DMSO,OHSU_HNSCC_derm002
31066,20003,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.683,0,DMSO ,OHSU_HNSCC_derm002
31067,20003,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.776,0,DMSO,OHSU_HNSCC_derm002
31068,20003,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.67,0,DMSO ,OHSU_HNSCC_derm002
31069,20003,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.696,0,DMSO,OHSU_HNSCC_derm002
31070,20003,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.719,0,DMSO ,OHSU_HNSCC_derm002
31071,20003,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.713,0,DMSO,OHSU_HNSCC_derm002
31072,20003,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.569,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
31073,20003,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.577,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
31074,20003,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.603,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
31075,20003,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.619,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
31076,20003,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.675,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
31077,20003,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.644,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
31078,20003,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.721,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
31079,20003,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.749,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
31080,20003,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.592,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
31081,20003,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.696,0,DMSO,OHSU_HNSCC_derm002
31082,20003,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.699,0,DMSO ,OHSU_HNSCC_derm002
31083,20003,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.711,0,DMSO,OHSU_HNSCC_derm002
31084,20003,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.64,0,DMSO ,OHSU_HNSCC_derm002
31085,20003,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.689,0,DMSO,OHSU_HNSCC_derm002
31086,20003,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.715,0,DMSO ,OHSU_HNSCC_derm002
31087,20003,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.648,0,DMSO,OHSU_HNSCC_derm002
31088,20003,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.601,0,NONE,OHSU_HNSCC_derm002
31089,20003,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.634,0,NONE,OHSU_HNSCC_derm002
31090,20003,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.671,0,NONE,OHSU_HNSCC_derm002
31091,20003,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.682,0,NONE,OHSU_HNSCC_derm002
31092,20003,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.621,0,NONE,OHSU_HNSCC_derm002
31093,20003,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.657,0,NONE,OHSU_HNSCC_derm002
31094,20003,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.656,0,NONE,OHSU_HNSCC_derm002
31095,20003,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.672,0,NONE,OHSU_HNSCC_derm002
31096,20003,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.69,0,NONE,OHSU_HNSCC_derm002
31097,20003,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.715,0,NONE,OHSU_HNSCC_derm002
31098,20003,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.683,0,NONE,OHSU_HNSCC_derm002
31099,20003,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.668,0,NONE,OHSU_HNSCC_derm002
31100,20003,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.631,0,NONE,OHSU_HNSCC_derm002
31101,20003,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.612,0,NONE,OHSU_HNSCC_derm002
31102,20003,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.666,0,NONE,OHSU_HNSCC_derm002
31103,20003,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.682,0,NONE,OHSU_HNSCC_derm002
31104,20004,Blank 490,1,A,OHSU_HNSCC_derm002,1,0.038,10;10, JQ1;BEZ235,OHSU_HNSCC_derm002
31105,20004,Blank 490,1,B,OHSU_HNSCC_derm002,1,0.364,10,Lucitanib ,OHSU_HNSCC_derm002
31106,20004,Blank 490,1,C,OHSU_HNSCC_derm002,1,0.377,10,Resveratrol,OHSU_HNSCC_derm002
31107,20004,Blank 490,1,D,OHSU_HNSCC_derm002,1,0.138,10,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31108,20004,Blank 490,1,E,OHSU_HNSCC_derm002,1,0.38,10,Bicalutamide,OHSU_HNSCC_derm002
31109,20004,Blank 490,1,F,OHSU_HNSCC_derm002,1,0.413,10,Methotrexate ,OHSU_HNSCC_derm002
31110,20004,Blank 490,1,G,OHSU_HNSCC_derm002,1,0.172,10,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31111,20004,Blank 490,1,H,OHSU_HNSCC_derm002,1,0.293,10,Gefitinib,OHSU_HNSCC_derm002
31112,20004,Blank 490,1,I,OHSU_HNSCC_derm002,1,0.074,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
31113,20004,Blank 490,1,J,OHSU_HNSCC_derm002,1,0.269,10,Tamatinib/R406,OHSU_HNSCC_derm002
31114,20004,Blank 490,1,K,OHSU_HNSCC_derm002,1,0.228,10,Bosutinib,OHSU_HNSCC_derm002
31115,20004,Blank 490,1,L,OHSU_HNSCC_derm002,1,0.032,10,PI-103,OHSU_HNSCC_derm002
31116,20004,Blank 490,1,M,OHSU_HNSCC_derm002,1,0.425,10,Glycyrrhizin,OHSU_HNSCC_derm002
31117,20004,Blank 490,1,N,OHSU_HNSCC_derm002,1,0.294,10,Luteolin (direct interaction),OHSU_HNSCC_derm002
31118,20004,Blank 490,1,O,OHSU_HNSCC_derm002,1,0.31,10,GSK-690693,OHSU_HNSCC_derm002
31119,20004,Blank 490,1,P,OHSU_HNSCC_derm002,1,0.278,10,Ibrutinib,OHSU_HNSCC_derm002
31120,20004,Blank 490,1,A,OHSU_HNSCC_derm002,2,0.054,3.33333;3.33333, JQ1;BEZ235,OHSU_HNSCC_derm002
31121,20004,Blank 490,1,B,OHSU_HNSCC_derm002,2,0.384,3.3333333333333335,Lucitanib ,OHSU_HNSCC_derm002
31122,20004,Blank 490,1,C,OHSU_HNSCC_derm002,2,0.532,3.3333333333333335,Resveratrol,OHSU_HNSCC_derm002
31123,20004,Blank 490,1,D,OHSU_HNSCC_derm002,2,0.325,3.3333333333333335,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31124,20004,Blank 490,1,E,OHSU_HNSCC_derm002,2,0.453,3.3333333333333335,Bicalutamide,OHSU_HNSCC_derm002
31125,20004,Blank 490,1,F,OHSU_HNSCC_derm002,2,0.488,3.3333333333333335,Methotrexate ,OHSU_HNSCC_derm002
31126,20004,Blank 490,1,G,OHSU_HNSCC_derm002,2,0.345,3.3333333333333335,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31127,20004,Blank 490,1,H,OHSU_HNSCC_derm002,2,0.335,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
31128,20004,Blank 490,1,I,OHSU_HNSCC_derm002,2,0.288,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
31129,20004,Blank 490,1,J,OHSU_HNSCC_derm002,2,0.271,3.3333333333333335,Tamatinib/R406,OHSU_HNSCC_derm002
31130,20004,Blank 490,1,K,OHSU_HNSCC_derm002,2,0.325,3.3333333333333335,Bosutinib,OHSU_HNSCC_derm002
31131,20004,Blank 490,1,L,OHSU_HNSCC_derm002,2,0.045,3.3333333333333335,PI-103,OHSU_HNSCC_derm002
31132,20004,Blank 490,1,M,OHSU_HNSCC_derm002,2,0.457,3.3333333333333335,Glycyrrhizin,OHSU_HNSCC_derm002
31133,20004,Blank 490,1,N,OHSU_HNSCC_derm002,2,0.388,3.3333333333333335,Luteolin (direct interaction),OHSU_HNSCC_derm002
31134,20004,Blank 490,1,O,OHSU_HNSCC_derm002,2,0.216,3.3333333333333335,GSK-690693,OHSU_HNSCC_derm002
31135,20004,Blank 490,1,P,OHSU_HNSCC_derm002,2,0.286,3.3333333333333335,Ibrutinib,OHSU_HNSCC_derm002
31136,20004,Blank 490,1,A,OHSU_HNSCC_derm002,3,0.108,1.1111;1.11111, JQ1;BEZ235,OHSU_HNSCC_derm002
31137,20004,Blank 490,1,B,OHSU_HNSCC_derm002,3,0.439,1.1111111111111112,Lucitanib ,OHSU_HNSCC_derm002
31138,20004,Blank 490,1,C,OHSU_HNSCC_derm002,3,0.51,1.1111111111111112,Resveratrol,OHSU_HNSCC_derm002
31139,20004,Blank 490,1,D,OHSU_HNSCC_derm002,3,0.373,1.1111111111111112,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31140,20004,Blank 490,1,E,OHSU_HNSCC_derm002,3,0.56,1.1111111111111112,Bicalutamide,OHSU_HNSCC_derm002
31141,20004,Blank 490,1,F,OHSU_HNSCC_derm002,3,0.474,1.1111111111111112,Methotrexate ,OHSU_HNSCC_derm002
31142,20004,Blank 490,1,G,OHSU_HNSCC_derm002,3,0.514,1.1111111111111112,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31143,20004,Blank 490,1,H,OHSU_HNSCC_derm002,3,0.378,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
31144,20004,Blank 490,1,I,OHSU_HNSCC_derm002,3,0.412,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
31145,20004,Blank 490,1,J,OHSU_HNSCC_derm002,3,0.325,1.1111111111111112,Tamatinib/R406,OHSU_HNSCC_derm002
31146,20004,Blank 490,1,K,OHSU_HNSCC_derm002,3,0.515,1.1111111111111112,Bosutinib,OHSU_HNSCC_derm002
31147,20004,Blank 490,1,L,OHSU_HNSCC_derm002,3,0.076,1.1111111111111112,PI-103,OHSU_HNSCC_derm002
31148,20004,Blank 490,1,M,OHSU_HNSCC_derm002,3,0.509,1.1111111111111112,Glycyrrhizin,OHSU_HNSCC_derm002
31149,20004,Blank 490,1,N,OHSU_HNSCC_derm002,3,0.464,1.1111111111111112,Luteolin (direct interaction),OHSU_HNSCC_derm002
31150,20004,Blank 490,1,O,OHSU_HNSCC_derm002,3,0.332,1.1111111111111112,GSK-690693,OHSU_HNSCC_derm002
31151,20004,Blank 490,1,P,OHSU_HNSCC_derm002,3,0.29,1.1111111111111112,Ibrutinib,OHSU_HNSCC_derm002
31152,20004,Blank 490,1,A,OHSU_HNSCC_derm002,4,0.159,0.37037;0.37037, JQ1;BEZ235,OHSU_HNSCC_derm002
31153,20004,Blank 490,1,B,OHSU_HNSCC_derm002,4,0.439,0.3703703703703704,Lucitanib ,OHSU_HNSCC_derm002
31154,20004,Blank 490,1,C,OHSU_HNSCC_derm002,4,0.55,0.3703703703703704,Resveratrol,OHSU_HNSCC_derm002
31155,20004,Blank 490,1,D,OHSU_HNSCC_derm002,4,0.365,0.3703703703703704,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31156,20004,Blank 490,1,E,OHSU_HNSCC_derm002,4,0.47,0.3703703703703704,Bicalutamide,OHSU_HNSCC_derm002
31157,20004,Blank 490,1,F,OHSU_HNSCC_derm002,4,0.451,0.3703703703703704,Methotrexate ,OHSU_HNSCC_derm002
31158,20004,Blank 490,1,G,OHSU_HNSCC_derm002,4,0.522,0.3703703703703704,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31159,20004,Blank 490,1,H,OHSU_HNSCC_derm002,4,0.407,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
31160,20004,Blank 490,1,I,OHSU_HNSCC_derm002,4,0.42,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
31161,20004,Blank 490,1,J,OHSU_HNSCC_derm002,4,0.337,0.3703703703703704,Tamatinib/R406,OHSU_HNSCC_derm002
31162,20004,Blank 490,1,K,OHSU_HNSCC_derm002,4,0.547,0.3703703703703704,Bosutinib,OHSU_HNSCC_derm002
31163,20004,Blank 490,1,L,OHSU_HNSCC_derm002,4,0.126,0.3703703703703704,PI-103,OHSU_HNSCC_derm002
31164,20004,Blank 490,1,M,OHSU_HNSCC_derm002,4,0.478,0.3703703703703704,Glycyrrhizin,OHSU_HNSCC_derm002
31165,20004,Blank 490,1,N,OHSU_HNSCC_derm002,4,0.43,0.3703703703703704,Luteolin (direct interaction),OHSU_HNSCC_derm002
31166,20004,Blank 490,1,O,OHSU_HNSCC_derm002,4,0.326,0.3703703703703704,GSK-690693,OHSU_HNSCC_derm002
31167,20004,Blank 490,1,P,OHSU_HNSCC_derm002,4,0.281,0.3703703703703704,Ibrutinib,OHSU_HNSCC_derm002
31168,20004,Blank 490,1,A,OHSU_HNSCC_derm002,5,0.279,0.123456;0.123456, JQ1;BEZ235,OHSU_HNSCC_derm002
31169,20004,Blank 490,1,B,OHSU_HNSCC_derm002,5,0.427,0.1234567901234568,Lucitanib ,OHSU_HNSCC_derm002
31170,20004,Blank 490,1,C,OHSU_HNSCC_derm002,5,0.547,0.1234567901234568,Resveratrol,OHSU_HNSCC_derm002
31171,20004,Blank 490,1,D,OHSU_HNSCC_derm002,5,0.384,0.1234567901234568,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31172,20004,Blank 490,1,E,OHSU_HNSCC_derm002,5,0.523,0.1234567901234568,Bicalutamide,OHSU_HNSCC_derm002
31173,20004,Blank 490,1,F,OHSU_HNSCC_derm002,5,0.487,0.1234567901234568,Methotrexate ,OHSU_HNSCC_derm002
31174,20004,Blank 490,1,G,OHSU_HNSCC_derm002,5,0.492,0.1234567901234568,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31175,20004,Blank 490,1,H,OHSU_HNSCC_derm002,5,0.419,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
31176,20004,Blank 490,1,I,OHSU_HNSCC_derm002,5,0.395,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
31177,20004,Blank 490,1,J,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Tamatinib/R406,OHSU_HNSCC_derm002
31178,20004,Blank 490,1,K,OHSU_HNSCC_derm002,5,0.573,0.1234567901234568,Bosutinib,OHSU_HNSCC_derm002
31179,20004,Blank 490,1,L,OHSU_HNSCC_derm002,5,0.243,0.1234567901234568,PI-103,OHSU_HNSCC_derm002
31180,20004,Blank 490,1,M,OHSU_HNSCC_derm002,5,0.466,0.1234567901234568,Glycyrrhizin,OHSU_HNSCC_derm002
31181,20004,Blank 490,1,N,OHSU_HNSCC_derm002,5,0.47,0.1234567901234568,Luteolin (direct interaction),OHSU_HNSCC_derm002
31182,20004,Blank 490,1,O,OHSU_HNSCC_derm002,5,0.367,0.1234567901234568,GSK-690693,OHSU_HNSCC_derm002
31183,20004,Blank 490,1,P,OHSU_HNSCC_derm002,5,0.32,0.1234567901234568,Ibrutinib,OHSU_HNSCC_derm002
31184,20004,Blank 490,1,A,OHSU_HNSCC_derm002,6,0.411,0.04115226;0.0411526, JQ1;BEZ235,OHSU_HNSCC_derm002
31185,20004,Blank 490,1,B,OHSU_HNSCC_derm002,6,0.425,0.0411522633744856,Lucitanib ,OHSU_HNSCC_derm002
31186,20004,Blank 490,1,C,OHSU_HNSCC_derm002,6,0.519,0.0411522633744856,Resveratrol,OHSU_HNSCC_derm002
31187,20004,Blank 490,1,D,OHSU_HNSCC_derm002,6,0.364,0.0411522633744856,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31188,20004,Blank 490,1,E,OHSU_HNSCC_derm002,6,0.51,0.0411522633744856,Bicalutamide,OHSU_HNSCC_derm002
31189,20004,Blank 490,1,F,OHSU_HNSCC_derm002,6,0.505,0.0411522633744856,Methotrexate ,OHSU_HNSCC_derm002
31190,20004,Blank 490,1,G,OHSU_HNSCC_derm002,6,0.47,0.0411522633744856,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31191,20004,Blank 490,1,H,OHSU_HNSCC_derm002,6,0.42,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
31192,20004,Blank 490,1,I,OHSU_HNSCC_derm002,6,0.428,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
31193,20004,Blank 490,1,J,OHSU_HNSCC_derm002,6,0.351,0.0411522633744856,Tamatinib/R406,OHSU_HNSCC_derm002
31194,20004,Blank 490,1,K,OHSU_HNSCC_derm002,6,0.491,0.0411522633744856,Bosutinib,OHSU_HNSCC_derm002
31195,20004,Blank 490,1,L,OHSU_HNSCC_derm002,6,0.359,0.0411522633744856,PI-103,OHSU_HNSCC_derm002
31196,20004,Blank 490,1,M,OHSU_HNSCC_derm002,6,0.456,0.0411522633744856,Glycyrrhizin,OHSU_HNSCC_derm002
31197,20004,Blank 490,1,N,OHSU_HNSCC_derm002,6,0.479,0.0411522633744856,Luteolin (direct interaction),OHSU_HNSCC_derm002
31198,20004,Blank 490,1,O,OHSU_HNSCC_derm002,6,0.433,0.0411522633744856,GSK-690693,OHSU_HNSCC_derm002
31199,20004,Blank 490,1,P,OHSU_HNSCC_derm002,6,0.344,0.0411522633744856,Ibrutinib,OHSU_HNSCC_derm002
31200,20004,Blank 490,1,A,OHSU_HNSCC_derm002,7,0.401,0.01371742;0.01371742, JQ1;BEZ235,OHSU_HNSCC_derm002
31201,20004,Blank 490,1,B,OHSU_HNSCC_derm002,7,0.441,0.013717421124828532,Lucitanib ,OHSU_HNSCC_derm002
31202,20004,Blank 490,1,C,OHSU_HNSCC_derm002,7,0.536,0.013717421124828532,Resveratrol,OHSU_HNSCC_derm002
31203,20004,Blank 490,1,D,OHSU_HNSCC_derm002,7,0.376,0.013717421124828532,Pelitinib (EKB-569) ,OHSU_HNSCC_derm002
31204,20004,Blank 490,1,E,OHSU_HNSCC_derm002,7,0.511,0.013717421124828532,Bicalutamide,OHSU_HNSCC_derm002
31205,20004,Blank 490,1,F,OHSU_HNSCC_derm002,7,0.47,0.013717421124828532,Methotrexate ,OHSU_HNSCC_derm002
31206,20004,Blank 490,1,G,OHSU_HNSCC_derm002,7,0.485,0.013717421124828532,Midostaurin (PKC-412),OHSU_HNSCC_derm002
31207,20004,Blank 490,1,H,OHSU_HNSCC_derm002,7,0.483,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
31208,20004,Blank 490,1,I,OHSU_HNSCC_derm002,7,0.432,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
31209,20004,Blank 490,1,J,OHSU_HNSCC_derm002,7,0.383,0.013717421124828532,Tamatinib/R406,OHSU_HNSCC_derm002
31210,20004,Blank 490,1,K,OHSU_HNSCC_derm002,7,0.452,0.013717421124828532,Bosutinib,OHSU_HNSCC_derm002
31211,20004,Blank 490,1,L,OHSU_HNSCC_derm002,7,0.444,0.013717421124828532,PI-103,OHSU_HNSCC_derm002
31212,20004,Blank 490,1,M,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Glycyrrhizin,OHSU_HNSCC_derm002
31213,20004,Blank 490,1,N,OHSU_HNSCC_derm002,7,0.458,0.013717421124828532,Luteolin (direct interaction),OHSU_HNSCC_derm002
31214,20004,Blank 490,1,O,OHSU_HNSCC_derm002,7,0.335,0.013717421124828532,GSK-690693,OHSU_HNSCC_derm002
31215,20004,Blank 490,1,P,OHSU_HNSCC_derm002,7,0.338,0.013717421124828532,Ibrutinib,OHSU_HNSCC_derm002
31216,20004,Blank 490,1,A,OHSU_HNSCC_derm002,8,0.399,0,NONE,OHSU_HNSCC_derm002
31217,20004,Blank 490,1,B,OHSU_HNSCC_derm002,8,0.455,0,NONE,OHSU_HNSCC_derm002
31218,20004,Blank 490,1,C,OHSU_HNSCC_derm002,8,0.479,0,NONE,OHSU_HNSCC_derm002
31219,20004,Blank 490,1,D,OHSU_HNSCC_derm002,8,0.432,0,NONE,OHSU_HNSCC_derm002
31220,20004,Blank 490,1,E,OHSU_HNSCC_derm002,8,0.535,0,NONE,OHSU_HNSCC_derm002
31221,20004,Blank 490,1,F,OHSU_HNSCC_derm002,8,0.496,0,NONE,OHSU_HNSCC_derm002
31222,20004,Blank 490,1,G,OHSU_HNSCC_derm002,8,0.49,0,NONE,OHSU_HNSCC_derm002
31223,20004,Blank 490,1,H,OHSU_HNSCC_derm002,8,0.0,10,F-S-V,OHSU_HNSCC_derm002
31224,20004,Blank 490,1,I,OHSU_HNSCC_derm002,8,0.408,0,NONE,OHSU_HNSCC_derm002
31225,20004,Blank 490,1,J,OHSU_HNSCC_derm002,8,0.417,0,NONE,OHSU_HNSCC_derm002
31226,20004,Blank 490,1,K,OHSU_HNSCC_derm002,8,0.413,0,NONE,OHSU_HNSCC_derm002
31227,20004,Blank 490,1,L,OHSU_HNSCC_derm002,8,0.405,0,NONE,OHSU_HNSCC_derm002
31228,20004,Blank 490,1,M,OHSU_HNSCC_derm002,8,0.432,0,NONE,OHSU_HNSCC_derm002
31229,20004,Blank 490,1,N,OHSU_HNSCC_derm002,8,0.441,0,NONE,OHSU_HNSCC_derm002
31230,20004,Blank 490,1,O,OHSU_HNSCC_derm002,8,0.345,0,NONE,OHSU_HNSCC_derm002
31231,20004,Blank 490,1,P,OHSU_HNSCC_derm002,8,0.377,0,NONE,OHSU_HNSCC_derm002
31232,20004,Blank 490,1,A,OHSU_HNSCC_derm002,9,0.132,10;10,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31233,20004,Blank 490,1,B,OHSU_HNSCC_derm002,9,0.28,10,Sorafenib,OHSU_HNSCC_derm002
31234,20004,Blank 490,1,C,OHSU_HNSCC_derm002,9,0.539,10,Rosmarinic acid,OHSU_HNSCC_derm002
31235,20004,Blank 490,1,D,OHSU_HNSCC_derm002,9,0.355,10,Rapamycin,OHSU_HNSCC_derm002
31236,20004,Blank 490,1,E,OHSU_HNSCC_derm002,9,0.493,10,Vismodegib,OHSU_HNSCC_derm002
31237,20004,Blank 490,1,F,OHSU_HNSCC_derm002,9,0.183,10,PP242,OHSU_HNSCC_derm002
31238,20004,Blank 490,1,G,OHSU_HNSCC_derm002,9,0.221,10,Alectinib,OHSU_HNSCC_derm002
31239,20004,Blank 490,1,H,OHSU_HNSCC_derm002,9,0.039,10,Brigatinib,OHSU_HNSCC_derm002
31240,20004,Blank 490,1,I,OHSU_HNSCC_derm002,9,0.079,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31241,20004,Blank 490,1,J,OHSU_HNSCC_derm002,9,0.197,10,MK-2206,OHSU_HNSCC_derm002
31242,20004,Blank 490,1,K,OHSU_HNSCC_derm002,9,0.348,10;10,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31243,20004,Blank 490,1,L,OHSU_HNSCC_derm002,9,0.009,10,Flavopiridol ,OHSU_HNSCC_derm002
31244,20004,Blank 490,1,M,OHSU_HNSCC_derm002,9,0.531,10,Indirubin,OHSU_HNSCC_derm002
31245,20004,Blank 490,1,N,OHSU_HNSCC_derm002,9,0.588,10,PF-533228,OHSU_HNSCC_derm002
31246,20004,Blank 490,1,O,OHSU_HNSCC_derm002,9,0.345,10,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31247,20004,Blank 490,1,P,OHSU_HNSCC_derm002,9,0.105,10,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31248,20004,Blank 490,1,A,OHSU_HNSCC_derm002,10,0.204,3.33333;3.33333,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31249,20004,Blank 490,1,B,OHSU_HNSCC_derm002,10,0.36,3.3333333333333335,Sorafenib,OHSU_HNSCC_derm002
31250,20004,Blank 490,1,C,OHSU_HNSCC_derm002,10,0.493,3.3333333333333335,Rosmarinic acid,OHSU_HNSCC_derm002
31251,20004,Blank 490,1,D,OHSU_HNSCC_derm002,10,0.389,3.3333333333333335,Rapamycin,OHSU_HNSCC_derm002
31252,20004,Blank 490,1,E,OHSU_HNSCC_derm002,10,0.502,3.3333333333333335,Vismodegib,OHSU_HNSCC_derm002
31253,20004,Blank 490,1,F,OHSU_HNSCC_derm002,10,0.213,3.3333333333333335,PP242,OHSU_HNSCC_derm002
31254,20004,Blank 490,1,G,OHSU_HNSCC_derm002,10,0.259,3.3333333333333335,Alectinib,OHSU_HNSCC_derm002
31255,20004,Blank 490,1,H,OHSU_HNSCC_derm002,10,0.14,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
31256,20004,Blank 490,1,I,OHSU_HNSCC_derm002,10,0.23,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31257,20004,Blank 490,1,J,OHSU_HNSCC_derm002,10,0.242,3.3333333333333335,MK-2206,OHSU_HNSCC_derm002
31258,20004,Blank 490,1,K,OHSU_HNSCC_derm002,10,0.411,3.33333;3.33333,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31259,20004,Blank 490,1,L,OHSU_HNSCC_derm002,10,0.005,3.3333333333333335,Flavopiridol ,OHSU_HNSCC_derm002
31260,20004,Blank 490,1,M,OHSU_HNSCC_derm002,10,0.504,3.3333333333333335,Indirubin,OHSU_HNSCC_derm002
31261,20004,Blank 490,1,N,OHSU_HNSCC_derm002,10,0.662,3.3333333333333335,PF-533228,OHSU_HNSCC_derm002
31262,20004,Blank 490,1,O,OHSU_HNSCC_derm002,10,0.412,3.3333333333333335,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31263,20004,Blank 490,1,P,OHSU_HNSCC_derm002,10,0.126,3.3333333333333335,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31264,20004,Blank 490,1,A,OHSU_HNSCC_derm002,11,0.177,1.1111;1.11111,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31265,20004,Blank 490,1,B,OHSU_HNSCC_derm002,11,0.382,1.1111111111111112,Sorafenib,OHSU_HNSCC_derm002
31266,20004,Blank 490,1,C,OHSU_HNSCC_derm002,11,0.485,1.1111111111111112,Rosmarinic acid,OHSU_HNSCC_derm002
31267,20004,Blank 490,1,D,OHSU_HNSCC_derm002,11,0.404,1.1111111111111112,Rapamycin,OHSU_HNSCC_derm002
31268,20004,Blank 490,1,E,OHSU_HNSCC_derm002,11,0.491,1.1111111111111112,Vismodegib,OHSU_HNSCC_derm002
31269,20004,Blank 490,1,F,OHSU_HNSCC_derm002,11,0.282,1.1111111111111112,PP242,OHSU_HNSCC_derm002
31270,20004,Blank 490,1,G,OHSU_HNSCC_derm002,11,0.393,1.1111111111111112,Alectinib,OHSU_HNSCC_derm002
31271,20004,Blank 490,1,H,OHSU_HNSCC_derm002,11,0.349,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
31272,20004,Blank 490,1,I,OHSU_HNSCC_derm002,11,0.278,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31273,20004,Blank 490,1,J,OHSU_HNSCC_derm002,11,0.282,1.1111111111111112,MK-2206,OHSU_HNSCC_derm002
31274,20004,Blank 490,1,K,OHSU_HNSCC_derm002,11,0.375,1.1111;1.11111,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31275,20004,Blank 490,1,L,OHSU_HNSCC_derm002,11,0.003,1.1111111111111112,Flavopiridol ,OHSU_HNSCC_derm002
31276,20004,Blank 490,1,M,OHSU_HNSCC_derm002,11,0.502,1.1111111111111112,Indirubin,OHSU_HNSCC_derm002
31277,20004,Blank 490,1,N,OHSU_HNSCC_derm002,11,0.574,1.1111111111111112,PF-533228,OHSU_HNSCC_derm002
31278,20004,Blank 490,1,O,OHSU_HNSCC_derm002,11,0.405,1.1111111111111112,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31279,20004,Blank 490,1,P,OHSU_HNSCC_derm002,11,0.184,1.1111111111111112,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31280,20004,Blank 490,1,A,OHSU_HNSCC_derm002,12,0.169,0.37037;0.37037,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31281,20004,Blank 490,1,B,OHSU_HNSCC_derm002,12,0.433,0.3703703703703704,Sorafenib,OHSU_HNSCC_derm002
31282,20004,Blank 490,1,C,OHSU_HNSCC_derm002,12,0.54,0.3703703703703704,Rosmarinic acid,OHSU_HNSCC_derm002
31283,20004,Blank 490,1,D,OHSU_HNSCC_derm002,12,0.379,0.3703703703703704,Rapamycin,OHSU_HNSCC_derm002
31284,20004,Blank 490,1,E,OHSU_HNSCC_derm002,12,0.495,0.3703703703703704,Vismodegib,OHSU_HNSCC_derm002
31285,20004,Blank 490,1,F,OHSU_HNSCC_derm002,12,0.423,0.3703703703703704,PP242,OHSU_HNSCC_derm002
31286,20004,Blank 490,1,G,OHSU_HNSCC_derm002,12,0.446,0.3703703703703704,Alectinib,OHSU_HNSCC_derm002
31287,20004,Blank 490,1,H,OHSU_HNSCC_derm002,12,0.452,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
31288,20004,Blank 490,1,I,OHSU_HNSCC_derm002,12,0.315,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31289,20004,Blank 490,1,J,OHSU_HNSCC_derm002,12,0.314,0.3703703703703704,MK-2206,OHSU_HNSCC_derm002
31290,20004,Blank 490,1,K,OHSU_HNSCC_derm002,12,0.363,0.37037;0.37037,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31291,20004,Blank 490,1,L,OHSU_HNSCC_derm002,12,0.042,0.3703703703703704,Flavopiridol ,OHSU_HNSCC_derm002
31292,20004,Blank 490,1,M,OHSU_HNSCC_derm002,12,0.528,0.3703703703703704,Indirubin,OHSU_HNSCC_derm002
31293,20004,Blank 490,1,N,OHSU_HNSCC_derm002,12,0.557,0.3703703703703704,PF-533228,OHSU_HNSCC_derm002
31294,20004,Blank 490,1,O,OHSU_HNSCC_derm002,12,0.542,0.3703703703703704,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31295,20004,Blank 490,1,P,OHSU_HNSCC_derm002,12,0.305,0.3703703703703704,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31296,20004,Blank 490,1,A,OHSU_HNSCC_derm002,13,0.17,0.123456;0.123456,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31297,20004,Blank 490,1,B,OHSU_HNSCC_derm002,13,0.438,0.1234567901234568,Sorafenib,OHSU_HNSCC_derm002
31298,20004,Blank 490,1,C,OHSU_HNSCC_derm002,13,0.49,0.1234567901234568,Rosmarinic acid,OHSU_HNSCC_derm002
31299,20004,Blank 490,1,D,OHSU_HNSCC_derm002,13,0.414,0.1234567901234568,Rapamycin,OHSU_HNSCC_derm002
31300,20004,Blank 490,1,E,OHSU_HNSCC_derm002,13,0.495,0.1234567901234568,Vismodegib,OHSU_HNSCC_derm002
31301,20004,Blank 490,1,F,OHSU_HNSCC_derm002,13,0.473,0.1234567901234568,PP242,OHSU_HNSCC_derm002
31302,20004,Blank 490,1,G,OHSU_HNSCC_derm002,13,0.448,0.1234567901234568,Alectinib,OHSU_HNSCC_derm002
31303,20004,Blank 490,1,H,OHSU_HNSCC_derm002,13,0.432,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
31304,20004,Blank 490,1,I,OHSU_HNSCC_derm002,13,0.321,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31305,20004,Blank 490,1,J,OHSU_HNSCC_derm002,13,0.369,0.1234567901234568,MK-2206,OHSU_HNSCC_derm002
31306,20004,Blank 490,1,K,OHSU_HNSCC_derm002,13,0.385,0.123456;0.123456,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31307,20004,Blank 490,1,L,OHSU_HNSCC_derm002,13,0.222,0.1234567901234568,Flavopiridol ,OHSU_HNSCC_derm002
31308,20004,Blank 490,1,M,OHSU_HNSCC_derm002,13,0.49,0.1234567901234568,Indirubin,OHSU_HNSCC_derm002
31309,20004,Blank 490,1,N,OHSU_HNSCC_derm002,13,0.474,0.1234567901234568,PF-533228,OHSU_HNSCC_derm002
31310,20004,Blank 490,1,O,OHSU_HNSCC_derm002,13,0.4,0.1234567901234568,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31311,20004,Blank 490,1,P,OHSU_HNSCC_derm002,13,0.389,0.1234567901234568,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31312,20004,Blank 490,1,A,OHSU_HNSCC_derm002,14,0.243,0.04115226;0.0411526,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31313,20004,Blank 490,1,B,OHSU_HNSCC_derm002,14,0.409,0.0411522633744856,Sorafenib,OHSU_HNSCC_derm002
31314,20004,Blank 490,1,C,OHSU_HNSCC_derm002,14,0.507,0.0411522633744856,Rosmarinic acid,OHSU_HNSCC_derm002
31315,20004,Blank 490,1,D,OHSU_HNSCC_derm002,14,0.439,0.0411522633744856,Rapamycin,OHSU_HNSCC_derm002
31316,20004,Blank 490,1,E,OHSU_HNSCC_derm002,14,0.508,0.0411522633744856,Vismodegib,OHSU_HNSCC_derm002
31317,20004,Blank 490,1,F,OHSU_HNSCC_derm002,14,0.514,0.0411522633744856,PP242,OHSU_HNSCC_derm002
31318,20004,Blank 490,1,G,OHSU_HNSCC_derm002,14,0.477,0.0411522633744856,Alectinib,OHSU_HNSCC_derm002
31319,20004,Blank 490,1,H,OHSU_HNSCC_derm002,14,0.45,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
31320,20004,Blank 490,1,I,OHSU_HNSCC_derm002,14,0.306,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31321,20004,Blank 490,1,J,OHSU_HNSCC_derm002,14,0.374,0.0411522633744856,MK-2206,OHSU_HNSCC_derm002
31322,20004,Blank 490,1,K,OHSU_HNSCC_derm002,14,0.389,0.04115226;0.0411526,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31323,20004,Blank 490,1,L,OHSU_HNSCC_derm002,14,0.324,0.0411522633744856,Flavopiridol ,OHSU_HNSCC_derm002
31324,20004,Blank 490,1,M,OHSU_HNSCC_derm002,14,0.525,0.0411522633744856,Indirubin,OHSU_HNSCC_derm002
31325,20004,Blank 490,1,N,OHSU_HNSCC_derm002,14,0.488,0.0411522633744856,PF-533228,OHSU_HNSCC_derm002
31326,20004,Blank 490,1,O,OHSU_HNSCC_derm002,14,0.385,0.0411522633744856,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31327,20004,Blank 490,1,P,OHSU_HNSCC_derm002,14,0.386,0.0411522633744856,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31328,20004,Blank 490,1,A,OHSU_HNSCC_derm002,15,0.299,0.01371742;0.01371742,Dasatinib;Gefitinib,OHSU_HNSCC_derm002
31329,20004,Blank 490,1,B,OHSU_HNSCC_derm002,15,0.454,0.013717421124828532,Sorafenib,OHSU_HNSCC_derm002
31330,20004,Blank 490,1,C,OHSU_HNSCC_derm002,15,0.535,0.013717421124828532,Rosmarinic acid,OHSU_HNSCC_derm002
31331,20004,Blank 490,1,D,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Rapamycin,OHSU_HNSCC_derm002
31332,20004,Blank 490,1,E,OHSU_HNSCC_derm002,15,0.48,0.013717421124828532,Vismodegib,OHSU_HNSCC_derm002
31333,20004,Blank 490,1,F,OHSU_HNSCC_derm002,15,0.533,0.013717421124828532,PP242,OHSU_HNSCC_derm002
31334,20004,Blank 490,1,G,OHSU_HNSCC_derm002,15,0.483,0.013717421124828532,Alectinib,OHSU_HNSCC_derm002
31335,20004,Blank 490,1,H,OHSU_HNSCC_derm002,15,0.455,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
31336,20004,Blank 490,1,I,OHSU_HNSCC_derm002,15,0.341,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31337,20004,Blank 490,1,J,OHSU_HNSCC_derm002,15,0.375,0.013717421124828532,MK-2206,OHSU_HNSCC_derm002
31338,20004,Blank 490,1,K,OHSU_HNSCC_derm002,15,0.424,0.01371742;0.01371742,Ruxolitinib;Gefitinib,OHSU_HNSCC_derm002
31339,20004,Blank 490,1,L,OHSU_HNSCC_derm002,15,0.374,0.013717421124828532,Flavopiridol ,OHSU_HNSCC_derm002
31340,20004,Blank 490,1,M,OHSU_HNSCC_derm002,15,0.509,0.013717421124828532,Indirubin,OHSU_HNSCC_derm002
31341,20004,Blank 490,1,N,OHSU_HNSCC_derm002,15,0.481,0.013717421124828532,PF-533228,OHSU_HNSCC_derm002
31342,20004,Blank 490,1,O,OHSU_HNSCC_derm002,15,0.461,0.013717421124828532,Licochalcone A (from licorice),OHSU_HNSCC_derm002
31343,20004,Blank 490,1,P,OHSU_HNSCC_derm002,15,0.381,0.013717421124828532,17-AAG (Tanespimycin),OHSU_HNSCC_derm002
31344,20004,Blank 490,1,A,OHSU_HNSCC_derm002,16,0.401,0,NONE,OHSU_HNSCC_derm002
31345,20004,Blank 490,1,B,OHSU_HNSCC_derm002,16,0.458,0,NONE,OHSU_HNSCC_derm002
31346,20004,Blank 490,1,C,OHSU_HNSCC_derm002,16,0.509,0,NONE,OHSU_HNSCC_derm002
31347,20004,Blank 490,1,D,OHSU_HNSCC_derm002,16,0.514,0,NONE,OHSU_HNSCC_derm002
31348,20004,Blank 490,1,E,OHSU_HNSCC_derm002,16,0.478,0,NONE,OHSU_HNSCC_derm002
31349,20004,Blank 490,1,F,OHSU_HNSCC_derm002,16,0.52,0,NONE,OHSU_HNSCC_derm002
31350,20004,Blank 490,1,G,OHSU_HNSCC_derm002,16,0.468,0,NONE,OHSU_HNSCC_derm002
31351,20004,Blank 490,1,H,OHSU_HNSCC_derm002,16,0.0,10,F-S-V,OHSU_HNSCC_derm002
31352,20004,Blank 490,1,I,OHSU_HNSCC_derm002,16,0.468,0,NONE,OHSU_HNSCC_derm002
31353,20004,Blank 490,1,J,OHSU_HNSCC_derm002,16,0.434,0,NONE,OHSU_HNSCC_derm002
31354,20004,Blank 490,1,K,OHSU_HNSCC_derm002,16,0.419,0,NONE,OHSU_HNSCC_derm002
31355,20004,Blank 490,1,L,OHSU_HNSCC_derm002,16,0.447,0,NONE,OHSU_HNSCC_derm002
31356,20004,Blank 490,1,M,OHSU_HNSCC_derm002,16,0.459,0,NONE,OHSU_HNSCC_derm002
31357,20004,Blank 490,1,N,OHSU_HNSCC_derm002,16,0.464,0,NONE,OHSU_HNSCC_derm002
31358,20004,Blank 490,1,O,OHSU_HNSCC_derm002,16,0.519,0,NONE,OHSU_HNSCC_derm002
31359,20004,Blank 490,1,P,OHSU_HNSCC_derm002,16,0.389,0,NONE,OHSU_HNSCC_derm002
31360,20004,Blank 490,1,A,OHSU_HNSCC_derm002,17,0.374,10,Emodin,OHSU_HNSCC_derm002
31361,20004,Blank 490,1,B,OHSU_HNSCC_derm002,17,0.471,10,Baicalin,OHSU_HNSCC_derm002
31362,20004,Blank 490,1,C,OHSU_HNSCC_derm002,17,0.02,10,NVP-TAE-684,OHSU_HNSCC_derm002
31363,20004,Blank 490,1,D,OHSU_HNSCC_derm002,17,0.041,10,Panobinostat,OHSU_HNSCC_derm002
31364,20004,Blank 490,1,E,OHSU_HNSCC_derm002,17,0.116,10;10,PP242;Gefitinib,OHSU_HNSCC_derm002
31365,20004,Blank 490,1,F,OHSU_HNSCC_derm002,17,0.589,10,Fulvestrant,OHSU_HNSCC_derm002
31366,20004,Blank 490,1,G,OHSU_HNSCC_derm002,17,0.392,10,SCH-772984,OHSU_HNSCC_derm002
31367,20004,Blank 490,1,H,OHSU_HNSCC_derm002,17,0.367,10,Trametinib,OHSU_HNSCC_derm002
31368,20004,Blank 490,1,I,OHSU_HNSCC_derm002,17,0.12,10,BEZ235,OHSU_HNSCC_derm002
31369,20004,Blank 490,1,J,OHSU_HNSCC_derm002,17,0.361,10,MLN120B,OHSU_HNSCC_derm002
31370,20004,Blank 490,1,K,OHSU_HNSCC_derm002,17,0.32,10,Ixabepilone,OHSU_HNSCC_derm002
31371,20004,Blank 490,1,L,OHSU_HNSCC_derm002,17,0.003,10,Canertinib (CI-1033),OHSU_HNSCC_derm002
31372,20004,Blank 490,1,M,OHSU_HNSCC_derm002,17,0.395,10,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31373,20004,Blank 490,1,N,OHSU_HNSCC_derm002,17,0.272,10;10, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31374,20004,Blank 490,1,O,OHSU_HNSCC_derm002,17,0.318,10,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31375,20004,Blank 490,1,P,OHSU_HNSCC_derm002,17,0.377,10,Letrozole,OHSU_HNSCC_derm002
31376,20004,Blank 490,1,A,OHSU_HNSCC_derm002,18,0.421,3.3333333333333335,Emodin,OHSU_HNSCC_derm002
31377,20004,Blank 490,1,B,OHSU_HNSCC_derm002,18,0.446,3.3333333333333335,Baicalin,OHSU_HNSCC_derm002
31378,20004,Blank 490,1,C,OHSU_HNSCC_derm002,18,0.134,3.3333333333333335,NVP-TAE-684,OHSU_HNSCC_derm002
31379,20004,Blank 490,1,D,OHSU_HNSCC_derm002,18,0.07,3.3333333333333335,Panobinostat,OHSU_HNSCC_derm002
31380,20004,Blank 490,1,E,OHSU_HNSCC_derm002,18,0.136,3.33333;3.33333,PP242;Gefitinib,OHSU_HNSCC_derm002
31381,20004,Blank 490,1,F,OHSU_HNSCC_derm002,18,0.549,3.3333333333333335,Fulvestrant,OHSU_HNSCC_derm002
31382,20004,Blank 490,1,G,OHSU_HNSCC_derm002,18,0.393,3.3333333333333335,SCH-772984,OHSU_HNSCC_derm002
31383,20004,Blank 490,1,H,OHSU_HNSCC_derm002,18,0.403,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
31384,20004,Blank 490,1,I,OHSU_HNSCC_derm002,18,0.122,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
31385,20004,Blank 490,1,J,OHSU_HNSCC_derm002,18,0.391,3.3333333333333335,MLN120B,OHSU_HNSCC_derm002
31386,20004,Blank 490,1,K,OHSU_HNSCC_derm002,18,0.328,3.3333333333333335,Ixabepilone,OHSU_HNSCC_derm002
31387,20004,Blank 490,1,L,OHSU_HNSCC_derm002,18,0.241,3.3333333333333335,Canertinib (CI-1033),OHSU_HNSCC_derm002
31388,20004,Blank 490,1,M,OHSU_HNSCC_derm002,18,0.403,3.3333333333333335,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31389,20004,Blank 490,1,N,OHSU_HNSCC_derm002,18,0.359,3.33333;3.33333, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31390,20004,Blank 490,1,O,OHSU_HNSCC_derm002,18,0.401,3.3333333333333335,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31391,20004,Blank 490,1,P,OHSU_HNSCC_derm002,18,0.35,3.3333333333333335,Letrozole,OHSU_HNSCC_derm002
31392,20004,Blank 490,1,A,OHSU_HNSCC_derm002,19,0.439,1.1111111111111112,Emodin,OHSU_HNSCC_derm002
31393,20004,Blank 490,1,B,OHSU_HNSCC_derm002,19,0.502,1.1111111111111112,Baicalin,OHSU_HNSCC_derm002
31394,20004,Blank 490,1,C,OHSU_HNSCC_derm002,19,0.253,1.1111111111111112,NVP-TAE-684,OHSU_HNSCC_derm002
31395,20004,Blank 490,1,D,OHSU_HNSCC_derm002,19,0.095,1.1111111111111112,Panobinostat,OHSU_HNSCC_derm002
31396,20004,Blank 490,1,E,OHSU_HNSCC_derm002,19,0.272,1.1111;1.11111,PP242;Gefitinib,OHSU_HNSCC_derm002
31397,20004,Blank 490,1,F,OHSU_HNSCC_derm002,19,0.532,1.1111111111111112,Fulvestrant,OHSU_HNSCC_derm002
31398,20004,Blank 490,1,G,OHSU_HNSCC_derm002,19,0.409,1.1111111111111112,SCH-772984,OHSU_HNSCC_derm002
31399,20004,Blank 490,1,H,OHSU_HNSCC_derm002,19,0.397,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
31400,20004,Blank 490,1,I,OHSU_HNSCC_derm002,19,0.129,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
31401,20004,Blank 490,1,J,OHSU_HNSCC_derm002,19,0.427,1.1111111111111112,MLN120B,OHSU_HNSCC_derm002
31402,20004,Blank 490,1,K,OHSU_HNSCC_derm002,19,0.313,1.1111111111111112,Ixabepilone,OHSU_HNSCC_derm002
31403,20004,Blank 490,1,L,OHSU_HNSCC_derm002,19,0.28,1.1111111111111112,Canertinib (CI-1033),OHSU_HNSCC_derm002
31404,20004,Blank 490,1,M,OHSU_HNSCC_derm002,19,0.404,1.1111111111111112,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31405,20004,Blank 490,1,N,OHSU_HNSCC_derm002,19,0.432,1.1111;1.11111, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31406,20004,Blank 490,1,O,OHSU_HNSCC_derm002,19,0.38,1.1111111111111112,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31407,20004,Blank 490,1,P,OHSU_HNSCC_derm002,19,0.394,1.1111111111111112,Letrozole,OHSU_HNSCC_derm002
31408,20004,Blank 490,1,A,OHSU_HNSCC_derm002,20,0.456,0.3703703703703704,Emodin,OHSU_HNSCC_derm002
31409,20004,Blank 490,1,B,OHSU_HNSCC_derm002,20,0.453,0.3703703703703704,Baicalin,OHSU_HNSCC_derm002
31410,20004,Blank 490,1,C,OHSU_HNSCC_derm002,20,0.452,0.3703703703703704,NVP-TAE-684,OHSU_HNSCC_derm002
31411,20004,Blank 490,1,D,OHSU_HNSCC_derm002,20,0.16,0.3703703703703704,Panobinostat,OHSU_HNSCC_derm002
31412,20004,Blank 490,1,E,OHSU_HNSCC_derm002,20,0.425,0.37037;0.37037,PP242;Gefitinib,OHSU_HNSCC_derm002
31413,20004,Blank 490,1,F,OHSU_HNSCC_derm002,20,0.509,0.3703703703703704,Fulvestrant,OHSU_HNSCC_derm002
31414,20004,Blank 490,1,G,OHSU_HNSCC_derm002,20,0.418,0.3703703703703704,SCH-772984,OHSU_HNSCC_derm002
31415,20004,Blank 490,1,H,OHSU_HNSCC_derm002,20,0.415,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
31416,20004,Blank 490,1,I,OHSU_HNSCC_derm002,20,0.177,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
31417,20004,Blank 490,1,J,OHSU_HNSCC_derm002,20,0.441,0.3703703703703704,MLN120B,OHSU_HNSCC_derm002
31418,20004,Blank 490,1,K,OHSU_HNSCC_derm002,20,0.355,0.3703703703703704,Ixabepilone,OHSU_HNSCC_derm002
31419,20004,Blank 490,1,L,OHSU_HNSCC_derm002,20,0.336,0.3703703703703704,Canertinib (CI-1033),OHSU_HNSCC_derm002
31420,20004,Blank 490,1,M,OHSU_HNSCC_derm002,20,0.395,0.3703703703703704,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31421,20004,Blank 490,1,N,OHSU_HNSCC_derm002,20,0.444,0.37037;0.37037, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31422,20004,Blank 490,1,O,OHSU_HNSCC_derm002,20,0.411,0.3703703703703704,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31423,20004,Blank 490,1,P,OHSU_HNSCC_derm002,20,0.392,0.3703703703703704,Letrozole,OHSU_HNSCC_derm002
31424,20004,Blank 490,1,A,OHSU_HNSCC_derm002,21,0.452,0.1234567901234568,Emodin,OHSU_HNSCC_derm002
31425,20004,Blank 490,1,B,OHSU_HNSCC_derm002,21,0.414,0.1234567901234568,Baicalin,OHSU_HNSCC_derm002
31426,20004,Blank 490,1,C,OHSU_HNSCC_derm002,21,0.458,0.1234567901234568,NVP-TAE-684,OHSU_HNSCC_derm002
31427,20004,Blank 490,1,D,OHSU_HNSCC_derm002,21,0.292,0.1234567901234568,Panobinostat,OHSU_HNSCC_derm002
31428,20004,Blank 490,1,E,OHSU_HNSCC_derm002,21,0.473,0.123456;0.123456,PP242;Gefitinib,OHSU_HNSCC_derm002
31429,20004,Blank 490,1,F,OHSU_HNSCC_derm002,21,0.481,0.1234567901234568,Fulvestrant,OHSU_HNSCC_derm002
31430,20004,Blank 490,1,G,OHSU_HNSCC_derm002,21,0.49,0.1234567901234568,SCH-772984,OHSU_HNSCC_derm002
31431,20004,Blank 490,1,H,OHSU_HNSCC_derm002,21,0.391,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
31432,20004,Blank 490,1,I,OHSU_HNSCC_derm002,21,0.216,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
31433,20004,Blank 490,1,J,OHSU_HNSCC_derm002,21,0.459,0.1234567901234568,MLN120B,OHSU_HNSCC_derm002
31434,20004,Blank 490,1,K,OHSU_HNSCC_derm002,21,0.33,0.1234567901234568,Ixabepilone,OHSU_HNSCC_derm002
31435,20004,Blank 490,1,L,OHSU_HNSCC_derm002,21,0.329,0.1234567901234568,Canertinib (CI-1033),OHSU_HNSCC_derm002
31436,20004,Blank 490,1,M,OHSU_HNSCC_derm002,21,0.386,0.1234567901234568,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31437,20004,Blank 490,1,N,OHSU_HNSCC_derm002,21,0.472,0.123456;0.123456, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31438,20004,Blank 490,1,O,OHSU_HNSCC_derm002,21,0.385,0.1234567901234568,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31439,20004,Blank 490,1,P,OHSU_HNSCC_derm002,21,0.356,0.1234567901234568,Letrozole,OHSU_HNSCC_derm002
31440,20004,Blank 490,1,A,OHSU_HNSCC_derm002,22,0.431,0.0411522633744856,Emodin,OHSU_HNSCC_derm002
31441,20004,Blank 490,1,B,OHSU_HNSCC_derm002,22,0.46,0.0411522633744856,Baicalin,OHSU_HNSCC_derm002
31442,20004,Blank 490,1,C,OHSU_HNSCC_derm002,22,0.488,0.0411522633744856,NVP-TAE-684,OHSU_HNSCC_derm002
31443,20004,Blank 490,1,D,OHSU_HNSCC_derm002,22,0.339,0.0411522633744856,Panobinostat,OHSU_HNSCC_derm002
31444,20004,Blank 490,1,E,OHSU_HNSCC_derm002,22,0.537,0.04115226;0.0411526,PP242;Gefitinib,OHSU_HNSCC_derm002
31445,20004,Blank 490,1,F,OHSU_HNSCC_derm002,22,0.507,0.0411522633744856,Fulvestrant,OHSU_HNSCC_derm002
31446,20004,Blank 490,1,G,OHSU_HNSCC_derm002,22,0.488,0.0411522633744856,SCH-772984,OHSU_HNSCC_derm002
31447,20004,Blank 490,1,H,OHSU_HNSCC_derm002,22,0.455,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
31448,20004,Blank 490,1,I,OHSU_HNSCC_derm002,22,0.384,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
31449,20004,Blank 490,1,J,OHSU_HNSCC_derm002,22,0.451,0.0411522633744856,MLN120B,OHSU_HNSCC_derm002
31450,20004,Blank 490,1,K,OHSU_HNSCC_derm002,22,0.382,0.0411522633744856,Ixabepilone,OHSU_HNSCC_derm002
31451,20004,Blank 490,1,L,OHSU_HNSCC_derm002,22,0.349,0.0411522633744856,Canertinib (CI-1033),OHSU_HNSCC_derm002
31452,20004,Blank 490,1,M,OHSU_HNSCC_derm002,22,0.395,0.0411522633744856,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31453,20004,Blank 490,1,N,OHSU_HNSCC_derm002,22,0.495,0.04115226;0.0411526, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31454,20004,Blank 490,1,O,OHSU_HNSCC_derm002,22,0.44,0.0411522633744856,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31455,20004,Blank 490,1,P,OHSU_HNSCC_derm002,22,0.391,0.0411522633744856,Letrozole,OHSU_HNSCC_derm002
31456,20004,Blank 490,1,A,OHSU_HNSCC_derm002,23,0.435,0.013717421124828532,Emodin,OHSU_HNSCC_derm002
31457,20004,Blank 490,1,B,OHSU_HNSCC_derm002,23,0.446,0.013717421124828532,Baicalin,OHSU_HNSCC_derm002
31458,20004,Blank 490,1,C,OHSU_HNSCC_derm002,23,0.512,0.013717421124828532,NVP-TAE-684,OHSU_HNSCC_derm002
31459,20004,Blank 490,1,D,OHSU_HNSCC_derm002,23,0.346,0.013717421124828532,Panobinostat,OHSU_HNSCC_derm002
31460,20004,Blank 490,1,E,OHSU_HNSCC_derm002,23,0.478,0.01371742;0.01371742,PP242;Gefitinib,OHSU_HNSCC_derm002
31461,20004,Blank 490,1,F,OHSU_HNSCC_derm002,23,0.466,0.013717421124828532,Fulvestrant,OHSU_HNSCC_derm002
31462,20004,Blank 490,1,G,OHSU_HNSCC_derm002,23,0.473,0.013717421124828532,SCH-772984,OHSU_HNSCC_derm002
31463,20004,Blank 490,1,H,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
31464,20004,Blank 490,1,I,OHSU_HNSCC_derm002,23,0.398,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
31465,20004,Blank 490,1,J,OHSU_HNSCC_derm002,23,0.422,0.013717421124828532,MLN120B,OHSU_HNSCC_derm002
31466,20004,Blank 490,1,K,OHSU_HNSCC_derm002,23,0.37,0.013717421124828532,Ixabepilone,OHSU_HNSCC_derm002
31467,20004,Blank 490,1,L,OHSU_HNSCC_derm002,23,0.355,0.013717421124828532,Canertinib (CI-1033),OHSU_HNSCC_derm002
31468,20004,Blank 490,1,M,OHSU_HNSCC_derm002,23,0.431,0.013717421124828532,Selumetinib (AZD6244),OHSU_HNSCC_derm002
31469,20004,Blank 490,1,N,OHSU_HNSCC_derm002,23,0.447,0.01371742;0.01371742, I-BET 762;Gefitinib,OHSU_HNSCC_derm002
31470,20004,Blank 490,1,O,OHSU_HNSCC_derm002,23,0.318,0.013717421124828532,NF-kB (QNZ) ,OHSU_HNSCC_derm002
31471,20004,Blank 490,1,P,OHSU_HNSCC_derm002,23,0.354,0.013717421124828532,Letrozole,OHSU_HNSCC_derm002
31472,20004,Blank 490,1,A,OHSU_HNSCC_derm002,24,0.44,0,NONE,OHSU_HNSCC_derm002
31473,20004,Blank 490,1,B,OHSU_HNSCC_derm002,24,0.401,0,NONE,OHSU_HNSCC_derm002
31474,20004,Blank 490,1,C,OHSU_HNSCC_derm002,24,0.401,0,NONE,OHSU_HNSCC_derm002
31475,20004,Blank 490,1,D,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
31476,20004,Blank 490,1,E,OHSU_HNSCC_derm002,24,0.389,0,NONE,OHSU_HNSCC_derm002
31477,20004,Blank 490,1,F,OHSU_HNSCC_derm002,24,0.38,0,NONE,OHSU_HNSCC_derm002
31478,20004,Blank 490,1,G,OHSU_HNSCC_derm002,24,0.315,0,NONE,OHSU_HNSCC_derm002
31479,20004,Blank 490,1,H,OHSU_HNSCC_derm002,24,0.362,0,NONE,OHSU_HNSCC_derm002
31480,20004,Blank 490,1,I,OHSU_HNSCC_derm002,24,0.277,0,NONE,OHSU_HNSCC_derm002
31481,20004,Blank 490,1,J,OHSU_HNSCC_derm002,24,0.299,0,NONE,OHSU_HNSCC_derm002
31482,20004,Blank 490,1,K,OHSU_HNSCC_derm002,24,0.366,0,NONE,OHSU_HNSCC_derm002
31483,20004,Blank 490,1,L,OHSU_HNSCC_derm002,24,0.346,0,NONE,OHSU_HNSCC_derm002
31484,20004,Blank 490,1,M,OHSU_HNSCC_derm002,24,0.328,0,NONE,OHSU_HNSCC_derm002
31485,20004,Blank 490,1,N,OHSU_HNSCC_derm002,24,0.345,0,NONE,OHSU_HNSCC_derm002
31486,20004,Blank 490,1,O,OHSU_HNSCC_derm002,24,0.422,0,NONE,OHSU_HNSCC_derm002
31487,20004,Blank 490,1,P,OHSU_HNSCC_derm002,24,0.407,0,NONE,OHSU_HNSCC_derm002
31488,20004,Blank 490,2,A,OHSU_HNSCC_derm002,1,0.395,10,Coumarin,OHSU_HNSCC_derm002
31489,20004,Blank 490,2,B,OHSU_HNSCC_derm002,1,0.009,10;10,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31490,20004,Blank 490,2,C,OHSU_HNSCC_derm002,1,0.129,10,Foretinib (XL-880),OHSU_HNSCC_derm002
31491,20004,Blank 490,2,D,OHSU_HNSCC_derm002,1,0.1,10,Elesclomol,OHSU_HNSCC_derm002
31492,20004,Blank 490,2,E,OHSU_HNSCC_derm002,1,0.436,10,Vemurafenib,OHSU_HNSCC_derm002
31493,20004,Blank 490,2,F,OHSU_HNSCC_derm002,1,0.086,10;10,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31494,20004,Blank 490,2,G,OHSU_HNSCC_derm002,1,0.009,10,Ponatinib,OHSU_HNSCC_derm002
31495,20004,Blank 490,2,H,OHSU_HNSCC_derm002,1,0.293,10,Gefitinib,OHSU_HNSCC_derm002
31496,20004,Blank 490,2,I,OHSU_HNSCC_derm002,1,0.058,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
31497,20004,Blank 490,2,J,OHSU_HNSCC_derm002,1,0.514,1,Sunitinib (1mM),OHSU_HNSCC_derm002
31498,20004,Blank 490,2,K,OHSU_HNSCC_derm002,1,0.45,10,Curcumin,OHSU_HNSCC_derm002
31499,20004,Blank 490,2,L,OHSU_HNSCC_derm002,1,0.047,10,PF-562271,OHSU_HNSCC_derm002
31500,20004,Blank 490,2,M,OHSU_HNSCC_derm002,1,0.374,10,STO609,OHSU_HNSCC_derm002
31501,20004,Blank 490,2,N,OHSU_HNSCC_derm002,1,0.235,10,Lenvatinib,OHSU_HNSCC_derm002
31502,20004,Blank 490,2,O,OHSU_HNSCC_derm002,1,0.056,10,Entrectinib,OHSU_HNSCC_derm002
31503,20004,Blank 490,2,P,OHSU_HNSCC_derm002,1,0.434,10,Ethyl Gallate ,OHSU_HNSCC_derm002
31504,20004,Blank 490,2,A,OHSU_HNSCC_derm002,2,0.445,3.3333333333333335,Coumarin,OHSU_HNSCC_derm002
31505,20004,Blank 490,2,B,OHSU_HNSCC_derm002,2,0.229,3.33333;3.33333,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31506,20004,Blank 490,2,C,OHSU_HNSCC_derm002,2,0.235,3.3333333333333335,Foretinib (XL-880),OHSU_HNSCC_derm002
31507,20004,Blank 490,2,D,OHSU_HNSCC_derm002,2,0.066,3.3333333333333335,Elesclomol,OHSU_HNSCC_derm002
31508,20004,Blank 490,2,E,OHSU_HNSCC_derm002,2,0.372,3.3333333333333335,Vemurafenib,OHSU_HNSCC_derm002
31509,20004,Blank 490,2,F,OHSU_HNSCC_derm002,2,0.121,3.33333;3.33333,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31510,20004,Blank 490,2,G,OHSU_HNSCC_derm002,2,0.15,3.3333333333333335,Ponatinib,OHSU_HNSCC_derm002
31511,20004,Blank 490,2,H,OHSU_HNSCC_derm002,2,0.336,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
31512,20004,Blank 490,2,I,OHSU_HNSCC_derm002,2,0.219,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
31513,20004,Blank 490,2,J,OHSU_HNSCC_derm002,2,0.45,0.3333333333333333,Sunitinib (1mM),OHSU_HNSCC_derm002
31514,20004,Blank 490,2,K,OHSU_HNSCC_derm002,2,0.371,3.3333333333333335,Curcumin,OHSU_HNSCC_derm002
31515,20004,Blank 490,2,L,OHSU_HNSCC_derm002,2,0.29,3.3333333333333335,PF-562271,OHSU_HNSCC_derm002
31516,20004,Blank 490,2,M,OHSU_HNSCC_derm002,2,0.43,3.3333333333333335,STO609,OHSU_HNSCC_derm002
31517,20004,Blank 490,2,N,OHSU_HNSCC_derm002,2,0.314,3.3333333333333335,Lenvatinib,OHSU_HNSCC_derm002
31518,20004,Blank 490,2,O,OHSU_HNSCC_derm002,2,0.258,3.3333333333333335,Entrectinib,OHSU_HNSCC_derm002
31519,20004,Blank 490,2,P,OHSU_HNSCC_derm002,2,0.421,3.3333333333333335,Ethyl Gallate ,OHSU_HNSCC_derm002
31520,20004,Blank 490,2,A,OHSU_HNSCC_derm002,3,0.465,1.1111111111111112,Coumarin,OHSU_HNSCC_derm002
31521,20004,Blank 490,2,B,OHSU_HNSCC_derm002,3,0.277,1.1111;1.11111,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31522,20004,Blank 490,2,C,OHSU_HNSCC_derm002,3,0.393,1.1111111111111112,Foretinib (XL-880),OHSU_HNSCC_derm002
31523,20004,Blank 490,2,D,OHSU_HNSCC_derm002,3,0.049,1.1111111111111112,Elesclomol,OHSU_HNSCC_derm002
31524,20004,Blank 490,2,E,OHSU_HNSCC_derm002,3,0.516,1.1111111111111112,Vemurafenib,OHSU_HNSCC_derm002
31525,20004,Blank 490,2,F,OHSU_HNSCC_derm002,3,0.149,1.1111;1.11111,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31526,20004,Blank 490,2,G,OHSU_HNSCC_derm002,3,0.32,1.1111111111111112,Ponatinib,OHSU_HNSCC_derm002
31527,20004,Blank 490,2,H,OHSU_HNSCC_derm002,3,0.376,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
31528,20004,Blank 490,2,I,OHSU_HNSCC_derm002,3,0.428,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
31529,20004,Blank 490,2,J,OHSU_HNSCC_derm002,3,0.445,0.1111111111111111,Sunitinib (1mM),OHSU_HNSCC_derm002
31530,20004,Blank 490,2,K,OHSU_HNSCC_derm002,3,0.451,1.1111111111111112,Curcumin,OHSU_HNSCC_derm002
31531,20004,Blank 490,2,L,OHSU_HNSCC_derm002,3,0.483,1.1111111111111112,PF-562271,OHSU_HNSCC_derm002
31532,20004,Blank 490,2,M,OHSU_HNSCC_derm002,3,0.553,1.1111111111111112,STO609,OHSU_HNSCC_derm002
31533,20004,Blank 490,2,N,OHSU_HNSCC_derm002,3,0.368,1.1111111111111112,Lenvatinib,OHSU_HNSCC_derm002
31534,20004,Blank 490,2,O,OHSU_HNSCC_derm002,3,0.419,1.1111111111111112,Entrectinib,OHSU_HNSCC_derm002
31535,20004,Blank 490,2,P,OHSU_HNSCC_derm002,3,0.397,1.1111111111111112,Ethyl Gallate ,OHSU_HNSCC_derm002
31536,20004,Blank 490,2,A,OHSU_HNSCC_derm002,4,0.403,0.3703703703703704,Coumarin,OHSU_HNSCC_derm002
31537,20004,Blank 490,2,B,OHSU_HNSCC_derm002,4,0.27,0.37037;0.37037,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31538,20004,Blank 490,2,C,OHSU_HNSCC_derm002,4,0.392,0.3703703703703704,Foretinib (XL-880),OHSU_HNSCC_derm002
31539,20004,Blank 490,2,D,OHSU_HNSCC_derm002,4,0.038,0.3703703703703704,Elesclomol,OHSU_HNSCC_derm002
31540,20004,Blank 490,2,E,OHSU_HNSCC_derm002,4,0.443,0.3703703703703704,Vemurafenib,OHSU_HNSCC_derm002
31541,20004,Blank 490,2,F,OHSU_HNSCC_derm002,4,0.211,0.37037;0.37037,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31542,20004,Blank 490,2,G,OHSU_HNSCC_derm002,4,0.372,0.3703703703703704,Ponatinib,OHSU_HNSCC_derm002
31543,20004,Blank 490,2,H,OHSU_HNSCC_derm002,4,0.379,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
31544,20004,Blank 490,2,I,OHSU_HNSCC_derm002,4,0.463,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
31545,20004,Blank 490,2,J,OHSU_HNSCC_derm002,4,0.45,0.037037037037037035,Sunitinib (1mM),OHSU_HNSCC_derm002
31546,20004,Blank 490,2,K,OHSU_HNSCC_derm002,4,0.448,0.3703703703703704,Curcumin,OHSU_HNSCC_derm002
31547,20004,Blank 490,2,L,OHSU_HNSCC_derm002,4,0.445,0.3703703703703704,PF-562271,OHSU_HNSCC_derm002
31548,20004,Blank 490,2,M,OHSU_HNSCC_derm002,4,0.286,0.3703703703703704,STO609,OHSU_HNSCC_derm002
31549,20004,Blank 490,2,N,OHSU_HNSCC_derm002,4,0.432,0.3703703703703704,Lenvatinib,OHSU_HNSCC_derm002
31550,20004,Blank 490,2,O,OHSU_HNSCC_derm002,4,0.458,0.3703703703703704,Entrectinib,OHSU_HNSCC_derm002
31551,20004,Blank 490,2,P,OHSU_HNSCC_derm002,4,0.454,0.3703703703703704,Ethyl Gallate ,OHSU_HNSCC_derm002
31552,20004,Blank 490,2,A,OHSU_HNSCC_derm002,5,0.424,0.1234567901234568,Coumarin,OHSU_HNSCC_derm002
31553,20004,Blank 490,2,B,OHSU_HNSCC_derm002,5,0.258,0.123456;0.123456,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31554,20004,Blank 490,2,C,OHSU_HNSCC_derm002,5,0.388,0.1234567901234568,Foretinib (XL-880),OHSU_HNSCC_derm002
31555,20004,Blank 490,2,D,OHSU_HNSCC_derm002,5,0.061,0.1234567901234568,Elesclomol,OHSU_HNSCC_derm002
31556,20004,Blank 490,2,E,OHSU_HNSCC_derm002,5,0.375,0.1234567901234568,Vemurafenib,OHSU_HNSCC_derm002
31557,20004,Blank 490,2,F,OHSU_HNSCC_derm002,5,0.264,0.123456;0.123456,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31558,20004,Blank 490,2,G,OHSU_HNSCC_derm002,5,0.426,0.1234567901234568,Ponatinib,OHSU_HNSCC_derm002
31559,20004,Blank 490,2,H,OHSU_HNSCC_derm002,5,0.374,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
31560,20004,Blank 490,2,I,OHSU_HNSCC_derm002,5,0.458,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
31561,20004,Blank 490,2,J,OHSU_HNSCC_derm002,5,0.445,0.012345679012345678,Sunitinib (1mM),OHSU_HNSCC_derm002
31562,20004,Blank 490,2,K,OHSU_HNSCC_derm002,5,0.42,0.1234567901234568,Curcumin,OHSU_HNSCC_derm002
31563,20004,Blank 490,2,L,OHSU_HNSCC_derm002,5,0.491,0.1234567901234568,PF-562271,OHSU_HNSCC_derm002
31564,20004,Blank 490,2,M,OHSU_HNSCC_derm002,5,0.611,0.1234567901234568,STO609,OHSU_HNSCC_derm002
31565,20004,Blank 490,2,N,OHSU_HNSCC_derm002,5,0.414,0.1234567901234568,Lenvatinib,OHSU_HNSCC_derm002
31566,20004,Blank 490,2,O,OHSU_HNSCC_derm002,5,0.449,0.1234567901234568,Entrectinib,OHSU_HNSCC_derm002
31567,20004,Blank 490,2,P,OHSU_HNSCC_derm002,5,0.418,0.1234567901234568,Ethyl Gallate ,OHSU_HNSCC_derm002
31568,20004,Blank 490,2,A,OHSU_HNSCC_derm002,6,0.431,0.0411522633744856,Coumarin,OHSU_HNSCC_derm002
31569,20004,Blank 490,2,B,OHSU_HNSCC_derm002,6,0.269,0.04115226;0.0411526,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31570,20004,Blank 490,2,C,OHSU_HNSCC_derm002,6,0.34,0.0411522633744856,Foretinib (XL-880),OHSU_HNSCC_derm002
31571,20004,Blank 490,2,D,OHSU_HNSCC_derm002,6,0.079,0.0411522633744856,Elesclomol,OHSU_HNSCC_derm002
31572,20004,Blank 490,2,E,OHSU_HNSCC_derm002,6,0.343,0.0411522633744856,Vemurafenib,OHSU_HNSCC_derm002
31573,20004,Blank 490,2,F,OHSU_HNSCC_derm002,6,0.355,0.04115226;0.0411526,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31574,20004,Blank 490,2,G,OHSU_HNSCC_derm002,6,0.488,0.0411522633744856,Ponatinib,OHSU_HNSCC_derm002
31575,20004,Blank 490,2,H,OHSU_HNSCC_derm002,6,0.484,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
31576,20004,Blank 490,2,I,OHSU_HNSCC_derm002,6,0.469,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
31577,20004,Blank 490,2,J,OHSU_HNSCC_derm002,6,0.461,0.004115226337448559,Sunitinib (1mM),OHSU_HNSCC_derm002
31578,20004,Blank 490,2,K,OHSU_HNSCC_derm002,6,0.464,0.0411522633744856,Curcumin,OHSU_HNSCC_derm002
31579,20004,Blank 490,2,L,OHSU_HNSCC_derm002,6,0.447,0.0411522633744856,PF-562271,OHSU_HNSCC_derm002
31580,20004,Blank 490,2,M,OHSU_HNSCC_derm002,6,0.509,0.0411522633744856,STO609,OHSU_HNSCC_derm002
31581,20004,Blank 490,2,N,OHSU_HNSCC_derm002,6,0.441,0.0411522633744856,Lenvatinib,OHSU_HNSCC_derm002
31582,20004,Blank 490,2,O,OHSU_HNSCC_derm002,6,0.377,0.0411522633744856,Entrectinib,OHSU_HNSCC_derm002
31583,20004,Blank 490,2,P,OHSU_HNSCC_derm002,6,0.387,0.0411522633744856,Ethyl Gallate ,OHSU_HNSCC_derm002
31584,20004,Blank 490,2,A,OHSU_HNSCC_derm002,7,0.401,0.013717421124828532,Coumarin,OHSU_HNSCC_derm002
31585,20004,Blank 490,2,B,OHSU_HNSCC_derm002,7,0.324,0.01371742;0.01371742,Afatinib;Gefitinib,OHSU_HNSCC_derm002
31586,20004,Blank 490,2,C,OHSU_HNSCC_derm002,7,0.396,0.013717421124828532,Foretinib (XL-880),OHSU_HNSCC_derm002
31587,20004,Blank 490,2,D,OHSU_HNSCC_derm002,7,0.232,0.013717421124828532,Elesclomol,OHSU_HNSCC_derm002
31588,20004,Blank 490,2,E,OHSU_HNSCC_derm002,7,0.354,0.013717421124828532,Vemurafenib,OHSU_HNSCC_derm002
31589,20004,Blank 490,2,F,OHSU_HNSCC_derm002,7,0.435,0.01371742;0.01371742,I-BET 762;BEZ235,OHSU_HNSCC_derm002
31590,20004,Blank 490,2,G,OHSU_HNSCC_derm002,7,0.468,0.013717421124828532,Ponatinib,OHSU_HNSCC_derm002
31591,20004,Blank 490,2,H,OHSU_HNSCC_derm002,7,0.418,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
31592,20004,Blank 490,2,I,OHSU_HNSCC_derm002,7,0.249,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
31593,20004,Blank 490,2,J,OHSU_HNSCC_derm002,7,0.425,0.0013717421124828531,Sunitinib (1mM),OHSU_HNSCC_derm002
31594,20004,Blank 490,2,K,OHSU_HNSCC_derm002,7,0.506,0.013717421124828532,Curcumin,OHSU_HNSCC_derm002
31595,20004,Blank 490,2,L,OHSU_HNSCC_derm002,7,0.47,0.013717421124828532,PF-562271,OHSU_HNSCC_derm002
31596,20004,Blank 490,2,M,OHSU_HNSCC_derm002,7,0.457,0.013717421124828532,STO609,OHSU_HNSCC_derm002
31597,20004,Blank 490,2,N,OHSU_HNSCC_derm002,7,0.49,0.013717421124828532,Lenvatinib,OHSU_HNSCC_derm002
31598,20004,Blank 490,2,O,OHSU_HNSCC_derm002,7,0.406,0.013717421124828532,Entrectinib,OHSU_HNSCC_derm002
31599,20004,Blank 490,2,P,OHSU_HNSCC_derm002,7,0.424,0.013717421124828532,Ethyl Gallate ,OHSU_HNSCC_derm002
31600,20004,Blank 490,2,A,OHSU_HNSCC_derm002,8,0.413,0,NONE,OHSU_HNSCC_derm002
31601,20004,Blank 490,2,B,OHSU_HNSCC_derm002,8,0.309,0,NONE,OHSU_HNSCC_derm002
31602,20004,Blank 490,2,C,OHSU_HNSCC_derm002,8,0.386,0,NONE,OHSU_HNSCC_derm002
31603,20004,Blank 490,2,D,OHSU_HNSCC_derm002,8,0.306,0,NONE,OHSU_HNSCC_derm002
31604,20004,Blank 490,2,E,OHSU_HNSCC_derm002,8,0.407,0,NONE,OHSU_HNSCC_derm002
31605,20004,Blank 490,2,F,OHSU_HNSCC_derm002,8,0.403,0,NONE,OHSU_HNSCC_derm002
31606,20004,Blank 490,2,G,OHSU_HNSCC_derm002,8,0.437,0,NONE,OHSU_HNSCC_derm002
31607,20004,Blank 490,2,H,OHSU_HNSCC_derm002,8,-0.001,10,F-S-V,OHSU_HNSCC_derm002
31608,20004,Blank 490,2,I,OHSU_HNSCC_derm002,8,0.625,0,NONE,OHSU_HNSCC_derm002
31609,20004,Blank 490,2,J,OHSU_HNSCC_derm002,8,0.49,0,NONE,OHSU_HNSCC_derm002
31610,20004,Blank 490,2,K,OHSU_HNSCC_derm002,8,0.457,0,NONE,OHSU_HNSCC_derm002
31611,20004,Blank 490,2,L,OHSU_HNSCC_derm002,8,0.402,0,NONE,OHSU_HNSCC_derm002
31612,20004,Blank 490,2,M,OHSU_HNSCC_derm002,8,0.422,0,NONE,OHSU_HNSCC_derm002
31613,20004,Blank 490,2,N,OHSU_HNSCC_derm002,8,0.475,0,NONE,OHSU_HNSCC_derm002
31614,20004,Blank 490,2,O,OHSU_HNSCC_derm002,8,0.4,0,NONE,OHSU_HNSCC_derm002
31615,20004,Blank 490,2,P,OHSU_HNSCC_derm002,8,0.41,0,NONE,OHSU_HNSCC_derm002
31616,20004,Blank 490,2,A,OHSU_HNSCC_derm002,9,0.078,10,GDC-0941,OHSU_HNSCC_derm002
31617,20004,Blank 490,2,B,OHSU_HNSCC_derm002,9,0.328,10,Dovitinib,OHSU_HNSCC_derm002
31618,20004,Blank 490,2,C,OHSU_HNSCC_derm002,9,0.087,10,BI-2536,OHSU_HNSCC_derm002
31619,20004,Blank 490,2,D,OHSU_HNSCC_derm002,9,0.011,10,TP-0903 ,OHSU_HNSCC_derm002
31620,20004,Blank 490,2,E,OHSU_HNSCC_derm002,9,0.077,10,Belinostat,OHSU_HNSCC_derm002
31621,20004,Blank 490,2,F,OHSU_HNSCC_derm002,9,0.036,10,INK-128,OHSU_HNSCC_derm002
31622,20004,Blank 490,2,G,OHSU_HNSCC_derm002,9,0.253,10;10,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31623,20004,Blank 490,2,H,OHSU_HNSCC_derm002,9,0.057,10,Brigatinib,OHSU_HNSCC_derm002
31624,20004,Blank 490,2,I,OHSU_HNSCC_derm002,9,0.08,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31625,20004,Blank 490,2,J,OHSU_HNSCC_derm002,9,0.095,10;10,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31626,20004,Blank 490,2,K,OHSU_HNSCC_derm002,9,0.458,10,Pazopanib,OHSU_HNSCC_derm002
31627,20004,Blank 490,2,L,OHSU_HNSCC_derm002,9,0.385,10,AZD4547,OHSU_HNSCC_derm002
31628,20004,Blank 490,2,M,OHSU_HNSCC_derm002,9,0.399,10,Pomalidomide ,OHSU_HNSCC_derm002
31629,20004,Blank 490,2,N,OHSU_HNSCC_derm002,9,0.332,10,Idelasib (GS-1101),OHSU_HNSCC_derm002
31630,20004,Blank 490,2,O,OHSU_HNSCC_derm002,9,0.414,10,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31631,20004,Blank 490,2,P,OHSU_HNSCC_derm002,9,-0.002,10,Staurosporin,OHSU_HNSCC_derm002
31632,20004,Blank 490,2,A,OHSU_HNSCC_derm002,10,0.077,3.3333333333333335,GDC-0941,OHSU_HNSCC_derm002
31633,20004,Blank 490,2,B,OHSU_HNSCC_derm002,10,0.42,3.3333333333333335,Dovitinib,OHSU_HNSCC_derm002
31634,20004,Blank 490,2,C,OHSU_HNSCC_derm002,10,0.258,3.3333333333333335,BI-2536,OHSU_HNSCC_derm002
31635,20004,Blank 490,2,D,OHSU_HNSCC_derm002,10,0.009,3.3333333333333335,TP-0903 ,OHSU_HNSCC_derm002
31636,20004,Blank 490,2,E,OHSU_HNSCC_derm002,10,0.134,3.3333333333333335,Belinostat,OHSU_HNSCC_derm002
31637,20004,Blank 490,2,F,OHSU_HNSCC_derm002,10,0.074,3.3333333333333335,INK-128,OHSU_HNSCC_derm002
31638,20004,Blank 490,2,G,OHSU_HNSCC_derm002,10,0.297,3.33333;3.33333,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31639,20004,Blank 490,2,H,OHSU_HNSCC_derm002,10,0.17,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
31640,20004,Blank 490,2,I,OHSU_HNSCC_derm002,10,0.287,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31641,20004,Blank 490,2,J,OHSU_HNSCC_derm002,10,0.369,3.33333;3.33333,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31642,20004,Blank 490,2,K,OHSU_HNSCC_derm002,10,0.471,3.3333333333333335,Pazopanib,OHSU_HNSCC_derm002
31643,20004,Blank 490,2,L,OHSU_HNSCC_derm002,10,0.487,3.3333333333333335,AZD4547,OHSU_HNSCC_derm002
31644,20004,Blank 490,2,M,OHSU_HNSCC_derm002,10,0.442,3.3333333333333335,Pomalidomide ,OHSU_HNSCC_derm002
31645,20004,Blank 490,2,N,OHSU_HNSCC_derm002,10,0.424,3.3333333333333335,Idelasib (GS-1101),OHSU_HNSCC_derm002
31646,20004,Blank 490,2,O,OHSU_HNSCC_derm002,10,0.4,3.3333333333333335,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31647,20004,Blank 490,2,P,OHSU_HNSCC_derm002,10,-0.001,3.3333333333333335,Staurosporin,OHSU_HNSCC_derm002
31648,20004,Blank 490,2,A,OHSU_HNSCC_derm002,11,0.13,1.1111111111111112,GDC-0941,OHSU_HNSCC_derm002
31649,20004,Blank 490,2,B,OHSU_HNSCC_derm002,11,0.458,1.1111111111111112,Dovitinib,OHSU_HNSCC_derm002
31650,20004,Blank 490,2,C,OHSU_HNSCC_derm002,11,0.405,1.1111111111111112,BI-2536,OHSU_HNSCC_derm002
31651,20004,Blank 490,2,D,OHSU_HNSCC_derm002,11,0.001,1.1111111111111112,TP-0903 ,OHSU_HNSCC_derm002
31652,20004,Blank 490,2,E,OHSU_HNSCC_derm002,11,0.206,1.1111111111111112,Belinostat,OHSU_HNSCC_derm002
31653,20004,Blank 490,2,F,OHSU_HNSCC_derm002,11,0.081,1.1111111111111112,INK-128,OHSU_HNSCC_derm002
31654,20004,Blank 490,2,G,OHSU_HNSCC_derm002,11,0.315,1.1111;1.11111,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31655,20004,Blank 490,2,H,OHSU_HNSCC_derm002,11,0.357,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
31656,20004,Blank 490,2,I,OHSU_HNSCC_derm002,11,0.338,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31657,20004,Blank 490,2,J,OHSU_HNSCC_derm002,11,0.43,1.1111;1.11111,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31658,20004,Blank 490,2,K,OHSU_HNSCC_derm002,11,0.468,1.1111111111111112,Pazopanib,OHSU_HNSCC_derm002
31659,20004,Blank 490,2,L,OHSU_HNSCC_derm002,11,0.491,1.1111111111111112,AZD4547,OHSU_HNSCC_derm002
31660,20004,Blank 490,2,M,OHSU_HNSCC_derm002,11,0.432,1.1111111111111112,Pomalidomide ,OHSU_HNSCC_derm002
31661,20004,Blank 490,2,N,OHSU_HNSCC_derm002,11,0.416,1.1111111111111112,Idelasib (GS-1101),OHSU_HNSCC_derm002
31662,20004,Blank 490,2,O,OHSU_HNSCC_derm002,11,0.423,1.1111111111111112,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31663,20004,Blank 490,2,P,OHSU_HNSCC_derm002,11,0.0,1.1111111111111112,Staurosporin,OHSU_HNSCC_derm002
31664,20004,Blank 490,2,A,OHSU_HNSCC_derm002,12,0.227,0.3703703703703704,GDC-0941,OHSU_HNSCC_derm002
31665,20004,Blank 490,2,B,OHSU_HNSCC_derm002,12,0.441,0.3703703703703704,Dovitinib,OHSU_HNSCC_derm002
31666,20004,Blank 490,2,C,OHSU_HNSCC_derm002,12,0.438,0.3703703703703704,BI-2536,OHSU_HNSCC_derm002
31667,20004,Blank 490,2,D,OHSU_HNSCC_derm002,12,0.101,0.3703703703703704,TP-0903 ,OHSU_HNSCC_derm002
31668,20004,Blank 490,2,E,OHSU_HNSCC_derm002,12,0.281,0.3703703703703704,Belinostat,OHSU_HNSCC_derm002
31669,20004,Blank 490,2,F,OHSU_HNSCC_derm002,12,0.118,0.3703703703703704,INK-128,OHSU_HNSCC_derm002
31670,20004,Blank 490,2,G,OHSU_HNSCC_derm002,12,0.331,0.37037;0.37037,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31671,20004,Blank 490,2,H,OHSU_HNSCC_derm002,12,0.416,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
31672,20004,Blank 490,2,I,OHSU_HNSCC_derm002,12,0.384,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31673,20004,Blank 490,2,J,OHSU_HNSCC_derm002,12,0.534,0.37037;0.37037,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31674,20004,Blank 490,2,K,OHSU_HNSCC_derm002,12,0.461,0.3703703703703704,Pazopanib,OHSU_HNSCC_derm002
31675,20004,Blank 490,2,L,OHSU_HNSCC_derm002,12,0.499,0.3703703703703704,AZD4547,OHSU_HNSCC_derm002
31676,20004,Blank 490,2,M,OHSU_HNSCC_derm002,12,0.419,0.3703703703703704,Pomalidomide ,OHSU_HNSCC_derm002
31677,20004,Blank 490,2,N,OHSU_HNSCC_derm002,12,0.421,0.3703703703703704,Idelasib (GS-1101),OHSU_HNSCC_derm002
31678,20004,Blank 490,2,O,OHSU_HNSCC_derm002,12,0.462,0.3703703703703704,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31679,20004,Blank 490,2,P,OHSU_HNSCC_derm002,12,0.07,0.3703703703703704,Staurosporin,OHSU_HNSCC_derm002
31680,20004,Blank 490,2,A,OHSU_HNSCC_derm002,13,0.284,0.1234567901234568,GDC-0941,OHSU_HNSCC_derm002
31681,20004,Blank 490,2,B,OHSU_HNSCC_derm002,13,0.394,0.1234567901234568,Dovitinib,OHSU_HNSCC_derm002
31682,20004,Blank 490,2,C,OHSU_HNSCC_derm002,13,0.386,0.1234567901234568,BI-2536,OHSU_HNSCC_derm002
31683,20004,Blank 490,2,D,OHSU_HNSCC_derm002,13,0.303,0.1234567901234568,TP-0903 ,OHSU_HNSCC_derm002
31684,20004,Blank 490,2,E,OHSU_HNSCC_derm002,13,0.269,0.1234567901234568,Belinostat,OHSU_HNSCC_derm002
31685,20004,Blank 490,2,F,OHSU_HNSCC_derm002,13,0.134,0.1234567901234568,INK-128,OHSU_HNSCC_derm002
31686,20004,Blank 490,2,G,OHSU_HNSCC_derm002,13,0.368,0.123456;0.123456,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31687,20004,Blank 490,2,H,OHSU_HNSCC_derm002,13,0.468,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
31688,20004,Blank 490,2,I,OHSU_HNSCC_derm002,13,0.354,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31689,20004,Blank 490,2,J,OHSU_HNSCC_derm002,13,0.48,0.123456;0.123456,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31690,20004,Blank 490,2,K,OHSU_HNSCC_derm002,13,0.49,0.1234567901234568,Pazopanib,OHSU_HNSCC_derm002
31691,20004,Blank 490,2,L,OHSU_HNSCC_derm002,13,0.484,0.1234567901234568,AZD4547,OHSU_HNSCC_derm002
31692,20004,Blank 490,2,M,OHSU_HNSCC_derm002,13,0.462,0.1234567901234568,Pomalidomide ,OHSU_HNSCC_derm002
31693,20004,Blank 490,2,N,OHSU_HNSCC_derm002,13,0.446,0.1234567901234568,Idelasib (GS-1101),OHSU_HNSCC_derm002
31694,20004,Blank 490,2,O,OHSU_HNSCC_derm002,13,0.404,0.1234567901234568,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31695,20004,Blank 490,2,P,OHSU_HNSCC_derm002,13,0.229,0.1234567901234568,Staurosporin,OHSU_HNSCC_derm002
31696,20004,Blank 490,2,A,OHSU_HNSCC_derm002,14,0.315,0.0411522633744856,GDC-0941,OHSU_HNSCC_derm002
31697,20004,Blank 490,2,B,OHSU_HNSCC_derm002,14,0.402,0.0411522633744856,Dovitinib,OHSU_HNSCC_derm002
31698,20004,Blank 490,2,C,OHSU_HNSCC_derm002,14,0.337,0.0411522633744856,BI-2536,OHSU_HNSCC_derm002
31699,20004,Blank 490,2,D,OHSU_HNSCC_derm002,14,0.392,0.0411522633744856,TP-0903 ,OHSU_HNSCC_derm002
31700,20004,Blank 490,2,E,OHSU_HNSCC_derm002,14,0.306,0.0411522633744856,Belinostat,OHSU_HNSCC_derm002
31701,20004,Blank 490,2,F,OHSU_HNSCC_derm002,14,0.194,0.0411522633744856,INK-128,OHSU_HNSCC_derm002
31702,20004,Blank 490,2,G,OHSU_HNSCC_derm002,14,0.374,0.04115226;0.0411526,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31703,20004,Blank 490,2,H,OHSU_HNSCC_derm002,14,0.445,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
31704,20004,Blank 490,2,I,OHSU_HNSCC_derm002,14,0.358,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31705,20004,Blank 490,2,J,OHSU_HNSCC_derm002,14,0.458,0.04115226;0.0411526,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31706,20004,Blank 490,2,K,OHSU_HNSCC_derm002,14,0.491,0.0411522633744856,Pazopanib,OHSU_HNSCC_derm002
31707,20004,Blank 490,2,L,OHSU_HNSCC_derm002,14,0.477,0.0411522633744856,AZD4547,OHSU_HNSCC_derm002
31708,20004,Blank 490,2,M,OHSU_HNSCC_derm002,14,0.437,0.0411522633744856,Pomalidomide ,OHSU_HNSCC_derm002
31709,20004,Blank 490,2,N,OHSU_HNSCC_derm002,14,0.453,0.0411522633744856,Idelasib (GS-1101),OHSU_HNSCC_derm002
31710,20004,Blank 490,2,O,OHSU_HNSCC_derm002,14,0.441,0.0411522633744856,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31711,20004,Blank 490,2,P,OHSU_HNSCC_derm002,14,0.255,0.0411522633744856,Staurosporin,OHSU_HNSCC_derm002
31712,20004,Blank 490,2,A,OHSU_HNSCC_derm002,15,0.348,0.013717421124828532,GDC-0941,OHSU_HNSCC_derm002
31713,20004,Blank 490,2,B,OHSU_HNSCC_derm002,15,0.379,0.013717421124828532,Dovitinib,OHSU_HNSCC_derm002
31714,20004,Blank 490,2,C,OHSU_HNSCC_derm002,15,0.327,0.013717421124828532,BI-2536,OHSU_HNSCC_derm002
31715,20004,Blank 490,2,D,OHSU_HNSCC_derm002,15,0.328,0.013717421124828532,TP-0903 ,OHSU_HNSCC_derm002
31716,20004,Blank 490,2,E,OHSU_HNSCC_derm002,15,0.384,0.013717421124828532,Belinostat,OHSU_HNSCC_derm002
31717,20004,Blank 490,2,F,OHSU_HNSCC_derm002,15,0.219,0.013717421124828532,INK-128,OHSU_HNSCC_derm002
31718,20004,Blank 490,2,G,OHSU_HNSCC_derm002,15,0.402,0.01371742;0.01371742,Trametinib;Gefitinib,OHSU_HNSCC_derm002
31719,20004,Blank 490,2,H,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
31720,20004,Blank 490,2,I,OHSU_HNSCC_derm002,15,0.365,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
31721,20004,Blank 490,2,J,OHSU_HNSCC_derm002,15,0.489,0.01371742;0.01371742,Bosutinib;Gefitinib,OHSU_HNSCC_derm002
31722,20004,Blank 490,2,K,OHSU_HNSCC_derm002,15,0.464,0.013717421124828532,Pazopanib,OHSU_HNSCC_derm002
31723,20004,Blank 490,2,L,OHSU_HNSCC_derm002,15,0.476,0.013717421124828532,AZD4547,OHSU_HNSCC_derm002
31724,20004,Blank 490,2,M,OHSU_HNSCC_derm002,15,0.451,0.013717421124828532,Pomalidomide ,OHSU_HNSCC_derm002
31725,20004,Blank 490,2,N,OHSU_HNSCC_derm002,15,0.441,0.013717421124828532,Idelasib (GS-1101),OHSU_HNSCC_derm002
31726,20004,Blank 490,2,O,OHSU_HNSCC_derm002,15,0.422,0.013717421124828532,(+)-Anwulignan (macelignan),OHSU_HNSCC_derm002
31727,20004,Blank 490,2,P,OHSU_HNSCC_derm002,15,0.286,0.013717421124828532,Staurosporin,OHSU_HNSCC_derm002
31728,20004,Blank 490,2,A,OHSU_HNSCC_derm002,16,0.425,0,NONE,OHSU_HNSCC_derm002
31729,20004,Blank 490,2,B,OHSU_HNSCC_derm002,16,0.402,0,NONE,OHSU_HNSCC_derm002
31730,20004,Blank 490,2,C,OHSU_HNSCC_derm002,16,0.356,0,NONE,OHSU_HNSCC_derm002
31731,20004,Blank 490,2,D,OHSU_HNSCC_derm002,16,0.323,0,NONE,OHSU_HNSCC_derm002
31732,20004,Blank 490,2,E,OHSU_HNSCC_derm002,16,0.332,0,NONE,OHSU_HNSCC_derm002
31733,20004,Blank 490,2,F,OHSU_HNSCC_derm002,16,0.331,0,NONE,OHSU_HNSCC_derm002
31734,20004,Blank 490,2,G,OHSU_HNSCC_derm002,16,0.464,0,NONE,OHSU_HNSCC_derm002
31735,20004,Blank 490,2,H,OHSU_HNSCC_derm002,16,0.001,10,F-S-V,OHSU_HNSCC_derm002
31736,20004,Blank 490,2,I,OHSU_HNSCC_derm002,16,0.488,0,NONE,OHSU_HNSCC_derm002
31737,20004,Blank 490,2,J,OHSU_HNSCC_derm002,16,0.468,0,NONE,OHSU_HNSCC_derm002
31738,20004,Blank 490,2,K,OHSU_HNSCC_derm002,16,0.39,0,NONE,OHSU_HNSCC_derm002
31739,20004,Blank 490,2,L,OHSU_HNSCC_derm002,16,0.446,0,NONE,OHSU_HNSCC_derm002
31740,20004,Blank 490,2,M,OHSU_HNSCC_derm002,16,0.434,0,NONE,OHSU_HNSCC_derm002
31741,20004,Blank 490,2,N,OHSU_HNSCC_derm002,16,0.445,0,NONE,OHSU_HNSCC_derm002
31742,20004,Blank 490,2,O,OHSU_HNSCC_derm002,16,0.37,0,NONE,OHSU_HNSCC_derm002
31743,20004,Blank 490,2,P,OHSU_HNSCC_derm002,16,0.406,0,NONE,OHSU_HNSCC_derm002
31744,20004,Blank 490,2,A,OHSU_HNSCC_derm002,17,0.35,10,Tozasertib (VX-680),OHSU_HNSCC_derm002
31745,20004,Blank 490,2,B,OHSU_HNSCC_derm002,17,0.384,10,Hesperidin,OHSU_HNSCC_derm002
31746,20004,Blank 490,2,C,OHSU_HNSCC_derm002,17,0.385,10,Esculetin,OHSU_HNSCC_derm002
31747,20004,Blank 490,2,D,OHSU_HNSCC_derm002,17,0.048,10,Selinexor ,OHSU_HNSCC_derm002
31748,20004,Blank 490,2,E,OHSU_HNSCC_derm002,17,0.047,10,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31749,20004,Blank 490,2,F,OHSU_HNSCC_derm002,17,0.269,10,BMX-IN-1,OHSU_HNSCC_derm002
31750,20004,Blank 490,2,G,OHSU_HNSCC_derm002,17,0.226,1,Dasatinib (1mM),OHSU_HNSCC_derm002
31751,20004,Blank 490,2,H,OHSU_HNSCC_derm002,17,0.335,10,Trametinib,OHSU_HNSCC_derm002
31752,20004,Blank 490,2,I,OHSU_HNSCC_derm002,17,0.135,10,BEZ235,OHSU_HNSCC_derm002
31753,20004,Blank 490,2,J,OHSU_HNSCC_derm002,17,0.031,10,Bortezomib (Velcade),OHSU_HNSCC_derm002
31754,20004,Blank 490,2,K,OHSU_HNSCC_derm002,17,0.249,10,Nilotinib,OHSU_HNSCC_derm002
31755,20004,Blank 490,2,L,OHSU_HNSCC_derm002,17,0.357,10,Enzalutamide,OHSU_HNSCC_derm002
31756,20004,Blank 490,2,M,OHSU_HNSCC_derm002,17,0.493,10,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31757,20004,Blank 490,2,N,OHSU_HNSCC_derm002,17,0.144,10;10,JQ1;Gefitinib,OHSU_HNSCC_derm002
31758,20004,Blank 490,2,O,OHSU_HNSCC_derm002,17,0.015,10,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31759,20004,Blank 490,2,P,OHSU_HNSCC_derm002,17,0.305,10,Axitinib,OHSU_HNSCC_derm002
31760,20004,Blank 490,2,A,OHSU_HNSCC_derm002,18,0.399,3.3333333333333335,Tozasertib (VX-680),OHSU_HNSCC_derm002
31761,20004,Blank 490,2,B,OHSU_HNSCC_derm002,18,0.38,3.3333333333333335,Hesperidin,OHSU_HNSCC_derm002
31762,20004,Blank 490,2,C,OHSU_HNSCC_derm002,18,0.369,3.3333333333333335,Esculetin,OHSU_HNSCC_derm002
31763,20004,Blank 490,2,D,OHSU_HNSCC_derm002,18,0.041,3.3333333333333335,Selinexor ,OHSU_HNSCC_derm002
31764,20004,Blank 490,2,E,OHSU_HNSCC_derm002,18,0.313,3.3333333333333335,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31765,20004,Blank 490,2,F,OHSU_HNSCC_derm002,18,0.3,3.3333333333333335,BMX-IN-1,OHSU_HNSCC_derm002
31766,20004,Blank 490,2,G,OHSU_HNSCC_derm002,18,0.204,0.3333333333333333,Dasatinib (1mM),OHSU_HNSCC_derm002
31767,20004,Blank 490,2,H,OHSU_HNSCC_derm002,18,0.385,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
31768,20004,Blank 490,2,I,OHSU_HNSCC_derm002,18,0.135,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
31769,20004,Blank 490,2,J,OHSU_HNSCC_derm002,18,0.037,3.3333333333333335,Bortezomib (Velcade),OHSU_HNSCC_derm002
31770,20004,Blank 490,2,K,OHSU_HNSCC_derm002,18,0.382,3.3333333333333335,Nilotinib,OHSU_HNSCC_derm002
31771,20004,Blank 490,2,L,OHSU_HNSCC_derm002,18,0.377,3.3333333333333335,Enzalutamide,OHSU_HNSCC_derm002
31772,20004,Blank 490,2,M,OHSU_HNSCC_derm002,18,0.427,3.3333333333333335,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31773,20004,Blank 490,2,N,OHSU_HNSCC_derm002,18,0.278,3.33333;3.33333,JQ1;Gefitinib,OHSU_HNSCC_derm002
31774,20004,Blank 490,2,O,OHSU_HNSCC_derm002,18,0.008,3.3333333333333335,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31775,20004,Blank 490,2,P,OHSU_HNSCC_derm002,18,0.33,3.3333333333333335,Axitinib,OHSU_HNSCC_derm002
31776,20004,Blank 490,2,A,OHSU_HNSCC_derm002,19,0.364,1.1111111111111112,Tozasertib (VX-680),OHSU_HNSCC_derm002
31777,20004,Blank 490,2,B,OHSU_HNSCC_derm002,19,0.349,1.1111111111111112,Hesperidin,OHSU_HNSCC_derm002
31778,20004,Blank 490,2,C,OHSU_HNSCC_derm002,19,0.349,1.1111111111111112,Esculetin,OHSU_HNSCC_derm002
31779,20004,Blank 490,2,D,OHSU_HNSCC_derm002,19,0.081,1.1111111111111112,Selinexor ,OHSU_HNSCC_derm002
31780,20004,Blank 490,2,E,OHSU_HNSCC_derm002,19,0.31,1.1111111111111112,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31781,20004,Blank 490,2,F,OHSU_HNSCC_derm002,19,0.306,1.1111111111111112,BMX-IN-1,OHSU_HNSCC_derm002
31782,20004,Blank 490,2,G,OHSU_HNSCC_derm002,19,0.222,0.1111111111111111,Dasatinib (1mM),OHSU_HNSCC_derm002
31783,20004,Blank 490,2,H,OHSU_HNSCC_derm002,19,0.391,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
31784,20004,Blank 490,2,I,OHSU_HNSCC_derm002,19,0.123,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
31785,20004,Blank 490,2,J,OHSU_HNSCC_derm002,19,0.058,1.1111111111111112,Bortezomib (Velcade),OHSU_HNSCC_derm002
31786,20004,Blank 490,2,K,OHSU_HNSCC_derm002,19,0.422,1.1111111111111112,Nilotinib,OHSU_HNSCC_derm002
31787,20004,Blank 490,2,L,OHSU_HNSCC_derm002,19,0.426,1.1111111111111112,Enzalutamide,OHSU_HNSCC_derm002
31788,20004,Blank 490,2,M,OHSU_HNSCC_derm002,19,0.461,1.1111111111111112,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31789,20004,Blank 490,2,N,OHSU_HNSCC_derm002,19,0.26,1.1111;1.11111,JQ1;Gefitinib,OHSU_HNSCC_derm002
31790,20004,Blank 490,2,O,OHSU_HNSCC_derm002,19,0.017,1.1111111111111112,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31791,20004,Blank 490,2,P,OHSU_HNSCC_derm002,19,0.355,1.1111111111111112,Axitinib,OHSU_HNSCC_derm002
31792,20004,Blank 490,2,A,OHSU_HNSCC_derm002,20,0.395,0.3703703703703704,Tozasertib (VX-680),OHSU_HNSCC_derm002
31793,20004,Blank 490,2,B,OHSU_HNSCC_derm002,20,0.403,0.3703703703703704,Hesperidin,OHSU_HNSCC_derm002
31794,20004,Blank 490,2,C,OHSU_HNSCC_derm002,20,0.376,0.3703703703703704,Esculetin,OHSU_HNSCC_derm002
31795,20004,Blank 490,2,D,OHSU_HNSCC_derm002,20,0.155,0.3703703703703704,Selinexor ,OHSU_HNSCC_derm002
31796,20004,Blank 490,2,E,OHSU_HNSCC_derm002,20,0.307,0.3703703703703704,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31797,20004,Blank 490,2,F,OHSU_HNSCC_derm002,20,0.392,0.3703703703703704,BMX-IN-1,OHSU_HNSCC_derm002
31798,20004,Blank 490,2,G,OHSU_HNSCC_derm002,20,0.321,0.037037037037037035,Dasatinib (1mM),OHSU_HNSCC_derm002
31799,20004,Blank 490,2,H,OHSU_HNSCC_derm002,20,0.354,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
31800,20004,Blank 490,2,I,OHSU_HNSCC_derm002,20,0.16,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
31801,20004,Blank 490,2,J,OHSU_HNSCC_derm002,20,0.106,0.3703703703703704,Bortezomib (Velcade),OHSU_HNSCC_derm002
31802,20004,Blank 490,2,K,OHSU_HNSCC_derm002,20,0.432,0.3703703703703704,Nilotinib,OHSU_HNSCC_derm002
31803,20004,Blank 490,2,L,OHSU_HNSCC_derm002,20,0.439,0.3703703703703704,Enzalutamide,OHSU_HNSCC_derm002
31804,20004,Blank 490,2,M,OHSU_HNSCC_derm002,20,0.454,0.3703703703703704,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31805,20004,Blank 490,2,N,OHSU_HNSCC_derm002,20,0.3,0.37037;0.37037,JQ1;Gefitinib,OHSU_HNSCC_derm002
31806,20004,Blank 490,2,O,OHSU_HNSCC_derm002,20,0.192,0.3703703703703704,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31807,20004,Blank 490,2,P,OHSU_HNSCC_derm002,20,0.4,0.3703703703703704,Axitinib,OHSU_HNSCC_derm002
31808,20004,Blank 490,2,A,OHSU_HNSCC_derm002,21,0.415,0.1234567901234568,Tozasertib (VX-680),OHSU_HNSCC_derm002
31809,20004,Blank 490,2,B,OHSU_HNSCC_derm002,21,0.361,0.1234567901234568,Hesperidin,OHSU_HNSCC_derm002
31810,20004,Blank 490,2,C,OHSU_HNSCC_derm002,21,0.357,0.1234567901234568,Esculetin,OHSU_HNSCC_derm002
31811,20004,Blank 490,2,D,OHSU_HNSCC_derm002,21,0.308,0.1234567901234568,Selinexor ,OHSU_HNSCC_derm002
31812,20004,Blank 490,2,E,OHSU_HNSCC_derm002,21,0.42,0.1234567901234568,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31813,20004,Blank 490,2,F,OHSU_HNSCC_derm002,21,0.365,0.1234567901234568,BMX-IN-1,OHSU_HNSCC_derm002
31814,20004,Blank 490,2,G,OHSU_HNSCC_derm002,21,0.303,0.012345679012345678,Dasatinib (1mM),OHSU_HNSCC_derm002
31815,20004,Blank 490,2,H,OHSU_HNSCC_derm002,21,0.393,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
31816,20004,Blank 490,2,I,OHSU_HNSCC_derm002,21,0.261,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
31817,20004,Blank 490,2,J,OHSU_HNSCC_derm002,21,0.344,0.1234567901234568,Bortezomib (Velcade),OHSU_HNSCC_derm002
31818,20004,Blank 490,2,K,OHSU_HNSCC_derm002,21,0.411,0.1234567901234568,Nilotinib,OHSU_HNSCC_derm002
31819,20004,Blank 490,2,L,OHSU_HNSCC_derm002,21,0.408,0.1234567901234568,Enzalutamide,OHSU_HNSCC_derm002
31820,20004,Blank 490,2,M,OHSU_HNSCC_derm002,21,0.422,0.1234567901234568,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31821,20004,Blank 490,2,N,OHSU_HNSCC_derm002,21,0.467,0.123456;0.123456,JQ1;Gefitinib,OHSU_HNSCC_derm002
31822,20004,Blank 490,2,O,OHSU_HNSCC_derm002,21,0.393,0.1234567901234568,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31823,20004,Blank 490,2,P,OHSU_HNSCC_derm002,21,0.419,0.1234567901234568,Axitinib,OHSU_HNSCC_derm002
31824,20004,Blank 490,2,A,OHSU_HNSCC_derm002,22,0.442,0.0411522633744856,Tozasertib (VX-680),OHSU_HNSCC_derm002
31825,20004,Blank 490,2,B,OHSU_HNSCC_derm002,22,0.351,0.0411522633744856,Hesperidin,OHSU_HNSCC_derm002
31826,20004,Blank 490,2,C,OHSU_HNSCC_derm002,22,0.372,0.0411522633744856,Esculetin,OHSU_HNSCC_derm002
31827,20004,Blank 490,2,D,OHSU_HNSCC_derm002,22,0.391,0.0411522633744856,Selinexor ,OHSU_HNSCC_derm002
31828,20004,Blank 490,2,E,OHSU_HNSCC_derm002,22,0.377,0.0411522633744856,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31829,20004,Blank 490,2,F,OHSU_HNSCC_derm002,22,0.357,0.0411522633744856,BMX-IN-1,OHSU_HNSCC_derm002
31830,20004,Blank 490,2,G,OHSU_HNSCC_derm002,22,0.4,0.004115226337448559,Dasatinib (1mM),OHSU_HNSCC_derm002
31831,20004,Blank 490,2,H,OHSU_HNSCC_derm002,22,0.421,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
31832,20004,Blank 490,2,I,OHSU_HNSCC_derm002,22,0.37,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
31833,20004,Blank 490,2,J,OHSU_HNSCC_derm002,22,0.435,0.0411522633744856,Bortezomib (Velcade),OHSU_HNSCC_derm002
31834,20004,Blank 490,2,K,OHSU_HNSCC_derm002,22,0.33,0.0411522633744856,Nilotinib,OHSU_HNSCC_derm002
31835,20004,Blank 490,2,L,OHSU_HNSCC_derm002,22,0.41,0.0411522633744856,Enzalutamide,OHSU_HNSCC_derm002
31836,20004,Blank 490,2,M,OHSU_HNSCC_derm002,22,0.456,0.0411522633744856,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31837,20004,Blank 490,2,N,OHSU_HNSCC_derm002,22,0.479,0.04115226;0.0411526,JQ1;Gefitinib,OHSU_HNSCC_derm002
31838,20004,Blank 490,2,O,OHSU_HNSCC_derm002,22,0.397,0.0411522633744856,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31839,20004,Blank 490,2,P,OHSU_HNSCC_derm002,22,0.375,0.0411522633744856,Axitinib,OHSU_HNSCC_derm002
31840,20004,Blank 490,2,A,OHSU_HNSCC_derm002,23,0.436,0.013717421124828532,Tozasertib (VX-680),OHSU_HNSCC_derm002
31841,20004,Blank 490,2,B,OHSU_HNSCC_derm002,23,0.381,0.013717421124828532,Hesperidin,OHSU_HNSCC_derm002
31842,20004,Blank 490,2,C,OHSU_HNSCC_derm002,23,0.366,0.013717421124828532,Esculetin,OHSU_HNSCC_derm002
31843,20004,Blank 490,2,D,OHSU_HNSCC_derm002,23,0.383,0.013717421124828532,Selinexor ,OHSU_HNSCC_derm002
31844,20004,Blank 490,2,E,OHSU_HNSCC_derm002,23,0.402,0.013717421124828532,Infigratinib/NVPBGJ398,OHSU_HNSCC_derm002
31845,20004,Blank 490,2,F,OHSU_HNSCC_derm002,23,0.46,0.013717421124828532,BMX-IN-1,OHSU_HNSCC_derm002
31846,20004,Blank 490,2,G,OHSU_HNSCC_derm002,23,0.424,0.0013717421124828531,Dasatinib (1mM),OHSU_HNSCC_derm002
31847,20004,Blank 490,2,H,OHSU_HNSCC_derm002,23,0.405,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
31848,20004,Blank 490,2,I,OHSU_HNSCC_derm002,23,0.345,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
31849,20004,Blank 490,2,J,OHSU_HNSCC_derm002,23,0.399,0.013717421124828532,Bortezomib (Velcade),OHSU_HNSCC_derm002
31850,20004,Blank 490,2,K,OHSU_HNSCC_derm002,23,0.472,0.013717421124828532,Nilotinib,OHSU_HNSCC_derm002
31851,20004,Blank 490,2,L,OHSU_HNSCC_derm002,23,0.393,0.013717421124828532,Enzalutamide,OHSU_HNSCC_derm002
31852,20004,Blank 490,2,M,OHSU_HNSCC_derm002,23,0.469,0.013717421124828532,Caffeic acid (oral cancer research),OHSU_HNSCC_derm002
31853,20004,Blank 490,2,N,OHSU_HNSCC_derm002,23,0.464,0.01371742;0.01371742,JQ1;Gefitinib,OHSU_HNSCC_derm002
31854,20004,Blank 490,2,O,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,BMS-387032 (SNS-032),OHSU_HNSCC_derm002
31855,20004,Blank 490,2,P,OHSU_HNSCC_derm002,23,0.431,0.013717421124828532,Axitinib,OHSU_HNSCC_derm002
31856,20004,Blank 490,2,A,OHSU_HNSCC_derm002,24,0.423,0,NONE,OHSU_HNSCC_derm002
31857,20004,Blank 490,2,B,OHSU_HNSCC_derm002,24,0.429,0,NONE,OHSU_HNSCC_derm002
31858,20004,Blank 490,2,C,OHSU_HNSCC_derm002,24,0.363,0,NONE,OHSU_HNSCC_derm002
31859,20004,Blank 490,2,D,OHSU_HNSCC_derm002,24,0.381,0,NONE,OHSU_HNSCC_derm002
31860,20004,Blank 490,2,E,OHSU_HNSCC_derm002,24,0.391,0,NONE,OHSU_HNSCC_derm002
31861,20004,Blank 490,2,F,OHSU_HNSCC_derm002,24,0.394,0,NONE,OHSU_HNSCC_derm002
31862,20004,Blank 490,2,G,OHSU_HNSCC_derm002,24,0.424,0,NONE,OHSU_HNSCC_derm002
31863,20004,Blank 490,2,H,OHSU_HNSCC_derm002,24,0.431,0,NONE,OHSU_HNSCC_derm002
31864,20004,Blank 490,2,I,OHSU_HNSCC_derm002,24,0.419,0,NONE,OHSU_HNSCC_derm002
31865,20004,Blank 490,2,J,OHSU_HNSCC_derm002,24,0.454,0,NONE,OHSU_HNSCC_derm002
31866,20004,Blank 490,2,K,OHSU_HNSCC_derm002,24,0.385,0,NONE,OHSU_HNSCC_derm002
31867,20004,Blank 490,2,L,OHSU_HNSCC_derm002,24,0.389,0,NONE,OHSU_HNSCC_derm002
31868,20004,Blank 490,2,M,OHSU_HNSCC_derm002,24,0.427,0,NONE,OHSU_HNSCC_derm002
31869,20004,Blank 490,2,N,OHSU_HNSCC_derm002,24,0.416,0,NONE,OHSU_HNSCC_derm002
31870,20004,Blank 490,2,O,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
31871,20004,Blank 490,2,P,OHSU_HNSCC_derm002,24,0.436,0,NONE,OHSU_HNSCC_derm002
31872,20004,Blank 490,3,A,OHSU_HNSCC_derm002,1,0.354,10,Thalidomide ,OHSU_HNSCC_derm002
31873,20004,Blank 490,3,B,OHSU_HNSCC_derm002,1,0.211,10,Vandetanib,OHSU_HNSCC_derm002
31874,20004,Blank 490,3,C,OHSU_HNSCC_derm002,1,0.426,10,Oleic acid,OHSU_HNSCC_derm002
31875,20004,Blank 490,3,D,OHSU_HNSCC_derm002,1,0.006,10,A-674563,OHSU_HNSCC_derm002
31876,20004,Blank 490,3,E,OHSU_HNSCC_derm002,1,0.206,10,Lapatinib,OHSU_HNSCC_derm002
31877,20004,Blank 490,3,F,OHSU_HNSCC_derm002,1,0.399,10,Apocynin (vanillin),OHSU_HNSCC_derm002
31878,20004,Blank 490,3,G,OHSU_HNSCC_derm002,1,0.017,10,AT-7519,OHSU_HNSCC_derm002
31879,20004,Blank 490,3,H,OHSU_HNSCC_derm002,1,0.271,10,Gefitinib,OHSU_HNSCC_derm002
31880,20004,Blank 490,3,I,OHSU_HNSCC_derm002,1,0.024,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
31881,20004,Blank 490,3,J,OHSU_HNSCC_derm002,1,0.164,10;10,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31882,20004,Blank 490,3,K,OHSU_HNSCC_derm002,1,0.08,10;10,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31883,20004,Blank 490,3,L,OHSU_HNSCC_derm002,1,0.267,10,JQ1,OHSU_HNSCC_derm002
31884,20004,Blank 490,3,M,OHSU_HNSCC_derm002,1,0.545,10,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31885,20004,Blank 490,3,N,OHSU_HNSCC_derm002,1,0.47,10,Cerdulatinib,OHSU_HNSCC_derm002
31886,20004,Blank 490,3,O,OHSU_HNSCC_derm002,1,0.002,10,Romidepsin,OHSU_HNSCC_derm002
31887,20004,Blank 490,3,P,OHSU_HNSCC_derm002,1,0.079,10,Gilteritinib,OHSU_HNSCC_derm002
31888,20004,Blank 490,3,A,OHSU_HNSCC_derm002,2,0.421,3.3333333333333335,Thalidomide ,OHSU_HNSCC_derm002
31889,20004,Blank 490,3,B,OHSU_HNSCC_derm002,2,0.253,3.3333333333333335,Vandetanib,OHSU_HNSCC_derm002
31890,20004,Blank 490,3,C,OHSU_HNSCC_derm002,2,0.407,3.3333333333333335,Oleic acid,OHSU_HNSCC_derm002
31891,20004,Blank 490,3,D,OHSU_HNSCC_derm002,2,0.345,3.3333333333333335,A-674563,OHSU_HNSCC_derm002
31892,20004,Blank 490,3,E,OHSU_HNSCC_derm002,2,0.296,3.3333333333333335,Lapatinib,OHSU_HNSCC_derm002
31893,20004,Blank 490,3,F,OHSU_HNSCC_derm002,2,0.431,3.3333333333333335,Apocynin (vanillin),OHSU_HNSCC_derm002
31894,20004,Blank 490,3,G,OHSU_HNSCC_derm002,2,0.013,3.3333333333333335,AT-7519,OHSU_HNSCC_derm002
31895,20004,Blank 490,3,H,OHSU_HNSCC_derm002,2,0.319,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
31896,20004,Blank 490,3,I,OHSU_HNSCC_derm002,2,0.195,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
31897,20004,Blank 490,3,J,OHSU_HNSCC_derm002,2,0.223,3.33333;3.33333,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31898,20004,Blank 490,3,K,OHSU_HNSCC_derm002,2,0.194,3.33333;3.33333,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31899,20004,Blank 490,3,L,OHSU_HNSCC_derm002,2,0.257,3.3333333333333335,JQ1,OHSU_HNSCC_derm002
31900,20004,Blank 490,3,M,OHSU_HNSCC_derm002,2,0.595,3.3333333333333335,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31901,20004,Blank 490,3,N,OHSU_HNSCC_derm002,2,0.617,3.3333333333333335,Cerdulatinib,OHSU_HNSCC_derm002
31902,20004,Blank 490,3,O,OHSU_HNSCC_derm002,2,0.01,3.3333333333333335,Romidepsin,OHSU_HNSCC_derm002
31903,20004,Blank 490,3,P,OHSU_HNSCC_derm002,2,0.433,3.3333333333333335,Gilteritinib,OHSU_HNSCC_derm002
31904,20004,Blank 490,3,A,OHSU_HNSCC_derm002,3,0.396,1.1111111111111112,Thalidomide ,OHSU_HNSCC_derm002
31905,20004,Blank 490,3,B,OHSU_HNSCC_derm002,3,0.291,1.1111111111111112,Vandetanib,OHSU_HNSCC_derm002
31906,20004,Blank 490,3,C,OHSU_HNSCC_derm002,3,0.482,1.1111111111111112,Oleic acid,OHSU_HNSCC_derm002
31907,20004,Blank 490,3,D,OHSU_HNSCC_derm002,3,0.423,1.1111111111111112,A-674563,OHSU_HNSCC_derm002
31908,20004,Blank 490,3,E,OHSU_HNSCC_derm002,3,0.404,1.1111111111111112,Lapatinib,OHSU_HNSCC_derm002
31909,20004,Blank 490,3,F,OHSU_HNSCC_derm002,3,0.475,1.1111111111111112,Apocynin (vanillin),OHSU_HNSCC_derm002
31910,20004,Blank 490,3,G,OHSU_HNSCC_derm002,3,0.044,1.1111111111111112,AT-7519,OHSU_HNSCC_derm002
31911,20004,Blank 490,3,H,OHSU_HNSCC_derm002,3,0.343,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
31912,20004,Blank 490,3,I,OHSU_HNSCC_derm002,3,0.349,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
31913,20004,Blank 490,3,J,OHSU_HNSCC_derm002,3,0.272,1.1111;1.11111,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31914,20004,Blank 490,3,K,OHSU_HNSCC_derm002,3,0.338,1.1111;1.11111,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31915,20004,Blank 490,3,L,OHSU_HNSCC_derm002,3,0.364,1.1111111111111112,JQ1,OHSU_HNSCC_derm002
31916,20004,Blank 490,3,M,OHSU_HNSCC_derm002,3,0.507,1.1111111111111112,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31917,20004,Blank 490,3,N,OHSU_HNSCC_derm002,3,0.645,1.1111111111111112,Cerdulatinib,OHSU_HNSCC_derm002
31918,20004,Blank 490,3,O,OHSU_HNSCC_derm002,3,0.041,1.1111111111111112,Romidepsin,OHSU_HNSCC_derm002
31919,20004,Blank 490,3,P,OHSU_HNSCC_derm002,3,0.403,1.1111111111111112,Gilteritinib,OHSU_HNSCC_derm002
31920,20004,Blank 490,3,A,OHSU_HNSCC_derm002,4,0.394,0.3703703703703704,Thalidomide ,OHSU_HNSCC_derm002
31921,20004,Blank 490,3,B,OHSU_HNSCC_derm002,4,0.328,0.3703703703703704,Vandetanib,OHSU_HNSCC_derm002
31922,20004,Blank 490,3,C,OHSU_HNSCC_derm002,4,0.445,0.3703703703703704,Oleic acid,OHSU_HNSCC_derm002
31923,20004,Blank 490,3,D,OHSU_HNSCC_derm002,4,0.466,0.3703703703703704,A-674563,OHSU_HNSCC_derm002
31924,20004,Blank 490,3,E,OHSU_HNSCC_derm002,4,0.398,0.3703703703703704,Lapatinib,OHSU_HNSCC_derm002
31925,20004,Blank 490,3,F,OHSU_HNSCC_derm002,4,0.417,0.3703703703703704,Apocynin (vanillin),OHSU_HNSCC_derm002
31926,20004,Blank 490,3,G,OHSU_HNSCC_derm002,4,0.328,0.3703703703703704,AT-7519,OHSU_HNSCC_derm002
31927,20004,Blank 490,3,H,OHSU_HNSCC_derm002,4,0.403,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
31928,20004,Blank 490,3,I,OHSU_HNSCC_derm002,4,0.438,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
31929,20004,Blank 490,3,J,OHSU_HNSCC_derm002,4,0.362,0.37037;0.37037,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31930,20004,Blank 490,3,K,OHSU_HNSCC_derm002,4,0.365,0.37037;0.37037,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31931,20004,Blank 490,3,L,OHSU_HNSCC_derm002,4,0.505,0.3703703703703704,JQ1,OHSU_HNSCC_derm002
31932,20004,Blank 490,3,M,OHSU_HNSCC_derm002,4,0.518,0.3703703703703704,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31933,20004,Blank 490,3,N,OHSU_HNSCC_derm002,4,0.588,0.3703703703703704,Cerdulatinib,OHSU_HNSCC_derm002
31934,20004,Blank 490,3,O,OHSU_HNSCC_derm002,4,0.045,0.3703703703703704,Romidepsin,OHSU_HNSCC_derm002
31935,20004,Blank 490,3,P,OHSU_HNSCC_derm002,4,0.406,0.3703703703703704,Gilteritinib,OHSU_HNSCC_derm002
31936,20004,Blank 490,3,A,OHSU_HNSCC_derm002,5,0.409,0.1234567901234568,Thalidomide ,OHSU_HNSCC_derm002
31937,20004,Blank 490,3,B,OHSU_HNSCC_derm002,5,0.369,0.1234567901234568,Vandetanib,OHSU_HNSCC_derm002
31938,20004,Blank 490,3,C,OHSU_HNSCC_derm002,5,0.522,0.1234567901234568,Oleic acid,OHSU_HNSCC_derm002
31939,20004,Blank 490,3,D,OHSU_HNSCC_derm002,5,0.433,0.1234567901234568,A-674563,OHSU_HNSCC_derm002
31940,20004,Blank 490,3,E,OHSU_HNSCC_derm002,5,0.456,0.1234567901234568,Lapatinib,OHSU_HNSCC_derm002
31941,20004,Blank 490,3,F,OHSU_HNSCC_derm002,5,0.465,0.1234567901234568,Apocynin (vanillin),OHSU_HNSCC_derm002
31942,20004,Blank 490,3,G,OHSU_HNSCC_derm002,5,0.413,0.1234567901234568,AT-7519,OHSU_HNSCC_derm002
31943,20004,Blank 490,3,H,OHSU_HNSCC_derm002,5,0.44,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
31944,20004,Blank 490,3,I,OHSU_HNSCC_derm002,5,0.484,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
31945,20004,Blank 490,3,J,OHSU_HNSCC_derm002,5,0.402,0.123456;0.123456,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31946,20004,Blank 490,3,K,OHSU_HNSCC_derm002,5,0.443,0.123456;0.123456,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31947,20004,Blank 490,3,L,OHSU_HNSCC_derm002,5,0.63,0.1234567901234568,JQ1,OHSU_HNSCC_derm002
31948,20004,Blank 490,3,M,OHSU_HNSCC_derm002,5,0.488,0.1234567901234568,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31949,20004,Blank 490,3,N,OHSU_HNSCC_derm002,5,0.534,0.1234567901234568,Cerdulatinib,OHSU_HNSCC_derm002
31950,20004,Blank 490,3,O,OHSU_HNSCC_derm002,5,0.045,0.1234567901234568,Romidepsin,OHSU_HNSCC_derm002
31951,20004,Blank 490,3,P,OHSU_HNSCC_derm002,5,0.412,0.1234567901234568,Gilteritinib,OHSU_HNSCC_derm002
31952,20004,Blank 490,3,A,OHSU_HNSCC_derm002,6,0.412,0.0411522633744856,Thalidomide ,OHSU_HNSCC_derm002
31953,20004,Blank 490,3,B,OHSU_HNSCC_derm002,6,0.365,0.0411522633744856,Vandetanib,OHSU_HNSCC_derm002
31954,20004,Blank 490,3,C,OHSU_HNSCC_derm002,6,0.489,0.0411522633744856,Oleic acid,OHSU_HNSCC_derm002
31955,20004,Blank 490,3,D,OHSU_HNSCC_derm002,6,0.418,0.0411522633744856,A-674563,OHSU_HNSCC_derm002
31956,20004,Blank 490,3,E,OHSU_HNSCC_derm002,6,0.453,0.0411522633744856,Lapatinib,OHSU_HNSCC_derm002
31957,20004,Blank 490,3,F,OHSU_HNSCC_derm002,6,0.405,0.0411522633744856,Apocynin (vanillin),OHSU_HNSCC_derm002
31958,20004,Blank 490,3,G,OHSU_HNSCC_derm002,6,0.433,0.0411522633744856,AT-7519,OHSU_HNSCC_derm002
31959,20004,Blank 490,3,H,OHSU_HNSCC_derm002,6,0.425,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
31960,20004,Blank 490,3,I,OHSU_HNSCC_derm002,6,0.484,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
31961,20004,Blank 490,3,J,OHSU_HNSCC_derm002,6,0.396,0.04115226;0.0411526,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31962,20004,Blank 490,3,K,OHSU_HNSCC_derm002,6,0.375,0.04115226;0.0411526,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31963,20004,Blank 490,3,L,OHSU_HNSCC_derm002,6,0.472,0.0411522633744856,JQ1,OHSU_HNSCC_derm002
31964,20004,Blank 490,3,M,OHSU_HNSCC_derm002,6,0.464,0.0411522633744856,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31965,20004,Blank 490,3,N,OHSU_HNSCC_derm002,6,0.474,0.0411522633744856,Cerdulatinib,OHSU_HNSCC_derm002
31966,20004,Blank 490,3,O,OHSU_HNSCC_derm002,6,0.055,0.0411522633744856,Romidepsin,OHSU_HNSCC_derm002
31967,20004,Blank 490,3,P,OHSU_HNSCC_derm002,6,0.391,0.0411522633744856,Gilteritinib,OHSU_HNSCC_derm002
31968,20004,Blank 490,3,A,OHSU_HNSCC_derm002,7,0.408,0.013717421124828532,Thalidomide ,OHSU_HNSCC_derm002
31969,20004,Blank 490,3,B,OHSU_HNSCC_derm002,7,0.353,0.013717421124828532,Vandetanib,OHSU_HNSCC_derm002
31970,20004,Blank 490,3,C,OHSU_HNSCC_derm002,7,0.518,0.013717421124828532,Oleic acid,OHSU_HNSCC_derm002
31971,20004,Blank 490,3,D,OHSU_HNSCC_derm002,7,0.42,0.013717421124828532,A-674563,OHSU_HNSCC_derm002
31972,20004,Blank 490,3,E,OHSU_HNSCC_derm002,7,0.501,0.013717421124828532,Lapatinib,OHSU_HNSCC_derm002
31973,20004,Blank 490,3,F,OHSU_HNSCC_derm002,7,0.437,0.013717421124828532,Apocynin (vanillin),OHSU_HNSCC_derm002
31974,20004,Blank 490,3,G,OHSU_HNSCC_derm002,7,0.454,0.013717421124828532,AT-7519,OHSU_HNSCC_derm002
31975,20004,Blank 490,3,H,OHSU_HNSCC_derm002,7,0.467,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
31976,20004,Blank 490,3,I,OHSU_HNSCC_derm002,7,0.475,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
31977,20004,Blank 490,3,J,OHSU_HNSCC_derm002,7,0.444,0.01371742;0.01371742,Axitinib;Gefitinib,OHSU_HNSCC_derm002
31978,20004,Blank 490,3,K,OHSU_HNSCC_derm002,7,0.439,0.01371742;0.01371742,Crizotinib;Gefitinib,OHSU_HNSCC_derm002
31979,20004,Blank 490,3,L,OHSU_HNSCC_derm002,7,0.511,0.013717421124828532,JQ1,OHSU_HNSCC_derm002
31980,20004,Blank 490,3,M,OHSU_HNSCC_derm002,7,0.442,0.013717421124828532,Andrographolide (structurally similar to quercetin),OHSU_HNSCC_derm002
31981,20004,Blank 490,3,N,OHSU_HNSCC_derm002,7,0.503,0.013717421124828532,Cerdulatinib,OHSU_HNSCC_derm002
31982,20004,Blank 490,3,O,OHSU_HNSCC_derm002,7,0.055,0.013717421124828532,Romidepsin,OHSU_HNSCC_derm002
31983,20004,Blank 490,3,P,OHSU_HNSCC_derm002,7,0.415,0.013717421124828532,Gilteritinib,OHSU_HNSCC_derm002
31984,20004,Blank 490,3,A,OHSU_HNSCC_derm002,8,0.383,0,NONE,OHSU_HNSCC_derm002
31985,20004,Blank 490,3,B,OHSU_HNSCC_derm002,8,0.348,0,NONE,OHSU_HNSCC_derm002
31986,20004,Blank 490,3,C,OHSU_HNSCC_derm002,8,0.405,0,NONE,OHSU_HNSCC_derm002
31987,20004,Blank 490,3,D,OHSU_HNSCC_derm002,8,0.404,0,NONE,OHSU_HNSCC_derm002
31988,20004,Blank 490,3,E,OHSU_HNSCC_derm002,8,0.514,0,NONE,OHSU_HNSCC_derm002
31989,20004,Blank 490,3,F,OHSU_HNSCC_derm002,8,0.413,0,NONE,OHSU_HNSCC_derm002
31990,20004,Blank 490,3,G,OHSU_HNSCC_derm002,8,0.47,0,NONE,OHSU_HNSCC_derm002
31991,20004,Blank 490,3,H,OHSU_HNSCC_derm002,8,0.001,10,F-S-V,OHSU_HNSCC_derm002
31992,20004,Blank 490,3,I,OHSU_HNSCC_derm002,8,0.479,0,NONE,OHSU_HNSCC_derm002
31993,20004,Blank 490,3,J,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
31994,20004,Blank 490,3,K,OHSU_HNSCC_derm002,8,0.493,0,NONE,OHSU_HNSCC_derm002
31995,20004,Blank 490,3,L,OHSU_HNSCC_derm002,8,0.509,0,NONE,OHSU_HNSCC_derm002
31996,20004,Blank 490,3,M,OHSU_HNSCC_derm002,8,0.524,0,NONE,OHSU_HNSCC_derm002
31997,20004,Blank 490,3,N,OHSU_HNSCC_derm002,8,0.449,0,NONE,OHSU_HNSCC_derm002
31998,20004,Blank 490,3,O,OHSU_HNSCC_derm002,8,0.377,0,NONE,OHSU_HNSCC_derm002
31999,20004,Blank 490,3,P,OHSU_HNSCC_derm002,8,0.387,0,NONE,OHSU_HNSCC_derm002
32000,20004,Blank 490,3,A,OHSU_HNSCC_derm002,9,0.427,10,Anastrazole,OHSU_HNSCC_derm002
32001,20004,Blank 490,3,B,OHSU_HNSCC_derm002,9,0.239,10,JNJ-28312141 ,OHSU_HNSCC_derm002
32002,20004,Blank 490,3,C,OHSU_HNSCC_derm002,9,0.411,10,Genistein,OHSU_HNSCC_derm002
32003,20004,Blank 490,3,D,OHSU_HNSCC_derm002,9,0.509,10,Abscisic acid,OHSU_HNSCC_derm002
32004,20004,Blank 490,3,E,OHSU_HNSCC_derm002,9,0.316,10,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32005,20004,Blank 490,3,F,OHSU_HNSCC_derm002,9,0.611,10,Ruxolitinib,OHSU_HNSCC_derm002
32006,20004,Blank 490,3,G,OHSU_HNSCC_derm002,9,0.51,10,TAK-659,OHSU_HNSCC_derm002
32007,20004,Blank 490,3,H,OHSU_HNSCC_derm002,9,0.05,10,Brigatinib,OHSU_HNSCC_derm002
32008,20004,Blank 490,3,I,OHSU_HNSCC_derm002,9,0.071,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32009,20004,Blank 490,3,J,OHSU_HNSCC_derm002,9,0.037,10,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32010,20004,Blank 490,3,K,OHSU_HNSCC_derm002,9,0.158,10,Vorinostat,OHSU_HNSCC_derm002
32011,20004,Blank 490,3,L,OHSU_HNSCC_derm002,9,0.434,10,Lenalidomide,OHSU_HNSCC_derm002
32012,20004,Blank 490,3,M,OHSU_HNSCC_derm002,9,0.055,10,NVP-ADW742,OHSU_HNSCC_derm002
32013,20004,Blank 490,3,N,OHSU_HNSCC_derm002,9,0.416,10,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32014,20004,Blank 490,3,O,OHSU_HNSCC_derm002,9,0.52,10,Echinatin,OHSU_HNSCC_derm002
32015,20004,Blank 490,3,P,OHSU_HNSCC_derm002,9,-0.015,10,YM-155,OHSU_HNSCC_derm002
32016,20004,Blank 490,3,A,OHSU_HNSCC_derm002,10,0.42,3.3333333333333335,Anastrazole,OHSU_HNSCC_derm002
32017,20004,Blank 490,3,B,OHSU_HNSCC_derm002,10,0.515,3.3333333333333335,JNJ-28312141 ,OHSU_HNSCC_derm002
32018,20004,Blank 490,3,C,OHSU_HNSCC_derm002,10,0.469,3.3333333333333335,Genistein,OHSU_HNSCC_derm002
32019,20004,Blank 490,3,D,OHSU_HNSCC_derm002,10,0.495,3.3333333333333335,Abscisic acid,OHSU_HNSCC_derm002
32020,20004,Blank 490,3,E,OHSU_HNSCC_derm002,10,0.396,3.3333333333333335,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32021,20004,Blank 490,3,F,OHSU_HNSCC_derm002,10,0.591,3.3333333333333335,Ruxolitinib,OHSU_HNSCC_derm002
32022,20004,Blank 490,3,G,OHSU_HNSCC_derm002,10,0.59,3.3333333333333335,TAK-659,OHSU_HNSCC_derm002
32023,20004,Blank 490,3,H,OHSU_HNSCC_derm002,10,0.117,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
32024,20004,Blank 490,3,I,OHSU_HNSCC_derm002,10,0.303,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32025,20004,Blank 490,3,J,OHSU_HNSCC_derm002,10,0.265,3.3333333333333335,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32026,20004,Blank 490,3,K,OHSU_HNSCC_derm002,10,0.233,3.3333333333333335,Vorinostat,OHSU_HNSCC_derm002
32027,20004,Blank 490,3,L,OHSU_HNSCC_derm002,10,0.442,3.3333333333333335,Lenalidomide,OHSU_HNSCC_derm002
32028,20004,Blank 490,3,M,OHSU_HNSCC_derm002,10,0.168,3.3333333333333335,NVP-ADW742,OHSU_HNSCC_derm002
32029,20004,Blank 490,3,N,OHSU_HNSCC_derm002,10,0.448,3.3333333333333335,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32030,20004,Blank 490,3,O,OHSU_HNSCC_derm002,10,0.415,3.3333333333333335,Echinatin,OHSU_HNSCC_derm002
32031,20004,Blank 490,3,P,OHSU_HNSCC_derm002,10,0.019,3.3333333333333335,YM-155,OHSU_HNSCC_derm002
32032,20004,Blank 490,3,A,OHSU_HNSCC_derm002,11,0.407,1.1111111111111112,Anastrazole,OHSU_HNSCC_derm002
32033,20004,Blank 490,3,B,OHSU_HNSCC_derm002,11,0.478,1.1111111111111112,JNJ-28312141 ,OHSU_HNSCC_derm002
32034,20004,Blank 490,3,C,OHSU_HNSCC_derm002,11,0.531,1.1111111111111112,Genistein,OHSU_HNSCC_derm002
32035,20004,Blank 490,3,D,OHSU_HNSCC_derm002,11,0.504,1.1111111111111112,Abscisic acid,OHSU_HNSCC_derm002
32036,20004,Blank 490,3,E,OHSU_HNSCC_derm002,11,0.411,1.1111111111111112,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32037,20004,Blank 490,3,F,OHSU_HNSCC_derm002,11,0.547,1.1111111111111112,Ruxolitinib,OHSU_HNSCC_derm002
32038,20004,Blank 490,3,G,OHSU_HNSCC_derm002,11,0.472,1.1111111111111112,TAK-659,OHSU_HNSCC_derm002
32039,20004,Blank 490,3,H,OHSU_HNSCC_derm002,11,0.32,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
32040,20004,Blank 490,3,I,OHSU_HNSCC_derm002,11,0.35,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32041,20004,Blank 490,3,J,OHSU_HNSCC_derm002,11,0.497,1.1111111111111112,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32042,20004,Blank 490,3,K,OHSU_HNSCC_derm002,11,0.342,1.1111111111111112,Vorinostat,OHSU_HNSCC_derm002
32043,20004,Blank 490,3,L,OHSU_HNSCC_derm002,11,0.451,1.1111111111111112,Lenalidomide,OHSU_HNSCC_derm002
32044,20004,Blank 490,3,M,OHSU_HNSCC_derm002,11,0.286,1.1111111111111112,NVP-ADW742,OHSU_HNSCC_derm002
32045,20004,Blank 490,3,N,OHSU_HNSCC_derm002,11,0.481,1.1111111111111112,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32046,20004,Blank 490,3,O,OHSU_HNSCC_derm002,11,0.433,1.1111111111111112,Echinatin,OHSU_HNSCC_derm002
32047,20004,Blank 490,3,P,OHSU_HNSCC_derm002,11,0.047,1.1111111111111112,YM-155,OHSU_HNSCC_derm002
32048,20004,Blank 490,3,A,OHSU_HNSCC_derm002,12,0.382,0.3703703703703704,Anastrazole,OHSU_HNSCC_derm002
32049,20004,Blank 490,3,B,OHSU_HNSCC_derm002,12,0.392,0.3703703703703704,JNJ-28312141 ,OHSU_HNSCC_derm002
32050,20004,Blank 490,3,C,OHSU_HNSCC_derm002,12,0.406,0.3703703703703704,Genistein,OHSU_HNSCC_derm002
32051,20004,Blank 490,3,D,OHSU_HNSCC_derm002,12,0.453,0.3703703703703704,Abscisic acid,OHSU_HNSCC_derm002
32052,20004,Blank 490,3,E,OHSU_HNSCC_derm002,12,0.436,0.3703703703703704,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32053,20004,Blank 490,3,F,OHSU_HNSCC_derm002,12,0.503,0.3703703703703704,Ruxolitinib,OHSU_HNSCC_derm002
32054,20004,Blank 490,3,G,OHSU_HNSCC_derm002,12,0.44,0.3703703703703704,TAK-659,OHSU_HNSCC_derm002
32055,20004,Blank 490,3,H,OHSU_HNSCC_derm002,12,0.403,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
32056,20004,Blank 490,3,I,OHSU_HNSCC_derm002,12,0.347,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32057,20004,Blank 490,3,J,OHSU_HNSCC_derm002,12,0.612,0.3703703703703704,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32058,20004,Blank 490,3,K,OHSU_HNSCC_derm002,12,0.291,0.3703703703703704,Vorinostat,OHSU_HNSCC_derm002
32059,20004,Blank 490,3,L,OHSU_HNSCC_derm002,12,0.448,0.3703703703703704,Lenalidomide,OHSU_HNSCC_derm002
32060,20004,Blank 490,3,M,OHSU_HNSCC_derm002,12,0.382,0.3703703703703704,NVP-ADW742,OHSU_HNSCC_derm002
32061,20004,Blank 490,3,N,OHSU_HNSCC_derm002,12,0.466,0.3703703703703704,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32062,20004,Blank 490,3,O,OHSU_HNSCC_derm002,12,0.391,0.3703703703703704,Echinatin,OHSU_HNSCC_derm002
32063,20004,Blank 490,3,P,OHSU_HNSCC_derm002,12,0.138,0.3703703703703704,YM-155,OHSU_HNSCC_derm002
32064,20004,Blank 490,3,A,OHSU_HNSCC_derm002,13,0.414,0.1234567901234568,Anastrazole,OHSU_HNSCC_derm002
32065,20004,Blank 490,3,B,OHSU_HNSCC_derm002,13,0.407,0.1234567901234568,JNJ-28312141 ,OHSU_HNSCC_derm002
32066,20004,Blank 490,3,C,OHSU_HNSCC_derm002,13,0.443,0.1234567901234568,Genistein,OHSU_HNSCC_derm002
32067,20004,Blank 490,3,D,OHSU_HNSCC_derm002,13,0.421,0.1234567901234568,Abscisic acid,OHSU_HNSCC_derm002
32068,20004,Blank 490,3,E,OHSU_HNSCC_derm002,13,0.452,0.1234567901234568,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32069,20004,Blank 490,3,F,OHSU_HNSCC_derm002,13,0.458,0.1234567901234568,Ruxolitinib,OHSU_HNSCC_derm002
32070,20004,Blank 490,3,G,OHSU_HNSCC_derm002,13,0.422,0.1234567901234568,TAK-659,OHSU_HNSCC_derm002
32071,20004,Blank 490,3,H,OHSU_HNSCC_derm002,13,0.441,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
32072,20004,Blank 490,3,I,OHSU_HNSCC_derm002,13,0.327,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32073,20004,Blank 490,3,J,OHSU_HNSCC_derm002,13,0.622,0.1234567901234568,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32074,20004,Blank 490,3,K,OHSU_HNSCC_derm002,13,0.415,0.1234567901234568,Vorinostat,OHSU_HNSCC_derm002
32075,20004,Blank 490,3,L,OHSU_HNSCC_derm002,13,0.471,0.1234567901234568,Lenalidomide,OHSU_HNSCC_derm002
32076,20004,Blank 490,3,M,OHSU_HNSCC_derm002,13,0.481,0.1234567901234568,NVP-ADW742,OHSU_HNSCC_derm002
32077,20004,Blank 490,3,N,OHSU_HNSCC_derm002,13,0.486,0.1234567901234568,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32078,20004,Blank 490,3,O,OHSU_HNSCC_derm002,13,0.426,0.1234567901234568,Echinatin,OHSU_HNSCC_derm002
32079,20004,Blank 490,3,P,OHSU_HNSCC_derm002,13,0.207,0.1234567901234568,YM-155,OHSU_HNSCC_derm002
32080,20004,Blank 490,3,A,OHSU_HNSCC_derm002,14,0.426,0.0411522633744856,Anastrazole,OHSU_HNSCC_derm002
32081,20004,Blank 490,3,B,OHSU_HNSCC_derm002,14,0.366,0.0411522633744856,JNJ-28312141 ,OHSU_HNSCC_derm002
32082,20004,Blank 490,3,C,OHSU_HNSCC_derm002,14,0.412,0.0411522633744856,Genistein,OHSU_HNSCC_derm002
32083,20004,Blank 490,3,D,OHSU_HNSCC_derm002,14,0.386,0.0411522633744856,Abscisic acid,OHSU_HNSCC_derm002
32084,20004,Blank 490,3,E,OHSU_HNSCC_derm002,14,0.48,0.0411522633744856,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32085,20004,Blank 490,3,F,OHSU_HNSCC_derm002,14,0.403,0.0411522633744856,Ruxolitinib,OHSU_HNSCC_derm002
32086,20004,Blank 490,3,G,OHSU_HNSCC_derm002,14,0.412,0.0411522633744856,TAK-659,OHSU_HNSCC_derm002
32087,20004,Blank 490,3,H,OHSU_HNSCC_derm002,14,0.443,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
32088,20004,Blank 490,3,I,OHSU_HNSCC_derm002,14,0.383,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32089,20004,Blank 490,3,J,OHSU_HNSCC_derm002,14,0.601,0.0411522633744856,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32090,20004,Blank 490,3,K,OHSU_HNSCC_derm002,14,0.422,0.0411522633744856,Vorinostat,OHSU_HNSCC_derm002
32091,20004,Blank 490,3,L,OHSU_HNSCC_derm002,14,0.463,0.0411522633744856,Lenalidomide,OHSU_HNSCC_derm002
32092,20004,Blank 490,3,M,OHSU_HNSCC_derm002,14,0.516,0.0411522633744856,NVP-ADW742,OHSU_HNSCC_derm002
32093,20004,Blank 490,3,N,OHSU_HNSCC_derm002,14,0.469,0.0411522633744856,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32094,20004,Blank 490,3,O,OHSU_HNSCC_derm002,14,0.395,0.0411522633744856,Echinatin,OHSU_HNSCC_derm002
32095,20004,Blank 490,3,P,OHSU_HNSCC_derm002,14,0.315,0.0411522633744856,YM-155,OHSU_HNSCC_derm002
32096,20004,Blank 490,3,A,OHSU_HNSCC_derm002,15,0.443,0.013717421124828532,Anastrazole,OHSU_HNSCC_derm002
32097,20004,Blank 490,3,B,OHSU_HNSCC_derm002,15,0.37,0.013717421124828532,JNJ-28312141 ,OHSU_HNSCC_derm002
32098,20004,Blank 490,3,C,OHSU_HNSCC_derm002,15,0.412,0.013717421124828532,Genistein,OHSU_HNSCC_derm002
32099,20004,Blank 490,3,D,OHSU_HNSCC_derm002,15,0.39,0.013717421124828532,Abscisic acid,OHSU_HNSCC_derm002
32100,20004,Blank 490,3,E,OHSU_HNSCC_derm002,15,0.482,0.013717421124828532,Alisertib (MLN-8237),OHSU_HNSCC_derm002
32101,20004,Blank 490,3,F,OHSU_HNSCC_derm002,15,0.402,0.013717421124828532,Ruxolitinib,OHSU_HNSCC_derm002
32102,20004,Blank 490,3,G,OHSU_HNSCC_derm002,15,0.432,0.013717421124828532,TAK-659,OHSU_HNSCC_derm002
32103,20004,Blank 490,3,H,OHSU_HNSCC_derm002,15,0.437,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
32104,20004,Blank 490,3,I,OHSU_HNSCC_derm002,15,0.357,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32105,20004,Blank 490,3,J,OHSU_HNSCC_derm002,15,0.544,0.013717421124828532,Lestaurtinib (CEP-701),OHSU_HNSCC_derm002
32106,20004,Blank 490,3,K,OHSU_HNSCC_derm002,15,0.477,0.013717421124828532,Vorinostat,OHSU_HNSCC_derm002
32107,20004,Blank 490,3,L,OHSU_HNSCC_derm002,15,0.478,0.013717421124828532,Lenalidomide,OHSU_HNSCC_derm002
32108,20004,Blank 490,3,M,OHSU_HNSCC_derm002,15,0.466,0.013717421124828532,NVP-ADW742,OHSU_HNSCC_derm002
32109,20004,Blank 490,3,N,OHSU_HNSCC_derm002,15,0.494,0.013717421124828532,"Piceatannol (resveratrol metabolite, maybe more potent)",OHSU_HNSCC_derm002
32110,20004,Blank 490,3,O,OHSU_HNSCC_derm002,15,0.402,0.013717421124828532,Echinatin,OHSU_HNSCC_derm002
32111,20004,Blank 490,3,P,OHSU_HNSCC_derm002,15,0.347,0.013717421124828532,YM-155,OHSU_HNSCC_derm002
32112,20004,Blank 490,3,A,OHSU_HNSCC_derm002,16,0.415,0,NONE,OHSU_HNSCC_derm002
32113,20004,Blank 490,3,B,OHSU_HNSCC_derm002,16,0.39,0,NONE,OHSU_HNSCC_derm002
32114,20004,Blank 490,3,C,OHSU_HNSCC_derm002,16,0.457,0,NONE,OHSU_HNSCC_derm002
32115,20004,Blank 490,3,D,OHSU_HNSCC_derm002,16,0.49,0,NONE,OHSU_HNSCC_derm002
32116,20004,Blank 490,3,E,OHSU_HNSCC_derm002,16,0.379,0,NONE,OHSU_HNSCC_derm002
32117,20004,Blank 490,3,F,OHSU_HNSCC_derm002,16,0.387,0,NONE,OHSU_HNSCC_derm002
32118,20004,Blank 490,3,G,OHSU_HNSCC_derm002,16,0.274,0,NONE,OHSU_HNSCC_derm002
32119,20004,Blank 490,3,H,OHSU_HNSCC_derm002,16,-0.001,10,F-S-V,OHSU_HNSCC_derm002
32120,20004,Blank 490,3,I,OHSU_HNSCC_derm002,16,0.447,0,NONE,OHSU_HNSCC_derm002
32121,20004,Blank 490,3,J,OHSU_HNSCC_derm002,16,0.433,0,NONE,OHSU_HNSCC_derm002
32122,20004,Blank 490,3,K,OHSU_HNSCC_derm002,16,0.476,0,NONE,OHSU_HNSCC_derm002
32123,20004,Blank 490,3,L,OHSU_HNSCC_derm002,16,0.456,0,NONE,OHSU_HNSCC_derm002
32124,20004,Blank 490,3,M,OHSU_HNSCC_derm002,16,0.48,0,NONE,OHSU_HNSCC_derm002
32125,20004,Blank 490,3,N,OHSU_HNSCC_derm002,16,0.435,0,NONE,OHSU_HNSCC_derm002
32126,20004,Blank 490,3,O,OHSU_HNSCC_derm002,16,0.414,0,NONE,OHSU_HNSCC_derm002
32127,20004,Blank 490,3,P,OHSU_HNSCC_derm002,16,0.401,0,NONE,OHSU_HNSCC_derm002
32128,20004,Blank 490,3,A,OHSU_HNSCC_derm002,17,0.393,10,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32129,20004,Blank 490,3,B,OHSU_HNSCC_derm002,17,0.373,10,Stevioside,OHSU_HNSCC_derm002
32130,20004,Blank 490,3,C,OHSU_HNSCC_derm002,17,0.48,10,Pemetrexed,OHSU_HNSCC_derm002
32131,20004,Blank 490,3,D,OHSU_HNSCC_derm002,17,0.067,10,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32132,20004,Blank 490,3,E,OHSU_HNSCC_derm002,17,0.033,10,GSK-1838705A,OHSU_HNSCC_derm002
32133,20004,Blank 490,3,F,OHSU_HNSCC_derm002,17,-0.006,10;10,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32134,20004,Blank 490,3,G,OHSU_HNSCC_derm002,17,0.447,10,Imatinib,OHSU_HNSCC_derm002
32135,20004,Blank 490,3,H,OHSU_HNSCC_derm002,17,0.343,10,Trametinib,OHSU_HNSCC_derm002
32136,20004,Blank 490,3,I,OHSU_HNSCC_derm002,17,0.116,10,BEZ235,OHSU_HNSCC_derm002
32137,20004,Blank 490,3,J,OHSU_HNSCC_derm002,17,0.226,10,Saracatinib,OHSU_HNSCC_derm002
32138,20004,Blank 490,3,K,OHSU_HNSCC_derm002,17,0.448,10,I-BET 762,OHSU_HNSCC_derm002
32139,20004,Blank 490,3,L,OHSU_HNSCC_derm002,17,0.343,10,Neratinib (HKI-272),OHSU_HNSCC_derm002
32140,20004,Blank 490,3,M,OHSU_HNSCC_derm002,17,0.235,10,Ginsenoside Rb2,OHSU_HNSCC_derm002
32141,20004,Blank 490,3,N,OHSU_HNSCC_derm002,17,0.305,10,Crizotinib,OHSU_HNSCC_derm002
32142,20004,Blank 490,3,O,OHSU_HNSCC_derm002,17,0.392,10,MGCD-265,OHSU_HNSCC_derm002
32143,20004,Blank 490,3,P,OHSU_HNSCC_derm002,17,0.262,10,Erlotinib,OHSU_HNSCC_derm002
32144,20004,Blank 490,3,A,OHSU_HNSCC_derm002,18,0.411,3.3333333333333335,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32145,20004,Blank 490,3,B,OHSU_HNSCC_derm002,18,0.383,3.3333333333333335,Stevioside,OHSU_HNSCC_derm002
32146,20004,Blank 490,3,C,OHSU_HNSCC_derm002,18,0.439,3.3333333333333335,Pemetrexed,OHSU_HNSCC_derm002
32147,20004,Blank 490,3,D,OHSU_HNSCC_derm002,18,0.074,3.3333333333333335,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32148,20004,Blank 490,3,E,OHSU_HNSCC_derm002,18,0.13,3.3333333333333335,GSK-1838705A,OHSU_HNSCC_derm002
32149,20004,Blank 490,3,F,OHSU_HNSCC_derm002,18,0.063,3.33333;3.33333,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32150,20004,Blank 490,3,G,OHSU_HNSCC_derm002,18,0.44,3.3333333333333335,Imatinib,OHSU_HNSCC_derm002
32151,20004,Blank 490,3,H,OHSU_HNSCC_derm002,18,0.377,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
32152,20004,Blank 490,3,I,OHSU_HNSCC_derm002,18,0.128,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
32153,20004,Blank 490,3,J,OHSU_HNSCC_derm002,18,0.259,3.3333333333333335,Saracatinib,OHSU_HNSCC_derm002
32154,20004,Blank 490,3,K,OHSU_HNSCC_derm002,18,0.465,3.3333333333333335,I-BET 762,OHSU_HNSCC_derm002
32155,20004,Blank 490,3,L,OHSU_HNSCC_derm002,18,0.36,3.3333333333333335,Neratinib (HKI-272),OHSU_HNSCC_derm002
32156,20004,Blank 490,3,M,OHSU_HNSCC_derm002,18,0.417,3.3333333333333335,Ginsenoside Rb2,OHSU_HNSCC_derm002
32157,20004,Blank 490,3,N,OHSU_HNSCC_derm002,18,0.456,3.3333333333333335,Crizotinib,OHSU_HNSCC_derm002
32158,20004,Blank 490,3,O,OHSU_HNSCC_derm002,18,0.464,3.3333333333333335,MGCD-265,OHSU_HNSCC_derm002
32159,20004,Blank 490,3,P,OHSU_HNSCC_derm002,18,0.278,3.3333333333333335,Erlotinib,OHSU_HNSCC_derm002
32160,20004,Blank 490,3,A,OHSU_HNSCC_derm002,19,0.358,1.1111111111111112,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32161,20004,Blank 490,3,B,OHSU_HNSCC_derm002,19,0.38,1.1111111111111112,Stevioside,OHSU_HNSCC_derm002
32162,20004,Blank 490,3,C,OHSU_HNSCC_derm002,19,0.433,1.1111111111111112,Pemetrexed,OHSU_HNSCC_derm002
32163,20004,Blank 490,3,D,OHSU_HNSCC_derm002,19,0.092,1.1111111111111112,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32164,20004,Blank 490,3,E,OHSU_HNSCC_derm002,19,0.184,1.1111111111111112,GSK-1838705A,OHSU_HNSCC_derm002
32165,20004,Blank 490,3,F,OHSU_HNSCC_derm002,19,0.224,1.1111;1.11111,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32166,20004,Blank 490,3,G,OHSU_HNSCC_derm002,19,0.443,1.1111111111111112,Imatinib,OHSU_HNSCC_derm002
32167,20004,Blank 490,3,H,OHSU_HNSCC_derm002,19,0.37,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
32168,20004,Blank 490,3,I,OHSU_HNSCC_derm002,19,0.143,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
32169,20004,Blank 490,3,J,OHSU_HNSCC_derm002,19,0.384,1.1111111111111112,Saracatinib,OHSU_HNSCC_derm002
32170,20004,Blank 490,3,K,OHSU_HNSCC_derm002,19,0.484,1.1111111111111112,I-BET 762,OHSU_HNSCC_derm002
32171,20004,Blank 490,3,L,OHSU_HNSCC_derm002,19,0.366,1.1111111111111112,Neratinib (HKI-272),OHSU_HNSCC_derm002
32172,20004,Blank 490,3,M,OHSU_HNSCC_derm002,19,0.481,1.1111111111111112,Ginsenoside Rb2,OHSU_HNSCC_derm002
32173,20004,Blank 490,3,N,OHSU_HNSCC_derm002,19,0.437,1.1111111111111112,Crizotinib,OHSU_HNSCC_derm002
32174,20004,Blank 490,3,O,OHSU_HNSCC_derm002,19,0.484,1.1111111111111112,MGCD-265,OHSU_HNSCC_derm002
32175,20004,Blank 490,3,P,OHSU_HNSCC_derm002,19,0.313,1.1111111111111112,Erlotinib,OHSU_HNSCC_derm002
32176,20004,Blank 490,3,A,OHSU_HNSCC_derm002,20,0.394,0.3703703703703704,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32177,20004,Blank 490,3,B,OHSU_HNSCC_derm002,20,0.38,0.3703703703703704,Stevioside,OHSU_HNSCC_derm002
32178,20004,Blank 490,3,C,OHSU_HNSCC_derm002,20,0.414,0.3703703703703704,Pemetrexed,OHSU_HNSCC_derm002
32179,20004,Blank 490,3,D,OHSU_HNSCC_derm002,20,0.125,0.3703703703703704,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32180,20004,Blank 490,3,E,OHSU_HNSCC_derm002,20,0.253,0.3703703703703704,GSK-1838705A,OHSU_HNSCC_derm002
32181,20004,Blank 490,3,F,OHSU_HNSCC_derm002,20,0.293,0.37037;0.37037,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32182,20004,Blank 490,3,G,OHSU_HNSCC_derm002,20,0.468,0.3703703703703704,Imatinib,OHSU_HNSCC_derm002
32183,20004,Blank 490,3,H,OHSU_HNSCC_derm002,20,0.377,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
32184,20004,Blank 490,3,I,OHSU_HNSCC_derm002,20,0.186,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
32185,20004,Blank 490,3,J,OHSU_HNSCC_derm002,20,0.405,0.3703703703703704,Saracatinib,OHSU_HNSCC_derm002
32186,20004,Blank 490,3,K,OHSU_HNSCC_derm002,20,0.541,0.3703703703703704,I-BET 762,OHSU_HNSCC_derm002
32187,20004,Blank 490,3,L,OHSU_HNSCC_derm002,20,0.354,0.3703703703703704,Neratinib (HKI-272),OHSU_HNSCC_derm002
32188,20004,Blank 490,3,M,OHSU_HNSCC_derm002,20,0.517,0.3703703703703704,Ginsenoside Rb2,OHSU_HNSCC_derm002
32189,20004,Blank 490,3,N,OHSU_HNSCC_derm002,20,0.479,0.3703703703703704,Crizotinib,OHSU_HNSCC_derm002
32190,20004,Blank 490,3,O,OHSU_HNSCC_derm002,20,0.426,0.3703703703703704,MGCD-265,OHSU_HNSCC_derm002
32191,20004,Blank 490,3,P,OHSU_HNSCC_derm002,20,0.36,0.3703703703703704,Erlotinib,OHSU_HNSCC_derm002
32192,20004,Blank 490,3,A,OHSU_HNSCC_derm002,21,0.413,0.1234567901234568,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32193,20004,Blank 490,3,B,OHSU_HNSCC_derm002,21,0.38,0.1234567901234568,Stevioside,OHSU_HNSCC_derm002
32194,20004,Blank 490,3,C,OHSU_HNSCC_derm002,21,0.407,0.1234567901234568,Pemetrexed,OHSU_HNSCC_derm002
32195,20004,Blank 490,3,D,OHSU_HNSCC_derm002,21,0.186,0.1234567901234568,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32196,20004,Blank 490,3,E,OHSU_HNSCC_derm002,21,0.359,0.1234567901234568,GSK-1838705A,OHSU_HNSCC_derm002
32197,20004,Blank 490,3,F,OHSU_HNSCC_derm002,21,0.389,0.123456;0.123456,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32198,20004,Blank 490,3,G,OHSU_HNSCC_derm002,21,0.468,0.1234567901234568,Imatinib,OHSU_HNSCC_derm002
32199,20004,Blank 490,3,H,OHSU_HNSCC_derm002,21,0.425,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
32200,20004,Blank 490,3,I,OHSU_HNSCC_derm002,21,0.254,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
32201,20004,Blank 490,3,J,OHSU_HNSCC_derm002,21,0.433,0.1234567901234568,Saracatinib,OHSU_HNSCC_derm002
32202,20004,Blank 490,3,K,OHSU_HNSCC_derm002,21,0.391,0.1234567901234568,I-BET 762,OHSU_HNSCC_derm002
32203,20004,Blank 490,3,L,OHSU_HNSCC_derm002,21,0.304,0.1234567901234568,Neratinib (HKI-272),OHSU_HNSCC_derm002
32204,20004,Blank 490,3,M,OHSU_HNSCC_derm002,21,0.441,0.1234567901234568,Ginsenoside Rb2,OHSU_HNSCC_derm002
32205,20004,Blank 490,3,N,OHSU_HNSCC_derm002,21,0.442,0.1234567901234568,Crizotinib,OHSU_HNSCC_derm002
32206,20004,Blank 490,3,O,OHSU_HNSCC_derm002,21,0.444,0.1234567901234568,MGCD-265,OHSU_HNSCC_derm002
32207,20004,Blank 490,3,P,OHSU_HNSCC_derm002,21,0.414,0.1234567901234568,Erlotinib,OHSU_HNSCC_derm002
32208,20004,Blank 490,3,A,OHSU_HNSCC_derm002,22,0.405,0.0411522633744856,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32209,20004,Blank 490,3,B,OHSU_HNSCC_derm002,22,0.405,0.0411522633744856,Stevioside,OHSU_HNSCC_derm002
32210,20004,Blank 490,3,C,OHSU_HNSCC_derm002,22,0.424,0.0411522633744856,Pemetrexed,OHSU_HNSCC_derm002
32211,20004,Blank 490,3,D,OHSU_HNSCC_derm002,22,0.247,0.0411522633744856,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32212,20004,Blank 490,3,E,OHSU_HNSCC_derm002,22,0.409,0.0411522633744856,GSK-1838705A,OHSU_HNSCC_derm002
32213,20004,Blank 490,3,F,OHSU_HNSCC_derm002,22,0.446,0.04115226;0.0411526,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32214,20004,Blank 490,3,G,OHSU_HNSCC_derm002,22,0.405,0.0411522633744856,Imatinib,OHSU_HNSCC_derm002
32215,20004,Blank 490,3,H,OHSU_HNSCC_derm002,22,0.371,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
32216,20004,Blank 490,3,I,OHSU_HNSCC_derm002,22,0.354,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
32217,20004,Blank 490,3,J,OHSU_HNSCC_derm002,22,0.419,0.0411522633744856,Saracatinib,OHSU_HNSCC_derm002
32218,20004,Blank 490,3,K,OHSU_HNSCC_derm002,22,0.397,0.0411522633744856,I-BET 762,OHSU_HNSCC_derm002
32219,20004,Blank 490,3,L,OHSU_HNSCC_derm002,22,0.385,0.0411522633744856,Neratinib (HKI-272),OHSU_HNSCC_derm002
32220,20004,Blank 490,3,M,OHSU_HNSCC_derm002,22,0.446,0.0411522633744856,Ginsenoside Rb2,OHSU_HNSCC_derm002
32221,20004,Blank 490,3,N,OHSU_HNSCC_derm002,22,0.397,0.0411522633744856,Crizotinib,OHSU_HNSCC_derm002
32222,20004,Blank 490,3,O,OHSU_HNSCC_derm002,22,0.405,0.0411522633744856,MGCD-265,OHSU_HNSCC_derm002
32223,20004,Blank 490,3,P,OHSU_HNSCC_derm002,22,0.389,0.0411522633744856,Erlotinib,OHSU_HNSCC_derm002
32224,20004,Blank 490,3,A,OHSU_HNSCC_derm002,23,0.377,0.013717421124828532,Herniarin (derivative of coumarin),OHSU_HNSCC_derm002
32225,20004,Blank 490,3,B,OHSU_HNSCC_derm002,23,0.375,0.013717421124828532,Stevioside,OHSU_HNSCC_derm002
32226,20004,Blank 490,3,C,OHSU_HNSCC_derm002,23,0.426,0.013717421124828532,Pemetrexed,OHSU_HNSCC_derm002
32227,20004,Blank 490,3,D,OHSU_HNSCC_derm002,23,0.296,0.013717421124828532,Taselisib (GDC-0032),OHSU_HNSCC_derm002
32228,20004,Blank 490,3,E,OHSU_HNSCC_derm002,23,0.405,0.013717421124828532,GSK-1838705A,OHSU_HNSCC_derm002
32229,20004,Blank 490,3,F,OHSU_HNSCC_derm002,23,0.419,0.01371742;0.01371742,Ceritinib;Gefitinib,OHSU_HNSCC_derm002
32230,20004,Blank 490,3,G,OHSU_HNSCC_derm002,23,0.336,0.013717421124828532,Imatinib,OHSU_HNSCC_derm002
32231,20004,Blank 490,3,H,OHSU_HNSCC_derm002,23,0.402,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
32232,20004,Blank 490,3,I,OHSU_HNSCC_derm002,23,0.385,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
32233,20004,Blank 490,3,J,OHSU_HNSCC_derm002,23,0.424,0.013717421124828532,Saracatinib,OHSU_HNSCC_derm002
32234,20004,Blank 490,3,K,OHSU_HNSCC_derm002,23,0.396,0.013717421124828532,I-BET 762,OHSU_HNSCC_derm002
32235,20004,Blank 490,3,L,OHSU_HNSCC_derm002,23,0.313,0.013717421124828532,Neratinib (HKI-272),OHSU_HNSCC_derm002
32236,20004,Blank 490,3,M,OHSU_HNSCC_derm002,23,0.382,0.013717421124828532,Ginsenoside Rb2,OHSU_HNSCC_derm002
32237,20004,Blank 490,3,N,OHSU_HNSCC_derm002,23,0.394,0.013717421124828532,Crizotinib,OHSU_HNSCC_derm002
32238,20004,Blank 490,3,O,OHSU_HNSCC_derm002,23,0.45,0.013717421124828532,MGCD-265,OHSU_HNSCC_derm002
32239,20004,Blank 490,3,P,OHSU_HNSCC_derm002,23,0.446,0.013717421124828532,Erlotinib,OHSU_HNSCC_derm002
32240,20004,Blank 490,3,A,OHSU_HNSCC_derm002,24,0.394,0,NONE,OHSU_HNSCC_derm002
32241,20004,Blank 490,3,B,OHSU_HNSCC_derm002,24,0.378,0,NONE,OHSU_HNSCC_derm002
32242,20004,Blank 490,3,C,OHSU_HNSCC_derm002,24,0.381,0,NONE,OHSU_HNSCC_derm002
32243,20004,Blank 490,3,D,OHSU_HNSCC_derm002,24,0.412,0,NONE,OHSU_HNSCC_derm002
32244,20004,Blank 490,3,E,OHSU_HNSCC_derm002,24,0.417,0,NONE,OHSU_HNSCC_derm002
32245,20004,Blank 490,3,F,OHSU_HNSCC_derm002,24,0.439,0,NONE,OHSU_HNSCC_derm002
32246,20004,Blank 490,3,G,OHSU_HNSCC_derm002,24,0.44,0,NONE,OHSU_HNSCC_derm002
32247,20004,Blank 490,3,H,OHSU_HNSCC_derm002,24,0.415,0,NONE,OHSU_HNSCC_derm002
32248,20004,Blank 490,3,I,OHSU_HNSCC_derm002,24,0.409,0,NONE,OHSU_HNSCC_derm002
32249,20004,Blank 490,3,J,OHSU_HNSCC_derm002,24,0.44,0,NONE,OHSU_HNSCC_derm002
32250,20004,Blank 490,3,K,OHSU_HNSCC_derm002,24,0.37,0,NONE,OHSU_HNSCC_derm002
32251,20004,Blank 490,3,L,OHSU_HNSCC_derm002,24,0.397,0,NONE,OHSU_HNSCC_derm002
32252,20004,Blank 490,3,M,OHSU_HNSCC_derm002,24,0.369,0,NONE,OHSU_HNSCC_derm002
32253,20004,Blank 490,3,N,OHSU_HNSCC_derm002,24,0.425,0,NONE,OHSU_HNSCC_derm002
32254,20004,Blank 490,3,O,OHSU_HNSCC_derm002,24,0.408,0,NONE,OHSU_HNSCC_derm002
32255,20004,Blank 490,3,P,OHSU_HNSCC_derm002,24,0.419,0,NONE,OHSU_HNSCC_derm002
32256,20004,Blank 490,4,A,OHSU_HNSCC_derm002,1,0.048,5;10,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32257,20004,Blank 490,4,B,OHSU_HNSCC_derm002,1,0.095,10;10;10,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32258,20004,Blank 490,4,C,OHSU_HNSCC_derm002,1,0.377,1;10;10,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32259,20004,Blank 490,4,D,OHSU_HNSCC_derm002,1,0.131,10;10;10,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32260,20004,Blank 490,4,E,OHSU_HNSCC_derm002,1,0.019,10;10;10,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32261,20004,Blank 490,4,F,OHSU_HNSCC_derm002,1,0.019,10;10;10,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32262,20004,Blank 490,4,G,OHSU_HNSCC_derm002,1,0.005,1;10;10,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32263,20004,Blank 490,4,H,OHSU_HNSCC_derm002,1,0.034,10,Gefitinib,OHSU_HNSCC_derm002
32264,20004,Blank 490,4,I,OHSU_HNSCC_derm002,1,0.0,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
32265,20004,Blank 490,4,J,OHSU_HNSCC_derm002,1,0.013,10;10;10,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32266,20004,Blank 490,4,K,OHSU_HNSCC_derm002,1,0.065,10;10,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32267,20004,Blank 490,4,L,OHSU_HNSCC_derm002,1,0.052,1;10;10,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32268,20004,Blank 490,4,M,OHSU_HNSCC_derm002,1,0.098,10;10;10,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32269,20004,Blank 490,4,N,OHSU_HNSCC_derm002,1,0.012,10,VOLASERTIB x,OHSU_HNSCC_derm002
32270,20004,Blank 490,4,O,OHSU_HNSCC_derm002,1,0.287,5;10;10,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32271,20004,Blank 490,4,P,OHSU_HNSCC_derm002,1,-0.002,10;10,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32272,20004,Blank 490,4,A,OHSU_HNSCC_derm002,2,0.066,1.6667;3.33333,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32273,20004,Blank 490,4,B,OHSU_HNSCC_derm002,2,0.196,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32274,20004,Blank 490,4,C,OHSU_HNSCC_derm002,2,0.373,0.333333;3.33333;3.33333,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32275,20004,Blank 490,4,D,OHSU_HNSCC_derm002,2,0.29,3.33333;3.33333;3.33333,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32276,20004,Blank 490,4,E,OHSU_HNSCC_derm002,2,0.072,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32277,20004,Blank 490,4,F,OHSU_HNSCC_derm002,2,0.04,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32278,20004,Blank 490,4,G,OHSU_HNSCC_derm002,2,0.054,0.333333;3.33333;3.33333,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32279,20004,Blank 490,4,H,OHSU_HNSCC_derm002,2,0.305,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
32280,20004,Blank 490,4,I,OHSU_HNSCC_derm002,2,0.224,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
32281,20004,Blank 490,4,J,OHSU_HNSCC_derm002,2,0.06,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32282,20004,Blank 490,4,K,OHSU_HNSCC_derm002,2,0.139,3.33333;3.33333,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32283,20004,Blank 490,4,L,OHSU_HNSCC_derm002,2,0.09,0.333333;3.33333;3.33333,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32284,20004,Blank 490,4,M,OHSU_HNSCC_derm002,2,0.152,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32285,20004,Blank 490,4,N,OHSU_HNSCC_derm002,2,0.172,3.3333333333333335,VOLASERTIB x,OHSU_HNSCC_derm002
32286,20004,Blank 490,4,O,OHSU_HNSCC_derm002,2,0.353,1.6667;3.33333;3.33333,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32287,20004,Blank 490,4,P,OHSU_HNSCC_derm002,2,0.029,3.33333;3.33333,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32288,20004,Blank 490,4,A,OHSU_HNSCC_derm002,3,0.15,0.55555;1.11111,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32289,20004,Blank 490,4,B,OHSU_HNSCC_derm002,3,0.238,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32290,20004,Blank 490,4,C,OHSU_HNSCC_derm002,3,0.441,0.11111;1.11111;1.11111,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32291,20004,Blank 490,4,D,OHSU_HNSCC_derm002,3,0.318,1.1111;1.11111;1.11111,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32292,20004,Blank 490,4,E,OHSU_HNSCC_derm002,3,0.202,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32293,20004,Blank 490,4,F,OHSU_HNSCC_derm002,3,0.094,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32294,20004,Blank 490,4,G,OHSU_HNSCC_derm002,3,0.062,0.11111;1.11111;1.11111,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32295,20004,Blank 490,4,H,OHSU_HNSCC_derm002,3,0.364,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
32296,20004,Blank 490,4,I,OHSU_HNSCC_derm002,3,0.447,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
32297,20004,Blank 490,4,J,OHSU_HNSCC_derm002,3,0.133,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32298,20004,Blank 490,4,K,OHSU_HNSCC_derm002,3,0.251,1.1111;1.11111,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32299,20004,Blank 490,4,L,OHSU_HNSCC_derm002,3,0.201,0.11111;1.11111;1.11111,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32300,20004,Blank 490,4,M,OHSU_HNSCC_derm002,3,0.243,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32301,20004,Blank 490,4,N,OHSU_HNSCC_derm002,3,0.415,1.1111111111111112,VOLASERTIB x,OHSU_HNSCC_derm002
32302,20004,Blank 490,4,O,OHSU_HNSCC_derm002,3,0.433,0.55555;1.11111;1.11111,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32303,20004,Blank 490,4,P,OHSU_HNSCC_derm002,3,0.079,1.1111;1.11111,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32304,20004,Blank 490,4,A,OHSU_HNSCC_derm002,4,0.192,0.185118;0.37037,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32305,20004,Blank 490,4,B,OHSU_HNSCC_derm002,4,0.306,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32306,20004,Blank 490,4,C,OHSU_HNSCC_derm002,4,0.394,0.037037;0.37037;0.37037,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32307,20004,Blank 490,4,D,OHSU_HNSCC_derm002,4,0.434,0.37037;0.37037;0.37037,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32308,20004,Blank 490,4,E,OHSU_HNSCC_derm002,4,0.26,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32309,20004,Blank 490,4,F,OHSU_HNSCC_derm002,4,0.128,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32310,20004,Blank 490,4,G,OHSU_HNSCC_derm002,4,0.062,0.037037;0.37037;0.37037,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32311,20004,Blank 490,4,H,OHSU_HNSCC_derm002,4,0.376,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
32312,20004,Blank 490,4,I,OHSU_HNSCC_derm002,4,0.473,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
32313,20004,Blank 490,4,J,OHSU_HNSCC_derm002,4,0.161,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32314,20004,Blank 490,4,K,OHSU_HNSCC_derm002,4,0.236,0.37037;0.37037,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32315,20004,Blank 490,4,L,OHSU_HNSCC_derm002,4,0.27,0.037037;0.37037;0.37037,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32316,20004,Blank 490,4,M,OHSU_HNSCC_derm002,4,0.331,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32317,20004,Blank 490,4,N,OHSU_HNSCC_derm002,4,0.44,0.3703703703703704,VOLASERTIB x,OHSU_HNSCC_derm002
32318,20004,Blank 490,4,O,OHSU_HNSCC_derm002,4,0.401,0.185118;0.37037;0.37037,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32319,20004,Blank 490,4,P,OHSU_HNSCC_derm002,4,0.129,0.37037;0.37037,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32320,20004,Blank 490,4,A,OHSU_HNSCC_derm002,5,0.297,0.0617284;0.123456,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32321,20004,Blank 490,4,B,OHSU_HNSCC_derm002,5,0.328,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32322,20004,Blank 490,4,C,OHSU_HNSCC_derm002,5,0.39,0.0123456;0.123456;0.123456,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32323,20004,Blank 490,4,D,OHSU_HNSCC_derm002,5,0.414,0.123456;0.123456;0.123456,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32324,20004,Blank 490,4,E,OHSU_HNSCC_derm002,5,0.284,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32325,20004,Blank 490,4,F,OHSU_HNSCC_derm002,5,0.237,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32326,20004,Blank 490,4,G,OHSU_HNSCC_derm002,5,0.046,0.0123456;0.123456;0.123456,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32327,20004,Blank 490,4,H,OHSU_HNSCC_derm002,5,0.334,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
32328,20004,Blank 490,4,I,OHSU_HNSCC_derm002,5,0.525,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
32329,20004,Blank 490,4,J,OHSU_HNSCC_derm002,5,0.259,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32330,20004,Blank 490,4,K,OHSU_HNSCC_derm002,5,0.308,0.123456;0.123456,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32331,20004,Blank 490,4,L,OHSU_HNSCC_derm002,5,0.286,0.0123456;0.123456;0.123456,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32332,20004,Blank 490,4,M,OHSU_HNSCC_derm002,5,0.386,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32333,20004,Blank 490,4,N,OHSU_HNSCC_derm002,5,0.368,0.1234567901234568,VOLASERTIB x,OHSU_HNSCC_derm002
32334,20004,Blank 490,4,O,OHSU_HNSCC_derm002,5,0.455,0.0617284;0.123456;0.123456,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32335,20004,Blank 490,4,P,OHSU_HNSCC_derm002,5,0.206,0.123456;0.123456,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32336,20004,Blank 490,4,A,OHSU_HNSCC_derm002,6,0.36,0.02057613;0.0411526,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32337,20004,Blank 490,4,B,OHSU_HNSCC_derm002,6,0.374,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32338,20004,Blank 490,4,C,OHSU_HNSCC_derm002,6,0.462,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32339,20004,Blank 490,4,D,OHSU_HNSCC_derm002,6,0.482,0.04115226;0.0411526;0.0411526,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32340,20004,Blank 490,4,E,OHSU_HNSCC_derm002,6,0.367,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32341,20004,Blank 490,4,F,OHSU_HNSCC_derm002,6,0.336,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32342,20004,Blank 490,4,G,OHSU_HNSCC_derm002,6,0.082,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32343,20004,Blank 490,4,H,OHSU_HNSCC_derm002,6,0.373,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
32344,20004,Blank 490,4,I,OHSU_HNSCC_derm002,6,0.496,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
32345,20004,Blank 490,4,J,OHSU_HNSCC_derm002,6,0.328,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32346,20004,Blank 490,4,K,OHSU_HNSCC_derm002,6,0.358,0.04115226;0.0411526,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32347,20004,Blank 490,4,L,OHSU_HNSCC_derm002,6,0.391,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32348,20004,Blank 490,4,M,OHSU_HNSCC_derm002,6,0.426,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32349,20004,Blank 490,4,N,OHSU_HNSCC_derm002,6,0.377,0.0411522633744856,VOLASERTIB x,OHSU_HNSCC_derm002
32350,20004,Blank 490,4,O,OHSU_HNSCC_derm002,6,0.458,0.02057613;0.0411526;0.0411526,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32351,20004,Blank 490,4,P,OHSU_HNSCC_derm002,6,0.299,0.04115226;0.0411526,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32352,20004,Blank 490,4,A,OHSU_HNSCC_derm002,7,0.401,0.00685871;0.01371742,Vandetanib;GDC-0941,OHSU_HNSCC_derm002
32353,20004,Blank 490,4,B,OHSU_HNSCC_derm002,7,0.34,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Axitinib,OHSU_HNSCC_derm002
32354,20004,Blank 490,4,C,OHSU_HNSCC_derm002,7,0.433,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Axitinib,OHSU_HNSCC_derm002
32355,20004,Blank 490,4,D,OHSU_HNSCC_derm002,7,0.51,0.01371742;0.01371742;0.01371742,Gefitinib;Sorafenib;Tosylate,OHSU_HNSCC_derm002
32356,20004,Blank 490,4,E,OHSU_HNSCC_derm002,7,0.484,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Belinostat,OHSU_HNSCC_derm002
32357,20004,Blank 490,4,F,OHSU_HNSCC_derm002,7,0.411,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;BEZ235,OHSU_HNSCC_derm002
32358,20004,Blank 490,4,G,OHSU_HNSCC_derm002,7,0.088,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Romidepsin,OHSU_HNSCC_derm002
32359,20004,Blank 490,4,H,OHSU_HNSCC_derm002,7,0.473,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
32360,20004,Blank 490,4,I,OHSU_HNSCC_derm002,7,0.467,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
32361,20004,Blank 490,4,J,OHSU_HNSCC_derm002,7,0.399,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;GDC-0941,OHSU_HNSCC_derm002
32362,20004,Blank 490,4,K,OHSU_HNSCC_derm002,7,0.423,0.01371742;0.01371742,Gefitinib;Vorinostat,OHSU_HNSCC_derm002
32363,20004,Blank 490,4,L,OHSU_HNSCC_derm002,7,0.415,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Belinostat,OHSU_HNSCC_derm002
32364,20004,Blank 490,4,M,OHSU_HNSCC_derm002,7,0.429,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Axitinib,OHSU_HNSCC_derm002
32365,20004,Blank 490,4,N,OHSU_HNSCC_derm002,7,0.419,0.013717421124828532,VOLASERTIB x,OHSU_HNSCC_derm002
32366,20004,Blank 490,4,O,OHSU_HNSCC_derm002,7,0.401,0.00685871;0.01371742;0.01371742,Vandetanib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32367,20004,Blank 490,4,P,OHSU_HNSCC_derm002,7,0.327,0.01371742;0.01371742,Canertinib (CI-1033);PI-103,OHSU_HNSCC_derm002
32368,20004,Blank 490,4,A,OHSU_HNSCC_derm002,8,0.441,0,NONE,OHSU_HNSCC_derm002
32369,20004,Blank 490,4,B,OHSU_HNSCC_derm002,8,0.414,0,NONE,OHSU_HNSCC_derm002
32370,20004,Blank 490,4,C,OHSU_HNSCC_derm002,8,0.449,0,NONE,OHSU_HNSCC_derm002
32371,20004,Blank 490,4,D,OHSU_HNSCC_derm002,8,0.482,0,NONE,OHSU_HNSCC_derm002
32372,20004,Blank 490,4,E,OHSU_HNSCC_derm002,8,0.479,0,NONE,OHSU_HNSCC_derm002
32373,20004,Blank 490,4,F,OHSU_HNSCC_derm002,8,0.459,0,NONE,OHSU_HNSCC_derm002
32374,20004,Blank 490,4,G,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
32375,20004,Blank 490,4,H,OHSU_HNSCC_derm002,8,-0.006,10,F-S-V,OHSU_HNSCC_derm002
32376,20004,Blank 490,4,I,OHSU_HNSCC_derm002,8,0.499,0,NONE,OHSU_HNSCC_derm002
32377,20004,Blank 490,4,J,OHSU_HNSCC_derm002,8,0.471,0,NONE,OHSU_HNSCC_derm002
32378,20004,Blank 490,4,K,OHSU_HNSCC_derm002,8,0.465,0,NONE,OHSU_HNSCC_derm002
32379,20004,Blank 490,4,L,OHSU_HNSCC_derm002,8,0.401,0,NONE,OHSU_HNSCC_derm002
32380,20004,Blank 490,4,M,OHSU_HNSCC_derm002,8,0.464,0,NONE,OHSU_HNSCC_derm002
32381,20004,Blank 490,4,N,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
32382,20004,Blank 490,4,O,OHSU_HNSCC_derm002,8,0.387,0,NONE,OHSU_HNSCC_derm002
32383,20004,Blank 490,4,P,OHSU_HNSCC_derm002,8,0.425,0,NONE,OHSU_HNSCC_derm002
32384,20004,Blank 490,4,A,OHSU_HNSCC_derm002,9,0.046,10;10;10,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32385,20004,Blank 490,4,B,OHSU_HNSCC_derm002,9,0.265,10;10,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32386,20004,Blank 490,4,C,OHSU_HNSCC_derm002,9,0.027,5;10,Vandetanib;PI-103,OHSU_HNSCC_derm002
32387,20004,Blank 490,4,D,OHSU_HNSCC_derm002,9,0.482,1;10;10;10,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32388,20004,Blank 490,4,E,OHSU_HNSCC_derm002,9,0.22,10;10;10,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32389,20004,Blank 490,4,F,OHSU_HNSCC_derm002,9,0.03,10;10,Gefitinib;PI-103,OHSU_HNSCC_derm002
32390,20004,Blank 490,4,G,OHSU_HNSCC_derm002,9,0.097,10,AZD2014 x ,OHSU_HNSCC_derm002
32391,20004,Blank 490,4,H,OHSU_HNSCC_derm002,9,0.069,10,Brigatinib,OHSU_HNSCC_derm002
32392,20004,Blank 490,4,I,OHSU_HNSCC_derm002,9,0.13,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32393,20004,Blank 490,4,J,OHSU_HNSCC_derm002,9,0.06,5;10,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32394,20004,Blank 490,4,K,OHSU_HNSCC_derm002,9,0.357,1;10;10;10,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32395,20004,Blank 490,4,L,OHSU_HNSCC_derm002,9,-0.004,1,MLN7243 x (1mM),OHSU_HNSCC_derm002
32396,20004,Blank 490,4,M,OHSU_HNSCC_derm002,9,0.046,5;10;10,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32397,20004,Blank 490,4,N,OHSU_HNSCC_derm002,9,0.385,10;10;10,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32398,20004,Blank 490,4,O,OHSU_HNSCC_derm002,9,0.193,10;10;10,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32399,20004,Blank 490,4,P,OHSU_HNSCC_derm002,9,0.161,1;10;5,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32400,20004,Blank 490,4,A,OHSU_HNSCC_derm002,10,0.15,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32401,20004,Blank 490,4,B,OHSU_HNSCC_derm002,10,0.306,3.33333;3.33333,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32402,20004,Blank 490,4,C,OHSU_HNSCC_derm002,10,0.041,1.6667;3.33333,Vandetanib;PI-103,OHSU_HNSCC_derm002
32403,20004,Blank 490,4,D,OHSU_HNSCC_derm002,10,0.557,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32404,20004,Blank 490,4,E,OHSU_HNSCC_derm002,10,0.332,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32405,20004,Blank 490,4,F,OHSU_HNSCC_derm002,10,0.047,3.33333;3.33333,Gefitinib;PI-103,OHSU_HNSCC_derm002
32406,20004,Blank 490,4,G,OHSU_HNSCC_derm002,10,0.126,3.3333333333333335,AZD2014 x ,OHSU_HNSCC_derm002
32407,20004,Blank 490,4,H,OHSU_HNSCC_derm002,10,0.174,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
32408,20004,Blank 490,4,I,OHSU_HNSCC_derm002,10,0.351,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32409,20004,Blank 490,4,J,OHSU_HNSCC_derm002,10,0.118,1.6667;3.33333,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32410,20004,Blank 490,4,K,OHSU_HNSCC_derm002,10,0.362,0.333333;3.33333;3.33333;3.33333,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32411,20004,Blank 490,4,L,OHSU_HNSCC_derm002,10,0.0,0.3333333333333333,MLN7243 x (1mM),OHSU_HNSCC_derm002
32412,20004,Blank 490,4,M,OHSU_HNSCC_derm002,10,0.26,1.6667;3.33333;3.33333,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32413,20004,Blank 490,4,N,OHSU_HNSCC_derm002,10,0.382,3.33333;3.33333;3.33333,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32414,20004,Blank 490,4,O,OHSU_HNSCC_derm002,10,0.343,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32415,20004,Blank 490,4,P,OHSU_HNSCC_derm002,10,0.23,0.33333;3.33333;1.66667,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32416,20004,Blank 490,4,A,OHSU_HNSCC_derm002,11,0.221,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32417,20004,Blank 490,4,B,OHSU_HNSCC_derm002,11,0.345,1.1111;1.11111,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32418,20004,Blank 490,4,C,OHSU_HNSCC_derm002,11,0.085,0.55555;1.11111,Vandetanib;PI-103,OHSU_HNSCC_derm002
32419,20004,Blank 490,4,D,OHSU_HNSCC_derm002,11,0.496,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32420,20004,Blank 490,4,E,OHSU_HNSCC_derm002,11,0.331,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32421,20004,Blank 490,4,F,OHSU_HNSCC_derm002,11,0.079,1.1111;1.11111,Gefitinib;PI-103,OHSU_HNSCC_derm002
32422,20004,Blank 490,4,G,OHSU_HNSCC_derm002,11,0.169,1.1111111111111112,AZD2014 x ,OHSU_HNSCC_derm002
32423,20004,Blank 490,4,H,OHSU_HNSCC_derm002,11,0.346,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
32424,20004,Blank 490,4,I,OHSU_HNSCC_derm002,11,0.378,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32425,20004,Blank 490,4,J,OHSU_HNSCC_derm002,11,0.188,0.55555;1.11111,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32426,20004,Blank 490,4,K,OHSU_HNSCC_derm002,11,0.404,0.11111;1.11111;1.11111;1.1111,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32427,20004,Blank 490,4,L,OHSU_HNSCC_derm002,11,0.01,0.1111111111111111,MLN7243 x (1mM),OHSU_HNSCC_derm002
32428,20004,Blank 490,4,M,OHSU_HNSCC_derm002,11,0.328,0.55555;1.11111;1.11111,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32429,20004,Blank 490,4,N,OHSU_HNSCC_derm002,11,0.41,1.1111;1.11111;1.11111,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32430,20004,Blank 490,4,O,OHSU_HNSCC_derm002,11,0.382,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32431,20004,Blank 490,4,P,OHSU_HNSCC_derm002,11,0.286,0.11111;1.11111;0.555555,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32432,20004,Blank 490,4,A,OHSU_HNSCC_derm002,12,0.268,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32433,20004,Blank 490,4,B,OHSU_HNSCC_derm002,12,0.322,0.37037;0.37037,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32434,20004,Blank 490,4,C,OHSU_HNSCC_derm002,12,0.148,0.185118;0.37037,Vandetanib;PI-103,OHSU_HNSCC_derm002
32435,20004,Blank 490,4,D,OHSU_HNSCC_derm002,12,0.497,0.037037;0.37037;0.37037,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32436,20004,Blank 490,4,E,OHSU_HNSCC_derm002,12,0.419,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32437,20004,Blank 490,4,F,OHSU_HNSCC_derm002,12,0.138,0.37037;0.37037,Gefitinib;PI-103,OHSU_HNSCC_derm002
32438,20004,Blank 490,4,G,OHSU_HNSCC_derm002,12,0.222,0.3703703703703704,AZD2014 x ,OHSU_HNSCC_derm002
32439,20004,Blank 490,4,H,OHSU_HNSCC_derm002,12,0.442,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
32440,20004,Blank 490,4,I,OHSU_HNSCC_derm002,12,0.407,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32441,20004,Blank 490,4,J,OHSU_HNSCC_derm002,12,0.268,0.185118;0.37037,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32442,20004,Blank 490,4,K,OHSU_HNSCC_derm002,12,0.479,0.037037;0.37037;0.37037,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32443,20004,Blank 490,4,L,OHSU_HNSCC_derm002,12,0.13,0.037037037037037035,MLN7243 x (1mM),OHSU_HNSCC_derm002
32444,20004,Blank 490,4,M,OHSU_HNSCC_derm002,12,0.366,0.185118;0.37037;0.37037,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32445,20004,Blank 490,4,N,OHSU_HNSCC_derm002,12,0.443,0.37037;0.37037;0.37037,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32446,20004,Blank 490,4,O,OHSU_HNSCC_derm002,12,0.437,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32447,20004,Blank 490,4,P,OHSU_HNSCC_derm002,12,0.312,0.037037;0.37037;0.185118,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32448,20004,Blank 490,4,A,OHSU_HNSCC_derm002,13,0.286,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32449,20004,Blank 490,4,B,OHSU_HNSCC_derm002,13,0.343,0.123456;0.123456,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32450,20004,Blank 490,4,C,OHSU_HNSCC_derm002,13,0.293,0.0617284;0.123456,Vandetanib;PI-103,OHSU_HNSCC_derm002
32451,20004,Blank 490,4,D,OHSU_HNSCC_derm002,13,0.544,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32452,20004,Blank 490,4,E,OHSU_HNSCC_derm002,13,0.431,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32453,20004,Blank 490,4,F,OHSU_HNSCC_derm002,13,0.271,0.123456;0.123456,Gefitinib;PI-103,OHSU_HNSCC_derm002
32454,20004,Blank 490,4,G,OHSU_HNSCC_derm002,13,0.276,0.1234567901234568,AZD2014 x ,OHSU_HNSCC_derm002
32455,20004,Blank 490,4,H,OHSU_HNSCC_derm002,13,0.497,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
32456,20004,Blank 490,4,I,OHSU_HNSCC_derm002,13,0.383,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32457,20004,Blank 490,4,J,OHSU_HNSCC_derm002,13,0.355,0.0617284;0.123456,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32458,20004,Blank 490,4,K,OHSU_HNSCC_derm002,13,0.437,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32459,20004,Blank 490,4,L,OHSU_HNSCC_derm002,13,0.357,0.012345679012345678,MLN7243 x (1mM),OHSU_HNSCC_derm002
32460,20004,Blank 490,4,M,OHSU_HNSCC_derm002,13,0.392,0.0617284;0.123456;0.123456,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32461,20004,Blank 490,4,N,OHSU_HNSCC_derm002,13,0.475,0.123456;0.123456;0.123456,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32462,20004,Blank 490,4,O,OHSU_HNSCC_derm002,13,0.427,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32463,20004,Blank 490,4,P,OHSU_HNSCC_derm002,13,0.353,0.0123456;0.123456;0.0617284,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32464,20004,Blank 490,4,A,OHSU_HNSCC_derm002,14,0.343,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32465,20004,Blank 490,4,B,OHSU_HNSCC_derm002,14,0.396,0.04115226;0.0411526,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32466,20004,Blank 490,4,C,OHSU_HNSCC_derm002,14,0.35,0.02057613;0.0411526,Vandetanib;PI-103,OHSU_HNSCC_derm002
32467,20004,Blank 490,4,D,OHSU_HNSCC_derm002,14,0.509,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32468,20004,Blank 490,4,E,OHSU_HNSCC_derm002,14,0.431,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32469,20004,Blank 490,4,F,OHSU_HNSCC_derm002,14,0.374,0.04115226;0.0411526,Gefitinib;PI-103,OHSU_HNSCC_derm002
32470,20004,Blank 490,4,G,OHSU_HNSCC_derm002,14,0.347,0.0411522633744856,AZD2014 x ,OHSU_HNSCC_derm002
32471,20004,Blank 490,4,H,OHSU_HNSCC_derm002,14,0.513,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
32472,20004,Blank 490,4,I,OHSU_HNSCC_derm002,14,0.356,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32473,20004,Blank 490,4,J,OHSU_HNSCC_derm002,14,0.388,0.02057613;0.0411526,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32474,20004,Blank 490,4,K,OHSU_HNSCC_derm002,14,0.419,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32475,20004,Blank 490,4,L,OHSU_HNSCC_derm002,14,0.484,0.004115226337448559,MLN7243 x (1mM),OHSU_HNSCC_derm002
32476,20004,Blank 490,4,M,OHSU_HNSCC_derm002,14,0.393,0.02057613;0.0411526;0.0411526,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32477,20004,Blank 490,4,N,OHSU_HNSCC_derm002,14,0.437,0.04115226;0.0411526;0.0411526,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32478,20004,Blank 490,4,O,OHSU_HNSCC_derm002,14,0.417,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32479,20004,Blank 490,4,P,OHSU_HNSCC_derm002,14,0.343,0.004115226;0.0411526;0.02057613,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32480,20004,Blank 490,4,A,OHSU_HNSCC_derm002,15,0.332,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Vorinostat,OHSU_HNSCC_derm002
32481,20004,Blank 490,4,B,OHSU_HNSCC_derm002,15,0.343,0.01371742;0.01371742,Gefitinib;Fulvestrant,OHSU_HNSCC_derm002
32482,20004,Blank 490,4,C,OHSU_HNSCC_derm002,15,0.413,0.00685871;0.01371742,Vandetanib;PI-103,OHSU_HNSCC_derm002
32483,20004,Blank 490,4,D,OHSU_HNSCC_derm002,15,0.457,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32484,20004,Blank 490,4,E,OHSU_HNSCC_derm002,15,0.438,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Idelasib (GS-1101),OHSU_HNSCC_derm002
32485,20004,Blank 490,4,F,OHSU_HNSCC_derm002,15,0.409,0.01371742;0.01371742,Gefitinib;PI-103,OHSU_HNSCC_derm002
32486,20004,Blank 490,4,G,OHSU_HNSCC_derm002,15,0.396,0.013717421124828532,AZD2014 x ,OHSU_HNSCC_derm002
32487,20004,Blank 490,4,H,OHSU_HNSCC_derm002,15,0.474,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
32488,20004,Blank 490,4,I,OHSU_HNSCC_derm002,15,0.381,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32489,20004,Blank 490,4,J,OHSU_HNSCC_derm002,15,0.379,0.00685871;0.01371742,Vandetanib;Belinostat,OHSU_HNSCC_derm002
32490,20004,Blank 490,4,K,OHSU_HNSCC_derm002,15,0.505,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Erlotinib;Hydrochloride;Malate,OHSU_HNSCC_derm002
32491,20004,Blank 490,4,L,OHSU_HNSCC_derm002,15,0.507,0.0013717421124828531,MLN7243 x (1mM),OHSU_HNSCC_derm002
32492,20004,Blank 490,4,M,OHSU_HNSCC_derm002,15,0.436,0.00685871;0.01371742;0.01371742,Vandetanib;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32493,20004,Blank 490,4,N,OHSU_HNSCC_derm002,15,0.499,0.01371742;0.01371742;0.01371742,Gefitinib;Pemetrexed;Disodium,OHSU_HNSCC_derm002
32494,20004,Blank 490,4,O,OHSU_HNSCC_derm002,15,0.476,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Fulvestrant,OHSU_HNSCC_derm002
32495,20004,Blank 490,4,P,OHSU_HNSCC_derm002,15,0.405,0.001371742;0.01371742;0.00685871,Sunitinib;Malate;Vorinostat,OHSU_HNSCC_derm002
32496,20004,Blank 490,4,A,OHSU_HNSCC_derm002,16,0.454,0,NONE,OHSU_HNSCC_derm002
32497,20004,Blank 490,4,B,OHSU_HNSCC_derm002,16,0.417,0,NONE,OHSU_HNSCC_derm002
32498,20004,Blank 490,4,C,OHSU_HNSCC_derm002,16,0.419,0,NONE,OHSU_HNSCC_derm002
32499,20004,Blank 490,4,D,OHSU_HNSCC_derm002,16,0.4,0,NONE,OHSU_HNSCC_derm002
32500,20004,Blank 490,4,E,OHSU_HNSCC_derm002,16,0.483,0,NONE,OHSU_HNSCC_derm002
32501,20004,Blank 490,4,F,OHSU_HNSCC_derm002,16,0.492,0,NONE,OHSU_HNSCC_derm002
32502,20004,Blank 490,4,G,OHSU_HNSCC_derm002,16,0.469,0,NONE,OHSU_HNSCC_derm002
32503,20004,Blank 490,4,H,OHSU_HNSCC_derm002,16,0.006,10,F-S-V,OHSU_HNSCC_derm002
32504,20004,Blank 490,4,I,OHSU_HNSCC_derm002,16,0.464,0,NONE,OHSU_HNSCC_derm002
32505,20004,Blank 490,4,J,OHSU_HNSCC_derm002,16,0.47,0,NONE,OHSU_HNSCC_derm002
32506,20004,Blank 490,4,K,OHSU_HNSCC_derm002,16,0.423,0,NONE,OHSU_HNSCC_derm002
32507,20004,Blank 490,4,L,OHSU_HNSCC_derm002,16,0.503,0,NONE,OHSU_HNSCC_derm002
32508,20004,Blank 490,4,M,OHSU_HNSCC_derm002,16,0.523,0,NONE,OHSU_HNSCC_derm002
32509,20004,Blank 490,4,N,OHSU_HNSCC_derm002,16,0.414,0,NONE,OHSU_HNSCC_derm002
32510,20004,Blank 490,4,O,OHSU_HNSCC_derm002,16,0.456,0,NONE,OHSU_HNSCC_derm002
32511,20004,Blank 490,4,P,OHSU_HNSCC_derm002,16,0.447,0,NONE,OHSU_HNSCC_derm002
32512,20004,Blank 490,4,A,OHSU_HNSCC_derm002,17,0.127,1;10;10,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32513,20004,Blank 490,4,B,OHSU_HNSCC_derm002,17,0.06,10;10;10,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32514,20004,Blank 490,4,C,OHSU_HNSCC_derm002,17,0.091,10;10;10,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32515,20004,Blank 490,4,D,OHSU_HNSCC_derm002,17,-0.004,10;10;10,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32516,20004,Blank 490,4,E,OHSU_HNSCC_derm002,17,0.189,5;10,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32517,20004,Blank 490,4,F,OHSU_HNSCC_derm002,17,0.096,10;10;10,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32518,20004,Blank 490,4,G,OHSU_HNSCC_derm002,17,0.135,10;10;10,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32519,20004,Blank 490,4,H,OHSU_HNSCC_derm002,17,0.364,10,Trametinib,OHSU_HNSCC_derm002
32520,20004,Blank 490,4,I,OHSU_HNSCC_derm002,17,0.106,10,BEZ235,OHSU_HNSCC_derm002
32521,20004,Blank 490,4,J,OHSU_HNSCC_derm002,17,0.041,10;10;10,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32522,20004,Blank 490,4,K,OHSU_HNSCC_derm002,17,0.369,5;10;10,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32523,20004,Blank 490,4,L,OHSU_HNSCC_derm002,17,0.081,1;10;10,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32524,20004,Blank 490,4,M,OHSU_HNSCC_derm002,17,0.31,10;10;10,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32525,20004,Blank 490,4,N,OHSU_HNSCC_derm002,17,0.528,1;10;10;10,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32526,20004,Blank 490,4,O,OHSU_HNSCC_derm002,17,0.292,10;10;10;10,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32527,20004,Blank 490,4,P,OHSU_HNSCC_derm002,17,0.156,10;10;10,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32528,20004,Blank 490,4,A,OHSU_HNSCC_derm002,18,0.35,0.333333;3.33333;3.33333,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32529,20004,Blank 490,4,B,OHSU_HNSCC_derm002,18,0.275,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32530,20004,Blank 490,4,C,OHSU_HNSCC_derm002,18,0.307,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32531,20004,Blank 490,4,D,OHSU_HNSCC_derm002,18,0.027,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32532,20004,Blank 490,4,E,OHSU_HNSCC_derm002,18,0.056,1.6667;3.33333,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32533,20004,Blank 490,4,F,OHSU_HNSCC_derm002,18,0.267,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32534,20004,Blank 490,4,G,OHSU_HNSCC_derm002,18,0.335,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32535,20004,Blank 490,4,H,OHSU_HNSCC_derm002,18,0.42,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
32536,20004,Blank 490,4,I,OHSU_HNSCC_derm002,18,0.08,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
32537,20004,Blank 490,4,J,OHSU_HNSCC_derm002,18,0.088,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32538,20004,Blank 490,4,K,OHSU_HNSCC_derm002,18,0.473,1.6667;3.33333;3.33333,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32539,20004,Blank 490,4,L,OHSU_HNSCC_derm002,18,0.222,0.333333;3.33333;3.33333,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32540,20004,Blank 490,4,M,OHSU_HNSCC_derm002,18,0.277,3.33333;3.33333;3.33333,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32541,20004,Blank 490,4,N,OHSU_HNSCC_derm002,18,0.649,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32542,20004,Blank 490,4,O,OHSU_HNSCC_derm002,18,0.31,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32543,20004,Blank 490,4,P,OHSU_HNSCC_derm002,18,0.222,3.33333;3.33333;3.33333,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32544,20004,Blank 490,4,A,OHSU_HNSCC_derm002,19,0.428,0.11111;1.11111;1.11111,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32545,20004,Blank 490,4,B,OHSU_HNSCC_derm002,19,0.277,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32546,20004,Blank 490,4,C,OHSU_HNSCC_derm002,19,0.307,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32547,20004,Blank 490,4,D,OHSU_HNSCC_derm002,19,0.023,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32548,20004,Blank 490,4,E,OHSU_HNSCC_derm002,19,0.337,0.55555;1.11111,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32549,20004,Blank 490,4,F,OHSU_HNSCC_derm002,19,0.313,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32550,20004,Blank 490,4,G,OHSU_HNSCC_derm002,19,0.41,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32551,20004,Blank 490,4,H,OHSU_HNSCC_derm002,19,0.409,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
32552,20004,Blank 490,4,I,OHSU_HNSCC_derm002,19,0.138,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
32553,20004,Blank 490,4,J,OHSU_HNSCC_derm002,19,0.206,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32554,20004,Blank 490,4,K,OHSU_HNSCC_derm002,19,0.436,0.55555;1.11111;1.11111,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32555,20004,Blank 490,4,L,OHSU_HNSCC_derm002,19,0.196,0.11111;1.11111;1.11111,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32556,20004,Blank 490,4,M,OHSU_HNSCC_derm002,19,0.427,1.1111;1.11111;1.11111,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32557,20004,Blank 490,4,N,OHSU_HNSCC_derm002,19,0.525,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32558,20004,Blank 490,4,O,OHSU_HNSCC_derm002,19,0.329,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32559,20004,Blank 490,4,P,OHSU_HNSCC_derm002,19,0.289,1.1111;1.11111;1.11111,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32560,20004,Blank 490,4,A,OHSU_HNSCC_derm002,20,0.551,0.037037;0.37037;0.37037,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32561,20004,Blank 490,4,B,OHSU_HNSCC_derm002,20,0.296,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32562,20004,Blank 490,4,C,OHSU_HNSCC_derm002,20,0.281,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32563,20004,Blank 490,4,D,OHSU_HNSCC_derm002,20,0.043,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32564,20004,Blank 490,4,E,OHSU_HNSCC_derm002,20,0.084,0.185118;0.37037,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32565,20004,Blank 490,4,F,OHSU_HNSCC_derm002,20,0.378,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32566,20004,Blank 490,4,G,OHSU_HNSCC_derm002,20,0.525,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32567,20004,Blank 490,4,H,OHSU_HNSCC_derm002,20,0.393,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
32568,20004,Blank 490,4,I,OHSU_HNSCC_derm002,20,0.168,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
32569,20004,Blank 490,4,J,OHSU_HNSCC_derm002,20,0.244,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32570,20004,Blank 490,4,K,OHSU_HNSCC_derm002,20,0.466,0.185118;0.37037;0.37037,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32571,20004,Blank 490,4,L,OHSU_HNSCC_derm002,20,0.255,0.037037;0.37037;0.37037,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32572,20004,Blank 490,4,M,OHSU_HNSCC_derm002,20,0.477,0.37037;0.37037;0.37037,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32573,20004,Blank 490,4,N,OHSU_HNSCC_derm002,20,0.534,0.037037;0.37037;0.37037,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32574,20004,Blank 490,4,O,OHSU_HNSCC_derm002,20,0.387,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32575,20004,Blank 490,4,P,OHSU_HNSCC_derm002,20,0.33,0.37037;0.37037;0.37037,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32576,20004,Blank 490,4,A,OHSU_HNSCC_derm002,21,0.505,0.0123456;0.123456;0.123456,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32577,20004,Blank 490,4,B,OHSU_HNSCC_derm002,21,0.391,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32578,20004,Blank 490,4,C,OHSU_HNSCC_derm002,21,0.4,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32579,20004,Blank 490,4,D,OHSU_HNSCC_derm002,21,0.04,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32580,20004,Blank 490,4,E,OHSU_HNSCC_derm002,21,0.144,0.0617284;0.123456,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32581,20004,Blank 490,4,F,OHSU_HNSCC_derm002,21,0.385,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32582,20004,Blank 490,4,G,OHSU_HNSCC_derm002,21,0.546,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32583,20004,Blank 490,4,H,OHSU_HNSCC_derm002,21,0.419,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
32584,20004,Blank 490,4,I,OHSU_HNSCC_derm002,21,0.233,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
32585,20004,Blank 490,4,J,OHSU_HNSCC_derm002,21,0.38,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32586,20004,Blank 490,4,K,OHSU_HNSCC_derm002,21,0.44,0.0617284;0.123456;0.123456,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32587,20004,Blank 490,4,L,OHSU_HNSCC_derm002,21,0.268,0.0123456;0.123456;0.123456,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32588,20004,Blank 490,4,M,OHSU_HNSCC_derm002,21,0.313,0.123456;0.123456;0.123456,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32589,20004,Blank 490,4,N,OHSU_HNSCC_derm002,21,0.491,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32590,20004,Blank 490,4,O,OHSU_HNSCC_derm002,21,0.423,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32591,20004,Blank 490,4,P,OHSU_HNSCC_derm002,21,0.384,0.123456;0.123456;0.123456,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32592,20004,Blank 490,4,A,OHSU_HNSCC_derm002,22,0.471,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32593,20004,Blank 490,4,B,OHSU_HNSCC_derm002,22,0.416,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32594,20004,Blank 490,4,C,OHSU_HNSCC_derm002,22,0.399,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32595,20004,Blank 490,4,D,OHSU_HNSCC_derm002,22,0.034,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32596,20004,Blank 490,4,E,OHSU_HNSCC_derm002,22,0.108,0.02057613;0.0411526,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32597,20004,Blank 490,4,F,OHSU_HNSCC_derm002,22,0.411,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32598,20004,Blank 490,4,G,OHSU_HNSCC_derm002,22,0.572,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32599,20004,Blank 490,4,H,OHSU_HNSCC_derm002,22,0.446,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
32600,20004,Blank 490,4,I,OHSU_HNSCC_derm002,22,0.451,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
32601,20004,Blank 490,4,J,OHSU_HNSCC_derm002,22,0.407,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32602,20004,Blank 490,4,K,OHSU_HNSCC_derm002,22,0.462,0.02057613;0.0411526;0.0411526,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32603,20004,Blank 490,4,L,OHSU_HNSCC_derm002,22,0.389,0.004115226;0.0411526;0.0411526,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32604,20004,Blank 490,4,M,OHSU_HNSCC_derm002,22,0.271,0.04115226;0.0411526;0.0411526,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32605,20004,Blank 490,4,N,OHSU_HNSCC_derm002,22,0.433,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32606,20004,Blank 490,4,O,OHSU_HNSCC_derm002,22,0.438,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32607,20004,Blank 490,4,P,OHSU_HNSCC_derm002,22,0.395,0.04115226;0.0411526;0.0411526,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32608,20004,Blank 490,4,A,OHSU_HNSCC_derm002,23,0.448,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Bosutinib,OHSU_HNSCC_derm002
32609,20004,Blank 490,4,B,OHSU_HNSCC_derm002,23,0.478,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Crizotinib,OHSU_HNSCC_derm002
32610,20004,Blank 490,4,C,OHSU_HNSCC_derm002,23,0.384,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32611,20004,Blank 490,4,D,OHSU_HNSCC_derm002,23,0.081,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Romidepsin,OHSU_HNSCC_derm002
32612,20004,Blank 490,4,E,OHSU_HNSCC_derm002,23,0.461,0.00685871;0.01371742,Vandetanib;Idelasib (GS-1101),OHSU_HNSCC_derm002
32613,20004,Blank 490,4,F,OHSU_HNSCC_derm002,23,0.392,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Idelasib (GS-1101),OHSU_HNSCC_derm002
32614,20004,Blank 490,4,G,OHSU_HNSCC_derm002,23,0.458,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Bosutinib,OHSU_HNSCC_derm002
32615,20004,Blank 490,4,H,OHSU_HNSCC_derm002,23,0.436,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
32616,20004,Blank 490,4,I,OHSU_HNSCC_derm002,23,0.479,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
32617,20004,Blank 490,4,J,OHSU_HNSCC_derm002,23,0.372,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Belinostat,OHSU_HNSCC_derm002
32618,20004,Blank 490,4,K,OHSU_HNSCC_derm002,23,0.417,0.00685871;0.01371742;0.01371742,Vandetanib;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32619,20004,Blank 490,4,L,OHSU_HNSCC_derm002,23,0.262,0.001371742;0.01371742;0.01371742,Dasatinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
32620,20004,Blank 490,4,M,OHSU_HNSCC_derm002,23,0.235,0.01371742;0.01371742;0.01371742,Gefitinib;Imatinib;Mesylate,OHSU_HNSCC_derm002
32621,20004,Blank 490,4,N,OHSU_HNSCC_derm002,23,0.415,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32622,20004,Blank 490,4,O,OHSU_HNSCC_derm002,23,0.494,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Imatinib;Mesylate,OHSU_HNSCC_derm002
32623,20004,Blank 490,4,P,OHSU_HNSCC_derm002,23,0.446,0.01371742;0.01371742;0.01371742,Gefitinib;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
32624,20004,Blank 490,4,A,OHSU_HNSCC_derm002,24,0.451,0,NONE,OHSU_HNSCC_derm002
32625,20004,Blank 490,4,B,OHSU_HNSCC_derm002,24,0.446,0,NONE,OHSU_HNSCC_derm002
32626,20004,Blank 490,4,C,OHSU_HNSCC_derm002,24,0.367,0,NONE,OHSU_HNSCC_derm002
32627,20004,Blank 490,4,D,OHSU_HNSCC_derm002,24,0.478,0,NONE,OHSU_HNSCC_derm002
32628,20004,Blank 490,4,E,OHSU_HNSCC_derm002,24,0.451,0,NONE,OHSU_HNSCC_derm002
32629,20004,Blank 490,4,F,OHSU_HNSCC_derm002,24,0.5,0,NONE,OHSU_HNSCC_derm002
32630,20004,Blank 490,4,G,OHSU_HNSCC_derm002,24,0.493,0,NONE,OHSU_HNSCC_derm002
32631,20004,Blank 490,4,H,OHSU_HNSCC_derm002,24,0.463,0,NONE,OHSU_HNSCC_derm002
32632,20004,Blank 490,4,I,OHSU_HNSCC_derm002,24,0.493,0,NONE,OHSU_HNSCC_derm002
32633,20004,Blank 490,4,J,OHSU_HNSCC_derm002,24,0.52,0,NONE,OHSU_HNSCC_derm002
32634,20004,Blank 490,4,K,OHSU_HNSCC_derm002,24,0.403,0,NONE,OHSU_HNSCC_derm002
32635,20004,Blank 490,4,L,OHSU_HNSCC_derm002,24,0.345,0,NONE,OHSU_HNSCC_derm002
32636,20004,Blank 490,4,M,OHSU_HNSCC_derm002,24,0.392,0,NONE,OHSU_HNSCC_derm002
32637,20004,Blank 490,4,N,OHSU_HNSCC_derm002,24,0.404,0,NONE,OHSU_HNSCC_derm002
32638,20004,Blank 490,4,O,OHSU_HNSCC_derm002,24,0.371,0,NONE,OHSU_HNSCC_derm002
32639,20004,Blank 490,4,P,OHSU_HNSCC_derm002,24,0.372,0,NONE,OHSU_HNSCC_derm002
32640,20004,Blank 490,5,A,OHSU_HNSCC_derm002,1,0.226,1;10;10;10,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32641,20004,Blank 490,5,B,OHSU_HNSCC_derm002,1,0.203,10;5,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32642,20004,Blank 490,5,C,OHSU_HNSCC_derm002,1,-0.016,10;10;10,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32643,20004,Blank 490,5,D,OHSU_HNSCC_derm002,1,0.002,5;10,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32644,20004,Blank 490,5,E,OHSU_HNSCC_derm002,1,0.013,10;10;10,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32645,20004,Blank 490,5,F,OHSU_HNSCC_derm002,1,0.035,1;10;1,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32646,20004,Blank 490,5,G,OHSU_HNSCC_derm002,1,0.029,5;10,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32647,20004,Blank 490,5,H,OHSU_HNSCC_derm002,1,0.029,10,Gefitinib,OHSU_HNSCC_derm002
32648,20004,Blank 490,5,I,OHSU_HNSCC_derm002,1,0.024,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
32649,20004,Blank 490,5,J,OHSU_HNSCC_derm002,1,0.016,10;10,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32650,20004,Blank 490,5,K,OHSU_HNSCC_derm002,1,0.037,1;10;10,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32651,20004,Blank 490,5,L,OHSU_HNSCC_derm002,1,0.015,10;10;10;10,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32652,20004,Blank 490,5,M,OHSU_HNSCC_derm002,1,0.022,5;10,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32653,20004,Blank 490,5,N,OHSU_HNSCC_derm002,1,0.007,10;10;10,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32654,20004,Blank 490,5,O,OHSU_HNSCC_derm002,1,-0.018,5;10,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32655,20004,Blank 490,5,P,OHSU_HNSCC_derm002,1,-0.013,10;10,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32656,20004,Blank 490,5,A,OHSU_HNSCC_derm002,2,0.289,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32657,20004,Blank 490,5,B,OHSU_HNSCC_derm002,2,0.306,3.33333;1.66667,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32658,20004,Blank 490,5,C,OHSU_HNSCC_derm002,2,0.031,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32659,20004,Blank 490,5,D,OHSU_HNSCC_derm002,2,0.225,1.6667;3.33333,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32660,20004,Blank 490,5,E,OHSU_HNSCC_derm002,2,0.104,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32661,20004,Blank 490,5,F,OHSU_HNSCC_derm002,2,0.248,0.333333;3.33333;0.333333,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32662,20004,Blank 490,5,G,OHSU_HNSCC_derm002,2,0.368,1.6667;3.33333,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32663,20004,Blank 490,5,H,OHSU_HNSCC_derm002,2,0.349,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
32664,20004,Blank 490,5,I,OHSU_HNSCC_derm002,2,0.238,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
32665,20004,Blank 490,5,J,OHSU_HNSCC_derm002,2,0.056,3.33333;3.33333,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32666,20004,Blank 490,5,K,OHSU_HNSCC_derm002,2,0.523,0.333333;3.33333;3.33333,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32667,20004,Blank 490,5,L,OHSU_HNSCC_derm002,2,0.301,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32668,20004,Blank 490,5,M,OHSU_HNSCC_derm002,2,0.053,1.6667;3.33333,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32669,20004,Blank 490,5,N,OHSU_HNSCC_derm002,2,0.276,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32670,20004,Blank 490,5,O,OHSU_HNSCC_derm002,2,0.069,1.6667;3.33333,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32671,20004,Blank 490,5,P,OHSU_HNSCC_derm002,2,0.094,3.33333;3.33333,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32672,20004,Blank 490,5,A,OHSU_HNSCC_derm002,3,0.322,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32673,20004,Blank 490,5,B,OHSU_HNSCC_derm002,3,0.318,1.11111;0.555555,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32674,20004,Blank 490,5,C,OHSU_HNSCC_derm002,3,0.059,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32675,20004,Blank 490,5,D,OHSU_HNSCC_derm002,3,0.386,0.55555;1.11111,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32676,20004,Blank 490,5,E,OHSU_HNSCC_derm002,3,0.243,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32677,20004,Blank 490,5,F,OHSU_HNSCC_derm002,3,0.274,0.11111;1.11111;0.111111,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32678,20004,Blank 490,5,G,OHSU_HNSCC_derm002,3,0.478,0.55555;1.11111,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32679,20004,Blank 490,5,H,OHSU_HNSCC_derm002,3,0.383,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
32680,20004,Blank 490,5,I,OHSU_HNSCC_derm002,3,0.435,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
32681,20004,Blank 490,5,J,OHSU_HNSCC_derm002,3,0.131,1.1111;1.11111,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32682,20004,Blank 490,5,K,OHSU_HNSCC_derm002,3,0.507,0.11111;1.11111;1.11111,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32683,20004,Blank 490,5,L,OHSU_HNSCC_derm002,3,0.326,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32684,20004,Blank 490,5,M,OHSU_HNSCC_derm002,3,0.084,0.55555;1.11111,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32685,20004,Blank 490,5,N,OHSU_HNSCC_derm002,3,0.333,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32686,20004,Blank 490,5,O,OHSU_HNSCC_derm002,3,0.093,0.55555;1.11111,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32687,20004,Blank 490,5,P,OHSU_HNSCC_derm002,3,0.178,1.1111;1.11111,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32688,20004,Blank 490,5,A,OHSU_HNSCC_derm002,4,0.321,0.037037;0.37037;0.37037,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32689,20004,Blank 490,5,B,OHSU_HNSCC_derm002,4,0.368,0.37037;0.185118,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32690,20004,Blank 490,5,C,OHSU_HNSCC_derm002,4,0.048,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32691,20004,Blank 490,5,D,OHSU_HNSCC_derm002,4,0.423,0.185118;0.37037,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32692,20004,Blank 490,5,E,OHSU_HNSCC_derm002,4,0.336,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32693,20004,Blank 490,5,F,OHSU_HNSCC_derm002,4,0.331,0.037037;0.37037;0.037037,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32694,20004,Blank 490,5,G,OHSU_HNSCC_derm002,4,0.519,0.185118;0.37037,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32695,20004,Blank 490,5,H,OHSU_HNSCC_derm002,4,0.436,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
32696,20004,Blank 490,5,I,OHSU_HNSCC_derm002,4,0.498,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
32697,20004,Blank 490,5,J,OHSU_HNSCC_derm002,4,0.203,0.37037;0.37037,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32698,20004,Blank 490,5,K,OHSU_HNSCC_derm002,4,0.485,0.037037;0.37037;0.37037,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32699,20004,Blank 490,5,L,OHSU_HNSCC_derm002,4,0.453,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32700,20004,Blank 490,5,M,OHSU_HNSCC_derm002,4,0.128,0.185118;0.37037,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32701,20004,Blank 490,5,N,OHSU_HNSCC_derm002,4,0.366,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32702,20004,Blank 490,5,O,OHSU_HNSCC_derm002,4,0.168,0.185118;0.37037,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32703,20004,Blank 490,5,P,OHSU_HNSCC_derm002,4,0.234,0.37037;0.37037,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32704,20004,Blank 490,5,A,OHSU_HNSCC_derm002,5,0.326,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32705,20004,Blank 490,5,B,OHSU_HNSCC_derm002,5,0.396,0.123456;0.0617284,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32706,20004,Blank 490,5,C,OHSU_HNSCC_derm002,5,0.05,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32707,20004,Blank 490,5,D,OHSU_HNSCC_derm002,5,0.406,0.0617284;0.123456,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32708,20004,Blank 490,5,E,OHSU_HNSCC_derm002,5,0.356,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32709,20004,Blank 490,5,F,OHSU_HNSCC_derm002,5,0.449,0.0123456;0.123456;0.0123456,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32710,20004,Blank 490,5,G,OHSU_HNSCC_derm002,5,0.519,0.0617284;0.123456,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32711,20004,Blank 490,5,H,OHSU_HNSCC_derm002,5,0.463,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
32712,20004,Blank 490,5,I,OHSU_HNSCC_derm002,5,0.524,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
32713,20004,Blank 490,5,J,OHSU_HNSCC_derm002,5,0.32,0.123456;0.123456,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32714,20004,Blank 490,5,K,OHSU_HNSCC_derm002,5,0.463,0.0123456;0.123456;0.123456,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32715,20004,Blank 490,5,L,OHSU_HNSCC_derm002,5,0.446,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32716,20004,Blank 490,5,M,OHSU_HNSCC_derm002,5,0.174,0.0617284;0.123456,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32717,20004,Blank 490,5,N,OHSU_HNSCC_derm002,5,0.356,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32718,20004,Blank 490,5,O,OHSU_HNSCC_derm002,5,0.237,0.0617284;0.123456,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32719,20004,Blank 490,5,P,OHSU_HNSCC_derm002,5,0.333,0.123456;0.123456,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32720,20004,Blank 490,5,A,OHSU_HNSCC_derm002,6,0.367,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32721,20004,Blank 490,5,B,OHSU_HNSCC_derm002,6,0.429,0.0411526;0.02057613,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32722,20004,Blank 490,5,C,OHSU_HNSCC_derm002,6,0.086,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32723,20004,Blank 490,5,D,OHSU_HNSCC_derm002,6,0.445,0.02057613;0.0411526,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32724,20004,Blank 490,5,E,OHSU_HNSCC_derm002,6,0.467,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32725,20004,Blank 490,5,F,OHSU_HNSCC_derm002,6,0.456,0.004115226;0.0411526;0.00411526,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32726,20004,Blank 490,5,G,OHSU_HNSCC_derm002,6,0.473,0.02057613;0.0411526,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32727,20004,Blank 490,5,H,OHSU_HNSCC_derm002,6,0.477,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
32728,20004,Blank 490,5,I,OHSU_HNSCC_derm002,6,0.509,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
32729,20004,Blank 490,5,J,OHSU_HNSCC_derm002,6,0.377,0.04115226;0.0411526,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32730,20004,Blank 490,5,K,OHSU_HNSCC_derm002,6,0.505,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32731,20004,Blank 490,5,L,OHSU_HNSCC_derm002,6,0.435,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32732,20004,Blank 490,5,M,OHSU_HNSCC_derm002,6,0.295,0.02057613;0.0411526,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32733,20004,Blank 490,5,N,OHSU_HNSCC_derm002,6,0.405,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32734,20004,Blank 490,5,O,OHSU_HNSCC_derm002,6,0.375,0.02057613;0.0411526,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32735,20004,Blank 490,5,P,OHSU_HNSCC_derm002,6,0.411,0.04115226;0.0411526,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32736,20004,Blank 490,5,A,OHSU_HNSCC_derm002,7,0.338,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32737,20004,Blank 490,5,B,OHSU_HNSCC_derm002,7,0.412,0.01371742;0.00685871,Gefitinib;Vandetanib,OHSU_HNSCC_derm002
32738,20004,Blank 490,5,C,OHSU_HNSCC_derm002,7,0.089,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Romidepsin,OHSU_HNSCC_derm002
32739,20004,Blank 490,5,D,OHSU_HNSCC_derm002,7,0.507,0.00685871;0.01371742,Vandetanib;Axitinib,OHSU_HNSCC_derm002
32740,20004,Blank 490,5,E,OHSU_HNSCC_derm002,7,0.476,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Vorinostat,OHSU_HNSCC_derm002
32741,20004,Blank 490,5,F,OHSU_HNSCC_derm002,7,0.463,0.001371742;0.01371742;0.001371742,Sunitinib;Malate;Dasatinib,OHSU_HNSCC_derm002
32742,20004,Blank 490,5,G,OHSU_HNSCC_derm002,7,0.517,0.00685871;0.01371742,Vandetanib;Fulvestrant,OHSU_HNSCC_derm002
32743,20004,Blank 490,5,H,OHSU_HNSCC_derm002,7,0.465,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
32744,20004,Blank 490,5,I,OHSU_HNSCC_derm002,7,0.518,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
32745,20004,Blank 490,5,J,OHSU_HNSCC_derm002,7,0.475,0.01371742;0.01371742,Gefitinib;GDC-0941,OHSU_HNSCC_derm002
32746,20004,Blank 490,5,K,OHSU_HNSCC_derm002,7,0.515,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Pemetrexed Disodium,OHSU_HNSCC_derm002
32747,20004,Blank 490,5,L,OHSU_HNSCC_derm002,7,0.48,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32748,20004,Blank 490,5,M,OHSU_HNSCC_derm002,7,0.336,0.00685871;0.01371742,Vandetanib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32749,20004,Blank 490,5,N,OHSU_HNSCC_derm002,7,0.437,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pemetrexed Disodium,OHSU_HNSCC_derm002
32750,20004,Blank 490,5,O,OHSU_HNSCC_derm002,7,0.444,0.00685871;0.01371742,Vandetanib;BEZ235,OHSU_HNSCC_derm002
32751,20004,Blank 490,5,P,OHSU_HNSCC_derm002,7,0.409,0.01371742;0.01371742,Gefitinib;Belinostat,OHSU_HNSCC_derm002
32752,20004,Blank 490,5,A,OHSU_HNSCC_derm002,8,0.439,0,NONE,OHSU_HNSCC_derm002
32753,20004,Blank 490,5,B,OHSU_HNSCC_derm002,8,0.362,0,NONE,OHSU_HNSCC_derm002
32754,20004,Blank 490,5,C,OHSU_HNSCC_derm002,8,0.49,0,NONE,OHSU_HNSCC_derm002
32755,20004,Blank 490,5,D,OHSU_HNSCC_derm002,8,0.513,0,NONE,OHSU_HNSCC_derm002
32756,20004,Blank 490,5,E,OHSU_HNSCC_derm002,8,0.546,0,NONE,OHSU_HNSCC_derm002
32757,20004,Blank 490,5,F,OHSU_HNSCC_derm002,8,0.453,0,NONE,OHSU_HNSCC_derm002
32758,20004,Blank 490,5,G,OHSU_HNSCC_derm002,8,0.524,0,NONE,OHSU_HNSCC_derm002
32759,20004,Blank 490,5,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
32760,20004,Blank 490,5,I,OHSU_HNSCC_derm002,8,0.52,0,NONE,OHSU_HNSCC_derm002
32761,20004,Blank 490,5,J,OHSU_HNSCC_derm002,8,0.473,0,NONE,OHSU_HNSCC_derm002
32762,20004,Blank 490,5,K,OHSU_HNSCC_derm002,8,0.493,0,NONE,OHSU_HNSCC_derm002
32763,20004,Blank 490,5,L,OHSU_HNSCC_derm002,8,0.467,0,NONE,OHSU_HNSCC_derm002
32764,20004,Blank 490,5,M,OHSU_HNSCC_derm002,8,0.519,0,NONE,OHSU_HNSCC_derm002
32765,20004,Blank 490,5,N,OHSU_HNSCC_derm002,8,0.428,0,NONE,OHSU_HNSCC_derm002
32766,20004,Blank 490,5,O,OHSU_HNSCC_derm002,8,0.413,0,NONE,OHSU_HNSCC_derm002
32767,20004,Blank 490,5,P,OHSU_HNSCC_derm002,8,0.453,0,NONE,OHSU_HNSCC_derm002
32768,20004,Blank 490,5,A,OHSU_HNSCC_derm002,9,-0.001,10;10,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32769,20004,Blank 490,5,B,OHSU_HNSCC_derm002,9,0.182,10,APTO-253 x,OHSU_HNSCC_derm002
32770,20004,Blank 490,5,C,OHSU_HNSCC_derm002,9,0.028,10;10;10,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32771,20004,Blank 490,5,D,OHSU_HNSCC_derm002,9,0.707,1;10;10,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32772,20004,Blank 490,5,E,OHSU_HNSCC_derm002,9,0.306,1;10;10;10,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32773,20004,Blank 490,5,F,OHSU_HNSCC_derm002,9,0.033,10;10;10,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32774,20004,Blank 490,5,G,OHSU_HNSCC_derm002,9,0.01,10;10;10;10,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32775,20004,Blank 490,5,H,OHSU_HNSCC_derm002,9,0.027,10,Brigatinib,OHSU_HNSCC_derm002
32776,20004,Blank 490,5,I,OHSU_HNSCC_derm002,9,0.158,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32777,20004,Blank 490,5,J,OHSU_HNSCC_derm002,9,0.025,10;10;10,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32778,20004,Blank 490,5,K,OHSU_HNSCC_derm002,9,-0.001,10;10;10;10,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32779,20004,Blank 490,5,L,OHSU_HNSCC_derm002,9,0.037,10;10,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32780,20004,Blank 490,5,M,OHSU_HNSCC_derm002,9,0.322,10;10;10,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32781,20004,Blank 490,5,N,OHSU_HNSCC_derm002,9,0.254,10;10;10;10,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32782,20004,Blank 490,5,O,OHSU_HNSCC_derm002,9,0.001,10;10;10,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32783,20004,Blank 490,5,P,OHSU_HNSCC_derm002,9,-0.004,10;10;10;10,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32784,20004,Blank 490,5,A,OHSU_HNSCC_derm002,10,0.029,3.33333;3.33333,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32785,20004,Blank 490,5,B,OHSU_HNSCC_derm002,10,0.134,3.3333333333333335,APTO-253 x,OHSU_HNSCC_derm002
32786,20004,Blank 490,5,C,OHSU_HNSCC_derm002,10,0.044,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32787,20004,Blank 490,5,D,OHSU_HNSCC_derm002,10,0.56,0.333333;3.33333;3.33333,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32788,20004,Blank 490,5,E,OHSU_HNSCC_derm002,10,0.387,0.333333;3.33333;3.33333;3.33333,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32789,20004,Blank 490,5,F,OHSU_HNSCC_derm002,10,0.06,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32790,20004,Blank 490,5,G,OHSU_HNSCC_derm002,10,0.258,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32791,20004,Blank 490,5,H,OHSU_HNSCC_derm002,10,0.143,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
32792,20004,Blank 490,5,I,OHSU_HNSCC_derm002,10,0.388,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32793,20004,Blank 490,5,J,OHSU_HNSCC_derm002,10,0.068,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32794,20004,Blank 490,5,K,OHSU_HNSCC_derm002,10,0.098,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32795,20004,Blank 490,5,L,OHSU_HNSCC_derm002,10,0.052,3.33333;3.33333,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32796,20004,Blank 490,5,M,OHSU_HNSCC_derm002,10,0.346,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32797,20004,Blank 490,5,N,OHSU_HNSCC_derm002,10,0.405,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32798,20004,Blank 490,5,O,OHSU_HNSCC_derm002,10,0.083,3.33333;3.33333;3.33333,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32799,20004,Blank 490,5,P,OHSU_HNSCC_derm002,10,0.057,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32800,20004,Blank 490,5,A,OHSU_HNSCC_derm002,11,0.042,1.1111;1.11111,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32801,20004,Blank 490,5,B,OHSU_HNSCC_derm002,11,0.272,1.1111111111111112,APTO-253 x,OHSU_HNSCC_derm002
32802,20004,Blank 490,5,C,OHSU_HNSCC_derm002,11,0.052,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32803,20004,Blank 490,5,D,OHSU_HNSCC_derm002,11,0.526,0.11111;1.11111;1.11111,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32804,20004,Blank 490,5,E,OHSU_HNSCC_derm002,11,0.395,0.11111;1.11111;1.11111;1.1111,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32805,20004,Blank 490,5,F,OHSU_HNSCC_derm002,11,0.057,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32806,20004,Blank 490,5,G,OHSU_HNSCC_derm002,11,0.345,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32807,20004,Blank 490,5,H,OHSU_HNSCC_derm002,11,0.313,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
32808,20004,Blank 490,5,I,OHSU_HNSCC_derm002,11,0.339,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32809,20004,Blank 490,5,J,OHSU_HNSCC_derm002,11,0.079,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32810,20004,Blank 490,5,K,OHSU_HNSCC_derm002,11,0.145,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32811,20004,Blank 490,5,L,OHSU_HNSCC_derm002,11,0.054,1.1111;1.11111,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32812,20004,Blank 490,5,M,OHSU_HNSCC_derm002,11,0.341,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32813,20004,Blank 490,5,N,OHSU_HNSCC_derm002,11,0.442,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32814,20004,Blank 490,5,O,OHSU_HNSCC_derm002,11,0.151,1.1111;1.11111;1.11111,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32815,20004,Blank 490,5,P,OHSU_HNSCC_derm002,11,0.151,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32816,20004,Blank 490,5,A,OHSU_HNSCC_derm002,12,0.042,0.37037;0.37037,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32817,20004,Blank 490,5,B,OHSU_HNSCC_derm002,12,0.454,0.3703703703703704,APTO-253 x,OHSU_HNSCC_derm002
32818,20004,Blank 490,5,C,OHSU_HNSCC_derm002,12,0.094,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32819,20004,Blank 490,5,D,OHSU_HNSCC_derm002,12,0.498,0.037037;0.37037;0.37037,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32820,20004,Blank 490,5,E,OHSU_HNSCC_derm002,12,0.445,0.037037;0.37037;0.37037,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32821,20004,Blank 490,5,F,OHSU_HNSCC_derm002,12,0.114,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32822,20004,Blank 490,5,G,OHSU_HNSCC_derm002,12,0.362,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32823,20004,Blank 490,5,H,OHSU_HNSCC_derm002,12,0.454,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
32824,20004,Blank 490,5,I,OHSU_HNSCC_derm002,12,0.388,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32825,20004,Blank 490,5,J,OHSU_HNSCC_derm002,12,0.136,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32826,20004,Blank 490,5,K,OHSU_HNSCC_derm002,12,0.253,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32827,20004,Blank 490,5,L,OHSU_HNSCC_derm002,12,0.093,0.37037;0.37037,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32828,20004,Blank 490,5,M,OHSU_HNSCC_derm002,12,0.407,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32829,20004,Blank 490,5,N,OHSU_HNSCC_derm002,12,0.416,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32830,20004,Blank 490,5,O,OHSU_HNSCC_derm002,12,0.27,0.37037;0.37037;0.37037,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32831,20004,Blank 490,5,P,OHSU_HNSCC_derm002,12,0.276,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32832,20004,Blank 490,5,A,OHSU_HNSCC_derm002,13,0.053,0.123456;0.123456,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32833,20004,Blank 490,5,B,OHSU_HNSCC_derm002,13,0.413,0.1234567901234568,APTO-253 x,OHSU_HNSCC_derm002
32834,20004,Blank 490,5,C,OHSU_HNSCC_derm002,13,0.206,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32835,20004,Blank 490,5,D,OHSU_HNSCC_derm002,13,0.511,0.0123456;0.123456;0.123456,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32836,20004,Blank 490,5,E,OHSU_HNSCC_derm002,13,0.448,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32837,20004,Blank 490,5,F,OHSU_HNSCC_derm002,13,0.187,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32838,20004,Blank 490,5,G,OHSU_HNSCC_derm002,13,0.393,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32839,20004,Blank 490,5,H,OHSU_HNSCC_derm002,13,0.548,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
32840,20004,Blank 490,5,I,OHSU_HNSCC_derm002,13,0.4,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32841,20004,Blank 490,5,J,OHSU_HNSCC_derm002,13,0.216,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32842,20004,Blank 490,5,K,OHSU_HNSCC_derm002,13,0.378,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32843,20004,Blank 490,5,L,OHSU_HNSCC_derm002,13,0.199,0.123456;0.123456,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32844,20004,Blank 490,5,M,OHSU_HNSCC_derm002,13,0.469,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32845,20004,Blank 490,5,N,OHSU_HNSCC_derm002,13,0.436,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32846,20004,Blank 490,5,O,OHSU_HNSCC_derm002,13,0.354,0.123456;0.123456;0.123456,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32847,20004,Blank 490,5,P,OHSU_HNSCC_derm002,13,0.36,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32848,20004,Blank 490,5,A,OHSU_HNSCC_derm002,14,0.058,0.04115226;0.0411526,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32849,20004,Blank 490,5,B,OHSU_HNSCC_derm002,14,0.453,0.0411522633744856,APTO-253 x,OHSU_HNSCC_derm002
32850,20004,Blank 490,5,C,OHSU_HNSCC_derm002,14,0.302,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32851,20004,Blank 490,5,D,OHSU_HNSCC_derm002,14,0.502,0.004115226;0.0411526;0.0411526,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32852,20004,Blank 490,5,E,OHSU_HNSCC_derm002,14,0.467,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32853,20004,Blank 490,5,F,OHSU_HNSCC_derm002,14,0.286,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32854,20004,Blank 490,5,G,OHSU_HNSCC_derm002,14,0.365,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32855,20004,Blank 490,5,H,OHSU_HNSCC_derm002,14,0.484,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
32856,20004,Blank 490,5,I,OHSU_HNSCC_derm002,14,0.392,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32857,20004,Blank 490,5,J,OHSU_HNSCC_derm002,14,0.336,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32858,20004,Blank 490,5,K,OHSU_HNSCC_derm002,14,0.443,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32859,20004,Blank 490,5,L,OHSU_HNSCC_derm002,14,0.306,0.04115226;0.0411526,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32860,20004,Blank 490,5,M,OHSU_HNSCC_derm002,14,0.477,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32861,20004,Blank 490,5,N,OHSU_HNSCC_derm002,14,0.434,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32862,20004,Blank 490,5,O,OHSU_HNSCC_derm002,14,0.414,0.04115226;0.0411526;0.0411526,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32863,20004,Blank 490,5,P,OHSU_HNSCC_derm002,14,0.421,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32864,20004,Blank 490,5,A,OHSU_HNSCC_derm002,15,0.074,0.01371742;0.01371742,Gefitinib;Romidepsin,OHSU_HNSCC_derm002
32865,20004,Blank 490,5,B,OHSU_HNSCC_derm002,15,0.43,0.013717421124828532,APTO-253 x,OHSU_HNSCC_derm002
32866,20004,Blank 490,5,C,OHSU_HNSCC_derm002,15,0.379,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Panobinostat,OHSU_HNSCC_derm002
32867,20004,Blank 490,5,D,OHSU_HNSCC_derm002,15,0.496,0.001371742;0.01371742;0.01371742,Sunitinib;Malate;Fulvestrant,OHSU_HNSCC_derm002
32868,20004,Blank 490,5,E,OHSU_HNSCC_derm002,15,0.546,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Lapatinib;Ditosylate;Malate,OHSU_HNSCC_derm002
32869,20004,Blank 490,5,F,OHSU_HNSCC_derm002,15,0.349,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32870,20004,Blank 490,5,G,OHSU_HNSCC_derm002,15,0.409,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32871,20004,Blank 490,5,H,OHSU_HNSCC_derm002,15,0.493,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
32872,20004,Blank 490,5,I,OHSU_HNSCC_derm002,15,0.435,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
32873,20004,Blank 490,5,J,OHSU_HNSCC_derm002,15,0.484,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;BEZ235,OHSU_HNSCC_derm002
32874,20004,Blank 490,5,K,OHSU_HNSCC_derm002,15,0.495,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32875,20004,Blank 490,5,L,OHSU_HNSCC_derm002,15,0.337,0.01371742;0.01371742,Gefitinib;Panobinostat,OHSU_HNSCC_derm002
32876,20004,Blank 490,5,M,OHSU_HNSCC_derm002,15,0.47,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Fulvestrant,OHSU_HNSCC_derm002
32877,20004,Blank 490,5,N,OHSU_HNSCC_derm002,15,0.442,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32878,20004,Blank 490,5,O,OHSU_HNSCC_derm002,15,0.469,0.01371742;0.01371742;0.01371742,Gefitinib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32879,20004,Blank 490,5,P,OHSU_HNSCC_derm002,15,0.461,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32880,20004,Blank 490,5,A,OHSU_HNSCC_derm002,16,0.451,0,NONE,OHSU_HNSCC_derm002
32881,20004,Blank 490,5,B,OHSU_HNSCC_derm002,16,0.443,0,NONE,OHSU_HNSCC_derm002
32882,20004,Blank 490,5,C,OHSU_HNSCC_derm002,16,0.483,0,NONE,OHSU_HNSCC_derm002
32883,20004,Blank 490,5,D,OHSU_HNSCC_derm002,16,0.515,0,NONE,OHSU_HNSCC_derm002
32884,20004,Blank 490,5,E,OHSU_HNSCC_derm002,16,0.49,0,NONE,OHSU_HNSCC_derm002
32885,20004,Blank 490,5,F,OHSU_HNSCC_derm002,16,0.492,0,NONE,OHSU_HNSCC_derm002
32886,20004,Blank 490,5,G,OHSU_HNSCC_derm002,16,0.544,0,NONE,OHSU_HNSCC_derm002
32887,20004,Blank 490,5,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
32888,20004,Blank 490,5,I,OHSU_HNSCC_derm002,16,0.466,0,NONE,OHSU_HNSCC_derm002
32889,20004,Blank 490,5,J,OHSU_HNSCC_derm002,16,0.482,0,NONE,OHSU_HNSCC_derm002
32890,20004,Blank 490,5,K,OHSU_HNSCC_derm002,16,0.535,0,NONE,OHSU_HNSCC_derm002
32891,20004,Blank 490,5,L,OHSU_HNSCC_derm002,16,0.449,0,NONE,OHSU_HNSCC_derm002
32892,20004,Blank 490,5,M,OHSU_HNSCC_derm002,16,0.416,0,NONE,OHSU_HNSCC_derm002
32893,20004,Blank 490,5,N,OHSU_HNSCC_derm002,16,0.459,0,NONE,OHSU_HNSCC_derm002
32894,20004,Blank 490,5,O,OHSU_HNSCC_derm002,16,0.454,0,NONE,OHSU_HNSCC_derm002
32895,20004,Blank 490,5,P,OHSU_HNSCC_derm002,16,0.405,0,NONE,OHSU_HNSCC_derm002
32896,20004,Blank 490,5,A,OHSU_HNSCC_derm002,17,-0.004,5;10;10,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32897,20004,Blank 490,5,B,OHSU_HNSCC_derm002,17,-0.001,1;10;10;10,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32898,20004,Blank 490,5,C,OHSU_HNSCC_derm002,17,0.04,10;10,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32899,20004,Blank 490,5,D,OHSU_HNSCC_derm002,17,0.095,10;10;10,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32900,20004,Blank 490,5,E,OHSU_HNSCC_derm002,17,0.32,5;10,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32901,20004,Blank 490,5,F,OHSU_HNSCC_derm002,17,0.213,10;10;10,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32902,20004,Blank 490,5,G,OHSU_HNSCC_derm002,17,0.403,10;10;10;10,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32903,20004,Blank 490,5,H,OHSU_HNSCC_derm002,17,0.424,10,Trametinib,OHSU_HNSCC_derm002
32904,20004,Blank 490,5,I,OHSU_HNSCC_derm002,17,0.109,10,BEZ235,OHSU_HNSCC_derm002
32905,20004,Blank 490,5,J,OHSU_HNSCC_derm002,17,0.09,5;10,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32906,20004,Blank 490,5,K,OHSU_HNSCC_derm002,17,0.382,1;10;10,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32907,20004,Blank 490,5,L,OHSU_HNSCC_derm002,17,0.016,10;10;10,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32908,20004,Blank 490,5,M,OHSU_HNSCC_derm002,17,0.207,10;10,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32909,20004,Blank 490,5,N,OHSU_HNSCC_derm002,17,0.195,5;10;10,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32910,20004,Blank 490,5,O,OHSU_HNSCC_derm002,17,0.418,1;10;10;10,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32911,20004,Blank 490,5,P,OHSU_HNSCC_derm002,17,0.029,10;10;10;10,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32912,20004,Blank 490,5,A,OHSU_HNSCC_derm002,18,0.097,1.6667;3.33333;3.33333,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32913,20004,Blank 490,5,B,OHSU_HNSCC_derm002,18,0.17,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32914,20004,Blank 490,5,C,OHSU_HNSCC_derm002,18,0.055,3.33333;3.33333,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32915,20004,Blank 490,5,D,OHSU_HNSCC_derm002,18,0.269,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32916,20004,Blank 490,5,E,OHSU_HNSCC_derm002,18,0.334,1.6667;3.33333,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32917,20004,Blank 490,5,F,OHSU_HNSCC_derm002,18,0.345,3.33333;3.33333;3.33333,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32918,20004,Blank 490,5,G,OHSU_HNSCC_derm002,18,0.449,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32919,20004,Blank 490,5,H,OHSU_HNSCC_derm002,18,0.417,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
32920,20004,Blank 490,5,I,OHSU_HNSCC_derm002,18,0.135,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
32921,20004,Blank 490,5,J,OHSU_HNSCC_derm002,18,0.198,1.6667;3.33333,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32922,20004,Blank 490,5,K,OHSU_HNSCC_derm002,18,0.412,0.333333;3.33333;3.33333,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32923,20004,Blank 490,5,L,OHSU_HNSCC_derm002,18,0.038,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32924,20004,Blank 490,5,M,OHSU_HNSCC_derm002,18,0.294,3.33333;3.33333,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32925,20004,Blank 490,5,N,OHSU_HNSCC_derm002,18,0.311,1.6667;3.33333;3.33333,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32926,20004,Blank 490,5,O,OHSU_HNSCC_derm002,18,0.496,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32927,20004,Blank 490,5,P,OHSU_HNSCC_derm002,18,0.226,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32928,20004,Blank 490,5,A,OHSU_HNSCC_derm002,19,0.18,0.55555;1.11111;1.11111,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32929,20004,Blank 490,5,B,OHSU_HNSCC_derm002,19,0.275,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32930,20004,Blank 490,5,C,OHSU_HNSCC_derm002,19,0.075,1.1111;1.11111,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32931,20004,Blank 490,5,D,OHSU_HNSCC_derm002,19,0.324,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32932,20004,Blank 490,5,E,OHSU_HNSCC_derm002,19,0.421,0.55555;1.11111,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32933,20004,Blank 490,5,F,OHSU_HNSCC_derm002,19,0.37,1.1111;1.11111;1.11111,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32934,20004,Blank 490,5,G,OHSU_HNSCC_derm002,19,0.466,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32935,20004,Blank 490,5,H,OHSU_HNSCC_derm002,19,0.493,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
32936,20004,Blank 490,5,I,OHSU_HNSCC_derm002,19,0.164,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
32937,20004,Blank 490,5,J,OHSU_HNSCC_derm002,19,0.27,0.55555;1.11111,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32938,20004,Blank 490,5,K,OHSU_HNSCC_derm002,19,0.385,0.11111;1.11111;1.11111,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32939,20004,Blank 490,5,L,OHSU_HNSCC_derm002,19,0.071,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32940,20004,Blank 490,5,M,OHSU_HNSCC_derm002,19,0.377,1.1111;1.11111,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32941,20004,Blank 490,5,N,OHSU_HNSCC_derm002,19,0.383,0.55555;1.11111;1.11111,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32942,20004,Blank 490,5,O,OHSU_HNSCC_derm002,19,0.443,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32943,20004,Blank 490,5,P,OHSU_HNSCC_derm002,19,0.298,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32944,20004,Blank 490,5,A,OHSU_HNSCC_derm002,20,0.318,0.185118;0.37037;0.37037,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32945,20004,Blank 490,5,B,OHSU_HNSCC_derm002,20,0.346,0.037037;0.37037;0.37037,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32946,20004,Blank 490,5,C,OHSU_HNSCC_derm002,20,0.101,0.37037;0.37037,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32947,20004,Blank 490,5,D,OHSU_HNSCC_derm002,20,0.412,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32948,20004,Blank 490,5,E,OHSU_HNSCC_derm002,20,0.449,0.185118;0.37037,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32949,20004,Blank 490,5,F,OHSU_HNSCC_derm002,20,0.381,0.37037;0.37037;0.37037,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32950,20004,Blank 490,5,G,OHSU_HNSCC_derm002,20,0.494,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32951,20004,Blank 490,5,H,OHSU_HNSCC_derm002,20,0.42,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
32952,20004,Blank 490,5,I,OHSU_HNSCC_derm002,20,0.189,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
32953,20004,Blank 490,5,J,OHSU_HNSCC_derm002,20,0.319,0.185118;0.37037,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32954,20004,Blank 490,5,K,OHSU_HNSCC_derm002,20,0.511,0.037037;0.37037;0.37037,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32955,20004,Blank 490,5,L,OHSU_HNSCC_derm002,20,0.116,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32956,20004,Blank 490,5,M,OHSU_HNSCC_derm002,20,0.415,0.37037;0.37037,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32957,20004,Blank 490,5,N,OHSU_HNSCC_derm002,20,0.386,0.185118;0.37037;0.37037,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32958,20004,Blank 490,5,O,OHSU_HNSCC_derm002,20,0.445,0.037037;0.37037;0.37037,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32959,20004,Blank 490,5,P,OHSU_HNSCC_derm002,20,0.346,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32960,20004,Blank 490,5,A,OHSU_HNSCC_derm002,21,0.364,0.0617284;0.123456;0.123456,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32961,20004,Blank 490,5,B,OHSU_HNSCC_derm002,21,0.4,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32962,20004,Blank 490,5,C,OHSU_HNSCC_derm002,21,0.17,0.123456;0.123456,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32963,20004,Blank 490,5,D,OHSU_HNSCC_derm002,21,0.525,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32964,20004,Blank 490,5,E,OHSU_HNSCC_derm002,21,0.536,0.0617284;0.123456,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32965,20004,Blank 490,5,F,OHSU_HNSCC_derm002,21,0.426,0.123456;0.123456;0.123456,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32966,20004,Blank 490,5,G,OHSU_HNSCC_derm002,21,0.518,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32967,20004,Blank 490,5,H,OHSU_HNSCC_derm002,21,0.438,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
32968,20004,Blank 490,5,I,OHSU_HNSCC_derm002,21,0.291,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
32969,20004,Blank 490,5,J,OHSU_HNSCC_derm002,21,0.418,0.0617284;0.123456,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32970,20004,Blank 490,5,K,OHSU_HNSCC_derm002,21,0.461,0.0123456;0.123456;0.123456,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32971,20004,Blank 490,5,L,OHSU_HNSCC_derm002,21,0.186,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32972,20004,Blank 490,5,M,OHSU_HNSCC_derm002,21,0.422,0.123456;0.123456,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32973,20004,Blank 490,5,N,OHSU_HNSCC_derm002,21,0.408,0.0617284;0.123456;0.123456,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32974,20004,Blank 490,5,O,OHSU_HNSCC_derm002,21,0.469,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32975,20004,Blank 490,5,P,OHSU_HNSCC_derm002,21,0.304,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32976,20004,Blank 490,5,A,OHSU_HNSCC_derm002,22,0.411,0.02057613;0.0411526;0.0411526,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32977,20004,Blank 490,5,B,OHSU_HNSCC_derm002,22,0.446,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32978,20004,Blank 490,5,C,OHSU_HNSCC_derm002,22,0.263,0.04115226;0.0411526,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32979,20004,Blank 490,5,D,OHSU_HNSCC_derm002,22,0.558,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32980,20004,Blank 490,5,E,OHSU_HNSCC_derm002,22,0.595,0.02057613;0.0411526,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32981,20004,Blank 490,5,F,OHSU_HNSCC_derm002,22,0.541,0.04115226;0.0411526;0.0411526,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32982,20004,Blank 490,5,G,OHSU_HNSCC_derm002,22,0.499,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32983,20004,Blank 490,5,H,OHSU_HNSCC_derm002,22,0.478,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
32984,20004,Blank 490,5,I,OHSU_HNSCC_derm002,22,0.461,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
32985,20004,Blank 490,5,J,OHSU_HNSCC_derm002,22,0.438,0.02057613;0.0411526,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
32986,20004,Blank 490,5,K,OHSU_HNSCC_derm002,22,0.447,0.004115226;0.0411526;0.0411526,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
32987,20004,Blank 490,5,L,OHSU_HNSCC_derm002,22,0.253,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32988,20004,Blank 490,5,M,OHSU_HNSCC_derm002,22,0.46,0.04115226;0.0411526,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
32989,20004,Blank 490,5,N,OHSU_HNSCC_derm002,22,0.447,0.02057613;0.0411526;0.0411526,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32990,20004,Blank 490,5,O,OHSU_HNSCC_derm002,22,0.447,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
32991,20004,Blank 490,5,P,OHSU_HNSCC_derm002,22,0.332,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
32992,20004,Blank 490,5,A,OHSU_HNSCC_derm002,23,0.445,0.00685871;0.01371742;0.01371742,Vandetanib;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32993,20004,Blank 490,5,B,OHSU_HNSCC_derm002,23,0.441,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Ponatinib;Hydrochloride,OHSU_HNSCC_derm002
32994,20004,Blank 490,5,C,OHSU_HNSCC_derm002,23,0.35,0.01371742;0.01371742,Gefitinib;Taselisib (GDC-0032),OHSU_HNSCC_derm002
32995,20004,Blank 490,5,D,OHSU_HNSCC_derm002,23,0.456,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Nilotinib,OHSU_HNSCC_derm002
32996,20004,Blank 490,5,E,OHSU_HNSCC_derm002,23,0.469,0.00685871;0.01371742,Vandetanib;Pemetrexed Disodium,OHSU_HNSCC_derm002
32997,20004,Blank 490,5,F,OHSU_HNSCC_derm002,23,0.444,0.01371742;0.01371742;0.01371742,Gefitinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
32998,20004,Blank 490,5,G,OHSU_HNSCC_derm002,23,0.464,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Ruxolitinib;Phosphate,OHSU_HNSCC_derm002
32999,20004,Blank 490,5,H,OHSU_HNSCC_derm002,23,0.448,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
33000,20004,Blank 490,5,I,OHSU_HNSCC_derm002,23,0.475,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
33001,20004,Blank 490,5,J,OHSU_HNSCC_derm002,23,0.446,0.00685871;0.01371742,Vandetanib;Vorinostat,OHSU_HNSCC_derm002
33002,20004,Blank 490,5,K,OHSU_HNSCC_derm002,23,0.456,0.001371742;0.01371742;0.01371742,Sunitinib;Gefitinib;Malate,OHSU_HNSCC_derm002
33003,20004,Blank 490,5,L,OHSU_HNSCC_derm002,23,0.303,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Taselisib (GDC-0032),OHSU_HNSCC_derm002
33004,20004,Blank 490,5,M,OHSU_HNSCC_derm002,23,0.474,0.01371742;0.01371742,Gefitinib;Nilotinib,OHSU_HNSCC_derm002
33005,20004,Blank 490,5,N,OHSU_HNSCC_derm002,23,0.436,0.00685871;0.01371742;0.01371742,Vandetanib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33006,20004,Blank 490,5,O,OHSU_HNSCC_derm002,23,0.47,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Imatinib;Mesylate,OHSU_HNSCC_derm002
33007,20004,Blank 490,5,P,OHSU_HNSCC_derm002,23,0.387,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Afatinib;Dimaleate,OHSU_HNSCC_derm002
33008,20004,Blank 490,5,A,OHSU_HNSCC_derm002,24,0.241,0,NONE,OHSU_HNSCC_derm002
33009,20004,Blank 490,5,B,OHSU_HNSCC_derm002,24,0.406,0,NONE,OHSU_HNSCC_derm002
33010,20004,Blank 490,5,C,OHSU_HNSCC_derm002,24,0.487,0,NONE,OHSU_HNSCC_derm002
33011,20004,Blank 490,5,D,OHSU_HNSCC_derm002,24,0.431,0,NONE,OHSU_HNSCC_derm002
33012,20004,Blank 490,5,E,OHSU_HNSCC_derm002,24,0.567,0,NONE,OHSU_HNSCC_derm002
33013,20004,Blank 490,5,F,OHSU_HNSCC_derm002,24,0.47,0,NONE,OHSU_HNSCC_derm002
33014,20004,Blank 490,5,G,OHSU_HNSCC_derm002,24,0.5,0,NONE,OHSU_HNSCC_derm002
33015,20004,Blank 490,5,H,OHSU_HNSCC_derm002,24,0.484,0,NONE,OHSU_HNSCC_derm002
33016,20004,Blank 490,5,I,OHSU_HNSCC_derm002,24,0.455,0,NONE,OHSU_HNSCC_derm002
33017,20004,Blank 490,5,J,OHSU_HNSCC_derm002,24,0.486,0,NONE,OHSU_HNSCC_derm002
33018,20004,Blank 490,5,K,OHSU_HNSCC_derm002,24,0.454,0,NONE,OHSU_HNSCC_derm002
33019,20004,Blank 490,5,L,OHSU_HNSCC_derm002,24,0.533,0,NONE,OHSU_HNSCC_derm002
33020,20004,Blank 490,5,M,OHSU_HNSCC_derm002,24,0.544,0,NONE,OHSU_HNSCC_derm002
33021,20004,Blank 490,5,N,OHSU_HNSCC_derm002,24,0.359,0,NONE,OHSU_HNSCC_derm002
33022,20004,Blank 490,5,O,OHSU_HNSCC_derm002,24,0.424,0,NONE,OHSU_HNSCC_derm002
33023,20004,Blank 490,5,P,OHSU_HNSCC_derm002,24,0.506,0,NONE,OHSU_HNSCC_derm002
33024,20004,Blank 490,6,A,OHSU_HNSCC_derm002,1,0.231,10;10;10;10,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33025,20004,Blank 490,6,B,OHSU_HNSCC_derm002,1,0.166,5;1,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33026,20004,Blank 490,6,C,OHSU_HNSCC_derm002,1,0.036,10;10;10,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33027,20004,Blank 490,6,D,OHSU_HNSCC_derm002,1,0.1,10;10;10,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33028,20004,Blank 490,6,E,OHSU_HNSCC_derm002,1,0.035,10;10;10,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33029,20004,Blank 490,6,F,OHSU_HNSCC_derm002,1,0.182,1;10;10,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33030,20004,Blank 490,6,G,OHSU_HNSCC_derm002,1,0.349,10,IMR 1,OHSU_HNSCC_derm002
33031,20004,Blank 490,6,H,OHSU_HNSCC_derm002,1,0.311,10,Gefitinib,OHSU_HNSCC_derm002
33032,20004,Blank 490,6,I,OHSU_HNSCC_derm002,1,0.018,10,Ceritinib (LDK378),OHSU_HNSCC_derm002
33033,20004,Blank 490,6,J,OHSU_HNSCC_derm002,1,0.5,0,DMSO,OHSU_HNSCC_derm002
33034,20004,Blank 490,6,K,OHSU_HNSCC_derm002,1,0.485,0,DMSO ,OHSU_HNSCC_derm002
33035,20004,Blank 490,6,L,OHSU_HNSCC_derm002,1,0.47,0,DMSO,OHSU_HNSCC_derm002
33036,20004,Blank 490,6,M,OHSU_HNSCC_derm002,1,0.407,0,DMSO ,OHSU_HNSCC_derm002
33037,20004,Blank 490,6,N,OHSU_HNSCC_derm002,1,0.423,0,DMSO,OHSU_HNSCC_derm002
33038,20004,Blank 490,6,O,OHSU_HNSCC_derm002,1,0.534,0,DMSO ,OHSU_HNSCC_derm002
33039,20004,Blank 490,6,P,OHSU_HNSCC_derm002,1,0.468,0,DMSO,OHSU_HNSCC_derm002
33040,20004,Blank 490,6,A,OHSU_HNSCC_derm002,2,0.232,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33041,20004,Blank 490,6,B,OHSU_HNSCC_derm002,2,0.189,1.6667;0.333333,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33042,20004,Blank 490,6,C,OHSU_HNSCC_derm002,2,0.056,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33043,20004,Blank 490,6,D,OHSU_HNSCC_derm002,2,0.333,3.33333;3.33333;3.33333,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33044,20004,Blank 490,6,E,OHSU_HNSCC_derm002,2,0.241,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33045,20004,Blank 490,6,F,OHSU_HNSCC_derm002,2,0.182,0.333333;3.33333;3.33333,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33046,20004,Blank 490,6,G,OHSU_HNSCC_derm002,2,0.475,3.3333333333333335,IMR 1,OHSU_HNSCC_derm002
33047,20004,Blank 490,6,H,OHSU_HNSCC_derm002,2,0.355,3.3333333333333335,Gefitinib,OHSU_HNSCC_derm002
33048,20004,Blank 490,6,I,OHSU_HNSCC_derm002,2,0.225,3.3333333333333335,Ceritinib (LDK378),OHSU_HNSCC_derm002
33049,20004,Blank 490,6,J,OHSU_HNSCC_derm002,2,0.469,0,DMSO,OHSU_HNSCC_derm002
33050,20004,Blank 490,6,K,OHSU_HNSCC_derm002,2,0.468,0,DMSO ,OHSU_HNSCC_derm002
33051,20004,Blank 490,6,L,OHSU_HNSCC_derm002,2,0.424,0,DMSO,OHSU_HNSCC_derm002
33052,20004,Blank 490,6,M,OHSU_HNSCC_derm002,2,0.412,0,DMSO ,OHSU_HNSCC_derm002
33053,20004,Blank 490,6,N,OHSU_HNSCC_derm002,2,0.452,0,DMSO,OHSU_HNSCC_derm002
33054,20004,Blank 490,6,O,OHSU_HNSCC_derm002,2,0.508,0,DMSO ,OHSU_HNSCC_derm002
33055,20004,Blank 490,6,P,OHSU_HNSCC_derm002,2,0.488,0,DMSO,OHSU_HNSCC_derm002
33056,20004,Blank 490,6,A,OHSU_HNSCC_derm002,3,0.34,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33057,20004,Blank 490,6,B,OHSU_HNSCC_derm002,3,0.2,0.55555;0.111111,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33058,20004,Blank 490,6,C,OHSU_HNSCC_derm002,3,0.138,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33059,20004,Blank 490,6,D,OHSU_HNSCC_derm002,3,0.369,1.1111;1.11111;1.11111,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33060,20004,Blank 490,6,E,OHSU_HNSCC_derm002,3,0.55,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33061,20004,Blank 490,6,F,OHSU_HNSCC_derm002,3,0.189,0.11111;1.11111;1.11111,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33062,20004,Blank 490,6,G,OHSU_HNSCC_derm002,3,0.501,1.1111111111111112,IMR 1,OHSU_HNSCC_derm002
33063,20004,Blank 490,6,H,OHSU_HNSCC_derm002,3,0.346,1.1111111111111112,Gefitinib,OHSU_HNSCC_derm002
33064,20004,Blank 490,6,I,OHSU_HNSCC_derm002,3,0.421,1.1111111111111112,Ceritinib (LDK378),OHSU_HNSCC_derm002
33065,20004,Blank 490,6,J,OHSU_HNSCC_derm002,3,0.494,0,DMSO,OHSU_HNSCC_derm002
33066,20004,Blank 490,6,K,OHSU_HNSCC_derm002,3,0.499,0,DMSO ,OHSU_HNSCC_derm002
33067,20004,Blank 490,6,L,OHSU_HNSCC_derm002,3,0.475,0,DMSO,OHSU_HNSCC_derm002
33068,20004,Blank 490,6,M,OHSU_HNSCC_derm002,3,0.503,0,DMSO ,OHSU_HNSCC_derm002
33069,20004,Blank 490,6,N,OHSU_HNSCC_derm002,3,0.426,0,DMSO,OHSU_HNSCC_derm002
33070,20004,Blank 490,6,O,OHSU_HNSCC_derm002,3,0.514,0,DMSO ,OHSU_HNSCC_derm002
33071,20004,Blank 490,6,P,OHSU_HNSCC_derm002,3,0.428,0,DMSO,OHSU_HNSCC_derm002
33072,20004,Blank 490,6,A,OHSU_HNSCC_derm002,4,0.34,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33073,20004,Blank 490,6,B,OHSU_HNSCC_derm002,4,0.263,0.185118;0.037037,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33074,20004,Blank 490,6,C,OHSU_HNSCC_derm002,4,0.184,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33075,20004,Blank 490,6,D,OHSU_HNSCC_derm002,4,0.37,0.37037;0.37037;0.37037,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33076,20004,Blank 490,6,E,OHSU_HNSCC_derm002,4,0.52,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33077,20004,Blank 490,6,F,OHSU_HNSCC_derm002,4,0.233,0.037037;0.37037;0.37037,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33078,20004,Blank 490,6,G,OHSU_HNSCC_derm002,4,0.437,0.3703703703703704,IMR 1,OHSU_HNSCC_derm002
33079,20004,Blank 490,6,H,OHSU_HNSCC_derm002,4,0.358,0.3703703703703704,Gefitinib,OHSU_HNSCC_derm002
33080,20004,Blank 490,6,I,OHSU_HNSCC_derm002,4,0.482,0.3703703703703704,Ceritinib (LDK378),OHSU_HNSCC_derm002
33081,20004,Blank 490,6,J,OHSU_HNSCC_derm002,4,0.517,0,DMSO,OHSU_HNSCC_derm002
33082,20004,Blank 490,6,K,OHSU_HNSCC_derm002,4,0.542,0,DMSO ,OHSU_HNSCC_derm002
33083,20004,Blank 490,6,L,OHSU_HNSCC_derm002,4,0.459,0,DMSO,OHSU_HNSCC_derm002
33084,20004,Blank 490,6,M,OHSU_HNSCC_derm002,4,0.481,0,DMSO ,OHSU_HNSCC_derm002
33085,20004,Blank 490,6,N,OHSU_HNSCC_derm002,4,0.463,0,DMSO,OHSU_HNSCC_derm002
33086,20004,Blank 490,6,O,OHSU_HNSCC_derm002,4,0.481,0,DMSO ,OHSU_HNSCC_derm002
33087,20004,Blank 490,6,P,OHSU_HNSCC_derm002,4,0.467,0,DMSO,OHSU_HNSCC_derm002
33088,20004,Blank 490,6,A,OHSU_HNSCC_derm002,5,0.418,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33089,20004,Blank 490,6,B,OHSU_HNSCC_derm002,5,0.373,0.0617284;0.0123456,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33090,20004,Blank 490,6,C,OHSU_HNSCC_derm002,5,0.33,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33091,20004,Blank 490,6,D,OHSU_HNSCC_derm002,5,0.374,0.123456;0.123456;0.123456,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33092,20004,Blank 490,6,E,OHSU_HNSCC_derm002,5,0.512,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33093,20004,Blank 490,6,F,OHSU_HNSCC_derm002,5,0.335,0.0123456;0.123456;0.123456,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33094,20004,Blank 490,6,G,OHSU_HNSCC_derm002,5,0.476,0.1234567901234568,IMR 1,OHSU_HNSCC_derm002
33095,20004,Blank 490,6,H,OHSU_HNSCC_derm002,5,0.425,0.1234567901234568,Gefitinib,OHSU_HNSCC_derm002
33096,20004,Blank 490,6,I,OHSU_HNSCC_derm002,5,0.521,0.1234567901234568,Ceritinib (LDK378),OHSU_HNSCC_derm002
33097,20004,Blank 490,6,J,OHSU_HNSCC_derm002,5,0.457,0,DMSO,OHSU_HNSCC_derm002
33098,20004,Blank 490,6,K,OHSU_HNSCC_derm002,5,0.492,0,DMSO ,OHSU_HNSCC_derm002
33099,20004,Blank 490,6,L,OHSU_HNSCC_derm002,5,0.48,0,DMSO,OHSU_HNSCC_derm002
33100,20004,Blank 490,6,M,OHSU_HNSCC_derm002,5,0.449,0,DMSO ,OHSU_HNSCC_derm002
33101,20004,Blank 490,6,N,OHSU_HNSCC_derm002,5,0.427,0,DMSO,OHSU_HNSCC_derm002
33102,20004,Blank 490,6,O,OHSU_HNSCC_derm002,5,0.488,0,DMSO ,OHSU_HNSCC_derm002
33103,20004,Blank 490,6,P,OHSU_HNSCC_derm002,5,0.438,0,DMSO,OHSU_HNSCC_derm002
33104,20004,Blank 490,6,A,OHSU_HNSCC_derm002,6,0.327,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33105,20004,Blank 490,6,B,OHSU_HNSCC_derm002,6,0.351,0.02057613;0.00411526,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33106,20004,Blank 490,6,C,OHSU_HNSCC_derm002,6,0.387,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33107,20004,Blank 490,6,D,OHSU_HNSCC_derm002,6,0.466,0.04115226;0.0411526;0.0411526,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33108,20004,Blank 490,6,E,OHSU_HNSCC_derm002,6,0.506,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33109,20004,Blank 490,6,F,OHSU_HNSCC_derm002,6,0.383,0.004115226;0.0411526;0.0411526,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33110,20004,Blank 490,6,G,OHSU_HNSCC_derm002,6,0.487,0.0411522633744856,IMR 1,OHSU_HNSCC_derm002
33111,20004,Blank 490,6,H,OHSU_HNSCC_derm002,6,0.448,0.0411522633744856,Gefitinib,OHSU_HNSCC_derm002
33112,20004,Blank 490,6,I,OHSU_HNSCC_derm002,6,0.494,0.0411522633744856,Ceritinib (LDK378),OHSU_HNSCC_derm002
33113,20004,Blank 490,6,J,OHSU_HNSCC_derm002,6,0.461,0,DMSO,OHSU_HNSCC_derm002
33114,20004,Blank 490,6,K,OHSU_HNSCC_derm002,6,0.493,0,DMSO ,OHSU_HNSCC_derm002
33115,20004,Blank 490,6,L,OHSU_HNSCC_derm002,6,0.499,0,DMSO,OHSU_HNSCC_derm002
33116,20004,Blank 490,6,M,OHSU_HNSCC_derm002,6,0.527,0,DMSO ,OHSU_HNSCC_derm002
33117,20004,Blank 490,6,N,OHSU_HNSCC_derm002,6,0.466,0,DMSO,OHSU_HNSCC_derm002
33118,20004,Blank 490,6,O,OHSU_HNSCC_derm002,6,0.419,0,DMSO ,OHSU_HNSCC_derm002
33119,20004,Blank 490,6,P,OHSU_HNSCC_derm002,6,0.44,0,DMSO,OHSU_HNSCC_derm002
33120,20004,Blank 490,6,A,OHSU_HNSCC_derm002,7,0.427,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33121,20004,Blank 490,6,B,OHSU_HNSCC_derm002,7,0.391,0.00685871;0.001371742,Vandetanib;Dasatinib,OHSU_HNSCC_derm002
33122,20004,Blank 490,6,C,OHSU_HNSCC_derm002,7,0.452,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;GDC-0941,OHSU_HNSCC_derm002
33123,20004,Blank 490,6,D,OHSU_HNSCC_derm002,7,0.417,0.01371742;0.01371742;0.01371742,Gefitinib;Lapatinib;Ditosylate,OHSU_HNSCC_derm002
33124,20004,Blank 490,6,E,OHSU_HNSCC_derm002,7,0.439,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Bosutinib,OHSU_HNSCC_derm002
33125,20004,Blank 490,6,F,OHSU_HNSCC_derm002,7,0.423,0.001371742;0.01371742;0.01371742,Dasatinib;Erlotinib;Hydrochloride,OHSU_HNSCC_derm002
33126,20004,Blank 490,6,G,OHSU_HNSCC_derm002,7,0.484,0.013717421124828532,IMR 1,OHSU_HNSCC_derm002
33127,20004,Blank 490,6,H,OHSU_HNSCC_derm002,7,0.45,0.013717421124828532,Gefitinib,OHSU_HNSCC_derm002
33128,20004,Blank 490,6,I,OHSU_HNSCC_derm002,7,0.48,0.013717421124828532,Ceritinib (LDK378),OHSU_HNSCC_derm002
33129,20004,Blank 490,6,J,OHSU_HNSCC_derm002,7,0.444,0,DMSO,OHSU_HNSCC_derm002
33130,20004,Blank 490,6,K,OHSU_HNSCC_derm002,7,0.498,0,DMSO ,OHSU_HNSCC_derm002
33131,20004,Blank 490,6,L,OHSU_HNSCC_derm002,7,0.498,0,DMSO,OHSU_HNSCC_derm002
33132,20004,Blank 490,6,M,OHSU_HNSCC_derm002,7,0.43,0,DMSO ,OHSU_HNSCC_derm002
33133,20004,Blank 490,6,N,OHSU_HNSCC_derm002,7,0.487,0,DMSO,OHSU_HNSCC_derm002
33134,20004,Blank 490,6,O,OHSU_HNSCC_derm002,7,0.44,0,DMSO ,OHSU_HNSCC_derm002
33135,20004,Blank 490,6,P,OHSU_HNSCC_derm002,7,0.463,0,DMSO,OHSU_HNSCC_derm002
33136,20004,Blank 490,6,A,OHSU_HNSCC_derm002,8,0.444,0,NONE,OHSU_HNSCC_derm002
33137,20004,Blank 490,6,B,OHSU_HNSCC_derm002,8,0.41,0,NONE,OHSU_HNSCC_derm002
33138,20004,Blank 490,6,C,OHSU_HNSCC_derm002,8,0.468,0,NONE,OHSU_HNSCC_derm002
33139,20004,Blank 490,6,D,OHSU_HNSCC_derm002,8,0.462,0,NONE,OHSU_HNSCC_derm002
33140,20004,Blank 490,6,E,OHSU_HNSCC_derm002,8,0.447,0,NONE,OHSU_HNSCC_derm002
33141,20004,Blank 490,6,F,OHSU_HNSCC_derm002,8,0.471,0,NONE,OHSU_HNSCC_derm002
33142,20004,Blank 490,6,G,OHSU_HNSCC_derm002,8,0.495,0,NONE,OHSU_HNSCC_derm002
33143,20004,Blank 490,6,H,OHSU_HNSCC_derm002,8,-0.004,10,F-S-V,OHSU_HNSCC_derm002
33144,20004,Blank 490,6,I,OHSU_HNSCC_derm002,8,0.486,0,NONE,OHSU_HNSCC_derm002
33145,20004,Blank 490,6,J,OHSU_HNSCC_derm002,8,0.495,0,NONE,OHSU_HNSCC_derm002
33146,20004,Blank 490,6,K,OHSU_HNSCC_derm002,8,0.49,0,NONE,OHSU_HNSCC_derm002
33147,20004,Blank 490,6,L,OHSU_HNSCC_derm002,8,0.466,0,NONE,OHSU_HNSCC_derm002
33148,20004,Blank 490,6,M,OHSU_HNSCC_derm002,8,0.47,0,NONE,OHSU_HNSCC_derm002
33149,20004,Blank 490,6,N,OHSU_HNSCC_derm002,8,0.468,0,NONE,OHSU_HNSCC_derm002
33150,20004,Blank 490,6,O,OHSU_HNSCC_derm002,8,0.492,0,NONE,OHSU_HNSCC_derm002
33151,20004,Blank 490,6,P,OHSU_HNSCC_derm002,8,0.449,0,NONE,OHSU_HNSCC_derm002
33152,20004,Blank 490,6,A,OHSU_HNSCC_derm002,9,0.376,1;10;10;10,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33153,20004,Blank 490,6,B,OHSU_HNSCC_derm002,9,0.01,10;10;10,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33154,20004,Blank 490,6,C,OHSU_HNSCC_derm002,9,0.181,10;10;10;10,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33155,20004,Blank 490,6,D,OHSU_HNSCC_derm002,9,0.255,10;10,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33156,20004,Blank 490,6,E,OHSU_HNSCC_derm002,9,0.314,5,Vandetanib (5mM),OHSU_HNSCC_derm002
33157,20004,Blank 490,6,F,OHSU_HNSCC_derm002,9,0.49,0,DMSO,OHSU_HNSCC_derm002
33158,20004,Blank 490,6,G,OHSU_HNSCC_derm002,9,0.52,0,DMSO ,OHSU_HNSCC_derm002
33159,20004,Blank 490,6,H,OHSU_HNSCC_derm002,9,0.058,10,Brigatinib,OHSU_HNSCC_derm002
33160,20004,Blank 490,6,I,OHSU_HNSCC_derm002,9,0.15,10,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33161,20004,Blank 490,6,J,OHSU_HNSCC_derm002,9,0.444,0,DMSO,OHSU_HNSCC_derm002
33162,20004,Blank 490,6,K,OHSU_HNSCC_derm002,9,0.486,0,DMSO ,OHSU_HNSCC_derm002
33163,20004,Blank 490,6,L,OHSU_HNSCC_derm002,9,0.434,0,DMSO,OHSU_HNSCC_derm002
33164,20004,Blank 490,6,M,OHSU_HNSCC_derm002,9,0.46,0,DMSO ,OHSU_HNSCC_derm002
33165,20004,Blank 490,6,N,OHSU_HNSCC_derm002,9,0.429,0,DMSO,OHSU_HNSCC_derm002
33166,20004,Blank 490,6,O,OHSU_HNSCC_derm002,9,0.449,0,DMSO ,OHSU_HNSCC_derm002
33167,20004,Blank 490,6,P,OHSU_HNSCC_derm002,9,0.448,0,DMSO,OHSU_HNSCC_derm002
33168,20004,Blank 490,6,A,OHSU_HNSCC_derm002,10,0.366,0.333333;3.33333;3.33333;3.33333,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33169,20004,Blank 490,6,B,OHSU_HNSCC_derm002,10,0.025,3.33333;3.33333;3.33333,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33170,20004,Blank 490,6,C,OHSU_HNSCC_derm002,10,0.249,3.33333;3.33333;3.33333;3.33333,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33171,20004,Blank 490,6,D,OHSU_HNSCC_derm002,10,0.337,3.33333;3.33333,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33172,20004,Blank 490,6,E,OHSU_HNSCC_derm002,10,0.365,1.6666666666666667,Vandetanib (5mM),OHSU_HNSCC_derm002
33173,20004,Blank 490,6,F,OHSU_HNSCC_derm002,10,0.487,0,DMSO,OHSU_HNSCC_derm002
33174,20004,Blank 490,6,G,OHSU_HNSCC_derm002,10,0.464,0,DMSO ,OHSU_HNSCC_derm002
33175,20004,Blank 490,6,H,OHSU_HNSCC_derm002,10,0.216,3.3333333333333335,Brigatinib,OHSU_HNSCC_derm002
33176,20004,Blank 490,6,I,OHSU_HNSCC_derm002,10,0.313,3.3333333333333335,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33177,20004,Blank 490,6,J,OHSU_HNSCC_derm002,10,0.432,0,DMSO,OHSU_HNSCC_derm002
33178,20004,Blank 490,6,K,OHSU_HNSCC_derm002,10,0.533,0,DMSO ,OHSU_HNSCC_derm002
33179,20004,Blank 490,6,L,OHSU_HNSCC_derm002,10,0.473,0,DMSO,OHSU_HNSCC_derm002
33180,20004,Blank 490,6,M,OHSU_HNSCC_derm002,10,0.451,0,DMSO ,OHSU_HNSCC_derm002
33181,20004,Blank 490,6,N,OHSU_HNSCC_derm002,10,0.431,0,DMSO,OHSU_HNSCC_derm002
33182,20004,Blank 490,6,O,OHSU_HNSCC_derm002,10,0.485,0,DMSO ,OHSU_HNSCC_derm002
33183,20004,Blank 490,6,P,OHSU_HNSCC_derm002,10,0.466,0,DMSO,OHSU_HNSCC_derm002
33184,20004,Blank 490,6,A,OHSU_HNSCC_derm002,11,0.434,0.11111;1.11111;1.11111;1.1111,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33185,20004,Blank 490,6,B,OHSU_HNSCC_derm002,11,0.055,1.1111;1.11111;1.11111,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33186,20004,Blank 490,6,C,OHSU_HNSCC_derm002,11,0.333,1.1111;1.11111;1.11111;1.11111,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33187,20004,Blank 490,6,D,OHSU_HNSCC_derm002,11,0.326,1.1111;1.11111,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33188,20004,Blank 490,6,E,OHSU_HNSCC_derm002,11,0.451,0.5555555555555556,Vandetanib (5mM),OHSU_HNSCC_derm002
33189,20004,Blank 490,6,F,OHSU_HNSCC_derm002,11,0.469,0,DMSO,OHSU_HNSCC_derm002
33190,20004,Blank 490,6,G,OHSU_HNSCC_derm002,11,0.466,0,DMSO ,OHSU_HNSCC_derm002
33191,20004,Blank 490,6,H,OHSU_HNSCC_derm002,11,0.372,1.1111111111111112,Brigatinib,OHSU_HNSCC_derm002
33192,20004,Blank 490,6,I,OHSU_HNSCC_derm002,11,0.359,1.1111111111111112,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33193,20004,Blank 490,6,J,OHSU_HNSCC_derm002,11,0.487,0,DMSO,OHSU_HNSCC_derm002
33194,20004,Blank 490,6,K,OHSU_HNSCC_derm002,11,0.483,0,DMSO ,OHSU_HNSCC_derm002
33195,20004,Blank 490,6,L,OHSU_HNSCC_derm002,11,0.48,0,DMSO,OHSU_HNSCC_derm002
33196,20004,Blank 490,6,M,OHSU_HNSCC_derm002,11,0.481,0,DMSO ,OHSU_HNSCC_derm002
33197,20004,Blank 490,6,N,OHSU_HNSCC_derm002,11,0.47,0,DMSO,OHSU_HNSCC_derm002
33198,20004,Blank 490,6,O,OHSU_HNSCC_derm002,11,0.481,0,DMSO ,OHSU_HNSCC_derm002
33199,20004,Blank 490,6,P,OHSU_HNSCC_derm002,11,0.484,0,DMSO,OHSU_HNSCC_derm002
33200,20004,Blank 490,6,A,OHSU_HNSCC_derm002,12,0.386,0.037037;0.37037;0.37037,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33201,20004,Blank 490,6,B,OHSU_HNSCC_derm002,12,0.129,0.37037;0.37037;0.37037,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33202,20004,Blank 490,6,C,OHSU_HNSCC_derm002,12,0.412,0.37037;0.37037;0.37037;0.37037,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33203,20004,Blank 490,6,D,OHSU_HNSCC_derm002,12,0.416,0.37037;0.37037,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33204,20004,Blank 490,6,E,OHSU_HNSCC_derm002,12,0.429,0.1851851851851852,Vandetanib (5mM),OHSU_HNSCC_derm002
33205,20004,Blank 490,6,F,OHSU_HNSCC_derm002,12,0.454,0,DMSO,OHSU_HNSCC_derm002
33206,20004,Blank 490,6,G,OHSU_HNSCC_derm002,12,0.505,0,DMSO ,OHSU_HNSCC_derm002
33207,20004,Blank 490,6,H,OHSU_HNSCC_derm002,12,0.439,0.3703703703703704,Brigatinib,OHSU_HNSCC_derm002
33208,20004,Blank 490,6,I,OHSU_HNSCC_derm002,12,0.37,0.3703703703703704,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33209,20004,Blank 490,6,J,OHSU_HNSCC_derm002,12,0.485,0,DMSO,OHSU_HNSCC_derm002
33210,20004,Blank 490,6,K,OHSU_HNSCC_derm002,12,0.475,0,DMSO ,OHSU_HNSCC_derm002
33211,20004,Blank 490,6,L,OHSU_HNSCC_derm002,12,0.495,0,DMSO,OHSU_HNSCC_derm002
33212,20004,Blank 490,6,M,OHSU_HNSCC_derm002,12,0.45,0,DMSO ,OHSU_HNSCC_derm002
33213,20004,Blank 490,6,N,OHSU_HNSCC_derm002,12,0.5,0,DMSO,OHSU_HNSCC_derm002
33214,20004,Blank 490,6,O,OHSU_HNSCC_derm002,12,0.498,0,DMSO ,OHSU_HNSCC_derm002
33215,20004,Blank 490,6,P,OHSU_HNSCC_derm002,12,0.471,0,DMSO,OHSU_HNSCC_derm002
33216,20004,Blank 490,6,A,OHSU_HNSCC_derm002,13,0.426,0.0123456;0.123456;0.123456;0.123456,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33217,20004,Blank 490,6,B,OHSU_HNSCC_derm002,13,0.252,0.123456;0.123456;0.123456,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33218,20004,Blank 490,6,C,OHSU_HNSCC_derm002,13,0.424,0.123456;0.123456;0.123456;0.123456,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33219,20004,Blank 490,6,D,OHSU_HNSCC_derm002,13,0.483,0.123456;0.123456,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33220,20004,Blank 490,6,E,OHSU_HNSCC_derm002,13,0.443,0.0617283950617284,Vandetanib (5mM),OHSU_HNSCC_derm002
33221,20004,Blank 490,6,F,OHSU_HNSCC_derm002,13,0.45,0,DMSO,OHSU_HNSCC_derm002
33222,20004,Blank 490,6,G,OHSU_HNSCC_derm002,13,0.486,0,DMSO ,OHSU_HNSCC_derm002
33223,20004,Blank 490,6,H,OHSU_HNSCC_derm002,13,0.449,0.1234567901234568,Brigatinib,OHSU_HNSCC_derm002
33224,20004,Blank 490,6,I,OHSU_HNSCC_derm002,13,0.398,0.1234567901234568,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33225,20004,Blank 490,6,J,OHSU_HNSCC_derm002,13,0.444,0,DMSO,OHSU_HNSCC_derm002
33226,20004,Blank 490,6,K,OHSU_HNSCC_derm002,13,0.465,0,DMSO ,OHSU_HNSCC_derm002
33227,20004,Blank 490,6,L,OHSU_HNSCC_derm002,13,0.428,0,DMSO,OHSU_HNSCC_derm002
33228,20004,Blank 490,6,M,OHSU_HNSCC_derm002,13,0.468,0,DMSO ,OHSU_HNSCC_derm002
33229,20004,Blank 490,6,N,OHSU_HNSCC_derm002,13,0.462,0,DMSO,OHSU_HNSCC_derm002
33230,20004,Blank 490,6,O,OHSU_HNSCC_derm002,13,0.482,0,DMSO ,OHSU_HNSCC_derm002
33231,20004,Blank 490,6,P,OHSU_HNSCC_derm002,13,0.463,0,DMSO,OHSU_HNSCC_derm002
33232,20004,Blank 490,6,A,OHSU_HNSCC_derm002,14,0.448,0.004115226;0.0411526;0.0411526;0.0411526,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33233,20004,Blank 490,6,B,OHSU_HNSCC_derm002,14,0.372,0.04115226;0.0411526;0.0411526,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33234,20004,Blank 490,6,C,OHSU_HNSCC_derm002,14,0.465,0.04115226;0.0411526;0.0411526;0.0411526,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33235,20004,Blank 490,6,D,OHSU_HNSCC_derm002,14,0.461,0.04115226;0.0411526,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33236,20004,Blank 490,6,E,OHSU_HNSCC_derm002,14,0.477,0.0205761316872428,Vandetanib (5mM),OHSU_HNSCC_derm002
33237,20004,Blank 490,6,F,OHSU_HNSCC_derm002,14,0.419,0,DMSO,OHSU_HNSCC_derm002
33238,20004,Blank 490,6,G,OHSU_HNSCC_derm002,14,0.473,0,DMSO ,OHSU_HNSCC_derm002
33239,20004,Blank 490,6,H,OHSU_HNSCC_derm002,14,0.48,0.0411522633744856,Brigatinib,OHSU_HNSCC_derm002
33240,20004,Blank 490,6,I,OHSU_HNSCC_derm002,14,0.383,0.0411522633744856,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33241,20004,Blank 490,6,J,OHSU_HNSCC_derm002,14,0.492,0,DMSO,OHSU_HNSCC_derm002
33242,20004,Blank 490,6,K,OHSU_HNSCC_derm002,14,0.522,0,DMSO ,OHSU_HNSCC_derm002
33243,20004,Blank 490,6,L,OHSU_HNSCC_derm002,14,0.474,0,DMSO,OHSU_HNSCC_derm002
33244,20004,Blank 490,6,M,OHSU_HNSCC_derm002,14,0.462,0,DMSO ,OHSU_HNSCC_derm002
33245,20004,Blank 490,6,N,OHSU_HNSCC_derm002,14,0.452,0,DMSO,OHSU_HNSCC_derm002
33246,20004,Blank 490,6,O,OHSU_HNSCC_derm002,14,0.419,0,DMSO ,OHSU_HNSCC_derm002
33247,20004,Blank 490,6,P,OHSU_HNSCC_derm002,14,0.45,0,DMSO,OHSU_HNSCC_derm002
33248,20004,Blank 490,6,A,OHSU_HNSCC_derm002,15,0.377,0.001371742;0.01371742;0.01371742;0.013717,Sunitinib;Malate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33249,20004,Blank 490,6,B,OHSU_HNSCC_derm002,15,0.4,0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;PI-103,OHSU_HNSCC_derm002
33250,20004,Blank 490,6,C,OHSU_HNSCC_derm002,15,0.483,0.01371742;0.01371742;0.01371742;0.01371742,Sorafenib;Erlotinib;Hydrochloride;Tosylate,OHSU_HNSCC_derm002
33251,20004,Blank 490,6,D,OHSU_HNSCC_derm002,15,0.464,0.01371742;0.01371742,Gefitinib;Idelasib (GS-1101),OHSU_HNSCC_derm002
33252,20004,Blank 490,6,E,OHSU_HNSCC_derm002,15,0.514,0.006858710562414266,Vandetanib (5mM),OHSU_HNSCC_derm002
33253,20004,Blank 490,6,F,OHSU_HNSCC_derm002,15,0.477,0,DMSO,OHSU_HNSCC_derm002
33254,20004,Blank 490,6,G,OHSU_HNSCC_derm002,15,0.471,0,DMSO ,OHSU_HNSCC_derm002
33255,20004,Blank 490,6,H,OHSU_HNSCC_derm002,15,0.48,0.013717421124828532,Brigatinib,OHSU_HNSCC_derm002
33256,20004,Blank 490,6,I,OHSU_HNSCC_derm002,15,0.393,0.013717421124828532,BIBW-2992 (EGFR irrev.),OHSU_HNSCC_derm002
33257,20004,Blank 490,6,J,OHSU_HNSCC_derm002,15,0.523,0,DMSO,OHSU_HNSCC_derm002
33258,20004,Blank 490,6,K,OHSU_HNSCC_derm002,15,0.484,0,DMSO ,OHSU_HNSCC_derm002
33259,20004,Blank 490,6,L,OHSU_HNSCC_derm002,15,0.45,0,DMSO,OHSU_HNSCC_derm002
33260,20004,Blank 490,6,M,OHSU_HNSCC_derm002,15,0.443,0,DMSO ,OHSU_HNSCC_derm002
33261,20004,Blank 490,6,N,OHSU_HNSCC_derm002,15,0.467,0,DMSO,OHSU_HNSCC_derm002
33262,20004,Blank 490,6,O,OHSU_HNSCC_derm002,15,0.43,0,DMSO ,OHSU_HNSCC_derm002
33263,20004,Blank 490,6,P,OHSU_HNSCC_derm002,15,0.465,0,DMSO,OHSU_HNSCC_derm002
33264,20004,Blank 490,6,A,OHSU_HNSCC_derm002,16,0.375,0,NONE,OHSU_HNSCC_derm002
33265,20004,Blank 490,6,B,OHSU_HNSCC_derm002,16,0.413,0,NONE,OHSU_HNSCC_derm002
33266,20004,Blank 490,6,C,OHSU_HNSCC_derm002,16,0.512,0,NONE,OHSU_HNSCC_derm002
33267,20004,Blank 490,6,D,OHSU_HNSCC_derm002,16,0.46,0,NONE,OHSU_HNSCC_derm002
33268,20004,Blank 490,6,E,OHSU_HNSCC_derm002,16,0.528,0,NONE,OHSU_HNSCC_derm002
33269,20004,Blank 490,6,F,OHSU_HNSCC_derm002,16,0.503,0,NONE,OHSU_HNSCC_derm002
33270,20004,Blank 490,6,G,OHSU_HNSCC_derm002,16,0.438,0,NONE,OHSU_HNSCC_derm002
33271,20004,Blank 490,6,H,OHSU_HNSCC_derm002,16,0.004,10,F-S-V,OHSU_HNSCC_derm002
33272,20004,Blank 490,6,I,OHSU_HNSCC_derm002,16,0.502,0,NONE,OHSU_HNSCC_derm002
33273,20004,Blank 490,6,J,OHSU_HNSCC_derm002,16,0.484,0,NONE,OHSU_HNSCC_derm002
33274,20004,Blank 490,6,K,OHSU_HNSCC_derm002,16,0.503,0,NONE,OHSU_HNSCC_derm002
33275,20004,Blank 490,6,L,OHSU_HNSCC_derm002,16,0.463,0,NONE,OHSU_HNSCC_derm002
33276,20004,Blank 490,6,M,OHSU_HNSCC_derm002,16,0.504,0,NONE,OHSU_HNSCC_derm002
33277,20004,Blank 490,6,N,OHSU_HNSCC_derm002,16,0.497,0,NONE,OHSU_HNSCC_derm002
33278,20004,Blank 490,6,O,OHSU_HNSCC_derm002,16,0.45,0,NONE,OHSU_HNSCC_derm002
33279,20004,Blank 490,6,P,OHSU_HNSCC_derm002,16,0.464,0,NONE,OHSU_HNSCC_derm002
33280,20004,Blank 490,6,A,OHSU_HNSCC_derm002,17,0.168,10;10;10;10,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33281,20004,Blank 490,6,B,OHSU_HNSCC_derm002,17,0.106,10;10;10;10,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33282,20004,Blank 490,6,C,OHSU_HNSCC_derm002,17,0.431,4.54,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33283,20004,Blank 490,6,D,OHSU_HNSCC_derm002,17,0.039,10;10;10,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33284,20004,Blank 490,6,E,OHSU_HNSCC_derm002,17,0.459,10,LY3039478 ,OHSU_HNSCC_derm002
33285,20004,Blank 490,6,F,OHSU_HNSCC_derm002,17,0.327,10;10,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33286,20004,Blank 490,6,G,OHSU_HNSCC_derm002,17,0.301,10;10,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33287,20004,Blank 490,6,H,OHSU_HNSCC_derm002,17,0.373,10,Trametinib,OHSU_HNSCC_derm002
33288,20004,Blank 490,6,I,OHSU_HNSCC_derm002,17,0.11,10,BEZ235,OHSU_HNSCC_derm002
33289,20004,Blank 490,6,J,OHSU_HNSCC_derm002,17,0.478,0,DMSO,OHSU_HNSCC_derm002
33290,20004,Blank 490,6,K,OHSU_HNSCC_derm002,17,0.495,0,DMSO ,OHSU_HNSCC_derm002
33291,20004,Blank 490,6,L,OHSU_HNSCC_derm002,17,0.517,0,DMSO,OHSU_HNSCC_derm002
33292,20004,Blank 490,6,M,OHSU_HNSCC_derm002,17,0.546,0,DMSO ,OHSU_HNSCC_derm002
33293,20004,Blank 490,6,N,OHSU_HNSCC_derm002,17,0.464,0,DMSO,OHSU_HNSCC_derm002
33294,20004,Blank 490,6,O,OHSU_HNSCC_derm002,17,0.476,0,DMSO ,OHSU_HNSCC_derm002
33295,20004,Blank 490,6,P,OHSU_HNSCC_derm002,17,0.459,0,DMSO,OHSU_HNSCC_derm002
33296,20004,Blank 490,6,A,OHSU_HNSCC_derm002,18,0.225,3.33333;3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33297,20004,Blank 490,6,B,OHSU_HNSCC_derm002,18,0.239,3.33333;3.33333;3.33333;3.33333,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33298,20004,Blank 490,6,C,OHSU_HNSCC_derm002,18,0.487,1.5133333333333334,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33299,20004,Blank 490,6,D,OHSU_HNSCC_derm002,18,0.04,3.33333;3.33333;3.33333,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33300,20004,Blank 490,6,E,OHSU_HNSCC_derm002,18,0.415,3.3333333333333335,LY3039478 ,OHSU_HNSCC_derm002
33301,20004,Blank 490,6,F,OHSU_HNSCC_derm002,18,0.271,3.33333;3.33333,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33302,20004,Blank 490,6,G,OHSU_HNSCC_derm002,18,0.309,3.33333;3.33333,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33303,20004,Blank 490,6,H,OHSU_HNSCC_derm002,18,0.374,3.3333333333333335,Trametinib,OHSU_HNSCC_derm002
33304,20004,Blank 490,6,I,OHSU_HNSCC_derm002,18,0.108,3.3333333333333335,BEZ235,OHSU_HNSCC_derm002
33305,20004,Blank 490,6,J,OHSU_HNSCC_derm002,18,0.486,0,DMSO,OHSU_HNSCC_derm002
33306,20004,Blank 490,6,K,OHSU_HNSCC_derm002,18,0.498,0,DMSO ,OHSU_HNSCC_derm002
33307,20004,Blank 490,6,L,OHSU_HNSCC_derm002,18,0.447,0,DMSO,OHSU_HNSCC_derm002
33308,20004,Blank 490,6,M,OHSU_HNSCC_derm002,18,0.458,0,DMSO ,OHSU_HNSCC_derm002
33309,20004,Blank 490,6,N,OHSU_HNSCC_derm002,18,0.47,0,DMSO,OHSU_HNSCC_derm002
33310,20004,Blank 490,6,O,OHSU_HNSCC_derm002,18,0.486,0,DMSO ,OHSU_HNSCC_derm002
33311,20004,Blank 490,6,P,OHSU_HNSCC_derm002,18,0.437,0,DMSO,OHSU_HNSCC_derm002
33312,20004,Blank 490,6,A,OHSU_HNSCC_derm002,19,0.284,1.1111;1.11111;1.11111;1.11111,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33313,20004,Blank 490,6,B,OHSU_HNSCC_derm002,19,0.277,1.1111;1.11111;1.11111;1.11111,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33314,20004,Blank 490,6,C,OHSU_HNSCC_derm002,19,0.452,0.5044444444444445,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33315,20004,Blank 490,6,D,OHSU_HNSCC_derm002,19,0.079,1.1111;1.11111;1.11111,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33316,20004,Blank 490,6,E,OHSU_HNSCC_derm002,19,0.435,1.1111111111111112,LY3039478 ,OHSU_HNSCC_derm002
33317,20004,Blank 490,6,F,OHSU_HNSCC_derm002,19,0.366,1.1111;1.11111,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33318,20004,Blank 490,6,G,OHSU_HNSCC_derm002,19,0.345,1.1111;1.11111,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33319,20004,Blank 490,6,H,OHSU_HNSCC_derm002,19,0.37,1.1111111111111112,Trametinib,OHSU_HNSCC_derm002
33320,20004,Blank 490,6,I,OHSU_HNSCC_derm002,19,0.124,1.1111111111111112,BEZ235,OHSU_HNSCC_derm002
33321,20004,Blank 490,6,J,OHSU_HNSCC_derm002,19,0.485,0,DMSO,OHSU_HNSCC_derm002
33322,20004,Blank 490,6,K,OHSU_HNSCC_derm002,19,0.498,0,DMSO ,OHSU_HNSCC_derm002
33323,20004,Blank 490,6,L,OHSU_HNSCC_derm002,19,0.455,0,DMSO,OHSU_HNSCC_derm002
33324,20004,Blank 490,6,M,OHSU_HNSCC_derm002,19,0.492,0,DMSO ,OHSU_HNSCC_derm002
33325,20004,Blank 490,6,N,OHSU_HNSCC_derm002,19,0.422,0,DMSO,OHSU_HNSCC_derm002
33326,20004,Blank 490,6,O,OHSU_HNSCC_derm002,19,0.488,0,DMSO ,OHSU_HNSCC_derm002
33327,20004,Blank 490,6,P,OHSU_HNSCC_derm002,19,0.461,0,DMSO,OHSU_HNSCC_derm002
33328,20004,Blank 490,6,A,OHSU_HNSCC_derm002,20,0.319,0.37037;0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33329,20004,Blank 490,6,B,OHSU_HNSCC_derm002,20,0.342,0.37037;0.37037;0.37037;0.37037,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33330,20004,Blank 490,6,C,OHSU_HNSCC_derm002,20,0.484,0.16814814814814816,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33331,20004,Blank 490,6,D,OHSU_HNSCC_derm002,20,0.153,0.37037;0.37037;0.37037,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33332,20004,Blank 490,6,E,OHSU_HNSCC_derm002,20,0.447,0.3703703703703704,LY3039478 ,OHSU_HNSCC_derm002
33333,20004,Blank 490,6,F,OHSU_HNSCC_derm002,20,0.391,0.37037;0.37037,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33334,20004,Blank 490,6,G,OHSU_HNSCC_derm002,20,0.315,0.37037;0.37037,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33335,20004,Blank 490,6,H,OHSU_HNSCC_derm002,20,0.426,0.3703703703703704,Trametinib,OHSU_HNSCC_derm002
33336,20004,Blank 490,6,I,OHSU_HNSCC_derm002,20,0.136,0.3703703703703704,BEZ235,OHSU_HNSCC_derm002
33337,20004,Blank 490,6,J,OHSU_HNSCC_derm002,20,0.444,0,DMSO,OHSU_HNSCC_derm002
33338,20004,Blank 490,6,K,OHSU_HNSCC_derm002,20,0.455,0,DMSO ,OHSU_HNSCC_derm002
33339,20004,Blank 490,6,L,OHSU_HNSCC_derm002,20,0.495,0,DMSO,OHSU_HNSCC_derm002
33340,20004,Blank 490,6,M,OHSU_HNSCC_derm002,20,0.494,0,DMSO ,OHSU_HNSCC_derm002
33341,20004,Blank 490,6,N,OHSU_HNSCC_derm002,20,0.497,0,DMSO,OHSU_HNSCC_derm002
33342,20004,Blank 490,6,O,OHSU_HNSCC_derm002,20,0.495,0,DMSO ,OHSU_HNSCC_derm002
33343,20004,Blank 490,6,P,OHSU_HNSCC_derm002,20,0.461,0,DMSO,OHSU_HNSCC_derm002
33344,20004,Blank 490,6,A,OHSU_HNSCC_derm002,21,0.397,0.123456;0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33345,20004,Blank 490,6,B,OHSU_HNSCC_derm002,21,0.365,0.123456;0.123456;0.123456;0.123456,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33346,20004,Blank 490,6,C,OHSU_HNSCC_derm002,21,0.507,0.05604938271604939,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33347,20004,Blank 490,6,D,OHSU_HNSCC_derm002,21,0.268,0.123456;0.123456;0.123456,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33348,20004,Blank 490,6,E,OHSU_HNSCC_derm002,21,0.428,0.1234567901234568,LY3039478 ,OHSU_HNSCC_derm002
33349,20004,Blank 490,6,F,OHSU_HNSCC_derm002,21,0.434,0.123456;0.123456,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33350,20004,Blank 490,6,G,OHSU_HNSCC_derm002,21,0.375,0.123456;0.123456,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33351,20004,Blank 490,6,H,OHSU_HNSCC_derm002,21,0.428,0.1234567901234568,Trametinib,OHSU_HNSCC_derm002
33352,20004,Blank 490,6,I,OHSU_HNSCC_derm002,21,0.16,0.1234567901234568,BEZ235,OHSU_HNSCC_derm002
33353,20004,Blank 490,6,J,OHSU_HNSCC_derm002,21,0.463,0,DMSO,OHSU_HNSCC_derm002
33354,20004,Blank 490,6,K,OHSU_HNSCC_derm002,21,0.455,0,DMSO ,OHSU_HNSCC_derm002
33355,20004,Blank 490,6,L,OHSU_HNSCC_derm002,21,0.509,0,DMSO,OHSU_HNSCC_derm002
33356,20004,Blank 490,6,M,OHSU_HNSCC_derm002,21,0.437,0,DMSO ,OHSU_HNSCC_derm002
33357,20004,Blank 490,6,N,OHSU_HNSCC_derm002,21,0.466,0,DMSO,OHSU_HNSCC_derm002
33358,20004,Blank 490,6,O,OHSU_HNSCC_derm002,21,0.427,0,DMSO ,OHSU_HNSCC_derm002
33359,20004,Blank 490,6,P,OHSU_HNSCC_derm002,21,0.435,0,DMSO,OHSU_HNSCC_derm002
33360,20004,Blank 490,6,A,OHSU_HNSCC_derm002,22,0.401,0.04115226;0.0411526;0.0411526;0.0411526,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33361,20004,Blank 490,6,B,OHSU_HNSCC_derm002,22,0.371,0.04115226;0.0411526;0.0411526;0.0411526,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33362,20004,Blank 490,6,C,OHSU_HNSCC_derm002,22,0.428,0.018683127572016463,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33363,20004,Blank 490,6,D,OHSU_HNSCC_derm002,22,0.426,0.04115226;0.0411526;0.0411526,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33364,20004,Blank 490,6,E,OHSU_HNSCC_derm002,22,0.471,0.0411522633744856,LY3039478 ,OHSU_HNSCC_derm002
33365,20004,Blank 490,6,F,OHSU_HNSCC_derm002,22,0.422,0.04115226;0.0411526,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33366,20004,Blank 490,6,G,OHSU_HNSCC_derm002,22,0.366,0.04115226;0.0411526,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33367,20004,Blank 490,6,H,OHSU_HNSCC_derm002,22,0.426,0.0411522633744856,Trametinib,OHSU_HNSCC_derm002
33368,20004,Blank 490,6,I,OHSU_HNSCC_derm002,22,0.283,0.0411522633744856,BEZ235,OHSU_HNSCC_derm002
33369,20004,Blank 490,6,J,OHSU_HNSCC_derm002,22,0.496,0,DMSO,OHSU_HNSCC_derm002
33370,20004,Blank 490,6,K,OHSU_HNSCC_derm002,22,0.517,0,DMSO ,OHSU_HNSCC_derm002
33371,20004,Blank 490,6,L,OHSU_HNSCC_derm002,22,0.496,0,DMSO,OHSU_HNSCC_derm002
33372,20004,Blank 490,6,M,OHSU_HNSCC_derm002,22,0.487,0,DMSO ,OHSU_HNSCC_derm002
33373,20004,Blank 490,6,N,OHSU_HNSCC_derm002,22,0.489,0,DMSO,OHSU_HNSCC_derm002
33374,20004,Blank 490,6,O,OHSU_HNSCC_derm002,22,0.474,0,DMSO ,OHSU_HNSCC_derm002
33375,20004,Blank 490,6,P,OHSU_HNSCC_derm002,22,0.501,0,DMSO,OHSU_HNSCC_derm002
33376,20004,Blank 490,6,A,OHSU_HNSCC_derm002,23,0.437,0.01371742;0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;Pazopanib;Hydrochloride,OHSU_HNSCC_derm002
33377,20004,Blank 490,6,B,OHSU_HNSCC_derm002,23,0.429,0.01371742;0.01371742;0.01371742;0.01371742,Lapatinib;Ditosylate;Sorafenib;Tosylate,OHSU_HNSCC_derm002
33378,20004,Blank 490,6,C,OHSU_HNSCC_derm002,23,0.468,0.006227709190672154,BS-181-HCI x (4.54mM),OHSU_HNSCC_derm002
33379,20004,Blank 490,6,D,OHSU_HNSCC_derm002,23,0.421,0.01371742;0.01371742;0.01371742,Erlotinib;Hydrochloride;PI-103,OHSU_HNSCC_derm002
33380,20004,Blank 490,6,E,OHSU_HNSCC_derm002,23,0.448,0.013717421124828532,LY3039478 ,OHSU_HNSCC_derm002
33381,20004,Blank 490,6,F,OHSU_HNSCC_derm002,23,0.451,0.01371742;0.01371742,Gefitinib;IMR 1,OHSU_HNSCC_derm002
33382,20004,Blank 490,6,G,OHSU_HNSCC_derm002,23,0.376,0.01371742;0.01371742,Gefitinib;LY3039478,OHSU_HNSCC_derm002
33383,20004,Blank 490,6,H,OHSU_HNSCC_derm002,23,0.43,0.013717421124828532,Trametinib,OHSU_HNSCC_derm002
33384,20004,Blank 490,6,I,OHSU_HNSCC_derm002,23,0.411,0.013717421124828532,BEZ235,OHSU_HNSCC_derm002
33385,20004,Blank 490,6,J,OHSU_HNSCC_derm002,23,0.484,0,DMSO,OHSU_HNSCC_derm002
33386,20004,Blank 490,6,K,OHSU_HNSCC_derm002,23,0.435,0,DMSO ,OHSU_HNSCC_derm002
33387,20004,Blank 490,6,L,OHSU_HNSCC_derm002,23,0.445,0,DMSO,OHSU_HNSCC_derm002
33388,20004,Blank 490,6,M,OHSU_HNSCC_derm002,23,0.498,0,DMSO ,OHSU_HNSCC_derm002
33389,20004,Blank 490,6,N,OHSU_HNSCC_derm002,23,0.457,0,DMSO,OHSU_HNSCC_derm002
33390,20004,Blank 490,6,O,OHSU_HNSCC_derm002,23,0.482,0,DMSO ,OHSU_HNSCC_derm002
33391,20004,Blank 490,6,P,OHSU_HNSCC_derm002,23,0.449,0,DMSO,OHSU_HNSCC_derm002
33392,20004,Blank 490,6,A,OHSU_HNSCC_derm002,24,0.474,0,NONE,OHSU_HNSCC_derm002
33393,20004,Blank 490,6,B,OHSU_HNSCC_derm002,24,0.43,0,NONE,OHSU_HNSCC_derm002
33394,20004,Blank 490,6,C,OHSU_HNSCC_derm002,24,0.496,0,NONE,OHSU_HNSCC_derm002
33395,20004,Blank 490,6,D,OHSU_HNSCC_derm002,24,0.461,0,NONE,OHSU_HNSCC_derm002
33396,20004,Blank 490,6,E,OHSU_HNSCC_derm002,24,0.512,0,NONE,OHSU_HNSCC_derm002
33397,20004,Blank 490,6,F,OHSU_HNSCC_derm002,24,0.478,0,NONE,OHSU_HNSCC_derm002
33398,20004,Blank 490,6,G,OHSU_HNSCC_derm002,24,0.501,0,NONE,OHSU_HNSCC_derm002
33399,20004,Blank 490,6,H,OHSU_HNSCC_derm002,24,0.494,0,NONE,OHSU_HNSCC_derm002
33400,20004,Blank 490,6,I,OHSU_HNSCC_derm002,24,0.493,0,NONE,OHSU_HNSCC_derm002
33401,20004,Blank 490,6,J,OHSU_HNSCC_derm002,24,0.437,0,NONE,OHSU_HNSCC_derm002
33402,20004,Blank 490,6,K,OHSU_HNSCC_derm002,24,0.42,0,NONE,OHSU_HNSCC_derm002
33403,20004,Blank 490,6,L,OHSU_HNSCC_derm002,24,0.503,0,NONE,OHSU_HNSCC_derm002
33404,20004,Blank 490,6,M,OHSU_HNSCC_derm002,24,0.443,0,NONE,OHSU_HNSCC_derm002
33405,20004,Blank 490,6,N,OHSU_HNSCC_derm002,24,0.452,0,NONE,OHSU_HNSCC_derm002
33406,20004,Blank 490,6,O,OHSU_HNSCC_derm002,24,0.521,0,NONE,OHSU_HNSCC_derm002
33407,20004,Blank 490,6,P,OHSU_HNSCC_derm002,24,0.324,0,NONE,OHSU_HNSCC_derm002
